Psyllid ID: psy16843
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 810 | 2.2.26 [Sep-21-2011] | |||||||
| Q6P0Q8 | 1798 | Microtubule-associated se | yes | N/A | 0.911 | 0.410 | 0.564 | 0.0 | |
| O15021 | 2626 | Microtubule-associated se | no | N/A | 0.866 | 0.267 | 0.576 | 0.0 | |
| Q811L6 | 2618 | Microtubule-associated se | no | N/A | 0.862 | 0.266 | 0.569 | 0.0 | |
| Q9Y2H9 | 1570 | Microtubule-associated se | no | N/A | 0.858 | 0.442 | 0.589 | 0.0 | |
| Q60592 | 1734 | Microtubule-associated se | yes | N/A | 0.912 | 0.426 | 0.556 | 0.0 | |
| Q810W7 | 1570 | Microtubule-associated se | no | N/A | 0.864 | 0.445 | 0.583 | 0.0 | |
| Q9R1L5 | 1570 | Microtubule-associated se | no | N/A | 0.864 | 0.445 | 0.583 | 0.0 | |
| O60307 | 1309 | Microtubule-associated se | no | N/A | 0.833 | 0.515 | 0.588 | 0.0 | |
| Q3U214 | 1321 | Microtubule-associated se | no | N/A | 0.834 | 0.511 | 0.591 | 0.0 | |
| Q6AX33 | 1482 | Microtubule-associated se | N/A | N/A | 0.849 | 0.464 | 0.569 | 0.0 |
| >sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 843 bits (2177), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/802 (56%), Positives = 565/802 (70%), Gaps = 64/802 (7%)
Query: 1 MKDLTVPS-GCLRKTSRIHAHRKSFI--ANTSPTLPRCYSPM----PSSPLESPRVASNQ 53
+K+L++P G +TS +RKS I ++TSPTLPR +SP+ +SPL+SPR S
Sbjct: 156 LKELSLPRRGSFCRTS----NRKSLIVTSSTSPTLPRPHSPLHGHTGNSPLDSPRNFSPN 211
Query: 54 ---HFPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQ 110
HF F+P +R +DG RRWS+ASLPSSGYGT SS VSS CSSQEKLHQ
Sbjct: 212 APAHFSFVPARR----------TDG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQEKLHQ 260
Query: 111 LPNIPTSDELHELTKHFSSNDT-DEEIRRS-FMRPRSKSLSSPSRSPI-LDNDIIAMNML 167
LP PT+DELH LTKHFS+ DEE R+S MRPRS+SLS P RSP+ D++II MN +
Sbjct: 261 LPFQPTADELHFLTKHFSTESVPDEEGRQSPAMRPRSRSLS-PGRSPVSFDSEIIMMNHV 319
Query: 168 YKERFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKS 227
YKERFPKA QME RL+ FI+ N+ ++ P A + F+HHQ++E+ARDCL KS
Sbjct: 320 YKERFPKATAQMEERLAEFISSNTP------DSVLPLADGALSFIHHQVIEMARDCLDKS 373
Query: 228 KEKLISSRYFYEMSEKLERLLTETKEKSLEAATVLTFTL-KKLLLIISRPARLLECLEFD 286
+ LI+S+YFYE+ + LE+LL + E+S + L KKL++II+RPARLLECLEFD
Sbjct: 374 RSGLITSQYFYELQDNLEKLLQDAHERSESSEVAFVMQLVKKLMIIIARPARLLECLEFD 433
Query: 287 PEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDN----DIQNISLTDTS 342
PEEFYH LE AEG AK QGIK DIP+YI+ +LG+ + ++ D + TD S
Sbjct: 434 PEEFYHLLEAAEGHAKEGQGIKCDIPRYIVSQLGLTRDPLEEMAQLSSCDSPDTPETDDS 493
Query: 343 IESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL 402
IE + S SKK TP+E DF IKLISNGAYG+V+LVRHK TRQRFAMKKI K +L
Sbjct: 494 IEGHGASLPSKK-----TPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQNL 548
Query: 403 MLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLP 462
+LRNQ++Q F ERDI++F +NPFVV+M+CSF+TK+HLC+VMEYVEGGDCA+LLKN G LP
Sbjct: 549 ILRNQIQQAFVERDILTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCATLLKNIGALP 608
Query: 463 ADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522
DM R YFAETVLA+EYLH+YGIVHRDLKPDNLLIT++GHIKLTDFGLSK+GLMSL TNL
Sbjct: 609 VDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 668
Query: 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE 582
YE ++E+DA++F DKQV GTPEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+
Sbjct: 669 YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 728
Query: 583 TPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
TPEELF ++D+I WP E D + +A+ + + LL QNP +RLGTG +EVK+HP+F+
Sbjct: 729 TPEELFGQVISDEIVWP-EGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEVKQHPFFTG 787
Query: 643 LDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNH--DIGEDTDETEDSFSLGTFSSCTH 700
LDW LLR KAEFIPQL+ E+DTSYFD+R ERY+H E+ + + FSSC+
Sbjct: 788 LDWTGLLRQKAEFIPQLESEDDTSYFDTRSERYHHMDSEDEEEVSEDGCLEIRQFSSCSP 847
Query: 701 QYKKVQSQLSSQSSLE---VTPPRKSSEKDETSSTSD-------------VSSSPVAHVV 744
++ KV S + S LE PP K S +E SD + S +
Sbjct: 848 RFNKVYSSMERLSLLEERRTPPPTKRSLSEEKEDHSDGLAGLKGRDRSWVIGSPEILRKR 907
Query: 745 TSTPESSQTESDDISPQVQRKR 766
S ESS TESD P R+R
Sbjct: 908 LSVSESSHTESDSSPPMTVRRR 929
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O15021|MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 821 bits (2120), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/758 (57%), Positives = 554/758 (73%), Gaps = 56/758 (7%)
Query: 1 MKDLTVPS-GCLRKTSRIHAHRKSFIANT-SPTLPRCYSPMPS----SPLESPR---VAS 51
+K+L++P G L +TS +RKS I N SP LPR +SP+ + SP +SPR ++
Sbjct: 214 LKELSLPRRGSLCRTS----NRKSLIGNGQSPALPRPHSPLSAHAGNSPQDSPRNFSPSA 269
Query: 52 NQHFPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQL 111
+ HF F R N R+DG RRWS+ASLPSSGYGT SS VSS CSSQEKLHQL
Sbjct: 270 SAHFSFA---RSLN------RTDG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQEKLHQL 319
Query: 112 PNIPTSDELHELTKHFSSND---TDEEIRRSFMRPRSKSLSSPSRSPIL-DNDIIAMNML 167
P PT DELH L+KHF + + T+ R + MRPRS+SLS P RSP D++II MN +
Sbjct: 320 PYQPTPDELHFLSKHFCTTESIATENRCRNTPMRPRSRSLS-PGRSPACCDHEIIMMNHV 378
Query: 168 YKERFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKS 227
YKERFPKA QME RL I +S + +N+ P A ++ F HHQI+E+ARDCL KS
Sbjct: 379 YKERFPKATAQMEERLKEII---TSYSPDNV---LPLADGVLSFTHHQIIELARDCLDKS 432
Query: 228 KEKLISSRYFYEMSEKLERLLTETKEKSLEAATVLTFTL-KKLLLIISRPARLLECLEFD 286
+ LI+SRYF E+ KL++LL E ++S L +K+L++I+RPARLLECLEFD
Sbjct: 433 HQGLITSRYFLELQHKLDKLLQEAHDRSESGELAFIKQLVRKILIVIARPARLLECLEFD 492
Query: 287 PEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDL------DNDIQNISLTD 340
PEEFY+ LE AEG AK QGIK DIP+YII +LG+NK ++ D+ TD
Sbjct: 493 PEEFYYLLEAAEGHAKEGQGIKTDIPRYIISQLGLNKDPLEEMAHLGNYDSGTAETPETD 552
Query: 341 TSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKN 400
S+ S++ S K + P E+DF IKLISNGAYG+VY VRHKE+RQRFAMKKI K
Sbjct: 553 ESVSSSNASL-----KLRRKPRESDFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQ 607
Query: 401 SLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP 460
+L+LRNQ++Q F ERDI++F +NPFVV+MYCSFET++HLC+VMEYVEGGDCA+L+KN GP
Sbjct: 608 NLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGP 667
Query: 461 LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520
LP DMAR YFAETVLA+EYLH+YGIVHRDLKPDNLL+T++GHIKLTDFGLSK+GLMS+ T
Sbjct: 668 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTT 727
Query: 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF 580
NLYE ++E+DA++F DKQV GTPEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFF
Sbjct: 728 NLYEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 787
Query: 581 GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
G+TPEELF ++D+I WP +D+ P +A+ +IT LL+QNP +RLGTGG +EVK+H +F
Sbjct: 788 GDTPEELFGQVISDEINWPEKDEAP-PPDAQDLITLLLRQNPLERLGTGGAYEVKQHRFF 846
Query: 641 SNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETED---SFSLGTFSS 697
+LDWNSLLR KAEFIPQL+ E+DTSYFD+R E+Y+H E+ D+T D + + FSS
Sbjct: 847 RSLDWNSLLRQKAEFIPQLESEDDTSYFDTRSEKYHHMETEEEDDTNDEDFNVEIRQFSS 906
Query: 698 CTHQYKKVQSQLS--SQSSLEVTPPRKSSEKDETSSTS 733
C+H++ KV S + +Q+S E K D+T ST+
Sbjct: 907 CSHRFSKVFSSIDRITQNSAE----EKEDSVDKTKSTT 940
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q811L6|MAST4_MOUSE Microtubule-associated serine/threonine-protein kinase 4 OS=Mus musculus GN=Mast4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 815 bits (2106), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/758 (56%), Positives = 549/758 (72%), Gaps = 59/758 (7%)
Query: 1 MKDLTVPS-GCLRKTSRIHAHRKSFIANT-SPTLPRCYSPMPS----SPLESPR---VAS 51
+K+L++P G L +TS +RKS I N SP LPR +SP+ + SP +SPR ++
Sbjct: 212 LKELSLPRRGSLCRTS----NRKSLIGNGQSPALPRPHSPLSAHAGNSPQDSPRNFSPSA 267
Query: 52 NQHFPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQL 111
+ HF F R+DG RRWS+ASLPSSGYGT SS VSS CSSQEKLHQL
Sbjct: 268 SAHFSFA------------RRTDG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQEKLHQL 314
Query: 112 PNIPTSDELHELTKHFSSND---TDEEIRRSFMRPRSKSLSSPSRSPIL-DNDIIAMNML 167
P PT DELH L+KHF + + T+ R + MRPRS+SLS P RSP D++II MN +
Sbjct: 315 PYQPTPDELHFLSKHFCTTESIATENRCRNTPMRPRSRSLS-PGRSPACCDHEIIMMNHV 373
Query: 168 YKERFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKS 227
YKERFPKA QME RL I S + P A ++ F HHQI+E+ARDCL KS
Sbjct: 374 YKERFPKATAQMEERLKEIITSYSP------DHVLPLADGVLSFTHHQIIELARDCLDKS 427
Query: 228 KEKLISSRYFYEMSEKLERLLTETKEKSLEAATVLTFTL-KKLLLIISRPARLLECLEFD 286
+ LI+SRYF+E+ KL++LL E ++S L +K+L++I+RPARLLECLEFD
Sbjct: 428 HQGLITSRYFFELQHKLDKLLQEAHDRSESGELAFIKQLVRKILIVIARPARLLECLEFD 487
Query: 287 PEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDL------DNDIQNISLTD 340
PEEFY+ LE AEG AK QGIK DIP+YII +LG+NK ++ D+ D
Sbjct: 488 PEEFYYLLEAAEGHAKEGQGIKTDIPRYIISQLGLNKDPLEEMAQLGNYDSRTAETPEMD 547
Query: 341 TSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKN 400
S+ S++ S + + P E+DF IKLISNGAYG+VY VRHKE+RQRFAMKKI K
Sbjct: 548 ESVSSSNTSL-----RLRRKPRESDFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQ 602
Query: 401 SLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP 460
+L+LRNQ++Q F ERDI++F +NPFVV+MYCSFET++HLC+VMEYVEGGDCA+L+KN GP
Sbjct: 603 NLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGP 662
Query: 461 LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520
LP DMAR YFAETVLA+EYLH+YGIVHRDLKPDNLL+T++GHIKLTDFGLSK+GLMS+ T
Sbjct: 663 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTT 722
Query: 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF 580
NLYE ++E+DA++F DKQV GTPEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFF
Sbjct: 723 NLYEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 782
Query: 581 GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
G+TPEELF ++D+I WP +D+ P +A+ +IT LL+QNP +RLGTGG +EVK+H +F
Sbjct: 783 GDTPEELFGQVISDEINWPEKDEAP-PPDAQELITLLLRQNPLERLGTGGAYEVKQHRFF 841
Query: 641 SNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETED---SFSLGTFSS 697
+LDWNSLLR KAEFIPQL+ E+DTSYFD+R E+Y+H E+ D+T D + + FSS
Sbjct: 842 RSLDWNSLLRQKAEFIPQLESEDDTSYFDTRSEKYHHMETEEEDDTNDEDFTVEIRQFSS 901
Query: 698 CTHQYKKVQSQLS--SQSSLEVTPPRKSSEKDETSSTS 733
C+H++ KV S + +Q+S E K +D+T ST+
Sbjct: 902 CSHRFSKVFSSIDRITQNSGE----DKDDSEDKTKSTT 935
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H9|MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 813 bits (2099), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/735 (58%), Positives = 533/735 (72%), Gaps = 40/735 (5%)
Query: 5 TVPSGCL--RKTSRIHAHRKSFI-ANTSPTLPRCYSPMP----SSPLESPRVASNQ---H 54
+ P G + R S ++RKS I +TSPTLPR +SP+P SSPL+SPR S H
Sbjct: 16 SFPGGSMFRRTKSCRTSNRKSLILTSTSPTLPRPHSPLPGHLGSSPLDSPRNFSPNTPAH 75
Query: 55 FPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNI 114
F F + R+DG RRWS+ASLPSSGYGT SS VSS CSSQE+LHQLP
Sbjct: 76 FSFA----------SSRRADG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQERLHQLPYQ 124
Query: 115 PTSDELHELTKHFSSND--TDEEI-RRS-FMRPRSKSLSSPSRSPI-LDNDIIAMNMLYK 169
PT DELH L+KHF S + TDE+ RRS +RPRS+SLS P RSP DN+I+ MN +YK
Sbjct: 125 PTVDELHFLSKHFGSTESITDEDGGRRSPAVRPRSRSLS-PGRSPSSYDNEIVMMNHVYK 183
Query: 170 ERFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSKE 229
ERFPKA QME +L +F ++ P A ++ F+HHQI+E+ARDCL KS++
Sbjct: 184 ERFPKATAQMEEKLRDFTR------AYEPDSVLPLADGVLSFIHHQIIELARDCLTKSRD 237
Query: 230 KLISSRYFYEMSEKLERLLTETKEKS--LEAATVLTFTLKKLLLIISRPARLLECLEFDP 287
LI++ YFYE+ E LE+LL + E+S LE A V T +KKLL+IISRPARLLECLEF+P
Sbjct: 238 GLITTVYFYELQENLEKLLQDAYERSESLEVAFV-TQLVKKLLIIISRPARLLECLEFNP 296
Query: 288 EEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDNDIQNISLTDTSIESNS 347
EEFYH LE AEG AK +K DIP+YII +LG+ + F D+ + + S + E +
Sbjct: 297 EEFYHLLEAAEGHAKEGHLVKTDIPRYIIRQLGLTRDPFPDVVHLEEQDSGGSNTPEQD- 355
Query: 348 DSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQ 407
D + K K P ENDF IKLISNGAYG+VYLVRH++TRQRFAMKKI K +L+LRNQ
Sbjct: 356 DLSEGRSSKAKKPPGENDFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQ 415
Query: 408 MEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMAR 467
++Q F ERDI++F +NPFVV M+CSFET++HLC+VMEYVEGGDCA+LLKN G LP +MAR
Sbjct: 416 IQQAFVERDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMAR 475
Query: 468 FYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYV 527
YFAETVLA+EYLH+YGIVHRDLKPDNLLIT++GHIKLTDFGLSKMGLMSL TNLYE ++
Sbjct: 476 MYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNLYEGHI 535
Query: 528 ERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL 587
E+DA++F DKQV GTPEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+TPEEL
Sbjct: 536 EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 595
Query: 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647
F ++DDI WP E D + EA+ +I+ LLQ NP RLG GG EVK+H +F +LDW
Sbjct: 596 FGQVISDDILWP-EGDEALPTEAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFRDLDWTG 654
Query: 648 LLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDET--EDSFSLGTFSSCTHQYKKV 705
LLR KAEFIP L+ E+DTSYFD+R +RY+H D D+T E+ + FSSC+ ++ KV
Sbjct: 655 LLRQKAEFIPHLESEDDTSYFDTRSDRYHHVNSYDEDDTTEEEPVEIRQFSSCSPRFSKV 714
Query: 706 QSQLSSQSSLEVTPP 720
S + S E P
Sbjct: 715 YSSMEQLSQHEPKTP 729
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q60592|MAST2_MOUSE Microtubule-associated serine/threonine-protein kinase 2 OS=Mus musculus GN=Mast2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 812 bits (2098), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/802 (55%), Positives = 551/802 (68%), Gaps = 63/802 (7%)
Query: 1 MKDLTVPS-GCLRKTSRIHAHRKSFI--ANTSPTLPRCYSPM----PSSPLESPRVASNQ 53
+K+L++P G +TS +RKS I ++TSPTLPR +SP+ +SPL+SPR S
Sbjct: 96 LKELSLPRRGSFCRTS----NRKSLIVTSSTSPTLPRPHSPLHGHTGNSPLDSPRNFSPN 151
Query: 54 ---HFPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQ 110
HF F+P +R +DG RRWS+ASLPSSGYGT SS VSS CSSQEKLHQ
Sbjct: 152 APAHFSFVPARR----------TDG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQEKLHQ 200
Query: 111 LPNIPTSDELHELTKHFSS-NDTDEEIRRSFMRPRSKSLSSPSRSPI-LDNDIIAMNMLY 168
LP PT+DELH LTKHFS+ N DEE RRS SP RSP+ D++II MN +Y
Sbjct: 201 LPFQPTADELHFLTKHFSTENVPDEEGRRSPRMRPRSRSLSPGRSPVSFDSEIIMMNHVY 260
Query: 169 KERFPKAIQQMETRLS-NFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKS 227
KERFPKA QME R S FI+ N+ ++ P A + F+HHQ++E+ARDCL KS
Sbjct: 261 KERFPKATAQMEERPSLTFISSNTP------DSVLPLADGALSFIHHQVIEMARDCLDKS 314
Query: 228 KEKLISSRYFYEMSEKLERLLTETKEKSLEAATVLTFTL-KKLLLIISRPARLLECLEFD 286
+ LI+S YFYE+ E LE+LL + E+S + L KKL++II+RPARLLECLEFD
Sbjct: 315 RSGLITSHYFYELQENLEKLLQDAHERSESSDVAFVIQLVKKLMIIIARPARLLECLEFD 374
Query: 287 PEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDN----DIQNISLTDTS 342
PEEFYH LE AEG AK GIK DIP+YI+ +LG+ + ++ D + TD S
Sbjct: 375 PEEFYHLLEAAEGHAKEGHGIKCDIPRYIVSQLGLTRDPLEEMAQLSSYDSPDTPETDDS 434
Query: 343 IESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL 402
+E S S+K TP+E DF IKLISNGAYG+V+LVRHK TRQRFAMKKI K +L
Sbjct: 435 VEGRGVSQPSQK-----TPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQNL 489
Query: 403 MLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLP 462
+LRNQ++Q F ERDI++F +NPFVV+M+CSFETK+HLC+VMEYVEGGDCA+LLKN G LP
Sbjct: 490 ILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALP 549
Query: 463 ADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522
DM R YFAETVLA+EYLH+YGIVHRDLKPDNLLIT++GHIKLTDFGLSK+GLMSL TNL
Sbjct: 550 VDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 609
Query: 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE 582
YE ++E+DA++F DKQV GTPEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+
Sbjct: 610 YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 669
Query: 583 TPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
TPEELF ++D+I WP DD + +A+ + + LL QNP +RLGT +EVK+HP+F
Sbjct: 670 TPEELFGQVISDEIVWPEGDDA-LPPDAQDLTSKLLHQNPLERLGTSSAYEVKQHPFFMG 728
Query: 643 LDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNH--DIGEDTDETEDSFSLGTFSSCTH 700
LDW LLR KAEFIPQL+ E+DTSYFD+R ERY+H E+ + + FSSC+
Sbjct: 729 LDWTGLLRQKAEFIPQLESEDDTSYFDTRSERYHHVDSEDEEEVSEDGCLEIRQFSSCSP 788
Query: 701 QYKKVQSQLSSQSSLE---VTPPRKSSEKDETSSTSD-------------VSSSPVAHVV 744
++ KV S + S LE PP K S +E SD + S +
Sbjct: 789 RFSKVYSSMERLSLLEERRTPPPTKRSLSEEKEDHSDGLAGLKGRDRSWVIGSPEILRKR 848
Query: 745 TSTPESSQTESDDISPQVQRKR 766
S ESS TESD P R R
Sbjct: 849 LSVSESSHTESDSSPPMTVRHR 870
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q810W7|MAST1_RAT Microtubule-associated serine/threonine-protein kinase 1 OS=Rattus norvegicus GN=Mast1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 811 bits (2095), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/740 (58%), Positives = 537/740 (72%), Gaps = 40/740 (5%)
Query: 5 TVPSGCL--RKTSRIHAHRKSFI-ANTSPTLPRCYSPMP----SSPLESPRVASNQ---H 54
+ P G + R S ++RKS I +TSPTLPR +SP+P SSPL+SPR S H
Sbjct: 16 SFPGGSMFRRTKSCRTSNRKSLILTSTSPTLPRPHSPLPGHLGSSPLDSPRNFSPNTPAH 75
Query: 55 FPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNI 114
F F + R+DG RRWS+ASLPSSGYGT SS VSS CSSQE+LHQLP
Sbjct: 76 FSFA----------SSRRADG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQERLHQLPYQ 124
Query: 115 PTSDELHELTKHFSSND--TDEEI-RRS-FMRPRSKSLSSPSRSPI-LDNDIIAMNMLYK 169
PT DELH L+KHF S + TDE+ RRS +RPRS+SLS P RSP DN+I+ MN +YK
Sbjct: 125 PTVDELHFLSKHFGSTESITDEDGGRRSPAVRPRSRSLS-PGRSPSSYDNEIVMMNHVYK 183
Query: 170 ERFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSKE 229
ERFPKA QME +L +F ++ P A ++ F+HHQI+E+ARDCL KS++
Sbjct: 184 ERFPKATAQMEEKLRDFAR------AYEPDSVLPLADGVLSFIHHQIIELARDCLTKSRD 237
Query: 230 KLISSRYFYEMSEKLERLLTETKEKS--LEAATVLTFTLKKLLLIISRPARLLECLEFDP 287
LI++ YFYE+ E LE+LL + E+S LE A V T +KKLL+IISRPARLLECLEF+P
Sbjct: 238 GLITTVYFYELQENLEKLLQDAYERSESLEVAFV-TQLVKKLLIIISRPARLLECLEFNP 296
Query: 288 EEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDN-DIQNISLTDTSIESN 346
EEFYH LE AEG AK +K DIP+YII +LG+ + F D+ + Q+ ++T + +
Sbjct: 297 EEFYHLLEAAEGHAKEGHLVKTDIPRYIIRQLGLTRDPFPDVVRLEEQDSGGSNTPEQDD 356
Query: 347 SDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRN 406
+ S K K P E+DF IKLISNGAYG+VYLVRH++TRQRFAMKKI K +L+LRN
Sbjct: 357 TSEGRSSTSKAKKPPGESDFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRN 416
Query: 407 QMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMA 466
Q++Q F ERDI++F +NPFVV M+CSFET++HLC+VMEYVEGGDCA+LLKN G LP +MA
Sbjct: 417 QIQQAFVERDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMA 476
Query: 467 RFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECY 526
R YFAETVLA+EYLH+YGIVHRDLKPDNLLIT++GHIKLTDFGLSKMGLMSL TNLYE +
Sbjct: 477 RMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNLYEGH 536
Query: 527 VERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE 586
+E+DA++F DKQV GTPEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+TPEE
Sbjct: 537 IEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 596
Query: 587 LFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646
LF ++DDI WP E D + +A+ +I+ LLQ NP RLG GG EVK+H +F +LDW
Sbjct: 597 LFGQVISDDILWP-EGDEALPTDAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFRDLDWT 655
Query: 647 SLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDET--EDSFSLGTFSSCTHQYKK 704
LLR KAEFIP L+ E+DTSYFD+R +RY+H D D+T E+ + FSSC+ ++ K
Sbjct: 656 GLLRQKAEFIPHLESEDDTSYFDTRSDRYHHVNSYDEDDTTEEEPVEIRQFSSCSPRFSK 715
Query: 705 VQSQLSSQSSLEVTPPRKSS 724
V S + S E P +S
Sbjct: 716 VYSSMEQLSQHEPKTPVSAS 735
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Isoform 2 may play a role in neuronal transcriptional regulation. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9R1L5|MAST1_MOUSE Microtubule-associated serine/threonine-protein kinase 1 OS=Mus musculus GN=Mast1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 811 bits (2095), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/740 (58%), Positives = 537/740 (72%), Gaps = 40/740 (5%)
Query: 5 TVPSGCL--RKTSRIHAHRKSFI-ANTSPTLPRCYSPMP----SSPLESPRVASNQ---H 54
+ P G + R S ++RKS I +TSPTLPR +SP+P SSPL+SPR S H
Sbjct: 16 SFPGGSMFRRTKSCRTSNRKSLILTSTSPTLPRPHSPLPGHLGSSPLDSPRNFSPNTPAH 75
Query: 55 FPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNI 114
F F + R+DG RRWS+ASLPSSGYGT SS VSS CSSQE+LHQLP
Sbjct: 76 FSFA----------SSRRADG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQERLHQLPYQ 124
Query: 115 PTSDELHELTKHFSSND--TDEEI-RRS-FMRPRSKSLSSPSRSPI-LDNDIIAMNMLYK 169
PT DELH L+KHF S + TDE+ RRS +RPRS+SLS P RSP DN+I+ MN +YK
Sbjct: 125 PTVDELHFLSKHFGSTESITDEDGGRRSPAVRPRSRSLS-PGRSPSSYDNEIVMMNHVYK 183
Query: 170 ERFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSKE 229
ERFPKA QME +L +F ++ P A ++ F+HHQI+E+ARDCL KS++
Sbjct: 184 ERFPKATAQMEEKLRDFAR------AYEPDSVLPLADGVLSFIHHQIIELARDCLTKSRD 237
Query: 230 KLISSRYFYEMSEKLERLLTETKEKS--LEAATVLTFTLKKLLLIISRPARLLECLEFDP 287
LI++ YFYE+ E LE+LL + E+S LE A V T +KKLL+IISRPARLLECLEF+P
Sbjct: 238 GLITTVYFYELQENLEKLLQDAYERSESLEVAFV-TQLVKKLLIIISRPARLLECLEFNP 296
Query: 288 EEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDN-DIQNISLTDTSIESN 346
EEFYH LE AEG AK +K DIP+YII +LG+ + F D+ + Q+ ++T + +
Sbjct: 297 EEFYHLLEAAEGHAKEGHLVKTDIPRYIIRQLGLTRDPFPDVVRLEEQDSGGSNTPEQDD 356
Query: 347 SDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRN 406
+ S K K P E+DF IKLISNGAYG+VYLVRH++TRQRFAMKKI K +L+LRN
Sbjct: 357 TSEGRSSTSKAKKPPGESDFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRN 416
Query: 407 QMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMA 466
Q++Q F ERDI++F +NPFVV M+CSFET++HLC+VMEYVEGGDCA+LLKN G LP +MA
Sbjct: 417 QIQQAFVERDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMA 476
Query: 467 RFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECY 526
R YFAETVLA+EYLH+YGIVHRDLKPDNLLIT++GHIKLTDFGLSKMGLMSL TNLYE +
Sbjct: 477 RMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNLYEGH 536
Query: 527 VERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE 586
+E+DA++F DKQV GTPEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+TPEE
Sbjct: 537 IEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 596
Query: 587 LFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646
LF ++DDI WP E D + +A+ +I+ LLQ NP RLG GG EVK+H +F +LDW
Sbjct: 597 LFGQVISDDILWP-EGDEALPTDAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFRDLDWT 655
Query: 647 SLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDET--EDSFSLGTFSSCTHQYKK 704
LLR KAEFIP L+ E+DTSYFD+R +RY+H D D+T E+ + FSSC+ ++ K
Sbjct: 656 GLLRQKAEFIPHLESEDDTSYFDTRSDRYHHVNSYDEDDTTEEEPVEIRQFSSCSPRFSK 715
Query: 705 VQSQLSSQSSLEVTPPRKSS 724
V S + S E P +S
Sbjct: 716 VYSSMEQLSQHEPKTPVSAS 735
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O60307|MAST3_HUMAN Microtubule-associated serine/threonine-protein kinase 3 OS=Homo sapiens GN=MAST3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 807 bits (2085), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/727 (58%), Positives = 526/727 (72%), Gaps = 52/727 (7%)
Query: 2 KDLTVPS---GCLRKTSRIHAHRKSFIANT-SPTLPRCYSPMP-----SSPLESPR---V 49
K+L++P GC +RKS + T SPTL R SP+ SSPL+SPR
Sbjct: 14 KELSLPRRGRGCR------SGNRKSLVVGTPSPTLSRPLSPLSVPTAGSSPLDSPRNFSA 67
Query: 50 ASNQHFPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLH 109
AS +FPF R+DG RRWS+ASLPSSGYGT SS +SS SS+E+LH
Sbjct: 68 ASALNFPFA------------RRADG-RRWSLASLPSSGYGTNTPSSTLSSSSSSRERLH 114
Query: 110 QLPNIPTSDELHELTKHF--SSNDTDEEIRRSFMRPRSKSLSSPSRS-PILDNDIIAMNM 166
QLP PT DELH L+KHF S N DEE RS SP R+ DN+I+ MN
Sbjct: 115 QLPFQPTPDELHFLSKHFRSSENVLDEEGGRSPRLRPRSRSLSPGRATGTFDNEIVMMNH 174
Query: 167 LYKERFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFK 226
+Y+ERFPKA QME RL F+ + A L A ++ F+HHQI+E+ARDCL K
Sbjct: 175 VYRERFPKATAQMEGRLQEFLTAYAPGARLAL------ADGVLGFIHHQIVELARDCLAK 228
Query: 227 SKEKLISSRYFYEMSEKLERLLTETKEKS-LEAATVLTFTLKKLLLIISRPARLLECLEF 285
S E L++SRYF EM EKLERLL + E+S E + + ++KLL+IISRPARLLECLEF
Sbjct: 229 SGENLVTSRYFLEMQEKLERLLQDAHERSDSEEVSFIVQLVRKLLIIISRPARLLECLEF 288
Query: 286 DPEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDNDIQNISLTDTSIES 345
DPEEFYH LE AEG A+ QGIK D+PQYIIG+LG+ K D ++ +S +
Sbjct: 289 DPEEFYHLLEAAEGHAREGQGIKTDLPQYIIGQLGLAK----DPLEEMVPLSHLEEEQPP 344
Query: 346 NSDSYCSKK--DKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM 403
+S S+ + + P E+DF IKLISNGAYG+VYLVRH++TRQRFA+KKI K +L+
Sbjct: 345 APESPESRALVGQSRRKPCESDFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLI 404
Query: 404 LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPA 463
LRNQ++QVF ERDI++F +NPFVV+M+CSFET++HLC+VMEYVEGGDCA+LLKN GPLP
Sbjct: 405 LRNQIQQVFVERDILTFAENPFVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPV 464
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523
DMAR YFAETVLA+EYLH+YGIVHRDLKPDNLLIT+LGHIKLTDFGLSK+GLMS+ATNLY
Sbjct: 465 DMARLYFAETVLALEYLHNYGIVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLY 524
Query: 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET 583
E ++E+DA++F DKQV GTPEYIAPEVI RQGYGKPVDWW+MGV+LYEFLVGCVPFFG+T
Sbjct: 525 EGHIEKDAREFIDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFFGDT 584
Query: 584 PEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643
PEELF V+D+I WP E D + +A+ +IT LL+Q+P DRLGTGG HEVK+HP+F L
Sbjct: 585 PEELFGQVVSDEIMWP-EGDEALPADAQDLITRLLRQSPLDRLGTGGTHEVKQHPFFLAL 643
Query: 644 DWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETED---SFSLGTFSSCTH 700
DW LLRHKAEF+PQL+ E+DTSYFD+R ERY H +G + DET D S + FSSC+H
Sbjct: 644 DWAGLLRHKAEFVPQLEAEDDTSYFDTRSERYRH-LGSEDDETNDEESSTEIPQFSSCSH 702
Query: 701 QYKKVQS 707
++ KV S
Sbjct: 703 RFSKVYS 709
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U214|MAST3_MOUSE Microtubule-associated serine/threonine-protein kinase 3 OS=Mus musculus GN=Mast3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 797 bits (2059), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/719 (59%), Positives = 524/719 (72%), Gaps = 43/719 (5%)
Query: 7 PSGCLRKTSRIHAHRKSFIANT-SPTLPRCYSPMP-----SSPLESPR---VASNQHFPF 57
PS L+ S +RKS + T SPTL R SP+ +SPL+SPR A+ FPF
Sbjct: 38 PSLGLQPWSCRSGNRKSLVVGTPSPTLSRPLSPLSVPTAGNSPLDSPRNFSAAAAISFPF 97
Query: 58 IPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNIPTS 117
R+DG RRWS+ASLPSSGYGT SS VSS SS+E+LHQLP PT+
Sbjct: 98 A------------RRADG-RRWSLASLPSSGYGTNTPSSTVSSSSSSRERLHQLPFQPTA 144
Query: 118 DELHELTKHFSSNDT--DEEIRRSFMRPRSKSLSSPSR-SPILDNDIIAMNMLYKERFPK 174
DEL L+KHF S+++ DE+ RS SP R S DN+I+ MN +Y+ERFPK
Sbjct: 145 DELRFLSKHFRSSESVVDEDGGRSPRLRPRSRSLSPGRTSGTFDNEIVMMNHVYRERFPK 204
Query: 175 AIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSKEKLISS 234
A QME RL +F+ ++ A + A D ++ F+HHQI+E+ARDCL KS E L++S
Sbjct: 205 ATAQMEGRLQDFL---AAFAPGD-RLALADG--VLGFIHHQIVELARDCLAKSGEALVTS 258
Query: 235 RYFYEMSEKLERLLTETKEKSLEAATVLTFTL-KKLLLIISRPARLLECLEFDPEEFYHF 293
RYF EM +KLERLL + E+S A L +KLL+IISRPARLLECLEFDPEEFYH
Sbjct: 259 RYFLEMQDKLERLLQDAHERSDSAEVGFIVQLVRKLLIIISRPARLLECLEFDPEEFYHL 318
Query: 294 LEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDNDIQNISLTDTSIESNSDSYCSK 353
LE AEG A+ QG+K D+P+YII +LG+ K D +IQ ++ D S S S+
Sbjct: 319 LEAAEGQAREDQGVKTDLPRYIIRQLGLAK----DPLEEIQPLNDLDESQPPAPGSPESR 374
Query: 354 K--DKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQV 411
+ P E+DF IKLISNGAYG+VYLVRH++TRQRFA+KKI K +L+LRNQ++QV
Sbjct: 375 GLGGPSRRKPCESDFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQV 434
Query: 412 FAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFA 471
F ERDI++F +NPFVV M+CSFET++HLC+VMEYVEGGDCA+LLKN GPLP DMAR YFA
Sbjct: 435 FVERDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFA 494
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531
ETVLA+EYLH+YGIVHRDLKPDNLLIT+LGHIKLTDFGLSK+GLMS+ATNLYE ++E+DA
Sbjct: 495 ETVLALEYLHNYGIVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLYEGHIEKDA 554
Query: 532 KQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591
++F DKQV GTPEYIAPEVI RQGYGKPVDWW+MGVILYEFLVGCVPFFG+TPEELF
Sbjct: 555 REFVDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVILYEFLVGCVPFFGDTPEELFGQV 614
Query: 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRH 651
V+D+I WP E D + ++A+ +IT LL+Q+P DRLGTGG HEVK+HP+F LDW LLRH
Sbjct: 615 VSDEIMWP-EGDEALPLDAQDLITRLLRQSPMDRLGTGGTHEVKQHPFFLALDWAGLLRH 673
Query: 652 KAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETED---SFSLGTFSSCTHQYKKVQS 707
KAEF+PQL+ E+DTSYFD+R ERY H +G + DET D S + FSSC+H++ KV S
Sbjct: 674 KAEFVPQLEAEDDTSYFDTRSERYRH-LGSEDDETNDEESSTEIPQFSSCSHRFSKVYS 731
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6AX33|MAST3_XENLA Microtubule-associated serine/threonine-protein kinase 3 OS=Xenopus laevis GN=mast3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 796 bits (2057), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/741 (56%), Positives = 539/741 (72%), Gaps = 53/741 (7%)
Query: 19 AHRKSFIANT-SPTLPRCYSPMP-----SSPLESPR---VASNQHFPFIPMKRPFNHLNT 69
++RKS + + SPTL R SP+ SSPL+SPR +++ +FPF +H
Sbjct: 50 SNRKSLVVGSPSPTLSRPLSPLSVPTAGSSPLDSPRNFSTSASVNFPFA-----RSHGPR 104
Query: 70 DCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNIPTSDELHELTKHFSS 129
R+DG RRWS+ASLPSSGYGT SS +SS SSQE+LHQLP PT+DELH L+KHF S
Sbjct: 105 ADRADG-RRWSLASLPSSGYGTNTPSSTLSSSSSSQERLHQLPFQPTADELHFLSKHFRS 163
Query: 130 ND--TDEEIRRS-FMRPRSKSLSSPSRSPILDNDIIAMNMLYKERFPKAIQQMETRLSNF 186
+ TD++ RRS MRPRS+SLS S DN+II MN +YKERFPKA QME RL +
Sbjct: 164 TESVTDDDGRRSPCMRPRSRSLSPGRASSNFDNEIIMMNHVYKERFPKATAQMEERLQDI 223
Query: 187 INENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSKEKLISSRYFYEMSEKLER 246
I T P A ++ F+HHQI+E+ARDCL KSK LI+SRYF E+ EKLE+
Sbjct: 224 ITHFCPSQT------LPLADGVLGFIHHQIIELARDCLDKSKGALITSRYFLELQEKLEK 277
Query: 247 LLTETKEKS-LEAATVLTFTLKKLLLIISRPARLLECLEFDPEEFYHFLEMAEGDAKSLQ 305
+L + +S E + +KLL++I+RP RLLECLEFDPE+FYH LE AEG AK Q
Sbjct: 278 MLQDAHNRSESEEVMFINHLARKLLMVIARPGRLLECLEFDPEQFYHLLEAAEGQAKVGQ 337
Query: 306 GIKADIPQYIIGKLGINKTVFSDLDNDIQNISL----TDTSIESNSDSYCSKKDKF---- 357
GIK DIP+YII +LG+ K ++ + L T++S++ + + Y D +
Sbjct: 338 GIKTDIPRYIISQLGLTKDPLEEI------VQLDHYDTESSLQLDQEDY---HDPYIPST 388
Query: 358 --SKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAER 415
K P E+DF IKLISNGAYG+VYLVRHKETRQRFAMKKI K +L+LRNQ+ QVF ER
Sbjct: 389 PSRKKPCESDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIHQVFVER 448
Query: 416 DIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL 475
DI++F +NPFVV+M+CSFET++HLC+VMEYVEGGDCA+LLKN GPLP DM+R YFAETVL
Sbjct: 449 DILTFAENPFVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMSRMYFAETVL 508
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
A+EYLH+YGIVHRDLKPDNLLIT+LGHIKLTDFGLSK+GLM++ TNLYE ++E+D ++F
Sbjct: 509 ALEYLHNYGIVHRDLKPDNLLITSLGHIKLTDFGLSKVGLMNMTTNLYEGHIEKDTREFL 568
Query: 536 DKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595
DKQV GTPEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+TPEELF ++DD
Sbjct: 569 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 628
Query: 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEF 655
I WP ++ + +++ +IT LL+QN +RLGTGG EVK+H +F +LDWN LLR KAEF
Sbjct: 629 IIWPGGEE-ALPADSQDLITRLLRQNSLERLGTGGAQEVKQHTFFLSLDWNGLLRQKAEF 687
Query: 656 IPQLDDEEDTSYFDSRMERYNH---DIGEDTDETEDSFSLGTFSSCTHQYKKVQS---QL 709
+PQL+ ++DTSYFD+R ERY+H + E+T++ E S + FSSC+H++ KV S L
Sbjct: 688 VPQLEADDDTSYFDTRSERYHHLASEEDEETNDDESSVEIRQFSSCSHRFSKVYSSSEHL 747
Query: 710 SSQSSLEVTPPRK--SSEKDE 728
++Q +L + + S EK+E
Sbjct: 748 ATQLNLSFSSTERSHSDEKEE 768
|
Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 810 | ||||||
| 328714787 | 1565 | PREDICTED: microtubule-associated serine | 0.935 | 0.484 | 0.68 | 0.0 | |
| 328791849 | 1762 | PREDICTED: microtubule-associated serine | 0.946 | 0.435 | 0.627 | 0.0 | |
| 380028504 | 1762 | PREDICTED: microtubule-associated serine | 0.946 | 0.435 | 0.626 | 0.0 | |
| 383865100 | 1763 | PREDICTED: microtubule-associated serine | 0.929 | 0.427 | 0.633 | 0.0 | |
| 242012635 | 1618 | Microtubule-associated serine/threonine- | 0.924 | 0.462 | 0.648 | 0.0 | |
| 307188180 | 1693 | Microtubule-associated serine/threonine- | 0.946 | 0.453 | 0.615 | 0.0 | |
| 189234010 | 1469 | PREDICTED: similar to MAST205 [Tribolium | 0.938 | 0.517 | 0.633 | 0.0 | |
| 350418976 | 1756 | PREDICTED: microtubule-associated serine | 0.958 | 0.441 | 0.617 | 0.0 | |
| 340708957 | 1756 | PREDICTED: microtubule-associated serine | 0.958 | 0.441 | 0.616 | 0.0 | |
| 350418979 | 1766 | PREDICTED: microtubule-associated serine | 0.946 | 0.434 | 0.622 | 0.0 |
| >gi|328714787|ref|XP_001951139.2| PREDICTED: microtubule-associated serine/threonine-protein kinase 1 [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 1060 bits (2740), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 544/800 (68%), Positives = 634/800 (79%), Gaps = 42/800 (5%)
Query: 1 MKDLTVPSGCLRKTSRIHAHRKSFIANTSPTLPRCYSPMPSSPLESPRVA-SNQHFPFIP 59
+++L V +G R++++ +HRKSFI+NTSPTLPRC+SPM SSPLESP+V S+ HFPF+
Sbjct: 44 LRELHV-AGSGRRSNKA-SHRKSFISNTSPTLPRCHSPMSSSPLESPKVVHSHPHFPFVS 101
Query: 60 MKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNIPTSDE 119
+KRP+N L TDCR DG RRWSVASLPSSGYGTT GSSNVSSQCSSQE+LHQLPN+PTSDE
Sbjct: 102 IKRPYNLLTTDCR-DG-RRWSVASLPSSGYGTTSGSSNVSSQCSSQERLHQLPNMPTSDE 159
Query: 120 LHELTKHFSSNDTD---EEIRRSFMRPR----SKSLSSPSRSPILDNDIIAMNMLYKERF 172
LH +KHFSSND+ EE + +PR SPSRSP+LDNDI+ MN+LYK+RF
Sbjct: 160 LHMFSKHFSSNDSTHSAEEDNIIYRKPRFNRPRSRSLSPSRSPVLDNDIVMMNVLYKDRF 219
Query: 173 PKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSKEKLI 232
PKA QME RLS FINE L+ ++E ++ DA PI+RFV+HQ+LEIARDCL KS+EKLI
Sbjct: 220 PKATHQMEERLSMFINEYEKLSLEHIEISA-DAVPIVRFVNHQVLEIARDCLKKSEEKLI 278
Query: 233 SSRYFYEMSEKLERLLTETKEKSLEAATVLTFTLKKLLLIISRPARLLECLEFDPEEFYH 292
+ YFYEMSE LE LL E +EKS EA +LT T+KKLLLIISRPARLLECLEFDPEEFYH
Sbjct: 279 TRGYFYEMSENLELLLAEAREKSEEATALLTGTMKKLLLIISRPARLLECLEFDPEEFYH 338
Query: 293 FLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDNDIQNISLTDTSIESNSDSYCS 352
LE AEG AK QGIK +IPQYIIGKLG+ + D+D + + +S+ + +
Sbjct: 339 LLEQAEGQAKICQGIKDEIPQYIIGKLGLTRNSVDDIDVNFHKLDEYSSSLMKKTQQQST 398
Query: 353 KKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVF 412
KKD FS P+E DF VIKLISNGAYG+VYLVRHK+TRQRFAMKKIIKN+LMLRNQ+EQVF
Sbjct: 399 KKDTFSSPPSEVDFDVIKLISNGAYGAVYLVRHKQTRQRFAMKKIIKNNLMLRNQIEQVF 458
Query: 413 AERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAE 472
AERDIMSFTDNPFVVTMYCSFET+KHLCLVMEYVEGGDCASLLKN GPLP DMA+FYFAE
Sbjct: 459 AERDIMSFTDNPFVVTMYCSFETRKHLCLVMEYVEGGDCASLLKNIGPLPPDMAKFYFAE 518
Query: 473 TVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAK 532
TVLAVEYLH+YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE +V+RD +
Sbjct: 519 TVLAVEYLHNYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEVHVDRDTR 578
Query: 533 QFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592
QFSDKQV+GTPEYIAPEVILRQGYGKPVDWWSMG+ILYEFLVGCVPFFGETPEELFAHTV
Sbjct: 579 QFSDKQVFGTPEYIAPEVILRQGYGKPVDWWSMGIILYEFLVGCVPFFGETPEELFAHTV 638
Query: 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHK 652
NDDIEWP E++WPIQ EAK+II+ LLQQNPRDRLGTGG HEVK+HPYF +DWNSLLR K
Sbjct: 639 NDDIEWPDENEWPIQPEAKNIISSLLQQNPRDRLGTGGSHEVKDHPYFYGVDWNSLLRQK 698
Query: 653 AEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETEDSFSLGTFSSCTHQYKKVQSQLSSQ 712
AEF+PQL +EEDTSYFDSR +RY+H+I EDTD +DS LGTFSSC+ Q+KKV S+LS
Sbjct: 699 AEFMPQLGNEEDTSYFDSRTDRYSHEIDEDTD--DDSLILGTFSSCSPQFKKVASKLSMS 756
Query: 713 SSLEVTPPRKSSEKD-------------------------ETSSTSDVSSSPVAHVVTST 747
+ P + + D E + + SP+A +T
Sbjct: 757 NEYSSLSPSVNYKDDSLSINTGKNIEIIFFSVECLYTSASEGETVDESLKSPIAK--KTT 814
Query: 748 PESSQTESDDISPQVQRKRR 767
+ SQ E ++ + Q+ R+RR
Sbjct: 815 IDKSQNEDNESNTQISRRRR 834
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328791849|ref|XP_392717.4| PREDICTED: microtubule-associated serine/threonine-protein kinase 4 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 1015 bits (2624), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 554/883 (62%), Positives = 642/883 (72%), Gaps = 116/883 (13%)
Query: 1 MKDLTVPSGCLRKTSRIHAHRKSFIANTSPTLPRCYSPMPS------SPLESPRVASNQH 54
M+D +P R+T++ AHRKSFIA TSPTLPRC+SP+ + SPLESPR++S+ H
Sbjct: 86 MRDFNIP----RRTAKA-AHRKSFIATTSPTLPRCHSPLSAFVPIVGSPLESPRMSSSPH 140
Query: 55 FPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNI 114
F F P+KR + RRWSVASLPSSGYGTTPGSSNVSSQ SSQE+LHQLPN+
Sbjct: 141 FAFAPIKR---IGGGTTGTGDGRRWSVASLPSSGYGTTPGSSNVSSQYSSQERLHQLPNV 197
Query: 115 PTSDELHELTKHFSSNDT------------------------DEEIRRS-FMRPRSKSLS 149
PT DEL L+ HFS T DEE RRS RPRS+SLS
Sbjct: 198 PTKDELRMLSCHFSKPGTPCSSHPGFPGSSISSIPGSVSLSLDEEGRRSPLHRPRSRSLS 257
Query: 150 SPSRSPILDNDIIAMNMLYKERFPKAIQQMETRLSNFINENSSLATNN-LETASPDAAPI 208
SPSRSP+LD++I+ MN LYKERFPKA QQME RL+NFINEN L + + D+ PI
Sbjct: 258 SPSRSPVLDSEIVMMNTLYKERFPKATQQMEERLTNFINENKELDEYEVMANMTQDSLPI 317
Query: 209 IRFVHHQILEIARDCLFKSKEKLISSRYFYEMSEKLERLLTETKEKSLEAATVLTFTLKK 268
+RFVHHQ++E+ARDCL KS+EKLI++RYFYEMSE LE LL ETK+KSLEAAT LT +KK
Sbjct: 318 LRFVHHQVIEMARDCLQKSQEKLITTRYFYEMSENLEHLLMETKDKSLEAATRLTGLIKK 377
Query: 269 LLLIISRPARLLECLEFDPEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSD 328
LLL+ISRPARLLECLEFDPEEFYH LE AEG AK GIK DIPQYII KL +N+ S+
Sbjct: 378 LLLVISRPARLLECLEFDPEEFYHLLEQAEGQAKINAGIKTDIPQYIINKLSLNRDPISE 437
Query: 329 LDNDIQNISLTDTSIESN---SDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRH 385
L D+ + + +S +SN + S DK + P E+D+ V+KLISNGAYG+VYLV+
Sbjct: 438 LQEDLNKLEDSASSSDSNLQIASSPNKDDDKSQRIPCESDYEVLKLISNGAYGAVYLVKE 497
Query: 386 KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445
K TRQRFAMKKI KN+LMLRNQ+EQVFAERDIMSFTDNPFVV+MYCSFETKKHLCLVMEY
Sbjct: 498 KTTRQRFAMKKINKNNLMLRNQVEQVFAERDIMSFTDNPFVVSMYCSFETKKHLCLVMEY 557
Query: 446 VEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 505
VEGGDCA+LLKN GPLP DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL
Sbjct: 558 VEGGDCANLLKNIGPLPPDMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 617
Query: 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSM 565
TDFGLSKMGLMSLATNLYE Y++RD +QFSDKQV+GTPEYIAPEVILRQGYGKPVDWWSM
Sbjct: 618 TDFGLSKMGLMSLATNLYEGYIDRDTRQFSDKQVFGTPEYIAPEVILRQGYGKPVDWWSM 677
Query: 566 GVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
G+ILYEFL+GCVPFFG+TPEELFAHTVNDDIEWP EDDWP+Q EAK IIT LLQQ+PRDR
Sbjct: 678 GIILYEFLIGCVPFFGDTPEELFAHTVNDDIEWPDEDDWPVQPEAKDIITALLQQSPRDR 737
Query: 626 LGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDE 685
LGTGG HEVKEH YF ++WNSLLR KAEF+PQL ++EDTSYFD+RM+RYNHDIG+DTD+
Sbjct: 738 LGTGGSHEVKEHLYFYGVNWNSLLRQKAEFVPQLVNDEDTSYFDTRMDRYNHDIGDDTDD 797
Query: 686 TEDSFSLGTFSSCTHQYKKVQ------------------------------SQLSSQSSL 715
T+DS G+FSS + Q +K+ +QLSS S+
Sbjct: 798 TDDSPLFGSFSSYSPQSRKISQTRPPQINSEQTELDISKKQLFRTELERTVAQLSSGSNS 857
Query: 716 EVTPPRKSSE---------------KDETSSTSDVSSSPVAHVVT--------------- 745
+TPP K +E +ET +D S++ T
Sbjct: 858 SITPPSKLAESTLPEKNRSSSIKITNNETPPKADKSNASFTSPATVTSGESQLTVIRNNQ 917
Query: 746 --------STPESSQTESDDISPQVQRKRRAMTSHQMSRAKLP 780
STP+SSQTES+DISPQ+QRKR H SR KLP
Sbjct: 918 IEGTSISLSTPDSSQTESEDISPQIQRKR-----HLHSRDKLP 955
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380028504|ref|XP_003697939.1| PREDICTED: microtubule-associated serine/threonine-protein kinase 4-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 1011 bits (2613), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 553/883 (62%), Positives = 643/883 (72%), Gaps = 116/883 (13%)
Query: 1 MKDLTVPSGCLRKTSRIHAHRKSFIANTSPTLPRCYSPMPS------SPLESPRVASNQH 54
M+D +P R+T++ AHRKSFIA TSPTLPRC+SP+ + SPLESPR++S+ H
Sbjct: 86 MRDFNIP----RRTAKA-AHRKSFIATTSPTLPRCHSPLSAFVPIVGSPLESPRMSSSPH 140
Query: 55 FPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNI 114
F F P+KR + RRWSVASLPSSGYGTTPGSSNVSSQ SSQE+LHQLPN+
Sbjct: 141 FAFAPIKR---IGGGTTGTGDGRRWSVASLPSSGYGTTPGSSNVSSQYSSQERLHQLPNV 197
Query: 115 PTSDELHELTKHFSSNDT------------------------DEEIRRS-FMRPRSKSLS 149
PT DEL L+ HFS T DEE RRS RPRS+SLS
Sbjct: 198 PTKDELRMLSCHFSKPGTPCSSHPGFPGSSISSIPGSVSLSLDEEGRRSPLHRPRSRSLS 257
Query: 150 SPSRSPILDNDIIAMNMLYKERFPKAIQQMETRLSNFINENSSLATNN-LETASPDAAPI 208
SPSRSP+LD++I+ MN LYKERFPKA QQME RL+NFINEN L + + D+ PI
Sbjct: 258 SPSRSPVLDSEIVMMNTLYKERFPKATQQMEERLTNFINENKELDEYEVMANMTQDSLPI 317
Query: 209 IRFVHHQILEIARDCLFKSKEKLISSRYFYEMSEKLERLLTETKEKSLEAATVLTFTLKK 268
+RFVHHQ++E+ARDCL KS+EKLI++RYFYEMSE LE LL ETK+KSLEAAT LT +KK
Sbjct: 318 LRFVHHQVIEMARDCLQKSQEKLITTRYFYEMSENLEHLLMETKDKSLEAATRLTGLIKK 377
Query: 269 LLLIISRPARLLECLEFDPEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSD 328
LLL+ISRPARLLECLEFDPEEFYH LE AEG AK GIK DIPQYII KL +N+ S+
Sbjct: 378 LLLVISRPARLLECLEFDPEEFYHLLEQAEGQAKINAGIKTDIPQYIINKLSLNRDPISE 437
Query: 329 LDNDIQNISLTDTSIESN---SDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRH 385
L D+ + + +S +SN + S DK + P E+D+ V+KLISNGAYG+VYLV+
Sbjct: 438 LQEDLNKLEDSASSSDSNLQIASSPNKDDDKSQRIPCESDYEVLKLISNGAYGAVYLVKE 497
Query: 386 KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445
K TRQRFAMKKI KN+LMLRNQ+EQVFAERDIMSFTDNPFVV+MYCSFETKKHLCLVMEY
Sbjct: 498 KTTRQRFAMKKINKNNLMLRNQVEQVFAERDIMSFTDNPFVVSMYCSFETKKHLCLVMEY 557
Query: 446 VEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 505
VEGGDCA+LLKN GPLP DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL
Sbjct: 558 VEGGDCANLLKNIGPLPPDMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 617
Query: 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSM 565
TDFGLSKMGLMSLATNLYE Y++RD +QFSDKQV+GTPEYIAPEVILRQGYGKPVDWWSM
Sbjct: 618 TDFGLSKMGLMSLATNLYEGYIDRDTRQFSDKQVFGTPEYIAPEVILRQGYGKPVDWWSM 677
Query: 566 GVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
G+ILYEFL+GCVPFFG+TPEELFAHTVNDDIEWP EDDWP+Q EAK IIT LLQQ+PRDR
Sbjct: 678 GIILYEFLIGCVPFFGDTPEELFAHTVNDDIEWPDEDDWPVQPEAKDIITALLQQSPRDR 737
Query: 626 LGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDE 685
LGTGG HEVKEH YF ++WNSLLR KAEF+PQL ++EDTSYFD+RM+RYNHDIG+DTD+
Sbjct: 738 LGTGGSHEVKEHLYFYGVNWNSLLRQKAEFVPQLVNDEDTSYFDTRMDRYNHDIGDDTDD 797
Query: 686 TEDSFSLGTFSSCTHQYKKVQ------------------------------SQLSSQSSL 715
T+DS G+FSS + Q +K+ +QLSS S+
Sbjct: 798 TDDSPLFGSFSSYSPQSRKISQTRPPQINSEQTELDISKKQLFRTELERTVAQLSSGSNS 857
Query: 716 EVTPPRKSS-----EKDETSS--TSDVSSSPVA--------------------------- 741
TP K + EK+ +SS +++ + P A
Sbjct: 858 STTPSSKLAESTLPEKNRSSSIKITNIETPPKADKSNASFTSPATVTSGESQLTIIRNNQ 917
Query: 742 ----HVVTSTPESSQTESDDISPQVQRKRRAMTSHQMSRAKLP 780
+ STP+SSQTES+DISPQ+QRKR H SR KLP
Sbjct: 918 IEGTSISLSTPDSSQTESEDISPQIQRKR-----HLHSRDKLP 955
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383865100|ref|XP_003708013.1| PREDICTED: microtubule-associated serine/threonine-protein kinase 2 [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 1002 bits (2591), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 548/865 (63%), Positives = 630/865 (72%), Gaps = 112/865 (12%)
Query: 20 HRKSFIANTSPTLPRCYSPMPS------SPLESPRVASNQHFPFIPMKRPFNHLNTDCRS 73
HRKSFIA TSPTLPRC+SP+ + SPLESPR++S+ HF F P+KR
Sbjct: 100 HRKSFIATTSPTLPRCHSPLSAFVPIVGSPLESPRMSSSPHFAFAPIKRISG--GATGTG 157
Query: 74 DGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNIPTSDELHELTKHFSSNDT- 132
DG RRWSV SLPSSGYGTTPGSSNVSSQ SSQE+LHQLPN+PT DEL L+ HFS T
Sbjct: 158 DG-RRWSVTSLPSSGYGTTPGSSNVSSQYSSQERLHQLPNVPTKDELRMLSCHFSKPGTP 216
Query: 133 -----------------------DEEIRRS-FMRPRSKSLSSPSRSPILDNDIIAMNMLY 168
DEE RRS RPRS+SLSSPSRSP+LD++I+ MN LY
Sbjct: 217 CSSHPGFPGSSISSIPGSVSLSLDEEGRRSPLHRPRSRSLSSPSRSPVLDSEIVMMNTLY 276
Query: 169 KERFPKAIQQMETRLSNFINENSSLATNN-LETASPDAAPIIRFVHHQILEIARDCLFKS 227
KERFPKA QQME RL+NFINEN L + + D+ PI+RFVHHQ++E+ARDCL KS
Sbjct: 277 KERFPKATQQMEERLTNFINENKELDEYEVMANMTQDSLPILRFVHHQVIEMARDCLQKS 336
Query: 228 KEKLISSRYFYEMSEKLERLLTETKEKSLEAATVLTFTLKKLLLIISRPARLLECLEFDP 287
+EKLI++RYFYEMSE LE LL ETK+KSLEAAT LT +KKLLL+ISRPARLLECLEFDP
Sbjct: 337 QEKLITTRYFYEMSENLEHLLMETKDKSLEAATRLTGLIKKLLLVISRPARLLECLEFDP 396
Query: 288 EEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDNDIQNISLTDTSIESN- 346
EEFYH LE AEG AK GIK DIPQYII KL +N+ S+L D+ + + +S +SN
Sbjct: 397 EEFYHLLEQAEGQAKINAGIKTDIPQYIINKLSLNRDPISELQEDLNKLEDSASSSDSNL 456
Query: 347 --SDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML 404
+ S + +K + P E+D+ V+KLISNGAYG+VYLV+ K TRQRFAMKKI KN+LML
Sbjct: 457 QIASSPNKEDEKSQRIPCESDYEVLKLISNGAYGAVYLVKEKTTRQRFAMKKINKNNLML 516
Query: 405 RNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPAD 464
RNQ+EQVFAERDIMSFTDNPFVV+MYCSFETKKHLCLVMEYVEGGDCA+LLKN GPLP D
Sbjct: 517 RNQVEQVFAERDIMSFTDNPFVVSMYCSFETKKHLCLVMEYVEGGDCANLLKNIGPLPPD 576
Query: 465 MARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524
MARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE
Sbjct: 577 MARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 636
Query: 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
Y++RD +QFSDKQV+GTPEYIAPEVILRQGYGKPVDWWSMG+ILYEFL+GCVPFFG+TP
Sbjct: 637 GYIDRDTRQFSDKQVFGTPEYIAPEVILRQGYGKPVDWWSMGIILYEFLIGCVPFFGDTP 696
Query: 585 EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644
EELFAHTVNDDIEWP EDDWP+Q EAK IIT LLQQ+PRDRLGTGG HEVKEH YF ++
Sbjct: 697 EELFAHTVNDDIEWPDEDDWPVQPEAKDIITALLQQSPRDRLGTGGSHEVKEHLYFYGVN 756
Query: 645 WNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETEDSFSLGTFSSCTHQYKK 704
WNSLLR KAEF+PQL ++EDTSYFD+RM+RYNHDIG+DTD+T+DS G+FSS + Q +K
Sbjct: 757 WNSLLRQKAEFVPQLVNDEDTSYFDTRMDRYNHDIGDDTDDTDDSPLFGSFSSYSPQSRK 816
Query: 705 VQ-----------------------------SQLSSQSSLEVTPPRKSSE---------- 725
+ +QLS S+ TPP K E
Sbjct: 817 ISQTRPPQLNPESESDSSKKQLFRSELERTVAQLSLGSNNSTTPPSKLIESTPSDKSRFS 876
Query: 726 -------------KDETSSTSDVSSSPV-----------------AHVVTSTPESSQTES 755
K + S+TS S + V + STP+SSQTES
Sbjct: 877 SSIKSSTSSETPPKPDKSNTSFASPATVTSGESQLTVIKNNQIEGTSINLSTPDSSQTES 936
Query: 756 DDISPQVQRKRRAMTSHQMSRAKLP 780
+DISPQ+QRKR H SR KLP
Sbjct: 937 EDISPQIQRKR-----HVHSRDKLP 956
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242012635|ref|XP_002427035.1| Microtubule-associated serine/threonine-protein kinase, putative [Pediculus humanus corporis] gi|212511280|gb|EEB14297.1| Microtubule-associated serine/threonine-protein kinase, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 998 bits (2580), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/805 (64%), Positives = 618/805 (76%), Gaps = 56/805 (6%)
Query: 6 VPSGCLRKTSRIHAHRKSFIANTSPTLPRCYSPMPSSPLESPRVA-SNQHFPFIPMKRPF 64
V G + + + + AHRKS ++ TSPTLPRC+SP+P+SPLESPR++ S HF F+ +KR
Sbjct: 75 VKEGAISRKTSLIAHRKSLVSATSPTLPRCHSPIPASPLESPRMSPSMGHFSFVSLKR-- 132
Query: 65 NHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNIPTSDELHELT 124
DG RRWSVASLPSSGYGTTPGSS+VSSQCSSQE+LHQLP++PT DEL L+
Sbjct: 133 --------GDG-RRWSVASLPSSGYGTTPGSSDVSSQCSSQERLHQLPSVPTVDELQMLS 183
Query: 125 KHFSSNDTDEE--IRRSFMRPRSKSLSSPSRSPILDNDIIAMNMLYKERFPKAIQQMETR 182
+HFSSND EE R RPRS+SLSSPSR P+ DNDI+ MN LYKERFPKA QQME +
Sbjct: 184 QHFSSNDHGEEEGRRSPRFRPRSRSLSSPSRLPVFDNDIVLMNTLYKERFPKATQQMEEK 243
Query: 183 LSNFINENSSLATNNL-ETASPDAAPIIRFVHHQILEIARDCLFKSKEKLISSRYFYEMS 241
L +FI EN+S A ++ + S D+ PIIRFVHHQI+E+ARDCL KS+EKLI+S YFYEM+
Sbjct: 244 LKSFIIENTSEAHCDIFDNVSQDSVPIIRFVHHQIIEMARDCLQKSQEKLITSLYFYEMT 303
Query: 242 EKLERLLTETKEKSLEAATVLTFTLKKLLLIISRPARLLECLEFDPEEFYHFLEMAEGDA 301
E LE LLTETKEKS +AA+ +T PARLLECLEF+PEEFY LE EG A
Sbjct: 304 ENLEILLTETKEKSPQAASKITG-----------PARLLECLEFNPEEFYRILEKVEGHA 352
Query: 302 KSLQGIKADIPQYIIGKLGINKTVFSDLDNDI---QNISLTDTSIESNSDSYCSKKDKFS 358
KS QGIK D+PQYI+GKLG+N+ ++ D+ +N S + +++ ++ ++
Sbjct: 353 KSNQGIKDDLPQYIVGKLGLNRDPIAEFQEDLDLLENFSKENNQSVQYNNAPVTQSEEMK 412
Query: 359 KT----PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAE 414
K P E+DF +IKLISNGAYG+VYLVR KETRQRFAMKKI KN+LMLRNQ+EQVFAE
Sbjct: 413 KITVKPPAEDDFEIIKLISNGAYGAVYLVRLKETRQRFAMKKINKNNLMLRNQVEQVFAE 472
Query: 415 RDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
RDIMSFTDNPFVV+M CS ETK+HLCLVMEYVEGGDCA+LLK+ GPLP+DMARFYFAETV
Sbjct: 473 RDIMSFTDNPFVVSMICSIETKRHLCLVMEYVEGGDCANLLKSIGPLPSDMARFYFAETV 532
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN+YE Y++++ KQF
Sbjct: 533 LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNIYEGYIDKETKQF 592
Query: 535 SDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND 594
SDKQV GTPEYIAPEVILRQGYGKPVDWWSMG+ILYEFLVGCVPFFGETPEELFAHT+ D
Sbjct: 593 SDKQVIGTPEYIAPEVILRQGYGKPVDWWSMGIILYEFLVGCVPFFGETPEELFAHTIYD 652
Query: 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAE 654
DIEWP E DWP+Q EAKS+IT LLQQNPRDRLGTGG EVKEH YFS +DWNSLLR KAE
Sbjct: 653 DIEWPDESDWPVQSEAKSLITLLLQQNPRDRLGTGGAQEVKEHQYFSTIDWNSLLRQKAE 712
Query: 655 FIPQLDDEEDTSYFDSRMERYNHDIGEDTDETEDSFSLGTFSSCTHQYKKVQSQLSSQSS 714
F+PQLD EEDTSYFDSR +RYNHD+GEDTD+T++S G+F+S + QY+K Q +L+
Sbjct: 713 FVPQLDHEEDTSYFDSRTDRYNHDMGEDTDDTDESPLFGSFASYSPQYRKAQGRLNLNDE 772
Query: 715 LEVTPPRKSSEK------DETSSTSDVSSSPVAHVVT-----------------STPESS 751
+E +K K D + S++ +P + STPESS
Sbjct: 773 IEGCLSKKGKGKVLVGTDDLDNQMSNLVVTPEVETIKEMYDAKTISESKPTALPSTPESS 832
Query: 752 QTESDDISPQVQRKRRAMTSHQMSR 776
QTESDD+SPQVQRKRR + + R
Sbjct: 833 QTESDDVSPQVQRKRRLHSRESLPR 857
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307188180|gb|EFN73012.1| Microtubule-associated serine/threonine-protein kinase 2 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 998 bits (2579), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 547/888 (61%), Positives = 632/888 (71%), Gaps = 121/888 (13%)
Query: 1 MKDLTVPSGCLRKTSRIHAHRKSFIANTSPTLPRCYSPMPS------SPLESPRVASNQH 54
++D +P R+ ++ AHRKS I+ TSPTLPRC+SP+ + SPLESPR++S+ H
Sbjct: 86 VRDFNIP----RRAAKA-AHRKSLISTTSPTLPRCHSPLSAFVPIVGSPLESPRMSSSPH 140
Query: 55 FPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNI 114
F F P+KR + RRWSVASLPSSGYGTTPGSSNVSSQ SSQE+LHQLPN+
Sbjct: 141 FAFAPIKR---IGGGATGTGDGRRWSVASLPSSGYGTTPGSSNVSSQYSSQERLHQLPNV 197
Query: 115 PTSDELHELTKHFSSNDT-------------------------DEEIRRSFMRPRSKSLS 149
PT DEL L+ HFS T +E R RPRS+SLS
Sbjct: 198 PTKDELRMLSCHFSKPGTPCSSHPGFPGSSISSIPGSASLSLEEEGCRSPLHRPRSRSLS 257
Query: 150 SPSRSPILDNDIIAMNMLYKERFPKAIQQMETRLSNFINENSSLATNNL-ETASPDAAPI 208
SPSRSP+LD++I+ MN LYKERFPKA QQME RL+NFINEN + + + D+ PI
Sbjct: 258 SPSRSPVLDSEIVMMNTLYKERFPKATQQMEERLTNFINENKEIDEYEVVANMTQDSLPI 317
Query: 209 IRFVHHQILEIARDCLFKSKEKLISSRYFYEMSEKLERLLTETKEKSLEAATVLTFTLKK 268
+RFVHHQ++E+ARDCL KS+EKLI++RYFYEMSE LE LL ETK+KSLEAAT LT +KK
Sbjct: 318 LRFVHHQVIEMARDCLQKSQEKLITTRYFYEMSENLEHLLMETKDKSLEAATRLTGLIKK 377
Query: 269 LLLIISRPARLLECLEFDPEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSD 328
LLL+ISRPARLLECLEFDPEEFYH LE AEG AK GIK DIPQYII KL +N+ S+
Sbjct: 378 LLLVISRPARLLECLEFDPEEFYHLLEQAEGQAKVNAGIKTDIPQYIITKLSLNRDPISE 437
Query: 329 LDNDIQNISLTDTSIESN---SDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRH 385
L D+ + + +S +SN + S DK + P E+D+ V+KLISNGAYG+VYLV+
Sbjct: 438 LQEDLNKLEDSASSSDSNLQVTSSPNKDDDKCQRIPCESDYEVLKLISNGAYGAVYLVKE 497
Query: 386 KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445
K RQRFAMKKI KN+LMLRNQ+EQVFAERDIMSFTDNPFVV+MYCSFETKKHLCLVMEY
Sbjct: 498 KIARQRFAMKKINKNNLMLRNQVEQVFAERDIMSFTDNPFVVSMYCSFETKKHLCLVMEY 557
Query: 446 VEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 505
VEGGDCA+LLKN GPLP DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL
Sbjct: 558 VEGGDCANLLKNIGPLPPDMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 617
Query: 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSM 565
TDFGLSKMGLMSLATNLYE Y++RD +QFSDKQV+GTPEYIAPEVILRQGYGKPVDWWSM
Sbjct: 618 TDFGLSKMGLMSLATNLYEGYIDRDTRQFSDKQVFGTPEYIAPEVILRQGYGKPVDWWSM 677
Query: 566 GVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
G+ILYEFL+GCVPFFGETPEELFAHTVNDDIEWP EDDWP+Q E K IIT LL QNPRDR
Sbjct: 678 GIILYEFLIGCVPFFGETPEELFAHTVNDDIEWPDEDDWPVQPEGKDIITALLHQNPRDR 737
Query: 626 LGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDE 685
LGTGG HEVKEHPYF ++WNSLLR KAEF+PQL ++EDTSYFD+RM+RYNHD+G+DTD+
Sbjct: 738 LGTGGSHEVKEHPYFYGVNWNSLLRQKAEFVPQLINDEDTSYFDTRMDRYNHDLGDDTDD 797
Query: 686 TEDSFSLGTFSSCTHQYKKV------------------------------QSQLSSQSSL 715
T+DS G+FSS + Q +K+ Q L S SSL
Sbjct: 798 TDDSPLFGSFSSYSPQSRKISQTRPPLNPDADVDVSKKQLFRTELEGTFAQLSLGSNSSL 857
Query: 716 EVTPPRK--------SSEKDETSSTSDVSSSPV--------------------------- 740
PP K SSEK T S S+S
Sbjct: 858 VTPPPSKLADPQSTQSSEKHRTPLLSVKSNSYAENQKADKLNIMSSSCTTSSSNESQLTI 917
Query: 741 --------AHVVTSTPESSQTESDDISPQVQRKRRAMTSHQMSRAKLP 780
A + STP+SSQTES+DISPQ+QRKR H SR KLP
Sbjct: 918 VKGTQAEGASINLSTPDSSQTESEDISPQIQRKR-----HTHSRDKLP 960
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|189234010|ref|XP_972656.2| PREDICTED: similar to MAST205 [Tribolium castaneum] gi|270014736|gb|EFA11184.1| hypothetical protein TcasGA2_TC004792 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 987 bits (2551), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 525/829 (63%), Positives = 622/829 (75%), Gaps = 69/829 (8%)
Query: 1 MKDLTVPSGCLRKTSRIHA-HRKSFIANTSPTLPRCYSPMPSSPLESPRVASN-QHFPFI 58
MKD+ V R+ SR A HR SF+ANTSP LPR SP+ SP++SPR ++ +FPF
Sbjct: 74 MKDVNVG----RRNSRPAAVHRLSFVANTSPVLPRSQSPICGSPIDSPRTHNSFINFPFA 129
Query: 59 PMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNIPTSD 118
P+KR + CR DG RRWSVASLPSSGYGTTPGSSN+SS+CSSQE+LHQLP++PTSD
Sbjct: 130 PIKR----IVAGCRGDG-RRWSVASLPSSGYGTTPGSSNMSSKCSSQERLHQLPHVPTSD 184
Query: 119 ELHELTKHFSSNDTDEEIRRSFMRPRSKSLSSP------------SRSPILDNDIIAMNM 166
++ LT HFSSN+++ + S SP SRSP++DN+I MN+
Sbjct: 185 DMRILTHHFSSNESNPSLPTGNYEENPISHRSPLHRPRSRSLSSPSRSPVMDNEICMMNV 244
Query: 167 LYKERFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFK 226
LYKERFPKA QQME RL+++I EN + D PI+RFVHHQ+LE+ARDCL K
Sbjct: 245 LYKERFPKATQQMEERLNHYIEENKTFDFGE----DCDYLPIVRFVHHQVLEMARDCLHK 300
Query: 227 SKEKLISSRYFYEMSEKLERLLTETKEKSLEAATVLTFTLKKLLLIISRPARLLECLEFD 286
S+ KLI+SRYFYEMSE LERLLTETK+KS EAA ++T +KKLLLIISRPARLLECLEFD
Sbjct: 301 SQSKLITSRYFYEMSENLERLLTETKDKSEEAANLVTGFIKKLLLIISRPARLLECLEFD 360
Query: 287 PEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDNDIQNISLTDTSIESN 346
PEEFYHFLE AEG K +QGIKADIPQYII KLG+N+ ++L ++++ + + +
Sbjct: 361 PEEFYHFLEAAEGQVKVVQGIKADIPQYIIQKLGLNRDPIAELQEELRDCNWSSNQSSRS 420
Query: 347 S---DSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM 403
S S S K S PNE DF V+KLISNGAYG+VYLV+HK+TRQRFAMKKI KN+L+
Sbjct: 421 SVCLTSTPSTKKSLS-NPNEQDFEVVKLISNGAYGAVYLVKHKQTRQRFAMKKINKNNLI 479
Query: 404 LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPA 463
LRNQ+EQVFAERDI+SF DNPFVV+MYCSFET+KHLCLVMEYVEGGDCASLLKN GPLP+
Sbjct: 480 LRNQVEQVFAERDILSFADNPFVVSMYCSFETRKHLCLVMEYVEGGDCASLLKNIGPLPS 539
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523
DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY
Sbjct: 540 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 599
Query: 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET 583
E YV+ +A+QFSDKQV+GTPEYIAPEVILRQGYGKPVDWWSMG+ILYEFLVGCVPFFG+T
Sbjct: 600 EGYVDTEARQFSDKQVFGTPEYIAPEVILRQGYGKPVDWWSMGIILYEFLVGCVPFFGDT 659
Query: 584 PEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643
PEELFAHTV DDIEWP +DWP+Q EAK +IT LLQ +PRDRLGTGG HEVKEH YFS L
Sbjct: 660 PEELFAHTVQDDIEWPDSEDWPVQEEAKDLITALLQHSPRDRLGTGGAHEVKEHVYFSGL 719
Query: 644 DWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETEDSFSLGTFSSCTHQYK 703
DWNSLLR KAEF+PQL+ +EDTSYFDSR++RYNH++ +DTD+T+DS G FSSC+ QY+
Sbjct: 720 DWNSLLRQKAEFVPQLEHDEDTSYFDSRIDRYNHELEDDTDDTDDSPVFGLFSSCSPQYR 779
Query: 704 KVQS--------------------------------QLSSQSSLEVTPPRKSSEKDETSS 731
K +L ++ + + P + E+ E +
Sbjct: 780 KANVSKLSSSDPDNSSDGIKINTTVTTPDTPDVPDFKLRPRAPISLQTPER--ERQEIAP 837
Query: 732 TSDVSSSPVAHVVTSTPESSQTESDDISPQVQRKRRAMTSHQMSRAKLP 780
S STPESSQT+SDD+SPQ+QR+R+ T H SR LP
Sbjct: 838 IEHRKISLDFGKTISTPESSQTDSDDVSPQIQRRRK--TGH--SRDILP 882
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350418976|ref|XP_003492030.1| PREDICTED: microtubule-associated serine/threonine-protein kinase 4-like isoform 1 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 984 bits (2545), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 554/897 (61%), Positives = 647/897 (72%), Gaps = 121/897 (13%)
Query: 1 MKDLTVPSGCLRKTSRIHAHRKSFIANTSPTLPRCYSPMPS------SPLESPRVASNQH 54
++D +P R+ ++ AHRKSFIA TSPTLPRC+SP+ + SPLESPR++S+ H
Sbjct: 86 VRDFNIP----RRAAKA-AHRKSFIATTSPTLPRCHSPLSAFVPIVGSPLESPRMSSSPH 140
Query: 55 FPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNI 114
F F P+KR + RRWSVASLPSSGYGTTPGSSNVSSQ SSQE+LHQLPN+
Sbjct: 141 FAFAPIKR---IGGGTTGTGDGRRWSVASLPSSGYGTTPGSSNVSSQYSSQERLHQLPNV 197
Query: 115 PTSDELHELTKHFSSNDT------------------------DEEIRRS-FMRPRSKSLS 149
PT DEL L+ HFS T DEE RRS RPRS+SLS
Sbjct: 198 PTKDELRMLSCHFSKPGTPCSSHPGFPGSSISSIPGSVSLSLDEEGRRSPLHRPRSRSLS 257
Query: 150 SPSRSPILDNDIIAMNMLYKERFPKAIQQMETRLSNFINENSSLATNN-LETASPDAAPI 208
SPSRSP+LD++I+ MN LYKERFPKA QQME RL+NFINEN L + + D+ PI
Sbjct: 258 SPSRSPVLDSEIVMMNTLYKERFPKATQQMEERLTNFINENKELDEYEVMANMTQDSLPI 317
Query: 209 IRFVHHQILEIARDCLFKSKEKLISSRYFYEMSEKLERLLTETKEKSLEAATVLTFTLKK 268
+RFVHHQ++E+ARDCL KS+EKLI++RYFYEMSE LE LL ETK+KSL+AAT LT +KK
Sbjct: 318 LRFVHHQVIEMARDCLQKSQEKLITTRYFYEMSENLEHLLMETKDKSLDAATRLTGLIKK 377
Query: 269 LLLIISRPARLLECLEFDPEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSD 328
LLL+ISRPARLLECLEFDPEEFYH LE AEG AK GIK DIPQYII KL +N+ S+
Sbjct: 378 LLLVISRPARLLECLEFDPEEFYHLLEQAEGQAKINAGIKNDIPQYIINKLSLNRDPISE 437
Query: 329 LDNDIQNISLTDTSIESN---SDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRH 385
L D+ + + +S +SN + S +K + P E D+ V+KLISNGAYG+VYLV+
Sbjct: 438 LQEDLNKLEDSASSSDSNLQIASSPNKDDEKSHRVPCEGDYEVLKLISNGAYGAVYLVKE 497
Query: 386 KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445
K TRQRFAMKKI KN+LMLRNQ+EQVFAERDIMSFTDNPFVV+MYCSFETKKHLCLVMEY
Sbjct: 498 KTTRQRFAMKKINKNNLMLRNQVEQVFAERDIMSFTDNPFVVSMYCSFETKKHLCLVMEY 557
Query: 446 VEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 505
VEGGDCA+LLKN GPLP DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL
Sbjct: 558 VEGGDCANLLKNIGPLPPDMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 617
Query: 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSM 565
TDFGLSKMGLMSLATNLYE Y++RD +QFSDKQV+GTPEYIAPEVILRQGYGKPVDWWSM
Sbjct: 618 TDFGLSKMGLMSLATNLYEGYIDRDTRQFSDKQVFGTPEYIAPEVILRQGYGKPVDWWSM 677
Query: 566 GVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
G+ILYEFL+GCVPFFG+TPEELFAHTVNDDI+WP EDDWP+Q EAK IIT LLQQ+PRDR
Sbjct: 678 GIILYEFLIGCVPFFGDTPEELFAHTVNDDIDWPDEDDWPVQPEAKDIITALLQQSPRDR 737
Query: 626 LGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDE 685
LGTGG HEVKEHPYF ++WNSLLR KAEF+PQL ++EDTSYFD+RM+RYNHDIG+DTD+
Sbjct: 738 LGTGGSHEVKEHPYFYGVNWNSLLRQKAEFVPQLINDEDTSYFDTRMDRYNHDIGDDTDD 797
Query: 686 TEDSFSLGTFSSCTHQYKKVQ------------------------------SQLSSQSSL 715
T+DS G+FSS + Q +K+ +QLS S+
Sbjct: 798 TDDSPLFGSFSSYSPQSRKISQTRPPQINPEQTESDVSKKQLFRTELERTVAQLSFGSNS 857
Query: 716 EVTPPRK-----SSEKDETSS----TSDVSSSPVAH------------------------ 742
TPP K SEK+ SS T+ + + P A
Sbjct: 858 STTPPSKLAESTPSEKNRPSSSIRNTTYIETPPKADKSNTSFTSPATVTSGESQLTVIKN 917
Query: 743 -------VVTSTPESSQTESDDISPQVQRKRRAMTSHQMSRAKLPCRQRINVFVRIR 792
+ STP+SSQTES+DISPQ+QRKR H SR KLP R+++F R
Sbjct: 918 SHIEGTCISLSTPDSSQTESEDISPQIQRKR-----HVHSRDKLP---RLDLFAANR 966
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340708957|ref|XP_003393083.1| PREDICTED: microtubule-associated serine/threonine-protein kinase 4-like isoform 1 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 983 bits (2541), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 553/897 (61%), Positives = 647/897 (72%), Gaps = 121/897 (13%)
Query: 1 MKDLTVPSGCLRKTSRIHAHRKSFIANTSPTLPRCYSPMPS------SPLESPRVASNQH 54
++D +P R+ ++ AHRKSFIA TSPTLPRC+SP+ + SPLESPR++S+ H
Sbjct: 86 VRDFNIP----RRAAKA-AHRKSFIATTSPTLPRCHSPLSAFVPIVGSPLESPRMSSSPH 140
Query: 55 FPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNI 114
F F P+KR + RRWSVASLPSSGYGTTPGSSNVSSQ SSQE+LHQLPN+
Sbjct: 141 FAFAPIKR---IGGGTTGTGDGRRWSVASLPSSGYGTTPGSSNVSSQYSSQERLHQLPNV 197
Query: 115 PTSDELHELTKHFSSNDT------------------------DEEIRRS-FMRPRSKSLS 149
PT DEL L+ HFS T DEE RRS RPRS+SLS
Sbjct: 198 PTKDELRMLSCHFSKPGTPCSSHPGFPGSSISSIPGSVSLSLDEEGRRSPLHRPRSRSLS 257
Query: 150 SPSRSPILDNDIIAMNMLYKERFPKAIQQMETRLSNFINENSSLATNN-LETASPDAAPI 208
SPSRSP+LD++I+ MN LYKERFPKA QQME RL+NFINEN L + + D+ PI
Sbjct: 258 SPSRSPVLDSEIVMMNTLYKERFPKATQQMEERLTNFINENKELDEYEVMANMTQDSLPI 317
Query: 209 IRFVHHQILEIARDCLFKSKEKLISSRYFYEMSEKLERLLTETKEKSLEAATVLTFTLKK 268
+RFVHHQ++E+ARDCL KS+EKLI++RYFYEMSE LE LL ETK+KSL+AA LT +KK
Sbjct: 318 LRFVHHQVIEMARDCLQKSQEKLITTRYFYEMSENLEHLLMETKDKSLDAAARLTGLIKK 377
Query: 269 LLLIISRPARLLECLEFDPEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSD 328
LLL+ISRPARLLECLEFDPEEFYH LE AEG AK GIK DIPQYII KL +N+ S+
Sbjct: 378 LLLVISRPARLLECLEFDPEEFYHLLEQAEGQAKINAGIKNDIPQYIINKLSLNRDPISE 437
Query: 329 LDNDIQNISLTDTSIESN---SDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRH 385
L D+ + + +S +SN + S +K + P E D+ V+KLISNGAYG+VYLV+
Sbjct: 438 LQEDLNKLEDSASSSDSNLQIASSPNKDDEKSHRVPCEGDYEVLKLISNGAYGAVYLVKE 497
Query: 386 KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445
K TRQRFAMKKI KN+LMLRNQ+EQVFAERDIMSFTDNPFVV+MYCSFETKKHLCLVMEY
Sbjct: 498 KTTRQRFAMKKINKNNLMLRNQVEQVFAERDIMSFTDNPFVVSMYCSFETKKHLCLVMEY 557
Query: 446 VEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 505
VEGGDCA+LLKN GPLP DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL
Sbjct: 558 VEGGDCANLLKNIGPLPPDMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 617
Query: 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSM 565
TDFGLSKMGLMSLATNLYE Y++RD +QFSDKQV+GTPEYIAPEVILRQGYGKPVDWWSM
Sbjct: 618 TDFGLSKMGLMSLATNLYEGYIDRDTRQFSDKQVFGTPEYIAPEVILRQGYGKPVDWWSM 677
Query: 566 GVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
G+ILYEFL+GCVPFFG+TPEELFAHTVNDDI+WP EDDWP+Q EAK IIT LLQQ+PRDR
Sbjct: 678 GIILYEFLIGCVPFFGDTPEELFAHTVNDDIDWPDEDDWPVQPEAKDIITALLQQSPRDR 737
Query: 626 LGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDE 685
LGTGG HEVKEHPYF ++WNSLLR KAEF+PQL ++EDTSYFD+RM+RYNHDIG+DTD+
Sbjct: 738 LGTGGSHEVKEHPYFYGVNWNSLLRQKAEFVPQLINDEDTSYFDTRMDRYNHDIGDDTDD 797
Query: 686 TEDSFSLGTFSSCTHQYKKVQ------------------------------SQLSSQSSL 715
T+DS G+FSS + Q +K+ +QLS S+
Sbjct: 798 TDDSPLFGSFSSYSPQSRKISQTRPPQINPEQTESDVSKKQLFRTELERTVAQLSFGSNS 857
Query: 716 EVTPPRK-----SSEKDETSS----TSDVSSSPVAH------------------------ 742
TPP K SEK+ +SS T+ + + P A
Sbjct: 858 STTPPSKLAESTPSEKNRSSSSIRNTTYIETPPKADKSNTSFTSPATVTSGESQLTVIKN 917
Query: 743 -------VVTSTPESSQTESDDISPQVQRKRRAMTSHQMSRAKLPCRQRINVFVRIR 792
+ STP+SSQTES+DISPQ+QRKR H SR KLP R+++F R
Sbjct: 918 SHIEGTCISLSTPDSSQTESEDISPQIQRKR-----HVHSRDKLP---RLDLFAANR 966
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350418979|ref|XP_003492031.1| PREDICTED: microtubule-associated serine/threonine-protein kinase 4-like isoform 2 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 981 bits (2537), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 551/885 (62%), Positives = 641/885 (72%), Gaps = 118/885 (13%)
Query: 1 MKDLTVPSGCLRKTSRIHAHRKSFIANTSPTLPRCYSPMPS------SPLESPRVASNQH 54
++D +P R+ ++ AHRKSFIA TSPTLPRC+SP+ + SPLESPR++S+ H
Sbjct: 86 VRDFNIP----RRAAKA-AHRKSFIATTSPTLPRCHSPLSAFVPIVGSPLESPRMSSSPH 140
Query: 55 FPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNI 114
F F P+KR + RRWSVASLPSSGYGTTPGSSNVSSQ SSQE+LHQLPN+
Sbjct: 141 FAFAPIKR---IGGGTTGTGDGRRWSVASLPSSGYGTTPGSSNVSSQYSSQERLHQLPNV 197
Query: 115 PTSDELHELTKHFSSNDT------------------------DEEIRRS-FMRPRSKSLS 149
PT DEL L+ HFS T DEE RRS RPRS+SLS
Sbjct: 198 PTKDELRMLSCHFSKPGTPCSSHPGFPGSSISSIPGSVSLSLDEEGRRSPLHRPRSRSLS 257
Query: 150 SPSRSPILDNDIIAMNMLYKERFPKAIQQMETRLSNFINENSSLATNN-LETASPDAAPI 208
SPSRSP+LD++I+ MN LYKERFPKA QQME RL+NFINEN L + + D+ PI
Sbjct: 258 SPSRSPVLDSEIVMMNTLYKERFPKATQQMEERLTNFINENKELDEYEVMANMTQDSLPI 317
Query: 209 IRFVHHQILEIARDCLFKSKEKLISSRYFYEMSEKLERLLTETKEKSLEAATVLTFTLKK 268
+RFVHHQ++E+ARDCL KS+EKLI++RYFYEMSE LE LL ETK+KSL+AAT LT +KK
Sbjct: 318 LRFVHHQVIEMARDCLQKSQEKLITTRYFYEMSENLEHLLMETKDKSLDAATRLTGLIKK 377
Query: 269 LLLIISRPARLLECLEFDPEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSD 328
LLL+ISRPARLLECLEFDPEEFYH LE AEG AK GIK DIPQYII KL +N+ S+
Sbjct: 378 LLLVISRPARLLECLEFDPEEFYHLLEQAEGQAKINAGIKNDIPQYIINKLSLNRDPISE 437
Query: 329 LDNDIQNISLTDTSIESN---SDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRH 385
L D+ + + +S +SN + S +K + P E D+ V+KLISNGAYG+VYLV+
Sbjct: 438 LQEDLNKLEDSASSSDSNLQIASSPNKDDEKSHRVPCEGDYEVLKLISNGAYGAVYLVKE 497
Query: 386 KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445
K TRQRFAMKKI KN+LMLRNQ+EQVFAERDIMSFTDNPFVV+MYCSFETKKHLCLVMEY
Sbjct: 498 KTTRQRFAMKKINKNNLMLRNQVEQVFAERDIMSFTDNPFVVSMYCSFETKKHLCLVMEY 557
Query: 446 VEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 505
VEGGDCA+LLKN GPLP DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL
Sbjct: 558 VEGGDCANLLKNIGPLPPDMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 617
Query: 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSM 565
TDFGLSKMGLMSLATNLYE Y++RD +QFSDKQV+GTPEYIAPEVILRQGYGKPVDWWSM
Sbjct: 618 TDFGLSKMGLMSLATNLYEGYIDRDTRQFSDKQVFGTPEYIAPEVILRQGYGKPVDWWSM 677
Query: 566 GVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
G+ILYEFL+GCVPFFG+TPEELFAHTVNDDI+WP EDDWP+Q EAK IIT LLQQ+PRDR
Sbjct: 678 GIILYEFLIGCVPFFGDTPEELFAHTVNDDIDWPDEDDWPVQPEAKDIITALLQQSPRDR 737
Query: 626 LGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDE 685
LGTGG HEVKEHPYF ++WNSLLR KAEF+PQL ++EDTSYFD+RM+RYNHDIG+DTD+
Sbjct: 738 LGTGGSHEVKEHPYFYGVNWNSLLRQKAEFVPQLINDEDTSYFDTRMDRYNHDIGDDTDD 797
Query: 686 TEDSFSLGTFSSCTHQYKKVQ------------------------------SQLSSQSSL 715
T+DS G+FSS + Q +K+ +QLS S+
Sbjct: 798 TDDSPLFGSFSSYSPQSRKISQTRPPQINPEQTESDVSKKQLFRTELERTVAQLSFGSNS 857
Query: 716 EVTPPRK-----SSEKDETSS----TSDVSSSPVAH------------------------ 742
TPP K SEK+ SS T+ + + P A
Sbjct: 858 STTPPSKLAESTPSEKNRPSSSIRNTTYIETPPKADKSNTSFTSPATVTSGESQLTVIKN 917
Query: 743 -------VVTSTPESSQTESDDISPQVQRKRRAMTSHQMSRAKLP 780
+ STP+SSQTES+DISPQ+QRKR H SR KLP
Sbjct: 918 SHIEGTCISLSTPDSSQTESEDISPQIQRKR-----HVHSRDKLP 957
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 810 | ||||||
| FB|FBgn0036511 | 2139 | CG6498 [Drosophila melanogaste | 0.425 | 0.161 | 0.809 | 2.4e-223 | |
| UNIPROTKB|J9NXP5 | 1806 | MAST2 "Uncharacterized protein | 0.845 | 0.379 | 0.546 | 1.7e-200 | |
| UNIPROTKB|F1NAH4 | 1370 | MAST2 "Uncharacterized protein | 0.838 | 0.495 | 0.549 | 4.5e-200 | |
| RGD|1304573 | 1795 | Mast2 "microtubule associated | 0.864 | 0.389 | 0.539 | 2e-199 | |
| UNIPROTKB|Q6P0Q8 | 1798 | MAST2 "Microtubule-associated | 0.855 | 0.385 | 0.537 | 2e-199 | |
| UNIPROTKB|F1PRV4 | 1799 | MAST2 "Uncharacterized protein | 0.837 | 0.376 | 0.541 | 2.2e-198 | |
| UNIPROTKB|E1B754 | 1710 | LOC535643 "Uncharacterized pro | 0.838 | 0.397 | 0.541 | 5.9e-198 | |
| MGI|MGI:894676 | 1734 | Mast2 "microtubule associated | 0.855 | 0.399 | 0.535 | 1.1e-196 | |
| MGI|MGI:1918885 | 2618 | Mast4 "microtubule associated | 0.846 | 0.262 | 0.538 | 1.4e-195 | |
| UNIPROTKB|E7EWQ5 | 2444 | MAST4 "Microtubule-associated | 0.833 | 0.276 | 0.545 | 1.6e-195 |
| FB|FBgn0036511 CG6498 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1539 (546.8 bits), Expect = 2.4e-223, Sum P(4) = 2.4e-223
Identities = 281/347 (80%), Positives = 315/347 (90%)
Query: 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS 419
+P ENDF ++KLISNGAYG+VYLV+HK TRQRFAMKKI KN+L+LRNQ+EQVFAERDI+S
Sbjct: 829 SPQENDFDIVKLISNGAYGAVYLVKHKTTRQRFAMKKINKNNLILRNQVEQVFAERDILS 888
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEY 479
F DNPFVV+MYCSFETKKHLCLVMEYVEGGDC +LLKN GPLPADMARFYFAETVLAVEY
Sbjct: 889 FADNPFVVSMYCSFETKKHLCLVMEYVEGGDCGTLLKNIGPLPADMARFYFAETVLAVEY 948
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE Y++ + +QFSDKQV
Sbjct: 949 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEGYIDSETRQFSDKQV 1008
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599
YGTPEYIAPEVILRQGYGKPVDWWSMG+ILYEFL+GCVPFFGET EELFAHTVNDDIEWP
Sbjct: 1009 YGTPEYIAPEVILRQGYGKPVDWWSMGIILYEFLIGCVPFFGETTEELFAHTVNDDIEWP 1068
Query: 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGT-GGPHEVKEHPYFSNLDWNSLLRHKAEFIPQ 658
+DWP+Q EAK II+ LLQQNPRDRLGT G E+KEH YF +DWNSLLR KAEF+PQ
Sbjct: 1069 DSEDWPVQAEAKDIISQLLQQNPRDRLGTQSGALEMKEHEYFLGMDWNSLLRQKAEFVPQ 1128
Query: 659 LDDEEDTSYFDSRMERYNHDIG-EDTDETEDSFSLGTFSSCTHQYKK 704
L ++DTSYFD+RM+RYNHD+G EDTD+T+D+ G+F+S T QY+K
Sbjct: 1129 LSHDDDTSYFDTRMDRYNHDLGGEDTDDTDDTPVFGSFNSYTPQYRK 1175
|
|
| UNIPROTKB|J9NXP5 MAST2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1915 (679.2 bits), Expect = 1.7e-200, Sum P(2) = 1.7e-200
Identities = 396/724 (54%), Positives = 492/724 (67%)
Query: 1 MKDLTVPS-GCLRKTSRIHAHRKSFI--ANTSPTLPRCYSPMP----SSPLESPRVASNQ 53
+K+L++P G +TS +RKS I ++TSPTLPR +SP+ +SPL+SPR S
Sbjct: 160 LKELSLPRRGSFCRTS----NRKSLIVTSSTSPTLPRPHSPLHGHTGNSPLDSPRNFSPS 215
Query: 54 ---HFPFIPMKRPFNHLNTDCRSDGTRRWSVAXXXXXXXXXXXXXXXXXXXXXXQEKLHQ 110
HF F+P R H TD R+DG RRWS+A QEKLHQ
Sbjct: 216 APAHFSFVPA-RSHGH-RTD-RTDG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQEKLHQ 271
Query: 111 LPNIPTSDELHELTKHFSSNDT-DEEIRRS-FMXXXXXXXXXXXXXXILDNDIIAMNMLY 168
LP PT+DELH LTKHFS+ DEE R+S M D++II MN +Y
Sbjct: 272 LPFQPTADELHFLTKHFSTESVPDEEGRQSPAMRPRSRSLSPGRSPVSFDSEIIMMNHVY 331
Query: 169 KERFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSK 228
KERFPKA QME RL+ FI+ N+ ++ P A + F+HHQ++E+ARDCL KS+
Sbjct: 332 KERFPKATAQMEERLAEFISSNTP------DSVLPLADGTLSFIHHQVIEMARDCLDKSR 385
Query: 229 EKLISSRYFYEMXXXXXXXXXXXXXXXXXAATVXXXXXXXXXXXX-SRPARLLECLEFDP 287
+LI+S YFYE+ + +RPARLLECLEFDP
Sbjct: 386 NRLITSHYFYELQENLEKLIQDAHERSESSEVAFVMQLVKKLMIVIARPARLLECLEFDP 445
Query: 288 EEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDN----DIQNISLTDTSI 343
EEFYH LE AEG AK QGIK DIP+YI+ +LG+ + ++ D + TD S+
Sbjct: 446 EEFYHLLEAAEGHAKEGQGIKCDIPRYIVSQLGLTRDPLEEMAQLSSYDSPDTPETDDSV 505
Query: 344 ESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM 403
E S SK+ TP+E DF IKLISNGAYG+V+LVRHK TRQRFAMKK+ K +L+
Sbjct: 506 EGRGASVTSKR-----TPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKVNKQNLI 560
Query: 404 LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPA 463
LRNQ++Q F ERDI++F +NPFVV+M+CSFETK+HLC+VMEYVEGGDCA+LLKN G LP
Sbjct: 561 LRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPV 620
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523
DM R YFAETVLA+EYLH+YGIVHRDLKPDNLLIT++GHIKLTDFGLSK+GLMSL TNLY
Sbjct: 621 DMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 680
Query: 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET 583
E ++E+DA++F DKQV GTPEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+T
Sbjct: 681 EGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 740
Query: 584 PEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643
PEELF ++D+I WP DD + +A+ + + LL QNP +RLGTG EVK+H +F+ L
Sbjct: 741 PEELFGQVISDEIVWPEGDD-ALPPDAQDLTSKLLHQNPLERLGTGSATEVKQHSFFTGL 799
Query: 644 DWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDE-TEDS-FSLGTFSSCTHQ 701
DW LLR KAEFIPQL+ E+DTSYFD+R ERY H ED DE +ED + FSSC+ +
Sbjct: 800 DWTGLLRQKAEFIPQLESEDDTSYFDTRSERYQHVDSEDEDEASEDGCLEIRQFSSCSPR 859
Query: 702 YKKV 705
+ KV
Sbjct: 860 FSKV 863
|
|
| UNIPROTKB|F1NAH4 MAST2 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1908 (676.7 bits), Expect = 4.5e-200, Sum P(2) = 4.5e-200
Identities = 397/722 (54%), Positives = 488/722 (67%)
Query: 19 AHRKSFI--ANTSPTLPRCYSPMPS----SPLESPRVASNQ---HFPFIPMKRPFNHLNT 69
++RKS I ++TSPTLPR +SP+ SPL+SPR S HF F+P +R
Sbjct: 6 SNRKSLIVTSSTSPTLPRPHSPLHGHAGGSPLDSPRNFSPNAPAHFSFVPARR------- 58
Query: 70 DCRSDGTRRWSVAXXXXXXXXXXXXXXXXXXXXXXQEKLHQLPNIPTSDELHELTKHFSS 129
+DG RRWS+A QEKLHQLP PT+DELH LTKHFS+
Sbjct: 59 ---TDG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQEKLHQLPFQPTADELHFLTKHFST 114
Query: 130 ND-TDEEIRRSFMXXXXXXXXXXXXXXI-LDNDIIAMNMLYKERFPKAIQQMETRLSNFI 187
TDEE R S I D++II MN +YKERFPKA QME RL+ FI
Sbjct: 115 ESITDEEGRHSPALRPRSRSLSPGRSPISFDSEIIMMNHVYKERFPKATAQMEERLAEFI 174
Query: 188 NENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSKEKLISSRYFYEMXXXXXXX 247
N+ N L+ A D ++ F+HHQ++E+ARDCL KS+E LI+SRYFYE+
Sbjct: 175 ASNAP--ENVLQLA--DG--VLSFIHHQVIELARDCLDKSREGLITSRYFYELQENLEKL 228
Query: 248 XXXXXXXXXXAATVXXXXXXXXXXXX-SRPARLLECLEFDPEEFYHFLEMAEGDAKSLQG 306
+ +RPARLLECLEFDPEEFYH LE AEG AK QG
Sbjct: 229 LQDAHERSESSEVAFVTQLVKKLMIIIARPARLLECLEFDPEEFYHLLEAAEGHAKEGQG 288
Query: 307 IKADIPQYIIGKLGINKTVFSDLDN----DIQNISLTDTSIESNSDSYCSKKDKFSKTPN 362
IK DIP+YII +LG+ + ++ D + TD S+ES + SKK TP+
Sbjct: 289 IKCDIPRYIISQLGLTRDPLEEMAQLNSYDSPDTPETDDSVESRGATVQSKK-----TPS 343
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
E +F IKLISNGAYG+VYLVRHK TRQRFAMKKI K +L+LRNQ++Q F ERDI++F +
Sbjct: 344 EEEFETIKLISNGAYGAVYLVRHKTTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAE 403
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
NPFVV+M+CSFETK+HLC+VMEYVEGGDCA+LLKN G LP DMAR YFAETVLA+EYLH+
Sbjct: 404 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN 463
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
YGIVHRDLKPDNLLIT++GHIKLTDFGLSK+GLMSL TNLYE ++E+D ++F DKQV GT
Sbjct: 464 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 523
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602
PEYIAPEVILRQGYGKPVDWW+MGVILYEFLVGCVPFFG+TPEELF ++D+I WP D
Sbjct: 524 PEYIAPEVILRQGYGKPVDWWAMGVILYEFLVGCVPFFGDTPEELFGQVISDEIAWPEGD 583
Query: 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDE 662
D + +A+ +I+ LL+QNP +R+GTG EVK+H +F +LDWN LLR KAEFIPQL+ E
Sbjct: 584 D-ALPPDAQDLISKLLRQNPLERMGTGSAFEVKQHRFFKDLDWNGLLRQKAEFIPQLESE 642
Query: 663 EDTSYFDSRMERYNHDIGEDTDET--EDSFSLGTFSSCTHQYKKVXXXXXXXXXXEV--T 718
+DTSYFD+R ERY H E+ ++T +D + FSSC+ ++ KV E T
Sbjct: 643 DDTSYFDTRSERYQHLDSEEEEDTNDDDHVEIRQFSSCSPRFSKVYSSMERLSIHEERKT 702
Query: 719 PP 720
PP
Sbjct: 703 PP 704
|
|
| RGD|1304573 Mast2 "microtubule associated serine/threonine kinase 2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1905 (675.7 bits), Expect = 2.0e-199, Sum P(2) = 2.0e-199
Identities = 400/741 (53%), Positives = 495/741 (66%)
Query: 1 MKDLTVPS-GCLRKTSRIHAHRKSFI--ANTSPTLPRCYSPMP----SSPLESPRVASNQ 53
+K+L++P G +TS +RKS I ++TSPTLPR +SP+ +SPL+SPR S
Sbjct: 157 LKELSLPRRGSFCRTS----NRKSLIVTSSTSPTLPRPHSPLHGHTGNSPLDSPRNFSPN 212
Query: 54 ---HFPFIPMKRPFNHLNTDCRSDGTRRWSVAXXXXXXXXXXXXXXXXXXXXXXQEKLHQ 110
HF F+P R H D R+DG RRWS+A QEKLHQ
Sbjct: 213 APAHFSFVPA-RSHGH-RAD-RTDG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQEKLHQ 268
Query: 111 LPNIPTSDELHELTKHFSS-NDTDEEIRRS-FMXXXXXXXXXXXXXXILDNDIIAMNMLY 168
LP PT+DELH LTKHFS+ N DEE R+S M D++II MN +Y
Sbjct: 269 LPFQPTADELHFLTKHFSTENVPDEEGRQSPAMRPRSRSLSPGRSPVSFDSEIIMMNHVY 328
Query: 169 KERFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSK 228
KERFPKA QME RL+ FI+ N+ ++ P A + F+HHQ++E+ARDCL KS+
Sbjct: 329 KERFPKATAQMEERLAEFISCNTP------DSVLPLADGALSFIHHQVIEMARDCLDKSR 382
Query: 229 EKLISSRYFYEMXXXXXXXXXXXXXXXXXA-ATVXXXXXXXXXXXXSRPARLLECLEFDP 287
LI+S YFYE+ + +RPARLLECLEFDP
Sbjct: 383 SGLITSHYFYELQENLEKLLQDAHERSESSDVAFVIQLVKKLMIIIARPARLLECLEFDP 442
Query: 288 EEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDL----DNDIQNISLTDTSI 343
EEFYH LE AEG AK GIK DIP+YI+ +LG+ + ++ D + TD S+
Sbjct: 443 EEFYHLLEAAEGHAKEGHGIKCDIPRYIVSQLGLTRDPLEEMVQLSSYDSPDTPETDDSV 502
Query: 344 ESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM 403
E S SKK TP+E DF IKLISNGAYG+V+LVRHK TRQRFAMKKI K +L+
Sbjct: 503 EGRGASQPSKK-----TPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQNLI 557
Query: 404 LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPA 463
LRNQ++Q F ERDI++F +NPFVV+M+CSFETK+HLC+VMEYVEGGDCA+LLKN G LP
Sbjct: 558 LRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPV 617
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523
DM R YFAETVLA+EYLH+YGIVHRDLKPDNLLIT++GHIKLTDFGLSK+GLMSL TNLY
Sbjct: 618 DMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 677
Query: 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET 583
E ++E+DA++F DKQV GTPEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+T
Sbjct: 678 EGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 737
Query: 584 PEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643
PEELF ++D+I WP DD + +A+ + + LL QNP +RLGT +EVK+HP+F L
Sbjct: 738 PEELFGQVISDEIVWPEGDD-ALPPDAQDLTSKLLHQNPLERLGTSSAYEVKQHPFFMGL 796
Query: 644 DWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDE-TEDS-FSLGTFSSCTHQ 701
DW LLR KAEFIPQL+ E+DTSYFD+R ERY+H ED +E +ED + FSSC+ +
Sbjct: 797 DWTGLLRQKAEFIPQLESEDDTSYFDTRSERYHHVDSEDEEEVSEDGCLEIRQFSSCSPR 856
Query: 702 YKKVXXXXXXXXXXEV--TPP 720
+ KV E TPP
Sbjct: 857 FSKVYSSMERLSLLEGHRTPP 877
|
|
| UNIPROTKB|Q6P0Q8 MAST2 "Microtubule-associated serine/threonine-protein kinase 2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1903 (674.9 bits), Expect = 2.0e-199, Sum P(2) = 2.0e-199
Identities = 398/741 (53%), Positives = 497/741 (67%)
Query: 1 MKDLTVPS-GCLRKTSRIHAHRKSFI--ANTSPTLPRCYSPMP----SSPLESPRVASNQ 53
+K+L++P G +TS +RKS I ++TSPTLPR +SP+ +SPL+SPR S
Sbjct: 156 LKELSLPRRGSFCRTS----NRKSLIVTSSTSPTLPRPHSPLHGHTGNSPLDSPRNFSPN 211
Query: 54 ---HFPFIPMKRPFNHLNTDCRSDGTRRWSVAXXXXXXXXXXXXXXXXXXXXXXQEKLHQ 110
HF F+P +R +DG RRWS+A QEKLHQ
Sbjct: 212 APAHFSFVPARR----------TDG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQEKLHQ 260
Query: 111 LPNIPTSDELHELTKHFSSNDT-DEEIRRS-FMXXXXXXXXXXXXXXILDNDIIAMNMLY 168
LP PT+DELH LTKHFS+ DEE R+S M D++II MN +Y
Sbjct: 261 LPFQPTADELHFLTKHFSTESVPDEEGRQSPAMRPRSRSLSPGRSPVSFDSEIIMMNHVY 320
Query: 169 KERFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSK 228
KERFPKA QME RL+ FI+ N+ ++ P A + F+HHQ++E+ARDCL KS+
Sbjct: 321 KERFPKATAQMEERLAEFISSNTP------DSVLPLADGALSFIHHQVIEMARDCLDKSR 374
Query: 229 EKLISSRYFYEMXXXXXXXXXXXXXXXXXAATVXXXXXXXXXXXX-SRPARLLECLEFDP 287
LI+S+YFYE+ + +RPARLLECLEFDP
Sbjct: 375 SGLITSQYFYELQDNLEKLLQDAHERSESSEVAFVMQLVKKLMIIIARPARLLECLEFDP 434
Query: 288 EEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDN----DIQNISLTDTSI 343
EEFYH LE AEG AK QGIK DIP+YI+ +LG+ + ++ D + TD SI
Sbjct: 435 EEFYHLLEAAEGHAKEGQGIKCDIPRYIVSQLGLTRDPLEEMAQLSSCDSPDTPETDDSI 494
Query: 344 ESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM 403
E + S SKK TP+E DF IKLISNGAYG+V+LVRHK TRQRFAMKKI K +L+
Sbjct: 495 EGHGASLPSKK-----TPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQNLI 549
Query: 404 LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPA 463
LRNQ++Q F ERDI++F +NPFVV+M+CSF+TK+HLC+VMEYVEGGDCA+LLKN G LP
Sbjct: 550 LRNQIQQAFVERDILTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCATLLKNIGALPV 609
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523
DM R YFAETVLA+EYLH+YGIVHRDLKPDNLLIT++GHIKLTDFGLSK+GLMSL TNLY
Sbjct: 610 DMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 669
Query: 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET 583
E ++E+DA++F DKQV GTPEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+T
Sbjct: 670 EGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 729
Query: 584 PEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643
PEELF ++D+I WP E D + +A+ + + LL QNP +RLGTG +EVK+HP+F+ L
Sbjct: 730 PEELFGQVISDEIVWP-EGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEVKQHPFFTGL 788
Query: 644 DWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDE-TEDS-FSLGTFSSCTHQ 701
DW LLR KAEFIPQL+ E+DTSYFD+R ERY+H ED +E +ED + FSSC+ +
Sbjct: 789 DWTGLLRQKAEFIPQLESEDDTSYFDTRSERYHHMDSEDEEEVSEDGCLEIRQFSSCSPR 848
Query: 702 YKKVXXXXXXXXXXEV--TPP 720
+ KV E TPP
Sbjct: 849 FNKVYSSMERLSLLEERRTPP 869
|
|
| UNIPROTKB|F1PRV4 MAST2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1895 (672.1 bits), Expect = 2.2e-198, Sum P(2) = 2.2e-198
Identities = 392/724 (54%), Positives = 489/724 (67%)
Query: 1 MKDLTVPS-GCLRKTSRIHAHRKSFI--ANTSPTLPRCYSPMP----SSPLESPRVASNQ 53
+K+L++P G +TS +RKS I ++TSPTLPR +SP+ +SPL+SPR S
Sbjct: 160 LKELSLPRRGSFCRTS----NRKSLIVTSSTSPTLPRPHSPLHGHTGNSPLDSPRNFSPS 215
Query: 54 ---HFPFIPMKRPFNHLNTDCRSDGTRRWSVAXXXXXXXXXXXXXXXXXXXXXXQEKLHQ 110
HF F+P +R +DG RRWS+A QEKLHQ
Sbjct: 216 APAHFSFVPARR----------TDG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQEKLHQ 264
Query: 111 LPNIPTSDELHELTKHFSSNDT-DEEIRRS-FMXXXXXXXXXXXXXXILDNDIIAMNMLY 168
LP PT+DELH LTKHFS+ DEE R+S M D++II MN +Y
Sbjct: 265 LPFQPTADELHFLTKHFSTESVPDEEGRQSPAMRPRSRSLSPGRSPVSFDSEIIMMNHVY 324
Query: 169 KERFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSK 228
KERFPKA QME RL+ FI+ N+ ++ P A + F+HHQ++E+ARDCL KS+
Sbjct: 325 KERFPKATAQMEERLAEFISSNTP------DSVLPLADGTLSFIHHQVIEMARDCLDKSR 378
Query: 229 EKLISSRYFYEMXXXXXXXXXXXXXXXXXAATVXXXXXXXXXXXX-SRPARLLECLEFDP 287
+LI+S YFYE+ + +RPARLLECLEFDP
Sbjct: 379 NRLITSHYFYELQENLEKLIQDAHERSESSEVAFVMQLVKKLMIVIARPARLLECLEFDP 438
Query: 288 EEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDN----DIQNISLTDTSI 343
EEFYH LE AEG AK QGIK DIP+YI+ +LG+ + ++ D + TD S+
Sbjct: 439 EEFYHLLEAAEGHAKEGQGIKCDIPRYIVSQLGLTRDPLEEMAQLSSYDSPDTPETDDSV 498
Query: 344 ESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM 403
E S SK+ TP+E DF IKLISNGAYG+V+LVRHK TRQRFAMKK+ K +L+
Sbjct: 499 EGRGASVTSKR-----TPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKVNKQNLI 553
Query: 404 LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPA 463
LRNQ++Q F ERDI++F +NPFVV+M+CSFETK+HLC+VMEYVEGGDCA+LLKN G LP
Sbjct: 554 LRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPV 613
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523
DM R YFAETVLA+EYLH+YGIVHRDLKPDNLLIT++GHIKLTDFGLSK+GLMSL TNLY
Sbjct: 614 DMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 673
Query: 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET 583
E ++E+DA++F DKQV GTPEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+T
Sbjct: 674 EGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 733
Query: 584 PEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643
PEELF ++D+I WP DD + +A+ + + LL QNP +RLGTG EVK+H +F+ L
Sbjct: 734 PEELFGQVISDEIVWPEGDD-ALPPDAQDLTSKLLHQNPLERLGTGSATEVKQHSFFTGL 792
Query: 644 DWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDE-TEDS-FSLGTFSSCTHQ 701
DW LLR KAEFIPQL+ E+DTSYFD+R ERY H ED DE +ED + FSSC+ +
Sbjct: 793 DWTGLLRQKAEFIPQLESEDDTSYFDTRSERYQHVDSEDEDEASEDGCLEIRQFSSCSPR 852
Query: 702 YKKV 705
+ KV
Sbjct: 853 FSKV 856
|
|
| UNIPROTKB|E1B754 LOC535643 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1896 (672.5 bits), Expect = 5.9e-198, Sum P(2) = 5.9e-198
Identities = 391/722 (54%), Positives = 485/722 (67%)
Query: 19 AHRKSFI--ANTSPTLPRCYSPMP----SSPLESPRVASNQ---HFPFIPMKRPFNHLNT 69
++RKS I ++TSPTLPR +SP+ +SPL+SPR S HF F+P +R
Sbjct: 85 SNRKSLIVTSSTSPTLPRPHSPLHGHTGNSPLDSPRNFSPNAPAHFSFVPARR------- 137
Query: 70 DCRSDGTRRWSVAXXXXXXXXXXXXXXXXXXXXXXQEKLHQLPNIPTSDELHELTKHFSS 129
+DG RRWS+A QEKLHQLP PT+DELH LTKHFS+
Sbjct: 138 ---TDG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQEKLHQLPFQPTADELHFLTKHFST 193
Query: 130 NDT-DEEIRRSFMXXXXXXXXXXXXXXI-LDNDIIAMNMLYKERFPKAIQQMETRLSNFI 187
+ DEE R+S + D++II MN +YKERFPKA QME RL+ FI
Sbjct: 194 DSVPDEEGRQSPALRPRSRSLSPGRSPVSFDSEIIMMNHVYKERFPKATAQMEERLAEFI 253
Query: 188 NENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSKEKLISSRYFYEMXXXXXXX 247
+ N+ + P A + F+HHQ++E+ARDCL KS+ LI+S YFYE+
Sbjct: 254 SSNTP------DNVLPLADGTLSFIHHQVIEMARDCLDKSRSGLITSHYFYELQENLEKL 307
Query: 248 XXXXXXXXXXAATVXXXXXXXXXXXX-SRPARLLECLEFDPEEFYHFLEMAEGDAKSLQG 306
+ +RPARLLECLEFDPEEFYH LE AEG AK QG
Sbjct: 308 LQDAHERSESSEVAFVMQLVKKLMIVIARPARLLECLEFDPEEFYHLLEAAEGHAKEGQG 367
Query: 307 IKADIPQYIIGKLGINKTVFSDLDN----DIQNISLTDTSIESNSDSYCSKKDKFSKTPN 362
IK DIP+YI+ +LG+ + ++ D + TD S+E S SKK TP+
Sbjct: 368 IKCDIPRYIVSQLGLTRDPLEEMAQLSSYDSPDTPETDDSVEGRGASLTSKK-----TPS 422
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
E DF IKLISNGAYG+V+LVRHK TRQRFAMKKI K +L+LRNQ++Q F ERDI++F +
Sbjct: 423 EEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAE 482
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
NPFVV+M+CSFETK+HLC+VMEYVEGGDCA+LLKN G LP DM R YFAETVLA+EYLH+
Sbjct: 483 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMVRLYFAETVLALEYLHN 542
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
YGIVHRDLKPDNLLIT++GHIKLTDFGLSK+GLMSL TNLYE ++E+DA++F DKQV GT
Sbjct: 543 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDAREFLDKQVCGT 602
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602
PEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+TPEELF ++D+I WP D
Sbjct: 603 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGD 662
Query: 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDE 662
D + +A+ + + LL QNP +RLGTG +EVK+HP+F+ LDW LLR KAEFIPQL+ E
Sbjct: 663 D-ALPPDAQDLTSKLLHQNPLERLGTGSAYEVKQHPFFTGLDWTGLLRQKAEFIPQLESE 721
Query: 663 EDTSYFDSRMERYNHDIGEDTDE-TEDS-FSLGTFSSCTHQYKKVXXXXXXXXXXEV--T 718
+DTSYFD+R ERY+H ED +E +ED + FSSC+ ++ KV E T
Sbjct: 722 DDTSYFDTRSERYHHVDSEDEEEVSEDGCLEIRQFSSCSPRFSKVYSSMERLSLLEERRT 781
Query: 719 PP 720
PP
Sbjct: 782 PP 783
|
|
| MGI|MGI:894676 Mast2 "microtubule associated serine/threonine kinase 2" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1880 (666.9 bits), Expect = 1.1e-196, Sum P(2) = 1.1e-196
Identities = 397/742 (53%), Positives = 492/742 (66%)
Query: 1 MKDLTVPS-GCLRKTSRIHAHRKSFI--ANTSPTLPRCYSPMP----SSPLESPRVASNQ 53
+K+L++P G +TS +RKS I ++TSPTLPR +SP+ +SPL+SPR S
Sbjct: 96 LKELSLPRRGSFCRTS----NRKSLIVTSSTSPTLPRPHSPLHGHTGNSPLDSPRNFSPN 151
Query: 54 ---HFPFIPMKRPFNHLNTDCRSDGTRRWSVAXXXXXXXXXXXXXXXXXXXXXXQEKLHQ 110
HF F+P +R +DG RRWS+A QEKLHQ
Sbjct: 152 APAHFSFVPARR----------TDG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQEKLHQ 200
Query: 111 LPNIPTSDELHELTKHFSS-NDTDEEIRRS-FMXXXXXXXXXXXXXXILDNDIIAMNMLY 168
LP PT+DELH LTKHFS+ N DEE RRS M D++II MN +Y
Sbjct: 201 LPFQPTADELHFLTKHFSTENVPDEEGRRSPRMRPRSRSLSPGRSPVSFDSEIIMMNHVY 260
Query: 169 KERFPKAIQQMETRLS-NFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKS 227
KERFPKA QME R S FI+ N+ ++ P A + F+HHQ++E+ARDCL KS
Sbjct: 261 KERFPKATAQMEERPSLTFISSNTP------DSVLPLADGALSFIHHQVIEMARDCLDKS 314
Query: 228 KEKLISSRYFYEMXXXXXXXXXXXXXXXXXA-ATVXXXXXXXXXXXXSRPARLLECLEFD 286
+ LI+S YFYE+ + +RPARLLECLEFD
Sbjct: 315 RSGLITSHYFYELQENLEKLLQDAHERSESSDVAFVIQLVKKLMIIIARPARLLECLEFD 374
Query: 287 PEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDN----DIQNISLTDTS 342
PEEFYH LE AEG AK GIK DIP+YI+ +LG+ + ++ D + TD S
Sbjct: 375 PEEFYHLLEAAEGHAKEGHGIKCDIPRYIVSQLGLTRDPLEEMAQLSSYDSPDTPETDDS 434
Query: 343 IESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL 402
+E S S+K TP+E DF IKLISNGAYG+V+LVRHK TRQRFAMKKI K +L
Sbjct: 435 VEGRGVSQPSQK-----TPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQNL 489
Query: 403 MLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLP 462
+LRNQ++Q F ERDI++F +NPFVV+M+CSFETK+HLC+VMEYVEGGDCA+LLKN G LP
Sbjct: 490 ILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALP 549
Query: 463 ADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522
DM R YFAETVLA+EYLH+YGIVHRDLKPDNLLIT++GHIKLTDFGLSK+GLMSL TNL
Sbjct: 550 VDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 609
Query: 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE 582
YE ++E+DA++F DKQV GTPEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+
Sbjct: 610 YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 669
Query: 583 TPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
TPEELF ++D+I WP DD + +A+ + + LL QNP +RLGT +EVK+HP+F
Sbjct: 670 TPEELFGQVISDEIVWPEGDD-ALPPDAQDLTSKLLHQNPLERLGTSSAYEVKQHPFFMG 728
Query: 643 LDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDE-TEDS-FSLGTFSSCTH 700
LDW LLR KAEFIPQL+ E+DTSYFD+R ERY+H ED +E +ED + FSSC+
Sbjct: 729 LDWTGLLRQKAEFIPQLESEDDTSYFDTRSERYHHVDSEDEEEVSEDGCLEIRQFSSCSP 788
Query: 701 QYKKVXXXXXXXXXXEV--TPP 720
++ KV E TPP
Sbjct: 789 RFSKVYSSMERLSLLEERRTPP 810
|
|
| MGI|MGI:1918885 Mast4 "microtubule associated serine/threonine kinase family member 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1876 (665.4 bits), Expect = 1.4e-195, Sum P(2) = 1.4e-195
Identities = 386/717 (53%), Positives = 483/717 (67%)
Query: 1 MKDLTVPS-GCLRKTSRIHAHRKSFIAN-TSPTLPRCYSPMPSSPLESPRVASNQHFPFI 58
+K+L++P G L +TS +RKS I N SP LPR +SP+ + SP+ + F
Sbjct: 212 LKELSLPRRGSLCRTS----NRKSLIGNGQSPALPRPHSPLSAHAGNSPQDSPRN---FS 264
Query: 59 PMKRPFNHLNTDCRSDGTRRWSVAXXXXXXXXXXXXXXXXXXXXXXQEKLHQLPNIPTSD 118
P H + R+DG RRWS+A QEKLHQLP PT D
Sbjct: 265 PSASA--HFSFARRTDG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQEKLHQLPYQPTPD 321
Query: 119 ELHELTKHFSSND---TDEEIRRSFMXXXXXXXXXXXXXXILDNDIIAMNMLYKERFPKA 175
ELH L+KHF + + T+ R + M D++II MN +YKERFPKA
Sbjct: 322 ELHFLSKHFCTTESIATENRCRNTPMRPRSRSLSPGRSPACCDHEIIMMNHVYKERFPKA 381
Query: 176 IQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSKEKLISSR 235
QME RL I S + P A ++ F HHQI+E+ARDCL KS + LI+SR
Sbjct: 382 TAQMEERLKEIITSYSP------DHVLPLADGVLSFTHHQIIELARDCLDKSHQGLITSR 435
Query: 236 YFYEMXXXXXXXXXXXXXXXXXAATVXXXXXXXXXXXX-SRPARLLECLEFDPEEFYHFL 294
YF+E+ +RPARLLECLEFDPEEFY+ L
Sbjct: 436 YFFELQHKLDKLLQEAHDRSESGELAFIKQLVRKILIVIARPARLLECLEFDPEEFYYLL 495
Query: 295 EMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSD---LDNDIQNISLTDTSIESNSDSYC 351
E AEG AK QGIK DIP+YII +LG+NK + L N + T ES S S
Sbjct: 496 EAAEGHAKEGQGIKTDIPRYIISQLGLNKDPLEEMAQLGNYDSRTAETPEMDESVSSSNT 555
Query: 352 SKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQV 411
S + + P E+DF IKLISNGAYG+VY VRHKE+RQRFAMKKI K +L+LRNQ++Q
Sbjct: 556 SLR--LRRKPRESDFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQNLILRNQIQQA 613
Query: 412 FAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFA 471
F ERDI++F +NPFVV+MYCSFET++HLC+VMEYVEGGDCA+L+KN GPLP DMAR YFA
Sbjct: 614 FVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGPLPVDMARMYFA 673
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531
ETVLA+EYLH+YGIVHRDLKPDNLL+T++GHIKLTDFGLSK+GLMS+ TNLYE ++E+DA
Sbjct: 674 ETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTTNLYEGHIEKDA 733
Query: 532 KQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591
++F DKQV GTPEYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+TPEELF
Sbjct: 734 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 793
Query: 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRH 651
++D+I WP +D+ P +A+ +IT LL+QNP +RLGTGG +EVK+H +F +LDWNSLLR
Sbjct: 794 ISDEINWPEKDEAP-PPDAQELITLLLRQNPLERLGTGGAYEVKQHRFFRSLDWNSLLRQ 852
Query: 652 KAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETEDS-FS--LGTFSSCTHQYKKV 705
KAEFIPQL+ E+DTSYFD+R E+Y+H E+ D+T D F+ + FSSC+H++ KV
Sbjct: 853 KAEFIPQLESEDDTSYFDTRSEKYHHMETEEEDDTNDEDFTVEIRQFSSCSHRFSKV 909
|
|
| UNIPROTKB|E7EWQ5 MAST4 "Microtubule-associated serine/threonine-protein kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1874 (664.7 bits), Expect = 1.6e-195, Sum P(2) = 1.6e-195
Identities = 381/698 (54%), Positives = 475/698 (68%)
Query: 19 AHRKSFIAN-TSPTLPRCYSPMPSSPLESPRVASNQHFPFIPMKRPFNHLNTDCRSDGTR 77
++RKS I N SP LPR +SP+ + SP+ + P F N R+DG R
Sbjct: 47 SNRKSLIGNGQSPALPRPHSPLSAHAGNSPQDSPRNFSPSASAHFSFARRND--RTDG-R 103
Query: 78 RWSVAXXXXXXXXXXXXXXXXXXXXXXQEKLHQLPNIPTSDELHELTKHFSSND---TDE 134
RWS+A QEKLHQLP PT DELH L+KHF + + T+
Sbjct: 104 RWSLASLPSSGYGTNTPSSTVSSSCSSQEKLHQLPYQPTPDELHFLSKHFCTTESIATEN 163
Query: 135 EIRRSFMXXXXXXXXXXXXXXILDNDIIAMNMLYKERFPKAIQQMETRLSNFINENSSLA 194
R + M D++II MN +YKERFPKA QME RL I +S +
Sbjct: 164 RCRNTPMRPRSRSLSPGRSPACCDHEIIMMNHVYKERFPKATAQMEERLKEII---TSYS 220
Query: 195 TNNLETASPDAAPIIRFVHHQILEIARDCLFKSKEKLISSRYFYEMXXXXXXXXXXXXXX 254
+N+ P A ++ F HHQI+E+ARDCL KS + LI+SRYF E+
Sbjct: 221 PDNV---LPLADGVLSFTHHQIIELARDCLDKSHQGLITSRYFLELQHKLDKLLQEAHDR 277
Query: 255 XXXAATVXXXXXXXXXXXX-SRPARLLECLEFDPEEFYHFLEMAEGDAKSLQGIKADIPQ 313
+RPARLLECLEFDPEEFY+ LE AEG AK QGIK DIP+
Sbjct: 278 SESGELAFIKQLVRKILIVIARPARLLECLEFDPEEFYYLLEAAEGHAKEGQGIKTDIPR 337
Query: 314 YIIGKLGINKTVFSD---LDNDIQNISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIK 370
YII +LG+NK + L N + T + ES S S S K + P E+DF IK
Sbjct: 338 YIISQLGLNKDPLEEMAHLGNYDSGTAETPETDESVSSSNASLK--LRRKPRESDFETIK 395
Query: 371 LISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMY 430
LISNGAYG+VY VRHKE+RQRFAMKKI K +L+LRNQ++Q F ERDI++F +NPFVV+MY
Sbjct: 396 LISNGAYGAVYFVRHKESRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVSMY 455
Query: 431 CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDL 490
CSFET++HLC+VMEYVEGGDCA+L+KN GPLP DMAR YFAETVLA+EYLH+YGIVHRDL
Sbjct: 456 CSFETRRHLCMVMEYVEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYGIVHRDL 515
Query: 491 KPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEV 550
KPDNLL+T++GHIKLTDFGLSK+GLMS+ TNLYE ++E+DA++F DKQV GTPEYIAPEV
Sbjct: 516 KPDNLLVTSMGHIKLTDFGLSKVGLMSMTTNLYEGHIEKDAREFLDKQVCGTPEYIAPEV 575
Query: 551 ILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEA 610
ILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+TPEELF ++D+I WP +D+ P +A
Sbjct: 576 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAP-PPDA 634
Query: 611 KSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDS 670
+ +IT LL+QNP +RLGTGG +EVK+H +F +LDWNSLLR KAEFIPQL+ E+DTSYFD+
Sbjct: 635 QDLITLLLRQNPLERLGTGGAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDT 694
Query: 671 RMERYNHDIGEDTDETEDS-FS--LGTFSSCTHQYKKV 705
R E+Y+H E+ D+T D F+ + FSSC+H++ KV
Sbjct: 695 RSEKYHHMETEEEDDTNDEDFNVEIRQFSSCSHRFSKV 732
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q60592 | MAST2_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.5561 | 0.9123 | 0.4261 | yes | N/A |
| Q6P0Q8 | MAST2_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.5648 | 0.9111 | 0.4104 | yes | N/A |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 810 | |||
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.0 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-138 | |
| pfam08926 | 282 | pfam08926, DUF1908, Domain of unknown function (DU | 1e-125 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-117 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-108 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-104 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-101 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-98 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-97 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-94 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-91 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-86 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-84 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-83 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-82 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-82 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-80 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-77 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-75 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-75 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-75 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-72 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-71 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-70 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-70 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-69 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-69 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-68 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-68 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-68 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-68 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-68 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-68 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-67 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-67 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-67 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-67 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-66 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-65 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-65 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-64 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-63 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-63 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-63 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-63 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-62 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-60 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-60 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-59 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-59 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-58 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-58 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-55 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-55 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-55 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-55 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-54 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-53 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-52 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-52 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-52 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-51 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-48 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-46 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-45 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-44 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-44 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-43 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-41 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-41 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-40 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-39 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-38 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-37 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-37 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-37 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-37 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-37 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-37 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-37 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-36 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-36 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-35 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-34 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-34 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-33 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-32 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-32 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-31 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-31 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-31 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-31 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-30 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-29 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-29 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-28 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-27 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-27 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-27 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-26 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-26 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-26 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-25 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-25 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-25 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-25 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-24 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-24 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-24 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-24 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-24 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-23 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-23 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-22 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-22 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-22 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-22 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-22 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-21 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-20 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-20 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-20 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-19 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-19 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-19 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-17 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-14 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-06 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 6e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 1e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-04 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 2e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 8e-04 | |
| TIGR01982 | 437 | TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase | 0.002 | |
| smart00133 | 64 | smart00133, S_TK_X, Extension to Ser/Thr-type prot | 0.003 | |
| cd05145 | 190 | cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 | 0.003 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 626 bits (1615), Expect = 0.0
Identities = 230/306 (75%), Positives = 270/306 (88%), Gaps = 1/306 (0%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
DF IKLISNGAYG+VYLVRHKETRQRFAMKKI K +L+LRNQ++QVF ERDI++F +N
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
PFVV+M+CSFETK+HLC+VMEYVEGGDCA+LLKN G LP DMAR YFAETVLA+EYLH+Y
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
GIVHRDLKPDNLLIT++GHIKLTDFGLSK+GLMSL TNLYE ++E+D ++F DKQV GTP
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
EYIAPEVILRQGYGKPVDWW+MG+ILYEFLVGCVPFFG+TPEELF ++DDIEWP D+
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEE 663
+ +A+ +I+ LL+QNP +RLGTGG EVK+H +F LDWN LLR KAEFIPQL+ E+
Sbjct: 241 -ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESED 299
Query: 664 DTSYFD 669
DTSYFD
Sbjct: 300 DTSYFD 305
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 409 bits (1054), Expect = e-138
Identities = 147/274 (53%), Positives = 191/274 (69%), Gaps = 9/274 (3%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYC 431
IS GAYG V+L + K T +A+K I K ++ +NQ++QV ERDI+S +P+VV +Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 432 SFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLK 491
SF+ KK+L LVMEY+ GGD ASLL+N G L D+AR Y AE VLA+EYLHS GI+HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 492 PDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI 551
PDN+LI + GH+KLTDFGLSK+GL+ N + + DK++ GTP+YIAPEVI
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQIN-------LNDDEKEDKRIVGTPDYIAPEVI 173
Query: 552 LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAK 611
L QG+ K VDWWS+G ILYEFLVG PF GETPEE+F + +N IEWP + + + EA
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVE--VSDEAI 231
Query: 612 SIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645
+I+ LL +P RLG E+K HP+F +DW
Sbjct: 232 DLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|204097 pfam08926, DUF1908, Domain of unknown function (DUF1908) | Back alignment and domain information |
|---|
Score = 376 bits (968), Expect = e-125
Identities = 172/295 (58%), Positives = 206/295 (69%), Gaps = 21/295 (7%)
Query: 43 PLESPRVASNQ---HFPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVS 99
PL+SPR S +FPF + R+DG RRWSVASLPSSGYGT P SS VS
Sbjct: 1 PLDSPRNFSASASINFPFAR-----RIASRRGRADG-RRWSVASLPSSGYGTNPPSSTVS 54
Query: 100 SQCSSQEKLHQLPNIPTSDELHELTKHFSSND--TDEEIRRS-FMRPRSKSLSSPSRSPI 156
S SSQE+LHQLP PT D+LH L+KHF S + TDE+ RRS RPRS+SLS P RSPI
Sbjct: 55 SSSSSQERLHQLPFQPTQDDLHFLSKHFRSTESVTDEDGRRSPHFRPRSRSLS-PGRSPI 113
Query: 157 -LDNDIIAMNMLYKERFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQ 215
DN+I+ MN +YKERFPKA QME RL +FI E ++ P A ++ F+HHQ
Sbjct: 114 TFDNEIVMMNHVYKERFPKATAQMEERLQDFIAEFKP------CSSLPLADGVLGFIHHQ 167
Query: 216 ILEIARDCLFKSKEKLISSRYFYEMSEKLERLLTETKEKSL-EAATVLTFTLKKLLLIIS 274
++E+ARDCL KS+ KLI+SRYFYE+ EKLERLL E KE+S E +T +KKLL+IIS
Sbjct: 168 VVELARDCLDKSQAKLITSRYFYELQEKLERLLHEAKERSESEEVAEITGLVKKLLIIIS 227
Query: 275 RPARLLECLEFDPEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDL 329
RPARLLECLEFDPEEFYH LE AEG AK QGIK DIP+YII +LG+ + +L
Sbjct: 228 RPARLLECLEFDPEEFYHLLEAAEGQAKVGQGIKTDIPRYIISQLGLTRDPLEEL 282
|
This domain is found in a set of hypothetical/structural eukaryotic proteins. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 353 bits (909), Expect = e-117
Identities = 118/269 (43%), Positives = 172/269 (63%), Gaps = 19/269 (7%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYC 431
+ G++G V LVR K+T + +AMK + K ++ R ++E ER+I+S ++PF+V ++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 432 SFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLK 491
+F+T++ L LV+EY GG+ S L G + ARFY AE VLA+EYLHS GI++RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 492 PDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI 551
P+N+L+ A GHIKLTDFGL+K + F GTPEY+APEV+
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSR----------TNTFC-----GTPEYLAPEVL 165
Query: 552 LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAK 611
L +GYGK VDWWS+GV+LYE L G PF+ E +E++ + D + +P + EA+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEAR 221
Query: 612 SIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
+I+ LLQ++P RLG+GG E+K HP+F
Sbjct: 222 DLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 334 bits (859), Expect = e-108
Identities = 139/327 (42%), Positives = 189/327 (57%), Gaps = 31/327 (9%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+DF VIK+I GA+G V+LVR K+T Q +AMK + K+ ++ RNQ+ V AERDI++ D+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
P++V +Y SF+ ++HL LVMEY+ GGD +LL P + ARFY AE VLA++ +H
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSK-------MGLMSLATNLYECYVERDAKQFSD 536
G +HRD+KPDN+LI A GHIKL DFGL K ++ + + D
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF-RDNVLVRRRD 179
Query: 537 KQVY--------GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELF 588
+ GTP+YIAPEV+ YG DWWS+GVILYE L G PF+ +T +E
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE-- 237
Query: 589 AHTVNDDIEW------PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
T N I W P + EA +I LL +P DRLG+ E+K HP+F
Sbjct: 238 --TYNKIINWKESLRFPPDPPVS--PEAIDLICRLL-CDPEDRLGSFE--EIKSHPFFKG 290
Query: 643 LDWNSLLRHKAEFIPQLDDEEDTSYFD 669
+DW +L K F+P+L DTS FD
Sbjct: 291 IDWENLRETKPPFVPELSSPLDTSNFD 317
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 321 bits (826), Expect = e-104
Identities = 130/315 (41%), Positives = 190/315 (60%), Gaps = 36/315 (11%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMK-----KIIKNSLMLRNQMEQVFAERDIM 418
+DF IK + G++G V LVRHK + + +A+K KI+K Q+E V E+ I+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKL-----KQVEHVLNEKRIL 55
Query: 419 SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVE 478
+PF+V +Y SF+ +L LVMEYV GG+ S L+ +G P +ARFY A+ VLA+E
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ 538
YLHS IV+RDLKP+NLL+ + G+IK+TDFG +K V+
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK-------------RVKGRTYTLC--- 159
Query: 539 VYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598
GTPEY+APE+IL +GYGK VDWW++G+++YE L G PFF + P +++ + + +
Sbjct: 160 --GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF 217
Query: 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHK--AE 654
PS +AK +I +LLQ + RLG G +++K HP+F+ +DW +LL+ K A
Sbjct: 218 PS----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAP 273
Query: 655 FIPQLDDEEDTSYFD 669
FIP++ DTS FD
Sbjct: 274 FIPKVKGPGDTSNFD 288
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 314 bits (805), Expect = e-101
Identities = 127/279 (45%), Positives = 174/279 (62%), Gaps = 20/279 (7%)
Query: 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI-MSFTDNPFVV 427
+K IS GA+GSVYL + + T FA+K + K+ ++ +NQ+ V AER I M ++P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVH 487
+Y SF++K +L LVMEY+ GGDCASL+K G LP D A+ Y AE VL VE LH GI+H
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 488 RDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIA 547
RD+KP+NLLI GH+KLTDFGLS+ GL + K+ GTP+Y+A
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------------------KKFVGTPDYLA 161
Query: 548 PEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQ 607
PE IL G K DWWS+G +++EFL G PF ETP+ +F + ++ I WP E
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCS 221
Query: 608 VEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646
EA +I LL +P RLG G E+K HP+F +++W+
Sbjct: 222 PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 306 bits (786), Expect = 1e-98
Identities = 111/275 (40%), Positives = 153/275 (55%), Gaps = 21/275 (7%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+ +++ + G++G VYL R K+T + A+K I K + + E++ E I+ +P
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
+V +Y FE + L LVMEY EGGD LLK G L D ARFY + + A+EYLHS GI
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
VHRDLKP+N+L+ GH+KL DFGL++ + D + V GTPEY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---------------QLDPGEKLTTFV-GTPEY 162
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWP 605
+APEV+L +GYGK VD WS+GVILYE L G PF G+ + +W
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD 222
Query: 606 IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
I EAK +I LL ++P RL E +HP+F
Sbjct: 223 ISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 306 bits (787), Expect = 3e-97
Identities = 134/330 (40%), Positives = 188/330 (56%), Gaps = 26/330 (7%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+DF IK+I GA+G V LV+ K+T +AMKK+ K+ ++ + Q+ V AERDI++ DN
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
P+VV +Y SF+ + +L L+MEY+ GGD +LL + RFY AET+LA++ +H
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE---------CYVERDAKQF 534
G +HRD+KPDNLL+ A GHIKL+DFGL GL + +++ +K
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCT-GLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 535 SDKQ---------------VYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPF 579
S K+ GTP+YIAPEV L+ GY K DWWS+GVI+YE LVG PF
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239
Query: 580 FGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639
+ P+E + +N D+ P+ EAK +I L RLG G +E+K HP+
Sbjct: 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPF 298
Query: 640 FSNLDWNSLLRHKAEFIPQLDDEEDTSYFD 669
F +DW + A IP+L DTS FD
Sbjct: 299 FKGVDWEHIRERPAPIIPELKSITDTSNFD 328
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 298 bits (764), Expect = 1e-94
Identities = 126/318 (39%), Positives = 187/318 (58%), Gaps = 21/318 (6%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
F IKL+ G G V+LVR K T + FA+K + K ++ RN++++V E++I++ D+P
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLK--NTGPLPADMARFYFAETVLAVEYLHS 482
F+ T+Y SF+T+ +LCLVM+Y GG+ LL+ L ++ARFY AE +LA+EYLH
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKM--------------GLMSLATNLYECYVE 528
GIV+RDLKP+N+L+ GHI L+DF LSK G + N
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELF 588
+ F GT EYIAPEVI G+G VDWW++G++LYE L G PF G +E F
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241
Query: 589 AHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT-GGPHEVKEHPYFSNLDWNS 647
++ + ++ +P P+ A+ +I LL ++P RLG+ G E+K+HP+F ++W +
Sbjct: 242 SNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW-A 298
Query: 648 LLRH-KAEFIPQLDDEED 664
L+RH IP+ DD D
Sbjct: 299 LIRHTTPPIIPRPDDGID 316
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 288 bits (740), Expect = 7e-91
Identities = 128/310 (41%), Positives = 183/310 (59%), Gaps = 25/310 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
DF ++ + G YG V+L + K+T + A+K++ K+ L N++ V ERDI++ T +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
++V + +F+ ++L L MEYV GGD +LL N G L D ARFY AE AV+ LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
G +HRDLKP+N LI A GHIKLTDFGLSK G+++ A V G+P
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK-GIVTYA-----------------NSVVGSP 162
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN--DDIEWPSE 601
+Y+APEV+ +GY VD+WS+G +LYEFL G PF G TP E + + + ++ P
Sbjct: 163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY 222
Query: 602 DD--WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQL 659
DD + + EA +IT L+ +P R G ++K HP+F +DWN L K F+P+L
Sbjct: 223 DDPRFNLSDEAWDLITKLI-NDPSRRF--GSLEDIKNHPFFKEVDWNELRELKPPFVPEL 279
Query: 660 DDEEDTSYFD 669
+ E DT YFD
Sbjct: 280 ESEIDTGYFD 289
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 279 bits (715), Expect = 1e-86
Identities = 145/353 (41%), Positives = 192/353 (54%), Gaps = 38/353 (10%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
F IK I GA+G V LVR +T +AMK + K +++RNQ V AERDI++ DN +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
VV +Y SF+ K +L VM+Y+ GGD SLL G D+ARFY AE A+E +H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 486 VHRDLKPDNLLITALGHIKLTDFGL---------SK------------MGLMSLATNLYE 524
+HRD+KPDN+LI GHIKLTDFGL SK M + +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 525 CY---VERDAKQFSDK----QVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCV 577
C +ER K+ + + GTP YIAPEV+LR GY + DWWS+GVILYE LVG
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 578 PFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQ---NPRDRLGTGGPHEV 634
PF +TP E T I W + P Q + +DL+ + DRLG G E+
Sbjct: 243 PFLADTPAE----TQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEI 298
Query: 635 KEHPYFSNLDWNSLLRH-KAEFIPQLDDEEDTSYFD--SRMERYNHDIGEDTD 684
K HP+F +D+ SL+R KA +IP++ DTS FD + + D GE +
Sbjct: 299 KAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSP 351
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 269 bits (690), Expect = 9e-84
Identities = 114/306 (37%), Positives = 174/306 (56%), Gaps = 24/306 (7%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN-PFVVT 428
K++ G++G V L K T + +A+K + K+ ++ + +E E+ +++ PF+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
++ F+TK L VMEYV GGD ++ +G ARFY AE VL +++LH GI++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLK DN+L+ + GHIK+ DFG+ K G++ T C GTP+YIAP
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC---------------GTPDYIAP 165
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608
E++ Q YG VDWW++GV+LYE L G PF G+ +ELF + D++ +P W +
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR---W-LSK 221
Query: 609 EAKSIITDLLQQNPRDRLG--TGGPHEVKEHPYFSNLDWNSLLRHKAE--FIPQLDDEED 664
EAKSI+ L +NP RLG G ++K HP+F +DW+ L R + + F P++ D
Sbjct: 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFD 281
Query: 665 TSYFDS 670
S FD
Sbjct: 282 VSNFDD 287
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 269 bits (688), Expect = 9e-83
Identities = 132/340 (38%), Positives = 199/340 (58%), Gaps = 39/340 (11%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
DF +K+I GA+G V LV+ K+T + +AMK ++K+ + ++Q+ V AERD+++ +D+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
P+VV++Y SF+ ++L L+ME++ GGD ++L D+ RFY AE VLA+E +H
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY--ECYVERDAKQFSDKQ--- 538
G +HRD+KPDN+LI GHIKL+DFGLS G + Y + + K D +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLS-TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSV 179
Query: 539 ----------------------------VYGTPEYIAPEVILRQGYGKPVDWWSMGVILY 570
GTP+YIAPE+ L+QGYG+ DWWS+G I++
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239
Query: 571 EFLVGCVPFFGETPEELFAHTVN--DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628
E L+G PF E E + +N + + +P DD + VEA+ +I L+ N +RLG
Sbjct: 240 ECLIGWPPFCSENSHETYRKIINWRETLYFP--DDIHLSVEAEDLIRRLI-TNAENRLGR 296
Query: 629 GGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYF 668
GG HE+K HP+F +DW+++ + +A FIPQL DTSYF
Sbjct: 297 GGAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYF 336
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 263 bits (674), Expect = 4e-82
Identities = 107/281 (38%), Positives = 170/281 (60%), Gaps = 26/281 (9%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYC 431
+ G +G V LV+ K + FA+K + K ++ Q E +F+E++I+ ++PF+V +Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 432 SFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLK 491
+F+ KK++ ++MEY GG+ ++L++ G ARFY A VLA EYLH+ GI++RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 492 PDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI 551
P+NLL+ + G++KL DFG +K ++ K ++ GTPEY+APE+I
Sbjct: 121 PENLLLDSNGYVKLVDFGFAK-------------KLKSGQKTWT---FCGTPEYVAPEII 164
Query: 552 LRQGYGKPVDWWSMGVILYEFLVGCVPFFG--ETPEELFAHTV--NDDIEWPSEDDWPIQ 607
L +GY VD+WS+G++LYE L G PF E P E++ + N +E+P+ I
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY----ID 220
Query: 608 VEAKSIITDLLQQNPRDRLG--TGGPHEVKEHPYFSNLDWN 646
AK +I LL++NP +RLG GG ++K+H +F+ DW
Sbjct: 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 265 bits (678), Expect = 7e-82
Identities = 121/333 (36%), Positives = 189/333 (56%), Gaps = 30/333 (9%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
DF + + + G++G V + +HK T + +A+K + K ++ Q++ V E+ I+ +P
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG 484
F+V M CSF+ + + ++E+V GG+ + L+ G P D+A+FY AE VLA EYLHS
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 485 IVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK--QVYGT 542
I++RDLKP+NLL+ GH+K+TDFG AK+ D+ + GT
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGF--------------------AKKVPDRTFTLCGT 178
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602
PEY+APEVI +G+GK VDWW+MGV+LYEF+ G PFF +TP ++ + +++P+
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN-- 236
Query: 603 DWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLL-RHKAEFIP-Q 658
W A+ ++ LLQ + RLGT GG +VK HPYF +W+ L R+ IP +
Sbjct: 237 -W-FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVR 294
Query: 659 LDDEEDTSYFDSRMERYNHDIGEDTDETEDSFS 691
+ DTS F+ + + T + F+
Sbjct: 295 VKSPGDTSNFEKYPDSPVDRLPPLTAAQQAEFA 327
|
Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 262 bits (672), Expect = 2e-80
Identities = 130/338 (38%), Positives = 187/338 (55%), Gaps = 40/338 (11%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
DF VIK+I GA+G V LVRHK ++Q +AMK + K ++ R+ + ERDIM+
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLH 481
++ ++V ++ +F+ K+L +VMEY+ GGD +L+ N +P ARFY AE VLA++ +H
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIH 159
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLS-KMGLMSLATNLYECYVERDAKQFSDKQVY 540
S G +HRD+KPDN+L+ GH+KL DFG KM + + D V
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM--------------DANGMVRCDTAV- 204
Query: 541 GTPEYIAPEVILRQG----YGKPVDWWSMGVILYEFLVGCVPFFGE----TPEELFAHTV 592
GTP+YI+PEV+ QG YG+ DWWS+GV LYE LVG PF+ + T ++ H
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH-- 262
Query: 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN--SLLR 650
+ + +P DD I +AK +I L RLG G E+K HP+F N W ++
Sbjct: 263 KNSLTFP--DDIEISKQAKDLICAFLTDRE-VRLGRNGVDEIKSHPFFKNDQWTFDNIRE 319
Query: 651 HKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETED 688
A +P+L + DTS FD DI +D E
Sbjct: 320 TVAPVVPELSSDIDTSNFD--------DIEDDDKNEET 349
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 257 bits (660), Expect = 4e-80
Identities = 100/279 (35%), Positives = 146/279 (52%), Gaps = 23/279 (8%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+ +++ + +G++G+VY +HK T + A+K I+K + + E I+ +P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVK-ILKKRSEKSKKDQTARREIRILRRLSHPN 59
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
+V + +FE K HL LVMEY EGGD L GPL D A+ + + +EYLHS GI
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
+HRDLKP+N+L+ G +K+ DFGL+K L S ++ GTP Y
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV---------------GTPWY 164
Query: 546 IAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGE---TPEELFAHTVNDDIEWPSE 601
+APEV+L GYG VD WS+GVILYE L G PF GE +L + +E+
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEP 224
Query: 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
EAK +I L ++P R E+ +HP+F
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRP---TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 252 bits (645), Expect = 1e-77
Identities = 111/313 (35%), Positives = 176/313 (56%), Gaps = 32/313 (10%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKI-IKNSLMLRNQMEQVFAERDIMSFTDN 423
D IK + G +G V+LVR + + +A+K + I + L+ Q + V E+ ++ +
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLK-QEQHVHNEKRVLKEVSH 60
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
PF++ ++ + ++ L ++MEYV GG+ S L+N+G FY +E V A+EYLHS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK--QVYG 541
IV+RDLKP+N+L+ GHIKLTDFG AK+ D+ + G
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGF--------------------AKKLRDRTWTLCG 160
Query: 542 TPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601
TPEY+APEVI +G+ K VDWW++G+++YE LVG PFF + P ++ + +E+P
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH 220
Query: 602 DDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHKAE--FIP 657
D + AK +I LL + RLG G +VK H +F ++DW+ + + K + +P
Sbjct: 221 LD----LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVP 276
Query: 658 QLDDEEDTSYFDS 670
++ + DTS FD
Sbjct: 277 KVSHDGDTSNFDD 289
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 246 bits (631), Expect = 4e-75
Identities = 114/312 (36%), Positives = 175/312 (56%), Gaps = 27/312 (8%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM---SFTD 422
F + ++ G +G V L +K+T + +A+K + K ++ R+++E + E+ I +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+PF+V ++ F+T+ H+C VMEY GGD + +T A FY A VL ++YLH
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
IV+RDLK DNLL+ G +K+ DFGL K G+ C GT
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC---------------GT 164
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602
PE++APEV+ Y + VDWW +GV++YE LVG PF G+ EE+F VND++ +P
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF- 223
Query: 603 DWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLL--RHKAEFIPQ 658
+ EA SI+ LL++NP RLG+G +VK+ P+F +++W+ LL + K F+P
Sbjct: 224 ---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPT 280
Query: 659 LDDEEDTSYFDS 670
+ ED S FD
Sbjct: 281 IKGPEDVSNFDE 292
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 244 bits (626), Expect = 6e-75
Identities = 95/284 (33%), Positives = 162/284 (57%), Gaps = 11/284 (3%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF-TD 422
+DF K+I G++ +V L + KET + +A+K + K L+ +++ V E+++++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+P ++ +Y +F+ +++L V+EY G+ ++ G L RFY AE +LA+EYLHS
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSK-MGLMSLATNLYECYVERDAKQFSDKQ--- 538
GI+HRDLKP+N+L+ HIK+TDFG +K + S + D++ +++
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 539 -VYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597
GT EY++PE++ + GK D W++G I+Y+ L G PF G F + +
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240
Query: 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG-GPHEVKEHPYF 640
+P ++P +AK +I LL +P+DRLG G E+K HP+F
Sbjct: 241 FP--PNFP--PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 248 bits (634), Expect = 6e-75
Identities = 142/340 (41%), Positives = 189/340 (55%), Gaps = 40/340 (11%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
F IK + GA+G V L R +T+ +AMK + K ++LRNQ+ V AERDI++ DN +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
VV +Y SF+ K +L VM+Y+ GGD SLL G P D+ARFY AE AVE +H G
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC--YVERDAKQFSDK------ 537
+HRD+KPDN+LI GHIKLTDFGL + + Y+ +V +D+ FS++
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 538 ------------------------QVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL 573
+ GTP YIAPEV+LR GY + DWWS+GVILYE L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 574 VGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDL---LQQNPRDRLGTGG 630
VG PF +TP E T I W + P Q + +DL L + P DRLG G
Sbjct: 243 VGQPPFLAQTPLE----TQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNG 298
Query: 631 PHEVKEHPYFSNLDWNSLLR-HKAEFIPQLDDEEDTSYFD 669
E+K HP+F +D++S LR A +IP++ DTS FD
Sbjct: 299 ADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFD 338
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 240 bits (613), Expect = 1e-72
Identities = 120/305 (39%), Positives = 178/305 (58%), Gaps = 25/305 (8%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTM 429
KL+ G +G V LVR K T + +AMK + K ++ ++++ E ++ T +PF+ +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 430 YCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRD 489
SF+T LC VMEY GG+ L D ARFY AE V A+ YLHS +V+RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 490 LKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPE 549
LK +NL++ GHIK+TDFGL K G+ AT C GTPEY+APE
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---------------GTPEYLAPE 165
Query: 550 VILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVE 609
V+ YG+ VDWW +GV++YE + G +PF+ + E+LF + ++I +P + E
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPE 221
Query: 610 AKSIITDLLQQNPRDRLGTGGPHEVKE---HPYFSNLDWNSLLRHKAE--FIPQLDDEED 664
AKS++ LL+++P+ RLG GGP + KE H +F++++W +++ K E F PQ+ E D
Sbjct: 222 AKSLLAGLLKKDPKQRLG-GGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETD 280
Query: 665 TSYFD 669
T YFD
Sbjct: 281 TRYFD 285
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 3e-71
Identities = 116/305 (38%), Positives = 175/305 (57%), Gaps = 25/305 (8%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM---SFTDNPFVVT 428
I G +G VY VR K+TR+ +AMK + K ++ + ++ ER+I+ ++PF+V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
+ SF+T L LV +Y+ GG+ L+ G D A+FY AE VLA+E+LH Y IV+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLKP+N+L+ A GHI L DFGLSK L T C GT EY+AP
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---------------GTTEYLAP 165
Query: 549 EVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQ 607
EV+L + GY K VD+WS+GV+++E G PF+ E ++++ + + +P +
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLS 222
Query: 608 VEAKSIITDLLQQNPRDRLG-TGGPHEVKEHPYFSNLDWNSLLRHKAE--FIPQLDDEED 664
E + + LL +NP+ RLG E+KEHP+F+++DW+ L + + F P +D +ED
Sbjct: 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDED 282
Query: 665 TSYFD 669
S FD
Sbjct: 283 VSNFD 287
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 3e-70
Identities = 141/364 (38%), Positives = 197/364 (54%), Gaps = 43/364 (11%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
F IK + GA+G V L +T +AMK + K ++ RNQ+ V AERDI++ DN +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
VV +Y SF+ K +L VM+Y+ GGD SLL P +ARFY AE LA+E +H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE--CYVERDAKQFSD------- 536
+HRD+KPDN+LI GHIKLTDFGL + + Y+ ++ +D+ + SD
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 537 ---------------KQ--------VYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL 573
KQ + GTP YIAPEV+LR+GY + DWWS+GVIL+E L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 574 VGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV----EAKSIITDLLQQNPRDRLGTG 629
VG PF TP E +N W + P QV EA +IT L + +RLG
Sbjct: 243 VGQPPFLAPTPTETQLKVIN----WENTLHIPPQVKLSPEAVDLITKLC-CSAEERLGRN 297
Query: 630 GPHEVKEHPYFSNLDWNSLLRHK-AEFIPQLDDEEDTSYFDSRMERYN-HDIGEDTDETE 687
G ++K HP+FS +D++S +R + A ++P++ DTS FD E +D D+ T
Sbjct: 298 GADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTW 357
Query: 688 DSFS 691
D+
Sbjct: 358 DTLC 361
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 6e-70
Identities = 113/303 (37%), Positives = 174/303 (57%), Gaps = 24/303 (7%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF-TDNPFVVT 428
K++ G++G V L K T + FA+K + K+ ++ + +E ER +++ ++PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
++C+F+TK+HL VMEY+ GGD ++++G ARFY AE + +++LH GI++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLK DN+L+ GHIK+ DFG+ K E A F GTP+YIAP
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKE----------NMNGEGKASTFC-----GTPDYIAP 165
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608
E++ Q Y + VDWWS GV+LYE L+G PF GE +ELF +ND +P W I
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR---W-ISK 221
Query: 609 EAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAE--FIPQLDDEEDTS 666
EAK ++ L +++P RLG G +++HP+F +DW L + + F P++ D S
Sbjct: 222 EAKDCLSKLFERDPTKRLGVDGD--IRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDAS 279
Query: 667 YFD 669
FD
Sbjct: 280 NFD 282
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 6e-69
Identities = 130/354 (36%), Positives = 202/354 (57%), Gaps = 37/354 (10%)
Query: 346 NSDSYCSKKDKFSKTPNE-----NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKN 400
N D++ ++ +K + + D+ V+K+I GA+G V LVRHK +++ +AMK + K
Sbjct: 20 NIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF 79
Query: 401 SLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP 460
++ R+ + ERDIM+F ++P+VV ++C+F+ K+L +VMEY+ GGD +L+ N
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD- 138
Query: 461 LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS-KMGLMSLA 519
+P A+FY AE VLA++ +HS G++HRD+KPDN+L+ GH+KL DFG KM
Sbjct: 139 VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD----E 194
Query: 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG----YGKPVDWWSMGVILYEFLVG 575
T + C D V GTP+YI+PEV+ QG YG+ DWWS+GV L+E LVG
Sbjct: 195 TGMVRC----------DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
Query: 576 CVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635
PF+ ++ ++ ++ +D I AK++I L RLG G E+K
Sbjct: 244 DTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDR-EVRLGRNGVEEIK 302
Query: 636 EHPYFSNLDWN--SLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETE 687
+HP+F N WN ++ A +P+L + D+S FD DI +D + E
Sbjct: 303 QHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFD--------DIEDDKGDVE 348
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 6e-69
Identities = 117/320 (36%), Positives = 173/320 (54%), Gaps = 39/320 (12%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
DF V L+ G +G V +VR K T +AMK + K+ L+ + + ERDI+S +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEYLHS 482
P++ + +F+ K +L LVMEY GGD SLL + DMA+FY AE VLA+ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY-- 540
G VHRD+KP+N+LI GHIKL DFG + A+ ++K V
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSA-------------------ARLTANKMVNSK 161
Query: 541 ---GTPEYIAPEVIL------RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591
GTP+YIAPEV+ + YG DWWS+GVI YE + G PF T + + +
Sbjct: 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
Query: 592 VN--DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLL 649
+N +++P +D + + +I LL ++RLG G + HP+FS +DWN++
Sbjct: 222 MNFQRFLKFP--EDPKVSSDFLDLIQSLL-CGQKERLGYEG---LCCHPFFSKIDWNNIR 275
Query: 650 RHKAEFIPQLDDEEDTSYFD 669
F+P L ++DTS FD
Sbjct: 276 NSLPPFVPTLKSDDDTSNFD 295
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 231 bits (589), Expect = 1e-68
Identities = 131/333 (39%), Positives = 188/333 (56%), Gaps = 38/333 (11%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
D+ V+K+I GA+G V LVRHK TR+ +AMK + K ++ R+ + ERDIM+F ++P
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG 484
+VV ++ +F+ ++L +VMEY+ GGD +L+ N +P ARFY AE VLA++ +HS G
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMG 162
Query: 485 IVHRDLKPDNLLITALGHIKLTDFG----LSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
+HRD+KPDN+L+ GH+KL DFG ++K G++ T +
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV------------------ 204
Query: 541 GTPEYIAPEVILRQG----YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596
GTP+YI+PEV+ QG YG+ DWWS+GV LYE LVG PF+ ++ ++ +N
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 264
Query: 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN--LDWNSLLRHKAE 654
DD I EAK++I L RLG G E+K H +F N W +L A
Sbjct: 265 SLTFPDDNDISKEAKNLICAFLTDR-EVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 323
Query: 655 FIPQLDDEEDTSYFDSRMERYNHDIGEDTDETE 687
+P L + DTS FD DI ED E E
Sbjct: 324 VVPDLSSDIDTSNFD--------DIEEDKGEEE 348
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 230 bits (587), Expect = 2e-68
Identities = 124/328 (37%), Positives = 185/328 (56%), Gaps = 25/328 (7%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+DF +K+I GA+G V LV+ K+T +AMK + K ++ + Q+ + AERDI+ D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
+VV M+ SF+ K++L L+ME++ GGD +LL L + +FY AETVLA++ +H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV---- 539
G +HRD+KPDNLL+ A GH+KL+DFGL + T Y FS + +
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 540 ----------------YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET 583
GTP+YIAPEV ++ GY K DWWS+GVI+YE L+G PF ET
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 584 PEELFAHTVN--DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641
P+E + +N + + +P E PI +AK +I + +R+G+ G E+K HP+F
Sbjct: 241 PQETYRKVMNWKETLVFPPE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFE 297
Query: 642 NLDWNSLLRHKAEFIPQLDDEEDTSYFD 669
+DW + A ++ +DTS FD
Sbjct: 298 GVDWGHIRERPAAIPIEIKSIDDTSNFD 325
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 229 bits (584), Expect = 2e-68
Identities = 118/305 (38%), Positives = 176/305 (57%), Gaps = 25/305 (8%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTM 429
KL+ G +G V LVR K T + +AMK + K ++ ++++ E ++ T +PF+ +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 430 YCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRD 489
+F+T LC VMEY GG+ L + ARFY AE V A+EYLHS +V+RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 490 LKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPE 549
+K +NL++ GHIK+TDFGL K G+ AT C GTPEY+APE
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---------------GTPEYLAPE 165
Query: 550 VILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVE 609
V+ YG+ VDWW +GV++YE + G +PF+ + E LF + ++I +P + E
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPE 221
Query: 610 AKSIITDLLQQNPRDRLGTGGP---HEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEED 664
AKS++ LL+++P+ RLG GGP EV EH +F +++W +++ K F PQ+ E D
Sbjct: 222 AKSLLAGLLKKDPKQRLG-GGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVD 280
Query: 665 TSYFD 669
T YFD
Sbjct: 281 TRYFD 285
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 228 bits (584), Expect = 2e-68
Identities = 106/304 (34%), Positives = 168/304 (55%), Gaps = 23/304 (7%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVT 428
K+I G++G V L +HK + +A+K + K +++ + + + + AER+++ +PF+V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
++ SF+T L V++YV GG+ L+ P ARFY AE A+ YLHS I++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLKP+N+L+ + GH+ LTDFGL K G+ T C GTPEY+AP
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC---------------GTPEYLAP 165
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608
EV+ +Q Y + VDWW +G +LYE L G PF+ E++ + +N + I V
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN----ISV 221
Query: 609 EAKSIITDLLQQNPRDRLGTGGP-HEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDT 665
A+ ++ LLQ++ RLG E+K H +FS+++W+ L+ K F P + D
Sbjct: 222 SARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDL 281
Query: 666 SYFD 669
+FD
Sbjct: 282 KHFD 285
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 227 bits (581), Expect = 3e-68
Identities = 109/305 (35%), Positives = 169/305 (55%), Gaps = 21/305 (6%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYC 431
I G++G V VR ++T++ +A+K I K ++ R+++ AER +++ + PF+V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 432 SFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLK 491
SF++ + L LV+ ++ GG+ L+ G ARFY AE + A+E LH + +++RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 492 PDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI 551
P+N+L+ GHI L DFGL K+ + C GTPEY+APE++
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---------------GTPEYLAPELL 165
Query: 552 LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAK 611
L GY K VDWW++GV+LYE L G PF+ E E++ + + + +P +AK
Sbjct: 166 LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAK 221
Query: 612 SIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAE--FIPQLDDEEDTSYFD 669
++ LL ++P RLG G E+K HP+FS L W LL + F P + DTS FD
Sbjct: 222 DLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFD 281
Query: 670 SRMER 674
R
Sbjct: 282 EEFTR 286
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 5e-68
Identities = 99/278 (35%), Positives = 154/278 (55%), Gaps = 24/278 (8%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
F ++++I GA+G V +V+ ++T++ FAMK + K + + + V ER I+ ++PF
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
+V ++ SF+ ++++ LV++ + GGD L + +F+ E VLA+EYLHS GI
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
+HRD+KPDN+L+ GH+ +TDF ++ V D S GTP Y
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATK-------------VTPDTLTTS---TSGTPGY 165
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG--ETPEELFAHT-VNDDIEWPSED 602
+APEV+ RQGY VDWWS+GV YE L G P+ G T + D+ +P+
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT- 224
Query: 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
W EA I LL+++P+ RLG ++K HPYF
Sbjct: 225 -WST--EAIDAINKLLERDPQKRLG-DNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 1e-67
Identities = 119/315 (37%), Positives = 182/315 (57%), Gaps = 26/315 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+DF ++K+I GA+G V +V+ K T Q +AMK + K ++ R + ERD++ D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEYLHS 482
++ ++ +F+ + +L LVM+Y GGD +LL K LP DMARFY AE VLA++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
G VHRD+KPDN+L+ GHI+L DFG S + L++ D S+ V GT
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLA------------DGTVQSNVAV-GT 166
Query: 543 PEYIAPEVILRQ------GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN--D 594
P+YI+PE IL+ YG DWWS+GV +YE L G PF+ E+ E + +N +
Sbjct: 167 PDYISPE-ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225
Query: 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAE 654
++P + + EAK +I L+ +P RLG G + K+HP+F +DW+++ A
Sbjct: 226 HFQFPPDVT-DVSEEAKDLIRRLI-CSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAP 283
Query: 655 FIPQLDDEEDTSYFD 669
++P++ DTS FD
Sbjct: 284 YVPEVSSPTDTSNFD 298
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 225 bits (574), Expect = 5e-67
Identities = 109/310 (35%), Positives = 165/310 (53%), Gaps = 24/310 (7%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
DF + ++ G++G V L K T + +A+K + K+ ++ + +E E+ +++ P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 425 -FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
F+ ++ F+T L VMEYV GGD ++ G A FY AE + + +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
GI++RDLK DN+++ A GHIK+ DFG+ K + T C GTP
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---------------GTP 165
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
+YIAPE+I Q YGK VDWW+ GV+LYE L G PF GE +ELF + ++ +P
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS-- 223
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHKAE--FIPQL 659
+ EA SI LL ++P RLG G G +++EH +F +DW L R + + F P++
Sbjct: 224 --LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKV 281
Query: 660 DDEEDTSYFD 669
FD
Sbjct: 282 KGRRSAENFD 291
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 6e-67
Identities = 115/309 (37%), Positives = 184/309 (59%), Gaps = 27/309 (8%)
Query: 369 IKLISNGAYGSVYLVRH---KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+K++ G++G V+LVR + Q +AMK + K +L +R+++ ERDI++ ++PF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPF 59
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
+V ++ +F+T+ L L+++++ GGD + L + +FY AE LA+++LHS GI
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
++RDLKP+N+L+ GHIKLTDFGLSK ++ + K +S GT EY
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKES------------IDHEKKAYS---FCGTVEY 164
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWP 605
+APEV+ R+G+ + DWWS GV+++E L G +PF G+ +E + + P
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF---- 220
Query: 606 IQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRH--KAEFIPQLDD 661
+ EA+S++ L ++NP +RLG G G E+K HP+FS +DWN L R K F P +
Sbjct: 221 LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGR 280
Query: 662 EEDTSYFDS 670
+DT YFD
Sbjct: 281 PDDTFYFDP 289
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 224 bits (571), Expect = 9e-67
Identities = 114/303 (37%), Positives = 174/303 (57%), Gaps = 24/303 (7%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVT 428
K++ G++G V+L K T Q FA+K + K+ +++ + +E E+ ++S ++PF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
+YC+F+TK++L VMEY+ GGD +++ A FY AE + +++LHS GIV+R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLK DN+L+ GHIK+ DFG+ K ++ A C GTP+YIAP
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC---------------GTPDYIAP 165
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608
E++L Q Y VDWWS GV+LYE L+G PF G EELF D+ +P W +
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR---W-LTR 221
Query: 609 EAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAE--FIPQLDDEEDTS 666
EAK I+ L + P RLG G ++++HP+F +DW++L + E F P++ D S
Sbjct: 222 EAKDILVKLFVREPERRLGVKG--DIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCS 279
Query: 667 YFD 669
FD
Sbjct: 280 NFD 282
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 1e-66
Identities = 120/316 (37%), Positives = 180/316 (56%), Gaps = 31/316 (9%)
Query: 369 IKLISNGAYGSVYLVRH---KETRQRFAMKKIIKNSLMLRNQMEQVF--AERDIMSFTDN 423
+K++ G YG V+ VR +T + FAMK ++K + ++RNQ + AER+I+ +
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKH 59
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
PF+V + +F+T L L++EY+ GG+ L+ G D A FY +E LA+E+LH
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
GI++RDLKP+N+L+ A GH+KLTDFGL K + C GT
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---------------GTI 164
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
EY+APE+++R G+GK VDWWS+G ++Y+ L G PF E ++ + + P
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPY-- 222
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTGGP---HEVKEHPYFSNLDWNSLLRHKAE--FIPQ 658
+ EA+ ++ LL++NP RLG GP EV+ HP+F +++W+ LL K E F P
Sbjct: 223 --LTPEARDLLKKLLKRNPSSRLG-AGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPL 279
Query: 659 LDDEEDTSYFDSRMER 674
L EED S FDS+ R
Sbjct: 280 LQSEEDVSQFDSKFTR 295
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 1e-65
Identities = 114/306 (37%), Positives = 170/306 (55%), Gaps = 25/306 (8%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN-PFVVT 428
+++ G++G V L R KE+ + +A+K + K+ ++ + +E E+ I+S N PF+
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
+YC F+T L VME+V GGD ++ + ARFY AE A+ +LH GI++R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLK DN+L+ GH KL DFG+ K G+ + T C GTP+YIAP
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC---------------GTPDYIAP 165
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608
E++ YG VDWW+MGV+LYE L G PF E ++LF +ND++ +P+ W +
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT---W-LSQ 221
Query: 609 EAKSIITDLLQQNPRDRLGT---GGPHEVKEHPYFSNLDWNSLLRHKAE--FIPQLDDEE 663
+A I+ + +NP RLG+ GG + HP+F LDW L R + E F P++ E
Sbjct: 222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSRE 281
Query: 664 DTSYFD 669
D S FD
Sbjct: 282 DVSNFD 287
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 1e-65
Identities = 120/305 (39%), Positives = 177/305 (58%), Gaps = 25/305 (8%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTM 429
KL+ G +G V LVR K + + +AMK + K ++ ++++ E ++ T +PF+ ++
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 430 YCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRD 489
SF+TK LC VMEYV GG+ L D RFY AE V A++YLHS IV+RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 490 LKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPE 549
LK +NL++ GHIK+TDFGL K G+ AT C GTPEY+APE
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC---------------GTPEYLAPE 165
Query: 550 VILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVE 609
V+ YG+ VDWW +GV++YE + G +PF+ + E+LF + +DI++P + +
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT----LSAD 221
Query: 610 AKSIITDLLQQNPRDRLGTGGPHEVKE---HPYFSNLDWNSLLRHK--AEFIPQLDDEED 664
AKS+++ LL ++P RLG GGP + KE H +F+ ++W + K F PQ+ E D
Sbjct: 222 AKSLLSGLLIKDPNKRLG-GGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETD 280
Query: 665 TSYFD 669
T YFD
Sbjct: 281 TRYFD 285
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 217 bits (553), Expect = 5e-64
Identities = 107/312 (34%), Positives = 174/312 (55%), Gaps = 26/312 (8%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN-PFVVT 428
K++ G++G V L K T + +A+K + K+ ++ + ++ E+ I++ PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
++C F+TK L VMEYV GGD ++ + +RFY AE LA+ +LH +G+++R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLK DN+L+ A GH KL DFG+ K G+++ T C GTP+YIAP
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC---------------GTPDYIAP 165
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608
E++ YG VDWW++GV++YE + G PF + ++LF ++DD+ +P W +
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV---W-LSK 221
Query: 609 EAKSIITDLLQQNPRDRLG----TGGPHEVKEHPYFSNLDWNSLLRHKAE--FIPQLDDE 662
EA SI+ + +NP RLG GG +K+HP+F +DW L + K + F P++ +
Sbjct: 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTK 281
Query: 663 EDTSYFDSRMER 674
D + FD +
Sbjct: 282 RDVNNFDQDFTK 293
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 1e-63
Identities = 121/341 (35%), Positives = 185/341 (54%), Gaps = 27/341 (7%)
Query: 338 LTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHK-ETRQRFAMKK 396
L + + DS +K+ K DF I+ + G++G V L +K E A+K+
Sbjct: 4 LKNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKR 63
Query: 397 IIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK 456
K+ ++ + Q++ VF+ER I+++ ++PF V +Y SF+ + +L LV+E+V GG+ + L+
Sbjct: 64 FEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR 123
Query: 457 NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516
P D+ FY A+ VL EYL S IV+RDLKP+NLL+ G IK+TDFG +K+
Sbjct: 124 RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--- 180
Query: 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC 576
+ T Y + GTPEYIAPE++L G+GK DWW++G+ +YE LVGC
Sbjct: 181 -VDTRTY--------------TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGC 225
Query: 577 VPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEV 634
PF+ P ++ + I +P D K ++ LL + R G G V
Sbjct: 226 PPFYANEPLLIYQKILEGIIYFPKFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNV 281
Query: 635 KEHPYFSNLDWNSLLRHKAE--FIPQLDDEEDTSYFDSRME 673
KEHP+F N+DW SLL E + P+ + D+S F+ E
Sbjct: 282 KEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERVQE 322
|
Length = 340 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 3e-63
Identities = 105/306 (34%), Positives = 165/306 (53%), Gaps = 31/306 (10%)
Query: 365 DFTVIKLISNGAYGSVYLVRH---KETRQRFAMKKIIKNSLMLRNQ-MEQVFAERDIM-S 419
+F +++++ GAYG V+LVR + + +AMK + K +++ + + E ER ++ +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEY 479
PF+VT++ +F+T L L+++YV GG+ + L R Y AE VLA+++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
LH GI++RD+K +N+L+ + GH+ LTDFGLSK LA Y
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK---EFLAEEEERAY-----------SF 166
Query: 540 YGTPEYIAPEVILR--QGYGKPVDWWSMGVILYEFLVGCVPFFGE----TPEELFAHTVN 593
GT EY+APEVI G+ K VDWWS+GV+ +E L G PF + + E+ +
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK 226
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLL--RH 651
+P + EA+ I LL+++P+ RLG G E+K HP+F +DW+ L R
Sbjct: 227 SKPPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRI 282
Query: 652 KAEFIP 657
A F P
Sbjct: 283 PAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 5e-63
Identities = 117/306 (38%), Positives = 175/306 (57%), Gaps = 26/306 (8%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTM 429
KL+ G +G V LV+ K T + +AMK + K ++ ++++ E ++ + +PF+ +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 430 YCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS-YGIVHR 488
SF+T LC VMEY GG+ L D ARFY AE V A++YLHS +V+R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLK +NL++ GHIK+TDFGL K G+ AT C GTPEY+AP
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---------------GTPEYLAP 165
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608
EV+ YG+ VDWW +GV++YE + G +PF+ + E+LF + ++I +P +
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSP 221
Query: 609 EAKSIITDLLQQNPRDRLGTGGPHEVKE---HPYFSNLDWNSLLRHK--AEFIPQLDDEE 663
EAKS+++ LL+++P+ RLG GGP + KE H +F+ + W + K F PQ+ E
Sbjct: 222 EAKSLLSGLLKKDPKQRLG-GGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSET 280
Query: 664 DTSYFD 669
DT YFD
Sbjct: 281 DTRYFD 286
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 5e-63
Identities = 122/328 (37%), Positives = 186/328 (56%), Gaps = 27/328 (8%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
DF +K+I GA+G V LV+ K+T +AMK + K ++ + Q+ + AERDI+ D+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG 484
+VV M+ SF+ K +L L+ME++ GGD +LL L + +FY AETVLA++ +H G
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 485 IVHRDLKPDNLLITALGHIKLTDFGL---------------------SKMGLMSLATNLY 523
+HRD+KPDNLL+ + GH+KL+DFGL S ++ +
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET 583
+R+ +Q + V GTP+YIAPEV ++ GY K DWWS+GVI+YE L+G PF ET
Sbjct: 182 AETWKRNRRQLAFSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 584 PEELFAHTVN--DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641
P+E + +N + + +P E PI +AK +I + R+G G E+K +P+F
Sbjct: 241 PQETYKKVMNWKETLIFPPE--VPISEKAKDLILRFCCEW-EHRIGAPGVEEIKTNPFFE 297
Query: 642 NLDWNSLLRHKAEFIPQLDDEEDTSYFD 669
+DW + A ++ +DTS FD
Sbjct: 298 GVDWEHIRERPAAIPIEIKSIDDTSNFD 325
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 208 bits (533), Expect = 7e-62
Identities = 91/269 (33%), Positives = 137/269 (50%), Gaps = 31/269 (11%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
+ +IK I G++G VYLVR K + + +K+I S M + E E I+ ++P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEI-DLSNMSEKEREDALNEVKILKKLNHP 59
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT----GPLPADMARFYFAETVLAVEYL 480
++ Y SFE K LC+VMEY +GGD + +K P P + +F + LA++YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
HS I+HRD+KP N+ +T+ G +KL DFG+SK+ L S K V
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSS--------------TVDLAKTVV 164
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600
GTP Y++PE+ + Y D WS+G +LYE PF GE EL +
Sbjct: 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP--- 221
Query: 601 EDDWPI----QVEAKSIITDLLQQNPRDR 625
PI E +++++ LLQ++P +R
Sbjct: 222 ----PIPSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 4e-60
Identities = 114/314 (36%), Positives = 171/314 (54%), Gaps = 24/314 (7%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+DF +IK+I GA+G V +V+ K T + +AMK + K ++ R + ER+++ D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEYLHS 482
++ T++ +F+ + +L LVM+Y GGD +LL K LP DMARFY AE VLA+ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
VHRD+KPDN+L+ GHI+L DFG C GT
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFG--------------SCLKMNQDGTVQSSVAVGT 166
Query: 543 PEYIAPEVI--LRQG---YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD-- 595
P+YI+PE++ + G YG DWWS+GV +YE L G PF+ E+ E + +N +
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER 226
Query: 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEF 655
++PS + EAK +I L+ R RLG G + K+H +F +DW ++ +A +
Sbjct: 227 FQFPSHIT-DVSEEAKDLIQRLICSRER-RLGQNGIEDFKKHAFFEGIDWENIRNLEAPY 284
Query: 656 IPQLDDEEDTSYFD 669
IP + DTS FD
Sbjct: 285 IPDVSSPSDTSNFD 298
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 4e-60
Identities = 108/317 (34%), Positives = 175/317 (55%), Gaps = 34/317 (10%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVT 428
++I G+Y V LV K+TR+ +AMK I K + ++ V E+ + + +++PF+V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
++ F+T+ L V+E+V GGD ++ LP + ARFY AE LA+ +LH GI++R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLK DN+L+ A GHIKLTD+G+ K G+ T C GTP YIAP
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC---------------GTPNYIAP 165
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPF----FGETPEE-----LFAHTVNDDIEWP 599
E++ + YG VDWW++GV+++E + G PF + P++ LF + I P
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP 225
Query: 600 SEDDWPIQVEAKSIITDLLQQNPRDRLG---TGGPHEVKEHPYFSNLDWNSLLRHKA--E 654
+ V+A S++ L ++P++RLG G ++K HP+F N+DW+ L + +
Sbjct: 226 RS----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP 281
Query: 655 FIPQLDDEEDTSYFDSR 671
+ P ++ + D FD +
Sbjct: 282 YKPNIESDRDLDNFDPQ 298
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 1e-59
Identities = 107/303 (35%), Positives = 172/303 (56%), Gaps = 24/303 (7%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVT 428
K++ G++G V L K + FA+K + K+ +++ + +E E+ +++ +NPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
+YC+F+TK+HL VME++ GGD +++ G A FY AE V +++LHS GI++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLK DN+++ GHIK+ DFG+ K + + + A F GTP+YIAP
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENV----------FGDNRASTFC-----GTPDYIAP 165
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608
E++ Y VDWWS GV+LYE L+G PF G+ +ELF D +P W I
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR---W-ITK 221
Query: 609 EAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAE--FIPQLDDEEDTS 666
E+K I+ L +++P RLG G ++ HP+F ++W +L + + + F P++ D S
Sbjct: 222 ESKDILEKLFERDPTRRLGVVG--NIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYS 279
Query: 667 YFD 669
FD
Sbjct: 280 NFD 282
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 9e-59
Identities = 118/318 (37%), Positives = 184/318 (57%), Gaps = 32/318 (10%)
Query: 365 DFTVIKLISNGAYGSVYLVRH---KETRQRFAMKKIIKNSLMLRNQ-MEQVFAERDIMSF 420
+F ++K++ GAYG V+LVR +T + +AMK + K +L+ + + +E ER+++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 421 T-DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEY 479
+PF+VT++ +F+T+ L L+++YV GG+ + L D RFY E +LA+E+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
LH GIV+RD+K +N+L+ + GH+ LTDFGLSK E E + +S
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK-----------EFLSEEKERTYS---F 166
Query: 540 YGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGE----TPEELFAHTVND 594
GT EY+APE+I + G+GK VDWWS+G++++E L G PF E T E+ +
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC 226
Query: 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK 652
D +PS I EA+ ++ LL+++P+ RLG G G E+KEHP+F LDW +L K
Sbjct: 227 DPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRK 282
Query: 653 --AEFIPQLDDEEDTSYF 668
F P + +E D F
Sbjct: 283 VNPPFRPSIRNELDVGNF 300
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 4e-58
Identities = 108/316 (34%), Positives = 168/316 (53%), Gaps = 25/316 (7%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
DF + ++ G++G V L K T + +A+K + K+ ++ + +E E+ +++ + P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 425 -FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
F+ ++ F+T L VMEYV GGD ++ G A FY AE + + +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
GI++RDLK DN+++ + GHIK+ DFG+ K + T C GTP
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC---------------GTP 165
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
+YIAPE+I Q YGK VDWW+ GV+LYE L G PF GE +ELF + ++ +P
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS-- 223
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHKAE--FIPQL 659
+ EA +I L+ ++P RLG G G ++KEH +F +DW L R + + + P+
Sbjct: 224 --MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKA 281
Query: 660 DDEEDTSYFDSRMERY 675
D FD R+
Sbjct: 282 CG-RDAENFDKFFTRH 296
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 201 bits (511), Expect = 5e-58
Identities = 115/313 (36%), Positives = 179/313 (57%), Gaps = 24/313 (7%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
DF ++K+I GA+G V +V+ K + FAMK + K ++ R + ERD++ DN
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEYLHSY 483
++ T++ +F+ + +L LVM+Y GGD +LL K LP DMARFY AE V+A++ +H
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
VHRD+KPDN+L+ GHI+L DFG S + LM T GTP
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGT-------------VQSSVAVGTP 167
Query: 544 EYIAPEVI--LRQG---YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN--DDI 596
+YI+PE++ + G YG DWWS+GV +YE L G PF+ E+ E + +N +
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 227
Query: 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFI 656
++P++ + +AK +I L+ RLG G + K+HP+F+ +DW+++ +A +I
Sbjct: 228 QFPAQVT-DVSEDAKDLIRRLICSR-EHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYI 285
Query: 657 PQLDDEEDTSYFD 669
P++ DTS FD
Sbjct: 286 PEVSSPTDTSNFD 298
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 1e-56
Identities = 87/284 (30%), Positives = 130/284 (45%), Gaps = 40/284 (14%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQ--MEQVFAERDIMSFTD 422
F +++ I G +G VY RHK T + A+K I L ++ E++ E I+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-----KLESKEKKEKIINEIQILKKCK 55
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLH 481
+P +V Y S+ K L +VME+ GG LLK+T L + E + +EYLH
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ--- 538
S GI+HRD+K N+L+T+ G +KL DFGLS Q SD +
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLS--------------------AQLSDTKARN 155
Query: 539 -VYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597
+ GTP ++APEVI + Y D WS+G+ E G P+ P + +
Sbjct: 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG-- 213
Query: 598 WPSEDDWPIQV--EAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639
P P + E K + LQ+NP R ++ +HP+
Sbjct: 214 -PPGLRNPEKWSDEFKDFLKKCLQKNPEKR---PTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 1e-55
Identities = 93/270 (34%), Positives = 131/270 (48%), Gaps = 58/270 (21%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYC 431
+ G +G+VYL R K+T ++ A+K I K + +E++ E +I+ ++P +V +Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS--SLLEELLREIEILKKLNHPNIVKLYG 58
Query: 432 SFETKKHLCLVMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDL 490
FE + HL LVMEY EGG LLK N G L D + + +EYLHS GI+HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 491 KPDNLLITAL-GHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPE 549
KP+N+L+ + G +KL DFGLSK + K V GTP Y+APE
Sbjct: 119 KPENILLDSDNGKVKLADFGLSK--------------LLTSDKSLLKTIV-GTPAYMAPE 163
Query: 550 VILRQG-YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608
V+L +G Y + D WS+GVILYE
Sbjct: 164 VLLGKGYYSEKSDIWSLGVILYEL-----------------------------------P 188
Query: 609 EAKSIITDLLQQNPRDRLGTGGPHEVKEHP 638
E K +I +LQ++P R E+ EH
Sbjct: 189 ELKDLIRKMLQKDPEKRP---SAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 194 bits (493), Expect = 1e-55
Identities = 108/306 (35%), Positives = 170/306 (55%), Gaps = 25/306 (8%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVT 428
K+I G++G V L + K + +A+K + K ++ R + + + AER+++ +PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
++ SF+T + L V+++V GG+ L+ P ARFY AE A+ YLHS IV+R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLKP+N+L+ + GH+ LTDFGL K G+ T C GTPEY+AP
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC---------------GTPEYLAP 165
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW-PSEDDWPIQ 607
EVI +Q Y VDWW +G +LYE L G PF+ E++ + ++ + P
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPG-----AS 220
Query: 608 VEAKSIITDLLQQNPRDRLGTGGP-HEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEED 664
+ A SI+ +LL+++ + RLG E++EHP+F +L W L + K F P ++ +D
Sbjct: 221 LTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDD 280
Query: 665 TSYFDS 670
S FD+
Sbjct: 281 ISNFDA 286
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 2e-55
Identities = 102/287 (35%), Positives = 158/287 (55%), Gaps = 22/287 (7%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
DF + ++ G++G V L K T + +A+K + K+ ++ + +E E+ +++ D P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 425 -FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
F+ ++ F+T L VMEYV GGD ++ G A FY AE + + +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
GI++RDLK DN+++ + GHIK+ DFG+ K ++ T C GTP
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC---------------GTP 165
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
+YIAPE+I Q YGK VDWW+ GV+LYE L G PF GE +ELF + ++ +P
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS-- 223
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSL 648
+ EA SI L+ ++P RLG G G +++EH +F +DW+ L
Sbjct: 224 --LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKL 268
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 4e-55
Identities = 104/296 (35%), Positives = 152/296 (51%), Gaps = 30/296 (10%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYC 431
+ G +G V + K T + +A KK+ K L R + E+ I+ + F+V++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 432 SFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMAR--FYFAETVLAVEYLHSYGIVHRD 489
+FETK LCLVM + GGD + N G AR FY A+ + +E+LH IV+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 490 LKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPE 549
LKP+N+L+ G+++++D GL+ VE + K GTP Y+APE
Sbjct: 121 LKPENVLLDDHGNVRISDLGLA---------------VELKGGK-KIKGRAGTPGYMAPE 164
Query: 550 VILRQGYGKPVDWWSMGVILYEFLVGCVPF--FGE--TPEELFAHTVNDDIEWPSEDDWP 605
V+ + Y VDW+++G LYE + G PF E EEL T+ +E+P + P
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYP-DKFSP 223
Query: 606 IQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHKAE--FIP 657
EAK + LLQ++P RLG G EV+EHP F +L+W L E FIP
Sbjct: 224 ---EAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 8e-54
Identities = 89/284 (31%), Positives = 137/284 (48%), Gaps = 32/284 (11%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
++T +L+ G++GSVYL K+T + A+K + + ++E + E I+S +P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSG-DSEEELEALEREIRILSSLQHP 59
Query: 425 FVVTMY-CSF-ETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+V Y E K L + +EYV GG +SLLK G LP + R Y + + + YLHS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
GIVHRD+K N+L+ + G +KL DFG +K L V GT
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAK----RLGDIETGEG---------TGSVRGT 166
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPF--FGETPEELFAHTVNDDI---- 596
P ++APEVI + YG+ D WS+G + E G P+ G L+ + +
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIP 226
Query: 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
E SE EAK + L+++P+ R E+ +HP+
Sbjct: 227 EHLSE-------EAKDFLRKCLRRDPKKRPTAD---ELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 3e-53
Identities = 111/331 (33%), Positives = 175/331 (52%), Gaps = 34/331 (10%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN-PFVVT 428
++I G+Y V LVR K+T + +AMK + K + ++ V E+ + N PF+V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
++ F+T+ L V+EYV GGD ++ LP + ARFY AE LA+ YLH GI++R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLK DN+L+ + GHIKLTD+G+ K GL T C GTP YIAP
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---------------GTPNYIAP 165
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPF----FGETPEE-----LFAHTVNDDIEWP 599
E++ + YG VDWW++GV+++E + G PF + P++ LF + I P
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 225
Query: 600 SEDDWPIQVEAKSIITDLLQQNPRDRLG---TGGPHEVKEHPYFSNLDWNSLLRHKA--E 654
+ V+A S++ L ++P++RLG G +++ HP+F N+DW+ + + +
Sbjct: 226 RS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPP 281
Query: 655 FIPQLDDEEDTSYFDSRMERYNHDIGEDTDE 685
F P + E FD++ + D D+
Sbjct: 282 FKPNISGEFGLDNFDAQFTNEPVQLTPDDDD 312
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 2e-52
Identities = 109/315 (34%), Positives = 169/315 (53%), Gaps = 32/315 (10%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVT 428
++I G+Y V LVR K+ Q +AMK + K + ++ V E+ + + NPF+V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
++ F+T L LV+EYV GGD ++ LP + ARFY AE +A+ +LH GI++R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLK DN+L+ A GHIKLTD+G+ K GL T C GTP YIAP
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC---------------GTPNYIAP 165
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPF-------FGETPEELFAHTVNDDIEWPSE 601
E++ + YG VDWW++GV+++E + G PF T + LF + I P
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF 225
Query: 602 DDWPIQVEAKSIITDLLQQNPRDRLG---TGGPHEVKEHPYFSNLDWNSLLRHKA--EFI 656
+ V+A ++ L ++P++RLG G ++K H +F ++DW+ L + + F
Sbjct: 226 ----LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFK 281
Query: 657 PQLDDEEDTSYFDSR 671
PQ+ D+ FD++
Sbjct: 282 PQITDDYGLENFDTQ 296
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 5e-52
Identities = 106/328 (32%), Positives = 172/328 (52%), Gaps = 25/328 (7%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVT 428
K+I G++G V L + K +A+K + K +++ + + + AER+++ +PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
++ SF+T + L V++YV GG+ L+ ARFY AE A+ YLHS I++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLKP+N+L+ + GH+ LTDFGL K G+ T C GTPEY+AP
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC---------------GTPEYLAP 165
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608
EV+ ++ Y + VDWW +G +LYE L G PF+ +++ + ++ ++ P V
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGK----TV 221
Query: 609 EAKSIITDLLQQNPRDRLGTGGPH-EVKEHPYFSNLDWNSLL--RHKAEFIPQLDDEEDT 665
A ++ LL ++ R RLG E+K H +FS ++W+ L R + P + D
Sbjct: 222 AACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADL 281
Query: 666 SYFDSRM--ERYNHDIGEDTDETEDSFS 691
+FD E + +G+ D T S S
Sbjct: 282 RHFDPEFTQEAVSSSVGQTPDLTASSSS 309
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 6e-52
Identities = 104/304 (34%), Positives = 165/304 (54%), Gaps = 23/304 (7%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVT 428
K+I G++G V L RHK + +A+K + K +++ + + + + +ER+++ +PF+V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
++ SF+T L V++Y+ GG+ L+ ARFY AE A+ YLHS IV+R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DLKP+N+L+ + GHI LTDFGL K + T C GTPEY+AP
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC---------------GTPEYLAP 165
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608
EV+ +Q Y + VDWW +G +LYE L G PF+ E++ + +N ++ I
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN----ITN 221
Query: 609 EAKSIITDLLQQNPRDRLG-TGGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDT 665
A+ ++ LLQ++ RLG E+K H +FS ++W+ L+ K F P + D
Sbjct: 222 SARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDL 281
Query: 666 SYFD 669
+FD
Sbjct: 282 RHFD 285
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 6e-51
Identities = 109/308 (35%), Positives = 173/308 (56%), Gaps = 33/308 (10%)
Query: 365 DFTVIKLISNGAYGSVYLVRH---KETRQRFAMKKIIKNSLMLRNQM-EQVFAERDIMS- 419
+F ++K++ GAYG V+LVR ++ + +AMK + K +++ + + E ER ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEY 479
+PF+VT++ +F+T L L+++Y+ GG+ + L + Y E VLA+E+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
LH GI++RD+K +N+L+ + GH+ LTDFGLSK +E VER A F
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--------EFHEDEVER-AYSFC---- 167
Query: 540 YGTPEYIAPEVIL--RQGYGKPVDWWSMGVILYEFLVGCVPFF--GE--TPEELFAHTVN 593
GT EY+AP+++ G+ K VDWWSMGV++YE L G PF GE + E+ +
Sbjct: 168 -GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK 226
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRH 651
+ +P E + AK II LL ++P+ RLG G E+K+HP+F ++W+ L
Sbjct: 227 SEPPYPQE----MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAK 282
Query: 652 K--AEFIP 657
K A F P
Sbjct: 283 KVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 87/282 (30%), Positives = 142/282 (50%), Gaps = 32/282 (11%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+D +K++ G+ G VY VRHK T + +A+KKI + +Q+ E + ++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCES 58
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
P+VV Y +F + + +V+EY++GG A LLK G +P + + + + ++YLH+
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 484 -GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC--YVERDAKQFSDKQVY 540
I+HRD+KP NLLI + G +K+ DFG+SK L L +C +V
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISK----VLENTLDQCNTFV------------- 161
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF---GETPEELFAHTVNDD-I 596
GT Y++PE I + Y D WS+G+ L E +G PF + EL +
Sbjct: 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP 221
Query: 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHP 638
P+E+ P E + I+ LQ++P+ R E+ +HP
Sbjct: 222 SLPAEEFSP---EFRDFISACLQKDPKKRPSA---AELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 9e-46
Identities = 79/262 (30%), Positives = 120/262 (45%), Gaps = 21/262 (8%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
++ + LI GA+G VY + ET A+K+I + ++ + E D++ +P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHP 59
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG 484
+V S ET L +++EY E G ++K GP P + Y + + + YLH G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 485 IVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPE 544
++HRD+K N+L T G +KL DFG +AT L + D V GTP
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFG--------VATKL-------NDVSKDDASVVGTPY 164
Query: 545 YIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFAHTVNDDIEWPSEDD 603
++APEVI G D WS+G + E L G P++ P LF +D P
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEG-- 222
Query: 604 WPIQVEAKSIITDLLQQNPRDR 625
I E K + Q++P R
Sbjct: 223 --ISPELKDFLMQCFQKDPNLR 242
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 93/290 (32%), Positives = 141/290 (48%), Gaps = 26/290 (8%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
F +++ G +G V + + T + +A KK+ K + R E+ I+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP--LPADMARFYFAETVLAVEYLHSY 483
VV++ ++ETK LCLV+ + GGD + N G + A FY AE +E LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
IV+RDLKP+N+L+ GHI+++D GL+ VE + +V GT
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA---------------VEIPEGETIRGRV-GTV 165
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG---ETPEELFAHTVNDDIEWPS 600
Y+APEV+ + Y DWW +G ++YE + G PF + E V +D E S
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS 225
Query: 601 EDDWPIQVEAKSIITDLLQQNPRDRLG--TGGPHEVKEHPYFSNLDWNSL 648
E A+SI LL ++P RLG G EVK HP+F ++ L
Sbjct: 226 EKFSE---AARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 2e-44
Identities = 97/302 (32%), Positives = 150/302 (49%), Gaps = 40/302 (13%)
Query: 371 LISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT---DNPFVV 427
+I G +G VY R +T + +AMK + K + ++ ER ++S D PF+V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVH 487
M +F T L +++ + GGD L G RFY AE +L +E++H+ +V+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 488 RDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY---GTPE 544
RDLKP N+L+ GH++++D GL A FS K+ + GT
Sbjct: 121 RDLKPANILLDEHGHVRISDLGL--------------------ACDFSKKKPHASVGTHG 160
Query: 545 YIAPEVILRQG--YGKPVDWWSMGVILYEFLVGCVPFFGETPE---ELFAHTVNDDIEWP 599
Y+APEV L++G Y DW+S+G +L++ L G PF + E+ T+ +E P
Sbjct: 161 YMAPEV-LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 219
Query: 600 SEDDWPIQVEAKSIITDLLQQNPRDRLG--TGGPHEVKEHPYFSNLDWNS--LLRHKAEF 655
E +S++ LLQ++ RLG G EVKEHP+F +LDW L ++
Sbjct: 220 DS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPL 275
Query: 656 IP 657
IP
Sbjct: 276 IP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 4e-44
Identities = 90/285 (31%), Positives = 152/285 (53%), Gaps = 28/285 (9%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYC 431
+ G +G V V+ K T + +A KK+ K L ++ + E++I+ ++PF+V +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 432 SFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMAR--FYFAETVLAVEYLHSYGIVHRD 489
+FE+K HLCLVM + GGD + N G +M R Y A+ + +LHS IV+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 490 LKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE-RDAKQFSDKQVYGTPEYIAP 548
+KP+N+L+ G+ +L+D GL+ VE +D K + + GT Y+AP
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLA---------------VELKDGKTITQRA--GTNGYMAP 163
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPF--FGE--TPEELFAHTVNDDIEWPSEDDW 604
E++ + Y PVDW++MG +YE + G PF E EEL T+ D++++ ++
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQN-- 221
Query: 605 PIQVEAKSIITDLLQQNPRDRLGTGGPH-EVKEHPYFSNLDWNSL 648
E+K I L + P DRLG+ + + ++H +F +++ L
Sbjct: 222 -FTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 90/284 (31%), Positives = 143/284 (50%), Gaps = 29/284 (10%)
Query: 375 GAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE 434
G +G V + + T + +A KK+ K L R E E+ I++ + F+V++ +F+
Sbjct: 4 GGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ 63
Query: 435 TKKHLCLVMEYVEGGDCASLLKNTGP----LPADMARFYFAETVLAVEYLHSYGIVHRDL 490
TK LCLVM + GGD + N P A FY A+ + +E+LH I++RDL
Sbjct: 64 TKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDL 123
Query: 491 KPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEV 550
KP+N+L+ G+++++D GL+ VE Q K GTP ++APE+
Sbjct: 124 KPENVLLDNDGNVRISDLGLA---------------VELKDGQSKTKGYAGTPGFMAPEL 168
Query: 551 ILRQGYGKPVDWWSMGVILYEFLVGCVPF--FGETPE--ELFAHTVNDDIEWPSEDDWPI 606
+ + Y VD++++GV LYE + PF GE E EL +ND + +P +
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK----F 224
Query: 607 QVEAKSIITDLLQQNPRDRLG--TGGPHEVKEHPYFSNLDWNSL 648
+KS LL ++P RLG G ++ HP F +L+W L
Sbjct: 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-43
Identities = 74/155 (47%), Positives = 107/155 (69%)
Query: 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF 420
P+ +F ++K IS GA+G VYL R K + +A+K + K ++ +N + QV AERD ++
Sbjct: 1 PSIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL 60
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYL 480
+ +PF+V +Y S ++ ++ LVMEY+ GGD SLL G +MA Y +E LA++YL
Sbjct: 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYL 120
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515
H +GI+HRDLKPDN+LI+ GHIKLTDFGLSK+ L
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 156 bits (394), Expect = 1e-41
Identities = 107/396 (27%), Positives = 170/396 (42%), Gaps = 31/396 (7%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDN 423
+ +++ + G++G VYL R + + A+K + K ++E+ E I+ S
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG---PLPADMARFYFAETVLAVEYL 480
P +V +Y F+ + L LVMEYV+GG LLK G PL A F A+ + A+EYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 481 HSYGIVHRDLKPDNLLITALGH-IKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
HS GI+HRD+KP+N+L+ G +KL DFGL+K+ L + V
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL--------LPDPGSTSSIPALPSTSV 169
Query: 540 YGTPEYIAPEVILRQG---YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV---- 592
GTP Y+APEV+L D WS+G+ LYE L G PF GE + T+
Sbjct: 170 -GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228
Query: 593 -----NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDW 645
+ + I A ++ LL ++P++RL + H++ H D
Sbjct: 229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDL 288
Query: 646 NSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETEDSFSLGTFSSCTHQYKKV 705
+ LL+ +L S + + + + + +
Sbjct: 289 SDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNS 348
Query: 706 QSQLSSQSSLEVTPPRKSSEKDETSSTSDVSSSPVA 741
S L S +S + + K S + SS S S +
Sbjct: 349 SSLLLSTASSKRSSLPKISARSSPSSLSSSSRQQAS 384
|
Length = 384 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 47/278 (16%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
DF V+K + G+YGSVY V+ Q +A+K++ M + + E E I++ ++P
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHP 59
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG----PLPADMARFYFAETVLAVEYL 480
+++ +F LC+VMEY GD + + +P F + + ++ L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
H I+HRDLK N+L+ A +K+ D G+SK+ K+ K
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKV-----------------LKKNMAKTQI 162
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL-----------FA 589
GTP Y+APEV + Y D WS+G +LYE PF + ++L
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP 222
Query: 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLG 627
+ D++ + I +LQ P+ R
Sbjct: 223 PIYSQDLQ--------------NFIRSMLQVKPKLRPN 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 84/285 (29%), Positives = 129/285 (45%), Gaps = 28/285 (9%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQ-MEQVFAERDIMSFTDNP 424
+ ++ I GA G VY + T + A+KK+ LR Q E + E IM +P
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-----LRKQNKELIINEILIMKDCKHP 75
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEYLHSY 483
+V Y S+ L +VMEY++GG ++ +N + + E + +EYLHS
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
++HRD+K DN+L++ G +KL DFG A L ++ V GTP
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFG--------FAAQL-------TKEKSKRNSVVGTP 180
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE-LFAHTVNDDIEWPSED 602
++APEVI R+ YG VD WS+G++ E G P+ E P LF T + +
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPE 240
Query: 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647
W E K + L ++P R E+ +HP+
Sbjct: 241 KW--SPEFKDFLNKCLVKDPEKRPSA---EELLQHPFLKKACPKE 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 3e-40
Identities = 92/296 (31%), Positives = 144/296 (48%), Gaps = 36/296 (12%)
Query: 371 LISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT---DNPFVV 427
+I G +G VY R +T + +AMK + K + ++ ER ++S D PF+V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVH 487
M +F T LC +++ + GGD L G RFY E +L +E++H+ +V+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 488 RDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY---GTPE 544
RDLKP N+L+ GH++++D GL A FS K+ + GT
Sbjct: 121 RDLKPANILLDEHGHVRISDLGL--------------------ACDFSKKKPHASVGTHG 160
Query: 545 YIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPE---ELFAHTVNDDIEWPS 600
Y+APEV+ + Y DW+S+G +L++ L G PF + E+ T+ ++E P
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD 220
Query: 601 EDDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHKAE 654
E KS++ LLQ++ RLG G EVKEH +F +DW + K
Sbjct: 221 S----FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYP 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 91/291 (31%), Positives = 143/291 (49%), Gaps = 28/291 (9%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
F +++ G +G V + + T + +A K++ K + R E+ I+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP--LPADMARFYFAETVLAVEYLHSY 483
VV + ++ETK LCLV+ + GGD + N G + A FY AE + +E LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
V+RDLKP+N+L+ GHI+++D GL A + E R GT
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGL--------AVKIPEGESIRGR--------VGTV 165
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP----EELFAHTVNDDIEWP 599
Y+APEV+ Q Y D+W +G ++YE + G PF G EE+ + + +
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS 225
Query: 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSL 648
++ EAKSI LL ++P+ RLG G EVK HP+F N+++ L
Sbjct: 226 AK----FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 33/285 (11%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNS-LMLRNQMEQVFAERDIMSFTD 422
+D + + G G V V H+ T + A+K I ++ Q+ + E DI+ +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR---ELDILHKCN 57
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLH 481
+P++V Y +F + + MEY++GG +LK G +P + + + YLH
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 482 S-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
+ I+HRD+KP N+L+ + G IKL DFG+S + SLA K
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-----------------KTFV 160
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE-----TPEELFAHTVNDD 595
GT Y+APE I Y D WS+G+ L E G P+ E EL + VN+
Sbjct: 161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP 220
Query: 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
+ + + + L ++PR+R E+ EHP+
Sbjct: 221 PPRLPSGKFS--PDFQDFVNLCLIKDPRER---PSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 72/224 (32%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKI-IKNSLMLRNQMEQVFAERDIMSFT 421
E F +++ + G+YGSVY HKET Q A+K + ++ L +++ E I+
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL------QEIIKEISILKQC 55
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYL 480
D+P++V Y S+ L +VMEY G + ++K T L + +T+ +EYL
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
HS +HRD+K N+L+ G KL DFG+S L + +R V
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGVS--------GQLTDTMAKR-------NTVI 160
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
GTP ++APEVI GY D WS+G+ E G P+ P
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 95/318 (29%), Positives = 142/318 (44%), Gaps = 74/318 (23%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKI-IKNS------LMLRNQMEQVFAERDIM 418
+ + I GAYG+VY R T + A+KK+ + S LR ++ + +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR----EIALLKQLE 56
Query: 419 SFTDNPFVVTMY-----CSFETKKHLCLVMEYVEGGDCASLLKNTGP--LPADMARFYFA 471
SF ++P +V + + + L LV E+V+ D A+ L LP + +
Sbjct: 57 SF-EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMR 114
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK-----MGLMSLATNLYECY 526
+ + V++LHS+ IVHRDLKP N+L+T+ G +K+ DFGL++ M L S+ L+
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLW--- 171
Query: 527 VERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE 586
Y APEV+L+ Y PVD WS+G I E L P F T E
Sbjct: 172 ------------------YRAPEVLLQSSYATPVDMWSVGCIFAE-LFRRRPLFRGTSEA 212
Query: 587 LFAHTVNDDIEWPSEDDWPIQV-------------EAKSIIT-------DLLQQ----NP 622
+ D I PSE++WP V KS + DLL++ NP
Sbjct: 213 DQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNP 272
Query: 623 RDRLGTGGPHEVKEHPYF 640
R+ E +HPYF
Sbjct: 273 HKRISA---FEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 1e-37
Identities = 93/290 (32%), Positives = 146/290 (50%), Gaps = 26/290 (8%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
F +++ G +G V + + T + +A KK+ K + R E+ I+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMAR--FYFAETVLAVEYLHSY 483
VV++ ++ETK LCLV+ + GGD + + G + R FY AE +E LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
IV+RDLKP+N+L+ GHI+++D GL+ +V + K GT
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA-------------VHVPEGQ---TIKGRVGTV 165
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPF---FGETPEELFAHTVNDDIEWPS 600
Y+APEV+ + Y DWW++G +LYE + G PF + E V + E S
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYS 225
Query: 601 EDDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSL 648
E P +A+S+ LL ++P++RLG GG EVKEHP F +++ L
Sbjct: 226 EKFSP---DARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 82/288 (28%), Positives = 130/288 (45%), Gaps = 32/288 (11%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+D+ +I++I GA VY ++ A+K+I + + ++++ E MS ++
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI--DLEKCQTSVDELRKEVQAMSQCNH 58
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK---NTGPLPADMARFYFAETVLAVEYL 480
P VV Y SF L LVM Y+ GG ++K G L + E + +EYL
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
HS G +HRD+K N+L+ G +K+ DFG+S LA D + K
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSAS----LADG-------GDRTRKVRKTFV 167
Query: 541 GTPEYIAPEVI-LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599
GTP ++APEV+ GY D WS G+ E G P+ P ++ T+ +D P
Sbjct: 168 GTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND---P 224
Query: 600 S-----EDDWPIQVEAKSIITDLLQQNPRDRLGTGGP--HEVKEHPYF 640
D + +I+ LQ++P R P E+ +H +F
Sbjct: 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKR-----PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 5e-37
Identities = 85/311 (27%), Positives = 137/311 (44%), Gaps = 65/311 (20%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFA----ERDIMSFT 421
+ ++ + G YG VY R K+T + A+KKI L N+ E + + E ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-----LDNEEEGIPSTALREISLLKEL 55
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYL 480
+P +V + T++ L LV EY + D L GPL ++ + + + + Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
HS+ I+HRDLKP N+LI G +KL DFGL++ + ++ + V
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLAR-------------AFGIPLRTYTHEVV- 160
Query: 541 GTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFAHTVNDDIEW 598
T Y APE++L Y VD WS+G I E + G F G++ ++LF + +
Sbjct: 161 -TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLF--KIFQILGT 217
Query: 599 PSEDDWP--------------------------IQVEAKSIITDLLQQNPRDRLGTGGPH 632
P+E+ WP + E +++ +LQ NP R+
Sbjct: 218 PTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS----- 272
Query: 633 EVKE---HPYF 640
KE HPYF
Sbjct: 273 -AKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 96/290 (33%), Positives = 141/290 (48%), Gaps = 26/290 (8%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
F +++ G +G V + + T + +A KK+ K + R E+ I+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMAR--FYFAETVLAVEYLHSY 483
VV++ ++ETK LCLV+ + GGD + N G D R FY AE +E L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
IV+RDLKP+N+L+ GHI+++D G LA + E R GT
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLG--------LAVQIPEGETVRGR--------VGTV 165
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG---ETPEELFAHTVNDDIEWPS 600
Y+APEVI + Y DWW +G ++YE + G PF E V +D E S
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYS 225
Query: 601 EDDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSL 648
E +AKSI LL +NP++RLG G VK+HP F N+++ L
Sbjct: 226 EK---FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 8e-37
Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 38/276 (13%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
D+ V++ I G++G+V VR K + K+I + M + +Q+ +E +I+ +P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEKQQLVSEVNILRELKHP 59
Query: 425 FVVTMYCSF--ETKKHLCLVMEYVEGGDCASLLKNT----GPLPADMARFYFAETVLAVE 478
+V Y + + L +VMEY EGGD A L++ + + + +LA+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 479 YLH-----SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC--YVERDA 531
H ++HRDLKP N+ + A ++KL DFGL+K+ L + YV
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI----LGHDSSFAKTYV---- 171
Query: 532 KQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591
GTP Y++PE + Y + D WS+G ++YE PF +L
Sbjct: 172 ---------GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL---- 218
Query: 592 VNDDIEWPSEDDWPIQV--EAKSIITDLLQQNPRDR 625
I+ P + E +I +L +P R
Sbjct: 219 -ASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 81/273 (29%), Positives = 129/273 (47%), Gaps = 24/273 (8%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMK--KIIKNSLMLRNQMEQVFAERDIMSFTDNPFVV 427
+L+ +G++GSVY + + FA+K + + + ++Q+ E ++S +P +V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVH 487
+ + +L + +E V GG A LLK G P + R Y + +L +EYLH VH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 488 RDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIA 547
RD+K N+L+ G +KL DFG++K ++ + AK F G+P ++A
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQ-VVEFSF----------AKSFK-----GSPYWMA 169
Query: 548 PEVILRQG-YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPI 606
PEVI +QG YG D WS+G + E G P+ P D +
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDH--L 227
Query: 607 QVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639
EAK I LQ++P R E+ EHP+
Sbjct: 228 SDEAKDFILKCLQRDPSLRPTAA---ELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 75/287 (26%), Positives = 122/287 (42%), Gaps = 46/287 (16%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTM 429
I G +G VY + +T + A+K+I + ++++ E ++ +P +V
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELLKHPNLVKY 64
Query: 430 YCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRD 489
Y ++ + + MEY GG LL++ L + R Y + + + YLHS+GIVHRD
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRD 124
Query: 490 LKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPE 549
+KP N+ + G IKL DFG + + T V+ A GTP Y+APE
Sbjct: 125 IKPANIFLDHNGVIKLGDFGCAVK--LKNNTTTMGEEVQSLA---------GTPAYMAPE 173
Query: 550 VILRQ---GYGKPVDWWSMGVILYEFLVGCVPF--------------FGETPEELFAHTV 592
VI G+G+ D WS+G ++ E G P+ G P
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-------- 225
Query: 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639
P + E K + L+ +P+ R E+ +HP+
Sbjct: 226 ----PIPDSLQ--LSPEGKDFLDRCLESDPKKRPTAS---ELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 83/312 (26%), Positives = 126/312 (40%), Gaps = 66/312 (21%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT--DN 423
+ + I G YG VY R K T + A+KKI L ++ A R+I ++
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKELNH 57
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
P ++ + F K L LV E+++ + LP + + Y + + + + HS+
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
GI+HRDLKP+NLLI G +KL DFGL A+ F T
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGL--------------------ARSFGSPVRPYTH 157
Query: 544 E-----YIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPE--ELFAHTVNDD 595
Y APE++L +GY PVD WS+G I E L P F E +LF +
Sbjct: 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLF--KIFRT 214
Query: 596 IEWPSEDDWP---------------------------IQVEAKSIITDLLQQNPRDRLGT 628
+ P + WP +A +++ +L +P R+
Sbjct: 215 LGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA 274
Query: 629 GGPHEVKEHPYF 640
+ HPYF
Sbjct: 275 ---EQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-35
Identities = 63/145 (43%), Positives = 92/145 (63%), Gaps = 4/145 (2%)
Query: 527 VERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE 586
V R A +++ GTP+Y+APE++L + +G VDWW++GV L+EFL G PF ETP++
Sbjct: 528 VRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQ 587
Query: 587 LFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646
+F + +N DI WP ++ + V A++ I LL +P R G E+K+HP F +DW
Sbjct: 588 VFQNILNRDIPWPEGEE-KLSVNAQNAIEILLTMDPTKR---AGLKELKQHPLFHGVDWE 643
Query: 647 SLLRHKAEFIPQLDDEEDTSYFDSR 671
+L FIPQ DDE DTSYF++R
Sbjct: 644 NLQNQTMPFIPQPDDETDTSYFEAR 668
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 79/248 (31%), Positives = 122/248 (49%), Gaps = 29/248 (11%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQME----QVFAERDIMSF 420
+ ++ I GA+G V+ + +ET + A+KK+ LR Q E +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKV-----ALRRLEGGIPNQALREIKALQA 55
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEY 479
+P+VV + F LVMEY+ D + +L++ PLP + Y + V Y
Sbjct: 56 CQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
+H+ GI+HRDLKP NLLI+A G +K+ DFGL+++ + E + + +S QV
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARL------------FSEEEPRLYS-HQV 161
Query: 540 YGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFF-GETPEELFAHTVNDDIE 597
T Y APE++ + Y VD W++G I E L+ P F GE E A V +
Sbjct: 162 -ATRWYRAPELLYGARKYDPGVDLWAVGCIFAE-LLNGSPLFPGENDIEQLA-IVFRTLG 218
Query: 598 WPSEDDWP 605
P+E+ WP
Sbjct: 219 TPNEETWP 226
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 80/264 (30%), Positives = 129/264 (48%), Gaps = 23/264 (8%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKI-IKNSLMLRNQMEQVFAERDIMSFTDN 423
DF ++ I G++G V+ V K ++ +AMK+I + M R + E+ E +++ D+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK--MNRREREEAIDEARVLAKLDS 58
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLH 481
+++ Y SF K L +VMEY E GD LLK PLP D +F + +L + +LH
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
S I+HRD+K NL + A ++K+ D G++K L+S TN + G
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNF-------------ANTIVG 163
Query: 542 TPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601
TP Y++PE+ + Y + D W++GV+LYE G PF L + S+
Sbjct: 164 TPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ 223
Query: 602 DDWPIQVEAKSIITDLLQQNPRDR 625
+ +I L ++ R R
Sbjct: 224 ---MYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 73/220 (33%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVT 428
+KLI +G +G V +++HK T++ F ++KIIK N +E +M DNP +
Sbjct: 22 LKLI-DGKFGKVSVLKHKPTQKLF-VQKIIKAKNF--NAIE--PMVHQLMK--DNPNFIK 73
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
+Y S T K L+M+Y++ GD LLK G L + + V A+ LH + I+H
Sbjct: 74 LYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHN 133
Query: 489 DLKPDNLLIT-ALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIA 547
D+K +N+L A I L D+GL K+ D GT +Y +
Sbjct: 134 DIKLENVLYDRAKDRIYLCDYGLCKI---------------IGTPSCYD----GTLDYFS 174
Query: 548 PEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL 587
PE I Y DWW++GV+ YE L G PF + EEL
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214
|
Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 71/213 (33%), Positives = 109/213 (51%), Gaps = 20/213 (9%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKI-IKNSLMLRNQMEQVFAERDIMSFTD 422
FT+++ I G++G VY K T Q A+K I ++ + +++E + E +S
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE---DEIEDIQQEIQFLSQCR 57
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+P++ Y SF L ++MEY GG C LLK G L F E +L +EYLH
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK-PGKLDETYIAFILREVLLGLEYLHE 116
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
G +HRD+K N+L++ G +KL DFG+S G ++ + +V GT
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFV-------------GT 161
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVG 575
P ++APEVI + GY + D WS+G+ E G
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKI--IKNSLMLRNQMEQVFAERDIMSFTDNPFVV 427
KL+ GA+G VYL +T + A+K++ +S + ++ + E ++ + +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVH 487
Y + L + MEY+ GG LK G L + R Y + + VEYLHS IVH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 488 RDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIA 547
RD+K N+L + G++KL DFG SK L ++ + K V GTP +++
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKR-LQTICS-----------SGTGMKSVTGTPYWMS 175
Query: 548 PEVILRQGYGKPVDWWSMGVILYEFL 573
PEVI +GYG+ D WS+G + E L
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 66/312 (21%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIK--NSLMLRNQMEQVFAERDIMSFTDN 423
+ VIK + +G +GSVYL R+KET + A+KK+ K S + +V + + ++
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK-----NTGPLPADMARFYFAETVLAVE 478
P +V + F L V EY+EG +L + P + R + + +
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ 538
++H +G HRDLKP+NLL++ +K+ DFGL++ + S Y YV
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSRPP--YTDYV----------- 159
Query: 539 VYGTPEYIAPEVILRQG-YGKPVDWWSMGVILYEFLVGCVPFFGETPE--ELFAHTVNDD 595
T Y APE++LR Y PVD W++G I+ E L P F + E +L+ +
Sbjct: 160 --STRWYRAPEILLRSTSYSSPVDIWALGCIMAE-LYTLRPLFPGSSEIDQLY--KICSV 214
Query: 596 IEWPSEDDWP----------------IQV-----------EAKSIITDLLQQNPRDRLGT 628
+ P++ DWP EA +I D+L+ +P+ R T
Sbjct: 215 LGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP-T 273
Query: 629 GGPHEVKEHPYF 640
+ +HPYF
Sbjct: 274 AS--QALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 96/316 (30%), Positives = 143/316 (45%), Gaps = 67/316 (21%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL-MLRNQMEQVFAERDIMSFT--D 422
+ K + G Y VY R KET + A+KKI ++ + A R+I
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFT-ALREIKLLQELK 60
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPL--PADMARFYFAETVLAVEYL 480
+P ++ + F K ++ LV E++E D ++K+ + PAD+ + Y T+ +EYL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADI-KSYMLMTLRGLEYL 118
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF-SDKQV 539
HS I+HRDLKP+NLLI + G +KL DFGL A+ F S +
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGL--------------------ARSFGSPNRK 158
Query: 540 YG----TPEYIAPEVIL--RQGYGKPVDWWSMGVILYEFLVGCVPFF-GETPEELFAHTV 592
T Y APE++ R YG VD WS+G I E L+ VPF G++ +
Sbjct: 159 MTHQVVTRWYRAPELLFGARH-YGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQLGKIF 216
Query: 593 NDDIEWPSEDDWP--------IQVEA------KSIIT-------DLLQQ----NPRDRLG 627
+ P+E++WP ++ + K I DLLQ+ NP R+
Sbjct: 217 E-ALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT 275
Query: 628 TGGPHEVKEHPYFSNL 643
+ EHPYFSN
Sbjct: 276 AR---QALEHPYFSND 288
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 72/220 (32%), Positives = 113/220 (51%), Gaps = 24/220 (10%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKK------IIKNSLMLRNQM-EQVFAERDIMSFTD 422
+LI G YG VYL + T + A+K+ I + M + + +E + + D
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 423 NPFVVTMYCSFETKK-HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLH 481
+ +V Y FET + +L + +EYV GG S L+ G + RF+ + + + YLH
Sbjct: 67 HLNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
S GI+HRDLK DNLL+ A G K++DFG+SK + ++Y+ + + G
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKK-----SDDIYD--------NDQNMSMQG 172
Query: 542 TPEYIAPEVI--LRQGYGKPVDWWSMGVILYEFLVGCVPF 579
+ ++APEVI QGY VD WS+G ++ E G P+
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 87/294 (29%), Positives = 137/294 (46%), Gaps = 41/294 (13%)
Query: 358 SKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQM--EQVFAER 415
+ I G+ G V + K T ++ A+KK + LR Q E +F E
Sbjct: 13 DPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKK-----MDLRKQQRRELLFNEV 67
Query: 416 DIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL 475
IM +P +V MY S+ L +VME++EGG ++ +T +A VL
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVL 125
Query: 476 -AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
A+ +LH+ G++HRD+K D++L+T+ G +KL+DFG C Q
Sbjct: 126 KALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGF--------------C------AQV 165
Query: 535 SD-----KQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589
S K + GTP ++APEVI R YG VD WS+G+++ E + G P+F E P L A
Sbjct: 166 SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--LQA 223
Query: 590 HTVNDDIEWP-SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
D P ++ + +S + +L ++P R E+ HP+ +
Sbjct: 224 MKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR---ATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 94/303 (31%), Positives = 133/303 (43%), Gaps = 62/303 (20%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKII-KNSLMLRNQMEQVFAERDIMSFTD 422
+ + GA GSV R K T FA+K I + L +Q+ E +I
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL---QKQILRELEINKSCK 57
Query: 423 NPFVVTMYCSF--ETKKHLCLVMEYVEGGDCASLLKN-------TGPLPADMARFYFAET 473
+P++V Y +F E+ + + MEY EGG S+ K G AE+
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK----IAES 113
Query: 474 VL-AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAK 532
VL + YLHS I+HRD+KP N+L+T G +KL DFG+S + SL A
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL------------AG 161
Query: 533 QFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET-----PEEL 587
F+ GT Y+APE I + Y D WS+G+ L E PF E P EL
Sbjct: 162 TFT-----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL 216
Query: 588 FAHTVN-----------DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636
++ VN + I+W SE E K I L+++P R P ++ E
Sbjct: 217 LSYIVNMPNPELKDEPGNGIKW-SE-------EFKDFIKQCLEKDPTRR---PTPWDMLE 265
Query: 637 HPY 639
HP+
Sbjct: 266 HPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 82/267 (30%), Positives = 131/267 (49%), Gaps = 30/267 (11%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKI--IKNSLMLRNQMEQVFAERDIMSFTD 422
+ V++++ G++G LV+H + Q++AMK+I K+S + +E E +++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS----SAVEDSRKEAVLLAKMK 56
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-GPL-PADMARFYFAETVLAVEYL 480
+P +V SFE HL +VMEY +GGD +K G L P D +F + L V+++
Sbjct: 57 HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC-YVERDAKQFSDKQV 539
H ++HRD+K N+ +T G +KL DFG +++ A Y C YV
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA---YACTYV------------ 161
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE-W 598
GTP Y+ PE+ Y D WS+G ILYE PF + + L +
Sbjct: 162 -GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL 220
Query: 599 PSEDDWPIQVEAKSIITDLLQQNPRDR 625
PS + E +S+I + ++NPR R
Sbjct: 221 PSHYSY----ELRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 68/228 (29%), Positives = 103/228 (45%), Gaps = 29/228 (12%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+F + K I G + VY + A+KK+ +M + E D++ D+
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG----PLPADMARFYFAETVLAVEY 479
P V+ SF L +V+E + GD + ++K+ +P YF + A+E+
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
+HS I+HRD+KP N+ ITA G +KL D GL + FS K
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGL--------------------GRFFSSKTT 161
Query: 540 Y-----GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE 582
GTP Y++PE I GY D WS+G +LYE PF+G+
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 69/226 (30%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
+ D+ +I+ I +G YG VY R T + A+K I L + E + E ++
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECR 58
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLH 481
+P +V + S+ + L +VMEY GG + + T GPL + ET+ + YLH
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
G +HRD+K N+L+T G +KL DFG+S L +R K G
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVS--------AQLTATIAKR-------KSFIG 163
Query: 542 TPEYIAPEVI---LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
TP ++APEV + GY D W++G+ E P F P
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 73/262 (27%), Positives = 111/262 (42%), Gaps = 21/262 (8%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+ I+++ GA+G L R E K++ L + + E I+S +P
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK-ERRDALNEIVILSLLQHPN 60
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP--LPADMARFYFAETVLAVEYLHSY 483
++ Y F L + MEY GG + +M +Y + V AV Y+H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
GI+HRD+K N+ +T G IKL DFG+SK+ + ++ E V GTP
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVV-------------GTP 165
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
Y++PE+ Y D W++G +LYE L F P L V +
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYTPVVS 223
Query: 604 WPIQVEAKSIITDLLQQNPRDR 625
E S++ LLQQ+P R
Sbjct: 224 -VYSSELISLVHSLLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 84/315 (26%), Positives = 136/315 (43%), Gaps = 68/315 (21%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQ----VFAERDIMSFT 421
+ I I G YG VY R+K+T + A+KKI R + E+ + A R+I
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI-------RMENEKEGFPITAIREIKLLQ 53
Query: 422 --DNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLA 476
+P +V + + + K + +V EY++ D LL + + Y + +
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEG 112
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
++YLHS GI+HRD+K N+LI G +KL DFGL++ Y +R++ +++
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLAR------------PYTKRNSADYTN 160
Query: 537 KQVYGTPEYIAPEVILRQG---YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH--- 590
+ + T Y PE++L G YG VD WS+G IL E +G F G T E
Sbjct: 161 RVI--TLWYRPPELLL--GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216
Query: 591 ---TVNDDIEWPSEDDWP------IQVEAKSIITD----------------LLQQNPRDR 625
+ D+ WP P + K + + LL +P+ R
Sbjct: 217 LCGSPTDEN-WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKR 275
Query: 626 LGTGGPHEVKEHPYF 640
+ + +H YF
Sbjct: 276 ISA---DQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 82/299 (27%), Positives = 138/299 (46%), Gaps = 35/299 (11%)
Query: 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF 420
PN+ + +I + +GA+G VY +HKET A K I S ++E E DI+S
Sbjct: 3 PNDI-WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSE 58
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEY 479
+P +V +Y ++ + L +++E+ +GG S++ L R+ + + A+ +
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
LHS+ ++HRDLK N+L+T G +KL DFG+S A N Q D +
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGVS-------AKNKST-------LQKRDTFI 164
Query: 540 YGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND 594
GTP ++APEV+ Y D WS+G+ L E P P + +
Sbjct: 165 -GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS 223
Query: 595 D---IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLR 650
+ ++ PS+ W + L ++P DR E+ +HP+ S+ N ++
Sbjct: 224 EPPTLDQPSK--W--SSSFNDFLKSCLVKDPDDRPTAA---ELLKHPFVSDQSDNKAIK 275
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 81/268 (30%), Positives = 125/268 (46%), Gaps = 36/268 (13%)
Query: 375 GAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE 434
G V LV T+Q F +K + K+S R ++ + + P +V ++
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTII--PHCV------PNMVCLHKYIV 55
Query: 435 TKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDN 494
++ + LV+++ EGG S + +P + + + AE V+A++ LH GIV RDL P+N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 495 LLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ 554
+L+ GHI+LT F + + D + Y APEV
Sbjct: 116 ILLDDRGHIQLTYFSRW-----------------SEVEDSCDGEAVEN-MYCAPEVGGIS 157
Query: 555 GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSII 614
+ DWWS+G IL+E L G P + HT + EW SE EA+S++
Sbjct: 158 EETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWVSE-------EARSLL 209
Query: 615 TDLLQQNPRDRLGTG--GPHEVKEHPYF 640
LLQ NP +RLG G G ++K HP+F
Sbjct: 210 QQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 77/275 (28%), Positives = 127/275 (46%), Gaps = 44/275 (16%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKI-----------IKNSLMLRNQMEQVFAE 414
+ ++LI GAYG+VY +H T + A+K I I+ + L +Q+ Q
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ---- 58
Query: 415 RDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
+ P + Y S+ L ++MEY EGG +L+K GP+ E +
Sbjct: 59 ------SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK-AGPIAEKYISVIIREVL 111
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
+A++Y+H G++HRD+K N+L+T G++KL DFG++ L N
Sbjct: 112 VALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAA----LLNQN------------- 154
Query: 535 SDKQV--YGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591
S K+ GTP ++APEVI + Y D WS+G+ +YE G P+ + A
Sbjct: 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV--DAFRAMM 212
Query: 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRL 626
+ + P +D + + L + P++RL
Sbjct: 213 LIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERL 247
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 80/320 (25%), Positives = 136/320 (42%), Gaps = 72/320 (22%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAER-----DIMSF 420
+ ++K I +GAYG V K T ++ A+KKI S + + + A+R ++
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI---SNVFDDL---IDAKRILREIKLLRH 55
Query: 421 TDNPFVVTMY-----CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL 475
+ ++ + S E + +V E +E D ++K+ PL D +++ + +
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILR 114
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK--MGLMSLATNLYECYVERDAKQ 533
++YLHS ++HRDLKP N+L+ + +K+ DFGL++ L E YV
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE-YVV----- 168
Query: 534 FSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPE---ELFA 589
T Y APE++L Y K +D WS+G I E L F G L
Sbjct: 169 --------TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIV 220
Query: 590 HTVNDDIEWPSEDD--WPIQVEAKSIIT----------------------DLLQQ----N 621
+ PSE+D + +A++ + DLL++ +
Sbjct: 221 EVLGT----PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFD 276
Query: 622 PRDRLGTGGPHEVKEHPYFS 641
P+ R+ T E HPY +
Sbjct: 277 PKKRI-TAD--EALAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 74/289 (25%), Positives = 129/289 (44%), Gaps = 38/289 (13%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
D I + G GSV V+H T A K + + + +Q+ E IM +P
Sbjct: 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSP 63
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS-Y 483
++V+ Y +F + ++C+ ME+++ G + K GP+P ++ V + YL++ +
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
I+HRD+KP N+L+ + G IKL DFG+S + S+A + +V GT
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA----DTFV-------------GTS 166
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE------------ELFAHT 591
Y++PE I Y D WS+G+ + E +G P F + +L
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP-FAFSNIDDDGQDDPMGILDLLQQI 225
Query: 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
V + D+P + + + L ++P +R P ++ P F
Sbjct: 226 VQEPPPRLPSSDFP--EDLRDFVDACLLKDPTER---PTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 35/237 (14%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTD 422
F ++++I G YG VY RHK+T Q A+K I+ ++ E++ E +I+ +++
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIE---DEEEEIKEEYNILRKYSN 61
Query: 423 NPFVVTMYCSFETKKHLC------LVMEYVEGGDCASLLKNT----GPLPADMARFYFAE 472
+P + T Y +F K LVME GG L+K L + + E
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 473 TVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAK 532
T+ + YLH ++HRD+K N+L+T +KL DFG+S L + L R+
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ----LDSTLG----RRNT- 172
Query: 533 QFSDKQVYGTPEYIAPEVI-----LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
GTP ++APEVI Y D WS+G+ E G P P
Sbjct: 173 ------FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 66/242 (27%), Positives = 105/242 (43%), Gaps = 39/242 (16%)
Query: 367 TVIKLISNGAYGSVYL----VRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
T+ K + GA+G VY + A+K + K Q+E+ E IM D
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDAS-EQQIEEFLREARIMRKLD 59
Query: 423 NPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPL---PADMARFYF--AETVL 475
+P +V + C+ ++ L +VMEY+ GGD L+ P +D+ F A
Sbjct: 60 HPNIVKLLGVCT--EEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR--- 114
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC--YVERDAKQ 533
+EYL S +HRDL N L+ +K++DFGLS+ +LY+ Y + K
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--------DLYDDDYYKVKGGK- 165
Query: 534 FSDKQVYGTP-EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC-VPFFGETPEELFAHT 591
P ++APE + + D WS GV+L+E P+ G + E+ +
Sbjct: 166 --------LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL 217
Query: 592 VN 593
Sbjct: 218 KK 219
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 71/226 (31%), Positives = 111/226 (49%), Gaps = 33/226 (14%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKK--------IIKNSLMLRNQMEQVFAER 415
N + V+ ++ GAYG V R+K T + A+KK +K + + ++ +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 416 DIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL 475
+I++ + +F K L LV EYVE L + G LP D R Y + +
Sbjct: 61 NIVNLKE---------AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQ 111
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
A+ Y HS+ I+HRD+KP+N+L++ G +KL DFG ++ L + + YV
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARA-LRARPASPLTDYV-------- 162
Query: 536 DKQVYGTPEYIAPEVILRQG-YGKPVDWWSMGVILYEFLVGCVPFF 580
T Y APE+++ YGKPVD W++G I+ E L G P F
Sbjct: 163 -----ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG-EPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 80/269 (29%), Positives = 135/269 (50%), Gaps = 23/269 (8%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYC 431
I G+ G V + K T ++ A+KK+ L + + E +F E IM + VV MY
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 432 SFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLK 491
S+ L +VME++EGG ++ +T +A + + A+ YLH+ G++HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSYLHNQGVIHRDIK 145
Query: 492 PDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI 551
D++L+T+ G IKL+DFG V ++ + K + GTP ++APEVI
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQ-------------VSKEVPK--RKSLVGTPYWMAPEVI 190
Query: 552 LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAK 611
R YG VD WS+G+++ E + G P+F E P + + D++ +D + +
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM-RRIRDNLPPRVKDSHKVSSVLR 249
Query: 612 SIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
+ +L + P R E+ +HP+
Sbjct: 250 GFLDLMLVREPSQR---ATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 73/265 (27%), Positives = 127/265 (47%), Gaps = 33/265 (12%)
Query: 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVT 428
+K I G++G LV+ KE +++ +K+I S M + E+ E ++S +P +V
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEI-NISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIV 486
SFE +L +VM+Y EGGD + P D +F + LA++++H I+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123
Query: 487 HRDLKPDNLLITALGHIKLTDFGLSKM--GLMSLATNLYECYVERDAKQFSDKQVYGTPE 544
HRD+K N+ +T G IKL DFG++++ + LA + GTP
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA-----------------RTCIGTPY 166
Query: 545 YIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDW 604
Y++PE+ + Y D W++G +LYE F + L + +P
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYP----- 219
Query: 605 PIQV----EAKSIITDLLQQNPRDR 625
P+ + +++++ L ++NPRDR
Sbjct: 220 PVSSHYSYDLRNLVSQLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 70/277 (25%), Positives = 126/277 (45%), Gaps = 21/277 (7%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKI--IKNSLMLRNQ-MEQVFAERDIMSFTDNPFV 426
+ + GA+ S Y R +T A+K++ ++N+ + + +E + E +M+ ++P +
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 427 VTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIV 486
+ M + H L +E++ GG + LL G + Y + + + YLH I+
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 487 HRDLKPDNLLITALGH-IKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
HRD+K NLLI + G +++ DFG + LA A +F Q+ GT +
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAA----ARLAAKG------TGAGEFQG-QLLGTIAF 174
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA--HTVNDDIEWPSEDD 603
+APEV+ + YG+ D WS+G ++ E P+ E A + PS +
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
+ + + L+ P DR + E+ +HP F
Sbjct: 235 -HLSPGLRDVTLRCLELQPEDRPPS---RELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 8e-27
Identities = 72/241 (29%), Positives = 112/241 (46%), Gaps = 38/241 (15%)
Query: 367 TVIKLISNGAYGSVYL----VRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
T+ K + GA+G VY + + + A+K + K Q+E+ E IM D
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDAS-EQQIEEFLREARIMRKLD 59
Query: 423 NPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGP--LPADMARFYF--AETVLA 476
+P VV + C+ ++ L +VMEY+EGGD S L+ P +D+ F A
Sbjct: 60 HPNVVKLLGVCT--EEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR---G 114
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC--YVERDAKQF 534
+EYL S +HRDL N L+ +K++DFGLS+ +LY+ Y +R K
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--------DLYDDDYYRKRGGK-- 164
Query: 535 SDKQVYGTP-EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC-VPFFGETPEELFAHTV 592
P ++APE + + D WS GV+L+E P+ G + EE+ +
Sbjct: 165 -------LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK 217
Query: 593 N 593
N
Sbjct: 218 N 218
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 66/218 (30%), Positives = 111/218 (50%), Gaps = 21/218 (9%)
Query: 371 LISNGAYGSVYLVRHKETRQRFAMKKI------IKNSLMLRNQMEQVFAERDIMSFTDNP 424
LI +G++GSVYL + + + A+K++ + R+ ++ + E ++ +
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG 484
+V S HL + +EYV GG A+LL N G + R + + + + YLH+ G
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 485 IVHRDLKPDNLLITALGHIKLTDFGLSK---MGLMSLATNLYECYVERDAKQFSDKQVYG 541
I+HRD+K N+L+ G IK++DFG+SK +S TN R + Q G
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN-----GARPSLQ-------G 174
Query: 542 TPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPF 579
+ ++APEV+ + Y + D WS+G ++ E L G PF
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVT 428
I+++ GA+G V+L R K ++ +K+I M +++ E ++ +P ++
Sbjct: 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ-MTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGP--LPADMARFYFAETVLAVEYLHSYGIV 486
Y +F K L +VMEY GG A ++ L D +F + +LA+ ++H+ I+
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 487 HRDLKPDNLLITALGHI-KLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
HRDLK N+L+ + K+ DFG+SK ++S + Y V GTP Y
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAY--------------TVVGTPCY 167
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFL 573
I+PE+ + Y + D W++G +LYE
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 71/214 (33%), Positives = 116/214 (54%), Gaps = 21/214 (9%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYC 431
I G+ G V + R K + ++ A+K + L + + E +F E IM + VV MY
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 432 SFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL-AVEYLHSYGIVHRDL 490
S+ + L ++ME+++GG ++ T +A E+VL A+ YLHS G++HRD+
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV--CESVLQALCYLHSQGVIHRDI 143
Query: 491 KPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEV 550
K D++L+T G +KL+DFG + +D + K + GTP ++APEV
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQ-------------ISKDVPK--RKSLVGTPYWMAPEV 188
Query: 551 ILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
I R YG VD WS+G+++ E + G P+F ++P
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-26
Identities = 90/314 (28%), Positives = 148/314 (47%), Gaps = 32/314 (10%)
Query: 358 SKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI 417
S P E+ + + L+ + ++ TR +K++ +ML ++ + +A ++
Sbjct: 61 SNNPREHMYVLTTLVGRNPTTAAFVA----TRGSDPKEKVVAKFVMLNDERQAAYARSEL 116
Query: 418 --MSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGD----CASLLKNTGPLPADMARFYFA 471
++ D+ +V + F++ L L+MEY GGD LK P F
Sbjct: 117 HCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFY 176
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531
+ VLA++ +HS ++HRDLK N+ + G IKL DFG SK S++ ++ +
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC---- 232
Query: 532 KQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591
GTP Y+APE+ R+ Y K D WS+GVILYE L PF G + E+
Sbjct: 233 ---------GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283
Query: 592 VNDDIEWPSEDDWPIQVEA--KSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLL 649
+ + D +P V + K+++ LL +NP R T + Y +NL + ++
Sbjct: 284 L-----YGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANL-FQDIV 337
Query: 650 RHKAEFIPQLDDEE 663
RH +E I D EE
Sbjct: 338 RH-SETISPHDREE 350
|
Length = 478 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 76/268 (28%), Positives = 122/268 (45%), Gaps = 32/268 (11%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+T + I GA G+VY T Q A+K++ +L + + E + E +M +P
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRENKHPN 77
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
+V S+ L +VMEY+ GG ++ T +A E + A+E+LHS +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQV 136
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
+HRD+K DN+L+ G +KLTDFG + +Q + GTP +
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFC---------------AQITPEQSKRSTMVGTPYW 181
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFAHTVNDDIEWPSEDDW 604
+APEV+ R+ YG VD WS+G++ E + G P+ E P L+ N E + +
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
Query: 605 P------------IQVEAKSIITDLLQQ 620
+ VE + +LLQ
Sbjct: 242 SAIFRDFLNRCLEMDVEKRGSAKELLQH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 4e-26
Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+T + I GA G+VY T Q A++++ +L + + E + E +M NP
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPN 78
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
+V S+ L +VMEY+ GG ++ T +A E + A+E+LHS +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQV 137
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
+HRD+K DN+L+ G +KLTDFG + +Q + GTP +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFC---------------AQITPEQSKRSTMVGTPYW 182
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
+APEV+ R+ YG VD WS+G++ E + G P+ E P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 76/226 (33%), Positives = 113/226 (50%), Gaps = 16/226 (7%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
N F V+ ++ GAYG V RHKET++ A+KK K+S E E ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQ 59
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
+V + +F + L LV EYVE L + +P + R Y + + A+ + H
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
IVHRD+KP+NLLI+ +KL DFG ++ +L+ Y E A ++
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFAR----NLSEGSNANYTEYVATRW--------- 166
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELF 588
Y +PE++L YGK VD WS+G IL E G F GE+ ++LF
Sbjct: 167 -YRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 21/217 (9%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKII---KNSLMLRNQMEQVFAERDIMSFTDNPFV 426
+++ GAYG+VY Q A+K++ N L + E++ E D++ + +
Sbjct: 6 EVLGKGAYGTVYC-GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 427 VTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIV 486
V + + + ME+V GG +S+L GPLP + Y + + V YLH+ +V
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 487 HRDLKPDNLLITALGHIKLTDFGLSK----MGLMSLATNLYECYVERDAKQFSDKQVYGT 542
HRD+K +N+++ G IKL DFG ++ +GL +N+ K ++GT
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML-------------KSMHGT 171
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPF 579
P ++APEVI GYG+ D WS+G ++E G P
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+T + I GA G+VY T Q A+K++ +L + + E + E +M NP
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRENKNPN 77
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
+V S+ L +VMEY+ GG ++ T +A E + A+++LHS +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALDFLHSNQV 136
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
+HRD+K DN+L+ G +KLTDFG + +Q + GTP +
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFC---------------AQITPEQSKRSTMVGTPYW 181
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
+APEV+ R+ YG VD WS+G++ E + G P+ E P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 82/249 (32%), Positives = 118/249 (47%), Gaps = 33/249 (13%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKII----KNSLMLRNQMEQVFAERDIMSFTDNPFVV 427
I GAYG+VY R + A+K + ++ L L E +R + D+P +V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKR--LEAFDHPNIV 65
Query: 428 -------TMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP-LPADMARFYFAETVLAVEY 479
T ETK + LV E+V+ L K P LPA+ + + + +++
Sbjct: 66 RLMDVCATSRTDRETK--VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
LH+ IVHRDLKP+N+L+T+ G +KL DFGL++ +Y C Q + V
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLAR---------IYSC-------QMALTPV 167
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599
T Y APEV+L+ Y PVD WS+G I E F G + + + D I P
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG-KIFDLIGLP 226
Query: 600 SEDDWPIQV 608
EDDWP V
Sbjct: 227 PEDDWPRDV 235
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
+F + K I G + VY A+KK+ LM E D++ ++P
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP----LPADMARFYFAETVLAVEYL 480
V+ Y SF L +V+E + GD + ++K+ +P YF + A+E++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
HS ++HRD+KP N+ ITA G +KL D GL + +K + +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRF---------------FSSKTTAAHSLV 167
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE 582
GTP Y++PE I GY D WS+G +LYE PF+G+
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
+F + K I G + VY R+ A+KK+ +M + E D++ ++P
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLL----KNTGPLPADMARFYFAETVLAVEYL 480
V+ SF L +V+E + GD + ++ K +P YF + AVE++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
HS ++HRD+KP N+ ITA G +KL D GL + +K + +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRF---------------FSSKTTAAHSLV 167
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE 582
GTP Y++PE I GY D WS+G +LYE PF+G+
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 70/267 (26%), Positives = 113/267 (42%), Gaps = 26/267 (9%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMK---KIIKNSLMLRNQMEQVFAERDIMSFTD 422
+ K + GA+G VY K + K K +K + E+ E IM
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE-EREEFLEEASIMKKLS 59
Query: 423 NPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV-LAVEY 479
+P +V + C+ + L +V EY+ GGD L+ G A + +EY
Sbjct: 60 HPNIVRLLGVCT--QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
L S VHRDL N L+T +K++DFGLS+ + Y +R + K
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED------DYYRKRGGGKLPIK-- 169
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAHTVNDDIEW 598
++APE + + D WS GV+L+E F +G P+ G + EE+ + D
Sbjct: 170 -----WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL-LEDGYRL 223
Query: 599 PSEDDWPIQVEAKSIITDLLQQNPRDR 625
P ++ P ++ ++ +P DR
Sbjct: 224 PRPENCPDEL--YELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 70/219 (31%), Positives = 109/219 (49%), Gaps = 19/219 (8%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+T + I GA G+V+ T Q A+K+I +L + + E + E +M NP
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPN 77
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
+V SF L +VMEY+ GG ++ T A +A E + A+E+LH+ +
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV-CRECLQALEFLHANQV 136
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
+HRD+K DN+L+ G +KLTDFG + +Q + GTP +
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFC---------------AQITPEQSKRSTMVGTPYW 181
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
+APEV+ R+ YG VD WS+G++ E + G P+ E P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 78/270 (28%), Positives = 134/270 (49%), Gaps = 23/270 (8%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYC 431
I G+ G V + K + + A+KK+ L + + E +F E IM + VV MY
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 432 SFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLK 491
S+ L +VME++EGG ++ +T +A A + A+ LH+ G++HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLKALSVLHAQGVIHRDIK 143
Query: 492 PDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI 551
D++L+T G +KL+DFG V ++ + K + GTP ++APE+I
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQ-------------VSKEVPR--RKSLVGTPYWMAPELI 188
Query: 552 LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAK 611
R YG VD WS+G+++ E + G P+F E P + + D++ ++ + K
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPKLKNLHKVSPSLK 247
Query: 612 SIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641
+ LL ++P R E+ +HP+ +
Sbjct: 248 GFLDRLLVRDPAQR---ATAAELLKHPFLA 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 84/283 (29%), Positives = 127/283 (44%), Gaps = 48/283 (16%)
Query: 375 GAYGSVYLVRHKETRQRFAMKKIIKNSLML-RNQMEQVFAERDIMSFTDNPFVVTMYCSF 433
G YGSVY V H+ T AMK+I L L ++ Q+ E DI+ +P++V Y +F
Sbjct: 12 GNYGSVYKVLHRPTGVTMAMKEI---RLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 434 ETKKHLCLVMEYVEGGDCASLL---KNTGPLPADMARFYFAETVLAVEYL-HSYGIVHRD 489
+ + + MEY++ G L T +P D+ R V +++L + I+HRD
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRD 128
Query: 490 LKPDNLLITALGHIKLTDFGLSKMGLMSLA-TNLYECYVERDAKQFSDKQVYGTPEYIAP 548
+KP N+L+ G +KL DFG+S + SLA TN+ G Y+AP
Sbjct: 129 VKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI------------------GCQSYMAP 170
Query: 549 EVILRQG------YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV----NDDIEW 598
E I G Y D WS+G+ + E +G P+ ET +FA D
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230
Query: 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGP--HEVKEHPY 639
PS +A+ + L + P R P ++ EHP+
Sbjct: 231 PSG----YSDDAQDFVAKCLNKIPNRR-----PTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 32/236 (13%)
Query: 370 KLISNGAYGSVY---LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFV 426
K + GA+G VY L A+K + ++ + + E +M +P V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNV 58
Query: 427 VTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL--------- 475
V + C+ ++ L LV+EY+EGGD L+ + P+ + + L
Sbjct: 59 VRLLGVCT--EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
+EYL S VHRDL N L+ +K++DFGLS+ + Y ++ +
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR------DVYDDDYYRKKTGGKLP 170
Query: 536 DKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
+ ++APE + + D WS GV+L+E F +G P+ G + EE+ +
Sbjct: 171 IR-------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY 219
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 77/256 (30%), Positives = 114/256 (44%), Gaps = 31/256 (12%)
Query: 355 DKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAE 414
D + P E DF +I+ I +G YG VY R+ T + A+K I L V E
Sbjct: 1 DLSRRNPQE-DFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQE 56
Query: 415 RDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
+M + +V + S+ + L + ME+ GG + TGPL + ET+
Sbjct: 57 IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL 116
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
+ YLHS G +HRD+K N+L+T GH+KL DFG+S ++A
Sbjct: 117 QGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR------------- 163
Query: 535 SDKQVYGTPEYIAPEVIL---RQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFAH 590
K GTP ++APEV + GY + D W++G+ E P F P LF
Sbjct: 164 --KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221
Query: 591 T--------VNDDIEW 598
T + D ++W
Sbjct: 222 TKSNFQPPKLKDKMKW 237
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 70/224 (31%), Positives = 112/224 (50%), Gaps = 30/224 (13%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-- 421
+ + L+ G+YG V +HKET Q A+KK +++ ++M + A R+I
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE---DDKMVKKIAMREIRMLKQL 57
Query: 422 --DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEY 479
+N +V + F KK L LV E+V+ L K L R Y + + +E+
Sbjct: 58 RHEN--LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEF 115
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT--NLYECYVERDAKQFSDK 537
HS+ I+HRD+KP+N+L++ G +KL DFG ++ +LA +Y YV
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR----TLAAPGEVYTDYV---------- 161
Query: 538 QVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFF 580
T Y APE+++ YG+ VD W++G ++ E L G P F
Sbjct: 162 ---ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG-EPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 71/263 (26%), Positives = 125/263 (47%), Gaps = 22/263 (8%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+ +IK I G++G +YL + K + +K+I + M + E E +++ +P
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEI-DLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPL-PADMARFYFAETVLAVEYLHSY 483
+VT + SF+ L +VMEY +GGD + + G L D +F + L ++++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 484 GIVHRDLKPDNLLITALGHI-KLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
I+HRD+K N+ ++ G + KL DFG+++ D+ + + GT
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIAR--------------QLNDSMELA-YTCVGT 165
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602
P Y++PE+ + Y D WS+G +LYE PF G +L S +
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPN 225
Query: 603 DWPIQVEAKSIITDLLQQNPRDR 625
+ +S+I+ L + +PRDR
Sbjct: 226 ---FSRDLRSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 83/265 (31%), Positives = 127/265 (47%), Gaps = 33/265 (12%)
Query: 371 LISNGAYGSVYLVRHKETRQRFAMKKI-IKNSLMLRNQMEQVFAERDIMSFTDNPFVVTM 429
++ G YG VY R T+ R A+K+I ++S ++ E++ + S+ + +V
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEI----ALHSYLKHRNIVQY 70
Query: 430 YCSFETKKHLCLVMEYVEGGDCASLLKNT-GPLPA--DMARFYFAETVLAVEYLHSYGIV 486
S + ME V GG ++LL++ GPL FY + + ++YLH IV
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130
Query: 487 HRDLKPDNLLI-TALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
HRD+K DN+L+ T G +K++DFG SK LA + C + F+ GT +Y
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSK----RLA-GINPC-----TETFT-----GTLQY 175
Query: 546 IAPEVILR--QGYGKPVDWWSMGVILYEFLVGCVPF--FGETPEELF-AHTVNDDIEWPS 600
+APEVI + +GYG P D WS+G + E G PF GE +F E P
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE 235
Query: 601 EDDWPIQVEAKSIITDLLQQNPRDR 625
+ EAK+ I + +P R
Sbjct: 236 S----LSAEAKNFILRCFEPDPDKR 256
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 80/249 (32%), Positives = 121/249 (48%), Gaps = 32/249 (12%)
Query: 372 ISNGAYGSVYLVRHKETRQRF-AMKKI---IKNSLMLRNQMEQVFAERDIMSFTDNPFVV 427
I GAYG V+ R + RF A+K++ M + + +V R + +F ++P VV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF-EHPNVV 67
Query: 428 TMY--CSF-----ETKKHLCLVMEYVEGGDCASLLKNTGP-LPADMARFYFAETVLAVEY 479
++ C+ ETK L LV E+V+ L K P +P + + + + +++
Sbjct: 68 RLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
LHS+ +VHRDLKP N+L+T+ G IKL DFGL+++ +A V
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS----------------V 169
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599
T Y APEV+L+ Y PVD WS+G I E F G + + + D I P
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG-KILDVIGLP 228
Query: 600 SEDDWPIQV 608
E+DWP V
Sbjct: 229 GEEDWPRDV 237
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 80/279 (28%), Positives = 126/279 (45%), Gaps = 38/279 (13%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMK--KIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTM 429
+ G++G+VYLV+ K+ +K K I + N+ Q E ++S D+P +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 430 YCSFETKKHLCLVMEYVEGGD----CASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
+ SF + C++ EY EG D L L + +F + +L V Y+H I
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSK--MGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
+HRDLK N+ + +K+ DFG+S+ MG LAT GTP
Sbjct: 128 LHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFT-----------------GTP 169
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS--- 600
Y++PE + QGY D WS+G ILYE F G+ F V +E P+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVLRIVEGPTPSL 225
Query: 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639
+ + Q+ SI+ +L ++P R E+ +P+
Sbjct: 226 PETYSRQL--NSIMQSMLNKDPSLRPSAA---EILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 75/282 (26%), Positives = 129/282 (45%), Gaps = 35/282 (12%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
D +++ +G G+VY H TR+ A+K +I + + Q +Q+ +E +I+ D+P
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVK-VIPLDITVELQ-KQIMSELEILYKCDSP 59
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG 484
+++ Y +F + + + E+++GG L +P + V + YL S
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGS----LDVYRKIPEHVLGRIAVAVVKGLTYLWSLK 115
Query: 485 IVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPE 544
I+HRD+KP N+L+ G +KL DFG+S + S+A YV GT
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT----YV-------------GTNA 158
Query: 545 YIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP---FFGE----TPEELFAHTVNDDIE 597
Y+APE I + YG D WS+G+ E +G P P +L V++D
Sbjct: 159 YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP- 217
Query: 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639
P + IT +++ P++R P + +HP+
Sbjct: 218 -PVLPVGQFSEKFVHFITQCMRKQPKERP---APENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 39/288 (13%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-D 422
ND + I +G G VY +R K+T A+K++ + + + +++ + D++ + D
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHD 72
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCAS-LLKNT-GPLPADMARFYFAETVLAVEYL 480
P++V Y F T + + ME + C LLK GP+P D+ V A+ YL
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYL 130
Query: 481 -HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
+G++HRD+KP N+L+ A G++KL DFG+S G + V+ AK S
Sbjct: 131 KEKHGVIHRDVKPSNILLDASGNVKLCDFGIS--GRL----------VDSKAKTRSA--- 175
Query: 540 YGTPEYIAPEVI----LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE-ELFAHTVND 594
G Y+APE I Y D WS+G+ L E G P+ E E+ + +
Sbjct: 176 -GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE 234
Query: 595 DI-EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGP--HEVKEHPY 639
+ P + + S + L ++ R R P E+ +HP+
Sbjct: 235 EPPSLPPNEGFSPDF--CSFVDLCLTKDHRKR-----PKYRELLQHPF 275
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 84/310 (27%), Positives = 136/310 (43%), Gaps = 62/310 (20%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQV--FAERDI--MSFT 421
F ++ I G YG VY R+K T + A+KKI L + E V A R+I +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-----RLDTETEGVPSTAIREISLLKEL 56
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGG-----DCASLLKNTGPLPADMARFYFAETVLA 476
++P +V + T+ L LV E++ D + L +P + + Y + +
Sbjct: 57 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPL----SGIPLPLIKSYLFQLLQG 112
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
+ + HS+ ++HRDLKP NLLI G IKL DFGL++ + + T +E
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---------- 162
Query: 537 KQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFA--HTV 592
T Y APE++L + Y VD WS+G I E + F G++ ++LF T+
Sbjct: 163 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 217
Query: 593 N--DDIEWP----------SEDDWPIQ----------VEAKSIITDLLQQNPRDRLGTGG 630
D++ WP S W Q + + +++ +L +P R+
Sbjct: 218 GTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA-- 275
Query: 631 PHEVKEHPYF 640
HP+F
Sbjct: 276 -KAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 84/299 (28%), Positives = 141/299 (47%), Gaps = 35/299 (11%)
Query: 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF 420
PNE + +I + +GA+G VY ++KET A K I S ++E E +I++
Sbjct: 10 PNEV-WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILAT 65
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDC-ASLLKNTGPLPADMARFYFAETVLAVEY 479
++P++V + +F L +++E+ GG A +L+ L + + + A++Y
Sbjct: 66 CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY 125
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
LHS I+HRDLK N+L+T G IKL DFG+S + +L RD+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--------RRDS-------F 170
Query: 540 YGTPEYIAPEVILRQG-----YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND 594
GTP ++APEV++ + Y D WS+G+ L E P P +
Sbjct: 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 230
Query: 595 D---IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLR 650
+ + PS+ W +E + + L ++P R ++ EHP+ S++ N LR
Sbjct: 231 EPPTLSQPSK--W--SMEFRDFLKTALDKHPETRPSAA---QLLEHPFVSSVTSNRPLR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 25/210 (11%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKII--KNSLMLRNQMEQVFAERDI--MSFTDNPFVV 427
I G+YG V+ R++ET Q A+KK + ++ +++ A R+I + +P +V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKK-----IALREIRMLKQLKHPNLV 63
Query: 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVH 487
+ F K+ L LV EY + L KN +P + + +T+ AV + H + +H
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH 123
Query: 488 RDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIA 547
RD+KP+N+LIT G IKL DFG +++ ++ + Y YV T Y A
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYV-------------ATRWYRA 168
Query: 548 PEVIL-RQGYGKPVDWWSMGVILYEFLVGC 576
PE+++ YG PVD W++G + E L G
Sbjct: 169 PELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 8e-23
Identities = 78/284 (27%), Positives = 130/284 (45%), Gaps = 49/284 (17%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRF-AMKKI-IKNSLMLRNQMEQVFAERDIMSFTD- 422
+ V++ + +GA+G VY VR K Q A+K+I + N +++ E+ + DI+S
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 423 ------NPFVVTMYCSFETKKHLCLVMEYVEG---GDCASLLKNTGP-LPADMARFYFAE 472
+P +V Y +F L +VM+ +EG G+ + LK + F +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 473 TVLAVEYLHSYG-IVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531
VLA+ YLH IVHRDL P+N+++ + +TDFGL+K + ++
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK-------------QPES 168
Query: 532 KQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET-------- 583
K S V GT Y PE++ + YG+ D W+ G ILY+ PF+
Sbjct: 169 KLTS---VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI 225
Query: 584 --------PEELFAHTVNDDIEW---PSEDDWPIQVEAKSIITD 616
PE +++ V D I P + P ++ ++I+D
Sbjct: 226 VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 8e-23
Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
E FT ++ I G++G VY T++ A+K I +++E + E ++S D
Sbjct: 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD 60
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+P++ Y S+ L ++MEY+ GG LLK GPL E + ++YLHS
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHS 119
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV--- 539
+HRD+K N+L++ G +KL DFG+ A Q +D Q+
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGV--------------------AGQLTDTQIKRN 159
Query: 540 --YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPF 579
GTP ++APEVI + Y D WS+G+ E G P
Sbjct: 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 72/219 (32%), Positives = 104/219 (47%), Gaps = 35/219 (15%)
Query: 412 FAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG----PLPADMAR 467
FA++D NP V M + LV++Y GD +K+ A
Sbjct: 100 FAKKD----PRNPENVLM---------IALVLDYANAGDLRQEIKSRAKTNRTFREHEAG 146
Query: 468 FYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYV 527
F + +LAV ++HS ++HRD+K N+L+ + G +KL DFG SKM Y V
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM---------YAATV 197
Query: 528 ERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL 587
D + GTP Y+APE+ R+ Y K D +S+GV+LYE L PF GE EE+
Sbjct: 198 SDDV----GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV 253
Query: 588 FAHTVNDDIE-WPSEDDWPIQVEAKSIITDLLQQNPRDR 625
T+ + P I E + I+T LL +P+ R
Sbjct: 254 MHKTLAGRYDPLPPS----ISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 76/249 (30%), Positives = 121/249 (48%), Gaps = 29/249 (11%)
Query: 338 LTDTSIESNSDSYCS-KKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKK 396
L S S+S S S S + ++ + I +GA G+VY V H+ T + +A+K
Sbjct: 47 LPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKV 106
Query: 397 IIKN-SLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL 455
I N +R Q+ + E +I+ ++P VV + F+ + +++E+++GG
Sbjct: 107 IYGNHEDTVRRQICR---EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH 163
Query: 456 KNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515
AD+AR + + + YLH IVHRD+KP NLLI + ++K+ DFG+S++
Sbjct: 164 IADEQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI-- 217
Query: 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI---LRQGY--GKPVDWWSMGVILY 570
LA + C GT Y++PE I L G G D WS+GV +
Sbjct: 218 --LAQTMDPC-----------NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264
Query: 571 EFLVGCVPF 579
EF +G PF
Sbjct: 265 EFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 28/221 (12%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
E FT ++ I G++G V+ T++ A+K I +++E + E ++S D
Sbjct: 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD 60
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+P+V Y S+ L ++MEY+ GG LL+ GPL E + ++YLHS
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHS 119
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV--- 539
+HRD+K N+L++ G +KL DFG+ A Q +D Q+
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGV--------------------AGQLTDTQIKRN 159
Query: 540 --YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP 578
GTP ++APEVI + Y D WS+G+ E G P
Sbjct: 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 67/221 (30%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
E FT ++ I G++G V+ T+Q A+K I +++E + E ++S D
Sbjct: 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD 60
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+P+V Y S+ L ++MEY+ GG LL+ GP E + ++YLHS
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHS 119
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV--- 539
+HRD+K N+L++ G +KL DFG+ A Q +D Q+
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGV--------------------AGQLTDTQIKRN 159
Query: 540 --YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP 578
GTP ++APEVI + Y D WS+G+ E G P
Sbjct: 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 3e-22
Identities = 89/312 (28%), Positives = 141/312 (45%), Gaps = 57/312 (18%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM---SFTD 422
+ +++ + GAYG V+ + T++ A+KKI RN + R+IM D
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD---AFRNATDAQRTFREIMFLQELGD 65
Query: 423 NPFVVTMYCSF--ETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYL 480
+P +V + E K + LV EY+E D ++++ L R+ + + A++Y+
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIR-ANILEDVHKRYIMYQLLKALKYI 123
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
HS ++HRDLKP N+L+ + +KL DFGL++ SL+ + + Y
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLAR----SLSEL-------EENPENPVLTDY 172
Query: 541 -GTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGE---------------- 582
T Y APE++L Y K VD WS+G IL E L+G F G
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232
Query: 583 TPEEL------FAHTVNDDIEWPSEDDWPI-------QVEAKSIITDLLQQNPRDRLGTG 629
+ E++ FA T+ D + PS P+ +A ++ LL NP RL
Sbjct: 233 SAEDIESIKSPFAATMLDSL--PSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA- 289
Query: 630 GPHEVKEHPYFS 641
E EHPY +
Sbjct: 290 --EEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 69/215 (32%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
E + +I + +GA+G VY ++KET A K I S ++E E DI++ D
Sbjct: 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCD 60
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDC-ASLLKNTGPLPADMARFYFAETVLAVEYLH 481
+P +V + +F + +L +++E+ GG A +L+ PL R +T+ A+ YLH
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
I+HRDLK N+L T G IKL DFG+S ++ RD+ G
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--------RRDS-------FIG 165
Query: 542 TPEYIAPEVIL-----RQGYGKPVDWWSMGVILYE 571
TP ++APEV++ + Y D WS+G+ L E
Sbjct: 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 86/298 (28%), Positives = 134/298 (44%), Gaps = 51/298 (17%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKII---KNSLMLRNQME----QVFAERDI 417
+ + I GAYG V HK T + A+KKI + R E + F +I
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 418 MSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAV 477
+ D + SFE+ + +V E +E D L+K T L D +++ + + +
Sbjct: 66 IGILD----IIRPPSFESFNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGL 119
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537
+Y+HS ++HRDLKP NLL+ +K+ DFGL++ +A E D F +
Sbjct: 120 KYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR-----IADP------EHDHTGFLTE 168
Query: 538 QVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN--- 593
V T Y APE++L +GY K +D WS+G IL E L P F P + + H +N
Sbjct: 169 YV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS-NRPLF---PGKDYLHQLNLIL 223
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRH 651
+ PS++D II + R R + +K P+ + WN L +
Sbjct: 224 GVLGTPSQEDL------NCII------SLRAR------NYIKSLPFKPKVPWNKLFPN 263
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 4e-22
Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 38/233 (16%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKI---IKNSLMLRNQMEQVFAERDIMSFT 421
DF + + G G V V H+ + A K I IK ++ RNQ + E ++
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAI--RNQ---IIRELKVLHEC 56
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAV---- 477
++P++V Y +F + + + ME+++GG +LK G +P + + +AV
Sbjct: 57 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEN----ILGKISIAVLRGL 112
Query: 478 EYL---HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
YL H I+HRD+KP N+L+ + G IKL DFG+S + S+A +
Sbjct: 113 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------------ 158
Query: 535 SDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL 587
GT Y++PE + Y D WS+G+ L E +G P +EL
Sbjct: 159 -----VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 76/257 (29%), Positives = 116/257 (45%), Gaps = 46/257 (17%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKI-------------IKN-SLMLRNQMEQ 410
D+T I+ I G YG VY R+K+T Q AMKKI I+ SL+ Q
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 411 VFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYF 470
+ +D++ +++ + S + KK+L L + A++ + Y
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYL-------------DSLPKGQYMDAELVKSYL 107
Query: 471 AETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERD 530
+ + + + HS ++HRDLKP NLLI G IKL DFGL++ + + +E
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV---- 163
Query: 531 AKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELF 588
T Y APEV+L Y PVD WS+G I E F G++ ++LF
Sbjct: 164 -----------TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF 212
Query: 589 AHTVNDDIEWPSEDDWP 605
+ + P+ED WP
Sbjct: 213 --RIFRILGTPTEDVWP 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 68/215 (31%), Positives = 111/215 (51%), Gaps = 18/215 (8%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKN--SLMLRNQMEQVFAERDIMSFTDNPFVV 427
KL+ GA+G VYL +T + A+K++ + S ++ + E ++ + +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 428 TMY-CSFET-KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
Y C + ++ L + ME++ GG LK+ G L ++ R Y + + V YLHS I
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSK-MGLMSLATNLYECYVERDAKQFSDKQVYGTPE 544
VHRD+K N+L ++G++KL DFG SK + + L+ K V GTP
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGT-------------GMKSVTGTPY 174
Query: 545 YIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPF 579
+++PEVI +GYG+ D WS+G + E L P+
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 7e-22
Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 20/216 (9%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKII--KNSLMLRNQMEQVFAERDIMSFTDNPFVV 427
KL+ GA+G VYL +T + A+K++ +S ++ + E ++ + +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 428 TMYCSFE--TKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
Y +K L + +EY+ GG LK G L ++ R Y + + V YLHS I
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSK--MGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
VHRD+K N+L + G++KL DFG SK + T + K V GTP
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI--------------KSVTGTP 173
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPF 579
+++PEVI +GYG+ D WS+ + E L P+
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 86/311 (27%), Positives = 128/311 (41%), Gaps = 62/311 (19%)
Query: 367 TVIKL--ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQ---VFAERDIMSFT 421
T KL + G+Y +VY R K T Q A+K+I R + E+ A R+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEI-------RLEHEEGAPFTAIREASLLK 58
Query: 422 D--NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEY 479
D + +VT++ TKK L LV EY++ + G L R + + + + Y
Sbjct: 59 DLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
H ++HRDLKP NLLI+ G +KL DFGL++ S+ + Y S++ V
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARA--KSVPSKTY-----------SNEVV 165
Query: 540 YGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598
T Y P+V+L Y +D W +G I YE G F G T E H + +
Sbjct: 166 --TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT 223
Query: 599 PSEDDWP-----------------------------IQVEAKSIITDLLQQNPRDRLGTG 629
P+E+ WP + + LQ P+ R+
Sbjct: 224 PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA- 282
Query: 630 GPHEVKEHPYF 640
E +HPYF
Sbjct: 283 --AEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 73/308 (23%), Positives = 135/308 (43%), Gaps = 48/308 (15%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+ I+ I +GAYG V + ++ A+KKI + ++ E I+ +
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA-KRTLRELKILRHFKHDN 65
Query: 426 VVTMYCSFETK----KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLH 481
++ + K + +VM+ +E D ++ + PL + R++ + + ++Y+H
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
S ++HRDLKP NLL+ +++ DFG+++ GL S T + K F + V
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMAR-GLSSSPT---------EHKYFMTEYV-A 173
Query: 542 TPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGE--------------TPEE 586
T Y APE++L Y +D WS+G I E L F G+ +P E
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233
Query: 587 LFAHTVNDD-----IE-WPSEDDWPIQV-------EAKSIITDLLQQNPRDRLGTGGPHE 633
+ + D I+ P + P EA +++ +LQ +P +R+ +
Sbjct: 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV---EQ 290
Query: 634 VKEHPYFS 641
+HP+ +
Sbjct: 291 ALQHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 78/256 (30%), Positives = 109/256 (42%), Gaps = 52/256 (20%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD--------- 422
I G YG VY R + + A+KK+ +M+ ERD + +
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV---------RMDN---ERDGIPISSLREITLLLN 62
Query: 423 --NPFVVTMYCSFETKKHL---CLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLA 476
+P +V + KHL LVMEY E D ASLL N P + + +
Sbjct: 63 LRHPNIVELK-EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
++YLH I+HRDLK NLL+T G +K+ DFGL++ AK +
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART-------------YGLPAKPMTP 167
Query: 537 KQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH----- 590
K V T Y APE++L Y +D W++G IL E L G++ E
Sbjct: 168 KVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLL 225
Query: 591 -TVNDDIEWPSEDDWP 605
T N+ I WP D P
Sbjct: 226 GTPNESI-WPGFSDLP 240
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 2e-21
Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 16/214 (7%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKII--KNSLMLRNQMEQVFAERDIMSFTDNPFVV 427
KL+ GA+G VYL +T + A K++ S ++ + E ++ + +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 428 TMYCSFE--TKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
Y +K L + MEY+ GG LK G L + R Y + + + YLHS I
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
VHRD+K N+L + G++KL DFG SK L ++ + + V GTP +
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKR-LQTICMS-----------GTGIRSVTGTPYW 175
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPF 579
++PEVI +GYG+ D WS+G + E L P+
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 6e-21
Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKI-IKN-SLMLRNQMEQVFAERDIMSFTDN 423
+ ++++ G+YG V LVRH+ +++ +KK+ ++N S R EQ E ++S +
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKH 58
Query: 424 PFVVTMYCSFETKK-HLCLVMEYVEGGDCASLLKNTGP--LPADMARFYFAETVLAVEYL 480
P +V S+E + L +VM + EGGD LK LP + +F + +A++YL
Sbjct: 59 PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
H I+HRDLK N+ +T IK+ D G++++ +E S +
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARV-------------LENQCDMAS--TLI 163
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYE 571
GTP Y++PE+ + Y D W++G +YE
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYE 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 80/316 (25%), Positives = 130/316 (41%), Gaps = 71/316 (22%)
Query: 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQ----VFAERDI---MSFT 421
++ I G YG VY R K T + A+KK R +M++ A R+I +
Sbjct: 6 LEKIGEGTYGKVYKARDKNTGKLVALKKT-------RLEMDEEGIPPTALREISLLQMLS 58
Query: 422 DNPFVVTMYCSFET-----KKHLCLVMEYVEGGDCASLLKNTG-----PLPADMARFYFA 471
++ ++V + K L LV EY++ D + + G PLPA + +
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLI-TALGHIKLTDFGLSKMGLMSLATNLYECYVERD 530
+ + V + H +G++HRDLKP NLL+ G +K+ D GL + + +
Sbjct: 118 QLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV------------ 165
Query: 531 AKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589
K ++ + V T Y APEV+L Y PVD WS+G I E F G++ +
Sbjct: 166 -KSYTHEIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL 222
Query: 590 HTVNDDIEWPSEDDWP-------------------------IQVEAKSIITDLLQQNPRD 624
H + + P+E WP + E ++ +L+ +P
Sbjct: 223 H-IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAK 281
Query: 625 RLGTGGPHEVKEHPYF 640
R+ HPYF
Sbjct: 282 RISAKA---ALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 75/315 (23%), Positives = 135/315 (42%), Gaps = 77/315 (24%)
Query: 368 VIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM---SFTDNP 424
++ I G + V + ++T + +A+K + K+ +EQV R+I + +P
Sbjct: 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF----KSLEQVNNLREIQALRRLSPHP 58
Query: 425 FVVTMY-CSFETK-KHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLH 481
++ + F+ K L LV E ++ + L+K PLP + Y + + +++++H
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
GI HRD+KP+N+LI +KL DFG S + +Y
Sbjct: 118 RNGIFHRDIKPENILIKD-DILKLADFG-------------------------SCRGIYS 151
Query: 542 TP---EYI------APEVILRQG-YGKPVDWWSMGVILYEFLVGCVPFF-GE-------- 582
P EYI APE +L G YG +D W++G + +E ++ P F G
Sbjct: 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFE-ILSLFPLFPGTNELDQIAK 210
Query: 583 ------TPE----ELFAHTVNDDIEWPSEDDWPIQ-------VEAKSIITDLLQQNPRDR 625
TP+ + F + + + +PS+ ++ E ++ LL +P +R
Sbjct: 211 IHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDER 270
Query: 626 LGTGGPHEVKEHPYF 640
+ + HPYF
Sbjct: 271 ITA---KQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 77/275 (28%), Positives = 119/275 (43%), Gaps = 26/275 (9%)
Query: 355 DKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAE 414
+ FSK E FT ++ I +G++G+VY R T + A+KK+ + + + + E
Sbjct: 6 ELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 415 RDIMSFTDNPFVVTMYCSFETKKHLC-LVMEYVEGGDCASLLKNTGPLPADMARFYFAET 473
+ +P + Y ++H LVMEY G L + PL
Sbjct: 66 VRFLQQLRHPNTIE-YKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGA 124
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
+ + YLHS+ +HRD+K N+L+T G +KL DFG L+S A +
Sbjct: 125 LQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG--SASLVSPANSF----------- 171
Query: 534 FSDKQVYGTPEYIAPEVILRQGYGK---PVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590
GTP ++APEVIL G+ VD WS+G+ E P F H
Sbjct: 172 ------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
Query: 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
+D S +DW ++ + LQ+ P+DR
Sbjct: 226 IAQNDSPTLSSNDW--SDYFRNFVDSCLQKIPQDR 258
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 22/229 (9%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKI-IKNSLMLRNQMEQVFAERDIMSFT 421
++DF I + G G V V+HK + A K I ++ +RNQ + E ++
Sbjct: 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ---IIRELQVLHEC 60
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYL- 480
++P++V Y +F + + + ME+++GG +LK +P ++ + + YL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 120
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
+ I+HRD+KP N+L+ + G IKL DFG+S + S+A +
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----------------V 163
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589
GT Y++PE + Y D WSMG+ L E +G P +EL A
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 70/248 (28%), Positives = 115/248 (46%), Gaps = 28/248 (11%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKI-IKNSLMLRNQMEQVFAERDIMSFT 421
++DF I + G G V+ V HK + A K I ++ +RNQ + E ++
Sbjct: 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ---IIRELQVLHEC 60
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYL- 480
++P++V Y +F + + + ME+++GG +LK G +P + + + YL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
+ I+HRD+KP N+L+ + G IKL DFG+S + S+A +
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----------------V 163
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL---FAHTVNDDIE 597
GT Y++PE + Y D WSMG+ L E +G P +EL F V D
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD-- 221
Query: 598 WPSEDDWP 605
P+E +
Sbjct: 222 -PAESETS 228
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 79/249 (31%), Positives = 119/249 (47%), Gaps = 35/249 (14%)
Query: 367 TVIKL--ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQ-----VFAERDIMS 419
T +KL + G Y +V+ R K T A+K+I R + E+ E ++
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEI-------RLEHEEGAPCTAIREVSLLK 58
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPA-DMARFYFAETVLAVE 478
+ +VT++ T++ L LV EY++ D L N G L + + + + + +
Sbjct: 59 NLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLS 117
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ 538
Y H I+HRDLKP NLLI G +KL DFGL++ S+ T K +S++
Sbjct: 118 YCHKRKILHRDLKPQNLLINEKGELKLADFGLARA--KSVPT-----------KTYSNEV 164
Query: 539 VYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGET-PEELFAHTVNDDI 596
V T Y P+V+L Y P+D W +G ILYE G F G T EEL H + +
Sbjct: 165 V--TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL--HLIFRLL 220
Query: 597 EWPSEDDWP 605
P+E+ WP
Sbjct: 221 GTPTEETWP 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 68/233 (29%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 355 DKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAE 414
D + P ++D+ +I+ + +G YG VY R+ T + A KIIK L + + E
Sbjct: 1 DILRRNP-QHDYELIQRVGSGTYGDVYKARNLHTGE-LAAVKIIK--LEPGDDFSLIQQE 56
Query: 415 RDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
++ + +V + S+ +++ L + MEY GG + TGPL + ET+
Sbjct: 57 IFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL 116
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
+ YLHS G +HRD+K N+L+T G +KL DFG++ ++A
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR------------- 163
Query: 535 SDKQVYGTPEYIAPEVILRQ---GYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
K GTP ++APEV + GY + D W++G+ E P F P
Sbjct: 164 --KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 35/229 (15%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERD-IMSFTD 422
D + I GA+G+V + HK + A+K+I S + + +++ + D +M +D
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSD 61
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASL--------LKNTGPLPADMARFYFAETV 474
P++V Y + + + ME ++ SL +P ++ TV
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMD----ISLDKFYKYVYEVLKSVIPEEILGKIAVATV 117
Query: 475 LAVEYL-HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
A+ YL I+HRD+KP N+L+ G+IKL DFG+S + S+A RDA
Sbjct: 118 KALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT-------RDA-- 168
Query: 534 FSDKQVYGTPEYIAPEVIL---RQGYGKPVDWWSMGVILYEFLVGCVPF 579
G Y+APE I R GY D WS+G+ LYE G P+
Sbjct: 169 -------GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 76/302 (25%), Positives = 124/302 (41%), Gaps = 62/302 (20%)
Query: 374 NGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI--MSFTDNPFVVTMYC 431
G Y +VY R++ T + A+K+I ++ + A R+I M + +V ++
Sbjct: 10 EGTYATVYKGRNRTTGEIVALKEIHLDA----EEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 432 SFETKKHLCLVMEYVEGGDCASLLK-------NTGPLPADMARFYFAETVLAVEYLHSYG 484
T+ L LV EY++ LK G L + + + + + + + H
Sbjct: 66 VIHTENKLMLVFEYMDKD-----LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120
Query: 485 IVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPE 544
++HRDLKP NLLI G +KL DFGL++ + + T FS++ V T
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-------------FSNEVV--TLW 165
Query: 545 YIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN-----DDIEW 598
Y AP+V+L + Y +D WS+G I+ E + G F G E+ + W
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225
Query: 599 PSEDDWP--------------------IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHP 638
P P ++ LLQ NP R+ H+ +HP
Sbjct: 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA---HDALQHP 282
Query: 639 YF 640
+F
Sbjct: 283 WF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 87/309 (28%), Positives = 139/309 (44%), Gaps = 60/309 (19%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQV--FAERDI--MSFT 421
+ ++ I G YG VY R K T + A+KKI L + E V A R+I +
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-----RLETEDEGVPSTAIREISLLKEL 55
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEY 479
++P +V + ++ L LV E+++ D + ++ L + + Y + + + Y
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
HS+ ++HRDLKP NLLI G +KL DFGL++ + + T +E
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV------------- 161
Query: 540 YGTPEYIAPEVIL--RQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFA-----HT 591
T Y APE++L RQ Y PVD WS+G I E + F G++ ++LF T
Sbjct: 162 --TLWYRAPEILLGSRQ-YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGT 218
Query: 592 VNDDIEWP----------SEDDWPIQVEAKSIIT------DLLQQ----NPRDRLGTGGP 631
++D+ WP + W Q +K + DLL + +P R+
Sbjct: 219 PDEDV-WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA--- 274
Query: 632 HEVKEHPYF 640
+HPYF
Sbjct: 275 KAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 81/329 (24%), Positives = 126/329 (38%), Gaps = 87/329 (26%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQ--RFAMKKI---IKNSLMLRNQMEQVFAERDIM-- 418
+ +IK + GAYG V R+ ET + A+KKI ++ + A R++
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR------ALRELKLL 55
Query: 419 -SFTDNPFVVTMY----CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAET 473
F + + +Y L L E +E D ++++ PL + + +
Sbjct: 56 RHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
+ ++Y+HS ++HRDLKP NLL+ A +K+ DFGL A+
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGL--------------------ARG 154
Query: 534 FSDKQVYGTP---EYI------APEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFF--- 580
FS+ EY+ APE++L Q Y K +D WS+G IL E L G P F
Sbjct: 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGK 213
Query: 581 -------------GETPEELFAHT---------------VNDDIEWPSEDDWPIQVEAKS 612
G EE + E + P A
Sbjct: 214 DYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANP---LALD 270
Query: 613 IITDLLQQNPRDRLGTGGPHEVKEHPYFS 641
++ LL +P R+ E EHPY +
Sbjct: 271 LLEKLLAFDPTKRISV---EEALEHPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-19
Identities = 76/286 (26%), Positives = 131/286 (45%), Gaps = 33/286 (11%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKI----IKNSLMLRNQMEQVFAERDIMSFT 421
+ +I+LI G G VYL +R A+KKI +N L L+ + E I +
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPL-LKKRF---LREAKIAADL 59
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT---GPLPADMARFYFAETVLA-- 476
+P +V +Y + M Y+EG SLLK+ L ++A L+
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 477 ------VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERD 530
+EY+HS G++HRDLKPDN+L+ G + + D+G + + +L + V+
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLE-EEDLLDIDVDER 178
Query: 531 AKQFSD----KQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE 586
+S ++ GTP+Y+APE +L + D +++GVILY+ L P+ + +
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238
Query: 587 L-FAHTVNDDIEWPSEDDWP---IQVEAKSIITDLLQQNPRDRLGT 628
+ + + IE + P Q+ K++ D P +R +
Sbjct: 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVD-----PAERYSS 279
|
Length = 932 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 88/330 (26%), Positives = 139/330 (42%), Gaps = 97/330 (29%)
Query: 369 IKLISNGAYGSVYLVRHKETRQRFAMKKII---------KNSL----MLRN-QMEQVFAE 414
IK I GAYG V ++ ET ++ A+KKI K +L +LR+ E V A
Sbjct: 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 415 RDIM------SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARF 468
+DIM +F D V +Y +T H +++++ L D ++
Sbjct: 70 KDIMPPPHREAFND---VYIVYELMDTDLH--------------QIIRSSQTLSDDHCQY 112
Query: 469 YFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528
+ + + ++Y+HS ++HRDLKP NLL+ A +K+ DFGL++
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--------------TT 158
Query: 529 RDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL 587
+ F + V T Y APE++L Y +D WS+G I E L+G P F P +
Sbjct: 159 SEKGDFMTEYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAE-LLGRKPLF---PGKD 213
Query: 588 FAHTVNDDIEW---PSEDD---------------------------WPIQVEAKSIITDL 617
+ H + E PSE+D +P +I DL
Sbjct: 214 YVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFP-HANPLAI--DL 270
Query: 618 LQQ----NPRDRLGTGGPHEVKEHPYFSNL 643
L++ +P R+ E HPY ++L
Sbjct: 271 LEKMLVFDPSKRITV---EEALAHPYLASL 297
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 70/250 (28%), Positives = 108/250 (43%), Gaps = 46/250 (18%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQME--QVFAERDI---MSFTDNPFV 426
I G YG VY R K+T + A+KK+ + + E + + R+I + +P +
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLK-----MEKEKEGFPITSLREINILLKL-QHPNI 66
Query: 427 VTMYCSFE-----TKKHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYL 480
VT+ E + +VMEYVE D SL++ P + + + V +L
Sbjct: 67 VTVK---EVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
H I+HRDLK NLL+ G +K+ DFGL++ K ++ V
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGILKICDFGLAR-------------EYGSPLKPYTQLVV- 168
Query: 541 GTPEYIAPEVILRQG-YGKPVDWWSMGVILYEFLVGCVPFFG----ETPEELFAHTVNDD 595
T Y APE++L Y +D WS+G I E L F G + ++F
Sbjct: 169 -TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF-----KL 222
Query: 596 IEWPSEDDWP 605
+ P+E WP
Sbjct: 223 LGTPTEKIWP 232
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 88/313 (28%), Positives = 134/313 (42%), Gaps = 63/313 (20%)
Query: 367 TVIKL--ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQ---VFAERDIMSFT 421
T IKL + G Y +VY R K T A+K+I R + E+ A R++
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLLK 59
Query: 422 D--NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPL-PADMARFYFAETVLAVE 478
D + +VT++ T+K L LV EY++ D L + G + + + + +
Sbjct: 60 DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLN 118
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ 538
Y H ++HRDLKP NLLI G +KL DFGL++ S+ T K +S++
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSIPT-----------KTYSNEV 165
Query: 539 VYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597
V T Y P+++L Y +D W +G I YE G F G T EE H + +
Sbjct: 166 V--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL-HFIFRILG 222
Query: 598 WPSEDDWP---------------------------IQVEAKSIITDLLQQNPRDRLGTGG 630
P+E+ WP + + +++ LLQ R R+
Sbjct: 223 TPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA-- 280
Query: 631 PHEVKEHPYFSNL 643
E +HPYF L
Sbjct: 281 -EEAMKHPYFHCL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 73/250 (29%), Positives = 114/250 (45%), Gaps = 54/250 (21%)
Query: 344 ESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM 403
+ +C + K+ K + I G +G V+ RHK+T+Q A+KK+ LM
Sbjct: 1 DQYEFPFCDEVSKYEK---------LAKIGQGTFGEVFKARHKKTKQIVALKKV----LM 47
Query: 404 LRNQME--QVFAERD--IMSFTDNPFVVTMY--CSFETKKH------LCLVMEYVEGGDC 451
N+ E + A R+ I+ + VV + C + + LV E+ E D
Sbjct: 48 E-NEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DL 105
Query: 452 ASLLKNTGPLPADMARFYFAE--TVL-----AVEYLHSYGIVHRDLKPDNLLITALGHIK 504
A LL N +F +E V+ + Y+H I+HRD+K N+LIT G +K
Sbjct: 106 AGLLSNK------NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILK 159
Query: 505 LTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL--RQGYGKPVDW 562
L DFGL++ SL+ N +++++ V T Y PE++L R YG P+D
Sbjct: 160 LADFGLARA--FSLSKN-------SKPNRYTNRVV--TLWYRPPELLLGERD-YGPPIDM 207
Query: 563 WSMGVILYEF 572
W G I+ E
Sbjct: 208 WGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 69/236 (29%), Positives = 105/236 (44%), Gaps = 34/236 (14%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ + +I+ I G YG VY V +K+ A+K + + + E++ AE +I+ N
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP----ISDVDEEIEAEYNILQSLPN 77
Query: 424 -PFVVTMYCSFETKKH-----LCLVMEYVEGGDCASLLKNT----GPLPADMARFYFAET 473
P VV Y F L LV+E GG L+K L M +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
+L +++LH+ I+HRD+K +N+L+T G +KL DFG+S L + R+
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS--------AQLTSTRLRRNTS- 188
Query: 534 FSDKQVYGTPEYIAPEVILRQ-----GYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
GTP ++APEVI + Y D WS+G+ E G P F P
Sbjct: 189 ------VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 84/313 (26%), Positives = 132/313 (42%), Gaps = 80/313 (25%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQV--FAERDIMSFTD--NPFVV 427
I G YG+V+ +++ET + A+K++ L + E V A R+I + + +V
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKN-----TGPLPADMARFYFAETVLAVEYLHS 482
+Y + K L LV EY C LK G + ++ + + + + + + HS
Sbjct: 63 RLYDVLHSDKKLTLVFEY-----CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSK-MGLMSLATNLYECYVERDAKQFSDKQVYG 541
+ ++HRDLKP NLLI G +KL DFGL++ G+ + +S + V
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--------------PVRCYSAEVV-- 161
Query: 542 TPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE--- 597
T Y P+V+ + Y +D WS G I E P F P + V+D ++
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF---P----GNDVDDQLKRIF 214
Query: 598 ----WPSEDDWP--------------------IQVEAK--SIITDLLQQ----NPRDRLG 627
P+E+ WP + V K S DLLQ NP R+
Sbjct: 215 RLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS 274
Query: 628 TGGPHEVKEHPYF 640
E +HPYF
Sbjct: 275 A---EEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 33/228 (14%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS-FTDNP 424
F +++++ NG YG VY RH +T Q A+K + + ++ E++ E +++ ++ +
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73
Query: 425 FVVTMYCSFETKK------HLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLA 476
+ T Y +F K L LVME+ G L+KNT L D + E +
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
+ +LH++ ++HRD+K N+L+T +KL DFG+S + D
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS---------------AQLDRTVGRR 178
Query: 537 KQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPF 579
GTP ++APEVI Y D WS+G+ E G P
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-18
Identities = 81/322 (25%), Positives = 134/322 (41%), Gaps = 74/322 (22%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQ-----VFAERDIM 418
+ + ++ + G+Y +VY + K + A+K ++R Q E+ E ++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALK-------VIRLQEEEGTPFTAIREASLL 57
Query: 419 SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVE 478
+ +V ++ TK+ L LV EYV C + K+ G L + + + + + +
Sbjct: 58 KGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ 538
Y+H I+HRDLKP NLLI+ G +KL DFGL++ S+ ++ Y S++
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTY-----------SNEV 164
Query: 539 VYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597
V T Y P+V+L Y +D W +G I E + G F G + D +E
Sbjct: 165 V--TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG-------MKDIQDQLE 215
Query: 598 -------WPSEDDWP-----------------------------IQVEAKSIITDLLQQN 621
P+ED WP A+ + + LLQ
Sbjct: 216 RIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCF 275
Query: 622 PRDRLGTGGPHEVKEHPYFSNL 643
P++RL H YFS+L
Sbjct: 276 PKNRLSA---QAALSHEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 6e-18
Identities = 78/289 (26%), Positives = 125/289 (43%), Gaps = 40/289 (13%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS-FTDNP 424
F +++L+ NG YG VY RH +T Q A+K + ++ E++ E +++ ++ +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHR 63
Query: 425 FVVTMYCSFETKK------HLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLA 476
+ T Y +F K L LVME+ G L+KNT L + + E +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
+ +LH + ++HRD+K N+L+T +KL DFG+S + D
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS---------------AQLDRTVGRR 168
Query: 537 KQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFAH 590
GTP ++APEVI Y D WS+G+ E G P P LF
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
Query: 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639
N S+ W + + S I L +N R T ++ +HP+
Sbjct: 229 PRNPAPRLKSK-KWSKKFQ--SFIESCLVKNHSQRPTT---EQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-18
Identities = 70/272 (25%), Positives = 114/272 (41%), Gaps = 24/272 (8%)
Query: 357 FSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERD 416
F K E FT ++ I +G++G+VY R T + A+KK+ + + + + E
Sbjct: 18 FFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77
Query: 417 IMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLA 476
+ +P + + + LVMEY G L + PL +
Sbjct: 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
+ YLHS+ ++HRD+K N+L+T G +KL DFG + + A F
Sbjct: 138 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA--------------SPANSF-- 181
Query: 537 KQVYGTPEYIAPEVILRQGYGK---PVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593
GTP ++APEVIL G+ VD WS+G+ E P F H
Sbjct: 182 ---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
++ ++W ++ + LQ+ P+DR
Sbjct: 239 NESPTLQSNEWSDYF--RNFVDSCLQKIPQDR 268
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 68/239 (28%), Positives = 111/239 (46%), Gaps = 35/239 (14%)
Query: 357 FSKTPNEND-FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAER 415
F P+ +D + +I+ I G YG V+ V +K+ + A+K + + + E++ AE
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP----IHDIDEEIEAEY 65
Query: 416 DIM-SFTDNPFVVTMYCSFETKK-----HLCLVMEYVEGGDCASL----LKNTGPLPADM 465
+I+ + +D+P VV Y + K L LV+E GG L LK + +
Sbjct: 66 NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125
Query: 466 ARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC 525
+ E ++ +++LH +HRD+K +N+L+T G +KL DFG+S L
Sbjct: 126 IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS--------AQLTST 177
Query: 526 YVERDAKQFSDKQVYGTPEYIAPEVI-----LRQGYGKPVDWWSMGVILYEFLVGCVPF 579
+ R+ GTP ++APEVI L Y D WS+G+ E G P
Sbjct: 178 RLRRNTS-------VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 81/288 (28%), Positives = 134/288 (46%), Gaps = 33/288 (11%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI-MSFTD 422
+D VI+ + GAYG V +RH T A+K+I + ++ + Q +++ + DI M D
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQ-KRLLMDLDISMRSVD 58
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASL-------LKNTGPLPADMARFYFAETVL 475
P+ VT Y + + + + ME ++ SL +P D+ V
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMD----TSLDKFYKKVYDKGLTIPEDILGKIAVSIVK 114
Query: 476 AVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
A+EYLHS ++HRD+KP N+LI G +KL DFG+S + S+A ++ K
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT-----IDAGCKP- 168
Query: 535 SDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG-ETPEELFAHTVN 593
Y PE I PE + ++GY D WS+G+ + E G P+ +TP + V
Sbjct: 169 -----YMAPERINPE-LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641
+ P E + + L++N ++R E+ +HP+F
Sbjct: 223 EPS--PQLPAEKFSPEFQDFVNKCLKKNYKER---PNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-17
Identities = 57/193 (29%), Positives = 83/193 (43%), Gaps = 25/193 (12%)
Query: 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG 501
V EYV G +L G LPA + + A+ H+ GIVHRDLKP N++++ G
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 502 ---HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS-DKQVYGTPEYIAPEVILRQGYG 557
H K+ DFG+ + + D + +V GTP Y APE Q G
Sbjct: 117 VRPHAKVLDFGIGTLL---------PGVRDADVATLTRTTEVLGTPTYCAPE----QLRG 163
Query: 558 KPV----DWWSMGVILYEFLVGCVPFFGETPEE-LFAHTVNDDIEWPSEDDWPIQVEAKS 612
+PV D ++ G+I E L G G + E L+ D+ P W
Sbjct: 164 EPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPP---WIAGHPLGQ 220
Query: 613 IITDLLQQNPRDR 625
++ L ++PR R
Sbjct: 221 VLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 46/241 (19%)
Query: 359 KTPNE--NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAER- 415
KT E + + + + +GAYG V +T ++ A+KK + R + A+R
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKK------LSRPFQSAIHAKRT 61
Query: 416 -------------DIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLP 462
+++ D V T S E + + LV + G D +++K L
Sbjct: 62 YRELRLLKHMDHENVIGLLD---VFTPASSLEDFQDVYLVTHLM-GADLNNIVK-CQKLS 116
Query: 463 ADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522
D +F + + ++Y+HS GI+HRDLKP N+ + +K+ DFGL++ +
Sbjct: 117 DDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH-----TDDE 171
Query: 523 YECYVERDAKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFG 581
YV T Y APE++L Y + VD WS+G I+ E L G F G
Sbjct: 172 MTGYV-------------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218
Query: 582 E 582
Sbjct: 219 S 219
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 36/222 (16%)
Query: 378 GSVYLVRHKETRQRFAMKKI---IKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE 434
V+L +HK T A+KKI + L+ + E +P ++ SF
Sbjct: 14 MIVHLAKHKPTNTLVAVKKINLDSCSKEDLK----LLQQEIITSRQLQHPNILPYVTSFI 69
Query: 435 TKKHLCLVMEYVEGGDCASLLKNTGP--LPADMARFYFAETVLAVEYLHSYGIVHRDLKP 492
L +V + G C LLK P LP F + + A++Y+HS G +HR +K
Sbjct: 70 VDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKA 129
Query: 493 DNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYI------ 546
++L++ G + L+ GL M ++ +Q + V+ P+
Sbjct: 130 SHILLSGDGKVVLS--GLRYSVSM----------IKHGKRQ---RVVHDFPKSSVKNLPW 174
Query: 547 -APEVILRQ---GYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
+PEV L+Q GY + D +S+G+ E G VPF + P
Sbjct: 175 LSPEV-LQQNLQGYNEKSDIYSVGITACELANGHVPFK-DMP 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 69/274 (25%), Positives = 111/274 (40%), Gaps = 24/274 (8%)
Query: 355 DKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAE 414
D F K E F + I +G++G+VY + T + A+KK+ + + + + E
Sbjct: 12 DLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKE 71
Query: 415 RDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
+ +P + + + LVMEY G L + PL +
Sbjct: 72 VKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL 131
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
+ YLHS+ ++HRD+K N+L+T G +KL DFG + A F
Sbjct: 132 QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS--------------KSSPANSF 177
Query: 535 SDKQVYGTPEYIAPEVILRQGYGK---PVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591
GTP ++APEVIL G+ VD WS+G+ E P F H
Sbjct: 178 -----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
Query: 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
+D ++W + + LQ+ P++R
Sbjct: 233 AQNDSPTLQSNEWTDSF--RGFVDYCLQKIPQER 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-17
Identities = 72/236 (30%), Positives = 106/236 (44%), Gaps = 53/236 (22%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIK------------NSLMLRNQM--EQV 411
+T +K + +GAYGSV K T ++ A+KK+ + L L M E V
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 412 FAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG-PLPADMARFYF 470
D+ FT S + + LVM Y++ L K G PL D ++
Sbjct: 77 IGLLDV--FTSAV-------SGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLV 123
Query: 471 AETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERD 530
+ + ++Y+HS GI+HRDLKP NL + +K+ DFGL++
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR------------------ 165
Query: 531 AKQFSDKQVYG---TPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGE 582
+D ++ G T Y APEVIL Y + VD WS+G I+ E L G F G+
Sbjct: 166 ---HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 67/274 (24%), Positives = 112/274 (40%), Gaps = 24/274 (8%)
Query: 355 DKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAE 414
+ F K E F+ ++ I +G++G+VY R + A+KK+ + + + + E
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 415 RDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
+ +P + + + LVMEY G L + PL +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL 125
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
+ YLHS+ ++HRD+K N+L++ G +KL DFG +M+ A
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG--SASIMAPANXF------------ 171
Query: 535 SDKQVYGTPEYIAPEVILRQGYGK---PVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591
GTP ++APEVIL G+ VD WS+G+ E P F H
Sbjct: 172 -----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
Query: 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
++ W ++ + LQ+ P+DR
Sbjct: 227 AQNESPALQSGHWSEYF--RNFVDSCLQKIPQDR 258
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 23/219 (10%)
Query: 369 IKLISNGAYGSVYLVRHK----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
IK + G +G V L R+ T ++ A+K + N E +I+ D+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRTLDHE 66
Query: 425 FVVTM-YCSFET-KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL-AVEYLH 481
+V + + L L+MEY+ G L+ F+ + ++YL
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
S +HRDL N+L+ + +K++DFGL+K + + Y ++ +
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAK-----VLPEDKDYYYVKEPGES------- 174
Query: 542 TP-EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPF 579
P + APE + + D WS GV LYE P
Sbjct: 175 -PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 74/253 (29%), Positives = 116/253 (45%), Gaps = 43/253 (16%)
Query: 367 TVIKL--ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQ---VFAERDIMSFT 421
T IKL + G Y +V+ R K T A+K+I R + E+ A R++
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEI-------RLEHEEGAPCTAIREVSLLK 59
Query: 422 D--NPFVVTMYCSFETKKHLCLVMEYVEGG------DCASLLKNTGPLPADMARFYFAET 473
D + +VT++ T K L LV EY++ DC +++ + + +
Sbjct: 60 DLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMS------MHNVKIFLYQI 113
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
+ + Y H ++HRDLKP NLLI G +KL DFGL++ S+ T K
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSVPT-----------KT 160
Query: 534 FSDKQVYGTPEYIAPEVILRQG-YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592
+S++ V T Y P+V+L Y +D W +G I +E G F G T E+ H +
Sbjct: 161 YSNEVV--TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL-HLI 217
Query: 593 NDDIEWPSEDDWP 605
+ P+E+ WP
Sbjct: 218 FRLLGTPTEETWP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (211), Expect = 6e-17
Identities = 83/302 (27%), Positives = 137/302 (45%), Gaps = 68/302 (22%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
N++ VIK I NG +G V+LV+HK T++ F K I L R + Q+ E ++M +
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEVNVMRELKH 71
Query: 424 PFVVTMYCSFETK--KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAET----VLAV 477
+V F K + L ++ME+ + GD + ++ + + + + A+
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 478 EYLHSYG-------IVHRDLKPDNLLI-TALGHI----------------KLTDFGLSK- 512
Y H+ ++HRDLKP N+ + T + HI K+ DFGLSK
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ--GYGKPVDWWSMGVILY 570
+G+ S+A + C GTP Y +PE++L + Y D W++G I+Y
Sbjct: 192 IGIESMA---HSC--------------VGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 571 EFLVGCVPFFGETPEELFAHTVNDDIEWPSE----DDWPIQVEAKS---IITDLLQQNPR 623
E G PF H N+ + SE D PI+ ++K +I +LL + +
Sbjct: 235 ELCSGKTPF----------HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAK 284
Query: 624 DR 625
+R
Sbjct: 285 ER 286
|
Length = 1021 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 73/328 (22%), Positives = 123/328 (37%), Gaps = 79/328 (24%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKI----IKNSLM-LRNQMEQV------FAERDIM 418
+ G YG V T + A+KK+ I N + R + E IM
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 419 SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVE 478
+ + ++ + + + LVM+ + D ++ L + + + +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLN 133
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK-----MGLMSLATNLYECYVERDAKQ 533
LH + +HRDL P N+ I + G K+ DFGL++ +L+ + E
Sbjct: 134 VLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE---- 189
Query: 534 FSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592
+ K V T Y APE+++ + Y VD WS+G I E L G F GE
Sbjct: 190 MTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE---------- 237
Query: 593 NDDIEW----------PSEDDWPIQVEAKS----------------------------II 614
++I+ P+ED+WP +AK ++
Sbjct: 238 -NEIDQLGRIFELLGTPNEDNWP---QAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLL 293
Query: 615 TDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
LL+ NP +R+ E +H YF +
Sbjct: 294 QSLLKLNPLERISA---KEALKHEYFKS 318
|
Length = 335 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 36/230 (15%)
Query: 366 FTV------IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQM--EQVFAERDI 417
FTV +K I +GA G V T Q A+KK+ S +N ++ + E +
Sbjct: 12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL---SRPFQNVTHAKRAYRELVL 68
Query: 418 MSFTDNPFVV------TMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFA 471
M ++ ++ T S E + + LVME ++ C + + L + +
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLY 125
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531
+ + +++LHS GI+HRDLKP N+++ + +K+ DFGL++ S Y V R
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--VVTR-- 181
Query: 532 KQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG 581
Y Y APEVIL GY + VD WS+G I+ E + G V F G
Sbjct: 182 --------Y----YRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 76/247 (30%), Positives = 114/247 (46%), Gaps = 40/247 (16%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQV--FAERDIMSFT-----DNP 424
I G YG VY R + T + A+KKI L + E V A R+I S N
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-----RLEQEDEGVPSTAIREI-SLLKEMQHGN- 62
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPAD--MARFYFAETVLAVEYLHS 482
+V + ++K L LV EY++ D + ++ + + + Y + + + Y HS
Sbjct: 63 -IVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 483 YGIVHRDLKPDNLLIT-ALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
+ ++HRDLKP NLLI +KL DFGL++ + + T +E
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--------------- 165
Query: 542 TPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE--ELFAHTVNDDIEW 598
T Y APE++L + Y PVD WS+G I E +V P F E ELF + +
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAE-MVNQKPLFPGDSEIDELF--KIFRILGT 222
Query: 599 PSEDDWP 605
P+E+ WP
Sbjct: 223 PNEETWP 229
|
Length = 294 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-16
Identities = 66/247 (26%), Positives = 105/247 (42%), Gaps = 52/247 (21%)
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
+V ++ TK+ L V EY+ ++++ G L R + + + + Y+H I
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
+HRDLKP NLLI+ LG +KL DFGL++ S+ + Y V T Y
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSEVV-------------TLWY 169
Query: 546 IAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFG--ETPEELFAHTVNDDIEWPSED 602
P+V+L Y +D W G I E L G F G + E+L + + P+ED
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL--EKIWTVLGVPTED 227
Query: 603 DWP--------------------IQV---------EAKSIITDLLQQNPRDRLGTGGPHE 633
WP ++V +A+ + + +L P+DR+ +
Sbjct: 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA---QD 284
Query: 634 VKEHPYF 640
HPYF
Sbjct: 285 ALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 81/284 (28%), Positives = 119/284 (41%), Gaps = 80/284 (28%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIK------------NSLMLRNQMEQV 411
N + ++ + GA+G V R + T Q A+KKI+K L L +
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH- 68
Query: 412 FAERDIMSFTD---NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARF 468
+I+S +D +P + + V E + G D LL + PL ++
Sbjct: 69 ---ENIISLSDIFISPL-----------EDIYFVTE-LLGTDLHRLLT-SRPLEKQFIQY 112
Query: 469 YFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528
+ + + ++Y+HS G+VHRDLKP N+LI +K+ DFGL+++
Sbjct: 113 FLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--------------- 157
Query: 529 RDAKQFSDKQVYG---TPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
D Q+ G T Y APE++L Q Y VD WS G I E L G
Sbjct: 158 ------QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG--------- 202
Query: 585 EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628
+ LF P +D V SIITDLL P D + T
Sbjct: 203 KPLF----------PGKD----HVNQFSIITDLLGTPPDDVINT 232
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 60/260 (23%), Positives = 110/260 (42%), Gaps = 38/260 (14%)
Query: 322 NKTVFSDL-DNDIQNISLTDTSIESNSDSYCSK--KDKFSKTPNENDFTVIKLISNGAYG 378
++ ++SD+ D D++ S + D K K + +TVIK ++ G+ G
Sbjct: 21 DEDLYSDISDGDLEYSDDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEG 80
Query: 379 SVYLVRHKETRQRFAMKKIIKNS-----LMLRNQMEQVFAERDIMSFTDNPFVVTMYCSF 433
V++ +K K + ++L+N ++P V+ M +
Sbjct: 81 RVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQN--------------VNHPSVIRMKDTL 126
Query: 434 ETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPD 493
+ C+V+ + L K + PLP D A + + + YLH+ I+HRD+K +
Sbjct: 127 VSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTE 186
Query: 494 NLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR 553
N+ I + + + D G ++ +++ A + GT E APEV+ R
Sbjct: 187 NIFINDVDQVCIGDLGAAQFPVVAPA----------------FLGLAGTVETNAPEVLAR 230
Query: 554 QGYGKPVDWWSMGVILYEFL 573
Y D WS G++L+E L
Sbjct: 231 DKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 54/233 (23%), Positives = 103/233 (44%), Gaps = 24/233 (10%)
Query: 358 SKTPNENDFTVIKLISNGAYGSVY---LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAE 414
+ E + IK++ +GA+G+VY + E + K+++ + E + E
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE-ILDE 59
Query: 415 RDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAET 473
+M+ D+P VV + + + L+ + + G ++N + + + +
Sbjct: 60 AYVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI 118
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
+ YL +VHRDL N+L+ H+K+TDFGL+K+ ++ D K+
Sbjct: 119 AKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL-------------LDVDEKE 165
Query: 534 FSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE 586
+ + +++A E IL + Y D WS GV ++E + FG P E
Sbjct: 166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT-----FGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 51/270 (18%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETR--QRFAMKKIIKNSLMLRNQMEQV--FAERDIMSFT 421
+ + I G YG VY + K + + +A+KK K + Q + A R+I
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGD---KEQYTGISQSACREIALLR 57
Query: 422 --DNPFVVTMYCSFETKKHLC--LVMEYVEGGDCASLLK-----NTGPLPADMARFYFAE 472
+ VV++ F L+ +Y E D ++K +P M + +
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 473 TVLAVEYLHSYGIVHRDLKPDNLLITALGH----IKLTDFGLSKM---GLMSLATNLYEC 525
+ V YLHS ++HRDLKP N+L+ G +K+ D GL+++ L LA
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD----- 171
Query: 526 YVERDAKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
D V T Y APE++L + Y K +D W++G I E L F G
Sbjct: 172 ---------LDPVVV-TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR-E 220
Query: 585 EEL-----FAHTVNDDI----EWPSEDDWP 605
++ F + I P+E DWP
Sbjct: 221 AKIKKSNPFQRDQLERIFEVLGTPTEKDWP 250
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 27/235 (11%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
N + + I G +G V L ++ Q+ A+K + +S + AE +M+
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAA----QAFLAEASVMTTL 57
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMA-RFYFA-ETVLAVEY 479
+P +V + L +V EY+ G L++ G +A + FA + +EY
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
L VHRDL N+L++ K++DFGL+K E +D+ + K
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----------EASQGQDSGKLPVK-- 164
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAHTVN 593
+ APE + + + D WS G++L+E + G VP+ +++ H
Sbjct: 165 -----WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 76/330 (23%), Positives = 127/330 (38%), Gaps = 79/330 (23%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQME--QVFAERDI--MS 419
D+ ++ + G +G VY R +T + A+KKI+ + N+ + + A R+I +
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL-----MHNEKDGFPITALREIKILK 62
Query: 420 FTDNPFVVTM------YCSFETKKHLC--LVMEYVEGGDCASLLKNTGP---LPADMARF 468
+P VV + +K +V Y++ D + LL+N P L +
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKC 119
Query: 469 YFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528
Y + + + YLH I+HRD+K N+LI G +K+ DFG LA
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG--------LARPYDGP--- 168
Query: 529 RDAKQFSDKQVYGTPEYI---------APEVIL--RQGYGKPVDWWSMGVILYEFLVGCV 577
GT +Y PE++L R+ Y VD W +G + E
Sbjct: 169 --PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERR-YTTAVDIWGIGCVFAEMFTRRP 225
Query: 578 PFFGETPEELFAHTVNDDIEWPSEDDWPI------------------QVEAK-------- 611
G++ + H + P+E+ WP +E +
Sbjct: 226 ILQGKSDIDQ-LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEG 284
Query: 612 -SIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
+++ LL +P RL + EHPYF
Sbjct: 285 LDLLSKLLSLDPYKRLTA---SDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 41/227 (18%)
Query: 375 GAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE 434
G+ G V+ + +R A+KKI L ++ E I+ D+ +V +Y
Sbjct: 16 GSNGLVFSAVDSDCDKRVAVKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 435 TKKH--------------LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYL 480
+ +V EY+E D A++L GPL + AR + + + ++Y+
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLSEEHARLFMYQLLRGLKYI 130
Query: 481 HSYGIVHRDLKPDNLLI-TALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK-- 537
HS ++HRDLKP N+ I T +K+ DFGL+++ V+ +S K
Sbjct: 131 HSANVLHRDLKPANVFINTEDLVLKIGDFGLARI-------------VDPH---YSHKGY 174
Query: 538 --QVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFG 581
+ T Y +P ++L Y K +D W+ G I E L G F G
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
N ++ T +K + +G +G V+L + + + + A+K I + ++ E E +M
Sbjct: 2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKL 56
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYL 480
+P +V +Y +K L +V E++E G + L+ G L DM + +EYL
Sbjct: 57 SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL 116
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
+HRDL N L+++ G +K++DFG+++ L + Y +F K
Sbjct: 117 ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY-------VLDDEYTSSSGAKFPVK--- 166
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPF 579
+ PEV Y D WS GV+++E F G +PF
Sbjct: 167 ----WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 69/263 (26%), Positives = 109/263 (41%), Gaps = 51/263 (19%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKI-------------IKNSLMLR------- 405
F +I I G YG VY R K+T + A+KK+ I+ +LR
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 406 -NQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKN-TGPLPA 463
N E V ++D + F + K LV EY++ D LL++
Sbjct: 69 VNLKEIVTDKQDALDFKKD------------KGAFYLVFEYMDH-DLMGLLESGLVHFSE 115
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523
D + + + + + Y H +HRD+K N+L+ G IKL DFGL+++
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL---------- 165
Query: 524 ECYVERDAKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGE 582
Y +++ +++K + T Y PE++L + YG +D WS G IL E P F
Sbjct: 166 --YNSEESRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK-KPIFQA 220
Query: 583 TPEELFAHTVNDDIEWPSEDDWP 605
E ++ P WP
Sbjct: 221 NQELAQLELISRLCGSPCPAVWP 243
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-14
Identities = 90/360 (25%), Positives = 154/360 (42%), Gaps = 62/360 (17%)
Query: 320 GINKTVFSDLDNDIQNISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGS 379
G K +D D + S + + E + D +++PN++ + + +I NG++G
Sbjct: 24 GSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDND-INRSPNKS-YKLGNIIGNGSFGV 81
Query: 380 VYLVRHKETRQRFAMKKIIKN------SLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSF 433
VY +T ++ A+KK++++ L++ + + +I+ D + +
Sbjct: 82 VYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI----NIIFLKDY-YYTECFKKN 136
Query: 434 ETKKHLCLVMEYVEGGDCASL---LKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDL 490
E L +VME++ + +N LP + + Y + A+ Y+HS I HRDL
Sbjct: 137 EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDL 196
Query: 491 KPDNLLITALGH-IKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPE 549
KP NLLI H +KL DFG +K L + Y C +F Y APE
Sbjct: 197 KPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC------SRF----------YRAPE 240
Query: 550 VIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGE--------------TPEELFAHTVND 594
++L Y +D WS+G I+ E ++G F G+ TP E +N
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300
Query: 595 ---DIEWPSEDDWPIQV--------EAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643
DI++P ++ +A + I+ L+ P RL P E P+F +L
Sbjct: 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL---NPIEALADPFFDDL 357
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-14
Identities = 71/246 (28%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 352 SKKDK--FSKTPNENDFTVIKL------ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM 403
SK+D +S ++ FTV+K I +GA G V + A+KK+ S
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRP 60
Query: 404 LRNQMEQVFAERDI--MSFTDNPFVVTMYCSFETKKHL------CLVMEYVEGGDCASLL 455
+NQ A R++ M ++ ++ + F +K L +VME ++ C +
Sbjct: 61 FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ 120
Query: 456 KNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515
L + + + + +++LHS GI+HRDLKP N+++ + +K+ DFGL++
Sbjct: 121 ME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177
Query: 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVG 575
S + YV T Y APEVIL GY + VD WS+G I+ E + G
Sbjct: 178 TSF---MMTPYVV-------------TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 576 CVPFFG 581
V F G
Sbjct: 222 GVLFPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 49/156 (31%), Positives = 75/156 (48%), Gaps = 19/156 (12%)
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
V T S E + + LVME ++ C + L + + + + +++LHS GI
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLLYQMLCGIKHLHSAGI 144
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
+HRDLKP N+++ + +K+ DFGL++ + Y T Y
Sbjct: 145 IHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV----------------TRYY 188
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG 581
APEVIL GY + VD WS+G I+ E + G V F G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 50/231 (21%)
Query: 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAER------------- 415
+K + +GAYG+V + T + A+KK + R ++FA+R
Sbjct: 20 LKQVGSGAYGTVCSALDRRTGAKVAIKK------LYRPFQSELFAKRAYRELRLLKHMKH 73
Query: 416 -DIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
+++ D V T S + LVM ++ G D L+K+ L D +F + +
Sbjct: 74 ENVIGLLD---VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE-KLSEDRIQFLVYQML 128
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
++Y+H+ GI+HRDLKP NL + +K+ DFGL++
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--------------------- 167
Query: 535 SDKQVYG---TPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFG 581
+D ++ G T Y APEVIL Y + VD WS+G I+ E L G F G
Sbjct: 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 66/239 (27%), Positives = 108/239 (45%), Gaps = 36/239 (15%)
Query: 357 FSKTPNENDFTVIKL------ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQ 410
+S ++ FTV+K I +GA G V + A+KK+ S +NQ
Sbjct: 4 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHA 60
Query: 411 VFAERDI--MSFTDNPFVVTMYCSFETKKHL------CLVMEYVEGGDCASLLKNTGPLP 462
A R++ M ++ ++++ F +K L LVME ++ C + L
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LD 117
Query: 463 ADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522
+ + + + +++LHS GI+HRDLKP N+++ + +K+ DFGL++ S
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 177
Query: 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG 581
Y T Y APEVIL GY + VD WS+G I+ E + + F G
Sbjct: 178 YVV----------------TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 25/225 (11%)
Query: 372 ISNGAYGSV---YLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVT 428
+ +G +GSV + A+K +K + + E E +M+ D+P +V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVK-TLKQEHIAAGKKE-FLREASVMAQLDHPCIVR 60
Query: 429 MY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIV 486
+ C E L LVME G LK +P + + + + YL S V
Sbjct: 61 LIGVCKGEP---LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 487 HRDLKPDNLLITALGHIKLTDFGLSK-MGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
HRDL N+L+ K++DFG+S+ +G A + Y Y A ++ K +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALG----AGSDY--YRATTAGRWPLK-------W 164
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFA 589
APE I + D WS GV L+E F G P+ E+ A
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA 209
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 66/246 (26%), Positives = 105/246 (42%), Gaps = 37/246 (15%)
Query: 362 NENDFTVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERD 416
T+I+ + G++G VY V E R A+K + +N+ M R ++E E
Sbjct: 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-RERIE-FLNEAS 61
Query: 417 IMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK--------NTGPLPADMARF 468
+M + VV + T + +VME + GD S L+ N G P + +F
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 469 Y--FAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC- 525
AE + YL + VHRDL N ++ +K+ DFG + ++YE
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFG--------MTRDIYETD 173
Query: 526 YVERDAKQFSDKQVYGTP-EYIAPEVILRQGYGKPV-DWWSMGVILYEFL-VGCVPFFGE 582
Y + K P ++APE L+ G D WS GV+L+E + P+ G
Sbjct: 174 YYRKGGKGL-------LPVRWMAPES-LKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225
Query: 583 TPEELF 588
+ EE+
Sbjct: 226 SNEEVL 231
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-13
Identities = 60/256 (23%), Positives = 108/256 (42%), Gaps = 36/256 (14%)
Query: 326 FSDLDNDIQNISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRH 385
+ D DI + ES++D+ + + + F++++ + GA G +
Sbjct: 54 YEDKHMDIDIFDIFADEDESDADASLALCAEARAGIEKAGFSILETFTPGAEGFAFACID 113
Query: 386 KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445
+T + +K Q E I+ ++P ++ + +F K CL++
Sbjct: 114 NKTCEHVVIKA---------GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164
Query: 446 VEGGDCASLLKNTGPLP-ADMARFYFAETVL-AVEYLHSYGIVHRDLKPDNLLITALGHI 503
+ D L + D+ +VL A++YLH I+HRD+K +N+ I G +
Sbjct: 165 YKT-DLYCYLAAKRNIAICDI--LAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDV 221
Query: 504 KLTDFGLSKMGLMSLATNLYECY-VERDAKQFSDKQVYGTPEYIA---PEVILRQGYGKP 559
L DFG + C+ V+ +A ++ YG IA PE++ R YG
Sbjct: 222 CLGDFGAA-------------CFPVDINANKY-----YGWAGTIATNAPELLARDPYGPA 263
Query: 560 VDWWSMGVILYEFLVG 575
VD WS G++L+E
Sbjct: 264 VDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYC 431
I G +G V+ R + A+K + + + E I+ +P +V +
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 432 SFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLA-VEYLHSYGIVHRDL 490
K+ + +VME V+GGD + L+ GP E A +EYL S +HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 491 KPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP-EYIAPE 549
N L+T +K++DFG+S+ E D S + P ++ APE
Sbjct: 121 AARNCLVTEKNVLKISDFGMSRE--------------EEDGVYASTGGMKQIPVKWTAPE 166
Query: 550 VILRQGYGKPVDWWSMGVILYE-FLVGCVPF 579
+ Y D WS G++L+E F +G VP+
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 7e-13
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 46/227 (20%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIK------------NSLMLRNQMEQVFAERDIMS 419
+ +GAYGSV RQ+ A+KK+ + L L M+ +++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKH----ENVIG 78
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEY 479
D V T S E + LV + G D +++K L + +F + + ++Y
Sbjct: 79 LLD---VFTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKY 133
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
+HS GI+HRDLKP N+ + +++ DFGL++ +D ++
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ---------------------ADDEM 172
Query: 540 YG---TPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGE 582
G T Y APE++L Y + VD WS+G I+ E L G F G
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 61/228 (26%), Positives = 113/228 (49%), Gaps = 26/228 (11%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQM--EQVFAERDIMSFTD 422
D + I GA+G V+ V +R A+KK+ + +N + ++VF E ++ F
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN---VFQNLVSCKRVFRELKMLCFFK 57
Query: 423 NPFVVTMYCSFETK-----KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAV 477
+ V++ + + + +V E ++ D ++ + PL +D + + + + +
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGL 116
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537
+YLHS GI+HRD+KP NLL+ + +K+ DFGL+++ E D + +
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE-------------EPDESKHMTQ 163
Query: 538 QVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
+V T Y APE+++ + Y VD WS+G I E L + F ++P
Sbjct: 164 EVV-TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIK--NSLMLRNQMEQVFAERDIMSFTDNPFVVTM 429
+ +GAYGSV +T R A+KK+ + S++ ++ + E ++ + V+ +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHMKHENVIGL 81
Query: 430 YCSFETKKHL-----CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG 484
F + L ++ ++ G D +++K L D +F + + ++Y+HS
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSAD 140
Query: 485 IVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG--- 541
I+HRDLKP NL + +K+ DFGL++ +D ++ G
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLAR---------------------HTDDEMTGYVA 179
Query: 542 TPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFG 581
T Y APE++L Y + VD WS+G I+ E L G F G
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 57/229 (24%), Positives = 104/229 (45%), Gaps = 23/229 (10%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
+ T +K + +G +G V+L + + A+K I + ++ + E +M +P
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAM----SEDDFIEEAKVMMKLSHP 59
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSY 483
+V +Y ++ + +V EY+ G + L+ G L + ++ A+EYL S
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
G +HRDL N L+ +K++DFGL++ YV D Q++ Q P
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLAR-------------YVLDD--QYTSSQGTKFP 164
Query: 544 -EYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
++ PEV + D WS GV+++E F G +P+ + E+
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 8e-12
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 372 ISNGAYGSVY--LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTM 429
+ +G +G+V + + K++ + A+K I+KN +++ E ++M DNP++V M
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 430 Y--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVH 487
C E+ LVME E G L+ + + + ++YL VH
Sbjct: 62 IGICEAES---WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118
Query: 488 RDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIA 547
RDL N+L+ + K++DFGLSK + N Y+ AK V ++ A
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKA--LGADENYYK------AKTHGKWPV----KWYA 166
Query: 548 PEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFG 581
PE + + D WS GV+++E F G P+ G
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 66/256 (25%), Positives = 102/256 (39%), Gaps = 45/256 (17%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKE--TRQRFAMK--KIIKNSLMLRNQMEQVFAERDIMS 419
N+ ++ I GA+G V+ R + F M K++K Q + E +M+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMA 63
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP-------LPADMARFY--- 469
D+P +V + K +CL+ EY+ GD L++ P AR
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 470 -----------FAETVLA-VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517
A+ V A + YL VHRDL N L+ +K+ DFGLS+
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR----- 178
Query: 518 LATNLYEC-YVERDAKQFSDKQVYGTP-EYIAPEVILRQGYGKPVDWWSMGVILYE-FLV 574
N+Y Y + P ++ PE I Y D W+ GV+L+E F
Sbjct: 179 ---NIYSADYYKASENDA-------IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 228
Query: 575 GCVPFFGETPEELFAH 590
G P++G EE+ +
Sbjct: 229 GMQPYYGMAHEEVIYY 244
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+ + ++I G+YG V T ++ A+KKI + + ++ E ++ +P
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 426 VVTMY-----CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYL 480
+V + S K + +V E +E D ++K L + +F+ + + A++Y+
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC-YVERDAKQFSDKQV 539
H+ + HRDLKP N+L A +K+ DFGL+++ T ++ YV
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV------------ 167
Query: 540 YGTPEYIAPEVI--LRQGYGKPVDWWSMGVILYEFLVGCVPFF 580
T Y APE+ Y +D WS+G I E L G P F
Sbjct: 168 -ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 375 GAYGSVYL-VRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTM--YC 431
G +G V V +Q K++KN ++ +++ E +IM DNP++V M C
Sbjct: 6 GNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVC 64
Query: 432 SFETKKHLCLVMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDL 490
E L LVME GG L + + + ++YL VHRDL
Sbjct: 65 EAEA---LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDL 121
Query: 491 KPDNLLITALGHIKLTDFGLSK-MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPE 549
N+L+ + K++DFGLSK +G A + Y Y R A ++ K + APE
Sbjct: 122 AARNVLLVNQHYAKISDFGLSKALG----ADDSY--YKARSAGKWPLK-------WYAPE 168
Query: 550 VILRQGYGKPVDWWSMGVILYE-FLVGCVPF 579
I + + D WS G+ ++E F G P+
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 64/272 (23%), Positives = 121/272 (44%), Gaps = 35/272 (12%)
Query: 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF 420
P E ++K + G +G V++ + + A+K + + S+ E AE ++M
Sbjct: 4 PRET-LKLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSM----SPEAFLAEANLMKQ 57
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG----PLPA--DMARFYFAETV 474
+P +V +Y + T++ + ++ EY+E G LK + DMA A+
Sbjct: 58 LQHPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMA----AQIA 112
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
+ ++ +HRDL+ N+L++ K+ DFGL+++ + N Y R+ +F
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL----IEDNE---YTAREGAKF 165
Query: 535 SDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVN 593
K + APE I + D WS G++L E + G +P+ G T E+ + +
Sbjct: 166 PIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LE 217
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
P D+ P E ++ ++ P +R
Sbjct: 218 RGYRMPRPDNCP--EELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 31/223 (13%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDIMS- 419
N + +++ I G +G V L ++ + K IKN + Q F AE +M+
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYRGNK---VAVKCIKN-----DATAQAFLAEASVMTQ 55
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP--LPADMARFYFAETVLAV 477
+ V + E K L +V EY+ G L++ G L D + + A+
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537
EYL + VHRDL N+L++ K++DFGL+K E +D + K
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVK 164
Query: 538 QVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPF 579
+ APE + + + D WS G++L+E + G VP+
Sbjct: 165 -------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 64/292 (21%), Positives = 115/292 (39%), Gaps = 44/292 (15%)
Query: 365 DFTVIKLISNGAYGSVYL--VRHKETRQRFAMK--KIIKNSLMLRNQMEQVFAERDIMSF 420
+ + + GA+G V+L H E + K +K + + + E ++++
Sbjct: 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET-ASNDARKDFEREAELLTN 64
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP-------LPADMARFYFAET 473
+ +V Y +V EY+E GD L++ GP + M ++
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 474 V-------LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECY 526
+ + YL S VHRDL N L+ +K+ DFG+S+ ++Y
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------DVYTTD 176
Query: 527 VERDAKQFSDKQVYGTP----EYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFG 581
R V G ++ PE I+ + + D WS GV+L+E F G P++G
Sbjct: 177 YYR---------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227
Query: 582 ETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHE 633
+ EE+ + P +V I+ +++P+ R+ HE
Sbjct: 228 LSNEEVI-ECITQGRLLQRPRTCPSEVYD--IMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 18/219 (8%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTM 429
+ I G +G VY K A+K S + + + E +I+ D+P +V +
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTC--RSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57
Query: 430 YCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
K+ + +VME V GG + L K L + +EYL S +HR
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHR 117
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DL N L+ +K++DFG+S+ +Y V KQ K + AP
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR----EEEGGIYT--VSDGLKQIPIK-------WTAP 164
Query: 549 EVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEE 586
E + Y D WS G++L+E F +G P+ G + ++
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 54/219 (24%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 366 FTVIKLISNGAYGSVYL-VRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
+ ++ ++ G+ G V++ +H + +++ K I+K + ++ DI+ +
Sbjct: 94 YNILSSLTPGSEGEVFVCTKHGDEQRK---KVIVKAVTGGKTPGREI----DILKTISHR 146
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL-AVEYLHSY 483
++ + ++ K +C+VM + D + + +GPLP + A +L A+ YLH
Sbjct: 147 AIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALAYLHGR 204
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLS-KMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
GI+HRD+K +N+ + + L DFG + K+ + +CY GT
Sbjct: 205 GIIHRDVKTENIFLDEPENAVLGDFGAACKLD---AHPDTPQCY-----------GWSGT 250
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG 581
E +PE++ Y D WS G++L+E V V FG
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 34/230 (14%)
Query: 414 ERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGD---------------CASLLKNT 458
E +M+ +P +V + ++ +C++ EY+ GD C+S T
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 459 GPLPADMARF-YFAETVLA-VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516
D F + A + A +EYL S+ VH+DL N+LI H+K++D GLS+
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR---- 172
Query: 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVG 575
E Y D + K + ++ PE I+ + D WS GV+L+E F G
Sbjct: 173 -------EIY-SADYYRVQPKSLLPI-RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFG 223
Query: 576 CVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
P++G + +E+ V P +D P ++ S++T+ Q+ P R
Sbjct: 224 LQPYYGFSNQEVI-EMVRKRQLLPCSEDCPPRM--YSLMTECWQEGPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 74/280 (26%), Positives = 121/280 (43%), Gaps = 44/280 (15%)
Query: 367 TVIKLISNGAYGSVY--LVRHKE---TRQRFAMKKIIKNSLMLRNQMEQVF-AERDIMS- 419
T+++ + +GA+G VY L R ++ + A+K + ++ Q E F E IMS
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSK 65
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPAD-----MARFYFA--E 472
F V + SFE +++E + GGD S L+ P P M F +
Sbjct: 66 FNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 473 TVLAVEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLATNLYEC-YVE 528
+YL +HRD+ N L+T G K+ DFG+++ ++Y Y
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--------DIYRASYYR 176
Query: 529 RDAKQFSDKQVYGTP-EYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEE 586
+ + P +++ PE L + D WS GV+L+E F +G +P+ G T +E
Sbjct: 177 KGGRAM-------LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
Query: 587 LFAH-TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
+ T ++ P P+ I+TD Q P DR
Sbjct: 230 VMEFVTGGGRLDPPKGCPGPVY----RIMTDCWQHTPEDR 265
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 25/225 (11%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
D T +K + G +G V + + Q K+IK M ++ E +M +
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRG--QYDVAIKMIKEGSMSEDEF---IEEAKVMMKLSHE 59
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL-AVEYLHSY 483
+V +Y ++ + +V EY+ G + L+ G + V + YL S
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
+HRDL N L+ G +K++DFGLS+ L + Y +F +
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRY-------VLDDEYTSSVGSKFPVR------ 166
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELF 588
+ PEV+L + D W+ GV+++E V G+ P E F
Sbjct: 167 -WSPPEVLLYSKFSSKSDVWAFGVLMWE-----VYSLGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 62/240 (25%), Positives = 103/240 (42%), Gaps = 26/240 (10%)
Query: 369 IKLISNGAYGSVYLVRHK----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
I+ + G +GSV L R+ T + A+KK+ ++ + E +I+ +
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHD 65
Query: 425 FVVTM--YCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEYLH 481
+V C +++L LVMEY+ G L K+ L Y ++ +EYL
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
S VHRDL N+L+ + +K+ DFGL+K+ L + E Y R+ +
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKV----LPQD-KEYYKVREPGE-------- 172
Query: 542 TPEY-IAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600
+P + APE + + D WS GV+LYE +P F + +D +
Sbjct: 173 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK--SCSPPAEFMRMMGNDKQGQM 230
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 55/235 (23%), Positives = 96/235 (40%), Gaps = 37/235 (15%)
Query: 375 GAYGSVY-----LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTM 429
GA+G VY + + A+K + +N+ ++ E ++MS +P +V +
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNIVCL 73
Query: 430 YCSFETKKHLCLVMEYVEGGD---------------CASLLKNTG-PLPADMARFYFAET 473
++ C++ EY+ GD S + L +
Sbjct: 74 LGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQI 133
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
+EYL S+ VHRDL N L+ +K++DFGLS+ + D +
Sbjct: 134 AAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA------------DYYR 181
Query: 534 FSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEEL 587
K + ++ PE IL + D WS GV+L+E F G P++G + +E+
Sbjct: 182 VQSKSLLPV-RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 369 IKLISNGAYGSVYLVRHK----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS--FTD 422
I+ + G +G V L R+ T ++ A+K + S N + + E +I+ + +
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHE 66
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEYLH 481
N C+ + + L+ME++ G L +N + Y + ++YL
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
S VHRDL N+L+ + +K+ DFGL+K ++ T+ E Y +D D V+
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTK----AIETD-KEYYTVKDDL---DSPVF- 177
Query: 542 TPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC 576
+ APE +++ + D WS GV LYE L C
Sbjct: 178 ---WYAPECLIQSKFYIASDVWSFGVTLYELLTYC 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 370 KLISNGAYGSVY--LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVV 427
+L+ G +G V+ ++ K K+ + L ++ +E I+ D+P +V
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIV 55
Query: 428 TMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEYLHSYGIV 486
+ ++ + +VME V GGD S L K L + + + YL S +
Sbjct: 56 KLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115
Query: 487 HRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP-EY 545
HRDL N L+ +K++DFG+S+ + D +S + P ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---------------QEDDGIYSSSGLKQIPIKW 160
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEE 586
APE + Y D WS G++L+E F +G P+ G T ++
Sbjct: 161 TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 24/228 (10%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
+FT+ + + +G +G V+ K R A+K I+K+ +L+ Q Q E + +
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRV-RVAIK-ILKSDDLLKQQDFQ--KEVQALKRLRHK 62
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARF-YFAETVL-AVEYLHS 482
+++++ + + ++ E +E G + L++ +A A V + YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
+HRDL N+L+ K+ DFGL+++ ++ D SDK++
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARL-------------IKEDVYLSSDKKI--- 166
Query: 543 P-EYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELF 588
P ++ APE + D WS G++LYE F G VP+ G E++
Sbjct: 167 PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY 214
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 56/225 (24%), Positives = 100/225 (44%), Gaps = 48/225 (21%)
Query: 393 AMKKIIKNSLMLRNQME--QVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGD 450
A+K + +N+ + E + +E +++ ++P V+ +Y + L L++EY + G
Sbjct: 34 AVKMLKENA----SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGS 89
Query: 451 CASLLK----------------NTGPLPADMARFYFAETVLA--------VEYLHSYGIV 486
S L+ N+ L R +++ ++YL +V
Sbjct: 90 LRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLV 149
Query: 487 HRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE--CYVERDAKQFSDKQVYGTPE 544
HRDL N+L+ +K++DFGLS+ ++YE YV+R + K
Sbjct: 150 HRDLAARNVLVAEGRKMKISDFGLSR--------DVYEEDSYVKRSKGRIPVK------- 194
Query: 545 YIAPEVILRQGYGKPVDWWSMGVILYEFL-VGCVPFFGETPEELF 588
++A E + Y D WS GV+L+E + +G P+ G PE LF
Sbjct: 195 WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
+ ++ T+++ I +G +G V+L E R+ A+K I + ++ E E +M
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAM----SEEDFIEEAQVMMKL 56
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYL 480
+P +V +Y + +CLV E++E G + L+ G + + + YL
Sbjct: 57 SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL 116
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
S ++HRDL N L+ +K++DFG+++ L + Y +F K
Sbjct: 117 ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF-------VLDDQYTSSTGTKFPVK--- 166
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEEL 587
+ +PEV Y D WS GV+++E F G P+ + E+
Sbjct: 167 ----WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 7e-10
Identities = 67/263 (25%), Positives = 115/263 (43%), Gaps = 52/263 (19%)
Query: 372 ISNGAYGSVYLVRHKETR--QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD--NPFVV 427
+ G YG VY + K+ + + +A+K+I + + A R+I + +P V+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMS-------ACREIALLRELKHPNVI 61
Query: 428 TMYCSF--ETKKHLCLVMEYVEGGDCASLLK-------NTGP--LPADMARFYFAETVLA 476
+ F + + + L+ +Y E D ++K N P LP M + + +
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 477 VEYLHSYGIVHRDLKPDNLLITA----LGHIKLTDFGLSKMGLMSLATNLYECYVERDAK 532
+ YLH+ ++HRDLKP N+L+ G +K+ D G +++ K
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-------------FNSPLK 167
Query: 533 QFSD-KQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL--- 587
+D V T Y APE++L + Y K +D W++G I E L P F E++
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTS 226
Query: 588 --FAHTVNDDI----EWPSEDDW 604
F H D I +P++ DW
Sbjct: 227 NPFHHDQLDRIFSVMGFPADKDW 249
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 53/261 (20%), Positives = 117/261 (44%), Gaps = 25/261 (9%)
Query: 368 VIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVV 427
++K + G +G V++ + + + A+K + ++ ++ +E E ++M + +V
Sbjct: 10 LVKKLGAGQFGEVWMGYYNNS-TKVAVKTLKPGTMSVQAFLE----EANLMKTLQHDKLV 64
Query: 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARF--YFAETVLAVEYLHSYGI 485
+Y ++ + ++ EY+ G LK+ + + + A+ + Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
+HRDL+ N+L++ K+ DFGL+++ + N Y R+ +F K +
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARV----IEDNE---YTAREGAKFPIK-------W 170
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDW 604
APE I + D WS G++LYE + G +P+ G + ++ + + P ++
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS-ALQRGYRMPRMENC 229
Query: 605 PIQVEAKSIITDLLQQNPRDR 625
P E I+ ++ +R
Sbjct: 230 P--DELYDIMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 24/232 (10%)
Query: 363 ENDFTVIKLISNGAYGSVY----LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM 418
E +F IK++ +GA+G+VY + ++ + A+K++ + + N+ ++ E +M
Sbjct: 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVM 63
Query: 419 SFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLA 476
+ DNP V + C T + + +M + G + ++ + + + +
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKG 121
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
+ YL +VHRDL N+L+ H+K+TDFGL+K+ + D K++
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL-------------LGADEKEYHA 168
Query: 537 KQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEEL 587
+ +++A E IL + Y D WS GV ++E + G P+ G E+
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 220
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 41/144 (28%), Positives = 69/144 (47%), Gaps = 21/144 (14%)
Query: 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFY-FAETVL-AVEYLHSYGIVHRDLKPDNLL 496
L +VME + G+ + L+ G + + F+ V +EYL S +VHRDL N+L
Sbjct: 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL 132
Query: 497 ITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY 556
++ G K++DFGL+++G M + + ++ APE + + +
Sbjct: 133 VSEDGVAKVSDFGLARVGSMGVDNSKLPV------------------KWTAPEALKHKKF 174
Query: 557 GKPVDWWSMGVILYE-FLVGCVPF 579
D WS GV+L+E F G P+
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 23/219 (10%)
Query: 370 KLISNGAYGSVYLVRHK--ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVV 427
K+I G +G V R K R+ K +K + Q +E IM D+P ++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-QRRDFLSEASIMGQFDHPNII 68
Query: 428 TMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEYLHSYGIV 486
+ K + +V EY+E G + L K+ G ++YL G V
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128
Query: 487 HRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP-EY 545
HRDL N+L+ + K++DFGLS++ L + Y R K P +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRV----LEDDPEAAYTTRGGK---------IPIRW 175
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
APE I + + D WS G++++E V +GE P
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWE-----VMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 50/175 (28%), Positives = 73/175 (41%), Gaps = 25/175 (14%)
Query: 414 ERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK-----------NTGPLP 462
E IMS NP ++ + + LC++ EY+E GD L N P
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 463 ADMARFYFAETVLA-VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521
+ Y A + + ++YL S VHRDL N L+ IK+ DFG+S+ N
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR--------N 178
Query: 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC 576
LY D + + V ++A E IL + D W+ GV L+E C
Sbjct: 179 LY----SGDYYRIQGRAVLPI-RWMAWESILLGKFTTASDVWAFGVTLWEMFTLC 228
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 57/238 (23%), Positives = 107/238 (44%), Gaps = 36/238 (15%)
Query: 363 ENDFTVIKLISNGAYGSVY---LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS 419
E + +K++ +GA+G+VY V ET + KI+ + + +E E IM+
Sbjct: 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMA 64
Query: 420 FTDNPFVV---------TMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYF 470
D+P +V T+ + H CL ++YV ++ + + + +
Sbjct: 65 SMDHPHLVRLLGVCLSPTIQLVTQLMPHGCL-LDYVH--------EHKDNIGSQLLLNWC 115
Query: 471 AETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERD 530
+ + YL +VHRDL N+L+ + H+K+TDFGL+++ +E D
Sbjct: 116 VQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL-------------LEGD 162
Query: 531 AKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEEL 587
K+++ +++A E I + + D WS GV ++E + G P+ G E+
Sbjct: 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 59/261 (22%), Positives = 118/261 (45%), Gaps = 30/261 (11%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTM 429
K + G +G V++ + + + A+K + S+ +E AE ++M + +V +
Sbjct: 12 KKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL 66
Query: 430 YCSFETKKHLCLVMEYVEGGDCASLLK----NTGPLPADMARFYFAETVLAVEYLHSYGI 485
+ + TK+ + ++ E++ G LK + PLP + + A+ + ++
Sbjct: 67 H-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID--FSAQIAEGMAFIEQRNY 123
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
+HRDL+ N+L++A K+ DFGL+++ + N Y R+ +F K +
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARV----IEDNE---YTAREGAKFPIK-------W 169
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDW 604
APE I + D WS G++L E + G +P+ G + E+ + P ++
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRMPRPENC 228
Query: 605 PIQVEAKSIITDLLQQNPRDR 625
P E +I+ + P +R
Sbjct: 229 P--EELYNIMMRCWKNRPEER 247
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 379 SVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS-FTDNPFVVTMYCSFETKK 437
SVYL RH T ++ I + + + ++S F +P ++T + F T
Sbjct: 15 SVYLARHTPTGTLVTVR--ITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS 72
Query: 438 HLCLVMEYVEGGDCASLLKNTGP--LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNL 495
L ++ ++ G SLLK P + + + + YLH G +HR++K ++
Sbjct: 73 WLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHI 132
Query: 496 LITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ- 554
LI+ G + L+ GLS L SL N + V D QFS + +++PE +LRQ
Sbjct: 133 LISGDGLVSLS--GLSH--LYSLVRNGQKAKVVYDFPQFSTSVL----PWLSPE-LLRQD 183
Query: 555 --GYGKPVDWWSMGVILYEFLVGCVPF 579
GY D +S+G+ E G VPF
Sbjct: 184 LYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 54/236 (22%), Positives = 109/236 (46%), Gaps = 28/236 (11%)
Query: 363 ENDFTVIKLISNGAYGSVY----LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM 418
E + +K++ +GA+G+VY + + + A+K + +N+ N+ ++ E +M
Sbjct: 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK--EILDEAYVM 63
Query: 419 SFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLA 476
+ +P+V + C T + + +M Y G + +N + + + +
Sbjct: 64 AGVGSPYVCRLLGICLTSTVQLVTQLMPY--GCLLDYVRENKDRIGSQDLLNWCVQIAKG 121
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
+ YL +VHRDL N+L+ + H+K+TDFGL+++ ++ D ++
Sbjct: 122 MSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL-------------LDIDETEYHA 168
Query: 537 KQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFG----ETPEEL 587
+++A E IL + + D WS GV ++E + G P+ G E P+ L
Sbjct: 169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 44/245 (17%)
Query: 370 KLISNGAYGSVY------LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ +GA+G VY ++ R A+K + K + + ++ E +MS ++
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNH 58
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL-------- 475
P +V + + ++ME +EGGD S L++ A + RF L
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRD-----ARVERFGPPLLTLKELLDICL 113
Query: 476 ----AVEYLHSYGIVHRDLKPDNLLITALGH-----IKLTDFGLSKMGLMSLATNLYECY 526
YL +HRDL N L++ G+ +K+ DFGL++ + + Y Y
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDY--Y 167
Query: 527 VERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL-VGCVPFFGETPE 585
+ + ++APE +L + D WS GV+++E L +G P+ +
Sbjct: 168 RKEGEGLLPVR-------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ 220
Query: 586 ELFAH 590
E+ H
Sbjct: 221 EVLQH 225
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 48/191 (25%), Positives = 78/191 (40%), Gaps = 32/191 (16%)
Query: 405 RNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKN------- 457
+N E I+S +P ++ + + LC++ EY+E GD L +
Sbjct: 60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKE 119
Query: 458 -----------TGPLPADMARFYFAETVLA-VEYLHSYGIVHRDLKPDNLLITALGHIKL 505
P + + + A + + ++YL S VHRDL N L+ IK+
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKI 179
Query: 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSM 565
DFG+S+ NLY D + + V ++A E IL + D W+
Sbjct: 180 ADFGMSR--------NLY----AGDYYRIQGRAVLPI-RWMAWECILMGKFTTASDVWAF 226
Query: 566 GVILYEFLVGC 576
GV L+E L+ C
Sbjct: 227 GVTLWEILMLC 237
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 64/277 (23%), Positives = 114/277 (41%), Gaps = 43/277 (15%)
Query: 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR--NQMEQVF-AERDIMSFTDNPF 425
I + G +G V+L + K + ++ +L ++ F E D+ +
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG---------PLPADMARFYFAETVLA 476
VV + + +++EY + GD L+ T PL + L
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY--ECYVERDAKQF 534
+++L + VHRDL N L+++ +K++ LSK ++Y E Y R+A
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK--------DVYNSEYYKLRNAL-- 179
Query: 535 SDKQVYGTP-EYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAHTV 592
P ++APE + + D WS GV+++E F G +PF+G + EE+
Sbjct: 180 -------IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ 232
Query: 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQ----NPRDR 625
+E P + P S + L+ + NP+DR
Sbjct: 233 AGKLELPVPEGCP------SRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 66/263 (25%), Positives = 115/263 (43%), Gaps = 52/263 (19%)
Query: 372 ISNGAYGSVYLVRHKETR--QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD--NPFVV 427
+ G YG VY + K+ + + +A+K+I + + A R+I + +P V+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMS-------ACREIALLRELKHPNVI 61
Query: 428 TMYCSF--ETKKHLCLVMEYVEGGDCASLLK-------NTGP--LPADMARFYFAETVLA 476
++ F + + L+ +Y E D ++K N P LP M + + +
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 477 VEYLHSYGIVHRDLKPDNLLITA----LGHIKLTDFGLSKMGLMSLATNLYECYVERDAK 532
+ YLH+ ++HRDLKP N+L+ G +K+ D G +++ K
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-------------FNSPLK 167
Query: 533 QFSD-KQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL--- 587
+D V T Y APE++L + Y K +D W++G I E L P F E++
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTS 226
Query: 588 --FAHTVNDDI----EWPSEDDW 604
+ H D I +P++ DW
Sbjct: 227 NPYHHDQLDRIFNVMGFPADKDW 249
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 46/151 (30%), Positives = 68/151 (45%), Gaps = 17/151 (11%)
Query: 431 CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFY-FAETVL-AVEYLHSYGIVHR 488
CS + K L L+MEYV G SL ++A+ FA+ + + YLHS +HR
Sbjct: 75 CSEQGGKGLQLIMEYVPLG---SLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHR 131
Query: 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
DL N+L+ +K+ DFGL+K + E + ++ D V+ + A
Sbjct: 132 DLAARNVLLDNDRLVKIGDFGLAK--------AVPEGHEYYRVREDGDSPVF----WYAV 179
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPF 579
E + + D WS GV LYE L C
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSK 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 49/184 (26%), Positives = 75/184 (40%), Gaps = 22/184 (11%)
Query: 404 LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKN-----T 458
L + M+ E IM D+ ++ +Y T L +V E G SLL
Sbjct: 36 LSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLG---SLLDRLRKDAL 91
Query: 459 GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518
G Y + + YL S +HRDL N+L+ + +K+ DFGL + +L
Sbjct: 92 GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMR----AL 147
Query: 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCV 577
N + YV + K + + APE + + + D W GV L+E F G
Sbjct: 148 PQN-EDHYV----MEEHLKVPFA---WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEE 199
Query: 578 PFFG 581
P+ G
Sbjct: 200 PWAG 203
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
D T+ + G YG VY K+ A+K + ++++ ++E+ E +M +P
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 62
Query: 425 FVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYL 480
+V + C+ E ++ + E++ G+ L+ + A + + + A+EYL
Sbjct: 63 NLVQLLGVCTREPPFYI--ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
+HRDL N L+ +K+ DFGLS++ M+ T Y +F K
Sbjct: 121 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDT-----YTAHAGAKFPIK--- 170
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFG 581
+ APE + + D W+ GV+L+E G P+ G
Sbjct: 171 ----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 365 DFTVIKL---ISNGAYGSVYLVRHKET--RQRFAMKKIIKNSLMLRNQMEQVFAERDIMS 419
D + +K+ I G +G V R K R+ F K +K+ + Q +E IM
Sbjct: 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMG 60
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVE 478
D+P ++ + + + ++ E++E G S L+ N G ++
Sbjct: 61 QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ 538
YL VHRDL N+L+ + K++DFGLS+ ++E D +
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR-------------FLEDDTSDPTYTS 167
Query: 539 VYGTP---EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
G + APE I + + D WS G++++E V +GE P
Sbjct: 168 SLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE-----VMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 58/239 (24%), Positives = 93/239 (38%), Gaps = 52/239 (21%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQR---FAMKKIIKNSLMLR-----NQMEQVFAER 415
+ T+ K+I G +G V R K ++ A+K L+ Q E
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIK-------TLKAGSSDKQRLDFLTEA 56
Query: 416 DIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL 475
IM D+P ++ + + + ++ EY+E G L+ F L
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN--------DGKFTVGQL 108
Query: 476 ---------AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECY 526
++YL VHRDL N+L+ + K++DFGLS+ S AT Y
Sbjct: 109 VGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-----Y 163
Query: 527 VERDAKQFSDKQVYGTP-EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
+ K P + APE I + + D WS G++++E V +GE P
Sbjct: 164 TTKGGK---------IPIRWTAPEAIAYRKFTSASDVWSFGIVMWE-----VMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 64/236 (27%), Positives = 103/236 (43%), Gaps = 22/236 (9%)
Query: 365 DFTVIKLISNGAYGSVYL-VRHKETRQRFAMK-KIIKNSLMLRNQMEQVFAERDIMSFTD 422
D T+ + I G +G VY V ++ A+ K KN + E+ E IM D
Sbjct: 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR-EKFLQEAYIMRQFD 65
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEYLH 481
+P +V + T+ + +VME G+ S L N L Y + A+ YL
Sbjct: 66 HPHIVKL-IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
S VHRD+ N+L+++ +KL DFGLS+ Y+E ++ +
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-------------YLEDES--YYKASKGK 169
Query: 542 TP-EYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595
P +++APE I + + D W GV ++E L+ G PF G ++ N +
Sbjct: 170 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE 225
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 13/105 (12%)
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
A++Y+H GI+HRD+K +N+L+ I L DFG + C+
Sbjct: 272 AIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA-------------CFARGSWSTPF 318
Query: 536 DKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF 580
+ GT + APEV+ Y VD WS G++++E V F
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363
|
Length = 461 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 47/176 (26%), Positives = 70/176 (39%), Gaps = 34/176 (19%)
Query: 417 IMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK-----------NTGPLPADM 465
I+S +P + + LC++MEY+E GD L+ N+ L
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 466 ARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC 525
+ + + YL S VHRDL N L+ IK+ DFG+S+ NLY
Sbjct: 132 LLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR--------NLYSS 183
Query: 526 -YVERDAKQFSDKQVYGTP----EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC 576
Y +V G ++A E +L + D W+ GV L+E L C
Sbjct: 184 DYY----------RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 41/144 (28%), Positives = 61/144 (42%), Gaps = 15/144 (10%)
Query: 447 EGGDCASLLKNTGPLPADMARFYFAETVL-AVEYLHSYGIVHRDLKPDNLLITALGHIKL 505
L N P + M F+ V +E+L S VHRDL N+LI +K+
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKI 280
Query: 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSM 565
DFGL++ + RD+ S + +++APE I Y D WS
Sbjct: 281 CDFGLARD-------------IMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSF 327
Query: 566 GVILYE-FLVGCVPFFGETPEELF 588
G++L+E F +G P+ E F
Sbjct: 328 GILLWEIFTLGGTPYPELPMNEQF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 59/249 (23%), Positives = 99/249 (39%), Gaps = 46/249 (18%)
Query: 365 DFTVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS 419
D + + + GA+G V+L + + + A+K + +L R ++ E ++++
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLT 62
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP----------------LPA 463
+ +V Y L +V EY++ GD L+ GP L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523
++ + YL S VHRDL N L+ A +K+ DFG+S
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS------------ 170
Query: 524 ECYVERDAKQFSDKQVYGTP----EYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVP 578
RD +V G ++ PE I+ + + D WS GVIL+E F G P
Sbjct: 171 -----RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
Query: 579 FFGETPEEL 587
+F + E+
Sbjct: 226 WFQLSNTEV 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 64/265 (24%), Positives = 112/265 (42%), Gaps = 34/265 (12%)
Query: 368 VIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVV 427
+IK + NG +G V++ + A+K + ++ E E IM + +V
Sbjct: 10 LIKKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLV 64
Query: 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKNTG------PLPADMARFYFAETVLAVEYLH 481
+Y + +++ + +V EY+ G LK+ P DMA A+ + Y+
Sbjct: 65 QLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYIE 119
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
+HRDL+ N+L+ K+ DFGL+++ + N Y R +F K
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARL----IEDNEY---TARQGAKFPIK---- 168
Query: 542 TPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPS 600
+ APE L + D WS G++L E + G VP+ G E+ V P
Sbjct: 169 ---WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ-VERGYRMPC 224
Query: 601 EDDWPIQVEAKSIITDLLQQNPRDR 625
D PI + ++ +++P +R
Sbjct: 225 PQDCPISLH--ELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 37/114 (32%), Positives = 57/114 (50%), Gaps = 14/114 (12%)
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
+EYL S +HRDL N+L+T +K+ DFGL++ N + Y + +
Sbjct: 149 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR------DVNNIDYYKKTTNGRLP 202
Query: 536 DKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELF 588
K ++APE + + Y D WS GV+++E F +G P+ G EELF
Sbjct: 203 VK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 59/227 (25%), Positives = 90/227 (39%), Gaps = 38/227 (16%)
Query: 375 GAYGSVYLVR----HKETRQRFAMKKIIKNSL-----MLR-----NQMEQVFAERDIMSF 420
G +G V+L K + F++ + MLR N E IMS
Sbjct: 16 GQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSR 75
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMA----------RFY 469
+P ++ + T LC++ EY+E GD L ++ A+ A F
Sbjct: 76 LKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFM 135
Query: 470 FAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVER 529
+ ++YL S VHRDL N L+ IK+ DFG+S+ NLY
Sbjct: 136 ATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR--------NLY----SG 183
Query: 530 DAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC 576
D + + V +++ E IL + D W+ GV L+E L C
Sbjct: 184 DYYRIQGRAVLPI-RWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 41/238 (17%)
Query: 372 ISNGAYGSVYLVRH----KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVV 427
+ GA+G V+L E + K +K++ N + E ++++ + +V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIV 70
Query: 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMAR------------FYFAETVL 475
Y L +V EY++ GD L+ GP MA + A+ +
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 476 A-VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
A + YL S VHRDL N L+ +K+ DFG+S RD
Sbjct: 131 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS-----------------RDVYST 173
Query: 535 SDKQVYGTP----EYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEEL 587
+V G ++ PE I+ + + D WS+GV+L+E F G P++ + E+
Sbjct: 174 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 53/184 (28%), Positives = 80/184 (43%), Gaps = 31/184 (16%)
Query: 413 AERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKN-TG---PLPA--DMA 466
E IM + +V +Y ++ + +V EY+ G LK+ G LP DMA
Sbjct: 50 QEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA 109
Query: 467 RFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECY 526
A+ + YL S +HRDL N+L+ K+ DFGL+++ + + Y
Sbjct: 110 ----AQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL----IEDDEYTA- 160
Query: 527 VERDAKQFSDKQVYGTPEYIAPEVILRQGYGK---PVDWWSMGVILYE-FLVGCVPFFGE 582
R+ +F K + APE YG+ D WS G++L E G VP+ G
Sbjct: 161 --REGAKFPIK-------WTAPEAAN---YGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208
Query: 583 TPEE 586
T E
Sbjct: 209 TNRE 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 20/160 (12%)
Query: 469 YFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE--CY 526
Y + +E+L S +HRDL N+L++ +K+ DFG LA ++Y+ Y
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG--------LARDIYKDPDY 230
Query: 527 VERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPE 585
V + + + K ++APE I + Y D WS GV+L+E F +G P+ G
Sbjct: 231 VRKGSARLPLK-------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN 283
Query: 586 ELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
E F + D + ++ E I+ Q +P++R
Sbjct: 284 EEFCQRLKDGTRMRAPEN--ATPEIYRIMLACWQGDPKER 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 48/293 (16%)
Query: 363 ENDFTVIKLISN---GAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS 419
E D T I+L+ G +G V+ T A+K + K M + AE IM
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTL-KPGTM---DPKDFLAEAQIMK 56
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG------PLPADMARFYFAET 473
+P ++ +Y ++ + +V E ++ G L+ P DMA A+
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQV 112
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
+ YL + +HRDL N+L+ K+ DFGL+++ + ++YE R+ +
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV----IKEDIYEA---REGAK 165
Query: 534 FSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTV 592
F K + APE L + D WS G++L E + G +P+ G T E+ V
Sbjct: 166 FPIK-------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ-V 217
Query: 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645
+ P P ++ I+ D +++P DR P F L W
Sbjct: 218 DQGYRMPCPPGCPKEL--YDIMLDCWKEDPDDR------------PTFETLQW 256
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 39/118 (33%), Positives = 56/118 (47%), Gaps = 22/118 (18%)
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ-- 533
+EYL S +HRDL N+L+T +K+ DFGL+ RD
Sbjct: 152 GMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA-----------------RDIHHID 194
Query: 534 FSDKQVYG--TPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELF 588
+ K G +++APE + + Y D WS GV+L+E F +G P+ G EELF
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 37/113 (32%), Positives = 63/113 (55%), Gaps = 14/113 (12%)
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
+EYL S +HRDL N+L+T +K+ DFGL++ G+ + + Y K+ S+
Sbjct: 147 MEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR-GVHDI--DYY--------KKTSN 195
Query: 537 KQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELF 588
++ +++APE + + Y D WS G++++E F +G P+ G EELF
Sbjct: 196 GRL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 31/235 (13%)
Query: 370 KLISNGAYGSVY--LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVV 427
K + G +GSV + ++ + A+K + K ++ R++ME +E M D+P V+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 428 TMY------CSFETKKHLCLVMEYVEGGDCASLL--KNTGP----LPADMARFYFAETVL 475
+ E +++ +++ GD S L G LP M + +
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
+EYL S +HRDL N ++ ++ + DFGLSK +Y + +
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK--------KIY------NGDYYR 169
Query: 536 DKQVYGTP-EYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELF 588
++ P ++IA E + + Y D WS GV ++E G P+ G E++
Sbjct: 170 QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 433 FETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKP 492
F +K L V E + L K L + Y + +E+L S +HRDL
Sbjct: 152 FVEEKSLSDVEEEEAEQE--DLYKK--VLTLEDLICYSFQVAKGMEFLASRKCIHRDLAA 207
Query: 493 DNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL 552
N+L++ +K+ DFGL++ + Y + D + D ++ +++APE I
Sbjct: 208 RNILLSENNVVKICDFGLAR-----------DIYKDPDYVRKGDARL--PLKWMAPETIF 254
Query: 553 RQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELF 588
+ Y D WS GV+L+E F +G P+ G +E F
Sbjct: 255 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 53/241 (21%), Positives = 98/241 (40%), Gaps = 44/241 (18%)
Query: 371 LISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR-----NQMEQVFAERDIM-SFTDNP 424
+I G +G V ++ + + M IK ++ + E +++ +P
Sbjct: 2 VIGEGNFGQV--LKARIKKDGLRMDAAIK---RMKEYASKDDHRDFAGELEVLCKLGHHP 56
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPAD--MARFYFAETVLA------ 476
++ + + E + +L L +EY G+ L+ + L D A + L+
Sbjct: 57 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 477 --------VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528
++YL +HRDL N+L+ K+ DFGLS+ E YV+
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---------QEVYVK 167
Query: 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL-VGCVPFFGETPEEL 587
+ + + ++A E + Y D WS GV+L+E + +G P+ G T EL
Sbjct: 168 KTMGRLPVR-------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 220
Query: 588 F 588
+
Sbjct: 221 Y 221
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 39/118 (33%), Positives = 56/118 (47%), Gaps = 22/118 (18%)
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ-- 533
+EYL S +HRDL N+L+T +K+ DFGL+ RD
Sbjct: 146 GMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA-----------------RDVHNID 188
Query: 534 FSDKQVYG--TPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELF 588
+ K G +++APE + + Y D WS GV+L+E F +G P+ G EELF
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 56/245 (22%), Positives = 99/245 (40%), Gaps = 28/245 (11%)
Query: 370 KLISNGAYGSVY--LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVV 427
K+I G +G V+ +++ ++ K +K Q + +E IM + ++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNII 69
Query: 428 TMYCSFETKKHLCLVMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIV 486
+ K ++ EY+E G L+ + G + ++YL V
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 487 HRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP-EY 545
HRDL N+L+ + K++DFGLS++ +E D + P +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRV-------------LEDDPEGTYTTSGGKIPIRW 176
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE-ELFAHTV----NDDIEWPS 600
APE I + + D WS G++++E + FGE P ++ H V ND P+
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMS-----FGERPYWDMSNHEVMKAINDGFRLPA 231
Query: 601 EDDWP 605
D P
Sbjct: 232 PMDCP 236
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 49/170 (28%), Positives = 75/170 (44%), Gaps = 32/170 (18%)
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC--YVERDAKQF 534
+E+L S +HRDL N+L++ +K+ DFG LA ++Y+ YV + +
Sbjct: 186 MEFLASRKCIHRDLAARNILLSENNVVKICDFG--------LARDIYKDPDYVRKGDARL 237
Query: 535 SDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAHTVN 593
K ++APE I + Y D WS GV+L+E F +G P+ G +E F +
Sbjct: 238 PLK-------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK 290
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643
+ + + E SI+ D NP DR P FS L
Sbjct: 291 EGTRMRAPEY--ATPEIYSIMLDCWHNNPEDR------------PTFSEL 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 19/220 (8%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKN--SLMLRNQMEQVFAERDIMSFTDN 423
F ++ L+ G +G V ++ R+ + KI++N ++E F E+ + +
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRK-RKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPAD 189
Query: 424 PFV---VTMYCSFETKKHLCLVMEYVEGGDCA-SLLKNTGPLP-ADMARFYFAETVLAVE 478
F + Y ET H+C+VM + G C + GP +A+ F +T +A++
Sbjct: 190 RFPLMKIQRYFQNETG-HMCIVMP--KYGPCLLDWIMKHGPFSHRHLAQIIF-QTGVALD 245
Query: 479 YLHS-YGIVHRDLKPDNLLITALGHI--KLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
Y H+ ++H DLKP+N+L+ + +T+ L +L C ER S
Sbjct: 246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----S 301
Query: 536 DKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVG 575
+ T Y +PEV+L G+ D WSMG I+YE G
Sbjct: 302 RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 38/124 (30%), Positives = 55/124 (44%), Gaps = 29/124 (23%)
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531
+ + + LH GIVHRD+KP+NLL+T G +K+ DFG + M N Y D
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVD--MCTGINFNPLYGMLDP 374
Query: 532 KQFSDKQVYGTP-EYIAPEVILRQG--------------YGKP--VDWWSMGVILYEFLV 574
+ Y P E + P+ R YG+P D ++ GV+L +
Sbjct: 375 R-------YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQM-- 425
Query: 575 GCVP 578
CVP
Sbjct: 426 -CVP 428
|
Length = 507 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 57/247 (23%), Positives = 100/247 (40%), Gaps = 44/247 (17%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR-----NQMEQVFAERDIM- 418
D +I G +G V +R + M IK ML+ N E +++
Sbjct: 3 DIKFEDVIGEGNFGQV--IRAMIKKDGLKMNAAIK---MLKEFASENDHRDFAGELEVLC 57
Query: 419 SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPAD--MARFYFAETVLA 476
+P ++ + + E + +L + +EY G+ L+ + L D A+ + + L
Sbjct: 58 KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117
Query: 477 --------------VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522
++YL +HRDL N+L+ K+ DFGLS+
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRG--------- 168
Query: 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL-VGCVPFFG 581
E YV++ + + ++A E + Y D WS GV+L+E + +G P+ G
Sbjct: 169 EEVYVKKTMGRLPVR-------WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221
Query: 582 ETPEELF 588
T EL+
Sbjct: 222 MTCAELY 228
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 37/124 (29%), Positives = 56/124 (45%), Gaps = 24/124 (19%)
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHI-KLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
+ +L S +HRDL N+L+T G I K+ DFGL+ RD S
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLA-----------------RDIMNDS 195
Query: 536 DKQVYGTP----EYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
+ V G +++APE I Y D WS G++L+E F +G P+ G + F
Sbjct: 196 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255
Query: 591 TVND 594
+ +
Sbjct: 256 LIKE 259
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 31/116 (26%), Positives = 56/116 (48%), Gaps = 14/116 (12%)
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
+ YLH G++H+D+ N +I +K+TD LS+ L Y C + + +
Sbjct: 129 GMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR----DLFPMDYHCLGDNENRPV- 183
Query: 536 DKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL-VGCVPFFGETPEELFAH 590
+++A E ++ + Y D WS GV+L+E + +G P+ P E+ A+
Sbjct: 184 --------KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY 231
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 56/236 (23%), Positives = 95/236 (40%), Gaps = 49/236 (20%)
Query: 372 ISNGAYGSVYLVR-----HKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFV 426
+ GA+G V+L ++ + A+K + + S R ++ E ++++ + +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQHI 69
Query: 427 VTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP-----------------LPADMARFY 469
V Y + L +V EY+ GD L++ GP L +A
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA--I 127
Query: 470 FAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVER 529
++ + YL S VHRDL N L+ +K+ DFG+S R
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS-----------------R 170
Query: 530 DAKQFSDKQVYGTP----EYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFF 580
D +V G ++ PE IL + + D WS GV+L+E F G P++
Sbjct: 171 DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 57/245 (23%), Positives = 101/245 (41%), Gaps = 38/245 (15%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKET--RQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SF 420
ND +I G +G V R K+ R A+K++ ++ E +++
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKL 64
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMA-------------- 466
+P ++ + + E + +L L +EY G+ L+ + L D A
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 467 --RFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524
+ A+ ++YL +HRDL N+L+ K+ DFGLS+ E
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---------QE 175
Query: 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL-VGCVPFFGET 583
YV++ + + ++A E + Y D WS GV+L+E + +G P+ G T
Sbjct: 176 VYVKKTMGRLPVR-------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
Query: 584 PEELF 588
EL+
Sbjct: 229 CAELY 233
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 28/168 (16%)
Query: 441 LVMEYVEGGDCASLLK------NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDN 494
LVME+ GD L+ P P + R E L + +LH +H DL N
Sbjct: 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC-EIALGLLHLHKNNFIHSDLALRN 130
Query: 495 LLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI--- 551
L+TA +K+ D+GLS + D D Q++ +IAPE++
Sbjct: 131 CLLTADLTVKIGDYGLS------------HNKYKEDYYVTPD-QLWVPLRWIAPELVDEV 177
Query: 552 ----LRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAHTVND 594
L K + WS+GV ++E F +G P+ + E++ +TV +
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 14/98 (14%)
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
AVEY+H ++HRD+K +N+ + G I L DFG + M ER+A +
Sbjct: 279 AVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA----MPFEK-------EREAFDYG 327
Query: 536 DKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL 573
GT +PE++ GY + D WS G+IL + L
Sbjct: 328 ---WVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 370 KLISNGAYGSVY---LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFV 426
++I G +G VY L+ + A+K + N + ++EQ E IM +P V
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 427 VTMY-CSFETKKHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSY 483
+++ ++ +V+ Y++ GD + +++ P D+ F + +EYL S
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL-QVAKGMEYLASK 117
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
VHRDL N ++ +K+ DFG LA ++Y +++ + P
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFG--------LARDIY----DKEYYSVHNHTGAKLP 165
Query: 544 -EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP 578
+++A E + Q + D WS GV+L+E + P
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 32/221 (14%)
Query: 367 TVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
T+++ + G++G VY + E R A+K + S LR ++E E +M
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIE-FLNEASVMKGF 66
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK--------NTGPLPADMARF--YFA 471
VV + + +VME + GD S L+ N G P + A
Sbjct: 67 TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC-YVERD 530
E + YL++ VHRDL N ++ +K+ DFG+++ ++YE Y +
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYYRKG 178
Query: 531 AKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE 571
K + ++APE + + D WS GV+L+E
Sbjct: 179 GKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWE 213
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 6e-06
Identities = 27/72 (37%), Positives = 41/72 (56%), Gaps = 5/72 (6%)
Query: 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL 500
+VMEY+EG L+ + G +++R E V LHS GI+H DL N++++
Sbjct: 76 IVMEYIEGEPLKDLINSNGMEELELSR----EIGRLVGKLHSAGIIHGDLTTSNMILSG- 130
Query: 501 GHIKLTDFGLSK 512
G I L DFGL++
Sbjct: 131 GKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 55/245 (22%), Positives = 104/245 (42%), Gaps = 34/245 (13%)
Query: 366 FTVIKLISNGAYGSV---YLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
FT+ +++ G +GSV L + Q+ A+K ++K + + +E+ E M D
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVK-MLKADIFSSSDIEEFLREAACMKEFD 59
Query: 423 NPFVVTMY---CSFETKKHL---CLVMEYVEGGDCASLL------KNTGPLPADMARFYF 470
+P V+ + K L +++ +++ GD + L + LP +
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 471 AETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY--ECYVE 528
+ +EYL S +HRDL N ++ + + DFGLSK +Y + Y +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK--------KIYSGDYYRQ 171
Query: 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEEL 587
A + K ++A E + Y D W+ GV ++E + G P+ G E+
Sbjct: 172 GCASKLPVK-------WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224
Query: 588 FAHTV 592
+ + +
Sbjct: 225 YNYLI 229
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 31/224 (13%)
Query: 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYC 431
+ G +G V++ T + A+K + ++M E E IM + +V +Y
Sbjct: 14 LGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLY- 67
Query: 432 SFETKKHLCLVMEYVEGGDCASLLKNTG------PLPADMARFYFAETVLAVEYLHSYGI 485
+ +++ + +V E++ G LK P DMA A+ + Y+
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA----AQIADGMAYIERMNY 123
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
+HRDL+ N+L+ K+ DFGL+++ + N Y R +F K +
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARL----IEDNE---YTARQGAKFPIK-------W 169
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELF 588
APE L + D WS G++L E + G VP+ G E+
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 37/146 (25%), Positives = 63/146 (43%), Gaps = 15/146 (10%)
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523
D+ F + + +E+L S VHRDL N+L+ +K+ DFGL++
Sbjct: 238 DLLSFTY-QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARD---------- 286
Query: 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGE 582
+ D+ S + +++APE I Y D WS G++L+E F +G P+ G
Sbjct: 287 ---IMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343
Query: 583 TPEELFAHTVNDDIEWPSEDDWPIQV 608
+ F + + D +V
Sbjct: 344 IVDSTFYNKIKSGYRMAKPDHATQEV 369
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 18/115 (15%)
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC--YVERDAKQFS 535
E+L S +HRDL N+L+T +K+ DFGL++ +++ Y + +
Sbjct: 146 EFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--------DIHHIDYYRKTTNGRLP 197
Query: 536 DKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFA 589
K ++APE + + Y D WS GV+L+E F +G P+ G EELF
Sbjct: 198 VK-------WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 32/235 (13%)
Query: 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF 420
P E+ +KL G +G V++ T R A+K + ++ E E +M
Sbjct: 4 PRESLRLEVKL-GQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKK 57
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK-NTG-----PLPADMARFYFAETV 474
+ +V +Y + +++ + +V EY+ G LK G P DMA A+
Sbjct: 58 LRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMA----AQIA 112
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
+ Y+ VHRDL+ N+L+ K+ DFGL+++ + N Y R +F
Sbjct: 113 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL----IEDNE---YTARQGAKF 165
Query: 535 SDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELF 588
K + APE L + D WS G++L E G VP+ G E+
Sbjct: 166 PIK-------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 33/148 (22%), Positives = 55/148 (37%), Gaps = 13/148 (8%)
Query: 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF--TDNPFV 426
IKL+ G VYL+ + + +K I S E+ E I+ V
Sbjct: 3 IKLLKGGLTNRVYLL--GTKDEDYVLK--INPSREKGADRER---EVAILQLLARKGLPV 55
Query: 427 VTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIV 486
+ S E+ L+ME++EG L + AE + + L +
Sbjct: 56 PKVLASGESDGWSYLLMEWIEG----ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 487 HRDLKPDNLLITALGHIKLTDFGLSKMG 514
H DL P N+L+ + + D+ + G
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 379 SVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDIMSFTDNPFVVTMYCSFETKK 437
+V L R+K T + +++I N N+M E + ++P +V +F
Sbjct: 15 TVNLARYKPTGEYVTVRRI--NLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72
Query: 438 HLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVL-AVEYLHSYGIVHRDLKPDNL 495
L +V ++ G L+ + +++A Y + VL A++Y+H G VHR +K ++
Sbjct: 73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 132
Query: 496 LITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-- 553
LI+ G + L+ GL S + + R F V P +++PEV+ +
Sbjct: 133 LISVDGKVYLS-------GLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNL 184
Query: 554 QGYGKPVDWWSMGVILYEFLVGCVPF 579
QGY D +S+G+ E G VPF
Sbjct: 185 QGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 31/110 (28%), Positives = 54/110 (49%), Gaps = 14/110 (12%)
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ 538
YL + +VHR+L N+L+ + +++ DFG++ + LY D K++ +
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL--------LYP-----DDKKYFYSE 170
Query: 539 VYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEEL 587
+++A E IL Y D WS GV ++E + G P+ G P E+
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV 220
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 44/188 (23%), Positives = 73/188 (38%), Gaps = 41/188 (21%)
Query: 441 LVMEYVEGGDCASLLKNTGPLPAD--------MARFYFAETVLAVEYLHSYGIVHRDLKP 492
LV EY E GD S L + MA E V ++H + +H DL
Sbjct: 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMA----CEIAAGVTHMHKHNFLHSDLAL 127
Query: 493 DNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL 552
N +T+ +K+ D+G+ + E Y+E + + ++APE++
Sbjct: 128 RNCFLTSDLTVKVGDYGIG-------PSRYKEDYIETEDDK------CVPLRWLAPELVG 174
Query: 553 -RQG------YGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAHTVND--------DI 596
G KP + W++GV L+E F P+ + E+ H + D +
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234
Query: 597 EWPSEDDW 604
E P + W
Sbjct: 235 ELPYSERW 242
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 33/239 (13%)
Query: 367 TVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
T+ + + G++G VY V E R A+K + + +R ++E E +M
Sbjct: 9 TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV-NEAASMRERIE-FLNEASVMKEF 66
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK--------NTGPLPADMARF--YFA 471
+ VV + + ++ME + GD S L+ N P + +
Sbjct: 67 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC-YVERD 530
E + YL++ VHRDL N ++ +K+ DFG+++ ++YE Y +
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYETDYYRKG 178
Query: 531 AKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEF-LVGCVPFFGETPEELF 588
K + +++PE + + D WS GV+L+E + P+ G + E++
Sbjct: 179 GKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 39/148 (26%), Positives = 67/148 (45%), Gaps = 16/148 (10%)
Query: 462 PADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521
PAD + +E+L S+ +VH+DL N+L+ ++K++D GL +
Sbjct: 123 PADFVHI-VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFR--------- 172
Query: 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFF 580
E Y K + + +++PE I+ + D WS GV+L+E F G P+
Sbjct: 173 --EVYAADYYKLMGNSLL--PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228
Query: 581 GETPEELFAHTVNDDIEWPSEDDWPIQV 608
G + +++ N + P DD P V
Sbjct: 229 GYSNQDVIEMIRNRQV-LPCPDDCPAWV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 27/175 (15%)
Query: 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYF-----AETVLAVEYLHSYGIVHRDLKPD 493
LV+E+ GD + L++ + A MA+ E + +LH +H DL
Sbjct: 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALR 129
Query: 494 NLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI-L 552
N +TA +K+ D+GL+ E Y E D D ++APE++ +
Sbjct: 130 NCQLTADLSVKIGDYGLA-----------LEQYPE-DYYITKDCHAVPL-RWLAPELVEI 176
Query: 553 RQGYGKPVDW------WSMGVILYE-FLVGCVPFFGETPEELFAHTVND-DIEWP 599
R P D WS+GV ++E F P+ + E++ V + DI+ P
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 34/110 (30%), Positives = 51/110 (46%), Gaps = 22/110 (20%)
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
+ +L S +HRDL N+L+T K+ DFGL+ RD + S+
Sbjct: 227 MSFLASKNCIHRDLAARNILLTHGRITKICDFGLA-----------------RDIRNDSN 269
Query: 537 KQVYGTP----EYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFG 581
V G +++APE I Y D WS G++L+E F +G P+ G
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 24/73 (32%), Positives = 32/73 (43%), Gaps = 8/73 (10%)
Query: 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL 500
+VMEY+EG ++ G E V LH GIVH DL N+++
Sbjct: 74 IVMEYIEGKPLKDVI-EEGNDE------LLREIGRLVGKLHKAGIVHGDLTTSNIIVRD- 125
Query: 501 GHIKLTDFGLSKM 513
+ L DFGL K
Sbjct: 126 DKLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 54/240 (22%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 366 FTVIKLISNGAYGSVYLVRHKE---TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
+ K++ G +GSV + + ++ + A+K +K + +++E+ +E M D
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVK-TMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 423 NPFVVTMY-CSFETKKHLCL-----VMEYVEGGDCASLL----KNTGP--LPADMARFYF 470
+P V+ + FE + ++ +++ GD S L P LP +
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 471 AETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERD 530
+ L +EYL + +HRDL N ++ + + DFGLSK + Y
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK-----------KIYSGDY 168
Query: 531 AKQFSDKQVYGTP-EYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELF 588
+Q ++ P ++IA E + + Y D W+ GV ++E G P+ G E++
Sbjct: 169 YRQ---GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY 225
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-04
Identities = 21/77 (27%), Positives = 34/77 (44%), Gaps = 8/77 (10%)
Query: 436 KKHLCLVMEYVEGGDCAS-LLKNTGPLPADMARFYFAETVLA--VEYLHSYGIVHRDLKP 492
+H LVME++ G + LK+ L D Y + +L + G+VH DL
Sbjct: 88 NRH-VLVMEFIGGDGIPAPRLKDV-RLLEDPEELY--DQILELMRKLYREAGLVHGDLSE 143
Query: 493 DNLLITALGHIKLTDFG 509
N+L+ G + + D
Sbjct: 144 YNILVDD-GKVYIIDVP 159
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 3e-04
Identities = 24/73 (32%), Positives = 32/73 (43%), Gaps = 9/73 (12%)
Query: 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL 500
+VMEY+ G D +L+ L + V LH GIVH DL N ++
Sbjct: 413 IVMEYIGGKDLKDVLEGNPELVRKVGE--------IVAKLHKAGIVHGDLTTSNFIVRD- 463
Query: 501 GHIKLTDFGLSKM 513
+ L DFGL K
Sbjct: 464 DRLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 36/123 (29%), Positives = 56/123 (45%), Gaps = 23/123 (18%)
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523
D+ RF + +++L S +HRD+ N+L+T K+ DFGL+
Sbjct: 213 DLLRFSS-QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA------------ 259
Query: 524 ECYVERDAKQFSDKQVYGTP----EYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVP 578
RD S+ V G +++APE I Y D WS G++L+E F +G P
Sbjct: 260 -----RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
Query: 579 FFG 581
+ G
Sbjct: 315 YPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 23/72 (31%), Positives = 31/72 (43%), Gaps = 8/72 (11%)
Query: 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL 500
+VMEY+EG + E V LH GIVH DL N++++
Sbjct: 76 IVMEYIEG-ELLKDALEEARPD------LLREVGRLVGKLHKAGIVHGDLTTSNIILSG- 127
Query: 501 GHIKLTDFGLSK 512
G I DFGL +
Sbjct: 128 GRIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|233667 TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 28/100 (28%), Positives = 42/100 (42%), Gaps = 14/100 (14%)
Query: 441 LVMEYVEG--GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLIT 498
L ME+++G + L G +A A + L G H DL P N+ +
Sbjct: 235 LTMEWIDGIPLSDIAALDEAGLDRKALAE-NLARSFLNQVL--RDGFFHADLHPGNIFVL 291
Query: 499 ALGHIKLTDFGLSKMGLMS------LATNLYECYVERDAK 532
G I DFG+ +G +S LA LY ++ RD +
Sbjct: 292 KDGKIIALDFGI--VGRLSEEDRRYLAEILYG-FLNRDYR 328
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol -> 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]. Length = 437 |
| >gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Score = 36.2 bits (84), Expect = 0.003
Identities = 11/31 (35%), Positives = 17/31 (54%), Gaps = 2/31 (6%)
Query: 641 SNLDWNSLLRHKAE--FIPQLDDEEDTSYFD 669
+DW+ L + E F+P++ DTS FD
Sbjct: 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFD 31
|
Length = 64 |
| >gnl|CDD|240168 cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Score = 39.0 bits (92), Expect = 0.003
Identities = 18/59 (30%), Positives = 27/59 (45%), Gaps = 3/59 (5%)
Query: 441 LVMEYV-EGGDCASLLKNTGPLPADMARFYFAETVLAVEYL-HSYGIVHRDLKPDNLLI 497
LVME++ + G A LK+ + Y + V + L G+VH DL N+L
Sbjct: 94 LVMEFIGDDGSPAPRLKDVPLEEEEAEELY-EQVVEQMRRLYQEAGLVHGDLSEYNILY 151
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and chromosome maintenance. The biological substrates for RIO1 are unknown. The function of RIO3 is also unknown. Length = 190 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 810 | |||
| PF08926 | 282 | DUF1908: Domain of unknown function (DUF1908); Int | 100.0 | |
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0606|consensus | 1205 | 100.0 | ||
| KOG0612|consensus | 1317 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0986|consensus | 591 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0595|consensus | 429 | 100.0 | ||
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0583|consensus | 370 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0593|consensus | 396 | 100.0 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0591|consensus | 375 | 100.0 | ||
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0579|consensus | 1187 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| KOG1187|consensus | 361 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| KOG1006|consensus | 361 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| KOG0603|consensus | 612 | 100.0 | ||
| KOG0665|consensus | 369 | 100.0 | ||
| KOG0576|consensus | 829 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1290|consensus | 590 | 99.98 | ||
| KOG1094|consensus | 807 | 99.98 | ||
| KOG1027|consensus | 903 | 99.97 | ||
| KOG0984|consensus | 282 | 99.97 | ||
| KOG0200|consensus | 609 | 99.97 | ||
| KOG1025|consensus | 1177 | 99.97 | ||
| KOG1167|consensus | 418 | 99.97 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG2052|consensus | 513 | 99.96 | ||
| KOG3653|consensus | 534 | 99.96 | ||
| KOG1345|consensus | 378 | 99.96 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0590|consensus | 601 | 99.93 | ||
| KOG1024|consensus | 563 | 99.92 | ||
| KOG1164|consensus | 322 | 99.91 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0606|consensus | 1205 | 99.91 | ||
| KOG1163|consensus | 341 | 99.89 | ||
| KOG1165|consensus | 449 | 99.88 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG1240|consensus | 1431 | 99.86 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG0195|consensus | 448 | 99.82 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG1166|consensus | 974 | 99.79 | ||
| KOG0590|consensus | 601 | 99.79 | ||
| KOG4158|consensus | 598 | 99.79 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| KOG1033|consensus | 516 | 99.71 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| KOG1023|consensus | 484 | 99.63 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG0601|consensus | 524 | 99.46 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| KOG1266|consensus | 458 | 99.38 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| KOG0601|consensus | 524 | 99.34 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| KOG1243|consensus | 690 | 99.24 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG3087|consensus | 229 | 98.93 | ||
| KOG2137|consensus | 700 | 98.86 | ||
| KOG3741|consensus | 655 | 98.84 | ||
| KOG0576|consensus | 829 | 98.75 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.7 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.4 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.39 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.3 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.2 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.19 | |
| KOG1826|consensus | 2724 | 98.17 | ||
| KOG1035|consensus | 1351 | 98.12 | ||
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.11 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.09 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.02 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.83 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.83 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.78 | |
| KOG1235|consensus | 538 | 97.76 | ||
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.71 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.61 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.5 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.44 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.44 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.3 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.21 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.09 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.94 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.87 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.77 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.65 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.5 | |
| PLN02236 | 344 | choline kinase | 96.19 | |
| KOG2268|consensus | 465 | 96.16 | ||
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.0 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.97 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.89 | |
| KOG2270|consensus | 520 | 95.63 | ||
| KOG1093|consensus | 725 | 95.46 | ||
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.09 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.02 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.49 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.47 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.03 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.88 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 93.08 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 92.65 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.86 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 91.44 | |
| KOG1236|consensus | 565 | 88.9 | ||
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 88.27 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 87.69 |
| >PF08926 DUF1908: Domain of unknown function (DUF1908); InterPro: IPR015022 This domain is found in microtubule-associated serine/threonine-protein kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-108 Score=840.24 Aligned_cols=274 Identities=64% Similarity=1.005 Sum_probs=86.8
Q ss_pred CCCCCcCCC---CCCcccccCCCCCCCCCccccCCCCcceeeeccCCCCCCCCCCCCccccccchhhhhccCCCCCCchh
Q psy16843 43 PLESPRVAS---NQHFPFIPMKRPFNHLNTDCRSDGTRRWSVASLPSSGYGTTPGSSNVSSQCSSQEKLHQLPNIPTSDE 119 (810)
Q Consensus 43 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (810)
|+||||||| ++||+|++..++.. .++|| ||||||||||||||||||||+|||+|||||||||||||||+||
T Consensus 1 p~dsprn~~~~~~~~f~f~~~~~~~~-----~~~D~-RRWSlASLPSSGYgT~~~sS~vSSscSSQE~Lhqlp~qpt~de 74 (282)
T PF08926_consen 1 PLDSPRNFSPNSPAHFSFASSHVPRS-----DRADG-RRWSLASLPSSGYGTNTPSSTVSSSCSSQERLHQLPFQPTPDE 74 (282)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCCCCCCCCCCCccCccccccccccc-----cccCC-CccccccCCCCCCCcCCCCCeeecchhhHHHhhCCCCCCChhH
Confidence 899999999 67999988654432 35555 9999999999999999999999999999999999999999999
Q ss_pred hhhhhhcccC-CC-chhhhhcc-CCCcCCCCCCCCCCCCC-ccchhhhhhhhhhhhchhHHHHHHHHHHHHHhhcCcccc
Q psy16843 120 LHELTKHFSS-ND-TDEEIRRS-FMRPRSKSLSSPSRSPI-LDNDIIAMNMLYKERFPKAIQQMETRLSNFINENSSLAT 195 (810)
Q Consensus 120 ~~~~~~~~~~-~~-~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (810)
||||+|||++ |+ ++|+++++ .+|||||||| |||+|+ +|+|||||||||||||||||+||||||++||+++++
T Consensus 75 l~~ls~hf~S~eS~~~e~g~~sp~~RpRSRSLS-P~rsp~~~d~ei~mmn~vYKERFPKAt~QMEErL~~fI~e~sp--- 150 (282)
T PF08926_consen 75 LHFLSKHFSSNESITDEDGRRSPAMRPRSRSLS-PGRSPGSFDNEIVMMNHVYKERFPKATAQMEERLQDFIDENSP--- 150 (282)
T ss_dssp -----------------------------------------------------------TTHHHHHHHHHHHHHS-B---
T ss_pred HHHHhccCCcccCccccccccCCcCCccccccC-CCCCCcccCcccccccccchhhcchhhHHHHHHHHHHHHHcCc---
Confidence 9999999986 66 66677777 6999999997 899999 899999999999999999999999999999999999
Q ss_pred CCcCCcCCCcchhhhhhHHHHHHHHHHHHhhccccceehHHHHHHHHHHHHHHHHHhhhh-hHHHhHHHHHhhheeeeee
Q psy16843 196 NNLETASPDAAPIIRFVHHQILEIARDCLFKSKEKLISSRYFYEMSEKLERLLTETKEKS-LEAATVLTFTLKKLLLIIS 274 (810)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~ii~ 274 (810)
++++++|||+++||||||||+|||||+|+++++||++|||||+||||+|++|+++|| .++++++..+|||++|||+
T Consensus 151 ---~~~~~~aDgv~~FihHQivElARDCL~KS~~~lITs~YF~ElsEnLekLl~ea~erS~~~~~~~~~~lvrklL~Iis 227 (282)
T PF08926_consen 151 ---DNVLPLADGVLRFIHHQIVELARDCLQKSREGLITSRYFYELSENLEKLLQEAHERSESEEVAFVTQLVRKLLIIIS 227 (282)
T ss_dssp ---TTTB--S-HHHHHHHHHHHHHHHHHHHHHHTT---HHHHHHHHHHHHHHHHHHHHTS-HHHHHHHHHHHHHHHHHHS
T ss_pred ---cccccccHHHHHHHHHHHHHHHHHHHHHHhccCchHHHHHHHHHHHHHHHHhcccCCcHHHHHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999999999999999999999999999999999 6699999999999999999
Q ss_pred CCCceeecccCChHHHHHHHHhhhcchhhccccccCcchhhcccccccccccccc
Q psy16843 275 RPARLLECLEFDPEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDL 329 (810)
Q Consensus 275 rp~k~l~~~~fdPee~~~~~~~a~~~ak~~~gl~~di~~~ii~~l~l~~~~F~~l 329 (810)
||||+|+|+||||++||+.+++|+|++|..+|++.|+|+|||.++|++++++.++
T Consensus 228 RPARLLEcLEFdPeefy~lLe~aEg~ak~~~~~k~DiP~Yii~kLGL~rdpl~e~ 282 (282)
T PF08926_consen 228 RPARLLECLEFDPEEFYHLLEAAEGQAKEGQGIKTDIPQYIISKLGLTRDPLEEM 282 (282)
T ss_dssp S------------------------------------------------------
T ss_pred chhhhhhhhccChHHHHHHHHHHHHhhhhcCCcccCchHhHHHHhcCCCCccccC
Confidence 9999999999999999999999999999999999999999999999999887653
|
; GO: 0000287 magnesium ion binding, 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 1V9V_A. |
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-67 Score=557.70 Aligned_cols=300 Identities=41% Similarity=0.812 Sum_probs=277.9
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
....++|++++.||+|+||+||+|+.+++++.||||++.|..+...+.+++...|+.||..++||+||++++.|++.+++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 35668999999999999999999999999999999999999988888999999999999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|||+||+.||+|+.+|++.+.|+|+.+++|+++|+.||.|||++|||||||||||||||.+|||+|+||||++.....
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-- 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-- 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999863321
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
.....++|||+.|||||++.+.+|+.++|||||||++|||++|.+||.+.+..+++++|..++...+
T Consensus 179 -------------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~ 245 (357)
T KOG0598|consen 179 -------------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP 245 (357)
T ss_pred -------------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC
Confidence 1233578999999999999999999999999999999999999999999999999999999985544
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCC-CChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHhhhc
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGT-GGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRMERYN 676 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta-~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~~~~ 676 (810)
+. .++.+++|||+++|++||++|+++ +++++|.+||||.++||+++..++ ++|.|.....++.++||..+..+.
T Consensus 246 p~---~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd~eft~~~ 322 (357)
T KOG0598|consen 246 PG---YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTSNFDNEFTSYT 322 (357)
T ss_pred Cc---cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccccccHHHHhcc
Confidence 43 267999999999999999999984 468999999999999999998876 789999999999999999887654
Q ss_pred C
Q psy16843 677 H 677 (810)
Q Consensus 677 ~ 677 (810)
.
T Consensus 323 ~ 323 (357)
T KOG0598|consen 323 V 323 (357)
T ss_pred c
Confidence 3
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-66 Score=576.29 Aligned_cols=310 Identities=46% Similarity=0.800 Sum_probs=276.6
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
.+..+||+++++||+|+||.||+|+.+.||+.||||++.|..+...++++++..|++||...++|+||+||++|++.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
||||||++|||+..+|.+.+.|+++.+++|+++++.|++-||+.|+|||||||+|+|||..||+||+||||++.......
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999964332111
Q ss_pred ccchh---------------hhhh-----------------cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHH
Q psy16843 520 TNLYE---------------CYVE-----------------RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGV 567 (810)
Q Consensus 520 ~~~~~---------------~~~~-----------------~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGv 567 (810)
...+. .... +........+.+|||.|||||++.+.+|+..+|||||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 11000 0000 000111124579999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhh
Q psy16843 568 ILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647 (810)
Q Consensus 568 ILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~ 647 (810)
||||||.|.+||.+.++.+++.+|++....+.-+....++++++|||.+||. ||++|++.+|++||++||||++++|+.
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence 9999999999999999999999999876444333444588999999999999 999999999999999999999999999
Q ss_pred hhhccCCcccCCCCCccCcccch
Q psy16843 648 LLRHKAEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 648 l~~~~~~f~P~~~~~~d~~~fd~ 670 (810)
+....++|+|.+++++|+.|||+
T Consensus 456 l~~~~apfvP~v~~~~DT~yFdd 478 (550)
T KOG0605|consen 456 LREMPAPFVPQVNSELDTQYFDD 478 (550)
T ss_pred hhcCCCCCCCCCCCccccccccc
Confidence 99999999999999999999984
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-63 Score=515.67 Aligned_cols=289 Identities=40% Similarity=0.777 Sum_probs=271.9
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||.|+||+|.+++++.+|..||+|++.+......+++++...|..+|+.+.||+++++++.|.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 45689999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
|||||++||.|+.+|++.++|++..+++|++||+.||+|||+++|++|||||||||||.+|++||+|||+|+....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---- 196 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---- 196 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999986221
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
...+.||||.|+|||+++.++|+.++|||||||++|||+.|.+||++.++.+++.+|+.+++.+|.
T Consensus 197 --------------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~ 262 (355)
T KOG0616|consen 197 --------------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS 262 (355)
T ss_pred --------------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc
Confidence 135789999999999999999999999999999999999999999999999999999999999998
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCC--CChhHHhcCCCcCCCChhhhhhcc--CCccc-CCCCCccCcccchH
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHK--AEFIP-QLDDEEDTSYFDSR 671 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta--~~~~EiL~HPfF~~id~~~l~~~~--~~f~P-~~~~~~d~~~fd~~ 671 (810)
. .+.+++|||+++|+.|-.+|.+- +|..+|+.||||++++|..++.++ +|+.| ......|+++||.-
T Consensus 263 ~----fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y 334 (355)
T KOG0616|consen 263 Y----FSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTSNFDDY 334 (355)
T ss_pred c----cCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCccccccccc
Confidence 7 78999999999999999999775 478999999999999999998775 67777 77888899999853
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-62 Score=551.05 Aligned_cols=299 Identities=39% Similarity=0.778 Sum_probs=278.0
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccc
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKK 437 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~ 437 (810)
...+.++|.++++||+|.||+|+++..+.+++.||||+++|..+..+..++..+.|.+|+...+ ||+++.+|.+|++++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4567899999999999999999999999999999999999999999999999999999998875 999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
++|+||||+.||+ ..+++..+.|++..+++|+++|+.||.|||++||||||||.+|||||.+|++||+|||++|.....
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999999999 555566689999999999999999999999999999999999999999999999999999864321
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
.....++||||.|||||++.++.|+.++|||||||+|||||.|..||.|++.++++..|++..+.
T Consensus 522 ---------------g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~ 586 (694)
T KOG0694|consen 522 ---------------GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR 586 (694)
T ss_pred ---------------CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC
Confidence 12346899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCC--CChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHh
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRME 673 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta--~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~ 673 (810)
+|.. +|.++.+++++||.+||++|+++ .++++|+.||||+.|||++|+.+. |||+|.+.+..|.+|||+++.
T Consensus 587 yP~~----ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt 662 (694)
T KOG0694|consen 587 YPRF----LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFT 662 (694)
T ss_pred CCCc----ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhh
Confidence 9875 88999999999999999999999 467999999999999999998775 899999999999999999887
Q ss_pred hhcC
Q psy16843 674 RYNH 677 (810)
Q Consensus 674 ~~~~ 677 (810)
....
T Consensus 663 ~e~p 666 (694)
T KOG0694|consen 663 SEKP 666 (694)
T ss_pred cCCC
Confidence 5443
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-59 Score=491.06 Aligned_cols=299 Identities=38% Similarity=0.744 Sum_probs=281.0
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
..+..++|+.+++||+|.||+|.+++.+.+++.||||+++|+.+..+..+.+...|-++|+..+||++..|.++|++.+.
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 44567999999999999999999999999999999999999988888999999999999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|+||||+.||+|+.+|.+...|+|+.+++|.++|+.||.|||+++||+||||.+|+|||.+|+|||+||||++....-
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~- 321 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY- 321 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999864321
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
....+++||||.|+|||++....|+.++|||.+||+||||++|++||++.+...++..|+.+.+.|
T Consensus 322 --------------g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kF 387 (516)
T KOG0690|consen 322 --------------GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKF 387 (516)
T ss_pred --------------cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccC
Confidence 223468999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHhh
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRMER 674 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~~ 674 (810)
|.. ++++++.|+..+|.+||.+|++.+ ++.||.+|+||.+++|+.+.+++ +||.|++.++.|+.|||+.+..
T Consensus 388 Pr~----ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT~ 463 (516)
T KOG0690|consen 388 PRT----LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEEFTS 463 (516)
T ss_pred Ccc----CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhhhhc
Confidence 986 789999999999999999999984 58999999999999999998876 7899999999999999998865
Q ss_pred hc
Q psy16843 675 YN 676 (810)
Q Consensus 675 ~~ 676 (810)
..
T Consensus 464 q~ 465 (516)
T KOG0690|consen 464 QP 465 (516)
T ss_pred ce
Confidence 43
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-57 Score=502.72 Aligned_cols=284 Identities=35% Similarity=0.634 Sum_probs=258.8
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~ly 440 (810)
..+||.+.+.||.|+|++|++|+.+.+++.||||++.|.-+...+.++.+..|.++|..| +||.||+||..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 458999999999999999999999999999999999998888888889999999999999 9999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+|+||+++|+|.++|++.|.|++..+++|++||+.||+|||++|||||||||||||||.+|++||+|||.|+........
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999976544322
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
.. .............+++||-.|.+||++.....++.+|||+||||||.|+.|.+||.+.++.-++++|+.-.+.||.
T Consensus 231 ~~--~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~ 308 (604)
T KOG0592|consen 231 QE--NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE 308 (604)
T ss_pred cc--CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence 11 1111111112236799999999999999999999999999999999999999999999999999999999999997
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAE 654 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~ 654 (810)
. .++.++|||+++|..||.+|+|+ +||++||||.++||++|.+..+|
T Consensus 309 ~----fp~~a~dLv~KLLv~dp~~Rlt~---~qIk~HpFF~~Vdw~nlw~~~PP 355 (604)
T KOG0592|consen 309 G----FPEDARDLIKKLLVRDPSDRLTS---QQIKAHPFFEGVDWENLWQQTPP 355 (604)
T ss_pred C----CCHHHHHHHHHHHccCccccccH---HHHhhCcccccCChhhhhhcCCC
Confidence 6 56999999999999999999999 99999999999999998877654
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-57 Score=489.95 Aligned_cols=301 Identities=40% Similarity=0.703 Sum_probs=266.4
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
....++|++++.||.|.-|+||+|+.+.++..+|||++.|..+..++.+.++..|.+||+.++||+++.||..|++++++
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 34567899999999999999999999999999999999999998889999999999999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
|+|||||+||+|..+++++ +.|++..+++|+++++.||+|||-.|||+||||||||||.++|||.|+||.|+......
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999999754 57999999999999999999999999999999999999999999999999998653221
Q ss_pred ccccc-----------------hhhhh-------h-----------------cccccccCCcccCCCCcCChhHHhhcCC
Q psy16843 518 LATNL-----------------YECYV-------E-----------------RDAKQFSDKQVYGTPEYIAPEVILRQGY 556 (810)
Q Consensus 518 ~~~~~-----------------~~~~~-------~-----------------~~~~~~~~~~~~GTp~YmAPEvl~~~~y 556 (810)
.+-.. ..++. . .+......++++||-.|+|||+|.|.+.
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 10000 00110 0 0122344578999999999999999999
Q ss_pred CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCC-CChhHHh
Q psy16843 557 GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT-GGPHEVK 635 (810)
Q Consensus 557 s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta-~~~~EiL 635 (810)
+.++|||.|||+|||||+|..||.|.+..+++.+|+...+.+|... .++.+++|||+++|.+||.+|++. .|+.||+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 9999999999999999999999999999999999999999999875 478999999999999999999996 4779999
Q ss_pred cCCCcCCCChhhhhhccCCcccCCCCC
Q psy16843 636 EHPYFSNLDWNSLLRHKAEFIPQLDDE 662 (810)
Q Consensus 636 ~HPfF~~id~~~l~~~~~~f~P~~~~~ 662 (810)
+||||++++|.-+.-..+|++|...+.
T Consensus 391 ~HpFF~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 391 RHPFFEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred cCccccCCChhheeccCCCcCCCcccc
Confidence 999999999996666678999976554
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-57 Score=532.70 Aligned_cols=385 Identities=70% Similarity=1.163 Sum_probs=342.0
Q ss_pred HHHHHHHHHHHhhccccceehHHHHHHHHHHHHHHHHHhhhhhHHHhHHHHHhhheeeeeeCCCceeecccCChHHHHHH
Q psy16843 214 HQILEIARDCLFKSKEKLISSRYFYEMSEKLERLLTETKEKSLEAATVLTFTLKKLLLIISRPARLLECLEFDPEEFYHF 293 (810)
Q Consensus 214 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~rp~k~l~~~~fdPee~~~~ 293 (810)
|||||+|||||.|+++.+||++|||||+ +.++++++++ ||++|+| | |||||+.
T Consensus 1 hq~~e~a~dcl~ks~~~lits~yf~e~~------l~~~~~~~~~------------------parllec-e--peefy~l 53 (1205)
T KOG0606|consen 1 HQIVEMARDCLRKSQPTLITSQYFYEMS------LQEAHEKSPS------------------PARLLEC-E--PEEFYHL 53 (1205)
T ss_pred CcccccchhhhcCCCCceeecchhhhhh------hhhhhhccCC------------------chhhccC-C--HHHHHHH
Confidence 7999999999999999999999999999 7888888887 9999999 6 9999999
Q ss_pred HHhhhcchhhccccccCcchhhcccccccccccccchhhhcccCCCCccccCCCCcccccCCcccCCCCCCCcEEEEEec
Q psy16843 294 LEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDNDIQNISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLIS 373 (810)
Q Consensus 294 ~~~a~~~ak~~~gl~~di~~~ii~~l~l~~~~F~~l~~di~~~s~sd~s~e~~~~s~~~~~~~~~~~~~~~dy~ilk~LG 373 (810)
++.|+|+++. ..++++.+.... ....+..++|+.++.|.
T Consensus 54 le~aeg~~~~---------------------------------p~~~~s~~~~~a--------s~~~p~e~df~~Iklis 92 (1205)
T KOG0606|consen 54 LEAAEGHARK---------------------------------PMTDESPESRGA--------SRRAPSESDFNTIKLIS 92 (1205)
T ss_pred HHhhhccccC---------------------------------CCCCCCcccccc--------cccCCCccccceeEeec
Confidence 9999999872 111111111110 14567789999999999
Q ss_pred ccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcchhh
Q psy16843 374 NGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCAS 453 (810)
Q Consensus 374 ~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL~~ 453 (810)
.|+||.||+++|+.+.+.+|+ +|.++....++ |+....+|++| ||+..
T Consensus 93 ngAygavylvrh~~trqrfa~-kiNkq~lilRn----------ilt~a~npfvv---------------------gDc~t 140 (1205)
T KOG0606|consen 93 NGAYGAVYLVRHKETRQRFAM-KINKQNLILRN----------ILTFAGNPFVV---------------------GDCAT 140 (1205)
T ss_pred cCCCCceeeeeccccccchhh-cccccchhhhc----------cccccCCccee---------------------chhhh
Confidence 999999999999999999999 47776554332 77778888887 79999
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhccccc
Q psy16843 454 LLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533 (810)
Q Consensus 454 lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~ 533 (810)
++++-|+++.+. +.|++|||+.||+|||+||+|.+|+.-|++|++|||+++.+++...++.|+.+++.+..+
T Consensus 141 llk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~E 212 (1205)
T KOG0606|consen 141 LLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHE 212 (1205)
T ss_pred hcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHH
Confidence 999988888766 889999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHH
Q psy16843 534 FSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSI 613 (810)
Q Consensus 534 ~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dL 613 (810)
+..+..||||.|+|||++..++|+..+|||++|+|+||++.|..||+|+++++++..++...+.||.. ++.+.++++++
T Consensus 213 f~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~-dea~p~Ea~dl 291 (1205)
T KOG0606|consen 213 FQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE-DEALPPEAQDL 291 (1205)
T ss_pred hhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc-CcCCCHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999987 67788999999
Q ss_pred HHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCccCcccchHHhhhcCCCCCCCcccccccccC
Q psy16843 614 ITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETEDSFSLG 693 (810)
Q Consensus 614 I~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d~~~fd~~~~~~~~~~~~~~~e~~d~~~~~ 693 (810)
|.+||+.+|..|++..+.-++++|+||..+||..|++++++|+|.+..++|++|||.+.++|.+...++....+..+...
T Consensus 292 i~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfdTRs~Ryh~~~se~~~~ees~~~~~ 371 (1205)
T KOG0606|consen 292 IEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFDTRSDRYHHFESEDTGDEESSLEFR 371 (1205)
T ss_pred HHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccccchhhcccchheeeccccCCcccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999444444545555556678
Q ss_pred Ccccchhhhhhhhh
Q psy16843 694 TFSSCTHQYKKVQS 707 (810)
Q Consensus 694 ~f~~~~~~~~~~~~ 707 (810)
.|++|...+.++..
T Consensus 372 qFsscs~r~~kv~s 385 (1205)
T KOG0606|consen 372 QFSSCSPRFSKVYS 385 (1205)
T ss_pred cccccccccccccc
Confidence 89998887765543
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-57 Score=532.98 Aligned_cols=293 Identities=40% Similarity=0.750 Sum_probs=270.6
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...+||+++++||+|+||.|.+++++.+++.||||++.|..+..+.....+..|++||...+.++||.+++.|+++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 45589999999999999999999999999999999999988888888889999999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+|||||+||||..++.+.++++++.|++|+++|+.||+-||+.|+|||||||+|||||..|||||+|||.+-...
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~----- 226 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD----- 226 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC-----
Confidence 999999999999999998899999999999999999999999999999999999999999999999999874321
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhh-----cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC-
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-----QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND- 594 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~- 594 (810)
..........+|||.|++||++.. ..||..+||||+||++|||++|..||+.++..++|.+|++.
T Consensus 227 ---------~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk 297 (1317)
T KOG0612|consen 227 ---------ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK 297 (1317)
T ss_pred ---------CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh
Confidence 112233457799999999999973 45899999999999999999999999999999999999986
Q ss_pred -CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCccCcccch
Q psy16843 595 -DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 595 -~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d~~~fd~ 670 (810)
.+.||... .+|+++++||.++|. +|+.|++-+|++++..||||.+++|+.+....+|++|.+.++.|+++||.
T Consensus 298 ~~l~FP~~~--~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnFd~ 371 (1317)
T KOG0612|consen 298 ESLSFPDET--DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNFDV 371 (1317)
T ss_pred hhcCCCccc--ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccccccc
Confidence 77888443 399999999999997 99999999999999999999999999999999999999999999999964
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-57 Score=485.86 Aligned_cols=264 Identities=32% Similarity=0.500 Sum_probs=237.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhh----HHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML----RNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~----~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
.+.|.+.+.||+|+||.|.+|..+.||+.||||++.+..... ......+.+|++||++++|||||+++++|+..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 366889999999999999999999999999999998765443 1233446799999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC---CcEEEeccCCccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL---GHIKLTDFGLSKMGL 515 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~---g~VKL~DFGLAk~~~ 515 (810)
.||||||++||+|++.+-.++.+.++..+.++.||+.||.|||++||+||||||+|||+..+ -.+||+|||+|+...
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 99999999999999999999999999999999999999999999999999999999999876 679999999999743
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCC---CCCcchhhhHHHHHHHHhCCCCCCCCCHHH-HHHhh
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY---GKPVDWWSMGVILYEFLVGCVPFFGETPEE-LFAHT 591 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y---s~ksDIWSLGvILyELLtG~~PF~~~~~~e-~~~~I 591 (810)
.. -..+++||||.|.|||++.+.++ ..++|||||||+||-+++|.+||.+..... +.++|
T Consensus 331 ~~----------------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI 394 (475)
T KOG0615|consen 331 EG----------------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI 394 (475)
T ss_pred cc----------------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH
Confidence 21 12368999999999999987654 558899999999999999999999876666 88999
Q ss_pred ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 592 ~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
..+.+.+.+..+..+|+++++||.+||..||++||++ .|+|+||||+...-
T Consensus 395 ~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~---~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 395 LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSA---DEALNHPWFKDAPC 445 (475)
T ss_pred hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCH---HHHhcChhhhcccc
Confidence 9999999888888899999999999999999999999 99999999998753
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-54 Score=484.51 Aligned_cols=256 Identities=34% Similarity=0.582 Sum_probs=243.4
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
.+|...+.||+|||+.||.+++..+|+.||+|+|.+..+....+.+.+.+|++|.+.|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999999998888889999999999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
|+|..|+|..+++.++.++|.++++|+.||+.||.|||+++|||||||..||+|+++.+|||+|||||.....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~------- 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY------- 170 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC-------
Confidence 9999999999999999999999999999999999999999999999999999999999999999999975321
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
......++||||.|+|||++.+.+++..+||||+||+||-||+|++||...+..+++.+|....+.+|..
T Consensus 171 --------~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~-- 240 (592)
T KOG0575|consen 171 --------DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSH-- 240 (592)
T ss_pred --------cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccc--
Confidence 1123468999999999999999999999999999999999999999999999999999999999999984
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
+|.+++|||.+||+.||.+||++ ++|+.|+||.
T Consensus 241 --ls~~A~dLI~~lL~~~P~~Rpsl---~~vL~h~Ff~ 273 (592)
T KOG0575|consen 241 --LSAEAKDLIRKLLRPNPSERPSL---DEVLDHPFFK 273 (592)
T ss_pred --cCHHHHHHHHHHhcCCcccCCCH---HHHhcCHhhh
Confidence 88999999999999999999999 9999999993
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-55 Score=468.48 Aligned_cols=301 Identities=37% Similarity=0.737 Sum_probs=278.9
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecccccee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~l 439 (810)
+...||.++.+||+|+||+|.++..+.+.+.||||+++|+.+.....++--+.|.++|... +-|++|+++.+|++-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 4457999999999999999999999999999999999999888888888889999999887 568999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||+.||+|..+|+.-|+|.|..|.+|+++|+.||-|||++|||+||||.+|||||.+|+|||+|||+++.....
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-- 503 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-- 503 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999864332
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
....+++||||.|+|||++..++|+.++||||+||+||||+.|++||.|++.+++++.|......+|
T Consensus 504 -------------~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP 570 (683)
T KOG0696|consen 504 -------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP 570 (683)
T ss_pred -------------CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc
Confidence 2234789999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHhhh
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRMERY 675 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~~~ 675 (810)
.. +|.++.++++.+|.+.|.+|++++ +..+|..||||+.|||+++.+.. +||.|.+....+.++||..+.+.
T Consensus 571 Ks----lSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~ 646 (683)
T KOG0696|consen 571 KS----LSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTRE 646 (683)
T ss_pred cc----ccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHhcC
Confidence 76 889999999999999999999984 56899999999999999998765 78999998888999999998876
Q ss_pred cCCCC
Q psy16843 676 NHDIG 680 (810)
Q Consensus 676 ~~~~~ 680 (810)
..++.
T Consensus 647 ~~~lT 651 (683)
T KOG0696|consen 647 PTDLT 651 (683)
T ss_pred CCCCC
Confidence 65553
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-54 Score=475.48 Aligned_cols=308 Identities=43% Similarity=0.726 Sum_probs=272.7
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
...-|..++.||-|+||+|.+++..+|...||+|.+.|.....++++.++..|++||...++++||+||+.|++++.+|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 34569999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||++|||+..+|-+.|.|.|+.+++|++++..|+++.|+.|+|||||||+|||||.+|+|||+||||+.-........
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999997544443333
Q ss_pred chhhh---------------------------hhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh
Q psy16843 522 LYECY---------------------------VERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV 574 (810)
Q Consensus 522 ~~~~~---------------------------~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt 574 (810)
.|... .............+||+.|+|||+|...+|+..+||||.|||||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 22110 001111223346799999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHhhccC--CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhcc
Q psy16843 575 GCVPFFGETPEELFAHTVND--DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHK 652 (810)
Q Consensus 575 G~~PF~~~~~~e~~~~I~~~--~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~ 652 (810)
|++||-+.++.++..+|++- .+.++.. ..+|.++.+||.+|.. +++.|++-.+.+|++.||||++|||.++.+..
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~--~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ 943 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQ--GNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLRKQR 943 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccc--cccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhhhhcc
Confidence 99999999998888888763 3444433 3489999999999775 99999999999999999999999999998889
Q ss_pred CCcccCCCCCccCcccchHH
Q psy16843 653 AEFIPQLDDEEDTSYFDSRM 672 (810)
Q Consensus 653 ~~f~P~~~~~~d~~~fd~~~ 672 (810)
++++|.+....|+++||..-
T Consensus 944 ApYIP~ItHptDTSNFdpvd 963 (1034)
T KOG0608|consen 944 APYIPRITHPTDTSNFDPVD 963 (1034)
T ss_pred CCcCccccCCCccccCCcCC
Confidence 99999999999999999743
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=448.83 Aligned_cols=258 Identities=29% Similarity=0.553 Sum_probs=232.2
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc-ee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK-HL 439 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~-~l 439 (810)
....+.+.++.||+|..|+||+++|+.|++.||+|+|... ......+++.+|++|++.++|||||.+|++|..+. .+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 3446899999999999999999999999999999998433 23445588999999999999999999999999999 49
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|+||||.||+|.++++..|+++|.....++.+|++||.|||+ ++||||||||+||||+..|.|||||||.|+....+
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999999999999999999999999999999999995 89999999999999999999999999999864322
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC-----CHHHHHHhhcc
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE-----TPEELFAHTVN 593 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~-----~~~e~~~~I~~ 593 (810)
..++++||..|||||.+.+..|+.++||||||+.++||++|+.||... +..+++..|..
T Consensus 233 ----------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 233 ----------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD 296 (364)
T ss_pred ----------------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence 235789999999999999999999999999999999999999999874 77889999998
Q ss_pred CCC-CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 594 DDI-EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 594 ~~~-~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
+.. .+|.. ..|+++++||..||++||.+|+++ +|+++|||+...
T Consensus 297 ~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~---~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 297 EPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSA---KQLLQHPFIKKF 341 (364)
T ss_pred CCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCH---HHHhcCHHHhhc
Confidence 544 44443 378999999999999999999999 999999999754
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-53 Score=457.35 Aligned_cols=325 Identities=33% Similarity=0.569 Sum_probs=279.4
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
....+.|..-++||+||||.||-++.+.||+.||+|++.|+.+..+......+.|..||.+++.++||.+-++|++.+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 45668899999999999999999999999999999999998888777778889999999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
|+||..|+||||..+|.+.| .|++..+++|++||+.||++||+.+||+|||||+|||||+.|+|+|+|+|||..+...
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999999998877 8999999999999999999999999999999999999999999999999999753321
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC----CHHHHHHhhcc
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE----TPEELFAHTVN 593 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~----~~~e~~~~I~~ 593 (810)
.+....+||.+|||||++.+..|+..+|||||||+||||+.|+.||... ..+++-.+++.
T Consensus 341 ----------------~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~ 404 (591)
T KOG0986|consen 341 ----------------KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE 404 (591)
T ss_pred ----------------CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc
Confidence 1224458999999999999999999999999999999999999999754 33467777787
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccc
Q psy16843 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFD 669 (810)
Q Consensus 594 ~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd 669 (810)
....++.. .|+++++|++.+|++||.+|++.. ++.++.+||||+++||..+.... |||+|......-..-+|
T Consensus 405 ~~~ey~~k----FS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~D 480 (591)
T KOG0986|consen 405 DPEEYSDK----FSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLD 480 (591)
T ss_pred chhhcccc----cCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhh
Confidence 77777743 789999999999999999999994 68999999999999999997664 78999765443333333
Q ss_pred hHHhhhcCCCCCCCcccccccc-cCCcccchhhhhhhh
Q psy16843 670 SRMERYNHDIGEDTDETEDSFS-LGTFSSCTHQYKKVQ 706 (810)
Q Consensus 670 ~~~~~~~~~~~~~~~e~~d~~~-~~~f~~~~~~~~~~~ 706 (810)
++++....|...++.++++. .+....+.++|+.-.
T Consensus 481 --IeqFs~VKGV~ld~~D~~fy~~F~tg~vsipWQnE~ 516 (591)
T KOG0986|consen 481 --IEQFSTVKGVKLDDTDTDFYKNFATGSVSIPWQNEM 516 (591)
T ss_pred --hhhcccccceecccccHHHHHhccCCcccchHHHHH
Confidence 33444555665555555555 567778888887654
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=461.87 Aligned_cols=260 Identities=35% Similarity=0.615 Sum_probs=241.2
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..+-|++.+.||+|+-|.|.+|+|..||+..|||+|.+...........+.+|+-||+.+.||||+.+|++|++..++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 34679999999999999999999999999999999988754555556778999999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|.||++||.|+++|-.+|++++.++.+++.||+.|+.|||..+|+||||||+|+|||..++|||+|||+|.....+
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g---- 165 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG---- 165 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999753211
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
..-.+-||+|.|.|||++.|.+| +.++||||+|||||.||+|++||.+.+...++.++..+.+.+|.
T Consensus 166 ------------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs 233 (786)
T KOG0588|consen 166 ------------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS 233 (786)
T ss_pred ------------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC
Confidence 11246799999999999999999 99999999999999999999999999999999999999999996
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
. ++.+++|||.+||..||.+|++. +||++|||+.+..
T Consensus 234 ~----Is~eaQdLLr~ml~VDp~~RiT~---~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 234 N----ISSEAQDLLRRMLDVDPSTRITT---EEILKHPFLSGYT 270 (786)
T ss_pred c----CCHHHHHHHHHHhccCccccccH---HHHhhCchhhcCC
Confidence 5 88999999999999999999999 9999999998754
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=446.77 Aligned_cols=305 Identities=44% Similarity=0.778 Sum_probs=255.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|+++.+|+.||||++.+...........+..|+.+|..++||||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765544556677889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..........+
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998753221110000
Q ss_pred hhhhh-----------------c------ccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCC
Q psy16843 524 ECYVE-----------------R------DAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF 580 (810)
Q Consensus 524 ~~~~~-----------------~------~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~ 580 (810)
..... . ..........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 00000 0 000001124579999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCC
Q psy16843 581 GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLD 660 (810)
Q Consensus 581 ~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~ 660 (810)
+.+..+.+..+......++......+++++++||.+||. +|.+|++...+.|++.||||.+++|+.+....+++.|...
T Consensus 241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~ 319 (364)
T cd05599 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPELK 319 (364)
T ss_pred CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCCCC
Confidence 999888888887644333322333478999999999997 9999999555699999999999999998887888888877
Q ss_pred CCccCcccc
Q psy16843 661 DEEDTSYFD 669 (810)
Q Consensus 661 ~~~d~~~fd 669 (810)
...+.++|+
T Consensus 320 ~~~~~~~~~ 328 (364)
T cd05599 320 SITDTSNFD 328 (364)
T ss_pred Cchhhhhcc
Confidence 777767665
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=446.36 Aligned_cols=303 Identities=40% Similarity=0.725 Sum_probs=247.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||+||+|+++.+++.||||++.+...........+..|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999998765555556677889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++..........+
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998753221110000
Q ss_pred hhh---hhc-----------------ccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC
Q psy16843 524 ECY---VER-----------------DAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET 583 (810)
Q Consensus 524 ~~~---~~~-----------------~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~ 583 (810)
... ... ..........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 000 000 000011135689999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccC--CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCC
Q psy16843 584 PEELFAHTVND--DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDD 661 (810)
Q Consensus 584 ~~e~~~~I~~~--~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~ 661 (810)
..+.+.++... .+.+|.. .++++++++||.+|+. +|.+|++..+++|+++||||.+++|+.+.....+..+....
T Consensus 241 ~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~ 317 (363)
T cd05628 241 PQETYKKVMNWKETLIFPPE--VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKS 317 (363)
T ss_pred HHHHHHHHHcCcCcccCCCc--CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCCCCCCccCCC
Confidence 99998888864 3444432 3478999999999886 67777655456999999999999999987665444334444
Q ss_pred CccCcccc
Q psy16843 662 EEDTSYFD 669 (810)
Q Consensus 662 ~~d~~~fd 669 (810)
..+.+.|+
T Consensus 318 ~~~~~~~~ 325 (363)
T cd05628 318 IDDTSNFD 325 (363)
T ss_pred cchhhccC
Confidence 44444444
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=431.81 Aligned_cols=323 Identities=35% Similarity=0.668 Sum_probs=280.8
Q ss_pred ccCCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhc-CCCCeEEEeeeeccc
Q psy16843 357 FSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF-TDNPFVVTMYCSFET 435 (810)
Q Consensus 357 ~~~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~-l~HPnIVkl~~~f~~ 435 (810)
..+....++|.++++||.|+|++|.+++++.|.+.||||+++|+.......+...+.|..+... .+||++|.++.+|++
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 4556778999999999999999999999999999999999988877777777888889888765 489999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
+..+++|.||++||+|..++++..+++|+++++|.++|+.||.|||++|||+||||.+|+|||..|++||+|+|+++.++
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998644
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCC-------C-CCHHHH
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF-------G-ETPEEL 587 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~-------~-~~~~e~ 587 (810)
.. .....++||||.|+|||++.+..|+..+|||+|||+|+||+.|+.||. . .+..-+
T Consensus 403 ~~---------------gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl 467 (593)
T KOG0695|consen 403 GP---------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL 467 (593)
T ss_pred CC---------------CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH
Confidence 32 122368999999999999999999999999999999999999999994 1 234456
Q ss_pred HHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC---ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCC
Q psy16843 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG---GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDE 662 (810)
Q Consensus 588 ~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~---~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~ 662 (810)
++-|+.+++..|.. +|..+..+++..|++||.+|++.. ++.++..|+||+.+||+.+.++. +||.|.+.++
T Consensus 468 fqvilekqiriprs----lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d 543 (593)
T KOG0695|consen 468 FQVILEKQIRIPRS----LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDD 543 (593)
T ss_pred HHHHhhhcccccce----eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccc
Confidence 77778888998876 778889999999999999999983 78999999999999999998765 7999999999
Q ss_pred ccCcccchHHhhhcCCCCCCCcccccccccCCcccc
Q psy16843 663 EDTSYFDSRMERYNHDIGEDTDETEDSFSLGTFSSC 698 (810)
Q Consensus 663 ~d~~~fd~~~~~~~~~~~~~~~e~~d~~~~~~f~~~ 698 (810)
.+..+||..+..--.++.-+.+++..-+.+..|..+
T Consensus 544 ~~l~~fd~qft~e~~qltpdd~d~i~ridqsefegf 579 (593)
T KOG0695|consen 544 YGLDNFDTQFTSEPVQLTPDDEDAIKRIDQSEFEGF 579 (593)
T ss_pred cCccccccccccCCcccCCCCHHHHHhcchhhcCcc
Confidence 999999988875544444444444444444444444
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=433.91 Aligned_cols=285 Identities=37% Similarity=0.731 Sum_probs=253.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|.++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999987654444445567889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~------- 153 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------- 153 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-------
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......+|..
T Consensus 154 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-- 220 (291)
T cd05612 154 -----------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH-- 220 (291)
T ss_pred -----------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCcc--
Confidence 1124579999999999999999999999999999999999999999999999999998888777754
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCC--CChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccch
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta--~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~ 670 (810)
.+..+++||++||+.||.+|++. ..++|++.||||..++|..+.... +++.|.+....++.+|++
T Consensus 221 --~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 289 (291)
T cd05612 221 --LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDD 289 (291)
T ss_pred --CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCccccccccC
Confidence 57899999999999999999973 135999999999999999876553 567888887788887764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=440.66 Aligned_cols=260 Identities=32% Similarity=0.597 Sum_probs=234.1
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
...+|.+.+.||.|+||+||+|+++.++..||||.|.+... ..+..+.+..|+.||+.++|||||.+++++++++.+||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 34789999999999999999999999999999999988765 34566788999999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC------CcEEEeccCCccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL------GHIKLTDFGLSKMGL 515 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~------g~VKL~DFGLAk~~~ 515 (810)
|||||.||||.++|++.+.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+...
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999875 358999999998643
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
.. ....+.||+|.|||||++..+.|+.|+|+||+|+|||+|++|++||...+..+++..+.++.
T Consensus 167 ~~----------------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~ 230 (429)
T KOG0595|consen 167 PG----------------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN 230 (429)
T ss_pred ch----------------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc
Confidence 21 11247899999999999999999999999999999999999999999999999999888876
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
...|.... ..+..+.+|+..+|+.+|.+|.+. .+.+.|++...
T Consensus 231 ~~~~~~~~-~~s~~~~~Ll~~ll~~~~~~~~~~---~~~~~~~~l~~ 273 (429)
T KOG0595|consen 231 EIVPVLPA-ELSNPLRELLISLLQRNPKDRISF---EDFFDHPFLAA 273 (429)
T ss_pred cccCchhh-hccCchhhhhhHHHhcCccccCch---HHhhhhhhccc
Confidence 65554433 256778899999999999999998 88999998754
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=446.71 Aligned_cols=305 Identities=45% Similarity=0.758 Sum_probs=253.8
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
.|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+..|+++++.++|||||+++++|.+++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999987665556667789999999999999999999999999999999999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++...........+.
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999975321110000000
Q ss_pred h--------------------------------hhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHH
Q psy16843 525 C--------------------------------YVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEF 572 (810)
Q Consensus 525 ~--------------------------------~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyEL 572 (810)
. ............+.+||+.|+|||++.+.+|+.++|||||||+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 0 00000001112346899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhh-c
Q psy16843 573 LVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLR-H 651 (810)
Q Consensus 573 LtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~-~ 651 (810)
++|++||.+.+..+...++.......+.+....+++++.+||.+|+ .+|.+|++..+++|++.||||.+++|..... .
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~ 320 (382)
T cd05625 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQ 320 (382)
T ss_pred HhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChHHHHhcC
Confidence 9999999999888887777764333322222347899999999986 5999999966679999999999999987544 4
Q ss_pred cCCcccCCCCCccCcccch
Q psy16843 652 KAEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 652 ~~~f~P~~~~~~d~~~fd~ 670 (810)
.+++.|.+....+..+|+.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~ 339 (382)
T cd05625 321 SAPYIPKITHPTDTSNFDP 339 (382)
T ss_pred CCCccCcCCCcchhhhcCC
Confidence 5688898888888888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=451.02 Aligned_cols=260 Identities=36% Similarity=0.624 Sum_probs=236.0
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH--HHHHHHHHHHHHHhcCC-CCeEEEeeeeccccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR--NQMEQVFAERDIMSFTD-NPFVVTMYCSFETKK 437 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~--~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~ 437 (810)
...+.|.+.+.||+|+||+|++|.+..++..||+|++.+...... ...+.+.+|+.+++.+. ||||+++++++.+..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345789999999999999999999999999999997766522211 34466778999999999 999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC-CcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL-GHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~-g~VKL~DFGLAk~~~~ 516 (810)
.+|+|||||.||+|++++.+.+++.|..++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||+++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999997531
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcC-C-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG-Y-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND 594 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~ 594 (810)
.......+.|||+.|+|||++.+.+ | +.++||||+||+||.|++|+.||.+.+...++.+|..+
T Consensus 173 --------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~ 238 (370)
T KOG0583|consen 173 --------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG 238 (370)
T ss_pred --------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC
Confidence 0112236789999999999999988 9 69999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcc-cHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 595 DIEWPSEDDWPI-QVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 595 ~~~~p~~~~~~~-S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.+.+|.. + |+++++||.+||..||.+|+++ .+|+.||||+.
T Consensus 239 ~~~~p~~----~~S~~~~~Li~~mL~~~P~~R~t~---~~i~~h~w~~~ 280 (370)
T KOG0583|consen 239 EFKIPSY----LLSPEARSLIEKMLVPDPSTRITL---LEILEHPWFQK 280 (370)
T ss_pred CccCCCC----cCCHHHHHHHHHHcCCCcccCCCH---HHHhhChhhcc
Confidence 9999875 4 8999999999999999999999 99999999986
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=445.81 Aligned_cols=302 Identities=42% Similarity=0.821 Sum_probs=249.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|.++.+++.||||++.+.........+.+..|+++++.++|||||+++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999987765555556678889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..........+
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998632211100000
Q ss_pred hhhhhcc--------------------------------cccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHH
Q psy16843 524 ECYVERD--------------------------------AKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE 571 (810)
Q Consensus 524 ~~~~~~~--------------------------------~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyE 571 (810)
....... .........+||+.|+|||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0000000 00000123579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHhhccC--CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhh
Q psy16843 572 FLVGCVPFFGETPEELFAHTVND--DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLL 649 (810)
Q Consensus 572 LLtG~~PF~~~~~~e~~~~I~~~--~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~ 649 (810)
|++|.+||.+.+..+.+..+... .+.+|.. ..++.++++||.+||. +|.+|++..++.|++.||||.+++|+.+.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~~ 317 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTIR 317 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHc
Confidence 99999999998888888877753 3344432 2367899999999997 88888755556999999999999999998
Q ss_pred hccCCcccCCCCCccCccc
Q psy16843 650 RHKAEFIPQLDDEEDTSYF 668 (810)
Q Consensus 650 ~~~~~f~P~~~~~~d~~~f 668 (810)
....+++|......+..+|
T Consensus 318 ~~~~~~~~~~~~~~~~~~~ 336 (377)
T cd05629 318 QIRAPFIPQLKSITDTSYF 336 (377)
T ss_pred cCCCCcccCCCCccccccC
Confidence 7778888877665555544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=458.65 Aligned_cols=292 Identities=36% Similarity=0.675 Sum_probs=271.2
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
......+++++..||-||||.|-+++.+.....+|+|+++|..+....+.+++..|.+||..+++|+||++|-.|.+.++
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 34556789999999999999999999887777799999999888888899999999999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|++||-|-||+|+..|..+|.|++..+++|++.+++|++|||++|||+|||||+|+||+.+|.+||.|||+|+....+.
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998754332
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC--CC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND--DI 596 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~--~~ 596 (810)
...++||||.|.|||++++++.+.++|+||||+++||||+|.+||.+.+++.++..|+++ .+
T Consensus 575 ----------------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i 638 (732)
T KOG0614|consen 575 ----------------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI 638 (732)
T ss_pred ----------------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh
Confidence 236899999999999999999999999999999999999999999999999999999985 56
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCC--CCChhHHhcCCCcCCCChhhhhhc--cCCcccCCCCCccCcccch
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLG--TGGPHEVKEHPYFSNLDWNSLLRH--KAEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpt--a~~~~EiL~HPfF~~id~~~l~~~--~~~f~P~~~~~~d~~~fd~ 670 (810)
.||.. ++..+.+||+++...+|.+|++ .+++.||.+|.||.++||+-|..+ .+|++|.+.+..|.+|||.
T Consensus 639 ~~Pr~----I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~ 712 (732)
T KOG0614|consen 639 EFPRR----ITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDN 712 (732)
T ss_pred hcccc----cchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccC
Confidence 67754 7789999999999999999999 478999999999999999998765 4789999999999999985
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=443.03 Aligned_cols=304 Identities=40% Similarity=0.761 Sum_probs=251.6
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|+++.+++.||||++.+...........+..|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987655444556678889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++..........+
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998753221111000
Q ss_pred hhhh-------------h-------cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC
Q psy16843 524 ECYV-------------E-------RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET 583 (810)
Q Consensus 524 ~~~~-------------~-------~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~ 583 (810)
.... . ...........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 0000 0 0000011234689999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCC--CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCC
Q psy16843 584 PEELFAHTVNDD--IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDD 661 (810)
Q Consensus 584 ~~e~~~~I~~~~--~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~ 661 (810)
..+.+.++.... +.+|.. .+++.++++||.+|+. ||.+|++..++.|++.||||.+++|..+.....+..+.+..
T Consensus 241 ~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~ 317 (360)
T cd05627 241 PQETYRKVMNWKETLVFPPE--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKS 317 (360)
T ss_pred HHHHHHHHHcCCCceecCCC--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCCCCccCCC
Confidence 998888887633 344432 3478999999999874 99999998778999999999999999987765544444555
Q ss_pred CccCcccch
Q psy16843 662 EEDTSYFDS 670 (810)
Q Consensus 662 ~~d~~~fd~ 670 (810)
..+.++|+.
T Consensus 318 ~~~~~~~~~ 326 (360)
T cd05627 318 IDDTSNFDE 326 (360)
T ss_pred cchhhhcCC
Confidence 566666653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=439.60 Aligned_cols=282 Identities=41% Similarity=0.799 Sum_probs=246.3
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCc
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGG 449 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GG 449 (810)
+.||+|+||.||+|+++.+|+.||||++.+...........+..|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999988765544556677889999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhc
Q psy16843 450 DCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVER 529 (810)
Q Consensus 450 sL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~ 529 (810)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------------ 148 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------------ 148 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC------------
Confidence 99999998889999999999999999999999999999999999999999999999999998642110
Q ss_pred ccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHH
Q psy16843 530 DAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVE 609 (810)
Q Consensus 530 ~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~e 609 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+....+..+..+...+|.. ++++
T Consensus 149 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~----~~~~ 221 (323)
T cd05571 149 ---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPE 221 (323)
T ss_pred ---CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC----CCHH
Confidence 011235679999999999999999999999999999999999999999999888888888887777654 6799
Q ss_pred HHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccch
Q psy16843 610 AKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 610 l~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~ 670 (810)
+.+||.+||++||++||+.. .+.++++||||.+++|..+.... +++.|......+..+|++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDE 286 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCc
Confidence 99999999999999999532 34999999999999999987654 456666666666666543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=437.85 Aligned_cols=285 Identities=40% Similarity=0.767 Sum_probs=249.4
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 34789999999999999999999999999999999877655444556778999999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~----- 170 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD----- 170 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-----
Confidence 999999999999999888999999999999999999999999999999999999999999999999999864211
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+..+.+.+|..
T Consensus 171 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~ 237 (329)
T PTZ00263 171 -------------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW 237 (329)
T ss_pred -------------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCC
Confidence 0124579999999999999999999999999999999999999999999999999988887776643
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCC--CChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCccc
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYF 668 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta--~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~f 668 (810)
++.++++||.+||+.||.+|+++ ..+++++.||||.+.+|..+.... +++.+......+..+|
T Consensus 238 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (329)
T PTZ00263 238 ----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNF 304 (329)
T ss_pred ----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcccchhc
Confidence 67899999999999999999985 346999999999999999887654 3344433333344444
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=430.76 Aligned_cols=282 Identities=38% Similarity=0.777 Sum_probs=248.8
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcch
Q psy16843 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDC 451 (810)
Q Consensus 372 LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL 451 (810)
||+|+||.||+|+++.+++.||+|++.+...........+..|+.+++.++||||+++++++.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999998766544455667788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhccc
Q psy16843 452 ASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531 (810)
Q Consensus 452 ~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~ 531 (810)
.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-------------- 146 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-------------- 146 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--------------
Confidence 999988889999999999999999999999999999999999999999999999999998642110
Q ss_pred ccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHH
Q psy16843 532 KQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAK 611 (810)
Q Consensus 532 ~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~ 611 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+..+......+|.. ++++++
T Consensus 147 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 221 (312)
T cd05585 147 -DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAK 221 (312)
T ss_pred -CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCc----CCHHHH
Confidence 011235679999999999999999999999999999999999999999999999999998887777654 678999
Q ss_pred HHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHH
Q psy16843 612 SIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRM 672 (810)
Q Consensus 612 dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~ 672 (810)
+||.+||..||.+||++..+.|++.||||.+.+|..+.... +++.|......+.+.|++..
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEF 284 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCccc
Confidence 99999999999999998778999999999999998876543 46777776666777776544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=436.06 Aligned_cols=288 Identities=38% Similarity=0.758 Sum_probs=252.5
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCC-cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETR-QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg-~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
....++|++.+.||+|+||.||+|.++.++ ..||+|.+.+.........+.+..|+.+++.++||||+++++++.+++.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 345678999999999999999999977655 6899999877655445566788899999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999864211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
.....+||+.|||||++.+..++.++|||||||++|||++|.+||.+.+...++..+..+...+
T Consensus 184 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~ 247 (340)
T PTZ00426 184 ----------------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF 247 (340)
T ss_pred ----------------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 1134579999999999999999999999999999999999999999999988899998887777
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCC--CChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccc
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFD 669 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta--~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd 669 (810)
|.. ++.++++||++||+.||.+|++. .+++|+++||||.+++|..+.... .++.|......+.++|+
T Consensus 248 p~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 318 (340)
T PTZ00426 248 PKF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFE 318 (340)
T ss_pred CCC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCCcchhhcC
Confidence 654 67899999999999999999853 245999999999999999887654 57788776665555554
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=440.42 Aligned_cols=301 Identities=42% Similarity=0.715 Sum_probs=247.5
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
.|++++.||+|+||+||+|+++.+++.||||++.+.........+.+..|+++++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 69999999999999999999999999999999987665556667789999999999999999999999999999999999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
|++||+|.+++.+.+.+++..++.+++||+.||+|||++||+||||||+||||+.+|++||+|||+++..........+.
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 99999999999988899999999999999999999999999999999999999999999999999986421110000000
Q ss_pred hh----------------------------hh----cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHH
Q psy16843 525 CY----------------------------VE----RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEF 572 (810)
Q Consensus 525 ~~----------------------------~~----~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyEL 572 (810)
.. .. .........+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 00 00 00000012356899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHhhccC--CCCCCCCCCCcccHHHHHHHHhhhcC--CCCCCCCCCChhHHhcCCCcCCCChhhh
Q psy16843 573 LVGCVPFFGETPEELFAHTVND--DIEWPSEDDWPIQVEAKSIITDLLQQ--NPRDRLGTGGPHEVKEHPYFSNLDWNSL 648 (810)
Q Consensus 573 LtG~~PF~~~~~~e~~~~I~~~--~~~~p~~~~~~~S~el~dLI~klL~~--dP~~Rpta~~~~EiL~HPfF~~id~~~l 648 (810)
++|..||.+.+..+....+... .+.+|. ...+++++++||.+||.. +|..|+++ .|+++||||.+++|...
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~---~~~l~hp~f~~~~~~~~ 316 (381)
T cd05626 242 LVGQPPFLAPTPTETQLKVINWENTLHIPP--QVKLSPEAVDLITKLCCSAEERLGRNGA---DDIKAHPFFSEVDFSSD 316 (381)
T ss_pred HhCCCCCcCCCHHHHHHHHHccccccCCCC--CCCCCHHHHHHHHHHccCcccccCCCCH---HHHhcCcccCCCChhHH
Confidence 9999999998887777776643 233333 234789999999997654 44458888 99999999999999886
Q ss_pred hhcc-CCcccCCCCCccCcccch
Q psy16843 649 LRHK-AEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 649 ~~~~-~~f~P~~~~~~d~~~fd~ 670 (810)
.... +++.|.+....+.++|+.
T Consensus 317 ~~~~~~~~~p~~~~~~~~~~~~~ 339 (381)
T cd05626 317 IRTQPAPYVPKISHPMDTSNFDP 339 (381)
T ss_pred hhcCCCCccCcCCCcchhhhcCC
Confidence 5443 578888877777777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=432.02 Aligned_cols=285 Identities=43% Similarity=0.765 Sum_probs=249.6
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|++++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999988765544455677889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-------
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC--CCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI--EWPSE 601 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~--~~p~~ 601 (810)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+..+..... ..|..
T Consensus 154 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 222 (333)
T cd05600 154 -----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY 222 (333)
T ss_pred -----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCC
Confidence 12356799999999999999999999999999999999999999999988888777664322 22221
Q ss_pred C--CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCccCcccc
Q psy16843 602 D--DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFD 669 (810)
Q Consensus 602 ~--~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d~~~fd 669 (810)
. ...++.++.+||.+||..+|.+|+++ .|+++||||.+++|..+....+++.|......+..+|+
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~---~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSL---EDIKNHPFFKEVDWNELRELKPPFVPELESEIDTGYFD 289 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCH---HHHHhCcccCCCCHHHHhhCCCCCCCCCCCcchhhhcc
Confidence 1 12367899999999999999999998 99999999999999998877788988877666655554
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-49 Score=426.16 Aligned_cols=289 Identities=37% Similarity=0.745 Sum_probs=250.4
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCC-eEEEeeeeccccceeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP-FVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HP-nIVkl~~~f~~~~~lyLVm 443 (810)
+|++++.||+|+||.||+|+++.+++.||||++.+.........+.+..|.+++..++|+ +|+.+++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999998876544445567788899999988765 6889999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~------ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG------ 154 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC------
Confidence 99999999999988889999999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+......+|..
T Consensus 155 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~-- 223 (324)
T cd05587 155 ---------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS-- 223 (324)
T ss_pred ---------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC--
Confidence 011234679999999999999999999999999999999999999999999999999988877766653
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHH
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRM 672 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~ 672 (810)
++.++.+||.+||.+||.+|++.+ ...++++||||..++|..+.... +++.|......+.++|+...
T Consensus 224 --~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (324)
T cd05587 224 --LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFF 294 (324)
T ss_pred --CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchhhhcCccc
Confidence 678999999999999999999873 35799999999999999886543 46777766666666666543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=437.58 Aligned_cols=305 Identities=44% Similarity=0.744 Sum_probs=248.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+++|+.++||||+++++.|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987665544555677889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...........+
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999997532110000000
Q ss_pred hh----------------------------hhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhC
Q psy16843 524 EC----------------------------YVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVG 575 (810)
Q Consensus 524 ~~----------------------------~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG 575 (810)
.. ..............+||+.|||||++.+..|+.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00 00000001112346899999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhh-hccCC
Q psy16843 576 CVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLL-RHKAE 654 (810)
Q Consensus 576 ~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~-~~~~~ 654 (810)
..||.+.+..+....+..............++.++.+||.+|+ .+|.+|++...+.|+++||||.+++|..+. ...++
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~~~~~~~~~ 319 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAP 319 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHHHHhhcCCCC
Confidence 9999999888877776654333322222347899999999977 599999955445999999999999999885 33467
Q ss_pred cccCCCCCccCcccc
Q psy16843 655 FIPQLDDEEDTSYFD 669 (810)
Q Consensus 655 f~P~~~~~~d~~~fd 669 (810)
+.|.+....+.++|+
T Consensus 320 ~~~~~~~~~~~~~~~ 334 (376)
T cd05598 320 YIPKITHPTDTSNFD 334 (376)
T ss_pred CCCcCCCcchhhhcC
Confidence 777776666666554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=424.68 Aligned_cols=289 Identities=37% Similarity=0.736 Sum_probs=248.6
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+|++++.||+|+||.||+|+++.+++.||||++.+.........+.+..|..++..+ .|++|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 689999999999999999999999999999998876544445556677788888776 5899999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~------ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD------ 154 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC------
Confidence 99999999999988889999999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+......+|..
T Consensus 155 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~-- 223 (323)
T cd05616 155 ---------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS-- 223 (323)
T ss_pred ---------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc--
Confidence 111235679999999999999999999999999999999999999999999999999998887777653
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHh
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRME 673 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~ 673 (810)
++.++.+||.+||++||.+|++.. ...++++||||+.++|..+.+.. +++.|.... .+..+++..+.
T Consensus 224 --~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 294 (323)
T cd05616 224 --MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACG-RDAENFDKFFT 294 (323)
T ss_pred --CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCC-chhhhcCchhc
Confidence 679999999999999999999973 46899999999999999987654 466665432 34444544333
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=427.54 Aligned_cols=283 Identities=38% Similarity=0.764 Sum_probs=248.0
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
+.||+|+||.||+|+++.+++.||+|++.+.........+.+..|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999998776544445566777888888765 799999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~----------- 149 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN----------- 149 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998642111
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccH
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~ 608 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+++..+....+.+|.. ++.
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----~~~ 221 (320)
T cd05590 150 ----GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW----LSQ 221 (320)
T ss_pred ----CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCC----CCH
Confidence 011234579999999999999999999999999999999999999999999999999998877766643 678
Q ss_pred HHHHHHHhhhcCCCCCCCCCC---ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchH
Q psy16843 609 EAKSIITDLLQQNPRDRLGTG---GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSR 671 (810)
Q Consensus 609 el~dLI~klL~~dP~~Rpta~---~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~ 671 (810)
++++||.+||++||.+|+++. +.++++.||||.+++|+.+.... +++.|......+.++|+..
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPD 289 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcc
Confidence 999999999999999999983 45899999999999999886543 5788888888888888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-49 Score=428.60 Aligned_cols=284 Identities=40% Similarity=0.784 Sum_probs=248.2
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCc
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGG 449 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GG 449 (810)
+.||+|+||.||+++++.+|+.||+|++.+...........+..|+++++.++||||+++++++.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555556678889999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhc
Q psy16843 450 DCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVER 529 (810)
Q Consensus 450 sL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~ 529 (810)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------------ 148 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------------ 148 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc------------
Confidence 99999988889999999999999999999999999999999999999999999999999998642111
Q ss_pred ccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHH
Q psy16843 530 DAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVE 609 (810)
Q Consensus 530 ~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~e 609 (810)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......+|.. ++.+
T Consensus 149 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~----~~~~ 221 (328)
T cd05593 149 ---AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT----LSAD 221 (328)
T ss_pred ---ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCC----CCHH
Confidence 001134579999999999999999999999999999999999999999998888888888777777654 6799
Q ss_pred HHHHHHhhhcCCCCCCCCC--CChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHH
Q psy16843 610 AKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRM 672 (810)
Q Consensus 610 l~dLI~klL~~dP~~Rpta--~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~ 672 (810)
+.+||.+||++||.+|++. ..+.|+++||||.+++|..+.... +++.|....+.+..+|+..+
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEF 288 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCccc
Confidence 9999999999999999853 235999999999999999886553 56777777777777776543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-49 Score=428.81 Aligned_cols=301 Identities=46% Similarity=0.834 Sum_probs=254.5
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|+++.+|+.||||++.+...........+..|++++..++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999988765544456677889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++...........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998754322100000
Q ss_pred h--------------hhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16843 524 E--------------CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589 (810)
Q Consensus 524 ~--------------~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~ 589 (810)
. ...............+||+.|+|||++.+..++.++|||||||+||||++|..||.+.+..+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 0 00000000112245679999999999999999999999999999999999999999999888888
Q ss_pred hhcc--CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCC-CCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCccCc
Q psy16843 590 HTVN--DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLG-TGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTS 666 (810)
Q Consensus 590 ~I~~--~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpt-a~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d~~ 666 (810)
++.. ....+|... .+++++++||.+||. ||.+|++ + +|+++||||.+++|+......+++.|.+....+..
T Consensus 241 ~i~~~~~~~~~p~~~--~~~~~~~~li~~ll~-dp~~R~~s~---~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (350)
T cd05573 241 KIINWKESLRFPPDP--PVSPEAIDLICRLLC-DPEDRLGSF---EEIKSHPFFKGIDWENLRETKPPFVPELSSPLDTS 314 (350)
T ss_pred HHhccCCcccCCCCC--CCCHHHHHHHHHHcc-ChhhcCCCH---HHHhcCCCcCCCCHHHHhhCCCCcCCCCCCchhhh
Confidence 8877 444555433 268999999999997 9999999 7 99999999999999998877888888877766666
Q ss_pred ccch
Q psy16843 667 YFDS 670 (810)
Q Consensus 667 ~fd~ 670 (810)
.|+.
T Consensus 315 ~~~~ 318 (350)
T cd05573 315 NFDD 318 (350)
T ss_pred hcCC
Confidence 6653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=424.96 Aligned_cols=282 Identities=37% Similarity=0.758 Sum_probs=242.9
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
+.||+|+||.||+|+++.+++.||+|++.+.........+.+..|.+++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999999999999999998876554455566777899988765 899999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~----------- 149 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN----------- 149 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998642111
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccH
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~ 608 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+..+......+|.. ++.
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~----~~~ 221 (321)
T cd05591 150 ----GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW----LSK 221 (321)
T ss_pred ----CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC----CCH
Confidence 011234679999999999999999999999999999999999999999999999999998887766643 678
Q ss_pred HHHHHHHhhhcCCCCCCCCCC----ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccch
Q psy16843 609 EAKSIITDLLQQNPRDRLGTG----GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 609 el~dLI~klL~~dP~~Rpta~----~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~ 670 (810)
++.+||.+||++||.+|++.. .++++++||||..++|..+.... +++.|......+...|+.
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQ 289 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhhcCC
Confidence 999999999999999999542 35899999999999999886544 456666555555555543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=421.87 Aligned_cols=283 Identities=38% Similarity=0.779 Sum_probs=242.2
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhc-CCCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF-TDNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~-l~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
+.||+|+||.||+|+++.+++.||+|++.+.........+.+..|..++.. .+||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999877554444445566667777764 5899999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~----------- 149 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----------- 149 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998642111
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccH
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~ 608 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+......+|.. ++.
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~----~~~ 221 (316)
T cd05592 150 ----EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRW----ISK 221 (316)
T ss_pred ----CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC----CCH
Confidence 011235679999999999999999999999999999999999999999999988888887765555533 678
Q ss_pred HHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHh
Q psy16843 609 EAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRME 673 (810)
Q Consensus 609 el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~ 673 (810)
++.+||.+||..||.+|+++. .+++.||||..++|..+.... +++.|......+..+|+..+.
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~--~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVD--GDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFT 286 (316)
T ss_pred HHHHHHHHHccCCHHHcCCCh--HHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccc
Confidence 999999999999999999872 589999999999999876543 467777766667777775544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=426.52 Aligned_cols=282 Identities=40% Similarity=0.788 Sum_probs=245.9
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCc
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGG 449 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GG 449 (810)
+.||+|+||.||+++++.+|+.||+|++.+...........+..|+++++.++||||++++++|...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999988765544555677888999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhc
Q psy16843 450 DCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVER 529 (810)
Q Consensus 450 sL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~ 529 (810)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~------------ 148 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD------------ 148 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC------------
Confidence 99999988889999999999999999999999999999999999999999999999999998642111
Q ss_pred ccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHH
Q psy16843 530 DAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVE 609 (810)
Q Consensus 530 ~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~e 609 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+..+......+|.. ++++
T Consensus 149 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~----~~~~ 221 (323)
T cd05595 149 ---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPE 221 (323)
T ss_pred ---CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCC----CCHH
Confidence 011134579999999999999999999999999999999999999999999888888888777777653 6799
Q ss_pred HHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccch
Q psy16843 610 AKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 610 l~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~ 670 (810)
+++||.+||++||.+|++.. .+.++++||||.+++|..+.... +++.|....+.+..+|+.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDD 286 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCc
Confidence 99999999999999999542 45999999999999999887654 567776666666666653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=420.73 Aligned_cols=291 Identities=37% Similarity=0.742 Sum_probs=249.3
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhc-CCCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF-TDNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~-l~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
+.||+|+||.||+|+++.+++.||||++.+.........+....|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999877544333444566778888875 5999999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~----------- 149 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----------- 149 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-----------
Confidence 999999988888999999999999999999999999999999999999999999999999998642110
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccH
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~ 608 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+......+|.. ++.
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~----~~~ 221 (316)
T cd05619 150 ----DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRW----LTR 221 (316)
T ss_pred ----CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc----CCH
Confidence 001134579999999999999999999999999999999999999999999888888877665554432 678
Q ss_pred HHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhc--cCCcccCCCCCccCcccchHHhhhcCCCCC
Q psy16843 609 EAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRH--KAEFIPQLDDEEDTSYFDSRMERYNHDIGE 681 (810)
Q Consensus 609 el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~--~~~f~P~~~~~~d~~~fd~~~~~~~~~~~~ 681 (810)
++++||.+||++||.+|+++. .+++.||||.+++|..+... .+++.|......+.++|+.........++.
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~--~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVK--GDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSV 294 (316)
T ss_pred HHHHHHHHHhccCHhhcCCCh--HHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChhhhcCCcccCC
Confidence 999999999999999999983 48999999999999987654 367888888888899998877665555543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=424.56 Aligned_cols=285 Identities=39% Similarity=0.780 Sum_probs=248.1
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCc
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGG 449 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GG 449 (810)
+.||+|+||.||+++++.+|+.||+|++.+...........+..|++++..++||||+++++++.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999988765544555667788999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 450 DCASLLKNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 450 sL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
+|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~----------- 149 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD----------- 149 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-----------
Confidence 999999888899999999999999999999997 79999999999999999999999999998642111
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccH
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~ 608 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....+....+.+|.. +++
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~----~~~ 221 (325)
T cd05594 150 ----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSP 221 (325)
T ss_pred ----CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCC----CCH
Confidence 001134579999999999999999999999999999999999999999999888888888877777654 679
Q ss_pred HHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHh
Q psy16843 609 EAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRME 673 (810)
Q Consensus 609 el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~ 673 (810)
++.+||.+||++||.+|++.. .+.++++||||.++.|....... +++.|....+.+..+|+..+.
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFT 290 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCchhh
Confidence 999999999999999998431 34999999999999999887554 567777777777788876544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=421.60 Aligned_cols=284 Identities=38% Similarity=0.706 Sum_probs=242.6
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
+.||+|+||.||+|+++.+++.||+|++.+.........+.+..|+.++..+ +||||+.+++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555667788999998877 699999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~----------- 149 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP----------- 149 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998642110
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC-------CHHHHHHhhccCCCCCCCC
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE-------TPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~-------~~~e~~~~I~~~~~~~p~~ 601 (810)
.......+||+.|+|||++.+..|+.++|||||||+||||++|..||... ........+......+|..
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 225 (327)
T cd05617 150 ----GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF 225 (327)
T ss_pred ----CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCC
Confidence 01113467999999999999999999999999999999999999999532 2344555666666665543
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCC---ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHH
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTG---GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRM 672 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~---~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~ 672 (810)
++..+.++|.+||++||.+|+++. ++++++.||||..++|+.+.... +++.|...+..+.++|+..+
T Consensus 226 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (327)
T cd05617 226 ----LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFDTQF 297 (327)
T ss_pred ----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCCcchhhcCCcc
Confidence 678999999999999999999973 56899999999999999887554 56888877777777776543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-51 Score=413.26 Aligned_cols=263 Identities=33% Similarity=0.513 Sum_probs=239.8
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..+.|++.+.||+|.|+.|+++.++.+|+.||+|+|........ ..+.+.+|+.|-+.++|||||+|++.+...+..||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 34789999999999999999999999999999998876655443 56889999999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC---CcEEEeccCCcccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL---GHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~---g~VKL~DFGLAk~~~~s~ 518 (810)
|+|+|.||+|..-|-.+-.++|..+..+++||+.||.|||.+||||||+||+|+|+.+. .-+||+|||+|.....
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~-- 165 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND-- 165 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC--
Confidence 99999999998887766789999999999999999999999999999999999999753 3599999999975331
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
......++|||.|||||++...+|+..+|||+.|||||-|+.|++||++++...+++.|+.+.+.+
T Consensus 166 --------------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~ 231 (355)
T KOG0033|consen 166 --------------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDY 231 (355)
T ss_pred --------------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCC
Confidence 111245789999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
+.+.+..+++++++||++||..||.+|+|+ .|+|+|||+.+-+
T Consensus 232 ~~~~w~~is~~Ak~LvrrML~~dP~kRIta---~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 232 PSPEWDTVTPEAKSLIRRMLTVNPKKRITA---DEALKHPWICNRE 274 (355)
T ss_pred CCcccCcCCHHHHHHHHHHhccChhhhccH---HHHhCCchhcchH
Confidence 998888899999999999999999999999 9999999997743
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=420.16 Aligned_cols=282 Identities=37% Similarity=0.746 Sum_probs=241.1
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhc-CCCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF-TDNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~-l~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
+.||+|+||.||+|+++.+|+.||+|++.+.........+....|..++.. .+||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999877544333445667778888765 5999999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----------- 149 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----------- 149 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998632110
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccH
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~ 608 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+......+|.. ++.
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----~~~ 221 (316)
T cd05620 150 ----DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRW----ITK 221 (316)
T ss_pred ----CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC----CCH
Confidence 011234679999999999999999999999999999999999999999999888888887766555542 678
Q ss_pred HHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHH
Q psy16843 609 EAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRM 672 (810)
Q Consensus 609 el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~ 672 (810)
++++||.+||..||.+|+++. +++++||||..++|..+.... +++.|......+.++|+...
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~--~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVV--GNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREF 285 (316)
T ss_pred HHHHHHHHHccCCHHHcCCCh--HHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccc
Confidence 999999999999999999982 589999999999999876543 56777776666666666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=413.50 Aligned_cols=274 Identities=33% Similarity=0.566 Sum_probs=231.9
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
.|++++.||+|+||.||+|.++.+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999876654444444567889999999999999999999999999999999
Q ss_pred eccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 445 YVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 445 y~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|++||+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-----
Confidence 99999999887543 46999999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH----HHHHhhccCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE----ELFAHTVNDDIEW 598 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~----e~~~~I~~~~~~~ 598 (810)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.... .+...+......+
T Consensus 156 -----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
T cd05631 156 -----------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY 224 (285)
T ss_pred -----------CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccC
Confidence 0112457999999999999999999999999999999999999999876542 2333333333333
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhc--cCCcccC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRH--KAEFIPQ 658 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~--~~~f~P~ 658 (810)
+. .++.++.+||.+||+.||.+||++. +++++++||||.+++|+.+... +++|.|.
T Consensus 225 ~~----~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 225 SE----KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred Cc----cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence 32 2678999999999999999999852 4699999999999999999877 4678774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-48 Score=418.94 Aligned_cols=287 Identities=36% Similarity=0.735 Sum_probs=247.4
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccceeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~~lyLVm 443 (810)
+|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999988765444455667788899988775 578889999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~------ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD------ 154 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC------
Confidence 99999999999998889999999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+++..+......+|..
T Consensus 155 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~-- 223 (323)
T cd05615 155 ---------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS-- 223 (323)
T ss_pred ---------CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc--
Confidence 111235679999999999999999999999999999999999999999999999999988877776653
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchH
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSR 671 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~ 671 (810)
++.++.+||.+||++||.+|++.. ..+++++||||..++|..+.... +++.|..... ...+|+..
T Consensus 224 --~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 292 (323)
T cd05615 224 --LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKF 292 (323)
T ss_pred --CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCCC-chhhcCcc
Confidence 678999999999999999999974 46899999999999999887653 5677765443 34445443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=421.97 Aligned_cols=284 Identities=37% Similarity=0.728 Sum_probs=239.1
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
+.||+|+||.||+|+++.+++.||+|++.+.........+.+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876544445567788899999888 799999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----------- 149 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP----------- 149 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998642110
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC---------CHHHHHHhhccCCCCCC
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE---------TPEELFAHTVNDDIEWP 599 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~---------~~~e~~~~I~~~~~~~p 599 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||... ........+....+.+|
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p 225 (329)
T cd05588 150 ----GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP 225 (329)
T ss_pred ----CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC
Confidence 01123467999999999999999999999999999999999999999531 22334555666666666
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCC---ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHH
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTG---GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRM 672 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~---~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~ 672 (810)
.. ++.++.+||.+||++||.+|+++. ++.++++||||..++|..+.... +++.|......+..+|+..+
T Consensus 226 ~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (329)
T cd05588 226 RS----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDPQF 299 (329)
T ss_pred CC----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCcchhhhcCCcc
Confidence 43 678999999999999999999862 46899999999999999886543 45667666655656665443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=439.47 Aligned_cols=255 Identities=35% Similarity=0.572 Sum_probs=236.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|.+.+.||+|+||.||+|+.|.+.+.||||.+.|... ..++++.+.+|++|++.++|||||.++++|++..++|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 689999999999999999999999999999999987653 4567788999999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
|||.| +|+.+|...+.++|+.++.++.+++.||.|||+++|+|||+||.||||+..|++|+||||+|+....
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~------- 152 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST------- 152 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-------
Confidence 99987 9999999999999999999999999999999999999999999999999999999999999986321
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
+.....++.|||.|||||++.+++|+..+|+||||||+|||+.|++||+.....++...|..++..||..
T Consensus 153 --------~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~-- 222 (808)
T KOG0597|consen 153 --------NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPST-- 222 (808)
T ss_pred --------CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCccc--
Confidence 1112246679999999999999999999999999999999999999999999999999999999999874
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+|.++++|++.+|.+||.+|++- .+++.|||.++
T Consensus 223 --~S~~f~nfl~gLL~kdP~~RltW---~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 223 --ASSSFVNFLQGLLIKDPAQRLTW---TDLLGHPFWKG 256 (808)
T ss_pred --ccHHHHHHHHHHhhcChhhcccH---HHHhcChHHhh
Confidence 78999999999999999999987 89999999865
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=422.83 Aligned_cols=286 Identities=40% Similarity=0.723 Sum_probs=245.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+..|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544455677889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~----- 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN----- 155 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC-----
Confidence 999999999999876 68999999999999999999999999999999999999999999999999998653211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHh------hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVIL------RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD- 595 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~------~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~- 595 (810)
........+||+.|+|||++. +..|+.++|||||||++|||++|..||.+.+..+.+.++....
T Consensus 156 ---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~ 226 (330)
T cd05601 156 ---------KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR 226 (330)
T ss_pred ---------CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC
Confidence 001112347999999999997 4568899999999999999999999999988888888776543
Q ss_pred -CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCccCcccc
Q psy16843 596 -IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFD 669 (810)
Q Consensus 596 -~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d~~~fd 669 (810)
..+|.. ..++.++.+||.+||+ +|.+||++ .+++.||||..++|..+....+++.|.+....+.++|+
T Consensus 227 ~~~~~~~--~~~~~~~~~li~~ll~-~p~~R~t~---~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (330)
T cd05601 227 FLKFPED--PKVSSDFLDLIQSLLC-GQKERLGY---EGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNFD 295 (330)
T ss_pred ccCCCCC--CCCCHHHHHHHHHHcc-ChhhCCCH---HHHhCCCCcCCCCHHHHhhCCCCccCcCCCcchhhhcC
Confidence 333432 2367899999999998 99999999 89999999999999998877777877776665555543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=419.13 Aligned_cols=286 Identities=39% Similarity=0.777 Sum_probs=245.6
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHH---hcCCCCeEEEeeeeccccceeeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM---SFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL---~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
|++++.||+|+||.||+|.++.+++.||||++.+.........+.+..|++++ +.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999998776544444556677777665 567899999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||++||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~----- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF----- 154 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-----
Confidence 999999999988865 57999999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~ 602 (810)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......+|..
T Consensus 155 ----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~- 223 (324)
T cd05589 155 ----------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF- 223 (324)
T ss_pred ----------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC-
Confidence 011235679999999999999999999999999999999999999999999999988888877766643
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchH
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSR 671 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~ 671 (810)
++.++.+||.+||+.||.+||+.+ .+.++++||||.+++|..+.... +++.|......|.++|+..
T Consensus 224 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 293 (324)
T cd05589 224 ---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEE 293 (324)
T ss_pred ---CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcchhhhcCcc
Confidence 678999999999999999999753 46999999999999999876543 5677777666666666543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=426.88 Aligned_cols=269 Identities=34% Similarity=0.598 Sum_probs=230.0
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH-----------HHHHHHHHHHHHHhcCCCCeEE
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR-----------NQMEQVFAERDIMSFTDNPFVV 427 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~-----------~~~~~i~~E~~iL~~l~HPnIV 427 (810)
.....++|++++.||+|.||+|.+|++..+++.||||++.|...... ..++++.+|+.||+++.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 34456899999999999999999999999999999999977544322 1236789999999999999999
Q ss_pred Eeeeecccc--ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEE
Q psy16843 428 TMYCSFETK--KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 505 (810)
Q Consensus 428 kl~~~f~~~--~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL 505 (810)
+|+++..+. +++|||+|||..|.+...=.....+++.++++|++.++.||+|||.+|||||||||+|+||+.+|+|||
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 999999875 589999999999887654443333999999999999999999999999999999999999999999999
Q ss_pred eccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc---CC-CCCcchhhhHHHHHHHHhCCCCCCC
Q psy16843 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ---GY-GKPVDWWSMGVILYEFLVGCVPFFG 581 (810)
Q Consensus 506 ~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~---~y-s~ksDIWSLGvILyELLtG~~PF~~ 581 (810)
+|||.+.....+.... ....+ ...+|||.|||||.+.+. .| +.+.||||+||+||.|+.|+.||.+
T Consensus 252 sDFGVs~~~~~~~~~~--------~d~~L--~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEG--------SDDQL--SRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred eccceeeecccCCccc--------cHHHH--hhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 9999987533221111 01111 226899999999999873 34 8899999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 582 ETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 582 ~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
....+++.+|++..+.+|.... +.++++|||.+||++||++|++. .+|+.|||...
T Consensus 322 ~~~~~l~~KIvn~pL~fP~~pe--~~e~~kDli~~lL~KdP~~Ri~l---~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 322 DFELELFDKIVNDPLEFPENPE--INEDLKDLIKRLLEKDPEQRITL---PDIKLHPWVTR 377 (576)
T ss_pred chHHHHHHHHhcCcccCCCccc--ccHHHHHHHHHHhhcChhheeeh---hhheecceecc
Confidence 9999999999999999997653 67999999999999999999999 89999999754
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=419.90 Aligned_cols=280 Identities=37% Similarity=0.732 Sum_probs=239.4
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHH-HHhcCCCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERD-IMSFTDNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~-iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
+.||+|+||+||+|+++.+|+.||+|++.+.........+.+..|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999987765444444455666655 46789999999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~----------- 149 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH----------- 149 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-----------
Confidence 999999998889999999999999999999999999999999999999999999999999998642111
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccH
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~ 608 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+.......+.. ++.
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~----~~~ 221 (323)
T cd05575 150 ----SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN----ISV 221 (323)
T ss_pred ----CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC----CCH
Confidence 011234579999999999999999999999999999999999999999999999999888877666543 578
Q ss_pred HHHHHHHhhhcCCCCCCCCCC-ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCccc
Q psy16843 609 EAKSIITDLLQQNPRDRLGTG-GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYF 668 (810)
Q Consensus 609 el~dLI~klL~~dP~~Rpta~-~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~f 668 (810)
++.+||.+||++||.+||++. .+.|++.||||..++|..+.... +++.|......+...|
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHF 284 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhc
Confidence 999999999999999999984 56799999999999999887654 4566655444443333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-48 Score=427.45 Aligned_cols=289 Identities=40% Similarity=0.725 Sum_probs=245.5
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+..|+.+++.++||||+++++++.+++.+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999999999999999987655444445566788999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+||||++||+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~--- 195 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN--- 195 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC---
Confidence 99999999999999875 46899999999999999999999999999999999999999999999999998642110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhc----CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ----GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD- 595 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~----~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~- 595 (810)
........+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+....+.++....
T Consensus 196 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 264 (370)
T cd05596 196 -----------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN 264 (370)
T ss_pred -----------CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC
Confidence 01112356799999999999764 37999999999999999999999999999888888887654
Q ss_pred -CCCCCCCCCcccHHHHHHHHhhhcCCCCC--CCCCCChhHHhcCCCcCCCChhhh--hhccCCcccCCCCCccCcccc
Q psy16843 596 -IEWPSEDDWPIQVEAKSIITDLLQQNPRD--RLGTGGPHEVKEHPYFSNLDWNSL--LRHKAEFIPQLDDEEDTSYFD 669 (810)
Q Consensus 596 -~~~p~~~~~~~S~el~dLI~klL~~dP~~--Rpta~~~~EiL~HPfF~~id~~~l--~~~~~~f~P~~~~~~d~~~fd 669 (810)
+.+|. ...++.++++||.+||+.+|.+ |+++ +|+++||||.+.+|... ....+++.|......+..+|+
T Consensus 265 ~~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~---~ell~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 338 (370)
T cd05596 265 SLTFPD--DIEISKQAKDLICAFLTDREVRLGRNGV---DEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFD 338 (370)
T ss_pred cCCCCC--cCCCCHHHHHHHHHHccChhhccCCCCH---HHHhcCcccCCCChhhHHhcCCCcCccCcCCCcchhhhcC
Confidence 34443 2347899999999999999987 8887 99999999999887643 344467888877766666665
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=416.01 Aligned_cols=285 Identities=39% Similarity=0.787 Sum_probs=247.4
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
+.||+|+||.||+|+++.+++.||||++.+...........+..|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999998876544445566778898998877 799999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~----------- 149 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG----------- 149 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-----------
Confidence 999999998889999999999999999999999999999999999999999999999999998642111
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccH
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~ 608 (810)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.+..+......+|.. ++.
T Consensus 150 ----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~----~~~ 221 (318)
T cd05570 150 ----GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW----LSK 221 (318)
T ss_pred ----CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc----CCH
Confidence 011234579999999999999999999999999999999999999999999988888888877766643 678
Q ss_pred HHHHHHHhhhcCCCCCCCCC--CChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHh
Q psy16843 609 EAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRME 673 (810)
Q Consensus 609 el~dLI~klL~~dP~~Rpta--~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~ 673 (810)
++.+||++||++||.+||++ ....+++.||||..++|..+.... +++.|......+.++|+..+.
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFT 290 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCchhc
Confidence 99999999999999999998 335899999999999998776543 567777777777777776543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=418.58 Aligned_cols=282 Identities=38% Similarity=0.722 Sum_probs=237.3
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
+.||+|+||.||+|+++.+++.||+|++.+.........+.+..|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876544445566788888888765 899999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~----------- 149 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP----------- 149 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998642110
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCC---------CCHHHHHHhhccCCCCCC
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG---------ETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~---------~~~~e~~~~I~~~~~~~p 599 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.. .....+...+......+|
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p 225 (329)
T cd05618 150 ----GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 225 (329)
T ss_pred ----CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC
Confidence 0112346799999999999999999999999999999999999999952 122335555666666666
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCC---ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccch
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTG---GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~---~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~ 670 (810)
.. ++.++.+||.+||++||.+|+++. ++.++++||||.+++|..+.... +++.|......+..+|++
T Consensus 226 ~~----~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (329)
T cd05618 226 RS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFDA 297 (329)
T ss_pred CC----CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCcccchhcCc
Confidence 53 678999999999999999999962 46899999999999998776543 567776666555556654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=408.97 Aligned_cols=260 Identities=27% Similarity=0.472 Sum_probs=220.4
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+.|+.+.++|+|+||.||++++++||+.||||++..... ...-.+-.++|+++|++++|||+|.++++|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 579999999999999999999999999999998865443 2233356789999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
|||+..-|.++-..-..++++.++.|+.|++.|+.|||+++|||||||||||||+.+|.+||||||+|+.... ....|
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~Y 158 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNY 158 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccchh
Confidence 9998765555544556799999999999999999999999999999999999999999999999999986432 22233
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC--------
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND-------- 594 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~-------- 594 (810)
. ..+.|.||.|||.+.| ..|+..+||||+||++.||++|.+.|.|.+..+.+..|...
T Consensus 159 T-------------DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh 225 (396)
T KOG0593|consen 159 T-------------DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH 225 (396)
T ss_pred h-------------hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH
Confidence 2 3467999999999998 78999999999999999999999999999887766665531
Q ss_pred -----------CCCCCCCCC--------CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 595 -----------DIEWPSEDD--------WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 595 -----------~~~~p~~~~--------~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.+.+|.... ..++.-+.||+++||..||.+|++. +|++.||||.+
T Consensus 226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc---~qll~H~yFd~ 289 (396)
T KOG0593|consen 226 QSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSC---EQLLHHPYFDG 289 (396)
T ss_pred HHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccH---HHHhcChHHHH
Confidence 123333222 1256678999999999999999999 99999999954
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=425.64 Aligned_cols=289 Identities=40% Similarity=0.781 Sum_probs=241.9
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999987655444445567888999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~--- 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET--- 195 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC---
Confidence 99999999999999975 46899999999999999999999999999999999999999999999999998752110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcC----CCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG----YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD- 595 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~----ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~- 595 (810)
........+||+.|||||++.+.+ |+.++|||||||+||||++|..||.+.+....+.++....
T Consensus 196 -----------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~ 264 (370)
T cd05621 196 -----------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN 264 (370)
T ss_pred -----------CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Confidence 011123567999999999998653 7899999999999999999999999999888888887644
Q ss_pred -CCCCCCCCCcccHHHHHHHHhhhcCCCCC--CCCCCChhHHhcCCCcCCCCh--hhhhhccCCcccCCCCCccCcccc
Q psy16843 596 -IEWPSEDDWPIQVEAKSIITDLLQQNPRD--RLGTGGPHEVKEHPYFSNLDW--NSLLRHKAEFIPQLDDEEDTSYFD 669 (810)
Q Consensus 596 -~~~p~~~~~~~S~el~dLI~klL~~dP~~--Rpta~~~~EiL~HPfF~~id~--~~l~~~~~~f~P~~~~~~d~~~fd 669 (810)
+.+|. ...++..+++||.+||+.++.+ |+++ .|+++||||+..+| ..+....+++.|.+....+.++|+
T Consensus 265 ~~~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~---~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 338 (370)
T cd05621 265 SLNFPE--DVEISKHAKNLICAFLTDREVRLGRNGV---EEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFD 338 (370)
T ss_pred ccCCCC--cccCCHHHHHHHHHHccCchhccCCCCH---HHHhcCcccCCCCcChHhcCCCCCCcCCCCCCcchhhhcC
Confidence 34443 2347899999999999854433 6666 99999999998655 444444567888877776666665
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=411.91 Aligned_cols=250 Identities=29% Similarity=0.479 Sum_probs=220.2
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeee-eccccce-
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYC-SFETKKH- 438 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~-~f~~~~~- 438 (810)
....+|+++++||.|+||.||++++..+|+.+|.|.|.-.. ...+..+.+..|+.+|++++|||||++|+ .|.++..
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 34578999999999999999999999999999999998544 44556678999999999999999999998 6666555
Q ss_pred eeeeeeeccCcchhhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhh--cc--cccccCCCCceEeccCCcEEEeccCC
Q psy16843 439 LCLVMEYVEGGDCASLLK----NTGPLPADMARFYFAETVLAVEYLHS--YG--IVHRDLKPDNLLITALGHIKLTDFGL 510 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~----~~g~lse~~~~~i~~QIl~AL~yLHs--~g--IIHRDLKPeNILLd~~g~VKL~DFGL 510 (810)
++||||||.+|||..+|+ .+..++|..+++|+.|++.||++||+ .. |+||||||.||+|+.+|.|||+||||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 999999999999999996 34579999999999999999999999 44 99999999999999999999999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~ 590 (810)
++..... .....+.+|||.||+||++.+.+|+.++||||+||++|||..-.+||+|.+-.++..+
T Consensus 175 ~r~l~s~---------------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~K 239 (375)
T KOG0591|consen 175 GRFLSSK---------------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKK 239 (375)
T ss_pred HhHhcch---------------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHH
Confidence 9864321 1112468999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 591 I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
|.++.+. +..+..+|.++..||.-|+..||..||+.
T Consensus 240 I~qgd~~--~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 240 IEQGDYP--PLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHcCCCC--CCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 9998664 22223488999999999999999999985
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=407.60 Aligned_cols=305 Identities=75% Similarity=1.317 Sum_probs=263.2
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||++.++.+++.||+|.+.+.........+.+..|+++++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987765444455677889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++..........+
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998754333322222
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
.................|+..|+|||.+.+..++.++|+|||||++|||++|..||.+.+..+.+..+....+.+|....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence 11111111222223457899999999999989999999999999999999999999999988888888777666555432
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCccCcccc
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFD 669 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d~~~fd 669 (810)
.++.++.+||.+||++||++||+...+.++++||||...+|..+.+.+..++|.++...+.+|||
T Consensus 241 -~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (305)
T cd05609 241 -ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESEDDTSYFD 305 (305)
T ss_pred -cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCCCCCCCccccccCC
Confidence 46789999999999999999999877899999999999999999988889999998888888875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=417.13 Aligned_cols=281 Identities=37% Similarity=0.716 Sum_probs=239.6
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHH-HHhcCCCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERD-IMSFTDNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~-iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
+.||+|+||+||+|+++.+|+.||+|++.+...........+..|.. +++.++||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999987654433344455566655 46789999999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~----------- 149 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ----------- 149 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998642111
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccH
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~ 608 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+......++.. .+.
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~ 221 (325)
T cd05604 150 ----SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPG----ASL 221 (325)
T ss_pred ----CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCC----CCH
Confidence 011235679999999999999999999999999999999999999999999999988888776655442 678
Q ss_pred HHHHHHHhhhcCCCCCCCCCC-ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccc
Q psy16843 609 EAKSIITDLLQQNPRDRLGTG-GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFD 669 (810)
Q Consensus 609 el~dLI~klL~~dP~~Rpta~-~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd 669 (810)
++.++|.+||++||.+||++. .+.+++.||||..++|..+.... +++.|......+.++|+
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFD 285 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcC
Confidence 999999999999999999984 56799999999999999887654 45666555555555544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=416.79 Aligned_cols=257 Identities=30% Similarity=0.572 Sum_probs=239.3
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
..+|++.+.||+|.||+|.++.....|+.||||.|.|+.+....++-++.+|++||..++||||+.+|++|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 36899999999999999999999999999999999999988888889999999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||..||+|++|+.+.+.++|.+++.+++||+.|+.|||+++++|||||.+|||||.++++||+||||+.....
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~------ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD------ 205 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999864211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
...-.++||+|-|.+||++.|.+| ++.+|-|||||+||-|++|..||.|.+...+..+|..+.+.-|..
T Consensus 206 ----------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~ 275 (668)
T KOG0611|consen 206 ----------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET 275 (668)
T ss_pred ----------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC
Confidence 111257999999999999999999 999999999999999999999999999999999999998877653
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
+.++..||++||..||++|.|+ ++|..|-|. +|.
T Consensus 276 -----PSdA~gLIRwmLmVNP~RRATi---eDiAsHWWv---Nwg 309 (668)
T KOG0611|consen 276 -----PSDASGLIRWMLMVNPERRATI---EDIASHWWV---NWG 309 (668)
T ss_pred -----CchHHHHHHHHHhcCcccchhH---HHHhhhhee---ecc
Confidence 3678999999999999999998 999999996 565
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=421.09 Aligned_cols=291 Identities=42% Similarity=0.770 Sum_probs=243.6
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34589999999999999999999999999999999987655444455567888999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~--- 195 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--- 195 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC---
Confidence 99999999999999876 46899999999999999999999999999999999999999999999999998753211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcC----CCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG----YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD- 595 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~----ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~- 595 (810)
........+||+.|||||++.+.. |+.++|||||||++|||++|.+||.+.+....+.++....
T Consensus 196 -----------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 264 (371)
T cd05622 196 -----------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 264 (371)
T ss_pred -----------CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 011123567999999999998643 7899999999999999999999999999988888887654
Q ss_pred -CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC--hhhhhhccCCcccCCCCCccCcccc
Q psy16843 596 -IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD--WNSLLRHKAEFIPQLDDEEDTSYFD 669 (810)
Q Consensus 596 -~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id--~~~l~~~~~~f~P~~~~~~d~~~fd 669 (810)
+.+|.. ..++.++++||.+||. +|..|++..+++|+++||||.+.+ |..+....+++.|.+....+.++|+
T Consensus 265 ~~~~~~~--~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (371)
T cd05622 265 SLTFPDD--NDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFD 338 (371)
T ss_pred cccCCCc--CCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcCcccCCCChhHHhcCCCCCCCCCCCCCcchhhhcC
Confidence 334432 3478999999999998 677666555569999999999865 4555555567888776666666554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=412.73 Aligned_cols=288 Identities=37% Similarity=0.717 Sum_probs=241.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+++++.+++.||+|++.+...........+..|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987655444455566888999999999999999999999999999999
Q ss_pred eeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~----- 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED----- 155 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-----
Confidence 99999999999976 467999999999999999999999999999999999999999999999999998642111
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHh-----hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-----~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
........+||+.|+|||++. ...|+.++|||||||++|||++|+.||.+.+..+.+.++......
T Consensus 156 ---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~ 226 (332)
T cd05623 156 ---------GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 226 (332)
T ss_pred ---------CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc
Confidence 011123457999999999997 346899999999999999999999999999999988888765433
Q ss_pred --CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCccCcc
Q psy16843 598 --WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSY 667 (810)
Q Consensus 598 --~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d~~~ 667 (810)
+|.. ...++.++++||.+||..++ +|++..+++|+++||||.+++|+.+.....+++|......+.+.
T Consensus 227 ~~~p~~-~~~~s~~~~~li~~ll~~~~-~r~~r~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (332)
T cd05623 227 FQFPAQ-VTDVSEDAKDLIRRLICSRE-HRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSN 296 (332)
T ss_pred ccCCCc-cccCCHHHHHHHHHHccChh-hhcCCCCHHHHhCCCCcCCCCHHHHhhCCCCccCCCCCCccccc
Confidence 3322 12368999999999997644 44443345999999999999999998777777776554444443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=414.38 Aligned_cols=280 Identities=36% Similarity=0.706 Sum_probs=236.3
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHH-HHhcCCCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERD-IMSFTDNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~-iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
+.||+|+||.||+|+++.+++.||+|++.+...........+..|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999987654433333344555544 56889999999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|.+++...+.+.+..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~----------- 149 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH----------- 149 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-----------
Confidence 999999998889999999999999999999999999999999999999999999999999998642110
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccH
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~ 608 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..+......++. .++.
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~ 221 (325)
T cd05602 150 ----NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITN 221 (325)
T ss_pred ----CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCC----CCCH
Confidence 01123567999999999999999999999999999999999999999999999988888877665543 2678
Q ss_pred HHHHHHHhhhcCCCCCCCCCC-ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCccc
Q psy16843 609 EAKSIITDLLQQNPRDRLGTG-GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYF 668 (810)
Q Consensus 609 el~dLI~klL~~dP~~Rpta~-~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~f 668 (810)
++.+||.+||++||.+|+++. .+.++++|+||..++|..+.... +++.|......+...|
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHF 284 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhc
Confidence 999999999999999999984 46799999999999999987543 3455554444333333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=416.39 Aligned_cols=281 Identities=41% Similarity=0.792 Sum_probs=239.4
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC---CCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT---DNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 372 LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l---~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
||+|+||.||+|+++.+++.||+|++.+..............|..++... +||||+++++++.+...+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999998776554444555666677777655 799999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~----------- 149 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD----------- 149 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-----------
Confidence 999999998889999999999999999999999999999999999999999999999999998642111
Q ss_pred cccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCccc
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQ 607 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S 607 (810)
.......+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.+..+.+..+..+...++.. .++
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~ 222 (330)
T cd05586 150 ----NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLS 222 (330)
T ss_pred ----CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc---cCC
Confidence 0112356799999999999765 58999999999999999999999999999999988888877776653 267
Q ss_pred HHHHHHHHhhhcCCCCCCCCCC-ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccch
Q psy16843 608 VEAKSIITDLLQQNPRDRLGTG-GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 608 ~el~dLI~klL~~dP~~Rpta~-~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~ 670 (810)
+++++||++||+.||.+||++. .+.++++||||.+.+|..+.... +++.|......+.++|+.
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDP 288 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcCc
Confidence 8999999999999999999763 46999999999999999876543 456666655555555553
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=412.46 Aligned_cols=271 Identities=35% Similarity=0.711 Sum_probs=233.6
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHH-HHhcCCCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERD-IMSFTDNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~-iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
+.||+|+||.||+|+++.+++.||+|++.+...........+..|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999987765444444455555654 67889999999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----------- 149 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP----------- 149 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-----------
Confidence 999999988888999999999999999999999999999999999999999999999999998642111
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccH
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~ 608 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+......+|.. .+.
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~----~~~ 221 (321)
T cd05603 150 ----EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGG----KTV 221 (321)
T ss_pred ----CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC----CCH
Confidence 011234679999999999999999999999999999999999999999999888888888877766643 568
Q ss_pred HHHHHHHhhhcCCCCCCCCCC-ChhHHhcCCCcCCCChhhhhhcc--CCcccCC
Q psy16843 609 EAKSIITDLLQQNPRDRLGTG-GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQL 659 (810)
Q Consensus 609 el~dLI~klL~~dP~~Rpta~-~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~ 659 (810)
++.++|.+||++||.+|+++. .+.|+++||||..++|..+.... +++.|..
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNV 275 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCC
Confidence 899999999999999999973 56799999999999999886543 3444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=412.91 Aligned_cols=288 Identities=38% Similarity=0.687 Sum_probs=242.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+++++.+++.||+|++.+...........+..|+.++..++|+||+++++++.+++.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999987655444455567888999999999999999999999999999999
Q ss_pred eeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----- 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD----- 155 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC-----
Confidence 99999999999976 468999999999999999999999999999999999999999999999999998642211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhh-----cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILR-----QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI- 596 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~- 596 (810)
........+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+..+.....
T Consensus 156 ---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~ 226 (331)
T cd05624 156 ---------GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER 226 (331)
T ss_pred ---------CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc
Confidence 0111124579999999999976 4688999999999999999999999999988888888876543
Q ss_pred -CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCccCcc
Q psy16843 597 -EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSY 667 (810)
Q Consensus 597 -~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d~~~ 667 (810)
.+|... ..++.++++||.+||..++ +|+...+++++++||||.+++|..+....+++.|......+...
T Consensus 227 ~~~p~~~-~~~~~~~~~li~~ll~~~~-~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p~~~~~~~~~~ 296 (331)
T cd05624 227 FQFPSHI-TDVSEEAKDLIQRLICSRE-RRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSN 296 (331)
T ss_pred ccCCCcc-ccCCHHHHHHHHHHccCch-hhcCCCCHHHHhcCCCcCCCCHHHHhhCCCCccCCCCCcchhhh
Confidence 333321 2367899999999998654 56555556999999999999999998777788776544443333
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=412.69 Aligned_cols=290 Identities=39% Similarity=0.746 Sum_probs=242.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+++++.+++.||+|++.+.........+.+..|+.++..++|+||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999987755555555677889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD----- 155 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC-----
Confidence 99999999999976 467999999999999999999999999999999999999999999999999998642211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhh-----cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC--
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILR-----QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD-- 595 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~-- 595 (810)
........+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 156 ---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~ 226 (331)
T cd05597 156 ---------GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH 226 (331)
T ss_pred ---------CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 0011123469999999999974 457899999999999999999999999998888888876543
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCccCcccc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFD 669 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d~~~fd 669 (810)
+.++.. ...++.++++||++||.. |.+|++...++++++||||.+++|..+....+++.|......+..+|+
T Consensus 227 ~~~~~~-~~~~~~~~~~li~~ll~~-~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (331)
T cd05597 227 FQFPPD-VTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNFD 298 (331)
T ss_pred ccCCCc-cCCCCHHHHHHHHHHccC-cccccCCCCHHHHhcCCCCCCCCHHHHhhCCCCccCcCCCcchhhhcC
Confidence 333332 123688999999999975 555544334499999999999999998877777777766655555554
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=396.09 Aligned_cols=260 Identities=33% Similarity=0.562 Sum_probs=241.6
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
..-..++|++.+.||+|-||.||+|+.+.++-.||+|++.|..+......+++.+|++|...|+||||+++|++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 34456899999999999999999999999999999999999887777777889999999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhh--cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 439 LCLVMEYVEGGDCASLLK--NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~--~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+|+++||..+|+|+..|+ ..+.|++..+..|+.|++.||.|||.++||||||||+|+|++..|.+||+|||.+....
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999999998 66789999999999999999999999999999999999999999999999999875411
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||...+..+++++|.+-.+
T Consensus 176 ----------------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~ 239 (281)
T KOG0580|consen 176 ----------------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL 239 (281)
T ss_pred ----------------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc
Confidence 1123578999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.+|.. ++.+++|||.+||.++|.+|+.. .|++.|||+..
T Consensus 240 ~~p~~----is~~a~dlI~~ll~~~p~~r~~l---~~v~~hpwI~a 278 (281)
T KOG0580|consen 240 KFPST----ISGGAADLISRLLVKNPIERLAL---TEVMDHPWIVA 278 (281)
T ss_pred cCCcc----cChhHHHHHHHHhccCccccccH---HHHhhhHHHHh
Confidence 98854 88999999999999999999998 99999999753
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=411.57 Aligned_cols=279 Identities=41% Similarity=0.747 Sum_probs=231.3
Q ss_pred CcEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccchh-hHHHHHHHHHHHHHHhcC-CCCeEEEeeeecccccee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHK---ETRQRFAMKKIIKNSLM-LRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k---~tg~~vAIK~I~k~~~~-~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~l 439 (810)
+|++++.||+|+||.||+|++. .+++.||+|++.+.... .....+.+..|++++..+ +||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 47899999998765432 223446678899999999 589999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~- 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE- 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999987422110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCC----CHHHHHHhhccC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGE----TPEELFAHTVND 594 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~----~~~e~~~~I~~~ 594 (810)
.......+||+.|+|||++.+. .++.++|||||||++|||++|..||... ....+...+...
T Consensus 160 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 226 (332)
T cd05614 160 -------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC 226 (332)
T ss_pred -------------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC
Confidence 0112346799999999999875 4799999999999999999999999643 334455555555
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCC
Q psy16843 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDD 661 (810)
Q Consensus 595 ~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~ 661 (810)
...++.. ++..+++||.+||+.||++||+++ .++++++||||.+.+|..+.... +++.|....
T Consensus 227 ~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (332)
T cd05614 227 DPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRN 293 (332)
T ss_pred CCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 5444432 678999999999999999999775 67999999999999998876433 345554433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=413.01 Aligned_cols=281 Identities=40% Similarity=0.763 Sum_probs=236.7
Q ss_pred EEEecccCceEEEEEEEc---CCCcEEEEEEeeccchh-hHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 369 IKLISNGAYGSVYLVRHK---ETRQRFAMKKIIKNSLM-LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k---~tg~~vAIK~I~k~~~~-~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
++.||+|+||.||+++.. .+++.||+|++.+.... .......+..|+.+|+.++||||++++++|.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999874 47889999998765432 22334567889999999999999999999999999999999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
|+.||+|.+++...+.+.+..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------- 153 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE------- 153 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-------
Confidence 9999999999998889999999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDW 604 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~ 604 (810)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......+|..
T Consensus 154 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~--- 222 (323)
T cd05584 154 --------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPY--- 222 (323)
T ss_pred --------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---
Confidence 011234579999999999999999999999999999999999999999999888888888877766653
Q ss_pred cccHHHHHHHHhhhcCCCCCCCCC--CChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCccc
Q psy16843 605 PIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYF 668 (810)
Q Consensus 605 ~~S~el~dLI~klL~~dP~~Rpta--~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~f 668 (810)
+++++.+||.+||++||++||+. ..+++++.||||...+|..+.... +++.+....+.+.+.|
T Consensus 223 -~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (323)
T cd05584 223 -LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQF 289 (323)
T ss_pred -CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhc
Confidence 67899999999999999999943 234999999999999999887544 3344444333333333
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=411.56 Aligned_cols=275 Identities=29% Similarity=0.461 Sum_probs=238.9
Q ss_pred cCCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 358 SKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 358 ~~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
...++.++|++...||.|.-+.||+|++..+++.||||++..+... ..++.+.+|+..|+.++||||++++.+|..+.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 4567779999999999999999999999999999999999877654 34788999999999999999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
.+|+||.||.+|++.++++.. ..|+|..+..++++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+....
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999999999754 359999999999999999999999999999999999999999999999999986533
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhh--cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR--QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~ 593 (810)
.+. .+ .....++++|||.|||||++.. .+|+.|+||||||++..||.+|..||....+++++-..++
T Consensus 178 ~~G---------~R--~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq 246 (516)
T KOG0582|consen 178 DSG---------DR--QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ 246 (516)
T ss_pred ccC---------ce--eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 221 11 1111278899999999999764 5899999999999999999999999999999999888888
Q ss_pred CCCCCCC------CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhh
Q psy16843 594 DDIEWPS------EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSL 648 (810)
Q Consensus 594 ~~~~~p~------~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l 648 (810)
+.+..+. ......+..++.+|..||++||.+||++ .++|+|+||+...-.++
T Consensus 247 n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptA---skLlkh~FFk~~k~~~~ 304 (516)
T KOG0582|consen 247 NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTA---SKLLKHAFFKKAKSKEY 304 (516)
T ss_pred CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCH---HHHhccHHHhhccchhh
Confidence 7764332 2223366789999999999999999999 99999999988654333
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=410.65 Aligned_cols=263 Identities=39% Similarity=0.748 Sum_probs=231.3
Q ss_pred EEEecccCceEEEEEEE---cCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeee
Q psy16843 369 IKLISNGAYGSVYLVRH---KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~---k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy 445 (810)
++.||+|+||.||++++ +.+|+.||+|++.+.... ......+..|+++++.++||||+++++++.+++.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 36799999999999986 357899999998765432 23345677899999999999999999999999999999999
Q ss_pred ccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhh
Q psy16843 446 VEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC 525 (810)
Q Consensus 446 ~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~ 525 (810)
++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-------- 151 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-------- 151 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--------
Confidence 999999999988888999999999999999999999999999999999999999999999999998642111
Q ss_pred hhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCc
Q psy16843 526 YVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWP 605 (810)
Q Consensus 526 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~ 605 (810)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......+|..
T Consensus 152 -------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~---- 220 (318)
T cd05582 152 -------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF---- 220 (318)
T ss_pred -------CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCC----
Confidence 011134679999999999999999999999999999999999999999999998888888877776653
Q ss_pred ccHHHHHHHHhhhcCCCCCCCCCCC--hhHHhcCCCcCCCChhhhhhc
Q psy16843 606 IQVEAKSIITDLLQQNPRDRLGTGG--PHEVKEHPYFSNLDWNSLLRH 651 (810)
Q Consensus 606 ~S~el~dLI~klL~~dP~~Rpta~~--~~EiL~HPfF~~id~~~l~~~ 651 (810)
+++++.+||.+||++||.+||++.. +.+++.||||..++|..+...
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRR 268 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhc
Confidence 6789999999999999999999865 789999999999999987654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=421.01 Aligned_cols=261 Identities=38% Similarity=0.593 Sum_probs=241.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccceeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~~lyL 441 (810)
...|++.+.||.|.||.||+++++.+|+.||+|++.+.........+.+.+|+.||+.+. |||||.++++|++...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 467999999999999999999999999999999998887765556678999999999998 9999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC----CcEEEeccCCccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL----GHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~----g~VKL~DFGLAk~~~~s 517 (810)
|||+|.||+|++.|... .++|..+..++.||+.|+.|||+.||+||||||+|+|+... +.+|++|||+|.....
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~- 191 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP- 191 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence 99999999999999876 49999999999999999999999999999999999999753 4799999999986332
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
.......|||+.|+|||++.+.+|+..+||||+||++|.|++|.+||.+.+..+.+.+|..+.+.
T Consensus 192 ---------------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~ 256 (382)
T KOG0032|consen 192 ---------------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFD 256 (382)
T ss_pred ---------------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCC
Confidence 12235789999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
++...+..+|..+++||.+||..||.+|+++ .++|+|||+.+.
T Consensus 257 f~~~~w~~is~~akd~i~~ll~~dp~~R~ta---~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 257 FTSEPWDDISESAKDFIRKLLEFDPRKRLTA---AQALQHPWIKSI 299 (382)
T ss_pred CCCCCccccCHHHHHHHHHhcccCcccCCCH---HHHhcCccccCC
Confidence 9988888899999999999999999999999 999999998764
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=425.33 Aligned_cols=257 Identities=30% Similarity=0.497 Sum_probs=228.6
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
..|....+||+|+-|.||.++...+++.||||.+....... .+-++.|+.+|+..+|+|||.+++.|...+.+|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 56888999999999999999999999999999997765432 256889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
|||+||+|.+++... .++|.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||++..+...
T Consensus 350 Eym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~------ 422 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE------ 422 (550)
T ss_pred eecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc------
Confidence 999999999998764 5999999999999999999999999999999999999999999999999999763321
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc-CCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN-DDIEWPSED 602 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~-~~~~~p~~~ 602 (810)
.....+.+|||+|||||++....|+.++||||||++++||+-|++||..+++-..+..|.. +...+...+
T Consensus 423 ---------~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~ 493 (550)
T KOG0578|consen 423 ---------QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPE 493 (550)
T ss_pred ---------cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCcc
Confidence 1134678999999999999999999999999999999999999999999988887777765 444443332
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
.+|++++||+.+||+.|+.+|+++ .|+|.||||....
T Consensus 494 --klS~~~kdFL~~cL~~dv~~RasA---~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 494 --KLSPELKDFLDRCLVVDVEQRASA---KELLEHPFLKMAK 530 (550)
T ss_pred --ccCHHHHHHHHHHhhcchhcCCCH---HHHhcChhhhhcC
Confidence 389999999999999999999999 9999999995543
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=416.60 Aligned_cols=314 Identities=27% Similarity=0.449 Sum_probs=263.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
.-|.+.+.||+|-|+.|.+++|.-||+.||||+|.|..+.. ....++++|++.|+.++|||||+||++..+...+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45999999999999999999999999999999998877653 34578999999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe-ccCCcEEEeccCCccccccccccc
Q psy16843 444 EYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI-TALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL-d~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|+-.||+|+++|.++ ..+.|+.+++|++||+.|+.|||+..+|||||||+||++ .+-|-|||+|||++.....+.
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--- 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--- 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc---
Confidence 999999999999654 579999999999999999999999999999999999986 457999999999997643321
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
.-.+.||+..|-|||+++|..| .+++||||||||||-|++|++||...+..+++.+|+..++..|.
T Consensus 174 -------------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs 240 (864)
T KOG4717|consen 174 -------------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS 240 (864)
T ss_pred -------------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch
Confidence 1257899999999999999999 68999999999999999999999999999999999999999998
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCC-CCccCcccchHHhhhcCCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLD-DEEDTSYFDSRMERYNHDI 679 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~-~~~d~~~fd~~~~~~~~~~ 679 (810)
. +|.+++|||..||+.||.+|.+. +||..|+|++.+|-..-- ..|.+..-. .+++...+ +++.....
T Consensus 241 h----vS~eCrdLI~sMLvRdPkkRAsl---EeI~s~~Wlq~~D~~~sT--~iPLvsr~~L~ee~Ha~I---Iq~Mv~G~ 308 (864)
T KOG4717|consen 241 H----VSKECRDLIQSMLVRDPKKRASL---EEIVSTSWLQAGDRGLST--AIPLVSRHHLPEEAHATI---IQQMVAGA 308 (864)
T ss_pred h----hhHHHHHHHHHHHhcCchhhccH---HHHhccccccCCCCCccc--cCceeehhhCChHHHHHH---HHHHhccc
Confidence 6 89999999999999999999988 999999999988744322 233222111 11221111 22221111
Q ss_pred CCCCcccccccccCCcccchhhhhhhh
Q psy16843 680 GEDTDETEDSFSLGTFSSCTHQYKKVQ 706 (810)
Q Consensus 680 ~~~~~e~~d~~~~~~f~~~~~~~~~~~ 706 (810)
-.+.+++-..+....|+..+++|.++.
T Consensus 309 IAs~e~Il~aLe~n~YNhiTATYfLLA 335 (864)
T KOG4717|consen 309 IASEEDILRALENNEYNHITATYFLLA 335 (864)
T ss_pred ccCHHHHHHHHhccccchhhhHHHHHH
Confidence 234566777777889999999997653
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=417.64 Aligned_cols=261 Identities=28% Similarity=0.439 Sum_probs=222.4
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc--cee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK--KHL 439 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~--~~l 439 (810)
..+.|+.+++||+|+||.||+|++..+|+.||+|++..+... .....-..+|+.||+.++||||++|.+...+. ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 346799999999999999999999999999999999876533 34456678999999999999999999988776 689
Q ss_pred eeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
|||+|||+. ||.-++... -.|++.+++.|+.||+.||+|||++||+|||||..|||||.+|.+||+|||||++.....
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999999976 888888764 489999999999999999999999999999999999999999999999999998643321
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC--C
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND--D 595 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~--~ 595 (810)
.. .-...+-|.||.|||+++|. .|+.++|+||+||||.||+.|++.|.|.++.+.+.+|.+- .
T Consensus 273 ~~--------------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGS 338 (560)
T KOG0600|consen 273 SA--------------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGS 338 (560)
T ss_pred Cc--------------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCC
Confidence 11 11345679999999999984 7999999999999999999999999999999988888751 1
Q ss_pred ---CCCC-----CCC---------------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 596 ---IEWP-----SED---------------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 596 ---~~~p-----~~~---------------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
-.|+ ... ...++..+.+|+..||..||.+|.|+ .++|.|+||.
T Consensus 339 P~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA---~~aL~seyF~ 404 (560)
T KOG0600|consen 339 PTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTA---SSALQSEYFT 404 (560)
T ss_pred CChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccH---HHHhcCcccc
Confidence 1122 000 00166789999999999999999999 9999999994
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=395.13 Aligned_cols=262 Identities=32% Similarity=0.565 Sum_probs=222.1
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcch
Q psy16843 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDC 451 (810)
Q Consensus 372 LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL 451 (810)
||+|+||+||++.++.+++.||+|++.+.........+.+..|+++++.++||||+++++++..+..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998776554445556778899999999999999999999999999999999999999
Q ss_pred hhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhh
Q psy16843 452 ASLLK----NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYV 527 (810)
Q Consensus 452 ~~lL~----~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~ 527 (810)
..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~---------- 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG---------- 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC----------
Confidence 88774 3357999999999999999999999999999999999999999999999999998642211
Q ss_pred hcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH----HHHHHhhccCCCCCCCCCC
Q psy16843 528 ERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP----EELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 528 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~----~e~~~~I~~~~~~~p~~~~ 603 (810)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+......++.
T Consensus 151 -----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 222 (280)
T cd05608 151 -----QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--- 222 (280)
T ss_pred -----CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcc---
Confidence 0112345799999999999999999999999999999999999999976532 3344444444444433
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK 652 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~ 652 (810)
.++.++.+|+.+||+.||++||++. .++++++||||++++|..+....
T Consensus 223 -~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~ 272 (280)
T cd05608 223 -KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGM 272 (280)
T ss_pred -cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhcc
Confidence 2678999999999999999999663 35899999999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=406.93 Aligned_cols=259 Identities=33% Similarity=0.530 Sum_probs=219.0
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc--eee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK--HLC 440 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~--~ly 440 (810)
..+|...+.||+|+||.||++.++.+|..+|+|.+...... ..+.+.+|+.+|..++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 35688999999999999999999999999999998766322 1677899999999999999999999855544 699
Q ss_pred eeeeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc-CCcEEEeccCCcccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA-LGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~g~VKL~DFGLAk~~~~s~ 518 (810)
|.|||+.||+|.+++.+.+ .|+|..++.|.+||+.||+|||++||||+||||+||||+. +|.+||+|||+++.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~- 171 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK- 171 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc-
Confidence 9999999999999999876 8999999999999999999999999999999999999999 799999999998753210
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCC-CCHHHHHHhhccCC-
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFG-ETPEELFAHTVNDD- 595 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~-~~~~e~~~~I~~~~- 595 (810)
.........+.||+.|||||++... ..++++|||||||++.||+||.+||.. ....+.+..+....
T Consensus 172 -----------~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~ 240 (313)
T KOG0198|consen 172 -----------GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS 240 (313)
T ss_pred -----------cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC
Confidence 0011122457899999999999963 234599999999999999999999988 55566566666554
Q ss_pred -CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 596 -IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 596 -~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
+.+|. .+|.++++||.+||.+||++||++ .++|.|||....
T Consensus 241 ~P~ip~----~ls~~a~~Fl~~C~~~~p~~Rpta---~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 241 LPEIPD----SLSDEAKDFLRKCFKRDPEKRPTA---EELLEHPFLKQN 282 (313)
T ss_pred CCCCCc----ccCHHHHHHHHHHhhcCcccCcCH---HHHhhChhhhcc
Confidence 22333 388999999999999999999999 999999998653
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=393.62 Aligned_cols=261 Identities=30% Similarity=0.502 Sum_probs=236.4
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccch-----hhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccc
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL-----MLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKK 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~-----~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~ 437 (810)
+.|+..+.||.|..+.|..+.++.+|+.+|+|+|..... ......+....|+.||+++ .||+|+++.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 568888999999999999999999999999999854221 1233445677899999876 8999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.+++|+|.|+.|.|+++|...-.++|..++.+++|++.|++|||.++||||||||+|||+|++.+|||+|||+|+....+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999864332
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHh------hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL------RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~------~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I 591 (810)
. .-...||||+|+|||.+. ..+|+..+|+|++|||||.|+.|.+||.....+-++..|
T Consensus 177 e----------------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~I 240 (411)
T KOG0599|consen 177 E----------------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMI 240 (411)
T ss_pred h----------------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHH
Confidence 1 124679999999999996 347999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 592 ~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
+.+++.|..+.+..+|.+++|||.+||+.||.+|+|+ +|+|+||||..+
T Consensus 241 meGkyqF~speWadis~~~KdLIsrlLqVdp~~Rita---ke~LaHpff~q~ 289 (411)
T KOG0599|consen 241 MEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITA---KEALAHPFFIQI 289 (411)
T ss_pred HhcccccCCcchhhccccHHHHHHHHHeeCchhcccH---HHHhcChHHHHH
Confidence 9999999999988899999999999999999999999 999999999654
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=393.09 Aligned_cols=273 Identities=32% Similarity=0.551 Sum_probs=228.8
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
.|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999876554433444567789999999999999999999999999999999
Q ss_pred eccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 445 YVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 445 y~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG----- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-----
Confidence 99999999888643 46999999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHH----HhhccCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELF----AHTVNDDIEW 598 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~----~~I~~~~~~~ 598 (810)
......+|++.|+|||++.+..++.++|||||||++|||++|..||.+....... ..+......+
T Consensus 156 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
T cd05605 156 -----------ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY 224 (285)
T ss_pred -----------CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccccc
Confidence 0112347999999999999999999999999999999999999999887654332 2232233233
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCccc
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIP 657 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P 657 (810)
+. .++..+.+||.+||..||.+||+.. .+++++.||||...+|..+.+.. ++|.|
T Consensus 225 ~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05605 225 SE----KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCP 283 (285)
T ss_pred Cc----ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCC
Confidence 32 2678999999999999999999653 45899999999999999887654 35555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=412.55 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=232.5
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
+....|..+..||+|+||.||+|.+..+++.||+|++..+.. ...++.+++|+.+|..++++||.++|+.|..+..++
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence 344678889999999999999999999999999999977654 456788999999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
++||||.||++.++|+..+.+.|..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++.....
T Consensus 88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~---- 163 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN---- 163 (467)
T ss_pred HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec----
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999864221
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
......+++|||.|||||++.+.+|+.++||||||++.|||++|.+||.+..++.++..|.+..+..
T Consensus 164 -----------~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~-- 230 (467)
T KOG0201|consen 164 -----------TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPR-- 230 (467)
T ss_pred -----------hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCc--
Confidence 1122368999999999999999999999999999999999999999999999977766666554322
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
.. ...|+.+++||..||.+||+.||+| .++|+|+|++...
T Consensus 231 L~-~~~S~~~kEFV~~CL~k~P~~RpsA---~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 231 LD-GDFSPPFKEFVEACLDKNPEFRPSA---KELLKHKFIKRAK 270 (467)
T ss_pred cc-cccCHHHHHHHHHHhhcCcccCcCH---HHHhhhHHHHhcC
Confidence 22 2578999999999999999999999 9999999998743
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-47 Score=412.52 Aligned_cols=259 Identities=28% Similarity=0.451 Sum_probs=221.0
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccc-ee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKK-HL 439 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~-~l 439 (810)
..++|.++++||.|+||.||+|+.+.+|+.||||.++++-... .+ -.-.+|++-|++++ |||||++++++.+.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-EE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-HH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 4578999999999999999999999999999999887654332 22 23457999999999 999999999999888 99
Q ss_pred eeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
|+|||||+. +|+.+++.+ ..|++..++.|+.||+.||+|+|++|+.||||||||||+.....|||+|||||+......
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC
Confidence 999999954 899999754 579999999999999999999999999999999999999998999999999998744321
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc--C-
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN--D- 594 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~--~- 594 (810)
. | ...+-|.||+|||+++.. -|+.++|+|++|||++|+.+-++.|.|.++.+.+.+|.. +
T Consensus 165 P---Y-------------TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGt 228 (538)
T KOG0661|consen 165 P---Y-------------TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGT 228 (538)
T ss_pred C---c-------------chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCC
Confidence 1 1 345679999999999875 579999999999999999999999999999888877763 1
Q ss_pred ----------------CCCCCCCCCC-------cccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 595 ----------------DIEWPSEDDW-------PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 595 ----------------~~~~p~~~~~-------~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.+.+|..... ..+.++.+||.+||.+||.+|||| .|+|+||||+.
T Consensus 229 P~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA---~~al~~pffq~ 296 (538)
T KOG0661|consen 229 PDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTA---SQALQHPFFQV 296 (538)
T ss_pred CccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccH---HHHhcCccccc
Confidence 1233322221 167889999999999999999999 99999999975
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=389.05 Aligned_cols=259 Identities=31% Similarity=0.466 Sum_probs=215.4
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||+|+++.+++.||+|++...... ....+.+.+|+++++.++||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 4799999999999999999999999999999988654322 233466788999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++++.+..+....+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 154 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS----- 154 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-----
Confidence 999998887766666789999999999999999999999999999999999999999999999999987532110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC---------
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND--------- 594 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~--------- 594 (810)
.......+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+...
T Consensus 155 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 155 ---------NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred ---------cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 00112457999999999999999999999999999999999999999987665543332211
Q ss_pred ----------CCCCCCCCC---------CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 595 ----------DIEWPSEDD---------WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 595 ----------~~~~p~~~~---------~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
...++.... ..++.++++||++||++||.+||++ +|+++||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~---~~~l~hp~f 287 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT---EQCLNHPAF 287 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH---HHHhcCCCC
Confidence 011111100 1257789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=387.91 Aligned_cols=284 Identities=45% Similarity=0.844 Sum_probs=248.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||++.+..+++.||+|++.+.........+.+.+|+++++.++||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999987665544556678889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||+|+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence 99999999999998889999999999999999999999999999999999999999999999999998652211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
....+|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..+...+|..
T Consensus 155 ------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 220 (290)
T cd05580 155 ------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF-- 220 (290)
T ss_pred ------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCcc--
Confidence 134568999999999998889999999999999999999999999888888888888776666543
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccc
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFD 669 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd 669 (810)
.+..++++|.+||+.||.+|++.. .++|+++||||..++|..+.... .++.|...+.-+.+.|+
T Consensus 221 --~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (290)
T cd05580 221 --FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFD 288 (290)
T ss_pred --CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCCcccccccc
Confidence 578999999999999999999542 45999999999999999997654 46666655555555443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=382.12 Aligned_cols=260 Identities=28% Similarity=0.498 Sum_probs=221.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
.+|..++.||+|.||.||+|++..+|+.||||+|...... ........+|++.|+.++|+||+.+.++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 4688999999999999999999999999999999766432 222345788999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||+. +|...|+.. -.++..+++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+........
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-- 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-- 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence 99965 899999754 57999999999999999999999999999999999999999999999999999875432111
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC--C---C
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND--D---I 596 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~--~---~ 596 (810)
....+-|.||.|||++.| +.|+..+||||.|||+.||+.|.+-|.|.+.-+.+..|... . -
T Consensus 158 -------------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~ 224 (318)
T KOG0659|consen 158 -------------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPD 224 (318)
T ss_pred -------------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcc
Confidence 011267999999999987 57999999999999999999999999999998888877642 1 1
Q ss_pred CCCCCCC-------------------CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 597 EWPSEDD-------------------WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 597 ~~p~~~~-------------------~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.||.-.. ...+.++.||+.+||..||.+|+++ .|+++|+||...
T Consensus 225 ~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita---~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 225 QWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITA---SQALKHPYFKSL 287 (318)
T ss_pred cCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccH---HHHhcchhhhcC
Confidence 1221110 1166789999999999999999999 999999999863
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=393.23 Aligned_cols=262 Identities=26% Similarity=0.452 Sum_probs=210.7
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||+|+||.||+|+++.+++.||+|++...... .....+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 37899999999999999999999999999999988654321 1224567899999999999999999999999999999
Q ss_pred eeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|||+. ++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---- 156 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP---- 156 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC----
Confidence 99996 567776654 467999999999999999999999999999999999999999999999999998642110
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCH-HHHHHhhcc---CC-
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFAHTVN---DD- 595 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~-~e~~~~I~~---~~- 595 (810)
.......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+... .+.+..+.. ..
T Consensus 157 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 225 (303)
T cd07869 157 -----------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN 225 (303)
T ss_pred -----------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCC
Confidence 011123568999999999976 4589999999999999999999999987543 222222211 00
Q ss_pred -CCCCC----------------C-------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 596 -IEWPS----------------E-------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 596 -~~~p~----------------~-------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
..++. . .....+.++++||.+||+.||.+||++ .|+++||||.++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~---~~~l~h~~f~~~~~ 296 (303)
T cd07869 226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA---QAALSHEYFSDLPP 296 (303)
T ss_pred hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH---HHHhcCcccccCCh
Confidence 00000 0 000134678999999999999999999 99999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=383.81 Aligned_cols=267 Identities=33% Similarity=0.588 Sum_probs=221.6
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcch
Q psy16843 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDC 451 (810)
Q Consensus 372 LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL 451 (810)
||+|+||.||+++.+.+|+.||+|.+.+...........+..|+++++.++||||+++++++.++..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998765443333345566799999999999999999999999999999999999999
Q ss_pred hhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhc
Q psy16843 452 ASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVER 529 (810)
Q Consensus 452 ~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~ 529 (810)
.+++...+ .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~------------ 148 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG------------ 148 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC------------
Confidence 98886443 5889999999999999999999999999999999999999999999999998642211
Q ss_pred ccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH----HHHHHhhccCCCCCCCCCCCc
Q psy16843 530 DAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP----EELFAHTVNDDIEWPSEDDWP 605 (810)
Q Consensus 530 ~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~----~e~~~~I~~~~~~~p~~~~~~ 605 (810)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .++...+....+..+.. .
T Consensus 149 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 221 (277)
T cd05607 149 ----KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---N 221 (277)
T ss_pred ----ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccc---c
Confidence 011234689999999999998999999999999999999999999976432 34444444444333221 3
Q ss_pred ccHHHHHHHHhhhcCCCCCCCCCCC-hhHHhcCCCcCCCChhhhhhcc--CCccc
Q psy16843 606 IQVEAKSIITDLLQQNPRDRLGTGG-PHEVKEHPYFSNLDWNSLLRHK--AEFIP 657 (810)
Q Consensus 606 ~S~el~dLI~klL~~dP~~Rpta~~-~~EiL~HPfF~~id~~~l~~~~--~~f~P 657 (810)
++.++++||.+||++||++||++.. .++++.||||..++|..+.... ++|.|
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCCC
Confidence 6789999999999999999999843 4689999999999999887653 34544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=387.68 Aligned_cols=257 Identities=26% Similarity=0.434 Sum_probs=213.3
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||.|+||.||+|+++.+++.||+|++...... .....+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 46899999999999999999999999999999988654321 2234567899999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|||+.| +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~---- 156 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP---- 156 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC----
Confidence 999975 8988886544 5899999999999999999999999999999999999999999999999998642111
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-----
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD----- 595 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~----- 595 (810)
........||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..+....
T Consensus 157 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07871 157 -----------TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE 225 (288)
T ss_pred -----------CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 001123468999999999976 568999999999999999999999999888776665543210
Q ss_pred --------------CCCCCC-------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 596 --------------IEWPSE-------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 596 --------------~~~p~~-------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..++.. ....++.++++||.+||++||.+|||+ +|+++||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~---~~~l~hp~f 288 (288)
T cd07871 226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA---EAALRHSYF 288 (288)
T ss_pred HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCH---HHHhcCCCC
Confidence 001110 011257889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=389.23 Aligned_cols=263 Identities=26% Similarity=0.412 Sum_probs=221.3
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc--ce
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK--KH 438 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~--~~ 438 (810)
-..++|+.+..|++|+||.||+|+++.|++.||+|+++.+. .....--...+|+.+|.+++|||||.+..+.... +.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 34578999999999999999999999999999999986543 1122223457899999999999999998876543 57
Q ss_pred eeeeeeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
+|||||||+. ||..+|.+-+ +|...+++.++.|++.||+|||.+.|+||||||+|+|+...|.+||+|||||+.....
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999999976 8999998654 8999999999999999999999999999999999999999999999999999864332
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD- 595 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~- 595 (810)
. ......+-|.||.|||++++. .|+.++|+||+|||+.||+.+.+.|.|....+.+.+|..--
T Consensus 231 ~---------------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG 295 (419)
T KOG0663|consen 231 L---------------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG 295 (419)
T ss_pred c---------------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC
Confidence 1 112356779999999999985 68999999999999999999999999999998888887521
Q ss_pred ----CCCCCCCCC-----------------------cccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 596 ----IEWPSEDDW-----------------------PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 596 ----~~~p~~~~~-----------------------~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
-.||..... .++....+|+..+|.+||.+|+|+ +|.|+|.||.+.
T Consensus 296 tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA---~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 296 TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITA---EDGLKHEYFRET 367 (419)
T ss_pred CCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccH---HHhhcccccccC
Confidence 112211110 155889999999999999999999 999999999874
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=384.81 Aligned_cols=274 Identities=32% Similarity=0.582 Sum_probs=226.0
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
.|++.+.||+|+||.||++.++.+++.||+|.+.+...........+..|+.+++.++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999876554444444567789999999999999999999999999999999
Q ss_pred eccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 445 YVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 445 y~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-----
Confidence 99999999988643 35999999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH---HHHHhhccC-CCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE---ELFAHTVND-DIEW 598 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~---e~~~~I~~~-~~~~ 598 (810)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... +....+... ...+
T Consensus 156 -----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
T cd05630 156 -----------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY 224 (285)
T ss_pred -----------ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhc
Confidence 0112346999999999999999999999999999999999999999865432 222222211 1112
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhc--cCCcccC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRH--KAEFIPQ 658 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~--~~~f~P~ 658 (810)
+. .+++++++||.+||+.||++||++. +++|+++||||..++|..+... .++|.|.
T Consensus 225 ~~----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05630 225 SE----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284 (285)
T ss_pred Cc----cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence 21 2668899999999999999999942 3599999999999999977653 3466653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=410.00 Aligned_cols=317 Identities=30% Similarity=0.468 Sum_probs=270.9
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
......|.+++.||+|.|++|.++++..++..||||.|.|....... .+.+.+|+++|+.++|||||++|.+.+++..+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 34557899999999999999999999999999999988887665443 34589999999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||+.||+++++|.+.+.+.+..++.++.|++.|++|||+++|+|||||++||||+.+.++||+|||++......
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999764321
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
....++||++.|.|||++.+..| ++++|+||+|++||-|+.|.+||.|.+..++..+++.+.+.+
T Consensus 209 --------------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rI 274 (596)
T KOG0586|consen 209 --------------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRI 274 (596)
T ss_pred --------------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecc
Confidence 12357899999999999999998 899999999999999999999999999999999999999988
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCccCcccchHHhhhcCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHD 678 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d~~~fd~~~~~~~~~ 678 (810)
|-. ++.++.+||+++|..+|.+|+++ +++++|.|.....-...+ .++. .. .....+......+..
T Consensus 275 p~~----ms~dce~lLrk~lvl~Pskr~~~---dqim~~~W~n~~~~~~~l---~p~~---e~--~~~~~~~~r~~~m~~ 339 (596)
T KOG0586|consen 275 PFY----MSCDCEDLLRKFLVLNPSKRGPC---DQIMKDRWRNDLLEARLL---APLI---ER--STPFILAKRILHMNS 339 (596)
T ss_pred cce----eechhHHHHHHhhccCccccCCH---HHhhhhcccchhhhhhhh---hccc---cc--CccchhhHHHHHHHh
Confidence 865 88999999999999999999999 999999998653322111 1111 11 111222221223456
Q ss_pred CCCCCcccccccccCCcccchhhhhhhhhh
Q psy16843 679 IGEDTDETEDSFSLGTFSSCTHQYKKVQSQ 708 (810)
Q Consensus 679 ~~~~~~e~~d~~~~~~f~~~~~~~~~~~~~ 708 (810)
+|...+++.+++...+|....++|..+...
T Consensus 340 ~G~~~~~i~~sL~~~k~d~i~a~y~ll~~~ 369 (596)
T KOG0586|consen 340 IGHRRLKIEESLAKQKFDDINATYLLLGYR 369 (596)
T ss_pred hccchhhHHHHHhhhhHHHHHHHHhhcchh
Confidence 778888889999999999999999776543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=385.93 Aligned_cols=296 Identities=41% Similarity=0.764 Sum_probs=247.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+.........+.+..|+++++.++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765554456678899999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 444 EYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||+.|++|.+++... ..+++..++.++.||+.||+|||+.|++||||||+||+++.+|.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998753 579999999999999999999999999999999999999999999999999987532211100
Q ss_pred ch--------------hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHH
Q psy16843 522 LY--------------ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL 587 (810)
Q Consensus 522 ~~--------------~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~ 587 (810)
.. .................||..|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 00 0000000111223456799999999999998999999999999999999999999999988888
Q ss_pred HHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCC-CChhHHhcCCCcCCCChhhhhhccCCcccCCCC
Q psy16843 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT-GGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDD 661 (810)
Q Consensus 588 ~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta-~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~ 661 (810)
+..+......++... .++.++++||.+||..||++||+. ..++|++.||||.+.+|..+.-..+|.+|.++.
T Consensus 241 ~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (316)
T cd05574 241 FSNILKKEVTFPGSP--PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPDD 313 (316)
T ss_pred HHHHhcCCccCCCcc--ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCccc
Confidence 888887776666542 267899999999999999999992 123999999999999999888777777776544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=390.70 Aligned_cols=264 Identities=25% Similarity=0.406 Sum_probs=212.1
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc-----cee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK-----KHL 439 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~-----~~l 439 (810)
+|++.+.||+|+||.||+|+++.+|+.||||++..... .......+.+|+++++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 58999999999999999999999999999998864322 123345678999999999999999999887533 358
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 68999998888899999999999999999999999999999999999999999999999999875221100
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhh--cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc----
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR--QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN---- 593 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~---- 593 (810)
........+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+....+..+..
T Consensus 159 ------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 226 (338)
T cd07859 159 ------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226 (338)
T ss_pred ------------ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 0011134579999999999976 6789999999999999999999999987765433221110
Q ss_pred ----------------------CCCCCC-CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 594 ----------------------DDIEWP-SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 594 ----------------------~~~~~p-~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
.....+ .......++++.+||.+||+.||++||++ .|+++||||.++..
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~---~e~l~hp~f~~~~~ 298 (338)
T cd07859 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA---EEALADPYFKGLAK 298 (338)
T ss_pred CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCH---HHHhcCchhhhcCc
Confidence 000000 00011256788999999999999999998 99999999987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=388.91 Aligned_cols=260 Identities=26% Similarity=0.413 Sum_probs=219.3
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++++.||+|+||.||+++++.+|..||+|.+.... .....+.+.+|+++|+.++||||+++++++..++.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999886542 12344678899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY-GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||||++||+|.+++...+.+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 999999999999999888899999999999999999999986 6999999999999999999999999998642111
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC----
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI---- 596 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~---- 596 (810)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+.....
T Consensus 158 --------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (331)
T cd06649 158 --------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEE 223 (331)
T ss_pred --------------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccccccc
Confidence 11345799999999999999999999999999999999999999987766554322111000
Q ss_pred ----------------------------------------CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 597 ----------------------------------------EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 597 ----------------------------------------~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..+......+++++++||.+||++||++||++ .|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~---~ell~ 300 (331)
T cd06649 224 GEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADL---KMLMN 300 (331)
T ss_pred CCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCH---HHHhc
Confidence 00111111257889999999999999999999 99999
Q ss_pred CCCcCCC
Q psy16843 637 HPYFSNL 643 (810)
Q Consensus 637 HPfF~~i 643 (810)
||||...
T Consensus 301 h~~~~~~ 307 (331)
T cd06649 301 HTFIKRS 307 (331)
T ss_pred ChHHhhc
Confidence 9999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=378.95 Aligned_cols=274 Identities=32% Similarity=0.556 Sum_probs=228.5
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
.|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+..|+++|+.++|+||+.+++.+.+++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37889999999999999999999999999999876554444444567789999999999999999999999999999999
Q ss_pred eccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 445 YVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 445 y~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----- 155 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-----
Confidence 99999999888643 36999999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhc----cCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV----NDDIEW 598 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~----~~~~~~ 598 (810)
.......|++.|+|||++.+..++.++|+|||||++|||++|..||.+.........+. .....+
T Consensus 156 -----------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
T cd05632 156 -----------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY 224 (285)
T ss_pred -----------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccccc
Confidence 01123469999999999999999999999999999999999999998876654433332 222222
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQ 658 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~ 658 (810)
+ ..++.++.+|+.+||+.||++||++. .+.+++.|+||.+++|..+.... ++|.|.
T Consensus 225 ~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05632 225 S----AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284 (285)
T ss_pred C----ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence 2 23678899999999999999999952 24899999999999999875543 466653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=388.67 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=219.4
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc-----cce
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET-----KKH 438 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~-----~~~ 438 (810)
..|..++.||+|+||.|+.+.++.+|+.||||++... ....-..++..+|+++|+.++|+||+.+++++.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 5677789999999999999999999999999998642 2334566889999999999999999999999876 347
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|+|+|+| +-||..+|+.+..+++++++.++.||+.||+|+|+.||+||||||.|+|++.+..+||+|||+|+.....
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~- 178 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF- 178 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence 99999999 6699999999888999999999999999999999999999999999999999999999999999864221
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC---
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND--- 594 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~--- 594 (810)
.........+.|.||.|||++.. ..|+.++||||+||||.||++|++.|.|.+....+..|+.-
T Consensus 179 ------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 179 ------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred ------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 00111134578999999999975 68999999999999999999999999998765555544421
Q ss_pred --------------------CCCCCCC----CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 595 --------------------DIEWPSE----DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 595 --------------------~~~~p~~----~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
....|.. .....++++.||+.+||..||.+|+|+ +|+|+|||+...
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita---~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITA---EEALAHPYLAPY 316 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCH---HHHhcChhhhhh
Confidence 0111110 011277899999999999999999999 999999999764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=400.16 Aligned_cols=256 Identities=20% Similarity=0.358 Sum_probs=209.3
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|.++.+++.||+|.... ..+.+|+++++.++|||||+++++|......|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 445789999999999999999999999999999996432 34568999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+|||++. ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~--- 235 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI--- 235 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc---
Confidence 9999995 689999888788999999999999999999999999999999999999999999999999998642110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHhhcc
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET-------PEELFAHTVN 593 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~-------~~e~~~~I~~ 593 (810)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.. ....+..++.
T Consensus 236 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~ 304 (391)
T PHA03212 236 -----------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304 (391)
T ss_pred -----------cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence 0011134579999999999999999999999999999999999998886432 1111111111
Q ss_pred C--------------------------CCCCCCC-----CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 594 D--------------------------DIEWPSE-----DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 594 ~--------------------------~~~~p~~-----~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
. ....+.. ....++.++.+||.+||+.||.+||++ +|+++||||.+
T Consensus 305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta---~elL~hp~f~~ 381 (391)
T PHA03212 305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA---EALLDFAAFQD 381 (391)
T ss_pred HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH---HHHhcChhhcc
Confidence 0 0000000 001245689999999999999999999 99999999977
Q ss_pred C
Q psy16843 643 L 643 (810)
Q Consensus 643 i 643 (810)
+
T Consensus 382 ~ 382 (391)
T PHA03212 382 I 382 (391)
T ss_pred C
Confidence 4
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=369.58 Aligned_cols=258 Identities=49% Similarity=0.893 Sum_probs=224.9
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHH-hcCCCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL-~~l~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
+.||.|+||.||+|.++.+++.||+|.+.+...........+..|..++ ...+|+||+++++++..++.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999988765443333344455555544 556999999999999999999999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------------ 149 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------------ 149 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------------
Confidence 99999999888999999999999999999999999999999999999999999999999999864211
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccH
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~ 608 (810)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+.+..+......++......++.
T Consensus 150 -------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (260)
T cd05611 150 -------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSP 222 (260)
T ss_pred -------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCH
Confidence 1245689999999999988899999999999999999999999999988888888777666665444334789
Q ss_pred HHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 609 EAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 609 el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
++.++|.+||+.||.+||++.+++|++.||||.+++|+
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 99999999999999999999888999999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=398.40 Aligned_cols=258 Identities=33% Similarity=0.515 Sum_probs=230.3
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce-eee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH-LCL 441 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~-lyL 441 (810)
.++|+.++++|+|+||.+++++++..++.|++|+|.......+. .+...+|+.+++++.|||||.++++|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 46899999999999999999999999999999999876654333 3477889999999999999999999999887 999
Q ss_pred eeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
||+||+||+|.+.|.+. ..|+|+.+..|+.||+.|+.|||+++|+|||||+.||+++.++.|||+|||+|+......
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 99999999999999643 479999999999999999999999999999999999999999999999999998743221
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
-...+.+|||.||+||++.+.+|+.++|||||||++|||++-+++|.+.+...+..+|....+. |
T Consensus 161 --------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~-P 225 (426)
T KOG0589|consen 161 --------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS-P 225 (426)
T ss_pred --------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC-C
Confidence 0124678999999999999999999999999999999999999999999999999999988743 2
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.+. ..+.+++.||+.||.++|..||++ .++|.+|....
T Consensus 226 lp~--~ys~el~~lv~~~l~~~P~~RPsa---~~LL~~P~l~~ 263 (426)
T KOG0589|consen 226 LPS--MYSSELRSLVKSMLRKNPEHRPSA---LELLRRPHLLR 263 (426)
T ss_pred CCc--cccHHHHHHHHHHhhcCCccCCCH---HHHhhChhhhh
Confidence 222 378999999999999999999999 99999988654
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=373.01 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=206.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcC-CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC---CCCeEEEeeeecc-----
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKE-TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT---DNPFVVTMYCSFE----- 434 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~-tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l---~HPnIVkl~~~f~----- 434 (810)
++|++++.||+|+||.||+|++.. +++.||+|.+....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 379999999999999999999854 56889999886543221 1223445566666554 7999999999874
Q ss_pred ccceeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 435 TKKHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 435 ~~~~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457999999996 5888888643 458999999999999999999999999999999999999999999999999986
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~ 592 (810)
..... .......||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+.
T Consensus 159 ~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~ 222 (290)
T cd07862 159 IYSFQ----------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 222 (290)
T ss_pred eccCC----------------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 42111 11234579999999999999999999999999999999999999999988877777765
Q ss_pred cCCC-----CCCCC------------------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 593 NDDI-----EWPSE------------------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 593 ~~~~-----~~p~~------------------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.... .++.. ....++..+++||.+||+.||++||++ .|+++||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~---~~~l~hp~f 290 (290)
T cd07862 223 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA---YSALSHPYF 290 (290)
T ss_pred HHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH---HHHhcCCCC
Confidence 4211 11100 001256788999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=389.36 Aligned_cols=250 Identities=28% Similarity=0.483 Sum_probs=214.8
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcE-EEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQR-FAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~-vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
......+..+.+.||.|+||+||+|.++. +. ||+|++......... .+.+.+|+.+|..++|||||++++++....
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 33445667777889999999999999864 44 999988776544433 678999999999999999999999999887
Q ss_pred -eeeeeeeeccCcchhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcc-cccccCCCCceEeccCC-cEEEeccCCcc
Q psy16843 438 -HLCLVMEYVEGGDCASLLKN--TGPLPADMARFYFAETVLAVEYLHSYG-IVHRDLKPDNLLITALG-HIKLTDFGLSK 512 (810)
Q Consensus 438 -~lyLVmEy~~GGsL~~lL~~--~g~lse~~~~~i~~QIl~AL~yLHs~g-IIHRDLKPeNILLd~~g-~VKL~DFGLAk 512 (810)
.++|||||+++|+|..++.. .+.++...+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 79999999999999999987 688999999999999999999999999 99999999999999998 99999999997
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHh--hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL--RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~--~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~ 590 (810)
...... .......||+.|||||++. +..|+.++||||||++||||++|..||.+....++...
T Consensus 193 ~~~~~~---------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~ 257 (362)
T KOG0192|consen 193 EKVISK---------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA 257 (362)
T ss_pred eecccc---------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 632110 1223367999999999999 66999999999999999999999999999998877777
Q ss_pred hccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 591 I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
+..+....+.+.. .++.+..||.+||..||.+||++
T Consensus 258 v~~~~~Rp~~p~~--~~~~l~~l~~~CW~~dp~~RP~f 293 (362)
T KOG0192|consen 258 VVVGGLRPPIPKE--CPPHLSSLMERCWLVDPSRRPSF 293 (362)
T ss_pred HHhcCCCCCCCcc--CCHHHHHHHHHhCCCCCCcCCCH
Confidence 7655544332222 66899999999999999999998
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=401.98 Aligned_cols=264 Identities=27% Similarity=0.478 Sum_probs=229.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+.|+|+..||-|+||+||++..+.++-..|.|+|.... ...++.++-|++||..++||+||+|++.|-.++.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 56899999999999999999999999888899885443 456788999999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||.||-...++-.- ..+++.+++.+++|++.||.|||+++|||||||..|||++-+|.|+|+|||++.....
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~------ 182 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS------ 182 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh------
Confidence 999999988877544 5799999999999999999999999999999999999999999999999999854211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHh-----hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI- 596 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-----~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~- 596 (810)
......++.|||+|||||++. .++|++++||||||++|.||..+.+|...-+++.++.+|.+...
T Consensus 183 ---------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePP 253 (1187)
T KOG0579|consen 183 ---------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP 253 (1187)
T ss_pred ---------HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCC
Confidence 111235789999999999985 57899999999999999999999999999999999999887543
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhh
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLR 650 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~ 650 (810)
.+..+.. .+..+.||+++||.+||..||++ .++++||||.+++-++.++
T Consensus 254 TLlqPS~--Ws~~F~DfLk~cL~Knp~~Rp~a---aqll~Hpfv~~~~SnK~ir 302 (1187)
T KOG0579|consen 254 TLLQPSH--WSRSFSDFLKRCLVKNPRNRPPA---AQLLKHPFVQNAPSNKMIR 302 (1187)
T ss_pred cccCcch--hhhHHHHHHHHHHhcCCccCCCH---HHHhhCcccccCCcchHHH
Confidence 3333333 45789999999999999999999 8999999999887665443
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=383.59 Aligned_cols=252 Identities=29% Similarity=0.513 Sum_probs=212.0
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc-----cee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK-----KHL 439 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~-----~~l 439 (810)
.|.-.+++|.|+||.||.|....+++.||||++..+.. .-.+|++||+.++|||||+|..+|... -++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 48889999999999999999999999999999866542 223599999999999999999888532 256
Q ss_pred eeeeeeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC-CcEEEeccCCcccc
Q psy16843 440 CLVMEYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL-GHIKLTDFGLSKMG 514 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~-g~VKL~DFGLAk~~ 514 (810)
.+|||||+. +|...++. +..++.-.++.|+.||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+..
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 789999965 88888873 5789999999999999999999999999999999999999986 99999999999976
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~ 593 (810)
..+..+. +..-|..|+|||.+.| ..|+.++||||.||++.||+.|++.|.|++..+.+..|++
T Consensus 177 ~~~epni----------------SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik 240 (364)
T KOG0658|consen 177 VKGEPNI----------------SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIK 240 (364)
T ss_pred ccCCCce----------------eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHH
Confidence 5443332 3344889999999998 5799999999999999999999999999988777766653
Q ss_pred C-----------------CCCCCCC--------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 594 D-----------------DIEWPSE--------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 594 ~-----------------~~~~p~~--------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
- ...+|.. .....++++.+|+.++|+++|.+|.++ .|++.||||+.+
T Consensus 241 ~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~---~~~l~h~fFdel 312 (364)
T KOG0658|consen 241 VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA---LEALAHPFFDEL 312 (364)
T ss_pred HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH---HHHhcchhhHHh
Confidence 1 0111111 112367899999999999999999999 999999999875
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=401.49 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=207.8
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc-------
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET------- 435 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~------- 435 (810)
..+|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++|||||+++++|..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 468999999999999999999999999999999886532 223469999999999999999887633
Q ss_pred -cceeeeeeeeccCcchhhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC-cEEEeccC
Q psy16843 436 -KKHLCLVMEYVEGGDCASLLK----NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG-HIKLTDFG 509 (810)
Q Consensus 436 -~~~lyLVmEy~~GGsL~~lL~----~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g-~VKL~DFG 509 (810)
...+++||||+++ +|.+++. ..+.+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 2357899999975 5666553 456799999999999999999999999999999999999999765 69999999
Q ss_pred CcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHH
Q psy16843 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELF 588 (810)
Q Consensus 510 LAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~ 588 (810)
+|+..... ......+||+.|+|||++.+. .|+.++|||||||+||||++|.+||.+.+..+.+
T Consensus 217 la~~~~~~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 280 (440)
T PTZ00036 217 SAKNLLAG----------------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280 (440)
T ss_pred cchhccCC----------------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99753211 011245789999999998764 6899999999999999999999999998877666
Q ss_pred HhhccC-----------------CCCCCCCC--------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 589 AHTVND-----------------DIEWPSED--------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 589 ~~I~~~-----------------~~~~p~~~--------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.+++.. .+.+|... ....++++++||.+||++||.+||++ .|+++||||.++
T Consensus 281 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta---~e~l~hp~f~~~ 357 (440)
T PTZ00036 281 VRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP---IEALADPFFDDL 357 (440)
T ss_pred HHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH---HHHhCChhHHhh
Confidence 555431 11122110 01256789999999999999999999 999999999876
Q ss_pred Ch
Q psy16843 644 DW 645 (810)
Q Consensus 644 d~ 645 (810)
..
T Consensus 358 ~~ 359 (440)
T PTZ00036 358 RD 359 (440)
T ss_pred hc
Confidence 44
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=417.16 Aligned_cols=305 Identities=44% Similarity=0.819 Sum_probs=259.7
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|.+++.||+|+||.||+|.+..+++.||||++.+...........+..|+.+++.++||||+++++++.....+||
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 35789999999999999999999999999999999877655555566788899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc-
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT- 520 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~- 520 (810)
||||+.|++|.+++...+.+++..++.|+.||+.||+|||.+|||||||||+||||+.+|.+||+|||+++........
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~ 161 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM 161 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998732100000
Q ss_pred ---------------------------------------------------------------------------cch--
Q psy16843 521 ---------------------------------------------------------------------------NLY-- 523 (810)
Q Consensus 521 ---------------------------------------------------------------------------~~~-- 523 (810)
...
T Consensus 162 ~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (669)
T cd05610 162 MDILTTPSMAKPKNDYSRTPGQVLSLISSLGFNTPVGEKDQGSVNSGQNNGTSSVRTGTSHPLLMINKESLPMSLKLSKS 241 (669)
T ss_pred cccccCccccCccccccCCCCceeeeeeecCcCCccccccccccccccccccccccccCCCCcccccccccccccHhhhh
Confidence 000
Q ss_pred --------------------------------------------------------------------------------
Q psy16843 524 -------------------------------------------------------------------------------- 523 (810)
Q Consensus 524 -------------------------------------------------------------------------------- 523 (810)
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (669)
T cd05610 242 CLETSESSPSLPVRSLTPNLLKSRKRPEASTSSTHSCMTNSLSSCESECCSSNLKLLEQASSPSQSPRWSVDEGNIISEG 321 (669)
T ss_pred ccccccCCCCCCccccCcccccccccCCcccccchhhhhhhhhhccccccCcchhhhhhccCCCCCccccccCCCCcccc
Confidence
Q ss_pred ---------------------------------h----------------------------------------------
Q psy16843 524 ---------------------------------E---------------------------------------------- 524 (810)
Q Consensus 524 ---------------------------------~---------------------------------------------- 524 (810)
.
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (669)
T cd05610 322 EKSEKGSVKRSFELVEKSPCQELLQSKKTNAEYKRGCSITETNGNQSTGLTMEIQSLNLSKHKSRPKFLAGNEKRTGPKK 401 (669)
T ss_pred cccccCCccccccccccChHHHHhcccccccccccceeeccccccccccceeecchhhhhhhhcCchhhhccccccCccc
Confidence 0
Q ss_pred -----------hhhhc---------------------------------------------------c-----c------
Q psy16843 525 -----------CYVER---------------------------------------------------D-----A------ 531 (810)
Q Consensus 525 -----------~~~~~---------------------------------------------------~-----~------ 531 (810)
+.... . .
T Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (669)
T cd05610 402 KSNPVVAKNLMCELDDDGEKDGKYSNSSTSCGDDREIVLKLSLNSDSSFPEMSKNAVAFRSYNSPINVSNVSEPSTMSSL 481 (669)
T ss_pred CCCcchhhhhhccccccccccCCccccccccCccHHHhhhhhhccccccccccccceeeeccCchhhccccCCCCccccc
Confidence 00000 0 0
Q ss_pred ---------------------------------------------------ccccCCcccCCCCcCChhHHhhcCCCCCc
Q psy16843 532 ---------------------------------------------------KQFSDKQVYGTPEYIAPEVILRQGYGKPV 560 (810)
Q Consensus 532 ---------------------------------------------------~~~~~~~~~GTp~YmAPEvl~~~~ys~ks 560 (810)
.......++||+.|||||++.+..|+.++
T Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~ 561 (669)
T cd05610 482 DAMKMSGSQSGSYPAITPTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAV 561 (669)
T ss_pred chhhccccccCCCcccCCCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHH
Confidence 00001124789999999999999999999
Q ss_pred chhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 561 DWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 561 DIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
|||||||+||||++|.+||.+....+.+..++...+.++.... .++.++.+++.+||..||.+||++ .|++.||||
T Consensus 562 DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~-~~~~~~~~~l~~lL~~dP~~R~ta---~e~l~h~~~ 637 (669)
T cd05610 562 DWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEE-KLSVNAQNAIEILLTMDPTKRAGL---KELKQHPLF 637 (669)
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccc-cCCHHHHHHHHHHcccChhHCcCH---HHHHhCHhh
Confidence 9999999999999999999999999999999888777765432 467889999999999999999999 999999999
Q ss_pred CCCChhhhhhccCCcccCCCCCccCcccch
Q psy16843 641 SNLDWNSLLRHKAEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 641 ~~id~~~l~~~~~~f~P~~~~~~d~~~fd~ 670 (810)
..++|..+.....+|.|..++..|..||+-
T Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (669)
T cd05610 638 HGVDWENLQNQTMPFIPQPDDETDTSYFEA 667 (669)
T ss_pred cCCCHHHhcccCCCCCCCCCCccccccccc
Confidence 999999999888999998888888888863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=387.49 Aligned_cols=257 Identities=27% Similarity=0.420 Sum_probs=208.9
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
....++|++++.||+|+||.||+|+++.+++.||||++..... ....+.+.+|+++++.++|+||+++++++...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc--HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 3445789999999999999999999999999999998865432 23346788999999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||+.||+|... ....+..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-- 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-- 221 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--
Confidence 999999999998653 34577888999999999999999999999999999999999999999999998753211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhh-----cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH---HHHHhh
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-----QGYGKPVDWWSMGVILYEFLVGCVPFFGETPE---ELFAHT 591 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~---e~~~~I 591 (810)
.......+||+.|+|||++.. ..++.++|||||||++|||++|+.||...... .....+
T Consensus 222 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~ 288 (353)
T PLN00034 222 -------------MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI 288 (353)
T ss_pred -------------cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH
Confidence 001134579999999999853 23467999999999999999999999743322 222222
Q ss_pred ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 592 ~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.... +......++.++++||.+||..||++||++ .|+++||||...
T Consensus 289 ~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~---~ell~hp~~~~~ 334 (353)
T PLN00034 289 CMSQ---PPEAPATASREFRHFISCCLQREPAKRWSA---MQLLQHPFILRA 334 (353)
T ss_pred hccC---CCCCCCccCHHHHHHHHHHccCChhhCcCH---HHHhcCcccccC
Confidence 2211 111112367899999999999999999998 999999999774
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=382.74 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=216.5
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++.+.||+|+||.||++.++.++..+|+|.+.... .....+.+.+|+++++.++||||++++++|.+++.+|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 4578999999999999999999999999999999876542 12344678899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY-GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||||++||+|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.+|.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999999999999999888899999999999999999999975 7999999999999999999999999998642110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhh---------
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT--------- 591 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I--------- 591 (810)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+
T Consensus 158 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (333)
T cd06650 158 --------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPA 223 (333)
T ss_pred --------------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcc
Confidence 112457999999999999999999999999999999999999999876554332211
Q ss_pred -----------------------------------ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 592 -----------------------------------VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 592 -----------------------------------~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..... +.......+.++++||.+||++||++||++ .|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~---~ell~ 298 (333)
T cd06650 224 ESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAERADL---KQLMV 298 (333)
T ss_pred ccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCcccCcCH---HHHhh
Confidence 01000 000011256789999999999999999998 99999
Q ss_pred CCCcCC
Q psy16843 637 HPYFSN 642 (810)
Q Consensus 637 HPfF~~ 642 (810)
||||+.
T Consensus 299 h~~~~~ 304 (333)
T cd06650 299 HAFIKR 304 (333)
T ss_pred CHHHhc
Confidence 999965
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=386.70 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=216.4
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc-----ee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK-----HL 439 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~-----~l 439 (810)
+|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+++++.++||||+++++++...+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5889999999999999999999999999999886432 12234467889999999999999999999998876 89
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-- 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-- 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC--
Confidence 99999996 588888887788999999999999999999999999999999999999999999999999998752211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc-----
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN----- 593 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~----- 593 (810)
.........||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+..
T Consensus 157 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~ 224 (372)
T cd07853 157 ------------ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224 (372)
T ss_pred ------------ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 00111234689999999999875 579999999999999999999999998877665555432
Q ss_pred ------------------CCCCCCC-----CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 594 ------------------DDIEWPS-----EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 594 ------------------~~~~~p~-----~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
.....+. ......++++.+||.+||+.||.+||++ .|+++||||.+..+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~---~e~l~hp~~~~~~~ 296 (372)
T cd07853 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA---ADALAHPYLDEGRL 296 (372)
T ss_pred CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH---HHHhcCHhhCCCcc
Confidence 1111110 0111246889999999999999999999 99999999988653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=378.98 Aligned_cols=262 Identities=29% Similarity=0.487 Sum_probs=219.0
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCe-EEEeeeeccccc----
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF-VVTMYCSFETKK---- 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPn-IVkl~~~f~~~~---- 437 (810)
...|+.++.||+|+||+||+|+.+.+|+.||+|++...... +..-....+|+.+|+.++|+| ||.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45688888899999999999999999999999999765432 122245678999999999999 999999998877
Q ss_pred --eeeeeeeeccCcchhhhhhcCC----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 438 --HLCLVMEYVEGGDCASLLKNTG----PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 438 --~lyLVmEy~~GGsL~~lL~~~g----~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
.+++|+||+. -+|..++.... .++...++.++.||+.||+|||++||+||||||.||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999995 59999997654 5788899999999999999999999999999999999999999999999999
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~ 590 (810)
+....... .-..-++|.+|.|||++.+. .|+..+||||+|||++||+++++.|.|.+..+.+.+
T Consensus 168 ra~~ip~~---------------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~ 232 (323)
T KOG0594|consen 168 RAFSIPMR---------------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR 232 (323)
T ss_pred HHhcCCcc---------------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 84221110 01345789999999999986 789999999999999999999999999999888887
Q ss_pred hccC-----CCCCCCCCC--------------C-------cccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 591 TVND-----DIEWPSEDD--------------W-------PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 591 I~~~-----~~~~p~~~~--------------~-------~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
|..- ...||.... . ..++++.+++.+||+.+|.+|.++ +.++.||||.++.
T Consensus 233 If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa---~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 233 IFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISA---KGALTHPYFSELP 309 (323)
T ss_pred HHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCH---HHHhcChhhcccc
Confidence 7641 112221110 0 033579999999999999999999 9999999998873
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=369.21 Aligned_cols=255 Identities=29% Similarity=0.487 Sum_probs=205.0
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhc---CCCCeEEEeeeeccc-----c
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF---TDNPFVVTMYCSFET-----K 436 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~---l~HPnIVkl~~~f~~-----~ 436 (810)
+|++++.||+|+||.||+|+++.+++.||+|.+....... .....+.+|+.+++. ++||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5899999999999999999999999999999886542211 111234456666654 479999999998764 3
Q ss_pred ceeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~ 514 (810)
..+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 468999999975 888888653 35899999999999999999999999999999999999999999999999998642
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND 594 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~ 594 (810)
... .......||+.|+|||++.+..++.++|||||||++|||++|.+||.+....+.+.++...
T Consensus 159 ~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 222 (288)
T cd07863 159 SCQ----------------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 222 (288)
T ss_pred cCc----------------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHH
Confidence 110 1112356899999999999999999999999999999999999999888776665555431
Q ss_pred -----CCCCCCC------------------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 595 -----DIEWPSE------------------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 595 -----~~~~p~~------------------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
...++.. ....++.++++||.+||++||.+||++ .|++.||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~~~l~hp~f 288 (288)
T cd07863 223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA---FRALQHPFF 288 (288)
T ss_pred hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH---HHHhcCCCC
Confidence 0011100 001256788999999999999999998 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=372.01 Aligned_cols=259 Identities=32% Similarity=0.542 Sum_probs=225.8
Q ss_pred cCCCCCCCcEEE-EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHH-hcCCCCeEEEeeeeccc
Q psy16843 358 SKTPNENDFTVI-KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVTMYCSFET 435 (810)
Q Consensus 358 ~~~~~~~dy~il-k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL-~~l~HPnIVkl~~~f~~ 435 (810)
......+||.+- ++||-|-.|+|..+.++.||+.+|+|++... ....+|+++- ..-.|||||.++++|+.
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 445566889884 6799999999999999999999999976432 3455677764 34579999999998864
Q ss_pred ----cceeeeeeeeccCcchhhhhhcCCC--CCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc---CCcEEEe
Q psy16843 436 ----KKHLCLVMEYVEGGDCASLLKNTGP--LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA---LGHIKLT 506 (810)
Q Consensus 436 ----~~~lyLVmEy~~GGsL~~lL~~~g~--lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~---~g~VKL~ 506 (810)
...+.+|||.|+||+|+..|+.+|. |+|.++..|+.||..|+.|||+.+|.||||||+|+|... +..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 4678999999999999999987764 999999999999999999999999999999999999976 4469999
Q ss_pred ccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC---
Q psy16843 507 DFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET--- 583 (810)
Q Consensus 507 DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~--- 583 (810)
|||+|+.... ...-.+.|-||+|.|||++..++|+..+|+||+||++|-||+|.+||+...
T Consensus 207 DfGFAK~t~~----------------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a 270 (400)
T KOG0604|consen 207 DFGFAKETQE----------------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_pred ccccccccCC----------------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc
Confidence 9999986321 112246788999999999999999999999999999999999999998754
Q ss_pred -HHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 584 -PEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 584 -~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
...+..+|..+.+.||.+++..+|++++|+|++||..+|.+|+++ +|+++|||+.+.
T Consensus 271 ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI---~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 271 ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTI---EEVMDHPWINQY 328 (400)
T ss_pred CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeH---HHhhcCchhccc
Confidence 346788999999999999998899999999999999999999999 999999998763
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=399.16 Aligned_cols=254 Identities=23% Similarity=0.384 Sum_probs=202.8
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC------CCCeEEEeeeecccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT------DNPFVVTMYCSFETK 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l------~HPnIVkl~~~f~~~ 436 (810)
.++|++++.||+|+||+||+|.+..+++.||||++..... .......|+++++.+ +|.+|++++++|..+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 4789999999999999999999999999999998864321 122334455555554 455689999888764
Q ss_pred -ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCC-------------
Q psy16843 437 -KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALG------------- 501 (810)
Q Consensus 437 -~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g------------- 501 (810)
.++|+|||++ |++|.+++.+.+.+++..++.|+.||+.||+|||+ .|||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5799999998 77899999888899999999999999999999998 5999999999999998766
Q ss_pred ---cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCC
Q psy16843 502 ---HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP 578 (810)
Q Consensus 502 ---~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~P 578 (810)
.+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||+||||++|++|
T Consensus 283 ~~~~vkl~DfG~~~~~~------------------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER------------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred CCceEEECCCCccccCc------------------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 49999999875311 112356899999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhccCCCCCCC------------------------C--------------CCCcccHHHHHHHHhhhcC
Q psy16843 579 FFGETPEELFAHTVNDDIEWPS------------------------E--------------DDWPIQVEAKSIITDLLQQ 620 (810)
Q Consensus 579 F~~~~~~e~~~~I~~~~~~~p~------------------------~--------------~~~~~S~el~dLI~klL~~ 620 (810)
|.+.+..+.+..+......+|. . .....++.+.|||.+||++
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 9987766554433221100000 0 0000135678999999999
Q ss_pred CCCCCCCCCChhHHhcCCCcCC
Q psy16843 621 NPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 621 dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
||.+||++ +|+|+||||..
T Consensus 425 dP~~R~ta---~e~L~Hp~~~~ 443 (467)
T PTZ00284 425 DRQKRLNA---RQMTTHPYVLK 443 (467)
T ss_pred ChhhCCCH---HHHhcCccccc
Confidence 99999999 99999999975
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=360.14 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=221.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh--hHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM--LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~--~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+.+|+++++.++||||+++++++.++..+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4699999999999999999999999999999988654322 22345678899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~--- 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC--- 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc---
Confidence 99999999999999888889999999999999999999999999999999999999999999999999986422100
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
..........|+..|+|||++.+..++.++||||||+++|||++|+.||.+.+..+....+..........
T Consensus 159 ---------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd06625 159 ---------SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229 (263)
T ss_pred ---------cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCC
Confidence 00001124568899999999999999999999999999999999999998877766655555443322211
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..++.++.+||.+||.++|.+||++ .|+++||||
T Consensus 230 --~~~~~~~~~li~~~l~~~p~~Rpt~---~~ll~~~~~ 263 (263)
T cd06625 230 --SHVSPDARNFLRRTFVENAKKRPSA---EELLRHFFV 263 (263)
T ss_pred --ccCCHHHHHHHHHHhhcCcccCCCH---HHHhhCCCC
Confidence 2367899999999999999999998 999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=358.87 Aligned_cols=265 Identities=56% Similarity=0.982 Sum_probs=230.5
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcch
Q psy16843 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDC 451 (810)
Q Consensus 372 LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL 451 (810)
||.|+||.||++.+..+|+.||+|.+.+.........+.+..|+++++.++||||+++++.+.++..+|+||||+.|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999998766554455667889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhccc
Q psy16843 452 ASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531 (810)
Q Consensus 452 ~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~ 531 (810)
.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++........... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-------~~ 153 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL-------ND 153 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc-------cc
Confidence 99998878899999999999999999999999999999999999999999999999999875322111000 00
Q ss_pred ccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHH
Q psy16843 532 KQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAK 611 (810)
Q Consensus 532 ~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~ 611 (810)
.........|++.|+|||.+.+..++.++||||||+++|+|++|..||......+.+..+..+...++... .++.++.
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV--EVSDEAI 231 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccc--cCCHHHH
Confidence 01122345688999999999988899999999999999999999999999998888888887666666542 2478999
Q ss_pred HHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 612 SIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 612 dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
+||.+||+.+|.+||++..+.++++||||.+++|
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 232 DLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 9999999999999999988999999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=397.35 Aligned_cols=260 Identities=28% Similarity=0.458 Sum_probs=223.3
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCC-CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKET-RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~t-g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
....|.+.+.||+|+||.||+|....+ ++.||+|++.... ......+..|+.+|+.++|||||+++++|..++.+|
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 345699999999999999999998877 7889999765433 233456778999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 441 LVMEYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
|||||++||+|.++|.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999999999987753 45799999999999999999999999999999999999999999999999999975321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.. ........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+..+..
T Consensus 222 ~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 288 (478)
T PTZ00267 222 SV-------------SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY 288 (478)
T ss_pred cc-------------ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 10 01112456899999999999999999999999999999999999999999998888888877654
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.... ..++.++++||.+||.+||++||++ .+++.|||+..+
T Consensus 289 ~~~~---~~~s~~~~~li~~~L~~dP~~Rps~---~~~l~~~~~~~~ 329 (478)
T PTZ00267 289 DPFP---CPVSSGMKALLDPLLSKNPALRPTT---QQLLHTEFLKYV 329 (478)
T ss_pred CCCC---ccCCHHHHHHHHHHhccChhhCcCH---HHHHhCHHHHHH
Confidence 3211 2367899999999999999999999 899999998653
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=365.88 Aligned_cols=260 Identities=37% Similarity=0.623 Sum_probs=218.3
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcch
Q psy16843 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDC 451 (810)
Q Consensus 372 LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL 451 (810)
||+|+||+||+|.++.+|+.||+|.+.+...........+..|+++++.++||||+++++++...+.+|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999998765444344455667899999999999999999999999999999999999999
Q ss_pred hhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhc
Q psy16843 452 ASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVER 529 (810)
Q Consensus 452 ~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~ 529 (810)
.+++.+.+ .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------------- 147 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------------- 147 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-------------
Confidence 99997655 799999999999999999999999999999999999999999999999998864211
Q ss_pred ccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH----HHHHHhhccCCCCCCCCCCCc
Q psy16843 530 DAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP----EELFAHTVNDDIEWPSEDDWP 605 (810)
Q Consensus 530 ~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~----~e~~~~I~~~~~~~p~~~~~~ 605 (810)
........|+..|+|||++.+..++.++|||||||++|+|++|+.||.+... .++...+.......+. .
T Consensus 148 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 220 (277)
T cd05577 148 ---GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD----K 220 (277)
T ss_pred ---CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCc----c
Confidence 0011234578899999999988899999999999999999999999977543 3333333333333332 2
Q ss_pred ccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhc
Q psy16843 606 IQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRH 651 (810)
Q Consensus 606 ~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~ 651 (810)
.++++.+||.+||+.||.+||++. .+.+++.||||..++|..+...
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~ 268 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAG 268 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcC
Confidence 678999999999999999999652 2488999999999999887544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=380.20 Aligned_cols=257 Identities=26% Similarity=0.442 Sum_probs=211.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc------
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK------ 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~------ 436 (810)
.++|++++.||+|+||.||+|.++.+++.||||++.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4789999999999999999999999999999998865432 223446678899999999999999999887643
Q ss_pred ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
..+|+||||+++ +|..++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 357999999965 66666653 488999999999999999999999999999999999999999999999999874211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
. .......||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+.+++....
T Consensus 179 ~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 242 (364)
T cd07875 179 S----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242 (364)
T ss_pred C----------------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 1 111345789999999999999999999999999999999999999998887766665543100
Q ss_pred C------------------------------------CC--CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCC
Q psy16843 597 E------------------------------------WP--SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHP 638 (810)
Q Consensus 597 ~------------------------------------~p--~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HP 638 (810)
. ++ .......+.++++||.+||+.||.+||++ .|+++||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~---~e~L~hp 319 (364)
T cd07875 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV---DEALQHP 319 (364)
T ss_pred CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH---HHHhcCc
Confidence 0 00 00001134678999999999999999999 9999999
Q ss_pred CcCC
Q psy16843 639 YFSN 642 (810)
Q Consensus 639 fF~~ 642 (810)
||..
T Consensus 320 ~~~~ 323 (364)
T cd07875 320 YINV 323 (364)
T ss_pred cccc
Confidence 9964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=364.00 Aligned_cols=256 Identities=32% Similarity=0.560 Sum_probs=215.8
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy 445 (810)
|++++.||+|+||+||+++++.+++.||+|.+......... ......|+.+++.++||||+++++++.+...+++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999877544332 23445699999999999999999999999999999999
Q ss_pred ccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhh
Q psy16843 446 VEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC 525 (810)
Q Consensus 446 ~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~ 525 (810)
+.+++|.+++...+.+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--------- 150 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--------- 150 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS---------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---------
Confidence 99999999999778999999999999999999999999999999999999999999999999999864200
Q ss_pred hhhcccccccCCcccCCCCcCChhHHh-hcCCCCCcchhhhHHHHHHHHhCCCCCCCC---CHHHHHHhhccCCCCCCCC
Q psy16843 526 YVERDAKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGE---TPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 526 ~~~~~~~~~~~~~~~GTp~YmAPEvl~-~~~ys~ksDIWSLGvILyELLtG~~PF~~~---~~~e~~~~I~~~~~~~p~~ 601 (810)
.........|++.|+|||++. +..++.++||||||+++|+|++|..||... +....+.+...........
T Consensus 151 ------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T PF00069_consen 151 ------NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ 224 (260)
T ss_dssp ------TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT
T ss_pred ------cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc
Confidence 011123457899999999998 788999999999999999999999999987 3344444444332222211
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.......++.+||.+||+.||++||++ .++++||||
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~---~~l~~~~~~ 260 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSA---EELLKHPWF 260 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTH---HHHHTSGGG
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCH---HHHhcCCCC
Confidence 111124789999999999999999998 999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=373.45 Aligned_cols=260 Identities=25% Similarity=0.430 Sum_probs=213.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|.+++.||+|+||.||+|+++.+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++.+|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 47899999999999999999999999999999988654321 1224567899999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|||+++ +|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---- 157 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP---- 157 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC----
Confidence 999975 787777654 46899999999999999999999999999999999999999999999999998642111
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC------
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND------ 594 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~------ 594 (810)
........||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+...
T Consensus 158 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 226 (309)
T cd07872 158 -----------TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE 226 (309)
T ss_pred -----------ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 001123468999999999876 46899999999999999999999999988766554444321
Q ss_pred -------------CCCCCCC-------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 595 -------------DIEWPSE-------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 595 -------------~~~~p~~-------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
...++.. ....++.++++||.+||+.||.+||++ .|++.||||+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~---~e~l~h~~~~~~ 292 (309)
T cd07872 227 ETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA---EEAMKHAYFRSL 292 (309)
T ss_pred HHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCH---HHHhcChhhhhc
Confidence 0111110 011267889999999999999999998 999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=380.03 Aligned_cols=257 Identities=26% Similarity=0.463 Sum_probs=208.4
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc-----
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK----- 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~----- 437 (810)
.++|++++.||+|+||.||++.++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4789999999999999999999999999999998865432 2234466788999999999999999999886543
Q ss_pred -eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 -HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 -~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
.+|+||||+++ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 57999999976 5655554 3589999999999999999999999999999999999999999999999999864211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc---
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN--- 593 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~--- 593 (810)
. .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 176 ~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 239 (359)
T cd07876 176 N----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239 (359)
T ss_pred C----------------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 0 111345789999999999999999999999999999999999999988765443332221
Q ss_pred -------------------CCCCCCC--------------C--CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCC
Q psy16843 594 -------------------DDIEWPS--------------E--DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHP 638 (810)
Q Consensus 594 -------------------~~~~~p~--------------~--~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HP 638 (810)
....++. . .....+.++++||.+||+.||++||++ .|++.||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~---~e~l~hp 316 (359)
T cd07876 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV---DEALRHP 316 (359)
T ss_pred CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCH---HHHhcCc
Confidence 1111100 0 001135679999999999999999998 9999999
Q ss_pred CcCC
Q psy16843 639 YFSN 642 (810)
Q Consensus 639 fF~~ 642 (810)
||..
T Consensus 317 ~~~~ 320 (359)
T cd07876 317 YITV 320 (359)
T ss_pred hhhh
Confidence 9964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=360.03 Aligned_cols=255 Identities=41% Similarity=0.793 Sum_probs=222.6
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcch
Q psy16843 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDC 451 (810)
Q Consensus 372 LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL 451 (810)
||.|+||.||+|.+..+++.||+|++.+.........+.+..|+++++.++||||+++++.+.++..+|+||||++|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999999999999998776554445567889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhccc
Q psy16843 452 ASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531 (810)
Q Consensus 452 ~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~ 531 (810)
.+++.+...+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------------- 147 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------------- 147 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------------
Confidence 9999888889999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC--HHHHHHhhcc--CCCCCCCCCCCccc
Q psy16843 532 KQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET--PEELFAHTVN--DDIEWPSEDDWPIQ 607 (810)
Q Consensus 532 ~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~--~~e~~~~I~~--~~~~~p~~~~~~~S 607 (810)
.....+|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+.+..+.. ....+|.. .+
T Consensus 148 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 220 (262)
T cd05572 148 ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY----ID 220 (262)
T ss_pred ---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcc----cC
Confidence 1123468999999999998889999999999999999999999998777 6777777763 33344432 46
Q ss_pred HHHHHHHHhhhcCCCCCCCCC--CChhHHhcCCCcCCCChh
Q psy16843 608 VEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 608 ~el~dLI~klL~~dP~~Rpta--~~~~EiL~HPfF~~id~~ 646 (810)
.+++++|.+||..||.+|++. ..++|+++||||.+.+|+
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 899999999999999999993 234999999999999986
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=375.89 Aligned_cols=256 Identities=22% Similarity=0.355 Sum_probs=203.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFE 434 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~ 434 (810)
...++|++.+.||+|+||.||+|.+. .+++.||+|++..... ....+.+..|+.++..+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 44578999999999999999999853 3457899998864322 23446788999999999 8999999999877
Q ss_pred cc-ceeeeeeeeccCcchhhhhhcC-------------------------------------------------------
Q psy16843 435 TK-KHLCLVMEYVEGGDCASLLKNT------------------------------------------------------- 458 (810)
Q Consensus 435 ~~-~~lyLVmEy~~GGsL~~lL~~~------------------------------------------------------- 458 (810)
.. ..+|+||||++||+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 4689999999999999998642
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhccc
Q psy16843 459 -------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531 (810)
Q Consensus 459 -------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~ 531 (810)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~------------- 228 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------- 228 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc-------------
Confidence 247788899999999999999999999999999999999999999999999987532110
Q ss_pred ccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHH
Q psy16843 532 KQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEA 610 (810)
Q Consensus 532 ~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el 610 (810)
.........|++.|+|||++.+..|+.++|||||||+||||++ |..||.+....+.+...+......... ...++++
T Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 306 (338)
T cd05102 229 DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAP--ENATPEI 306 (338)
T ss_pred chhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCC--CCCCHHH
Confidence 0111123456789999999999999999999999999999997 999998865444333333322222211 1367899
Q ss_pred HHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 611 KSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 611 ~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.+||.+||..||.+||++ .|+++
T Consensus 307 ~~li~~cl~~dp~~RPs~---~el~~ 329 (338)
T cd05102 307 YRIMLACWQGDPKERPTF---SALVE 329 (338)
T ss_pred HHHHHHHccCChhhCcCH---HHHHH
Confidence 999999999999999998 56553
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=396.11 Aligned_cols=262 Identities=29% Similarity=0.447 Sum_probs=223.6
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc----
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK---- 437 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~---- 437 (810)
..++|++.+.||+|+||.||+|++..+|+.||||++...... ......+..|+.++..++|+||++++..+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 346899999999999999999999999999999998765432 344567888999999999999999988775432
Q ss_pred ----eeeeeeeeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccC
Q psy16843 438 ----HLCLVMEYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFG 509 (810)
Q Consensus 438 ----~lyLVmEy~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFG 509 (810)
.+++||||+++|+|.++|.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 47899999999999999864 2479999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16843 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589 (810)
Q Consensus 510 LAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~ 589 (810)
+++...... ........+||+.|+|||++.+..|+.++|||||||+||||++|..||.+.+..+++.
T Consensus 189 ls~~~~~~~-------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~ 255 (496)
T PTZ00283 189 FSKMYAATV-------------SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255 (496)
T ss_pred cCeeccccc-------------cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 987532110 0111245689999999999999999999999999999999999999999999888888
Q ss_pred hhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 590 ~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.+..+...... ..+++++.+||.+||+.||.+||++ .++++|||+...
T Consensus 256 ~~~~~~~~~~~---~~~~~~l~~li~~~L~~dP~~RPs~---~ell~~p~~~~~ 303 (496)
T PTZ00283 256 KTLAGRYDPLP---PSISPEMQEIVTALLSSDPKRRPSS---SKLLNMPICKLF 303 (496)
T ss_pred HHhcCCCCCCC---CCCCHHHHHHHHHHcccChhhCcCH---HHHHhCHHHHHh
Confidence 88766543211 2367899999999999999999999 899999998753
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=384.83 Aligned_cols=262 Identities=22% Similarity=0.396 Sum_probs=213.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcC--CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKE--TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~--tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
..+|++++.||+|+||.||++.... +++.||+|.+... ....+|+++|+.++|||||+++++|.....+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 3579999999999999999997653 5678999977543 22457999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+||||+. ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~- 240 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD- 240 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc-
Confidence 9999995 68888888778999999999999999999999999999999999999999999999999999865322110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH---HHHHHhhcc----
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP---EELFAHTVN---- 593 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~---~e~~~~I~~---- 593 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+... ...+..++.
T Consensus 241 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~ 308 (392)
T PHA03207 241 ------------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV 308 (392)
T ss_pred ------------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence 1112346799999999999999999999999999999999999999987542 122222211
Q ss_pred CCCCCCCC--------------------------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhh
Q psy16843 594 DDIEWPSE--------------------------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647 (810)
Q Consensus 594 ~~~~~p~~--------------------------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~ 647 (810)
....++.. ....++.++++||.+||..||++||++ .|++.||||....|+.
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa---~e~l~~p~f~~~~~~~ 385 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA---QDILSLPLFTKEPINL 385 (392)
T ss_pred CccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCH---HHHhhCchhhccchhh
Confidence 11111110 011245789999999999999999999 9999999999988876
Q ss_pred hh
Q psy16843 648 LL 649 (810)
Q Consensus 648 l~ 649 (810)
+.
T Consensus 386 ~~ 387 (392)
T PHA03207 386 LN 387 (392)
T ss_pred hc
Confidence 64
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=363.11 Aligned_cols=260 Identities=33% Similarity=0.617 Sum_probs=208.8
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHH---HHhcCCCCeEEEeeeeccccceeeeeeeecc
Q psy16843 371 LISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERD---IMSFTDNPFVVTMYCSFETKKHLCLVMEYVE 447 (810)
Q Consensus 371 ~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~---iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~ 447 (810)
.||+|+||.||++.+..+++.||+|.+.+..............|.. ++...+||||+.+++++..++.+|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999999999999999887654332222223334443 3444589999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhh
Q psy16843 448 GGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYV 527 (810)
Q Consensus 448 GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~ 527 (810)
||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---------- 150 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---------- 150 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----------
Confidence 9999999988889999999999999999999999999999999999999999999999999998532110
Q ss_pred hcccccccCCcccCCCCcCChhHHh-hcCCCCCcchhhhHHHHHHHHhCCCCCCCCC---HHHHHHhhccCCCCCCCCCC
Q psy16843 528 ERDAKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGET---PEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 528 ~~~~~~~~~~~~~GTp~YmAPEvl~-~~~ys~ksDIWSLGvILyELLtG~~PF~~~~---~~e~~~~I~~~~~~~p~~~~ 603 (810)
......||+.|+|||++. +..++.++|||||||++|||++|..||.+.. ...............+.
T Consensus 151 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 220 (279)
T cd05633 151 -------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD--- 220 (279)
T ss_pred -------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCcc---
Confidence 012346899999999987 4668999999999999999999999997543 22222222222222222
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhc
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRH 651 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~ 651 (810)
.++.++++||.+||..||.+|++.. .+.|+++||||++++|......
T Consensus 221 -~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 269 (279)
T cd05633 221 -SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQ 269 (279)
T ss_pred -ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcC
Confidence 3678999999999999999999621 2499999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=375.51 Aligned_cols=259 Identities=27% Similarity=0.487 Sum_probs=229.6
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
+..+-|.++.+||+|+||.||++.|+.+|+.+|||.+..+ ..++++..|+.||.+++.|++|++|+.|-....+|
T Consensus 30 ~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW 104 (502)
T KOG0574|consen 30 PPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW 104 (502)
T ss_pred ChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence 3446799999999999999999999999999999988654 34578899999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 441 LVMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
||||||..|+..++++ ++.+++|+++..+++..+.||+|||...-||||||..||||+.+|+.||+|||+|-.....+
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM- 183 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM- 183 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH-
Confidence 9999999999999997 55789999999999999999999999999999999999999999999999999986432111
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-CC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI-EW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~-~~ 598 (810)
...++..|||.|||||++..-+|..++||||||++..||..|++||.+..++..+..|..++. .|
T Consensus 184 --------------AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF 249 (502)
T KOG0574|consen 184 --------------AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTF 249 (502)
T ss_pred --------------HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCC
Confidence 123678899999999999999999999999999999999999999999999887777765433 33
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
..++. .|.++.|||++||.++|++|-++ .++++|||.++..
T Consensus 250 ~KPE~--WS~~F~DFi~~CLiK~PE~R~TA---~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 250 KKPEE--WSSEFNDFIRSCLIKKPEERKTA---LRLCEHTFIKNAP 290 (502)
T ss_pred CChHh--hhhHHHHHHHHHhcCCHHHHHHH---HHHhhhhhhcCCC
Confidence 33333 46899999999999999999998 9999999998754
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=362.26 Aligned_cols=261 Identities=34% Similarity=0.616 Sum_probs=213.9
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHH---HHHHhcCCCCeEEEeeeeccccceeeeeeeecc
Q psy16843 371 LISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAE---RDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVE 447 (810)
Q Consensus 371 ~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E---~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~ 447 (810)
.||+|+||.||+|.+..+++.||+|.+.+..............| ..++...+||+|+.+++++.+.+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 38999999999999999999999999876543322222223333 344555689999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhh
Q psy16843 448 GGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYV 527 (810)
Q Consensus 448 GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~ 527 (810)
||+|..++.+.+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---------- 150 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---------- 150 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----------
Confidence 9999999988889999999999999999999999999999999999999999999999999998642110
Q ss_pred hcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCC---CHHHHHHhhccCCCCCCCCCC
Q psy16843 528 ERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGE---TPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 528 ~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~---~~~e~~~~I~~~~~~~p~~~~ 603 (810)
.....+|+..|+|||++.+. .++.++||||+||++|||++|..||.+. ........+......+|..
T Consensus 151 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 221 (278)
T cd05606 151 -------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS-- 221 (278)
T ss_pred -------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCc--
Confidence 11234799999999999754 6899999999999999999999999876 3344434444334444432
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK 652 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~ 652 (810)
.+.++.++|.+||..+|.+|+... .+.++++||||++++|......+
T Consensus 222 --~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~ 270 (278)
T cd05606 222 --FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQK 270 (278)
T ss_pred --CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhcc
Confidence 578999999999999999999432 34999999999999999886554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=351.19 Aligned_cols=254 Identities=26% Similarity=0.460 Sum_probs=217.2
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc-cceeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET-KKHLCLVM 443 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~-~~~lyLVm 443 (810)
+|++++.||+|+||.||++.++.+++.||+|++...... ....+.+..|+++++.++|+||+++++.+.. +..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 589999999999999999999999999999998654332 3345668889999999999999999998864 44789999
Q ss_pred eeccCcchhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 444 EYVEGGDCASLLKN--TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 444 Ey~~GGsL~~lL~~--~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++.....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~---- 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ---- 155 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc----
Confidence 99999999999875 346999999999999999999999999999999999999999999999999998653110
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
........|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..+......
T Consensus 156 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~- 223 (257)
T cd08223 156 -----------CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMP- 223 (257)
T ss_pred -----------CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc-
Confidence 00123456899999999999999999999999999999999999999988877776666655442211
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
...++++.+||.+||+.||++||++ .++++||||
T Consensus 224 --~~~~~~~~~li~~~l~~~p~~Rp~~---~~~l~~~~~ 257 (257)
T cd08223 224 --KDYSPELGELIATMLSKRPEKRPSV---KSILRQPYI 257 (257)
T ss_pred --cccCHHHHHHHHHHhccCcccCCCH---HHHhcCCCC
Confidence 2367899999999999999999998 999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=376.16 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=208.7
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc------
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK------ 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~------ 436 (810)
.++|++++.||+|+||.||++.+..+++.||+|++.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 47899999999999999999999999999999988654322 23446777899999999999999999988643
Q ss_pred ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
..+|+||||+++ +|...+.. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 357999999976 56666653 589999999999999999999999999999999999999999999999999864211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD- 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~- 595 (810)
. ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+..++...
T Consensus 172 ~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (355)
T cd07874 172 S----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_pred c----------------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 1 11134578999999999999999999999999999999999999998877554443322110
Q ss_pred --------------------------CCCCC-----------CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCC
Q psy16843 596 --------------------------IEWPS-----------EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHP 638 (810)
Q Consensus 596 --------------------------~~~p~-----------~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HP 638 (810)
..++. ......+.++++||.+||+.||.+||++ .|+++||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~---~ell~hp 312 (355)
T cd07874 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV---DEALQHP 312 (355)
T ss_pred CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH---HHHhcCc
Confidence 00000 0001134678999999999999999999 9999999
Q ss_pred CcCC
Q psy16843 639 YFSN 642 (810)
Q Consensus 639 fF~~ 642 (810)
||..
T Consensus 313 ~~~~ 316 (355)
T cd07874 313 YINV 316 (355)
T ss_pred chhc
Confidence 9964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=376.85 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=210.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc------
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK------ 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~------ 436 (810)
.++|++++.||+|+||.||+|.+..+++.||+|++.+.... ....+.+.+|+++++.++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 36899999999999999999999999999999988654322 23345677899999999999999999988643
Q ss_pred ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
..+|++||++ |++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 3579999998 7789887764 5799999999999999999999999999999999999999999999999999864211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 171 ------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07878 171 ------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232 (343)
T ss_pred ------------------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 1124578999999999987 568999999999999999999999998876655544433210
Q ss_pred -----------------------CCCCCCC----CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 596 -----------------------IEWPSED----DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 596 -----------------------~~~p~~~----~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
...+... ....++.+.+||.+||+.||.+||++ .|++.||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~---~ell~hp~~~~~ 304 (343)
T cd07878 233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA---SEALAHPYFSQY 304 (343)
T ss_pred CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCH---HHHhcCcchhcc
Confidence 0001000 01145678999999999999999998 999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.14 Aligned_cols=255 Identities=37% Similarity=0.734 Sum_probs=221.6
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++.+.||.|+||.||+|.++.+++.||+|.+.+.........+.+.+|+++++.++||||+++++.+.++..+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987655444566789999999999999999999999999999999999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
|+.|++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------ 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT------ 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc------
Confidence 99999999999887899999999999999999999999999999999999999999999999999986432110
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC---HHHHHHhhccCCCCCCCC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET---PEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~---~~e~~~~I~~~~~~~p~~ 601 (810)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+ ..++...........|.
T Consensus 155 ----------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 223 (258)
T cd05578 155 ----------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPA- 223 (258)
T ss_pred ----------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcc-
Confidence 1123458899999999999889999999999999999999999998776 34444333323333332
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..+.++.++|.+||..||.+|+++. ++|+++||||
T Consensus 224 ---~~~~~~~~~i~~~l~~~p~~R~~~~-~~~l~~~~~~ 258 (258)
T cd05578 224 ---TWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258 (258)
T ss_pred ---cCcHHHHHHHHHHccCChhHcCCcc-HHHHhcCCCC
Confidence 2568999999999999999999986 6899999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=349.83 Aligned_cols=254 Identities=30% Similarity=0.516 Sum_probs=221.2
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|.+.+.||+|+||.||+|.++.+++.|++|.+...... ....+.+..|+++++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 589999999999999999999999999999988654333 3445678899999999999999999999999999999999
Q ss_pred eccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 445 YVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 445 y~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|++|++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~----- 154 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN----- 154 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc-----
Confidence 99999999999764 57999999999999999999999999999999999999999999999999998753211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~ 602 (810)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+..+......
T Consensus 155 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 222 (256)
T cd08529 155 ----------TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS-- 222 (256)
T ss_pred ----------cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--
Confidence 01113456899999999999999999999999999999999999999988888777777665433221
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..++.++.++|.+||+.+|++||++ .+++.|||+
T Consensus 223 -~~~~~~~~~~i~~~l~~~p~~Rp~~---~~ll~~~~~ 256 (256)
T cd08529 223 -QMYSQQLAQLIDQCLTKDYRQRPDT---FQLLRNPSL 256 (256)
T ss_pred -cccCHHHHHHHHHHccCCcccCcCH---HHHhhCCCC
Confidence 1367899999999999999999999 999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=386.70 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=226.3
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
...|.-++.||.|+||.||.+++..+.+.||||++...........+.+..|+..|..++|||+|.+.++|..+...|||
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 34588899999999999999999999999999999877766666678899999999999999999999999999999999
Q ss_pred eeeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||-| +-.++|. ...++-+..+..|+.+.+.||.|||+.+.||||||..||||...|.|||+|||.|...
T Consensus 105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~------- 176 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM------- 176 (948)
T ss_pred HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc-------
Confidence 999954 7777775 3468999999999999999999999999999999999999999999999999988542
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhh---cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILR---QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~---~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
.+.++++|||+|||||+|+. +.|+-++|||||||+..||...++|+++.+.+-.+..|..+....
T Consensus 177 ------------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt 244 (948)
T KOG0577|consen 177 ------------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT 244 (948)
T ss_pred ------------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC
Confidence 13368899999999999974 579999999999999999999999999999998888887654433
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
-.... .|..++.||..||++-|.+||+. ++++.|+|..-
T Consensus 245 Lqs~e--WS~~F~~Fvd~CLqKipqeRpts---e~ll~H~fv~R 283 (948)
T KOG0577|consen 245 LQSNE--WSDYFRNFVDSCLQKIPQERPTS---EELLKHRFVLR 283 (948)
T ss_pred CCCch--hHHHHHHHHHHHHhhCcccCCcH---HHHhhcchhcc
Confidence 33333 46899999999999999999999 99999999854
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=359.70 Aligned_cols=257 Identities=29% Similarity=0.476 Sum_probs=215.8
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++.+.||+|+||.||+|++..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 3468999999999999999999999999999999876543 2233567789999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||+++++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~---- 159 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT---- 159 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc----
Confidence 9999999999999988889999999999999999999999999999999999999999999999999998642111
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHh---hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVIL---RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~---~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
........|++.|+|||++. ...++.++|||||||++|+|++|..||....+..............
T Consensus 160 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd06645 160 -----------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP 228 (267)
T ss_pred -----------ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCC
Confidence 00113457999999999985 4568999999999999999999999998766555444433333322
Q ss_pred CCCC-CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCC
Q psy16843 599 PSED-DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639 (810)
Q Consensus 599 p~~~-~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPf 639 (810)
+... ...++..+.+||.+||+.+|++||++ .++++|||
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~---~~ll~~~~ 267 (267)
T cd06645 229 PKLKDKMKWSNSFHHFVKMALTKNPKKRPTA---EKLLQHPF 267 (267)
T ss_pred CcccccCCCCHHHHHHHHHHccCCchhCcCH---HHHhcCCC
Confidence 2111 12356789999999999999999998 99999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=388.70 Aligned_cols=253 Identities=27% Similarity=0.437 Sum_probs=213.4
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-C-----CeEEEeeeeccccce
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-N-----PFVVTMYCSFETKKH 438 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-H-----PnIVkl~~~f~~~~~ 438 (810)
+|++++.||+|+||.|.+|.+..|++.||||+|+... ....+...|+.||..++ | -|||+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 7999999999999999999999999999999886653 34567778999999987 4 489999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC--cEEEeccCCcccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG--HIKLTDFGLSKMG 514 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g--~VKL~DFGLAk~~ 514 (810)
+|||+|.+ +.+|+++|+.+. .|+...++.++.||+.||.+||+.||||.|||||||||..-+ .|||+|||.|...
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999998 569999998664 699999999999999999999999999999999999998644 7999999999752
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND 594 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~ 594 (810)
... ..+.+-+..|+|||+|+|.+|+.+.||||||||++||++|.+.|.|.+..+.+..|+.-
T Consensus 342 ~q~------------------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~ 403 (586)
T KOG0667|consen 342 SQR------------------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEV 403 (586)
T ss_pred CCc------------------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHH
Confidence 111 11456789999999999999999999999999999999999999999988877776620
Q ss_pred --------------------C-CC-------------------------------CC-CCCCC------cccHHHHHHHH
Q psy16843 595 --------------------D-IE-------------------------------WP-SEDDW------PIQVEAKSIIT 615 (810)
Q Consensus 595 --------------------~-~~-------------------------------~p-~~~~~------~~S~el~dLI~ 615 (810)
. .. .| ....+ .-...+.|||+
T Consensus 404 lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk 483 (586)
T KOG0667|consen 404 LGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLK 483 (586)
T ss_pred hCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHH
Confidence 0 00 01 00000 01234799999
Q ss_pred hhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 616 DLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 616 klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
+||.+||.+|++. .|+|+||||.+.
T Consensus 484 ~~L~~dP~~R~tp---~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 484 RCLEWDPAERITP---AQALNHPFLTGT 508 (586)
T ss_pred HHhccCchhcCCH---HHHhcCcccccc
Confidence 9999999999999 899999999864
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=365.43 Aligned_cols=257 Identities=27% Similarity=0.442 Sum_probs=215.5
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||++.+..++..||+|.+.... ......++..|+++++.++||||++++++|.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999876432 1234466888999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||++|++|.+++.+.+.+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 153 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----- 153 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-----
Confidence 999999999999988899999999999999999999997 59999999999999999999999999998642110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC----
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW---- 598 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~---- 598 (810)
.....+|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 154 ------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
T cd06615 154 ------------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKE 221 (308)
T ss_pred ------------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccC
Confidence 1134578999999999988889999999999999999999999997665444332221110000
Q ss_pred ------------------------------CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 599 ------------------------------PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 599 ------------------------------p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
|......++.++++||.+||..||++||++ .|++.||||.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~---~~ll~~~~~~~ 292 (308)
T cd06615 222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL---KELTKHPFIKR 292 (308)
T ss_pred CcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH---HHHhcChhhhh
Confidence 000011256789999999999999999998 99999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=361.22 Aligned_cols=266 Identities=27% Similarity=0.474 Sum_probs=224.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+.|++++.||.|+||.||+|++..+++.||+|.+.... ....+.+..|+.+++.++||||+++++++..+..+|+||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 67999999999999999999999999999999886543 334567888999999999999999999999999999999
Q ss_pred eeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||++|++|..++.+ ...+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~----- 163 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT----- 163 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-----
Confidence 99999999888754 467999999999999999999999999999999999999999999999999987642110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHh-----hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-----~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
........|++.|+|||++. ...++.++|||||||++|||++|.+||...+..+.+.++......
T Consensus 164 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 233 (292)
T cd06644 164 ----------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP 233 (292)
T ss_pred ----------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc
Confidence 01112446899999999985 345788999999999999999999999888777666666543321
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhc
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRH 651 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~ 651 (810)
.. .....++.++.+||.+||..||++||++ +|+++||||..++|....+.
T Consensus 234 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~---~~il~~~~~~~~~~~~~~~~ 283 (292)
T cd06644 234 TL-SQPSKWSMEFRDFLKTALDKHPETRPSA---AQLLEHPFVSSVTSNRPLRE 283 (292)
T ss_pred cC-CCCcccCHHHHHHHHHHhcCCcccCcCH---HHHhcCccccccccchhHHH
Confidence 11 1112367889999999999999999998 99999999999999875544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=365.88 Aligned_cols=267 Identities=30% Similarity=0.475 Sum_probs=229.5
Q ss_pred cEE-EEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeeeee
Q psy16843 366 FTV-IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 366 y~i-lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyLVm 443 (810)
|.+ .+.||+|+||.|--+....+|..||||+|.|... ....++++|++++.++ .|+||++|+++|+++..+||||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 444 3679999999999999999999999999987643 3446889999999887 6999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc---EEEeccCCcccccccccc
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~---VKL~DFGLAk~~~~s~~~ 520 (810)
|-|.||.|..+|+++..|+|.++..++..|+.||+|||.+||.||||||+|||-..-++ ||||||.|+.-......
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~- 234 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND- 234 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC-
Confidence 99999999999999999999999999999999999999999999999999999876554 89999998743211110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHh-----hcCCCCCcchhhhHHHHHHHHhCCCCCCCC-------------
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGE------------- 582 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-----~~~ys~ksDIWSLGvILyELLtG~~PF~~~------------- 582 (810)
+.. ...-.-.+.||+..|||||+.. ...|+.++|.||||||||-||.|++||.|.
T Consensus 235 ----~sp---astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 235 ----CSP---ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ----CCC---CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 000 1111124679999999999985 346899999999999999999999999764
Q ss_pred --CHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 583 --TPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 583 --~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
-...++..|..+.+.||..++..+|.+++|||..+|.+|+.+|+++ .++++|||+..+.-+
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa---~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSA---AQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhh---hhccCCccccccchh
Confidence 1356888999999999999988899999999999999999999999 899999999887544
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=363.99 Aligned_cols=262 Identities=27% Similarity=0.448 Sum_probs=213.9
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++++.||.|+||.||+|+++.+++.||+|.+...... .....+..|+.+++.++||||+++++++..++.+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 347899999999999999999999999999999988654321 122456789999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 442 VMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||||+. ++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 999997 588888764 4578999999999999999999999999999999999999999999999999986421110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC-----
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND----- 594 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~----- 594 (810)
.......+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+....+...
T Consensus 159 -------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 225 (301)
T cd07873 159 -------------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT 225 (301)
T ss_pred -------------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 011233578999999998764 5799999999999999999999999988776554433221
Q ss_pred --------------CCCCCCC-------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 595 --------------DIEWPSE-------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 595 --------------~~~~p~~-------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
...++.. ....+++++++||.+||+.||.+||++ +|++.||||..+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~---~eil~h~~f~~~~ 293 (301)
T cd07873 226 EETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA---EEAMKHPYFHCLG 293 (301)
T ss_pred hhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCH---HHHhcCccccccc
Confidence 0011110 011257889999999999999999998 9999999997753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=351.23 Aligned_cols=261 Identities=29% Similarity=0.476 Sum_probs=220.6
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||.|+||.||+|....++..+|+|++....... ..+.+.+|+++++.++|+||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999999999999999886544322 5577889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC---CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 444 EYVEGGDCASLLKNT---GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~---g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999763 46999999999999999999999999999999999999999999999999998653221100
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC-C
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE-W 598 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~-~ 598 (810)
........+|++.|+|||++... .++.++|+|||||++|+|++|..||...+..+.+..+...... +
T Consensus 159 -----------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd06610 159 -----------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSL 227 (267)
T ss_pred -----------cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCc
Confidence 00112345789999999999877 7899999999999999999999999988777766666554322 1
Q ss_pred CCCC-CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 599 PSED-DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 599 p~~~-~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
+... ...++.++++||.+||..||++||++ .+++.||||
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~---~~ll~~p~~ 267 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTA---EELLKHKFF 267 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCH---HHHhhCCCC
Confidence 1111 12367889999999999999999998 999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=357.89 Aligned_cols=252 Identities=27% Similarity=0.495 Sum_probs=211.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|.+..+++.||+|.+.+... ....+.+..|+++++.++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 478999999999999999999999999999998865422 234467889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||+++|+|..+ ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~------ 148 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------ 148 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc------
Confidence 99999998654 45789999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHhhccCC-
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-------EELFAHTVNDD- 595 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~-------~e~~~~I~~~~- 595 (810)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|..||..... .+....+....
T Consensus 149 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 217 (279)
T cd06619 149 -----------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP 217 (279)
T ss_pred -----------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC
Confidence 11345799999999999999999999999999999999999999965321 22223322221
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
...+. ...++++++||.+||+.||.+||++ +|++.||||...+
T Consensus 218 ~~~~~---~~~~~~~~~li~~~l~~~P~~Rp~~---~eil~~~~~~~~~ 260 (279)
T cd06619 218 PVLPV---GQFSEKFVHFITQCMRKQPKERPAP---ENLMDHPFIVQYN 260 (279)
T ss_pred CCCCC---CcCCHHHHHHHHHHhhCChhhCCCH---HHHhcCccccccc
Confidence 11111 2256889999999999999999998 9999999998754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=355.81 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=215.0
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++.+.||+|+||.||+|+++.+++.||+|++..... .....+..|+.+++.++||||+++++++..++.+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 4689999999999999999999999999999998864422 2335677899999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~----- 159 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT----- 159 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc-----
Confidence 999999999999988889999999999999999999999999999999999999999999999999998643211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHh---hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVIL---RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~---~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
........|++.|+|||.+. ...++.++|||||||++|||++|..||......+....+....+..+
T Consensus 160 ----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd06646 160 ----------IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP 229 (267)
T ss_pred ----------ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC
Confidence 00113456899999999985 34578899999999999999999999987665554444433333322
Q ss_pred CC-CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCC
Q psy16843 600 SE-DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639 (810)
Q Consensus 600 ~~-~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPf 639 (810)
.. ....++.++.+||.+||..+|++||++ +++++|+|
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~---~~il~~l~ 267 (267)
T cd06646 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTA---ERLLTHLF 267 (267)
T ss_pred CCccccccCHHHHHHHHHHhhCChhhCcCH---HHHhcCCC
Confidence 21 112357899999999999999999998 89999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.42 Aligned_cols=251 Identities=25% Similarity=0.431 Sum_probs=192.5
Q ss_pred EEEecccCceEEEEEEEcC--CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc--cceeeeeee
Q psy16843 369 IKLISNGAYGSVYLVRHKE--TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET--KKHLCLVME 444 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~--tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~--~~~lyLVmE 444 (810)
.++||+|+||.||+|+++. +++.||+|.+..... ...+.+|+++|+.++||||++++++|.. +..+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 4679999999999999764 678999998865432 1346689999999999999999998854 567899999
Q ss_pred eccCcchhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe----ccCCcEEEeccCCc
Q psy16843 445 YVEGGDCASLLKNT---------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI----TALGHIKLTDFGLS 511 (810)
Q Consensus 445 y~~GGsL~~lL~~~---------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL----d~~g~VKL~DFGLA 511 (810)
|+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 985 4787776421 258999999999999999999999999999999999999 45678999999999
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCH------
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETP------ 584 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~------ 584 (810)
+....... ........+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+...
T Consensus 160 ~~~~~~~~------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~ 227 (317)
T cd07868 160 RLFNSPLK------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 227 (317)
T ss_pred eccCCCCc------------cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccc
Confidence 75321100 00112345789999999999874 589999999999999999999999975432
Q ss_pred ---HHHHHhhccC---C-------------------------C------CCCCCCCCcccHHHHHHHHhhhcCCCCCCCC
Q psy16843 585 ---EELFAHTVND---D-------------------------I------EWPSEDDWPIQVEAKSIITDLLQQNPRDRLG 627 (810)
Q Consensus 585 ---~e~~~~I~~~---~-------------------------~------~~p~~~~~~~S~el~dLI~klL~~dP~~Rpt 627 (810)
...+..+... . . .+........+.++.+||.+||+.||.+|||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 307 (317)
T cd07868 228 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 307 (317)
T ss_pred cccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCC
Confidence 1111111110 0 0 0000001113467899999999999999999
Q ss_pred CCChhHHhcCCCc
Q psy16843 628 TGGPHEVKEHPYF 640 (810)
Q Consensus 628 a~~~~EiL~HPfF 640 (810)
+ +|+++||||
T Consensus 308 ~---~e~l~hp~f 317 (317)
T cd07868 308 S---EQAMQDPYF 317 (317)
T ss_pred H---HHHhcCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=359.55 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=206.1
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++.+.||+|+||.||+|+++.+|+.||+|.+...... ......+..|+++++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 489999999999999999999999999999988654321 2223456789999999999999999999999999999999
Q ss_pred eccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 445 YVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 445 y~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
|+.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----- 153 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV----- 153 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-----
Confidence 9975 77777654 5689999999999999999999999999999999999999999999999999986421110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCC-CCCCHHHHHHhhccCC------
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPF-FGETPEELFAHTVNDD------ 595 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF-~~~~~~e~~~~I~~~~------ 595 (810)
.......+++.|+|||++.+. .++.++|||||||++|||++|..|| .+.+..+.+..+....
T Consensus 154 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07839 154 ----------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 223 (284)
T ss_pred ----------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChH
Confidence 011234578999999998775 4799999999999999999988885 4445444444332100
Q ss_pred -----------CCCCCC--------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 596 -----------IEWPSE--------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 596 -----------~~~p~~--------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..++.. ....++.++++||.+||+.||.+||++ +|++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~---~~il~h~~f 284 (284)
T cd07839 224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA---EEALQHPYF 284 (284)
T ss_pred HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH---HHHhcCCCC
Confidence 000000 001257889999999999999999998 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=350.81 Aligned_cols=260 Identities=28% Similarity=0.458 Sum_probs=218.4
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh------hHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM------LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~------~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
+|.+.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+..|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 377889999999999999999999999999988654322 22344678899999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
.++||||+++++|.+++...+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999987532111
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-C
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI-E 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~-~ 597 (810)
... ..........|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+....+..+..... .
T Consensus 161 ~~~---------~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06628 161 LST---------KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE 231 (267)
T ss_pred ccC---------CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCc
Confidence 000 000011235689999999999998999999999999999999999999988776655555444211 2
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.+ ..++.++.++|.+||+.||.+||++ .|+++||||
T Consensus 232 ~~----~~~~~~~~~li~~~l~~~p~~Rp~~---~~il~~~~~ 267 (267)
T cd06628 232 IP----SNISSEAIDFLEKTFEIDHNKRPTA---AELLKHPFL 267 (267)
T ss_pred CC----cccCHHHHHHHHHHccCCchhCcCH---HHHhhCCCC
Confidence 22 2367899999999999999999998 999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=356.23 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=220.6
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||.|+||.||+|.+..+++.||+|.+.... ....+.+..|+++++.++||||+++++++.++..+|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 57999999999999999999999899999999886432 334567888999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||++||+|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~----- 156 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST----- 156 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc-----
Confidence 999999999998764 57999999999999999999999999999999999999999999999999987642110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhh-----cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILR-----QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
........|++.|+|||++.. ..++.++|||||||++|||++|.+||.+.+..+.+..+......
T Consensus 157 ----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 226 (280)
T cd06611 157 ----------LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPP 226 (280)
T ss_pred ----------ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCC
Confidence 001124568999999999863 45788999999999999999999999988887777666654321
Q ss_pred -CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 598 -WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 598 -~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
+... ..++.++.+||.+||+.+|.+||++ .++++||||.+...
T Consensus 227 ~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~---~~il~~~~~~~~~~ 270 (280)
T cd06611 227 TLDQP--SKWSSSFNDFLKSCLVKDPDDRPTA---AELLKHPFVSDQSD 270 (280)
T ss_pred CcCCc--ccCCHHHHHHHHHHhccChhhCcCH---HHHhcChhhcccch
Confidence 1111 1267899999999999999999998 99999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=354.43 Aligned_cols=258 Identities=30% Similarity=0.480 Sum_probs=213.2
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+..|+++++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 4699999999999999999999999999999988654321 122345778999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++++.|..++.....+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---- 155 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc----
Confidence 9999999988887777899999999999999999999999999999999999999999999999999865321100
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC--------
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND-------- 594 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~-------- 594 (810)
......|+..|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....+...
T Consensus 156 -----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07847 156 -----------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224 (286)
T ss_pred -----------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 1123457899999999876 45799999999999999999999999887765544333210
Q ss_pred -----------CCCCCCCC--------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 595 -----------DIEWPSED--------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 595 -----------~~~~p~~~--------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
....+... ...++..+.+||.+||+.+|++||++ .|++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~---~eil~~~~f 286 (286)
T cd07847 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSC---EELLEHPYF 286 (286)
T ss_pred hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCH---HHHhcCCCC
Confidence 00011110 01256789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=358.94 Aligned_cols=242 Identities=17% Similarity=0.195 Sum_probs=208.0
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc----cceeeeeeee
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET----KKHLCLVMEY 445 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~----~~~lyLVmEy 445 (810)
..||+|++|.||+|.. +|+.||||.+.+.........+.+.+|+.+|+.++|||||++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999987 688999999876544444445778899999999999999999999876 4578999999
Q ss_pred ccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 446 VEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 446 ~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
++||+|.+++.+.+.+++.....++.|++.||.|||+ .+++||||||+|||++.+|.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~------- 176 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP------- 176 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-------
Confidence 9999999999988889999999999999999999998 49999999999999999999999999998642110
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhh--cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILR--QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~ 602 (810)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+++..+......++..
T Consensus 177 -----------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~- 244 (283)
T PHA02988 177 -----------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP- 244 (283)
T ss_pred -----------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC-
Confidence 113468999999999987 689999999999999999999999999999888888876654443322
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
...+.++++||.+||+.||++||++ .|++.
T Consensus 245 -~~~~~~l~~li~~cl~~dp~~Rps~---~ell~ 274 (283)
T PHA02988 245 -LDCPLEIKCIVEACTSHDSIKRPNI---KEILY 274 (283)
T ss_pred -CcCcHHHHHHHHHHhcCCcccCcCH---HHHHH
Confidence 1267899999999999999999998 66653
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=348.40 Aligned_cols=255 Identities=29% Similarity=0.486 Sum_probs=218.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+..|+++++.++||||+++++++...+.+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 689999999999999999999999999999998865432 24577889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||++|++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.+|.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~----- 154 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT----- 154 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh-----
Confidence 999999999999766 78999999999999999999999999999999999999999999999999998642111
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhc---CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQ---GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~---~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
........|+..|+|||++.+. .++.++|+|||||++|||++|.+||.+.+..+....+....+..+
T Consensus 155 ----------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 224 (262)
T cd06613 155 ----------IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP 224 (262)
T ss_pred ----------hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc
Confidence 0011245689999999999877 889999999999999999999999998877766655555433222
Q ss_pred CC-CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCC
Q psy16843 600 SE-DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639 (810)
Q Consensus 600 ~~-~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPf 639 (810)
.. .....+.++.+||.+||..+|.+||++ .+++.|+|
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~---~~il~~~~ 262 (262)
T cd06613 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTA---TKLLQHPF 262 (262)
T ss_pred cccchhhhhHHHHHHHHHHcCCChhhCCCH---HHHhcCCC
Confidence 11 112356789999999999999999999 99999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=353.29 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=211.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecccc-----
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETK----- 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~----- 436 (810)
.+.|++.+.||+|+||.||+|.++.+++.||+|.+..... ....+..|+.++..+ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 4679999999999999999999999999999998865432 224677889999888 799999999998642
Q ss_pred -ceeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 437 -KHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 437 -~~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
..+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4689999999999999999753 4689999999999999999999999999999999999999999999999999864
Q ss_pred ccccccccchhhhhhcccccccCCcccCCCCcCChhHHh-----hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHH
Q psy16843 514 GLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELF 588 (810)
Q Consensus 514 ~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-----~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~ 588 (810)
.... ........|++.|+|||++. +..|+.++|||||||++|||++|..||.........
T Consensus 161 ~~~~---------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~ 225 (272)
T cd06637 161 LDRT---------------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 225 (272)
T ss_pred cccc---------------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 2111 00123457999999999996 346889999999999999999999999877666555
Q ss_pred HhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 589 AHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 589 ~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..+......... ....+.++.+||.+||..||.+||++ .|++.||||
T Consensus 226 ~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~---~~il~~~~~ 272 (272)
T cd06637 226 FLIPRNPAPRLK--SKKWSKKFQSFIESCLVKNHSQRPTT---EQLMKHPFI 272 (272)
T ss_pred HHHhcCCCCCCC--CCCcCHHHHHHHHHHcCCChhhCCCH---HHHhhCCCC
Confidence 544433222111 12367899999999999999999998 999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=349.84 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=216.7
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccch---hhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL---MLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~---~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
+|.+.+.||+|+||.||+|.. .+++.+|+|.+..... ........+.+|+++++.++|+||+++++++.+.+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588899999999999999976 4788999998864321 223445678899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||++|++|.+++.+.+.+++..+..++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++..........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999986532110000
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
..........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+.......+..
T Consensus 160 ---------~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd06631 160 ---------THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL 230 (265)
T ss_pred ---------cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCC
Confidence 00011134568999999999999999999999999999999999999998776655544444332222211
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
...++.++.+||.+||..+|.+||++ .|++.||||
T Consensus 231 -~~~~~~~~~~~i~~~l~~~p~~Rp~~---~~~l~~~~~ 265 (265)
T cd06631 231 -PDSFSAAAIDFVTSCLTRDQHERPSA---LQLLRHDFL 265 (265)
T ss_pred -CCCCCHHHHHHHHHHhcCCcccCCCH---HHHhcCCCC
Confidence 12367899999999999999999999 999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=374.20 Aligned_cols=253 Identities=23% Similarity=0.400 Sum_probs=201.9
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
...+|++++.||+|+||.||+|+++.+++.||+|+..+.. ...|+.+++.++||||+++++++......|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 4467999999999999999999999999999999754322 2458899999999999999999999999999
Q ss_pred eeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 442 VMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||||+. |+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 210 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--- 210 (357)
T ss_pred EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence 999995 577777754 467999999999999999999999999999999999999999999999999998642110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCC-CCCCH---------HHHHHh
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPF-FGETP---------EELFAH 590 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF-~~~~~---------~e~~~~ 590 (810)
.......||+.|+|||++.+..|+.++|||||||++|||+++..|+ .+... ...+..
T Consensus 211 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~ 277 (357)
T PHA03209 211 -------------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277 (357)
T ss_pred -------------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHH
Confidence 0112456999999999999999999999999999999999854444 33211 011111
Q ss_pred hcc----CCCCCCC--------------------------CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 591 TVN----DDIEWPS--------------------------EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 591 I~~----~~~~~p~--------------------------~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
++. ....++. .....++.++.+||.+||+.||.+||++ .|+++||||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta---~e~l~hp~f 354 (357)
T PHA03209 278 IISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA---EEILNYPMF 354 (357)
T ss_pred HHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCH---HHHhcCchh
Confidence 111 0111110 0011245678899999999999999999 999999999
Q ss_pred CCC
Q psy16843 641 SNL 643 (810)
Q Consensus 641 ~~i 643 (810)
+++
T Consensus 355 ~~~ 357 (357)
T PHA03209 355 AQL 357 (357)
T ss_pred ccC
Confidence 864
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=366.20 Aligned_cols=265 Identities=20% Similarity=0.347 Sum_probs=210.2
Q ss_pred EEEEeccc--CceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeee
Q psy16843 368 VIKLISNG--AYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445 (810)
Q Consensus 368 ilk~LG~G--~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy 445 (810)
++++||+| +||+||++.++.+|+.||+|.+...... ....+.+..|+++++.++||||++++++|.+++.+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 7889999999999999999988654332 33456778899999999999999999999999999999999
Q ss_pred ccCcchhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 446 VEGGDCASLLKN--TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 446 ~~GGsL~~lL~~--~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
+++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~-- 158 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL-- 158 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc--
Confidence 999999999964 3469999999999999999999999999999999999999999999999998654321100000
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhh--cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC---
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILR--QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW--- 598 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~--- 598 (810)
. .........+++..|+|||++.+ ..|+.++|||||||++|||++|..||.+....+............
T Consensus 159 -----~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (327)
T cd08227 159 -----R-VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 232 (327)
T ss_pred -----c-ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence 0 00001123457888999999986 468999999999999999999999998765554443333222110
Q ss_pred ----C-----------------------------------CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCC
Q psy16843 599 ----P-----------------------------------SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639 (810)
Q Consensus 599 ----p-----------------------------------~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPf 639 (810)
+ ......+++++.+||.+||+.||++||++ .|+++|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~---~ell~~p~ 309 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA---STLLNHSF 309 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH---HHHhcChh
Confidence 0 00011246789999999999999999999 99999999
Q ss_pred cCCCC
Q psy16843 640 FSNLD 644 (810)
Q Consensus 640 F~~id 644 (810)
|+.+.
T Consensus 310 f~~~~ 314 (327)
T cd08227 310 FKQIK 314 (327)
T ss_pred hhhcc
Confidence 98753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=355.52 Aligned_cols=263 Identities=21% Similarity=0.319 Sum_probs=216.0
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKE-----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~-----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
...++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+..|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 455789999999999999999998653 345799998754432 2233457789999999999999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEE
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNT----------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 505 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~----------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL 505 (810)
....|+||||+.+|+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999999643 23456788899999999999999999999999999999999999999
Q ss_pred eccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCH
Q psy16843 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETP 584 (810)
Q Consensus 506 ~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~ 584 (810)
+|||+++....... ........++..|+|||.+.+..++.++|+|||||++|||++ |..||.+...
T Consensus 161 ~Dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~ 227 (288)
T cd05061 161 GDFGMTRDIYETDY-------------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227 (288)
T ss_pred CcCCcccccccccc-------------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999875321100 001122346778999999999999999999999999999998 8999999888
Q ss_pred HHHHHhhccCCCC-CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc------CCCcCCCCh
Q psy16843 585 EELFAHTVNDDIE-WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE------HPYFSNLDW 645 (810)
Q Consensus 585 ~e~~~~I~~~~~~-~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~------HPfF~~id~ 645 (810)
.+.+..+...... .+. ..++.+.++|.+||+.||++||++ .++++ ||||.+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~---~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 228 EQVLKFVMDGGYLDQPD----NCPERVTDLMRMCWQFNPKMRPTF---LEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCChhHCcCH---HHHHHHHHhhcCCCCCCCCC
Confidence 8877776654322 221 256889999999999999999999 55554 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.57 Aligned_cols=260 Identities=26% Similarity=0.413 Sum_probs=216.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccc--hhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc--cee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNS--LMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK--KHL 439 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~--~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~--~~l 439 (810)
++|++.+.||+|+||.||+|.++.+++.||||.+.... ......++.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999999999999875432 12234567888999999999999999999998763 578
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999864211000
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
.........|+..|+|||++.+..++.++|||||||++|||++|+.||.+......+..+........
T Consensus 162 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06652 162 ------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPV 229 (265)
T ss_pred ------------cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCC
Confidence 00011234689999999999998999999999999999999999999988766665555443322111
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
. ...++..+.++|.+||. +|++||++ +|++.|||+.
T Consensus 230 ~--~~~~~~~~~~~i~~~l~-~p~~Rp~~---~~il~~~~~~ 265 (265)
T cd06652 230 L--PPHVSDHCRDFLKRIFV-EAKLRPSA---DELLRHTFVH 265 (265)
T ss_pred C--chhhCHHHHHHHHHHhc-ChhhCCCH---HHHhcCcccC
Confidence 1 12366889999999995 99999998 9999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=354.31 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=207.6
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++++.||.|+||.||+|.++.+++.||+|++...... ....+.+..|+.+++.++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999999999999988654321 2233567789999999999999999999999999999999
Q ss_pred eccCcchhhhhhcC---CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 445 YVEGGDCASLLKNT---GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 445 y~~GGsL~~lL~~~---g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|++ ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---- 154 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC----
Confidence 997 5788877532 56999999999999999999999999999999999999999999999999998642111
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC----
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI---- 596 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~---- 596 (810)
........|++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+...-.
T Consensus 155 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
T cd07861 155 -----------VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE 223 (285)
T ss_pred -----------cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 0011223578999999998764 579999999999999999999999988765443332211000
Q ss_pred --------------CCC-------CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 597 --------------EWP-------SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 597 --------------~~p-------~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.++ ......+++++++||.+||+.||.+||++ .+++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~---~~ll~~~~~ 285 (285)
T cd07861 224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA---KKALNHPYF 285 (285)
T ss_pred hhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCH---HHHhcCCCC
Confidence 000 00011267899999999999999999998 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=355.98 Aligned_cols=270 Identities=36% Similarity=0.701 Sum_probs=224.1
Q ss_pred CcEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccchh-hHHHHHHHHHHHHHHhcC-CCCeEEEeeeecccccee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHK---ETRQRFAMKKIIKNSLM-LRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k---~tg~~vAIK~I~k~~~~-~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~l 439 (810)
+|++.+.||+|+||.||++++. .+++.||+|.+.+.... .....+.+..|++++..+ +||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46788999988754332 223446678899999999 699999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||+.||+|.+++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-- 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc--
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998643211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcC--CCCCcchhhhHHHHHHHHhCCCCCCCCC----HHHHHHhhcc
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG--YGKPVDWWSMGVILYEFLVGCVPFFGET----PEELFAHTVN 593 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~--ys~ksDIWSLGvILyELLtG~~PF~~~~----~~e~~~~I~~ 593 (810)
........+|++.|+|||.+.+.. ++.++||||||+++|||++|..||.... ..+....+..
T Consensus 159 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd05583 159 ------------EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK 226 (288)
T ss_pred ------------cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc
Confidence 011112456899999999987754 7899999999999999999999996432 2333344444
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhcc
Q psy16843 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHK 652 (810)
Q Consensus 594 ~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~ 652 (810)
.....+. .++.++.++|.+||+.||++||++.++.++++||||+.++|+.+....
T Consensus 227 ~~~~~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~~ 281 (288)
T cd05583 227 SKPPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKR 281 (288)
T ss_pred cCCCCCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhhc
Confidence 3333332 266899999999999999999999888999999999999999886554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=352.69 Aligned_cols=258 Identities=29% Similarity=0.517 Sum_probs=221.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||.|+||.||+|++..+++.||+|.+..... ......+..|+++++.++|+||+++++++.++..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 468999999999999999999999999999998865432 234466788999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||+++++|.+++... .+++..++.++.||+.||.|||++||+||||+|+||+++.+|.++|+|||+++......
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~----- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM----- 152 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-----
Confidence 999999999999864 89999999999999999999999999999999999999999999999999987532110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
.......|++.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....+......... .
T Consensus 153 ----------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~ 220 (274)
T cd06609 153 ----------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--G 220 (274)
T ss_pred ----------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--c
Confidence 1113456899999999999988999999999999999999999999888777766665554322211 1
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
..++.++.++|.+||..+|++||++ ++++.||||....
T Consensus 221 ~~~~~~~~~~l~~~l~~~p~~Rpt~---~~il~~~~~~~~~ 258 (274)
T cd06609 221 NKFSKPFKDFVSLCLNKDPKERPSA---KELLKHKFIKKAK 258 (274)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCH---HHHhhChhhcCCC
Confidence 1267889999999999999999998 9999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=356.79 Aligned_cols=254 Identities=30% Similarity=0.515 Sum_probs=212.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|+++.+++.||+|.+.... .......+.+|+++++.++||||+++++++...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999999999999999886532 2233467889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC---CCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 444 EYVEGGDCASLLKNT---GPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~---g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
||++|++|..++... +.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999999988763 479999999999999999999996 59999999999999999999999999998642110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhc------CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHh---
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ------GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH--- 590 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~------~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~--- 590 (810)
......|++.|+|||++.+. .++.++|||||||++|+|++|..||...........
T Consensus 157 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 221 (286)
T cd06622 157 ---------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA 221 (286)
T ss_pred ---------------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH
Confidence 11234688999999998643 358899999999999999999999977655444333
Q ss_pred hccCC-CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 591 TVNDD-IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 591 I~~~~-~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
+.... ...+ ..++.++.+||.+||+.+|.+||++ .+++.||||...
T Consensus 222 ~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~---~~l~~~~~~~~~ 268 (286)
T cd06622 222 IVDGDPPTLP----SGYSDDAQDFVAKCLNKIPNRRPTY---AQLLEHPWLVKY 268 (286)
T ss_pred HhhcCCCCCC----cccCHHHHHHHHHHcccCcccCCCH---HHHhcChhhhhc
Confidence 22222 1222 2267899999999999999999998 999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=349.16 Aligned_cols=261 Identities=24% Similarity=0.407 Sum_probs=214.8
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh---hHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM---LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~---~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
+|+..+.||+|+||.||++..+.+++.||+|++...... .....+.+..|+++++.++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999999999999999988654321 12345778899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC-cEEEeccCCcccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG-HIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g-~VKL~DFGLAk~~~~s~~~ 520 (810)
||||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~- 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT- 159 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc-
Confidence 999999999999998888999999999999999999999999999999999999998876 599999999865321100
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHH---HHHhhccCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE---LFAHTVNDDIE 597 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e---~~~~I~~~~~~ 597 (810)
..........|+..|+|||++.+..++.++|+||||+++|+|++|..||....... ....+......
T Consensus 160 ----------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (268)
T cd06630 160 ----------GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA 229 (268)
T ss_pred ----------cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC
Confidence 00011234578999999999998899999999999999999999999997554322 22222211111
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
......+++++.++|.+||..+|.+||++ .|+++||||+
T Consensus 230 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~---~~ll~~~~~~ 268 (268)
T cd06630 230 --PSIPEHLSPGLRDVTLRCLELQPEDRPPS---RELLKHPVFR 268 (268)
T ss_pred --CCCchhhCHHHHHHHHHHcCCCcccCcCH---HHHhcCcccC
Confidence 11112367899999999999999999999 9999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=353.64 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=216.6
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
-|++++.||.|+||.||+|.+..++..+|+|.+.... ....+.+..|+++++.++||||+++++++......|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 4788999999999999999999999999999885543 2345677889999999999999999999999999999999
Q ss_pred eccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 445 YVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 445 y~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
|+++|+|..++.+ .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~------ 156 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT------ 156 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc------
Confidence 9999999988754 567999999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHh-----hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-----~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
........|++.|+|||++. +..++.++|||||||++|||++|.+||...+..+....+.......
T Consensus 157 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd06643 157 ---------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 227 (282)
T ss_pred ---------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC
Confidence 00113456899999999984 4567889999999999999999999999888777666665433221
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.. ....++.++++||.+||++||.+||++ .++++||||...
T Consensus 228 ~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~---~~il~~~~~~~~ 268 (282)
T cd06643 228 LA-QPSRWSSEFKDFLKKCLEKNVDARWTT---TQLLQHPFVTVN 268 (282)
T ss_pred CC-CccccCHHHHHHHHHHccCChhhCcCH---HHHhcCCCEecc
Confidence 11 112367899999999999999999998 999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.20 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=214.6
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccch--hhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc--ccee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL--MLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET--KKHL 439 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~--~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~--~~~l 439 (810)
.+|++.+.||+|+||.||+|.+..++..||+|++..... ......+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 479999999999999999999999999999998865422 223455678899999999999999999998865 3678
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
++||||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999864211000
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
.........|+..|+|||.+.+..++.++|||||||++|||++|..||......+....+...... +
T Consensus 162 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~-~ 228 (266)
T cd06651 162 ------------SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN-P 228 (266)
T ss_pred ------------cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC-C
Confidence 000112345899999999999989999999999999999999999999887666555544432211 1
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
. ....+++.+++|| +||..+|++||++ +|+++||||+
T Consensus 229 ~-~~~~~~~~~~~li-~~~~~~p~~Rp~~---~eil~hp~~~ 265 (266)
T cd06651 229 Q-LPSHISEHARDFL-GCIFVEARHRPSA---EELLRHPFAQ 265 (266)
T ss_pred C-CchhcCHHHHHHH-HHhcCChhhCcCH---HHHhcCcccc
Confidence 1 1112568899999 5777899999998 9999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=349.03 Aligned_cols=260 Identities=28% Similarity=0.460 Sum_probs=216.3
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh-------hHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM-------LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~-------~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
+|.+.+.||.|+||.||+|....+|+.||+|.+...... .....+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478899999999999999999999999999987542211 1223456788999999999999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.+++||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998642110
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcC--CCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG--YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~--ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
..........|+..|+|||++.... ++.++|+||||+++|||++|..||......+....+....
T Consensus 162 -------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 228 (272)
T cd06629 162 -------------YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR 228 (272)
T ss_pred -------------ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc
Confidence 0011123456899999999998754 8999999999999999999999998766655554443322
Q ss_pred --CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 596 --IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 596 --~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..++......++.++++||.+||.++|.+||++ +++++||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~~il~~~~~ 272 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTA---RELLQHPFI 272 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCH---HHHhhCCCC
Confidence 222332222367899999999999999999998 999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.22 Aligned_cols=254 Identities=27% Similarity=0.481 Sum_probs=220.0
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++.+.||+|+||.||+++...+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 589999999999999999999999999999988654332 2344678899999999999999999999999999999999
Q ss_pred eccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 445 YVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 445 y~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|+.|++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~----- 154 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----- 154 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc-----
Confidence 99999999998754 36899999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~ 602 (810)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+..+......
T Consensus 155 ----------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-- 222 (256)
T cd08218 155 ----------VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVS-- 222 (256)
T ss_pred ----------hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCc--
Confidence 00112345899999999999989999999999999999999999999988888888777765543211
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
...+.++.++|.+||+.+|.+||++ .|++.||||
T Consensus 223 -~~~~~~~~~li~~~l~~~p~~Rp~~---~~vl~~~~~ 256 (256)
T cd08218 223 -SHYSYDLRNLVSQLFKRNPRDRPSV---NSILEKNFI 256 (256)
T ss_pred -ccCCHHHHHHHHHHhhCChhhCcCH---HHHhhCcCC
Confidence 2367899999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=343.40 Aligned_cols=254 Identities=30% Similarity=0.479 Sum_probs=222.2
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++++.||.|+||.||.++...+++.+++|.+...... ....+.+.+|+++++.++|+||+++++++.+.+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 589999999999999999999999999999988655432 2345678899999999999999999999999999999999
Q ss_pred eccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 445 YVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 445 y~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|++||+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~---- 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---- 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence 99999999999764 568999999999999999999999999999999999999999999999999986532110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~ 602 (810)
.......|++.|+|||++.+..++.++||||||+++|||++|..||.+.+..+....+..+......
T Consensus 156 -----------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-- 222 (256)
T cd08221 156 -----------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV-- 222 (256)
T ss_pred -----------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc--
Confidence 0123456899999999999888999999999999999999999999998888888887766543322
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..++.++.++|.+||..+|.+||++ +|+++|||+
T Consensus 223 -~~~~~~~~~~i~~~l~~~p~~R~s~---~~ll~~~~l 256 (256)
T cd08221 223 -SVYSSELISLVHSLLQQDPEKRPTA---DEVLDQPLL 256 (256)
T ss_pred -cccCHHHHHHHHHHcccCcccCCCH---HHHhhCcCC
Confidence 2367899999999999999999998 999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=377.91 Aligned_cols=283 Identities=23% Similarity=0.378 Sum_probs=228.1
Q ss_pred ccccchhhhcccCCCCccccCCCCcccccC-----C-----cccCCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEE
Q psy16843 325 VFSDLDNDIQNISLTDTSIESNSDSYCSKK-----D-----KFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAM 394 (810)
Q Consensus 325 ~F~~l~~di~~~s~sd~s~e~~~~s~~~~~-----~-----~~~~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAI 394 (810)
.|..+.+.+..+..............+... . .-.+....+.+.+++.||+|-||.||+|.++.+ ..||+
T Consensus 157 ~F~~l~~lv~~~~~~~~gl~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vav 235 (468)
T KOG0197|consen 157 LFSSLQQLVNYYSKNADGLCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAV 235 (468)
T ss_pred hhhhHHHHHhhhhccCcchhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-Ccccc
Confidence 366666666666666555444333333221 1 112223334567789999999999999999754 46999
Q ss_pred EEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcchhhhhhc--CCCCCHHHHHHHHHH
Q psy16843 395 KKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKN--TGPLPADMARFYFAE 472 (810)
Q Consensus 395 K~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~--~g~lse~~~~~i~~Q 472 (810)
|.+....+.. +.+.+|++||++|+|++||++++++..++.+|||||||+.|+|.++|+. ++.+...+...++.|
T Consensus 236 k~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~q 311 (468)
T KOG0197|consen 236 KTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQ 311 (468)
T ss_pred eEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHH
Confidence 9887654332 5677999999999999999999999998899999999999999999986 567999999999999
Q ss_pred HHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHh
Q psy16843 473 TVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL 552 (810)
Q Consensus 473 Il~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~ 552 (810)
|++|++||+++++|||||-+.||||++++.+||+|||||+...... |.... ..--...|.|||.+.
T Consensus 312 IaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-------Y~~~~-------~~kfPIkWtAPEa~~ 377 (468)
T KOG0197|consen 312 IAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-------YTASE-------GGKFPIKWTAPEALN 377 (468)
T ss_pred HHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc-------eeecC-------CCCCCceecCHHHHh
Confidence 9999999999999999999999999999999999999998422110 11111 111256799999999
Q ss_pred hcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 553 RQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 553 ~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
...++.++|||||||+||||+| |+.||.+.+..+++..+..+ +.+|.+.. .++++.+++..||..+|++|||+.
T Consensus 378 ~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-yRlp~P~~--CP~~vY~lM~~CW~~~P~~RPtF~ 452 (468)
T KOG0197|consen 378 YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-YRLPRPEG--CPDEVYELMKSCWHEDPEDRPTFE 452 (468)
T ss_pred hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-CcCCCCCC--CCHHHHHHHHHHhhCCcccCCCHH
Confidence 9999999999999999999998 99999999999999887765 45666554 779999999999999999999993
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.97 Aligned_cols=254 Identities=30% Similarity=0.500 Sum_probs=216.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++.+.||+|+||.||+|.++.+++.||+|.+..... .+.+.+|+++++.++||||+++++++.+...+|+|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3689999999999999999999999899999998765421 57788999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
+||+.+++|.+++.. ...+++..++.++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--- 153 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--- 153 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc---
Confidence 999999999999975 4578999999999999999999999999999999999999999999999999986532110
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
.......|+..|+|||++.+..++.++||||||+++|+|++|..||......+....+.........
T Consensus 154 ------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 220 (256)
T cd06612 154 ------------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS- 220 (256)
T ss_pred ------------cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCC-
Confidence 0112345889999999999999999999999999999999999999887766555444332221111
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
....++.++.+||.+||+.||.+||++ .|++.||||
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~---~~il~~~~~ 256 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSA---IQLLQHPFI 256 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCH---HHHhcCCCC
Confidence 112256789999999999999999999 999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=353.86 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=213.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|.++.+++.||+|.+.+..... ...+.+.+|+++++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999999999999876543322 33456788999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++++.|..++...+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~----- 154 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG----- 154 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-----
Confidence 999999999888776779999999999999999999999999999999999999999999999999986422110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-------
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD------- 595 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~------- 595 (810)
.......|+..|+|||++.+ ..++.++|||||||++|||++|.+||.+....+....+....
T Consensus 155 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07846 155 ----------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH 224 (286)
T ss_pred ----------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhh
Confidence 01123468899999999976 457899999999999999999999998776544433332100
Q ss_pred ------------CCCCCCC--------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 596 ------------IEWPSED--------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 596 ------------~~~p~~~--------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
...+... ...++..+.+||.+||..+|++||++ .++++||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~---~~il~~~~~ 286 (286)
T cd07846 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS---SQLLHHEFF 286 (286)
T ss_pred HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhH---HHHhcCCCC
Confidence 0011000 11256889999999999999999999 899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=354.74 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=217.4
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
..+|++++.||+|+||.||+|.++.+++.||+|.+...... ..+.+..|+.+++.++||||+++++.|......|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 36899999999999999999999999999999988764432 236678899999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||++|++|.+++.+ +.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~----- 169 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE----- 169 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc-----
Confidence 999999999999865 56899999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~ 602 (810)
........|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...... +...
T Consensus 170 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~ 238 (296)
T cd06654 170 ----------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQN 238 (296)
T ss_pred ----------ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC-CCCC
Confidence 00112346899999999999988999999999999999999999999888765544333322211 1111
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
...++..+.+||.+||.+||++||++ .|++.||||...
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~---~eil~~~~~~~~ 276 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSA---KELLQHQFLKIA 276 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCH---HHHhhChhhhcc
Confidence 12367889999999999999999998 999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=375.51 Aligned_cols=263 Identities=32% Similarity=0.580 Sum_probs=231.5
Q ss_pred cEE--EEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 366 FTV--IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 366 y~i--lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
|++ .+.||+|.||+||-|+++.+|+.||||+|.|.....+ +..++..|+.||..+.||.||.+-..|++.+.+++||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 555 4789999999999999999999999999988776654 4478999999999999999999999999999999999
Q ss_pred eeccCcchhhhh-hcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC---cEEEeccCCccccccccc
Q psy16843 444 EYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 444 Ey~~GGsL~~lL-~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g---~VKL~DFGLAk~~~~s~~ 519 (810)
|-+.|.-|.-+| .+.|++++...++++.||+.||.|||.+||+|.||||+||||.... .+||||||+|+.+...
T Consensus 643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 999664444444 3568999999999999999999999999999999999999997643 6999999999975432
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
.-.++.+|||.|+|||++..++|...-|+||.|||+|--+.|..||... +++-.+|.+..+-+|
T Consensus 721 --------------sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyP 784 (888)
T KOG4236|consen 721 --------------SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYP 784 (888)
T ss_pred --------------hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccC
Confidence 1125789999999999999999999999999999999999999999643 456677888888899
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC-hhhhhh
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD-WNSLLR 650 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id-~~~l~~ 650 (810)
...+..+++++.|||..+|+..-.+|.+. +..+.|||+++.. |-+|..
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysv---dk~lsh~Wlq~yq~w~DLRe 833 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSV---DKSLSHPWLQDYQTWLDLRE 833 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcch---HhhccchhhhcchHHHHHHH
Confidence 88888899999999999999999999998 8999999999874 777654
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.19 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=210.2
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccc-----
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFET----- 435 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~----- 435 (810)
..+.|++.+.||.|+||.||+|+++.+++.||+|.+.... .....+..|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3478999999999999999999999999999999876542 2335677888888887 79999999999853
Q ss_pred -cceeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 436 -KKHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 436 -~~~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 46889999999999999999653 468899999999999999999999999999999999999999999999999986
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHh-----hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHH
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL 587 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-----~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~ 587 (810)
..... .......+|++.|+|||++. +..|+.++|||||||++|||++|..||....+.+.
T Consensus 170 ~~~~~---------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 170 QLDRT---------------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred hhhcc---------------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 42111 00123457899999999986 35688999999999999999999999987766555
Q ss_pred HHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 588 ~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
...+...... ......++.++.+||.+||..||.+||++ .|+++||||
T Consensus 235 ~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~---~ell~~~~~ 282 (282)
T cd06636 235 LFLIPRNPPP--KLKSKKWSKKFIDFIEGCLVKNYLSRPST---EQLLKHPFI 282 (282)
T ss_pred hhhHhhCCCC--CCcccccCHHHHHHHHHHhCCChhhCcCH---HHHhcCCCC
Confidence 4443332211 11112367899999999999999999998 999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=396.66 Aligned_cols=262 Identities=27% Similarity=0.449 Sum_probs=216.0
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc--cce
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET--KKH 438 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~--~~~ 438 (810)
...++|++++.||+|+||.||+|+++.+++.||+|++...... ......+..|+.+|+.++|||||+++++|.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3457899999999999999999999999999999988765432 3345678899999999999999999998854 457
Q ss_pred eeeeeeeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhc-------ccccccCCCCceEecc--------
Q psy16843 439 LCLVMEYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSY-------GIVHRDLKPDNLLITA-------- 499 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~-------gIIHRDLKPeNILLd~-------- 499 (810)
+||||||+++|+|.++|.. .+.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 9999999999999999864 36799999999999999999999984 4999999999999964
Q ss_pred ---------CCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh--cCCCCCcchhhhHHH
Q psy16843 500 ---------LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR--QGYGKPVDWWSMGVI 568 (810)
Q Consensus 500 ---------~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--~~ys~ksDIWSLGvI 568 (810)
.+.+||+|||+++..... ......+||+.|+|||++.+ ..|+.++||||||||
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~----------------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~I 232 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE----------------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc----------------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHH
Confidence 235999999998642110 01134579999999999975 458999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 569 LYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 569 LyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
||||++|..||........+...+.....++.. ..+.++.+||.+||..+|.+||++ .|+|.||||..+..
T Consensus 233 LYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~---~~S~eL~dLI~~~L~~dPeeRPSa---~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 233 IYELCSGKTPFHKANNFSQLISELKRGPDLPIK---GKSKELNILIKNLLNLSAKERPSA---LQCLGYQIIKNVGP 303 (1021)
T ss_pred HHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcC---CCCHHHHHHHHHHhcCChhHCcCH---HHHhccHHHhhcCC
Confidence 999999999998765554444444433333322 257899999999999999999999 99999999987643
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=352.24 Aligned_cols=269 Identities=35% Similarity=0.686 Sum_probs=222.1
Q ss_pred CcEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccchh-hHHHHHHHHHHHHHHhcC-CCCeEEEeeeecccccee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHK---ETRQRFAMKKIIKNSLM-LRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k---~tg~~vAIK~I~k~~~~-~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~l 439 (810)
+|++.+.||+|+||.||+|+.. .+|+.||+|.+...... .....+.+..|++++..+ +|+||+.++++++.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 47899999988654332 223346678899999999 689999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||++|++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999986422110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhh--cCCCCCcchhhhHHHHHHHHhCCCCCCCC----CHHHHHHhhcc
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR--QGYGKPVDWWSMGVILYEFLVGCVPFFGE----TPEELFAHTVN 593 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--~~ys~ksDIWSLGvILyELLtG~~PF~~~----~~~e~~~~I~~ 593 (810)
........|+..|+|||.+.+ ..++.++||||||+++|+|++|..||... ...++...+..
T Consensus 160 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 226 (290)
T cd05613 160 -------------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK 226 (290)
T ss_pred -------------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc
Confidence 011124568999999999975 35788999999999999999999999643 23344444444
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCC--CChhHHhcCCCcCCCChhhhhhc
Q psy16843 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRH 651 (810)
Q Consensus 594 ~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta--~~~~EiL~HPfF~~id~~~l~~~ 651 (810)
....++. .+++.+.+|+.+||+.||.+|++. ..+++++.||||..++|+.+..+
T Consensus 227 ~~~~~~~----~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 282 (290)
T cd05613 227 SEPPYPQ----EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAK 282 (290)
T ss_pred cCCCCCc----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhhc
Confidence 4433332 267889999999999999999965 25699999999999999887544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.95 Aligned_cols=260 Identities=30% Similarity=0.438 Sum_probs=214.4
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh--hHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM--LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~--~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
+|++.+.||.|+||.||+|.++.+++.||+|.+...... .......+..|+++++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999999999999999998765433 122335567899999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|||+ +|+|..++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.+|.+||+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--- 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC---
Confidence 9999 899999998766 89999999999999999999999999999999999999999999999999986532110
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC----
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI---- 596 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~---- 596 (810)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||.+.+..+.+.++.....
T Consensus 157 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (298)
T cd07841 157 ------------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE 224 (298)
T ss_pred ------------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCch
Confidence 00122346889999999865 4679999999999999999999999988777665555432100
Q ss_pred -CCC---------------C----CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 597 -EWP---------------S----EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 597 -~~p---------------~----~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.++ . ......+.++.+||.+||.+||.+||++ .|++.||||.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~---~e~l~~~~~~~~ 288 (298)
T cd07841 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITA---RQALEHPYFSND 288 (298)
T ss_pred hhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCH---HHHhhCccccCC
Confidence 000 0 0001246789999999999999999998 999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=342.02 Aligned_cols=249 Identities=29% Similarity=0.497 Sum_probs=214.4
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++.+.||.|+||.||++.++.+++.||+|.+..... ....+.+..|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999998865432 2345678889999999999999999999999999999999
Q ss_pred eccCcchhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 445 YVEGGDCASLLKN--TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 445 y~~GGsL~~lL~~--~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~----- 153 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----- 153 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-----
Confidence 9999999998864 346899999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~ 602 (810)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..+......
T Consensus 154 ----------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 221 (255)
T cd08219 154 ----------GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP-- 221 (255)
T ss_pred ----------ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC--
Confidence 00112456899999999999989999999999999999999999999998888777777665543221
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..++.++++||.+||+.||++||++ .+++.
T Consensus 222 -~~~~~~~~~li~~~l~~~P~~Rp~~---~~il~ 251 (255)
T cd08219 222 -SHYSYELRSLIKQMFKRNPRSRPSA---TTILS 251 (255)
T ss_pred -cccCHHHHHHHHHHHhCCcccCCCH---HHHhh
Confidence 1267889999999999999999998 77765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=379.69 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=205.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
...|.+.+.||+|+||.||++.+..+++.||||.... ..+.+|+++|+.++|+|||++++++..++..|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999995322 2345799999999999999999999999999999
Q ss_pred eeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||++. ++|..++.. .+.+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~--- 314 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW--- 314 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc---
Confidence 99995 688887765 3579999999999999999999999999999999999999999999999999987532110
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHhhcc
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET--------PEELFAHTVN 593 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~--------~~e~~~~I~~ 593 (810)
........+||+.|+|||++.+..|+.++|||||||+||||++|..|++... ..++...+..
T Consensus 315 ----------~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~ 384 (461)
T PHA03211 315 ----------STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQ 384 (461)
T ss_pred ----------ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHh
Confidence 0011124679999999999999999999999999999999999877654321 2223222222
Q ss_pred CCC---CCCC------------------------C---CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 594 DDI---EWPS------------------------E---DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 594 ~~~---~~p~------------------------~---~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
..+ .++. . ....++.++.+||.+||+.||.+||++ .|+|+||||++
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa---~elL~hp~f~~ 460 (461)
T PHA03211 385 AQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA---AELLRLPLFQS 460 (461)
T ss_pred hccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH---HHHhhCcccCC
Confidence 111 1110 0 001245689999999999999999999 99999999964
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.73 Aligned_cols=254 Identities=21% Similarity=0.335 Sum_probs=213.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCC-----cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETR-----QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg-----~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
.++|++++.||+|+||.||+|.+...+ ..||+|.+..... ......+.+|+.++..++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 368999999999999999999987655 6799998764432 234466889999999999999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC
Q psy16843 438 HLCLVMEYVEGGDCASLLKNT----------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG 501 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~----------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g 501 (810)
..|++|||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 999999999999999998754 4578899999999999999999999999999999999999999
Q ss_pred cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCC
Q psy16843 502 HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFF 580 (810)
Q Consensus 502 ~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~ 580 (810)
.+||+|||+++...... .........+++.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 162 ~~~L~dfg~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 162 TVKISDFGLSRDIYSAD-------------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred cEEECCCcceeeccccc-------------cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999987432110 0011123457889999999998899999999999999999997 999999
Q ss_pred CCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 581 GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 581 ~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
+....++...+..+..... . ...+.++.+|+.+||+.||.+||++ .|++++
T Consensus 229 ~~~~~~~~~~i~~~~~~~~-~--~~~~~~~~~l~~~c~~~~p~~Rp~~---~~i~~~ 279 (283)
T cd05048 229 GFSNQEVIEMIRSRQLLPC-P--EDCPARVYALMIECWNEIPARRPRF---KDIHTR 279 (283)
T ss_pred CCCHHHHHHHHHcCCcCCC-c--ccCCHHHHHHHHHHccCChhhCcCH---HHHHHH
Confidence 9988888877766543221 1 2367899999999999999999999 677653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=347.00 Aligned_cols=273 Identities=34% Similarity=0.628 Sum_probs=228.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccceeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~~lyLV 442 (810)
++|.+.+.||+|+||.||+|..+.+++.||+|++.+.........+.+..|++++..+. ||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999887655444445577888999999998 99999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||+++++|.+++.+.+.+++..+..++.||+.||.|||+.|++|+||||+||+++.+|.++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999875322111000
Q ss_pred hhh-----hhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC
Q psy16843 523 YEC-----YVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 523 ~~~-----~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
... ...............|+..|+|||++.+..++.++|+||||+++|+|++|..||...+....+..+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence 000 000000112234567899999999999888999999999999999999999999988877777777765555
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC-ChhHHhcCCCc
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG-GPHEVKEHPYF 640 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~-~~~EiL~HPfF 640 (810)
++.. +++.+.+||.+||+.+|.+||++. ..+++++||||
T Consensus 241 ~~~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 241 FPPN----FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCc----cCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 5543 578999999999999999999982 33699999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=354.61 Aligned_cols=257 Identities=27% Similarity=0.447 Sum_probs=215.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
.+|++++.||+|+||.||+|.++.+++.||+|.+...... ..+.+..|+.+++.++||||+++++++...+.+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 6899999999999999999999999999999988654322 2356788999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++|++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++......
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~------ 168 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------ 168 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC------
Confidence 99999999999865 56899999999999999999999999999999999999999999999999998642111
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
........|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.......+..... .+....
T Consensus 169 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 238 (297)
T cd06656 169 ---------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNP 238 (297)
T ss_pred ---------ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCC-CCCCCc
Confidence 0011234689999999999999999999999999999999999999988765443333222211 111111
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
..++..+++||.+||..||++||++ .+++.||||...
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~---~~il~~~~~~~~ 275 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSA---KELLQHPFLKLA 275 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCH---HHHhcCchhccc
Confidence 2366889999999999999999998 999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=340.27 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=217.2
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc--cceeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET--KKHLCLV 442 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~--~~~lyLV 442 (810)
+|++++.||.|+||.||+|.+..+++.||+|.+...... ....+.+..|+++++.++||||+++++.+.. ...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999988654432 3445678889999999999999999987753 4578999
Q ss_pred eeeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhh-----hcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 443 MEYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLH-----SYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 443 mEy~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLH-----s~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
|||+++++|.+++.. .+.+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 467999999999999999999999 89999999999999999999999999999875
Q ss_pred ccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy16843 514 GLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593 (810)
Q Consensus 514 ~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~ 593 (810)
.... ........|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..++...+..
T Consensus 160 ~~~~---------------~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 224 (265)
T cd08217 160 LGHD---------------SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE 224 (265)
T ss_pred ccCC---------------cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc
Confidence 3211 0001234689999999999988899999999999999999999999998887777777666
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 594 ~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
....... ...+.++.+|+.+||..+|.+||++ +++++|||+
T Consensus 225 ~~~~~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~---~~il~~~~~ 265 (265)
T cd08217 225 GKFRRIP---YRYSSELNEVIKSMLNVDPDKRPST---EELLQLPLI 265 (265)
T ss_pred CCCCCCc---cccCHHHHHHHHHHccCCcccCCCH---HHHhhCCCC
Confidence 5432211 2367899999999999999999999 999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=346.51 Aligned_cols=252 Identities=17% Similarity=0.287 Sum_probs=209.6
Q ss_pred CCCCcEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHK---ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k---~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
..++|++.+.||+|+||.||+|.++ ..+..||+|.+..... ......+.+|+.++..++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 3467999999999999999999875 3467899998765432 2334678899999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
+|+||||+++|+|.+++.. .+.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999999976 357999999999999999999999999999999999999999999999999987542110
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.........++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+.
T Consensus 161 --------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~- 225 (266)
T cd05064 161 --------------AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF- 225 (266)
T ss_pred --------------chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-
Confidence 0011112345778999999999999999999999999999775 999999988887777765542
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
..+... ..+..+.+++.+||+.+|.+||++ ++|+
T Consensus 226 ~~~~~~--~~~~~~~~li~~c~~~~p~~RP~~---~~i~ 259 (266)
T cd05064 226 RLPAPR--NCPNLLHQLMLDCWQKERGERPRF---SQIH 259 (266)
T ss_pred CCCCCC--CCCHHHHHHHHHHcCCCchhCCCH---HHHH
Confidence 222222 256889999999999999999998 5554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=341.12 Aligned_cols=259 Identities=32% Similarity=0.555 Sum_probs=221.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|++|.||+|.++.+++.||+|++...... ...+.+..|+.++..++|+||+++++++.....+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4799999999999999999999999999999988765432 34567889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||++|++|.+++...+.+++..+..++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~---- 154 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL---- 154 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC----
Confidence 999999999999888899999999999999999999999 999999999999999999999999999986532110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC---CHHHHHHhhccCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE---TPEELFAHTVNDDIEWP 599 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~---~~~e~~~~I~~~~~~~p 599 (810)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..||... ...+....+........
T Consensus 155 -----------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (264)
T cd06623 155 -----------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL 223 (264)
T ss_pred -----------CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCC
Confidence 0112446889999999999999999999999999999999999999876 45555555554332211
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
.. ..++..+.++|.+||..+|.+||++ .|+++||||+.++
T Consensus 224 ~~--~~~~~~l~~li~~~l~~~p~~R~~~---~~ll~~~~~~~~~ 263 (264)
T cd06623 224 PA--EEFSPEFRDFISACLQKDPKKRPSA---AELLQHPFIKKAD 263 (264)
T ss_pred Cc--ccCCHHHHHHHHHHccCChhhCCCH---HHHHhCHHHHhcc
Confidence 11 1156889999999999999999998 9999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=353.26 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=218.5
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
.+|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+..|+.+++.++||||+++++++...+.+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 579999999999999999999999999999998865432 23456788999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++|++|..++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.+|.+||+|||++......
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~------ 168 (296)
T cd06655 96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE------ 168 (296)
T ss_pred EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc------
Confidence 99999999998875 46999999999999999999999999999999999999999999999999998642111
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
........|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+...... +....
T Consensus 169 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~ 238 (296)
T cd06655 169 ---------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNP 238 (296)
T ss_pred ---------cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-ccCCc
Confidence 00112346899999999999989999999999999999999999999988776555544432211 11112
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
..+++.+.+||.+||..||.+||++ .+++.||||...
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~---~~il~~~~~~~~ 275 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSA---KELLQHPFLKLA 275 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCH---HHHhhChHhhhc
Confidence 2367899999999999999999998 999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=349.48 Aligned_cols=246 Identities=30% Similarity=0.522 Sum_probs=201.1
Q ss_pred CCcEEEEEe--cccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHh-cCCCCeEEEeeeeccccceee
Q psy16843 364 NDFTVIKLI--SNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS-FTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 364 ~dy~ilk~L--G~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~-~l~HPnIVkl~~~f~~~~~ly 440 (810)
++|++.+.+ |.|+||.||++.++.++..+|+|.+.+..... . |..+.. ..+||||+++++.|...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------I--EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------h--hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 456666665 99999999999999999999999876543211 1 222222 127999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC-cEEEeccCCccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG-HIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g-~VKL~DFGLAk~~~~s~~ 519 (810)
+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||+++....
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--- 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT--- 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC---
Confidence 9999999999999998878999999999999999999999999999999999999999998 999999999864210
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHH----HHhhccCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL----FAHTVNDD 595 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~----~~~I~~~~ 595 (810)
.....|+..|+|||++.+..++.++||||||+++|||++|..||........ +.......
T Consensus 163 ----------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 226 (267)
T PHA03390 163 ----------------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK 226 (267)
T ss_pred ----------------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc
Confidence 1234589999999999999999999999999999999999999986543322 11111222
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
...+. ..++.+.+||.+||+.||.+|++. ++|+++||||.+
T Consensus 227 ~~~~~----~~~~~~~~li~~~l~~~p~~R~~~--~~~~l~h~~~~~ 267 (267)
T PHA03390 227 LPFIK----NVSKNANDFVQSMLKYNINYRLTN--YNEIIKHPFLKI 267 (267)
T ss_pred CCccc----ccCHHHHHHHHHHhccChhhCCch--HHHHhcCCcccC
Confidence 22222 377999999999999999999964 389999999964
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=339.67 Aligned_cols=253 Identities=26% Similarity=0.445 Sum_probs=217.9
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++.+.||+|+||.||++....+++.+|+|.+...... ....+.+..|+++++.++||||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 589999999999999999999999999999998765432 3345778899999999999999999999999999999999
Q ss_pred eccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC-cEEEeccCCccccccccccc
Q psy16843 445 YVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG-HIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 445 y~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g-~VKL~DFGLAk~~~~s~~~~ 521 (810)
|++|++|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++ .+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----
Confidence 99999999999753 3589999999999999999999999999999999999998654 6899999998753211
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
.......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+.........
T Consensus 156 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 222 (256)
T cd08220 156 ------------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS- 222 (256)
T ss_pred ------------ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCC-
Confidence 0112356899999999999888999999999999999999999999988877777776654432111
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
...+.+++++|.+||..||.+||++ .|+++||||
T Consensus 223 --~~~~~~l~~li~~~l~~~p~~Rpt~---~~ll~~p~~ 256 (256)
T cd08220 223 --DRYSPDLRQLILSMLNLDPSKRPQL---SQIMAQPIC 256 (256)
T ss_pred --CCcCHHHHHHHHHHccCChhhCCCH---HHHhhCCCC
Confidence 1267899999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=340.36 Aligned_cols=259 Identities=27% Similarity=0.460 Sum_probs=216.7
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++.+.||+|+||.||+|....+++.||+|.+...... ....+.+..|+++++.++|+||+++++++.+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 589999999999999999999999999999998765433 4566889999999999999999999999999999999999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
|+++++|.+++.+.+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~---- 155 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT---- 155 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc----
Confidence 9999999999998878999999999999999999999999999999999999999999999999998753211110
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhhcC---CCCCcchhhhHHHHHHHHhCCCCCCCCCH-HHHHHhhccC-CCCCC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQG---YGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFAHTVND-DIEWP 599 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~---ys~ksDIWSLGvILyELLtG~~PF~~~~~-~e~~~~I~~~-~~~~p 599 (810)
.........|++.|+|||++.+.. ++.++||||||+++|+|++|..||.+... ......+... ...+|
T Consensus 156 -------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 228 (264)
T cd06626 156 -------MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIP 228 (264)
T ss_pred -------ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCC
Confidence 000012356889999999998766 89999999999999999999999976533 3333333322 22233
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.. ..++..+.+||.+||+.+|.+||++ .|++.|||+
T Consensus 229 ~~--~~~~~~~~~li~~~l~~~p~~R~~~---~~i~~~~~~ 264 (264)
T cd06626 229 DS--LQLSPEGKDFLDRCLESDPKKRPTA---SELLQHPFV 264 (264)
T ss_pred cc--cccCHHHHHHHHHHccCCcccCCCH---HHHhcCCCC
Confidence 22 2247889999999999999999999 899999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=346.10 Aligned_cols=255 Identities=26% Similarity=0.413 Sum_probs=208.6
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeec-----cc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSF-----ET 435 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f-----~~ 435 (810)
..++|++++.||+|+||.||+|.++.+++.||+|++..... ....+..|+.+++.+ +||||+++++++ ..
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 45789999999999999999999999999999997654321 224567899999888 799999999987 34
Q ss_pred cceeeeeeeeccCcchhhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 436 KKHLCLVMEYVEGGDCASLLK----NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~----~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
+..+|+||||++||+|.+++. ..+.+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 567999999999999998874 3357899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-----cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHH
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-----QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE 586 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e 586 (810)
+..... ........|++.|+|||++.. ..|+.++|||||||++|||++|..||.+.....
T Consensus 172 ~~~~~~---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~ 236 (286)
T cd06638 172 AQLTST---------------RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236 (286)
T ss_pred eecccC---------------CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH
Confidence 642110 111234468999999999853 458999999999999999999999998877655
Q ss_pred HHHhhccCC-CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 587 LFAHTVNDD-IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 587 ~~~~I~~~~-~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.+..+.... ...... ...+.++.+||.+||+.||++||++ .|+++|+||
T Consensus 237 ~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~---~ell~~~~~ 286 (286)
T cd06638 237 ALFKIPRNPPPTLHQP--ELWSNEFNDFIRKCLTKDYEKRPTV---SDLLQHVFI 286 (286)
T ss_pred HHhhccccCCCcccCC--CCcCHHHHHHHHHHccCCcccCCCH---HHHhhcccC
Confidence 544433221 111111 1246789999999999999999998 999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=351.45 Aligned_cols=256 Identities=28% Similarity=0.488 Sum_probs=216.7
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++++.||+|+||.||++.+..+|+.||+|++..... ....+.+..|+++++.++||||+++++++.....+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 34789999999999999999999999999999998765432 2334678899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||||+++|+|.+++.+.+.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 99999999999999888899999999999999999999997 59999999999999999999999999997532110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH-----------HHHH
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE-----------ELFA 589 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~-----------e~~~ 589 (810)
.....+|+..|+|||++.+..++.++|||||||++|+|++|..||...... +...
T Consensus 158 --------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd06620 158 --------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ 223 (284)
T ss_pred --------------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH
Confidence 112457999999999999889999999999999999999999999865442 2333
Q ss_pred hhccCCC-CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 590 HTVNDDI-EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 590 ~I~~~~~-~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.+..... .++. ..++.++.+||.+||++||.+||++ .|+++||||..
T Consensus 224 ~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~---~e~~~~~~~~~ 271 (284)
T cd06620 224 QIVQEPPPRLPS---SDFPEDLRDFVDACLLKDPTERPTP---QQLCAMPPFIQ 271 (284)
T ss_pred HHhhccCCCCCc---hhcCHHHHHHHHHHhcCCcccCcCH---HHHhcCccccc
Confidence 3333221 1111 1256789999999999999999999 99999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=346.13 Aligned_cols=258 Identities=30% Similarity=0.483 Sum_probs=207.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHH-HhcCCCCeEEEeeeeccccceeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI-MSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~i-L~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
++|++++.||+|+||.||+|.++.+|+.||||.+.+.... ... ..+..|..+ ++.++||||+++++++..++.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 4799999999999999999999999999999988654322 222 344445554 6778999999999999999999999
Q ss_pred eeeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 443 MEYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSY-GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 443 mEy~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
|||++ |+|.+++.. ...+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 577766643 35799999999999999999999997 9999999999999999999999999998642110
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhh----cCCCCCcchhhhHHHHHHHHhCCCCCCCC-CHHHHHHhhc
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR----QGYGKPVDWWSMGVILYEFLVGCVPFFGE-TPEELFAHTV 592 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~----~~ys~ksDIWSLGvILyELLtG~~PF~~~-~~~e~~~~I~ 592 (810)
.......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||... ...+.+..+.
T Consensus 158 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 221 (283)
T cd06617 158 ----------------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221 (283)
T ss_pred ----------------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH
Confidence 01123468999999999865 56789999999999999999999999753 2333333433
Q ss_pred cCC-CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 593 NDD-IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 593 ~~~-~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
... ...+. ..++.++.+||.+||..+|.+||++ .+++.||||....+.
T Consensus 222 ~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~---~~il~~~~~~~~~~~ 270 (283)
T cd06617 222 EEPSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNY---PELLQHPFFELHLSK 270 (283)
T ss_pred hcCCCCCCc---cccCHHHHHHHHHHccCChhhCcCH---HHHhcCchhhhcccc
Confidence 322 22222 2367899999999999999999999 999999999875433
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=349.30 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=205.7
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++.+.||.|+||.||+|.++.+++.||+|.+...... .....+.+|+++++.++||||+++++++.+++..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999988654321 1223456799999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|||+.+ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 156 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP---- 156 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC----
Confidence 999975 899888653 57899999999999999999999999999999999999999999999999998642110
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCC-HHHHHHhhcc---C--
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGET-PEELFAHTVN---D-- 594 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~-~~e~~~~I~~---~-- 594 (810)
........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ..+....+.. .
T Consensus 157 -----------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (291)
T cd07844 157 -----------SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPT 225 (291)
T ss_pred -----------CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCC
Confidence 001122347889999999876 468999999999999999999999997665 2222222211 0
Q ss_pred --------------CCCCCCC-------CCCccc--HHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 595 --------------DIEWPSE-------DDWPIQ--VEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 595 --------------~~~~p~~-------~~~~~S--~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
...++.. ....++ .++.++|.+||+.+|.+||++ .|++.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~---~e~l~~~~f 291 (291)
T cd07844 226 EETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA---AEAMKHPYF 291 (291)
T ss_pred hhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCH---HHHhcCCCC
Confidence 0000000 000123 788999999999999999998 999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=342.47 Aligned_cols=254 Identities=30% Similarity=0.458 Sum_probs=212.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecccc-----
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETK----- 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~----- 436 (810)
.++|++.+.||.|+||.||+|.++.+++.|++|++..... ..+.+..|+.+++.+ +|+||+++++++.+.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4789999999999999999999999999999998765432 235688899999988 799999999998654
Q ss_pred -ceeeeeeeeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 437 -KHLCLVMEYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 437 -~~lyLVmEy~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
..+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 458999999999999998864 357999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-----cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHH
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-----QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE 586 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e 586 (810)
....... .......|++.|+|||++.. ..++.++|||||||+||+|++|.+||.+.....
T Consensus 161 ~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 225 (275)
T cd06608 161 AQLDSTL---------------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225 (275)
T ss_pred eecccch---------------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH
Confidence 6422110 01123568999999999864 347889999999999999999999998877666
Q ss_pred HHHhhccCCCC-CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 587 LFAHTVNDDIE-WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 587 ~~~~I~~~~~~-~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
....+...... +... ...+.++++||.+||..||++||++ .|+++|||+
T Consensus 226 ~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt~---~~ll~~~~~ 275 (275)
T cd06608 226 ALFKIPRNPPPTLKSP--ENWSKKFNDFISECLIKNYEQRPFM---EELLEHPFI 275 (275)
T ss_pred HHHHhhccCCCCCCch--hhcCHHHHHHHHHHhhcChhhCcCH---HHHhcCCCC
Confidence 66666554321 1111 1256789999999999999999999 999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=343.16 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=210.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||+|+++.+++.||||.+.............+..|+++++.++||||+++++++.+.+.+|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999886544444455567888999999999999999999999999999999
Q ss_pred eeccCcchhhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 444 EYVEGGDCASLLK----NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 444 Ey~~GGsL~~lL~----~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
||+++|+|.+++. +...+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 9999999998885 23468999999999999999999999999999999999999999999999999986522110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC--HHHHHHhhccCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET--PEELFAHTVNDDIE 597 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~--~~e~~~~I~~~~~~ 597 (810)
.......|++.|+|||.+.+..++.++|+||||+++|||++|..||.... ..+....+....
T Consensus 161 --------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-- 224 (267)
T cd08228 161 --------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD-- 224 (267)
T ss_pred --------------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--
Confidence 01123468999999999999899999999999999999999999997653 234444443322
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.+.......+..+.+||.+||..+|.+||++ .++++
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~---~~vl~ 260 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDI---GYVHQ 260 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCH---HHHHH
Confidence 2222222356889999999999999999999 67664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=351.11 Aligned_cols=255 Identities=21% Similarity=0.291 Sum_probs=203.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcC----------------CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeE
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKE----------------TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFV 426 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~----------------tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnI 426 (810)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|++++..++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999998643 345799998765422 3345678899999999999999
Q ss_pred EEeeeeccccceeeeeeeeccCcchhhhhhcC-------------------CCCCHHHHHHHHHHHHHHHHHhhhccccc
Q psy16843 427 VTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-------------------GPLPADMARFYFAETVLAVEYLHSYGIVH 487 (810)
Q Consensus 427 Vkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~-------------------g~lse~~~~~i~~QIl~AL~yLHs~gIIH 487 (810)
+++++++.+.+.+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 99999999999999999999999999988543 13677888999999999999999999999
Q ss_pred ccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHH
Q psy16843 488 RDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGV 567 (810)
Q Consensus 488 RDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGv 567 (810)
|||||+|||++.++.+||+|||+++....... ........++..|||||++.+..++.++|||||||
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 228 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY-------------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV 228 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCce-------------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence 99999999999999999999999864321100 01112345688999999999989999999999999
Q ss_pred HHHHHHh--CCCCCCCCCHHHHHHhhcc---CC-CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 568 ILYEFLV--GCVPFFGETPEELFAHTVN---DD-IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 568 ILyELLt--G~~PF~~~~~~e~~~~I~~---~~-~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
++|||++ |..||.+.+..+.+..+.. .. ...........+..+.+||.+||..||.+||++ .||.
T Consensus 229 ~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~---~~i~ 299 (304)
T cd05096 229 TLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF---SDIH 299 (304)
T ss_pred HHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH---HHHH
Confidence 9999986 6788988776665554321 10 000001112356889999999999999999999 5653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=353.80 Aligned_cols=251 Identities=24% Similarity=0.426 Sum_probs=191.3
Q ss_pred EEEecccCceEEEEEEEcC--CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecc--ccceeeeeee
Q psy16843 369 IKLISNGAYGSVYLVRHKE--TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE--TKKHLCLVME 444 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~--tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~--~~~~lyLVmE 444 (810)
...||+|+||.||+|+++. ++..||+|.+..... ...+.+|+++++.++||||+++++++. .+..+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 3679999999999999765 568899998865432 134678999999999999999999884 4568899999
Q ss_pred eccCcchhhhhhc---------CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe----ccCCcEEEeccCCc
Q psy16843 445 YVEGGDCASLLKN---------TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI----TALGHIKLTDFGLS 511 (810)
Q Consensus 445 y~~GGsL~~lL~~---------~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL----d~~g~VKL~DFGLA 511 (810)
|+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.+|.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9865 77776642 1358899999999999999999999999999999999999 45679999999999
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHH-----
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPE----- 585 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~----- 585 (810)
+....... ........+||+.|+|||++.+. .++.++|||||||++|||++|.+||......
T Consensus 160 ~~~~~~~~------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~ 227 (317)
T cd07867 160 RLFNSPLK------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 227 (317)
T ss_pred eccCCCcc------------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccc
Confidence 75321110 00112345789999999999874 5899999999999999999999999754321
Q ss_pred ----HHHHhhccC--------------CCCC--------------------CCCCCCcccHHHHHHHHhhhcCCCCCCCC
Q psy16843 586 ----ELFAHTVND--------------DIEW--------------------PSEDDWPIQVEAKSIITDLLQQNPRDRLG 627 (810)
Q Consensus 586 ----e~~~~I~~~--------------~~~~--------------------p~~~~~~~S~el~dLI~klL~~dP~~Rpt 627 (810)
..+..+... ...+ ........+..+.+||.+||+.||.+|||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 307 (317)
T cd07867 228 PFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRIT 307 (317)
T ss_pred cccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccC
Confidence 001110000 0000 00001113456889999999999999999
Q ss_pred CCChhHHhcCCCc
Q psy16843 628 TGGPHEVKEHPYF 640 (810)
Q Consensus 628 a~~~~EiL~HPfF 640 (810)
+ .|+++||||
T Consensus 308 ~---~e~l~hp~f 317 (317)
T cd07867 308 S---EQALQDPYF 317 (317)
T ss_pred H---HHHhcCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=368.40 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=206.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKET-----RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFE 434 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~t-----g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~ 434 (810)
...++|++.+.||+|+||.||+|++... ++.||+|++..... ....+.+..|+++++.+ +|+|||++++++.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3456899999999999999999986543 35799998865432 23346788999999998 8999999999999
Q ss_pred ccceeeeeeeeccCcchhhhhhcC--------------------------------------------------------
Q psy16843 435 TKKHLCLVMEYVEGGDCASLLKNT-------------------------------------------------------- 458 (810)
Q Consensus 435 ~~~~lyLVmEy~~GGsL~~lL~~~-------------------------------------------------------- 458 (810)
..+.+|+||||+.+|+|.+++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999999999988532
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 459 --------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 459 --------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~----- 267 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----- 267 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-----
Confidence 2478888999999999999999999999999999999999999999999999875321100
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
........+++.|||||++.+..|+.++|||||||++|||++ |..||........+..+.......+...
T Consensus 268 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 338 (374)
T cd05106 268 --------YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPD- 338 (374)
T ss_pred --------eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCC-
Confidence 001122345678999999999999999999999999999997 9999988765555545444433322221
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
..++++.++|.+||+.||.+||++ .+++
T Consensus 339 -~~~~~l~~li~~cl~~dp~~RPs~---~~l~ 366 (374)
T cd05106 339 -FAPPEIYSIMKMCWNLEPTERPTF---SQIS 366 (374)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCH---HHHH
Confidence 257899999999999999999999 5554
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.49 Aligned_cols=254 Identities=31% Similarity=0.523 Sum_probs=216.2
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||.|+||.||+|.++.+++.+|+|.+..... ....+.+.+|+++++.++||||+++++.+.....+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468899999999999999999999999999998876532 234467888999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 444 EYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||++|++|.+++... ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.+|.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~---- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---- 154 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence 999999999999866 789999999999999999999999 99999999999999999999999999998642110
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC-----CHHHHHHhhccCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE-----TPEELFAHTVNDDI 596 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~-----~~~e~~~~I~~~~~ 596 (810)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||... ...+....+.....
T Consensus 155 ---------~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 221 (265)
T cd06605 155 ---------L----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP 221 (265)
T ss_pred ---------H----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC
Confidence 0 01256899999999999999999999999999999999999999764 33344444443321
Q ss_pred -CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 597 -EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 597 -~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
..+.. .++.++++||.+||..||.+||++ .|++.||||..
T Consensus 222 ~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~---~~ll~~~~~~~ 262 (265)
T cd06605 222 PRLPSG---KFSPDFQDFVNLCLIKDPRERPSY---KELLEHPFIKK 262 (265)
T ss_pred CCCChh---hcCHHHHHHHHHHcCCCchhCcCH---HHHhhCchhhc
Confidence 22211 167889999999999999999998 99999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=345.89 Aligned_cols=258 Identities=32% Similarity=0.511 Sum_probs=213.9
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++.+.||.|+||.||+|.++.+|+.||+|++...... ....+.+..|+.+++.++||||+++++++..+..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 589999999999999999999999999999988765422 2344678899999999999999999999999999999999
Q ss_pred eccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 445 YVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 445 y~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
|+ |++|.+++.. ...+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~----- 153 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE----- 153 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-----
Confidence 99 9999999864 4679999999999999999999999999999999999999999999999999986432110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-------
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD------- 595 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~------- 595 (810)
........|+..|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+...-
T Consensus 154 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07832 154 ---------PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEET 224 (286)
T ss_pred ---------CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHH
Confidence 0011234689999999998764 46999999999999999999999998887766555544310
Q ss_pred ------------CCCCCCC-------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 596 ------------IEWPSED-------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 596 ------------~~~p~~~-------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
..++... ....+.++.+||.+||..||++||++ ++++.||||.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~---~~~l~h~~~~ 286 (286)
T cd07832 225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA---AEALRHPYFT 286 (286)
T ss_pred HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH---HHHhhCcCcC
Confidence 1111110 01245889999999999999999999 9999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.67 Aligned_cols=255 Identities=29% Similarity=0.434 Sum_probs=210.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecccc-----
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETK----- 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~----- 436 (810)
.++|++.+.||+|+||.||+|..+.+++.+|+|.+..... ....+..|+.++..+ +||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 4789999999999999999999999999999998765321 224567788888888 899999999988643
Q ss_pred ceeeeeeeeccCcchhhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 437 KHLCLVMEYVEGGDCASLLK----NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~----~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
..+|+||||++||+|.++++ ....+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 36899999999999999885 34579999999999999999999999999999999999999999999999999986
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-----CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHH
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-----GYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL 587 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-----~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~ 587 (810)
..... .......+|+..|+|||++... .++.++|||||||++|||++|++||......+.
T Consensus 177 ~~~~~---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 177 QLTST---------------RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred hcccc---------------cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 42211 0111234689999999998643 368999999999999999999999998877666
Q ss_pred HHhhccCCC-CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 588 FAHTVNDDI-EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 588 ~~~I~~~~~-~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
+..+..... .+... ...+.++.+||.+||+++|++||++ .|++.||||+
T Consensus 242 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~---~~il~~~~~~ 291 (291)
T cd06639 242 LFKIPRNPPPTLLHP--EKWCRSFNHFISQCLIKDFEARPSV---THLLEHPFIK 291 (291)
T ss_pred HHHHhcCCCCCCCcc--cccCHHHHHHHHHHhhcChhhCcCH---HHHhcCcccC
Confidence 666554322 11111 1255789999999999999999998 9999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.17 Aligned_cols=255 Identities=31% Similarity=0.479 Sum_probs=215.9
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccch--hhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL--MLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~--~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
+|+..+.||+|+||+||+|..+.+++.|++|.+..... ......+.+..|+.+++.++|+||+++++++.+...+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47778999999999999999998999999998865432 1233456788999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||++|++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999986522110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcC-CCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQG-YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
......|++.|+|||.+.... ++.++|+|||||++|+|++|..||......+....+.... ..+.
T Consensus 157 ------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~- 222 (258)
T cd06632 157 ------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-ELPP- 222 (258)
T ss_pred ------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cCCC-
Confidence 113456899999999998776 8999999999999999999999998776555554444311 1111
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
....+++++++||.+||+.+|.+||++ .+++.|||+
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~---~~~l~~~~~ 258 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTA---AELLEHPFV 258 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCH---HHHhcCCCC
Confidence 112367899999999999999999998 999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=347.01 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=219.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+.|+.++.||.|+||.||+|.++.+++.||+|.+..... ....+.+..|+.+++.++||||+++++++.++..+|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 568899999999999999999999999999998865432 234577889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++||+|.+++.. +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~------ 154 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT------ 154 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC------
Confidence 99999999999875 57999999999999999999999999999999999999999999999999998642211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
........|+..|+|||++.+..++.++|+|||||++|||++|..||.+.+.......+..... ....
T Consensus 155 ---------~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~ 222 (277)
T cd06640 155 ---------QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLT 222 (277)
T ss_pred ---------ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCc
Confidence 0112334688999999999988899999999999999999999999998877766655433321 1111
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
..++.++.+||.+||..+|++||++ .+++.||||....
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~---~~il~~~~~~~~~ 260 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTA---KELLKHKFIVKNA 260 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCH---HHHHhChHhhhcc
Confidence 2366889999999999999999998 9999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=346.60 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=212.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKE-----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~-----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.+..... ....+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999998753 467899998765432 224467889999999999999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcE
Q psy16843 438 HLCLVMEYVEGGDCASLLKNT--------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHI 503 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~--------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~V 503 (810)
.+|+||||++||+|.++|... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 999999999999999999754 247889999999999999999999999999999999999999999
Q ss_pred EEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCC
Q psy16843 504 KLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGE 582 (810)
Q Consensus 504 KL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~ 582 (810)
||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 162 kl~d~g~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 162 KIGDFGMSRDVYTTDY-------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred EECCcccceecccCcc-------------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999864211100 001123346789999999999999999999999999999998 99999998
Q ss_pred CHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 583 TPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 583 ~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
+..+....+..+....+.. ..+.++++||.+||+.||.+||++ .|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~---~eil~ 276 (280)
T cd05049 229 SNEEVIECITQGRLLQRPR---TCPSEVYDIMLGCWKRDPQQRINI---KDIHE 276 (280)
T ss_pred CHHHHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcCCCcccCCCH---HHHHH
Confidence 8888888877655433322 367899999999999999999998 66653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=365.65 Aligned_cols=256 Identities=20% Similarity=0.306 Sum_probs=206.0
Q ss_pred CCCCCcEEEEEecccCceEEEEEEE-----cCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRH-----KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFE 434 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~-----k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~ 434 (810)
...++|++.+.||+|+||.||+|.+ ..++..||+|++..... ....+.+.+|+.++..+ +|||||++++++.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 3456899999999999999999974 34567899998764332 23346788899999999 8999999999999
Q ss_pred ccceeeeeeeeccCcchhhhhhcCC-------------------------------------------------------
Q psy16843 435 TKKHLCLVMEYVEGGDCASLLKNTG------------------------------------------------------- 459 (810)
Q Consensus 435 ~~~~lyLVmEy~~GGsL~~lL~~~g------------------------------------------------------- 459 (810)
+.+..|+|||||+||+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999886421
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 460 --------------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 460 --------------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 268 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS- 268 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc-
Confidence 47788899999999999999999999999999999999999999999999987532110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
.........++..|+|||++.+..++.++|||||||++|||++ |..||.+......+.+.+......
T Consensus 269 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 336 (375)
T cd05104 269 ------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM 336 (375)
T ss_pred ------------cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC
Confidence 0001122345678999999999999999999999999999997 999998766554444444433322
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.... ..+.++++||.+||+.||++||++ .|+++
T Consensus 337 ~~~~--~~~~~l~~li~~cl~~dP~~RPs~---~eil~ 369 (375)
T cd05104 337 LSPE--CAPSEMYDIMKSCWDADPLKRPTF---KQIVQ 369 (375)
T ss_pred CCCC--CCCHHHHHHHHHHccCChhHCcCH---HHHHH
Confidence 2211 246889999999999999999999 66654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=348.53 Aligned_cols=256 Identities=27% Similarity=0.478 Sum_probs=208.7
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++++.||.|+||.||+|+++.+|+.||||++...... ......+..|+++++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 589999999999999999999999999999988654322 2233567889999999999999999999999999999999
Q ss_pred eccCcchhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 445 YVEGGDCASLLKN--TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 445 y~~GGsL~~lL~~--~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|+. ++|..++.. .+.+++..+..++.||+.||+|||+.|++||||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--- 155 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--- 155 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc---
Confidence 996 588888754 45789999999999999999999999999999999999999999999999999864321100
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcC-CCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-----
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQG-YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI----- 596 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~----- 596 (810)
......+++.|+|||++.+.. ++.++|||||||++|||++|..||.+.+......++.....
T Consensus 156 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07860 156 ------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 223 (284)
T ss_pred ------------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 012235788999999887654 68999999999999999999999988776554444332100
Q ss_pred -------------CCCC-------CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 597 -------------EWPS-------EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 597 -------------~~p~-------~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.++. .....+++++++||.+||+.||.+||++ .|++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~---~~~l~~~~f 284 (284)
T cd07860 224 VWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA---KAALAHPFF 284 (284)
T ss_pred hhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH---HHHhcCCCC
Confidence 0000 0011256889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=346.08 Aligned_cols=259 Identities=31% Similarity=0.505 Sum_probs=214.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||+|.++.+++.||+|++..... .....+.+..|+++++.++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 469999999999999999999999999999998765332 2233467889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++++.+..++.+...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~---- 155 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA---- 155 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc----
Confidence 9999988887777777899999999999999999999999999999999999999999999999999865322100
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC--------
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND-------- 594 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~-------- 594 (810)
......+|+..|+|||++.+. .++.++||||||+++|+|++|.+||.+....+.+..+...
T Consensus 156 ----------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07833 156 ----------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSH 225 (288)
T ss_pred ----------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 111345689999999999988 8899999999999999999999999877655443332210
Q ss_pred -----------CCCCCCCC---------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 595 -----------DIEWPSED---------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 595 -----------~~~~p~~~---------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
...++... ...++.++++||++||..+|++||++ .++++||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~~il~~~~f 288 (288)
T cd07833 226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC---DELLQHPYF 288 (288)
T ss_pred hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH---HHHhcCCCC
Confidence 00111000 00137889999999999999999998 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.20 Aligned_cols=253 Identities=27% Similarity=0.436 Sum_probs=214.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
..|++.+.||+|+||.||+|.++.+++.||+|++...........+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56999999999999999999999999999999886554444455567889999999999999999999999999999999
Q ss_pred eeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||+.| +|.+++. ..+.+++..+..++.||+.||.|||+.||+||||+|+||+++.+|.+||+|||++.....
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~------ 167 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP------ 167 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC------
Confidence 99975 6666654 456799999999999999999999999999999999999999999999999999864211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHh---hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-CC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVIL---RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI-EW 598 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~---~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~-~~ 598 (810)
.....|++.|+|||++. ...++.++||||||+++|||++|.+||.+.+.......+..... ..
T Consensus 168 -------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (307)
T cd06607 168 -------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL 234 (307)
T ss_pred -------------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC
Confidence 12346889999999985 35689999999999999999999999998887766555544322 22
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+. ...+.++.+||.+||..||.+||++ .+++.||||..
T Consensus 235 ~~---~~~~~~~~~li~~~l~~~p~~Rp~~---~~il~~~~~~~ 272 (307)
T cd06607 235 SS---NDWSDYFRNFVDSCLQKIPQDRPSS---EELLKHRFVLR 272 (307)
T ss_pred Cc---hhhCHHHHHHHHHHhcCChhhCcCH---HHHhcChhhcc
Confidence 11 1256789999999999999999998 99999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.92 Aligned_cols=252 Identities=22% Similarity=0.368 Sum_probs=211.0
Q ss_pred CCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
..++|.+.+.||.|+||+||++... .++..+|+|.+.... ....+.+..|+++++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4568999999999999999999863 345678999876543 23456788999999999999999999999999
Q ss_pred ceeeeeeeeccCcchhhhhhcCC-------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcE
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTG-------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHI 503 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g-------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~V 503 (810)
+.+|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999987543 48999999999999999999999999999999999999999999
Q ss_pred EEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCC
Q psy16843 504 KLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGE 582 (810)
Q Consensus 504 KL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~ 582 (810)
||+|||+++...... .........|++.|+|||++.+..++.++|||||||++|||++ |.+||.+.
T Consensus 160 kl~dfg~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 160 KIGDFGMSRDVYSTD-------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred EeccCCccccccCCc-------------eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987432110 0011123446789999999999999999999999999999998 99999998
Q ss_pred CHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 583 TPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 583 ~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
...+....+..+...... ...+.++.+|+.+||+.||.+||++ .|++
T Consensus 227 ~~~~~~~~i~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~---~~v~ 273 (288)
T cd05093 227 SNNEVIECITQGRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNI---KEIH 273 (288)
T ss_pred CHHHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHccCChhhCCCH---HHHH
Confidence 888888888776532211 1266899999999999999999999 5553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.52 Aligned_cols=255 Identities=20% Similarity=0.262 Sum_probs=209.5
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKE-----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~-----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
...++|++.+.||+|+||.||+|.++. ++..||+|++..... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 345789999999999999999998753 356799998754322 2234568889999999999999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcCC----------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEE
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNTG----------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 505 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~g----------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL 505 (810)
....++||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999986532 3567788899999999999999999999999999999999999999
Q ss_pred eccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCH
Q psy16843 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETP 584 (810)
Q Consensus 506 ~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~ 584 (810)
+|||+++....... ........+++.|||||++.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 161 ~dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 161 GDFGMTRDIYETDY-------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred CCCCCccccCCcce-------------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999864321100 001122346788999999999999999999999999999998 7999999888
Q ss_pred HHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 585 EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 585 ~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.+.+..+.......... ..+..+.+||.+||+.||.+||++ .|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~---~e~l~ 273 (277)
T cd05062 228 EQVLRFVMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSF---LEIIS 273 (277)
T ss_pred HHHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcCCChhhCcCH---HHHHH
Confidence 88777766654322211 256889999999999999999998 67764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.42 Aligned_cols=250 Identities=47% Similarity=0.872 Sum_probs=221.9
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcch
Q psy16843 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDC 451 (810)
Q Consensus 372 LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL 451 (810)
||.|+||.||++.+..+++.||+|.+.+...........+..|+++++.++||||+++++.+..+..+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999998876655555677889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhccc
Q psy16843 452 ASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531 (810)
Q Consensus 452 ~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~ 531 (810)
.+++...+.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------------- 147 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------------- 147 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-------------
Confidence 9999988889999999999999999999999999999999999999999999999999986421110
Q ss_pred ccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHH
Q psy16843 532 KQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAK 611 (810)
Q Consensus 532 ~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~ 611 (810)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+......++.. .+.++.
T Consensus 148 --~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~ 221 (250)
T cd05123 148 --SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEF----LSPEAR 221 (250)
T ss_pred --CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC----CCHHHH
Confidence 11234568999999999998889999999999999999999999998888877778877765555543 568999
Q ss_pred HHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 612 SIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 612 dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
+||++||..||++||++..++++++||||
T Consensus 222 ~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 99999999999999998666899999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.99 Aligned_cols=258 Identities=28% Similarity=0.469 Sum_probs=207.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccce----
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKKH---- 438 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~~---- 438 (810)
++|++.+.||.|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 469999999999999999999999999999998755422 1223356778999999995 6999999999887665
Q ss_pred -eeeeeeeccCcchhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc-CCcEEEeccCCc
Q psy16843 439 -LCLVMEYVEGGDCASLLKN-----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA-LGHIKLTDFGLS 511 (810)
Q Consensus 439 -lyLVmEy~~GGsL~~lL~~-----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~g~VKL~DFGLA 511 (810)
+|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 78887753 235899999999999999999999999999999999999998 899999999998
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~ 590 (810)
+....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|.+||.+.+..+.+.+
T Consensus 159 ~~~~~~~~---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~ 223 (295)
T cd07837 159 RAFSIPVK---------------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH 223 (295)
T ss_pred eecCCCcc---------------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 64321100 0112357889999999876 4579999999999999999999999998877665554
Q ss_pred hccCC-----CCC------------C-------CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 591 TVNDD-----IEW------------P-------SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 591 I~~~~-----~~~------------p-------~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
+.... ..+ + ......++.++.+||.+||.+||.+||++ .|++.||||+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~---~eil~~~~~~ 295 (295)
T cd07837 224 IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA---KAALTHPYFD 295 (295)
T ss_pred HHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH---HHHhcCCCcC
Confidence 43210 000 0 00011267889999999999999999998 9999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.69 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=203.4
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|.+++.||+|+||.||+|.++.+|+.||+|.+...... .....+.+|+++++.++|+||+++++++.+++..|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 6899999999999999999999999999999988654321 12235668999999999999999999999999999999
Q ss_pred eeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||+. ++|..++. ..+.+++..++.++.||+.||.|||+.||+|+||||+|||++.+|.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP----- 156 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC-----
Confidence 9996 56665554 4467889999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHH-HHHHhhccC------
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPE-ELFAHTVND------ 594 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~-e~~~~I~~~------ 594 (810)
........+++.|+|||++.+. .++.++|||||||++|||++|..||.+.... +.+..+...
T Consensus 157 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
T cd07870 157 ----------SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTE 226 (291)
T ss_pred ----------CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCCh
Confidence 0011234579999999998764 5889999999999999999999999765432 222222100
Q ss_pred --------CC----C-C----CCC-----CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 595 --------DI----E-W----PSE-----DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 595 --------~~----~-~----p~~-----~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.. . + +.. .....+.++.+||.+||..||.+||++ +|++.||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~---~~~l~h~~~ 291 (291)
T cd07870 227 DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA---QDALLHPYF 291 (291)
T ss_pred hhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH---HHHhcCCCC
Confidence 00 0 0 000 001135688999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=352.21 Aligned_cols=262 Identities=27% Similarity=0.387 Sum_probs=212.5
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc--cee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK--KHL 439 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~--~~l 439 (810)
..++|++.+.||.|+||.||+|.++.+|+.||+|++...... ......+.+|+.+++.++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 347899999999999999999999999999999988644322 11223456799999999999999999998654 578
Q ss_pred eeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999965 78887764 4679999999999999999999999999999999999999999999999999987532110
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC--
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD-- 595 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~-- 595 (810)
.......+++.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+....
T Consensus 163 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~ 227 (309)
T cd07845 163 ---------------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT 227 (309)
T ss_pred ---------------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 00112346888999999876 568999999999999999999999999988887776655411
Q ss_pred -----------------CCCCCCC-------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 596 -----------------IEWPSED-------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 596 -----------------~~~p~~~-------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
+..+... ....++++.+||.+||+.||++||++ +|++.||||.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~---~~il~h~~f~~~ 296 (309)
T cd07845 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA---EEALESSYFKEK 296 (309)
T ss_pred CChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCH---HHHhcChhhccC
Confidence 0111000 01147889999999999999999998 999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=348.43 Aligned_cols=262 Identities=25% Similarity=0.410 Sum_probs=210.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccceeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~~lyLV 442 (810)
++|+..+.||+|+||.||++.+..+++.||+|.+.+.... .....+..|+.++..+. ||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 5678889999999999999999999999999988754332 34456788999998886 99999999999999999999
Q ss_pred eeeccCcchhhh---hh--cCCCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 443 MEYVEGGDCASL---LK--NTGPLPADMARFYFAETVLAVEYLHSY-GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 443 mEy~~GGsL~~l---L~--~~g~lse~~~~~i~~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
|||+.+ +|.++ +. ..+.+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999864 44433 22 346799999999999999999999975 999999999999999999999999999864211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhc---CCCCCcchhhhHHHHHHHHhCCCCCCCCCH-HHHHHhhc
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ---GYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFAHTV 592 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~---~ys~ksDIWSLGvILyELLtG~~PF~~~~~-~e~~~~I~ 592 (810)
. .......|++.|+|||++.+. .++.++|||||||++|||++|.+||..... .+....+.
T Consensus 161 ~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 224 (288)
T cd06616 161 S----------------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV 224 (288)
T ss_pred C----------------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc
Confidence 1 111234589999999999876 689999999999999999999999976542 23333333
Q ss_pred cCC-CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhh
Q psy16843 593 NDD-IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647 (810)
Q Consensus 593 ~~~-~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~ 647 (810)
... ...+......++.++.+||.+||++||.+||++ +++++||||+...|.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~---~~i~~~~~~~~~~~~~ 277 (288)
T cd06616 225 KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKY---KELLEHPFIKDYEERN 277 (288)
T ss_pred CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCH---HHHhcChhhhchhhcc
Confidence 322 222222223477899999999999999999999 9999999998866544
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.00 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=207.9
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEE--EEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRF--AMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKK 437 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~v--AIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~ 437 (810)
+..++|++.+.||+|+||.||+|.++.++..+ |+|.+... ........+.+|++++..+ +||||+++++++.+++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 45579999999999999999999998887654 66654432 2234456788899999998 8999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTG----------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG 501 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g----------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g 501 (810)
.+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999996432 578999999999999999999999999999999999999999
Q ss_pred cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCC
Q psy16843 502 HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFF 580 (810)
Q Consensus 502 ~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~ 580 (810)
.+||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 162 ~~kl~dfg~~~~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 162 VAKIADFGLSRGQEVY----------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred cEEeCccccCcccchh----------------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 9999999998531100 00111234678999999998889999999999999999998 999999
Q ss_pred CCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 581 GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 581 ~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
+.+..+....+.... .+.. ....+.++.+||.+||+.+|++||++ .+++.+
T Consensus 226 ~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~---~~il~~ 276 (303)
T cd05088 226 GMTCAELYEKLPQGY-RLEK--PLNCDDEVYDLMRQCWREKPYERPSF---AQILVS 276 (303)
T ss_pred cCChHHHHHHHhcCC-cCCC--CCCCCHHHHHHHHHHcCCChhhCcCH---HHHHHH
Confidence 888877776664431 1111 12366899999999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=352.77 Aligned_cols=257 Identities=29% Similarity=0.491 Sum_probs=216.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+.|.....||+|+||.||++.+..+++.||||++.... ....+.+..|+.+++.++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 45666788999999999999999999999999876533 233466889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++|++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~------ 171 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE------ 171 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc------
Confidence 99999999998865 57999999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
........|++.|+|||++.+..++.++|+||||+++|||++|..||.+.+..+.+..+.... .......
T Consensus 172 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 241 (292)
T cd06658 172 ---------VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRVKDS 241 (292)
T ss_pred ---------cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCccccc
Confidence 001134568999999999998899999999999999999999999999887776655544321 1111112
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
...+..+.+||.+||..||.+||++ +|+++||||...
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~---~~il~~~~~~~~ 278 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATA---QELLQHPFLKLA 278 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCH---HHHhhChhhhcc
Confidence 2367889999999999999999998 999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=357.20 Aligned_cols=257 Identities=26% Similarity=0.462 Sum_probs=209.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc------
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK------ 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~------ 436 (810)
.++|++++.||+|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3689999999999999999999999999999998765322 223345677899999999999999999988644
Q ss_pred ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
..+|+||||+. ++|.+.+... +++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 35799999996 4888877654 99999999999999999999999999999999999999999999999999865221
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD- 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~- 595 (810)
. .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+...-
T Consensus 171 ~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 234 (353)
T cd07850 171 S----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234 (353)
T ss_pred C----------------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 1 11123468999999999999999999999999999999999999998877655444432210
Q ss_pred -----------------------------------CCCCCCC---CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 596 -----------------------------------IEWPSED---DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 596 -----------------------------------~~~p~~~---~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
..++... ....+.++++||.+||+.||.+||++ .|++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~eiL~~ 311 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV---DDALQH 311 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCH---HHHhcC
Confidence 0000000 00135678999999999999999999 999999
Q ss_pred CCcCC
Q psy16843 638 PYFSN 642 (810)
Q Consensus 638 PfF~~ 642 (810)
|||+.
T Consensus 312 ~~~~~ 316 (353)
T cd07850 312 PYINV 316 (353)
T ss_pred hhHhh
Confidence 99973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=338.02 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=215.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccc--hhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc--cee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNS--LMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK--KHL 439 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~--~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~--~~l 439 (810)
++|++.+.||+|+||.||+|.++.+++.||+|.+.... .........+.+|+++++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875431 12234556788999999999999999999998654 468
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
++||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC- 160 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc-
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999987531100
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
..........|+..|+|||++.+..++.++|||||||++|+|++|..||.+....+...++.......
T Consensus 161 -----------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 228 (264)
T cd06653 161 -----------MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKP- 228 (264)
T ss_pred -----------ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCC-
Confidence 00011123568999999999999889999999999999999999999998877666655555432221
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.....+++++.++|.+||+ +|..||++ .+++.|||.
T Consensus 229 -~~p~~~~~~~~~~i~~~l~-~~~~r~~~---~~~~~~~~~ 264 (264)
T cd06653 229 -MLPDGVSDACRDFLKQIFV-EEKRRPTA---EFLLRHPFV 264 (264)
T ss_pred -CCCcccCHHHHHHHHHHhc-CcccCccH---HHHhcCCCC
Confidence 1112377899999999999 57999999 899999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=344.51 Aligned_cols=256 Identities=29% Similarity=0.498 Sum_probs=218.2
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
.|...+.||+|++|.||++.++.+++.+|+|++.... ....+.+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4666789999999999999999999999999875432 2234567889999999999999999999999999999999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
|+.|++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~------- 168 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------- 168 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-------
Confidence 9999999999987 67999999999999999999999999999999999999999999999999987542110
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDW 604 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~ 604 (810)
........|++.|+|||.+.+..++.++|||||||++|||++|..||.+.+..+....+......... ...
T Consensus 169 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 239 (285)
T cd06648 169 --------VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLH 239 (285)
T ss_pred --------CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccc
Confidence 00112346899999999999889999999999999999999999999988887777766654322211 112
Q ss_pred cccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 605 PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 605 ~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.++..+.+||.+||..+|++||++ .++++||||...
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~---~~il~~~~~~~~ 275 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATA---AELLNHPFLAKA 275 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCH---HHHccCcccccC
Confidence 367899999999999999999998 999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=349.83 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=217.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+.|+.++.||+|+||.||+|.+..+++.||+|.+..... ....+.+..|+++++.++||||+++++++..+..+|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 457778889999999999999999999999998765432 234467889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++|++|.+++.. +.+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~------ 154 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT------ 154 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc------
Confidence 99999999998865 57999999999999999999999999999999999999999999999999998643211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
........|+..|+|||++.+..++.++|+|||||++|||++|..||...........+...... ...
T Consensus 155 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~ 222 (277)
T cd06642 155 ---------QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLE 222 (277)
T ss_pred ---------chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCC
Confidence 01112346899999999999999999999999999999999999999877666655544333211 111
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
...+.++.+||.+||..+|.+||++ .++++||||....
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~---~~il~~~~~~~~~ 260 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTA---KELLKHKFITRYT 260 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCH---HHHHHhHHHHHHh
Confidence 2356889999999999999999998 9999999987643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.62 Aligned_cols=254 Identities=27% Similarity=0.487 Sum_probs=216.2
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++.+.||+|+||.||+|..+.+|..+|+|.+...... ....+.+.+|+++++.++|+||+++++.+.....+|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 589999999999999999999999999999988664322 2234567889999999999999999999999999999999
Q ss_pred eccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc-EEEeccCCccccccccccc
Q psy16843 445 YVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH-IKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 445 y~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~-VKL~DFGLAk~~~~s~~~~ 521 (810)
|+++++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+||+++.++. +||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--- 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence 999999999987543 5899999999999999999999999999999999999998864 6999999886432110
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
.......|++.|+|||++.+..++.++|+||||+++|||++|..||...+..+....+........
T Consensus 157 ------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 222 (257)
T cd08225 157 ------------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI-- 222 (257)
T ss_pred ------------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCC--
Confidence 011234589999999999988899999999999999999999999998887777766665443221
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
....+.++.++|.+||..+|++||++ .|+++||||
T Consensus 223 -~~~~~~~~~~~i~~~l~~~p~~Rpt~---~~ll~~~~~ 257 (257)
T cd08225 223 -SPNFSRDLRSLISQLFKVSPRDRPSI---TSILKRPFL 257 (257)
T ss_pred -CCCCCHHHHHHHHHHhccChhhCcCH---HHHhhCCCC
Confidence 12367899999999999999999998 999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=338.05 Aligned_cols=248 Identities=24% Similarity=0.393 Sum_probs=208.4
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||++.++. +..+|+|.+...... .+.+..|+++++.++||||+++++++...+.+|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 679999999999999999998865 467999987644322 246778999999999999999999999999999999
Q ss_pred eeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~---- 154 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE---- 154 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc----
Confidence 99999999999974 4578999999999999999999999999999999999999999999999999986432110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
........++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+.+..+..+.......
T Consensus 155 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 224 (256)
T cd05114 155 ----------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK 224 (256)
T ss_pred ----------eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Confidence 001112235678999999998899999999999999999999 999999988888888877654322111
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..+.++.+||.+||..+|.+||++ .|+++
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~---~~l~~ 253 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTF---AELLR 253 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCH---HHHHH
Confidence 256789999999999999999998 66653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.02 Aligned_cols=261 Identities=26% Similarity=0.436 Sum_probs=210.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||.|+||.||+|.++.+|+.||+|.+...... ......+..|+++++.++||||+++++++.+...+|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 5799999999999999999999999999999987654321 223356778999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc-CCcEEEeccCCcccccccccc
Q psy16843 444 EYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA-LGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||++ ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||++.......
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-- 157 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-- 157 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--
Confidence 9996 57877776543 3688899999999999999999999999999999999985 5579999999986422110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC---CC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND---DI 596 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~---~~ 596 (810)
.......|++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++... ..
T Consensus 158 -------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 224 (294)
T PLN00009 158 -------------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN 224 (294)
T ss_pred -------------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 001233578999999998764 5799999999999999999999999887776655544321 00
Q ss_pred ------------------CCCCC----CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 597 ------------------EWPSE----DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 597 ------------------~~p~~----~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
.++.. ....++++++++|.+||+.+|++||++ .+++.||||.+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~---~~~l~~~~~~~~~ 291 (294)
T PLN00009 225 EETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA---RAALEHEYFKDLG 291 (294)
T ss_pred hhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH---HHHhcCchHhHHh
Confidence 00000 012357889999999999999999998 9999999998753
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.32 Aligned_cols=248 Identities=29% Similarity=0.484 Sum_probs=208.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||+|.++.+++.||||.+.+...........+..|+.+++.++||||+++++++.+++.+++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999887654444455577889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 444 EYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 444 Ey~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC--
Confidence 99999999998863 456899999999999999999999999999999999999999999999999988642211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH--HHHHHhhccCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP--EELFAHTVNDDIE 597 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~--~e~~~~I~~~~~~ 597 (810)
.......+|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+... .+....+....
T Consensus 160 -------------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-- 224 (267)
T cd08229 160 -------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-- 224 (267)
T ss_pred -------------CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--
Confidence 0011234689999999999999999999999999999999999999976543 23333333222
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
++.......+.++++||.+||..||++||++
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 255 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDI 255 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCH
Confidence 2222222367899999999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.77 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=209.7
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++++.||.|++|.||+|+++.+|+.||+|++...... ...+.+..|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 589999999999999999999999999999988764322 223556789999999999999999999999999999999
Q ss_pred eccCcchhhhhhcC---CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 445 YVEGGDCASLLKNT---GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 445 y~~GGsL~~lL~~~---g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|+++ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~---- 153 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---- 153 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC----
Confidence 9985 888887643 46899999999999999999999999999999999999999999999999998642111
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC----
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI---- 596 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~---- 596 (810)
........|++.|++||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 154 -----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
T cd07836 154 -----------VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTE 222 (284)
T ss_pred -----------ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence 0011234578999999998764 579999999999999999999999998877666555432100
Q ss_pred --------------CCCCC-------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 597 --------------EWPSE-------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 597 --------------~~p~~-------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.++.. .....+.+++++|.+||+.||.+||++ .|+++||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~---~~~l~~~~f 284 (284)
T cd07836 223 STWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA---HDALQHPWF 284 (284)
T ss_pred hhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCH---HHHhcCCCC
Confidence 00000 001246789999999999999999998 999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=348.75 Aligned_cols=257 Identities=28% Similarity=0.408 Sum_probs=210.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc--ceeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK--KHLCL 441 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~--~~lyL 441 (810)
++|++.+.||.|+||.||+|.++.+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... ..+|+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 5799999999999999999999999999999988654332 22334567899999999999999999998877 89999
Q ss_pred eeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 160 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-- 160 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc--
Confidence 9999975 898888654 459999999999999999999999999999999999999999999999999986532110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC---
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI--- 596 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~--- 596 (810)
.......|++.|+|||++.+. .++.++||||||+++|||++|.+||.+....+.+.++...-.
T Consensus 161 -------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (293)
T cd07843 161 -------------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPT 227 (293)
T ss_pred -------------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 011234578999999999765 468999999999999999999999998877766655432100
Q ss_pred ----------------CC--C------CCCCC-cccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 597 ----------------EW--P------SEDDW-PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 597 ----------------~~--p------~~~~~-~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.+ . ..... .+++.+.+||.+||+.||++||++ .|++.||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~---~ell~~~~f 293 (293)
T cd07843 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA---EDALKHPYF 293 (293)
T ss_pred hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH---HHHhcCCCC
Confidence 00 0 00000 147889999999999999999998 999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.14 Aligned_cols=257 Identities=28% Similarity=0.512 Sum_probs=214.7
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC---CCeEEEeeeeccccceeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD---NPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~---HPnIVkl~~~f~~~~~lyL 441 (810)
.|++++.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.+. ||||+++++++..+..+|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 58889999999999999999999999999998765422 234466778999988886 9999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||++|++|.+++.. +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--- 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---
Confidence 9999999999999876 589999999999999999999999999999999999999999999999999986532110
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
.......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.........+..... +.
T Consensus 156 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~ 221 (277)
T cd06917 156 ------------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP--PR 221 (277)
T ss_pred ------------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCC--CC
Confidence 11123468999999999875 4579999999999999999999999988776655544333211 11
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
......+.++.+||.+||+.||.+||++ .|++.||||+...
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~---~~il~~~~~~~~~ 262 (277)
T cd06917 222 LEDNGYSKLLREFVAACLDEEPKERLSA---EELLKSKWIKAHS 262 (277)
T ss_pred CCcccCCHHHHHHHHHHcCCCcccCcCH---HHHhhChHhhccc
Confidence 1111256899999999999999999998 9999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=382.37 Aligned_cols=259 Identities=29% Similarity=0.449 Sum_probs=215.9
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeee-ccc---
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCS-FET--- 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~-f~~--- 435 (810)
+...++++.+.|.+|||+.||+|+....|..||+|++... .+...+.+.+|+++|+.|. |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 4556789999999999999999999988899999998765 3566788999999999996 9999999993 221
Q ss_pred ---cceeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCCCceEeccCCcEEEecc
Q psy16843 436 ---KKHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYG--IVHRDLKPDNLLITALGHIKLTDF 508 (810)
Q Consensus 436 ---~~~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~g--IIHRDLKPeNILLd~~g~VKL~DF 508 (810)
.-.++|.||||+||.|-+++..+ ..|+|.++.+|+.++++|+.+||... |||||||-|||||+.+|+.|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 13688999999999999999743 46999999999999999999999998 999999999999999999999999
Q ss_pred CCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHh---hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH
Q psy16843 509 GLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL---RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE 585 (810)
Q Consensus 509 GLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~---~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~ 585 (810)
|.+........+..-..+++.+.. ...|+.|+|||+|. +.+.+.|+|||+|||+||-|++...||.+...
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~------k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~- 263 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIE------KYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK- 263 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHH------hhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-
Confidence 998754333322111122333322 24699999999985 67889999999999999999999999976532
Q ss_pred HHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 586 ELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 586 e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
..|+++.+.+|... +++..+++||+.||+.||++||++ -|++.+
T Consensus 264 ---laIlng~Y~~P~~p--~ys~~l~~LI~~mL~~nP~~RPnI---~Qv~~~ 307 (738)
T KOG1989|consen 264 ---LAILNGNYSFPPFP--NYSDRLKDLIRTMLQPNPDERPNI---YQVLEE 307 (738)
T ss_pred ---eeEEeccccCCCCc--cHHHHHHHHHHHHhccCcccCCCH---HHHHHH
Confidence 57899999999864 488999999999999999999998 555543
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.00 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=205.4
Q ss_pred CcEEEEEecccCceEEEEEEEcC--CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc--ceee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKE--TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK--KHLC 440 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~--tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~--~~ly 440 (810)
.|++.+.||+|+||.||+|.++. +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 8999999988764322233345677899999999999999999999988 8899
Q ss_pred eeeeeccCcchhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc----CCcEEEeccCCc
Q psy16843 441 LVMEYVEGGDCASLLKN-----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA----LGHIKLTDFGLS 511 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~-----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~----~g~VKL~DFGLA 511 (810)
+||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +|.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 66666532 237899999999999999999999999999999999999999 999999999998
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHH----
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEE---- 586 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e---- 586 (810)
+....... ........+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.....
T Consensus 160 ~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 227 (316)
T cd07842 160 RLFNAPLK------------PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN 227 (316)
T ss_pred cccCCCcc------------cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccc
Confidence 75322100 01122345789999999998774 58999999999999999999999998654322
Q ss_pred -----HHHhhcc--------------------------CCCCCCCC-------CCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 587 -----LFAHTVN--------------------------DDIEWPSE-------DDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 587 -----~~~~I~~--------------------------~~~~~p~~-------~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
.+..+.. ....++.. .....+.++.++|.+||+.||++||++
T Consensus 228 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~ 307 (316)
T cd07842 228 PFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA 307 (316)
T ss_pred hhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH
Confidence 1111100 00011100 000255789999999999999999998
Q ss_pred CChhHHhcCCCc
Q psy16843 629 GGPHEVKEHPYF 640 (810)
Q Consensus 629 ~~~~EiL~HPfF 640 (810)
.|++.||||
T Consensus 308 ---~eil~~~~f 316 (316)
T cd07842 308 ---EEALEHPYF 316 (316)
T ss_pred ---HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=342.16 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=209.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEc----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHK----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
..+|++.+.||+|+||.||+|... .++..||+|.+..... ......+.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 468999999999999999999863 4567899998864332 3344678889999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC
Q psy16843 439 LCLVMEYVEGGDCASLLKNT-----------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG 501 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~-----------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g 501 (810)
.|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 99999999999999998522 2478889999999999999999999999999999999999999
Q ss_pred cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCC
Q psy16843 502 HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFF 580 (810)
Q Consensus 502 ~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~ 580 (810)
.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |.+||.
T Consensus 162 ~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~ 228 (283)
T cd05090 162 HVKISDLGLSREIYSADY-------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228 (283)
T ss_pred cEEeccccccccccCCcc-------------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 999999999875321110 011133456788999999998889999999999999999998 999999
Q ss_pred CCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 581 GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 581 ~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
+.....+...+...... +.. ..++.++.++|.+||+.||.+||++ .+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~li~~cl~~~p~~Rp~~---~~i~~~ 279 (283)
T cd05090 229 GFSNQEVIEMVRKRQLL-PCS--EDCPPRMYSLMTECWQEGPSRRPRF---KDIHTR 279 (283)
T ss_pred CCCHHHHHHHHHcCCcC-CCC--CCCCHHHHHHHHHHcccCcccCcCH---HHHHHH
Confidence 88877776666554432 211 2367899999999999999999999 666543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=330.99 Aligned_cols=253 Identities=31% Similarity=0.546 Sum_probs=219.6
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++.+.||+|++|.||++.++.+++.||+|.+...... ....+.+..|++++..++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999988766432 3455788999999999999999999999999999999999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
|+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----- 154 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK----- 154 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-----
Confidence 999999999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-CCCCCCC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI-EWPSEDD 603 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~-~~p~~~~ 603 (810)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..... .++
T Consensus 155 ----------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 220 (254)
T cd06627 155 ----------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLP---- 220 (254)
T ss_pred ----------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCC----
Confidence 01234689999999999888899999999999999999999999988776655555443222 222
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..++.+++++|.+||..+|++||++ .+++.||||
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~---~~~l~~~~~ 254 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTA---KQLLKHPWI 254 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCH---HHHhcCCCC
Confidence 2367899999999999999999998 999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=341.16 Aligned_cols=258 Identities=32% Similarity=0.478 Sum_probs=212.2
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc--cceeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET--KKHLCL 441 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~--~~~lyL 441 (810)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+++++.++||||++++++|.+ ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 479999999999999999999999999999998875432 2344678889999999999999999998854 347899
Q ss_pred eeeeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 442 VMEYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887642 456899999999999999999999999999999999999999999999999998642111
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC-----CHHHHHHhhc
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE-----TPEELFAHTV 592 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~-----~~~e~~~~I~ 592 (810)
......++..|+|||.+.+..++.++|||||||++|+|++|..||... ...+....+.
T Consensus 159 -----------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd06621 159 -----------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV 221 (287)
T ss_pred -----------------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh
Confidence 011345788999999999999999999999999999999999999765 3344444444
Q ss_pred cCC-CCCCCC--CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 593 NDD-IEWPSE--DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 593 ~~~-~~~p~~--~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
... ...+.. .....++++.+||.+||..+|.+||++ .|++.||||...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~---~eil~~~~~~~~ 272 (287)
T cd06621 222 NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTP---WDMLEHPWIKAQ 272 (287)
T ss_pred cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCH---HHHHhCcccccc
Confidence 321 111111 112246789999999999999999999 999999999664
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=341.49 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=217.6
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+-|++++.||.|+||.||+|.++.+++.||+|.+..... ....+.+.+|+++++.++||||+++++++..++.+|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 348889999999999999999999999999998754432 234467888999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||+++|+|..++.. +.+++..+..++.|++.||.|||+.|++|+||||+||+++.+|.++|+|||++......
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~------ 154 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT------ 154 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc------
Confidence 99999999999875 57899999999999999999999999999999999999999999999999998642210
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+....... ..
T Consensus 155 ---------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 222 (277)
T cd06641 155 ---------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT---LE 222 (277)
T ss_pred ---------hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC---CC
Confidence 011123468999999999998888999999999999999999999998877776666654432211 11
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
..++.++.++|.+||..+|.+||++ .++++||||..
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~---~~~l~~~~~~~ 258 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTA---KELLKHKFIVR 258 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCH---HHHHhCHHHhh
Confidence 2366889999999999999999998 99999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=341.58 Aligned_cols=252 Identities=25% Similarity=0.442 Sum_probs=203.5
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecccc--ceeeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETK--KHLCLV 442 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~--~~lyLV 442 (810)
|++++.||+|+||.||+|.++.+++.||+|++.+..... .. .....|+.++..+ +|+||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 788999999999999999999999999999876543221 12 2345688888877 499999999999887 899999
Q ss_pred eeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|||++| +|.+.+.. .+.+++..+..++.||+.||+|||+.||+||||||+||+++. |.+||+|||+++.....
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---- 152 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---- 152 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC----
Confidence 999975 77777764 467999999999999999999999999999999999999999 99999999998642211
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC------
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND------ 594 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~------ 594 (810)
.......|++.|+|||++.. ..++.++|||||||++|||++|.+||.+.+..+.+..+...
T Consensus 153 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
T cd07831 153 ------------PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA 220 (282)
T ss_pred ------------CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCH
Confidence 01123458899999998765 45699999999999999999999999988776654444320
Q ss_pred ------------CCCCCCCC-------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 595 ------------DIEWPSED-------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 595 ------------~~~~p~~~-------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
...++... ...++.++.+||.+||.++|++||++ .+++.||||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~---~~~l~~~~~ 282 (282)
T cd07831 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA---KQALRHPYF 282 (282)
T ss_pred HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCH---HHHhhCCCC
Confidence 11111111 01257899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=337.80 Aligned_cols=247 Identities=21% Similarity=0.329 Sum_probs=208.7
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
...+|++.+.||.|+||.||+|.++.+++.||+|.+.+.. .....+..|+++++.++||||+++++++..+..+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 4467999999999999999999999999999999876542 234567889999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999999998653 3689999999999999999999999999999999999999999999999999865321100
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
.......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+.... ..
T Consensus 160 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~ 224 (263)
T cd05052 160 --------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-RM 224 (263)
T ss_pred --------------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CC
Confidence 00112234678999999999999999999999999999998 999999988887777765432 11
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
+. ....+.++.+||.+||+.||++||++.
T Consensus 225 ~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~ 253 (263)
T cd05052 225 ER--PEGCPPKVYELMRACWQWNPSDRPSFA 253 (263)
T ss_pred CC--CCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 11 123678999999999999999999993
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=344.98 Aligned_cols=263 Identities=27% Similarity=0.426 Sum_probs=206.3
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc----
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK---- 437 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~---- 437 (810)
..++|++++.||+|+||.||+|.++.+++.||||.+...... ......+.+|+++++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 346899999999999999999999999999999988654321 122234567999999999999999999876543
Q ss_pred ----eeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 438 ----HLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 438 ----~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
..|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 46999999965 787777654 479999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I 591 (810)
........ .........|+..|+|||++.+. .++.++||||||+++|||++|.+||.+.+.......+
T Consensus 168 ~~~~~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~ 236 (310)
T cd07865 168 AFSLSKNS-----------KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236 (310)
T ss_pred cccCCccc-----------CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 53221110 00111234688999999998764 4789999999999999999999999887765443332
Q ss_pred cc--CC-----------------CCCCCCC---------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 592 VN--DD-----------------IEWPSED---------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 592 ~~--~~-----------------~~~p~~~---------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.. +. ...+... ....+..+.+||.+||..||.+||++ .|+++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~---~e~l~h~~f 310 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA---DTALNHDFF 310 (310)
T ss_pred HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH---HHHhcCCCC
Confidence 22 00 0011100 00124678899999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=349.28 Aligned_cols=255 Identities=22% Similarity=0.360 Sum_probs=208.1
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcE----EEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQR----FAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~----vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
....+|++++.||+|+||.||+|.+..+++. ||+|++..... ....+.+..|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 3457899999999999999999998766654 89998754322 23446788899999999999999999998764
Q ss_pred ceeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
..++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 578999999999999999764 468999999999999999999999999999999999999999999999999997532
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccC
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVND 594 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~ 594 (810)
... .........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+... +...
T Consensus 161 ~~~-------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~ 226 (316)
T cd05108 161 ADE-------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEK 226 (316)
T ss_pred CCC-------------cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhC
Confidence 110 0111122335678999999999999999999999999999997 999999887766544 3333
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 595 ~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
...++... ..+.++.++|.+||..||.+||++ .+++.+
T Consensus 227 ~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~---~~l~~~ 264 (316)
T cd05108 227 GERLPQPP--ICTIDVYMIMVKCWMIDADSRPKF---RELIIE 264 (316)
T ss_pred CCCCCCCC--CCCHHHHHHHHHHccCChhhCcCH---HHHHHH
Confidence 33333322 256889999999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=330.67 Aligned_cols=254 Identities=34% Similarity=0.613 Sum_probs=220.8
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++.+.||.|+||.||++.+..+++.||+|++...... ....+.+..|+++++.++|||++++++.+.....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999999999999988664432 3445678889999999999999999999999999999999
Q ss_pred eccCcchhhhhhcC----CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 445 YVEGGDCASLLKNT----GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 445 y~~GGsL~~lL~~~----g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
|++|++|.+++.+. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999763 679999999999999999999999999999999999999999999999999986422110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
.......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+.........
T Consensus 158 -------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (258)
T cd08215 158 -------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP 224 (258)
T ss_pred -------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 1123456899999999999999999999999999999999999999888877777776665432221
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
...+.++.++|.+||..+|.+||++ .|++.||||
T Consensus 225 ---~~~~~~~~~~i~~~l~~~p~~Rp~~---~~ll~~~~~ 258 (258)
T cd08215 225 ---SQYSSELRNLVSSLLQKDPEERPSI---AQILQSPFI 258 (258)
T ss_pred ---CCCCHHHHHHHHHHcCCChhhCcCH---HHHhcCCCC
Confidence 1367899999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.08 Aligned_cols=264 Identities=23% Similarity=0.407 Sum_probs=213.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc----ccee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET----KKHL 439 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~----~~~l 439 (810)
++|++.+.||.|+||.||+|.++.+|+.||+|++..... .....+.+..|+.+|+.++||||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999998875432 22344667789999999999999999998763 3578
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 68999998778899999999999999999999999999999999999999999999999999865322110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC--
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI-- 596 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~-- 596 (810)
. ........+|+..|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+....-
T Consensus 163 ~-----------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~ 231 (334)
T cd07855 163 E-----------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231 (334)
T ss_pred C-----------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence 0 0111124578999999999876 4689999999999999999999999988765443332221000
Q ss_pred ------------------CCCCCC-------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 597 ------------------EWPSED-------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 597 ------------------~~p~~~-------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.++... ....+.++++||++||+.+|.+||++ .+++.||||...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~---~~~l~~~~~~~~ 300 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV---EQALQHPFLAQY 300 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH---HHHHhChhhhhc
Confidence 001000 01257889999999999999999998 899999999764
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=336.74 Aligned_cols=247 Identities=19% Similarity=0.344 Sum_probs=207.6
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
+..++|++++.||+|+||.||+|... +++.||+|.+..... ..+.+..|+.+++.++|+||+++++++.+.+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 45578999999999999999999865 456799998765332 2467888999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 441 LVMEYVEGGDCASLLKN--TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~--~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999999964 3568999999999999999999999999999999999999999999999999987532110
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
........++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+... ..
T Consensus 158 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~ 222 (261)
T cd05072 158 --------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YR 222 (261)
T ss_pred --------------eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CC
Confidence 001122346778999999998889999999999999999998 99999988887777766544 23
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
++.. ..++.++.+||.+||..+|++||++.
T Consensus 223 ~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~ 252 (261)
T cd05072 223 MPRM--ENCPDELYDIMKTCWKEKAEERPTFD 252 (261)
T ss_pred CCCC--CCCCHHHHHHHHHHccCCcccCcCHH
Confidence 3322 23678999999999999999999993
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=348.97 Aligned_cols=256 Identities=28% Similarity=0.484 Sum_probs=216.3
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
.|+....||+|+||.||+|.++.+++.||+|.+..... ...+.+.+|+.++..++||||+++++++..++.+|+|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 45556689999999999999999999999998865432 223567889999999999999999999999999999999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
|+++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~------- 170 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD------- 170 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc-------
Confidence 9999999998765 57999999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDW 604 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~ 604 (810)
.......+|++.|+|||++.+..++.++|||||||++|||++|..||...+..+....+......... ...
T Consensus 171 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 241 (297)
T cd06659 171 --------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK-NAH 241 (297)
T ss_pred --------cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCcc-ccC
Confidence 01113457899999999999989999999999999999999999999988877766665443322211 122
Q ss_pred cccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 605 PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 605 ~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.++.++.++|.+||+.+|.+||++ .++++||||...
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~---~~ll~~~~~~~~ 277 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATA---QELLDHPFLLQT 277 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCH---HHHhhChhhccC
Confidence 367889999999999999999998 999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=337.06 Aligned_cols=254 Identities=23% Similarity=0.317 Sum_probs=210.7
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKET-----RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~t-----g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
...++|++.+.||+|+||.||+|..+.. +..||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 3457899999999999999999998754 47899998754432 2334567889999999999999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEE
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNT----------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 505 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~----------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL 505 (810)
....|+||||+++|+|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999998642 24678899999999999999999999999999999999999999999
Q ss_pred eccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCH
Q psy16843 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETP 584 (810)
Q Consensus 506 ~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~ 584 (810)
+|||+++...... .........|+..|+|||.+.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 161 ~dfg~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 161 GDFGMTRDIYETD-------------YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred CCcccchhhccCc-------------ccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence 9999986532110 0011123457889999999998889999999999999999998 9999999888
Q ss_pred HHHHHhhccCCC-CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 585 EELFAHTVNDDI-EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 585 ~e~~~~I~~~~~-~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.+....+..... ..|. ..+.++.+||.+||+.+|++||++ .++++
T Consensus 228 ~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~---~~l~~ 273 (277)
T cd05032 228 EEVLKFVIDGGHLDLPE----NCPDKLLELMRMCWQYNPKMRPTF---LEIVS 273 (277)
T ss_pred HHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCChhhCCCH---HHHHH
Confidence 887777664432 2222 257899999999999999999998 66654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=336.14 Aligned_cols=251 Identities=30% Similarity=0.508 Sum_probs=204.8
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
.+.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++.+|+|||
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 3444568999999999999999999999999876543 2344678899999999999999999999999999999999
Q ss_pred eccCcchhhhhhcC-CCC--CHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc-CCcEEEeccCCcccccccccc
Q psy16843 445 YVEGGDCASLLKNT-GPL--PADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA-LGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 445 y~~GGsL~~lL~~~-g~l--se~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~g~VKL~DFGLAk~~~~s~~~ 520 (810)
|++|++|.+++... +.+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--- 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC---
Confidence 99999999999754 556 88899999999999999999999999999999999986 679999999998642110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhc--CCCCCcchhhhHHHHHHHHhCCCCCCCCCHH-HHHHhhc--cCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ--GYGKPVDWWSMGVILYEFLVGCVPFFGETPE-ELFAHTV--NDD 595 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~--~ys~ksDIWSLGvILyELLtG~~PF~~~~~~-e~~~~I~--~~~ 595 (810)
........|++.|+|||++.+. .++.++|+||||+++|+|++|..||...... .....+. ...
T Consensus 163 ------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 230 (268)
T cd06624 163 ------------NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH 230 (268)
T ss_pred ------------CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccC
Confidence 0011233589999999998764 4899999999999999999999999754322 1111111 111
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..+|. .+++++++||.+||..+|.+||++ .|++.||||
T Consensus 231 ~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~---~~ll~~~~~ 268 (268)
T cd06624 231 PEIPE----SLSAEAKNFILRCFEPDPDKRASA---HDLLQDPFL 268 (268)
T ss_pred CCCCc----ccCHHHHHHHHHHcCCCchhCCCH---HHHHhCCCC
Confidence 22222 266899999999999999999999 999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=353.66 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=207.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc-----ce
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK-----KH 438 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~-----~~ 438 (810)
++|++.+.||+|+||.||+|.++.+|+.||+|.+.... .......+..|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 68999999999999999999999999999999885422 123345677899999999999999999876543 36
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|+||||+.+ +|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 8999999964 88877754 579999999999999999999999999999999999999999999999999987532110
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc---C
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN---D 594 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~---~ 594 (810)
. ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+.. .
T Consensus 161 ~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~ 228 (336)
T cd07849 161 D------------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228 (336)
T ss_pred c------------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 0 0001134578999999999765 5689999999999999999999999987654433222211 0
Q ss_pred ------------C-------CCCCCC-----CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 595 ------------D-------IEWPSE-----DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 595 ------------~-------~~~p~~-----~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
. ...... .....+.++.+||.+||+.+|++||++ .|++.||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~---~e~l~hp~~~~~ 298 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV---EEALAHPYLEQY 298 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCH---HHHhcCcccccc
Confidence 0 000000 001246789999999999999999998 999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=333.61 Aligned_cols=252 Identities=28% Similarity=0.455 Sum_probs=209.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||+|.++.+|+.||+|.+...........+.+.+|+++++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999999999999887544444445678889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 444 EYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 444 Ey~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
||++||+|..++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.+|.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 99999999998853 346899999999999999999999999999999999999999999999999998642111
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC--HHHHHHhhccCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET--PEELFAHTVNDDIE 597 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~--~~e~~~~I~~~~~~ 597 (810)
........|++.|+|||.+.+..++.++|||||||++|+|++|..||.... ..+....+..+...
T Consensus 160 -------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 226 (267)
T cd08224 160 -------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP 226 (267)
T ss_pred -------------CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC
Confidence 001123468999999999999999999999999999999999999997553 23444444433221
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
.......+.++.++|.+||..+|.+||++ .+++
T Consensus 227 --~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~---~~il 259 (267)
T cd08224 227 --PLPADHYSEELRDLVSRCINPDPEKRPDI---SYVL 259 (267)
T ss_pred --CCChhhcCHHHHHHHHHHcCCCcccCCCH---HHHH
Confidence 11111356789999999999999999999 5544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=376.49 Aligned_cols=268 Identities=21% Similarity=0.295 Sum_probs=199.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCc-EEEEE--------------EeeccchhhHHHHHHHHHHHHHHhcCCCCeEE
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQ-RFAMK--------------KIIKNSLMLRNQMEQVFAERDIMSFTDNPFVV 427 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~-~vAIK--------------~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIV 427 (810)
.++|++++.||+|+||+||+|..+.... .++.| .+.+...........+.+|+.+|+.++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987654322 22222 11111111222345678999999999999999
Q ss_pred EeeeeccccceeeeeeeeccCcchhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc
Q psy16843 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKNT-----GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH 502 (810)
Q Consensus 428 kl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~-----g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~ 502 (810)
++++++...+..|+|||++. ++|..++... .......++.|+.||+.||+|||++|||||||||+||||+.+|.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999995 5676666432 23456778899999999999999999999999999999999999
Q ss_pred EEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCC-C
Q psy16843 503 IKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF-G 581 (810)
Q Consensus 503 VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~-~ 581 (810)
+||+|||+++..... ........+||+.|+|||++.+..|+.++|||||||+||||++|..++. +
T Consensus 306 vkL~DFGla~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 306 IVLGDFGTAMPFEKE--------------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred EEEEeCCCceecCcc--------------cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 999999999753211 0111234679999999999999999999999999999999999876443 2
Q ss_pred C--CHHHHHHhhccC----CCCCCCC------------------------CCCcccHHHHHHHHhhhcCCCCCCCCCCCh
Q psy16843 582 E--TPEELFAHTVND----DIEWPSE------------------------DDWPIQVEAKSIITDLLQQNPRDRLGTGGP 631 (810)
Q Consensus 582 ~--~~~e~~~~I~~~----~~~~p~~------------------------~~~~~S~el~dLI~klL~~dP~~Rpta~~~ 631 (810)
. .....+.+++.. ...+|.. ....++.++.++|.+||++||.+||++
T Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa--- 448 (501)
T PHA03210 372 GGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA--- 448 (501)
T ss_pred CCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCH---
Confidence 2 222222222210 0011110 001245678889999999999999999
Q ss_pred hHHhcCCCcCCCChhhh
Q psy16843 632 HEVKEHPYFSNLDWNSL 648 (810)
Q Consensus 632 ~EiL~HPfF~~id~~~l 648 (810)
.|++.||||........
T Consensus 449 ~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 449 AELLALPLFSAEEEEEI 465 (501)
T ss_pred HHHhhChhhhcCCchHH
Confidence 99999999988765544
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.39 Aligned_cols=255 Identities=33% Similarity=0.533 Sum_probs=217.1
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc--ceeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK--KHLCLV 442 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~--~~lyLV 442 (810)
+|.+.+.||+|++|.||+|.++.+++.|++|++...... ....+.+..|+++++.++||||+++++.+... ..+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999999999999988665432 34567888999999999999999999999988 899999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||+.+++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET--- 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc---
Confidence 99999999999998877999999999999999999999999999999999999999999999999999865322110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC-HHHHHHhhcc--CCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET-PEELFAHTVN--DDIEWP 599 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~-~~e~~~~I~~--~~~~~p 599 (810)
........|+..|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+.. .....+
T Consensus 157 ----------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd06606 157 ----------GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIP 226 (260)
T ss_pred ----------cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCC
Confidence 001234568999999999998889999999999999999999999998765 3333334332 112222
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
. ..+.++++||.+||+.||.+||++ .|++.||||
T Consensus 227 ~----~~~~~l~~~i~~~l~~~p~~Rp~~---~~ll~~~~~ 260 (260)
T cd06606 227 E----HLSEEAKDFLRKCLRRDPKKRPTA---DELLQHPFL 260 (260)
T ss_pred c----ccCHHHHHHHHHhCcCChhhCCCH---HHHhhCCCC
Confidence 2 257899999999999999999998 999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=325.83 Aligned_cols=251 Identities=33% Similarity=0.529 Sum_probs=215.7
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+++++.++|+||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58999999999999999999998999999998866543 345678899999999999999999999999999999999
Q ss_pred eccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 445 YVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 445 y~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
|++|++|.+++... +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~----- 152 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK----- 152 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc-----
Confidence 99999999999765 689999999999999999999999999999999999999999999999999986532110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-CCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI-EWPSED 602 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~-~~p~~~ 602 (810)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..... ..+..
T Consensus 153 -----------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 220 (253)
T cd05122 153 -----------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNP- 220 (253)
T ss_pred -----------cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcc-
Confidence 02345689999999999988899999999999999999999999988766555544443221 12211
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCC
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPf 639 (810)
..++.++.++|.+||+.||.+||++ .|++.|||
T Consensus 221 -~~~~~~~~~~i~~~l~~~p~~R~t~---~~~l~~~~ 253 (253)
T cd05122 221 -EKWSDEFKDFLKKCLQKNPEKRPTA---EQLLKHPF 253 (253)
T ss_pred -cccCHHHHHHHHHHccCChhhCCCH---HHHhcCCC
Confidence 1136889999999999999999999 99999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=353.28 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=211.7
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc-----
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK----- 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~----- 437 (810)
.++|++++.||+|+||.||+|.+..+++.||||.+.+.. ......+.+..|+++|+.++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 367999999999999999999999999999999886532 22333456788999999999999999999987654
Q ss_pred -eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 -HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 -~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
.+|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 469999999 7799888864 5799999999999999999999999999999999999999999999999999864211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
......|++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+....+..+....
T Consensus 171 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 171 ------------------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred ------------------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 0123467999999999976 458999999999999999999999998877655554443321
Q ss_pred CCCC--------------------C-------CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 596 IEWP--------------------S-------EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 596 ~~~p--------------------~-------~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
...+ . .....++.++.++|.+||+.||.+||++ .+++.||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~---~~~l~~~~~~~~ 304 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITA---AEALAHPYFEEF 304 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCH---HHHhcCccHhhh
Confidence 1110 0 0011256789999999999999999999 899999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=339.14 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=208.8
Q ss_pred CCCcEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKE-----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~-----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
.++|.+.+.||+|+||.||+|.++. ++..||+|.+..... ......+..|+.+++.++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4679999999999999999999987 778899997754322 223356788999999999999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcCC-------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC---cEEEec
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTG-------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKLTD 507 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g-------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g---~VKL~D 507 (810)
..|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999997543 589999999999999999999999999999999999998765 599999
Q ss_pred cCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHH
Q psy16843 508 FGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEE 586 (810)
Q Consensus 508 FGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e 586 (810)
||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus 163 fg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~ 229 (277)
T cd05036 163 FGMARDIYRASY-------------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229 (277)
T ss_pred CccccccCCccc-------------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999875311100 000112234568999999999999999999999999999997 999999888877
Q ss_pred HHHhhccCC-CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 587 LFAHTVNDD-IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 587 ~~~~I~~~~-~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
....+.... ..++ ..++.++.+|+.+||+.+|++||++ .++++|
T Consensus 230 ~~~~~~~~~~~~~~----~~~~~~~~~~i~~cl~~~p~~Rps~---~~vl~~ 274 (277)
T cd05036 230 VMEFVTGGGRLDPP----KGCPGPVYRIMTDCWQHTPEDRPNF---ATILER 274 (277)
T ss_pred HHHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCCcccCcCH---HHHHHH
Confidence 766655432 2222 2367899999999999999999999 788765
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=355.84 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=205.9
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKE-----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFE 434 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~-----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~ 434 (810)
...++|++.+.||+|+||.||+|.+.. +++.||+|++..... ....+.+..|++++..+ +|+||+++++++.
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 345689999999999999999997543 457899998764322 23446678899999999 8999999999876
Q ss_pred c-cceeeeeeeeccCcchhhhhhcC-------------------------------------------------------
Q psy16843 435 T-KKHLCLVMEYVEGGDCASLLKNT------------------------------------------------------- 458 (810)
Q Consensus 435 ~-~~~lyLVmEy~~GGsL~~lL~~~------------------------------------------------------- 458 (810)
. +..+++||||++||+|.++|...
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 45789999999999999988532
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccc
Q psy16843 459 ------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAK 532 (810)
Q Consensus 459 ------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~ 532 (810)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~-------------~ 228 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-------------D 228 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc-------------c
Confidence 257889999999999999999999999999999999999999999999999987532110 1
Q ss_pred cccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHH
Q psy16843 533 QFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAK 611 (810)
Q Consensus 533 ~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~ 611 (810)
........|+..|+|||++.+..|+.++|||||||+||||++ |..||.+....+.+...+......... ...++++.
T Consensus 229 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 306 (337)
T cd05054 229 YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP--EYATPEIY 306 (337)
T ss_pred hhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCC--ccCCHHHH
Confidence 111233456788999999999999999999999999999997 999998765555444444333222211 13568999
Q ss_pred HHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 612 SIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 612 dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
+++.+||+.+|++||++ .|+++|
T Consensus 307 ~l~~~cl~~~p~~RPs~---~ell~~ 329 (337)
T cd05054 307 SIMLDCWHNNPEDRPTF---SELVEI 329 (337)
T ss_pred HHHHHHccCChhhCcCH---HHHHHH
Confidence 99999999999999999 777654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=340.68 Aligned_cols=255 Identities=21% Similarity=0.302 Sum_probs=209.0
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCC----------------cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeE
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETR----------------QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFV 426 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg----------------~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnI 426 (810)
.++|++++.||+|+||.||+|.+..++ ..||+|.+..... ....+.+.+|+++++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876544 4589998765432 2445778899999999999999
Q ss_pred EEeeeeccccceeeeeeeeccCcchhhhhhcCC-----------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCce
Q psy16843 427 VTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG-----------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNL 495 (810)
Q Consensus 427 Vkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g-----------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNI 495 (810)
+++++++..++.+++||||+.+++|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999997655 689999999999999999999999999999999999
Q ss_pred EeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-
Q psy16843 496 LITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV- 574 (810)
Q Consensus 496 LLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt- 574 (810)
+++.++.++|+|||+++...... .........+++.|+|||++.+..++.++|||||||++|||++
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 228 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSD-------------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228 (296)
T ss_pred eecCCCceEEccccceeecccCc-------------ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhc
Confidence 99999999999999986432110 0011124457889999999998889999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHhhccC----CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 575 -GCVPFFGETPEELFAHTVND----DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 575 -G~~PF~~~~~~e~~~~I~~~----~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
|..||...+..+.+..+... ............+.++.+||.+||+.||.+||++ .|++
T Consensus 229 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~---~el~ 291 (296)
T cd05051 229 CREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF---REIH 291 (296)
T ss_pred CCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCH---HHHH
Confidence 78899887777766655432 1111111112356899999999999999999999 6664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=335.43 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=211.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKET---RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~t---g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
.++|++.+.||+|+||.||+|.++.+ ...||+|.+..... ......+..|+.+++.++||||+++++++.+.+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46899999999999999999998754 45799998765432 33446678899999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
|+||||+++|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999999865 3579999999999999999999999999999999999999999999999999987532100
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
.........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....+.... .
T Consensus 161 -------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~ 226 (266)
T cd05033 161 -------------ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-R 226 (266)
T ss_pred -------------cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-C
Confidence 0111112335678999999999999999999999999999997 999998888877777766542 2
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.+... ..+..+.+|+.+||+.+|++||++ .|++++
T Consensus 227 ~~~~~--~~~~~l~~li~~cl~~~p~~Rp~~---~ei~~~ 261 (266)
T cd05033 227 LPPPM--DCPSALYQLMLDCWQKDRNERPTF---SQIVST 261 (266)
T ss_pred CCCCC--CCCHHHHHHHHHHcCCCcccCcCH---HHHHHH
Confidence 22222 267899999999999999999998 666653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=330.67 Aligned_cols=247 Identities=26% Similarity=0.356 Sum_probs=210.9
Q ss_pred EEecccCceEEEEEEEcCC---CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeec
Q psy16843 370 KLISNGAYGSVYLVRHKET---RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYV 446 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~t---g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~ 446 (810)
+.||+|+||.||+|..... +..||+|.+....... ..+.+..|++++..++|+||+++++++.+...+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 8899999886654322 4678889999999999999999999999999999999999
Q ss_pred cCcchhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 447 EGGDCASLLKNT---------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 447 ~GGsL~~lL~~~---------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 78999999999999999999999999999999999999999999999999998753211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.. ........+++.|+|||.+....++.++|||||||++|||++ |..||.+....+....+.....
T Consensus 159 ~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 225 (262)
T cd00192 159 DY-------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR 225 (262)
T ss_pred cc-------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 00 011234567899999999998899999999999999999998 6999999988888887775322
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.+.. ..++.++.++|.+||..||.+||++ .|+++|
T Consensus 226 -~~~~--~~~~~~~~~li~~~l~~~p~~Rps~---~~l~~~ 260 (262)
T cd00192 226 -LPKP--EYCPDELYELMLSCWQLDPEDRPTF---SELVER 260 (262)
T ss_pred -CCCC--ccCChHHHHHHHHHccCCcccCcCH---HHHHHh
Confidence 1211 2257899999999999999999998 787764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=346.17 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=218.0
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..+.|...+.||+|+||.||+|++..++..||+|++.............+..|+++++.++|||++++++++.++...|+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 34569999999999999999999999999999998876544444555678899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 442 VMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 442 VmEy~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||||+.| +|.+++. ....+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 9999975 6777664 456799999999999999999999999999999999999999999999999998753210
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHh---hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVIL---RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~---~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
.....|++.|+|||++. ...++.++|||||||++|||++|..||.+.+.......+......
T Consensus 178 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd06635 178 ---------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 242 (317)
T ss_pred ---------------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC
Confidence 12346899999999985 356899999999999999999999999988877777776665433
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.... ...+..+++||.+||+.+|.+||++ .++++|+|+..
T Consensus 243 ~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~---~~il~~~~~~~ 282 (317)
T cd06635 243 TLQS--NEWSDYFRNFVDSCLQKIPQDRPTS---EELLKHMFVLR 282 (317)
T ss_pred CCCC--ccccHHHHHHHHHHccCCcccCcCH---HHHHhChhhhc
Confidence 2222 2356889999999999999999998 99999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=371.55 Aligned_cols=248 Identities=31% Similarity=0.533 Sum_probs=211.2
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCc
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGG 449 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GG 449 (810)
-+||+|.||+||.|+++.|....|||.|.... ....+-+..|+.+-+.++|.|||++.+++..++++-|.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 36999999999999999999999999886543 345677899999999999999999999999999999999999999
Q ss_pred chhhhhhcC-CCC--CHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc-CCcEEEeccCCcccccccccccchhh
Q psy16843 450 DCASLLKNT-GPL--PADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA-LGHIKLTDFGLSKMGLMSLATNLYEC 525 (810)
Q Consensus 450 sL~~lL~~~-g~l--se~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~g~VKL~DFGLAk~~~~s~~~~~~~~ 525 (810)
+|.++|+.. |++ +|..+.+|.+||++||+|||++.|||||||-+||||+. .|.+||+|||-++....
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--------- 728 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--------- 728 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc---------
Confidence 999999854 787 89999999999999999999999999999999999985 79999999999875321
Q ss_pred hhhcccccccCCcccCCCCcCChhHHhh--cCCCCCcchhhhHHHHHHHHhCCCCCCCC-CHHHHHHhhcc--CCCCCCC
Q psy16843 526 YVERDAKQFSDKQVYGTPEYIAPEVILR--QGYGKPVDWWSMGVILYEFLVGCVPFFGE-TPEELFAHTVN--DDIEWPS 600 (810)
Q Consensus 526 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~--~~ys~ksDIWSLGvILyELLtG~~PF~~~-~~~e~~~~I~~--~~~~~p~ 600 (810)
-.-...++.||..|||||+|.. .+|+.++|||||||++.||.||++||... ++.....++-- ....+|.
T Consensus 729 ------inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPe 802 (1226)
T KOG4279|consen 729 ------INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPE 802 (1226)
T ss_pred ------CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcH
Confidence 0112357789999999999975 47999999999999999999999999743 23322233222 2223333
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.+|.+++.||.+|+..||.+||++ .++|..||+..
T Consensus 803 ----elsaeak~FilrcFepd~~~R~sA---~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 803 ----ELSAEAKNFILRCFEPDPCDRPSA---KDLLQDPFLQH 837 (1226)
T ss_pred ----HHHHHHHHHHHHHcCCCcccCccH---HHhccCccccc
Confidence 388999999999999999999999 89999999865
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=352.28 Aligned_cols=260 Identities=26% Similarity=0.385 Sum_probs=211.2
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc-----ce
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK-----KH 438 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~-----~~ 438 (810)
++|.+++.||+|+||.||+|++..+++.||||.+..... .......+..|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 579999999999999999999999999999998865422 223345677899999999999999999987654 35
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 899999995 6899999888899999999999999999999999999999999999999999999999999986522110
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC---
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND--- 594 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~--- 594 (810)
.......|+..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+...
T Consensus 163 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (337)
T cd07858 163 ---------------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227 (337)
T ss_pred ---------------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 01123468999999999875 46899999999999999999999999877654333222210
Q ss_pred --------------------CCCCC----CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 595 --------------------DIEWP----SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 595 --------------------~~~~p----~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
....+ ......+++++.+||.+||+.+|++||++ .|+++||||..+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~---~ell~h~~~~~~ 297 (337)
T cd07858 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV---EEALAHPYLASL 297 (337)
T ss_pred CChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCH---HHHHcCcchhhh
Confidence 00000 00012367889999999999999999998 999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=340.10 Aligned_cols=262 Identities=29% Similarity=0.471 Sum_probs=223.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.+.|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+..|+++++.++|+||+++++++......|+|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3569999999999999999999998899999998865432 346678899999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
+||++|++|.+++...+ .+++..+..++.||+.||.|||+.||+|+||||+||+++.+|.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--- 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--- 170 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch---
Confidence 99999999999998776 89999999999999999999999999999999999999999999999999875421110
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+........ .
T Consensus 171 ------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 237 (286)
T cd06614 171 ------------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL-K 237 (286)
T ss_pred ------------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-c
Confidence 011234588999999999988999999999999999999999999998877666555544332111 1
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhh
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~ 647 (810)
....++.++++||.+||+.+|.+||++ .+++.||||....|..
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~---~~il~~~~~~~~~~~~ 280 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSA---EELLQHPFLKKACPKE 280 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCH---HHHhhChHhhccCchH
Confidence 111256889999999999999999999 9999999999976654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=339.92 Aligned_cols=257 Identities=21% Similarity=0.319 Sum_probs=211.3
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeec
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKET-----RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSF 433 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~t-----g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f 433 (810)
....++|++.+.||+|+||.||++.++.. ...+|+|.+..... ......+.+|++++..+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 44557899999999999999999998744 36899998765422 23446688899999999 899999999999
Q ss_pred cccceeeeeeeeccCcchhhhhhc----------------CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe
Q psy16843 434 ETKKHLCLVMEYVEGGDCASLLKN----------------TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI 497 (810)
Q Consensus 434 ~~~~~lyLVmEy~~GGsL~~lL~~----------------~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL 497 (810)
..++.+|+||||+++|+|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 999999999999999999999853 2468899999999999999999999999999999999999
Q ss_pred ccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CC
Q psy16843 498 TALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GC 576 (810)
Q Consensus 498 d~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~ 576 (810)
+.++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |.
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 232 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDY-------------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 232 (293)
T ss_pred cCCCeEEeCccccccccccccc-------------eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCC
Confidence 9999999999999875321100 000111235678999999999999999999999999999997 99
Q ss_pred CCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 577 VPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 577 ~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.||.+....+.+..+..... +.. ....+.++.+||.+||..||++||++ .|++++
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~li~~~l~~~p~~Rps~---~eil~~ 287 (293)
T cd05053 233 SPYPGIPVEELFKLLKEGYR-MEK--PQNCTQELYHLMRDCWHEVPSQRPTF---KQLVED 287 (293)
T ss_pred CCCCCCCHHHHHHHHHcCCc-CCC--CCCCCHHHHHHHHHHcccCcccCcCH---HHHHHH
Confidence 99999888877776655432 111 12356899999999999999999999 777753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.01 Aligned_cols=258 Identities=25% Similarity=0.415 Sum_probs=216.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+-|...+.||+|+||.||+|++..+++.||+|++...........+.+..|+++++.++||||+++++++.+....|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 34777889999999999999999999999999987654444455567888999999999999999999999999999999
Q ss_pred eeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||+.| +|.+++. ..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------- 172 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------- 172 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-------
Confidence 99964 6766665 35679999999999999999999999999999999999999999999999999875310
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHh---hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVIL---RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~---~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
......|+..|+|||++. ...++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 173 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-- 238 (313)
T cd06633 173 ------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP-- 238 (313)
T ss_pred ------------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--
Confidence 112456899999999985 356899999999999999999999999988776666655543322
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
......++..+++||.+||+++|.+||++ .+++.||||...+-.
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~P~~Rp~~---~~~l~~~~~~~~~~~ 282 (313)
T cd06633 239 TLQSNEWTDSFRGFVDYCLQKIPQERPAS---AELLRHDFVRRDRPA 282 (313)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCH---HHHhcCcccCCCchh
Confidence 11122356789999999999999999998 999999999875533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=334.78 Aligned_cols=251 Identities=21% Similarity=0.314 Sum_probs=205.3
Q ss_pred cEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce----
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKET---RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH---- 438 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~t---g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~---- 438 (810)
|.+.+.||+|+||.||+|....+ +..||+|.+..... .......+..|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 57889999999999999998654 47899998765432 23445678899999999999999999998765443
Q ss_pred --eeeeeeeccCcchhhhhhcC------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCC
Q psy16843 439 --LCLVMEYVEGGDCASLLKNT------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGL 510 (810)
Q Consensus 439 --lyLVmEy~~GGsL~~lL~~~------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGL 510 (810)
.++||||+++|+|..++... ..+++..+..++.||+.||.|||++||+||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 89999999999999988432 3689999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFA 589 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~ 589 (810)
++....... ........++..|+|||.+.+..++.++|||||||++|||++ |.+||.+....+.+.
T Consensus 160 ~~~~~~~~~-------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~ 226 (273)
T cd05035 160 SKKIYSGDY-------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD 226 (273)
T ss_pred eeecccccc-------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 875322110 001112235678999999988899999999999999999999 999999888888877
Q ss_pred hhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 590 ~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.+..+... .. ....+.++.++|.+||+.||.+||++ .|+++
T Consensus 227 ~~~~~~~~-~~--~~~~~~~~~~li~~~l~~~p~~Rp~~---~e~~~ 267 (273)
T cd05035 227 YLRHGNRL-KQ--PEDCLDELYDLMYSCWRADPKDRPTF---TKLRE 267 (273)
T ss_pred HHHcCCCC-CC--CcCCCHHHHHHHHHHcCCChhhCcCH---HHHHH
Confidence 76654321 11 12367899999999999999999998 66664
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=334.38 Aligned_cols=250 Identities=20% Similarity=0.323 Sum_probs=209.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|.+++.||+|+||.||+|.++. +..+|+|.+..... ..+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998764 45699998765432 125678899999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||+++......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~--- 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--- 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc---
Confidence 9999999999999764 478999999999999999999999999999999999999999999999999986532110
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
........++..|+|||++.+..++.++|||||||++|||++ |..||......+....+.........
T Consensus 155 -----------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05113 155 -----------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP 223 (256)
T ss_pred -----------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC
Confidence 001112235678999999998889999999999999999998 99999988887777777765433222
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
. ..+..+++++.+||..||.+||++ .+++.+
T Consensus 224 ~---~~~~~~~~li~~cl~~~p~~Rp~~---~~ll~~ 254 (256)
T cd05113 224 H---LASEKVYAIMYSCWHEKAEERPTF---QQLLSS 254 (256)
T ss_pred C---CCCHHHHHHHHHHcCCCcccCCCH---HHHHHh
Confidence 1 256899999999999999999999 777753
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=341.18 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=208.9
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy 445 (810)
|++++.||.|++|.||+|.++.+|+.||+|++...... ......+..|+++++.++||||+++++++.+++..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67889999999999999999999999999988654322 22335677899999999999999999999999999999999
Q ss_pred ccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 446 VEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 446 ~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
++ ++|.+++.... .+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----- 153 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV----- 153 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-----
Confidence 95 68999987655 79999999999999999999999999999999999999999999999999986421110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC------
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI------ 596 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~------ 596 (810)
.......|++.|+|||++.+. .++.++||||||+++|+|++|.+||.+.+....+.++.....
T Consensus 154 ----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07835 154 ----------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV 223 (283)
T ss_pred ----------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 001223578899999988764 579999999999999999999999988776554444322100
Q ss_pred -------------------CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 597 -------------------EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 597 -------------------~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.........++.++.++|.+||+.||.+||++ +|++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~---~~il~~~~~ 283 (283)
T cd07835 224 WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA---KAALQHPYF 283 (283)
T ss_pred hhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH---HHHhcCCCC
Confidence 00001112356889999999999999999998 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=333.09 Aligned_cols=243 Identities=22% Similarity=0.334 Sum_probs=200.7
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcc
Q psy16843 371 LISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGD 450 (810)
Q Consensus 371 ~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGs 450 (810)
.||+|+||.||+|.++.+++.||+|.+.... .......+.+|+++++.++||||+++++++.....+|+||||++|++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 6899999999999999999999999875432 23344678889999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhc
Q psy16843 451 CASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVER 529 (810)
Q Consensus 451 L~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~ 529 (810)
|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~---------- 149 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY---------- 149 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc----------
Confidence 99999754 4689999999999999999999999999999999999999999999999999864211000
Q ss_pred ccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC-CCCCCCCCCccc
Q psy16843 530 DAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD-IEWPSEDDWPIQ 607 (810)
Q Consensus 530 ~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~-~~~p~~~~~~~S 607 (810)
........++..|+|||.+.+..++.++|||||||++|||++ |..||...+.......+.... ...+ ...+
T Consensus 150 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~ 222 (252)
T cd05084 150 ---ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCP----ELCP 222 (252)
T ss_pred ---cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCc----ccCC
Confidence 000011123567999999999899999999999999999997 999998877766655554432 2222 2357
Q ss_pred HHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 608 VEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 608 ~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
..+.+||.+||+.+|++||++ .+++
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~---~~~~ 247 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSF---STVH 247 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCH---HHHH
Confidence 899999999999999999999 5554
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.20 Aligned_cols=252 Identities=29% Similarity=0.455 Sum_probs=218.9
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+|++.+.||.|+||.||++.++.+++.||+|.+...... ......+..|+++++.++|+||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 589999999999999999999999999999988765433 3345677889999999999999999999999999999999
Q ss_pred eccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 445 YVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 445 y~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
|++|++|..++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999999865 357899999999999999999999999999999999999999999999999998653211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+....+....
T Consensus 157 --------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (256)
T cd08530 157 --------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP 222 (256)
T ss_pred --------------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc
Confidence 112345889999999999999999999999999999999999999998887777776655433221
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
...+.+++++|.+||..+|++||++ .|+++||+.
T Consensus 223 ---~~~~~~~~~li~~~l~~~p~~Rp~~---~~~l~~p~~ 256 (256)
T cd08530 223 ---PIYSQDLQNFIRSMLQVKPKLRPNC---DKILASPAV 256 (256)
T ss_pred ---hhhCHHHHHHHHHHcCCCcccCCCH---HHHhcCCCC
Confidence 1367899999999999999999999 999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=361.88 Aligned_cols=258 Identities=20% Similarity=0.305 Sum_probs=207.1
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeec
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKET-----RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSF 433 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~t-----g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f 433 (810)
....++|++++.||+|+||.||+|.+... +..||||++..... ....+.+..|+++++.+. |||||++++++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34457899999999999999999987533 35799998865432 234467889999999996 99999999999
Q ss_pred cccceeeeeeeeccCcchhhhhhcC-------------------------------------------------------
Q psy16843 434 ETKKHLCLVMEYVEGGDCASLLKNT------------------------------------------------------- 458 (810)
Q Consensus 434 ~~~~~lyLVmEy~~GGsL~~lL~~~------------------------------------------------------- 458 (810)
.+...+|||||||+||+|.++|...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999999999887532
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe
Q psy16843 459 -----------------------------------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI 497 (810)
Q Consensus 459 -----------------------------------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL 497 (810)
..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 237788889999999999999999999999999999999
Q ss_pred ccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CC
Q psy16843 498 TALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GC 576 (810)
Q Consensus 498 d~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~ 576 (810)
+.++.+||+|||+++..... ..........|++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 271 ~~~~~~kL~DfGla~~~~~~-------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~ 337 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHD-------------SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG 337 (400)
T ss_pred eCCCEEEEEeCCcceecccc-------------ccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999998753211 00111233457889999999999999999999999999999997 99
Q ss_pred CCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHH
Q psy16843 577 VPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEV 634 (810)
Q Consensus 577 ~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~Ei 634 (810)
.||.+......+...+.....++.. ..++.++.+||.+||+.||++||++..+.++
T Consensus 338 ~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 338 TPYPGMIVDSTFYNKIKSGYRMAKP--DHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred CCCcccchhHHHHHHHhcCCCCCCC--ccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 9998766554444444443333322 2367899999999999999999998433333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.89 Aligned_cols=253 Identities=18% Similarity=0.264 Sum_probs=210.8
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKET-----RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~t-----g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
..+|++.+.||+|+||.||+|.+..+ ++.||+|++..... ....+.+..|+.++..++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 45788999999999999999987643 57899998865432 233466888999999999999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhc----------------CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC
Q psy16843 438 HLCLVMEYVEGGDCASLLKN----------------TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG 501 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~----------------~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g 501 (810)
.+++++||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 99999999999999999852 13588889999999999999999999999999999999999999
Q ss_pred cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCC
Q psy16843 502 HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFF 580 (810)
Q Consensus 502 ~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~ 580 (810)
.+||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 162 NVKISDLGLFREVYAADY-------------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred ceEecccccccccccchh-------------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999875321100 001123346789999999998889999999999999999998 999999
Q ss_pred CCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 581 GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 581 ~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
+....+.+..+.......... ..+.++.+|+.+||+.+|.+||++ .+|+.
T Consensus 229 ~~~~~~~~~~i~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~---~~i~~ 278 (283)
T cd05091 229 GYSNQDVIEMIRNRQVLPCPD---DCPAWVYTLMLECWNEFPSRRPRF---KDIHS 278 (283)
T ss_pred CCCHHHHHHHHHcCCcCCCCC---CCCHHHHHHHHHHhCCCcccCCCH---HHHHH
Confidence 998888888887765432211 266889999999999999999998 67765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=350.25 Aligned_cols=262 Identities=26% Similarity=0.379 Sum_probs=218.1
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc-----ee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK-----HL 439 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~-----~l 439 (810)
+|++.+.||.|+||.||+|++..+++.||+|++..... .....+.+..|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 58999999999999999999999999999998865432 2334467888999999999999999999998775 89
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||++ ++|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999997 58999998878999999999999999999999999999999999999999999999999999875322110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
. ........|++.|+|||++.+. .++.++||||||+++|+|++|.+||.+.+..+.+..+.......
T Consensus 159 ~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 159 E------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred c------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 0 0011234689999999999987 88999999999999999999999999988777666655421111
Q ss_pred CCC---------------------------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 599 PSE---------------------------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 599 p~~---------------------------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
+.. ....++.++.+||.+||+++|.+||++ ++++.||||.++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~---~~ll~~~~~~~~ 295 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA---DEALAHPYLAQL 295 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCH---HHHHhCccHHhh
Confidence 100 001156789999999999999999998 999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=343.51 Aligned_cols=256 Identities=28% Similarity=0.454 Sum_probs=215.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||++....+++.||+|.+..... ...+.+..|+.+++.++||||+++++++...+..|+|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 689999999999999999999998999999998754322 23466788999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++|++|.+++.+ ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~------ 168 (293)
T cd06647 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------ 168 (293)
T ss_pred ecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc------
Confidence 99999999999876 46889999999999999999999999999999999999999999999999987642211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc-CCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN-DDIEWPSED 602 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~-~~~~~p~~~ 602 (810)
........|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+.. ....++.
T Consensus 169 ---------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 237 (293)
T cd06647 169 ---------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN-- 237 (293)
T ss_pred ---------ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCC--
Confidence 0111234689999999999988899999999999999999999999988766544333322 2222221
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
...++..+++||.+||..+|++||++ .+++.||||...
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~---~~il~h~~~~~~ 275 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSA---KELLQHPFLKIA 275 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCH---HHHhcCHHHhcC
Confidence 12256789999999999999999998 999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=333.91 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=206.5
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
.+|++.+.||+|+||.||+|.++ ++..+|+|++.+.... ...+..|+++++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 57999999999999999999886 4667999987654322 245677999999999999999999999999999999
Q ss_pred eeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~----- 153 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD----- 153 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc-----
Confidence 99999999999975 357899999999999999999999999999999999999999999999999998653211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
.........++..|+|||.+.+..++.++||||||+++|||++ |.+||.+.+..+....+.... ..+..
T Consensus 154 ---------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 223 (256)
T cd05059 154 ---------QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-RLYRP 223 (256)
T ss_pred ---------cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-cCCCC
Confidence 0001111224567999999999999999999999999999998 899999888777777665432 11211
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
...+.++.+++.+||..+|++||++ .|+++
T Consensus 224 --~~~~~~~~~li~~cl~~~p~~Rpt~---~~~l~ 253 (256)
T cd05059 224 --KLAPTEVYTIMYSCWHEKPEDRPAF---KKLLS 253 (256)
T ss_pred --CCCCHHHHHHHHHHhcCChhhCcCH---HHHHH
Confidence 1267899999999999999999998 77765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=334.23 Aligned_cols=248 Identities=21% Similarity=0.276 Sum_probs=202.7
Q ss_pred EecccCceEEEEEEE--cCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 371 LISNGAYGSVYLVRH--KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 371 ~LG~G~FG~Vyla~~--k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
.||+|+||.||+|.+ +.+++.+|+|++.... ......+.+..|+.+++.++||||+++++++.. +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999999999965 4567899999875443 223445778899999999999999999998764 567999999999
Q ss_pred cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 449 GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~-------- 151 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY-------- 151 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe--------
Confidence 999999988788999999999999999999999999999999999999999999999999998753211100
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCccc
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQ 607 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S 607 (810)
........+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....++...+..+.. ++.+ ...+
T Consensus 152 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~~~--~~~~ 224 (257)
T cd05116 152 ----YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-MECP--QRCP 224 (257)
T ss_pred ----eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CCCC--CCCC
Confidence 000112235689999999988889999999999999999997 9999998888887777765432 1211 1367
Q ss_pred HHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 608 VEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 608 ~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
.++++||.+||+.||++||++..+.+.|
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHH
Confidence 8999999999999999999994433333
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=341.66 Aligned_cols=269 Identities=24% Similarity=0.380 Sum_probs=208.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc------
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK------ 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~------ 436 (810)
.++|++.+.||.|+||.||+|.++.+++.||+|.+....... .....+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 578999999999999999999999999999999886543221 1223566899999999999999999887443
Q ss_pred --ceeeeeeeeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 437 --KHLCLVMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 437 --~~lyLVmEy~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
..+|+||||+.+ +|...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 357999999975 5666554 446899999999999999999999999999999999999999999999999999875
Q ss_pred ccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy16843 514 GLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592 (810)
Q Consensus 514 ~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~ 592 (810)
......... ..............|++.|+|||++.+. .++.++|||||||++|||++|.+||.+.+.......+.
T Consensus 165 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 165 YDGPPPNPK----GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred ccCCCcccc----cCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 322111000 0000011112345689999999998764 58999999999999999999999999888766555543
Q ss_pred cCCC-----CC------CCC---------------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 593 NDDI-----EW------PSE---------------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 593 ~~~~-----~~------p~~---------------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.... .+ +.. .....+.++.+||.+||+.||.+||++ .|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~---~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA---SDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH---HHHhcCCCC
Confidence 2100 00 000 001244678999999999999999998 999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=351.71 Aligned_cols=262 Identities=20% Similarity=0.320 Sum_probs=206.6
Q ss_pred EEeccc--CceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeecc
Q psy16843 370 KLISNG--AYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVE 447 (810)
Q Consensus 370 k~LG~G--~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~ 447 (810)
..||+| +||+||+++++.+|+.||+|++...... ....+.+.+|+.+++.++||||++++++|..++.+|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 9999999999999999999987654332 3445788899999999999999999999999999999999999
Q ss_pred CcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhh
Q psy16843 448 GGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC 525 (810)
Q Consensus 448 GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~ 525 (810)
+|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~---- 158 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA---- 158 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc----
Confidence 99999998764 358999999999999999999999999999999999999999999999998653211100000
Q ss_pred hhhcccccccCCcccCCCCcCChhHHhhc--CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC----
Q psy16843 526 YVERDAKQFSDKQVYGTPEYIAPEVILRQ--GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP---- 599 (810)
Q Consensus 526 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~--~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p---- 599 (810)
...........++..|+|||++.+. .|+.++|||||||++|||++|.+||.+....+....++......|
T Consensus 159 ----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 159 ----KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred ----cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 0000001112356789999999864 578999999999999999999999988776655544443221111
Q ss_pred ---------------------------------------CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 600 ---------------------------------------SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 600 ---------------------------------------~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.......+.++.+||.+||+.||++||++ .|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta---~e~l~~~~~ 311 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA---SSLLSHAFF 311 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCH---HHHhhCHHH
Confidence 00011256789999999999999999999 999999999
Q ss_pred CCC
Q psy16843 641 SNL 643 (810)
Q Consensus 641 ~~i 643 (810)
..+
T Consensus 312 ~~~ 314 (328)
T cd08226 312 KQV 314 (328)
T ss_pred HHH
Confidence 653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=364.43 Aligned_cols=241 Identities=25% Similarity=0.412 Sum_probs=210.2
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+...-++.||+|+.|.||+|+.+ ++.||||++..- -..+++-|++|+||||+.+.++|.....+||||
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred HHhhhhhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 33445788999999999999875 578999987421 124677899999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
|||..|-|..+|+....++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++....
T Consensus 192 EfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~------- 264 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD------- 264 (904)
T ss_pred eccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh-------
Confidence 9999999999999999999999999999999999999999999999999999999999999999999875221
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
.-..-+++||..|||||+|.+++.+.|+|||||||+|||||||..||.+.+...++.-+-.+.+.+|-+..
T Consensus 265 ---------~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPst 335 (904)
T KOG4721|consen 265 ---------KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPST 335 (904)
T ss_pred ---------hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCccc
Confidence 11234789999999999999999999999999999999999999999988877766666566665554433
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.++.++=||++||+-.|..||++ .+|+.|
T Consensus 336 --cP~GfklL~Kqcw~sKpRNRPSF---rqil~H 364 (904)
T KOG4721|consen 336 --CPDGFKLLLKQCWNSKPRNRPSF---RQILLH 364 (904)
T ss_pred --CchHHHHHHHHHHhcCCCCCccH---HHHHHH
Confidence 66889999999999999999998 888888
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.61 Aligned_cols=249 Identities=20% Similarity=0.327 Sum_probs=205.5
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCc--EEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQ--RFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~--~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~ly 440 (810)
++|++.+.||+|+||.||+|..+.++. .+++|.+.... .....+.+..|++++..+ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999887765 46887665321 223446788899999888 7999999999999999999
Q ss_pred eeeeeccCcchhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEE
Q psy16843 441 LVMEYVEGGDCASLLKNT----------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIK 504 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~----------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VK 504 (810)
+||||+++|+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999999653 2488899999999999999999999999999999999999999999
Q ss_pred EeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCC
Q psy16843 505 LTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGET 583 (810)
Q Consensus 505 L~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~ 583 (810)
|+|||++...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 160 l~dfg~~~~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 160 IADFGLSRGEEVY----------------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred ECCcCCCccccce----------------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999998531100 00011123557999999999999999999999999999997 999999998
Q ss_pred HHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 584 PEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 584 ~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..+....+..+. ..+.. ..++.++++||.+||..+|.+||++ .++++
T Consensus 224 ~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~---~~i~~ 270 (297)
T cd05089 224 CAELYEKLPQGY-RMEKP--RNCDDEVYELMRQCWRDRPYERPPF---AQISV 270 (297)
T ss_pred HHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCcCH---HHHHH
Confidence 888877776542 22111 2367899999999999999999999 66654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.32 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=203.5
Q ss_pred cEEEEEecccCceEEEEEEEcCCCc--EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc------cc
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQ--RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET------KK 437 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~--~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~------~~ 437 (810)
|.+.+.||+|+||.||+|....++. .+|+|.+.... ......+.+..|+++++.++||||+++++.+.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999887775 68999775542 234456778899999999999999999987532 12
Q ss_pred eeeeeeeeccCcchhhhhhc------CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 438 HLCLVMEYVEGGDCASLLKN------TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~------~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
..++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999988732 235899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAH 590 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~ 590 (810)
+....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....
T Consensus 160 ~~~~~~~~-------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 226 (272)
T cd05075 160 KKIYNGDY-------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY 226 (272)
T ss_pred cccCcccc-------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 75321100 001123346788999999999999999999999999999999 8999998888887777
Q ss_pred hccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 591 I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
+..+.... .. ...+..+.++|.+||+.||.+||++ .++++
T Consensus 227 ~~~~~~~~-~~--~~~~~~~~~li~~~l~~~p~~Rps~---~~l~~ 266 (272)
T cd05075 227 LRQGNRLK-QP--PDCLDGLYSLMSSCWLLNPKDRPSF---ETLRC 266 (272)
T ss_pred HHcCCCCC-CC--CCCCHHHHHHHHHHcCCCcccCcCH---HHHHH
Confidence 76654321 11 2366889999999999999999998 66664
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=335.39 Aligned_cols=253 Identities=21% Similarity=0.344 Sum_probs=206.5
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCc----EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQ----RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~----~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
..++|++++.||+|+||.||+|++..+++ .||+|.+..... ....+.+..|+.++..++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 45789999999999999999999887776 489998764432 2334678889999999999999999998875 4
Q ss_pred eeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
..+++|||+++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 57899999999999999976 45799999999999999999999999999999999999999999999999999875321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+....
T Consensus 162 ~~~-------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 228 (279)
T cd05109 162 DET-------------EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE 228 (279)
T ss_pred ccc-------------eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence 100 001112235678999999999999999999999999999998 999998877666655444432
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..+.. ...+.++.++|.+||..||++||++ .+++.
T Consensus 229 -~~~~~--~~~~~~~~~li~~~l~~dp~~Rp~~---~~l~~ 263 (279)
T cd05109 229 -RLPQP--PICTIDVYMIMVKCWMIDSECRPRF---RELVD 263 (279)
T ss_pred -cCCCC--ccCCHHHHHHHHHHcCCChhhCcCH---HHHHH
Confidence 22222 2367899999999999999999999 67663
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=339.12 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=208.4
Q ss_pred CCCcEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKE-----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~-----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
..+|.+.+.||+|+||.||+|++.. ++..+++|.+..... ...+.+.+|+++++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 3679999999999999999998643 456688887754332 23356788999999999999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC
Q psy16843 438 HLCLVMEYVEGGDCASLLKNT----------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG 501 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~----------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g 501 (810)
..++||||+++++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 999999999999999999653 3488999999999999999999999999999999999999999
Q ss_pred cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCC
Q psy16843 502 HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFF 580 (810)
Q Consensus 502 ~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~ 580 (810)
.+||+|||+++...... .........|++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 161 ~~~l~dfg~a~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 227 (291)
T cd05094 161 LVKIGDFGMSRDVYSTD-------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227 (291)
T ss_pred cEEECCCCcccccCCCc-------------eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999987532110 0011123457889999999999999999999999999999998 999999
Q ss_pred CCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 581 GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 581 ~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
..+..+....+..+...... ...+.++.+||.+||++||.+||++ .+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~---~~v~ 276 (291)
T cd05094 228 QLSNTEVIECITQGRVLERP---RVCPKEVYDIMLGCWQREPQQRLNI---KEIY 276 (291)
T ss_pred CCCHHHHHHHHhCCCCCCCC---ccCCHHHHHHHHHHcccChhhCcCH---HHHH
Confidence 88888777776655433221 1256889999999999999999999 4544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.83 Aligned_cols=256 Identities=30% Similarity=0.475 Sum_probs=210.6
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc--ceeeeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK--KHLCLVM 443 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~--~~lyLVm 443 (810)
|++++.||.|+||.||+|.+..+++.||+|.+.... ......+.+..|+++++.++||||+++++++... +.+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999987654 2233445678899999999999999999999888 8999999
Q ss_pred eeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||+++ +|..++... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.+|.+||+|||++........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~--- 155 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--- 155 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc---
Confidence 99975 888888765 6899999999999999999999999999999999999999999999999999875322110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-----C
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD-----I 596 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~-----~ 596 (810)
.......++..|+|||.+.+ ..++.++||||||+++|||++|..||...+....+..+.... .
T Consensus 156 -----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07840 156 -----------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDE 224 (287)
T ss_pred -----------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchh
Confidence 00122357889999998775 467999999999999999999999999887766655544311 0
Q ss_pred CCCCCC----------------------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 597 EWPSED----------------------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 597 ~~p~~~----------------------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.++... ....+.++.++|.+||..+|.+||++ .+++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~---~~~l~~~~~ 287 (287)
T cd07840 225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA---DQALQHEYF 287 (287)
T ss_pred hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH---HHHhhCcCC
Confidence 111000 00026889999999999999999998 999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=334.26 Aligned_cols=254 Identities=31% Similarity=0.496 Sum_probs=206.9
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC---CCCeEEEeeeeccccce----
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT---DNPFVVTMYCSFETKKH---- 438 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l---~HPnIVkl~~~f~~~~~---- 438 (810)
|++.+.||+|+||.||+|+++.+++.||+|.+...... ......+..|+.+++.+ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 78899999999999999999989999999988654322 22224455677766555 69999999999988776
Q ss_pred -eeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 439 -LCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 439 -lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 7888886543 59999999999999999999999999999999999999999999999999986521
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
.. .......|++.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+.++....
T Consensus 159 ~~----------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd07838 159 FE----------------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222 (287)
T ss_pred CC----------------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHc
Confidence 11 01123357899999999999999999999999999999999999999988877766664311
Q ss_pred -----CCCCCCC------------------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 596 -----IEWPSED------------------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 596 -----~~~p~~~------------------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..++... ...+++.+.+||.+||+.||.+||++ .|++.||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~---~~il~~~~~ 287 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA---FEALQHPYF 287 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH---HHHhcCcCC
Confidence 1111000 01245778999999999999999998 999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.18 Aligned_cols=252 Identities=22% Similarity=0.353 Sum_probs=208.5
Q ss_pred CCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
...+|++.++||+|+||.||+|... .++..+|+|.+.... ....+.+..|+++++.++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3468999999999999999999753 346789999776443 33456788999999999999999999999999
Q ss_pred ceeeeeeeeccCcchhhhhhcCC---------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTG---------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG 501 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g---------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g 501 (810)
...|+||||+.+|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999987543 488999999999999999999999999999999999999999
Q ss_pred cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCC
Q psy16843 502 HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFF 580 (810)
Q Consensus 502 ~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~ 580 (810)
.+||+|||+++...... .........+++.|+|||.+.+..++.++|||||||++|||++ |.+||.
T Consensus 160 ~~kL~dfg~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 160 VVKIGDFGMSRDIYSTD-------------YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred CEEECCCCceeEcCCCc-------------eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 99999999986422110 0001123346788999999999999999999999999999998 999998
Q ss_pred CCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 581 GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 581 ~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
.....+....+....... . ...+++.+.+||.+||+.||.+||++ .|++
T Consensus 227 ~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~li~~cl~~~P~~Rp~~---~~l~ 275 (280)
T cd05092 227 QLSNTEAIECITQGRELE-R--PRTCPPEVYAIMQGCWQREPQQRMVI---KDIH 275 (280)
T ss_pred cCCHHHHHHHHHcCccCC-C--CCCCCHHHHHHHHHHccCChhhCCCH---HHHH
Confidence 888777777665543211 1 12367899999999999999999999 5655
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.78 Aligned_cols=259 Identities=28% Similarity=0.498 Sum_probs=217.7
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecccccee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~l 439 (810)
...++.+.+..||.|+.|.|++++++.+|...|||.+.+... ....+++...++++... +.|+||+.+++|.++..+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N--kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC--HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 445788899999999999999999999999999999877643 44557788888877655 489999999999999999
Q ss_pred eeeeeeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 440 CLVMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
+|.||.|. .-+..+++ -.++++|..+-++..-++.||.||.. +||||||+||+|||+|..|+|||||||++-....+
T Consensus 167 ~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 167 FICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 99999983 34444444 34789999999999999999999986 59999999999999999999999999998664433
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhh---cCCCCCcchhhhHHHHHHHHhCCCCCCC-CCHHHHHHhhcc
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR---QGYGKPVDWWSMGVILYEFLVGCVPFFG-ETPEELFAHTVN 593 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~---~~ys~ksDIWSLGvILyELLtG~~PF~~-~~~~e~~~~I~~ 593 (810)
.+. ..-.|.+.|||||.+.- ..|+..+||||||++|+||.||..||.+ .+..+++.+|++
T Consensus 246 kAh----------------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln 309 (391)
T KOG0983|consen 246 KAH----------------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN 309 (391)
T ss_pred ccc----------------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence 222 23469999999999963 4799999999999999999999999988 466788888888
Q ss_pred CCCC-CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 594 DDIE-WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 594 ~~~~-~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.... +|... ..|+++++|+..||++|+.+||.. .++|+|||+...
T Consensus 310 ~ePP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y---~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 310 EEPPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKY---NKLLEHPFIKRY 355 (391)
T ss_pred cCCCCCCccc--CcCHHHHHHHHHHhhcCcccCcch---HHHhcCcceeec
Confidence 5542 33332 388999999999999999999999 899999998654
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.36 Aligned_cols=254 Identities=23% Similarity=0.387 Sum_probs=214.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKET-----RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~t-----g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
.++|++++.||.|+||.||+|+.+.+ .+.||+|.+..... ....+.+..|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 46899999999999999999997643 46789997754321 234567889999999999999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcCC---------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEecc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTG---------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDF 508 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g---------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DF 508 (810)
..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999997655 6999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHH
Q psy16843 509 GLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEEL 587 (810)
Q Consensus 509 GLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~ 587 (810)
|+++..... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+......
T Consensus 162 ~~~~~~~~~--------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~ 227 (275)
T cd05046 162 SLSKDVYNS--------------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227 (275)
T ss_pred ccccccCcc--------------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH
Confidence 998642111 0111223456788999999998889999999999999999998 8999988888888
Q ss_pred HHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 588 ~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
...+..+...++... ..+..+.++|.+||+.+|.+||++ .|++.+
T Consensus 228 ~~~~~~~~~~~~~~~--~~~~~l~~~i~~~l~~~p~~Rp~~---~~~l~~ 272 (275)
T cd05046 228 LNRLQAGKLELPVPE--GCPSRLYKLMTRCWAVNPKDRPSF---SELVSA 272 (275)
T ss_pred HHHHHcCCcCCCCCC--CCCHHHHHHHHHHcCCCcccCCCH---HHHHHH
Confidence 887776666655432 367899999999999999999998 777653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=362.39 Aligned_cols=289 Identities=25% Similarity=0.366 Sum_probs=234.2
Q ss_pred ccccccchhhhcccCCCCccccCCCCcccccCCcccCCCCCCCcEEEEEecccCceEEEEEEEcCCCc---E-EEEEEee
Q psy16843 323 KTVFSDLDNDIQNISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQ---R-FAMKKII 398 (810)
Q Consensus 323 ~~~F~~l~~di~~~s~sd~s~e~~~~s~~~~~~~~~~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~---~-vAIK~I~ 398 (810)
...|..+.+.+..+..+..++......-.....+-.+...-++..+.++||+|+||.||+|..+..+. . ||+|...
T Consensus 116 ~~~F~si~~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k 195 (474)
T KOG0194|consen 116 LRKFPTISELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTK 195 (474)
T ss_pred cccCCcHHHHHHHHHhcccceeccceeecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeec
Confidence 34456666655555544444333222111122233455566778888999999999999999876532 3 8999877
Q ss_pred ccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHH
Q psy16843 399 KNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAV 477 (810)
Q Consensus 399 k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL 477 (810)
......+.++..++.|+++|++++|||||++||+...+..+|||||+|.||+|.++|++.+ .++..+...++.+.+.||
T Consensus 196 ~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl 275 (474)
T KOG0194|consen 196 GSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGL 275 (474)
T ss_pred ccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHH
Confidence 5555567788999999999999999999999999999999999999999999999999876 599999999999999999
Q ss_pred HHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCC
Q psy16843 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYG 557 (810)
Q Consensus 478 ~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys 557 (810)
+|||++++|||||-..|+|++.++.+||+||||++.... +.. ......-...|+|||.+...-|+
T Consensus 276 ~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~---------~~~------~~~~~klPirWLAPEtl~~~~~s 340 (474)
T KOG0194|consen 276 EYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ---------YVM------KKFLKKLPIRWLAPETLNTGIFS 340 (474)
T ss_pred HHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc---------eee------ccccccCcceecChhhhccCccc
Confidence 999999999999999999999999999999999875320 000 00011235689999999999999
Q ss_pred CCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 558 KPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 558 ~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
.++|||||||++||+++ |..||.+....++..+|....+..+.+.. .+.++..++.+|+..||++|+++
T Consensus 341 ~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~--~p~~~~~~~~~c~~~~p~~R~tm 410 (474)
T KOG0194|consen 341 FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSK--TPKELAKVMKQCWKKDPEDRPTM 410 (474)
T ss_pred cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCC--CHHHHHHHHHHhccCChhhccCH
Confidence 99999999999999998 89999999999999999777766665543 56889999999999999999998
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=330.45 Aligned_cols=245 Identities=21% Similarity=0.342 Sum_probs=205.7
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++.+.||+|+||.||+|.... ++.||+|.+..... ..+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 44679999999999999999998754 56799998865432 23567789999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
||||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999999997643 699999999999999999999999999999999999999999999999999875321100
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+++..+.... ..
T Consensus 159 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~ 223 (261)
T cd05068 159 --------------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-RM 223 (261)
T ss_pred --------------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC
Confidence 00011223467999999999999999999999999999999 999999988887777765442 22
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
+.. ...+.++.+++.+||+.+|.+||++
T Consensus 224 ~~~--~~~~~~~~~li~~~l~~~P~~Rp~~ 251 (261)
T cd05068 224 PCP--PGCPKELYDIMLDCWKEDPDDRPTF 251 (261)
T ss_pred CCC--CcCCHHHHHHHHHHhhcCcccCCCH
Confidence 222 2366899999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.93 Aligned_cols=245 Identities=21% Similarity=0.362 Sum_probs=208.8
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
..+|++++.||.|+||.||+|.++. ++.+|+|.+..... .....+..|+.+++.++||||+++++++.+...+|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3679999999999999999999988 88899998866542 2345678899999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 443 MEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
|||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--- 157 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--- 157 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc---
Confidence 9999999999999753 46899999999999999999999999999999999999999999999999998643211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+++..+... ...+
T Consensus 158 ------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~ 224 (261)
T cd05148 158 ------------VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMP 224 (261)
T ss_pred ------------cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-CcCC
Confidence 001112346778999999998899999999999999999998 89999998888887777643 2222
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
.+ ...++++.++|.+||+.||.+||+++
T Consensus 225 ~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~ 252 (261)
T cd05148 225 CP--AKCPQEIYKIMLECWAAEPEDRPSFK 252 (261)
T ss_pred CC--CCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 22 23678999999999999999999993
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=340.37 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=210.0
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeec
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSF 433 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f 433 (810)
....++|++.+.||+|+||.||++.+. .++..||+|.+..... ....+.+..|+++++.+ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 445578999999999999999999753 3456899998765422 23446788999999999 899999999999
Q ss_pred cccceeeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 434 ETKKHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 434 ~~~~~lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
...+.+|+||||+.+|+|.+++.... .+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999999997532 3899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAH 590 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~ 590 (810)
+...... .........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+.+
T Consensus 189 ~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~ 255 (302)
T cd05055 189 RDIMNDS-------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255 (302)
T ss_pred ccccCCC-------------ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH
Confidence 7432110 0001123346788999999999999999999999999999998 9999988776665555
Q ss_pred hccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 591 I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
........+.. ...+.++.+||.+||.++|++||++ .|++.
T Consensus 256 ~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rpt~---~ell~ 296 (302)
T cd05055 256 LIKEGYRMAQP--EHAPAEIYDIMKTCWDADPLKRPTF---KQIVQ 296 (302)
T ss_pred HHHcCCcCCCC--CCCCHHHHHHHHHHcCCCchhCcCH---HHHHH
Confidence 54443332222 2357899999999999999999999 66653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=329.79 Aligned_cols=255 Identities=20% Similarity=0.317 Sum_probs=210.2
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCc---EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQ---RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~---~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
..++|+..+.||+|+||.||+|..+.+++ .+|+|.+..... ....+.+..|+++++.++||||+++++++.+.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 34679999999999999999999886654 799998755422 2334678889999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.|+||||+++++|.+++.. .+.+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999999999975 467999999999999999999999999999999999999999999999999998643211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.. .........+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+... .
T Consensus 161 ~~------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~ 227 (268)
T cd05063 161 PE------------GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-F 227 (268)
T ss_pred cc------------cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-C
Confidence 00 0011111223567999999998899999999999999999997 99999988887777776553 2
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..|... ..+.++.+|+.+||+.+|.+||++ .++++
T Consensus 228 ~~~~~~--~~~~~~~~li~~c~~~~p~~Rp~~---~~i~~ 262 (268)
T cd05063 228 RLPAPM--DCPSAVYQLMLQCWQQDRARRPRF---VDIVN 262 (268)
T ss_pred CCCCCC--CCCHHHHHHHHHHcCCCcccCcCH---HHHHH
Confidence 333322 356889999999999999999998 56653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.42 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=215.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.+.|...+.||+|+||.||+|+++.+++.+|+|.+...........+.+..|+++++.++|+|++++++++......|+|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 35688899999999999999999999999999988654333344456788899999999999999999999999999999
Q ss_pred eeeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|||+. |+|.+++. ....+++..+..++.|++.||.|||++|++||||||+|||++.+|.+||+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 99996 57777664 445799999999999999999999999999999999999999999999999999864211
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhh---cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILR---QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~---~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 168 --------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06634 168 --------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 233 (308)
T ss_pred --------------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC
Confidence 123468999999999863 457899999999999999999999998877666655555443322
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.. ....+..+.+||.+||..+|.+||++ ++++.|||+...
T Consensus 234 ~~--~~~~~~~~~~li~~cl~~~P~~Rp~~---~~ll~~~~~~~~ 273 (308)
T cd06634 234 LQ--SGHWSEYFRNFVDSCLQKIPQDRPTS---EVLLKHRFVLRE 273 (308)
T ss_pred cC--cccccHHHHHHHHHHhhCCcccCCCH---HHHhhCcccccc
Confidence 21 12366889999999999999999998 999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=356.55 Aligned_cols=259 Identities=26% Similarity=0.447 Sum_probs=209.7
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecccccee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~l 439 (810)
++...|+++++||+||-++||+|...+ .+.||+|++.....+ ...+.-+..|+.+|.++ .|.+||+||++-.+++++
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D-~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEAD-NQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcC-HHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 345679999999999999999998654 456787776554332 45567899999999888 689999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCC-CCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGP-LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~-lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
||||||= ..||..+|++.+. ++...+++|..||+.|+.++|..||||-||||.|+|+-. |.+||+|||+|+.+...
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D- 512 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD- 512 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCcc-
Confidence 9999974 5699999987654 444689999999999999999999999999999999976 99999999999864322
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcC-----------CCCCcchhhhHHHHHHHHhCCCCCCCCC-HHH
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG-----------YGKPVDWWSMGVILYEFLVGCVPFFGET-PEE 586 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-----------ys~ksDIWSLGvILyELLtG~~PF~~~~-~~e 586 (810)
.......+.+||+.||+||.+.... .++++||||||||||+|++|++||.... ...
T Consensus 513 ------------TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a 580 (677)
T KOG0596|consen 513 ------------TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA 580 (677)
T ss_pred ------------ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH
Confidence 2222334678999999999997432 5789999999999999999999997543 333
Q ss_pred HHHhhccC--CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 587 LFAHTVND--DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 587 ~~~~I~~~--~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
-+..|..- .+.||... -..++.++++.||..||.+||++ .|+|+|||...
T Consensus 581 Kl~aI~~P~~~Iefp~~~---~~~~li~~mK~CL~rdPkkR~si---~eLLqhpFl~~ 632 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIP---ENDELIDVMKCCLARDPKKRWSI---PELLQHPFLQI 632 (677)
T ss_pred HHHhhcCCCccccccCCC---CchHHHHHHHHHHhcCcccCCCc---HHHhcCccccc
Confidence 34444442 34565542 22459999999999999999999 89999999865
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.64 Aligned_cols=259 Identities=29% Similarity=0.470 Sum_probs=209.6
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc------
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK------ 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~------ 437 (810)
++|.+.+.||+|+||.||+|.++.+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 6899999999999999999999999999999988654321 223356788999999999999999999887543
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.+|+||||+.+ +|..++. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 94 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred eEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 56999999964 6766553 4689999999999999999999999999999999999999999999999999864210
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD- 595 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~- 595 (810)
......|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+....
T Consensus 170 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 232 (342)
T cd07879 170 -----------------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 232 (342)
T ss_pred -----------------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 1123467899999999976 468999999999999999999999999887655554433210
Q ss_pred ----------------------CCCCCCC----CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhh
Q psy16843 596 ----------------------IEWPSED----DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647 (810)
Q Consensus 596 ----------------------~~~p~~~----~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~ 647 (810)
...+... ....+.++.+||.+||+.||.+||++ .|++.||||..+...+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~---~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTA---TEALEHPYFDSFRDAD 307 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCH---HHHhcCcchhhccccc
Confidence 0001000 01256789999999999999999998 9999999998875443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.92 Aligned_cols=261 Identities=27% Similarity=0.425 Sum_probs=208.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc------
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK------ 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~------ 436 (810)
..+|.+.+.||.|+||.||+|.++.+|+.||+|++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 3689999999999999999999999999999998865543 3446788899999999999999999877654
Q ss_pred --------ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc-CCcEEEec
Q psy16843 437 --------KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA-LGHIKLTD 507 (810)
Q Consensus 437 --------~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~g~VKL~D 507 (810)
..+|+||||++ ++|.+++.. +.+++..++.++.||+.||+|||+.||+||||||+||+++. ++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35899999997 588888764 57999999999999999999999999999999999999985 55789999
Q ss_pred cCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHH
Q psy16843 508 FGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE 586 (810)
Q Consensus 508 FGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e 586 (810)
||++......... . .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+
T Consensus 159 fg~~~~~~~~~~~-----------~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~ 226 (342)
T cd07854 159 FGLARIVDPHYSH-----------K-GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226 (342)
T ss_pred cccceecCCcccc-----------c-cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9998643211000 0 00122357899999998765 568999999999999999999999998877655
Q ss_pred HHHhhccCCCC---------------------CCCC-----CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 587 LFAHTVNDDIE---------------------WPSE-----DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 587 ~~~~I~~~~~~---------------------~p~~-----~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
....+...... .... ....++.++++||.+||+.||.+||++ .|++.||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~ell~h~~~ 303 (342)
T cd07854 227 QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA---EEALMHPYM 303 (342)
T ss_pred HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH---HHHhCCCcc
Confidence 55444321100 0000 001256889999999999999999998 999999999
Q ss_pred CCC
Q psy16843 641 SNL 643 (810)
Q Consensus 641 ~~i 643 (810)
+.+
T Consensus 304 ~~~ 306 (342)
T cd07854 304 SCY 306 (342)
T ss_pred ccc
Confidence 764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=330.26 Aligned_cols=246 Identities=21% Similarity=0.354 Sum_probs=203.2
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|... ++..+|+|.+...... .+.+.+|+.+++.++|+||+++++++.. ...|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence 34578999999999999999999876 4567999988654332 2457889999999999999999998854 5689
Q ss_pred eeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999999753 468999999999999999999999999999999999999999999999999986422110
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
. .......|+..|+|||++.+..++.++||||||+++|||++ |.+||.+.+..+....+... ..
T Consensus 157 ~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~ 221 (260)
T cd05070 157 Y--------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YR 221 (260)
T ss_pred c--------------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CC
Confidence 0 00112235678999999998899999999999999999999 99999988887777776543 22
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
.+.. ...+.++.+||.+||.++|.+||+++
T Consensus 222 ~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~ 251 (260)
T cd05070 222 MPCP--QDCPISLHELMLQCWKKDPEERPTFE 251 (260)
T ss_pred CCCC--CcCCHHHHHHHHHHcccCcccCcCHH
Confidence 2222 23668899999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=340.18 Aligned_cols=256 Identities=21% Similarity=0.316 Sum_probs=207.6
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcC-------CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeee
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKE-------TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYC 431 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~-------tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~ 431 (810)
.+..++|.+.+.||+|+||.||+|++.. ++..+|+|.+.... .......+..|+++++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3445789999999999999999998753 23579999876542 223346688899999998 7999999999
Q ss_pred eccccceeeeeeeeccCcchhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCce
Q psy16843 432 SFETKKHLCLVMEYVEGGDCASLLKNT----------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNL 495 (810)
Q Consensus 432 ~f~~~~~lyLVmEy~~GGsL~~lL~~~----------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNI 495 (810)
++...+.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 999999999999999999999999753 2478889999999999999999999999999999999
Q ss_pred EeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-
Q psy16843 496 LITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV- 574 (810)
Q Consensus 496 LLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt- 574 (810)
|++.++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYY-------------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred EEcCCCcEEECCCcccccccccchh-------------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcC
Confidence 9999999999999998643211000 00111234578999999999999999999999999999998
Q ss_pred CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 575 GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 575 G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
|..||.+....++...+..... .+.. ...+.++.+||.+||..+|.+||++ .++++
T Consensus 239 g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~~l~~~p~~Rps~---~evl~ 294 (307)
T cd05098 239 GGSPYPGVPVEELFKLLKEGHR-MDKP--SNCTNELYMMMRDCWHAVPSQRPTF---KQLVE 294 (307)
T ss_pred CCCCCCcCCHHHHHHHHHcCCC-CCCC--CcCCHHHHHHHHHHcccChhhCcCH---HHHHH
Confidence 8999988887777666554432 1111 2367899999999999999999998 66654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=347.91 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=209.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc------
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK------ 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~------ 436 (810)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 3789999999999999999999999999999998865432 223345677899999999999999999987543
Q ss_pred ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
..+|++++++ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 3578899987 7899888765 4699999999999999999999999999999999999999999999999999864211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
......|++.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+....
T Consensus 173 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 173 ------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred ------------------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 1123468999999999877 568999999999999999999999998776655444332211
Q ss_pred C-----------------------CCCCC----CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 596 I-----------------------EWPSE----DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 596 ~-----------------------~~p~~----~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
. ..+.. .....++++++||.+||+.||.+|+++ .+++.||||.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~---~e~l~h~~f~~~ 306 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA---AQALAHAYFAQY 306 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCH---HHHhcChhhhhc
Confidence 0 00000 001246789999999999999999998 899999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=331.32 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=208.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCc---EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQ---RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~---~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
..+|++.+.||+|+||.||+|.++.++. .+|+|.+..... ....+.+..|+.+++.++||||+++++++.+++.+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3679999999999999999999875543 799998765332 23456788899999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999754 578999999999999999999999999999999999999999999999999987532110
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
. .........++..|+|||.+.+..++.++|+|||||++|||++ |..||.+....+....+... ..
T Consensus 161 ~------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~ 227 (267)
T cd05066 161 E------------AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YR 227 (267)
T ss_pred c------------eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-Cc
Confidence 0 0001112234578999999999899999999999999999886 99999988877777666554 23
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
.+.. ...+.++.+++.+||+++|.+||++ .+++
T Consensus 228 ~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~---~~i~ 260 (267)
T cd05066 228 LPAP--MDCPAALHQLMLDCWQKDRNERPKF---EQIV 260 (267)
T ss_pred CCCC--CCCCHHHHHHHHHHcccCchhCCCH---HHHH
Confidence 3322 2356899999999999999999998 5554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=333.46 Aligned_cols=253 Identities=19% Similarity=0.290 Sum_probs=204.2
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcE----EEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQR----FAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~----vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
..++|++++.||+|+||.||+|.+..+++. +++|.+.... .......+..|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 347899999999999999999999877764 6666553321 12334567788888999999999999998754 5
Q ss_pred eeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
..++|+||+++|+|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 67899999999999999975 46799999999999999999999999999999999999999999999999999875321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
.. .........|+..|+|||.+.+..|+.++|||||||++|||++ |..||.+....+....+..+.
T Consensus 162 ~~-------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 228 (279)
T cd05111 162 DD-------------KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE 228 (279)
T ss_pred CC-------------cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence 11 1111123457789999999998899999999999999999998 999999887776555544333
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.. +... ..+.++.+++.+||..||++||++ .|++.
T Consensus 229 ~~-~~~~--~~~~~~~~li~~c~~~~p~~Rps~---~el~~ 263 (279)
T cd05111 229 RL-AQPQ--ICTIDVYMVMVKCWMIDENVRPTF---KELAN 263 (279)
T ss_pred cC-CCCC--CCCHHHHHHHHHHcCCCcccCcCH---HHHHH
Confidence 22 2221 145788999999999999999999 66654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=380.16 Aligned_cols=263 Identities=26% Similarity=0.379 Sum_probs=207.4
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+++.+|+++++.++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999987654433444567889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC-----------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 444 EYVEGGDCASLLKNT-----------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~-----------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998631 235566788899999999999999999999999999999999999999999997
Q ss_pred cccccccccchhhhh---hcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16843 513 MGLMSLATNLYECYV---ERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~---~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~ 589 (810)
............... ............+||+.|||||++.+..++.++|||||||++|||++|..||.+........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~ 241 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence 642110000000000 00000111234679999999999999999999999999999999999999998766544332
Q ss_pred hh-ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 590 HT-VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 590 ~I-~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
.. ......+.. ...+++.+.+++.+||..||++|++.
T Consensus 242 ~~~i~~P~~~~p--~~~iP~~L~~LI~rcL~~DP~kR~ss 279 (932)
T PRK13184 242 RDVILSPIEVAP--YREIPPFLSQIAMKALAVDPAERYSS 279 (932)
T ss_pred hhhccChhhccc--cccCCHHHHHHHHHHccCChhhCcCH
Confidence 21 112111111 12367889999999999999999987
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=338.88 Aligned_cols=255 Identities=20% Similarity=0.303 Sum_probs=207.5
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcC-------CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKE-------TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCS 432 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~-------tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~ 432 (810)
+..++|.+.+.||+|+||.||+|++.. ....+|+|.+..... ......+..|+++++.+ +||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 445789999999999999999998642 345789998764322 33456788899999998 69999999999
Q ss_pred ccccceeeeeeeeccCcchhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceE
Q psy16843 433 FETKKHLCLVMEYVEGGDCASLLKNT----------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLL 496 (810)
Q Consensus 433 f~~~~~lyLVmEy~~GGsL~~lL~~~----------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNIL 496 (810)
+...+.+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 99999999999999999999999653 34888899999999999999999999999999999999
Q ss_pred eccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-C
Q psy16843 497 ITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-G 575 (810)
Q Consensus 497 Ld~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G 575 (810)
++.++.+||+|||+++....... ........+++.|||||++.+..++.++|||||||++|||++ |
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g 233 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDY-------------YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG 233 (314)
T ss_pred EcCCCcEEEcccccccccccccc-------------ccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCC
Confidence 99999999999999875321100 000011234568999999999999999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 576 CVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 576 ~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..||.+....+.+..+...... .. ....+.++++||.+||..||.+||++ .|+++
T Consensus 234 ~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~l~~li~~cl~~~p~~Rps~---~~ll~ 288 (314)
T cd05099 234 GSPYPGIPVEELFKLLREGHRM-DK--PSNCTHELYMLMRECWHAVPTQRPTF---KQLVE 288 (314)
T ss_pred CCCCCCCCHHHHHHHHHcCCCC-CC--CCCCCHHHHHHHHHHcCCCcccCcCH---HHHHH
Confidence 9999998888887776654321 11 12356789999999999999999998 55553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=347.73 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=213.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce----
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH---- 438 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~---- 438 (810)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+..|+.+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 46899999999999999999999999999999987654222 2344667789999999999999999998876654
Q ss_pred --eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 439 --LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 439 --lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+|+|+||+ |++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 89999999 6799998876 5799999999999999999999999999999999999999999999999999864211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
......|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..+....
T Consensus 171 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~ 232 (343)
T cd07851 171 ------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV 232 (343)
T ss_pred ------------------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence 0123468899999999876 367999999999999999999999998887766665554321
Q ss_pred CCCC--------------------C-------CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 596 IEWP--------------------S-------EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 596 ~~~p--------------------~-------~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
-..+ . ......+.++.+||.+||+.||.+||++ .|++.||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~---~ell~h~~~~~~ 304 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITA---AEALAHPYLAEY 304 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCH---HHHhcCCCcccc
Confidence 0000 0 0001257889999999999999999998 999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=334.16 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=208.7
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKE-----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~-----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
..++|++++.||+|+||.||+|.++. ++..||+|.+..... ......+.+|+.+++.++||||+++++++.++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 35789999999999999999998753 578899998765432 23346688899999999999999999999999
Q ss_pred ceeeeeeeeccCcchhhhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNT----------------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDN 494 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~----------------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeN 494 (810)
..+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 9999999999999999998642 147788899999999999999999999999999999
Q ss_pred eEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh
Q psy16843 495 LLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV 574 (810)
Q Consensus 495 ILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt 574 (810)
||++.++.+||+|||++........ ........+++.|+|||.+.+..++.++|||||||++|||++
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~ 227 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY-------------YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227 (288)
T ss_pred eEecCCCceEECccccceecccCcc-------------ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHh
Confidence 9999999999999999864221100 000112234678999999999999999999999999999997
Q ss_pred -CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 575 -GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 575 -G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
|..||.+.+..+....+..+.... .. ...+.++.+||.+||+.+|.+||++ .|++
T Consensus 228 ~~~~p~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~l~~li~~~l~~~p~~Rpt~---~el~ 283 (288)
T cd05050 228 YGMQPYYGMAHEEVIYYVRDGNVLS-CP--DNCPLELYNLMRLCWSKLPSDRPSF---ASIN 283 (288)
T ss_pred CCCCCCCCCCHHHHHHHHhcCCCCC-CC--CCCCHHHHHHHHHHcccCcccCCCH---HHHH
Confidence 889999988888887776654321 11 1256899999999999999999999 5554
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=327.36 Aligned_cols=242 Identities=24% Similarity=0.306 Sum_probs=199.7
Q ss_pred EEecccCceEEEEEEEcCCC---cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeec
Q psy16843 370 KLISNGAYGSVYLVRHKETR---QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYV 446 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg---~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~ 446 (810)
+.||+|+||.||+|....++ ..||+|.+...... ...+.+..|+++++.++||||+++++++.. ..+++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 46999999999999876554 78999988765443 344678889999999999999999998764 5689999999
Q ss_pred cCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhh
Q psy16843 447 EGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECY 526 (810)
Q Consensus 447 ~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~ 526 (810)
.+|+|.+++.+.+.+++..+..++.|++.||+|||..||+||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~------ 151 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY------ 151 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc------
Confidence 99999999988888999999999999999999999999999999999999999999999999998753221100
Q ss_pred hhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCc
Q psy16843 527 VERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWP 605 (810)
Q Consensus 527 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~ 605 (810)
........++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..+....+..... .+.. ..
T Consensus 152 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~ 222 (257)
T cd05060 152 ------YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER-LPRP--EE 222 (257)
T ss_pred ------cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-CCCC--CC
Confidence 000011224568999999999999999999999999999997 9999998887777666654432 1211 23
Q ss_pred ccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 606 IQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 606 ~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
.+..+++||.+||..+|++||++.
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~ 246 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFS 246 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHH
Confidence 678999999999999999999993
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=336.26 Aligned_cols=260 Identities=26% Similarity=0.396 Sum_probs=208.2
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc----
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK---- 437 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~---- 437 (810)
..++|++.+.||+|+||.||+|.++.+|+.||+|.+...... ......+..|+++++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 457899999999999999999999999999999988654321 122345678999999999999999999987655
Q ss_pred ------eeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCC
Q psy16843 438 ------HLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGL 510 (810)
Q Consensus 438 ------~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGL 510 (810)
.+|+||||+++ ++..++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 89999999986 66666654 35799999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~ 589 (810)
+........ .......++..|+|||++.+. .++.++|||||||++|||++|++||...+..+.+.
T Consensus 163 ~~~~~~~~~--------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~ 228 (302)
T cd07864 163 ARLYNSEES--------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228 (302)
T ss_pred cccccCCcc--------------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 865321100 011123468889999998754 57999999999999999999999998777665554
Q ss_pred hhccC---CC--CCCC---------------------CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 590 HTVND---DI--EWPS---------------------EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 590 ~I~~~---~~--~~p~---------------------~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.+... .. .+|. .....++..+.+||.+||..||.+||++ .+++.||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~---~~il~~~~~ 302 (302)
T cd07864 229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA---EEALNSPWL 302 (302)
T ss_pred HHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCH---HHHhcCCCC
Confidence 44321 10 0110 0011257889999999999999999998 999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=392.77 Aligned_cols=258 Identities=28% Similarity=0.445 Sum_probs=221.9
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+++-...||.|.||.||.|...++|+..|+|.|...... ......+.+|..++..++|||+|++|++=...+.+||.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 566778899999999999999999999999988765544 4556778899999999999999999999999999999999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
||+||+|.++++..+..+|...+.|..|++.||.|||+.|||||||||+||+|+.+|-+|++|||.|.....+..+..
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~-- 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP-- 1392 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC--
Confidence 999999999999988899999999999999999999999999999999999999999999999999976543311110
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhh---cCCCCCcchhhhHHHHHHHHhCCCCCCCCCH-HHHHHhhcc-CCCCCC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILR---QGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFAHTVN-DDIEWP 599 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~---~~ys~ksDIWSLGvILyELLtG~~PF~~~~~-~e~~~~I~~-~~~~~p 599 (810)
-.-+...|||.|||||+|.+ .+.+.+.|||||||++.||+||+.||...+. -++..++-. .++.+|
T Consensus 1393 ---------~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P 1463 (1509)
T KOG4645|consen 1393 ---------GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP 1463 (1509)
T ss_pred ---------HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc
Confidence 01136789999999999986 4678999999999999999999999976544 344444444 445555
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
.. +|.+.+|||.+||+.||.+|+++ .|+++|-|-+
T Consensus 1464 ~~----ls~~g~dFle~Cl~~dP~~Rw~~---~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1464 ER----LSSEGRDFLEHCLEQDPKMRWTA---SQLLEHAFGK 1498 (1509)
T ss_pred hh----hhHhHHHHHHHHHhcCchhhhHH---HHHHHhhccc
Confidence 44 89999999999999999999998 8999998854
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=326.09 Aligned_cols=245 Identities=23% Similarity=0.367 Sum_probs=208.2
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++.+.||.|+||.||+|... |+.||+|.+..... ..+++..|+.+++.++|+||+++++++.+....|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 4578999999999999999999874 78899998865532 45778899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-- 155 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-- 155 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc--
Confidence 999999999999997655 7999999999999999999999999999999999999999999999999998753110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
.....++..|+|||.+....++.++||||||+++|||++ |..||...+..++...+..+. ..
T Consensus 156 ----------------~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~ 218 (256)
T cd05039 156 ----------------QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-RM 218 (256)
T ss_pred ----------------cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CC
Confidence 011234667999999998889999999999999999997 999999888777766655432 11
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.. ....++++.+||.+||..+|++||++ .|+++
T Consensus 219 ~~--~~~~~~~~~~li~~~l~~~p~~Rp~~---~~l~~ 251 (256)
T cd05039 219 EA--PEGCPPEVYKVMKDCWELDPAKRPTF---KQLRE 251 (256)
T ss_pred CC--ccCCCHHHHHHHHHHhccChhhCcCH---HHHHH
Confidence 11 12367899999999999999999999 56653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=327.08 Aligned_cols=244 Identities=22% Similarity=0.354 Sum_probs=203.2
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeec-ccccee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSF-ETKKHL 439 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f-~~~~~l 439 (810)
....+|++.+.||+|+||.||++... |..||+|.+.... ..+.+..|+.+++.++|+||+++++++ .++..+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 34578999999999999999999764 7789999875432 235678899999999999999999865 556689
Q ss_pred eeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
|+||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999997643 4889999999999999999999999999999999999999999999999998642110
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+..+..
T Consensus 156 ------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 217 (256)
T cd05082 156 ------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 217 (256)
T ss_pred ------------------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC
Confidence 012235678999999999999999999999999999997 9999998888777776654321
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
. . .....++.+.+||.+||+.+|++||++ .+++
T Consensus 218 ~-~--~~~~~~~~~~~li~~~l~~~p~~Rpt~---~~l~ 250 (256)
T cd05082 218 M-D--APDGCPPVVYDVMKQCWHLDAATRPSF---LQLR 250 (256)
T ss_pred C-C--CCCCCCHHHHHHHHHHhcCChhhCcCH---HHHH
Confidence 1 1 112367899999999999999999999 5554
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=332.30 Aligned_cols=255 Identities=30% Similarity=0.489 Sum_probs=211.2
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy 445 (810)
|++.+.||.|+||.||+|+...+++.||+|++.... ......+.+..|+.+++.++|+||+++++++.+.+.+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999887654 2223345677899999999999999999999999999999999
Q ss_pred ccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 446 VEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 446 ~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
++ ++|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||+++......
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~------ 152 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL------ 152 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc------
Confidence 97 5899999876 589999999999999999999999999999999999999999999999999986522110
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC---------
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND--------- 594 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~--------- 594 (810)
. ......++..|+|||++.+. .++.++|+|||||++|||++|.+||.+.+..+.+.++...
T Consensus 153 -------~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
T cd07829 153 -------R--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW 223 (282)
T ss_pred -------c--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHH
Confidence 0 11223467889999999876 7899999999999999999999999888766655544321
Q ss_pred ---------CCCCCCC-------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 595 ---------DIEWPSE-------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 595 ---------~~~~p~~-------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
...++.. .....+.++.++|.+||..||++||++ .+++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~---~~~l~~p~~ 282 (282)
T cd07829 224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA---KEALKHPYF 282 (282)
T ss_pred HhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCH---HHHhhCcCC
Confidence 0011110 001246789999999999999999998 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=326.47 Aligned_cols=246 Identities=20% Similarity=0.327 Sum_probs=205.5
Q ss_pred EEecccCceEEEEEEEcC-CCc--EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeec
Q psy16843 370 KLISNGAYGSVYLVRHKE-TRQ--RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYV 446 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~-tg~--~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~ 446 (810)
+.||+|+||.||+|.+.. +++ .||+|.+...... ...+.+..|+.+++.++||||+++++.+.+ ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999865 333 6999988765543 556788899999999999999999999988 8999999999
Q ss_pred cCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 447 EGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 447 ~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
++|+|.+++.+.. .+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~----- 152 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED----- 152 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc-----
Confidence 9999999997654 689999999999999999999999999999999999999999999999999875322110
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
.........|+..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+......++...
T Consensus 153 -------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 224 (257)
T cd05040 153 -------HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPE- 224 (257)
T ss_pred -------ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCc-
Confidence 0001123457889999999999999999999999999999998 9999998888877777665433333222
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
..+.++.+++.+||+.+|.+||++ .|++
T Consensus 225 -~~~~~~~~li~~~l~~~p~~Rps~---~~~~ 252 (257)
T cd05040 225 -ACPQDIYNVMLQCWAHNPADRPTF---AALR 252 (257)
T ss_pred -cCCHHHHHHHHHHCCCCcccCCCH---HHHH
Confidence 256899999999999999999998 5554
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=328.45 Aligned_cols=250 Identities=23% Similarity=0.322 Sum_probs=200.8
Q ss_pred EecccCceEEEEEEEc--CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 371 LISNGAYGSVYLVRHK--ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 371 ~LG~G~FG~Vyla~~k--~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
.||+|+||.||+|.++ .++..||+|++.... .....+.+.+|+.+++.++||||++++++++. ..+++||||++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999775 445679999875442 23344678899999999999999999998864 578999999999
Q ss_pred cchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhh
Q psy16843 449 GDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYV 527 (810)
Q Consensus 449 GsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~ 527 (810)
|+|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~------- 151 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY------- 151 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccc-------
Confidence 999999874 467999999999999999999999999999999999999999999999999998642111000
Q ss_pred hcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC-CCCCCCCCc
Q psy16843 528 ERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI-EWPSEDDWP 605 (810)
Q Consensus 528 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~-~~p~~~~~~ 605 (810)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..+.. ..+. .
T Consensus 152 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~ 222 (257)
T cd05115 152 -----YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPA----E 222 (257)
T ss_pred -----eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC----C
Confidence 000111224678999999998899999999999999999996 9999998888777766655432 2222 2
Q ss_pred ccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCC
Q psy16843 606 IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639 (810)
Q Consensus 606 ~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPf 639 (810)
.++++.++|.+||..+|++||++..+.+.++.=|
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 5789999999999999999999954444444433
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.32 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=202.1
Q ss_pred CceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcchhhhh
Q psy16843 376 AYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL 455 (810)
Q Consensus 376 ~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL~~lL 455 (810)
++|.||+++.+.+++.||+|++..... .....+.+..|+++++.++||||++++++|.+.+..|++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 556677777777999999999876532 2345678999999999999999999999999999999999999999999999
Q ss_pred hcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhccccc
Q psy16843 456 KNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533 (810)
Q Consensus 456 ~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~ 533 (810)
.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||.+.......... ....
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~--------~~~~ 162 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ--------RVVH 162 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc--------cccc
Confidence 753 468999999999999999999999999999999999999999999999999886432111000 0000
Q ss_pred ccCCcccCCCCcCChhHHhh--cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC-------C------
Q psy16843 534 FSDKQVYGTPEYIAPEVILR--QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE-------W------ 598 (810)
Q Consensus 534 ~~~~~~~GTp~YmAPEvl~~--~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~-------~------ 598 (810)
.......++..|+|||++.+ ..|+.++|||||||++|||++|..||.+......+.....+... +
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence 11234467889999999976 46899999999999999999999999876654433222211100 0
Q ss_pred -----------------CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 599 -----------------PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 599 -----------------p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
+......++.++.+||.+||+.||.+||++ +|+++||||..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~---~~ll~~p~~~~~ 301 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA---SQLLNHSFFKQC 301 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCH---HHHhcCchHhhh
Confidence 000011245678999999999999999998 999999999765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=329.27 Aligned_cols=246 Identities=21% Similarity=0.315 Sum_probs=203.1
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++.+.||+|+||.||+|++..+ ..||+|++.+.... .+.+..|+++++.++||||+++++.+.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence 346799999999999999999988765 45999988653321 2467889999999999999999998754 56899
Q ss_pred eeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~- 156 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 156 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-
Confidence 99999999999999753 458999999999999999999999999999999999999999999999999986432110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
........|+..|+|||++.+..++.++|||||||++|||++ |.+||.+....+++..+.... ..
T Consensus 157 -------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~ 222 (262)
T cd05071 157 -------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RM 222 (262)
T ss_pred -------------cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CC
Confidence 001112346778999999998999999999999999999999 899999888877777665432 22
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGG 630 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~ 630 (810)
+.. ...+.++.+||.+||++||.+||+++.
T Consensus 223 ~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~ 252 (262)
T cd05071 223 PCP--PECPESLHDLMCQCWRKEPEERPTFEY 252 (262)
T ss_pred CCc--cccCHHHHHHHHHHccCCcccCCCHHH
Confidence 221 236788999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=326.84 Aligned_cols=249 Identities=21% Similarity=0.351 Sum_probs=205.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|..+ +++.||+|.+...... ...+..|+.+++.++|+||+++++++. .+.+|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 34578999999999999999999865 5678999988754432 256788999999999999999999874 46789
Q ss_pred eeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+||||+.+|+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998643 468999999999999999999999999999999999999999999999999986532110
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
........++..|+|||++.+..++.++||||||+++|||++ |++||.+.+..+....+... ..
T Consensus 157 --------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~ 221 (260)
T cd05067 157 --------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YR 221 (260)
T ss_pred --------------cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-CC
Confidence 001122346788999999998899999999999999999998 99999988877776665443 22
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
.+.. ...+.++.+||.+||..+|++||++ ++++
T Consensus 222 ~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~---~~l~ 254 (260)
T cd05067 222 MPRP--DNCPEELYELMRLCWKEKPEERPTF---EYLR 254 (260)
T ss_pred CCCC--CCCCHHHHHHHHHHccCChhhCCCH---HHHH
Confidence 2222 2356899999999999999999998 5554
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=337.40 Aligned_cols=257 Identities=20% Similarity=0.309 Sum_probs=210.4
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEc-------CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEee
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHK-------ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMY 430 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k-------~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~ 430 (810)
.....++|.+.+.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3456689999999999999999999853 234579999776432 233456788999999999 899999999
Q ss_pred eeccccceeeeeeeeccCcchhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCc
Q psy16843 431 CSFETKKHLCLVMEYVEGGDCASLLKNT----------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDN 494 (810)
Q Consensus 431 ~~f~~~~~lyLVmEy~~GGsL~~lL~~~----------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeN 494 (810)
+++.....+|+||||+++|+|.+++.+. ..++...+..++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 9999999999999999999999998753 246778889999999999999999999999999999
Q ss_pred eEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh
Q psy16843 495 LLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV 574 (810)
Q Consensus 495 ILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt 574 (810)
||++.++.+||+|||+++....... ........+++.|+|||++.+..|+.++||||||+++|||++
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 234 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDY-------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234 (304)
T ss_pred EEEcCCCcEEECCCccceecccccc-------------cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHc
Confidence 9999999999999999875321100 001122346788999999999999999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 575 -GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 575 -G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
|..||.+.+..++...+..... .... ...+.++++||.+||..+|.+||++ .|+++
T Consensus 235 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~cl~~~p~~Rps~---~e~l~ 291 (304)
T cd05101 235 LGGSPYPGIPVEELFKLLKEGHR-MDKP--ANCTNELYMMMRDCWHAIPSHRPTF---KQLVE 291 (304)
T ss_pred CCCCCcccCCHHHHHHHHHcCCc-CCCC--CCCCHHHHHHHHHHcccChhhCCCH---HHHHH
Confidence 8999999888888777655432 1111 2367899999999999999999998 66664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=363.86 Aligned_cols=245 Identities=34% Similarity=0.521 Sum_probs=211.7
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHH-hcCCCCeEEEeeeecccccee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL-~~l~HPnIVkl~~~f~~~~~l 439 (810)
+..+.|++...+|.|+|+.|..+.++.+++.+++|++.+... ...+|+.++ ..-+||||+++++.+.+..+.
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCcee
Confidence 346789999999999999999999999999999999877632 223456554 445899999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe-ccCCcEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI-TALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL-d~~g~VKL~DFGLAk~~~~s~ 518 (810)
|+|||++.||.|.+.+.....+. ..+..|++||+.|+.|||.+|||||||||+|||+ +..|+++|+|||.++.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999999999988766666 8888999999999999999999999999999999 68999999999998753211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH-HHHHhhccCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE-ELFAHTVNDDIE 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~-e~~~~I~~~~~~ 597 (810)
..+.|-|..|.|||++...+|+.++||||||++||+||+|+.||...... +++.+|...++.
T Consensus 470 -----------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s 532 (612)
T KOG0603|consen 470 -----------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS 532 (612)
T ss_pred -----------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc
Confidence 12446688999999999999999999999999999999999999765444 676666655443
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..+|.+++|||.+||+.||.+||++ .+++.||||
T Consensus 533 ------~~vS~~AKdLl~~LL~~dP~~Rl~~---~~i~~h~w~ 566 (612)
T KOG0603|consen 533 ------ECVSDEAKDLLQQLLQVDPALRLGA---DEIGAHPWF 566 (612)
T ss_pred ------cccCHHHHHHHHHhccCChhhCcCh---hhhccCcch
Confidence 2389999999999999999999999 899999999
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.21 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=212.9
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy 445 (810)
|+....||+|+||.||++..+.+++.||+|++.... ......+..|+.+++.++|+||+++++.+...+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 444567999999999999999999999999875432 23345688899999999999999999999999999999999
Q ss_pred ccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhh
Q psy16843 446 VEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC 525 (810)
Q Consensus 446 ~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~ 525 (810)
+++++|.+++.. +.+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~-------- 169 (292)
T cd06657 99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-------- 169 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--------
Confidence 999999998754 57899999999999999999999999999999999999999999999999987542110
Q ss_pred hhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-CCCCCCCC
Q psy16843 526 YVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI-EWPSEDDW 604 (810)
Q Consensus 526 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~-~~p~~~~~ 604 (810)
........|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+....+....+..... .+.. ..
T Consensus 170 -------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 240 (292)
T cd06657 170 -------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN--LH 240 (292)
T ss_pred -------cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCC--cc
Confidence 0011335689999999999888899999999999999999999999998877666555433211 1111 12
Q ss_pred cccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 605 PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 605 ~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.++.++.++|.+||..||.+||++ .+++.||||...
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~---~~ll~~~~~~~~ 276 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATA---AELLKHPFLAKA 276 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCH---HHHhcChHHhcc
Confidence 357889999999999999999999 899999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=328.79 Aligned_cols=254 Identities=28% Similarity=0.485 Sum_probs=211.0
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccch--hhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL--MLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~--~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
+|.+.+.||+|+||.||++++..++..+++|++..... .......++..|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58999999999999999999988877777776543221 1122334566789999999999999999999999999999
Q ss_pred eeeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 443 MEYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 443 mEy~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++. +.+||+|||+++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988853 457999999999999999999999999999999999999975 679999999986532110
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+....+.......
T Consensus 160 ---------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd08222 160 ---------------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS 224 (260)
T ss_pred ---------------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC
Confidence 01123468899999999988889999999999999999999999998887777766665543221
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
. ...++.++.++|.+||..||++||++ .|++.||||
T Consensus 225 ~---~~~~~~~~~~li~~~l~~~p~~Rp~~---~~il~~~~~ 260 (260)
T cd08222 225 L---PETYSRQLNSIMQSMLNKDPSLRPSA---AEILRNPFI 260 (260)
T ss_pred C---cchhcHHHHHHHHHHhcCChhhCcCH---HHHhhCCCC
Confidence 1 12367899999999999999999998 999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=333.35 Aligned_cols=250 Identities=22% Similarity=0.361 Sum_probs=205.0
Q ss_pred CcEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKE-----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~-----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
+|++.+.||+|+||.||+|.... ....+|+|.+..... ....+.+..|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 235688887765432 23446788999999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcC------------------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCce
Q psy16843 440 CLVMEYVEGGDCASLLKNT------------------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNL 495 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~------------------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNI 495 (810)
|+||||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999987532 2478889999999999999999999999999999999
Q ss_pred EeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-
Q psy16843 496 LITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV- 574 (810)
Q Consensus 496 LLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt- 574 (810)
|++.++.+||+|||+++...... .........++..|+|||.+.+..++.++||||||+++|||++
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~-------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~ 225 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEED-------------SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 225 (290)
T ss_pred EEcCCCcEEeccccccccccCcc-------------chhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhc
Confidence 99999999999999986432110 0011123346778999999998899999999999999999998
Q ss_pred CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 575 GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 575 G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
|..||.+..+.++...+... ..++.. ...+.++.+||.+||+.+|++||++ .|++
T Consensus 226 g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~cl~~~P~~Rp~~---~~i~ 280 (290)
T cd05045 226 GGNPYPGIAPERLFNLLKTG-YRMERP--ENCSEEMYNLMLTCWKQEPDKRPTF---ADIS 280 (290)
T ss_pred CCCCCCCCCHHHHHHHHhCC-CCCCCC--CCCCHHHHHHHHHHccCCcccCCCH---HHHH
Confidence 99999988887776655433 233222 2367899999999999999999999 5554
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.52 Aligned_cols=247 Identities=21% Similarity=0.330 Sum_probs=206.9
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++.+.||+|+||.||+|..+ +++.||||.+...... .+.+..|+.+++.++||||+++++++.+...++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 34578999999999999999999976 4577999988654332 256788999999999999999999999989999
Q ss_pred eeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999999999764 368999999999999999999999999999999999999999999999999986532110
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
+ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.+....+..+.... .
T Consensus 158 ----~----------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~ 222 (261)
T cd05034 158 ----Y----------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-R 222 (261)
T ss_pred ----h----------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C
Confidence 0 00012234678999999999899999999999999999998 999999888887777766532 2
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
.+... ..+.++.+++.+||+.+|.+||+++
T Consensus 223 ~~~~~--~~~~~~~~~i~~~l~~~p~~Rp~~~ 252 (261)
T cd05034 223 MPRPP--NCPEELYDLMLQCWDKDPEERPTFE 252 (261)
T ss_pred CCCCC--CCCHHHHHHHHHHcccCcccCCCHH
Confidence 22222 2468899999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.45 Aligned_cols=248 Identities=21% Similarity=0.350 Sum_probs=206.9
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCc----EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQ----RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~----~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
...+|++.+.||+|+||.||+|.++.+|+ .+|+|.+.+... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 44789999999999999999999887665 589997765533 3345678889999999999999999999887 7
Q ss_pred eeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
..++||||+++|+|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 899999999999999999764 5799999999999999999999999999999999999999999999999999875321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
... ........++..|+|||.+....++.++|||||||++|||++ |..||.+....++...+....
T Consensus 162 ~~~-------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 228 (279)
T cd05057 162 DEK-------------EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE 228 (279)
T ss_pred ccc-------------ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Confidence 100 011111224678999999998899999999999999999998 999999988888777766543
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
. ++... ..+.++.+++.+||..||.+||++
T Consensus 229 ~-~~~~~--~~~~~~~~~~~~~l~~~p~~Rp~~ 258 (279)
T cd05057 229 R-LPQPP--ICTIDVYMVLVKCWMIDAESRPTF 258 (279)
T ss_pred C-CCCCC--CCCHHHHHHHHHHcCCChhhCCCH
Confidence 2 22221 256789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=342.93 Aligned_cols=275 Identities=23% Similarity=0.302 Sum_probs=213.8
Q ss_pred CCcEE-EEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHH-----H------HHHHHHHHHHHhcCCCCeEEEeee
Q psy16843 364 NDFTV-IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRN-----Q------MEQVFAERDIMSFTDNPFVVTMYC 431 (810)
Q Consensus 364 ~dy~i-lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~-----~------~~~i~~E~~iL~~l~HPnIVkl~~ 431 (810)
++|.. .+.||.|+||.||+|.++.+++.||+|++......... . ...+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 57799999999999999999999999988654322100 0 124678999999999999999999
Q ss_pred eccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 432 SFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 432 ~f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
++..++.+|+||||+. |+|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999996 589999988888999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~ 590 (810)
............... .............+++.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..
T Consensus 167 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 167 RRYGYPPYSDTLSKD-ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeccccccccccccc-ccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 753211100000000 000000111234578999999999764 469999999999999999999999998887776655
Q ss_pred hccCC-----CCCCCC-------------------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 591 TVNDD-----IEWPSE-------------------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 591 I~~~~-----~~~p~~-------------------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
+.... ..|+.. .....+.++.+||.+||+.+|++||++ +|++.||||+..
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~---~~~l~~~~~~~~ 319 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA---KEALKHEYFKSD 319 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH---HHHhcCcccCCC
Confidence 54310 001100 001246789999999999999999998 999999999753
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.36 Aligned_cols=256 Identities=20% Similarity=0.316 Sum_probs=209.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCc---EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQ---RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~---~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
..+|++.+.||+|+||.||+|.++.+++ .||+|.+.... .....+.+..|+.+++.++||||+++++++.++..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3579999999999999999999987665 59999876532 234457789999999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
++||||+++|+|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999875 4578999999999999999999999999999999999999999999999999986532211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
... .........++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+... ..
T Consensus 161 ~~~----------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~ 229 (269)
T cd05065 161 SDP----------TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YR 229 (269)
T ss_pred ccc----------ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-Cc
Confidence 100 0000011112457999999999999999999999999999886 99999988887777776433 33
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
++... ..+.++.+++.+||..+|.+||++ .+++.
T Consensus 230 ~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~---~~i~~ 263 (269)
T cd05065 230 LPPPM--DCPTALHQLMLDCWQKDRNARPKF---GQIVS 263 (269)
T ss_pred CCCcc--cCCHHHHHHHHHHcCCChhhCcCH---HHHHH
Confidence 33322 256889999999999999999999 66654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=340.66 Aligned_cols=261 Identities=27% Similarity=0.378 Sum_probs=207.6
Q ss_pred CcEEEEEecccCceEEEEEEEcCC--CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecc----ccc
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKET--RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFE----TKK 437 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~t--g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~----~~~ 437 (810)
+|++.+.||+|+||.||++.+..+ ++.||+|.+.... ......+.+..|+.+++.+ +||||+++++.+. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 489999999999999999999988 8999999876432 1222345677899999988 6999999998643 234
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.+|++|||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6889999985 689999988888999999999999999999999999999999999999999999999999998753221
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD- 595 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~- 595 (810)
... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..++...
T Consensus 159 ~~~-----------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 159 PGE-----------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred ccc-----------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 110 0001134579999999999876 578999999999999999999999998776544443322210
Q ss_pred ---------------------------CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 596 ---------------------------IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 596 ---------------------------~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
..++. .....+.++.+||.+||+.||.+||++ .|++.||||+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~---~~ll~~~~~~~ 297 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISV---EEALEHPYLAI 297 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCH---HHHhcChhhhh
Confidence 00000 011246789999999999999999998 89999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=327.29 Aligned_cols=232 Identities=33% Similarity=0.462 Sum_probs=192.6
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcchhhh
Q psy16843 375 GAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASL 454 (810)
Q Consensus 375 G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL~~l 454 (810)
|.||+||+|+++.+++.||+|.+.+... ...|...+....||||+++++++.+.+.+|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999866431 22344445556799999999999999999999999999999999
Q ss_pred hhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccc
Q psy16843 455 LKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534 (810)
Q Consensus 455 L~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~ 534 (810)
+.+.+.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------------- 138 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------------- 138 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----------------
Confidence 988778999999999999999999999999999999999999999999999999987542110
Q ss_pred cCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHH
Q psy16843 535 SDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSII 614 (810)
Q Consensus 535 ~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI 614 (810)
.....++..|+|||.+.+..++.++|+||+||++|||++|..||...... .. ....+..|. .++.++++||
T Consensus 139 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~---~~~~~~~~~----~~~~~~~~li 209 (237)
T cd05576 139 -CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-IN---THTTLNIPE----WVSEEARSLL 209 (237)
T ss_pred -cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-cc---cccccCCcc----cCCHHHHHHH
Confidence 12234678899999998888999999999999999999999887643211 10 011122232 2678999999
Q ss_pred HhhhcCCCCCCCCCC--ChhHHhcCCCc
Q psy16843 615 TDLLQQNPRDRLGTG--GPHEVKEHPYF 640 (810)
Q Consensus 615 ~klL~~dP~~Rpta~--~~~EiL~HPfF 640 (810)
.+||++||.+|++++ .++|+++||||
T Consensus 210 ~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 210 QQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 999999999999973 46999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=334.39 Aligned_cols=254 Identities=20% Similarity=0.296 Sum_probs=203.8
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCC--------------CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEE
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKET--------------RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVT 428 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~t--------------g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVk 428 (810)
.++|++.+.||+|+||.||+|++..+ ...||+|.+..... ......+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCe
Confidence 36899999999999999999987543 23589998765422 334467889999999999999999
Q ss_pred eeeeccccceeeeeeeeccCcchhhhhhcCC------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceE
Q psy16843 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTG------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLL 496 (810)
Q Consensus 429 l~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNIL 496 (810)
+++++.....+|+||||+.+++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999986432 3688889999999999999999999999999999999
Q ss_pred eccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh--
Q psy16843 497 ITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-- 574 (810)
Q Consensus 497 Ld~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-- 574 (810)
++.++.+||+|||++....... .........+++.|+|||++.+..++.++|||||||++|||++
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~ 228 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD-------------YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLC 228 (295)
T ss_pred EcCCCcEEecccccccccccCc-------------ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcC
Confidence 9999999999999986422110 0001123346789999999999999999999999999999988
Q ss_pred CCCCCCCCCHHHHHHhhcc-----CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 575 GCVPFFGETPEELFAHTVN-----DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 575 G~~PF~~~~~~e~~~~I~~-----~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
|..||...+..+....+.. ....+. ......++.+.+||.+||+.||.+||++ .+++
T Consensus 229 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~RPs~---~~i~ 290 (295)
T cd05097 229 KEQPYSLLSDEQVIENTGEFFRNQGRQIYL-SQTPLCPSPVFKLMMRCWSRDIKDRPTF---NKIH 290 (295)
T ss_pred CCCCCcccChHHHHHHHHHhhhhccccccC-CCCCCCCHHHHHHHHHHcCCCchhCcCH---HHHH
Confidence 7789988777766554432 111111 1112356899999999999999999999 5554
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.87 Aligned_cols=249 Identities=27% Similarity=0.384 Sum_probs=210.6
Q ss_pred cEEEEEecccCceEEEEEEEcCCC----cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETR----QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg----~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
+++.+.||.|+||.||++.+...+ ..||+|.+..... ....+.+..|+.++..++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 457889999999999999998766 8999998865432 2245778899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCC--CCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGP--LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~--lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
||||++|++|.+++..... +++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||+++......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD- 157 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc-
Confidence 9999999999999976544 9999999999999999999999999999999999999999999999999987532210
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.+.+..+....+.......
T Consensus 158 -------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 224 (258)
T smart00219 158 -------------YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP 224 (258)
T ss_pred -------------ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 000011226889999999988889999999999999999998 899999888888888777654332
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.. ...+.++.+++.+||..||++||++ .|+++
T Consensus 225 ~~---~~~~~~~~~~i~~~l~~~p~~Rpt~---~~ll~ 256 (258)
T smart00219 225 KP---ENCPPEIYKLMLQCWAEDPEDRPTF---SELVE 256 (258)
T ss_pred CC---CcCCHHHHHHHHHHCcCChhhCcCH---HHHHh
Confidence 22 1267899999999999999999998 77764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=330.13 Aligned_cols=255 Identities=30% Similarity=0.488 Sum_probs=210.5
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy 445 (810)
|++.+.||.|++|.||+|.+..+++.+|+|.+...... ......+..|+++++.++|+||+++++++.++..+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999999999999988654432 23446778899999999999999999999999999999999
Q ss_pred ccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 446 VEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 446 ~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
+++ +|..++.. .+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~------ 152 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV------ 152 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc------
Confidence 975 78777765 4689999999999999999999999999999999999999999999999999986532210
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC--------
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD-------- 595 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~-------- 595 (810)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+.+.++...-
T Consensus 153 ---------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd05118 153 ---------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVW 223 (283)
T ss_pred ---------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhc
Confidence 011223578899999999877 78999999999999999999999998887766554443210
Q ss_pred -----------CCCCCC-------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 596 -----------IEWPSE-------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 596 -----------~~~p~~-------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..++.. ....++.++.+||.+||.+||.+||++ .+++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~---~~ll~~~~~ 283 (283)
T cd05118 224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA---EQALAHPYF 283 (283)
T ss_pred ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH---HHHhhCCCC
Confidence 000100 011256789999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.40 Aligned_cols=248 Identities=22% Similarity=0.386 Sum_probs=207.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
.+|++.+.||+|+||.||++.+.. +..+|+|.+...... ...+..|+++++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 579999999999999999998764 678999987654332 245778999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||+.+|+|.+++... +.++++.++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---- 154 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---- 154 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc----
Confidence 999999999999753 578999999999999999999999999999999999999999999999999986422110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
........++..|+|||++.+..++.++||||||+++|||++ |..||......+....+..+.......
T Consensus 155 ----------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05112 155 ----------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPR 224 (256)
T ss_pred ----------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCC
Confidence 000112235678999999998899999999999999999998 999999888887777765542222111
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..+.++.+|+.+||+.+|++||++ .|+++
T Consensus 225 ---~~~~~~~~l~~~~l~~~p~~Rp~~---~~~l~ 253 (256)
T cd05112 225 ---LASQSVYELMQHCWKERPEDRPSF---SLLLH 253 (256)
T ss_pred ---CCCHHHHHHHHHHcccChhhCCCH---HHHHH
Confidence 156889999999999999999998 77765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=344.89 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=202.3
Q ss_pred CCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFET 435 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~ 435 (810)
..++|++.+.||+|+||.||+|.+. .+++.||||.+..... ......+..|+.++..+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 3468999999999999999999853 4678999998865432 23446788899999999 68999999988754
Q ss_pred -cceeeeeeeeccCcchhhhhhcC--------------------------------------------------------
Q psy16843 436 -KKHLCLVMEYVEGGDCASLLKNT-------------------------------------------------------- 458 (810)
Q Consensus 436 -~~~lyLVmEy~~GGsL~~lL~~~-------------------------------------------------------- 458 (810)
+..+|+||||+++|+|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 45789999999999999988642
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhh
Q psy16843 459 -----------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYV 527 (810)
Q Consensus 459 -----------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~ 527 (810)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--------- 233 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP--------- 233 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc---------
Confidence 236778888999999999999999999999999999999999999999999986532110
Q ss_pred hcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcc
Q psy16843 528 ERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWPI 606 (810)
Q Consensus 528 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~ 606 (810)
.........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+...+......+.+. ..
T Consensus 234 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 307 (343)
T cd05103 234 ----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--YT 307 (343)
T ss_pred ----chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCC--CC
Confidence 0111122346778999999999999999999999999999996 9999987654433333332222222211 25
Q ss_pred cHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 607 QVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 607 S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
++++.+++.+||+.||.+||++ .|+++|
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~---~eil~~ 335 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTF---SELVEH 335 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCH---HHHHHH
Confidence 6889999999999999999998 788765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=360.32 Aligned_cols=254 Identities=22% Similarity=0.419 Sum_probs=219.0
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccc-hhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce--eeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNS-LMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH--LCLV 442 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~-~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~--lyLV 442 (810)
.....+||+|+|-+||+|.+..+|..||--.+.... .......+++..|+.+|+.|+|||||++|++|.+... +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 355678999999999999999999988865443322 2334556899999999999999999999999987765 8899
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCCCceEecc-CCcEEEeccCCccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG--IVHRDLKPDNLLITA-LGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~g--IIHRDLKPeNILLd~-~g~VKL~DFGLAk~~~~s~~ 519 (810)
+|++..|+|..|+++.+.++...++.|++||+.||.|||++. |||||||.+||+|+. .|.|||+|+|||+....+.
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 999999999999999999999999999999999999999985 999999999999986 5899999999998633221
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCC-CCHHHHHHhhccCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG-ETPEELFAHTVNDDIEW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~-~~~~e~~~~I~~~~~~~ 598 (810)
....+|||.|||||+.. ..|...+||||||++|.||+|+..||.. .++.++|.++..+...-
T Consensus 201 ----------------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~ 263 (632)
T KOG0584|consen 201 ----------------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA 263 (632)
T ss_pred ----------------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH
Confidence 24578999999999987 8899999999999999999999999964 78899999999875421
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
....--.+++++||.+||.. ..+|+++ .|+|+||||..-
T Consensus 264 --sl~kV~dPevr~fIekCl~~-~~~R~sa---~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 264 --ALSKVKDPEVREFIEKCLAT-KSERLSA---KELLKDPFFDED 302 (632)
T ss_pred --HhhccCCHHHHHHHHHHhcC-chhccCH---HHHhhChhhccc
Confidence 11112358999999999998 9999999 999999999874
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.50 Aligned_cols=244 Identities=20% Similarity=0.318 Sum_probs=201.1
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++...||+|+||.||+|.+..+ ..+|+|.+..... ..+.+..|+++++.++||||+++++++.. +..|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEE
Confidence 446799999999999999999988665 4599998764432 12457789999999999999999998854 56899
Q ss_pred eeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
||||+.+|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999999999753 3588999999999999999999999999999999999999999999999999865321100
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
.......++..|+|||.+.+..++.++|||||||++|||++ |.+||.+....+....+... ...
T Consensus 158 --------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~ 222 (260)
T cd05069 158 --------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRM 222 (260)
T ss_pred --------------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC
Confidence 00112346778999999998899999999999999999999 99999998887777766543 222
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
+.. ...+..+.+||.+||.+||++||++
T Consensus 223 ~~~--~~~~~~~~~li~~~l~~~p~~Rp~~ 250 (260)
T cd05069 223 PCP--QGCPESLHELMKLCWKKDPDERPTF 250 (260)
T ss_pred CCC--cccCHHHHHHHHHHccCCcccCcCH
Confidence 221 2366899999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.67 Aligned_cols=258 Identities=21% Similarity=0.304 Sum_probs=209.3
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCC-------CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEee
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKET-------RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMY 430 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~t-------g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~ 430 (810)
+.....+|++.+.||+|+||.||+|++... +..||+|.+.... .....+.+..|+++++.+ +||||++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 344556899999999999999999986432 2368999765432 233456788999999999 899999999
Q ss_pred eeccccceeeeeeeeccCcchhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCc
Q psy16843 431 CSFETKKHLCLVMEYVEGGDCASLLKNTG----------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDN 494 (810)
Q Consensus 431 ~~f~~~~~lyLVmEy~~GGsL~~lL~~~g----------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeN 494 (810)
+++...+.+|+||||+++|+|.+++.... .++...+..++.||+.||+|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 99999999999999999999999986532 36778888999999999999999999999999999
Q ss_pred eEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh
Q psy16843 495 LLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV 574 (810)
Q Consensus 495 ILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt 574 (810)
||++.++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 231 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDY-------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231 (334)
T ss_pred EEEcCCCcEEECCcccceecccccc-------------cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHh
Confidence 9999999999999999875321100 000112234578999999999999999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 575 -GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 575 -G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
|..||.+.+..+.+..+..... .+.. ...+.++.+||.+||..+|.+||++ .|++.+
T Consensus 232 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~l~~li~~cl~~~p~~Rps~---~ell~~ 289 (334)
T cd05100 232 LGGSPYPGIPVEELFKLLKEGHR-MDKP--ANCTHELYMIMRECWHAVPSQRPTF---KQLVED 289 (334)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCC-CCCC--CCCCHHHHHHHHHHcccChhhCcCH---HHHHHH
Confidence 8999999888887777655432 1111 2356899999999999999999998 777764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=344.67 Aligned_cols=265 Identities=28% Similarity=0.427 Sum_probs=211.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecccc--cee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETK--KHL 439 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~--~~l 439 (810)
.++|++.+.||+|+||.||+|.+..+++.+|+|++.+.... ......+..|+.+++.+ +||||+++++++... ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 46899999999999999999999999999999988653221 22345677899999999 999999999988643 478
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||+. ++|..++... .+++..++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||+++.......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 99999997 5999988775 889999999999999999999999999999999999999999999999999875322110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC--
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI-- 596 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~-- 596 (810)
. ..........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+...++.....
T Consensus 163 ~----------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 163 N----------PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred c----------ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 0 00011123568999999998865 4579999999999999999999999987766554443322110
Q ss_pred -------------------------CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 597 -------------------------EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 597 -------------------------~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.........++.++.+||.+||+.||.+||++ .++++||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~---~~il~~~~~~~~ 301 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA---EEALEHPYVAQF 301 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCH---HHHhhChhhhhh
Confidence 00001111256889999999999999999998 899999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.39 Aligned_cols=242 Identities=22% Similarity=0.377 Sum_probs=198.1
Q ss_pred EecccCceEEEEEEEcCCCcE--EEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeeeeeeecc
Q psy16843 371 LISNGAYGSVYLVRHKETRQR--FAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCLVMEYVE 447 (810)
Q Consensus 371 ~LG~G~FG~Vyla~~k~tg~~--vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyLVmEy~~ 447 (810)
.||+|+||.||+|+.+.++.. +|+|.+.... .....+.+..|++++..+ +||||+++++++...+.+|+||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 589999999999999888764 5777665322 233446788899999999 89999999999999999999999999
Q ss_pred CcchhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 448 GGDCASLLKNTG----------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 448 GGsL~~lL~~~g----------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
+|+|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999987532 4788999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAH 590 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~ 590 (810)
..... . .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..
T Consensus 160 ~~~~~---------~-------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~ 223 (270)
T cd05047 160 RGQEV---------Y-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223 (270)
T ss_pred cccch---------h-------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH
Confidence 52110 0 00111234667999999998999999999999999999996 9999998888777776
Q ss_pred hccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 591 I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
+.... ..+. ....+.++.+|+.+||..||.+||++ .|++.
T Consensus 224 ~~~~~-~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~---~~il~ 263 (270)
T cd05047 224 LPQGY-RLEK--PLNCDDEVYDLMRQCWREKPYERPSF---AQILV 263 (270)
T ss_pred HhCCC-CCCC--CCcCCHHHHHHHHHHcccChhhCCCH---HHHHH
Confidence 65432 1111 12366889999999999999999999 56653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=321.27 Aligned_cols=245 Identities=23% Similarity=0.341 Sum_probs=203.2
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCc
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGG 449 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GG 449 (810)
+.||+|+||.||++.+.. ++.||+|.+...... ...+.+..|+++++.++||||+++++++.+....|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 368999999999999887 999999987665432 34567889999999999999999999999999999999999999
Q ss_pred chhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 450 DCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 450 sL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~---------- 147 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI---------- 147 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc----------
Confidence 99999965 3568999999999999999999999999999999999999999999999999986421100
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCccc
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQ 607 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S 607 (810)
.........++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+... ...+.. ...+
T Consensus 148 ---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~ 221 (251)
T cd05041 148 ---YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMPAP--QLCP 221 (251)
T ss_pred ---ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-CCCCCC--ccCC
Confidence 0000112234667999999998899999999999999999998 89999888877666665543 222221 2266
Q ss_pred HHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 608 VEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 608 ~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.++.+||.+||+.+|.+||++ .|+++
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~---~ell~ 247 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSF---SEIYN 247 (251)
T ss_pred HHHHHHHHHHhccChhhCcCH---HHHHH
Confidence 899999999999999999998 67664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=351.08 Aligned_cols=258 Identities=20% Similarity=0.296 Sum_probs=208.1
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeee
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCS 432 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~ 432 (810)
+....++|.+.+.||+|+||.||+|++. .+++.||+|++..... ....+.+..|+++|..+. |||||+++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 3444568999999999999999999964 3456899999865432 233456889999999997 9999999999
Q ss_pred ccccceeeeeeeeccCcchhhhhhcCC-----------------------------------------------------
Q psy16843 433 FETKKHLCLVMEYVEGGDCASLLKNTG----------------------------------------------------- 459 (810)
Q Consensus 433 f~~~~~lyLVmEy~~GGsL~~lL~~~g----------------------------------------------------- 459 (810)
+.+.+.+|+||||+.||+|.++|...+
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986431
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCc
Q psy16843 460 ---------------------------------------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDN 494 (810)
Q Consensus 460 ---------------------------------------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeN 494 (810)
.+++..+..|+.||+.||+|||+.||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 35667788899999999999999999999999999
Q ss_pred eEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh
Q psy16843 495 LLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV 574 (810)
Q Consensus 495 ILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt 574 (810)
||++.++.+||+|||+++...... ........+|++.|+|||++.+..++.++|||||||++|||++
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~ 336 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDS-------------NYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccc-------------ccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence 999999999999999987532110 0011123467889999999999899999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 575 -GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 575 -G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
|..||......+.....+......+.+ ..++.++.+||.+||..+|.+||++ .||+.
T Consensus 337 ~g~~P~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~~P~~RPs~---~ell~ 394 (401)
T cd05107 337 LGGTPYPELPMNEQFYNAIKRGYRMAKP--AHASDEIYEIMQKCWEEKFEIRPDF---SQLVH 394 (401)
T ss_pred cCCCCCCCCCchHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHcCCChhHCcCH---HHHHH
Confidence 899998766555554444433322222 2267899999999999999999999 66664
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=331.27 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=200.2
Q ss_pred CCcEEEEEecccCceEEEEEEEcC----------------CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEE
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKE----------------TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVV 427 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~----------------tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIV 427 (810)
++|++.+.||+|+||.||++.+.. ++..||+|.+.... .....+.+..|+++++.++|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 579999999999999999986543 34578999876442 233446788999999999999999
Q ss_pred EeeeeccccceeeeeeeeccCcchhhhhhcCC-----------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceE
Q psy16843 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKNTG-----------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLL 496 (810)
Q Consensus 428 kl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g-----------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNIL 496 (810)
++++++...+.+|+||||+.+|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999986532 3667789999999999999999999999999999999
Q ss_pred eccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh--
Q psy16843 497 ITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-- 574 (810)
Q Consensus 497 Ld~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-- 574 (810)
++.++.+||+|||+++....... ........+++.|+|||+..+..++.++|||||||++|||++
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~-------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~ 229 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDY-------------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229 (296)
T ss_pred EcCCCCEEeccCcccccccCCcc-------------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhC
Confidence 99999999999999874321100 001122345778999999998899999999999999999998
Q ss_pred CCCCCCCCCHHHHHHhhcc------CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 575 GCVPFFGETPEELFAHTVN------DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 575 G~~PF~~~~~~e~~~~I~~------~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
|..||...+..+....... .....+.. ...+..+.+||.+||+.||.+||++.
T Consensus 230 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp~~~ 288 (296)
T cd05095 230 KEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKP--ALCPDSLYKLMLSCWRRNAKERPSFQ 288 (296)
T ss_pred CCCCccccChHHHHHHHHHHHhhccccccCCCC--CCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 7899988776665543321 11112222 12568899999999999999999993
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=331.38 Aligned_cols=259 Identities=28% Similarity=0.481 Sum_probs=207.7
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccce
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKH 438 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~ 438 (810)
....++|++.+.||+|+||.||+|.++.+++.||||.+.+.... .....+..|+.++... +||||+++++++.+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 34568899999999999999999999999999999988754322 2234455566655555 59999999999999999
Q ss_pred eeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+|+||||+. +.|.+++.. .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999999985 467776654 4579999999999999999999997 5999999999999999999999999999864211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcC----CCCCcchhhhHHHHHHHHhCCCCCCCCC-HHHHHHhh
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG----YGKPVDWWSMGVILYEFLVGCVPFFGET-PEELFAHT 591 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~----ys~ksDIWSLGvILyELLtG~~PF~~~~-~~e~~~~I 591 (810)
. .......|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.... ..+.+..+
T Consensus 168 ~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 231 (296)
T cd06618 168 S----------------KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231 (296)
T ss_pred C----------------CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH
Confidence 0 0012235788999999997653 8899999999999999999999997643 33455555
Q ss_pred ccCCC-CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 592 VNDDI-EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 592 ~~~~~-~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
..... .++.. ..++.++.+||.+||..||.+||++ ++++.||||..
T Consensus 232 ~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~---~~il~~~~~~~ 278 (296)
T cd06618 232 LQEEPPSLPPN--EGFSPDFCSFVDLCLTKDHRKRPKY---RELLQHPFIRR 278 (296)
T ss_pred hcCCCCCCCCC--CCCCHHHHHHHHHHccCChhhCCCH---HHHhcChhhhc
Confidence 54332 22221 1256889999999999999999999 99999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=328.79 Aligned_cols=248 Identities=31% Similarity=0.462 Sum_probs=201.3
Q ss_pred EEEEEecccCceEEEEEEEc----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 367 TVIKLISNGAYGSVYLVRHK----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 367 ~ilk~LG~G~FG~Vyla~~k----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.+.+.||.|+||.||+|.++ ..+..|+||.+... ......+.+..|+++++.++||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999998 44678999988442 2233467889999999999999999999999988889999
Q ss_pred eeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 443 MEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
|||+++|+|.++|... ..+++.....++.||+.||.|||+++|+|+||+++||+++.++.+||+|||++.......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~-- 157 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS-- 157 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--
Confidence 9999999999999876 689999999999999999999999999999999999999999999999999987531110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
.........+...|+|||.+.+..++.++||||||+++|||++ |..||.+.+..++...+..... .+
T Consensus 158 -----------~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-~~ 225 (259)
T PF07714_consen 158 -----------KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-LP 225 (259)
T ss_dssp -----------SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE-TT
T ss_pred -----------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ce
Confidence 0011123346778999999999999999999999999999999 7899999988888888755433 22
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
... ..+..+.++|.+||..||.+||++ .+++
T Consensus 226 ~~~--~~~~~~~~li~~C~~~~p~~RPs~---~~i~ 256 (259)
T PF07714_consen 226 IPD--NCPKDIYSLIQQCWSHDPEKRPSF---QEIL 256 (259)
T ss_dssp SBT--TSBHHHHHHHHHHT-SSGGGS--H---HHHH
T ss_pred ecc--chhHHHHHHHHHHcCCChhhCcCH---HHHH
Confidence 221 257889999999999999999998 6765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=376.55 Aligned_cols=271 Identities=27% Similarity=0.423 Sum_probs=213.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecc--------
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE-------- 434 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~-------- 434 (810)
.++|+.++.||+||||.||+|+++-+|..||||+|.... .......+.+|+.+|+.++|||||++|..|.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 368999999999999999999999999999999998765 3445577899999999999999999987760
Q ss_pred ----------------------------------------------------------------------c---------
Q psy16843 435 ----------------------------------------------------------------------T--------- 435 (810)
Q Consensus 435 ----------------------------------------------------------------------~--------- 435 (810)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ------------------------c--------ceeeeeeeeccCcchhhhhhcCCCC-CHHHHHHHHHHHHHHHHHhhh
Q psy16843 436 ------------------------K--------KHLCLVMEYVEGGDCASLLKNTGPL-PADMARFYFAETVLAVEYLHS 482 (810)
Q Consensus 436 ------------------------~--------~~lyLVmEy~~GGsL~~lL~~~g~l-se~~~~~i~~QIl~AL~yLHs 482 (810)
+ ..+||-||||+.-.|.+++..+... ....++.+++||+.||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 2479999999998888888765444 578899999999999999999
Q ss_pred cccccccCCCCceEeccCCcEEEeccCCcccccccc---cccchhhhhhcccccccCCcccCCCCcCChhHHhhcC---C
Q psy16843 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL---ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG---Y 556 (810)
Q Consensus 483 ~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~---~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~---y 556 (810)
+|||||||||.||+|+.++.|||+|||+|+...... ...............-...+.+||--|+|||++.+.. |
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999999999999999998632110 0000000001111111335679999999999998754 9
Q ss_pred CCCcchhhhHHHHHHHHhCCCCCCC-CCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 557 GKPVDWWSMGVILYEFLVGCVPFFG-ETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 557 s~ksDIWSLGvILyELLtG~~PF~~-~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
+.|+|+|||||||+||+. ||.. +....++..+..+.++.+.....+--+....+|.+||+.||.+|||| .|+|
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA---~eLL 869 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA---TELL 869 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH---HHHh
Confidence 999999999999999994 6643 34455666666666655522222333567899999999999999999 9999
Q ss_pred cCCCcC
Q psy16843 636 EHPYFS 641 (810)
Q Consensus 636 ~HPfF~ 641 (810)
++-||-
T Consensus 870 ~s~llp 875 (1351)
T KOG1035|consen 870 NSELLP 875 (1351)
T ss_pred hccCCC
Confidence 999986
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.79 Aligned_cols=251 Identities=20% Similarity=0.275 Sum_probs=194.3
Q ss_pred EEecccCceEEEEEEEcC--CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeecc
Q psy16843 370 KLISNGAYGSVYLVRHKE--TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVE 447 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~--tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~ 447 (810)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.+...+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997543 34568888765432 22334567889999999999999999999999999999999999
Q ss_pred CcchhhhhhcCC-----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 448 GGDCASLLKNTG-----PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 448 GGsL~~lL~~~g-----~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
+|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---- 154 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED---- 154 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch----
Confidence 999999996532 35678889999999999999999999999999999999999999999999986421110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhh-------cCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILR-------QGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVND 594 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-------~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~ 594 (810)
.........+++.|+|||++.. ..++.++|||||||++|||++ |..||......+.+..+...
T Consensus 155 ---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 225 (269)
T cd05042 155 ---------YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE 225 (269)
T ss_pred ---------heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc
Confidence 0001123346788999999863 356889999999999999998 88999888776666655443
Q ss_pred -CCCCCCC-CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 595 -DIEWPSE-DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 595 -~~~~p~~-~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
...++.. .....+..+.+++..|+ .||.+||+++.+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 226 QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2233322 12236688899999998 59999999944444443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.76 Aligned_cols=256 Identities=28% Similarity=0.462 Sum_probs=207.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc-cceeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET-KKHLCL 441 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~-~~~lyL 441 (810)
.++|++++.||.|+||.||+|.++.+++.||+|++.+.... ....+.+..|+++++.++||||++++++|.. ...+|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 46899999999999999999999999999999988654322 2334667789999999999999999999865 568999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||+ +++|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----- 160 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----- 160 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----
Confidence 99998 5688888764 5689999999999999999999999999999999999999999999999999864210
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc-------
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN------- 593 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~------- 593 (810)
......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+......+..+..
T Consensus 161 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 227 (328)
T cd07856 161 -------------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227 (328)
T ss_pred -------------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 0123467889999999866 5789999999999999999999999987765332221111
Q ss_pred --------C-----------CCCCCC-CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 594 --------D-----------DIEWPS-EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 594 --------~-----------~~~~p~-~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
. ....+. .....++.+++++|.+||+.+|++||++ .+++.||||..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~---~ell~~~~~~~ 293 (328)
T cd07856 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA---AEALAHPYLAP 293 (328)
T ss_pred HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCH---HHHhcCCcccc
Confidence 0 000010 0011256789999999999999999998 99999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=326.99 Aligned_cols=250 Identities=21% Similarity=0.272 Sum_probs=194.9
Q ss_pred cEEEEEecccCceEEEEEEE----cCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc--ccee
Q psy16843 366 FTVIKLISNGAYGSVYLVRH----KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET--KKHL 439 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~----k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~--~~~l 439 (810)
|++++.||+|+||+||++.. ..++..||+|.+..... ......+.+|+++++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 49999999999999988753 35678999998865432 2234567789999999999999999998755 3468
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 999999999999999976 4699999999999999999999999999999999999999999999999999875321100
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH--HHH---------
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE--ELF--------- 588 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~--e~~--------- 588 (810)
. ........++..|+|||++.+..++.++||||||+++|||++|..||...... +..
T Consensus 163 ~------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05080 163 Y------------YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230 (283)
T ss_pred h------------hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccch
Confidence 0 00011234567899999999888999999999999999999999998643221 111
Q ss_pred ---HhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 589 ---AHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 589 ---~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
..........+.. ...+.++.+|+.+||+.+|++||++ ++++
T Consensus 231 ~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~---~~i~ 275 (283)
T cd05080 231 VRLIELLERGMRLPCP--KNCPQEVYILMKNCWETEAKFRPTF---RSLI 275 (283)
T ss_pred hhhhhhhhcCCCCCCC--CCCCHHHHHHHHHHhccChhhCCCH---HHHH
Confidence 1111111111111 2356899999999999999999999 5555
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=323.66 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=205.9
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKET---RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~t---g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
..++|.+.+.||+|+||.||+|.+... ...||+|....... ....+.+..|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 346799999999999999999987654 34689997754432 2344678899999999999999999998876 45
Q ss_pred eeeeeeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.|+||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+.|++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 789999999999999997644 6899999999999999999999999999999999999999999999999998653211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.........+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+.....
T Consensus 161 --------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 226 (270)
T cd05056 161 --------------SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER 226 (270)
T ss_pred --------------cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc
Confidence 0011112235678999999998899999999999999999986 9999998887777766655432
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
. +.. ...+.++.+||.+||..+|.+||++ .+++.
T Consensus 227 ~-~~~--~~~~~~~~~li~~~l~~~P~~Rpt~---~~~~~ 260 (270)
T cd05056 227 L-PMP--PNCPPTLYSLMTKCWAYDPSKRPRF---TELKA 260 (270)
T ss_pred C-CCC--CCCCHHHHHHHHHHcCCChhhCcCH---HHHHH
Confidence 1 111 2367899999999999999999998 55553
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.83 Aligned_cols=254 Identities=17% Similarity=0.268 Sum_probs=208.3
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcC----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc-
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKE----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET- 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~- 435 (810)
+..++|++.+.||+|+||.||+|.+.. ++..|++|.+.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345789999999999999999999876 35788999775432 23455778899999999999999999997655
Q ss_pred cceeeeeeeeccCcchhhhhhcC--------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEec
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNT--------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTD 507 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~--------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~D 507 (810)
....++++||+.+|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 56889999999999999998643 4589999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHH
Q psy16843 508 FGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEE 586 (810)
Q Consensus 508 FGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e 586 (810)
||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+
T Consensus 161 ~g~~~~~~~~~~~-------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 227 (280)
T cd05043 161 NALSRDLFPMDYH-------------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227 (280)
T ss_pred CCCcccccCCceE-------------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH
Confidence 9999753221110 01122346778999999999999999999999999999998 999999888877
Q ss_pred HHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 587 LFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 587 ~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
+...+..+ ..++.. ...++++.+++.+||..||++||++ .|++
T Consensus 228 ~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~---~~~~ 270 (280)
T cd05043 228 MAAYLKDG-YRLAQP--INCPDELFAVMACCWALDPEERPSF---SQLV 270 (280)
T ss_pred HHHHHHcC-CCCCCC--CcCCHHHHHHHHHHcCCChhhCCCH---HHHH
Confidence 66655543 222222 2256889999999999999999998 5655
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=320.60 Aligned_cols=246 Identities=20% Similarity=0.324 Sum_probs=203.3
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
+..++|++.+.||+|+||.||++... .+..+|+|.+.... ...+.+.+|+++++.++|+||+++++++.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 45678999999999999999999865 45669999776432 234678889999999999999999999887 7889
Q ss_pred eeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999753 467888999999999999999999999999999999999999999999999986422110
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
........++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+.......+.... .
T Consensus 157 --------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~ 221 (260)
T cd05073 157 --------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-R 221 (260)
T ss_pred --------------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-C
Confidence 001112345678999999998889999999999999999998 999999888777766655432 2
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
.+.. ...+.++.+++.+||+++|++||++.
T Consensus 222 ~~~~--~~~~~~~~~~i~~~l~~~p~~Rp~~~ 251 (260)
T cd05073 222 MPRP--ENCPEELYNIMMRCWKNRPEERPTFE 251 (260)
T ss_pred CCCc--ccCCHHHHHHHHHHcccCcccCcCHH
Confidence 2222 23678999999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=325.93 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=199.0
Q ss_pred CCCcEEEEEecccCceEEEEEEE----cCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecc--cc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRH----KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE--TK 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~----k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~--~~ 436 (810)
..+|++++.||+|+||.||++.. ..+++.||+|.+.... ....+.+..|+++++.++||||+++++++. +.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 46899999999999999999984 4578899999876543 344567889999999999999999998764 34
Q ss_pred ceeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
..+|+||||+++|+|.+++.+. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 5789999999999999999754 568999999999999999999999999999999999999999999999999987532
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHH---------
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE--------- 586 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e--------- 586 (810)
..... ........++..|+|||++.+..++.++|||||||++|||++|..|+.......
T Consensus 160 ~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd05081 160 QDKEY------------YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ 227 (284)
T ss_pred CCCcc------------eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccc
Confidence 11000 000011224556999999998899999999999999999999877765432211
Q ss_pred ------HHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 587 ------LFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 587 ------~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.+..++.....++.. ..++.++.+||.+||..+|++||++ .|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rpt~---~ei~~ 278 (284)
T cd05081 228 GQMIVYHLIELLKNNGRLPAP--PGCPAEIYAIMKECWNNDPSQRPSF---SELAL 278 (284)
T ss_pred cccchHHHHHHHhcCCcCCCC--CCCCHHHHHHHHHHccCChhhCCCH---HHHHH
Confidence 011122222222222 2366899999999999999999999 66654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.93 Aligned_cols=253 Identities=30% Similarity=0.487 Sum_probs=205.6
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccceeeeeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~~lyLVmE 444 (810)
|++.+.||.|+||.||+|....+++.||||.+.+.... .......+|+..++.+. ||||+++++++.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999999999999987654321 11223456888899998 9999999999999999999999
Q ss_pred eccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 445 YVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 445 y~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|+ +|+|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++.....
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~----- 152 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR----- 152 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-----
Confidence 99 789999887654 7899999999999999999999999999999999999999999999999998642211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC---C---
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND---D--- 595 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~---~--- 595 (810)
.......|+..|+|||++.+ ..++.++|+||||+++|||++|.+||.+....+.+.++... .
T Consensus 153 -----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (283)
T cd07830 153 -----------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ 221 (283)
T ss_pred -----------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChh
Confidence 01123458899999998854 45799999999999999999999999887765554443320 0
Q ss_pred -----------C--CCCCCC-------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 596 -----------I--EWPSED-------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 596 -----------~--~~p~~~-------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
. .++... ....+.++++||.+||+.||++||++ +|++.||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~---~ei~~~~~~ 283 (283)
T cd07830 222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA---SQALQHPYF 283 (283)
T ss_pred hhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH---HHHhhCCCC
Confidence 0 000000 00124789999999999999999998 999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=353.74 Aligned_cols=257 Identities=18% Similarity=0.260 Sum_probs=212.4
Q ss_pred cCCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 358 SKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 358 ~~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
.+.+..+++.+...||+|.||+||+|++..+ ||||++...... ..+.+.++.|+.++++-+|.||+-+.+++..+.
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPT-PEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCC-HHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3445557788999999999999999999754 999988776554 448899999999999999999999999998877
Q ss_pred eeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
. .||..+|+|-+|+.+|+- ..+|.....+.|++||+.|+.|||.++|||||||..||+|.+++.|||+||||+..-..
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 6 999999999999999973 35799999999999999999999999999999999999999999999999999864111
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhh---cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR---QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~---~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~ 593 (810)
. .....-....|..-|||||++.. .+|++.+|||||||++|||++|.+||.....++++..+-.
T Consensus 541 -----w--------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr 607 (678)
T KOG0193|consen 541 -----W--------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR 607 (678)
T ss_pred -----e--------ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc
Confidence 0 00111234458889999999985 4799999999999999999999999998888877776666
Q ss_pred CCCCCCC-CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 594 DDIEWPS-EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 594 ~~~~~p~-~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
+...... ........++++|+..||.+++++||.+ .+||
T Consensus 608 G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F---~~il 647 (678)
T KOG0193|consen 608 GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLF---PQLL 647 (678)
T ss_pred cccCccchhhhccCHHHHHHHHHHHHhcCcccCccH---HHHH
Confidence 5221111 1111245689999999999999999998 5555
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=329.22 Aligned_cols=236 Identities=21% Similarity=0.308 Sum_probs=192.8
Q ss_pred EecccCceEEEEEEEcCCCc-------EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 371 LISNGAYGSVYLVRHKETRQ-------RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 371 ~LG~G~FG~Vyla~~k~tg~-------~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
.||+|+||.||+|.++..+. .+|+|.+.... ....+.+..|..+++.++||||+++++++..+...++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 58999999999999876543 37888764432 334467888999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc--------EEEeccCCcccc
Q psy16843 444 EYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH--------IKLTDFGLSKMG 514 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~--------VKL~DFGLAk~~ 514 (810)
||+.+|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 9999999999997644 6899999999999999999999999999999999999988765 699999987532
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhC-CCCCCCCCHHHHHHhhc
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVG-CVPFFGETPEELFAHTV 592 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG-~~PF~~~~~~e~~~~I~ 592 (810)
. ......|++.|+|||++.+ ..++.++|||||||++|||++| .+||...+...... +.
T Consensus 159 ~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~ 218 (258)
T cd05078 159 L-------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FY 218 (258)
T ss_pred C-------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HH
Confidence 1 1123468899999999987 4589999999999999999998 56776665554433 23
Q ss_pred cCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 593 ~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.....+|.. .+.++.+||.+||+.||++||++ +++++
T Consensus 219 ~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~---~~il~ 255 (258)
T cd05078 219 EDRHQLPAP----KWTELANLINQCMDYEPDFRPSF---RAIIR 255 (258)
T ss_pred HccccCCCC----CcHHHHHHHHHHhccChhhCCCH---HHHHH
Confidence 333334432 45789999999999999999998 77765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=323.64 Aligned_cols=263 Identities=23% Similarity=0.335 Sum_probs=212.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc---
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK--- 437 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~--- 437 (810)
++.++|.+.+.||.|||+.||+|+...+++.||+|+|.-.. ..+.+..++|++.-++++||||++++++...+.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 56689999999999999999999999999999999997654 456688999999999999999999998875443
Q ss_pred --eeeeeeeeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCCCceEeccCCcEEEeccC
Q psy16843 438 --HLCLVMEYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYG--IVHRDLKPDNLLITALGHIKLTDFG 509 (810)
Q Consensus 438 --~lyLVmEy~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~g--IIHRDLKPeNILLd~~g~VKL~DFG 509 (810)
..||+++|...|+|.+.|.. +..++|.++..|+.+|++||++||+.. ++||||||.|||+...+.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 59999999999999999863 237999999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh---cCCCCCcchhhhHHHHHHHHhCCCCCCCCCH--
Q psy16843 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR---QGYGKPVDWWSMGVILYEFLVGCVPFFGETP-- 584 (810)
Q Consensus 510 LAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~---~~ys~ksDIWSLGvILyELLtG~~PF~~~~~-- 584 (810)
.+........+..-.....+.+. . .-|..|.|||.+.- ...+.++|||||||+||+|++|..||...-.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~-----e-~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G 248 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAE-----E-RCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG 248 (302)
T ss_pred CccccceEeechHHHHHHHHHHH-----H-hCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence 98753322111111001111111 1 23889999999964 3458999999999999999999999953211
Q ss_pred HHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 585 EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 585 ~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.-+.-.+.+.++.+|.... +|+.+..||+.||+.||.+||++ .+++.+
T Consensus 249 gSlaLAv~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i---~~ll~~ 296 (302)
T KOG2345|consen 249 GSLALAVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTI---PELLSK 296 (302)
T ss_pred CeEEEeeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCH---HHHHHH
Confidence 1122345567788887643 88999999999999999999999 677653
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=318.74 Aligned_cols=244 Identities=22% Similarity=0.344 Sum_probs=200.5
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCc
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGG 449 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GG 449 (810)
+.||+|+||.||+|... ++..+|+|.+..... ......+.+|+++++.++||||+++++++...+..++||||++||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999865 678899998765432 223346788999999999999999999999999999999999999
Q ss_pred chhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhh
Q psy16843 450 DCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528 (810)
Q Consensus 450 sL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~ 528 (810)
+|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--------- 148 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY--------- 148 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc---------
Confidence 99999865 35689999999999999999999999999999999999999999999999999864211100
Q ss_pred cccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCccc
Q psy16843 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQ 607 (810)
Q Consensus 529 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S 607 (810)
.......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+..... .. ....++
T Consensus 149 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~ 220 (250)
T cd05085 149 -----SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR-MS--CPQKCP 220 (250)
T ss_pred -----ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCCCC
Confidence 00112234678999999998889999999999999999998 9999998887777666654321 11 112367
Q ss_pred HHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 608 VEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 608 ~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.++.+|+.+||..+|++||++ .|+++
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~---~~l~~ 246 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKF---SELQK 246 (250)
T ss_pred HHHHHHHHHHcccCcccCCCH---HHHHH
Confidence 899999999999999999998 66653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=323.64 Aligned_cols=247 Identities=22% Similarity=0.310 Sum_probs=193.7
Q ss_pred EEecccCceEEEEEEEcC--CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeecc
Q psy16843 370 KLISNGAYGSVYLVRHKE--TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVE 447 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~--tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~ 447 (810)
+.||+|+||.||+|.... ++..+|+|.+..... ......+.+|+.+++.++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 368999999999998653 456799998765432 2233467889999999999999999999999999999999999
Q ss_pred CcchhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 448 GGDCASLLKNT-----GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 448 GGsL~~lL~~~-----g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
+|+|.+++... ...++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~----- 153 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE----- 153 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCc-----
Confidence 99999998642 24567788899999999999999999999999999999999999999999998642111
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhc-------CCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhcc-
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-------GYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVN- 593 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-------~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~- 593 (810)
..........|++.|+|||++.+. .++.++|||||||++|||++ |..||......+.......
T Consensus 154 --------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 225 (269)
T cd05087 154 --------DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE 225 (269)
T ss_pred --------ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc
Confidence 001112235678899999998643 36889999999999999996 9999988776665544332
Q ss_pred CCCCCCCCC-CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 594 DDIEWPSED-DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 594 ~~~~~p~~~-~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
....++... ....+..+.+++.+|+ .+|.+||++ +||+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~---~~l~ 264 (269)
T cd05087 226 QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSA---EEVH 264 (269)
T ss_pred ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCH---HHHH
Confidence 222222221 1235678999999998 689999999 5554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=328.16 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=200.3
Q ss_pred CCcEEEEEecccCceEEEEEEE----cCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc--c
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRH----KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK--K 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~----k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~--~ 437 (810)
.-|++++.||+|+||.||+++. +.++..||+|.+..... ......+.+|+++++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3478999999999999999984 45688999998764422 33446788999999999999999999988775 5
Q ss_pred eeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
.+++||||++|++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 789999999999999999654 4689999999999999999999999999999999999999999999999999875321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH------------
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP------------ 584 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~------------ 584 (810)
.... ........|+..|+|||++.+..++.++|||||||++|||+++..|+.....
T Consensus 162 ~~~~------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05079 162 DKEY------------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ 229 (284)
T ss_pred Cccc------------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc
Confidence 1100 0011234578889999999988999999999999999999998776532211
Q ss_pred --HHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 585 --EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 585 --~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..............+.. ..++.++.+||.+||+.||.+||++ +++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~---~~il~ 278 (284)
T cd05079 230 MTVTRLVRVLEEGKRLPRP--PNCPEEVYQLMRKCWEFQPSKRTTF---QNLIE 278 (284)
T ss_pred ccHHHHHHHHHcCccCCCC--CCCCHHHHHHHHHHccCCcccCcCH---HHHHH
Confidence 11111112222222222 2367899999999999999999998 67764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=324.29 Aligned_cols=237 Identities=20% Similarity=0.268 Sum_probs=191.3
Q ss_pred EecccCceEEEEEEEcCC------------CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 371 LISNGAYGSVYLVRHKET------------RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 371 ~LG~G~FG~Vyla~~k~t------------g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
.||+|+||.||+|+.... ...+|+|.+.... ......+..|+.++..++||||+++++++..+..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 689999999999985422 2357888764432 2334567888999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc-------EEEeccCC
Q psy16843 439 LCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH-------IKLTDFGL 510 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~-------VKL~DFGL 510 (810)
.++||||+++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++. +|++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999999999999988875 467999999999999999999999999999999999999987664 89999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHh-hcCCCCCcchhhhHHHHHHHH-hCCCCCCCCCHHHHH
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFL-VGCVPFFGETPEELF 588 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-~~~ys~ksDIWSLGvILyELL-tG~~PF~~~~~~e~~ 588 (810)
+.... ......|+..|+|||++. +..++.++|||||||++|||+ .|..||.+....+..
T Consensus 159 ~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~ 219 (262)
T cd05077 159 PITVL-------------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219 (262)
T ss_pred Ccccc-------------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH
Confidence 85421 112345889999999987 467899999999999999998 589999876655443
Q ss_pred HhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 589 AHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 589 ~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
. .......... +.+.++.+||.+||+.||.+||++ .+|+.+
T Consensus 220 ~-~~~~~~~~~~----~~~~~~~~li~~cl~~dp~~Rp~~---~~il~~ 260 (262)
T cd05077 220 R-FYEGQCMLVT----PSCKELADLMTHCMNYDPNQRPFF---RAIMRD 260 (262)
T ss_pred H-HHhcCccCCC----CChHHHHHHHHHHcCCChhhCcCH---HHHHHh
Confidence 2 2222222221 245789999999999999999999 788764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=323.82 Aligned_cols=243 Identities=24% Similarity=0.385 Sum_probs=199.1
Q ss_pred EecccCceEEEEEEEcCCC------cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 371 LISNGAYGSVYLVRHKETR------QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 371 ~LG~G~FG~Vyla~~k~tg------~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
.||+|+||.||+|+++... +.+|+|.+.+... ......+.+|+++++.++||||+++++++...+..|+|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 6899999999999987544 6899998755422 2334578889999999999999999999999999999999
Q ss_pred eccCcchhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC-----cEEEeccCCcc
Q psy16843 445 YVEGGDCASLLKNT-------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG-----HIKLTDFGLSK 512 (810)
Q Consensus 445 y~~GGsL~~lL~~~-------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g-----~VKL~DFGLAk 512 (810)
|++||+|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++ .+||+|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999998642 3478899999999999999999999999999999999999887 89999999986
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHT 591 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I 591 (810)
....... ........++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+
T Consensus 160 ~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~ 226 (269)
T cd05044 160 DIYKSDY-------------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226 (269)
T ss_pred ccccccc-------------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH
Confidence 5321100 001122346788999999999999999999999999999998 99999888877776666
Q ss_pred ccCC-CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 592 VNDD-IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 592 ~~~~-~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
..+. +..+ ..++.++.+||.+||+++|.+||++ .+++
T Consensus 227 ~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~---~~i~ 264 (269)
T cd05044 227 TAGGRLQKP----ENCPDKIYQLMTNCWAQDPSERPTF---DRIQ 264 (269)
T ss_pred hcCCccCCc----ccchHHHHHHHHHHcCCCcccCCCH---HHHH
Confidence 5432 2222 2267889999999999999999999 5554
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=331.27 Aligned_cols=253 Identities=20% Similarity=0.320 Sum_probs=204.5
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCc----EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQ----RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~----~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
..++|++++.||+|+||.||+|.+..+|. .+|+|.+..... ......+..|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 45789999999999999999999987776 468887654322 22334678899999999999999999998754
Q ss_pred eeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
..++|+||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 578999999999999998764 4689999999999999999999999999999999999999999999999999875321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
.. .........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..+
T Consensus 162 ~~-------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~- 227 (303)
T cd05110 162 DE-------------KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG- 227 (303)
T ss_pred cc-------------cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-
Confidence 10 0111123346788999999999999999999999999999997 99999887766554444332
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..++... ..+.++.+++.+||..+|++||++ .+++.
T Consensus 228 ~~~~~~~--~~~~~~~~li~~c~~~~p~~Rp~~---~~l~~ 263 (303)
T cd05110 228 ERLPQPP--ICTIDVYMVMVKCWMIDADSRPKF---KELAA 263 (303)
T ss_pred CCCCCCC--CCCHHHHHHHHHHcCCChhhCcCH---HHHHH
Confidence 2233222 256789999999999999999999 66655
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.41 Aligned_cols=263 Identities=29% Similarity=0.460 Sum_probs=208.9
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCC----cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc-cc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETR----QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET-KK 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg----~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~-~~ 437 (810)
...|++++.||+|+||.||+|..+.++ +.||||++.-... .........+|+.+++.++|||||.|..+|.+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 357999999999999999999766553 3689998865422 11222456789999999999999999999987 78
Q ss_pred eeeeeeeeccCcchhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC----CcEEEecc
Q psy16843 438 HLCLVMEYVEGGDCASLLKN-----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL----GHIKLTDF 508 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~-----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~----g~VKL~DF 508 (810)
.+++++||.+. ||..+|+- ...++...++.++.||+.|+.|||++=|+||||||.||||..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999976 88888852 2469999999999999999999999999999999999999988 89999999
Q ss_pred CCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCH---
Q psy16843 509 GLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETP--- 584 (810)
Q Consensus 509 GLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~--- 584 (810)
|+++........ .......+-|.+|.|||+++|. .|+.++|+|+.|||+.||++-.+.|.+...
T Consensus 181 GlaR~~~~plkp------------l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~ 248 (438)
T KOG0666|consen 181 GLARLFNNPLKP------------LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIK 248 (438)
T ss_pred cHHHHhhccccc------------cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcc
Confidence 999874322111 1123456789999999999985 689999999999999999999999976522
Q ss_pred ------HHHHHhhccCCCCCCCCCCCc----------------------------------ccHHHHHHHHhhhcCCCCC
Q psy16843 585 ------EELFAHTVNDDIEWPSEDDWP----------------------------------IQVEAKSIITDLLQQNPRD 624 (810)
Q Consensus 585 ------~e~~~~I~~~~~~~p~~~~~~----------------------------------~S~el~dLI~klL~~dP~~ 624 (810)
.+.+.+|.. -+..|....|+ -++.+.+|+.+||++||.+
T Consensus 249 ~~~Pfq~dQl~rIf~-vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~k 327 (438)
T KOG0666|consen 249 TKNPFQHDQLDRIFE-VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIK 327 (438)
T ss_pred cCCCchHHHHHHHHH-HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchh
Confidence 123333332 11222222222 2345889999999999999
Q ss_pred CCCCCChhHHhcCCCcCCC
Q psy16843 625 RLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 625 Rpta~~~~EiL~HPfF~~i 643 (810)
|+++ +++++|+||..-
T Consensus 328 RIta---~qAleh~yF~~d 343 (438)
T KOG0666|consen 328 RITA---EQALEHPYFTED 343 (438)
T ss_pred hccH---HHHhcccccccC
Confidence 9999 999999999764
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=307.06 Aligned_cols=260 Identities=27% Similarity=0.526 Sum_probs=215.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
..|..+++||+|.||+||+++.+++++.||+|.+..+... +.--....+|+-+|+.++|.|||+++++...++.+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 3577788999999999999999999999999998765432 222245778999999999999999999999999999999
Q ss_pred eeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||. .+|..+... +|.++.+.++.++.|++.||.|+|+++++||||||.|+||+.+|.+||+|||+++......
T Consensus 81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv---- 155 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV---- 155 (292)
T ss_pred HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce----
Confidence 9995 478777764 5789999999999999999999999999999999999999999999999999998633211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccC-----C
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVND-----D 595 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~-----~ 595 (810)
.|| ..-+-|.+|.+|.++.+. -|+...|+||-|||+.|+.. |++.|.|.+..+.+.+|... .
T Consensus 156 -rcy----------saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~e 224 (292)
T KOG0662|consen 156 -RCY----------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224 (292)
T ss_pred -Eee----------eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcc
Confidence 111 123569999999999885 58999999999999999996 99999999998888887642 1
Q ss_pred CCCCCCCC------Cc--------------ccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 596 IEWPSEDD------WP--------------IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 596 ~~~p~~~~------~~--------------~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
-.||.... ++ ++...+||++++|..+|.+|+++ +++++||||.+.
T Consensus 225 d~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisa---eaalqhpyf~d~ 289 (292)
T KOG0662|consen 225 DQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISA---EAALQHPYFSDF 289 (292)
T ss_pred ccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCH---HHHhcCcccccc
Confidence 12222110 00 33457899999999999999999 999999999864
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=318.31 Aligned_cols=241 Identities=23% Similarity=0.378 Sum_probs=201.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+..|+.+++.++||||+++++++..+ ..|+|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 46799999999999999999864 67889999875432 225678899999999999999999998754 57999
Q ss_pred eeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
|||+.||+|.+++...+ .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 99999999999997543 5899999999999999999999999999999999999999999999999998642110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
.....++..|+|||.+.+..++.++|+|||||++|||++ |.+||.+.+..+....+..+. ..+
T Consensus 154 ---------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~ 217 (254)
T cd05083 154 ---------------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-RME 217 (254)
T ss_pred ---------------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-CCC
Confidence 011234567999999998899999999999999999997 999999888877776665442 222
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
.. ..++.++.+||.+||+.+|.+||++ .+++
T Consensus 218 ~~--~~~~~~~~~li~~~l~~~p~~Rp~~---~~l~ 248 (254)
T cd05083 218 PP--EGCPADVYVLMTSCWETEPKKRPSF---HKLR 248 (254)
T ss_pred CC--CcCCHHHHHHHHHHcCCChhhCcCH---HHHH
Confidence 11 2367899999999999999999998 5554
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=325.85 Aligned_cols=237 Identities=23% Similarity=0.318 Sum_probs=191.3
Q ss_pred EecccCceEEEEEEEcCC------------------------CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeE
Q psy16843 371 LISNGAYGSVYLVRHKET------------------------RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFV 426 (810)
Q Consensus 371 ~LG~G~FG~Vyla~~k~t------------------------g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnI 426 (810)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 589999999999985422 2358888765432 2334567889999999999999
Q ss_pred EEeeeeccccceeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC----
Q psy16843 427 VTMYCSFETKKHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---- 501 (810)
Q Consensus 427 Vkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g---- 501 (810)
+++++++.+....|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999864 56799999999999999999999999999999999999998654
Q ss_pred ---cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHH-hCC
Q psy16843 502 ---HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFL-VGC 576 (810)
Q Consensus 502 ---~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELL-tG~ 576 (810)
.+||+|||++..... .....|+..|+|||.+.+ ..++.++|||||||++|||+ +|.
T Consensus 159 ~~~~~kl~d~g~~~~~~~-------------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~ 219 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS-------------------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219 (274)
T ss_pred ccceeeecCCcccccccc-------------------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 489999998753110 112357889999999876 56899999999999999985 699
Q ss_pred CCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 577 VPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 577 ~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.||.+....+.... .......+.. .++++.+||.+||+.+|.+||++ .+++++
T Consensus 220 ~p~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~---~~il~~ 272 (274)
T cd05076 220 VPLKERTPSEKERF-YEKKHRLPEP----SCKELATLISQCLTYEPTQRPSF---RTILRD 272 (274)
T ss_pred CCccccChHHHHHH-HHhccCCCCC----CChHHHHHHHHHcccChhhCcCH---HHHHHh
Confidence 99988766554332 2223333322 45789999999999999999998 788754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.72 Aligned_cols=251 Identities=27% Similarity=0.455 Sum_probs=208.2
Q ss_pred CcEEEEEecccCceEEEEEEEcC-CCcEEEEEEeeccch-------hhHHHHHHHHHHHHHHh-cCCCCeEEEeeeeccc
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKE-TRQRFAMKKIIKNSL-------MLRNQMEQVFAERDIMS-FTDNPFVVTMYCSFET 435 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~-tg~~vAIK~I~k~~~-------~~~~~~~~i~~E~~iL~-~l~HPnIVkl~~~f~~ 435 (810)
+|++.+.||+|+||.||+|.++. +++.+|+|.+..... ........+..|+.++. .++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999988 688999998754321 22334556778888876 4799999999999999
Q ss_pred cceeeeeeeeccCcchhhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEEEeccCC
Q psy16843 436 KKHLCLVMEYVEGGDCASLLK----NTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGL 510 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~----~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VKL~DFGL 510 (810)
++..|+||||++|++|.+++. ....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999998874 34579999999999999999999996 7899999999999999999999999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~ 590 (810)
+....... ......|+..|+|||++.+..++.++|+||||+++|||++|.+||...........
T Consensus 161 ~~~~~~~~----------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~ 224 (269)
T cd08528 161 AKQKQPES----------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK 224 (269)
T ss_pred eeeccccc----------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH
Confidence 86422110 11245689999999999988899999999999999999999999988877776666
Q ss_pred hccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 591 I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
+.......... ...++++.+||.+||+.||++||++ .|+.+
T Consensus 225 ~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp~~---~e~~~ 265 (269)
T cd08528 225 IVEAVYEPLPE--GMYSEDVTDVITSCLTPDAEARPDI---IQVSA 265 (269)
T ss_pred HhhccCCcCCc--ccCCHHHHHHHHHHCCCCCccCCCH---HHHHH
Confidence 66544332211 1367899999999999999999998 66554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=361.78 Aligned_cols=257 Identities=24% Similarity=0.407 Sum_probs=218.6
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKE-----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~-----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
....+.+..+.||+|+||+||+|+... ....||||.++.... ....++|++|+++|..++|||||+|++++..
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~--~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE--NQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc--HHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 344678889999999999999998643 346799998876543 3355789999999999999999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcCC--------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNTG--------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG 501 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~g--------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g 501 (810)
++.+|+|+|||..|||.++|...+ +++..+...++.||+.||+||-++.+|||||-..|+||.++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 999999999999999999995321 278889999999999999999999999999999999999999
Q ss_pred cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCC
Q psy16843 502 HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFF 580 (810)
Q Consensus 502 ~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~ 580 (810)
.|||+||||++....+.. | . ...+ ..-...||+||.|+..+|+.++||||+||+|||+++ |..||+
T Consensus 641 ~VKIsDfGLsRdiYssDY------Y-k-----~~~~-t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDY------Y-K-----VRGN-TLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred EEEecccccchhhhhhhh------h-c-----ccCC-ceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc
Confidence 999999999986432211 1 1 1111 123678999999999999999999999999999997 999999
Q ss_pred CCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 581 GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 581 ~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
+.+.+|+++.|.++.+ ++.++. .+.++.+|+..||+.+|.+||++.++.-+|
T Consensus 708 glSn~EVIe~i~~g~l-L~~Pe~--CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L 759 (774)
T KOG1026|consen 708 GLSNQEVIECIRAGQL-LSCPEN--CPTEVYSLMLECWNENPKRRPSFKEIHSRL 759 (774)
T ss_pred ccchHHHHHHHHcCCc-ccCCCC--CCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 9999999999999988 666655 678999999999999999999994433333
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.52 Aligned_cols=248 Identities=19% Similarity=0.249 Sum_probs=196.2
Q ss_pred EEecccCceEEEEEEEcC---CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecc-ccceeeeeeee
Q psy16843 370 KLISNGAYGSVYLVRHKE---TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE-TKKHLCLVMEY 445 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~---tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~-~~~~lyLVmEy 445 (810)
+.||+|+||.||+|.+.. .+..+|+|.+.... .....+.+..|+.+++.++||||+++++++. .++..|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998754 34579999875322 2334567888999999999999999999765 45678999999
Q ss_pred ccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 446 VEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 446 ~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~---- 154 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY---- 154 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce----
Confidence 9999999999754 45677888899999999999999999999999999999999999999999998642211000
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
.........++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..+....+..+... +..
T Consensus 155 -------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-- 224 (262)
T cd05058 155 -------SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL-LQP-- 224 (262)
T ss_pred -------eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC-CCC--
Confidence 0001123346788999999998999999999999999999999 57788877777766666554322 111
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
...+..+.+++.+||..+|++||++ .|++.
T Consensus 225 ~~~~~~~~~li~~cl~~~p~~Rp~~---~~il~ 254 (262)
T cd05058 225 EYCPDPLYEVMLSCWHPKPEMRPTF---SELVS 254 (262)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCH---HHHHH
Confidence 1256889999999999999999999 66654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.17 Aligned_cols=257 Identities=14% Similarity=0.152 Sum_probs=192.1
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccchhhHHH--------HHHHHHHHHHHhcCCCCeEEEee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKET---RQRFAMKKIIKNSLMLRNQ--------MEQVFAERDIMSFTDNPFVVTMY 430 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~t---g~~vAIK~I~k~~~~~~~~--------~~~i~~E~~iL~~l~HPnIVkl~ 430 (810)
..++|++.+.||+|+||.||+|.+..+ +..+|+|+........... ......+...+..++|++|++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999999887 6677877543222111000 01122334456678999999999
Q ss_pred eeccccc----eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEe
Q psy16843 431 CSFETKK----HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLT 506 (810)
Q Consensus 431 ~~f~~~~----~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~ 506 (810)
+++.... ..+++||++. .++.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 8765443 4578888874 4666777665667899999999999999999999999999999999999999999999
Q ss_pred ccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH-H
Q psy16843 507 DFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-E 585 (810)
Q Consensus 507 DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~-~ 585 (810)
|||+|+.......... ..........||+.|+|||++.+..|+.++|||||||+||||++|.+||.+... .
T Consensus 169 DFGla~~~~~~~~~~~--------~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 169 DYGIASHFIIHGKHIE--------YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred EcCCceeeccCCcccc--------cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 9999976432111100 000112335799999999999999999999999999999999999999987632 1
Q ss_pred --------HHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 586 --------ELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 586 --------e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
+.+..+....+..+. .++++.+++..|+..+|++||++ .+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~rp~~---~~l~ 290 (294)
T PHA02882 241 NLIHAAKCDFIKRLHEGKIKIKN-----ANKFIYDFIECVTKLSYEEKPDY---DALI 290 (294)
T ss_pred HHHHHhHHHHHHHhhhhhhccCC-----CCHHHHHHHHHHHhCCCCCCCCH---HHHH
Confidence 223333333333332 45889999999999999999998 5554
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=317.04 Aligned_cols=235 Identities=20% Similarity=0.255 Sum_probs=192.0
Q ss_pred EEecccCceEEEEEEEcCCC----------cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 370 KLISNGAYGSVYLVRHKETR----------QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg----------~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
+.||+|+||.||+|.++.++ ..+++|.+..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999998776 3477776543321 14678889999999999999999999888 778
Q ss_pred eeeeeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC-------cEEEeccCCc
Q psy16843 440 CLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG-------HIKLTDFGLS 511 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g-------~VKL~DFGLA 511 (810)
|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998665 799999999999999999999999999999999999999888 8999999998
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc--CCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHH
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ--GYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELF 588 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~--~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~ 588 (810)
..... .....|+..|+|||++.+. .++.++|||||||++|||++ |..||...+..+..
T Consensus 156 ~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~ 216 (259)
T cd05037 156 ITVLS-------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216 (259)
T ss_pred ccccc-------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH
Confidence 64211 1233577889999999876 78999999999999999999 68888776544433
Q ss_pred HhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 589 AHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 589 ~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..... ....+.. ...++.+||.+||..+|.+||++ .|+++
T Consensus 217 ~~~~~-~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~---~~il~ 256 (259)
T cd05037 217 RFYQD-QHRLPMP----DCAELANLINQCWTYDPTKRPSF---RAILR 256 (259)
T ss_pred HHHhc-CCCCCCC----CchHHHHHHHHHhccChhhCCCH---HHHHH
Confidence 33222 2122221 23789999999999999999998 66664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.91 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=202.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcC----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc--cc
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKE----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET--KK 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~--~~ 437 (810)
.+|++++.||+|+||.||+|.+.. +++.||+|.+...... ...+.+..|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 578999999999999999998653 4789999988765432 345778999999999999999999998877 56
Q ss_pred eeeeeeeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
..|+||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 8999999999999999997654 699999999999999999999999999999999999999999999999999875321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHH----------
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE---------- 586 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e---------- 586 (810)
.... ........++..|+|||.+.+..++.++||||||+++|||++|..||.......
T Consensus 162 ~~~~------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05038 162 DKDY------------YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229 (284)
T ss_pred CCcc------------eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence 1000 000112235667999999998899999999999999999999999987543221
Q ss_pred ----HHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 587 ----LFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 587 ----~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
.....+.....++... ..+.++.+|+.+||+.+|.+||++ .|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rpt~---~ei~ 277 (284)
T cd05038 230 MIVTRLLELLKEGERLPRPP--SCPDEVYDLMKLCWEAEPQDRPSF---ADLI 277 (284)
T ss_pred ccHHHHHHHHHcCCcCCCCc--cCCHHHHHHHHHHhccChhhCCCH---HHHH
Confidence 1222223333333222 255789999999999999999999 5555
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.29 Aligned_cols=250 Identities=20% Similarity=0.332 Sum_probs=201.9
Q ss_pred cEEEEEecccCceEEEEEEEcC---CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc-----
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKE---TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK----- 437 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~---tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~----- 437 (810)
|.+.+.||+|+||.||+|..+. +++.||||.+..... .....+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6778899999999999998653 578999998865432 2334567889999999999999999999875432
Q ss_pred -eeeeeeeeccCcchhhhhhcC------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCC
Q psy16843 438 -HLCLVMEYVEGGDCASLLKNT------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGL 510 (810)
Q Consensus 438 -~lyLVmEy~~GGsL~~lL~~~------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGL 510 (810)
..++++||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347899999999998876421 2578899999999999999999999999999999999999999999999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFA 589 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~ 589 (810)
++...... .........+++.|++||.+.+..++.++|||||||++|||++ |.+||.+.+..+.+.
T Consensus 160 ~~~~~~~~-------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~ 226 (273)
T cd05074 160 SKKIYSGD-------------YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226 (273)
T ss_pred cccccCCc-------------ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH
Confidence 87532110 0011123346778999999999999999999999999999998 999999888877777
Q ss_pred hhccCCC-CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 590 HTVNDDI-EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 590 ~I~~~~~-~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.+..... ..+ ...+..+.+++.+||..+|.+||++ .|++.
T Consensus 227 ~~~~~~~~~~~----~~~~~~~~~l~~~~l~~~p~~Rps~---~~~~~ 267 (273)
T cd05074 227 YLIKGNRLKQP----PDCLEDVYELMCQCWSPEPKCRPSF---QHLRD 267 (273)
T ss_pred HHHcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCH---HHHHH
Confidence 6665432 212 1256899999999999999999998 66654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.74 Aligned_cols=246 Identities=20% Similarity=0.305 Sum_probs=192.3
Q ss_pred EecccCceEEEEEEEcCCC--cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccC
Q psy16843 371 LISNGAYGSVYLVRHKETR--QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 371 ~LG~G~FG~Vyla~~k~tg--~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
.||+|+||.||++.....+ ..+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+...+|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 5999999999999765432 3456665544322 23446788999999999999999999999999999999999999
Q ss_pred cchhhhhhcC----CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 449 GDCASLLKNT----GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 449 GsL~~lL~~~----g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
|+|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~------- 152 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE------- 152 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc-------
Confidence 9999999753 34677788899999999999999999999999999999999999999999997531110
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhh-------cCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC-
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILR-------QGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD- 595 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-------~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~- 595 (810)
.........+|++.|+|||++.. ..++.++|||||||++|||++ |..||...+..+.+..+..+.
T Consensus 153 ------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (268)
T cd05086 153 ------DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ 226 (268)
T ss_pred ------hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc
Confidence 00011134578999999999853 245789999999999999996 678998877777777665432
Q ss_pred CCCCC-CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 596 IEWPS-EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 596 ~~~p~-~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
...+. .....+++.+.+++..|| .+|.+||++ .|++
T Consensus 227 ~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~---~~i~ 263 (268)
T cd05086 227 VKLFKPQLELPYSERWYEVLQFCW-LSPEKRATA---EEVH 263 (268)
T ss_pred cccCCCccCCCCcHHHHHHHHHHh-hCcccCCCH---HHHH
Confidence 22221 112236788999999999 689999999 5654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=324.35 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=213.3
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc------
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK------ 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~------ 436 (810)
.+.|+-+.+||+|.||.||+|+.+.+|+.||+|++..+.. ....-....+|+++|..++|+|++.++++|.+.
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3568889999999999999999999999999997654221 112224567899999999999999999887532
Q ss_pred --ceeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 437 --KHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 437 --~~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
..+|+||++|+. +|+.+|.+. .+|+..+++.++.+++.||.|+|...|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 359999999976 899988765 6899999999999999999999999999999999999999999999999999976
Q ss_pred ccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy16843 514 GLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592 (810)
Q Consensus 514 ~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~ 592 (810)
...+.... +. .-...+-|.+|.+||.+.| ..|+++.|||+-||||.||.+|.+.|.+.+..+.+..|.
T Consensus 174 fs~~~n~~----------kp-rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 174 FSTSKNVV----------KP-RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred eecccccC----------CC-CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 43322110 00 0123456999999999998 579999999999999999999999999998877766654
Q ss_pred c-----CCCCCCCCCCCc--------------------------ccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 593 N-----DDIEWPSEDDWP--------------------------IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 593 ~-----~~~~~p~~~~~~--------------------------~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
. .+-.||..+..+ -.+++.||+.+||..||.+|+.+ .++++|.||.
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a---d~alnh~~F~ 319 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA---DQALNHDFFW 319 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch---Hhhhchhhhh
Confidence 2 112233222111 23578999999999999999999 8999999995
Q ss_pred C
Q psy16843 642 N 642 (810)
Q Consensus 642 ~ 642 (810)
.
T Consensus 320 k 320 (376)
T KOG0669|consen 320 K 320 (376)
T ss_pred c
Confidence 3
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=348.92 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=221.8
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecc-----cc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFE-----TK 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~-----~~ 436 (810)
.+.|++...||+|.+|+||+++++.+++..|+|+...... ..+.+..|.+||+.. +|||++.+|++|. .+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 3679999999999999999999999999999997755432 225677788888766 7999999999984 35
Q ss_pred ceeeeeeeeccCcchhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKN--TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~--~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~ 514 (810)
+.+|||||||.||+..+++++ ...+.|+.+..|+++++.||.+||.+.+||||||-.|||++.+|.|||+|||++...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 689999999999999999974 468999999999999999999999999999999999999999999999999998653
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-----cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-----QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~ 589 (810)
. ......++.+|||.|||||++.. ..|+..+|+||||++..||.-|.+|+.+..++..+.
T Consensus 174 d---------------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF 238 (953)
T KOG0587|consen 174 D---------------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF 238 (953)
T ss_pred e---------------cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence 2 22233467899999999999974 357889999999999999999999999999999988
Q ss_pred hhccCCCC-CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 590 HTVNDDIE-WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 590 ~I~~~~~~-~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
.|...+.. ...+. ..+.++.+||..||.+|-++||+. .+++.|||....-
T Consensus 239 ~IpRNPPPkLkrp~--kWs~~FndFIs~cL~Kd~e~RP~~---~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 239 LIPRNPPPKLKRPK--KWSKKFNDFISTCLVKDYEQRPST---EELLKHPFITEQP 289 (953)
T ss_pred cCCCCCCccccchh--hHHHHHHHHHHHHHhhccccCcch---hhhccCCcccccc
Confidence 88776542 22222 256899999999999999999999 8999999998544
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=330.11 Aligned_cols=255 Identities=29% Similarity=0.538 Sum_probs=208.9
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC--C----eEEEeeeecccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN--P----FVVTMYCSFETK 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H--P----nIVkl~~~f~~~ 436 (810)
.++|.+++.+|+|.||+|..+.+..++..||||+|+.- ....+..+-|+++|.++++ | -+|++.++|.-.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 47899999999999999999999999999999976432 2344567779999998843 2 478899999999
Q ss_pred ceeeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc---------------
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA--------------- 499 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~--------------- 499 (810)
++.|||+|.+ |-++++.|.+++ +|+.++++.++.||+.+++|||+.+++|-||||||||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999998 679999998764 7999999999999999999999999999999999999842
Q ss_pred -----CCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh
Q psy16843 500 -----LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV 574 (810)
Q Consensus 500 -----~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt 574 (810)
+-.|||+|||.|+.... ...+++.|..|.|||++++.+++..+||||+||||+|+.+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e------------------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHE------------------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eccCCCcceEEEecCCcceecc------------------CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 22599999999875211 1246788999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHH---HHHhhcc------------------CCCCCCCCCCCc---------------------ccHHHHH
Q psy16843 575 GCVPFFGETPEE---LFAHTVN------------------DDIEWPSEDDWP---------------------IQVEAKS 612 (810)
Q Consensus 575 G~~PF~~~~~~e---~~~~I~~------------------~~~~~p~~~~~~---------------------~S~el~d 612 (810)
|...|+..+..| +.++|+. +.+.|+...... .-.++.|
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 999998776544 4444442 122332211100 1134789
Q ss_pred HHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 613 IITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 613 LI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
||++||.+||.+|+|+ .|+|.||||...
T Consensus 385 Ll~~mL~fDP~~RiTl---~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITL---REALSHPFFARL 412 (415)
T ss_pred HHHHHHccCccccccH---HHHhcCHHhhcC
Confidence 9999999999999999 899999999764
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=358.05 Aligned_cols=255 Identities=22% Similarity=0.377 Sum_probs=215.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCc-----EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQ-----RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~-----~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
+.....++.+.||+|+||.||.|...+... .||||.+.+.. ....+..+.+|..+|+.++|||||++++++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 345678899999999999999999875433 48999886654 34566889999999999999999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEecc
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNT-------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDF 508 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~-------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DF 508 (810)
....+||+|||+||||..+|++. ..++......++.+|+.|++||+++++|||||-+.|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999865 35888999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHH
Q psy16843 509 GLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEEL 587 (810)
Q Consensus 509 GLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~ 587 (810)
|+|+.+.... +|. ... ...-...|||||.+....++.++|||||||+|||+++ |..||.+.+..++
T Consensus 847 GlArDiy~~~------yyr-~~~------~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v 913 (1025)
T KOG1095|consen 847 GLARDIYDKD------YYR-KHG------EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV 913 (1025)
T ss_pred chhHhhhhch------hee-ccC------ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH
Confidence 9998432111 111 000 0112457999999999999999999999999999998 9999999999999
Q ss_pred HHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 588 ~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
+..++.+. +++.+.. .+..+.+++.+||+.+|++||++ ..|++
T Consensus 914 ~~~~~~gg-RL~~P~~--CP~~ly~lM~~CW~~~pe~RP~F---~~i~~ 956 (1025)
T KOG1095|consen 914 LLDVLEGG-RLDPPSY--CPEKLYQLMLQCWKHDPEDRPSF---RTIVE 956 (1025)
T ss_pred HHHHHhCC-ccCCCCC--CChHHHHHHHHHccCChhhCccH---HHHHh
Confidence 98777766 4444433 66889999999999999999998 56654
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=328.85 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=195.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc-eeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK-HLCL 441 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~-~lyL 441 (810)
.++|.....||+|+||.||+|...++ ..||||.+....... ..++..|+.++..++|||+|+|+++|.+.+ ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 37888899999999999999998764 889999776544321 355999999999999999999999999988 5999
Q ss_pred eeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 442 VMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYG---IVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~g---IIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
|+|||++|+|.++|.... .++|.....|+.+++.||+|||... |||||||++|||||.+.+.||+|||+|+....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 999999999999997654 8999999999999999999999854 99999999999999999999999999975322
Q ss_pred cccccchhhhhhcccccccCCcc-cCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC------HHHHHH
Q psy16843 517 SLATNLYECYVERDAKQFSDKQV-YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET------PEELFA 589 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~-~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~------~~e~~~ 589 (810)
. . ....+. .||.+|+|||++.....+.++|||||||+|.||++|+.|..... ..+...
T Consensus 230 ~-~--------------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 230 G-D--------------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred c-c--------------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 0 0 000111 69999999999999889999999999999999999998876432 111111
Q ss_pred -hhccCCC-CC--CCC--CCCc---ccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 590 -HTVNDDI-EW--PSE--DDWP---IQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 590 -~I~~~~~-~~--p~~--~~~~---~S~el~dLI~klL~~dP~~Rpta 628 (810)
.+..+.+ .+ |.. ..+. .-..+..+..+|++.+|.+||+.
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m 342 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTM 342 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCH
Confidence 1111111 11 110 0111 11336678889999999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=346.65 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=181.5
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCC----CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeee----
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKET----RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCS---- 432 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~t----g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~---- 432 (810)
...++|++.+.||+|+||.||+|.+..+ +..||+|++...... +....| .+....+.+++.+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 3457899999999999999999999988 899999987543211 111111 1111222222222221
Q ss_pred --ccccceeeeeeeeccCcchhhhhhcCCC--------------------CCHHHHHHHHHHHHHHHHHhhhcccccccC
Q psy16843 433 --FETKKHLCLVMEYVEGGDCASLLKNTGP--------------------LPADMARFYFAETVLAVEYLHSYGIVHRDL 490 (810)
Q Consensus 433 --f~~~~~lyLVmEy~~GGsL~~lL~~~g~--------------------lse~~~~~i~~QIl~AL~yLHs~gIIHRDL 490 (810)
...+..+++||||+.+++|.+++..... ..+..++.++.||+.||+|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2456689999999999999999865321 123456789999999999999999999999
Q ss_pred CCCceEecc-CCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc---------------
Q psy16843 491 KPDNLLITA-LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ--------------- 554 (810)
Q Consensus 491 KPeNILLd~-~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~--------------- 554 (810)
||+|||++. ++.+||+|||+|+..... ........+||+.|||||.+...
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~--------------~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~ 347 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVG--------------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 347 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccc--------------cccCCcccccCCCccChHHhhccCCCCCCccccccccc
Confidence 999999986 589999999999742211 11122456899999999977532
Q ss_pred -------CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhc-cCCCC---C----CCC---C-------CCcccHH
Q psy16843 555 -------GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV-NDDIE---W----PSE---D-------DWPIQVE 609 (810)
Q Consensus 555 -------~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~-~~~~~---~----p~~---~-------~~~~S~e 609 (810)
.++.++|||||||+||||+++..|+.. ....+..++ ..... | +.. . .......
T Consensus 348 sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 425 (566)
T PLN03225 348 SPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGA 425 (566)
T ss_pred cchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchH
Confidence 244567999999999999997666432 221221111 11100 0 000 0 0001234
Q ss_pred HHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhh
Q psy16843 610 AKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647 (810)
Q Consensus 610 l~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~ 647 (810)
+++||.+||++||.+||++ .|+|+||||.+.++..
T Consensus 426 ~~dLi~~mL~~dP~kR~ta---~e~L~Hpff~~~~~~~ 460 (566)
T PLN03225 426 GWELLKSMMRFKGRQRISA---KAALAHPYFDREGLLG 460 (566)
T ss_pred HHHHHHHHccCCcccCCCH---HHHhCCcCcCCCCccc
Confidence 6799999999999999999 9999999999987753
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.79 Aligned_cols=268 Identities=28% Similarity=0.443 Sum_probs=218.3
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh----hHHHHHHHHHHHHHHhcCCCCeEEEeeeecc-cc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM----LRNQMEQVFAERDIMSFTDNPFVVTMYCSFE-TK 436 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~----~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~-~~ 436 (810)
..++|-++..||+|||+.||++.+....+.||+|+-.....+ ..+..++..+|.+|-+.|+||-||++|++|. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 447899999999999999999999999999999975433222 3345678899999999999999999999986 45
Q ss_pred ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc--ccccccCCCCceEecc---CCcEEEeccCCc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY--GIVHRDLKPDNLLITA---LGHIKLTDFGLS 511 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~--gIIHRDLKPeNILLd~---~g~VKL~DFGLA 511 (810)
+.+|-|+|||+|.+|..+|+.+..++|.+++.|+.||+.||.||... -|||-||||.||||-. .|.|||+||||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 68999999999999999999999999999999999999999999976 5999999999999964 578999999999
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc----CCCCCcchhhhHHHHHHHHhCCCCCCCCCH-HH
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ----GYGKPVDWWSMGVILYEFLVGCVPFFGETP-EE 586 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~----~ys~ksDIWSLGvILyELLtG~~PF~~~~~-~e 586 (810)
+........ . ...........||.||++||.+.-. +.+.++||||+|||+|.+++|+.||..... .+
T Consensus 621 KIMdddSy~----~----vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 621 KIMDDDSYN----S----VDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred hhccCCccC----c----ccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 863221110 0 0111123456899999999998632 469999999999999999999999976533 33
Q ss_pred HHHh--hc-cCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 587 LFAH--TV-NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 587 ~~~~--I~-~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+++. |+ ...+.||... .++.++++||++||++--++|... .++..||||..
T Consensus 693 ILqeNTIlkAtEVqFP~KP--vVsseAkaFIRRCLaYRKeDR~DV---~qLA~dpyllP 746 (775)
T KOG1151|consen 693 ILQENTILKATEVQFPPKP--VVSSEAKAFIRRCLAYRKEDRIDV---QQLACDPYLLP 746 (775)
T ss_pred HHhhhchhcceeccCCCCC--ccCHHHHHHHHHHHHhhhhhhhhH---HHHccCccccc
Confidence 3332 22 2456676553 388999999999999999999977 89999999854
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=340.57 Aligned_cols=246 Identities=34% Similarity=0.482 Sum_probs=195.2
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc------
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK------ 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~------ 437 (810)
..+..-+.||+||||.||+++++.+|+.||||...+... ....+...+|+++|++++|+|||+++++=++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 346777889999999999999999999999998877553 334577889999999999999999999876654
Q ss_pred eeeeeeeeccCcchhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc--CC--cEEEeccCC
Q psy16843 438 HLCLVMEYVEGGDCASLLK---NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA--LG--HIKLTDFGL 510 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~---~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~--~g--~VKL~DFGL 510 (810)
.-.+|||||.||+|..+|+ +...++|.+...++..++.||.|||++||+||||||+||++-. +| .-||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 4689999999999999996 4467999999999999999999999999999999999999843 34 379999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCC----CHH
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGE----TPE 585 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~----~~~ 585 (810)
|+..... ....+++||+.|++||+... +.|+..+|.|||||++|+++||..||-.. +..
T Consensus 171 Arel~d~----------------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~ 234 (732)
T KOG4250|consen 171 ARELDDN----------------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK 234 (732)
T ss_pred cccCCCC----------------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc
Confidence 9863221 13357899999999999995 78899999999999999999999999432 222
Q ss_pred HHHHhhcc---------------CCCCCCCCCCCc--cc----HHHHHHHHhhhcCCCCCCCC
Q psy16843 586 ELFAHTVN---------------DDIEWPSEDDWP--IQ----VEAKSIITDLLQQNPRDRLG 627 (810)
Q Consensus 586 e~~~~I~~---------------~~~~~p~~~~~~--~S----~el~dLI~klL~~dP~~Rpt 627 (810)
++...++. +++.|......+ .+ ..+-..+..+|..+|.+|..
T Consensus 235 ~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 235 EIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred hhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 33333332 222221111111 22 23567888899999999984
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=315.45 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=211.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHH-HhcCCCCeEEEeeeeccccceeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI-MSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~i-L~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
.++.+-+..||.|+||+|++..|+.+|+..|||.|..... ....+++..|.+. ++.-+.||||++|++.-.++..||
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi 140 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI 140 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence 3566778899999999999999999999999999977654 3445677777775 566688999999999999999999
Q ss_pred eeeeccCcchhhhh-----hcCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 442 VMEYVEGGDCASLL-----KNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 442 VmEy~~GGsL~~lL-----~~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
.||+|. .+|..+- .+...++|..+-.|....+.||+||-. .+|||||+||+||||+..|.|||||||++-...
T Consensus 141 CMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 141 CMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999994 3544332 234679999999999999999999986 589999999999999999999999999986533
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHh--hcCCCCCcchhhhHHHHHHHHhCCCCCCCCC-HHHHHHhhc
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL--RQGYGKPVDWWSMGVILYEFLVGCVPFFGET-PEELFAHTV 592 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~--~~~ys~ksDIWSLGvILyELLtG~~PF~~~~-~~e~~~~I~ 592 (810)
.+.+ ...-.|...|||||.+. +.+|+.++|+||||++|||+.||..|+.+.+ ..+.+..+.
T Consensus 220 ~SiA----------------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv 283 (361)
T KOG1006|consen 220 DSIA----------------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV 283 (361)
T ss_pred HHHH----------------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH
Confidence 2211 12336899999999996 4579999999999999999999999998754 345556666
Q ss_pred cCCCCC--CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 593 NDDIEW--PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 593 ~~~~~~--p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.+.... ........+..++.||.-||.+|-.+||.. .+++++||++..
T Consensus 284 ~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky---~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 284 IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKY---DDLKKFPFYRMY 333 (361)
T ss_pred cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcch---hhhhcCchhhhh
Confidence 654432 333345588999999999999999999999 899999998753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=292.88 Aligned_cols=243 Identities=45% Similarity=0.771 Sum_probs=206.8
Q ss_pred CceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcchhhhh
Q psy16843 376 AYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL 455 (810)
Q Consensus 376 ~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL~~lL 455 (810)
+||.||+|.+..+|+.+|+|++........ .+.+..|+++++.++|+||+++++.+......++||||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999999999999998866543221 577889999999999999999999999999999999999999999999
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhccccccc
Q psy16843 456 KNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535 (810)
Q Consensus 456 ~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~ 535 (810)
.....+++..+..++.+++.||.|||+.||+|+||+|.||+++.++.++|+|||++....... .
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----------------~ 142 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----------------L 142 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----------------c
Confidence 876669999999999999999999999999999999999999999999999999986532110 1
Q ss_pred CCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCC-CCHHHHHHhhccCCCCCCCCCCCcccHHHHHHH
Q psy16843 536 DKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG-ETPEELFAHTVNDDIEWPSEDDWPIQVEAKSII 614 (810)
Q Consensus 536 ~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~-~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI 614 (810)
.....|+..|++||.+.+..++.++||||||+++|+|++|..||.. .........+.......... ...++.++.+++
T Consensus 143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i 221 (244)
T smart00220 143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP-EWKISPEAKDLI 221 (244)
T ss_pred cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc-cccCCHHHHHHH
Confidence 1345688999999999988899999999999999999999999987 55555555555444433221 111568899999
Q ss_pred HhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 615 TDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 615 ~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.+||..+|++||++ .++++||||
T Consensus 222 ~~~l~~~p~~Rp~~---~~~~~~~~~ 244 (244)
T smart00220 222 RKLLVKDPEKRLTA---EEALQHPFF 244 (244)
T ss_pred HHHccCCchhccCH---HHHhhCCCC
Confidence 99999999999998 999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=323.72 Aligned_cols=262 Identities=20% Similarity=0.315 Sum_probs=188.8
Q ss_pred CCCCcEEEEEecccCceEEEEEEEc----------------CCCcEEEEEEeeccchhhHH-----------HHHHHHHH
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHK----------------ETRQRFAMKKIIKNSLMLRN-----------QMEQVFAE 414 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k----------------~tg~~vAIK~I~k~~~~~~~-----------~~~~i~~E 414 (810)
..++|++.++||+|+||.||+|... ..++.||||.+......... ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4578999999999999999999752 23567999988643211110 11223446
Q ss_pred HHHHhcCCCCeE-----EEeeeeccc--------cceeeeeeeeccCcchhhhhhcC-----------------------
Q psy16843 415 RDIMSFTDNPFV-----VTMYCSFET--------KKHLCLVMEYVEGGDCASLLKNT----------------------- 458 (810)
Q Consensus 415 ~~iL~~l~HPnI-----Vkl~~~f~~--------~~~lyLVmEy~~GGsL~~lL~~~----------------------- 458 (810)
+.++..++|.++ ++++++|.. .+..|+||||+++|+|.++|...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766654 556666542 35689999999999999988632
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCC
Q psy16843 459 -GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537 (810)
Q Consensus 459 -g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~ 537 (810)
..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++....... .....
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~--------------~~~~~ 368 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI--------------NFNPL 368 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC--------------ccCcc
Confidence 123567788999999999999999999999999999999999999999999986422110 00111
Q ss_pred cccCCCCcCChhHHhhcC--------------------CC--CCcchhhhHHHHHHHHhCCC-CCCCCC-----------
Q psy16843 538 QVYGTPEYIAPEVILRQG--------------------YG--KPVDWWSMGVILYEFLVGCV-PFFGET----------- 583 (810)
Q Consensus 538 ~~~GTp~YmAPEvl~~~~--------------------ys--~ksDIWSLGvILyELLtG~~-PF~~~~----------- 583 (810)
...+|+.|+|||++.... |+ .+.||||+||++|+|++|.. ||.+..
T Consensus 369 ~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~ 448 (507)
T PLN03224 369 YGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDN 448 (507)
T ss_pred ccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccc
Confidence 223589999999986422 22 34799999999999999876 775321
Q ss_pred HHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCC---CCCCCCCChhHHhcCCCcCC
Q psy16843 584 PEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNP---RDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 584 ~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP---~~Rpta~~~~EiL~HPfF~~ 642 (810)
....+..+....+.++.. ...++.++|||.+||.++| .+|+++ .|+|+||||..
T Consensus 449 ~~~~~r~~~~~~~~~~~~--d~~s~~~~dLi~~LL~~~~~~~~~RlSa---~eaL~Hp~f~~ 505 (507)
T PLN03224 449 DLNRWRMYKGQKYDFSLL--DRNKEAGWDLACKLITKRDQANRGRLSV---GQALSHRFFLP 505 (507)
T ss_pred hHHHHHhhcccCCCcccc--cccChHHHHHHHHHhccCCCCcccCCCH---HHHhCCCCcCC
Confidence 111222333344444422 2367899999999999876 689999 99999999954
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=322.57 Aligned_cols=257 Identities=27% Similarity=0.470 Sum_probs=210.8
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC------CeEEEeeeecc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN------PFVVTMYCSFE 434 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H------PnIVkl~~~f~ 434 (810)
....+|.+....|+|-|++|..|.+..-|..||||+|....... +.=+.|++||++|+. -|+++|+-.|.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 45578999999999999999999999999999999998765543 344579999999853 48999999999
Q ss_pred ccceeeeeeeeccCcchhhhhhcCC---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC-CcEEEeccCC
Q psy16843 435 TKKHLCLVMEYVEGGDCASLLKNTG---PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL-GHIKLTDFGL 510 (810)
Q Consensus 435 ~~~~lyLVmEy~~GGsL~~lL~~~g---~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~-g~VKL~DFGL 510 (810)
..+++|||+|-+ ..+|.++|++.| .|....++.|+.|+..||..|-..||+|.||||+|||++.. ..+||||||.
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 999999999987 568999998765 58889999999999999999999999999999999999975 4689999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~ 590 (810)
|........+ -..-+..|.|||+|+|.+|++..|+||+||+||||.||+..|.|.+..+++..
T Consensus 584 A~~~~eneit-----------------PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 584 ASFASENEIT-----------------PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred cccccccccc-----------------HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 8653322111 11235679999999999999999999999999999999999999988777665
Q ss_pred hccCCCCCCCCC--------------------------------------------------------CCcccHHHHHHH
Q psy16843 591 TVNDDIEWPSED--------------------------------------------------------DWPIQVEAKSII 614 (810)
Q Consensus 591 I~~~~~~~p~~~--------------------------------------------------------~~~~S~el~dLI 614 (810)
.+.-+-.||... ...+-.++++||
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL 726 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL 726 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence 442211111100 000123589999
Q ss_pred HhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 615 TDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 615 ~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.+||..||++|++. .|+|+||||..
T Consensus 727 dkml~LdP~KRit~---nqAL~HpFi~~ 751 (752)
T KOG0670|consen 727 DKMLILDPEKRITV---NQALKHPFITE 751 (752)
T ss_pred HHHhccChhhcCCH---HHHhcCCcccC
Confidence 99999999999999 89999999964
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=332.06 Aligned_cols=276 Identities=38% Similarity=0.697 Sum_probs=245.9
Q ss_pred EecccCceEEEEEEE---cCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccceeeeeeeec
Q psy16843 371 LISNGAYGSVYLVRH---KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKKHLCLVMEYV 446 (810)
Q Consensus 371 ~LG~G~FG~Vyla~~---k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~~lyLVmEy~ 446 (810)
.+|+|+||+|++++. .+.|..||+|+..+......... +...|..++..++ ||++|+++..|+++..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999998764 34678899999887765544443 6778999999887 999999999999999999999999
Q ss_pred cCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhh
Q psy16843 447 EGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECY 526 (810)
Q Consensus 447 ~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~ 526 (810)
.||+|+..+.+...+.+...+.+.++++.|++++|+.||+|||+|++||+++.+|++++.|||+++.....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~--------- 150 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE--------- 150 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh---------
Confidence 99999999999999999999999999999999999999999999999999999999999999999863211
Q ss_pred hhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcc
Q psy16843 527 VERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPI 606 (810)
Q Consensus 527 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~ 606 (810)
+..|||..|||||++. ++..++||||||++++||++|..||.+ ++...|+...+.+|.. +
T Consensus 151 ----------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~----l 210 (612)
T KOG0603|consen 151 ----------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRE----L 210 (612)
T ss_pred ----------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchh----h
Confidence 1128999999999998 788999999999999999999999988 7778888888888876 7
Q ss_pred cHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhc--cCCcccCCCCCccCcccchHHhhhc
Q psy16843 607 QVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRH--KAEFIPQLDDEEDTSYFDSRMERYN 676 (810)
Q Consensus 607 S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~--~~~f~P~~~~~~d~~~fd~~~~~~~ 676 (810)
+.++++++..++.++|..|++.+ ++.|+++|+||..++|+.+..+ .++|.|....+.+..+||+.+....
T Consensus 211 ~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~ 284 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQV 284 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCC
Confidence 79999999999999999999984 7899999999999999977665 4789999999999999999876543
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=302.01 Aligned_cols=254 Identities=25% Similarity=0.429 Sum_probs=210.5
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc------c
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK------K 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~------~ 437 (810)
.+|.-++.+|.|+- .|..+-+.-.++.||+|++... .......++..+|..++..++|+||++++.+|.-. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 57889999999998 7888888889999999998776 33344557788999999999999999999999654 3
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.+|+|||||. ++|...+. -.++.+.+++++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+...+.
T Consensus 95 e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 6899999995 57877776 34788899999999999999999999999999999999999999999999999752221
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC--
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD-- 595 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~-- 595 (810)
+.....+.|..|.|||++.+.+|...+||||+||++.||++|...|.|.+..+.+.++....
T Consensus 172 ----------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgt 235 (369)
T KOG0665|consen 172 ----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGT 235 (369)
T ss_pred ----------------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcC
Confidence 23345678999999999999999999999999999999999999999887765555544210
Q ss_pred -----------------------------CCCCCCCCC-------cccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCC
Q psy16843 596 -----------------------------IEWPSEDDW-------PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639 (810)
Q Consensus 596 -----------------------------~~~p~~~~~-------~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPf 639 (810)
-.+|+.... .-+..++||+.+||..||++|.++ +++|.|||
T Consensus 236 pd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv---~daL~HPY 312 (369)
T KOG0665|consen 236 PDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV---DDALRHPY 312 (369)
T ss_pred CCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH---HHHhcCCe
Confidence 011211110 123468999999999999999998 99999999
Q ss_pred cC
Q psy16843 640 FS 641 (810)
Q Consensus 640 F~ 641 (810)
|+
T Consensus 313 ~~ 314 (369)
T KOG0665|consen 313 IK 314 (369)
T ss_pred ee
Confidence 98
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=325.92 Aligned_cols=260 Identities=27% Similarity=0.479 Sum_probs=229.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|+++..+|.|+||.||+++++.+++..|+|+++.... ....-+++|+-+++.++|||||.+++.|...+.++|+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 4799999999999999999999999999999999876543 3445677899999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||||.||+|.+.-.-.|+++|.++.+.+++.+.||+|||++|-+|||||-.|||++..|.+||+|||.+..+..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita------ 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA------ 164 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999865321
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHh---hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVIL---RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~---~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
.....+++.|||+|||||+-. ..+|...+|||++|++..|+-.-++|-++..++..+...-+..+..|
T Consensus 165 ---------ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp 235 (829)
T KOG0576|consen 165 ---------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP 235 (829)
T ss_pred ---------hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC
Confidence 112236789999999999974 56899999999999999999999999999999988887777666555
Q ss_pred CCCCC-cccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 600 SEDDW-PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 600 ~~~~~-~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
...+. ..++.+.+|++.+|.++|++||++ +-+|.|||...-
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRpta---eklL~h~fvs~~ 277 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTA---EKLLQHPFVSQT 277 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCCh---hhheeceeeccc
Confidence 43322 256789999999999999999999 788889998764
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=326.09 Aligned_cols=262 Identities=21% Similarity=0.341 Sum_probs=222.2
Q ss_pred cccCCCCCCCcEEEEEecccCceEEEEEEEcCCCc---EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeee
Q psy16843 356 KFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQ---RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCS 432 (810)
Q Consensus 356 ~~~~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~---~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~ 432 (810)
.|.+++......|.++||.|.||.|+.|+.+..|+ .||||.++... ..++...++.|+.||.+.+||||++|.++
T Consensus 621 eFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 621 EFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGV 698 (996)
T ss_pred HhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEE
Confidence 34455666788999999999999999999987764 69999876543 34566789999999999999999999999
Q ss_pred ccccceeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 433 FETKKHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 433 f~~~~~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
....+.+.||.|||++|+|..+|++ .|.|+..+..-+++.|+.|++||-+.|+|||||-+.|||++.+-.+|++||||+
T Consensus 699 VTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 699 VTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred EecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence 9999999999999999999999975 478999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHH-hCCCCCCCCCHHHHHHh
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL-VGCVPFFGETPEELFAH 590 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELL-tG~~PF~~~~~~e~~~~ 590 (810)
+...... . ..+....-.=...|.|||.|...+++.++||||+||+|||.+ +|..||.+.+..+++..
T Consensus 779 Rvledd~-~-----------~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka 846 (996)
T KOG0196|consen 779 RVLEDDP-E-----------AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA 846 (996)
T ss_pred eecccCC-C-----------ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH
Confidence 8643221 0 011111111146899999999999999999999999999977 59999999999999888
Q ss_pred hccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 591 I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
|..+ +.+|.+.+ .+..+..|+..||++|-.+||.+ .||..+
T Consensus 847 Ie~g-yRLPpPmD--CP~aL~qLMldCWqkdR~~RP~F---~qiV~~ 887 (996)
T KOG0196|consen 847 IEQG-YRLPPPMD--CPAALYQLMLDCWQKDRNRRPKF---AQIVST 887 (996)
T ss_pred HHhc-cCCCCCCC--CcHHHHHHHHHHHHHHhhcCCCH---HHHHHH
Confidence 7654 66676655 56889999999999999999998 666653
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=319.95 Aligned_cols=202 Identities=30% Similarity=0.520 Sum_probs=181.9
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHH-----HHHHHHHHHHhcCC---CCeEEEeeeecc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQM-----EQVFAERDIMSFTD---NPFVVTMYCSFE 434 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~-----~~i~~E~~iL~~l~---HPnIVkl~~~f~ 434 (810)
..+|..++.+|.|+||+|++|.++.+...|+||.|.|..+....-+ -.+-.|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3579999999999999999999999999999999988766543332 23667999999998 999999999999
Q ss_pred ccceeeeeeeec-cCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 435 TKKHLCLVMEYV-EGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 435 ~~~~lyLVmEy~-~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
+++++||+||-. +|.+|+++|..+..++|.+++.|+.||+.|+++||++||||||||-+|+.++.+|.+||+|||.|..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999999976 4669999999999999999999999999999999999999999999999999999999999998753
Q ss_pred ccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCC
Q psy16843 514 GLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFG 581 (810)
Q Consensus 514 ~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~ 581 (810)
. +.-+...++||..|.|||++.|.+| +..-|||+||++||.+++...||++
T Consensus 720 ~-----------------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 T-----------------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred h-----------------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 1 2223467899999999999999999 9999999999999999999999975
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=315.28 Aligned_cols=261 Identities=21% Similarity=0.344 Sum_probs=219.2
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
++....+..+-.+||-|.||.||.|.++.-.-.||||.++.+.+ .+++++.|..+|+.++|||+|+|+++|..+..
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 33444566777899999999999999999888999998876654 45789999999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+|||.|||..|+|.+||++.. .++.-....++.||..|++||..+++|||||-..|+|+.++..||++||||++....
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 999999999999999998653 467777778889999999999999999999999999999999999999999986322
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
. .|... ....-.+-|.|||-+....++.++|||+|||+|||+.| |..||.|.+..+++.... +.
T Consensus 418 D----TYTAH----------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-kg 482 (1157)
T KOG4278|consen 418 D----TYTAH----------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-KG 482 (1157)
T ss_pred C----ceecc----------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-cc
Confidence 1 11111 11112567999999999999999999999999999997 999999999998887654 44
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
+.+..++. +++.+..|+..||+++|.+||+++.+.+.++.-|-
T Consensus 483 yRM~~PeG--CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 483 YRMDGPEG--CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ccccCCCC--CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 56655544 66899999999999999999999766666655443
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=313.87 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=206.7
Q ss_pred CCCCCCCcEEE-------EEecccCceEEEEEEEcCC----CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEE
Q psy16843 359 KTPNENDFTVI-------KLISNGAYGSVYLVRHKET----RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVV 427 (810)
Q Consensus 359 ~~~~~~dy~il-------k~LG~G~FG~Vyla~~k~t----g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIV 427 (810)
..+...+|++- +.||.|.||.||.|....- .--||||.-+.+.. ....+.++.|.-+|+.++|||||
T Consensus 377 ~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIi 454 (974)
T KOG4257|consen 377 STPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHII 454 (974)
T ss_pred cCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchh
Confidence 34555566654 6799999999999986432 33588886655443 23368899999999999999999
Q ss_pred EeeeeccccceeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEe
Q psy16843 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLT 506 (810)
Q Consensus 428 kl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~ 506 (810)
++++++.+ ...|||||+++-|.|..+|+.+ ..++......|+.||+.||.|||+.++|||||-..|||+.....|||+
T Consensus 455 kLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 455 KLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred heeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeec
Confidence 99999975 5789999999999999999854 579999999999999999999999999999999999999999999999
Q ss_pred ccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHH
Q psy16843 507 DFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPE 585 (810)
Q Consensus 507 DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~ 585 (810)
||||++..... ..+......-..-|||||-+.-..++.++|||.|||++||++. |..||.|-...
T Consensus 534 DFGLSR~~ed~--------------~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs 599 (974)
T KOG4257|consen 534 DFGLSRYLEDD--------------AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS 599 (974)
T ss_pred ccchhhhcccc--------------chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence 99999863221 1111122223567999999999999999999999999999886 99999999888
Q ss_pred HHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 586 ELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 586 e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
+++..|.++.- .|.+.. .++.+..|+.+||.++|.+||.+.
T Consensus 600 DVI~~iEnGeR-lP~P~n--CPp~LYslmskcWayeP~kRPrft 640 (974)
T KOG4257|consen 600 DVIGHIENGER-LPCPPN--CPPALYSLMSKCWAYEPSKRPRFT 640 (974)
T ss_pred ceEEEecCCCC-CCCCCC--CChHHHHHHHHHhccCcccCCcHH
Confidence 88888777653 233322 678999999999999999999984
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=289.90 Aligned_cols=255 Identities=25% Similarity=0.465 Sum_probs=205.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccc--
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKK-- 437 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~-- 437 (810)
...++|++++++|.|-|+.||.|.+..++++++||+++.- ..+.+.+|+.||..+. ||||++++++..+..
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 3568999999999999999999999999999999976432 2367889999999986 999999999987754
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC-CcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL-GHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~-g~VKL~DFGLAk~~~~ 516 (810)
..-+|+||+++.+...+- ..++.-.++.|+.|++.||.|||+.||+|||+||.|+|||.. ..++|+|+|||.+.-.
T Consensus 109 tpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred CchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 678999999988776654 358889999999999999999999999999999999999974 5799999999976432
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCC-CCCHHHHHHhhcc-
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFF-GETPEELFAHTVN- 593 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~-~~~~~e~~~~I~~- 593 (810)
... -+..+.+..|..||++.. +.|+..-|+|||||+|..|+..+-||+ |.+..+.+.+|.+
T Consensus 186 ~~e----------------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 186 GKE----------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred Cce----------------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 211 134467888999999986 568999999999999999999888875 4444333333321
Q ss_pred ------------CCCCCC--------------------CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 594 ------------DDIEWP--------------------SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 594 ------------~~~~~p--------------------~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
-.+.++ .....-+++++.|||.++|.+|-.+|+|+ +|++.||||.
T Consensus 250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTa---kEam~HpyF~ 326 (338)
T KOG0668|consen 250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTA---KEAMAHPYFA 326 (338)
T ss_pred hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccch---HHHhcCchHH
Confidence 111111 11111267999999999999999999999 9999999997
Q ss_pred CC
Q psy16843 642 NL 643 (810)
Q Consensus 642 ~i 643 (810)
.+
T Consensus 327 ~~ 328 (338)
T KOG0668|consen 327 PV 328 (338)
T ss_pred HH
Confidence 54
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=316.92 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=213.3
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCC-C--cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKET-R--QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~t-g--~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
-+.+++..+.++||+|.||.|+.|.++.- | -.||||.+...... ..+..|.+|+.+|..|+|||+++||++..+
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD- 182 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence 34557788889999999999999998753 3 35899988665443 266889999999999999999999999988
Q ss_pred ceeeeeeeeccCcchhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKN--TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~--~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~ 514 (810)
..+.||||++++|+|.+.|.+ .+.|.......|+.||+.||.||..+++|||||-..||||-....|||+||||.+..
T Consensus 183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 789999999999999999975 467999999999999999999999999999999999999999999999999998864
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhcc
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVN 593 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~ 593 (810)
...... |+.. ....-...|+|||.+....++.++|+|++||+||||++ |+-||.|-...+++.+|-.
T Consensus 263 g~ned~-----Yvm~-------p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~ 330 (1039)
T KOG0199|consen 263 GENEDM-----YVMA-------PQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA 330 (1039)
T ss_pred CCCCcc-----eEec-------CCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc
Confidence 332111 1111 11123557999999999999999999999999999997 9999999999999999884
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 594 ~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
.-.++.+.. .+.++.++++.||..+|.+||++.
T Consensus 331 -~erLpRPk~--csedIY~imk~cWah~paDRptFs 363 (1039)
T KOG0199|consen 331 -GERLPRPKY--CSEDIYQIMKNCWAHNPADRPTFS 363 (1039)
T ss_pred -cccCCCCCC--ChHHHHHHHHHhccCCccccccHH
Confidence 344454433 789999999999999999999983
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=293.80 Aligned_cols=262 Identities=25% Similarity=0.416 Sum_probs=212.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc-----e
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK-----H 438 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~-----~ 438 (810)
.|.+..+.||-|+||.||.+.+..+|+.||+|++..- ...-...+++++|.++|...+|.|++...++.+... .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 4566678899999999999999999999999987542 222334578999999999999999999988876553 6
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|+|.|+|. .+|..+|-.-+.++.++++-++.||++||+|||+.||+||||||.|+|++.+..+||||||+++......
T Consensus 132 iYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 899999995 4899999888899999999999999999999999999999999999999999999999999998632211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc----
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN---- 593 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~---- 593 (810)
. .....-+-|.+|.|||++.|. .|+.++||||.|||+.||+-.+..|...++.+.++.|..
T Consensus 211 ~--------------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGT 276 (449)
T KOG0664|consen 211 R--------------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGT 276 (449)
T ss_pred h--------------hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCC
Confidence 1 111233568899999999984 689999999999999999999999988877666655542
Q ss_pred -------------------CCCCCCCCCC-C------cccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 594 -------------------DDIEWPSEDD-W------PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 594 -------------------~~~~~p~~~~-~------~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
+....|.... + ....++.+++.++|..||.+|.+. .+.+.|+|.....
T Consensus 277 Ps~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~---~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 277 PSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISV---EEALQHRYLEEGR 350 (449)
T ss_pred CcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccH---hhhcccccccccc
Confidence 1222121100 0 023468899999999999999988 8999999987643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=342.40 Aligned_cols=239 Identities=22% Similarity=0.294 Sum_probs=186.3
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
.|...+.||+|+||.||+|+++.++..||+|++...... ...|+++++.++|||||++++++.+.+..|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 455677899999999999999999999999987643211 1235788999999999999999999999999999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLH---SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLH---s~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|++||+|.++++. +++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.+....
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------ 833 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------ 833 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------
Confidence 9999999999964 889999999999999999999 6799999999999999998888876 66543210
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHhhc----
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-----EELFAHTV---- 592 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~-----~e~~~~I~---- 592 (810)
......||+.|||||++.+..|+.++|||||||++|||++|+.||..... .+......
T Consensus 834 -------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 900 (968)
T PLN00113 834 -------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH 900 (968)
T ss_pred -------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc
Confidence 01223689999999999999999999999999999999999999853211 11111110
Q ss_pred -----cCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 593 -----NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 593 -----~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
................++.+++.+||+.||++||++ .|+++
T Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~---~evl~ 946 (968)
T PLN00113 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA---NDVLK 946 (968)
T ss_pred hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCH---HHHHH
Confidence 000100000111122467899999999999999998 66654
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=298.77 Aligned_cols=132 Identities=25% Similarity=0.502 Sum_probs=114.6
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-----C---CeEEEeeeec
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-----N---PFVVTMYCSF 433 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-----H---PnIVkl~~~f 433 (810)
...+|.+.++||+|-|++||++.+..+.+.||||+++.. ....+..+.|+++|+++. | .+||+|++.|
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 347899999999999999999999999999999987654 345577788999998772 3 4799999999
Q ss_pred cc----cceeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCCCceEec
Q psy16843 434 ET----KKHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSY-GIVHRDLKPDNLLIT 498 (810)
Q Consensus 434 ~~----~~~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~-gIIHRDLKPeNILLd 498 (810)
.. +.++|||+|++ |.+|..+|+.. +.++...++.|++||+.||.|||.. ||||-||||+||||.
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 64 45999999999 77888888743 5799999999999999999999975 999999999999994
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=304.68 Aligned_cols=251 Identities=21% Similarity=0.310 Sum_probs=204.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
....+.++||+|-||.|.++.... +..||+|++..... .+....+..|+++|.+++|||||.++++|..++.+++||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 457789999999999999998653 68999998865543 344578999999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 444 EYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|||+.|+|..+|..+. .+.......++.||+.||+||.+.++|||||.+.|+|+|.++++||+|||+++....+....
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 9999999999998663 23556667799999999999999999999999999999999999999999998533221110
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHH--hCCCCCCCCCHHHHHHhhcc---CC-
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL--VGCVPFFGETPEELFAHTVN---DD- 595 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELL--tG~~PF~~~~~~e~~~~I~~---~~- 595 (810)
.-...+-...|||+|.|.-.+++.++|+|+||++|||++ +...||...+.+++.++... .+
T Consensus 695 -------------vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 695 -------------VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG 761 (807)
T ss_pred -------------eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence 112345678999999999999999999999999999977 47899998888777665432 11
Q ss_pred --CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 596 --IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 596 --~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
...+.+. -.+..+..|+.+|+..+-++||++ +++-
T Consensus 762 ~~~~l~~P~--~cp~~lyelml~Cw~~es~~RPsF---e~lh 798 (807)
T KOG1094|consen 762 RQVVLSRPP--ACPQGLYELMLRCWRRESEQRPSF---EQLH 798 (807)
T ss_pred cceeccCCC--cCcHHHHHHHHHHhchhhhcCCCH---HHHH
Confidence 1111111 155788999999999999999998 5553
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=317.67 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=195.8
Q ss_pred EEEecccCce-EEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeeeeeeec
Q psy16843 369 IKLISNGAYG-SVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCLVMEYV 446 (810)
Q Consensus 369 lk~LG~G~FG-~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyLVmEy~ 446 (810)
.+.+|.|+-| .||+|.. .|+.||||.+.... ...+.+|+..|+.. +|||||++|+.-+++..+||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 4568999988 5789977 57899999775433 24567899999877 7999999999999999999999999
Q ss_pred cCcchhhhhhcCCC----CCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc---CC--cEEEeccCCccccccc
Q psy16843 447 EGGDCASLLKNTGP----LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA---LG--HIKLTDFGLSKMGLMS 517 (810)
Q Consensus 447 ~GGsL~~lL~~~g~----lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~---~g--~VKL~DFGLAk~~~~s 517 (810)
.. +|.++++..+. ......+.++.|++.||++||+.+||||||||.||||+. +| .++|+|||+++.....
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 54 99999987421 122456788999999999999999999999999999986 34 6899999999874332
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
... .....+..||-+|+|||++....-+.++||+||||++|+.++ |..||.+.-. ...+|+.+.+
T Consensus 665 ~sS------------~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~ 730 (903)
T KOG1027|consen 665 KSS------------FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNY 730 (903)
T ss_pred cch------------hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCcc
Confidence 111 001245679999999999999888999999999999999998 5999965433 3356777665
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
..-...... ..+++|||.+||..+|..||++ .++|.||||-+
T Consensus 731 ~L~~L~~~~-d~eA~dLI~~ml~~dP~~RPsa---~~VL~HPlFW~ 772 (903)
T KOG1027|consen 731 TLVHLEPLP-DCEAKDLISRMLNPDPQLRPSA---TDVLNHPLFWD 772 (903)
T ss_pred ceeeeccCc-hHHHHHHHHHhcCCCcccCCCH---HHHhCCCccCC
Confidence 443222111 1289999999999999999999 99999999964
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=267.80 Aligned_cols=217 Identities=30% Similarity=0.505 Sum_probs=180.3
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHH-hcCCCCeEEEeeeecccccee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL-~~l~HPnIVkl~~~f~~~~~l 439 (810)
...++...+..||+|++|.|-+.+|..+|+..|+|.+...- ..+..+++.+|+++. +....|++|.+|+.+..+..+
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 34467778889999999999999999999999999886432 234456777788875 556899999999999999999
Q ss_pred eeeeeeccCcchhh----hhhcCCCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCCCceEeccCCcEEEeccCCcccc
Q psy16843 440 CLVMEYVEGGDCAS----LLKNTGPLPADMARFYFAETVLAVEYLHSY-GIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514 (810)
Q Consensus 440 yLVmEy~~GGsL~~----lL~~~g~lse~~~~~i~~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~ 514 (810)
+|.||.|. .+|.. .+++.+.++|..+-+++..++.||.|||++ .|||||+||.||||+.+|+||+||||++-..
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 99999994 35544 346778999999999999999999999986 8999999999999999999999999998654
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhh----cCCCCCcchhhhHHHHHHHHhCCCCCCC-CCHHHHHH
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR----QGYGKPVDWWSMGVILYEFLVGCVPFFG-ETPEELFA 589 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~----~~ys~ksDIWSLGvILyELLtG~~PF~~-~~~~e~~~ 589 (810)
..+.+. ..-.|.-.|||||.+.. .+|+.++||||||+++.||.+++.||.. .++.+.+.
T Consensus 200 ~dSiAk----------------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLk 263 (282)
T KOG0984|consen 200 VDSIAK----------------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLK 263 (282)
T ss_pred hhhhHH----------------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHH
Confidence 332211 11348889999999963 4899999999999999999999999964 67788888
Q ss_pred hhccCCC
Q psy16843 590 HTVNDDI 596 (810)
Q Consensus 590 ~I~~~~~ 596 (810)
++...+.
T Consensus 264 qvVeep~ 270 (282)
T KOG0984|consen 264 QVVEEPS 270 (282)
T ss_pred HHhcCCC
Confidence 8876553
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=308.88 Aligned_cols=253 Identities=24% Similarity=0.373 Sum_probs=205.2
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcC-------CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEee
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKE-------TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMY 430 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~-------tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~ 430 (810)
+....++..+.+.||.|+||.|++|..+. ....||+|.+...... .+.+.+..|+++|+.+ .||||+.+.
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 34445566777899999999999987541 1457999977655433 5668899999999887 599999999
Q ss_pred eeccccceeeeeeeeccCcchhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCc
Q psy16843 431 CSFETKKHLCLVMEYVEGGDCASLLKNTG----------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDN 494 (810)
Q Consensus 431 ~~f~~~~~lyLVmEy~~GGsL~~lL~~~g----------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeN 494 (810)
+++..++.+++|+||+..|+|..+|+..+ .++......++.||+.|++||++.++|||||-..|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998655 38888999999999999999999999999999999
Q ss_pred eEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCC--CCcCChhHHhhcCCCCCcchhhhHHHHHHH
Q psy16843 495 LLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT--PEYIAPEVILRQGYGKPVDWWSMGVILYEF 572 (810)
Q Consensus 495 ILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GT--p~YmAPEvl~~~~ys~ksDIWSLGvILyEL 572 (810)
||+..+..+||+|||+|+...... .+....-.|+ ..|||||.+....|+.++|||||||+||||
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~--------------~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Ei 514 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKD--------------YYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEI 514 (609)
T ss_pred EEecCCCEEEEccccceeccCCCC--------------ceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHH
Confidence 999999999999999998532111 0111111232 349999999999999999999999999999
Q ss_pred Hh-CCCCCCCCC-HHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCC
Q psy16843 573 LV-GCVPFFGET-PEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGG 630 (810)
Q Consensus 573 Lt-G~~PF~~~~-~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~ 630 (810)
++ |..||.+.. ..+++..+..+ .....+.. .+.++.++++.||+.+|++||++.+
T Consensus 515 fsLG~~PYp~~~~~~~l~~~l~~G-~r~~~P~~--c~~eiY~iM~~CW~~~p~~RP~F~~ 571 (609)
T KOG0200|consen 515 FTLGGTPYPGIPPTEELLEFLKEG-NRMEQPEH--CSDEIYDLMKSCWNADPEDRPTFSE 571 (609)
T ss_pred hhCCCCCCCCCCcHHHHHHHHhcC-CCCCCCCC--CCHHHHHHHHHHhCCCcccCCCHHH
Confidence 98 999999865 56666644444 33333332 5799999999999999999999943
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=303.25 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=208.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCc----EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQ----RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~----~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
......++||+|+||+||+|.+-..|+ +||||++...... +..+.+..|+-+|..++|||+++|++++.... +
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 456678899999999999999876664 6888877665443 33467899999999999999999999998876 8
Q ss_pred eeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
.||++||++|.|.++++. ++.+-......|..||++||.|||.++++||||-..|||+..-.++||+|||+++....
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~-- 850 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP-- 850 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc--
Confidence 999999999999999975 46899999999999999999999999999999999999999999999999999986322
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
+.+.+......-.+.|||=|.+....|+.++|||||||++||++| |..|+.+....++-..+..+.-
T Consensus 851 -----------d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR- 918 (1177)
T KOG1025|consen 851 -----------DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER- 918 (1177)
T ss_pred -----------ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-
Confidence 222333333334678999999999999999999999999999998 9999999998887666555433
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
++.+.. .+.++.-++.+||..|+..||++
T Consensus 919 LsqPpi--CtiDVy~~mvkCwmid~~~rp~f 947 (1177)
T KOG1025|consen 919 LSQPPI--CTIDVYMVMVKCWMIDADSRPTF 947 (1177)
T ss_pred CCCCCC--ccHHHHHHHHHHhccCcccCccH
Confidence 444432 67899999999999999999998
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=283.71 Aligned_cols=270 Identities=26% Similarity=0.442 Sum_probs=204.0
Q ss_pred CCCcEEEEEecccCceEEEEEEEcC---CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccce
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKE---TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKH 438 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~---tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~ 438 (810)
.+.|.++++||.|.|+.||++.+.. .++.||+|.+...... .++..|+++|..+ .+.||+++.+++..++.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3679999999999999999998877 7889999998765433 5688899999877 68999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc-CCcEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA-LGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~g~VKL~DFGLAk~~~~s 517 (810)
+.+||||++..+-.++... ++...++.|+..++.||.++|.+|||||||||.|+|.+. .+.-.|+|||||......
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999999999888887764 678999999999999999999999999999999999986 578899999999721110
Q ss_pred c----------------cccchhh-----------hhh--cccccccCCcccCCCCcCChhHHhhcC-CCCCcchhhhHH
Q psy16843 518 L----------------ATNLYEC-----------YVE--RDAKQFSDKQVYGTPEYIAPEVILRQG-YGKPVDWWSMGV 567 (810)
Q Consensus 518 ~----------------~~~~~~~-----------~~~--~~~~~~~~~~~~GTp~YmAPEvl~~~~-ys~ksDIWSLGv 567 (810)
. ....+.+ +.. .+......-...||++|.|||++.+.+ .+.++||||.||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 0000000 000 011111123457999999999998865 599999999999
Q ss_pred HHHHHHhCCCCCCCCCH-HHHHHhhc--------------cCC---------------------CC------------CC
Q psy16843 568 ILYEFLVGCVPFFGETP-EELFAHTV--------------NDD---------------------IE------------WP 599 (810)
Q Consensus 568 ILyELLtG~~PF~~~~~-~e~~~~I~--------------~~~---------------------~~------------~p 599 (810)
|+.-+++++.||+.... .+.+..|. .+. +. .+
T Consensus 267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~ 346 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER 346 (418)
T ss_pred eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence 99999999999964311 01000000 000 00 00
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.......+..+.||+.+||..||.+|+++ +|+|+||||.+.
T Consensus 347 ~~~~d~~~~~~~dlLdk~le~np~kRitA---EeALkHpFF~~~ 387 (418)
T KOG1167|consen 347 EIGSDVFPALLLDLLDKCLELNPQKRITA---EDALKHPFFDEA 387 (418)
T ss_pred ccccccccHHHHHHHHHHccCChhhcccH---HHHhcCcCCcch
Confidence 00001134578999999999999999999 999999999854
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=253.78 Aligned_cols=214 Identities=44% Similarity=0.675 Sum_probs=184.2
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy 445 (810)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... ...+.+..|++.+..++|+|++++++++......++|+||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999998765432 2456788899999999999999999999999999999999
Q ss_pred ccCcchhhhhhcCCC-CCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 446 VEGGDCASLLKNTGP-LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 446 ~~GGsL~~lL~~~g~-lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
+.+++|.+++..... +++..+..++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~------ 152 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL------ 152 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc------
Confidence 999999999987666 8999999999999999999999999999999999999999999999999987532110
Q ss_pred hhhhcccccccCCcccCCCCcCChhHH-hhcCCCCCcchhhhHHHHHHHHhCCCCCCC--CCHHHHHHhhccCC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVI-LRQGYGKPVDWWSMGVILYEFLVGCVPFFG--ETPEELFAHTVNDD 595 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl-~~~~ys~ksDIWSLGvILyELLtG~~PF~~--~~~~e~~~~I~~~~ 595 (810)
........|+..|++||.+ ....++.++|+|+||+++|||++|+.||.+ ....++.+.+..+.
T Consensus 153 --------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 153 --------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred --------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 0012345688899999999 667788899999999999999999999988 44446667766655
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=245.88 Aligned_cols=212 Identities=42% Similarity=0.725 Sum_probs=185.6
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcch
Q psy16843 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDC 451 (810)
Q Consensus 372 LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL 451 (810)
||+|++|.||++....+++.+++|++....... ..+.+.+|+++++.+.|++|+++++++......+++|||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999886654321 346788999999999999999999999999999999999999999
Q ss_pred hhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc-CCcEEEeccCCcccccccccccchhhhhhc
Q psy16843 452 ASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA-LGHIKLTDFGLSKMGLMSLATNLYECYVER 529 (810)
Q Consensus 452 ~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~ 529 (810)
.+++... ..+++..+..++.+++.+|.|||+.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---------- 148 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---------- 148 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----------
Confidence 9999875 57999999999999999999999999999999999999999 89999999999864221100
Q ss_pred ccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccH
Q psy16843 530 DAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQV 608 (810)
Q Consensus 530 ~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~ 608 (810)
......+...|++||.+... .++.+.|+|++|+++|+| .
T Consensus 149 -----~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~ 188 (215)
T cd00180 149 -----LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------P 188 (215)
T ss_pred -----hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------H
Confidence 11234578899999999887 889999999999999998 5
Q ss_pred HHHHHHHhhhcCCCCCCCCCCChhHHhcCC
Q psy16843 609 EAKSIITDLLQQNPRDRLGTGGPHEVKEHP 638 (810)
Q Consensus 609 el~dLI~klL~~dP~~Rpta~~~~EiL~HP 638 (810)
.+.+++.+||..||.+||++ .++++|+
T Consensus 189 ~~~~~l~~~l~~~p~~R~~~---~~l~~~~ 215 (215)
T cd00180 189 ELKDLIRKMLQKDPEKRPSA---KEILEHL 215 (215)
T ss_pred HHHHHHHHHhhCCcccCcCH---HHHhhCC
Confidence 67899999999999999998 8888875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=272.32 Aligned_cols=245 Identities=21% Similarity=0.334 Sum_probs=192.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhc--CCCCeEEEeeeecccc----c
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF--TDNPFVVTMYCSFETK----K 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~--l~HPnIVkl~~~f~~~----~ 437 (810)
.+..+.+.||+|.||+||+|+++ |+.||||++.... .+..++|.+|-.. ++|+||+.++++=..+ .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 57889999999999999999986 7889999886432 2456677777654 6999999998764333 3
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc--------ccccccCCCCceEeccCCcEEEeccC
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY--------GIVHRDLKPDNLLITALGHIKLTDFG 509 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~--------gIIHRDLKPeNILLd~~g~VKL~DFG 509 (810)
.+|||.+|.+.|+|+|+|.. ..++.+.+.+++.-++.||+|||.. .|.|||||..|||+.++|..-|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 79999999999999999988 6899999999999999999999953 49999999999999999999999999
Q ss_pred CcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcC----C--CCCcchhhhHHHHHHHHhC--------
Q psy16843 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG----Y--GKPVDWWSMGVILYEFLVG-------- 575 (810)
Q Consensus 510 LAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~----y--s~ksDIWSLGvILyELLtG-------- 575 (810)
||-...... +.-....+..+||-.|||||++...- + -..+||||||.++||++..
T Consensus 362 LAv~h~~~t-----------~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e 430 (513)
T KOG2052|consen 362 LAVRHDSDT-----------DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE 430 (513)
T ss_pred eeEEecccC-----------CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence 996532211 11223446789999999999997531 1 3468999999999998752
Q ss_pred --CCCCCCC-----CHHHHHHhhccCCCCCCCCCCCcccHH---HHHHHHhhhcCCCCCCCCC
Q psy16843 576 --CVPFFGE-----TPEELFAHTVNDDIEWPSEDDWPIQVE---AKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 576 --~~PF~~~-----~~~e~~~~I~~~~~~~p~~~~~~~S~e---l~dLI~klL~~dP~~Rpta 628 (810)
.+||++. +.+++..-+...++....+..|.-.+. +..|++.||..||.-|+++
T Consensus 431 ey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 431 EYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred hhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 5788753 445666555556665554445544443 4578999999999999998
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=273.56 Aligned_cols=245 Identities=22% Similarity=0.290 Sum_probs=190.3
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHh--cCCCCeEEEeeeeccccc---
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS--FTDNPFVVTMYCSFETKK--- 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~--~l~HPnIVkl~~~f~~~~--- 437 (810)
....+++.+||+|.||.||+|+.. ++.||||++.. ...+.+..|.+|.+ .+.|+||+++++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 356778899999999999999875 58999998753 33466778888865 469999999998766554
Q ss_pred -eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc---------ccccccCCCCceEeccCCcEEEec
Q psy16843 438 -HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY---------GIVHRDLKPDNLLITALGHIKLTD 507 (810)
Q Consensus 438 -~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~---------gIIHRDLKPeNILLd~~g~VKL~D 507 (810)
.++||++|.+.|+|.++|+. ..+++.....++.-+++||+|||+. .|+|||||..||||..|+...|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 89999999999999999987 4799999999999999999999963 599999999999999999999999
Q ss_pred cCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcC-C-----CCCcchhhhHHHHHHHHhCC-----
Q psy16843 508 FGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG-Y-----GKPVDWWSMGVILYEFLVGC----- 576 (810)
Q Consensus 508 FGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y-----s~ksDIWSLGvILyELLtG~----- 576 (810)
||||.......... ....-+||..|||||++.+.- + -.++||||+|.+||||++..
T Consensus 360 FGLAl~~~p~~~~~-------------d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~ 426 (534)
T KOG3653|consen 360 FGLALRLEPGKPQG-------------DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP 426 (534)
T ss_pred cceeEEecCCCCCc-------------chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence 99997644221111 112368999999999998642 2 35799999999999999742
Q ss_pred -------CCCC-----CCCHHHHHHhhccCC--CCCCCCCCC-cccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 577 -------VPFF-----GETPEELFAHTVNDD--IEWPSEDDW-PIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 577 -------~PF~-----~~~~~e~~~~I~~~~--~~~p~~~~~-~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
+||. ..+.+++...+..++ ..+|..... ..-..+++.+..||..||+-|+|+.
T Consensus 427 ~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 427 GPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred CCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 2332 224455655555543 334432111 1234689999999999999999994
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=259.01 Aligned_cols=243 Identities=24% Similarity=0.393 Sum_probs=190.4
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeee-ecccccee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYC-SFETKKHL 439 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~-~f~~~~~l 439 (810)
..+.|.|.+.||+|.||++.+++|+.+++.+++|.+.+.... .+.+.+|...--.| .|.||+.-|+ .|++.+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 457899999999999999999999999999999998776433 35677777654444 6889998885 58899999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc--CCcEEEeccCCccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA--LGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~--~g~VKL~DFGLAk~~~~s 517 (810)
+++|||++.|+|..-+.. ..+.|...+.++.|+++||+|+|++++||||||.+||||-. ...|||||||+++.....
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 999999999999998876 45889999999999999999999999999999999999843 347999999998642110
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhh---cC--CCCCcchhhhHHHHHHHHhCCCCCCCCCH----HHHH
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR---QG--YGKPVDWWSMGVILYEFLVGCVPFFGETP----EELF 588 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~---~~--ys~ksDIWSLGvILyELLtG~~PF~~~~~----~e~~ 588 (810)
....--+..|.+||+... .. ..+..|+|.||+++|.+|+|.+||..... .--+
T Consensus 177 ------------------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~ 238 (378)
T KOG1345|consen 177 ------------------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW 238 (378)
T ss_pred ------------------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHH
Confidence 011123567999998863 23 37899999999999999999999974322 1222
Q ss_pred Hhhcc-CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 589 AHTVN-DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 589 ~~I~~-~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
.+... .....|.. ..+.|+.+..+.++-|..++++|--.
T Consensus 239 ~~w~~rk~~~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki 278 (378)
T KOG1345|consen 239 EQWLKRKNPALPKK-FNPFSEKALRLFKKSLTPRFKDRCKI 278 (378)
T ss_pred HHHhcccCccCchh-hcccCHHHHHHHHHhcCCcccccchh
Confidence 23332 22333433 23588999999999999999999443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-29 Score=303.82 Aligned_cols=214 Identities=15% Similarity=0.155 Sum_probs=149.8
Q ss_pred CCC-CeEEEeeeec-------cccceeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCC
Q psy16843 421 TDN-PFVVTMYCSF-------ETKKHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLK 491 (810)
Q Consensus 421 l~H-PnIVkl~~~f-------~~~~~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLK 491 (810)
++| +||+.++++| .....++++|||+ +++|.++|.. .+.+++..++.|+.||+.||+|||++||||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 344 4777777776 2334678889987 6699999975 4569999999999999999999999999999999
Q ss_pred CCceEeccCCcEEEeccCCccccccccccc--c----------------hhhhhhc--ccccccCCcccCCCCcCChhHH
Q psy16843 492 PDNLLITALGHIKLTDFGLSKMGLMSLATN--L----------------YECYVER--DAKQFSDKQVYGTPEYIAPEVI 551 (810)
Q Consensus 492 PeNILLd~~g~VKL~DFGLAk~~~~s~~~~--~----------------~~~~~~~--~~~~~~~~~~~GTp~YmAPEvl 551 (810)
|+||||+..|.+|++|||++.......... . +...... ..........+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999766666666555553321100000 0 0000000 0000111235789999999999
Q ss_pred hhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCCh
Q psy16843 552 LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGP 631 (810)
Q Consensus 552 ~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~ 631 (810)
.+..|+.++|||||||+||||++|.+||.... ..+..+.... .|... ....+.+.+++.+||+++|.+||++
T Consensus 188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~--- 259 (793)
T PLN00181 188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQI-LLNWPKEASFCLWLLHPEPSCRPSM--- 259 (793)
T ss_pred ccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChhh-hhcCHHHHHHHHHhCCCChhhCcCh---
Confidence 99999999999999999999999998876432 1222221111 11111 1123567899999999999999999
Q ss_pred hHHhcCCCcCCC
Q psy16843 632 HEVKEHPYFSNL 643 (810)
Q Consensus 632 ~EiL~HPfF~~i 643 (810)
.|+++||||...
T Consensus 260 ~eil~h~~~~~~ 271 (793)
T PLN00181 260 SELLQSEFINEP 271 (793)
T ss_pred HHHhhchhhhhh
Confidence 999999999763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-26 Score=235.50 Aligned_cols=261 Identities=34% Similarity=0.578 Sum_probs=208.5
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCC-eEEEeeeeccccceeeeeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP-FVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HP-nIVkl~~~f~~~~~lyLVmE 444 (810)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|..++..+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 77899988776554433567888999999999988 79999999987778899999
Q ss_pred eccCcchhhhhhcCC---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC-cEEEeccCCcccccccccc
Q psy16843 445 YVEGGDCASLLKNTG---PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG-HIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 445 y~~GGsL~~lL~~~g---~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g-~VKL~DFGLAk~~~~s~~~ 520 (810)
|+.|+++.+++.... .+.+..+..++.|++.+++|+|+.|++||||||+||+++..+ .++++|||+++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887664 799999999999999999999999999999999999999988 7999999998732211100
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhh---cCCCCCcchhhhHHHHHHHHhCCCCCCCCCH----HHHHHhhcc
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILR---QGYGKPVDWWSMGVILYEFLVGCVPFFGETP----EELFAHTVN 593 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~---~~ys~ksDIWSLGvILyELLtG~~PF~~~~~----~e~~~~I~~ 593 (810)
.. ........+||..|+|||.+.+ ..++...|+||+|+++++++.|..||..... .+....+..
T Consensus 159 ~~---------~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 229 (384)
T COG0515 159 SS---------IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229 (384)
T ss_pred cc---------ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence 00 0012356789999999999998 5789999999999999999999999887763 455555544
Q ss_pred CCCC-CCCCCCCc----ccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 594 DDIE-WPSEDDWP----IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 594 ~~~~-~p~~~~~~----~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
.... ........ ....+.+++.+++..+|..|.+. .+...++|..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~---~~~~~~~~~~ 279 (384)
T COG0515 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS---SSDLSHDLLA 279 (384)
T ss_pred cCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCH---HHHhhchHhh
Confidence 4432 22111111 12578999999999999999998 5666665443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=229.56 Aligned_cols=162 Identities=23% Similarity=0.249 Sum_probs=129.2
Q ss_pred cchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhh
Q psy16843 449 GDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYV 527 (810)
Q Consensus 449 GsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~ 527 (810)
|+|.+++.. .+.+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~----------- 61 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP----------- 61 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-----------
Confidence 689999986 456999999999999999999999998 999999999999999 999865211
Q ss_pred hcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH-HHHHhhccCCCCC-CC--CCC
Q psy16843 528 ERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE-ELFAHTVNDDIEW-PS--EDD 603 (810)
Q Consensus 528 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~-e~~~~I~~~~~~~-p~--~~~ 603 (810)
....||+.|||||++.+..|+.++|||||||++|||++|..||...... ..+..+....... +. ...
T Consensus 62 ---------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (176)
T smart00750 62 ---------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNL 132 (176)
T ss_pred ---------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccH
Confidence 1125899999999999999999999999999999999999999765432 3333333222111 00 011
Q ss_pred CcccH--HHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 604 WPIQV--EAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 604 ~~~S~--el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
..++. ++++||.+||..||.+||++ .|++.|+|+.
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~---~~ll~~~~~~ 169 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAA---NHYLAHCRAL 169 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCH---HHHHHHHHHH
Confidence 11333 69999999999999999999 8999999974
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-27 Score=279.11 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=205.1
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEeec---cchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 367 TVIKLISNGAYGSVYLVRHKETRQRFAMKKIIK---NSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 367 ~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k---~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
.....+|.|++|.|+.+......+.++.|.... ...........+..|.-+-..+.|||++.....+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999999988877777677775442 12222223333667777888899999998888887777666679
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
|||++ ||+.++...+.+....+..++.|++.||+|||+.||.|||||++|+|+..+|.+||+|||.+......
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~------ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP------ 473 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC------
Confidence 99999 99999998889999999999999999999999999999999999999999999999999998653322
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHH--HhhccCCCCC--
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELF--AHTVNDDIEW-- 598 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~--~~I~~~~~~~-- 598 (810)
.+........++|+..|+|||++.+..| ...+||||.|++++.|++|+.||......+.. ...-......
T Consensus 474 -----~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~ 548 (601)
T KOG0590|consen 474 -----WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFE 548 (601)
T ss_pred -----cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccccc
Confidence 1111233457899999999999999999 56799999999999999999999755433221 1111111111
Q ss_pred -CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 599 -PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 599 -p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
+......++...+.+|.+||+.||.+|.++ ++|++.+||+.++
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti---~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITI---EQILNDEWIRSIE 592 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecH---HHHhhChHhhhcc
Confidence 111111256678999999999999999999 9999999998864
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=238.96 Aligned_cols=250 Identities=18% Similarity=0.257 Sum_probs=200.9
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCC-----cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETR-----QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg-----~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
....++++...+-+|.||.||.|.+++.. +.|.+|.++... ..-++..+..|.-++..+.|||+..+.++...
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 34467888899999999999999887543 335555543332 23455677888888899999999999887654
Q ss_pred -cceeeeeeeeccCcchhhhhhcC--------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEe
Q psy16843 436 -KKHLCLVMEYVEGGDCASLLKNT--------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLT 506 (810)
Q Consensus 436 -~~~lyLVmEy~~GGsL~~lL~~~--------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~ 506 (810)
....+.++.++.-|+|..+|... +.++..+...++.|++.|++|||+.||||.||-..|.+||+.-.|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 45678889999999999998621 247777888899999999999999999999999999999999999999
Q ss_pred ccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHH
Q psy16843 507 DFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPE 585 (810)
Q Consensus 507 DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~ 585 (810)
|=.+++...+.... |. + ..-.....||+||.+.+..|+.++|+|||||+||||++ |+.|+...++.
T Consensus 439 DsaLSRDLFP~DYh----cL-G--------DnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf 505 (563)
T KOG1024|consen 439 DSALSRDLFPGDYH----CL-G--------DNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF 505 (563)
T ss_pred cchhccccCccccc----cc-C--------CCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH
Confidence 99999875443221 11 0 11123567999999999999999999999999999998 99999999999
Q ss_pred HHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 586 ELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 586 e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
|+...+..+ ++...+. ..++++-.++.-||..+|++||++
T Consensus 506 Em~~ylkdG-yRlaQP~--NCPDeLf~vMacCWallpeeRPsf 545 (563)
T KOG1024|consen 506 EMEHYLKDG-YRLAQPF--NCPDELFTVMACCWALLPEERPSF 545 (563)
T ss_pred HHHHHHhcc-ceecCCC--CCcHHHHHHHHHHHhcCcccCCCH
Confidence 998776654 4444443 367999999999999999999998
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=233.15 Aligned_cols=251 Identities=22% Similarity=0.234 Sum_probs=187.8
Q ss_pred CcEEEEEecccCceEEEEEEEcCCC-cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC----CCeEEEeeeec-cccce
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETR-QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD----NPFVVTMYCSF-ETKKH 438 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg-~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~----HPnIVkl~~~f-~~~~~ 438 (810)
+|.+.+.||+|+||.||+|.+..++ ..+|+|.......... ..+..|..++..+. ..++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 7999999999999999999998775 6789997765432211 14566888887776 26888999998 57889
Q ss_pred eeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC-----CcEEEeccCCc
Q psy16843 439 LCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL-----GHIKLTDFGLS 511 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~-----g~VKL~DFGLA 511 (810)
-||||+.+ |.+|.++.... +.|+...+..++.|++.||++||+.|+|||||||+|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999988 88999988543 589999999999999999999999999999999999999875 36999999999
Q ss_pred cc--ccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16843 512 KM--GLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589 (810)
Q Consensus 512 k~--~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~ 589 (810)
+. ........ . .........+.||..|+++.+..+...+.+.|+||++.++.||+.|.+||.+........
T Consensus 175 r~~~~~~~~~~~----~---~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~ 247 (322)
T KOG1164|consen 175 RRFKYVGDSGGN----L---RPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS 247 (322)
T ss_pred ccccccCCCCcc----c---ccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH
Confidence 83 21111100 0 000001134569999999999999999999999999999999999999997655322222
Q ss_pred hh---ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 590 HT---VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 590 ~I---~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
+. ........ .....+.++..+...+-..+...+|..
T Consensus 248 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Pdy 287 (322)
T KOG1164|consen 248 KFEKDPRKLLTDR--FGDLKPEEFAKILEYIDSLDYEDKPDY 287 (322)
T ss_pred HHHHHhhhhcccc--ccCCChHHHHHHHHHhhccCCcCCCCH
Confidence 22 22211111 111233567777777777788888877
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=239.29 Aligned_cols=176 Identities=18% Similarity=0.160 Sum_probs=132.9
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcC-CCcEEEEEEeeccch--hhHHHHHHHHHHHHHHhcCCCCeEEE-eeeeccc
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKE-TRQRFAMKKIIKNSL--MLRNQMEQVFAERDIMSFTDNPFVVT-MYCSFET 435 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~-tg~~vAIK~I~k~~~--~~~~~~~~i~~E~~iL~~l~HPnIVk-l~~~f~~ 435 (810)
.+..++|.+.+.||+|+||+||+|+++. +++.+|||++..... ......+.+.+|+++|+.++|+||+. +++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3456789999999999999999999886 678889998753311 12233466889999999999999985 5442
Q ss_pred cceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccC-CCCceEeccCCcEEEeccCCcccc
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDL-KPDNLLITALGHIKLTDFGLSKMG 514 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDL-KPeNILLd~~g~VKL~DFGLAk~~ 514 (810)
+..||||||++|++|... ...+ ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~~~------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RPHG------DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cccc------hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 457999999999999732 2111 1467899999999999999999999 999999999999999999999864
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhh
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR 553 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~ 553 (810)
....... .+. ....-...+|++.|+|||.+..
T Consensus 163 ~~~~~~~----~~~---~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALY----RIA---AYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchh----hhh---hhhhhhhhhccCccCCcccCCh
Confidence 3221100 000 0001135678999999999864
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=262.91 Aligned_cols=312 Identities=39% Similarity=0.635 Sum_probs=267.8
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...+++.+.+-+-+|+||.++.+.-..+|...++|+..+......++.+.+..+..++-...+|.++.....+.....++
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45678999999999999999999998889888888777666665666677777888877788899999888888888999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccC-Cccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFG-LSKMGLMSLA 519 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFG-LAk~~~~s~~ 519 (810)
+||+|+.|++|...|++.+..+++.++.++..++.+++|||...++|||++|.|+|+..+|+.+++||| +.+.+.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999 4444333211
Q ss_pred ccc-----------hhhhhhcc----cccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH
Q psy16843 520 TNL-----------YECYVERD----AKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584 (810)
Q Consensus 520 ~~~-----------~~~~~~~~----~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~ 584 (810)
+.. +....... .+.......+||+.|.|||.+.+...+..+|||++|++++|.++|.+||....+
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 111 00000000 011224567899999999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCcc
Q psy16843 585 EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEED 664 (810)
Q Consensus 585 ~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d 664 (810)
.++++.|.+..+.||.... ..+.++++++..+|..+|.+|.++.+..++..||||++++|+.+...+.+|+|...+..|
T Consensus 1041 q~~f~ni~~~~~~~p~g~~-~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~s~~d 1119 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPE-EGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQKAEFVPQPESTQD 1119 (1205)
T ss_pred hhhhhccccCCCCCCCCcc-ccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccccCccCCCCCCCCc
Confidence 9999999999999987643 377899999999999999999999888899999999999999999999999999999999
Q ss_pred CcccchHHh
Q psy16843 665 TSYFDSRME 673 (810)
Q Consensus 665 ~~~fd~~~~ 673 (810)
.+||.+++.
T Consensus 1120 tS~~~~r~~ 1128 (1205)
T KOG0606|consen 1120 TSYFESRFS 1128 (1205)
T ss_pred cchhhcccc
Confidence 999987654
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-23 Score=211.44 Aligned_cols=255 Identities=19% Similarity=0.250 Sum_probs=194.6
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC-CeEEEeeeeccccce
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN-PFVVTMYCSFETKKH 438 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H-PnIVkl~~~f~~~~~ 438 (810)
.+..+.|.+++.||+|+||.+|+|....+|+.||||+....... -++..|.++-+.+++ ..|..+..++.+..+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 34568899999999999999999999999999999976554322 346678888877765 567777788888889
Q ss_pred eeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc---CCcEEEeccCCcccc
Q psy16843 439 LCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA---LGHIKLTDFGLSKMG 514 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~---~g~VKL~DFGLAk~~ 514 (810)
-.+|||++ |.+|.++..- ...|+...+.-++-|++.-++|+|.+++|||||||+|+|+.- ...+.|+|||||+..
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999998 8899998863 357999999999999999999999999999999999999974 346999999999874
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC---CHHHHHHhh
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE---TPEELFAHT 591 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~---~~~e~~~~I 591 (810)
....+.. ...........||..|.+--...+...+...|+-|+|.+|..+.-|.+||.|. +..+-+++|
T Consensus 165 ~d~~t~~--------HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 165 RDIRTRQ--------HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred ccccccc--------cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 3322111 11122345678999999998888888899999999999999999999999885 445666777
Q ss_pred ccCCCCCCCCC-CCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 592 VNDDIEWPSED-DWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 592 ~~~~~~~p~~~-~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
...+...|... ....+.++.-.+.-|=..--++-|..
T Consensus 237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 76655443221 11234555555555554444444443
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-23 Score=216.58 Aligned_cols=220 Identities=22% Similarity=0.317 Sum_probs=181.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyL 441 (810)
.-.|.+.++||.|+||..++|...-+++.||||....+.. .-++..|.+.-+.| ..+.|...|++.+.+.+-.|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 4579999999999999999999999999999997654332 23556676666665 56899999999999999999
Q ss_pred eeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC-----cEEEeccCCccccc
Q psy16843 442 VMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG-----HIKLTDFGLSKMGL 515 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g-----~VKL~DFGLAk~~~ 515 (810)
|||++ |-+|.++..-. ..|+...+..++.|++.-++|+|++++|+|||||+|+||..-| .|.|+|||+|+...
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99998 77888888754 4799999999999999999999999999999999999998643 58999999999754
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCC---CCHHHHHHhhc
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG---ETPEELFAHTV 592 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~---~~~~e~~~~I~ 592 (810)
...+... ......++..||..||+-...+|...+...|+-|||.+++++|-|.+||.| .+..+-+++|-
T Consensus 181 Dp~TkqH--------IPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 181 DPKTKQH--------IPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred Ccccccc--------CccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 4322111 111123577899999999999999999999999999999999999999986 46667777776
Q ss_pred cCCC
Q psy16843 593 NDDI 596 (810)
Q Consensus 593 ~~~~ 596 (810)
..+-
T Consensus 253 e~Kr 256 (449)
T KOG1165|consen 253 ETKR 256 (449)
T ss_pred cccc
Confidence 5443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-22 Score=204.30 Aligned_cols=141 Identities=21% Similarity=0.194 Sum_probs=109.9
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHH-----------------------HHHHHHHHHHHHhcCCCCe
Q psy16843 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRN-----------------------QMEQVFAERDIMSFTDNPF 425 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~-----------------------~~~~i~~E~~iL~~l~HPn 425 (810)
...||+|+||.||+|.+. +|+.||||++......... .......|.+++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 8999999998654221111 0123345889998887766
Q ss_pred EEEeeeeccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHh-hhcccccccCCCCceEeccCCcEE
Q psy16843 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYL-HSYGIVHRDLKPDNLLITALGHIK 504 (810)
Q Consensus 426 IVkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yL-Hs~gIIHRDLKPeNILLd~~g~VK 504 (810)
+...+.... ...+|||||++|+++...+.+.+.+++..+..++.||+.+|.|| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 533222211 22389999999988776644557899999999999999999999 799999999999999998 58899
Q ss_pred EeccCCccc
Q psy16843 505 LTDFGLSKM 513 (810)
Q Consensus 505 L~DFGLAk~ 513 (810)
|+|||+|..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=205.10 Aligned_cols=173 Identities=14% Similarity=0.182 Sum_probs=134.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHH------HHHHHHHHhcCCCCeEEEeeeecccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQ------VFAERDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~------i~~E~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
.++|.+++.||.|+||.||++.. ++..+|+|.+............. +.+|++.+..+.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47899999999999999999655 46689999886544333333333 57899999999999999888876543
Q ss_pred --------ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEecc
Q psy16843 437 --------KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDF 508 (810)
Q Consensus 437 --------~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DF 508 (810)
...+|||||++|.+|.++.. +++ ....+|+.+|..||+.|++||||||.||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35899999999999987732 333 2456999999999999999999999999999989 999999
Q ss_pred CCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHH
Q psy16843 509 GLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL 573 (810)
Q Consensus 509 GLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELL 573 (810)
|..+..... .....++....|+.++|+|+||+++.-+.
T Consensus 179 g~~~~~~e~---------------------------~a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQR---------------------------KAKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccch---------------------------hhHHHHHHHhHhcccccccceeEeehHHH
Confidence 987542110 00111455667889999999999887654
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-22 Score=236.75 Aligned_cols=242 Identities=21% Similarity=0.335 Sum_probs=186.3
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccc--hhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNS--LMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~--~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
+|...+.||.+.|=+|.+|++.+ |. |+||+..+.. ...+.. .+...|++ ...+++||++.+..+-.+++..|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~-~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPF-KQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHH-HHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 68889999999999999998865 44 8999887654 233333 33344555 6778999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc-cccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS-LATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s-~~~~ 521 (810)
-+|+.. +|+|.|.-+.-+...+.++|+.||+.||.-||..||+|||||.|||||+.-+-+.|+||..-|..... .+..
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 999965 89999988888899999999999999999999999999999999999999999999999876542211 1111
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhc----------C-CCCCcchhhhHHHHHHHHh-CCCCCC---------
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ----------G-YGKPVDWWSMGVILYEFLV-GCVPFF--------- 580 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~----------~-ys~ksDIWSLGvILyELLt-G~~PF~--------- 580 (810)
.|.++. .+-..-..|+|||.+... + .+++.||||+||+++||++ |++||.
T Consensus 179 df~fFF---------DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~ 249 (1431)
T KOG1240|consen 179 DFTFFF---------DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRS 249 (1431)
T ss_pred cceEEE---------ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhc
Confidence 111111 111122359999998642 2 5789999999999999998 899984
Q ss_pred --CCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 581 --GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 581 --~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
..+++..+++|. +..++.||..|++.||.+|+++ ++.|+-
T Consensus 250 ~~~~~~e~~Le~Ie--------------d~~~Rnlil~Mi~rdPs~RlSA---edyL~~ 291 (1431)
T KOG1240|consen 250 GNADDPEQLLEKIE--------------DVSLRNLILSMIQRDPSKRLSA---EDYLQK 291 (1431)
T ss_pred cCccCHHHHHHhCc--------------CccHHHHHHHHHccCchhccCH---HHHHHh
Confidence 123333433332 2457999999999999999999 777764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=194.83 Aligned_cols=141 Identities=21% Similarity=0.166 Sum_probs=111.2
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH-----------------------HHHHHHHHHHHHHhcCCCCe
Q psy16843 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR-----------------------NQMEQVFAERDIMSFTDNPF 425 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~-----------------------~~~~~i~~E~~iL~~l~HPn 425 (810)
.+.||+|+||.||+|.+. +|+.||||++........ ........|.+.+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 899999998876421100 00123457889999998888
Q ss_pred EEEeeeeccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEE
Q psy16843 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIK 504 (810)
Q Consensus 426 IVkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VK 504 (810)
|.....+... ..||||||++|+++...+...+.+++..+..++.|++.+|.+||+ .||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 7433332222 248999999988655443344678899999999999999999999 9999999999999999 89999
Q ss_pred EeccCCccc
Q psy16843 505 LTDFGLSKM 513 (810)
Q Consensus 505 L~DFGLAk~ 513 (810)
|+|||++..
T Consensus 158 liDFG~a~~ 166 (190)
T cd05145 158 IIDVSQAVE 166 (190)
T ss_pred EEEccccee
Confidence 999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.7e-21 Score=195.05 Aligned_cols=203 Identities=19% Similarity=0.243 Sum_probs=144.4
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHH-HHHHHHHHHHHhcCCC-CeEEEeeeeccccceeeeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQ-MEQVFAERDIMSFTDN-PFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~-~~~i~~E~~iL~~l~H-PnIVkl~~~f~~~~~lyLVm 443 (810)
+.+...|++|+||+|+++.. .+.+++.+.+.......... ...+.+|+++|+.+.| ++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34577899999999997765 56777777665443322211 1247789999999954 778888875 3469999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccC-CCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDL-KPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDL-KPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||+.|.+|...+.. . ...++.|++.+|++||++||+|||| ||+|||++.+|.++|+|||+|...... ...
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~--~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR--ARW 148 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc--chH
Confidence 99999998755422 1 1357889999999999999999999 799999999999999999999753221 110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhc-CCC-CCcchhhhHHHHHHHHhCCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYG-KPVDWWSMGVILYEFLVGCVPFFGET 583 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys-~ksDIWSLGvILyELLtG~~PF~~~~ 583 (810)
.......|.......-..+++.|++|+...-. ..+ ...+|++.|+-+|.|+|+..|+.++.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00000112111111112378999999876533 233 67799999999999999999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=201.43 Aligned_cols=234 Identities=26% Similarity=0.370 Sum_probs=152.2
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC-----------CeE-----EE
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN-----------PFV-----VT 428 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H-----------PnI-----Vk 428 (810)
.+.....||.|+|+.||.+.+..||+.+|+|+...........++.+.+|.-....+.+ ..+ ++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45678899999999999999999999999999876665555667777777655544322 112 22
Q ss_pred eee---ecccc---c-----eeeeeeeeccCcchhhhhh---cCCCC---CHHHH-HHHHHHHHHHHHHhhhcccccccC
Q psy16843 429 MYC---SFETK---K-----HLCLVMEYVEGGDCASLLK---NTGPL---PADMA-RFYFAETVLAVEYLHSYGIVHRDL 490 (810)
Q Consensus 429 l~~---~f~~~---~-----~lyLVmEy~~GGsL~~lL~---~~g~l---se~~~-~~i~~QIl~AL~yLHs~gIIHRDL 490 (810)
+-+ ++... . +.+++|+-+ -++|.+++. ..... ....+ ..+..|++..+++||..||+|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 110 11111 1 347788877 458877753 22222 11233 344589999999999999999999
Q ss_pred CCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc--------CCCCCcch
Q psy16843 491 KPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ--------GYGKPVDW 562 (810)
Q Consensus 491 KPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~--------~ys~ksDI 562 (810)
||+|++++.+|.++|+||+....... .... ...+..|.+||..... .|+.+.|.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~----------------~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~Da 233 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT----------------RYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDA 233 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE----------------EEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc----------------eeec--cCCCcccCChhhhhhhcccCcccceeeeccCH
Confidence 99999999999999999987643111 0000 1245789999987543 47899999
Q ss_pred hhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCC
Q psy16843 563 WSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625 (810)
Q Consensus 563 WSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~R 625 (810)
|+||+++|.|.+|..||........... .|.... .+++.+++||.+||++||.+|
T Consensus 234 W~LG~~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~--~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 234 WQLGITLYSLWCGRLPFGLSSPEADPEW------DFSRCR--DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHHSS-STCCCGGGSTSGG------GGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHHHccCCCCCCCccccccc------cchhcC--CcCHHHHHHHHHHccCCcccC
Confidence 9999999999999999986644322111 111111 366899999999999999988
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-20 Score=194.25 Aligned_cols=245 Identities=15% Similarity=0.222 Sum_probs=195.2
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
..+...+..++.+|...-.|..|+|++.. ..+++|++...... ....+.+..|.--|+-..||||+.+++.+....+
T Consensus 185 ~gid~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 185 TGIDVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred cCcchhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 34455677788889999999999999864 45677766544332 2233567888888999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCCCceEeccCCcEEEe--ccCCcc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYG--IVHRDLKPDNLLITALGHIKLT--DFGLSK 512 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~g--IIHRDLKPeNILLd~~g~VKL~--DFGLAk 512 (810)
+.+|..||+.|+|+.+|.... ..+..++..++..|+.|+.|||+.. |.---|....++||++-+.+|. |--++-
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf 341 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF 341 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee
Confidence 999999999999999998654 4678899999999999999999873 4455688999999998776653 322221
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCC---CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY---GKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y---s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~ 589 (810)
......-.|.||+||.++..+- -.++|+|||+++||||.|...||.+..+++.-.
T Consensus 342 ----------------------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm 399 (448)
T KOG0195|consen 342 ----------------------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM 399 (448)
T ss_pred ----------------------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh
Confidence 1122234789999999997654 468999999999999999999999999999888
Q ss_pred hhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCC
Q psy16843 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGG 630 (810)
Q Consensus 590 ~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~ 630 (810)
+|.-+.+....+. .++.....|+.-|+..||.+||.+..
T Consensus 400 kialeglrv~ipp--gis~hm~klm~icmnedpgkrpkfdm 438 (448)
T KOG0195|consen 400 KIALEGLRVHIPP--GISRHMNKLMNICMNEDPGKRPKFDM 438 (448)
T ss_pred hhhhccccccCCC--CccHHHHHHHHHHhcCCCCcCCCcce
Confidence 8776665443322 27889999999999999999998843
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=188.17 Aligned_cols=135 Identities=17% Similarity=0.169 Sum_probs=108.5
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-----CCCeEEEeeeeccccc---ee
Q psy16843 368 VIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-----DNPFVVTMYCSFETKK---HL 439 (810)
Q Consensus 368 ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-----~HPnIVkl~~~f~~~~---~l 439 (810)
-.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ +||||+++|++++++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 357899999999995 7767665 6998865432 2336688999999999 6799999999999874 44
Q ss_pred e-eeeee--ccCcchhhhhhcCCCCCHHHHHHHHHHHHHHH-HHhhhcccccccCCCCceEeccC----CcEEEeccCCc
Q psy16843 440 C-LVMEY--VEGGDCASLLKNTGPLPADMARFYFAETVLAV-EYLHSYGIVHRDLKPDNLLITAL----GHIKLTDFGLS 511 (810)
Q Consensus 440 y-LVmEy--~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL-~yLHs~gIIHRDLKPeNILLd~~----g~VKL~DFGLA 511 (810)
+ +|||| +.+|+|.+++++ +.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+-+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 78999 557999999976 457666 35688888888 99999999999999999999753 37999995444
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=218.15 Aligned_cols=198 Identities=23% Similarity=0.315 Sum_probs=157.9
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC---CCeEEEeeeeccc
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD---NPFVVTMYCSFET 435 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~---HPnIVkl~~~f~~ 435 (810)
.....+.|.|-+.||+|+||+||+|.+.. |+.||+|+-.....+. -+ --.+++.+|+ -+-|..++.++.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-fY-----I~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-FY-----ICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-ee-----ehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34566889999999999999999999987 9999999765443321 11 1222333333 2345556666666
Q ss_pred cceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc-------CCcEEEecc
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA-------LGHIKLTDF 508 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~-------~g~VKL~DF 508 (810)
.+.-++|+||.+.|+|.+++...+.+++..+.+++.|++.-+++||..+|||+||||+|+||.. ..-++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 6778999999999999999998899999999999999999999999999999999999999954 235999999
Q ss_pred CCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCC
Q psy16843 509 GLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC 576 (810)
Q Consensus 509 GLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~ 576 (810)
|.|-.... + ......+..++|-.+-.+|+..|.+|++.+|.|.|+.++|-||.|+
T Consensus 846 G~siDm~l------f-------p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKL------F-------PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeE------c-------CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 98743111 0 1112335678999999999999999999999999999999999995
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.1e-21 Score=223.03 Aligned_cols=264 Identities=25% Similarity=0.405 Sum_probs=210.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcC-CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccceee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKE-TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~-tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~~ly 440 (810)
...|.+.+.||+|+|+.|-+..... ....+|+|.+.... .......++..|..+-+.+. |.|++.+++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 4678999999999999999887743 44567777665443 22344466677888887777 999999999999999999
Q ss_pred eeeeeccCcchhhhh-hcCC-CCCHHHHHHHHHHHHHHHHHhh-hcccccccCCCCceEeccCC-cEEEeccCCcccccc
Q psy16843 441 LVMEYVEGGDCASLL-KNTG-PLPADMARFYFAETVLAVEYLH-SYGIVHRDLKPDNLLITALG-HIKLTDFGLSKMGLM 516 (810)
Q Consensus 441 LVmEy~~GGsL~~lL-~~~g-~lse~~~~~i~~QIl~AL~yLH-s~gIIHRDLKPeNILLd~~g-~VKL~DFGLAk~~~~ 516 (810)
++++|..||++++.+ .... ..+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .+|++|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 6555 7888999999999999999999 99999999999999999999 999999999975322
Q ss_pred cccccchhhhhhcccccccCCcccC-CCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHH-HHhhcc
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYG-TPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEEL-FAHTVN 593 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~G-Tp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~-~~~I~~ 593 (810)
. ..........+| ++.|+|||...+..| +...|+||+|+++.-|++|..||........ +.....
T Consensus 178 ~------------~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~ 245 (601)
T KOG0590|consen 178 K------------NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS 245 (601)
T ss_pred c------------CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc
Confidence 0 112222345678 999999999998655 8899999999999999999999976544331 122222
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 594 ~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
....+-...+..++..+.+++.++|..+|..|.+. +++..+||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~---~~~~~d~~~~~ 291 (601)
T KOG0590|consen 246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSI---EELKLDNWLSS 291 (601)
T ss_pred cccccccCccccCChhhhhcccccccCCchhcccc---ccccccccccc
Confidence 21111112223477889999999999999999999 89999999987
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=193.73 Aligned_cols=212 Identities=24% Similarity=0.318 Sum_probs=148.5
Q ss_pred CCCCeEEEeeeeccc---------------------------cceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHH
Q psy16843 421 TDNPFVVTMYCSFET---------------------------KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAET 473 (810)
Q Consensus 421 l~HPnIVkl~~~f~~---------------------------~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QI 473 (810)
-.|||||+++.+|.+ ...+|+||--.. -+|..++.. ...+....+-+++|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-RHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-CCCchHHHHHHHHHH
Confidence 379999999988743 236899998774 488888875 356777888899999
Q ss_pred HHHHHHhhhcccccccCCCCceEec--cCC--cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChh
Q psy16843 474 VLAVEYLHSYGIVHRDLKPDNLLIT--ALG--HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPE 549 (810)
Q Consensus 474 l~AL~yLHs~gIIHRDLKPeNILLd--~~g--~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPE 549 (810)
++|+.|||++||.|||||.+||||. .++ .+.|+|||.+-......-.-.|... .-...|.-..||||
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~---------~Vd~GGNa~lmAPE 421 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESD---------EVDLGGNAKLMAPE 421 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccc---------cccCCCcceecchh
Confidence 9999999999999999999999984 344 5889999986421111011111110 11234777899999
Q ss_pred HHhhcC------CCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCC
Q psy16843 550 VILRQG------YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPR 623 (810)
Q Consensus 550 vl~~~~------ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~ 623 (810)
+....+ --.++|.|+.|.+.||++....||++...+.+-.+.-+ .-+.|... ..+++.+++|+..+|+.||.
T Consensus 422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq-e~qLPalp-~~vpp~~rqlV~~lL~r~ps 499 (598)
T KOG4158|consen 422 IATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ-ESQLPALP-SRVPPVARQLVFDLLKRDPS 499 (598)
T ss_pred hhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh-hhhCCCCc-ccCChHHHHHHHHHhcCCcc
Confidence 997532 13478999999999999999999998544322222111 11222211 13678999999999999999
Q ss_pred CCCCCCChhHHhcCCCcCCCCh
Q psy16843 624 DRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 624 ~Rpta~~~~EiL~HPfF~~id~ 645 (810)
+|++.+-+..+++--.+..-+|
T Consensus 500 kRvsp~iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 500 KRVSPNIAANVLNLSLWRMGED 521 (598)
T ss_pred ccCCccHHHhHHHHHHhcCchH
Confidence 9999854455665544444444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=7e-19 Score=185.22 Aligned_cols=144 Identities=19% Similarity=0.128 Sum_probs=114.8
Q ss_pred CcEEEEEecccCceEEEEEE-EcCCCcEEEEEEeeccchhh--------------------HH-HHHHHHHHHHHHhcCC
Q psy16843 365 DFTVIKLISNGAYGSVYLVR-HKETRQRFAMKKIIKNSLML--------------------RN-QMEQVFAERDIMSFTD 422 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~-~k~tg~~vAIK~I~k~~~~~--------------------~~-~~~~i~~E~~iL~~l~ 422 (810)
.|.+.+.||+|+||.||+|. +..+|+.||+|++....... .. ....+..|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 77789999999886532110 00 1123567999999887
Q ss_pred CCe--EEEeeeeccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcc-cccccCCCCceEecc
Q psy16843 423 NPF--VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG-IVHRDLKPDNLLITA 499 (810)
Q Consensus 423 HPn--IVkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~g-IIHRDLKPeNILLd~ 499 (810)
+.. +.++++. ...|+||||++|++|...+.....+.+..+..++.||+.+|.+||+.| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 532 3344432 235899999999888877655566777788899999999999999999 99999999999999
Q ss_pred CCcEEEeccCCccc
Q psy16843 500 LGHIKLTDFGLSKM 513 (810)
Q Consensus 500 ~g~VKL~DFGLAk~ 513 (810)
++.++|+|||.+..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999999864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=177.14 Aligned_cols=137 Identities=31% Similarity=0.373 Sum_probs=113.2
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccch-----hhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL-----MLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~-----~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+.||+|++|.||+|.+ .|..+++|+...... ........+..|+.++..+.|++|.....++.+.+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 667899997543221 111223457789999999999888766666666778899999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
|++|++|.+++..... ....++.+|+.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999875432 7788999999999999999999999999999999 78999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.8e-18 Score=170.07 Aligned_cols=133 Identities=28% Similarity=0.329 Sum_probs=106.3
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeeccch-----hhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeee
Q psy16843 371 LISNGAYGSVYLVRHKETRQRFAMKKIIKNSL-----MLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEY 445 (810)
Q Consensus 371 ~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~-----~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy 445 (810)
.||+|+||.||+|.+ +|..+++|....... .......++.+|++++..+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 389999999999984 567899997554321 1222346678899999999887654444344455677999999
Q ss_pred ccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 446 VEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 446 ~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
++|++|.+++...+. .++.|++.+|.+||+.|++|||+||.|||++ ++.++|+|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765322 7899999999999999999999999999999 79999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=2e-17 Score=168.34 Aligned_cols=138 Identities=18% Similarity=0.096 Sum_probs=107.9
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH-------------------HHHHHHHHHHHHHhcCCCC-
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR-------------------NQMEQVFAERDIMSFTDNP- 424 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~-------------------~~~~~i~~E~~iL~~l~HP- 424 (810)
.|.+.+.||+|+||.||++... +|+.||||++........ ........|..++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3778899999999999999875 799999998754321100 0112356788888888776
Q ss_pred -eEEEeeeeccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcE
Q psy16843 425 -FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHI 503 (810)
Q Consensus 425 -nIVkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~V 503 (810)
.+...++ ....++||||++|++|..+... .....++.+|+.++.++|+.||+||||||+||+++.++.+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 3444443 2356899999999998776431 3466788999999999999999999999999999999999
Q ss_pred EEeccCCccc
Q psy16843 504 KLTDFGLSKM 513 (810)
Q Consensus 504 KL~DFGLAk~ 513 (810)
+|+|||++..
T Consensus 165 ~liDfg~~~~ 174 (198)
T cd05144 165 YIIDWPQMVS 174 (198)
T ss_pred EEEECCcccc
Confidence 9999999853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.4e-18 Score=192.89 Aligned_cols=183 Identities=28% Similarity=0.378 Sum_probs=136.7
Q ss_pred ceeeeeeeeccCcchhhhhhcCC---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTG---PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g---~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
.++||.|++|.-++|.++|.... .-+......++.|++.|++| +|.+|||+||.||+...+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36899999999999999997443 46777889999999999999 9999999999999999999999999999754
Q ss_pred ccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhc
Q psy16843 514 GLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTV 592 (810)
Q Consensus 514 ~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~ 592 (810)
..... +.. ........-+||.+||+||.|.++.|+.++||||||+||+|++. =...|. ...++..+.
T Consensus 406 ~~~~~-~~~--------~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r 473 (516)
T KOG1033|consen 406 QDKDE-TVA--------PAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIR 473 (516)
T ss_pred cccCC-ccc--------chhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhh
Confidence 22211 000 00111245679999999999999999999999999999999996 222222 223333444
Q ss_pred cCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 593 ~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.+.+ |+.... --++-.+|+.+||...|.+||++ .+.--|+|.
T Consensus 474 ~g~i--p~~~~~-d~p~e~~ll~~lls~~p~~RP~~---~~~~~~~~~ 515 (516)
T KOG1033|consen 474 DGII--PPEFLQ-DYPEEYTLLQQLLSPSPEERPSA---IEVALHEFL 515 (516)
T ss_pred cCCC--ChHHhh-cCcHHHHHHHHhcCCCcccCchH---HHHhhhhhc
Confidence 4443 311111 12566799999999999999966 666666663
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.4e-17 Score=189.15 Aligned_cols=139 Identities=25% Similarity=0.235 Sum_probs=112.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccch-----hhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL-----MLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~-----~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
..|...+.||+|+||.||++.+... .+++|+...... ......+.+.+|++++..++|++|+..+.++.+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3456789999999999999987543 344444322111 111233568899999999999999887776666677
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
.++||||++|++|.+++. ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999886 356789999999999999999999999999999 678999999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-16 Score=158.99 Aligned_cols=137 Identities=20% Similarity=0.187 Sum_probs=97.4
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHH---------------------HHHHHHHHhcCCCCe--
Q psy16843 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQ---------------------VFAERDIMSFTDNPF-- 425 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~---------------------i~~E~~iL~~l~HPn-- 425 (810)
.+.||+|+||.||+|.+. +++.||||++............. ...|.+.+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 78999999876533211111111 134555555554332
Q ss_pred EEEeeeeccccceeeeeeeeccCcchhh-hhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcE
Q psy16843 426 VVTMYCSFETKKHLCLVMEYVEGGDCAS-LLKNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHI 503 (810)
Q Consensus 426 IVkl~~~f~~~~~lyLVmEy~~GGsL~~-lL~~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~V 503 (810)
+.+.++. ...++||||++|+.+.. .+... .. ...++.++.+++.++.++|. .||+||||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 3333332 24689999999965432 22211 11 16788999999999999999 9999999999999999 8999
Q ss_pred EEeccCCccc
Q psy16843 504 KLTDFGLSKM 513 (810)
Q Consensus 504 KL~DFGLAk~ 513 (810)
+|+|||.+..
T Consensus 154 ~liDfg~a~~ 163 (187)
T cd05119 154 YIIDVPQAVE 163 (187)
T ss_pred EEEECccccc
Confidence 9999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.63 E-value=8.1e-16 Score=175.06 Aligned_cols=199 Identities=23% Similarity=0.284 Sum_probs=154.0
Q ss_pred HhcCCCCeEEEeeeeccccceeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhccc-ccccCCCCce
Q psy16843 418 MSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGI-VHRDLKPDNL 495 (810)
Q Consensus 418 L~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gI-IHRDLKPeNI 495 (810)
|+.+.|.|+.++++.+.++..+++|.+||..|+|.+.+.. ...++.-....+++.|+.||.|||.--| .|+.|+..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999987 3567888888899999999999998765 9999999999
Q ss_pred EeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcC-------CCCCcchhhhHHH
Q psy16843 496 LITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG-------YGKPVDWWSMGVI 568 (810)
Q Consensus 496 LLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-------ys~ksDIWSLGvI 568 (810)
++|....+||+|||+...... +..+. ......-..-|.|||.+.+.. -+.+.||||+|++
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~---~~~~~----------~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii 147 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEE---TAEPE----------AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGII 147 (484)
T ss_pred eeeeeEEEEechhhhcccccc---ccccc----------ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHH
Confidence 999999999999999865321 00000 001111244699999998642 3677999999999
Q ss_pred HHHHHhCCCCCCC----CCHHHHHHhhccCCCCC--CCCCCC-cccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 569 LYEFLVGCVPFFG----ETPEELFAHTVNDDIEW--PSEDDW-PIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 569 LyELLtG~~PF~~----~~~~e~~~~I~~~~~~~--p~~~~~-~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
+||+++...||.. ..+.++...+.++.... |..... ...+++..++++|+..+|.+||++.
T Consensus 148 ~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~ 215 (484)
T KOG1023|consen 148 MYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIE 215 (484)
T ss_pred HHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHH
Confidence 9999999999965 23456666665522211 111101 2445799999999999999999983
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.9e-15 Score=142.60 Aligned_cols=132 Identities=21% Similarity=0.272 Sum_probs=111.8
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC--CeEEEeeeeccccceeeeeeee
Q psy16843 368 VIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN--PFVVTMYCSFETKKHLCLVMEY 445 (810)
Q Consensus 368 ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H--PnIVkl~~~f~~~~~lyLVmEy 445 (810)
+++.||.|.++.||++.... ..+++|....... ...+..|..++..+.| .++++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999999754 6799998755432 3467788888888876 5888999888888899999999
Q ss_pred ccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 446 VEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY---GIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 446 ~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~---gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
++|+.+..+ +......++.+++.+|++||.. +++|+||||+|||++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999887655 5567778899999999999984 799999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.3e-15 Score=157.60 Aligned_cols=137 Identities=18% Similarity=0.342 Sum_probs=104.0
Q ss_pred EEec-ccCceEEEEEEEcCCCcEEEEEEeeccchhh----------HHHHHHHHHHHHHHhcCCCCeE--EEeeeecccc
Q psy16843 370 KLIS-NGAYGSVYLVRHKETRQRFAMKKIIKNSLML----------RNQMEQVFAERDIMSFTDNPFV--VTMYCSFETK 436 (810)
Q Consensus 370 k~LG-~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~----------~~~~~~i~~E~~iL~~l~HPnI--Vkl~~~f~~~ 436 (810)
..|| .||.|+||.+... +..++||......... ......+.+|++++..+.|++| +..+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 7888888888763 6789999775432211 1223467889999999988774 5566554332
Q ss_pred c----eeeeeeeeccC-cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 437 K----HLCLVMEYVEG-GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 437 ~----~lyLVmEy~~G-GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
. ..++||||++| .+|.+++.. +.+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 23599999997 689888865 4566543 578999999999999999999999999999999999999988
Q ss_pred cc
Q psy16843 512 KM 513 (810)
Q Consensus 512 k~ 513 (810)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.2e-14 Score=162.37 Aligned_cols=260 Identities=23% Similarity=0.228 Sum_probs=193.9
Q ss_pred CCcEEEEEecc--cCceEEEEEEE--cCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccce
Q psy16843 364 NDFTVIKLISN--GAYGSVYLVRH--KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKH 438 (810)
Q Consensus 364 ~dy~ilk~LG~--G~FG~Vyla~~--k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~ 438 (810)
..|.+.+.+|. |.+|.||.+.. ..++..+|+|.-...... ...-..-.+|....+.+ .|++.|+.+..+++.+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~-p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP-PLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC-ccccccccchhhcccccCccccccccCcccccCCc
Confidence 56788899999 99999999998 889999999973322110 11112223455444444 58999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCCC-CCHHHHHHHHHHHHH----HHHHhhhcccccccCCCCceEeccC-CcEEEeccCCcc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGP-LPADMARFYFAETVL----AVEYLHSYGIVHRDLKPDNLLITAL-GHIKLTDFGLSK 512 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~-lse~~~~~i~~QIl~----AL~yLHs~gIIHRDLKPeNILLd~~-g~VKL~DFGLAk 512 (810)
+|+-+|+| |.+|..+...... +++..++.++.+... ||.++|+.+|+|-|+||+||++..+ ...+++|||+..
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 99999999 4788888876555 899999999999999 9999999999999999999999999 889999999987
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCC-CCCHHHHHHhh
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF-GETPEELFAHT 591 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~-~~~~~e~~~~I 591 (810)
.+........+.+ ....-|..-|++||.+. .-++...||++||.++.+-.+|..++. +.... +..+
T Consensus 272 ~i~~~~~~~~~~~----------~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--W~~~ 338 (524)
T KOG0601|consen 272 KISDGNFSSVFKV----------SKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS--WSQL 338 (524)
T ss_pred EccCCccccceee----------eecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC--cccc
Confidence 6544332221111 12224677899999875 457899999999999999888765543 31111 0011
Q ss_pred ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 592 ~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.....|.+...+.+.++...+.+|+..+|..|+++ ..+++|++....
T Consensus 339 --r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~---q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 339 --RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTA---QILTALNVIHSK 385 (524)
T ss_pred --ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHH---HHHhccccccch
Confidence 11113333333466777889999999999999999 899999998754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.8e-13 Score=159.11 Aligned_cols=143 Identities=19% Similarity=0.301 Sum_probs=96.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhh-------------------------------HHHHHHHH
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML-------------------------------RNQMEQVF 412 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~-------------------------------~~~~~~i~ 412 (810)
.+|+. +.||+|++|.||+|+.+++|+.||||++....... ....+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 78999999999999999889999999886432100 01112233
Q ss_pred HHHHHHh------cC----CCCeEEEeeeeccc-cceeeeeeeeccCcchhhh--hhcCC----CCCHHHHHHHHHHHHH
Q psy16843 413 AERDIMS------FT----DNPFVVTMYCSFET-KKHLCLVMEYVEGGDCASL--LKNTG----PLPADMARFYFAETVL 475 (810)
Q Consensus 413 ~E~~iL~------~l----~HPnIVkl~~~f~~-~~~lyLVmEy~~GGsL~~l--L~~~g----~lse~~~~~i~~QIl~ 475 (810)
+|++++. .+ .+...+.+-.+|.+ ....+|||||+.|+.+.++ +...+ .+.+..+..++.||+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 3433332 22 12222222222221 3456799999999999774 33433 355666666777765
Q ss_pred HHHHhhhcccccccCCCCceEeccCC----cEEEeccCCcccc
Q psy16843 476 AVEYLHSYGIVHRDLKPDNLLITALG----HIKLTDFGLSKMG 514 (810)
Q Consensus 476 AL~yLHs~gIIHRDLKPeNILLd~~g----~VKL~DFGLAk~~ 514 (810)
..|++|+|+||.||+++.+| .++++|||+....
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 48999999999999999988 9999999998654
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.3e-12 Score=139.48 Aligned_cols=214 Identities=21% Similarity=0.236 Sum_probs=156.1
Q ss_pred HHHhcCCCCeEEEeeeeccccc-----eeeeeeeeccCcchhhhhhcC----CCCCHHHHHHHHHHHHHHHHHhhhc--c
Q psy16843 416 DIMSFTDNPFVVTMYCSFETKK-----HLCLVMEYVEGGDCASLLKNT----GPLPADMARFYFAETVLAVEYLHSY--G 484 (810)
Q Consensus 416 ~iL~~l~HPnIVkl~~~f~~~~-----~lyLVmEy~~GGsL~~lL~~~----g~lse~~~~~i~~QIl~AL~yLHs~--g 484 (810)
.-|-++.|.|||+++.+|.+.+ ...++.|||..|+|..+|++. ..+.....++|+-||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3455678999999999987654 478999999999999999743 4688999999999999999999987 5
Q ss_pred cccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhh
Q psy16843 485 IVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWS 564 (810)
Q Consensus 485 IIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWS 564 (810)
|+|+.+..+-|++..+|-||+.--....... . .............|-++|.|||.=.-...+.++|||+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~---s--------~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~ 267 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHP---S--------VNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYK 267 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccch---h--------hhhhhHhhhhccccCCccccCCcCcccccccchhhhh
Confidence 9999999999999999999875322111100 0 0000111112234778999999766667788999999
Q ss_pred hHHHHHHHHhCCCC-CCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 565 MGVILYEFLVGCVP-FFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 565 LGvILyELLtG~~P-F~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
||....||..|..- =.+.+..+.-..|.+-.+.... .--+++|.+||+-.|..||++ .+++.||..-++
T Consensus 268 fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len-------~lqr~~i~kcl~~eP~~rp~a---r~llfHpllfeV 337 (458)
T KOG1266|consen 268 FGMCALEMAILEIQSTNSESKVEVEENIANVIIGLEN-------GLQRGSITKCLEGEPNGRPDA---RLLLFHPLLFEV 337 (458)
T ss_pred hhHHHHHHHHheeccCCCcceeehhhhhhhheeeccC-------ccccCcCcccccCCCCCCcch---hhhhcCceeeec
Confidence 99999999988654 3333333222233222222211 123679999999999999999 899999999888
Q ss_pred Chhhhhh
Q psy16843 644 DWNSLLR 650 (810)
Q Consensus 644 d~~~l~~ 650 (810)
...+++.
T Consensus 338 hslkll~ 344 (458)
T KOG1266|consen 338 HSLKLLM 344 (458)
T ss_pred chHHHHh
Confidence 7766654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.7e-12 Score=146.87 Aligned_cols=141 Identities=18% Similarity=0.183 Sum_probs=94.7
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhh-H--------------------------HHH----H------HHH
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML-R--------------------------NQM----E------QVF 412 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~-~--------------------------~~~----~------~i~ 412 (810)
+.||.|++|.||+|+.+ +|+.||||+........ . ..+ . .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999876 68999999874321000 0 000 0 133
Q ss_pred HHHHHHhcC-----CCCeEEEeeeeccccceeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHH-HHHHhhhccc
Q psy16843 413 AERDIMSFT-----DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVL-AVEYLHSYGI 485 (810)
Q Consensus 413 ~E~~iL~~l-----~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~-AL~yLHs~gI 485 (810)
.|...+..+ ++++|.-..-+..-....+|||||++|++|.++.... ..+ ....++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 344444433 2344332222222234569999999999998876532 112 23345555555 4778999999
Q ss_pred ccccCCCCceEeccCCcEEEeccCCcccc
Q psy16843 486 VHRDLKPDNLLITALGHIKLTDFGLSKMG 514 (810)
Q Consensus 486 IHRDLKPeNILLd~~g~VKL~DFGLAk~~ 514 (810)
+|+|+||.||+++.+|.++|+|||++...
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 99999999999999999999999998653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.1e-13 Score=151.01 Aligned_cols=249 Identities=20% Similarity=0.217 Sum_probs=183.3
Q ss_pred CCCcEEEEEecccCceEEEEEEEc-CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhc-CCCCeEEEeeeeccccceee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHK-ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF-TDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k-~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~-l~HPnIVkl~~~f~~~~~ly 440 (810)
..+|..+..||.|.|+.|+.+..+ .++..|++|.+.+.......++. -..|+.+... ..|.+++.++..|...+..|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 468999999999999999998766 67889999987665444333332 2334444433 36899999999999888999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC-CcEEEeccCCccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL-GHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~-g~VKL~DFGLAk~~~~s~~ 519 (810)
+-.|||.|+++..-+.-...+.+...+....|++.|+.++|+..++|+|+||+||++..+ +..++.|||..+....
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~--- 419 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF--- 419 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce---
Confidence 999999999988777555678999999999999999999999999999999999999986 7889999998753100
Q ss_pred ccchhhhhhcccccccCCcccCCCCcC--ChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYI--APEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~Ym--APEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
......+.-+++ +++......+..+.|++|||..++|.++|.+--.... ....|..+...
T Consensus 420 ---------------~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p 481 (524)
T KOG0601|consen 420 ---------------SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTP 481 (524)
T ss_pred ---------------ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeeccccc
Confidence 001122333444 4444456678999999999999999999854321111 11223333322
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.... ...++..+.+.++..++..|+.+ .++..|.-|
T Consensus 482 ~~~~----~~~~~q~~~kv~~~~~~~~~~l~---~~l~~~~~~ 517 (524)
T KOG0601|consen 482 NLPG----LKLQLQVLLKVMINPDRKRRPSA---VELSLHSEF 517 (524)
T ss_pred CCCc----hHHhhhhhhhhhcCCccccchhh---hhhcccchh
Confidence 2211 33788899999999999999988 677666554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=3e-12 Score=125.74 Aligned_cols=128 Identities=18% Similarity=0.236 Sum_probs=94.3
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeE-EEeeeeccccceeeeeeeecc
Q psy16843 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFV-VTMYCSFETKKHLCLVMEYVE 447 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnI-Vkl~~~f~~~~~lyLVmEy~~ 447 (810)
++.|+.|.++.||++... ++.|++|....... .......|..+++.+.+.++ .+++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 567899999999999864 77899997644321 11234567788877754443 34444433 23579999999
Q ss_pred CcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhccc-----ccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 448 GGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI-----VHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 448 GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gI-----IHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
|.++... ......++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+..
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887643 11123467899999999999885 9999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.9e-11 Score=138.75 Aligned_cols=169 Identities=19% Similarity=0.239 Sum_probs=128.5
Q ss_pred EEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcchhhhhhcCCCC
Q psy16843 382 LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPL 461 (810)
Q Consensus 382 la~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g~l 461 (810)
.|..+.++.+|.+.+...... .....+.+-++-|+.++||||+++++.++.++.+|||+|-+. -|..++++.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--
Confidence 466778888898887765443 334567778889999999999999999999999999999884 4666776644
Q ss_pred CHHHHHHHHHHHHHHHHHhh-hcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCccc
Q psy16843 462 PADMARFYFAETVLAVEYLH-SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540 (810)
Q Consensus 462 se~~~~~i~~QIl~AL~yLH-s~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~ 540 (810)
...+..-+.||+.||.||| +.+++|++|.-+-|+++..|.+||++|.++........ ......
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---------------~~~~~~ 166 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---------------PAKSLY 166 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---------------ccccch
Confidence 7778888999999999997 57999999999999999999999999998643110000 001111
Q ss_pred CCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhC
Q psy16843 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVG 575 (810)
Q Consensus 541 GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG 575 (810)
--..|..|+.+.... ...|.|.|||+++|++.|
T Consensus 167 ~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 167 LIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 223356666554322 457999999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.1e-11 Score=122.89 Aligned_cols=139 Identities=17% Similarity=0.113 Sum_probs=97.9
Q ss_pred EEecccCceEEEEEEEcC------CCcEEEEEEeeccchh-------------------hHHHHHH----HHHHHHHHhc
Q psy16843 370 KLISNGAYGSVYLVRHKE------TRQRFAMKKIIKNSLM-------------------LRNQMEQ----VFAERDIMSF 420 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~------tg~~vAIK~I~k~~~~-------------------~~~~~~~----i~~E~~iL~~ 420 (810)
..||.|--+.||.|.... .+..+|||+....... ..+..+. ..+|.+.|..
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 3578999975321100 0011122 3378888877
Q ss_pred CCC--CeEEEeeeeccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHh-hhcccccccCCCCceEe
Q psy16843 421 TDN--PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYL-HSYGIVHRDLKPDNLLI 497 (810)
Q Consensus 421 l~H--PnIVkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yL-Hs~gIIHRDLKPeNILL 497 (810)
+.. -++...+++ ..-+|||||+.++.+..-.-+...+++..+..+..|++.+|..| |+.||||+||++.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 743 234444443 45689999997765432222223566667788889999999998 89999999999999999
Q ss_pred ccCCcEEEeccCCccc
Q psy16843 498 TALGHIKLTDFGLSKM 513 (810)
Q Consensus 498 d~~g~VKL~DFGLAk~ 513 (810)
+ +|.++|+|||.+-.
T Consensus 159 ~-~~~v~iIDF~qav~ 173 (197)
T cd05146 159 H-DGKVWFIDVSQSVE 173 (197)
T ss_pred E-CCcEEEEECCCcee
Confidence 7 47899999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.2e-10 Score=116.72 Aligned_cols=141 Identities=21% Similarity=0.264 Sum_probs=106.6
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCC--eEEEeeeecccc---ceeeeee
Q psy16843 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP--FVVTMYCSFETK---KHLCLVM 443 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HP--nIVkl~~~f~~~---~~lyLVm 443 (810)
++.||.|..+.||++...+ |+.|++|........ .....+..|.++++.+.+. .+.+++.+.... +..++||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 3678999999999998754 678999986543321 1234677899999888653 345566665543 3678999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-----------------------------------------
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS----------------------------------------- 482 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs----------------------------------------- 482 (810)
||++|+++...+.. +.+++.....++.+++.+|.+||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999988876643 457777777788888888888874
Q ss_pred ---------------cccccccCCCCceEecc--CCcEEEeccCCccc
Q psy16843 483 ---------------YGIVHRDLKPDNLLITA--LGHIKLTDFGLSKM 513 (810)
Q Consensus 483 ---------------~gIIHRDLKPeNILLd~--~g~VKL~DFGLAk~ 513 (810)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999998 67789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=8.2e-10 Score=111.19 Aligned_cols=134 Identities=27% Similarity=0.295 Sum_probs=96.2
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeecc-----chhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKN-----SLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~-----~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
..+++|+-+.++.+.+. |..+++|.-.++ .++.+-..++..+|..++..+.--.|.-.+-++.+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999663 344666644332 22222233567789999887744333222223345567789999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
|++|..|.+.|... . -.++..+-.-+.-||..||+|+||.++||++...+ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888765 1 44566777778889999999999999999998744 99999999864
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.9e-09 Score=106.07 Aligned_cols=143 Identities=20% Similarity=0.194 Sum_probs=103.0
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEee-----ccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 368 VIKLISNGAYGSVYLVRHKETRQRFAMKKII-----KNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 368 ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~-----k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.+..|-+|+-+.|+++.. .|+.+.||.-. .......-..++..+|+++|.++.--.|.-..-+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 577788999999999876 56777777532 23333334446778899998877543332222234455567899
Q ss_pred eeeccC-cchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc---EEEeccCCcc
Q psy16843 443 MEYVEG-GDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSK 512 (810)
Q Consensus 443 mEy~~G-GsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~---VKL~DFGLAk 512 (810)
|||++| -++.+++.... .........++..|-..+.-||.++|||+||..+||+|..+|. +.|+|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999987 46777776432 2233333678889999999999999999999999999987663 5899999975
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.6e-09 Score=124.22 Aligned_cols=164 Identities=18% Similarity=0.282 Sum_probs=115.3
Q ss_pred HHHHHHHHhhhc-ccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhH
Q psy16843 472 ETVLAVEYLHSY-GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEV 550 (810)
Q Consensus 472 QIl~AL~yLHs~-gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEv 550 (810)
+++.||.|+|.. ++||+.|.|++|.++..|.+||+.|+++........ |.+..- + .. ..--..-...|.|||+
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~---~p~~~y-d-~~-lp~~~~~~~~f~apE~ 180 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE---YPFSEY-D-PP-LPLLLQPHLNFLAPEY 180 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc---cccccC-C-CC-CChhhccCcccccchh
Confidence 445999999975 999999999999999999999999998754322111 211110 0 00 0111234568999999
Q ss_pred HhhcCCCCCcchhhhHHHHHHHH-hCCCCCCCCCHHHHHHhhc--cC--CCCCCCCCCCcccHHHHHHHHhhhcCCCCCC
Q psy16843 551 ILRQGYGKPVDWWSMGVILYEFL-VGCVPFFGETPEELFAHTV--ND--DIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625 (810)
Q Consensus 551 l~~~~ys~ksDIWSLGvILyELL-tG~~PF~~~~~~e~~~~I~--~~--~~~~p~~~~~~~S~el~dLI~klL~~dP~~R 625 (810)
+.+...+.++|++|+||++|.+. .|..-+.+......+.... .+ ...+. ..++.++++=|.++|..++.-|
T Consensus 181 ~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s----~~~p~el~~~l~k~l~~~~~~r 256 (700)
T KOG2137|consen 181 LLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYS----NNLPSELRESLKKLLNGDSAVR 256 (700)
T ss_pred hccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccccc----ccCcHHHHHHHHHHhcCCcccC
Confidence 99988899999999999999988 4666665443222222111 11 11112 2367899999999999999999
Q ss_pred CCCCChhHHhcCCCcCCCChhhh
Q psy16843 626 LGTGGPHEVKEHPYFSNLDWNSL 648 (810)
Q Consensus 626 pta~~~~EiL~HPfF~~id~~~l 648 (810)
|++ .+++.-|||.+.....|
T Consensus 257 p~~---~~l~~~~ff~D~~~~aL 276 (700)
T KOG2137|consen 257 PTL---DLLLSIPFFSDPGLKAL 276 (700)
T ss_pred cch---hhhhcccccCCchhhhh
Confidence 977 89999999998654443
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.5e-08 Score=111.60 Aligned_cols=210 Identities=15% Similarity=0.178 Sum_probs=151.5
Q ss_pred eEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc----cceeeeeeeeccC-cchh
Q psy16843 378 GSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET----KKHLCLVMEYVEG-GDCA 452 (810)
Q Consensus 378 G~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~----~~~lyLVmEy~~G-GsL~ 452 (810)
.+.|++....+|..|++|.+.-...... .....-+++++++.|+|||++.++|.+ +..+++|++|.++ ++|.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 4779999999999999999843322211 123345778899999999999999984 3479999999987 5676
Q ss_pred hhhh---------------cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 453 SLLK---------------NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 453 ~lL~---------------~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
++-- +....+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+..|+|...|........
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 6531 1235789999999999999999999999999999999999999889999888875432111
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCC-CCCCCHHHH-HHhhccCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP-FFGETPEEL-FAHTVNDD 595 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~P-F~~~~~~e~-~~~I~~~~ 595 (810)
. | |-+.++ .+-|.=.||.++..|.+|..- +.....++. +..|. .
T Consensus 447 ~----------------------~-------~~le~~---Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-~- 492 (655)
T KOG3741|consen 447 P----------------------T-------EPLESQ---QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-T- 492 (655)
T ss_pred C----------------------C-------cchhHH---hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-h-
Confidence 0 0 111111 245778899999999998543 333333333 22221 1
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.+|.+++++|.-+...++++ -++ ++++.|
T Consensus 493 ---------~yS~D~rn~v~yl~s~~~~~-ksI---~~llp~ 521 (655)
T KOG3741|consen 493 ---------TYSTDLRNVVEYLESLNFRE-KSI---QDLLPM 521 (655)
T ss_pred ---------hhhHHHHHHHHHHHhcCccc-ccH---HHHHHH
Confidence 16789999999999999885 333 666665
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.4e-09 Score=125.04 Aligned_cols=244 Identities=19% Similarity=0.164 Sum_probs=172.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCe-EEEeeeeccccceeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF-VVTMYCSFETKKHLCLV 442 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPn-IVkl~~~f~~~~~lyLV 442 (810)
..|.....+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++.++.+.+.+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 45667778899999999998876655444 5655432 23445889999999999 88888888889999999
Q ss_pred eeeccCc-chhhhh-hcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 443 MEYVEGG-DCASLL-KNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 443 mEy~~GG-sL~~lL-~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
|+|+.+| +-.... ...-.+.+-+...+.+.-+.+|+|||+.--+||| ||+..+ +..|+.||+.......
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~---- 383 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR---- 383 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc----
Confidence 9999887 222222 1112345555566677778899999998889999 887765 8899999998754211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC--C
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE--W 598 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~--~ 598 (810)
....++..||+.|+|||++....|....|.|++|+--.+|.-|.+|-.. +......+-++.-. .
T Consensus 384 ------------~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L 449 (829)
T KOG0576|consen 384 ------------TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPML 449 (829)
T ss_pred ------------ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCcccc
Confidence 1134677899999999999999999999999999987888888877644 11111122111100 0
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.....|. ...-.++...|+...|..|+.. .+++.|.+|.+-
T Consensus 450 ~~~~aw~-~~~~~~~~~~~~~g~P~~pkv~---mgacfsKvfngC 490 (829)
T KOG0576|consen 450 TDKSAWS-PVFHRDFPAPCLNGLPPTPKVH---MGACFSKVFNGC 490 (829)
T ss_pred chhhhcC-cccccCCcccccCCCCCCCcch---hhHHHHHHhccC
Confidence 0000111 0112357888999999999988 789999999764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=7.6e-08 Score=98.34 Aligned_cols=127 Identities=23% Similarity=0.189 Sum_probs=82.5
Q ss_pred EEEEEEEcCCCcEEEEEEeeccc-----------------------hhhHHHHHHHHHHHHHHhcCCCC--eEEEeeeec
Q psy16843 379 SVYLVRHKETRQRFAMKKIIKNS-----------------------LMLRNQMEQVFAERDIMSFTDNP--FVVTMYCSF 433 (810)
Q Consensus 379 ~Vyla~~k~tg~~vAIK~I~k~~-----------------------~~~~~~~~~i~~E~~iL~~l~HP--nIVkl~~~f 433 (810)
.||.|... +|..+|+|+-.... ...........+|.+.|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38888763 56789999753211 01111224577899999988765 455555442
Q ss_pred cccceeeeeeeecc--CcchhhhhhcCCCCCHHHHHHHHHHHHHHHHH-hhhcccccccCCCCceEeccCCcEEEeccCC
Q psy16843 434 ETKKHLCLVMEYVE--GGDCASLLKNTGPLPADMARFYFAETVLAVEY-LHSYGIVHRDLKPDNLLITALGHIKLTDFGL 510 (810)
Q Consensus 434 ~~~~~lyLVmEy~~--GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~y-LHs~gIIHRDLKPeNILLd~~g~VKL~DFGL 510 (810)
.-+|||||++ |..+..+... .++.+....++.+++..+.. +|+.||+|+||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3479999998 6555444332 22356677888888886665 579999999999999999886 999999998
Q ss_pred ccc
Q psy16843 511 SKM 513 (810)
Q Consensus 511 Ak~ 513 (810)
+..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.6e-07 Score=101.02 Aligned_cols=102 Identities=15% Similarity=0.114 Sum_probs=77.2
Q ss_pred HHHHHHHHhcCC-----CCeEEEeeeeccc--cceeeeeeeeccCc-chhhhhhc--CCCCCHHHHHHHHHHHHHHHHHh
Q psy16843 411 VFAERDIMSFTD-----NPFVVTMYCSFET--KKHLCLVMEYVEGG-DCASLLKN--TGPLPADMARFYFAETVLAVEYL 480 (810)
Q Consensus 411 i~~E~~iL~~l~-----HPnIVkl~~~f~~--~~~lyLVmEy~~GG-sL~~lL~~--~g~lse~~~~~i~~QIl~AL~yL 480 (810)
+.+|...+..+. -|-+|-+...-.. ...-+||||+++|- +|.+++.. ....++.....++.+++..+.-|
T Consensus 75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L 154 (268)
T PRK15123 75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM 154 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 567777776553 3444433221111 23578999999886 78888853 34566778889999999999999
Q ss_pred hhcccccccCCCCceEecc-------CCcEEEeccCCcc
Q psy16843 481 HSYGIVHRDLKPDNLLITA-------LGHIKLTDFGLSK 512 (810)
Q Consensus 481 Hs~gIIHRDLKPeNILLd~-------~g~VKL~DFGLAk 512 (810)
|..||+|+||++.|||++. ++.+.|+||+.+.
T Consensus 155 H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 155 HAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999999999999999985 4689999999874
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.3e-07 Score=94.64 Aligned_cols=105 Identities=22% Similarity=0.233 Sum_probs=80.7
Q ss_pred HHHHHHHHHHhcCC-----CCeEEEeeeeccc-cceeeeeeeeccCc-chhhhhhcCCCCCHHHHHHHHHHHHHHHHHhh
Q psy16843 409 EQVFAERDIMSFTD-----NPFVVTMYCSFET-KKHLCLVMEYVEGG-DCASLLKNTGPLPADMARFYFAETVLAVEYLH 481 (810)
Q Consensus 409 ~~i~~E~~iL~~l~-----HPnIVkl~~~f~~-~~~lyLVmEy~~GG-sL~~lL~~~g~lse~~~~~i~~QIl~AL~yLH 481 (810)
....+|...+..+. -|-+|-+...-.. ....++|+|+++|. +|.+++......+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 34666777665553 3444433222111 13568999999884 79999987555788888999999999999999
Q ss_pred hcccccccCCCCceEeccCC---cEEEeccCCccc
Q psy16843 482 SYGIVHRDLKPDNLLITALG---HIKLTDFGLSKM 513 (810)
Q Consensus 482 s~gIIHRDLKPeNILLd~~g---~VKL~DFGLAk~ 513 (810)
.+||+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999987 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=9.8e-07 Score=93.95 Aligned_cols=137 Identities=22% Similarity=0.165 Sum_probs=98.2
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh-------------------hHHHHHHHHHHHHHHhcCCCC--
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM-------------------LRNQMEQVFAERDIMSFTDNP-- 424 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~-------------------~~~~~~~i~~E~~iL~~l~HP-- 424 (810)
+.+...||-|--+.||.|... .|.++|||.=...... ..-......+|.++|..+...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456788999999999999876 6788999953211000 001123457788888877554
Q ss_pred eEEEeeeeccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEE
Q psy16843 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIK 504 (810)
Q Consensus 425 nIVkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VK 504 (810)
.|.+.+++ +.-.+||||++|-.|...- ++.+.+..++..|+.-+.-+-..||||+|+.+-|||++.+|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 44444433 4568999999997776432 23455566666666666666689999999999999999999999
Q ss_pred EeccCCcc
Q psy16843 505 LTDFGLSK 512 (810)
Q Consensus 505 L~DFGLAk 512 (810)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99998764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.8e-06 Score=88.61 Aligned_cols=140 Identities=19% Similarity=0.293 Sum_probs=91.1
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHH------HHHHHHHHhcCC---C-----CeEE
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQ------VFAERDIMSFTD---N-----PFVV 427 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~------i~~E~~iL~~l~---H-----PnIV 427 (810)
..++|.+++.+-......|.+..- +|+.+.+|.........+..... ..+++..+..+. - ++++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 346899999998888887877654 56889999765433222222211 122222222221 1 2222
Q ss_pred EeeeeccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEec
Q psy16843 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTD 507 (810)
Q Consensus 428 kl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~D 507 (810)
-..-.+.-....+|||||++|..|.++.. +++ .+...|+.++.-||+.|++|+|.+|.|+++.. +.++++|
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID 177 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIID 177 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEE
Confidence 22222333345679999999988876542 333 24466778899999999999999999999986 5599999
Q ss_pred cCCcc
Q psy16843 508 FGLSK 512 (810)
Q Consensus 508 FGLAk 512 (810)
|+..+
T Consensus 178 ~~~k~ 182 (229)
T PF06176_consen 178 TQGKR 182 (229)
T ss_pred Ccccc
Confidence 99754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=6.5e-06 Score=91.67 Aligned_cols=236 Identities=15% Similarity=0.186 Sum_probs=149.0
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEE--------eeeeccccce
Q psy16843 367 TVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVT--------MYCSFETKKH 438 (810)
Q Consensus 367 ~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVk--------l~~~f~~~~~ 438 (810)
...+.||+|+-+-+|-.-.-.+ .+.|+..+....... ..-..+.+.-.||-+-. |++- .....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~a-----qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQA-----QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchhhc---hhheeecCCCchHHH-----HHHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 3457799999999996543221 245766554332111 11122334446664322 1111 11223
Q ss_pred eeeeeeeccCcc-hhhhhh------cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 439 LCLVMEYVEGGD-CASLLK------NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 439 lyLVmEy~~GGs-L~~lL~------~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
+-++|..+.|.. ...+.. ....+.++.+...++.|+.|..-||..|.+-+|+.++|+|+.+++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 778888887752 222221 1234788889999999999999999999999999999999999999999974432
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHh-----hcCCCCCcchhhhHHHHHHHHhC-CCCCCCC---
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVG-CVPFFGE--- 582 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-----~~~ys~ksDIWSLGvILyELLtG-~~PF~~~--- 582 (810)
.. ..+... ....+|.+.|.+||.-. +..-+...|-|.||+++++++.| +.||.|.
T Consensus 165 qi---~~ng~~-------------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~ 228 (637)
T COG4248 165 QI---NANGTL-------------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI 228 (637)
T ss_pred ee---ccCCce-------------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc
Confidence 11 011111 12357999999999875 33447789999999999999985 9999763
Q ss_pred ----CHHHHHHhhccC---------CCCCCCCCCCc---ccHHHHHHHHhhhcC--CCCCCCCCC
Q psy16843 583 ----TPEELFAHTVND---------DIEWPSEDDWP---IQVEAKSIITDLLQQ--NPRDRLGTG 629 (810)
Q Consensus 583 ----~~~e~~~~I~~~---------~~~~p~~~~~~---~S~el~dLI~klL~~--dP~~Rpta~ 629 (810)
.+.|. .|-.+ ....|.+..++ +.+++..|..+|+.. ++.-||++.
T Consensus 229 ~~ap~p~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 229 SDAPNPLET--DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred CCCCCcchh--hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 22221 11111 11112222222 567889999999874 356899984
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=4.8e-06 Score=97.06 Aligned_cols=136 Identities=21% Similarity=0.231 Sum_probs=87.6
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhh---------------------------HHHH----HH------HH
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML---------------------------RNQM----EQ------VF 412 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~---------------------------~~~~----~~------i~ 412 (810)
..|+.++-|.||.|+.+. |+.||||+....-... ...+ +. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 568999999999999886 9999999763221100 0001 11 22
Q ss_pred HHHHHHhcC-----CCCeEEEeeeeccccceeeeeeeeccCcchhhhh--hcCCCCCH-----HHHHHHHHHHHHHHHHh
Q psy16843 413 AERDIMSFT-----DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL--KNTGPLPA-----DMARFYFAETVLAVEYL 480 (810)
Q Consensus 413 ~E~~iL~~l-----~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL~~lL--~~~g~lse-----~~~~~i~~QIl~AL~yL 480 (810)
.|...+..+ +.++|.--.-+++-.+.-.|+|||+.|-.+.+.. +. ..++. .-+..++.|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~------- 281 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQL------- 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHH-------
Confidence 233333222 3344433333333345668999999999998874 44 33442 2233333333
Q ss_pred hhcccccccCCCCceEeccCCcEEEeccCCcccc
Q psy16843 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514 (810)
Q Consensus 481 Hs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~ 514 (810)
=..|++|.|.+|.||+++.+|.+-+.|||+....
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 2389999999999999999999999999997653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.2e-05 Score=78.06 Aligned_cols=138 Identities=23% Similarity=0.299 Sum_probs=79.6
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCC--eEEEeeeec---cccceeeeee
Q psy16843 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP--FVVTMYCSF---ETKKHLCLVM 443 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HP--nIVkl~~~f---~~~~~lyLVm 443 (810)
++.|+.|..+.||++.... ..+++|..... .....+..|..++..+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999998765 48999975443 2334566777777665322 234444422 2233579999
Q ss_pred eeccCcchhh----------------hh---hcC----CCCCHHH------HHHH---------------HHHHHH-HHH
Q psy16843 444 EYVEGGDCAS----------------LL---KNT----GPLPADM------ARFY---------------FAETVL-AVE 478 (810)
Q Consensus 444 Ey~~GGsL~~----------------lL---~~~----g~lse~~------~~~i---------------~~QIl~-AL~ 478 (810)
++++|..+.. .+ ... ..+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988777 11 111 1111100 0000 011222 233
Q ss_pred Hhh-------hcccccccCCCCceEec-cCCcEEEeccCCccc
Q psy16843 479 YLH-------SYGIVHRDLKPDNLLIT-ALGHIKLTDFGLSKM 513 (810)
Q Consensus 479 yLH-------s~gIIHRDLKPeNILLd-~~g~VKL~DFGLAk~ 513 (810)
.++ ...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 333 34699999999999999 667778999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.3e-07 Score=113.36 Aligned_cols=256 Identities=18% Similarity=0.038 Sum_probs=164.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccc--hhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc--cce
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNS--LMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET--KKH 438 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~--~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~--~~~ 438 (810)
.+++++.--+|.|.+++-...+.+..+ +.+|+..... ...+...+....|++.++...|++++..+.-... ...
T Consensus 1228 ~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 367788877888877654333333332 2334332211 1122333556667777778899999888776654 346
Q ss_pred eeeeeeeccCcchhhhhhcC----CCCCHHHHHHHHHHHHHHHHHhhhcc-----cccccCCCCceEeccCCcEEEeccC
Q psy16843 439 LCLVMEYVEGGDCASLLKNT----GPLPADMARFYFAETVLAVEYLHSYG-----IVHRDLKPDNLLITALGHIKLTDFG 509 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~----g~lse~~~~~i~~QIl~AL~yLHs~g-----IIHRDLKPeNILLd~~g~VKL~DFG 509 (810)
.|.+++|+.+|.++..|-++ ..+.+..+.....+.+.+..-+|+.. .+|++||+-|.+|..+..+|++++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 79999999999999998643 34555555555555588888888642 6899999999999999999999999
Q ss_pred CcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16843 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589 (810)
Q Consensus 510 LAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~ 589 (810)
+.+..... ....+..++++.|++|++...-.++.++|+|..|+.+|+.-.|..+|-......+..
T Consensus 1386 LdKIknp~---------------~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkg 1450 (2724)
T KOG1826|consen 1386 LDKIKNPV---------------LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKG 1450 (2724)
T ss_pred cccccCch---------------HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcC
Confidence 99831110 001235678899999999999999999999999999999998988874322222211
Q ss_pred hhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 590 ~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
.+.++.. +..+.. .+.++-.....+|-..-..||+- ...+.-+.|.
T Consensus 1451 iidn~tf-~sIe~l--~pgdaNve~~~~Ll~K~~~rp~q---~isls~d~~a 1496 (2724)
T KOG1826|consen 1451 IIDNHTF-FSIEKL--KPGDANVEALHRLLWKYMERPGQ---YISLSRDHFA 1496 (2724)
T ss_pred ccccccc-cccccc--CCCcccHHHHHHHHHHhhhcchh---hhhccccccc
Confidence 1111111 111111 12333334444444455567765 5566655554
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.6e-06 Score=100.91 Aligned_cols=238 Identities=18% Similarity=0.214 Sum_probs=158.4
Q ss_pred ecccCceEEEEEEEcCCC----cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc----eeeeee
Q psy16843 372 ISNGAYGSVYLVRHKETR----QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK----HLCLVM 443 (810)
Q Consensus 372 LG~G~FG~Vyla~~k~tg----~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~----~lyLVm 443 (810)
+..-.+|+|++.++...- +++-++.-.-.....+..+.....|...+.+..|+|++.++.+...+. .+.+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 555666777776653211 111111111111112234455566777888999999999988765433 334566
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCC---ceEeccCCcEEEe--ccCCcccccccc
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPD---NLLITALGHIKLT--DFGLSKMGLMSL 518 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPe---NILLd~~g~VKL~--DFGLAk~~~~s~ 518 (810)
++|.+-++..+++..+.++.+.++.+..+++.||.|+|+....|.-|-.. +--.+..+.+.+. ||+.++......
T Consensus 266 ~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~ 345 (1351)
T KOG1035|consen 266 EICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE 345 (1351)
T ss_pred hhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcc
Confidence 89999999999999999999999999999999999999986666655555 4445556677766 888776422110
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCC--cchhhhHHHHHHHHhCCCCCC-CCCHHHHHHhhccCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKP--VDWWSMGVILYEFLVGCVPFF-GETPEELFAHTVNDD 595 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~k--sDIWSLGvILyELLtG~~PF~-~~~~~e~~~~I~~~~ 595 (810)
. .....-+..|.|+|......+..+ .|+|.+|.++..+..|..+-. ....... +
T Consensus 346 ~----------------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~~----l--- 402 (1351)
T KOG1035|consen 346 K----------------SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPVSL----L--- 402 (1351)
T ss_pred c----------------chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchhhh----h---
Confidence 0 011223556778888877666444 799999999999998754421 1111111 1
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
... ...+..+++.+|+..++++|+++ .+++.|||.+.
T Consensus 403 ----~~~---~~~~~~d~~~~~~~~~~~~Rl~~---~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 403 ----DVL---STSELLDALPKCLDEDSEERLSA---LELLTHPFLRF 439 (1351)
T ss_pred ----ccc---cchhhhhhhhhhcchhhhhccch---hhhhhchhccc
Confidence 000 11157889999999999999999 89999999865
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.4e-05 Score=84.04 Aligned_cols=134 Identities=16% Similarity=0.124 Sum_probs=80.6
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCe--EEEeeeeccccceeeeeeeecc
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF--VVTMYCSFETKKHLCLVMEYVE 447 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPn--IVkl~~~f~~~~~lyLVmEy~~ 447 (810)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+.+++....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 67899999999974 24467888654322 1234577888887775322 3556666667777889999999
Q ss_pred Ccc-hhhhh---------------------hcC--CCCCHH-HHHHHHHH----------HHH-HHHHhh----hccccc
Q psy16843 448 GGD-CASLL---------------------KNT--GPLPAD-MARFYFAE----------TVL-AVEYLH----SYGIVH 487 (810)
Q Consensus 448 GGs-L~~lL---------------------~~~--g~lse~-~~~~i~~Q----------Il~-AL~yLH----s~gIIH 487 (810)
|.. +...+ +.. ...... ....+..+ +.. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 11111 110 001100 00111101 111 112222 124789
Q ss_pred ccCCCCceEeccCCcEEEeccCCccc
Q psy16843 488 RDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 488 RDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
+|+.|.||+++.+| +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999988 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.5e-05 Score=82.88 Aligned_cols=139 Identities=14% Similarity=0.159 Sum_probs=97.8
Q ss_pred cccCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHHHHHHHhcCCCCe--EEEeeeec--cc--cceeeeee
Q psy16843 373 SNGAYGSVYLVRHKETRQRFAMKKIIKN---SLMLRNQMEQVFAERDIMSFTDNPF--VVTMYCSF--ET--KKHLCLVM 443 (810)
Q Consensus 373 G~G~FG~Vyla~~k~tg~~vAIK~I~k~---~~~~~~~~~~i~~E~~iL~~l~HPn--IVkl~~~f--~~--~~~lyLVm 443 (810)
|.||-+-|+..... |+.|-+|.-... ..........+.+|...|..+..-+ +.+....- .. .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56888888887653 346778865311 1110123356788888887774322 33333111 11 12468999
Q ss_pred eeccC-cchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc--EEEeccCCccc
Q psy16843 444 EYVEG-GDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH--IKLTDFGLSKM 513 (810)
Q Consensus 444 Ey~~G-GsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~--VKL~DFGLAk~ 513 (810)
|-+.| .+|.+++.+. .+.++.....++.+|+.+|.-||+.|+.|+|+-+.||+++.+|. |+++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97765 5888888653 35677777899999999999999999999999999999997777 99999998765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.9e-05 Score=83.47 Aligned_cols=138 Identities=22% Similarity=0.216 Sum_probs=92.0
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHH---------------------HHHHHHHHHhcCCC--Ce
Q psy16843 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQME---------------------QVFAERDIMSFTDN--PF 425 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~---------------------~i~~E~~iL~~l~H--Pn 425 (810)
...|+.|--+.||+|.. .++..+|+|+........+.... ....|..-|+.+.. -.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 44788888889999976 45788999987544333222111 12345555544421 12
Q ss_pred EEEeeeeccccceeeeeeeeccCc-chhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcE
Q psy16843 426 VVTMYCSFETKKHLCLVMEYVEGG-DCASLLKNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHI 503 (810)
Q Consensus 426 IVkl~~~f~~~~~lyLVmEy~~GG-sL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~V 503 (810)
+.+-+.+ ..-.|||||+... .-.-.|+.- .+..+.+..+..+++..+.-|-. .|+||+||..-|||+. +|.+
T Consensus 132 vP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceee----cCCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 2222222 2357999999653 222233332 34444788899999999998877 8999999999999999 8999
Q ss_pred EEeccCCccc
Q psy16843 504 KLTDFGLSKM 513 (810)
Q Consensus 504 KL~DFGLAk~ 513 (810)
.|+|||-|..
T Consensus 206 ~iID~~QaV~ 215 (268)
T COG1718 206 YIIDVSQAVT 215 (268)
T ss_pred EEEECccccc
Confidence 9999998854
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.83 E-value=8.8e-05 Score=77.91 Aligned_cols=135 Identities=16% Similarity=0.128 Sum_probs=79.8
Q ss_pred EecccCc-eEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccceeeeeeeeccC
Q psy16843 371 LISNGAY-GSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKKHLCLVMEYVEG 448 (810)
Q Consensus 371 ~LG~G~F-G~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~~lyLVmEy~~G 448 (810)
.|-.|.. ..||++... +..+.+|...... ...+..|+++++.+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3445555 788998653 3578888654332 234556787777663 23355666766666678999999999
Q ss_pred cchhhhh-------------------hcC----CCCCHH------HHHHH-------------------HHHHHHHHHHh
Q psy16843 449 GDCASLL-------------------KNT----GPLPAD------MARFY-------------------FAETVLAVEYL 480 (810)
Q Consensus 449 GsL~~lL-------------------~~~----g~lse~------~~~~i-------------------~~QIl~AL~yL 480 (810)
..|.... +.. .++... ..... ..++...|...
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 7765331 110 011100 00000 01111111110
Q ss_pred ----hhcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 481 ----HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 481 ----Hs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123589999999999999988889999998754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00012 Score=90.56 Aligned_cols=146 Identities=21% Similarity=0.370 Sum_probs=90.7
Q ss_pred EEEEecccCceEEEEEEEcCCC--cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeE--EEeeeecccc---cee
Q psy16843 368 VIKLISNGAYGSVYLVRHKETR--QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFV--VTMYCSFETK---KHL 439 (810)
Q Consensus 368 ilk~LG~G~FG~Vyla~~k~tg--~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnI--Vkl~~~f~~~---~~l 439 (810)
.++.|+.|.++.+|+......+ ..+++|+........ ....+.+|.++|+.+. |.+| .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3678899999999998765433 467888654322111 1245678999998885 5554 6777776654 467
Q ss_pred eeeeeeccCcchhh--------------------hh---hcC----------CC---CCHHHHHHHHHH-----------
Q psy16843 440 CLVMEYVEGGDCAS--------------------LL---KNT----------GP---LPADMARFYFAE----------- 472 (810)
Q Consensus 440 yLVmEy~~GGsL~~--------------------lL---~~~----------g~---lse~~~~~i~~Q----------- 472 (810)
|+||||++|..+.+ .| +.. +. +...++..|..+
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999999864321 11 110 00 011223222211
Q ss_pred ----HHHHHHHhhh-----------cccccccCCCCceEeccC-Cc-EEEeccCCccccc
Q psy16843 473 ----TVLAVEYLHS-----------YGIVHRDLKPDNLLITAL-GH-IKLTDFGLSKMGL 515 (810)
Q Consensus 473 ----Il~AL~yLHs-----------~gIIHRDLKPeNILLd~~-g~-VKL~DFGLAk~~~ 515 (810)
+...+.+|.. ..+||+|+++.|||++.+ +. +-|.||+++..+.
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2233455632 359999999999999853 33 5799999987653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.78 E-value=6.2e-05 Score=75.96 Aligned_cols=130 Identities=21% Similarity=0.239 Sum_probs=90.5
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEE-eeeeccccceeeeeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVT-MYCSFETKKHLCLVME 444 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVk-l~~~f~~~~~lyLVmE 444 (810)
.+..+.||+|.+|.||++.+. |..+|+|+-..+.. ...+..|+++|..+..-++.. +|.+. ..++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhh
Confidence 345788999999999999985 55889996544432 255778999998887766643 33332 3356699
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCC-CCceEeccCCcEEEeccCCccc
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLK-PDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLK-PeNILLd~~g~VKL~DFGLAk~ 513 (810)
|+.|-.|.++-... + +.-+..++++---|-..||-|+.|. |..++|-.++.+.|+||.-|+.
T Consensus 93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 99997777654421 1 2223445555444667899999986 6666666667999999998863
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00013 Score=85.19 Aligned_cols=138 Identities=22% Similarity=0.247 Sum_probs=84.5
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH-----------------------------HHHHHHH------HH
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR-----------------------------NQMEQVF------AE 414 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~-----------------------------~~~~~i~------~E 414 (810)
+.||.-+.|.|++|+.+. |+.||||+-.. .+... ...+.+. .|
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P-~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHP-GLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCc-ChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 458999999999999987 99999996432 21111 0001112 22
Q ss_pred HHH----HhcCCCCe------EEEeeeeccccceeeeeeeeccCcchhhh--hhcCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy16843 415 RDI----MSFTDNPF------VVTMYCSFETKKHLCLVMEYVEGGDCASL--LKNTGPLPADMARFYFAETVLAVEYLHS 482 (810)
Q Consensus 415 ~~i----L~~l~HPn------IVkl~~~f~~~~~lyLVmEy~~GGsL~~l--L~~~g~lse~~~~~i~~QIl~AL~yLHs 482 (810)
.+. .+.+.|-. |.++|..+. ..-.|+||||+|.-+.++ |.+.+ ++...+...+.++..-+ +=.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~~q--If~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYLEQ--IFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHHHH--HHh
Confidence 222 12223333 445554443 356899999999877765 34433 44443332222222111 223
Q ss_pred cccccccCCCCceEecc----CCcEEEeccCCcccc
Q psy16843 483 YGIVHRDLKPDNLLITA----LGHIKLTDFGLSKMG 514 (810)
Q Consensus 483 ~gIIHRDLKPeNILLd~----~g~VKL~DFGLAk~~ 514 (810)
.|++|.|=+|.||++.. ++.+.+.|||+....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 68999999999999994 568999999998653
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00027 Score=73.09 Aligned_cols=128 Identities=22% Similarity=0.280 Sum_probs=87.2
Q ss_pred CCcEEEEEecccCc-eEEEEEEEcCCCcEEEEEEeec---cch------hh---------HHHHHHHHHHHHHH---hcC
Q psy16843 364 NDFTVIKLISNGAY-GSVYLVRHKETRQRFAMKKIIK---NSL------ML---------RNQMEQVFAERDIM---SFT 421 (810)
Q Consensus 364 ~dy~ilk~LG~G~F-G~Vyla~~k~tg~~vAIK~I~k---~~~------~~---------~~~~~~i~~E~~iL---~~l 421 (810)
.+++.++.||.|.- |.||+++. .|+.||+|+... ... .. .....-+..|-+.. +.+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 99999987 567999998221 000 00 01223455565554 444
Q ss_pred CCCeE--EEeeeecccc------------------ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhh
Q psy16843 422 DNPFV--VTMYCSFETK------------------KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLH 481 (810)
Q Consensus 422 ~HPnI--Vkl~~~f~~~------------------~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLH 481 (810)
.+..+ |+.|++..-. ....||.||++... .+.. .-+.+|++-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 55556 8888876211 12356777765533 2222 33567888899999
Q ss_pred hcccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 482 s~gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
..||+-+|+|+.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999987 2379999964
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00027 Score=74.14 Aligned_cols=31 Identities=32% Similarity=0.371 Sum_probs=26.3
Q ss_pred cccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 483 ~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
.+++|+|+.+.|||++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998766567999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0013 Score=74.79 Aligned_cols=79 Identities=15% Similarity=0.185 Sum_probs=52.4
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeeccch---h-hHHHHHHHHHHHHHHhcC---CCCeEEEeeeeccccceeee
Q psy16843 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL---M-LRNQMEQVFAERDIMSFT---DNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~---~-~~~~~~~i~~E~~iL~~l---~HPnIVkl~~~f~~~~~lyL 441 (810)
.+.||.|.++.||++....+++.++||.-..... . ..-..++...|.+.|..+ ...++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999865446899996431100 0 011335566677777664 23456667766 3356789
Q ss_pred eeeeccCc
Q psy16843 442 VMEYVEGG 449 (810)
Q Consensus 442 VmEy~~GG 449 (810)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00089 Score=69.23 Aligned_cols=135 Identities=23% Similarity=0.258 Sum_probs=89.7
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccch-------------hhHHHHHHHHHHHHHHhcC------CCCeEEEee
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL-------------MLRNQMEQVFAERDIMSFT------DNPFVVTMY 430 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~-------------~~~~~~~~i~~E~~iL~~l------~HPnIVkl~ 430 (810)
..||+|+.=.||.--+ .....||++..... .......+..+|+.-...+ .+.+|.++|
T Consensus 7 ~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4689999988886432 33467887765540 0001123344444443333 478999999
Q ss_pred eeccccceeeeeeeeccCc------chhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC---
Q psy16843 431 CSFETKKHLCLVMEYVEGG------DCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG--- 501 (810)
Q Consensus 431 ~~f~~~~~lyLVmEy~~GG------sL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g--- 501 (810)
++.+++.-+-+|+|.+.+. +|.+++++ +.+++ .. ...+-.-.+||-+.+|+.+||+|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999999999987542 47777754 34655 22 23334445678889999999999999997533
Q ss_pred -cEEEec-cCCcc
Q psy16843 502 -HIKLTD-FGLSK 512 (810)
Q Consensus 502 -~VKL~D-FGLAk 512 (810)
.+.|+| ||-..
T Consensus 159 ~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 159 FRLVLIDGLGEKE 171 (199)
T ss_pred eEEEEEeCCCCcc
Confidence 577887 67543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00081 Score=70.06 Aligned_cols=137 Identities=16% Similarity=0.244 Sum_probs=78.7
Q ss_pred EEEecccCceEEEEEEEcC-CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC-CeEEEeeeeccccceeeeeeeec
Q psy16843 369 IKLISNGAYGSVYLVRHKE-TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN-PFVVTMYCSFETKKHLCLVMEYV 446 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~-tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H-PnIVkl~~~f~~~~~lyLVmEy~ 446 (810)
++.|..|-...||++.... .++.|++|+....... ......|..+++.+.. ....++++.+.. .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 5678888889999997543 3567889965432111 1122357777776633 233444444332 4799999
Q ss_pred cCcchhhh--------------hh---cCC-CC----------C-HHHHHHHHHH----------------------H--
Q psy16843 447 EGGDCASL--------------LK---NTG-PL----------P-ADMARFYFAE----------------------T-- 473 (810)
Q Consensus 447 ~GGsL~~l--------------L~---~~g-~l----------s-e~~~~~i~~Q----------------------I-- 473 (810)
+|..+... +. ... .. . .+.+..|... +
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 99765311 11 100 11 0 1122222211 1
Q ss_pred -HHHHH-Hh----hhcccccccCCCCceEecc-CCcEEEeccCCccc
Q psy16843 474 -VLAVE-YL----HSYGIVHRDLKPDNLLITA-LGHIKLTDFGLSKM 513 (810)
Q Consensus 474 -l~AL~-yL----Hs~gIIHRDLKPeNILLd~-~g~VKL~DFGLAk~ 513 (810)
+..|. .+ ...+++|+|+.+.|||++. ++.+.|+||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 11111 11 1246999999999999998 57899999998753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0025 Score=69.78 Aligned_cols=78 Identities=13% Similarity=0.087 Sum_probs=52.4
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC---CeEEEeeeeccc---cceee
Q psy16843 367 TVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN---PFVVTMYCSFET---KKHLC 440 (810)
Q Consensus 367 ~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H---PnIVkl~~~f~~---~~~ly 440 (810)
.-.+.||.|..+.||.....+ + .+.+|. .+... ....+..|...|+.+.. -.+.++++++.. .+.-+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~-~~~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLM-ARSFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEE-ecccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 346789999999999986432 3 466675 33210 11456778888877643 356667766543 36689
Q ss_pred eeeeeccCcch
Q psy16843 441 LVMEYVEGGDC 451 (810)
Q Consensus 441 LVmEy~~GGsL 451 (810)
||||+++|+.+
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.001 Score=70.66 Aligned_cols=132 Identities=19% Similarity=0.219 Sum_probs=73.4
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeE-EEeeeeccccceeeeeeeeccCcc
Q psy16843 372 ISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFV-VTMYCSFETKKHLCLVMEYVEGGD 450 (810)
Q Consensus 372 LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnI-Vkl~~~f~~~~~lyLVmEy~~GGs 450 (810)
+..|-.+.+|++. .+++.+++|......... .+ ....|..+++.+..-.+ .+++.... -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GV-DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 4567778899886 356678888643321110 01 23457777776643222 23333322 368999999876
Q ss_pred hhhh--------------h---hcCC----CCCH-HHHHHHHHHH---------HHHHHHhhh--------cccccccCC
Q psy16843 451 CASL--------------L---KNTG----PLPA-DMARFYFAET---------VLAVEYLHS--------YGIVHRDLK 491 (810)
Q Consensus 451 L~~l--------------L---~~~g----~lse-~~~~~i~~QI---------l~AL~yLHs--------~gIIHRDLK 491 (810)
+... + +... +++. ..+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 5421 1 1110 1111 1222322222 111222211 258999999
Q ss_pred CCceEeccCCcEEEeccCCccc
Q psy16843 492 PDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 492 PeNILLd~~g~VKL~DFGLAk~ 513 (810)
|.|||++.++ +.|+||+.|..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 9999999877 78999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0014 Score=67.20 Aligned_cols=96 Identities=20% Similarity=0.162 Sum_probs=77.6
Q ss_pred HHHHHHhcCCC-CeEEEeeeeccccceeeeeeeeccCcchhhh---hhcCCCCCHHHHHHHHHHHHHHHHHhhh---ccc
Q psy16843 413 AERDIMSFTDN-PFVVTMYCSFETKKHLCLVMEYVEGGDCASL---LKNTGPLPADMARFYFAETVLAVEYLHS---YGI 485 (810)
Q Consensus 413 ~E~~iL~~l~H-PnIVkl~~~f~~~~~lyLVmEy~~GGsL~~l---L~~~g~lse~~~~~i~~QIl~AL~yLHs---~gI 485 (810)
.|.-+|..+.+ +++.+++|+|.. ++|.||...+++... +..-...++.....++.+++..+++|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 46777777766 699999999843 668999987766532 2222346889999999999999999987 357
Q ss_pred ccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 486 VHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 486 IHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
.-.|++++|+-++.+|++|++|....-
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcc
Confidence 789999999999999999999999753
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0034 Score=68.17 Aligned_cols=76 Identities=13% Similarity=0.134 Sum_probs=45.9
Q ss_pred EEEecccCceEEEEEEEcC------CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCe-EEEeeeeccccceeee
Q psy16843 369 IKLISNGAYGSVYLVRHKE------TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF-VVTMYCSFETKKHLCL 441 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~------tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPn-IVkl~~~f~~~~~lyL 441 (810)
++.|..|--..||++.... .++.|++|+...... .......|.+++..+.... ..++++++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4566677778899887643 257899997543221 1123456777776664322 2344555432 36
Q ss_pred eeeeccCcchh
Q psy16843 442 VMEYVEGGDCA 452 (810)
Q Consensus 442 VmEy~~GGsL~ 452 (810)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999987664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.011 Score=64.66 Aligned_cols=141 Identities=21% Similarity=0.239 Sum_probs=79.6
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCC--eEEEeeeec------cccc
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP--FVVTMYCSF------ETKK 437 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HP--nIVkl~~~f------~~~~ 437 (810)
...++.++.|.-..||++... +..+++|+...... .+.+..|.+++..+... .+.+++... ...+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~-----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVK-----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEeC--CCcEEEEEecCCCC-----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 445677788888899988642 33588886543211 12334455666555321 133333221 2245
Q ss_pred eeeeeeeeccCcchhh-----------hh---hcC-CCCC--------HHH-----HH----------HHHHHHHHHHHH
Q psy16843 438 HLCLVMEYVEGGDCAS-----------LL---KNT-GPLP--------ADM-----AR----------FYFAETVLAVEY 479 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~-----------lL---~~~-g~ls--------e~~-----~~----------~i~~QIl~AL~y 479 (810)
..++||+|++|..+.. .+ +.. ..++ ... .. .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 6789999999865421 11 100 0010 000 00 001112334555
Q ss_pred hh-------hcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 480 LH-------SYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 480 LH-------s~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
+. ..+++|+|+++.||+++.++.+.|+||+.+..
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 53 26899999999999999988778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.011 Score=63.77 Aligned_cols=137 Identities=18% Similarity=0.170 Sum_probs=79.8
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCC--eEEEeeee------ccccceee
Q psy16843 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP--FVVTMYCS------FETKKHLC 440 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HP--nIVkl~~~------f~~~~~ly 440 (810)
++.|..|....+|++.. .+..+++|+.... ....+..|..++..+.+- .+.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 66777888889998864 3346888976431 113455566666665322 23333322 12234678
Q ss_pred eeeeeccCcchhh----h-------h---hcC-CCCCH--------HHHH------------HHHHHHHHHHHHhhh---
Q psy16843 441 LVMEYVEGGDCAS----L-------L---KNT-GPLPA--------DMAR------------FYFAETVLAVEYLHS--- 482 (810)
Q Consensus 441 LVmEy~~GGsL~~----l-------L---~~~-g~lse--------~~~~------------~i~~QIl~AL~yLHs--- 482 (810)
+|++|++|..+.. . + +.. ..+.. .... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999976532 0 0 000 00000 0000 011112334444443
Q ss_pred ----cccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 483 ----YGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 483 ----~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999977789999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.017 Score=63.28 Aligned_cols=31 Identities=29% Similarity=0.367 Sum_probs=26.5
Q ss_pred cccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 483 ~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
.|+||+|++|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4899999999999999765568999998753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.02 Score=63.41 Aligned_cols=148 Identities=18% Similarity=0.171 Sum_probs=81.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC--CeEEEeeeeccccc--ee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN--PFVVTMYCSFETKK--HL 439 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H--PnIVkl~~~f~~~~--~l 439 (810)
....++..+-.|.--.+|..... ++.+++. ... ............+|..+|+.+.- --+...++.+.++. ..
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 34445555533433344444333 6777777 221 11223344566678888876643 22334455555554 67
Q ss_pred eeeeeeccCcchhhhhhcCC--------------------------------CCCHHHHHHHHHHH--------------
Q psy16843 440 CLVMEYVEGGDCASLLKNTG--------------------------------PLPADMARFYFAET-------------- 473 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g--------------------------------~lse~~~~~i~~QI-------------- 473 (810)
|.||+|++|..+.+.+.... .+...+...+..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 99999999954433221100 00111111111111
Q ss_pred HHHHHHhhh--------cccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 474 VLAVEYLHS--------YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 474 l~AL~yLHs--------~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
..-..+|+. -.++|+|+++.||+|+..+-+=+.||+++..+.
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 112333332 238999999999999999999999999997644
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.024 Score=63.35 Aligned_cols=137 Identities=14% Similarity=0.186 Sum_probs=76.7
Q ss_pred EEEecccCceEEEEEEEcC----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeE-EEeeeeccccceeeeee
Q psy16843 369 IKLISNGAYGSVYLVRHKE----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFV-VTMYCSFETKKHLCLVM 443 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnI-Vkl~~~f~~~~~lyLVm 443 (810)
+..|-.|-...+|++.... +++.|++|+..... ...+. ...|..+++.+..-.+ .++++.+... .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 4455557788999987532 34678888664432 11112 2457777766643222 2444555432 589
Q ss_pred eeccCcchhhh--------------h---hcCC------CCCHHHHHHHHHHHH-----------------HHHHH----
Q psy16843 444 EYVEGGDCASL--------------L---KNTG------PLPADMARFYFAETV-----------------LAVEY---- 479 (810)
Q Consensus 444 Ey~~GGsL~~l--------------L---~~~g------~lse~~~~~i~~QIl-----------------~AL~y---- 479 (810)
+|++|..|... + +... ....+.+..+..++. ..+..
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987665411 1 1110 111223333332221 11111
Q ss_pred h----hhcccccccCCCCceEecc-CCcEEEeccCCccc
Q psy16843 480 L----HSYGIVHRDLKPDNLLITA-LGHIKLTDFGLSKM 513 (810)
Q Consensus 480 L----Hs~gIIHRDLKPeNILLd~-~g~VKL~DFGLAk~ 513 (810)
+ +...++|+|+++.|||++. ++.+.|+||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 2236899999999999986 47899999998753
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.0051 Score=67.62 Aligned_cols=136 Identities=18% Similarity=0.181 Sum_probs=89.4
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhh-----------------HHHH--HHHHHHHHHHhcCC-CC
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML-----------------RNQM--EQVFAERDIMSFTD-NP 424 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~-----------------~~~~--~~i~~E~~iL~~l~-HP 424 (810)
-+.+..+||-|--+-||.+-+. .|+++++|.-....... +..+ -...+|...|+.+. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3667889999999999999765 57788888432111100 1111 12456777776653 32
Q ss_pred e-EEEeeeeccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcE
Q psy16843 425 F-VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHI 503 (810)
Q Consensus 425 n-IVkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~V 503 (810)
+ |.+.++ ...-++|||++.|-.|...-+- ..+..+...+..-+.-|-.+|+||+|..-=|||++.++.+
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 2 222222 2467899999988776544321 1233344455555666888999999999999999999999
Q ss_pred EEeccCCc
Q psy16843 504 KLTDFGLS 511 (810)
Q Consensus 504 KL~DFGLA 511 (810)
+++||--.
T Consensus 242 ~vIDFPQm 249 (465)
T KOG2268|consen 242 VVIDFPQM 249 (465)
T ss_pred EEeechHh
Confidence 99999753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.024 Score=63.72 Aligned_cols=76 Identities=14% Similarity=0.181 Sum_probs=46.6
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeeccch----hhHHHHHHHHHHHHHHhcCCC--C-eEEEeeeeccccceeeeee
Q psy16843 371 LISNGAYGSVYLVRHKETRQRFAMKKIIKNSL----MLRNQMEQVFAERDIMSFTDN--P-FVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 371 ~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~----~~~~~~~~i~~E~~iL~~l~H--P-nIVkl~~~f~~~~~lyLVm 443 (810)
.||-|.-..||++....+++.++||.-..... ...-...+...|...|+...- | ++.++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999764446789885421111 112233455567777765432 3 44444433 345566999
Q ss_pred eeccC
Q psy16843 444 EYVEG 448 (810)
Q Consensus 444 Ey~~G 448 (810)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.047 Score=62.42 Aligned_cols=77 Identities=19% Similarity=0.227 Sum_probs=49.8
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh----hHHHHHHHHHHHHHHhcCC---CCeEEEeeeeccccceee
Q psy16843 368 VIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM----LRNQMEQVFAERDIMSFTD---NPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 368 ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~----~~~~~~~i~~E~~iL~~l~---HPnIVkl~~~f~~~~~ly 440 (810)
..+.||.|.-..||++... ++.|+||.-...... ......+...|...|+.+. ..++.++|.+.. +.-+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4778999999999998863 456888864311110 0012344455666665543 346777887776 4467
Q ss_pred eeeeeccC
Q psy16843 441 LVMEYVEG 448 (810)
Q Consensus 441 LVmEy~~G 448 (810)
+||||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.057 Score=58.58 Aligned_cols=30 Identities=33% Similarity=0.512 Sum_probs=25.7
Q ss_pred ccccccCCCCceEeccCCc-EEEeccCCccc
Q psy16843 484 GIVHRDLKPDNLLITALGH-IKLTDFGLSKM 513 (810)
Q Consensus 484 gIIHRDLKPeNILLd~~g~-VKL~DFGLAk~ 513 (810)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 56999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.013 Score=65.56 Aligned_cols=142 Identities=25% Similarity=0.257 Sum_probs=92.4
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhh----------------------HHHHH-HHHHHHHHHhcCCC
Q psy16843 367 TVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML----------------------RNQME-QVFAERDIMSFTDN 423 (810)
Q Consensus 367 ~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~----------------------~~~~~-~i~~E~~iL~~l~H 423 (810)
++-..|..|--+.||.|... +|..+|||+.+...+.. +..++ ....|++-|+.++.
T Consensus 147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 34566888999999998754 57779999754221111 11111 23456666666654
Q ss_pred CeEEEeeeeccccceeeeeeeeccCcch-hhhhhcCCCCCHHHHHHHHHHHHHHHHHhh-hcccccccCCCCceEeccCC
Q psy16843 424 PFVVTMYCSFETKKHLCLVMEYVEGGDC-ASLLKNTGPLPADMARFYFAETVLAVEYLH-SYGIVHRDLKPDNLLITALG 501 (810)
Q Consensus 424 PnIVkl~~~f~~~~~lyLVmEy~~GGsL-~~lL~~~g~lse~~~~~i~~QIl~AL~yLH-s~gIIHRDLKPeNILLd~~g 501 (810)
-.|.-.--+.. ..-.|||+|+.+... .-.|+ ...++...+..+-.|++.-+.-|- ..++||.||.--|+|+.. |
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G 301 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-G 301 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccc-cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-C
Confidence 33211000000 234789999964222 22232 356888889999999998888774 569999999999999965 9
Q ss_pred cEEEeccCCccc
Q psy16843 502 HIKLTDFGLSKM 513 (810)
Q Consensus 502 ~VKL~DFGLAk~ 513 (810)
.+.|+|.+-+..
T Consensus 302 ~lyiIDVSQSVE 313 (520)
T KOG2270|consen 302 KLYIIDVSQSVE 313 (520)
T ss_pred EEEEEEcccccc
Confidence 999999998753
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.024 Score=65.57 Aligned_cols=164 Identities=20% Similarity=0.211 Sum_probs=104.2
Q ss_pred HHHHHHHHHHhcCCCCeEEEeeeeccccc-eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhccccc
Q psy16843 409 EQVFAERDIMSFTDNPFVVTMYCSFETKK-HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVH 487 (810)
Q Consensus 409 ~~i~~E~~iL~~l~HPnIVkl~~~f~~~~-~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIH 487 (810)
.++.-..++++.+.|+|...+.++-.... ...+|||++ +.+|.+++..+. +-.... + .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~-------~-------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESL-------L-------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhh-------c-------ccccce
Confidence 45566678899999999999998876543 588899998 668888887643 211111 0 122222
Q ss_pred ccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHH
Q psy16843 488 RDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGV 567 (810)
Q Consensus 488 RDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGv 567 (810)
- +.++++| -+.. + | | .+.++++|||++|.
T Consensus 91 ~------------~~~~~td-~~~t------------------------~-------~--~-----~~~~pKsdVwsl~~ 119 (725)
T KOG1093|consen 91 L------------NIIYITD-HFLT------------------------K-------Y--P-----SPIGPKSDVWSLGF 119 (725)
T ss_pred e------------hhhhccc-cccc------------------------c-------C--C-----CCCCcchhhhhHHH
Confidence 1 2233344 1100 0 0 0 11124999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC---------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCC
Q psy16843 568 ILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE---------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHP 638 (810)
Q Consensus 568 ILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~---------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HP 638 (810)
++.|+..|...|......+....+.+-. ..+.. ..+.++.-..++..+|+-..|..||.. .++.+|+
T Consensus 120 i~~el~L~~~l~~~~~~s~~l~~i~k~~-~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~---~~~~k~~ 195 (725)
T KOG1093|consen 120 IILELYLGISLEAELTESEYLEILLKYY-TDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP---MELSKRC 195 (725)
T ss_pred HHHHHHHhhHHHHHHHHHHHHHHHHHhc-cCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch---hHHhcCc
Confidence 9999999988877666555554444311 11110 011144557789999999999999965 8999999
Q ss_pred CcCCC
Q psy16843 639 YFSNL 643 (810)
Q Consensus 639 fF~~i 643 (810)
-|.++
T Consensus 196 i~~ev 200 (725)
T KOG1093|consen 196 SFTEV 200 (725)
T ss_pred cHHHH
Confidence 98776
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.083 Score=60.23 Aligned_cols=78 Identities=21% Similarity=0.302 Sum_probs=49.9
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHHHHHHHhcCC--CC-eEEEeeeeccccceeeee
Q psy16843 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKN---SLMLRNQMEQVFAERDIMSFTD--NP-FVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~---~~~~~~~~~~i~~E~~iL~~l~--HP-nIVkl~~~f~~~~~lyLV 442 (810)
++.||-|.-..||++.....++.++||.-... .....-..++...|.+.|+... -| ++.++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 77899999999999998544567888853211 1111223456667777777553 23 45555543 44567789
Q ss_pred eeeccC
Q psy16843 443 MEYVEG 448 (810)
Q Consensus 443 mEy~~G 448 (810)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.092 Score=58.35 Aligned_cols=28 Identities=29% Similarity=0.552 Sum_probs=25.0
Q ss_pred cccccCCCCceEecc-CCcEEEeccCCcc
Q psy16843 485 IVHRDLKPDNLLITA-LGHIKLTDFGLSK 512 (810)
Q Consensus 485 IIHRDLKPeNILLd~-~g~VKL~DFGLAk 512 (810)
++|.||.+.|||++. ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 789999999999975 5789999999874
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.11 Score=54.64 Aligned_cols=102 Identities=18% Similarity=0.233 Sum_probs=64.7
Q ss_pred cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHH
Q psy16843 390 QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFY 469 (810)
Q Consensus 390 ~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i 469 (810)
....+|++..-..... ..-+..+.++++.+. .|+++..- ....+-+|.|+|-. ......-++
T Consensus 86 G~L~lKKi~slp~~~~--~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~------------~~i~~~N~i 147 (308)
T PF07387_consen 86 GPLFLKKIRSLPCCIN--DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYK------------IKINFSNFI 147 (308)
T ss_pred chhhhhhccCCCcccc--hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccC------------cccchhHHH
Confidence 3455666644322211 123466777877664 47777622 34467789998843 111112222
Q ss_pred HHHHHHHHHHhhh--cccccccCCCCceEeccCCcEEEeccCC
Q psy16843 470 FAETVLAVEYLHS--YGIVHRDLKPDNLLITALGHIKLTDFGL 510 (810)
Q Consensus 470 ~~QIl~AL~yLHs--~gIIHRDLKPeNILLd~~g~VKL~DFGL 510 (810)
.+ =+.+|.-.|+ .+.+|+|-.|+|||-|+.|.+||.|=+.
T Consensus 148 ~a-gi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 148 TA-GIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HH-hHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 22 2467777884 4799999999999999999999999874
|
The function of this family is unknown. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.31 Score=53.36 Aligned_cols=75 Identities=17% Similarity=0.176 Sum_probs=44.5
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC---CCCeEEEeeeeccccceeeeee
Q psy16843 367 TVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT---DNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 367 ~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l---~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+-.+.||.|....+|... .+++.|.+|+-.... ...+..|..-|+.+ ..-.+.+.+.+....+.-||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 446778989999999987 677889999765221 13455566666555 4456777787777667779999
Q ss_pred eeccCc
Q psy16843 444 EYVEGG 449 (810)
Q Consensus 444 Ey~~GG 449 (810)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.03 E-value=0.11 Score=58.42 Aligned_cols=74 Identities=24% Similarity=0.356 Sum_probs=56.7
Q ss_pred cccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 434 ETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY-GIVHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 434 ~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
.+..++|++|++- |+.+.- + .....+++..++.+.+.-|+-+..+ ..-|||+.-+||||+ +|+|.|+||-+++
T Consensus 296 de~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 296 DETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred CCceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence 3445788999975 444432 2 2245677778888888777777765 688999999999999 8999999999998
Q ss_pred c
Q psy16843 513 M 513 (810)
Q Consensus 513 ~ 513 (810)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 5
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.88 E-value=0.25 Score=56.26 Aligned_cols=29 Identities=28% Similarity=0.259 Sum_probs=24.4
Q ss_pred cccccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 483 ~gIIHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
...+|.||-+.|||.+. +.++++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 45789999999999764 569999999874
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=93.08 E-value=0.62 Score=50.35 Aligned_cols=29 Identities=31% Similarity=0.563 Sum_probs=25.3
Q ss_pred cccccCCCCceEeccC--C---cEEEeccCCccc
Q psy16843 485 IVHRDLKPDNLLITAL--G---HIKLTDFGLSKM 513 (810)
Q Consensus 485 IIHRDLKPeNILLd~~--g---~VKL~DFGLAk~ 513 (810)
++|||++..|||+..+ | .+++.||-+++.
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccC
Confidence 8999999999999765 3 699999998864
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=92.65 E-value=0.29 Score=56.36 Aligned_cols=29 Identities=24% Similarity=0.299 Sum_probs=23.1
Q ss_pred cccccCCCCceEeccCCc-----EEEeccCCccc
Q psy16843 485 IVHRDLKPDNLLITALGH-----IKLTDFGLSKM 513 (810)
Q Consensus 485 IIHRDLKPeNILLd~~g~-----VKL~DFGLAk~ 513 (810)
++|+||...|||.+.++. ..|+||-.+..
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~ 303 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR 303 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence 789999999999998443 46888877654
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.86 E-value=2.3 Score=54.51 Aligned_cols=31 Identities=32% Similarity=0.461 Sum_probs=26.6
Q ss_pred cccccccCCCCceEeccCC--cEE-EeccCCccc
Q psy16843 483 YGIVHRDLKPDNLLITALG--HIK-LTDFGLSKM 513 (810)
Q Consensus 483 ~gIIHRDLKPeNILLd~~g--~VK-L~DFGLAk~ 513 (810)
.++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 565 999998754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=91.44 E-value=0.28 Score=53.19 Aligned_cols=29 Identities=24% Similarity=0.496 Sum_probs=25.9
Q ss_pred cccccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 483 ~gIIHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999988 778999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=88.90 E-value=0.77 Score=52.44 Aligned_cols=63 Identities=29% Similarity=0.284 Sum_probs=44.9
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHH-hhhcccccccCCCCceEeccCC
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEY-LHSYGIVHRDLKPDNLLITALG 501 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~y-LHs~gIIHRDLKPeNILLd~~g 501 (810)
...||-+|..|..+..+++.. ..+|+..+.++.-.+.||-- |--.+++|.|++|.||++..+.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 456777888898888888753 34555666666655666543 3346899999999999996533
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.27 E-value=0.42 Score=53.15 Aligned_cols=51 Identities=31% Similarity=0.496 Sum_probs=35.6
Q ss_pred HHHHHHHHHHHHHHHHHh---h-hcccccccCCCCceEeccCC------------------cEEEeccCCccc
Q psy16843 463 ADMARFYFAETVLAVEYL---H-SYGIVHRDLKPDNLLITALG------------------HIKLTDFGLSKM 513 (810)
Q Consensus 463 e~~~~~i~~QIl~AL~yL---H-s~gIIHRDLKPeNILLd~~g------------------~VKL~DFGLAk~ 513 (810)
.+-+++++.||+.-.-.+ - ..+++|-||||+||||=... ..+|.||.+|..
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 456778888987655333 2 34799999999999984322 256777777754
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=87.69 E-value=0.46 Score=53.08 Aligned_cols=52 Identities=33% Similarity=0.487 Sum_probs=36.0
Q ss_pred CHHHHHHHHHHHHHHHH---Hhh-hcccccccCCCCceEeccCC------------------cEEEeccCCccc
Q psy16843 462 PADMARFYFAETVLAVE---YLH-SYGIVHRDLKPDNLLITALG------------------HIKLTDFGLSKM 513 (810)
Q Consensus 462 se~~~~~i~~QIl~AL~---yLH-s~gIIHRDLKPeNILLd~~g------------------~VKL~DFGLAk~ 513 (810)
-.+-+++++.||+.-.- -|- ..+.+|-||||+||||=... ..+|.||.+|..
T Consensus 273 ~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 273 NVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred HHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence 34567778888865441 232 35799999999999984321 367889988864
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 810 | ||||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-59 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-59 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-59 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-59 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-59 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-59 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-59 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-59 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-59 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-59 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-58 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-57 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-57 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-57 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-57 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-56 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-56 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-56 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-56 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-56 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-56 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-56 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-56 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-56 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-56 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-56 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-56 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-56 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-56 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-56 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-56 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-56 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-56 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-56 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-56 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-56 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-56 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-56 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-56 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-56 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-56 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-56 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-56 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-56 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-56 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-56 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-56 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-55 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-55 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-55 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-55 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-55 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-55 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-55 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-55 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-55 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-55 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-55 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-55 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-55 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-55 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-55 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-55 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-55 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-55 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-55 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-55 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-55 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-55 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-54 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-54 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-54 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-54 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-53 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-53 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-53 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-53 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-51 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-51 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-51 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-50 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-50 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-49 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-49 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-49 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-49 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-49 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-48 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-48 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-48 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-44 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-40 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-40 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-40 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-40 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-40 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-40 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-40 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-40 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-40 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-40 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-40 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-40 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-40 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-40 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-40 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-40 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-39 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-39 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-39 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-39 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-39 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-36 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-36 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-36 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-36 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-36 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-33 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-32 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-32 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-32 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-31 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-31 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-31 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-31 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-31 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-31 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-31 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-30 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-30 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-30 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-30 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-30 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-30 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-30 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-30 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-30 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-30 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-30 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-30 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-30 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-30 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-30 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-30 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-30 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-30 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-30 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-30 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-30 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-30 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-30 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-30 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-30 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-30 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-30 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-29 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-29 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-29 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-29 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-29 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-29 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-29 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-29 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-29 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-29 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-29 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-29 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-29 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-29 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-29 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-29 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-29 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-29 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-29 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-29 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-29 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-29 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-28 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-28 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-28 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-28 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-28 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-28 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-28 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-28 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-28 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-27 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-27 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-27 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-27 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-27 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-27 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-27 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-27 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-26 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-26 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-26 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-26 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-26 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-26 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-26 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-26 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-26 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-26 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-26 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-26 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-26 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-26 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-26 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-26 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-26 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-26 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-26 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-26 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-26 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-26 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-26 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-26 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-26 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-26 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-26 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-26 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-26 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-26 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-25 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-25 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-25 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-25 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-25 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-25 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-25 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-25 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-25 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-25 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-25 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-25 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-25 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-25 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-25 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-25 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-25 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-25 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-25 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-25 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-25 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-25 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-25 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-24 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-24 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-24 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-24 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-24 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-24 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-24 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-24 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-24 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-24 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-23 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-23 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-23 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-23 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-23 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-23 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-23 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-23 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-23 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-23 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-23 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-23 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-23 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-23 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-23 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-23 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-23 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-22 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-22 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-22 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-22 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-22 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-21 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-21 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-21 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-21 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-21 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-21 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-21 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-21 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-21 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-21 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-21 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-20 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-20 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-20 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-20 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-20 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-20 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-20 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-20 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-20 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-20 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-20 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-20 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-20 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-20 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-20 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-20 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-20 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-20 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-20 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-20 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-20 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-20 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-20 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-20 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-20 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-20 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-20 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-20 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-20 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-20 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-19 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-19 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-19 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-19 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-19 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-19 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-19 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-19 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-19 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-19 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-19 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-19 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-19 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-18 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-18 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-18 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-18 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-18 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-18 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-18 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-18 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-18 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-18 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-18 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-18 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-18 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-18 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-18 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-18 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-18 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-18 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-18 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-17 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-17 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-17 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-17 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-17 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-17 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-17 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-16 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-16 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-16 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-16 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-16 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-16 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-16 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-16 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-16 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-16 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-16 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-16 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-16 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-16 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-16 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-16 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-16 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-16 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-16 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-16 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-16 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-16 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-16 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-16 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-16 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-16 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-16 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-16 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-16 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-15 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-15 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-15 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-15 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-15 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-15 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-15 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-15 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-14 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-14 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-13 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-13 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-12 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-11 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 1v9v_A | 114 | Solution Structure Of Putative Domain Of Human Kiaa | 4e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-09 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-09 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-08 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-08 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-08 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-07 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-07 |
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1V9V|A Chain A, Solution Structure Of Putative Domain Of Human Kiaa0561 Protein Length = 114 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 810 | |||
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-137 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-118 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-118 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-116 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-116 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-115 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-113 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-112 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-112 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-112 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-112 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-111 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-111 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-110 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-110 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-109 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-108 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-105 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-102 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-102 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 4e-99 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 6e-99 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-93 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-92 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-82 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-80 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-74 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-74 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 4e-74 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 5e-74 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-73 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-72 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-71 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-71 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-69 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-69 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-69 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-69 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-69 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 6e-69 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-68 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-68 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-68 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-68 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-68 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-68 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 7e-68 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 8e-68 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 8e-68 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-67 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-67 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-67 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-67 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-67 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-66 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-66 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-66 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-66 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-66 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 5e-66 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 5e-66 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-65 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-65 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-65 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-65 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 5e-65 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-65 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-64 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-64 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-64 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-64 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-64 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 4e-64 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-64 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-64 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-63 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-63 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-63 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-63 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 6e-62 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 7e-62 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-61 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-61 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-60 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 8e-60 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 8e-60 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-59 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-59 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 8e-59 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-57 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-56 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-54 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 4e-54 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-53 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 8e-52 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-51 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-50 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-49 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 8e-49 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 7e-47 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 8e-47 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 4e-46 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 5e-46 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 6e-46 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 8e-46 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-45 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-45 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 4e-45 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 5e-45 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-44 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 7e-44 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-43 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-42 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 4e-41 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-40 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-39 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-39 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 5e-39 | |
| 1v9v_A | 114 | KIAA0561 protein; helix bundle, MAST205, microtubu | 6e-39 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 7e-39 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-38 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-38 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 7e-38 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-37 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 4e-37 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-37 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-36 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-36 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 4e-36 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 5e-36 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 7e-36 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 8e-36 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 8e-36 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-35 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-35 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-35 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 6e-35 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 4e-34 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 6e-34 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-33 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-33 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-33 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 9e-32 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-31 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-30 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-30 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-30 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 7e-30 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-29 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-29 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-29 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-29 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-28 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-28 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-28 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-28 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-28 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 5e-28 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 6e-28 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 9e-28 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-27 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-27 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-27 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-27 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-27 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 5e-27 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 6e-27 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 7e-27 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-26 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-26 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-26 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-26 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-24 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-21 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 7e-20 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 9e-20 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-19 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 7e-19 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-18 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-18 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-18 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 6e-18 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 8e-18 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 8e-18 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 9e-18 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-17 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-17 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-17 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-17 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-17 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-17 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 4e-17 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 7e-17 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 9e-17 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-16 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-16 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-16 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-16 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-16 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-16 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 5e-16 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-16 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-15 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-15 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-15 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-15 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-15 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-15 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-15 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-15 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 7e-15 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 8e-15 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-14 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-14 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-14 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-14 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-14 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-14 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-14 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-14 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-14 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-14 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 5e-14 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 6e-14 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 7e-14 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 8e-14 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-13 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-13 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 5e-13 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 6e-13 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-12 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-12 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-12 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-12 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-08 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 8e-12 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-10 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-08 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-08 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 4e-04 |
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 411 bits (1057), Expect = e-137
Identities = 115/400 (28%), Positives = 183/400 (45%), Gaps = 32/400 (8%)
Query: 313 QYIIGKLGINKTVFSD-LDNDIQNISLTDTSIESNSDSYCSKKDKFSKTPNE-----NDF 366
Q ++ + D L Q + ++ + + + + E +DF
Sbjct: 4 QLVLDPGFLGLEPLLDLLLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDF 63
Query: 367 TVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFV 426
++K+I GA+ V +V+ K+T Q +AMK + K ++ R ++ ERD++ D ++
Sbjct: 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 427 VTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP-LPADMARFYFAETVLAVEYLHSYGI 485
++ +F+ + +L LVMEY GGD +LL G +PA+MARFY AE V+A++ +H G
Sbjct: 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY 183
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
VHRD+KPDN+L+ GHI+L DFG GTP+Y
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRAD--------------GTVRSLVAVGTPDY 229
Query: 546 IAPEVILRQG-------YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE- 597
++PE++ G YG DWW++GV YE G PF+ ++ E + V+
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289
Query: 598 -WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFI 656
P D+ + EA+ I LL P RLG GG + + HP+F LDW+ L F
Sbjct: 290 SLPLVDEG-VPEEARDFIQRLL-CPPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFT 347
Query: 657 PQLDDEEDTSYFDSRMERYNHDIGEDTDETEDSFSLGTFS 696
P + DT FD + + + D
Sbjct: 348 PDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLG 387
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 363 bits (934), Expect = e-118
Identities = 134/404 (33%), Positives = 203/404 (50%), Gaps = 44/404 (10%)
Query: 329 LDNDIQNISLTDTSIESNSDSYCSKKDKFSKTPNE-----NDFTVIKLISNGAYGSVYLV 383
LD + ++ N D++ S+ + D+ V+K+I GA+G V LV
Sbjct: 29 LDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLV 88
Query: 384 RHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443
RHK TR+ +AMK + K ++ R+ + ERDIM+F ++P+VV ++ +F+ ++L +VM
Sbjct: 89 RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148
Query: 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHI 503
EY+ GGD +L+ N +P ARFY AE VLA++ +HS G +HRD+KPDN+L+ GH+
Sbjct: 149 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 207
Query: 504 KLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG----YGKP 559
KL DFG + ++ D V GTP+YI+PEV+ QG YG+
Sbjct: 208 KLADFGTCM-------------KMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRE 253
Query: 560 VDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQ 619
DWWS+GV LYE LVG PF+ ++ ++ +N DD I EAK++I L
Sbjct: 254 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL- 312
Query: 620 QNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAE--FIPQLDDEEDTSYFDSRMERYNH 677
+ RLG G E+K H +F N W +P L + DTS FD
Sbjct: 313 TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDD------- 365
Query: 678 DIGEDTDET-EDSFSLGTFSSCTHQ------YKKVQSQLSSQSS 714
+ D+ E++F + Y + LSS +
Sbjct: 366 ---LEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANP 406
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 357 bits (920), Expect = e-118
Identities = 109/333 (32%), Positives = 180/333 (54%), Gaps = 27/333 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
DF +++ + G++G V+L+R + + +AMK + K ++ Q+E ER ++S +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
PF++ M+ +F+ + + ++M+Y+EGG+ SLL+ + P +A+FY AE LA+EYLHS
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 125
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
I++RDLKP+N+L+ GHIK+TDFG +K YV GTP
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAK-------------YVPDVTYTLC-----GTP 167
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
+YIAPEV+ + Y K +DWWS G+++YE L G PF+ + + +N ++ +P
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF-- 225
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHKAE--FIPQL 659
+ K +++ L+ ++ RLG G +VK HP+F + W LL E + P +
Sbjct: 226 --FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPI 283
Query: 660 -DDEEDTSYFDSRMERYNHDIGEDTDETEDSFS 691
+ DTS FD E + + D D F
Sbjct: 284 QQGQGDTSQFDKYPEEDINYGVQGEDPYADLFR 316
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-116
Identities = 122/401 (30%), Positives = 196/401 (48%), Gaps = 29/401 (7%)
Query: 302 KSLQGIKADIPQYIIGKLGINKTVFSDLDNDIQNISLTDTSIESNSDSYCSKKDKFSKTP 361
+ L+ D P G+ +T+ L + + E N Y F+
Sbjct: 7 RQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKV 66
Query: 362 NE-----NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERD 416
+ DF ++K+I GA+G V +V+ K + FAMK + K ++ R + ERD
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 417 IMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVL 475
++ D+ ++ T++ +F+ +L LVM+Y GGD +LL K LP +MARFY AE V+
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
A++ +H VHRD+KPDN+L+ GHI+L DFG + D S
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM-------------EDGTVQS 233
Query: 536 DKQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590
V GTP+YI+PE++ + YG DWWS+GV +YE L G PF+ E+ E +
Sbjct: 234 SVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292
Query: 591 TVN--DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSL 648
+N + ++P++ + AK +I L+ RLG G + K+HP+FS +DW+++
Sbjct: 293 IMNHKERFQFPTQVTD-VSENAKDLIRRLICSREH-RLGQNGIEDFKKHPFFSGIDWDNI 350
Query: 649 LRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETEDS 689
+A +IP++ DTS FD + +
Sbjct: 351 RNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAF 391
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-116
Identities = 114/310 (36%), Positives = 173/310 (55%), Gaps = 26/310 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ F IK + G++G V LV+HKE+ +AMK + K ++ Q+E E+ I+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
PF+V + SF+ +L +VMEYV GG+ S L+ G ARFY A+ VL EYLHS
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
+++RDLKP+NLLI G+I++TDFG +K V+ GTP
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-------------RVKGRTWTLC-----GTP 202
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
E +APE+IL +GY K VDWW++GV++YE G PFF + P +++ V+ + +PS
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH-- 260
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQL 659
+ K ++ +LLQ + R G G +++K H +F+ DW ++ + K A FIP+
Sbjct: 261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKF 318
Query: 660 DDEEDTSYFD 669
DTS FD
Sbjct: 319 KGPGDTSNFD 328
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 351 bits (902), Expect = e-115
Identities = 119/311 (38%), Positives = 178/311 (57%), Gaps = 23/311 (7%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
NDF +KL+ G +G V LVR K T + +AMK + K ++ ++++ E ++ T +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
PF+ + +F+T LC VMEY GG+ L + ARFY AE V A+EYLHS
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
+V+RD+K +NL++ GHIK+TDFGL K G+ AT C GTP
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---------------GTP 169
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
EY+APEV+ YG+ VDWW +GV++YE + G +PF+ + E LF + ++I +P
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT-- 227
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHKAE--FIPQL 659
+ EAKS++ LL+++P+ RLG G EV EH +F +++W +++ K F PQ+
Sbjct: 228 --LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 285
Query: 660 DDEEDTSYFDS 670
E DT YFD
Sbjct: 286 TSEVDTRYFDD 296
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 347 bits (893), Expect = e-113
Identities = 110/315 (34%), Positives = 168/315 (53%), Gaps = 27/315 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRH---KETRQRFAMKKIIKNSLMLR-NQMEQVFAERDIMS 419
F +++++ G YG V+ VR T + FAMK + K ++ AER+I+
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEY 479
+PF+V + +F+T L L++EY+ GG+ L+ G D A FY AE +A+ +
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
LH GI++RDLKP+N+++ GH+KLTDFGL K + C
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-------------- 182
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599
GT EY+APE+++R G+ + VDWWS+G ++Y+ L G PF GE ++ + + P
Sbjct: 183 -GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP 241
Query: 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHKAE--F 655
+ EA+ ++ LL++N RLG G EV+ HP+F +++W LL K E F
Sbjct: 242 PY----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPF 297
Query: 656 IPQLDDEEDTSYFDS 670
P L EED S FDS
Sbjct: 298 KPLLQSEEDVSQFDS 312
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 344 bits (886), Expect = e-112
Identities = 114/314 (36%), Positives = 181/314 (57%), Gaps = 27/314 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRH---KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF 420
+ F ++K++ G++G V+LV+ + RQ +AMK + K +L +R+++ ERDI+
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVE 82
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYL 480
++PF+V ++ +F+T+ L L+++++ GGD + L + +FY AE LA+++L
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
HS GI++RDLKP+N+L+ GHIKLTDFGLSK + C
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--------------- 187
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600
GT EY+APEV+ R+G+ + DWWS GV+++E L G +PF G+ +E + + P
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ 247
Query: 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHKAE--FI 656
+ EA+S++ L ++NP +RLG G G E+K H +FS +DWN L R + F
Sbjct: 248 F----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFK 303
Query: 657 PQLDDEEDTSYFDS 670
P EDT YFD
Sbjct: 304 PATGRPEDTFYFDP 317
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-112
Identities = 114/310 (36%), Positives = 178/310 (57%), Gaps = 24/310 (7%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF-TD 422
DF + K++ G++G V+L K+T Q FA+K + K+ +++ + +E E+ ++S +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+PF+ M+C+F+TK++L VMEY+ GGD +++ A FY AE +L +++LHS
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
GIV+RDLK DN+L+ GHIK+ DFG+ K ++ A C GT
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC---------------GT 181
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602
P+YIAPE++L Q Y VDWWS GV+LYE L+G PF G+ EELF D+ +P
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW- 240
Query: 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAE--FIPQLD 660
++ EAK ++ L + P RLG G ++++HP F ++W L R + + F P++
Sbjct: 241 ---LEKEAKDLLVKLFVREPEKRLGVRG--DIRQHPLFREINWEELERKEIDPPFRPKVK 295
Query: 661 DEEDTSYFDS 670
D S FD
Sbjct: 296 SPFDCSNFDK 305
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-112
Identities = 115/335 (34%), Positives = 178/335 (53%), Gaps = 29/335 (8%)
Query: 342 SIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNS 401
S + + + ++ ++F I+++ G++G V L R KET +A+K + K+
Sbjct: 5 SSKEGNGIGVNSSNRLGI----DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV 60
Query: 402 LMLRNQMEQVFAERDIMSFTDN-PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP 460
++ + +E E+ I+S N PF+ ++C F+T L VME+V GGD ++ +
Sbjct: 61 ILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR 120
Query: 461 LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520
ARFY AE + A+ +LH GI++RDLK DN+L+ GH KL DFG+ K G+ + T
Sbjct: 121 FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180
Query: 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF 580
C GTP+YIAPE++ YG VDWW+MGV+LYE L G PF
Sbjct: 181 TATFC---------------GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225
Query: 581 GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLG---TGGPHEVKEH 637
E ++LF +ND++ +P+ + +A I+ + +NP RLG GG H + H
Sbjct: 226 AENEDDLFEAILNDEVVYPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281
Query: 638 PYFSNLDWNSLLRHKAE--FIPQLDDEEDTSYFDS 670
P+F +DW L + E F P++ ED S FD
Sbjct: 282 PFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDP 316
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-112
Identities = 106/311 (34%), Positives = 169/311 (54%), Gaps = 23/311 (7%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS-FTD 422
+DF +K+I G++G V L RHK +A+K + K +++ + + + + +ER+++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+PF+V ++ SF+T L V++Y+ GG+ L+ ARFY AE A+ YLHS
Sbjct: 98 HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS 157
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
IV+RDLKP+N+L+ + GHI LTDFGL K + +T C GT
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---------------GT 202
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602
PEY+APEV+ +Q Y + VDWW +G +LYE L G PF+ E++ + +N ++
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN- 261
Query: 603 DWPIQVEAKSIITDLLQQNPRDRLG-TGGPHEVKEHPYFSNLDWNSLLRHKAE--FIPQL 659
I A+ ++ LLQ++ RLG E+K H +FS ++W+ L+ K F P +
Sbjct: 262 ---ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNV 318
Query: 660 DDEEDTSYFDS 670
D +FD
Sbjct: 319 SGPNDLRHFDP 329
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 341 bits (878), Expect = e-111
Identities = 87/297 (29%), Positives = 152/297 (51%), Gaps = 20/297 (6%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
DF K++ G++ +V L R T + +A+K + K ++ N++ V ERD+MS D+
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
PF V +Y +F+ + L + Y + G+ ++ G RFY AE V A+EYLH
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
GI+HRDLKP+N+L+ HI++TDFG +K+ + ++KQ GT
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANSFVGTA 196
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
+Y++PE++ + K D W++G I+Y+ + G PF +F + + ++P +
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK-- 254
Query: 604 WPIQVEAKSIITDLLQQNPRDRLG---TGGPHEVKEHPYFSNLDWNSLLRHKAEFIP 657
+A+ ++ LL + RLG G +K HP+F ++ W +L + +
Sbjct: 255 --FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 309
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 345 bits (886), Expect = e-111
Identities = 128/389 (32%), Positives = 200/389 (51%), Gaps = 37/389 (9%)
Query: 287 PEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDNDIQNISLTDTSIESN 346
E +H E E + I+ G+ K +++D + S + E
Sbjct: 84 IERTFHV-ETPEEREEWTTAIQTVAD-------GLKKQAAAEMDFRSGSPSDNSGAEEM- 134
Query: 347 SDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRN 406
S K + + N+F +KL+ G +G V LV+ K T + +AMK + K ++ ++
Sbjct: 135 EVSLAKPKHRVT----MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD 190
Query: 407 QMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMA 466
++ E ++ + +PF+ + SF+T LC VMEY GG+ L D A
Sbjct: 191 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA 250
Query: 467 RFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC 525
RFY AE V A++YLHS +V+RDLK +NL++ GHIK+TDFGL K G+ AT C
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 310
Query: 526 YVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE 585
GTPEY+APEV+ YG+ VDWW +GV++YE + G +PF+ + E
Sbjct: 311 ---------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 355
Query: 586 ELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNL 643
+LF + ++I +P + EAKS+++ LL+++P+ RLG G E+ +H +F+ +
Sbjct: 356 KLFELILMEEIRFPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411
Query: 644 DWNSLLRHKAE--FIPQLDDEEDTSYFDS 670
W + K F PQ+ E DT YFD
Sbjct: 412 VWQHVYEKKLSPPFKPQVTSETDTRYFDE 440
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 340 bits (875), Expect = e-110
Identities = 109/367 (29%), Positives = 173/367 (47%), Gaps = 40/367 (10%)
Query: 341 TSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKN 400
T+ + +D+ DF + ++ G++G V L K T + +A+K + K+
Sbjct: 1 TTNTVSKFDNNGNRDRMKL----TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD 56
Query: 401 SLMLRNQMEQVFAERDIMSFTDN-PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG 459
++ + +E E+ +++ PF+ ++ F+T L VMEYV GGD ++ G
Sbjct: 57 VVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG 116
Query: 460 PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519
A FY AE + + +L S GI++RDLK DN+++ + GHIK+ DFG+ K +
Sbjct: 117 RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176
Query: 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPF 579
T C GTP+YIAPE+I Q YGK VDWW+ GV+LYE L G PF
Sbjct: 177 TTKTFC---------------GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 221
Query: 580 FGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEH 637
GE +ELF + ++ +P + EA +I L+ ++P RLG G G ++KEH
Sbjct: 222 EGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277
Query: 638 PYFSNLDWNSLLRHKAE--FIPQLDDEEDTSYFDSRMERYNHDIGEDTDET-EDSFSLGT 694
+F +DW L R + + + P+ + FD T +
Sbjct: 278 AFFRYIDWEKLERKEIQPPYKPKACG-RNAENFDR----------FFTRHPPVLTPPDQE 326
Query: 695 FSSCTHQ 701
Q
Sbjct: 327 VIRNIDQ 333
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 339 bits (873), Expect = e-110
Identities = 112/322 (34%), Positives = 172/322 (53%), Gaps = 34/322 (10%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
DF ++++I G+Y V LVR K+T + +AMK + K + ++ V E+ + N
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 424 -PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
PF+V ++ F+T+ L V+EYV GGD ++ LP + ARFY AE LA+ YLH
Sbjct: 69 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
GI++RDLK DN+L+ + GHIKLTD+G+ K GL T C GT
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---------------GT 173
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF---------GETPEELFAHTVN 593
P YIAPE++ + YG VDWW++GV+++E + G PF T + LF +
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG---GPHEVKEHPYFSNLDWNSLLR 650
I P + V+A S++ L ++P++RLG G +++ HP+F N+DW+ + +
Sbjct: 234 KQIRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ 289
Query: 651 HKAE--FIPQLDDEEDTSYFDS 670
+ F P + E FDS
Sbjct: 290 KQVVPPFKPNISGEFGLDNFDS 311
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 338 bits (869), Expect = e-109
Identities = 115/356 (32%), Positives = 181/356 (50%), Gaps = 34/356 (9%)
Query: 330 DNDIQNISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETR 389
+N ++ E + K S + DF ++++I G+Y V LVR K+T
Sbjct: 18 ENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTD 77
Query: 390 QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN-PFVVTMYCSFETKKHLCLVMEYVEG 448
+ +AM+ + K + ++ V E+ + N PF+V ++ F+T+ L V+EYV G
Sbjct: 78 RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 137
Query: 449 GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDF 508
GD ++ LP + ARFY AE LA+ YLH GI++RDLK DN+L+ + GHIKLTD+
Sbjct: 138 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 197
Query: 509 GLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVI 568
G+ K GL T C GTP YIAPE++ + YG VDWW++GV+
Sbjct: 198 GMCKEGLRPGDTTSTFC---------------GTPNYIAPEILRGEDYGFSVDWWALGVL 242
Query: 569 LYEFLVGCVPFF---------GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQ 619
++E + G PF T + LF + I P + V+A S++ L
Sbjct: 243 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAASVLKSFLN 298
Query: 620 QNPRDRLGTG---GPHEVKEHPYFSNLDWNSLLRHKAE--FIPQLDDEEDTSYFDS 670
++P++RLG G +++ HP+F N+DW+ + + + F P + E FDS
Sbjct: 299 KDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDS 354
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-108
Identities = 110/358 (30%), Positives = 180/358 (50%), Gaps = 39/358 (10%)
Query: 327 SDLDNDIQNISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRH- 385
+ D L E + + +K +F ++K++ GAYG V+LVR
Sbjct: 21 TSADGGDGGEQLLTVKHELRTANLTGHAEKVG----IENFELLKVLGTGAYGKVFLVRKI 76
Query: 386 --KETRQRFAMKKIIKNSLMLR-NQMEQVFAERDIMSFTDN-PFVVTMYCSFETKKHLCL 441
+T + +AMK + K +++ + E ER ++ PF+VT++ +F+T+ L L
Sbjct: 77 SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 136
Query: 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG 501
+++Y+ GG+ + L + Y E VLA+E+LH GI++RD+K +N+L+ + G
Sbjct: 137 ILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG 196
Query: 502 HIKLTDFGLSKMGLMSLATNLYE-CYVERDAKQFSDKQVYGTPEYIAPEVIL--RQGYGK 558
H+ LTDFGLSK + Y+ C GT EY+AP+++ G+ K
Sbjct: 197 HVVLTDFGLSKEFVADETERAYDFC---------------GTIEYMAPDIVRGGDSGHDK 241
Query: 559 PVDWWSMGVILYEFLVGCVPFFGE----TPEELFAHTVNDDIEWPSEDDWPIQVEAKSII 614
VDWWS+GV++YE L G PF + + E+ + + +P E + AK +I
Sbjct: 242 AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE----MSALAKDLI 297
Query: 615 TDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHKAE--FIPQLDDEEDTSYF 668
LL ++P+ RLG G E+KEH +F ++W+ L K F P + DE D S F
Sbjct: 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 326 bits (839), Expect = e-105
Identities = 86/315 (27%), Positives = 156/315 (49%), Gaps = 34/315 (10%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ F +++ I G++G V +V+ +T++ +AMK + K + RN++ VF E IM ++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
PF+V ++ SF+ ++ + +V++ + GGD L+ + + + E V+A++YL +
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
I+HRD+KPDN+L+ GH+ +TDF ++ E + GT
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAA-----------MLPRETQITTMA-----GTK 178
Query: 544 EYIAPEVILRQ---GYGKPVDWWSMGVILYEFLVGCVPFFG---ETPEELFAHTVNDDIE 597
Y+APE+ + GY VDWWS+GV YE L G P+ + +E+ +
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT 238
Query: 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAE--F 655
+PS E S++ LL+ NP R +V+ PY ++++W+++ + + F
Sbjct: 239 YPSA----WSQEMVSLLKKLLEPNPDQRF--SQLSDVQNFPYMNDINWDAVFQKRLIPGF 292
Query: 656 IPQLDDEEDTSYFDS 670
IP D
Sbjct: 293 IPNK----GRLNCDP 303
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = e-102
Identities = 87/340 (25%), Positives = 154/340 (45%), Gaps = 36/340 (10%)
Query: 348 DSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQ 407
+ K ++ E+ F +++ G +G V+ + K T + +A KK+ K L R
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 408 MEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGD----CASLLKNTGPLPA 463
+ E+ I++ + F+V++ +FETK LCLVM + GGD ++ ++
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523
A FY A+ V +E+LH I++RDLKP+N+L+ G+++++D GL+
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
Query: 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE- 582
GTP ++APE++L + Y VD++++GV LYE + PF
Sbjct: 349 YA---------------GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393
Query: 583 ---TPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEH 637
+EL + + +P + +K LLQ++P RLG ++ H
Sbjct: 394 EKVENKELKQRVLEQAVTYPDK----FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449
Query: 638 PYFSNLDWNSLLRHKAE--FIPQLD-----DEEDTSYFDS 670
P F ++ W L F+P + +D F +
Sbjct: 450 PLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFST 489
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 328 bits (843), Expect = e-102
Identities = 105/312 (33%), Positives = 164/312 (52%), Gaps = 25/312 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
DF + ++ G++G V L K T + +A+K + K+ ++ + +E E+ +++
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 424 -PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
PF+ ++ F+T L VMEYV GGD ++ G A FY AE + + +L S
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
GI++RDLK DN+++ + GHIK+ DFG+ K + T C GT
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---------------GT 505
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602
P+YIAPE+I Q YGK VDWW+ GV+LYE L G PF GE +ELF + ++ +P
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS- 564
Query: 603 DWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHKAE--FIPQ 658
+ EA +I L+ ++P RLG G G ++KEH +F +DW L R + + + P+
Sbjct: 565 ---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPK 621
Query: 659 LDDEEDTSYFDS 670
+ FD
Sbjct: 622 ASG-RNAENFDR 632
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 321 bits (825), Expect = 4e-99
Identities = 123/478 (25%), Positives = 197/478 (41%), Gaps = 53/478 (11%)
Query: 221 RDCLFKSKEKLISSRYFYEMSEKLERLL----TETKEKSLEAATVLTFTLKKLLLIISRP 276
R + K E + S+KL LL + + +KK + +
Sbjct: 40 RSVMQKYLEDRGEVTFEKIFSQKLGYLLFRDFCLKHLEEAKPLVEFYEEIKKYEKLETEE 99
Query: 277 ARLLECLE-FDPEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDNDIQN 335
RL+ E FD L + +KS + Q + K + +F +I
Sbjct: 100 ERLVCSREIFDTYIMKELLACSHPFSKSA----IEHVQGHLVKKQVPPDLFQPYIEEICQ 155
Query: 336 ISLTDTSIESNSDSYCSKKDKFSKTPNEN------DFTVIKLISNGAYGSVYLVRHKETR 389
+L + +S + K N DF+V ++I G +G VY R +T
Sbjct: 156 -NLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTG 214
Query: 390 QRFAMKKIIKNSLMLRNQMEQVFAERDI---MSFTDNPFVVTMYCSFETKKHLCLVMEYV 446
+ +AMK + K + ++ ER + +S D PF+V M +F T L +++ +
Sbjct: 215 KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 274
Query: 447 EGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLT 506
GGD L G RFY AE +L +E++H+ +V+RDLKP N+L+ GH++++
Sbjct: 275 NGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 334
Query: 507 DFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSM 565
D GL+ ++ GT Y+APEV+ + Y DW+S+
Sbjct: 335 DLGLACDF------------SKKKPHASV-----GTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 566 GVILYEFLVGCVPFFGETP---EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNP 622
G +L++ L G PF E+ T+ +E P E +S++ LLQ++
Sbjct: 378 GCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS----FSPELRSLLEGLLQRDV 433
Query: 623 RDRLGTG--GPHEVKEHPYFSNLDWNSLLRHKAE--FIPQL-----DDEEDTSYFDSR 671
RLG G EVKE P+F +LDW + K IP D D FD
Sbjct: 434 NRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEE 491
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = 6e-99
Identities = 94/316 (29%), Positives = 144/316 (45%), Gaps = 30/316 (9%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
N F +++ G +G V + + T + +A KK+ K + R E+ I+ ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLH 481
FVV++ ++ETK LCLV+ + GGD + + G P A FY AE +E LH
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
IV+RDLKP+N+L+ GHI+++D GL+ + K G
Sbjct: 304 RERIVYRDLKPENILLDDHGHIRISDLGLAV-----------HVPEGQTIKGRV-----G 347
Query: 542 TPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE----TPEELFAHTVNDDIE 597
T Y+APEV+ + Y DWW++G +LYE + G PF EE+ E
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407
Query: 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHKAE- 654
+ +A+S+ + LL ++P +RLG EVKEHP F L++ L E
Sbjct: 408 YSER----FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEP 463
Query: 655 -FIPQLDDEEDTSYFD 669
F P D
Sbjct: 464 PFKPDPQAIYCKDVLD 479
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 292 bits (751), Expect = 2e-93
Identities = 85/291 (29%), Positives = 135/291 (46%), Gaps = 24/291 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
DF + + + G +G+VYL R K+++ A+K + K L Q+ E +I S +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
P ++ +Y F + L++EY G L+ Y E A+ Y HS
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
++HRD+KP+NLL+ + G +K+ DFG S S T+L C GT
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL--C---------------GTL 171
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
+Y+ PE+I + + + VD WS+GV+ YEFLVG PF T +E + + +P
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--- 228
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAE 654
+ + A+ +I+ LL+ NP R EV EHP+ + E
Sbjct: 229 F-VTEGARDLISRLLKHNPSQRPML---REVLEHPWITANSSKPSNCQNKE 275
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 2e-92
Identities = 81/277 (29%), Positives = 134/277 (48%), Gaps = 24/277 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+DF + + + G +G+VYL R K+ + A+K + K+ L Q+ E +I S +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
P ++ MY F +K + L++E+ G+ L+ G + + E A+ Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
++HRD+KP+NLL+ G +K+ DFG S + C GT
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM--C---------------GTL 176
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
+Y+ PE+I + + + VD W GV+ YEFLVG PF + E VN D+++P
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP--- 233
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
+ + +K +I+ LL+ +P RL V EHP+
Sbjct: 234 F-LSDGSKDLISKLLRYHPPQRLPL---KGVMEHPWV 266
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 2e-82
Identities = 73/304 (24%), Positives = 131/304 (43%), Gaps = 25/304 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+DF I ++ GA+G V R+ + +A+KKI ++ + +E +++ ++
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNH 61
Query: 424 PFVVTMYCSF-------------ETKKHLCLVMEYVEGGDCASLLKNTG-PLPADMARFY 469
+VV Y ++ + K L + MEY E G L+ + D
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 470 FAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVER 529
F + + A+ Y+HS GI+HRDLKP N+ I ++K+ DFGL+K SL +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 530 DAKQFSDKQVYGTPEYIAPEVILRQG-YGKPVDWWSMGVILYEFLVGCVPFFGETPEELF 588
+ + GT Y+A EV+ G Y + +D +S+G+I +E + G +
Sbjct: 182 GSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNIL 238
Query: 589 AHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSL 648
+ IE+P + D K II L+ +P R G + + + +
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA---RTLLNSGWLPVKHQDEV 295
Query: 649 LRHK 652
++
Sbjct: 296 IKEA 299
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 3e-80
Identities = 69/359 (19%), Positives = 135/359 (37%), Gaps = 64/359 (17%)
Query: 342 SIESNSDSYCSKKDKFSKTPNE-NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKN 400
I SN + + ND+ +I+ ++ G + + L + +A+KK K+
Sbjct: 8 DILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKS 65
Query: 401 SLM--------------LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYV 446
L ++++ + E I++ N + +T + ++ EY+
Sbjct: 66 LLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYM 125
Query: 447 EGGDCASLL--------KNTGPLPADMARFYFAETVLAVEYLHSY-GIVHRDLKPDNLLI 497
E T +P + + + + Y+H+ I HRD+KP N+L+
Sbjct: 126 ENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185
Query: 498 TALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG-- 555
G +KL+DFG S+ + GT E++ PE +
Sbjct: 186 DKNGRVKLSDFGESEYMVDKKIKGS--R---------------GTYEFMPPEFFSNESSY 228
Query: 556 YGKPVDWWSMGVILYEFLVGCVPFFGE-TPEELFAHTVNDDIEWPSEDDWPIQV------ 608
G VD WS+G+ LY VPF + + ELF + +IE+P + + +
Sbjct: 229 NGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKS 288
Query: 609 ---------EAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQ 658
E + L++NP +R+ + + +H + ++ + L E +
Sbjct: 289 TCSNNFLSNEDIDFLKLFLRKNPAERITS---EDALKHEWLADTNIEDLREFSKELYKK 344
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 1e-74
Identities = 88/278 (31%), Positives = 134/278 (48%), Gaps = 23/278 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
DF V L+ G++ VY T A+K I K ++ +++V E I +
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHS 482
P ++ +Y FE ++ LV+E G+ LKN P + AR + + + + YLHS
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
+GI+HRDL NLL+T +IK+ DFGL+ + E+ + GT
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLA---------TQLKMPHEK------HYTLCGT 175
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602
P YI+PE+ R +G D WS+G + Y L+G PF +T + V D E PS
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSF- 234
Query: 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
+ +EAK +I LL++NP DRL V +HP+
Sbjct: 235 ---LSIEAKDLIHQLLRRNPADRLSL---SSVLDHPFM 266
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 2e-74
Identities = 81/378 (21%), Positives = 152/378 (40%), Gaps = 59/378 (15%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ ++ I G++G LV+ E +++ +K+I + M + E+ E +++ +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKH 82
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK--NTGPLPADMARFYFAETVLAVEYLH 481
P +V SFE L +VM+Y EGGD + D +F + LA++++H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
I+HRD+K N+ +T G ++L DFG++++ ++ L + G
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACI-------------G 187
Query: 542 TPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE-WPS 600
TP Y++PE+ + Y D W++G +LYE F + + L ++
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSL 247
Query: 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLD 660
+ +S+++ L ++NPRDR NS+L
Sbjct: 248 H----YSYDLRSLVSQLFKRNPRDR-----------------PSVNSILEK--------- 277
Query: 661 DEEDTSYFDSRMERYNHDIGEDTDETEDSFSLGTFSSCTHQYKKVQSQLSSQSSLEVTPP 720
+ R+E++ + F L TFS Q + S Q+S+ V P
Sbjct: 278 -----GFIAKRIEKF-----LSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPA 327
Query: 721 RKSSEKDETSSTSDVSSS 738
+K ++
Sbjct: 328 QKITKPAAKYGIPLAYKK 345
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 4e-74
Identities = 78/286 (27%), Positives = 126/286 (44%), Gaps = 22/286 (7%)
Query: 355 DKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAE 414
+ + + + + G + + + +T++ FA K + K+ L+ +Q E++ E
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 415 RDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
I + VV + FE + +V+E L K L AR+Y + V
Sbjct: 66 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 125
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
L +YLH ++HRDLK NL + +K+ DFGL+ E ER
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGER----- 171
Query: 535 SDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND 594
K + GTP YIAPEV+ ++G+ VD WS+G I+Y LVG PF +E + +
Sbjct: 172 -KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 230
Query: 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
+ P I A S+I +LQ +P R +E+ +F
Sbjct: 231 EYSIPKH----INPVAASLIQKMLQTDPTARP---TINELLNDEFF 269
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 5e-74
Identities = 78/304 (25%), Positives = 129/304 (42%), Gaps = 22/304 (7%)
Query: 337 SLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKK 396
+ + + + + + + + G + + + +T++ FA K
Sbjct: 14 GVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKI 73
Query: 397 IIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK 456
+ K+ L+ +Q E++ E I + VV + FE + +V+E L K
Sbjct: 74 VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 133
Query: 457 NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516
L AR+Y + VL +YLH ++HRDLK NL + +K+ DFGL+
Sbjct: 134 RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA----- 188
Query: 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC 576
E ER K + GTP YIAPEV+ ++G+ VD WS+G I+Y LVG
Sbjct: 189 ----TKVEYDGER------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
Query: 577 VPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636
PF +E + ++ P I A S+I +LQ +P R +E+
Sbjct: 239 PPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDPTARP---TINELLN 291
Query: 637 HPYF 640
+F
Sbjct: 292 DEFF 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 2e-73
Identities = 72/310 (23%), Positives = 129/310 (41%), Gaps = 33/310 (10%)
Query: 334 QNISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFA 393
+ +S + E+ S + F + + +G+YG V+ VR KE + +A
Sbjct: 29 RRVSFRGEASETLQSPGYDPSRPESFF--QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYA 86
Query: 394 MKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCA 452
+K+ + +++ ++ AE +P V + ++E L L E G
Sbjct: 87 VKRSMSPFRGPKDRARKL-AEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQ 144
Query: 453 SLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511
+ G LP Y +T+LA+ +LHS G+VH D+KP N+ + G KL DFGL
Sbjct: 145 QHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL 204
Query: 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE 571
+ A + E G P Y+APE+ L+ YG D +S+G+ + E
Sbjct: 205 VELGTAGAGEVQE----------------GDPRYMAPEL-LQGSYGTAADVFSLGLTILE 247
Query: 572 FLVG-CVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGG 630
+P GE ++L + + + + E +S++ +L+ +P+ R
Sbjct: 248 VACNMELPHGGEGWQQLRQGYLPPEF--TAG----LSSELRSVLVMMLEPDPKLRATA-- 299
Query: 631 PHEVKEHPYF 640
+ P
Sbjct: 300 -EALLALPVL 308
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 3e-72
Identities = 76/305 (24%), Positives = 139/305 (45%), Gaps = 31/305 (10%)
Query: 346 NSDSYCSKKDKFSKTPN-ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML 404
+ + S ++ ++ F + + +GA+G V+LV + + +K I K+
Sbjct: 3 HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-- 60
Query: 405 RNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGD----CASLLKNTGP 460
+ MEQ+ AE +++ D+P ++ ++ FE ++ +VME EGG+ S
Sbjct: 61 QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA 120
Query: 461 LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLIT---ALGHIKLTDFGLSKMGLMS 517
L + + A+ Y HS +VH+DLKP+N+L IK+ DFGL+++
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---- 176
Query: 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCV 577
+ + ++ GT Y+APEV ++ D WS GV++Y L GC+
Sbjct: 177 ----------FKSDEHSTN--AAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTGCL 223
Query: 578 PFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637
PF G + EE+ + + E P+ +A ++ +L ++P R +V H
Sbjct: 224 PFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSA---AQVLHH 279
Query: 638 PYFSN 642
+F
Sbjct: 280 EWFKQ 284
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 3e-71
Identities = 74/303 (24%), Positives = 127/303 (41%), Gaps = 27/303 (8%)
Query: 345 SNSDSYCSKKDKFSKTPN-ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM 403
+ + S ++ + ++ ++ G++G V + + T+Q +A+K I K +
Sbjct: 2 HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINK-ASA 60
Query: 404 LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPA 463
+ E +++ D+P ++ ++ E +V E GG+ +
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE 120
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLMSLAT 520
A + + Y+H + IVHRDLKP+N+L+ + IK+ DFGLS
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC------- 173
Query: 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF 580
+ + D GT YIAPEV LR Y + D WS GVILY L G PF+
Sbjct: 174 -------FQQNTKMKD--RIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPPFY 223
Query: 581 GETPEELFAHTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639
G+ ++ + W I +AK +I +L +P R+ + EHP+
Sbjct: 224 GKNEYDILKRVETGKYAFDLP-QWRTISDDAKDLIRKMLTFHPSLRITA---TQCLEHPW 279
Query: 640 FSN 642
Sbjct: 280 IQK 282
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 233 bits (598), Expect = 4e-71
Identities = 87/301 (28%), Positives = 142/301 (47%), Gaps = 25/301 (8%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
+++ V + + GA+ V HK T FA K I L R+ +++ E I
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQ 63
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+P +V ++ S + + LV + V GG+ + A + + ++ Y HS
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 483 YGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
GIVHR+LKP+NLL+ + +KL DFGL+ D++ +
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--------------EVNDSEAWHG--F 167
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599
GTP Y++PEV+ + Y KPVD W+ GVILY LVG PF+ E L+A ++P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 227
Query: 600 SEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQ 658
S +W + EAKS+I +L NP+ R+ + + P+ N + + H+ + +
Sbjct: 228 SP-EWDTVTPEAKSLIDSMLTVNPKKRITA---DQALKVPWICNRERVASAIHRQDTVDC 283
Query: 659 L 659
L
Sbjct: 284 L 284
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-69
Identities = 78/327 (23%), Positives = 134/327 (40%), Gaps = 62/327 (18%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQ--MEQVFAERDIMSF 420
+ + + I G+YG V + +TR A+K + KN + N +E++ E +M
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGD------------------------------ 450
+P + +Y +E ++++CLVME GG
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 451 ----------CASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA- 499
+ + A+ YLH+ GI HRD+KP+N L +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 500 -LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI--LRQGY 556
IKL DFGLSK Y + + + GTP ++APEV+ + Y
Sbjct: 205 KSFEIKLVDFGLSKE-----------FYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253
Query: 557 GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWP-IQVEAKSIIT 615
G D WS GV+L+ L+G VPF G + + +N + + + ++ + A+ +++
Sbjct: 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP-NYNVLSPLARDLLS 312
Query: 616 DLLQQNPRDRLGTGGPHEVKEHPYFSN 642
+LL +N +R +HP+ S
Sbjct: 313 NLLNRNVDERF---DAMRALQHPWISQ 336
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 2e-69
Identities = 84/307 (27%), Positives = 139/307 (45%), Gaps = 29/307 (9%)
Query: 359 KTPN-ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQM---EQVFAE 414
+ N ++ + + + +G + V R K T ++A K I K + E + E
Sbjct: 5 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 415 RDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
I+ +P V+T++ +E K + L++E V GG+ L L + A + + +
Sbjct: 65 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 475 LAVEYLHSYGIVHRDLKPDNLLIT----ALGHIKLTDFGLSKMGLMSLATNLYECYVERD 530
V YLHS I H DLKP+N+++ IK+ DFGL+
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--------------IDF 170
Query: 531 AKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590
+F K ++GTPE++APE++ + G D WS+GVI Y L G PF G+T +E A+
Sbjct: 171 GNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 228
Query: 591 TVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLL 649
+ E+ E + AK I LL ++P+ R+ + +HP+ D L
Sbjct: 229 VSAVNYEFEDE-YFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKDTQQAL 284
Query: 650 RHKAEFI 656
KA +
Sbjct: 285 SRKASAV 291
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-69
Identities = 83/308 (26%), Positives = 140/308 (45%), Gaps = 28/308 (9%)
Query: 357 FSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQ---MEQVFA 413
F + E+ + + + + +G + V R K T +A K I K + E++
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 414 ERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAET 473
E I+ + V+T++ +E + + L++E V GG+ L L + A + +
Sbjct: 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITA----LGHIKLTDFGLSKMGLMSLATNLYECYVER 529
+ V YLH+ I H DLKP+N+++ + HIKL DFGL+
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------------IE 170
Query: 530 DAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589
D +F K ++GTPE++APE++ + G D WS+GVI Y L G PF G+T +E A
Sbjct: 171 DGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 590 HTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSL 648
+ + ++ E + AK I LL + R RL E HP+ + +D
Sbjct: 229 NITSVSYDFDEE-FFSHTSELAKDFIRKLLVKETRKRL---TIQEALRHPWITPVDNQQA 284
Query: 649 LRHKAEFI 656
+ + +
Sbjct: 285 MVRRESVV 292
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 3e-69
Identities = 81/305 (26%), Positives = 127/305 (41%), Gaps = 28/305 (9%)
Query: 345 SNSDSYCSKKDKFSKTPNEN---DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNS 401
S D + F + + +++ G++G V L + K T Q A+K I K
Sbjct: 4 SMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 63
Query: 402 LMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPL 461
+ + E + E ++ D+P ++ +Y FE K + LV E GG+ + +
Sbjct: 64 VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF 123
Query: 462 PADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLMSL 518
A + + + Y+H IVHRDLKP+NLL+ + +I++ DFGLS
Sbjct: 124 SEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH----- 178
Query: 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP 578
+K+ D GT YIAPEV L Y + D WS GVILY L GC P
Sbjct: 179 ---------FEASKKMKD--KIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226
Query: 579 FFGETPEELFAHTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637
F G ++ + W + AK +I +L P R+ + +H
Sbjct: 227 FNGANEYDILKKVEKGKYTFELP-QWKKVSESAKDLIRKMLTYVPSMRI---SARDALDH 282
Query: 638 PYFSN 642
+
Sbjct: 283 EWIQT 287
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 4e-69
Identities = 83/290 (28%), Positives = 129/290 (44%), Gaps = 29/290 (10%)
Query: 358 SKTPN-ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERD 416
S + +T+ I G++G V + K TR R A KKI K + +++ E +
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIE 58
Query: 417 IMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLA 476
IM D+P ++ +Y +FE + LVME GG+ + + A + + A
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
V Y H + HRDLKP+N L +KL DFGL+ + K
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--------------FKPGKM 164
Query: 534 FSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593
GTP Y++P+V L YG D WS GV++Y L G PF T E+
Sbjct: 165 MRT--KVGTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221
Query: 594 DDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
+P + DW + +A+S+I LL ++P+ R+ + + EH +F
Sbjct: 222 GTFTFPEK-DWLNVSPQAESLIRRLLTKSPKQRITS---LQALEHEWFEK 267
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 228 bits (585), Expect = 6e-69
Identities = 94/289 (32%), Positives = 138/289 (47%), Gaps = 29/289 (10%)
Query: 359 KTPN-ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI 417
+T N F ++++ +GA+ V+LV+ + T + FA+K I K+ + +E E +
Sbjct: 3 QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAV 59
Query: 418 MSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAV 477
+ + +VT+ +E+ H LVM+ V GG+ + G A + + AV
Sbjct: 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119
Query: 478 EYLHSYGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
+YLH GIVHRDLKP+NLL I +TDFGLSKM
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---------------QNGIM 164
Query: 535 SDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND 594
S GTP Y+APEV+ ++ Y K VD WS+GVI Y L G PF+ ET +LF
Sbjct: 165 ST--ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG 222
Query: 595 DIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
E+ S W I AK I LL+++P +R + HP+
Sbjct: 223 YYEFESP-FWDDISESAKDFICHLLEKDPNERYTC---EKALSHPWIDG 267
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-68
Identities = 78/337 (23%), Positives = 136/337 (40%), Gaps = 36/337 (10%)
Query: 345 SNSDSYCSKKDKFSKTPN-ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM 403
+ + S ++ + ++ ++ G++G V + + T+Q +A+K I K S
Sbjct: 2 HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA- 60
Query: 404 LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPA 463
+ E +++ D+P ++ ++ E +V E GG+ +
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE 120
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLMSLAT 520
A + + Y+H + IVHRDLKP+N+L+ + IK+ DFGLS
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC------- 173
Query: 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF 580
+ + D GT YIAPEV LR Y + D WS GVILY L G PF+
Sbjct: 174 -------FQQNTKMKD--RIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPPFY 223
Query: 581 GETPEELFAHTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639
G+ ++ + W I +AK +I +L +P R+ + EHP+
Sbjct: 224 GKNEYDILKRVETGKYAFDLP-QWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPW 279
Query: 640 FSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYN 676
+ +E D S + + ++
Sbjct: 280 IQK--------YSSETPTISDLPSLESAM-TNIRQFQ 307
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-68
Identities = 88/322 (27%), Positives = 145/322 (45%), Gaps = 28/322 (8%)
Query: 345 SNSDSYCSKKDKFSKTPNEN---DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNS 401
+ +F + ++ V + + GA+ V HK T FA K II
Sbjct: 7 MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTK 65
Query: 402 LMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPL 461
+ +++ E I +P +V ++ S + + LV + V GG+ +
Sbjct: 66 KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY 125
Query: 462 PADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLMSL 518
A + + ++ Y HS GIVHR+LKP+NLL+ + +KL DFGL+
Sbjct: 126 SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE----- 180
Query: 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP 578
D++ + GTP Y++PEV+ + Y KPVD W+ GVILY LVG P
Sbjct: 181 ---------VNDSEAWHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
Query: 579 FFGETPEELFAHTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637
F+ E L+A ++PS +W + EAKS+I +L NP+ R+ T + +
Sbjct: 230 FWDEDQHRLYAQIKAGAYDYPSP-EWDTVTPEAKSLIDSMLTVNPKKRI-T--ADQALKV 285
Query: 638 PYFSNLDWNSLLRHKAEFIPQL 659
P+ N + + H+ + + L
Sbjct: 286 PWICNRERVASAIHRQDTVDCL 307
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-68
Identities = 70/305 (22%), Positives = 122/305 (40%), Gaps = 40/305 (13%)
Query: 352 SKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQV 411
S + ++++K I +G V+ V ++ +Q +A+K + ++
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSY 73
Query: 412 FAERDIMSFTD--NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFY 469
E ++ + ++ +Y T +++ +VME D S LK + + Y
Sbjct: 74 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSY 132
Query: 470 FAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVER 529
+ + AV +H +GIVH DLKP N LI G +KL DFG++ ++
Sbjct: 133 WKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIAN-------------QMQP 178
Query: 530 DAKQFSDKQVYGTPEYIAPEVILRQG-----------YGKPVDWWSMGVILYEFLVGCVP 578
D GT Y+ PE I D WS+G ILY G P
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
Query: 579 FFGETP--EELFAHT-VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635
F +L A N +IE+P + + + ++ L+++P+ R+ E+
Sbjct: 239 FQQIINQISKLHAIIDPNHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISI---PELL 291
Query: 636 EHPYF 640
HPY
Sbjct: 292 AHPYV 296
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-68
Identities = 95/308 (30%), Positives = 142/308 (46%), Gaps = 55/308 (17%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR------------------ 405
N +T+ I G+YG V L ++ +AMK + K L+ +
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 406 -----NQMEQVFAERDIMSFTDNPFVVTMYCSFE--TKKHLCLVMEYVEGGDCASLLKNT 458
+EQV+ E I+ D+P VV + + + HL +V E V G +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL- 131
Query: 459 GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM---GL 515
PL D ARFYF + + +EYLH I+HRD+KP NLL+ GHIK+ DFG+S
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI--LRQGY-GKPVDWWSMGVILYEF 572
L+ GTP ++APE + R+ + GK +D W+MGV LY F
Sbjct: 192 ALLSNT---V---------------GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 573 LVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPH 632
+ G PF E L + + +E+P + D I + K +IT +L +NP R+
Sbjct: 234 VFGQCPFMDERIMCLHSKIKSQALEFPDQPD--IAEDLKDLITRMLDKNPESRIVV---P 288
Query: 633 EVKEHPYF 640
E+K HP+
Sbjct: 289 EIKLHPWV 296
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 2e-68
Identities = 80/294 (27%), Positives = 137/294 (46%), Gaps = 28/294 (9%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQ---MEQVFAERDIMS 419
E+ + + + + +G + V R K T + +A K I K L + E++ E +I+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEY 479
+P ++T++ FE K + L++E V GG+ L L D A + + + V Y
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 480 LHSYGIVHRDLKPDNLLIT----ALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
LHS I H DLKP+N+++ IKL DFG++ +F
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--------------IEAGNEFK 169
Query: 536 DKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595
+ ++GTPE++APE++ + G D WS+GVI Y L G PF GET +E + +
Sbjct: 170 N--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN 227
Query: 596 IEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSL 648
++ E + AK I LL ++P+ R+ + EH + + ++
Sbjct: 228 YDFDEE-YFSNTSELAKDFIRRLLVKDPKRRM---TIAQSLEHSWIKAIRRRNV 277
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 5e-68
Identities = 88/339 (25%), Positives = 155/339 (45%), Gaps = 38/339 (11%)
Query: 318 KLGINKTVFSDLDNDIQNISLTDTSIESNSDSYCSKKDKFSKTPN-ENDFTVIKLISNGA 376
+G K + +N I+L+ + + + D+ +++ + K + +GA
Sbjct: 91 LVGKGKRRPLN-NNSE--IALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGA 147
Query: 377 YGSVYLVRHKETRQRFAMKKIIKNSLMLR-----NQMEQVFAERDIMSFTDNPFVVTMYC 431
G V L ++T ++ A++ I K + + V E +I+ ++P ++ +
Sbjct: 148 CGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 207
Query: 432 SFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLK 491
F+ + + +V+E +EGG+ + L + YF + +LAV+YLH GI+HRDLK
Sbjct: 208 FFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 266
Query: 492 PDNLLITALG---HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
P+N+L+++ IK+TDFG SK + + + GTP Y+AP
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSK--------------ILGETSLMRT--LCGTPTYLAP 310
Query: 549 EVI---LRQGYGKPVDWWSMGVILYEFLVGCVPFFGE-TPEELFAHTVNDDIEWPSEDDW 604
EV+ GY + VD WS+GVIL+ L G PF T L + + E W
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE-VW 369
Query: 605 P-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
+ +A ++ LL +P+ R T E HP+ +
Sbjct: 370 AEVSEKALDLVKKLLVVDPKARFTT---EEALRHPWLQD 405
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 7e-68
Identities = 79/307 (25%), Positives = 135/307 (43%), Gaps = 30/307 (9%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQM--EQVFAERDIMSF 420
E+ + + ++I G + V ++ET Q+FA+K + + E + E I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGD----CASLLKNTGPLPADMARFYFAETVLA 476
+P +V + ++ + L +V E+++G D +A Y + + A
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
+ Y H I+HRD+KP +L+ + + +KL FG++ +
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI-------------QLGESGLV 189
Query: 534 FSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593
GTP ++APEV+ R+ YGKPVD W GVIL+ L GC+PF+G E LF +
Sbjct: 190 AGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIK 246
Query: 594 DDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHK 652
+ W I AK ++ +L +P +R+ +E HP+ D + H
Sbjct: 247 GKYKMNPR-QWSHISESAKDLVRRMLMLDPAERITV---YEALNHPWLKERDRYAYKIHL 302
Query: 653 AEFIPQL 659
E + QL
Sbjct: 303 PETVEQL 309
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 8e-68
Identities = 84/301 (27%), Positives = 136/301 (45%), Gaps = 24/301 (7%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
++ + + + GA+ V Q +A I L +++ E I
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLK 68
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+P +V ++ S + H L+ + V GG+ + A + + AV + H
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128
Query: 483 YGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
G+VHR+LKP+NLL+ + +KL DFGL+ VE + + +
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI-------------EVEGEQQAWFG--F 173
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599
GTP Y++PEV+ + YGKPVD W+ GVILY LVG PF+ E L+ ++P
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP 233
Query: 600 SEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQ 658
S +W + EAK +I +L NP R+ T E +HP+ S+ + H+ E +
Sbjct: 234 SP-EWDTVTPEAKDLINKMLTINPSKRI-T--AAEALKHPWISHRSTVASCMHRQETVDC 289
Query: 659 L 659
L
Sbjct: 290 L 290
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 8e-68
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 32/285 (11%)
Query: 375 GAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSF 433
G + V K T Q +A K +K ++ ++ E ++ P V+ ++ +
Sbjct: 40 GKFAVVRQCISKSTGQEYAAK-FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98
Query: 434 ETKKHLCLVMEYVEGGD----CASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRD 489
E + L++EY GG+ C + + + + + V YLH IVH D
Sbjct: 99 ENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLD 156
Query: 490 LKPDNLLI---TALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYI 546
LKP N+L+ LG IK+ DFG+S+ A + + + GTPEY+
Sbjct: 157 LKPQNILLSSIYPLGDIKIVDFGMSRK--------------IGHACELRE--IMGTPEYL 200
Query: 547 APEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWP- 605
APE++ D W++G+I Y L PF GE +E + + ++++ E +
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE-TFSS 259
Query: 606 IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLR 650
+ A I LL +NP R H + D+ +L
Sbjct: 260 VSQLATDFIQSLLVKNPEKRPTA---EICLSHSWLQQWDFENLFH 301
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-67
Identities = 83/308 (26%), Positives = 140/308 (45%), Gaps = 28/308 (9%)
Query: 357 FSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQ---MEQVFA 413
F + E+ + + + + +G + V R K T +A K I K + E++
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 414 ERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAET 473
E I+ +P ++T++ +E + + L++E V GG+ L L + A + +
Sbjct: 65 EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITA----LGHIKLTDFGLSKMGLMSLATNLYECYVER 529
+ V YLH+ I H DLKP+N+++ + HIKL DFGL+
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------------IE 170
Query: 530 DAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589
D +F K ++GTPE++APE++ + G D WS+GVI Y L G PF G+T +E A
Sbjct: 171 DGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 590 HTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSL 648
+ ++ E + AK I LL + R RL E HP+ + +D
Sbjct: 229 NITAVSYDFDEE-FFSQTSELAKDFIRKLLVKETRKRL---TIQEALRHPWITPVDTQQA 284
Query: 649 LRHKAEFI 656
+ + +
Sbjct: 285 MVRRESVV 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 2e-67
Identities = 69/297 (23%), Positives = 120/297 (40%), Gaps = 40/297 (13%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
++++K I +G V+ V ++ +Q +A+K + ++ E ++
Sbjct: 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKL 64
Query: 422 D--NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEY 479
+ ++ +Y T +++ +VME D S LK + + Y+ + AV
Sbjct: 65 QQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
+H +GIVH DLKP N LI G +KL DFG++ ++ D
Sbjct: 124 IHQHGIVHSDLKPANFLIVD-GMLKLIDFGIAN-------------QMQPDTTSVVKDSQ 169
Query: 540 YGTPEYIAPEVILRQG-----------YGKPVDWWSMGVILYEFLVGCVPFFGETP--EE 586
GT Y+ PE I D WS+G ILY G PF +
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229
Query: 587 LFAHT-VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
L A N +IE+P + + + ++ L+++P+ R+ E+ HPY
Sbjct: 230 LHAIIDPNHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISI---PELLAHPYVQI 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 3e-67
Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 29/271 (10%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+F + K I G + VY A+KK+ LM E D++ ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG----PLPADMARFYFAETVLAVEY 479
P V+ Y SF L +V+E + GD + ++K+ +P YF + A+E+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM--GLMSLATNLYECYVERDAKQFSDK 537
+HS ++HRD+KP N+ ITA G +KL D GL + + A
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-----------------H 194
Query: 538 QVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE--TPEELFAHTVNDD 595
+ GTP Y++PE I GY D WS+G +LYE PF+G+ L D
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 254
Query: 596 IE-WPSEDDWPIQVEAKSIITDLLQQNPRDR 625
PS+ E + ++ + +P R
Sbjct: 255 YPPLPSD---HYSEELRQLVNMCINPDPEKR 282
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 6e-67
Identities = 75/289 (25%), Positives = 124/289 (42%), Gaps = 35/289 (12%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
D+ V+ I G+YG +R K + K++ S M + + + +E +++ +
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELKH 64
Query: 424 PFVVTMYCSF--ETKKHLCLVMEYVEGGDCASLLK----NTGPLPADMARFYFAETVLAV 477
P +V Y T L +VMEY EGGD AS++ L + + LA+
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 478 EYLHS-----YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAK 532
+ H + ++HRDLKP N+ + ++KL DFGL+++ ++ T+ + +V
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFV----- 177
Query: 533 QFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592
GTP Y++PE + R Y + D WS+G +LYE PF + +EL
Sbjct: 178 --------GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 229
Query: 593 NDDIE-WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
P E IIT +L R E+ E+P
Sbjct: 230 EGKFRRIPYR----YSDELNEIITRMLNLKDYHRPSV---EEILENPLI 271
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 9e-67
Identities = 69/325 (21%), Positives = 126/325 (38%), Gaps = 63/325 (19%)
Query: 358 SKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI 417
S++ + + + + ++ GA +V+ RHK+T FA+K S + ++ E ++
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEV 60
Query: 418 MSFTDNPFVVTMYCSFE--TKKHLCLVMEYVEGGDCASLL---KNTGPLPADMARFYFAE 472
+ ++ +V ++ E T +H L+ME+ G ++L N LP +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 473 TVLAVEYLHSYGIVHRDLKPDNLLITAL----GHIKLTDFGLSKMGLMSLATNLYECYVE 528
V + +L GIVHR++KP N++ KLTDFG ++
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------------L 166
Query: 529 RDAKQFSDKQVYGTPEYIAPEVILR--------QGYGKPVDWWSMGVILYEFLVGCVPFF 580
D +QF +YGT EY+ P++ R + YG VD WS+GV Y G +PF
Sbjct: 167 EDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224
Query: 581 ----GETPEELFAH---------------TVNDDIEWPSEDDWPIQV------EAKSIIT 615
+E+ N I+W + + ++
Sbjct: 225 PFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284
Query: 616 DLLQQNPRDRLGTGGPHEVKEHPYF 640
++L+ + G +
Sbjct: 285 NILEADQEKCW---GFDQFFAETSD 306
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 1e-66
Identities = 90/314 (28%), Positives = 145/314 (46%), Gaps = 27/314 (8%)
Query: 352 SKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQV 411
S + P+ ++ ++K I G + V L RH T + A+K II + + ++++
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKL 61
Query: 412 FAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFA 471
F E IM ++P +V ++ ET+K L L+MEY GG+ L G + AR F
Sbjct: 62 FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR 121
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY-ECYVERD 530
+ V AV+Y H IVHRDLK +NLL+ A +IK+ DFG S ++ L C
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFC----- 174
Query: 531 AKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589
G P Y APE+ + Y G VD WS+GVILY + G +PF G+ +EL
Sbjct: 175 ----------GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE 224
Query: 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLL 649
+ P + + ++++ L NP R ++ + + + L
Sbjct: 225 RVLRGKYRIPFY----MSTDCENLLKRFLVLNPIKRGTL---EQIMKDRWINAGHEEDEL 277
Query: 650 RHKAEFIPQLDDEE 663
+ E + D++
Sbjct: 278 KPFVEPELDISDQK 291
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 2e-66
Identities = 90/331 (27%), Positives = 148/331 (44%), Gaps = 38/331 (11%)
Query: 353 KKDKFSKTPNEN---DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQME 409
F + + + +K + +GAYG V L R K T A+K I K S+ +
Sbjct: 23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNS 81
Query: 410 QVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFY 469
++ E ++ D+P ++ +Y FE K++ LVME +GG+ + + A
Sbjct: 82 KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI 141
Query: 470 FAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLMSLATNLYECY 526
+ + V YLH + IVHRDLKP+NLL+ + IK+ DFGLS +
Sbjct: 142 IKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV------------- 188
Query: 527 VERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE 586
+ K+ + GT YIAPEV LR+ Y + D WS+GVIL+ L G PF G+T +E
Sbjct: 189 -FENQKKMKE--RLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244
Query: 587 LFAHTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645
+ + S +W + AK +I +LQ + + R+ + EHP+
Sbjct: 245 ILRKVEKGKYTFDSP-EWKNVSEGAKDLIKQMLQFDSQRRI---SAQQALEHPWIKE--- 297
Query: 646 NSLLRHKAEFIPQLDDEEDTSYFDSRMERYN 676
++ ++ + M ++
Sbjct: 298 -----MCSKKESGIELPSLANAI-ENMRKFQ 322
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-66
Identities = 71/308 (23%), Positives = 123/308 (39%), Gaps = 52/308 (16%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
DF I+LI +G +G V+ +H+ + + +K++ N+ E ++ D+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER-------EVKALAKLDH 63
Query: 424 PFVVTMYCSFE----------------TKKHLCLVMEYVEGGDCASLLK--NTGPLPADM 465
+V ++ K L + ME+ + G ++ L +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 466 ARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC 525
A F + V+Y+HS +++RDLKP N+ + +K+ DFGL
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS------------ 171
Query: 526 YVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE 585
++ D K+ + GT Y++PE I Q YGK VD +++G+IL E L C F
Sbjct: 172 -LKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--S 225
Query: 586 ELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645
+ F + I + K+++ LL + P DR T E+
Sbjct: 226 KFFTDLRDGII--SDI----FDKKEKTLLQKLLSKKPEDRPNT---SEILRTLTVWKKSP 276
Query: 646 NSLLRHKA 653
RH A
Sbjct: 277 EKNERHTA 284
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-66
Identities = 84/302 (27%), Positives = 141/302 (46%), Gaps = 42/302 (13%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML-----RNQMEQVFAERDI 417
+++ + K + +GA G V L ++T ++ A+K I K + + V E +I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 418 MSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAV 477
+ ++P ++ + F+ + + +V+E +EGG+ + L + YF + +LAV
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 478 EYLHSYGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
+YLH GI+HRDLKP+N+L+++ IK+TDFG SK+
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--------------------L 167
Query: 535 SDKQVY----GTPEYIAPEVI---LRQGYGKPVDWWSMGVILYEFLVGCVPFFGE-TPEE 586
+ + GTP Y+APEV+ GY + VD WS+GVIL+ L G PF T
Sbjct: 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227
Query: 587 LFAHTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645
L + + E W + +A ++ LL +P+ R T E HP+ + D
Sbjct: 228 LKDQITSGKYNFIPE-VWAEVSEKALDLVKKLLVVDPKARFTT---EEALRHPWLQDEDM 283
Query: 646 NS 647
Sbjct: 284 KR 285
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 4e-66
Identities = 78/303 (25%), Positives = 125/303 (41%), Gaps = 35/303 (11%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQM------EQVFAERD 416
++ +++ G V HK T + +A+K I + E E D
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 417 IM-SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL 475
I+ + +P ++ + ++ET LV + ++ G+ L L R +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
+ LH IVHRDLKP+N+L+ +IKLTDFG S ++
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--------------LDPGEKLR 181
Query: 536 DKQVYGTPEYIAPEVI------LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589
+ V GTP Y+APE+I GYGK VD WS GVI+Y L G PF+ +
Sbjct: 182 E--VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239
Query: 590 HTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSL 648
++ + ++ S +W K +++ L P+ R E HP+F
Sbjct: 240 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTA---EEALAHPFFQQYVVEE- 294
Query: 649 LRH 651
+RH
Sbjct: 295 VRH 297
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 5e-66
Identities = 70/337 (20%), Positives = 128/337 (37%), Gaps = 40/337 (11%)
Query: 322 NKTVFSDLDNDIQNISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVY 381
+ + + + ++ D S + ++++K I +G V+
Sbjct: 14 GSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVF 73
Query: 382 LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD--NPFVVTMYCSFETKKHL 439
V ++ +Q +A+K + ++ E ++ + ++ +Y T +++
Sbjct: 74 QVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131
Query: 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA 499
+VME D S LK + + Y+ + AV +H +GIVH DLKP N LI
Sbjct: 132 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD 190
Query: 500 LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG---- 555
G +KL DFG++ ++ D G Y+ PE I
Sbjct: 191 -GMLKLIDFGIAN-------------QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 556 -------YGKPVDWWSMGVILYEFLVGCVPFFGETP--EELFAHTV-NDDIEWPSEDDWP 605
D WS+G ILY G PF +L A N +IE+P
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI---- 292
Query: 606 IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
+ + + ++ L+++P+ R+ E+ HPY
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISI---PELLAHPYVQI 326
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 5e-66
Identities = 66/277 (23%), Positives = 129/277 (46%), Gaps = 22/277 (7%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+ +++ + GAYG V L ++ T + A+K + + + E + E I ++
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 66
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
VV Y L +EY GG+ ++ +P A+ +F + + V YLH GI
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
HRD+KP+NLL+ ++K++DFGL+ + + + ++ +K GT Y
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATV------------FRYNNRERLLNKMC-GTLPY 173
Query: 546 IAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGET-PEELFAHTVNDDIEWPSEDD 603
+APE++ R+ + +PVD WS G++L L G +P+ + + ++
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
I +++ +L +NP R+ ++K+ ++
Sbjct: 234 --IDSAPLALLHKILVENPSARITI---PDIKKDRWY 265
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 2e-65
Identities = 85/341 (24%), Positives = 139/341 (40%), Gaps = 48/341 (14%)
Query: 353 KKDKFSKTPNEN---DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL------- 402
+ + + ++ + +GAYG V L + K A+K I K+
Sbjct: 22 NPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSD 81
Query: 403 ---MLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG 459
+ E+++ E ++ D+P ++ ++ FE KK+ LV E+ EGG+ + N
Sbjct: 82 DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH 141
Query: 460 PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLM 516
A + + + YLH + IVHRD+KP+N+L+ +IK+ DFGLS
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--- 198
Query: 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC 576
+ D GT YIAPEV L++ Y + D WS GVI+Y L G
Sbjct: 199 -----------FSKDYKLRD--RLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGY 244
Query: 577 VPFFGETPEELFAHTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635
PF G+ +++ + DW I EAK +I +L + R E
Sbjct: 245 PPFGGQNDQDIIKKVEKGKYYFDFN-DWKNISDEAKELIKLMLTYDYNKRC---TAEEAL 300
Query: 636 EHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYN 676
W ++ A I + D + S M ++
Sbjct: 301 NSR------W---IKKYANNINKSDQKTLCGAL-SNMRKFE 331
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-65
Identities = 80/279 (28%), Positives = 128/279 (45%), Gaps = 30/279 (10%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+ + + G +G V + H+ T + A+K + + + + + ++ E + +P
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
++ +Y T +VMEYV GG+ + G + AR F + + AV+Y H + +
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLS---KMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
VHRDLKP+N+L+ A + K+ DFGLS G L T+ C G+
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS---C---------------GS 173
Query: 543 PEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601
P Y APEVI + Y G VD WS GVILY L G +PF E LF P
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY 233
Query: 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
+ +++ +LQ +P R +++EH +F
Sbjct: 234 ----LNRSVATLLMHMLQVDPLKRATI---KDIREHEWF 265
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 5e-65
Identities = 78/320 (24%), Positives = 137/320 (42%), Gaps = 33/320 (10%)
Query: 330 DNDIQNISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETR 389
D I+ D E Y + + + + + +++ + +GA+G V+ K T
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76
Query: 390 QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGG 449
+ F K I + V E IM+ +P ++ ++ +FE K + L++E++ GG
Sbjct: 77 RVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133
Query: 450 DCASL----LKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA--LGHI 503
+ L + Y + ++++H + IVH D+KP+N++ +
Sbjct: 134 E---LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSV 190
Query: 504 KLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWW 563
K+ DFGL+ + K T E+ APE++ R+ G D W
Sbjct: 191 KIIDFGLATK--------------LNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 564 SMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNP 622
++GV+ Y L G PF GE E + D E+ + + + EAK I +LLQ+ P
Sbjct: 235 AIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED-AFSSVSPEAKDFIKNLLQKEP 293
Query: 623 RDRLGTGGPHEVKEHPYFSN 642
R RL H+ EHP+
Sbjct: 294 RKRLTV---HDALEHPWLKG 310
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 5e-65
Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 28/296 (9%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
DF I+ + G +G V+ ++K +A+K+I E+V E ++ ++
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLEH 62
Query: 424 PFVVTMYCSFETK------------KHLCLVMEYVEGGDCASLLKN---TGPLPADMARF 468
P +V + ++ K +L + M+ + + +
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 469 YFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528
F + AVE+LHS G++HRDLKP N+ T +K+ DFGL M
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQDEEEQTVLTP 180
Query: 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELF 588
A QV GT Y++PE I Y VD +S+G+IL+E PF +
Sbjct: 181 MPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL---LYPFSTQMERVRT 236
Query: 589 AHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644
V ++++P ++ D+L +P +R + E+ F +LD
Sbjct: 237 LTDVR-NLKFPPLFT-QKYPCEYVMVQDMLSPSPMERPEA---INIIENAVFEDLD 287
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 5e-65
Identities = 89/326 (27%), Positives = 148/326 (45%), Gaps = 35/326 (10%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+ + + + G++G V L H +T+Q+ A+K I + L + +V E + +P
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
++ +Y T + +V+EY GG+ + + D R +F + + A+EY H + I
Sbjct: 71 IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY-ECYVERDAKQFSDKQVYGTPE 544
VHRDLKP+NLL+ ++K+ DFGLS +M+ L C G+P
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSN--IMTDGNFLKTSC---------------GSPN 172
Query: 545 YIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
Y APEVI + Y G VD WS G++LY LVG +PF E LF + P
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF-- 230
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEE 663
+ A+S+I ++ +P R+ E++ P+F N++ LR E D
Sbjct: 231 --LSPGAQSLIRRMIVADPMQRITI---QEIRRDPWF-NVNLPDYLRPMEEVQGSYADSR 284
Query: 664 DTSYFDSRMERYNHDIGEDTDETEDS 689
+ + +G D ++
Sbjct: 285 -------IVSKLGEAMGFSEDYIVEA 303
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 5e-65
Identities = 59/289 (20%), Positives = 120/289 (41%), Gaps = 34/289 (11%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
+ + + + G +G V+ +++ + K + V E I++
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIAR 59
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASL----LKNTGPLPADMARFYFAETVLAVE 478
+ ++ ++ SFE+ + L ++ E++ G D + + L Y + A++
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLD---IFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 479 YLHSYGIVHRDLKPDNLLITAL--GHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
+LHS+ I H D++P+N++ IK+ +FG ++ + F
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--------------LKPGDNFRL 162
Query: 537 KQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596
++ PEY APEV D WS+G ++Y L G PF ET +++ + +N +
Sbjct: 163 --LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220
Query: 597 EWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644
+ E + I +EA + LL + + R+ E +HP+
Sbjct: 221 TFDEE-AFKEISIEAMDFVDRLLVKERKSRMTA---SEALQHPWLKQKI 265
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-64
Identities = 71/312 (22%), Positives = 127/312 (40%), Gaps = 60/312 (19%)
Query: 358 SKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI 417
S++ + + + + ++ GA +V+ RHK+T FA+K S + ++ E ++
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEV 60
Query: 418 MSFTDNPFVVTMYCSFE--TKKHLCLVMEYVEGGDCASLL---KNTGPLPADMARFYFAE 472
+ ++ +V ++ E T +H L+ME+ G ++L N LP +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 473 TVLAVEYLHSYGIVHRDLKPDNLLITAL----GHIKLTDFGLSKMGLMSLATNLYECYVE 528
V + +L GIVHR++KP N++ KLTDFG ++
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------------L 166
Query: 529 RDAKQFSDKQVYGTPEYIAPEVILR--------QGYGKPVDWWSMGVILYEFLVGCVPFF 580
D +QF +YGT EY+ P++ R + YG VD WS+GV Y G +PF
Sbjct: 167 EDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224
Query: 581 ----GETPEELFAH---------------TVNDDIEWPSEDDWP------IQVEAKSIIT 615
+E+ N I+W + +QV ++
Sbjct: 225 PFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284
Query: 616 DLLQQNPRDRLG 627
++L+ + G
Sbjct: 285 NILEADQEKCWG 296
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-64
Identities = 69/304 (22%), Positives = 134/304 (44%), Gaps = 24/304 (7%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+ +++ + GAYG V L ++ T + A+K + + + E + E I ++
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 66
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
VV Y L +EY GG+ ++ +P A+ +F + + V YLH GI
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
HRD+KP+NLL+ ++K++DFGL+ + + + ++ +K GT Y
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATV------------FRYNNRERLLNKMC-GTLPY 173
Query: 546 IAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPF--FGETPEELFAHTVNDDIEWPSED 602
+APE++ R+ + +PVD WS G++L L G +P+ ++ +E
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKEKKTYLNPWK 232
Query: 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDE 662
I +++ +L +NP R+ ++K+ +++ R + +
Sbjct: 233 K--IDSAPLALLHKILVENPSARITI---PDIKKDRWYNKPLKKGAKRPRVTSGGVSESP 287
Query: 663 EDTS 666
S
Sbjct: 288 SGFS 291
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-64
Identities = 84/285 (29%), Positives = 130/285 (45%), Gaps = 30/285 (10%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
+ F V + GA VY + K T++ +A+K + K + V E ++
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLS 106
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+P ++ + FET + LV+E V GG+ + G A + + AV YLH
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 483 YGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
GIVHRDLKP+NLL +K+ DFGLSK+ V
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI--------------VEHQVLMKT--V 210
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE-ELFAHTVNDDIEW 598
GTP Y APE++ YG VD WS+G+I Y L G PF+ E + +F +N + +
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF 270
Query: 599 PSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
S W + + AK ++ L+ +P+ RL T + +HP+ +
Sbjct: 271 ISP-WWDEVSLNAKDLVRKLIVLDPKKRLTT---FQALQHPWVTG 311
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 3e-64
Identities = 82/322 (25%), Positives = 125/322 (38%), Gaps = 43/322 (13%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVT 428
K + G++ HK++ Q FA+K I K E + +P +V
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLCEGHPNIVK 70
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLL---KNTGPLPADMARFYFAETVLAVEYLHSYGI 485
++ F + H LVME + GG+ L K A + + V AV ++H G+
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGE---LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 127
Query: 486 VHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
VHRDLKP+NLL T IK+ DFG +++ D + T
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARL-------------KPPDNQPLKT--PCFT 172
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET-------PEELFAHTVNDD 595
Y APE++ + GY + D WS+GVILY L G VPF E+ D
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
Query: 596 IEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAE 654
+ E W + EAK +I LL +P RL ++ + + + S
Sbjct: 233 FSFEGE-AWKNVSQEAKDLIQGLLTVDPNKRLKM---SGLRYNEWLQDGSQLSSNPLMTP 288
Query: 655 FIPQLDDEEDTSYFDSRMERYN 676
I + + +N
Sbjct: 289 DILGSSGAAVHTCVKATFHAFN 310
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-64
Identities = 78/280 (27%), Positives = 129/280 (46%), Gaps = 33/280 (11%)
Query: 375 GAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE 434
G +G V+ T + A K I + + E+V E +M+ D+ ++ +Y +FE
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 435 TKKHLCLVMEYVEGGDCASL----LKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDL 490
+K + LVMEYV+GG+ L + + L + + + ++H I+H DL
Sbjct: 157 SKNDIVLVMEYVDGGE---LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDL 213
Query: 491 KPDNLLITALG--HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAP 548
KP+N+L IK+ DFGL++ + ++ K +GTPE++AP
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARR--------------YKPREKL--KVNFGTPEFLAP 257
Query: 549 EVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWP-IQ 607
EV+ P D WS+GVI Y L G PF G+ E + + + E ++ I
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE-EFQDIS 316
Query: 608 VEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647
EAK I+ LL + R+ E +HP+ S+ +S
Sbjct: 317 EEAKEFISKLLIKEKSWRI---SASEALKHPWLSDHKLHS 353
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 4e-64
Identities = 101/362 (27%), Positives = 150/362 (41%), Gaps = 36/362 (9%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+ +K I +G +G L+R K T++ A+K I + + + E V E +P
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPN 77
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
+V T HL ++MEY GG+ + N G D ARF+F + + V Y HS I
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 486 VHRDLKPDNLLITA--LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
HRDLK +N L+ +K+ DFG SK L + K GTP
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--------------KSTVGTP 181
Query: 544 EYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND----DIEW 598
YIAPEV+LRQ Y GK D WS GV LY LVG PF + T+
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI 241
Query: 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQ 658
P DD I E +I+ + +P R+ E+K H +F + + L +++ Q
Sbjct: 242 P--DDIRISPECCHLISRIFVADPATRISI---PEIKTHSWF-LKNLPADLMNESNTGSQ 295
Query: 659 LDDEEDTSYFDSRMERYNHDIGEDTDETEDSFSLGTFSSCTHQYKKVQSQLSSQSSLEVT 718
+ E ++ I E T + L F + S+S +++
Sbjct: 296 FQEPEQPM---QSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDID 352
Query: 719 PP 720
Sbjct: 353 SS 354
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 4e-64
Identities = 78/296 (26%), Positives = 125/296 (42%), Gaps = 35/296 (11%)
Query: 358 SKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI 417
+ + + V + I G+Y HK T FA+K I K+ E +I
Sbjct: 16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS-------KRDPTEEIEI 68
Query: 418 M-SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLA 476
+ + +P ++T+ ++ K++ +V E ++GG+ + A
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGH----IKLTDFGLSKMGLMSLATNLYECYVERDAK 532
VEYLH+ G+VHRDLKP N+L I++ DFG +K + +
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK-------------QLRAENG 175
Query: 533 QFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG---ETPEELFA 589
T ++APEV+ RQGY D WS+GV+LY L G PF +TPEE+ A
Sbjct: 176 LLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA 233
Query: 590 HTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644
+ W + AK +++ +L +P RL V HP+ + D
Sbjct: 234 RIGSGKFSLSGG-YWNSVSDTAKDLVSKMLHVDPHQRLTA---ALVLRHPWIVHWD 285
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 5e-64
Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 33/291 (11%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL-----MLRNQMEQVFAERDI 417
+ +I G V H+ T FA+K + + L E E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 418 M-SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLA 476
+ +P ++T+ S+E+ + LV + + G+ L L R + A
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
V +LH+ IVHRDLKP+N+L+ I+L+DFG S ++ +
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--------------LEPGEKLRE 258
Query: 537 KQVYGTPEYIAPEVI------LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590
+ GTP Y+APE++ GYGK VD W+ GVIL+ L G PF+ +
Sbjct: 259 --LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316
Query: 591 TVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
+ ++ S +W K +I+ LLQ +P RL + +HP+F
Sbjct: 317 IMEGQYQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTA---EQALQHPFF 363
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-63
Identities = 53/289 (18%), Positives = 104/289 (35%), Gaps = 26/289 (8%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
+ + I+ + G + V LV +A+K+I+ + E+ E D+
Sbjct: 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLF 83
Query: 422 DNPFVVTMYCSF----ETKKHLCLVMEYVEGGDCASLLK----NTGPLPADMARFYFAET 473
++P ++ + K L++ + + G + ++ L D +
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
+E +H+ G HRDLKP N+L+ G L D G + + + ++ A Q
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 534 FSDKQVYGTPEYIAPEVILRQGY---GKPVDWWSMGVILYEFLVGCVPFFGET-PEELFA 589
T Y APE+ Q + + D WS+G +LY + G P+ + A
Sbjct: 204 ------RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257
Query: 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHP 638
V + + P ++ ++ +P R +
Sbjct: 258 LAVQNQLSIPQSPRHSS--ALWQLLNSMMTVDPHQRPHI---PLLLSQL 301
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-63
Identities = 102/450 (22%), Positives = 171/450 (38%), Gaps = 42/450 (9%)
Query: 352 SKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQV 411
++K K + + + G +G V + +H+ T + A+K + + + + + ++
Sbjct: 4 AEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKI 63
Query: 412 FAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFA 471
E + +P ++ +Y T + +VMEYV GG+ + G L +R F
Sbjct: 64 RREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ 123
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM---GLMSLATNLYECYVE 528
+ + V+Y H + +VHRDLKP+N+L+ A + K+ DFGLS M G L T+ C
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS---C--- 176
Query: 529 RDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEEL 587
G+P Y APEVI + Y G VD WS GVILY L G +PF + L
Sbjct: 177 ------------GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL 224
Query: 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647
F + P + S++ +LQ +P R +++EH +F D
Sbjct: 225 FKKICDGIFYTPQY----LNPSVISLLKHMLQVDPMKRATI---KDIREHEWF-KQDLPK 276
Query: 648 LLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETEDS-FSLGTFSSCTHQY---- 702
L P+ T D ++ +E ++ Y
Sbjct: 277 YL------FPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLII 330
Query: 703 KKVQSQLSSQSSLEVTPPRKSSEKDETSSTSDVSSSPVAHVVTSTPESSQTESDDISPQV 762
+ ++ T P S D + P T + E + +
Sbjct: 331 DNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKH 390
Query: 763 QRKRRAMTSHQMSRAKLPCRQRINVFVRIR 792
Q R+A + P V I+
Sbjct: 391 QGVRKAKWHLGIRSQSRPNDIMAEVCRAIK 420
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-63
Identities = 76/309 (24%), Positives = 123/309 (39%), Gaps = 34/309 (11%)
Query: 368 VIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQME-QVFAERDIMSFTDNPFV 426
+ L+ G+YG V V ET R A+K + K L E V E ++ + V
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 427 VTMY--CSFETKKHLCLVMEYVEGGDC---ASLLKNTGPLPADMARFYFAETVLAVEYLH 481
+ + E K+ + +VMEY G S+ + P A YF + + +EYLH
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLH 126
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE--CYVERDAKQFSDKQV 539
S GIVH+D+KP NLL+T G +K++ G+++ A +
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-------------- 172
Query: 540 YGTPEYIAPEVIL-RQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597
G+P + PE+ + G VD WS GV LY G PF G+ +LF +
Sbjct: 173 -GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA 231
Query: 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIP 657
P + ++ +L+ P R ++++H +F + P
Sbjct: 232 IPGD----CGPPLSDLLKGMLEYEPAKRFSI---RQIRQHSWFRKKHPPAEAPVPIPPSP 284
Query: 658 QLDDEEDTS 666
D +
Sbjct: 285 DTKDRWRSM 293
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 6e-62
Identities = 75/316 (23%), Positives = 129/316 (40%), Gaps = 28/316 (8%)
Query: 334 QNISLTDTSIESNSDSYCSKKDKFSKTPN-ENDFTVIKLISNGAYGSVYLVRHKETRQRF 392
+S + + + K + + + + + + GA+G V+ V + T F
Sbjct: 126 GTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNF 185
Query: 393 AMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDC- 451
A K ++ + E V E MS +P +V ++ +FE + ++ E++ GG+
Sbjct: 186 AAKFVMTPHESDK---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242
Query: 452 ASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG--HIKLTDFG 509
+ + D A Y + + ++H VH DLKP+N++ T +KL DFG
Sbjct: 243 EKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 302
Query: 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVIL 569
L+ + K GT E+ APEV + G D WS+GV+
Sbjct: 303 LTAH--------------LDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
Query: 570 YEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGT 628
Y L G PF GE +E + + D + I + K I LL +P R+
Sbjct: 347 YILLSGLSPFGGENDDETLRNVKSCDWNMDDS-AFSGISEDGKDFIRKLLLADPNTRMTI 405
Query: 629 GGPHEVKEHPYFSNLD 644
H+ EHP+ + +
Sbjct: 406 ---HQALEHPWLTPGN 418
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 7e-62
Identities = 78/330 (23%), Positives = 132/330 (40%), Gaps = 37/330 (11%)
Query: 342 SIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMK-----K 396
++E + + + ++ + + +GA+G V+ KE + +K K
Sbjct: 2 ALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEK 61
Query: 397 IIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME-YVEGGDCASLL 455
++++ + ++ +V E I+S ++ ++ + FE + LVME + G D + +
Sbjct: 62 VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI 121
Query: 456 KNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515
L +A + F + V AV YL I+HRD+K +N++I IKL DFG +
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA---- 177
Query: 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLV 574
E K F GT EY APEV++ Y G ++ WS+GV LY +
Sbjct: 178 -----AYLE-----RGKLF--YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
Query: 575 GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEV 634
PF TV I P + E S+++ LLQ P R ++
Sbjct: 226 EENPFCE------LEETVEAAIHPPY----LVSKELMSLVSGLLQPVPERRTTL---EKL 272
Query: 635 KEHPYFSNLDWNSLLRHKAEFIPQLDDEED 664
P+ N E E
Sbjct: 273 VTDPWV-TQPVNLADYTWEEVFRVNKPESG 301
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-61
Identities = 42/349 (12%), Positives = 94/349 (26%), Gaps = 81/349 (23%)
Query: 356 KFSKTPNENDFTVI--KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFA 413
+ E T++ ++ + +ET + F + N ++Q+
Sbjct: 63 RVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 122
Query: 414 ER-------------------------DIMSFTDNPFVVTMYCSFETK--KHLCLVMEYV 446
E D++ ++ + + +
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182
Query: 447 E------GGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL 500
+ G S L + + + LH YG+VH L+P ++++
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR 242
Query: 501 GHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG----- 555
G + LT F + + + + PE+ R+
Sbjct: 243 GGVFLTGFEHLV-------------------RDGARVVSSVSRGFEPPELEARRATISYH 283
Query: 556 ------YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVE 609
D W++G+++Y +P + P
Sbjct: 284 RDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQ--------P 335
Query: 610 AKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQ 658
++++ L+ DRL P + E P + L + +P
Sbjct: 336 VRALLEGFLRYPKEDRL---LPLQAMETPEYEQLR-----TELSAALPL 376
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-61
Identities = 87/476 (18%), Positives = 167/476 (35%), Gaps = 66/476 (13%)
Query: 353 KKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVF 412
+ T + + + + G +G V H++T ++ A+K + L +N+ E+
Sbjct: 3 GRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIK-QCRQELSPKNR-ERWC 60
Query: 413 AERDIMSFTDNPFVVTMYCSFETKKHL------CLVMEYVEGGDCASLL---KNTGPLPA 463
E IM ++P VV+ + + L L MEY EGGD L +N L
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLAT 520
R ++ A+ YLH I+HRDLKP+N+++ K+ D G +K +
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGE 178
Query: 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF 580
+ GT +Y+APE++ ++ Y VD+WS G + +E + G PF
Sbjct: 179 LC--------------TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
Query: 581 GETPEELFAHTV--------------NDDIEWPSEDDWP------IQVEAKSIITDLLQQ 620
+ V +++ S P + + + + +L
Sbjct: 225 PNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW 284
Query: 621 NPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNH--- 677
+ R R G + F LD S+L K + + +Y + E +
Sbjct: 285 HQRQR---GTDPQNPNVGCFQALD--SILSLKLLSVMNMVSGRVHTYPVTENENLQNLKS 339
Query: 678 DIGEDTD-ETEDSFSLGTFSSCTHQYKKVQSQLSSQSSLEVTPPRK----SSEKDETSST 732
+ +DT E+ L + + + + + ++ + +T
Sbjct: 340 WLQQDTGIPEEEQELLQASGLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYE 399
Query: 733 SDVSSSPVAHVVTSTPESSQTESDDISPQVQRKRRAMTSHQMSRAKLPCRQRINVF 788
+S V+ + + R+ + K C + +
Sbjct: 400 PQISLPAHPESVSIVLQDPKRPLTY---THLRRVWGQIWQTIRALKEDCARLLQGQ 452
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 2e-60
Identities = 56/325 (17%), Positives = 94/325 (28%), Gaps = 62/325 (19%)
Query: 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAE----- 414
+ E +++ + G V+LVR E + FA+K + R+++E++
Sbjct: 58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAA 117
Query: 415 -------------------RDIMSFTDNPFVVTMYCSFETKK--HLCLVMEYVEG----- 448
D ++ P + + + L+M
Sbjct: 118 RLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELL 177
Query: 449 -GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTD 507
+ G A+ + L S G+VH PDNL I G + L D
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGD 237
Query: 508 FGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG---YGKPVDWWS 564
K + P AP L + ++ W
Sbjct: 238 VSALW-------------------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQ 278
Query: 565 MGVILYEFLVGCVPFFGETPEELFAHTVNDDI-----EWPSEDDWPIQVEAKSIITDLLQ 619
+G+ +Y +PF TP + P+ K++I L
Sbjct: 279 LGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN 338
Query: 620 QNPRDRLGTGGPHEVKEHPYFSNLD 644
+ R RL P E E P F L
Sbjct: 339 FDRRRRL---LPLEAMETPEFLQLQ 360
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 8e-60
Identities = 39/343 (11%), Positives = 90/343 (26%), Gaps = 68/343 (19%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAER---------- 415
++ + +ET + F + N ++Q+ E
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 416 ---------------DIMSFTDNPFVVTMYCSFETK--KHLCLVMEYVEG------GDCA 452
D++ ++ + + ++
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 453 SLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK 512
S L + + + LH YG+VH L+P ++++ G + LT F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG-----YGKPVDWWSMGV 567
+ + + + PE A ++ D W++G+
Sbjct: 260 --------------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305
Query: 568 ILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLG 627
+Y +P + P ++++ L+ DRL
Sbjct: 306 AIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQ--------PVRALLEGFLRYPKEDRL- 356
Query: 628 TGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDS 670
P + E P + L + +P + + +
Sbjct: 357 --LPLQAMETPEYEQLR-----TELSAALPLYQTDGEPTREGG 392
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 8e-60
Identities = 79/298 (26%), Positives = 120/298 (40%), Gaps = 40/298 (13%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVT 428
++ GA+ V + T Q +A+K I K +R +VF E +++ + V+
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLE 75
Query: 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
+ FE + LV E + GG S + A + A+++LH+ GI HR
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 489 DLKPDNLLITALGH---IKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
DLKP+N+L +K+ DF L + G+ EY
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSG--------IKLNGDCSPISTPELLTPCGSAEY 187
Query: 546 IAPEVILRQ-----GYGKPVDWWSMGVILYEFLVGCVPFFGE---------------TPE 585
+APEV+ Y K D WS+GVILY L G PF G
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 586 ELFAHTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
LF E+P + DW I AK +I+ LL ++ + RL +V +HP+
Sbjct: 248 MLFESIQEGKYEFPDK-DWAHISCAAKDLISKLLVRDAKQRLSA---AQVLQHPWVQG 301
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-59
Identities = 72/311 (23%), Positives = 131/311 (42%), Gaps = 41/311 (13%)
Query: 358 SKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQ---VFAE 414
+ E ++ + L+ G +G+V+ R + A+K I +N ++ + + E
Sbjct: 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE 84
Query: 415 RDIMSFTDN----PFVVTMYCSFETKKHLCLVMEY-VEGGDCASLLKNTGPLPADMARFY 469
++ P V+ + FET++ LV+E + D + GPL +R +
Sbjct: 85 VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF 144
Query: 470 FAETVLAVEYLHSYGIVHRDLKPDNLLI-TALGHIKLTDFGLSKMGLMSLATNLYECYVE 528
F + V A+++ HS G+VHRD+K +N+LI G KL DFG + L Y +
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL----LHDEPYTDFD- 199
Query: 529 RDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEEL 587
GT Y PE I R Y P WS+G++LY+ + G +PF + +E+
Sbjct: 200 ------------GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD--QEI 245
Query: 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647
++ +P+ + + ++I L P R E+ P+
Sbjct: 246 LEA----ELHFPA----HVSPDCCALIRRCLAPKPSSRPSL---EEILLDPWM-QTPAED 293
Query: 648 LLRHKAEFIPQ 658
+ + ++ P
Sbjct: 294 VPLNPSKGGPA 304
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-59
Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 38/291 (13%)
Query: 358 SKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQM---EQVFAE 414
K P E+ + V L+ +G +GSVY A+K + K+ + ++ +V E
Sbjct: 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 96
Query: 415 RDIMSFTDN--PFVVTMYCSFETKKHLCLVMEYVEG-GDCASLLKNTGPLPADMARFYFA 471
++ + V+ + FE L++E E D + G L ++AR +F
Sbjct: 97 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 156
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLI-TALGHIKLTDFGLSKMGLMSLATNLYECYVERD 530
+ + AV + H+ G++HRD+K +N+LI G +KL DFG + L +Y +
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFD--- 209
Query: 531 AKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589
GT Y PE I Y G+ WS+G++LY+ + G +PF + EE+
Sbjct: 210 ----------GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--EEIIR 257
Query: 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
+ + + E + +I L P DR E++ HP+
Sbjct: 258 G----QVFFRQR----VSSECQHLIRWCLALRPSDRPTF---EEIQNHPWM 297
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 8e-59
Identities = 76/294 (25%), Positives = 126/294 (42%), Gaps = 56/294 (19%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVT 428
+++ G G V H+ T Q+ A+K + + + E D + P +V
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQASGGPHIVC 86
Query: 429 MYCSFETKKH----LCLVMEYVEGGDCASLL-----KNTGPLPADMARFYFAETVLAVEY 479
+ +E H L ++ME +EGG+ L + A + A+++
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGE---LFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 480 LHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
LHS+ I HRD+KP+NLL T+ +KLTDFG +K + +
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--------------------ETTQ 183
Query: 537 KQVY---GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET----PEELFA 589
+ TP Y+APEV+ + Y K D WS+GVI+Y L G PF+ T +
Sbjct: 184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243
Query: 590 HTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
+P+ +W + +AK +I LL+ +P +RL + HP+ +
Sbjct: 244 RIRLGQYGFPNP-EWSEVSEDAKQLIRLLLKTDPTERLTI---TQFMNHPWINQ 293
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-57
Identities = 80/306 (26%), Positives = 129/306 (42%), Gaps = 50/306 (16%)
Query: 356 KFSKTPNENDFTVI-KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAE 414
+ K +D+ V +++ G G V + +K T+++FA+K + R E
Sbjct: 53 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------E 104
Query: 415 RDIM-SFTDNPFVVTMYCSFET----KKHLCLVMEYVEGGDCASLL-----KNTGPLPAD 464
++ + P +V + +E +K L +VME ++GG+ L +
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTER 161
Query: 465 MARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLATN 521
A A++YLHS I HRD+KP+NLL T+ +KLTDFG +K
Sbjct: 162 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-------- 213
Query: 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG 581
+ TP Y+APEV+ + Y K D WS+GVI+Y L G PF+
Sbjct: 214 ------TTSHNSLTTPC--YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265
Query: 582 E----TPEELFAHTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636
+ E+P+ +W + E K +I +LL+ P R+ E
Sbjct: 266 NHGLAISPGMKTRIRMGQYEFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTI---TEFMN 321
Query: 637 HPYFSN 642
HP+
Sbjct: 322 HPWIMQ 327
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-56
Identities = 49/333 (14%), Positives = 96/333 (28%), Gaps = 65/333 (19%)
Query: 329 LDNDIQNISLTDTSIESNSDSYCSKKDKFSKTPN----------ENDFTVIKLISNGAYG 378
D+ + L+ + SY + + K P V L+ GA+
Sbjct: 22 WDDKLIFKLLS--GLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFA 79
Query: 379 SVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSF 433
VY + +Q+F +K + + + + + + Y +
Sbjct: 80 QVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAH 136
Query: 434 ETKKHLCLVMEYVEGGDCASLLK-----NTGPLPADMARFYFAETVLAVEYLHSYGIVHR 488
+ LV E G + + +P + + + +E +H I+H
Sbjct: 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHG 196
Query: 489 DLKPDNLLIT-----------ALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537
D+KPDN ++ + L D G S D K F
Sbjct: 197 DIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS-----------------IDMKLFPKG 239
Query: 538 QVY----GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593
++ T + E++ + + +D++ + +Y L G E +
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRL 626
P D W +L L
Sbjct: 300 R--RLPHLDMW------NEFFHVMLNIPDCHHL 324
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-54
Identities = 72/281 (25%), Positives = 115/281 (40%), Gaps = 28/281 (9%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SF 420
E V ++++ G + VY + + + +A+K+++ N + + E M
Sbjct: 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKL 82
Query: 421 TDNPFVVTMYCSFETKKH--------LCLVMEYVEGGDCASLLK--NTGPLPADMARFYF 470
+ +P +V + K L+ E +G L K + GPL D F
Sbjct: 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142
Query: 471 AETVLAVEYLHSYG--IVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVE 528
+T AV+++H I+HRDLK +NLL++ G IKL DFG + +S +
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT--ISHYPDYSWSAQR 200
Query: 529 RDAKQFSDKQVYGTPEYIAPEVI---LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE 585
R + + TP Y PE+I G+ D W++G ILY PF
Sbjct: 201 RALVE-EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259
Query: 586 ELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRL 626
+ VN P D S+I +LQ NP +RL
Sbjct: 260 RI----VNGKYSIPPHD--TQYTVFHSLIRAMLQVNPEERL 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-54
Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 25/297 (8%)
Query: 334 QNISLTDTSIESNSDSYCSKKDK---FSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQ 390
+ E N ++K K + + T + G++G V+ ++ K+T
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84
Query: 391 RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGD 450
+ A+KK+ L + E + +P +V +Y + + + ME +EGG
Sbjct: 85 QCAVKKV-----RLEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 451 CASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG-HIKLTDFG 509
L+K G LP D A +Y + + +EYLH+ I+H D+K DN+L+++ G L DFG
Sbjct: 137 LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG 196
Query: 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVIL 569
+ L + + + GT ++APEV++ + VD WS ++
Sbjct: 197 HAL----CLQPD------GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246
Query: 570 YEFLVGCVPFFGETPEE-LFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
L GC P+ I + L++ P R
Sbjct: 247 LHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA--PLTAQAIQEGLRKEPVHR 301
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 3e-53
Identities = 67/312 (21%), Positives = 117/312 (37%), Gaps = 56/312 (17%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
+N K++ G+ G+V + + A+K+++ + + E +++ +D
Sbjct: 14 KNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLID------FCDIALMEIKLLTESD 66
Query: 423 N-PFVVTMYCSFETKKHLCLVMEYVEGG------DCASLLKNTGPLPADMARFYFAETVL 475
+ P V+ YCS T + L + +E +N +
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGH-------------IKLTDFGLSKM---GLMSLA 519
V +LHS I+HRDLKP N+L++ I ++DFGL K G S
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL-------RQGYGKPVDWWSMGVILYEF 572
TNL GT + APE++ ++ + +D +SMG + Y
Sbjct: 187 TNL--------------NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 573 LVGCVPFFGE--TPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGG 630
L FG+ + E + E D + EA +I+ ++ +P R
Sbjct: 233 LSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA-- 290
Query: 631 PHEVKEHPYFSN 642
+V HP F
Sbjct: 291 -MKVLRHPLFWP 301
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 8e-52
Identities = 74/306 (24%), Positives = 119/306 (38%), Gaps = 71/306 (23%)
Query: 356 KFSKTPNENDFTVI-KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAE 414
+ K +D+ V +++ G G V + +K T+++FA+K + R E
Sbjct: 9 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------E 60
Query: 415 RDIM-SFTDNPFVVTMYCSFET----KKHLCLVMEYVEGGDCASLL-----KNTGPLPAD 464
++ + P +V + +E +K L +VME ++GG+ L +
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTER 117
Query: 465 MARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLATN 521
A A++YLHS I HRD+KP+NLL T+ +KLTDFG
Sbjct: 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------- 166
Query: 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG 581
A E + Y K D WS+GVI+Y L G PF+
Sbjct: 167 -------------------------AKET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYS 200
Query: 582 E----TPEELFAHTVNDDIEWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636
+ E+P+ +W + E K +I +LL+ P R+ E
Sbjct: 201 NHGLAISPGMKTRIRMGQYEFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTI---TEFMN 256
Query: 637 HPYFSN 642
HP+
Sbjct: 257 HPWIMQ 262
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-51
Identities = 59/289 (20%), Positives = 110/289 (38%), Gaps = 35/289 (12%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN- 423
F ++ +GA G++ R + A+K+I+ E ++ +D
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPE------CFSFADREVQLLRESDEH 77
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
P V+ +C+ + ++ + +E + + +T + +LHS
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 484 GIVHRDLKPDNLLITALGH-----IKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD-K 537
IVHRDLKP N+LI+ ++DFGL K + FS
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK-------------LAVGRHSFSRRS 184
Query: 538 QVYGTPEYIAPEVI---LRQGYGKPVDWWSMGVILYEFLVGCVPFFG-ETPEELFAHTVN 593
V GT +IAPE++ ++ VD +S G + Y + FG +
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA 244
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
++ + V A+ +I ++ +P+ R V +HP+F +
Sbjct: 245 CSLDCL-HPEKHEDVIARELIEKMIAMDPQKRPSA---KHVLKHPFFWS 289
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-50
Identities = 40/279 (14%), Positives = 88/279 (31%), Gaps = 33/279 (11%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
+F ++ I +G +GSV+ + +A+K+ K ++ +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK----NTGPLPADMARFYFAETVLAVE 478
+ VV + ++ H+ + EY GG A + + + +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS-----------KMGLMSLATNLYECYV 527
Y+HS +VH D+KP N+ I+ K+G + T + V
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 528 ERDAKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE 586
E G ++A EV+ + D +++ + + +
Sbjct: 190 EE-----------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---GD 235
Query: 587 LFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
+ + E ++ ++ +P R
Sbjct: 236 QWHEIRQGRLP-RIPQVLS--QEFTELLKVMIHPDPERR 271
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 1e-49
Identities = 73/309 (23%), Positives = 128/309 (41%), Gaps = 24/309 (7%)
Query: 332 DIQNISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQR 391
++ + L + + K+ ++DF I + G G V+ V HK +
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 392 FAMKKI-IKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGD 450
A K I ++ +RNQ+ + E ++ ++P++V Y +F + + + ME+++GG
Sbjct: 61 MARKLIHLEIKPAIRNQIIR---ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117
Query: 451 CASLLKNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFG 509
+LK G +P + + + YL + I+HRD+KP N+L+ + G IKL DFG
Sbjct: 118 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVIL 569
+S + S+A GT Y++PE + Y D WSMG+ L
Sbjct: 178 VSGQLIDSMA-----------------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 220
Query: 570 YEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG 629
E VG P +EL +E + + + + P +
Sbjct: 221 VEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL 280
Query: 630 GPHEVKEHP 638
+ V E P
Sbjct: 281 LDYIVNEPP 289
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 8e-49
Identities = 61/267 (22%), Positives = 102/267 (38%), Gaps = 22/267 (8%)
Query: 384 RHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443
+E + + + L + M+ + M V K +L + M
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 444 EYVEGGDCASLLKN---TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL 500
+ + + + F + AVE+LHS G++HRDLKP N+ T
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200
Query: 501 GHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPV 560
+K+ DFGL M A QV GT Y++PE I Y V
Sbjct: 201 DVVKVGDFGLVTA--MDQDEEEQTVLTPMPAYATHTGQV-GTKLYMSPEQIHGNNYSHKV 257
Query: 561 DWWSMGVILYEFLVGCVPFFGETPEELFAHTVND--DIEWPS--EDDWPIQVEAKSIITD 616
D +S+G+IL+E F T E + D ++++P +P + ++ D
Sbjct: 258 DIFSLGLILFEL---LYSFS--TQMER-VRIITDVRNLKFPLLFTQKYP---QEHMMVQD 308
Query: 617 LLQQNPRDRLGTGGPHEVKEHPYFSNL 643
+L +P +R ++ E+ F NL
Sbjct: 309 MLSPSPTERPEA---TDIIENAIFENL 332
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 7e-47
Identities = 65/290 (22%), Positives = 125/290 (43%), Gaps = 32/290 (11%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI-MSF 420
ND + + +G G V+ +R ++T A+K++ ++ + + +++ + D+ +
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKS 80
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYL 480
D P++V + +F T + + ME + + GP+P + V A+ YL
Sbjct: 81 HDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 481 HS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
+G++HRD+KP N+L+ G IKL DFG+S + A +
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS---------------- 184
Query: 540 YGTPEYIAPEVI-----LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE-ELFAHTVN 593
G Y+APE I + Y D WS+G+ L E G P+ + E+ +
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244
Query: 594 DDI-EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642
++ P + + +S + D L ++ R R +++ EH +
Sbjct: 245 EEPPLLPGHMGFSG--DFQSFVKDCLTKDHRKRP---KYNKLLEHSFIKR 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 8e-47
Identities = 81/292 (27%), Positives = 125/292 (42%), Gaps = 30/292 (10%)
Query: 342 SIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNS 401
S+ S + C D ++ ++ G YG VY R + R A+K+I
Sbjct: 1 SMRSTEEGDCES-DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---P 56
Query: 402 LMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-GP 460
+ + E + + +V SF + + ME V GG ++LL++ GP
Sbjct: 57 ERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP 116
Query: 461 LPAD--MARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL-GHIKLTDFGLSKMGLMS 517
L + FY + + ++YLH IVHRD+K DN+LI G +K++DFG SK
Sbjct: 117 LKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK----R 172
Query: 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL--RQGYGKPVDWWSMGVILYEFLVG 575
LA + GT +Y+APE+I +GYGK D WS+G + E G
Sbjct: 173 LAGI-----------NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221
Query: 576 CVPF--FGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
PF GE +F + P + + EAK+ I + +P R
Sbjct: 222 KPPFYELGEPQAAMFKVGMFKVH--PEIPES-MSAEAKAFILKCFEPDPDKR 270
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 35/290 (12%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI-MSF 420
+D I + GAYG V +RH + Q A+K+I + +++ + DI M
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRT 62
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT----GPLPADMARFYFAETVLA 476
D PF VT Y + + + + ME ++ K +P D+ V A
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTS-LDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 477 VEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
+E+LHS ++HRD+KP N+LI ALG +K+ DFG+S + +A + DA
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD-------IDA---- 170
Query: 536 DKQVYGTPEYIAPEVIL----RQGYGKPVDWWSMGVILYEFLVGCVPFFG-ETPEELFAH 590
G Y+APE I ++GY D WS+G+ + E + P+ TP +
Sbjct: 171 -----GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ 225
Query: 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
V + D + E + L++N ++R E+ +HP+F
Sbjct: 226 VVEEPSPQLPADKFS--AEFVDFTSQCLKKNSKERP---TYPELMQHPFF 270
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-46
Identities = 70/256 (27%), Positives = 117/256 (45%), Gaps = 35/256 (13%)
Query: 334 QNISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFA 393
Q+ +T ++ + D P I G+ G V L R K + ++ A
Sbjct: 21 QSGVVTHEQFKAALRMVVDQGD-----PRL-LLDSYVKIGEGSTGIVCLAREKHSGRQVA 74
Query: 394 MKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCAS 453
+K + L + + E +F E IM + VV MY S+ + L ++ME+++GG
Sbjct: 75 VKMM---DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD 131
Query: 454 LLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513
++ L + + A+ YLH+ G++HRD+K D++L+T G +KL+DFG
Sbjct: 132 IVSQV-RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC-- 188
Query: 514 GLMSLATNLYECYVERDAKQFSDKQ-----VYGTPEYIAPEVILRQGYGKPVDWWSMGVI 568
Q S + GTP ++APEVI R Y VD WS+G++
Sbjct: 189 ------------------AQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIM 230
Query: 569 LYEFLVGCVPFFGETP 584
+ E + G P+F ++P
Sbjct: 231 VIEMVDGEPPYFSDSP 246
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-46
Identities = 68/308 (22%), Positives = 130/308 (42%), Gaps = 30/308 (9%)
Query: 340 DTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIK 399
+ + D + + + I G++ +VY ET A ++ +
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL-Q 60
Query: 400 NSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSF----ETKKHLCLVMEYVEGGDCASLL 455
+ + +++ ++ E +++ +P +V Y S+ + KK + LV E + G + L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 456 KNTGPLPADMARFYFAETVLAVEYLHSYG--IVHRDLKPDNLLITAL-GHIKLTDFGLSK 512
K + + R + + + +++LH+ I+HRDLK DN+ IT G +K+ D GL+
Sbjct: 121 KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180
Query: 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEF 572
+ S A K V GTPE++APE+ + Y + VD ++ G+ + E
Sbjct: 181 LKRASFA-----------------KAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEM 222
Query: 573 LVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPH 632
P+ V ++ P+ D E K II ++QN +R
Sbjct: 223 ATSEYPYSECQNAAQIYRRVTSGVK-PASFDKVAIPEVKEIIEGCIRQNKDERYSI---K 278
Query: 633 EVKEHPYF 640
++ H +F
Sbjct: 279 DLLNHAFF 286
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-46
Identities = 74/251 (29%), Positives = 116/251 (46%), Gaps = 35/251 (13%)
Query: 339 TDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKII 398
+D I S S D P + +T + I GA G+VY T Q A++++
Sbjct: 1 SDEEILEKLRSIVSVGD-----PKK-KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM- 53
Query: 399 KNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT 458
+L + + E + E +M NP +V S+ L +VMEY+ GG ++ T
Sbjct: 54 --NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111
Query: 459 GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518
+ E + A+E+LHS ++HRD+K DN+L+ G +KLTDFG
Sbjct: 112 -CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC------- 163
Query: 519 ATNLYECYVERDAKQFSDKQ-----VYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL 573
Q + +Q + GTP ++APEV+ R+ YG VD WS+G++ E +
Sbjct: 164 -------------AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
Query: 574 VGCVPFFGETP 584
G P+ E P
Sbjct: 211 EGEPPYLNENP 221
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-45
Identities = 45/237 (18%), Positives = 90/237 (37%), Gaps = 15/237 (6%)
Query: 354 KDKFSKTPNENDFTVIKLISNGA--YGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQV 411
+ S P + ++ +I G +V L R+K T + ++ I + +
Sbjct: 15 QGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR-RINLEACSNEMVTFL 73
Query: 412 FAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT--GPLPADMARFY 469
E + ++P +V +F L +V ++ G L+ + +
Sbjct: 74 QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI 133
Query: 470 FAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVER 529
+ A++Y+H G VHR +K ++LI+ G + L+ + ++ +
Sbjct: 134 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN--------LSMISHGQRQ 185
Query: 530 DAKQFSDKQVYGTPEYIAPEVILR--QGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
K +++PEV+ + QGY D +S+G+ E G VPF
Sbjct: 186 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-45
Identities = 86/323 (26%), Positives = 133/323 (41%), Gaps = 43/323 (13%)
Query: 335 NISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAM 394
+ D K P E F V++ + G+YGSVY HKET Q A+
Sbjct: 6 QLRNPPRRQLKKLDEDSLTKQ-----PEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAI 59
Query: 395 KKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASL 454
K++ + + ++++ E IM D+P VV Y S+ L +VMEY G + +
Sbjct: 60 KQVP-----VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI 114
Query: 455 LKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513
++ L D T+ +EYLH +HRD+K N+L+ GH KL DFG++
Sbjct: 115 IRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG- 173
Query: 514 GLMSLATNLYECYVERDAKQFSDKQ-----VYGTPEYIAPEVILRQGYGKPVDWWSMGVI 568
Q +D V GTP ++APEVI GY D WS+G+
Sbjct: 174 -------------------QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGIT 214
Query: 569 LYEFLVGCVPFFGETP-EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLG 627
E G P+ P +F N + + W + L ++P R
Sbjct: 215 AIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW--SDNFTDFVKQCLVKSPEQRAT 272
Query: 628 TGGPHEVKEHPYFSNLDWNSLLR 650
++ +HP+ + S+LR
Sbjct: 273 A---TQLLQHPFVRSAKGVSILR 292
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-45
Identities = 83/316 (26%), Positives = 132/316 (41%), Gaps = 41/316 (12%)
Query: 342 SIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNS 401
SIES+ S + + T D + I GAYGSV + HK + Q A+K+I
Sbjct: 2 SIESSGKLKISPEQHWDFTAE--DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV 59
Query: 402 LMLRNQMEQVFAERDI-MSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-- 458
+ +Q+ + D+ M +D P++V Y + + + ME + K
Sbjct: 60 D--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS-FDKFYKYVYS 116
Query: 459 ---GPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514
+P ++ TV A+ +L I+HRD+KP N+L+ G+IKL DFG+S
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI----LRQGYGKPVDWWSMGVILY 570
+ S+A RDA G Y+APE I RQGY D WS+G+ LY
Sbjct: 177 VDSIAKT-------RDA---------GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
Query: 571 EFLVGCVPFFG-ETPEELFAHTVNDD---IEWPSEDDWPIQVEAKSIITDLLQQNPRDRL 626
E G P+ + + V D + E ++ + + L ++ R
Sbjct: 221 ELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSP--SFINFVNLCLTKDESKRP 278
Query: 627 GTGGPHEVKEHPYFSN 642
E+ +HP+
Sbjct: 279 ---KYKELLKHPFILM 291
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-45
Identities = 82/306 (26%), Positives = 136/306 (44%), Gaps = 30/306 (9%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
N +D+ + ++I +GA V +++ A+K+I N + M+++ E MS
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQC 70
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT--------GPLPADMARFYFAET 473
+P +V+ Y SF K L LVM+ + GG ++K+ G L E
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
+ +EYLH G +HRD+K N+L+ G +++ DFG+S LAT +
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA----FLATGG------DITRN 180
Query: 534 FSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFAHT 591
K GTP ++APEV+ + +GY D WS G+ E G P+ P + L
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240
Query: 592 VND--DIEWPSEDDWPIQV---EAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646
ND +E +D ++ + +I+ LQ++P R E+ H +F
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA---AELLRHKFFQKAKNK 297
Query: 647 SLLRHK 652
L+ K
Sbjct: 298 EFLQEK 303
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-44
Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
E FT ++ I G++G V+ T++ A+K I + +++E + E ++S D
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCD 78
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+P+V Y S+ L ++MEY+ GG LL+ GPL E + ++YLHS
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS 137
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
+HRD+K N+L++ G +KL DFG++ L K+ + GT
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAG----QLTDTQ--------IKRNT---FVGT 182
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
P ++APEVI + Y D WS+G+ E G P P
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 224
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 7e-44
Identities = 72/274 (26%), Positives = 114/274 (41%), Gaps = 33/274 (12%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQM--EQVFAER-----DIM 418
+ + +L+ G G VY + A+K ++ + + VF R
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALK-------LMSETLSSDPVFRTRMQREARTA 88
Query: 419 SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVE 478
P VV ++ E L + M + G D A++L+ GPL A + A++
Sbjct: 89 GRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALD 148
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ 538
H+ G HRD+KP+N+L++A L DFG++ AT D K
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIAS------ATT--------DEKLTQLGN 194
Query: 539 VYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598
GT Y+APE D +++ +LYE L G P+ G+ + AH +N I
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH-INQAIPR 253
Query: 599 PSE--DDWPIQVEAKSIITDLLQQNPRDRLGTGG 630
PS P+ +A +I + +NP DR T G
Sbjct: 254 PSTVRPGIPVAFDA--VIARGMAKNPEDRYVTCG 285
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 78/310 (25%), Positives = 137/310 (44%), Gaps = 34/310 (10%)
Query: 352 SKKDKFSKTPNEND----FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQ 407
K ++ + D + ++ + +GA+G VY ++KET A K I +
Sbjct: 3 RKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEE 59
Query: 408 MEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-GPLPADMA 466
+E E +I++ D+P++V + ++ L +++E+ GG +++ L
Sbjct: 60 LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 119
Query: 467 RFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECY 526
+ + + A+ +LHS I+HRDLK N+L+T G I+L DFG+S +
Sbjct: 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS--------AKNLKTL 171
Query: 527 VERDAKQFSDKQVYGTPEYIAPEVILRQ-----GYGKPVDWWSMGVILYEFLVGCVPFFG 581
+RD+ GTP ++APEV++ + Y D WS+G+ L E P
Sbjct: 172 QKRDS-------FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224
Query: 582 ETP-EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
P L +D + W VE + + L +NP R ++ EHP+
Sbjct: 225 LNPMRVLLKIAKSDPPTLLTPSKW--SVEFRDFLKIALDKNPETRPSA---AQLLEHPFV 279
Query: 641 SNLDWNSLLR 650
S++ N LR
Sbjct: 280 SSITSNKALR 289
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 70/310 (22%), Positives = 123/310 (39%), Gaps = 24/310 (7%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
+D +++ G +G V H+ET + MK++I+ + + E +M
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRCL 64
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETV-LAVEY 479
++P V+ K L + EY++GG ++K+ P R FA+ + + Y
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQ-RVSFAKDIASGMAY 123
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
LHS I+HRDL N L+ ++ + DFGL+++ ++ T + + V
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKNVVVADFGLARL-MVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFAHTVNDDIEW 598
G P ++APE+I + Y + VD +S G++L E + P F V ++
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242
Query: 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW--NSLLRHKAEFI 656
+ P I +P R P F L+ +L H A +
Sbjct: 243 YCPPNCPPSF--FPITVRCCDLDPEKR------------PSFVKLEHWLETLRMHLAGHL 288
Query: 657 PQLDDEEDTS 666
P E
Sbjct: 289 PLGPQLEQLD 298
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-40
Identities = 61/251 (24%), Positives = 99/251 (39%), Gaps = 32/251 (12%)
Query: 337 SLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKK 396
SL D + K D P + F+ ++ I +G++G+VY R + A+KK
Sbjct: 37 SLKDPDVAE----LFFKDD-----PEK-LFSDLREIGHGSFGAVYFARDVRNSEVVAIKK 86
Query: 397 IIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK 456
+ + + + + E + +P + + + LVMEY G L
Sbjct: 87 MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV 146
Query: 457 NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516
+ PL + + YLHS+ ++HRD+K N+L++ G +KL DFG +
Sbjct: 147 HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA----- 201
Query: 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL---RQGYGKPVDWWSMGVILYEFL 573
+ GTP ++APEVIL Y VD WS+G+ E
Sbjct: 202 --------------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247
Query: 574 VGCVPFFGETP 584
P F
Sbjct: 248 ERKPPLFNMNA 258
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 70/278 (25%), Positives = 117/278 (42%), Gaps = 53/278 (19%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ V +++ GA+G V + + + A+K+I S + + E +S ++
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRA--KDVAIKQIESES-----ERKAFIVELRQLSRVNH 60
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPA-----------DMARFYFAE 472
P +V +Y + +CLVMEY EGG ++L PLP ++
Sbjct: 61 PNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ----- 113
Query: 473 TVLAVEYLHSY---GIVHRDLKPDNLLITALG-HIKLTDFGLSKMGLMSLATNLYECYVE 528
V YLHS ++HRDLKP NLL+ A G +K+ DFG + + N
Sbjct: 114 ---GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK------ 164
Query: 529 RDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG-ETPEEL 587
G+ ++APEV Y + D +S G+IL+E + PF P
Sbjct: 165 ------------GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR 212
Query: 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
V++ P + P + +S++T ++P R
Sbjct: 213 IMWAVHNGTRPPLIKNLPKPI--ESLMTRCWSKDPSQR 248
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFA----ERDI 417
+N+ K I G +G V+ R + + A+K +I +M + F E I
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 418 MSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFA-ET 473
MS ++P +V +Y +VME+V GD L P+ + + +
Sbjct: 77 MSNLNHPNIVKLYGLM----HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSV-KLRLMLDI 131
Query: 474 VLAVEYLHSYG--IVHRDLKPDNLLITALG-----HIKLTDFGLSKMGLMSLATNLYECY 526
L +EY+ + IVHRDL+ N+ + +L K+ DFGLS+
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------------- 178
Query: 527 VERDAKQFSDKQVYGTPEYIAPEVILRQG--YGKPVDWWSMGVILYEFLVGCVPFFGETP 584
S + G +++APE I + Y + D +S +ILY L G PF +
Sbjct: 179 -----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233
Query: 585 EEL-FAHTVNDDIEWPS-EDDWPIQVEAKSIITDLLQQNPRDR 625
++ F + + ++ P+ +D P ++ +++I +P+ R
Sbjct: 234 GKIKFINMIREEGLRPTIPEDCPPRL--RNVIELCWSGDPKKR 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 55/191 (28%), Positives = 92/191 (48%), Gaps = 14/191 (7%)
Query: 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL 500
+VMEYV+G ++ GP+ A A+ A+ + H GI+HRD+KP N++I+A
Sbjct: 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT 152
Query: 501 GHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPV 560
+K+ DFG+++ S + V GT +Y++PE
Sbjct: 153 NAVKVMDFGIARAIADSGNS------------VTQTAAVIGTAQYLSPEQARGDSVDARS 200
Query: 561 DWWSMGVILYEFLVGCVPFFGETPEEL-FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQ 619
D +S+G +LYE L G PF G++P + + H V +D PS + + +++ L
Sbjct: 201 DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-VREDPIPPSARHEGLSADLDAVVLKALA 259
Query: 620 QNPRDRLGTGG 630
+NP +R T
Sbjct: 260 KNPENRYQTAA 270
|
| >1v9v_A KIAA0561 protein; helix bundle, MAST205, microtubule-associated serine/threonine protein kinase, structural genomics; NMR {Homo sapiens} SCOP: a.29.10.1 Length = 114 | Back alignment and structure |
|---|
Score = 139 bits (350), Expect = 6e-39
Identities = 51/109 (46%), Positives = 67/109 (61%), Gaps = 7/109 (6%)
Query: 171 RFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSKEK 230
PKA QME RL F+ + A ++ F+HHQI+E+ARDCL KS E
Sbjct: 6 SGPKATAQMEGRLQEFLTAYAP------GARLALADGVLGFIHHQIVELARDCLAKSGEN 59
Query: 231 LISSRYFYEMSEKLERLLTETKEKS-LEAATVLTFTLKKLLLIISRPAR 278
L++SRYF EM EKLERLL + E+S E + + ++KLL+IISRPAR
Sbjct: 60 LVTSRYFLEMQEKLERLLQDAHERSDSEEVSFIVQLVRKLLIIISRPAR 108
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 67/273 (24%), Positives = 118/273 (43%), Gaps = 43/273 (15%)
Query: 368 VIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQM--EQVFAERDIMSFT---- 421
++ + G +VYL + A+K + ++ +R F
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIK-------AIFIPPREKEETLKR----FEREVH 63
Query: 422 -----DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLA 476
+ +V+M E LVMEY+EG + +++ GPL D A + + +
Sbjct: 64 NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDG 123
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
+++ H IVHRD+KP N+LI + +K+ DFG++K A + +
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK------ALS--------ETSLTQT 169
Query: 537 KQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL-FAHTVNDD 595
V GT +Y +PE + + D +S+G++LYE LVG PF GET + H + D
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH-IQDS 228
Query: 596 IEWPSED---DWPIQVEAKSIITDLLQQNPRDR 625
+ + D D P + +I +++ +R
Sbjct: 229 VPNVTTDVRKDIPQSLSN--VILRATEKDKANR 259
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 81/333 (24%), Positives = 133/333 (39%), Gaps = 57/333 (17%)
Query: 342 SIESNSDSYCSKKDKFSKTPN-ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKN 400
S+ S+S + + S + F +++L+ NG YG VY RH +T Q A+K +
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 401 SLMLRNQMEQVFAERDIMS-FTDNPFVVTMYCSF------ETKKHLCLVMEYVEGGDCAS 453
++ E++ E +++ ++ + + T Y +F L LVME+ G
Sbjct: 61 G----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 454 LLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511
L+KNT L + + E + + +LH + ++HRD+K N+L+T +KL DFG+S
Sbjct: 117 LIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 512 KMGLMSLATNLYECYVERDAKQFSDKQ-----VYGTPEYIAPEVILRQ-----GYGKPVD 561
Q GTP ++APEVI Y D
Sbjct: 177 A--------------------QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSD 216
Query: 562 WWSMGVILYEFLVGCVPFFGETP-EELFAHTVNDDIEWP---SEDDWPIQVEAKSIITDL 617
WS+G+ E G P P LF N W + +S I
Sbjct: 217 LWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP----APRLKSKKWS--KKFQSFIESC 270
Query: 618 LQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLR 650
L +N R T ++ +HP+ + +R
Sbjct: 271 LVKNHSQRPAT---EQLMKHPFIRDQPNERQVR 300
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 67/272 (24%), Positives = 107/272 (39%), Gaps = 31/272 (11%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
D + + I G++G+V+ A+K + ++ + E IM
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEWHG--SDVAVKIL-MEQDFHAERVNEFLREVAIMKRL 91
Query: 422 DNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTG---PLPADMARFYFA-ETVL 475
+P +V + +L +V EY+ G LL +G L R A +
Sbjct: 92 RHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR-RLSMAYDVAK 148
Query: 476 AVEYLHSYG--IVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
+ YLH+ IVHR+LK NLL+ +K+ DFGLS+ + +
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR---------------LKASTF 193
Query: 534 FSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593
S K GTPE++APEV+ + + D +S GVIL+E P+ P ++ A
Sbjct: 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 253
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
+ QV +II P R
Sbjct: 254 KCKRLEIPRNLNPQV--AAIIEGCWTNEPWKR 283
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 71/326 (21%), Positives = 128/326 (39%), Gaps = 84/326 (25%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-- 421
+ ++ I G YG+V+ +++ET + A+K++ +++ + + + +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV---------RLDD---DDEGVPSSAL 49
Query: 422 ---------DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG-PLPADMARFYFA 471
+ +V ++ + K L LV E+ + D + L ++ + +
Sbjct: 50 REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLF 108
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531
+ + + + HS ++HRDLKP NLLI G +KL +FGL A
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL--------------------A 148
Query: 532 KQFSD-KQVYGTPE-----YIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFF-GET 583
+ F + Y + E Y P+V+ + Y +D WS G I E P F G
Sbjct: 149 RAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 584 -PEELFA-----HTVNDDIEWPSEDD---------WPIQVEAKSIIT-------DLLQQ- 620
++L T ++ WPS +P +++ DLLQ
Sbjct: 208 VDDQLKRIFRLLGTPTEEQ-WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNL 266
Query: 621 ---NPRDRLGTGGPHEVKEHPYFSNL 643
NP R+ E +HPYFS+
Sbjct: 267 LKCNPVQRISA---EEALQHPYFSDF 289
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-37
Identities = 62/277 (22%), Positives = 96/277 (34%), Gaps = 57/277 (20%)
Query: 368 VIKLISNGAYGSVYLVRHKETRQRF-AMKKIIKNSLMLRNQMEQVF-----AERDIMSFT 421
V I++G G +YL + R +K L + + AER ++
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLK-------GLVHSGDAEAQAMAMAERQFLAEV 136
Query: 422 DNPFVVTMYCSFETKKHLC-----LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLA 476
+P +V ++ E +VMEYV G LP A Y E + A
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPA 194
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
+ YLHS G+V+ DLKP+N+++T +KL D G F
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAV-----------------SRINSFG- 235
Query: 537 KQVYGTPEYIAPEVILRQGYGKPV---DWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593
+YGTP + APE P D +++G L + G + L
Sbjct: 236 -YLYGTPGFQAPE----IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL------ 284
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGG 630
E ++ + +PR R T
Sbjct: 285 --PEDDPVLKTYDSYGR--LLRRAIDPDPRQRFTTAE 317
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 4e-37
Identities = 83/336 (24%), Positives = 133/336 (39%), Gaps = 103/336 (30%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-- 421
+ + + G + +VY R K T Q A+KKI ++ +D ++ T
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI---------KLGHRSEAKDGINRTAL 60
Query: 422 ---------DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG-PLPADMARFYFA 471
+P ++ + +F K ++ LV +++E D ++K+ L + Y
Sbjct: 61 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYML 119
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531
T+ +EYLH + I+HRDLKP+NLL+ G +KL DFGL A
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL--------------------A 159
Query: 532 KQFSD-KQVYGTPE-----YIAPEVIL--RQGYGKPVDWWSMGVILYEFLVGCVPFF-GE 582
K F + Y T + Y APE++ R YG VD W++G IL E L+ VPF G+
Sbjct: 160 KSFGSPNRAY-THQVVTRWYRAPELLFGARM-YGVGVDMWAVGCILAELLLR-VPFLPGD 216
Query: 583 TPEELFAHTVNDDIEW----------PSEDDWP-------------------------IQ 607
+ D++ P+E+ WP
Sbjct: 217 S-----------DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAG 265
Query: 608 VEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643
+ +I L NP R+ + + YFSN
Sbjct: 266 DDLLDLIQGLFLFNPCARITA---TQALKMKYFSNR 298
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 77/326 (23%), Positives = 126/326 (38%), Gaps = 81/326 (24%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQV--FAERDI--MS 419
+ I I G+YG V+ R+++T Q A+KK + + A R+I +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-----LESEDDPVIKKIALREIRMLK 57
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVE 478
+P +V + F K+ L LV EY + L +P + + +T+ AV
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ 538
+ H + +HRD+KP+N+LIT IKL DFG A+ +
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGF--------------------ARLLTGPS 156
Query: 539 VYGTPE-----YIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFF-GET-PEELFAH 590
Y E Y +PE+++ YG PVD W++G + E L G VP + G++ ++L+
Sbjct: 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYL- 214
Query: 591 TVNDDIEW----PSEDDWP----------------------------IQVEAKSIITDLL 618
I I A ++ L
Sbjct: 215 -----IRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCL 269
Query: 619 QQNPRDRLGTGGPHEVKEHPYFSNLD 644
+P +RL ++ HPYF N+
Sbjct: 270 HMDPTERLTC---EQLLHHPYFENIR 292
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 83/344 (24%), Positives = 134/344 (38%), Gaps = 94/344 (27%)
Query: 351 CSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQ 410
++ + I GAYG+VY R + A+K + R
Sbjct: 5 SMATSRYEP---------VAEIGVGAYGTVYKARDPHSGHFVALKSV-------RVPNGG 48
Query: 411 -------VFAERDI-----MSFTDNPFVVTMYCSFETKKH-----LCLVMEYVEGGDCAS 453
+ R++ + ++P VV + T + + LV E+V+ D +
Sbjct: 49 GGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRT 107
Query: 454 LLKNTGP--LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511
L P LPA+ + + + +++LH+ IVHRDLKP+N+L+T+ G +KL DFGL
Sbjct: 108 YLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL- 166
Query: 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPE-----YIAPEVILRQGYGKPVDWWSMG 566
A+ +S + TP Y APEV+L+ Y PVD WS+G
Sbjct: 167 -------------------ARIYSYQMAL-TPVVVTLWYRAPEVLLQSTYATPVDMWSVG 206
Query: 567 VILYEFLVGCVPFF-GET-PEELFAHTVNDDIEWPSEDDWP------------------- 605
I E P F G + ++L + D I P EDDWP
Sbjct: 207 CIFAEMFRR-KPLFCGNSEADQLG--KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQ 263
Query: 606 -----IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644
++ ++ ++L NP R+ +H Y +
Sbjct: 264 SVVPEMEESGAQLLLEMLTFNPHKRISA---FRALQHSYLHKDE 304
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 57/270 (21%), Positives = 108/270 (40%), Gaps = 28/270 (10%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
TV + I +G++G+VY + A+K + + Q++ E ++ T +
Sbjct: 24 GQITVGQRIGSGSFGTVY---KGKWHGDVAVKML-NVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 424 PFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFA-ETVLAVEYL 480
++ T L +V ++ EG L + A +T ++YL
Sbjct: 80 VNILLFMGYS---TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
H+ I+HRDLK +N+ + +K+ DFGL+ R + +Q+
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-------------KSRWSGSHQFEQLS 183
Query: 541 GTPEYIAPEVILRQG---YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597
G+ ++APEVI Q Y D ++ G++LYE + G +P+ + V
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243
Query: 598 WPSEDDWPIQV--EAKSIITDLLQQNPRDR 625
P K ++ + L++ +R
Sbjct: 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 74/360 (20%), Positives = 128/360 (35%), Gaps = 111/360 (30%)
Query: 342 SIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNS 401
S+ ++ + D++ + I + G YG VY T + A+K+I
Sbjct: 21 SMSVSAAPSATSIDRYRR---------ITKLGEGTYGEVYKAIDTVTNETVAIKRI---- 67
Query: 402 LMLRNQMEQVFAERDIMSFT-----------DNPFVVTMYCSFETKKHLCLVMEYVEGGD 450
++E E + + T + ++ + L L+ EY E D
Sbjct: 68 -----RLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-D 118
Query: 451 CASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL-----GHIKL 505
+ + + + + + + V + HS +HRDLKP NLL++ +K+
Sbjct: 119 LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKI 178
Query: 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSD-KQVYGTPE-----YIAPEVIL-RQGYGK 558
DFGL A+ F + + T E Y PE++L + Y
Sbjct: 179 GDFGL--------------------ARAFGIPIRQF-THEIITLWYRPPEILLGSRHYST 217
Query: 559 PVDWWSMGVILYEFLVGCVPFF-GET-PEELFA-----HTVNDDIEWPSEDDWP------ 605
VD WS+ I E L+ P F G++ ++LF P + WP
Sbjct: 218 SVDIWSIACIWAEMLMK-TPLFPGDSEIDQLFKIFEVLGL-------PDDTTWPGVTALP 269
Query: 606 ---------------------IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644
+ E ++T +L+ +P R+ EHPYFS+ D
Sbjct: 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA---KNALEHPYFSHND 326
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-36
Identities = 69/346 (19%), Positives = 129/346 (37%), Gaps = 92/346 (26%)
Query: 345 SNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML 404
+ Y +K+ + L+ G+YG V R+K+T + A+KK +
Sbjct: 15 GTENLYFQSMEKYEN---------LGLVGEGSYGMVMKCRNKDTGRIVAIKKFL-----E 60
Query: 405 RNQMEQV--FAERDI--MSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-G 459
+ + V A R+I + + +V + + KK LV E+V+ L+
Sbjct: 61 SDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN 119
Query: 460 PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519
L + + Y + + + + HS+ I+HRD+KP+N+L++ G +KL DFG
Sbjct: 120 GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF--------- 170
Query: 520 TNLYECYVERDAKQFSDKQVYGTPE-----YIAPEVILRQG-YGKPVDWWSMGVILYEFL 573
A+ + E Y APE+++ YGK VD W++G ++ E
Sbjct: 171 -----------ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219
Query: 574 VGCVPFF-GETPEELFAH------TVNDDIEWPSEDDWPI-------------QVEAKSI 613
+G P F G++ + H + +++ +
Sbjct: 220 MG-EPLFPGDSDIDQLYHIMMCLGN-------LIPRHQELFNKNPVFAGVRLPEIKEREP 271
Query: 614 IT-----------DLLQQ----NPRDRLGTGGPHEVKEHPYFSNLD 644
+ DL ++ +P R E+ H +F
Sbjct: 272 LERRYPKLSEVVIDLAKKCLHIDPDKRPFC---AELLHHDFFQMDG 314
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 8e-36
Identities = 80/356 (22%), Positives = 135/356 (37%), Gaps = 108/356 (30%)
Query: 342 SIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNS 401
S + + +K+ K ++ + G YG VY + + A+K+I
Sbjct: 8 SSGRENLYFQGLMEKYQK---------LEKVGEGTYGVVYKAKDS-QGRIVALKRI---- 53
Query: 402 LMLRNQMEQVFAERDIMSFT-----------DNPFVVTMYCSFETKKHLCLVMEYVEGGD 450
+++ E + + T +P +V++ +++ L LV E++E D
Sbjct: 54 -----RLDA---EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-D 104
Query: 451 CASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFG 509
+L L + Y + + V + H + I+HRDLKP NLLI + G +KL DFG
Sbjct: 105 LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFG 164
Query: 510 LSKMGLMSLATNLYECYVERDAKQFSD-KQVYGTPE-----YIAPEVIL-RQGYGKPVDW 562
L A+ F + Y T E Y AP+V++ + Y VD
Sbjct: 165 L--------------------ARAFGIPVRSY-THEVVTLWYRAPDVLMGSKKYSTSVDI 203
Query: 563 WSMGVILYEFLVGCVPFF-GETPEELFAH------TVNDDIEWPSEDDWP---------- 605
WS+G I E + G P F G T ++ T P+ +WP
Sbjct: 204 WSIGCIFAEMITG-KPLFPGVTDDDQLPKIFSILGT-------PNPREWPQVQELPLWKQ 255
Query: 606 -----------------IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644
E +++++L +P R+ + HPYF +LD
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA---RDAMNHPYFKDLD 308
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 79/333 (23%), Positives = 131/333 (39%), Gaps = 98/333 (29%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-- 421
+ ++ I G YG VY ++ + FA+KKI ++E+ E + + T
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI---------RLEK---EDEGIPSTTI 48
Query: 422 ---------DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFA 471
+ +V +Y TKK L LV E+++ D LL G L + A+ +
Sbjct: 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLL 107
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531
+ + + Y H ++HRDLKP NLLI G +K+ DFGL A
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL--------------------A 147
Query: 532 KQFSD-KQVYGTPE-----YIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFF-GET 583
+ F + Y T E Y AP+V++ + Y +D WS+G I E + G P F G +
Sbjct: 148 RAFGIPVRKY-THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVS 205
Query: 584 -PEELFA-----HTVNDDIEWPSEDDWP--------------------------IQVEAK 611
++L T P+ +WP +
Sbjct: 206 EADQLMRIFRILGT-------PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGI 258
Query: 612 SIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644
+++ +L+ +P R+ + EH YF +
Sbjct: 259 DLLSKMLKLDPNQRITA---KQALEHAYFKENN 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 54/272 (19%), Positives = 101/272 (37%), Gaps = 27/272 (9%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ +LI G +G VY R A++ I +Q++ E T +
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW---HGEVAIRLI-DIERDNEDQLKAFKREVMAYRQTRH 88
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFA-ETVLAVEYLHS 482
VV + + HL ++ +G S++++ + A E V + YLH+
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
GI+H+DLK N+ G + +TDFGL + ++ ++ + G
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSI----------SGVLQAGRREDKLRIQNGW 197
Query: 543 PEYIAPEVI---------LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593
++APE+I + + K D +++G I YE PF + E +
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
S+ ++ I+ +R
Sbjct: 258 GMKPNLSQIGMGKEI--SDILLFCWAFEQEER 287
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 80/328 (24%), Positives = 129/328 (39%), Gaps = 87/328 (26%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVF---AERDI--M 418
+ + + G Y +VY + K T A+K+I R + E+ A R++ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLL 54
Query: 419 SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAV 477
+ +VT++ T+K L LV EY++ D L + G + + + + + +
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD- 536
Y H ++HRDLKP NLLI G +KL DFGL A+ S
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGL--------------------ARAKSIP 153
Query: 537 KQVYGTPE-----YIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFF-GET-PEELF 588
+ Y E Y P+++L Y +D W +G I YE G P F G T E+L
Sbjct: 154 TKTY-DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGSTVEEQLH 211
Query: 589 A-----HTVNDDIEWPSEDDWP---------------------------IQVEAKSIITD 616
T P+E+ WP + + ++T
Sbjct: 212 FIFRILGT-------PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTK 264
Query: 617 LLQQNPRDRLGTGGPHEVKEHPYFSNLD 644
LLQ R+R+ + +HP+F +L
Sbjct: 265 LLQFEGRNRISA---EDAMKHPFFLSLG 289
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 89/347 (25%), Positives = 141/347 (40%), Gaps = 92/347 (26%)
Query: 346 NSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRH-KETRQRFAMKKIIKNSLML 404
D C ++ + I GAYG V+ R K + A+K++
Sbjct: 2 EKDGLCRADQQYEC---------VAEIGEGAYGKVFKARDLKNGGRFVALKRV------- 45
Query: 405 RNQMEQ----VFAERDI-----MSFTDNPFVVTMY-----CSFETKKHLCLVMEYVEGGD 450
R Q + + R++ + ++P VV ++ + + L LV E+V+ D
Sbjct: 46 RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-D 104
Query: 451 CASLLKNTGP--LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDF 508
+ L +P + + + + +++LHS+ +VHRDLKP N+L+T+ G IKL DF
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164
Query: 509 GLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPE-----YIAPEVILRQGYGKPVDWW 563
GL A+ +S + T Y APEV+L+ Y PVD W
Sbjct: 165 GL--------------------ARIYSFQMAL-TSVVVTLWYRAPEVLLQSSYATPVDLW 203
Query: 564 SMGVILYEFLVGCVPFF-GET-PEELFAHTVNDDIEWPSEDDWP----------IQVEAK 611
S+G I E P F G + ++L + D I P E+DWP A+
Sbjct: 204 SVGCIFAEMFRR-KPLFRGSSDVDQLG--KILDVIGLPGEEDWPRDVALPRQAFHSKSAQ 260
Query: 612 SIIT----------DLLQQ----NPRDRLGTGGPHEVKEHPYFSNLD 644
I DLL + NP R+ + HPYF +L+
Sbjct: 261 PIEKFVTDIDELGKDLLLKCLTFNPAKRISA---YSALSHPYFQDLE 304
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 38/273 (13%), Positives = 87/273 (31%), Gaps = 34/273 (12%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
+ + ++ G ++ R + +K + R + E +
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQG--NDIVVKVLKVRDWSTR-KSRDFNEECPRLRIF 64
Query: 422 DNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMA-RFYFA-ETVLAV 477
+P V+ + C H L+ ++ G ++L D + FA + +
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 478 EYLHSYG--IVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
+LH+ I L +++I +++ + F
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS--------------------FQ 164
Query: 536 DKQVYGTPEYIAPEVILRQGYG---KPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592
P ++APE + ++ + D WS V+L+E + VPF + E+
Sbjct: 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224
Query: 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
+ + V ++ + ++P R
Sbjct: 225 LEGLRPTIPPGISPHV--SKLMKICMNEDPAKR 255
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 67/278 (24%), Positives = 111/278 (39%), Gaps = 38/278 (13%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFA-ERDIMSF 420
+ + T+ ++I G +G VY A+K + +Q + E + +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 421 TDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVE 478
+P ++ + C + +LCLVME+ GG +L +P D+ + + +
Sbjct: 63 LKHPNIIALRGVCL--KEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 119
Query: 479 YLHSYG---IVHRDLKPDNLLITALGH--------IKLTDFGLSKMGLMSLATNLYECYV 527
YLH I+HRDLK N+LI +K+TDFGL+
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA---------------- 163
Query: 528 ERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL 587
R+ + + G ++APEVI + K D WS GV+L+E L G VPF G +
Sbjct: 164 -REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV 222
Query: 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
+ + P P ++ D +P R
Sbjct: 223 AYGVAMNKLALPIPSTCPEPF--AKLMEDCWNPDPHSR 258
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 80/337 (23%), Positives = 128/337 (37%), Gaps = 96/337 (28%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVF---AERDI--M 418
+ F ++ + NG Y +VY +K T A+K++ + E+ A R+I M
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAIREISLM 57
Query: 419 SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT------GPLPADMARFYFAE 472
+ +V +Y T+ L LV E+++ D + + L ++ +++ +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 473 TVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAK 532
+ + + H I+HRDLKP NLLI G +KL DFGL A+
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL--------------------AR 156
Query: 533 QFSD-KQVYGTPE-----YIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFF-GET- 583
F + + E Y AP+V++ + Y +D WS G IL E + G P F G
Sbjct: 157 AFGIPVNTF-SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTND 214
Query: 584 PEELFA-----HTVNDDIEWPSEDDWP-----------------------IQVEAKSIIT 615
E+L T P+E WP +Q K +
Sbjct: 215 EEQLKLIFDIMGT-------PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLD 267
Query: 616 ----DLLQQ----NPRDRLGTGGPHEVKEHPYFSNLD 644
D L NP RL + HP+F+
Sbjct: 268 GNLMDFLHGLLQLNPDMRLSA---KQALHHPWFAEYY 301
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-33
Identities = 79/322 (24%), Positives = 123/322 (38%), Gaps = 78/322 (24%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM-LRNQMEQVFAERDIMSFTDNP 424
+T K+I NG++G VY + ++ + A+KK++++ R E IM D+
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDHC 107
Query: 425 FVVTMYCSF------ETKKHLCLVMEYVEGGD----CASLLKNTGPLPADMARFYFAETV 474
+V + F + + +L LV++YV + LP + Y +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITAL-GHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
++ Y+HS+GI HRD+KP NLL+ +KL DFG AKQ
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS--------------------AKQ 206
Query: 534 FSDKQVYGTPEYI------APEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGE---- 582
+ YI APE+I Y +D WS G +L E L+G F G+
Sbjct: 207 LVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
Query: 583 ----------TPEELFAHTVNDDIEWPSEDDWPIQ-----------VEAKSIITDLLQQN 621
TP +N + EA ++ + LL+
Sbjct: 265 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 324
Query: 622 PRDRLGTGGPHEVKEHPYFSNL 643
P RL P E H +F L
Sbjct: 325 PTARL---TPLEACAHSFFDEL 343
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-33
Identities = 82/327 (25%), Positives = 124/327 (37%), Gaps = 79/327 (24%)
Query: 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM-LRNQMEQVFAERDIMS 419
E +T K+I NG++G V+ + E+ + A+KK++++ R E IM
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR--------ELQIMR 87
Query: 420 FTDNPFVVTMYCSF------ETKKHLCLVMEYVEGGD----CASLLKNTGPLPADMARFY 469
+P VV + F + + L LV+EYV K +P + + Y
Sbjct: 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLY 146
Query: 470 FAETVLAVEYLHSYGIVHRDLKPDNLLITAL-GHIKLTDFGLSKMGLMSLATNLYECYVE 528
+ + ++ Y+HS GI HRD+KP NLL+ G +KL DFG
Sbjct: 147 MYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS------------------ 188
Query: 529 RDAKQFSDKQVYGTPEYI------APEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFG 581
AK + YI APE+I Y +D WS G ++ E + G F G
Sbjct: 189 --AKILIAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244
Query: 582 E--------------TPEELFAHTVNDDIEWPSEDDWPIQ-----------VEAKSIITD 616
E TP T+N + +A +I+
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISR 304
Query: 617 LLQQNPRDRLGTGGPHEVKEHPYFSNL 643
LL+ P RL E HP+F L
Sbjct: 305 LLEYTPSARL---TAIEALCHPFFDEL 328
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-32
Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 45/240 (18%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF----- 420
+ V+K+I G++G V + Q A+K +++N Q + E I+
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQAAE---EIRILEHLRKQD 154
Query: 421 -TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAV 477
+ V+ M +F + H+C+ E + + L+K + R + + +
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 478 EYLHSYGIVHRDLKPDNLLITALGH--IKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
+ LH I+H DLKP+N+L+ G IK+ DFG S C +
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-------------C--------YE 252
Query: 536 DKQVYGTPEYI------APEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589
++VY YI APEVIL YG P+D WS+G IL E L G GE + A
Sbjct: 253 HQRVY---TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA 309
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 71/324 (21%), Positives = 124/324 (38%), Gaps = 71/324 (21%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM--- 418
N++D+ +++ + G Y V+ + ++ +K + K + +R+I
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-KPVKKKK-------IKREIKILE 85
Query: 419 SFTDNPFVVTMYCSF--ETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLA 476
+ P ++T+ + LV E+V D L + L RFY E + A
Sbjct: 86 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKA 142
Query: 477 VEYLHSYGIVHRDLKPDNLLI-TALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
++Y HS GI+HRD+KP N++I ++L D+GL++ Y V
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRV-------- 191
Query: 536 DKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFF-GE----------- 582
+ + PE+++ Q Y +D WS+G +L + PFF G
Sbjct: 192 -----ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246
Query: 583 ---TPEEL---------FAHTVNDDIEWPSEDDWPIQVEAKSIIT------DLLQQ---- 620
T + ND + S W V +++ D L +
Sbjct: 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 306
Query: 621 NPRDRLGTGGPHEVKEHPYFSNLD 644
+ + RL T E EHPYF +
Sbjct: 307 DHQSRL-T--AREAMEHPYFYTVV 327
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 52/249 (20%), Positives = 98/249 (39%), Gaps = 47/249 (18%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF----- 420
+ +++ + G + +V+L + AMK I++ + E E ++
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAED---EIKLLQRVNDAD 76
Query: 421 ------TDNPFVVTMYCSFETK----KHLCLVMEYVEGGDCASLLK--NTGPLPADMARF 468
++ + F K H+ +V E V G + +L+K +P +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 469 YFAETVLAVEYLHSY-GIVHRDLKPDNLLI------TALGHIKLTDFGLSKMGLMSLATN 521
+ +L ++Y+H GI+H D+KP+N+L+ L IK+ D G +
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---------- 185
Query: 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG 581
C+ D + Q T EY +PEV+L +G D WS +++E + G F
Sbjct: 186 ---CWY--DEHYTNSIQ---TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237
Query: 582 ETPEELFAH 590
+
Sbjct: 238 DEGHSYTKD 246
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 83/335 (24%), Positives = 130/335 (38%), Gaps = 89/335 (26%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI----- 417
+ F V ++ G +G+V L + K T A+KK+I++ F R++
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD---------PRFRNRELQIMQD 72
Query: 418 MSFTDNPFVVTMYCSFETKKH-------LCLVMEYVEGGD----CASLLKNTGPLPADMA 466
++ +P +V + F T L +VMEYV C + + P +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILI 131
Query: 467 RFYFAETVLAVEYLH--SYGIVHRDLKPDNLLI-TALGHIKLTDFGLSKMGLMSLATNLY 523
+ + + + ++ LH S + HRD+KP N+L+ A G +KL DFG
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS------------- 178
Query: 524 ECYVERDAKQFSDKQVYGTPEYI------APEVILR-QGYGKPVDWWSMGVILYEFLVGC 576
AK+ S + YI APE+I Q Y VD WS+G I E ++G
Sbjct: 179 -------AKKLSPSEPN-V-AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
Query: 577 VPFFGE--------------TPEELFAHTVNDD-----------IEWP---SEDDWPIQV 608
F G+ P +N I W S+
Sbjct: 230 PIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAK 289
Query: 609 EAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643
EA +++ LLQ P +R+ P+E HPYF L
Sbjct: 290 EAYDLLSALLQYLPEERM---KPYEALCHPYFDEL 321
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-30
Identities = 60/255 (23%), Positives = 103/255 (40%), Gaps = 30/255 (11%)
Query: 345 SNSDSYCSKKDKFSKTPNENDFTV------IKLISNGAYGSVYLVRHKETRQRFAMKKII 398
+ S K S +D+ + LI G+YG V K ++ A+KKI
Sbjct: 28 QQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI- 86
Query: 399 KNSLMLRNQME--QVFAERDIMSFTDNPFVVTMY-----CSFETKKHLCLVMEYVEGGDC 451
+ + ++ ++ E I++ ++ VV + E L +V+E + D
Sbjct: 87 --LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DF 143
Query: 452 ASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511
L + L + ++ V+Y+HS GI+HRDLKP N L+ +K+ DFGL+
Sbjct: 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
Query: 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTP------EYI------APEVILR-QGYGK 558
+ N R+ + ++ APE+IL + Y +
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE 263
Query: 559 PVDWWSMGVILYEFL 573
+D WS+G I E L
Sbjct: 264 AIDVWSIGCIFAELL 278
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 72/331 (21%), Positives = 123/331 (37%), Gaps = 84/331 (25%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKII-KNS---------LMLRNQM--EQVFA 413
+ +K + G G V+ + +R A+KKI+ + + + ++ + +
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 414 ERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAET 473
+I+ + S + +V EY+E D A++L+ GPL + AR + +
Sbjct: 73 VFEILG-PSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE-QGPLLEEHARLFMYQL 129
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITALG-HIKLTDFGLSKMGLMSLATNLYECYVERDAK 532
+ ++Y+HS ++HRDLKP NL I +K+ DFGL+ R
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA-----------------RIMD 172
Query: 533 QFSDKQVYGTPEYI------APEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPE 585
+ + + E + +P ++L Y K +D W+ G I E L G F G
Sbjct: 173 PHYSHKGHLS-EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA--- 228
Query: 586 ELFAHTVN------DDIEWPSEDDWP-IQVEAKSIIT----------------------D 616
H + + I E+D + I D
Sbjct: 229 ----HELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVD 284
Query: 617 LLQQ----NPRDRLGTGGPHEVKEHPYFSNL 643
L+Q +P DRL E HPY S
Sbjct: 285 FLEQILTFSPMDRLTA---EEALSHPYMSIY 312
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 63/242 (26%), Positives = 104/242 (42%), Gaps = 47/242 (19%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQ--ME----QVFAERDIMS 419
+ + LI G++G V + ++ A+K IIKN NQ +E ++ + D
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHDT-- 112
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAV 477
++V + F + HLCLV E + + LL+NT + ++ R + + A+
Sbjct: 113 -EMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 478 EYLHSY--GIVHRDLKPDNLLITALGH--IKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
+L + I+H DLKP+N+L+ IK+ DFG S C
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-------------C-------- 209
Query: 534 FSDKQVYGTPEYI------APEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL 587
+++Y +YI +PEV+L Y +D WS+G IL E G F G +
Sbjct: 210 QLGQRIY---QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
Query: 588 FA 589
Sbjct: 267 MN 268
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 75/376 (19%), Positives = 134/376 (35%), Gaps = 95/376 (25%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKN--------SLM----------- 403
+++ K + G++G V V E+ +RFA+KK++++ +M
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKL 65
Query: 404 ------------LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGD- 450
Q + + N ++ + K+L ++MEYV
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TL 124
Query: 451 ---CASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL-GHIKLT 506
S +++ +P ++ Y + AV ++HS GI HRD+KP NLL+ + +KL
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 507 DFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYI------APEVILR-QGYGKP 559
DFG AK+ + YI APE++L Y
Sbjct: 185 DFGS--------------------AKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPS 222
Query: 560 VDWWSMGVILYEFLVGCVPFFGE--------------TPEELFAHTVNDDIEWPSEDDWP 605
+D WS+G + E ++G F GE TP + +N
Sbjct: 223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK 282
Query: 606 IQ-----------VEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL-DWNSLLRHKA 653
+ A ++ +L+ P R+ P+E HP+F +L +
Sbjct: 283 AKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHPFFDHLRNSYESEVKNN 339
Query: 654 EFIPQLDDEEDTSYFD 669
P ++ F+
Sbjct: 340 SNFPHGVNQNIPQLFN 355
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 59/329 (17%), Positives = 102/329 (31%), Gaps = 60/329 (18%)
Query: 337 SLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKK 396
+L D + + S + + + I G +G V+ + + + A+K
Sbjct: 15 TLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRG--EEVAVKI 72
Query: 397 IIKNSLMLRNQMEQVFAERDI--MSFTDNPFVVTMYCS----FETKKHLCLVMEYVEGGD 450
+ F E +I + ++ + T L LV +Y E G
Sbjct: 73 F------SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGS 126
Query: 451 CASLLKNTGPLPADMARFYFAETV-LAVEYLHSY--------GIVHRDLKPDNLLITALG 501
L M + A + + +LH I HRDLK N+L+ G
Sbjct: 127 LFDYLNRYTVTVEGMIKL--ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184
Query: 502 HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG------ 555
+ D GL+ + T GT Y+APEV+
Sbjct: 185 TCCIADLGLAVRHDSATDTIDIAPNHRV-----------GTKRYMAPEVLDDSINMKHFE 233
Query: 556 YGKPVDWWSMGVILYEFLVGC----------VPFFGETP-----EELFAHTVNDDI--EW 598
K D ++MG++ +E C +P++ P EE+ +
Sbjct: 234 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI 293
Query: 599 PSEDDW-PIQVEAKSIITDLLQQNPRDRL 626
P+ I+ + N RL
Sbjct: 294 PNRWQSCEALRVMAKIMRECWYANGAARL 322
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 68/283 (24%), Positives = 110/283 (38%), Gaps = 67/283 (23%)
Query: 350 YCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQME 409
+C + K+ K + I G +G V+ RH++T Q+ A+KK++ ME
Sbjct: 12 FCDEVSKYEK---------LAKIGQGTFGEVFKARHRKTGQKVALKKVL---------ME 53
Query: 410 QVFAERDIMSFT-----------DNPFVVTMY--------CSFETKKHLCLVMEYVEGGD 450
E++ T + VV + K + LV ++ E D
Sbjct: 54 N---EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-D 109
Query: 451 CASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFG 509
A LL N + + + Y+H I+HRD+K N+LIT G +KL DFG
Sbjct: 110 LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 169
Query: 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVI 568
L+ + +++++ V T Y PE++L + YG P+D W G I
Sbjct: 170 LA---------RAFSLAKNSQPNRYTNRVV--TLWYRPPELLLGERDYGPPIDLWGAGCI 218
Query: 569 LYEFLVGCVPFF-GET-PEELFAHTVNDDIEW----PSEDDWP 605
+ E P G T +L I + + WP
Sbjct: 219 MAEMWTR-SPIMQGNTEQHQLAL------ISQLCGSITPEVWP 254
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 78/361 (21%), Positives = 137/361 (37%), Gaps = 70/361 (19%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM---SFTD 422
+ ++K + GAYG V+ + T + A+KKI +N + R+IM +
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD---AFQNSTDAQRTFREIMILTELSG 67
Query: 423 NPFVVTMYCSF--ETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYL 480
+ +V + + + + LV +Y+E D ++++ L ++ + + ++YL
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIR-ANILEPVHKQYVVYQLIKVIKYL 125
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
HS G++HRD+KP N+L+ A H+K+ DFGLS+ + + + D
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 541 GTPEYI------APEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGE----------- 582
+Y+ APE++L Y K +D WS+G IL E L G F G
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 583 ---TPEELFAHTVNDD------------------IEWPSEDDWPIQV-----------EA 610
P ++ + W + EA
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305
Query: 611 KSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDS 670
++ LLQ NP R+ ++ +HP+ S H P D D+
Sbjct: 306 LDLLDKLLQFNPNKRISA---NDALKHPFVSIF-------HNPNEEPNCDHIITIPINDN 355
Query: 671 R 671
Sbjct: 356 V 356
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 21/240 (8%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQME--QVFAERDIMSFTDN 423
+ + LI G+YG VYL K T + A+KK+ + M + ++ ++ E I++ +
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILNRLKS 84
Query: 424 PFVVTMY-----CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVE 478
+++ +Y L +V+E + D L K L + + +L
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ 538
++H GI+HRDLKP N L+ +K+ DFGL++ TN+ E + +K
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 539 VYGT-PEYI------APEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE--LF 588
+ ++ APE+IL ++ Y K +D WS G I E L + LF
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 63/300 (21%), Positives = 102/300 (34%), Gaps = 58/300 (19%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI--MSFTD 422
D T+++ + G YG V+ + + A+K + F E ++
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQG--ENVAVKIF------SSRDEKSWFRETELYNTVMLR 60
Query: 423 NPFVVTMYCSFETKKH----LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVE 478
+ ++ S T +H L L+ Y E G L+ T R +
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLSIASGLA 119
Query: 479 YLHSY--------GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERD 530
+LH I HRDLK N+L+ G + D GL+ M
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----------HSQSTNQ 169
Query: 531 AKQFSDKQVYGTPEYIAPEVI------LRQGYGKPVDWWSMGVILYEFLVGC-------- 576
++ +V GT Y+APEV+ K VD W+ G++L+E
Sbjct: 170 LDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
Query: 577 --VPFFGETP-----EELFAHTVNDDI--EWPSE-DDWPIQVEAKSIITDLLQQNPRDRL 626
PF+ P E++ D P+ P ++ + QNP RL
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 66/331 (19%), Positives = 110/331 (33%), Gaps = 64/331 (19%)
Query: 337 SLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKK 396
SL D +S S S + ++K I G YG V++ + + ++ A+K
Sbjct: 10 SLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRG--EKVAVKV 67
Query: 397 IIKNSLMLRNQMEQVFAERDI--MSFTDNPFVVTMY----CSFETKKHLCLVMEYVEGGD 450
+ F E +I + ++ + L L+ +Y E G
Sbjct: 68 F------FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS 121
Query: 451 CASLLKNTGPLPADMARFYFAETV-LAVEYLHSY--------GIVHRDLKPDNLLITALG 501
LK+T M + A + + +LH+ I HRDLK N+L+ G
Sbjct: 122 LYDYLKSTTLDAKSMLKL--AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179
Query: 502 HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI------LRQG 555
+ D GL+ + GT Y+ PEV+
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRV-----------GTKRYMPPEVLDESLNRNHFQ 228
Query: 556 YGKPVDWWSMGVILYEFLVGCV----------PFFGETP-----EELFAHTVNDDI---- 596
D +S G+IL+E CV P+ P E++ +
Sbjct: 229 SYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF 288
Query: 597 -EWPSEDDWPIQVEAKSIITDLLQQNPRDRL 626
S D+ Q+ ++T+ NP RL
Sbjct: 289 PNRWSSDECLRQM--GKLMTECWAHNPASRL 317
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 56/256 (21%), Positives = 90/256 (35%), Gaps = 55/256 (21%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQ--ME----QVFAERDIMS 419
F VI+ + +G +G V L +H + ++ +A+K +++N +E + D
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-VVRNIKKYTRSAKIEADILKKIQNDD--- 92
Query: 420 FTDNPFVVTMYCSFETKKHLCLVME------YVEGGDCASLLKNTG--PLPADMARFYFA 471
+N +V + F H+CL+ E Y ++ + + Y
Sbjct: 93 -INNNNIVKYHGKFMYYDHMCLIFEPLGPSLY-------EIITRNNYNGFHIEDIKLYCI 144
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531
E + A+ YL + H DLKP+N+L L D K + +
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENIL--------LDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 532 KQ------------FSDKQVYGTPEYI------APEVILRQGYGKPVDWWSMGVILYEFL 573
K F I APEVIL G+ D WS G +L E
Sbjct: 197 KSTGIKLIDFGCATFKSDYHG---SIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253
Query: 574 VGCVPFFGETPEELFA 589
G + F E A
Sbjct: 254 TGSLLFRTHEHMEHLA 269
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 59/308 (19%), Positives = 103/308 (33%), Gaps = 61/308 (19%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-- 421
++ +++LI G YG+VY E + A+K + E++I
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSLDE--RPVAVKV------FSFANRQNFINEKNIYRVPLM 64
Query: 422 DNPFVVTMY-----CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLA 476
++ + + + + LVMEY G L R
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSVTRG 123
Query: 477 VEYLHSY---------GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYV 527
+ YLH+ I HRDL N+L+ G ++DFGLS + V
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR-------LV 176
Query: 528 ERDAKQFSDKQVYGTPEYIAPEVI-------LRQGYGKPVDWWSMGVILYEFLVGC---- 576
+ + GT Y+APEV+ + K VD +++G+I +E + C
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 577 ---------VPFFGETP-----EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLL---- 618
+ F E E++ + + W A + + +
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 619 QQNPRDRL 626
Q+ RL
Sbjct: 297 DQDAEARL 304
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-28
Identities = 74/344 (21%), Positives = 132/344 (38%), Gaps = 83/344 (24%)
Query: 349 SYCSKKDKFSKTPNENDFTV------IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL 402
S KK + + N+ + + + +GAYGSV K + ++ A+KK+ +
Sbjct: 3 SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--- 59
Query: 403 MLRNQME--QVFAERDIMSFTDNPFVVTMY------CSFETKKHLCLVMEYVEGGDCASL 454
++++ + + E ++ + V+ + S LVM +++ D +
Sbjct: 60 PFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKI 118
Query: 455 LKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514
+ + ++ + + ++Y+HS G+VHRDLKP NL + +K+ DFGL++
Sbjct: 119 MGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-- 174
Query: 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFL 573
+ YV T Y APEVIL Y + VD WS+G I+ E L
Sbjct: 175 --HADAEMTG-YV-------------VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
Query: 574 VGCVPFFGETPEELFAHTVN------DDIEWPSEDDWP-IQVE-AKSIIT---------- 615
G F G+ ++ P + + + AKS I
Sbjct: 219 TGKTLFKGK-------DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF 271
Query: 616 ------------DLLQQ----NPRDRLGTGGPHEVKEHPYFSNL 643
DLL++ + RL + HP+F
Sbjct: 272 TQLFPRASPQAADLLEKMLELDVDKRLTA---AQALTHPFFEPF 312
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-27
Identities = 90/462 (19%), Positives = 178/462 (38%), Gaps = 90/462 (19%)
Query: 344 ESNSDSYCSKKDKFSKTPNENDF----------------TVIKLISNGAYGSVYLVRHKE 387
+ SY +K SK+ +N F +K I +GA G V
Sbjct: 26 KQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAV 85
Query: 388 TRQRFAMKKIIKNSLMLRNQME--QVFAERDIMSFTDNPFVVTMY------CSFETKKHL 439
+ A+KK+ + +NQ + + E +M ++ ++++ + E + +
Sbjct: 86 LDRNVAIKKLSR---PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142
Query: 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA 499
LVME ++ + +++ L + + + + +++LHS GI+HRDLKP N+++ +
Sbjct: 143 YLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 500 LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKP 559
+K+ DFGL++ + + YV T Y APEVIL GY +
Sbjct: 200 DCTLKILDFGLART--AGTSFMMTP-YV-------------VTRYYRAPEVILGMGYKEN 243
Query: 560 VDWWSMGVILYEFLVGCVPFFGE--------------TPEELFAHTVNDDI--------- 596
VD WS+G I+ E + + F G TP F + +
Sbjct: 244 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 303
Query: 597 ---------------EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641
SE + +A+ +++ +L +P R+ + +HPY +
Sbjct: 304 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV---DDALQHPYIN 360
Query: 642 NL-DWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGEDTDETEDSFSLGTFSSCTH 700
D + + + DE + + + + Y ++ ++T++ G S
Sbjct: 361 VWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYK-EVMNSEEKTKNGVVKGQPSPSGA 419
Query: 701 QYKKVQS-QLSSQSSLEVTPPRKSSEKDETSSTSDVSSSPVA 741
+S SS + + + +T S+ + S+ P+
Sbjct: 420 AVNSSESLPPSSSVNDISSMSTDQTLASDTDSSLEASAGPLG 461
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 58/280 (20%), Positives = 106/280 (37%), Gaps = 65/280 (23%)
Query: 363 ENDFTVIKL-ISNGAYGSVYLVRHKE--TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS 419
E+ F + G YG VY + K+ + +A+K+I + + E ++
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREI-----ALLR 73
Query: 420 FTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL-- 475
+P V+++ + + L+ +Y E D ++K A+ ++
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 476 -------AVEYLHSYGIVHRDLKPDNLLITAL----GHIKLTDFGLSKMGLMSLATNLYE 524
+ YLH+ ++HRDLKP N+L+ G +K+ D G
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-------------- 178
Query: 525 CYVERDAKQFSD---KQVYGTPE-----YIAPEVIL--RQGYGKPVDWWSMGVILYEFLV 574
A+ F+ P Y APE++L R Y K +D W++G I E L
Sbjct: 179 ------ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLT 231
Query: 575 GCVPFF-GETPEELFAHTVNDD--------IEWPSEDDWP 605
P F + ++ + D + +P++ DW
Sbjct: 232 S-EPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWE 270
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 80/359 (22%), Positives = 136/359 (37%), Gaps = 89/359 (24%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQME--QVFAERDIMSFTDN 423
+ + + +GAYGSV +T R A+KK+ S ++ + + + E ++ +
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 424 PFVVTMY------CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAV 477
V+ + S E + LV + D +++K L D +F + + +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVK-CQKLTDDHVQFLIYQILRGL 145
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537
+Y+HS I+HRDLKP NL + +K+ DFGL++ A + YV
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTG-YV---------- 190
Query: 538 QVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN--- 593
T Y APE++L Y + VD WS+G I+ E L G F G ++
Sbjct: 191 ---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-------DHIDQLK 240
Query: 594 ---DDIEWPSEDD-WPIQVE-AKSIIT----------------------DLLQQ----NP 622
+ P + I E A++ I DLL++ +
Sbjct: 241 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 300
Query: 623 RDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGE 681
R+ + H YF+ H + DE +D +E + I E
Sbjct: 301 DKRITA---AQALAHAYFAQY-------HDPD------DEPVADPYDQSLESRDLLIDE 343
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 35/265 (13%), Positives = 71/265 (26%), Gaps = 51/265 (19%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+ ++ + ++ A+ + ++ + +++ + +S D P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
V + T+ +V E++ GG + T P P R A + H G+
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-TSPSPVGAIR-AMQSLAAAADAAHRAGV 150
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
P + ++ G + L
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA-----------------------------------T 175
Query: 546 IAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA---HTVNDDIEWPSE- 601
+ D +G LY LV P A P++
Sbjct: 176 MPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADI 228
Query: 602 -DDWPIQVEAKSIITDLLQQNPRDR 625
D P Q+ A + +Q + R
Sbjct: 229 DRDIPFQISA--VAARSVQGDGGIR 251
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 51/312 (16%), Positives = 93/312 (29%), Gaps = 78/312 (25%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI--MSF 420
++++ + G +G V+ + + A+K + E ++ +
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKI------FPIQDKQSWQNEYEVYSLPG 74
Query: 421 TDNPFVVTM--YC--SFETKKHLCLVMEYVEGGDCASLLKNTGPLP--------ADMARF 468
+ ++ L L+ + E G + LK + MAR
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMAR- 132
Query: 469 YFAETVLAVEYLHSY----------GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518
+ YLH I HRD+K N+L+ + DFGL+
Sbjct: 133 -------GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK----- 180
Query: 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI-----LRQGYGKPVDWWSMGVILYEFL 573
E GT Y+APEV+ ++ +D ++MG++L+E
Sbjct: 181 --------FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232
Query: 574 VGCVPFFGETP----------------EELFAHTVNDDIEWPSEDDWPIQVEAK---SII 614
C G E++ V+ D W I
Sbjct: 233 SRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETI 292
Query: 615 TDLLQQNPRDRL 626
+ + RL
Sbjct: 293 EECWDHDAEARL 304
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 79/358 (22%), Positives = 119/358 (33%), Gaps = 118/358 (32%)
Query: 366 FTVIKLISNGAYGSVYLVR-HKETRQRFAMKKIIKNSLMLRNQ--ME----QVFAERDIM 418
+ ++ + GA+G V HK + A+K I+KN E + D
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVK-IVKNVDRYCEAARSEIQVLEHLNTTDP- 73
Query: 419 SFTDNPFVVTMYCSFETKKHLCLVME------YVEGGDCASLLKNTG--PLPADMARFYF 470
V M FE H+C+V E Y +K G P D R
Sbjct: 74 --NSTFRCVQMLEWFEHHGHICIVFELLGLSTY-------DFIKENGFLPFRLDHIRKMA 124
Query: 471 AETVLAVEYLHSYGIVHRDLKPDNLLITALGH-------------------IKLTDFGLS 511
+ +V +LHS + H DLKP+N+L + IK+ DFG
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-- 182
Query: 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYI------APEVILRQGYGKPVDWWSM 565
S AT + D+ + APEVIL G+ +P D WS+
Sbjct: 183 -----S-AT-------------YDDEHHS---TLVSTRHYRAPEVILALGWSQPCDVWSI 220
Query: 566 GVILYEFLVGCVPF---------------FGETPEELFAHT------VNDDIEWPSEDDW 604
G IL E+ +G F G P+ + T +D ++W
Sbjct: 221 GCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSA 280
Query: 605 PIQVEAKS-------------------IITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643
V +I +L+ +P R+ E +HP+F L
Sbjct: 281 GRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI---TLREALKHPFFDLL 335
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 81/329 (24%), Positives = 129/329 (39%), Gaps = 88/329 (26%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAER-----DIMSF 420
+T + I GAYG V + R A+KKI Q + +R I+
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-------SPFEHQTYCQRTLREIKILLR 81
Query: 421 TDNPFVVTMY-----CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL 475
+ ++ + + E K + +V + +E D LLK T L D ++ + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLK-TQHLSNDHICYFLYQILR 139
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
++Y+HS ++HRDLKP NLL+ +K+ DFGL+ R A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA-----------------RVADPDH 182
Query: 536 DKQVYGTPEYI------APEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELF 588
D + T EY+ APE++L +GY K +D WS+G IL E L F G+
Sbjct: 183 DHTGFLT-EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK------ 235
Query: 589 AHTVN------DDIEWPSEDD-WPIQVE-AKSIIT----------------------DLL 618
H ++ + PS++D I A++ + DLL
Sbjct: 236 -HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL 294
Query: 619 QQ----NPRDRLGTGGPHEVKEHPYFSNL 643
+ NP R+ + HPY
Sbjct: 295 DKMLTFNPHKRIEV---EQALAHPYLEQY 320
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-27
Identities = 81/362 (22%), Positives = 139/362 (38%), Gaps = 78/362 (21%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQME-QVFAER-----DIMS 419
F + L+ GAYG V HK T + A+KKI + +FA R I+
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--------EPFDKPLFALRTLREIKILK 64
Query: 420 FTDNPFVVTMY-----CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
+ ++T++ SFE + ++ E ++ D ++ T L D +++ +T+
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIS-TQMLSDDHIQYFIYQTL 122
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
AV+ LH ++HRDLKP NLLI + +K+ DFGL+++ S A N +
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN----------SEP 172
Query: 535 SDKQVYGTPEYI------APEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGE----- 582
+ +Q E++ APEV+L Y + +D WS G IL E + F G
Sbjct: 173 TGQQSGMV-EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231
Query: 583 -----------TPEELFAHTVNDDI-----EWPSEDDWPIQV-------EAKSIITDLLQ 619
+ + P P++ + ++ +L
Sbjct: 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV 291
Query: 620 QNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDI 679
+P R+ E EHPY H P+ + S+F+ +
Sbjct: 292 FDPAKRITA---KEALEHPYLQTY-------HDPNDEPEG-EPIPPSFFEFDHYKEALTT 340
Query: 680 GE 681
+
Sbjct: 341 KD 342
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 78/379 (20%), Positives = 144/379 (37%), Gaps = 95/379 (25%)
Query: 352 SKKDKFSKTPNENDFTV------IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR 405
++ + + + + V ++ + +GAYG+V T + A+KK+ + +
Sbjct: 7 ARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQ 63
Query: 406 NQME--QVFAERDIMSFTDNPFVVTMY------CSFETKKHLCLVMEYVEGGDCASLLKN 457
+++ + + E ++ + V+ + + + LVM ++ D L+K
Sbjct: 64 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK- 121
Query: 458 TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517
L D +F + + + Y+H+ GI+HRDLKP NL + +K+ DFGL++
Sbjct: 122 HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----Q 177
Query: 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGC 576
+ + YV T Y APEVIL Y + VD WS+G I+ E + G
Sbjct: 178 ADSEMTG-YV-------------VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
Query: 577 VPFFGETPEELFAHTVN------DDIEWPSEDD-WPIQVE-AKSIIT------------- 615
F G ++ P + +Q + AK+ +
Sbjct: 224 TLFKGS-------DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 276
Query: 616 ---------DLLQQ----NPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDE 662
+LL++ + R+ E HPYF +L H E DE
Sbjct: 277 LTNASPLAVNLLEKMLVLDAEQRVTA---GEALAHPYFESL-------HDTE------DE 320
Query: 663 EDTSYFDSRMERYNHDIGE 681
+D + + + E
Sbjct: 321 PQVQKYDDSFDDVDRTLDE 339
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 80/372 (21%), Positives = 147/372 (39%), Gaps = 89/372 (23%)
Query: 353 KKDKFSKTPNENDFTV------IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRN 406
+ +S ++ FTV +K I +GA G V + A+KK+ + +N
Sbjct: 8 DNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR---PFQN 64
Query: 407 QME--QVFAERDIMSFTDNPFVVTMY------CSFETKKHLCLVMEYVEGGDCASLLKNT 458
Q + + E +M ++ ++ + S E + + +VME ++ + +++
Sbjct: 65 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM- 122
Query: 459 GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518
L + + + + +++LHS GI+HRDLKP N+++ + +K+ DFGL++
Sbjct: 123 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGT 179
Query: 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP 578
+ + YV T Y APEVIL GY + VD WS+G I+ E + G V
Sbjct: 180 SFMMTP-YV-------------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVL 225
Query: 579 FFGE--------------TP---------------------------EELFAHTVNDDIE 597
F G TP E+LF +
Sbjct: 226 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADS 285
Query: 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL----DWNSLLRHKA 653
++ +A+ +++ +L + R+ E +HPY + + +
Sbjct: 286 EHNKLKAS---QARDLLSKMLVIDASKRISV---DEALQHPYINVWYDPSEAEAPPPKI- 338
Query: 654 EFIPQLDDEEDT 665
QLD+ E T
Sbjct: 339 -PDKQLDEREHT 349
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 54/264 (20%), Positives = 86/264 (32%), Gaps = 75/264 (28%)
Query: 366 FTVIKLISNGAYGSVYLVR-HKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF---- 420
+ ++ + G +G V H + + A+K II+N R E +++
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALK-IIRNVGKYREAARL---EINVLKKIKEK 76
Query: 421 --TDNPFVVTMYCSFETKKHLCLVME------YVEGGDCASLLKNTG--PLPADMARFYF 470
+ V M F H+C+ E + LK P P R
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF-------EFLKENNFQPYPLPHVRHMA 129
Query: 471 AETVLAVEYLHSYGIVHRDLKPDNLLITALGH-------------------IKLTDFGLS 511
+ A+ +LH + H DLKP+N+L I++ DFG +
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYI------APEVILRQGYGKPVDWWSM 565
F + + PEVIL G+ +P D WS+
Sbjct: 190 -------------T--------FDHEHHT---TIVATRHYRPPEVILELGWAQPCDVWSI 225
Query: 566 GVILYEFLVGCVPFFGETPEELFA 589
G IL+E+ G F E
Sbjct: 226 GCILFEYYRGFTLFQTHENREHLV 249
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 70/366 (19%), Positives = 125/366 (34%), Gaps = 91/366 (24%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQM---EQVFAER-----DI 417
+TV + IS+G+YG+V E A+K++ R + +R +
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEG-IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 418 MSFTDNPFVVTMY-----CSFETKKHLCLVMEYVEGGDCASLLK-NTGPLPADMARFYFA 471
++ +P ++ + L LV E + D A ++ + +++
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY 141
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531
+L + LH G+VHRDL P N+L+ I + DF L++ + N YV
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE--DTADANKTH-YV---- 194
Query: 532 KQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590
Y APE+++ +G+ K VD WS G ++ E F G
Sbjct: 195 ---------THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS-------T 238
Query: 591 TVN------DDIEWPSEDDWP-IQVE-AKSIIT-----------------------DLLQ 619
N + + P +D A+ + DL+
Sbjct: 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIA 298
Query: 620 Q----NPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERY 675
+ NP+ R+ T + HPYF +L D + +
Sbjct: 299 KMLEFNPQRRIST---EQALRHPYFESL-------FDPL------DLTEGLSERFHFDES 342
Query: 676 NHDIGE 681
D+ +
Sbjct: 343 VTDVYD 348
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 54/267 (20%), Positives = 98/267 (36%), Gaps = 51/267 (19%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-----SF 420
+ VI+ + G + +V+L + ++ AMK ++K++ + E E ++ S
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSA---EHYTETALDEIRLLKSVRNSD 94
Query: 421 TDNP---FVVTMYCSFETK----KHLCLVMEYVEGGDCASLLK--NTGPLPADMARFYFA 471
++P VV + F+ H+C+V E V G + N LP +
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 472 ETVLAVEYLHSY-GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERD 530
+ + ++YLH+ I+H D+KP+N+L++ + S A V
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 531 AKQFSDKQVYG-------------------------------TPEYIAPEVILRQGYGKP 559
+ V T +Y + EV++ GY P
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 560 VDWWSMGVILYEFLVGCVPFFGETPEE 586
D WS + +E G F + EE
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-21
Identities = 72/324 (22%), Positives = 123/324 (37%), Gaps = 35/324 (10%)
Query: 314 YIIGKLG----INKTVFSDLDNDIQNISLTDTSIESNSDSYCSKKDKFSKTPNE---NDF 366
+II L + F + I ++ T + S + K D
Sbjct: 59 FIIQSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRA--VPKDKWVLNHEDL 116
Query: 367 TVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDIMSFTDNPF 425
+ + I G +G V+ R + A+K + +L + + F E I+ +P
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVK-SCRETLPPDLKAK--FLQEARILKQYSHPN 173
Query: 426 VVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV-LAVEYLHS 482
+V + C+ K+ + +VME V+GGD + L+ G +EYL S
Sbjct: 174 IVRLIGVCT--QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
+HRDL N L+T +K++DFG+S+ A +Y +Q K
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSRE----EADGVY--AASGGLRQVPVK----- 280
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAHTVNDDIEWPSE 601
+ APE + Y D WS G++L+E F +G P+ + ++ V P
Sbjct: 281 --WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-VEKGGRLPCP 337
Query: 602 DDWPIQVEAKSIITDLLQQNPRDR 625
+ P V ++ P R
Sbjct: 338 ELCPDAV--FRLMEQCWAYEPGQR 359
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 52/252 (20%), Positives = 96/252 (38%), Gaps = 42/252 (16%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMK---KIIKNSLMLRNQMEQVFAERDIM 418
E ++ + G +GSV + R+ + K +++S + E +I+
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEIL 65
Query: 419 SFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLL----KNTGPLPADMARFYFAE 472
+ +V C +++L L+MEY+ G SL K+ + Y ++
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG---SLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 473 TVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAK 532
+EYL + +HRDL N+L+ +K+ DFGL+K+ L + E + ++
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV----LPQD-KEFFKVKEPG 177
Query: 533 QFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE----------------FLVGC 576
+ + APE + + D WS GV+LYE ++G
Sbjct: 178 ESPIF-------WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230
Query: 577 VPFFGETPEELF 588
L
Sbjct: 231 DKQGQMIVFHLI 242
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 50/249 (20%), Positives = 93/249 (37%), Gaps = 36/249 (14%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMK---KIIKNSLMLRNQMEQVFAERDIM 418
E ++ + G +GSV + R+ + K +++S + E +I+
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEIL 96
Query: 419 SFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV-L 475
+ +V C +++L L+MEY+ G L+ + + +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
+EYL + +HRDL N+L+ +K+ DFGL+K+ L + E Y ++ +
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV----LPQD-KEYYKVKEPGESP 211
Query: 536 DKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE----------------FLVGCVPF 579
+ APE + + D WS GV+LYE ++G
Sbjct: 212 IF-------WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264
Query: 580 FGETPEELF 588
L
Sbjct: 265 GQMIVFHLI 273
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 26/235 (11%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMK---KIIKNSLMLRNQMEQVFAERDIM 418
E +F IK++ +GA+G+VY ++ + K ++ + +++ E +M
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVM 71
Query: 419 SFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCAS-LLKNTGPLPADMARFYFAETVL 475
+ DNP V + C + L+ + + G + ++ + + + +
Sbjct: 72 ASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
+ YL +VHRDL N+L+ H+K+TDFGL+K+ L E Y K
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL----LGAEEKE-YHAEGGK--- 180
Query: 536 DKQVYGTP-EYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELF 588
P +++A E IL + Y D WS GV ++E G P+ G E+
Sbjct: 181 ------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 50/233 (21%), Positives = 90/233 (38%), Gaps = 24/233 (10%)
Query: 362 NENDFTVIKLISNGAYGSVY---LVRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDI 417
E D +++ + +G++G V A+K +K ++ + + F E +
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK-CLKPDVLSQPEAMDDFIREVNA 74
Query: 418 MSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCAS-LLKNTGPLPADMARFYFAETV 474
M D+ ++ +Y + +V E G L K+ G Y +
Sbjct: 75 MHSLDHRNLIRLYGVV---LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQF 534
+ YL S +HRDL NLL+ +K+ DFGL + + YV ++ ++
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR-----ALPQNDDHYVMQEHRKV 186
Query: 535 SDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEE 586
+ APE + + + D W GV L+E F G P+ G +
Sbjct: 187 PFA-------WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 27/222 (12%)
Query: 368 VIKLISNGAYGSVY--LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
K + +G +G+V + K+ + A+K I+KN +++ AE ++M DNP+
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVK-ILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 426 VVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
+V M C + LVME E G L+ + + + ++YL
Sbjct: 80 IVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
VHRDL N+L+ + K++DFGLSK Y + ++ K
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSK-----ALRADENYYKAQTHGKWPVK------ 185
Query: 544 EYIAPEVILRQGYGK---PVDWWSMGVILYE-FLVGCVPFFG 581
+ APE I Y K D WS GV+++E F G P+ G
Sbjct: 186 -WYAPECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 52/254 (20%), Positives = 102/254 (40%), Gaps = 21/254 (8%)
Query: 342 SIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVY---LVRHKETRQRFAMKKII 398
+ + + P+ ++I G +G VY L+ + + A+K +
Sbjct: 3 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SL 61
Query: 399 KNSLMLRNQMEQVFAERDIMSFTDNPFVVTMY-CSFETKKHLCLVMEYVEGGDCASLLKN 457
+ ++ Q E IM +P V+++ ++ +V+ Y++ GD + ++N
Sbjct: 62 NRITDIG-EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 458 TGPLPADMARFYFAETV-LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516
P F V ++YL S VHRDL N ++ +K+ DFGL++
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---- 176
Query: 517 SLATNLYECYVERDAKQFSDKQVYGTP-EYIAPEVILRQGYGKPVDWWSMGVILYE-FLV 574
++Y+ + K P +++A E + Q + D WS GV+L+E
Sbjct: 177 ----DMYDKEYYSVHNKTGAK----LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 228
Query: 575 GCVPFFGETPEELF 588
G P+ ++
Sbjct: 229 GAPPYPDVNTFDIT 242
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 54/237 (22%), Positives = 83/237 (35%), Gaps = 28/237 (11%)
Query: 346 NSDSYCSKKDKFSKTPNE---NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL 402
+ + P I+ + G +G V L + T +K
Sbjct: 10 HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK--- 66
Query: 403 MLR-----NQMEQVFAERDIMSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLL 455
L+ E DI+ + ++ C L LVMEYV G L
Sbjct: 67 ALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL 126
Query: 456 KNTGPLPADMARFYFAETV-LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514
A + FA+ + + YLH+ +HRDL N+L+ +K+ DFGL+K
Sbjct: 127 PRHSIGLAQL--LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA- 183
Query: 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE 571
+ +E Y R+ + APE + + D WS GV LYE
Sbjct: 184 ---VPEG-HEYYRVREDGDSPVF-------WYAPECLKEYKFYYASDVWSFGVTLYE 229
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 23/218 (10%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR-----NQMEQVFAERD 416
+ I+ + G +G V L R+ + +K L+ N + + E +
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK---SLKPESGGNHIADLKKEIE 75
Query: 417 IMSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
I+ + +V C+ + + L+ME++ G L + +A +
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 475 -LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
++YL S VHRDL N+L+ + +K+ DFGL+K + T+ E Y +D +
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA----IETD-KEYYTVKDDRD 190
Query: 534 FSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE 571
+ APE +++ + D WS GV L+E
Sbjct: 191 SPVF-------WYAPECLMQSKFYIASDVWSFGVTLHE 221
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 8e-18
Identities = 51/234 (21%), Positives = 87/234 (37%), Gaps = 27/234 (11%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
+ + G +G V++ T + K +K M E E +M
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSP---EAFLQEAQVMKKL 236
Query: 422 DNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARF-YFAETV-LAV 477
+ +V +Y +++ + +V EY+ G LK + + A + +
Sbjct: 237 RHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537
Y+ VHRDL+ N+L+ K+ DFGL+++ Y R +F K
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-------IEDNEYTARQGAKFPIK 346
Query: 538 QVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
+ APE L + D WS G++L E G VP+ G E+
Sbjct: 347 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 393
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 26/235 (11%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMK---KIIKNSLMLRNQMEQVFAERDIM 418
E +F IK++ +GA+G+VY ++ + K ++ + +++ E +M
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVM 71
Query: 419 SFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCAS-LLKNTGPLPADMARFYFAETVL 475
+ DNP V + C + L+ + + G + ++ + + + +
Sbjct: 72 ASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
+ YL +VHRDL N+L+ H+K+TDFGL+K+ L E Y K
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL----LGAEEKE-YHAEGGK--- 180
Query: 536 DKQVYGTP-EYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELF 588
P +++A E IL + Y D WS GV ++E G P+ G E+
Sbjct: 181 ------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 9e-18
Identities = 51/234 (21%), Positives = 95/234 (40%), Gaps = 25/234 (10%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
D T+ + G YG VY K+ A+K + ++++ + E+ E +M
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEI 273
Query: 422 DNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARF-YFAETV-LAV 477
+P +V + C+ + ++ E++ G+ L+ Y A + A+
Sbjct: 274 KHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537
EYL +HR+L N L+ +K+ DFGLS++ + Y +F K
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-------MTGDTYTAHAGAKFPIK 384
Query: 538 QVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
+ APE + + D W+ GV+L+E G P+ G +++
Sbjct: 385 -------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 431
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 56/235 (23%), Positives = 91/235 (38%), Gaps = 31/235 (13%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDIMSFTD 422
D T+ + G YG VY K+ A+K +K M + F E +M
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTM----EVEEFLKEAAVMKEIK 67
Query: 423 NPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARF-YFAETV-LAVE 478
+P +V + C+ E ++ E++ G+ L+ Y A + A+E
Sbjct: 68 HPNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE--CYVERDAKQFSD 536
YL +HRDL N L+ +K+ DFGLS+ L Y +F
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR---------LMTGDTYTAHAGAKFPI 176
Query: 537 KQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
K + APE + + D W+ GV+L+E G P+ G +++
Sbjct: 177 K-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 224
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 62/244 (25%), Positives = 95/244 (38%), Gaps = 27/244 (11%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMK---KIIKNSLMLRNQMEQVFAERDIMS 419
E I + G +GSV L R+ K +++S +Q E I+
Sbjct: 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--DQQRDFQREIQILK 79
Query: 420 FTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLL----KNTGPLPADMARFYFAET 473
+ F+V ++ L LVMEY+ G L ++ L A Y ++
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG---CLRDFLQRHRARLDASRLLLYSSQI 136
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
+EYL S VHRDL N+L+ + H+K+ DFGL+K+ L + + YV R+ Q
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL----LPLD-KDYYVVREPGQ 191
Query: 534 FSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAHTV 592
+ APE + + + D WS GV+LYE F
Sbjct: 192 SPIF-------WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244
Query: 593 NDDI 596
D
Sbjct: 245 RDVP 248
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 51/234 (21%), Positives = 87/234 (37%), Gaps = 45/234 (19%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ V + I G++G ++ + Q+ A+K + S + + E R
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEY----RTYKLLAGC 65
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL-------- 475
+ +Y + H LV++ + G LL G R + +TV
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-------RKFSVKTVAMAAKQMLA 117
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGH-----IKLTDFGLSKMGLMSLATNLYECYVERD 530
V+ +H +V+RD+KPDN LI I + DFG+ K Y RD
Sbjct: 118 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF---------Y-----RD 163
Query: 531 AKQFS------DKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP 578
K + GT Y++ L + + D ++G + FL G +P
Sbjct: 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 49/253 (19%), Positives = 100/253 (39%), Gaps = 19/253 (7%)
Query: 342 SIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVY---LVRHKETRQRFAMKKII 398
+ + + P+ ++I G +G VY L+ + + A+K +
Sbjct: 67 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SL 125
Query: 399 KNSLMLRNQMEQVFAERDIMSFTDNPFVVTMY-CSFETKKHLCLVMEYVEGGDCASLLKN 457
+ ++ Q E IM +P V+++ ++ +V+ Y++ GD + ++N
Sbjct: 126 NRITDIG-EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 184
Query: 458 TGPLPADMARFYFAETV-LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516
P F V +++L S VHRDL N ++ +K+ DFGL++
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---- 240
Query: 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVG 575
+ ++ + + K ++A E + Q + D WS GV+L+E G
Sbjct: 241 DMYDKEFDSVHNKTGAKLPVK-------WMALESLQTQKFTTKSDVWSFGVLLWELMTRG 293
Query: 576 CVPFFGETPEELF 588
P+ ++
Sbjct: 294 APPYPDVNTFDIT 306
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 36/237 (15%)
Query: 362 NENDFTVIKLISNGAYGSVY---LVRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDI 417
D + +++ G +G VY HK + A+K K L N+ + F +E I
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVK-TCKKDCTLDNKEK--FMSEAVI 66
Query: 418 MSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV- 474
M D+P +V + ++ ++ME G+ L+ + ++ +
Sbjct: 67 MKNLDHPHIVKLIGII---EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE-CYVERDAKQ 533
A+ YL S VHRD+ N+L+ + +KL DFGLS+ + + Y + +
Sbjct: 124 KAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY--------IEDEDYYKASVTR 175
Query: 534 FSDKQVYGTPEYIAPEVILRQGYGK---PVDWWSMGVILYE-FLVGCVPFFGETPEE 586
K +++PE I + + D W V ++E G PFF ++
Sbjct: 176 LPIK-------WMSPESIN---FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 54/241 (22%), Positives = 92/241 (38%), Gaps = 44/241 (18%)
Query: 362 NENDFTVIKLISNGAYGSVY---LVRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDI 417
+ + I G +G V+ + + A+K KN + + F E
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCTSDSVREK--FLQEALT 69
Query: 418 MSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCAS-LLKNTGPLPA----DMARFYF 470
M D+P +V + T+ + ++ME G+ S L L A
Sbjct: 70 MRQFDHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY--- 123
Query: 471 AETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE-CYVER 529
+ A+ YL S VHRD+ N+L+++ +KL DFGLS+ + + Y +
Sbjct: 124 -QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--------MEDSTYYKA 174
Query: 530 DAKQFSDKQVYGTPEYIAPEVILRQGYGK---PVDWWSMGVILYE-FLVGCVPFFGETPE 585
+ K ++APE I + + D W GV ++E + G PF G
Sbjct: 175 SKGKLPIK-------WMAPESIN---FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224
Query: 586 E 586
+
Sbjct: 225 D 225
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 4e-17
Identities = 51/234 (21%), Positives = 87/234 (37%), Gaps = 27/234 (11%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
+ + G +G V++ T + K +K M E E +M
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSP---EAFLQEAQVMKKL 319
Query: 422 DNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARF-YFAETV-LAV 477
+ +V +Y +++ + +V EY+ G LK + + A + +
Sbjct: 320 RHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537
Y+ VHRDL+ N+L+ K+ DFGL+++ Y R +F K
Sbjct: 377 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-------IEDNEYTARQGAKFPIK 429
Query: 538 QVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
+ APE L + D WS G++L E G VP+ G E+
Sbjct: 430 -------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 476
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 7e-17
Identities = 54/234 (23%), Positives = 93/234 (39%), Gaps = 30/234 (12%)
Query: 364 NDFTVIKLISNGAYGSVY---LVRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDIMS 419
+ + I G +G V+ + + A+K KN + + F E M
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-TCKNCTSDSVREK--FLQEALTMR 446
Query: 420 FTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCAS-LLKNTGPLPADMARFYFAETVLA 476
D+P +V + T+ + ++ME G+ S L L Y + A
Sbjct: 447 QFDHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE-CYVERDAKQFS 535
+ YL S VHRD+ N+L+++ +KL DFGLS+ + + Y + +
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--------MEDSTYYKASKGKLP 555
Query: 536 DKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELF 588
K ++APE I + + D W GV ++E + G PF G ++
Sbjct: 556 IK-------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 48/226 (21%), Positives = 93/226 (41%), Gaps = 24/226 (10%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMK---KIIKNSLMLRNQMEQVF-AERDIMS 419
+ T K+I G +G VY K + + + K +K + +++ F E IM
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMG 101
Query: 420 FTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV-LA 476
+ ++ + S K + ++ EY+E G L+ + + +
Sbjct: 102 QFSHHNIIRLEGVIS--KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
++YL + VHRDL N+L+ + K++DFGLS+ + + E +
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR-----VLEDDPEATYTTSGGKIPI 214
Query: 537 KQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFG 581
+ + APE I + + D WS G++++E G P++
Sbjct: 215 R-------WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 47/234 (20%), Positives = 96/234 (41%), Gaps = 24/234 (10%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMK---KIIKNSLMLRNQMEQVFAERDIM 418
E + +K++ +G +G+V+ + + K+I++ R + V +
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLAI 69
Query: 419 SFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCAS-LLKNTGPLPADMARFYFAETVL 475
D+ +V + C L LV +Y+ G + ++ G L + + +
Sbjct: 70 GSLDHAHIVRLLGLC---PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
+ YL +G+VHR+L N+L+ + +++ DFG++ + L + + + +
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL----LPPD--DKQLLYSEAKTP 180
Query: 536 DKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELF 588
K ++A E I Y D WS GV ++E G P+ G E+
Sbjct: 181 IK-------WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP 227
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 50/245 (20%), Positives = 96/245 (39%), Gaps = 34/245 (13%)
Query: 364 NDFTVIKLISNGAYGSVY---LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF 420
FT+ +++ G +GSV L + + + A+K + K ++ + +E+ E M
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKE 81
Query: 421 TDNPFVVTMY--CS----FETKKHLCLVMEYVEGGDCASLLKNTGPLPADMA-----RFY 469
D+P V + +++ +++ GD + L +
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 470 FAETV-LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC--Y 526
F + +EYL S +HRDL N ++ + + DFGLS+ +Y Y
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR--------KIYSGDYY 193
Query: 527 VERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPE 585
+ A + K ++A E + Y D W+ GV ++E G P+ G
Sbjct: 194 RQGCASKLPVK-------WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246
Query: 586 ELFAH 590
E++ +
Sbjct: 247 EIYNY 251
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 56/234 (23%), Positives = 99/234 (42%), Gaps = 35/234 (14%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR-NQMEQVF-AERDIMSFT 421
+ +++ I G +G V L ++ + A+K ++ + Q F AE +M+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVK-------CIKNDATAQAFLAEASVMTQL 71
Query: 422 DNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARF-YFAETV-LAV 477
+ +V + E K L +V EY+ G L++ G F+ V A+
Sbjct: 72 RHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537
EYL VHRDL N+L++ K++DFGL+K E +D + K
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVK 179
Query: 538 QVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
+ APE + + + D WS G++L+E + G VP+ +++
Sbjct: 180 -------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 226
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 64/298 (21%), Positives = 117/298 (39%), Gaps = 49/298 (16%)
Query: 314 YII----GKLGIN-KTVFSDLDNDIQNISLTDTSIESNSDSYCSKKDKFSKTP------- 361
Y I KL I+ + F +L +++ + + + + +
Sbjct: 129 YRIMYHASKLSIDEEVYFENLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGW 188
Query: 362 --NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR-NQMEQVF-AERDI 417
N + +++ I G +G V L ++ K +K ++ + Q F AE +
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDYRGN------KVAVK---CIKNDATAQAFLAEASV 239
Query: 418 MSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARF-YFAETV 474
M+ + +V + E K L +V EY+ G L++ G F+ V
Sbjct: 240 MTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 475 -LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
A+EYL VHRDL N+L++ K++DFGL+K E +D +
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGK 347
Query: 534 FSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
K + APE + + + D WS G++L+E + G VP+ +++
Sbjct: 348 LPVK-------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 398
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 29/233 (12%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDIMSFTD 422
+ T++K + +G +G V L + K A+K +IK M E F E M
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQY-DVAVK-MIKEGSM----SEDEFFQEAQTMMKLS 61
Query: 423 NPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV-LAVEY 479
+P +V Y CS + + +V EY+ G + L++ G V + +
Sbjct: 62 HPKLVKFYGVCS--KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE-CYVERDAKQFSDKQ 538
L S+ +HRDL N L+ +K++DFG+++ + + YV +F K
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--------VLDDQYVSSVGTKFPVK- 170
Query: 539 VYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
+ APEV Y D W+ G++++E F +G +P+ T E+
Sbjct: 171 ------WSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 53/229 (23%), Positives = 96/229 (41%), Gaps = 35/229 (15%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+F V K I G +G + L ++ T + A+K ++++ Q+ E +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-----EPMKSRAPQLHLEYRFYKQLGS 63
Query: 424 -PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL------- 475
+ +Y K+ +V+E + G L R + +TVL
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD-------RTFSLKTVLMIAIQLI 115
Query: 476 -AVEYLHSYGIVHRDLKPDNLLITALGH-----IKLTDFGLSKMGLMSLATNLYECYVER 529
+EY+HS +++RD+KP+N LI G+ I + DF L+K + T + Y R
Sbjct: 116 SRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE-YIDPETKKHIPY--R 172
Query: 530 DAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP 578
+ K + GT Y++ L + + D ++G + FL G +P
Sbjct: 173 EHKSLT-----GTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 39/233 (16%)
Query: 364 NDFTVIKLISNGAYGSVY---LVRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDIMS 419
+ + K+I +G G V L + A+K +K R + + F +E IM
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK-ALKAGYTERQRRD--FLSEASIMG 105
Query: 420 FTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLK-NTGPLPA----DMARFYFAE 472
D+P ++ + + + +V EY+E G + L+ + G M R
Sbjct: 106 QFDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR----G 159
Query: 473 TVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAK 532
+ YL G VHRDL N+L+ + K++DFGLS++ L + Y K
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV----LEDDPDAAYTTTGGK 215
Query: 533 QFSDKQVYGTPEYIAPEVILRQGYGK---PVDWWSMGVILYE-FLVGCVPFFG 581
+ + APE I + D WS GV+++E G P++
Sbjct: 216 -IPIR-------WTAPEAIA---FRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-16
Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 29/235 (12%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDIMSF 420
+ ++ T ++ I +G +G V+L + A+K I+ M E+ F E ++M
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNK-DKVAIK-TIREGAM----SEEDFIEEAEVMMK 59
Query: 421 TDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV-LAV 477
+P +V +Y C + +CLV E++E G + L+ L A V +
Sbjct: 60 LSHPKLVQLYGVCL--EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 117
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE-CYVERDAKQFSD 536
YL ++HRDL N L+ IK++DFG+++ + + Y +F
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF--------VLDDQYTSSTGTKFPV 169
Query: 537 KQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
K + +PEV Y D WS GV+++E F G +P+ + E+
Sbjct: 170 K-------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 217
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 58/239 (24%), Positives = 101/239 (42%), Gaps = 33/239 (13%)
Query: 355 DKFSKTPNENDFTVIKLISNGAYGSVY---LVRHKETRQRFAMKKIIKNSLMLRNQMEQV 411
+F+K + + ++ K++ G +G V L + A+K +K + + +
Sbjct: 36 HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK-TLKVGYTEKQRRD-- 92
Query: 412 F-AERDIMSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPA---- 463
F E IM D+P ++ + + K + +V EY+E G S L K+
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523
M R ++YL G VHRDL N+LI + K++DFGL ++ L +
Sbjct: 151 GMLR----GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV----LEDDPE 202
Query: 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFG 581
Y R K + + +PE I + + D WS G++L+E G P++
Sbjct: 203 AAYTTRGGK-IPIR-------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 53/227 (23%), Positives = 90/227 (39%), Gaps = 33/227 (14%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS-FTD 422
N + + + I +G++G +YL + A+K + + Q+ E I
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQG 63
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL------- 475
+ T+ + +VME + G L R + +TVL
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-------RKFSLKTVLLLADQMI 115
Query: 476 -AVEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLATNLYECYVERDA 531
+EY+HS +HRD+KPDN L+ + + DFGL+K T+ + Y R+
Sbjct: 116 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK-YRDARTHQHIPY--REN 172
Query: 532 KQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP 578
K + GT Y + L + D S+G +L F +G +P
Sbjct: 173 KNLT-----GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 35/236 (14%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDIMSFTD 422
D T +K + G +G V + + A+K +IK M E F E +M
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQY-DVAIK-MIKEGSM----SEDEFIEEAKVMMNLS 77
Query: 423 NPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV-LAVEY 479
+ +V +Y C+ ++ + ++ EY+ G + L+ + V A+EY
Sbjct: 78 HEKLVQLYGVCT--KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC-YVERDAKQFSDKQ 538
L S +HRDL N L+ G +K++DFGLS+ + + Y +F +
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--------VLDDEYTSSVGSKFPVR- 186
Query: 539 VYGTPEYIAPEVILRQGYGK---PVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
+ PEV++ Y K D W+ GV+++E + +G +P+ T E H
Sbjct: 187 ------WSPPEVLM---YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 45/250 (18%), Positives = 79/250 (31%), Gaps = 54/250 (21%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMK------KIIKNSLMLRNQMEQVFAER 415
D + + G + ++ +E + K++ + N E F
Sbjct: 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAA 63
Query: 416 DIMSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAET 473
+MS + +V Y C LV E+V+ G + LK + + A+
Sbjct: 64 SMMSKLSHKHLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 474 V-LAVEYLHSYGIVHRDLKPDNLLITALGH--------IKLTDFGLSKMGLMSLATNLYE 524
+ A+ +L ++H ++ N+L+ IKL+D G+S
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI------------ 169
Query: 525 CYVERDAKQFSDKQVYGTPEYI---APEVILRQGYGKPV----DWWSMGVILYE-FLVGC 576
V + I PE I K + D WS G L+E G
Sbjct: 170 -TVLPK-------DILQER--IPWVPPECIE---NPKNLNLATDKWSFGTTLWEICSGGD 216
Query: 577 VPFFGETPEE 586
P +
Sbjct: 217 KPLSALDSQR 226
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 50/235 (21%), Positives = 101/235 (42%), Gaps = 29/235 (12%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
+++ + G +G V++ + + A+K +K M + AE ++M
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHT-KVAVK-SLKQGSMSP---DAFLAEANLMKQL 65
Query: 422 DNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMAR-FYFAETV-LAV 477
+ +V +Y T++ + ++ EY+E G LK + + + A + +
Sbjct: 66 QHQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC-YVERDAKQFSD 536
++ +HRDL+ N+L++ K+ DFGL+++ + + Y R+ +F
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL--------IEDNEYTAREGAKFPI 174
Query: 537 KQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
K + APE I + D WS G++L E G +P+ G T E+ +
Sbjct: 175 K-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 48/235 (20%), Positives = 98/235 (41%), Gaps = 29/235 (12%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
+ K + G +G V++ + + + K +K M AE ++M
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAF---LAEANVMKTL 240
Query: 422 DNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARF-YFAETV-LAV 477
+ +V ++ TK+ + ++ E++ G LK+ + + F+ + +
Sbjct: 241 QHDKLVKLHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC-YVERDAKQFSD 536
++ +HRDL+ N+L++A K+ DFGL+++ + + Y R+ +F
Sbjct: 298 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV--------IEDNEYTAREGAKFPI 349
Query: 537 KQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
K + APE I + D WS G++L E G +P+ G + E+
Sbjct: 350 K-------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 397
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 57/265 (21%), Positives = 101/265 (38%), Gaps = 66/265 (24%)
Query: 364 NDFTVIKLISNGAYGSVY---LVRHKETRQRFAMK---KIIKNSLMLRNQMEQVFAERDI 417
+ T+ K + GA+G V V + + + A+ K++K+ ++ + V +E ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEM 93
Query: 418 MS-FTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
M + ++ + C+ L +++EY G+ L+ P + +
Sbjct: 94 MKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 475 LAV----------------EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518
+ EYL S +HRDL N+L+T +K+ DFGL+
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------- 204
Query: 519 ATNLYECYVERDAKQFSDKQVYGTPEYI------------APEVILRQGYGKPVDWWSMG 566
RD + Y APE + + Y D WS G
Sbjct: 205 ----------RD--------INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 567 VILYE-FLVGCVPFFGETPEELFAH 590
V+++E F +G P+ G EELF
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEELFKL 271
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 5e-15
Identities = 63/257 (24%), Positives = 104/257 (40%), Gaps = 23/257 (8%)
Query: 331 NDIQNISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVY--LVRHKET 388
+ + + + + ES KDK +N + G +GSV + R ++
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK 362
Query: 389 RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMY--CSFETKKHLCLVMEYV 446
+ A+K ++K + E + E IM DNP++V + C + L LVME
Sbjct: 363 QIDVAIK-VLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMA 417
Query: 447 EGGDCAS-LLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 505
GG L+ +P + + ++YL VHR+L N+L+ + K+
Sbjct: 418 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKI 477
Query: 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSM 565
+DFGLSK Y R A ++ K + APE I + + D WS
Sbjct: 478 SDFGLSK-----ALGADDSYYTARSAGKWPLK-------WYAPECINFRKFSSRSDVWSY 525
Query: 566 GVILYE-FLVGCVPFFG 581
GV ++E G P+
Sbjct: 526 GVTMWEALSYGQKPYKK 542
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 56/272 (20%), Positives = 97/272 (35%), Gaps = 75/272 (27%)
Query: 364 NDFTVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDI 417
+ + K + G +G V ++ + A+K + K + + +E ++
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRD--LLSEFNV 79
Query: 418 MSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL 475
+ ++P V+ +Y CS L L++EY + G L+ + + +
Sbjct: 80 LKQVNHPHVIKLYGACS--QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 476 AV------------------------EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511
++ +YL +VHRDL N+L+ +K++DFGLS
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY------------IAPEVILRQGYGKP 559
RD VY Y +A E + Y
Sbjct: 198 -----------------RD--------VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 560 VDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
D WS GV+L+E +G P+ G PE LF
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL 264
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 56/265 (21%), Positives = 100/265 (37%), Gaps = 66/265 (24%)
Query: 364 NDFTVIKLISNGAYGSVY---LVRHKETRQRFAMK---KIIKNSLMLRNQMEQVFAERDI 417
+ T+ K + G +G V V + + + A+ K++K+ ++ + V +E ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEM 139
Query: 418 MS-FTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
M + ++ + C+ L +++EY G+ L+ P + +
Sbjct: 140 MKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 475 LAV----------------EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518
+ EYL S +HRDL N+L+T +K+ DFGL+
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------- 250
Query: 519 ATNLYECYVERDAKQFSDKQVYGTPEYI------------APEVILRQGYGKPVDWWSMG 566
RD + Y APE + + Y D WS G
Sbjct: 251 ----------RD--------INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 292
Query: 567 VILYE-FLVGCVPFFGETPEELFAH 590
V+++E F +G P+ G EELF
Sbjct: 293 VLMWEIFTLGGSPYPGIPVEELFKL 317
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 30/230 (13%)
Query: 362 NENDFTVIKL-ISNGAYGSVY--LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM 418
++ + + + G +GSV + R ++ + A+K ++K + E++ E IM
Sbjct: 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK-VLKQGTE-KADTEEMMREAQIM 64
Query: 419 SFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV-L 475
DNP++V + C + L LVME GG L V +
Sbjct: 65 HQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 121
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
++YL VHRDL N+L+ + K++DFGLSK Y R A ++
Sbjct: 122 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK-----ALGADDSYYTARSAGKWP 176
Query: 536 DKQVYGTPEYIAPEVILRQGYGK---PVDWWSMGVILYE-FLVGCVPFFG 581
K + APE I + K D WS GV ++E G P+
Sbjct: 177 LK-------WYAPECIN---FRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 57/268 (21%), Positives = 106/268 (39%), Gaps = 39/268 (14%)
Query: 346 NSDSYCSKKDKFSKTPNE------NDFTVIKLISNGAYGSVY---LVRHKETRQRFAMKK 396
+S + + + E N + K++ G +GSV L + T + A+K
Sbjct: 10 HSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKT 69
Query: 397 IIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMY--CSFE---TKKHLCLVMEYVEGGDC 451
+ K + ++E+ +E M +P V+ + C +++ +++ GD
Sbjct: 70 M-KLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128
Query: 452 ASLLKN----TGPLPADMARF-YFAETV-LAVEYLHSYGIVHRDLKPDNLLITALGHIKL 505
+ L TGP + F + L +EYL + +HRDL N ++ + +
Sbjct: 129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188
Query: 506 TDFGLSKMGLMSLATNLYEC--YVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWW 563
DFGLSK +Y Y + + K +IA E + + Y D W
Sbjct: 189 ADFGLSK--------KIYSGDYYRQGRIAKMPVK-------WIAIESLADRVYTSKSDVW 233
Query: 564 SMGVILYE-FLVGCVPFFGETPEELFAH 590
+ GV ++E G P+ G E++ +
Sbjct: 234 AFGVTMWEIATRGMTPYPGVQNHEMYDY 261
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 55/251 (21%), Positives = 108/251 (43%), Gaps = 47/251 (18%)
Query: 364 NDFTVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDI 417
+ T+I+ + +GA+G VY + + + + A+K + +++++ F E I
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELD--FLMEALI 86
Query: 418 MSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV- 474
+S ++ +V ++ME + GGD S L+ T P P+ + + +
Sbjct: 87 ISKFNHQNIVRCIGVSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 475 LAV------EYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLATNLYE- 524
+A +YL +HRD+ N L+T G K+ DFG+++ ++Y
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--------DIYRA 196
Query: 525 -CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGK---PVDWWSMGVILYE-FLVGCVPF 579
Y + K ++ PE + G D WS GV+L+E F +G +P+
Sbjct: 197 SYYRKGGCAMLPVK-------WMPPEAFM---EGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
Query: 580 FGETPEELFAH 590
++ +E+
Sbjct: 247 PSKSNQEVLEF 257
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 54/248 (21%), Positives = 104/248 (41%), Gaps = 41/248 (16%)
Query: 364 NDFTVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDI 417
T+ + + G++G VY V E R A+K + + +R ++E F E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK-TVNEAASMRERIE--FLNEASV 81
Query: 418 MSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGP--------LPADMAR 467
M + VV + S + ++ME + GD S L++ P P +++
Sbjct: 82 MKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 468 F-YFAETV-LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC 525
A + + YL++ VHRDL N ++ +K+ DFG+++ ++YE
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYET 191
Query: 526 --YVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGE 582
Y + + +++PE + + D WS GV+L+E + P+ G
Sbjct: 192 DYYRKGGKGLLPVR-------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 583 TPEELFAH 590
+ E++
Sbjct: 245 SNEQVLRF 252
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 47/238 (19%), Positives = 82/238 (34%), Gaps = 42/238 (17%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKI-IKNS----------LMLRNQMEQVFAE 414
+ + K I +G +G +YL ++ A + ++ R + +
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 415 RDIMSFTDNPFVVTMYCS----FETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYF 470
D + Y S F+ + + +VME + G D + G
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKK------- 150
Query: 471 AETVL--------AVEYLHSYGIVHRDLKPDNLLI--TALGHIKLTDFGLSKMGLMSLAT 520
TVL +EY+H VH D+K NLL+ + L D+GLS
Sbjct: 151 -STVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR-YCPNGN 208
Query: 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP 578
+ Y E K + GT E+ + + + D +G + +L G +P
Sbjct: 209 HKQ--YQENPRKGHN-----GTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 54/265 (20%), Positives = 95/265 (35%), Gaps = 66/265 (24%)
Query: 364 NDFTVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDI 417
+ + K + GA+G V + T + A+K + K +E I
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA--LMSELKI 83
Query: 418 MS-FTDNPFVVTMY-CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL 475
+ + VV + + L +++E+ + G+ ++ L++
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 476 AV----------------EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519
+ E+L S +HRDL N+L++ +K+ DFGL+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-------- 195
Query: 520 TNLYECYVERDAKQFSDKQVYGTPEYI------------APEVILRQGYGKPVDWWSMGV 567
RD +Y P+Y+ APE I + Y D WS GV
Sbjct: 196 ---------RD--------IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 568 ILYE-FLVGCVPFFG-ETPEELFAH 590
+L+E F +G P+ G + EE
Sbjct: 239 LLWEIFSLGASPYPGVKIDEEFCRR 263
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 53/228 (23%), Positives = 92/228 (40%), Gaps = 19/228 (8%)
Query: 367 TVIKLISNGAYGSVY---LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
++I G +G VY + + R + A+K + + + M Q+E E +M ++
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM--QQVEAFLREGLLMRGLNH 81
Query: 424 PFVVTMY-CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV-LAVEYLH 481
P V+ + + +++ Y+ GD +++ P F V +EYL
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
VHRDL N ++ +K+ DFGL++ L Y R A+ K
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARD---ILDREYYSVQQHRHAR-LPVK---- 193
Query: 542 TPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELF 588
+ A E + + D WS GV+L+E G P+ P +L
Sbjct: 194 ---WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT 238
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 54/251 (21%), Positives = 108/251 (43%), Gaps = 47/251 (18%)
Query: 364 NDFTVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDI 417
+ T+I+ + +GA+G VY + + + + A+K + +++++ F E I
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELD--FLMEALI 127
Query: 418 MSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV- 474
+S ++ +V +++E + GGD S L+ T P P+ + + +
Sbjct: 128 ISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 475 LAV------EYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLATNLYE- 524
+A +YL +HRD+ N L+T G K+ DFG+++ ++Y
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--------DIYRA 237
Query: 525 -CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGK---PVDWWSMGVILYE-FLVGCVPF 579
Y + K ++ PE + G D WS GV+L+E F +G +P+
Sbjct: 238 GYYRKGGCAMLPVK-------WMPPEAFM---EGIFTSKTDTWSFGVLLWEIFSLGYMPY 287
Query: 580 FGETPEELFAH 590
++ +E+
Sbjct: 288 PSKSNQEVLEF 298
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 49/230 (21%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHK---ETRQRFAMKKIIKNSLMLRNQMEQVF-AERDIMS 419
N+F LI +G +G VY K + A+K+ S Q + F E + +S
Sbjct: 39 NNFDHKFLIGHGVFGKVY----KGVLRDGAKVALKRRTPESS----QGIEEFETEIETLS 90
Query: 420 FTDNPFVVTM--YCSFETKKHLCLVMEYVEGGDCASLL----KNTGPLP--------ADM 465
F +P +V++ +C + + + L+ +Y+E G+ L T +
Sbjct: 91 FCRHPHLVSLIGFC--DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 466 ARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYEC 525
AR + YLH+ I+HRD+K N+L+ K+TDFG+SK G
Sbjct: 149 AR--------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT---------- 190
Query: 526 YVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVG 575
E D S V GT YI PE ++ + D +S GV+L+E L
Sbjct: 191 --ELDQTHLS-TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 52/272 (19%), Positives = 88/272 (32%), Gaps = 79/272 (29%)
Query: 364 NDFTVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLR---NQMEQV--FA 413
N + K + GA+G V + + A+K ML+ + E+ +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK-------MLKPSAHLTEREALMS 75
Query: 414 ERDIMS-FTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYF 470
E ++S ++ +V + C+ ++ EY GD + L+
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 471 AETVLA------------------VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK 512
+ +L S +HRDL N+L+T K+ DFGL+
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA- 192
Query: 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYI------------APEVILRQGYGKPV 560
RD + Y+ APE I Y
Sbjct: 193 ----------------RD--------IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 228
Query: 561 DWWSMGVILYE-FLVGCVPFFG-ETPEELFAH 590
D WS G+ L+E F +G P+ G + +
Sbjct: 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 58/248 (23%), Positives = 99/248 (39%), Gaps = 44/248 (17%)
Query: 364 NDFTVIKLISNGAYGSVY--LVRHKETRQRFAMKKIIKNSLMLRNQMEQVFA-ERDIMS- 419
ND +I G +G V ++ R A+K++ K + + FA E +++
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRD--FAGELEVLCK 81
Query: 420 FTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAV 477
+P ++ + C + +L L +EY G+ L+ + L D A T +
Sbjct: 82 LGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 478 ----------------EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521
+YL +HRDL N+L+ K+ DFGLS+
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ------- 192
Query: 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFF 580
E YV++ + + ++A E + Y D WS GV+L+E +G P+
Sbjct: 193 --EVYVKKTMGRLPVR-------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243
Query: 581 GETPEELF 588
G T EL+
Sbjct: 244 GMTCAELY 251
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 55/265 (20%), Positives = 99/265 (37%), Gaps = 66/265 (24%)
Query: 364 NDFTVIKLISNGAYGSVY---LVRHKETRQRFAMK---KIIKNSLMLRNQMEQVFAERDI 417
+ + K + GA+G V + + + K K++K+ ++ + + +E ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEM 127
Query: 418 MS-FTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
M + ++ + C+ L +++EY G+ L+ P + +
Sbjct: 128 MKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 475 LAV----------------EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518
+ EYL S +HRDL N+L+T +K+ DFGL+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------- 238
Query: 519 ATNLYECYVERDAKQFSDKQVYGTPEYI------------APEVILRQGYGKPVDWWSMG 566
RD ++ Y APE + + Y D WS G
Sbjct: 239 ----------RD--------IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 567 VILYE-FLVGCVPFFGETPEELFAH 590
V+L+E F +G P+ G EELF
Sbjct: 281 VLLWEIFTLGGSPYPGVPVEELFKL 305
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 7e-14
Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 33/227 (14%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS-FTD 422
N F + + I +G++G +YL + +T + A+K + + Q+ E I
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKIYRILQG 61
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL------- 475
+ + + LVM+ + G L R +TVL
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMI 113
Query: 476 -AVEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLATNLYECYVERDA 531
VE++HS +HRD+KPDN L+ + + DFGL+K +T+ + Y R+
Sbjct: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK-YRDTSTHQHIPY--REN 170
Query: 532 KQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP 578
K + GT Y + L + D S+G +L FL G +P
Sbjct: 171 KNLT-----GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 42/242 (17%), Positives = 82/242 (33%), Gaps = 43/242 (17%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETR--------QRFAMK--------KIIKNSLMLRNQ 407
+ + + G +Y T Q+F++K +N +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 408 MEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMAR 467
QV + + S M K+ LV+ + G S L + +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-------K 153
Query: 468 FYFAE-TVL--------AVEYLHSYGIVHRDLKPDNLLI--TALGHIKLTDFGLSKMGLM 516
+E +VL A+E+LH VH ++ +N+ + + L +G +
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF---R 210
Query: 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC 576
+ + YVE G E+I+ ++ G + D S+G + ++L G
Sbjct: 211 YCPSGKHVAYVEGSRSPHE-----GDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
Query: 577 VP 578
+P
Sbjct: 266 LP 267
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 54/263 (20%), Positives = 95/263 (36%), Gaps = 65/263 (24%)
Query: 364 NDFTVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM 418
N+ K + GA+G V + ++ + A+K + K++ + + +E IM
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM-SELKIM 103
Query: 419 S-FTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL 475
S + +V + C+ + ++ EY GD + L+ + F A +
Sbjct: 104 SHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 476 AV--------------EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521
+ +L S +HRD+ N+L+T K+ DFGL+
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---------- 211
Query: 522 LYECYVERDAKQFSDKQVYGTPEYI------------APEVILRQGYGKPVDWWSMGVIL 569
RD + YI APE I Y D WS G++L
Sbjct: 212 -------RD--------IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256
Query: 570 YE-FLVGCVPFFG-ETPEELFAH 590
+E F +G P+ G + +
Sbjct: 257 WEIFSLGLNPYPGILVNSKFYKL 279
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 63/266 (23%), Positives = 99/266 (37%), Gaps = 72/266 (27%)
Query: 364 NDFTVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM 418
D + + + GA+G V+L + + + A+K + +L R ++ E +++
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELL 71
Query: 419 SFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLA 476
+ + +V Y C L +V EY++ GD L+ GP + +
Sbjct: 72 TNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 477 V----------------EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520
+ YL S VHRDL N L+ A +K+ DFG+S
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS--------- 180
Query: 521 NLYECYVERDAKQFSDKQVYGTPEY------------IAPEVILRQGYGK---PVDWWSM 565
RD VY T Y + PE I+ Y K D WS
Sbjct: 181 --------RD--------VYSTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSF 221
Query: 566 GVILYE-FLVGCVPFFGETPEELFAH 590
GVIL+E F G P+F + E+
Sbjct: 222 GVILWEIFTYGKQPWFQLSNTEVIEC 247
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 52/273 (19%), Positives = 92/273 (33%), Gaps = 76/273 (27%)
Query: 364 NDFTVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDI 417
+ K++ +GA+G V + + A+K + K + +E +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREA--LMSELKM 101
Query: 418 MS-FTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETV 474
M+ + +V + C+ + L+ EY GD + L++ ++ Y +
Sbjct: 102 MTQLGSHENIVNLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 475 LAV-----------------------EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511
L E+L VHRDL N+L+T +K+ DFGL+
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYI------------APEVILRQGYGKP 559
RD + Y+ APE + Y
Sbjct: 220 -----------------RD--------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 254
Query: 560 VDWWSMGVILYE-FLVGCVPFFG-ETPEELFAH 590
D WS G++L+E F +G P+ G +
Sbjct: 255 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 287
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 57/267 (21%), Positives = 95/267 (35%), Gaps = 73/267 (27%)
Query: 364 NDFTVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDI 417
+ ++ + +G VY E Q A+K +K+ + E F E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK-TLKDKAEGPLREE--FRHEAML 65
Query: 418 MSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL 475
+ +P VV + + + + L ++ Y GD L P +
Sbjct: 66 RARLQHPNVVCLLGVVTKD--QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 476 AV----------------EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519
A+ EYL S+ +VH+DL N+L+ ++K++D GL
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF-------- 175
Query: 520 TNLYECYVERDAKQFSDKQVYGTPEYI------------APEVILRQGYGK---PVDWWS 564
R+ VY Y APE I+ YGK D WS
Sbjct: 176 ---------RE--------VYAADYYKLLGNSLLPIRWMAPEAIM---YGKFSIDSDIWS 215
Query: 565 MGVILYE-FLVGCVPFFGETPEELFAH 590
GV+L+E F G P+ G + +++
Sbjct: 216 YGVVLWEVFSYGLQPYCGYSNQDVVEM 242
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 64/275 (23%), Positives = 98/275 (35%), Gaps = 81/275 (29%)
Query: 364 NDFTVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDI 417
N+ ++ I GA+G V+ + E A+K ++K Q + F E +
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQAD--FQREAAL 103
Query: 418 MSFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL 475
M+ DNP +V + C+ K +CL+ EY+ GD L++ P T
Sbjct: 104 MAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 476 AV------------------------EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511
V YL VHRDL N L+ +K+ DFGLS
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY------------IAPEVILRQGYGK- 558
R+ +Y Y + PE I Y +
Sbjct: 222 -----------------RN--------IYSADYYKADGNDAIPIRWMPPESIF---YNRY 253
Query: 559 --PVDWWSMGVILYE-FLVGCVPFFGETPEELFAH 590
D W+ GV+L+E F G P++G EE+ +
Sbjct: 254 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 288
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 40/242 (16%), Positives = 80/242 (33%), Gaps = 43/242 (17%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNS--------LMLRNQMEQ 410
+ V I G +G +YL + +K ++ R +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 411 VFAERDIMSFTDNPFVVTMYCS----FETKKHLCLVMEYVEGGDCASLLKNTGPLPADMA 466
+ V + S K + ++M+ G D + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA------- 146
Query: 467 RFYFAETVL--------AVEYLHSYGIVHRDLKPDNLLI--TALGHIKLTDFGLSKMGLM 516
+ + +TVL +EY+H + VH D+K NLL+ + L D+GL+
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY---R 203
Query: 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC 576
+++ Y + GT E+ + + + D +G + ++L G
Sbjct: 204 YCPEGVHKAYAADPKRCHD-----GTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
Query: 577 VP 578
+P
Sbjct: 259 LP 260
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 61/265 (23%), Positives = 100/265 (37%), Gaps = 71/265 (26%)
Query: 364 NDFTVIKLISNGAYGSVYL-----VRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM 418
D + + GA+G V+L + ++ + A+K + + S R ++ E +++
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELL 97
Query: 419 SFTDNPFVVTMY--CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMAR--------- 467
+ + +V + C+ + L +V EY+ GD L++ GP +A
Sbjct: 98 TMLQHQHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155
Query: 468 -----FYFAETV-LAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521
A V + YL VHRDL N L+ +K+ DFG+S
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS---------- 205
Query: 522 LYECYVERDAKQFSDKQVYGTPEY------------IAPEVILRQGYGK---PVDWWSMG 566
RD +Y T Y + PE IL Y K D WS G
Sbjct: 206 -------RD--------IYSTDYYRVGGRTMLPIRWMPPESIL---YRKFTTESDVWSFG 247
Query: 567 VILYE-FLVGCVPFFGETPEELFAH 590
V+L+E F G P++ + E
Sbjct: 248 VVLWEIFTYGKQPWYQLSNTEAIDC 272
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 4e-12
Identities = 79/569 (13%), Positives = 149/569 (26%), Gaps = 189/569 (33%)
Query: 51 SNQHFP--FIPMKRPFNHLNTDCRSD------------GTRRWSVASLPSSGYGTTPGSS 96
NQ F + +P+ L G+ + VA Y
Sbjct: 122 DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMD 181
Query: 97 ------NVSSQCSSQEKLHQLPNIPT--SDELHELTKHFSS-----NDTDEEIRRSFM-R 142
N+ + S + L L + + H S+ + E+RR +
Sbjct: 182 FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241
Query: 143 PRSKSLSSPSRSPILDN----DII-AMN----MLYKERFPKAIQQMETRLSNFINENSSL 193
P L +L N A N +L + TR + S+
Sbjct: 242 PYENCLL------VLLNVQNAKAWNAFNLSCKIL-----------LTTRFKQVTDFLSAA 284
Query: 194 ATNNLETASPDAAPIIRFVHHQILEIARDCLFKSKEKL-----------IS--------- 233
T ++ ++ + L + L +S
Sbjct: 285 TTTHISLDHHSMT----LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG 340
Query: 234 ----SRYFYEMSEKLERLLTETKEKSLEAATVLTFT-LKKLL--LIISR-----PARLLE 281
+ + +KL ++ E SL VL +K+ L + P LL
Sbjct: 341 LATWDNWKHVNCDKLTTII----ESSLN---VLEPAEYRKMFDRLSVFPPSAHIPTILLS 393
Query: 282 CL-----EFDPEEFYHFLEMAEGDAKSLQGIKADIPQYIIGKLGINKTVFSDLDNDIQNI 336
+ + D + L SL ++ + I I + L+N+
Sbjct: 394 LIWFDVIKSDVMVVVNKLH-----KYSL--VEKQPKESTISIPSIYLELKVKLENEYA-- 444
Query: 337 SLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKK 396
L + ++ + D + Y ++ H +K
Sbjct: 445 -LHRSIVDHYNIPKTFDSDDLIPPYLDQ------------YFYSHIGHH--------LKN 483
Query: 397 IIKNSLMLRNQMEQVFAE-RDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL 455
I + + R + F D F+ E K +
Sbjct: 484 I---------EHPERMTLFRMV--FLDFRFL-------EQK------------------I 507
Query: 456 KNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515
++ A A T+ +++ Y I D K + L+ + DF L
Sbjct: 508 RHDS--TAWNASGSILNTLQQLKFYKPY-ICDNDPKYERLVNA------ILDF------L 552
Query: 516 MSLATNLYE----CYVERDAKQFSDKQVY 540
+ NL + A D+ ++
Sbjct: 553 PKIEENLICSKYTDLLRI-ALMAEDEAIF 580
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.9 bits (139), Expect = 1e-08
Identities = 77/652 (11%), Positives = 170/652 (26%), Gaps = 198/652 (30%)
Query: 213 HHQILEIA------RDCLFKSKEKLISSRYFYEMSEKLERLLTETKEKSLEAATVLTFTL 266
HH E +D L ++ + + ++ + + +L+ +E +
Sbjct: 5 HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILS-KEE------------I 51
Query: 267 KKLLLI---ISRPARLLECLEFDPEEFYH-FLEMAEGDAKSLQGIKADIPQYIIGKLGIN 322
+++ +S RL L EE F+E + L+ Y
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVE------EVLR------INY-------- 91
Query: 323 KTVFSDLDNDIQNISLTDTSIESNSDSYCSKKDKFSK--TPNENDFTVIK-----LISNG 375
K + S + + + S+ D + F+K + ++ L
Sbjct: 92 KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAK 151
Query: 376 AYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS-FTDNPFVVTM-YCS- 432
++ + K + L V + F + + C+
Sbjct: 152 -----NVLID-------GVLGSGKTWVAL-----DVCLSYKVQCKMDFKIFWLNLKNCNS 194
Query: 433 ----FETKKHLCLVME--YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIV 486
E + L ++ + D +S L + + + Y + +V
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSS----NIKLRIHSIQAELRRLLKSKPYENCL-LV 249
Query: 487 HRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYI 546
+++ + A + K+ L T R KQ +D +
Sbjct: 250 LLNVQ-NAKAWNAF------NLS-CKI----LLTT-------RF-KQVTD-FLSAATTTH 288
Query: 547 APEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPI 606
E + L ++ + D P
Sbjct: 289 ISLDHHSMTLTPD----------------------EV-KSLLLKYLDCRPQ-----DLPR 320
Query: 607 QVE-----AKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDD 661
+V SII + ++ + +++ + L + L+
Sbjct: 321 EVLTTNPRRLSIIAESIRDGL-ATWD-----------NWKHVNCDKLTTIIESSLNVLEP 368
Query: 662 EEDTSYFDS-------------RMERY-NHDIGEDTDETEDSF---SL-------GTFSS 697
E FD + I D + SL T S
Sbjct: 369 AEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS- 427
Query: 698 CTHQ-YKKVQSQLSSQSSL------EVTPPRKSSEKDETSSTSD--VSSSPVAHVVTSTP 748
Y +++ +L ++ +L P+ D D S H+
Sbjct: 428 -IPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHL----K 482
Query: 749 ESSQTESDDISPQV-------QRKRRAMTSHQMSRAKLPCRQRINVFVRIRF 793
E + V ++K R ++ + + +N +++F
Sbjct: 483 NIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSI-----LNTLQQLKF 529
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 8e-12
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 40/215 (18%)
Query: 375 GAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDIMSFTDNPFVVTM--YC 431
G +G VY A+KK+ + +++Q F E +M+ + +V + +
Sbjct: 42 GGFGVVYKGYVNN--TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS 99
Query: 432 SFETKKHLCLVMEYVEGGDCASLL---KNTGPLP--------ADMARFYFAETVLAVEYL 480
S LCLV Y+ G L T PL A + +L
Sbjct: 100 S--DGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------GINFL 149
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
H +HRD+K N+L+ K++DFGL++ E+ A+ ++
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARAS-------------EKFAQTVMTSRIV 196
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVG 575
GT Y+APE + + K D +S GV+L E + G
Sbjct: 197 GTTAYMAPEALRGEITPK-SDIYSFGVVLLEIITG 230
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 2e-10
Identities = 37/212 (17%), Positives = 55/212 (25%), Gaps = 52/212 (24%)
Query: 349 SYCSKKD--KFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRN 406
CS+K FS + I G +G V+ A+K I L N
Sbjct: 3 GECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVN 60
Query: 407 -----QMEQVFAERDIMSFTD-----------------NPFVVTMYC------------- 431
E++ E I + V
Sbjct: 61 GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120
Query: 432 ---------SFETKKHLCLVMEYVEGGDCASLLKNTGPLP-ADMARFYFAETVLAVEYLH 481
F L +V+E+ GG L + L A+ + ++
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAE 178
Query: 482 -SYGIVHRDLKPDNLLITALGHIKLTDFGLSK 512
S HRDL N+L+ KL K
Sbjct: 179 ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 56/242 (23%), Positives = 91/242 (37%), Gaps = 70/242 (28%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHK---ETRQRFAMKKIIKNSLMLRNQMEQVF-AERDIMS 419
++F+ ++ G +G VY K A+K++ + +++ F E +++S
Sbjct: 30 DNFSNKNILGRGGFGKVY----KGRLADGTLVAVKRLKEERTQ-GGELQ--FQTEVEMIS 82
Query: 420 FTDNPFVVTM--YCSFETKKHLCLVMEYVEGGDCASLL--KNTGPLPAD----------M 465
+ ++ + +C T LV Y+ G AS L + P D
Sbjct: 83 MAVHRNLLRLRGFCM--TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 466 ARFYFAETVLAVEYLHSYG---IVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522
AR + YLH + I+HRD+K N+L+ + DFGL
Sbjct: 141 AR--------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL------------ 180
Query: 523 YECYVERDAKQFSDKQ------VYGTPEYIAPEVILRQGYGKP---VDWWSMGVILYEFL 573
AK K V GT +IAPE + GK D + GV+L E +
Sbjct: 181 --------AKLMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELI 229
Query: 574 VG 575
G
Sbjct: 230 TG 231
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 35/118 (29%), Positives = 58/118 (49%), Gaps = 14/118 (11%)
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537
E+L S +HRDL N+L++ +K+ DFGL++ + + YV + + K
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD----IYKDPD--YVRKGDARLPLK 260
Query: 538 QVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE-FLVGCVPFFGETPEELFAHTVND 594
++APE I + Y D WS GV+L+E F +G P+ G +E F + +
Sbjct: 261 -------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 15/73 (20%), Positives = 30/73 (41%), Gaps = 10/73 (13%)
Query: 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL 500
++M Y+ G ++++ + + V LH ++H DL N +
Sbjct: 416 IMMSYINGKLAKDVIEDNLDIAYKIGE--------IVGKLHKNDVIHNDLTTSNFIFD-- 465
Query: 501 GHIKLTDFGLSKM 513
+ + DFGL K+
Sbjct: 466 KDLYIIDFGLGKI 478
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 810 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1v9v_A | 114 | KIAA0561 protein; helix bundle, MAST205, microtubu | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.3 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.23 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.14 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.97 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.91 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.89 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.53 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.3 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.19 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.9 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.8 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.78 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.77 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.76 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.72 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.72 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.17 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.01 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.0 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.64 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.79 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-66 Score=560.52 Aligned_cols=276 Identities=32% Similarity=0.624 Sum_probs=251.4
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+.++|||||+++++|++++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999999999999999999887665556678899999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||||+||+|.++|.+.+.++|..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~----- 185 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----- 185 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT-----
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC-----
Confidence 999999999999998899999999999999999999999999999999999999999999999999999863211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~ 602 (810)
.......++|||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++.+|....+.+|..
T Consensus 186 --------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~- 256 (311)
T 4aw0_A 186 --------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEK- 256 (311)
T ss_dssp --------TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-
T ss_pred --------CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc-
Confidence 11122357899999999999999999999999999999999999999999999999999999999888764
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCC---ChhHHhcCCCcCCCChhhhhhccCCc
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTG---GPHEVKEHPYFSNLDWNSLLRHKAEF 655 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~---~~~EiL~HPfF~~id~~~l~~~~~~f 655 (810)
+|+++++||.+||++||.+|||+. +..+|++||||+++||+.+.++++|.
T Consensus 257 ---~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~ 309 (311)
T 4aw0_A 257 ---FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPK 309 (311)
T ss_dssp ---CCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCC
T ss_pred ---cCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCC
Confidence 789999999999999999999983 23458999999999999998877653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-64 Score=543.64 Aligned_cols=275 Identities=39% Similarity=0.751 Sum_probs=240.7
Q ss_pred CCCcEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHK---ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k---~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
.++|++++.||+|+||+||+|++. .+++.||||++.+...... ....+.+|+++|+.++|||||+++++|++++.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 368999999999999999999984 4688999999976543322 224577899999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-- 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC--
Confidence 999999999999999999899999999999999999999999999999999999999999999999999999752211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
.....+.+||+.|||||++.+.+|+.++|||||||+||||++|++||.+.+..+++.+|.+..+.+|
T Consensus 180 -------------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p 246 (304)
T 3ubd_A 180 -------------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246 (304)
T ss_dssp --------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred -------------CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence 1122467899999999999999999999999999999999999999999999999999999888877
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCccc
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIP 657 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P 657 (810)
.. +|+++++||.+||++||++||++. +++|+++||||+++||+.+.+++ +||+|
T Consensus 247 ~~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 247 QF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp TT----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred Cc----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 54 789999999999999999999984 57899999999999999997664 67776
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-61 Score=565.46 Aligned_cols=290 Identities=33% Similarity=0.585 Sum_probs=253.8
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHH---HHHHhcCCCCeEEEeeeecccc
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAE---RDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E---~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
.+..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+..| +.+++.++|||||+++++|++.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 4567899999999999999999999999999999999987655444333444444 5667788999999999999999
Q ss_pred ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+.+|||||||+||+|.++|.+.+.|++..+++|++||+.||+|||++|||||||||+||||+.+|+|||+|||+|+....
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999975321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHh-hcCCCCCcchhhhHHHHHHHHhCCCCCCCC---CHHHHHHhhc
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGE---TPEELFAHTV 592 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-~~~ys~ksDIWSLGvILyELLtG~~PF~~~---~~~e~~~~I~ 592 (810)
....+.|||+.|||||++. +.+|+.++||||||||||||++|.+||.+. +..+++..+.
T Consensus 345 -----------------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~ 407 (689)
T 3v5w_A 345 -----------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407 (689)
T ss_dssp -----------------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH
T ss_pred -----------------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Confidence 1124679999999999997 468999999999999999999999999763 4566777888
Q ss_pred cCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCC--CChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCccc
Q psy16843 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYF 668 (810)
Q Consensus 593 ~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta--~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~f 668 (810)
...+.+|.. +|+++++||.+||++||.+|+++ .+++||++||||+++||+.+..++ +||+|.+....+.++|
T Consensus 408 ~~~~~~p~~----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~~~f 483 (689)
T 3v5w_A 408 TMAVELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAF 483 (689)
T ss_dssp HCCCCCCTT----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTTBCC
T ss_pred CCCCCCCcc----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCcCCCC
Confidence 888877754 78999999999999999999996 468999999999999999998664 7899988777766666
Q ss_pred ch
Q psy16843 669 DS 670 (810)
Q Consensus 669 d~ 670 (810)
|.
T Consensus 484 D~ 485 (689)
T 3v5w_A 484 DI 485 (689)
T ss_dssp C-
T ss_pred CC
Confidence 63
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-60 Score=509.93 Aligned_cols=256 Identities=32% Similarity=0.541 Sum_probs=219.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+.++|||||+++++|++++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999877655555567889999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||| +|+|.++|.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----- 165 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG----- 165 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-----
Confidence 9999 7899999999899999999999999999999999999999999999999999999999999999752211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
....+.+||+.|||||++.+..| +.++|||||||+||||++|++||.+.+..+++..+..+.+.+|..
T Consensus 166 -----------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~ 234 (275)
T 3hyh_A 166 -----------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF 234 (275)
T ss_dssp --------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred -----------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 11245789999999999999887 689999999999999999999999999999999999988887754
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+|+++++||.+||++||++|||+ +|+++||||+.
T Consensus 235 ----~s~~~~~li~~~L~~dP~~R~s~---~eil~hpw~k~ 268 (275)
T 3hyh_A 235 ----LSPGAAGLIKRMLIVNPLNRISI---HEIMQDDWFKV 268 (275)
T ss_dssp ----SCHHHHHHHHHHSCSSGGGSCCH---HHHHHCHHHHT
T ss_pred ----CCHHHHHHHHHHccCChhHCcCH---HHHHcCccccc
Confidence 78999999999999999999998 99999999963
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-60 Score=523.24 Aligned_cols=259 Identities=25% Similarity=0.463 Sum_probs=225.8
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+++|+.++|||||+++++|++++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 347899999999999999999999999999999999876543 3456789999999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|||||+||+|.++|... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999999999643 468999999999999999999999999999999999999999999999999998632110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
....+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++.+|..+.+...
T Consensus 180 --------------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~ 245 (350)
T 4b9d_A 180 --------------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV 245 (350)
T ss_dssp --------------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred --------------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence 011356899999999999999999999999999999999999999999999999999998765322
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
. ..+|+++++||.+||++||.+||++ .|+|+||||..
T Consensus 246 ~---~~~s~~~~~li~~~L~~dP~~R~s~---~e~l~hp~~~~ 282 (350)
T 4b9d_A 246 S---LHYSYDLRSLVSQLFKRNPRDRPSV---NSILEKGFIAK 282 (350)
T ss_dssp C---TTSCHHHHHHHHHHTCSSGGGSCCH---HHHHTSHHHHT
T ss_pred C---ccCCHHHHHHHHHHccCChhHCcCH---HHHhcCHHhhc
Confidence 1 2378999999999999999999998 99999999964
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-60 Score=519.76 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=228.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+.|+++++||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+++|+.++|||||+++++|++++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5699999999999999999999999999999999765432 2356788999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
|||+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~------ 223 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------ 223 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS------
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC------
Confidence 99999999999976 57999999999999999999999999999999999999999999999999999753211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
.....+.|||+.|||||++.+.+|+.++|||||||+||||++|++||.+.+..+++..|........ ...
T Consensus 224 ---------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-~~~ 293 (346)
T 4fih_A 224 ---------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-KNL 293 (346)
T ss_dssp ---------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-SCG
T ss_pred ---------CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-Ccc
Confidence 1122467999999999999999999999999999999999999999999999999988876532211 122
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
..+|+++++||.+||++||++||++ .|+|+||||...
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta---~e~l~Hp~~~~~ 330 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATA---AELLKHPFLAKA 330 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCH---HHHTTCGGGGGC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCH---HHHhcCHhhcCC
Confidence 3478999999999999999999998 999999999764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=521.25 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=228.2
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+.|++++.||+|+||.||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 5699999999999999999999999999999999765432 2356789999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
|||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.....
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~------ 300 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------ 300 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS------
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC------
Confidence 99999999999976 57999999999999999999999999999999999999999999999999999753211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
.....+.|||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++..|........ ...
T Consensus 301 ---------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-~~~ 370 (423)
T 4fie_A 301 ---------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-KNL 370 (423)
T ss_dssp ---------CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SCT
T ss_pred ---------CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-ccc
Confidence 1122467999999999999999999999999999999999999999999999999988876533211 112
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
..+|+++++||.+||++||.+||++ .|+|+||||...
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta---~ell~Hp~~~~~ 407 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATA---AELLKHPFLAKA 407 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCH---HHHTTCGGGGGC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCH---HHHhcCHHhcCC
Confidence 3478999999999999999999998 999999999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-58 Score=492.03 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=217.7
Q ss_pred CCc-EEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc----cce
Q psy16843 364 NDF-TVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET----KKH 438 (810)
Q Consensus 364 ~dy-~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~----~~~ 438 (810)
.+| ++.++||+|+||+||+|.++.++..||+|++.+.... ....+.+.+|+++|+.++|||||+++++|++ ++.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 344 7888999999999999999999999999998765443 3455789999999999999999999999865 467
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCCCceEecc-CCcEEEeccCCccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG--IVHRDLKPDNLLITA-LGHIKLTDFGLSKMGL 515 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~g--IIHRDLKPeNILLd~-~g~VKL~DFGLAk~~~ 515 (810)
+|||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999999998899999999999999999999999998 999999999999985 7999999999997421
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC-HHHHHHhhccC
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET-PEELFAHTVND 594 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~-~~e~~~~I~~~ 594 (810)
. ....+.+|||.|||||++.+ +|+.++|||||||+||||++|++||.+.+ ..+++..+..+
T Consensus 184 ~-----------------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~ 245 (290)
T 3fpq_A 184 A-----------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 245 (290)
T ss_dssp T-----------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred C-----------------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC
Confidence 1 11245789999999998865 69999999999999999999999998754 45555555544
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 595 ~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
... .......++++++||.+||++||.+||++ .|+++||||++
T Consensus 246 ~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~---~e~l~Hp~~~~ 288 (290)
T 3fpq_A 246 VKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSI---KDLLNHAFFQE 288 (290)
T ss_dssp CCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCH---HHHHTSGGGC-
T ss_pred CCC--CCCCccCCHHHHHHHHHHccCChhHCcCH---HHHhcCccccC
Confidence 321 11122367899999999999999999998 99999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-58 Score=503.99 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=223.8
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++.+.||+|+||+||+|+++.+|+.||||++.+.... .+|+.+|+.++|||||+++++|++++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 346799999999999999999999999999999999765432 359999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC-cEEEeccCCcccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG-HIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g-~VKL~DFGLAk~~~~s~~~ 520 (810)
|||||+||+|.++|++.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+........
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999889999999999999999999999999999999999999999998 6999999999863221100
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
........++||+.|||||++.+.+|+.++|||||||+||||++|++||.+.+..+++.+|......++.
T Consensus 208 ----------~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 277 (336)
T 4g3f_A 208 ----------KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIRE 277 (336)
T ss_dssp ----------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGG
T ss_pred ----------cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchh
Confidence 1111234578999999999999999999999999999999999999999998888888888876654321
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHH-------------hcCCCcCCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEV-------------KEHPYFSNL 643 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~Ei-------------L~HPfF~~i 643 (810)
. ...+++++++||.+||++||.+||++ .|+ ++|||+.+.
T Consensus 278 ~-~~~~s~~~~~li~~~L~~dP~~R~sa---~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 278 I-PPSCAPLTAQAIQEGLRKEPVHRASA---MELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp S-CTTSCHHHHHHHHHHTCSSGGGSCCH---HHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred c-CccCCHHHHHHHHHHccCCHhHCcCH---HHHHHHHHHHHhhhhhccCCCcCCC
Confidence 1 12378999999999999999999998 676 578998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-57 Score=496.98 Aligned_cols=297 Identities=37% Similarity=0.755 Sum_probs=263.9
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccce
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKH 438 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~ 438 (810)
....++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+..|+.++..+ +||||++++++|.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 35568999999999999999999999999999999999877655556667888999999987 79999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|+||||++||+|..++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~- 177 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN- 177 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999999742211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+++.+|....+.+
T Consensus 178 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~ 243 (353)
T 3txo_A 178 --------------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY 243 (353)
T ss_dssp ----------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred --------------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 112246789999999999999999999999999999999999999999999999999999998888
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCC---CChhHHhcCCCcCCCChhhhhhc--cCCcccCCCCCccCcccchHHh
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGT---GGPHEVKEHPYFSNLDWNSLLRH--KAEFIPQLDDEEDTSYFDSRME 673 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta---~~~~EiL~HPfF~~id~~~l~~~--~~~f~P~~~~~~d~~~fd~~~~ 673 (810)
|.. +++++++||++||++||.+||++ .+.+|+++||||++++|+.+..+ .+||+|.+.+..|.++||..+.
T Consensus 244 p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~~~~~ 319 (353)
T 3txo_A 244 PTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFI 319 (353)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCHHHH
T ss_pred CCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCcccccccCcccc
Confidence 754 67999999999999999999998 56689999999999999999765 4789999999999999998876
Q ss_pred hh
Q psy16843 674 RY 675 (810)
Q Consensus 674 ~~ 675 (810)
..
T Consensus 320 ~~ 321 (353)
T 3txo_A 320 KE 321 (353)
T ss_dssp TS
T ss_pred cC
Confidence 53
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=501.48 Aligned_cols=298 Identities=36% Similarity=0.696 Sum_probs=262.1
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccce
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKH 438 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~ 438 (810)
....++|++++.||+|+||+||+|+++.+++.||||++.+.........+.+..|+.++..+ +|||||+++++|++.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45568999999999999999999999999999999999887665555667788999999776 89999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|+||||++||+|..++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~- 206 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 206 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999999742211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC---------CHHHHHH
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE---------TPEELFA 589 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~---------~~~e~~~ 589 (810)
.....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+. ....++.
T Consensus 207 --------------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~ 272 (396)
T 4dc2_A 207 --------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 272 (396)
T ss_dssp --------------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH
T ss_pred --------------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH
Confidence 11234678999999999999999999999999999999999999999642 3455777
Q ss_pred hhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC---ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCcc
Q psy16843 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG---GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEED 664 (810)
Q Consensus 590 ~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~---~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d 664 (810)
.+....+.+|.. ++.++++||.+||++||.+||++. ++.|+++||||++++|+.+.+++ +||+|.+.++.|
T Consensus 273 ~i~~~~~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d 348 (396)
T 4dc2_A 273 VILEKQIRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFG 348 (396)
T ss_dssp HHHHCCCCCCTT----SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTT
T ss_pred HHhccccCCCCc----CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccc
Confidence 788888877764 789999999999999999999983 57899999999999999997664 799999999999
Q ss_pred CcccchHHhhhc
Q psy16843 665 TSYFDSRMERYN 676 (810)
Q Consensus 665 ~~~fd~~~~~~~ 676 (810)
.++||..+....
T Consensus 349 ~~~fd~~~~~~~ 360 (396)
T 4dc2_A 349 LDNFDSQFTNEP 360 (396)
T ss_dssp GGGSCHHHHTSC
T ss_pred hhhcChhhccCC
Confidence 999999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-56 Score=485.15 Aligned_cols=294 Identities=40% Similarity=0.775 Sum_probs=265.6
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+..|+.+|+.++||||++++++|++.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 45789999999999999999999999999999999987655444556788899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---- 158 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---- 158 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT----
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC----
Confidence 9999999999999998889999999999999999999999999999999999999999999999999999752211
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+....+.+|..
T Consensus 159 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~ 227 (337)
T 1o6l_A 159 -----------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 227 (337)
T ss_dssp -----------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred -----------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 112246789999999999999999999999999999999999999999999999999999888887754
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHhh
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRMER 674 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~~ 674 (810)
+++++++||.+||++||.+||+.+ +++|+++||||.+++|+.+.++. +||.|.+.++.|.++||..+..
T Consensus 228 ----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~~~~~~ 300 (337)
T 1o6l_A 228 ----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTA 300 (337)
T ss_dssp ----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHT
T ss_pred ----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhcccchhcc
Confidence 789999999999999999999642 56999999999999999997654 7899999999999999987654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-56 Score=487.33 Aligned_cols=296 Identities=35% Similarity=0.704 Sum_probs=262.8
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccce
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKH 438 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~ 438 (810)
....++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+..|+.++..+ +||||++++++|++.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 34568999999999999999999999999999999999876554445567788999999887 89999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|+||||++||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD- 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999999742111
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+++..|....+.+
T Consensus 175 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~ 240 (353)
T 2i0e_A 175 --------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 240 (353)
T ss_dssp --------------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred --------------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 112346789999999999999999999999999999999999999999999999999999988887
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHhh
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRMER 674 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~~ 674 (810)
|.. ++.++++||.+||++||.+||++. +++|+++||||++++|+.+.++. +||+|.+.+. |.++||..+..
T Consensus 241 p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~-~~~~f~~~~~~ 315 (353)
T 2i0e_A 241 PKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTR 315 (353)
T ss_dssp CTT----SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC---CHHHHHHHH
T ss_pred CCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc-chhhccchhcc
Confidence 753 789999999999999999999873 57999999999999999997654 7899998887 99999987665
Q ss_pred h
Q psy16843 675 Y 675 (810)
Q Consensus 675 ~ 675 (810)
.
T Consensus 316 ~ 316 (353)
T 2i0e_A 316 H 316 (353)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-56 Score=497.53 Aligned_cols=266 Identities=25% Similarity=0.399 Sum_probs=225.4
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc------cc
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET------KK 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~------~~ 437 (810)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|+.++|||||++++++.+ .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 679999999999999999999999999999999865433 33455778899999999999999999998754 46
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.+|||||||+ |+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 8999999995 689999999899999999999999999999999999999999999999999999999999999753221
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.. .......+.+||+.|||||++.+. .|+.++||||+|||+|||++|++||.+.+..+.+..|.....
T Consensus 212 ~~-----------~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g 280 (398)
T 4b99_A 212 PA-----------EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280 (398)
T ss_dssp ---------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred cc-----------ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 11 111223567999999999999886 569999999999999999999999999999998888765322
Q ss_pred CCC--------------------CCC-------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 597 EWP--------------------SED-------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 597 ~~p--------------------~~~-------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
..+ ... ...++++++|||.+||++||.+|||+ .|+|+||||.....
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta---~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA---AAALRHPFLAKYHD 353 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCH---HHHTTSGGGTTTCC
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCH---HHHhcCHhhCcCCC
Confidence 111 000 01257899999999999999999998 99999999988654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-55 Score=479.60 Aligned_cols=295 Identities=37% Similarity=0.709 Sum_probs=262.0
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecccccee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~l 439 (810)
...++|++++.||+|+||.||+|+++.+++.||||++.+.........+.+..|+.++..+ +||||++++++|.+.+.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 3457899999999999999999999999999999999887666666778889999999887 899999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-- 163 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-- 163 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT--
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC--
Confidence 999999999999999998889999999999999999999999999999999999999999999999999998742211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCC---------CCHHHHHHh
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG---------ETPEELFAH 590 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~---------~~~~e~~~~ 590 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.. .....++..
T Consensus 164 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (345)
T 3a8x_A 164 -------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230 (345)
T ss_dssp -------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred -------------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence 1112456899999999999999999999999999999999999999975 345567777
Q ss_pred hccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC---ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccC
Q psy16843 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG---GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDT 665 (810)
Q Consensus 591 I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~---~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~ 665 (810)
+....+.+|.. ++.++++||.+||++||.+||++. ++.|+++||||.+++|+.+.++. +||.|.+.+..|.
T Consensus 231 i~~~~~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~ 306 (345)
T 3a8x_A 231 ILEKQIRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGL 306 (345)
T ss_dssp HHHCCCCCCTT----SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCG
T ss_pred HHcCCCCCCCC----CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchh
Confidence 77777777653 779999999999999999999973 46899999999999999997654 7899999999999
Q ss_pred cccchHHhh
Q psy16843 666 SYFDSRMER 674 (810)
Q Consensus 666 ~~fd~~~~~ 674 (810)
++||..+..
T Consensus 307 ~~~~~~~~~ 315 (345)
T 3a8x_A 307 DNFDSQFTN 315 (345)
T ss_dssp GGSCHHHHT
T ss_pred hhcCccccc
Confidence 999987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-56 Score=485.77 Aligned_cols=293 Identities=38% Similarity=0.757 Sum_probs=243.9
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccce
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKH 438 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~ 438 (810)
....++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+..|+.++..+ +||||++++++|++.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34568999999999999999999999999999999999876544444556788899999876 99999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|+||||++||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 171 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG- 171 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999999742211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+......+
T Consensus 172 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (345)
T 1xjd_A 172 --------------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY 237 (345)
T ss_dssp --------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred --------------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 111246789999999999999999999999999999999999999999999999999998888777
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhc--cCCcccCCCCCccCcccchHHh
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRH--KAEFIPQLDDEEDTSYFDSRME 673 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~--~~~f~P~~~~~~d~~~fd~~~~ 673 (810)
|.. +++++++||.+||+.||.+||++. .|+++||||++++|+.+..+ .+||.|.+.+..|.++||..+.
T Consensus 238 p~~----~s~~~~~li~~lL~~dp~~R~~~~--~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~~~~ 308 (345)
T 1xjd_A 238 PRW----LEKEAKDLLVKLFVREPEKRLGVR--GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFL 308 (345)
T ss_dssp CTT----SCHHHHHHHHHHSCSSGGGSBTTB--SCGGGSGGGTTCCHHHHHTTCSCC--------------------
T ss_pred Ccc----cCHHHHHHHHHHhcCCHhHcCCCh--HHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcchhhc
Confidence 653 789999999999999999999982 29999999999999999765 4789999999999999997654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=483.45 Aligned_cols=270 Identities=24% Similarity=0.379 Sum_probs=204.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc------
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK------ 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~------ 437 (810)
++|++++.||+|+||+||+|+++.+|+.||||++..... ....+.+.+|+++|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 479999999999999999999999999999999876542 334467889999999999999999999987543
Q ss_pred ------eeeeeeeeccCcchhhhhhcCCCC---CHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEecc
Q psy16843 438 ------HLCLVMEYVEGGDCASLLKNTGPL---PADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDF 508 (810)
Q Consensus 438 ------~lyLVmEy~~GGsL~~lL~~~g~l---se~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DF 508 (810)
++|||||||+||+|.+++...+.+ .+..++.|+.||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 489999999999999999877654 44568899999999999999999999999999999999999999999
Q ss_pred CCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH-HHH
Q psy16843 509 GLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EEL 587 (810)
Q Consensus 509 GLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~-~e~ 587 (810)
|+|+............ ..........+.|||+.|||||++.+..|+.++|||||||+||||++ ||.+... ...
T Consensus 163 Gla~~~~~~~~~~~~~---~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVL---TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCC-----------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred ccceecCCCccccccc---cccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 9998643221110000 00001112245789999999999999999999999999999999996 8865432 233
Q ss_pred HHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhh
Q psy16843 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647 (810)
Q Consensus 588 ~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~ 647 (810)
+..+.... +|.. ....++++.+||.+||++||.+||++ .|+++||||++++|..
T Consensus 237 ~~~~~~~~--~p~~-~~~~~~~~~~li~~~L~~dP~~Rps~---~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 237 LTDVRNLK--FPPL-FTQKYPCEYVMVQDMLSPSPMERPEA---INIIENAVFEDLDFPG 290 (299)
T ss_dssp HHHHHTTC--CCHH-HHHHCHHHHHHHHHHTCSSGGGSCCH---HHHHTSGGGCCC----
T ss_pred HHHHhcCC--CCCC-CcccCHHHHHHHHHHcCCChhHCcCH---HHHhcCHhhCCCCCCC
Confidence 33443332 2221 11245778999999999999999998 9999999999999953
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=487.44 Aligned_cols=294 Identities=35% Similarity=0.698 Sum_probs=246.1
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHH-HhcCCCCeEEEeeeecccccee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI-MSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~i-L~~l~HPnIVkl~~~f~~~~~l 439 (810)
...++|++++.||+|+||+||+|+++.+++.||||++.+.........+.+..|..+ ++.++|||||+++++|++.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 455799999999999999999999999999999999988766555666777888887 5789999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||++||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-- 192 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-- 192 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC--
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC--
Confidence 999999999999999998889999999999999999999999999999999999999999999999999998742211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..|....+.++
T Consensus 193 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 259 (373)
T 2r5t_A 193 -------------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 259 (373)
T ss_dssp -------------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC
T ss_pred -------------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 1123467899999999999999999999999999999999999999999999999999999887776
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCC-ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHh
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTG-GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRME 673 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~-~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~ 673 (810)
.. ++.++++||.+||++||.+||++. ++.|+++||||++++|+.+..++ +||.|.+.+..|.++||..+.
T Consensus 260 ~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~ 332 (373)
T 2r5t_A 260 PN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFT 332 (373)
T ss_dssp SS----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC------------
T ss_pred CC----CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcchhhhcCcccc
Confidence 53 779999999999999999999984 57899999999999999997764 789999999999999987554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=470.45 Aligned_cols=288 Identities=35% Similarity=0.745 Sum_probs=250.9
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 34789999999999999999999999999999999987655444556778899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----- 158 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 158 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-----
Confidence 999999999999999888999999999999999999999999999999999999999999999999999975211
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
...+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+.++....+.+|..
T Consensus 159 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~ 225 (318)
T 1fot_A 159 -------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF 225 (318)
T ss_dssp -------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTT
T ss_pred -------------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence 1235689999999999999999999999999999999999999999999999999999988877754
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCC-CCccCcccchH
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLD-DEEDTSYFDSR 671 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~-~~~d~~~fd~~ 671 (810)
++.++++||.+||++||.+||+.. +++|+++||||++++|+.+..+. +||.|.+. ...|.++||..
T Consensus 226 ----~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~d~~~f~~~ 296 (318)
T 1fot_A 226 ----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKY 296 (318)
T ss_dssp ----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-------------
T ss_pred ----CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCCccchhhcCCC
Confidence 679999999999999999999542 45999999999999999997764 78999887 47888999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=475.01 Aligned_cols=287 Identities=39% Similarity=0.750 Sum_probs=261.6
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+++|+.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999998765544455678889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~---- 193 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC----
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999975211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+++.++..+.+.+|.
T Consensus 194 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~ 259 (350)
T 1rdq_E 194 --------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS 259 (350)
T ss_dssp --------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred --------------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 123568999999999999999999999999999999999999999999999999999998887775
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCC--CChhHHhcCCCcCCCChhhhhhc--cCCcccCCCCCccCcccc
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRH--KAEFIPQLDDEEDTSYFD 669 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta--~~~~EiL~HPfF~~id~~~l~~~--~~~f~P~~~~~~d~~~fd 669 (810)
. ++.++++||.+||+.||.+||+. .+++|+++||||.+++|..+.++ .+||+|.+.+..|.++||
T Consensus 260 ~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~ 328 (350)
T 1rdq_E 260 H----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328 (350)
T ss_dssp T----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC
T ss_pred C----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccccc
Confidence 4 67999999999999999999983 34599999999999999999765 478999999999999997
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=510.26 Aligned_cols=264 Identities=28% Similarity=0.425 Sum_probs=238.4
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... ...+.+.+|+++|+.++|||||+++++|++++.+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3689999999999999999999999999999999876542 3346788999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC--CcEEEeccCCccccccccc
Q psy16843 443 MEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL--GHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 443 mEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~--g~VKL~DFGLAk~~~~s~~ 519 (810)
||||+||+|+++|.+ .+.+++..++.|++||+.||+|||++||+||||||+|||++.+ |++||+|||+|+.....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 999999999999864 4689999999999999999999999999999999999999864 89999999999763211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
....+.|||+.|||||++.+.+|+.++|||||||+||||++|.+||.+.+..+++..|....+.++
T Consensus 311 --------------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~ 376 (573)
T 3uto_A 311 --------------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 376 (573)
T ss_dssp --------------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred --------------CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence 112356899999999999999999999999999999999999999999999999999999888777
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhh
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSL 648 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l 648 (810)
......+|+++++||.+||++||.+||++ .|+|+||||...+|...
T Consensus 377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~---~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 377 DSAFSGISEDGKDFIRKLLLADPNTRMTI---HQALEHPWLTPGNAPGR 422 (573)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCH---HHHHHSTTTSCCCCTTT
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCH---HHHhcCcCcCCCCCCCc
Confidence 65555589999999999999999999998 99999999999888654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-55 Score=489.14 Aligned_cols=295 Identities=36% Similarity=0.688 Sum_probs=252.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+..|+.++..++||||++++++|++.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 34578999999999999999999999999999999998765544455566889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
+||||++||+|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~-- 215 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-- 215 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC--
Confidence 999999999999999865 47999999999999999999999999999999999999999999999999999753211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhh-------cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-------QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-------~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~ 592 (810)
........+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+++.+|.
T Consensus 216 ------------~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 216 ------------GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp ------------SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred ------------CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1111235689999999999984 468999999999999999999999999999999999888
Q ss_pred cCC--CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCccCcccch
Q psy16843 593 NDD--IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 593 ~~~--~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d~~~fd~ 670 (810)
... +.+|.. ...+++++++||.+||+ +|.+|++..+++|+++||||++++|+.+....+||+|.+.+..|.++||.
T Consensus 284 ~~~~~~~~p~~-~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~ 361 (412)
T 2vd5_A 284 HYKEHLSLPLV-DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDL 361 (412)
T ss_dssp THHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC-----CCSSCC-
T ss_pred hcccCcCCCcc-ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCcCCCcccccccCc
Confidence 633 344421 12378999999999999 99999876677999999999999999998888999999999999999986
Q ss_pred H
Q psy16843 671 R 671 (810)
Q Consensus 671 ~ 671 (810)
.
T Consensus 362 ~ 362 (412)
T 2vd5_A 362 V 362 (412)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=512.97 Aligned_cols=296 Identities=35% Similarity=0.700 Sum_probs=265.6
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccce
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKH 438 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~ 438 (810)
....++|++++.||+|+||.||+|+++.+++.||||++.+.........+.+..|+.+|..+ +||||+.++++|++.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 34568999999999999999999999999999999999876555555567788999999887 79999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+||||||++||+|.++|...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~- 495 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD- 495 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT-
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999999742211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
.....+.+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+..+++..|+...+.+
T Consensus 496 --------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 561 (674)
T 3pfq_A 496 --------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 561 (674)
T ss_dssp --------------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC
T ss_pred --------------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 112346789999999999999999999999999999999999999999999999999999998888
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCC--CChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHhh
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRMER 674 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta--~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~~ 674 (810)
|.. +++++++||.+||++||.+||++ .+++||++||||+++||+.+.+++ +||+|.+.+ .|.++||..+..
T Consensus 562 p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~-~~~~~f~~~~~~ 636 (674)
T 3pfq_A 562 PKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG-RNAENFDRFFTR 636 (674)
T ss_dssp CTT----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG-GGHHHHTTTTTS
T ss_pred Ccc----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC-CchhhcCchhcc
Confidence 764 78999999999999999999998 457899999999999999998764 789999887 888999887654
Q ss_pred h
Q psy16843 675 Y 675 (810)
Q Consensus 675 ~ 675 (810)
.
T Consensus 637 ~ 637 (674)
T 3pfq_A 637 H 637 (674)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=477.83 Aligned_cols=270 Identities=28% Similarity=0.437 Sum_probs=210.6
Q ss_pred CCcEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecccccee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHK---ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k---~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~l 439 (810)
++|++++.||+|+||+||+|+++ .+++.||||++.+... ..++.+|+++|+.+ +|||||+++++|++.+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 57999999999999999999986 4578999998866432 24577899999888 799999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC-CcEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL-GHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~-g~VKL~DFGLAk~~~~s~ 518 (810)
|||||||+||+|.+++. .+++.+++.|+.||+.||+|||++|||||||||+||||+.+ |++||+|||+|+......
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999999999984 59999999999999999999999999999999999999876 899999999997533221
Q ss_pred cccchhhhhh-------------cccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCC-CC
Q psy16843 519 ATNLYECYVE-------------RDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFG-ET 583 (810)
Q Consensus 519 ~~~~~~~~~~-------------~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~-~~ 583 (810)
.......... .........+.+||++|||||++.+. .|+.++||||+||++|||++|++||.+ .+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1000000000 00001112456899999999999886 589999999999999999999999965 44
Q ss_pred HHHHHHhhcc--------------------------------------CCCCCC------------CCCCCcccHHHHHH
Q psy16843 584 PEELFAHTVN--------------------------------------DDIEWP------------SEDDWPIQVEAKSI 613 (810)
Q Consensus 584 ~~e~~~~I~~--------------------------------------~~~~~p------------~~~~~~~S~el~dL 613 (810)
..+.+..|.. .....| ......+|++++||
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 4444444321 000000 01122378999999
Q ss_pred HHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 614 ITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 614 I~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
|.+||++||.+|+|+ +|+|+||||++++
T Consensus 333 l~~lL~~dP~~R~ta---~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 333 LDKLLDLNPASRITA---EEALLHPFFKDMS 360 (361)
T ss_dssp HHHHTCSCTTTSCCH---HHHHTSGGGTTC-
T ss_pred HHHHCcCChhHCcCH---HHHhcCcccCCCC
Confidence 999999999999998 9999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=490.85 Aligned_cols=293 Identities=36% Similarity=0.695 Sum_probs=256.5
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++++.||+|+||+||+|+++.+++.||||++.+.........+.+..|+.++..++||||++++++|.+++.+||
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 44789999999999999999999999999999999977554444444558889999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 442 VMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
|||||+||+|.+++.+ .+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~--- 228 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED--- 228 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT---
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC---
Confidence 9999999999999987 578999999999999999999999999999999999999999999999999999753211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHh-----hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-----~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
........+||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+..+.+.+|+...
T Consensus 229 -----------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 229 -----------GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297 (437)
T ss_dssp -----------SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred -----------CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence 111223468999999999998 4568999999999999999999999999999999999988643
Q ss_pred --CCCCCCCCCcccHHHHHHHHhhhcCCCCC--CCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCccCcccchH
Q psy16843 596 --IEWPSEDDWPIQVEAKSIITDLLQQNPRD--RLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSR 671 (810)
Q Consensus 596 --~~~p~~~~~~~S~el~dLI~klL~~dP~~--Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d~~~fd~~ 671 (810)
+.+|... ..+++++++||++||+.+|++ |+++ +|+++||||++++|+.+.+..+||+|.+.++.|.++||..
T Consensus 298 ~~~~~p~~~-~~~s~~~~dLi~~lL~~~~~r~~r~~~---~eil~Hpff~~i~w~~l~~~~~p~~P~~~~~~d~~~fd~~ 373 (437)
T 4aw2_A 298 ERFQFPTQV-TDVSENAKDLIRRLICSREHRLGQNGI---EDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVD 373 (437)
T ss_dssp HHCCCCSSC-CCSCHHHHHHHHTTSSCGGGCTTTTTT---HHHHTSGGGTTCCTTTGGGSCCSCCCCCSSTTCCTTSCCC
T ss_pred ccccCCccc-ccCCHHHHHHHHHHhcccccccCCCCH---HHHhCCCccCCCCHHHHhhCCCCCCCcCCCccchhhcCCc
Confidence 4444321 237899999999999988877 7877 9999999999999999988889999999999999999864
Q ss_pred H
Q psy16843 672 M 672 (810)
Q Consensus 672 ~ 672 (810)
.
T Consensus 374 ~ 374 (437)
T 4aw2_A 374 D 374 (437)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=487.66 Aligned_cols=291 Identities=41% Similarity=0.740 Sum_probs=254.1
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.++|||||+++++|.+++.+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 34578999999999999999999999999999999997755443344456788999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+|||||+||+|.+++.+ +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~--- 221 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--- 221 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT---
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC---
Confidence 99999999999999976 57999999999999999999999999999999999999999999999999999753211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcC----CCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG----YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD- 595 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~----ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~- 595 (810)
......+.+||+.|+|||++.+.+ |+.++|||||||+||||++|.+||.+.+..+++.+|+...
T Consensus 222 -----------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 290 (410)
T 3v8s_A 222 -----------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 290 (410)
T ss_dssp -----------SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred -----------CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc
Confidence 111224678999999999998766 8999999999999999999999999999999999998754
Q ss_pred -CCCCCCCCCcccHHHHHHHHhhhcCCCCC--CCCCCChhHHhcCCCcCCCChhhhh--hccCCcccCCCCCccCcccch
Q psy16843 596 -IEWPSEDDWPIQVEAKSIITDLLQQNPRD--RLGTGGPHEVKEHPYFSNLDWNSLL--RHKAEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 596 -~~~p~~~~~~~S~el~dLI~klL~~dP~~--Rpta~~~~EiL~HPfF~~id~~~l~--~~~~~f~P~~~~~~d~~~fd~ 670 (810)
+.+|.. ..++.++++||.+||+.+|.+ |+++ +||++||||++++|+.+. +..+||+|.+.++.|.++||+
T Consensus 291 ~~~~p~~--~~~s~~~~~li~~lL~~~~~rlgR~~~---~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~ 365 (410)
T 3v8s_A 291 SLTFPDD--NDISKEAKNLICAFLTDREVRLGRNGV---EEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDD 365 (410)
T ss_dssp HCCCCTT--CCCCHHHHHHHHHHSSCGGGCTTSSCH---HHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCC
T ss_pred cccCCCc--ccccHHHHHHHHHHccChhhhCCCCCH---HHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhcCC
Confidence 444443 247899999999999988887 8877 999999999999987654 345899999999999999986
Q ss_pred H
Q psy16843 671 R 671 (810)
Q Consensus 671 ~ 671 (810)
.
T Consensus 366 ~ 366 (410)
T 3v8s_A 366 L 366 (410)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-54 Score=464.28 Aligned_cols=252 Identities=21% Similarity=0.360 Sum_probs=216.8
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
+..++|.+.+.||+|+||+||+|++. .++..||||++.... ....+.+.+|+++|+.++|||||++++++.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 44578999999999999999999875 357899999986543 3445779999999999999999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcC-------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNT-------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH 502 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~-------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~ 502 (810)
++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++||||||||+||||+.++.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 99999999999999999999754 36999999999999999999999999999999999999999999
Q ss_pred EEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCC
Q psy16843 503 IKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFG 581 (810)
Q Consensus 503 VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~ 581 (810)
+||+|||+|+...... ........+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+
T Consensus 167 ~Ki~DFGla~~~~~~~-------------~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~ 233 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTD-------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 233 (299)
T ss_dssp EEECCCSCHHHHTGGG-------------CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EEECCcccceecCCCC-------------ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999997532111 1111234579999999999999999999999999999999998 9999999
Q ss_pred CCHHHHHHhhccCCC-CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 582 ETPEELFAHTVNDDI-EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 582 ~~~~e~~~~I~~~~~-~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
.+..+++..+..+.. ..|. .+++++.+||.+||+.||++||++ .|+.
T Consensus 234 ~~~~~~~~~i~~~~~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~---~~i~ 281 (299)
T 4asz_A 234 LSNNEVIECITQGRVLQRPR----TCPQEVYELMLGCWQREPHMRKNI---KGIH 281 (299)
T ss_dssp SCHHHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCH---HHHH
T ss_pred CCHHHHHHHHHcCCCCCCCc----cchHHHHHHHHHHcCCChhHCcCH---HHHH
Confidence 999999999887654 2232 267999999999999999999998 7773
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=481.20 Aligned_cols=294 Identities=39% Similarity=0.767 Sum_probs=249.9
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 45578999999999999999999999999999999998765545555677889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 302 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-- 302 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC--
Confidence 999999999999999888899999999999999999999998 99999999999999999999999999998742211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
.......+||+.|+|||++.+..|+.++|||||||+||||++|..||.+.+..+++..+....+.+|
T Consensus 303 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p 369 (446)
T 4ejn_A 303 -------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP 369 (446)
T ss_dssp -----------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred -------------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 1112457899999999999999999999999999999999999999999999999999998888777
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHh
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRME 673 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~ 673 (810)
.. +++++++||.+||++||.+||+.. .++|+++||||.+++|+.+..++ +||.|.+.++.|..+||+.++
T Consensus 370 ~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~~~~ 443 (446)
T 4ejn_A 370 RT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFT 443 (446)
T ss_dssp TT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC-----
T ss_pred cc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhcchhhh
Confidence 54 679999999999999999999331 34999999999999999997664 689999999999999998765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=462.59 Aligned_cols=254 Identities=22% Similarity=0.383 Sum_probs=213.1
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
+..++|.+.++||+|+||+||+|+++ .+++.||||++.... ....+.+.+|+++|+.++|||||++++++.+
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34478999999999999999999875 368899999986543 3445779999999999999999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNT---------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL 500 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~---------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~ 500 (810)
++.+|||||||+||+|.++|++. +++++..+..|+.||+.||+|||+++||||||||+||||+.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 99999999999999999999653 469999999999999999999999999999999999999999
Q ss_pred CcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCC
Q psy16843 501 GHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPF 579 (810)
Q Consensus 501 g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF 579 (810)
+.+||+|||+|+...... ........+||+.|||||++.+..|+.++|||||||+||||++ |+.||
T Consensus 195 ~~~Ki~DFGla~~~~~~~-------------~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf 261 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTD-------------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261 (329)
T ss_dssp TEEEECCCC-----------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CcEEEcccccceeccCCC-------------cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCC
Confidence 999999999997532110 1112235679999999999999999999999999999999998 99999
Q ss_pred CCCCHHHHHHhhccCC-CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 580 FGETPEELFAHTVNDD-IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 580 ~~~~~~e~~~~I~~~~-~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.+.+..+++..+..+. +..|. .+++++.+||.+||++||++||++ .||+++
T Consensus 262 ~~~~~~~~~~~i~~g~~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~---~ei~~~ 313 (329)
T 4aoj_A 262 YQLSNTEAIDCITQGRELERPR----ACPPEVYAIMRGCWQREPQQRHSI---KDVHAR 313 (329)
T ss_dssp CSSCHHHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHCCSSTTTSCCH---HHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCCcc----cccHHHHHHHHHHcCcChhHCcCH---HHHHHH
Confidence 9999999988887753 33332 267999999999999999999998 777653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=455.42 Aligned_cols=294 Identities=37% Similarity=0.713 Sum_probs=239.0
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccchhh-HHHHHHHHHHHHHHhcCCCCeEEEeeeecccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHK---ETRQRFAMKKIIKNSLML-RNQMEQVFAERDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k---~tg~~vAIK~I~k~~~~~-~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
...++|++++.||+|+||.||+|++. .+|+.||+|++.+..... ......+.+|+.+|+.++||||+++++++.+.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 45578999999999999999999985 689999999987654321 23445678899999999999999999999999
Q ss_pred ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999864211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
. .......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+..+.....
T Consensus 174 ~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 238 (327)
T 3a62_A 174 D---------------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL 238 (327)
T ss_dssp --------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred C---------------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 1 0112356899999999999999999999999999999999999999999999999999988877
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHH
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRM 672 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~ 672 (810)
.+|.. ++.++++||.+||..||.+||++. ++.|+++||||++++|+.+.... +++.|.+...++.++|+..+
T Consensus 239 ~~p~~----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~~~~~~~~~ 314 (327)
T 3a62_A 239 NLPPY----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKF 314 (327)
T ss_dssp CCCTT----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC--------------
T ss_pred CCCCC----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcCChhhhhhcchhh
Confidence 77653 679999999999999999999774 67999999999999999987654 68999988888888888665
Q ss_pred h
Q psy16843 673 E 673 (810)
Q Consensus 673 ~ 673 (810)
.
T Consensus 315 ~ 315 (327)
T 3a62_A 315 T 315 (327)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=457.22 Aligned_cols=253 Identities=20% Similarity=0.267 Sum_probs=208.0
Q ss_pred cCCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 358 SKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 358 ~~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
.+++..+++++.+.||+|+||+||+|+++. .||||++.... ......+.+.+|+++|+.++|||||++++++.. +
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 355667899999999999999999998653 59999876443 234556789999999999999999999998754 5
Q ss_pred eeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
.+|||||||+||+|.++|.. .+.+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 78999999999999999965 46899999999999999999999999999999999999999999999999999975321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhc---CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ---GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~---~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~ 593 (810)
.. ......+.+||+.|||||++.+. +|+.++|||||||+||||++|+.||.+.+....+..++.
T Consensus 185 ~~-------------~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~ 251 (307)
T 3omv_A 185 WS-------------GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG 251 (307)
T ss_dssp ----------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred CC-------------cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence 10 11122456899999999999753 589999999999999999999999998776666555555
Q ss_pred CCCCCCCC--CCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 594 DDIEWPSE--DDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 594 ~~~~~p~~--~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
.....|.. ....+++++.+||.+||++||++||++
T Consensus 252 ~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 288 (307)
T 3omv_A 252 RGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLF 288 (307)
T ss_dssp TTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCH
T ss_pred cCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCH
Confidence 44433321 122367899999999999999999998
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=455.57 Aligned_cols=256 Identities=20% Similarity=0.301 Sum_probs=217.5
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
...++++++++||+|+||+||+|++. .+++.||||++..... ....+.+.+|+.+|+.++|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~--~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC--C-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC--hHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 44578999999999999999999864 4678999998865432 2234678999999999999999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNT----------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA 499 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~----------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~ 499 (810)
++.+|||||||++|+|.++|... +.+++..+..|+.||+.||+|||+++||||||||+||||+.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 99999999999999999999642 35899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCC
Q psy16843 500 LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVP 578 (810)
Q Consensus 500 ~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~P 578 (810)
++++||+|||+|+..... .........+||+.|||||++.+..|+.++|||||||+||||++ |..|
T Consensus 181 ~~~~Ki~DFGlar~~~~~-------------~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~P 247 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAA-------------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247 (308)
T ss_dssp GGCEEECCSCCBCGGGGG-------------GCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCEEECCcccceeccCC-------------CceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCC
Confidence 999999999999753211 11112345689999999999999999999999999999999998 9999
Q ss_pred CCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 579 FFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 579 F~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
|.+.+..+++..+..+... |.+. .+++++.+||.+||+.||.+||++ .||+++
T Consensus 248 f~~~~~~~~~~~i~~~~~~-~~p~--~~~~~~~~li~~C~~~dP~~RPs~---~ei~~~ 300 (308)
T 4gt4_A 248 YCGYSNQDVVEMIRNRQVL-PCPD--DCPAWVYALMIECWNEFPSRRPRF---KDIHSR 300 (308)
T ss_dssp TTTCCHHHHHHHHHTTCCC-CCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCC-CCcc--cchHHHHHHHHHHcCCChhHCcCH---HHHHHH
Confidence 9999999999888876532 2222 267899999999999999999998 676654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=462.83 Aligned_cols=279 Identities=31% Similarity=0.644 Sum_probs=246.2
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
....++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+++|+.++|||||+++++|.+.+.+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34568899999999999999999999999999999999876655555667889999999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||||+.||+|..++...+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 168 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-- 168 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence 999999999999999999889999999999999999999999999999999999999999999999999999753211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhh---cCCCCCcchhhhHHHHHHHHhCCCCCCC---CCHHHHHHhhcc
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR---QGYGKPVDWWSMGVILYEFLVGCVPFFG---ETPEELFAHTVN 593 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~---~~ys~ksDIWSLGvILyELLtG~~PF~~---~~~~e~~~~I~~ 593 (810)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+ ....+++..+..
T Consensus 169 --------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~ 234 (384)
T 4fr4_A 169 --------------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET 234 (384)
T ss_dssp --------------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH
T ss_pred --------------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh
Confidence 11245789999999999974 4689999999999999999999999974 445666666666
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhcc--CCcccCCC
Q psy16843 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLD 660 (810)
Q Consensus 594 ~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~ 660 (810)
....+|.. ++.++.+||.+||++||.+||++ ++++++||||.+++|+.+.++. ++|+|...
T Consensus 235 ~~~~~p~~----~s~~~~~li~~lL~~dP~~R~s~--~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~~ 297 (384)
T 4fr4_A 235 TVVTYPSA----WSQEMVSLLKKLLEPNPDQRFSQ--LSDVQNFPYMNDINWDAVFQKRLIPGFIPNKG 297 (384)
T ss_dssp CCCCCCTT----SCHHHHHHHHHHSCSSGGGSCCS--HHHHHTSGGGTTCCHHHHHTTCSCCCCCCSCC
T ss_pred cccCCCCc----CCHHHHHHHHHHhcCCHhHhccc--HHHHHcChhhhcCCHHHHHhCCCCCCCCCCCC
Confidence 66666653 67999999999999999999985 4899999999999999998765 67888654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=451.04 Aligned_cols=314 Identities=31% Similarity=0.485 Sum_probs=264.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
+..++|++++.||+|+||.||+|++..+|+.||||++.+.... ....+.+.+|+++|+.++||||+++++++.+.+.+|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 4457899999999999999999999999999999998765432 345577889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--- 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--- 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS---
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC---
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998642211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
......+||+.|+|||++.+..| +.++|||||||++|||++|..||.+.+..++...+..+.+.+|
T Consensus 168 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p 234 (328)
T 3fe3_A 168 -------------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 234 (328)
T ss_dssp -------------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred -------------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 01235689999999999999887 4899999999999999999999999999999999999888777
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCccCcccchHHhhhcCCC
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDI 679 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d~~~fd~~~~~~~~~~ 679 (810)
.. +++++.+||.+||+.||.+||++ +|+++||||....+..-+ .++.. ...+ ..++........+
T Consensus 235 ~~----~s~~~~~li~~~L~~dP~~R~t~---~eil~h~~~~~~~~~~~~---~~~~~---~~~~--~~~~~~~~~~~~~ 299 (328)
T 3fe3_A 235 FY----MSTDCENLLKRFLVLNPIKRGTL---EQIMKDRWINAGHEEDEL---KPFVE---PELD--ISDQKRIDIMVGM 299 (328)
T ss_dssp TT----SCHHHHHHHHHHCCSSTTTSCCH---HHHTTCTTTTTTCTTCCC---CCCCC---CCCC--CCCHHHHHHHHHT
T ss_pred CC----CCHHHHHHHHHHCCCChhHCcCH---HHHhcCHhhcCCCccccc---CcccC---CCcC--cccHHHHHHHHHC
Confidence 54 67999999999999999999999 999999999875433211 12211 1111 1122222233446
Q ss_pred CCCCcccccccccCCcccchhhhhhhh
Q psy16843 680 GEDTDETEDSFSLGTFSSCTHQYKKVQ 706 (810)
Q Consensus 680 ~~~~~e~~d~~~~~~f~~~~~~~~~~~ 706 (810)
+.+.++..+.+....++..++.|..+.
T Consensus 300 ~~~~~~~~~~l~~~~~~~~~~~y~ll~ 326 (328)
T 3fe3_A 300 GYSQEEIQESLSKMKYDEITATYLLLG 326 (328)
T ss_dssp TCCHHHHHHHHHTTCCSHHHHHHHHHT
T ss_pred CCCHHHHHHHHHcCCCCHHHHHHHHhc
Confidence 677778888888889999999998764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=477.87 Aligned_cols=319 Identities=29% Similarity=0.522 Sum_probs=261.7
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+..|+++|+.++||||++++++|++.+.+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 44578999999999999999999999999999999998766554455677889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcC----CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 441 LVMEYVEGGDCASLLKNT----GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~----g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+||||++||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999998753 4699999999999999999999999999999999999999999999999999975321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC----CHHHHHHhhc
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE----TPEELFAHTV 592 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~----~~~e~~~~I~ 592 (810)
. .......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+. ...++...+.
T Consensus 342 ~---------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~ 406 (543)
T 3c4z_A 342 G---------------QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL 406 (543)
T ss_dssp T---------------CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH
T ss_pred C---------------CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh
Confidence 1 11123468999999999999999999999999999999999999999875 4577888888
Q ss_pred cCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhc--cCCcccCCC-----CCc
Q psy16843 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRH--KAEFIPQLD-----DEE 663 (810)
Q Consensus 593 ~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~--~~~f~P~~~-----~~~ 663 (810)
.....+|.. +++++++||.+||++||.+||++. +++|+++||||++++|..+... .+||+|... +..
T Consensus 407 ~~~~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~ 482 (543)
T 3c4z_A 407 EQAVTYPDK----FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQ 482 (543)
T ss_dssp HCCCCCCTT----SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCSSSCCSCC--
T ss_pred hcccCCCcc----cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCccccccCCch
Confidence 877777643 789999999999999999999874 4689999999999999999865 478998764 234
Q ss_pred cCcccchHHhhhcCCCCCCC-cccccccccCCcccchhhhhhh
Q psy16843 664 DTSYFDSRMERYNHDIGEDT-DETEDSFSLGTFSSCTHQYKKV 705 (810)
Q Consensus 664 d~~~fd~~~~~~~~~~~~~~-~e~~d~~~~~~f~~~~~~~~~~ 705 (810)
|..+|+.. .+... +...+-+....+..+..+|+..
T Consensus 483 d~~~f~~~-------~~~~~~~~~~~~f~~f~~~~~~~~~~~~ 518 (543)
T 3c4z_A 483 DVGAFSTV-------KGVAFEKADTEFFQEFASGTCPIPWQEE 518 (543)
T ss_dssp --CCCC----------CCCCCHHHHHHHHHHCCEECHHHHHHH
T ss_pred hhhhcccc-------CCCCCCcchhhHhhcCCCCCCChhHHHh
Confidence 44555431 11111 2222333344555566667654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=458.21 Aligned_cols=259 Identities=22% Similarity=0.336 Sum_probs=215.0
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC-CeEEEeeee
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKET-----RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN-PFVVTMYCS 432 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~t-----g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H-PnIVkl~~~ 432 (810)
++...++|++.+.||+|+||+||+|.++.+ ++.||||++..... ....+.+.+|+++|..++| ||||+++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 345568999999999999999999998764 36799998865433 3345678999999999966 899999998
Q ss_pred ccc-cceeeeeeeeccCcchhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCce
Q psy16843 433 FET-KKHLCLVMEYVEGGDCASLLKNT----------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNL 495 (810)
Q Consensus 433 f~~-~~~lyLVmEy~~GGsL~~lL~~~----------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNI 495 (810)
|.+ ++.+|||||||+||+|.++|++. ..+++..+..|+.||+.||+|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 865 46799999999999999999642 3489999999999999999999999999999999999
Q ss_pred EeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-
Q psy16843 496 LITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV- 574 (810)
Q Consensus 496 LLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt- 574 (810)
||+.++.+||+|||+|+..... .......+.+||+.|||||++.+..|+.++|||||||+||||++
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~-------------~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~ 283 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKD-------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 283 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTC-------------TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred eeCCCCCEEECcchhhhhcccC-------------CCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhC
Confidence 9999999999999999853211 11112245689999999999999999999999999999999998
Q ss_pred CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 575 GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 575 G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
|..||.+.+..+.+.+++.....++.+. ..++++.+||.+||+.||.+||++ .||++|
T Consensus 284 G~~Pf~~~~~~~~~~~~i~~g~~~~~p~--~~~~~~~~li~~c~~~dP~~RPt~---~eil~~ 341 (353)
T 4ase_A 284 GASPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDCWHGEPSQRPTF---SELVEH 341 (353)
T ss_dssp SCCSSTTCCCSHHHHHHHHHTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCCCCCc--cCCHHHHHHHHHHcCcChhHCcCH---HHHHHH
Confidence 9999998765444444444333333222 267999999999999999999998 888876
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=450.19 Aligned_cols=270 Identities=30% Similarity=0.472 Sum_probs=240.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH---HHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR---NQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~---~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4679999999999999999999999999999999977543221 1236788999999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC----cEEEeccCCccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG----HIKLTDFGLSKMGL 515 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g----~VKL~DFGLAk~~~ 515 (810)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999999888999999999999999999999999999999999999998877 79999999997532
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
.. ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+++..+....
T Consensus 171 ~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 234 (361)
T 2yab_A 171 DG----------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234 (361)
T ss_dssp TT----------------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred CC----------------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence 11 11245689999999999999999999999999999999999999999999999999999888
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRH 651 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~ 651 (810)
+.++......++.++++||.+||.+||.+||++ .|+++||||.+++|......
T Consensus 235 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~---~e~l~hp~~~~~~~~~~~~~ 287 (361)
T 2yab_A 235 YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTI---QEALRHPWITPVDTQQAMVR 287 (361)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH---HHHHTSTTTSCSSHHHHHHH
T ss_pred CCCCchhccCCCHHHHHHHHHHCCCChhHCcCH---HHHhcCcCcCCCchhhhhhc
Confidence 777644333478999999999999999999998 99999999999999876544
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=476.18 Aligned_cols=280 Identities=33% Similarity=0.569 Sum_probs=245.7
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+++|+.++|||||+++++|++.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 45578999999999999999999999999999999998765554455567889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+||||++||+|.+++...+ .+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~- 339 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG- 339 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC-
Confidence 9999999999999998654 4999999999999999999999999999999999999999999999999999753211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC----CHHHHHHhhccC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE----TPEELFAHTVND 594 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~----~~~e~~~~I~~~ 594 (810)
......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+. ...++...+...
T Consensus 340 ---------------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~ 404 (576)
T 2acx_A 340 ---------------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 404 (576)
T ss_dssp ---------------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC
T ss_pred ---------------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc
Confidence 0112458999999999999999999999999999999999999999875 346677777766
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhc--cCCcccCCC
Q psy16843 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRH--KAEFIPQLD 660 (810)
Q Consensus 595 ~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~--~~~f~P~~~ 660 (810)
...++.. +++++++||.+||++||.+||++. ++.|+++||||++++|+.+... .+||+|...
T Consensus 405 ~~~~p~~----~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~~ 470 (576)
T 2acx_A 405 PEEYSER----FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQ 470 (576)
T ss_dssp CCCCCTT----SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred cccCCcc----CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCcc
Confidence 6666543 789999999999999999999763 4699999999999999999865 478988754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=442.00 Aligned_cols=313 Identities=29% Similarity=0.488 Sum_probs=258.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|.+++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999999999999999998765443333345788999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~----- 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG----- 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-----
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-----
Confidence 9999 7899999988889999999999999999999999999999999999999999999999999998752211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+....+++..+......+|..
T Consensus 162 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~ 230 (336)
T 3h4j_B 162 -----------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF 230 (336)
T ss_dssp -----------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTT
T ss_pred -----------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCccc
Confidence 11235689999999999998877 789999999999999999999999877666666665555555543
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhccCCcccCCCCCccCcccchHH-hhhcCCCC
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRM-ERYNHDIG 680 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~~~f~P~~~~~~d~~~fd~~~-~~~~~~~~ 680 (810)
+++++++||.+||+.||.+||++ .|+++||||..- ......... +....+.|... ......+|
T Consensus 231 ----~s~~~~~li~~~L~~dP~~Rpt~---~eil~hp~~~~~-~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 294 (336)
T 3h4j_B 231 ----LSPGAQSLIRRMIVADPMQRITI---QEIRRDPWFNVN-LPDYLRPME--------EVQGSYADSRIVSKLGEAMG 294 (336)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCH---HHHTTCHHHHTT-CCGGGSCCC--------CCCCCCCCHHHHHHHHHTTC
T ss_pred ----CCHHHHHHHHHHcCCChhHCcCH---HHHHhChhhccC-CccccCCch--------hcccccCCHHHHHHHHHHcC
Confidence 67999999999999999999998 999999999752 222111111 11123344433 23334567
Q ss_pred CCCcccccccccCCcccchhhhhhhhhh
Q psy16843 681 EDTDETEDSFSLGTFSSCTHQYKKVQSQ 708 (810)
Q Consensus 681 ~~~~e~~d~~~~~~f~~~~~~~~~~~~~ 708 (810)
.+.+++.+.+....++..++.|..+...
T Consensus 295 ~~~~~i~~~l~~~~~~~~~~~y~ll~~~ 322 (336)
T 3h4j_B 295 FSEDYIVEALRSDENNEVKEAYNLLHEN 322 (336)
T ss_dssp CCHHHHHHHTTSSSCCSSTTHHHHHHHH
T ss_pred CCHHHHHHHHhcCCCCHHHHHHHHHHhC
Confidence 7888888899999999999999887644
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=433.58 Aligned_cols=259 Identities=32% Similarity=0.512 Sum_probs=233.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+.+|+.+++.++|||||++++++.+.+.+|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999999999999999998765433 345577889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC---cEEEeccCCcccccccccc
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g---~VKL~DFGLAk~~~~s~~~ 520 (810)
||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~--- 184 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--- 184 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC---
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC---
Confidence 9999999999999888999999999999999999999999999999999999998754 5999999998652211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+++..+..+.+.++.
T Consensus 185 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 251 (362)
T 2bdw_A 185 -------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 251 (362)
T ss_dssp -------------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred -------------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 1123467999999999999999999999999999999999999999999999999999988888776
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.....+++++++||.+||+.||.+||++ .|+++||||.+
T Consensus 252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~---~e~l~hp~~~~ 290 (362)
T 2bdw_A 252 PEWDTVTPEAKSLIDSMLTVNPKKRITA---DQALKVPWICN 290 (362)
T ss_dssp TGGGGSCHHHHHHHHHHSCSSGGGSCCH---HHHTTSHHHHT
T ss_pred ccccCCCHHHHHHHHHHcCCChhhCcCH---HHHhcCcccCC
Confidence 6555678999999999999999999998 99999999965
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=425.95 Aligned_cols=269 Identities=30% Similarity=0.477 Sum_probs=236.6
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH---HHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR---NQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~---~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 579999999999999999999999999999999876543211 12467889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC----cEEEeccCCcccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG----HIKLTDFGLSKMGLM 516 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g----~VKL~DFGLAk~~~~ 516 (810)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 9999999999999999888999999999999999999999999999999999999999887 899999999875321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
. ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 171 ~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 234 (326)
T 2y0a_A 171 G----------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234 (326)
T ss_dssp T----------------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC
T ss_pred C----------------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC
Confidence 1 012345799999999999999999999999999999999999999999999988888887766
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhc
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRH 651 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~ 651 (810)
.++......++.++++||.+||+.||.+||++ .|+++||||.+.+|......
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~e~l~hp~~~~~~~~~~~~~ 286 (326)
T 2y0a_A 235 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI---QDSLQHPWIKPKDTQQALSR 286 (326)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCH---HHHHHSTTTSCCSHHHHHHH
T ss_pred CcCccccccCCHHHHHHHHHHccCChhhCCCH---HHHhcCCCccCCcchhhhhh
Confidence 65543223367899999999999999999998 99999999999988765543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=443.74 Aligned_cols=260 Identities=30% Similarity=0.484 Sum_probs=233.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|.++.+|+.||+|++.+.... ....+.+.+|+++++.++|||||++++++.+++.+|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999998776543 344567889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc---CCcEEEeccCCcccccccccc
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA---LGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~---~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~--- 166 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--- 166 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT---
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC---
Confidence 99999999999998899999999999999999999999999999999999999984 578999999999653211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+++..+..+.+.++.
T Consensus 167 ------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 167 ------------QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 234 (444)
T ss_dssp ------------CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT
T ss_pred ------------CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc
Confidence 11123468999999999999999999999999999999999999999999999999999999888887
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.....+++++++||.+||+.||.+||++ .|+++||||.+
T Consensus 235 ~~~~~~s~~~~~li~~~L~~dP~~Rpta---~e~L~hp~~~~ 273 (444)
T 3soa_A 235 PEWDTVTPEAKDLINKMLTINPSKRITA---AEALKHPWISH 273 (444)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCH---HHHHHSCTTHH
T ss_pred cccccCCHHHHHHHHHHcCCChhHCCCH---HHHhcCccccC
Confidence 6656689999999999999999999999 99999999964
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=430.14 Aligned_cols=290 Identities=36% Similarity=0.690 Sum_probs=238.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccchh-hHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHK---ETRQRFAMKKIIKNSLM-LRNQMEQVFAERDIMSFT-DNPFVVTMYCSFET 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k---~tg~~vAIK~I~k~~~~-~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~ 435 (810)
...++|++++.||+|+||.||+|++. .+++.||||++.+.... .....+.+..|+++++.+ +||||+++++++.+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 44578999999999999999999984 58999999998654321 112224566789999988 79999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
++.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999987532
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhh--cCCCCCcchhhhHHHHHHHHhCCCCCCCC----CHHHHHH
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR--QGYGKPVDWWSMGVILYEFLVGCVPFFGE----TPEELFA 589 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--~~ys~ksDIWSLGvILyELLtG~~PF~~~----~~~e~~~ 589 (810)
... .......+||+.|+|||++.+ ..++.++|||||||+||||++|..||... ...++..
T Consensus 211 ~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 276 (355)
T 1vzo_A 211 ADE--------------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276 (355)
T ss_dssp GGG--------------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred cCC--------------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH
Confidence 111 111234679999999999986 35799999999999999999999999743 3455555
Q ss_pred hhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccC
Q psy16843 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDT 665 (810)
Q Consensus 590 ~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~ 665 (810)
.+......++.. ++..+++||.+||..||.+||++. .++|+++||||..++|..+..+. ++|.|.+.++.|.
T Consensus 277 ~~~~~~~~~~~~----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~~~d~ 352 (355)
T 1vzo_A 277 RILKSEPPYPQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDV 352 (355)
T ss_dssp HHHHCCCCCCTT----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CCC
T ss_pred HHhccCCCCCcc----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCcccccccc
Confidence 666555555443 678999999999999999999543 45999999999999999998765 5788988887777
Q ss_pred ccc
Q psy16843 666 SYF 668 (810)
Q Consensus 666 ~~f 668 (810)
++|
T Consensus 353 ~~~ 355 (355)
T 1vzo_A 353 SNF 355 (355)
T ss_dssp ---
T ss_pred ccC
Confidence 765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=426.07 Aligned_cols=257 Identities=23% Similarity=0.415 Sum_probs=229.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++.+.||+|+||.||+|.++.+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 378999999999999999999999999999999886543 2335678999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc--CCcEEEeccCCccccccccc
Q psy16843 443 MEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA--LGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~--~g~VKL~DFGLAk~~~~s~~ 519 (810)
|||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999999999999765 47999999999999999999999999999999999999997 7899999999997532110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+++..+....+.++
T Consensus 159 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 223 (321)
T 1tki_A 159 ---------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223 (321)
T ss_dssp ---------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC
T ss_pred ---------------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC
Confidence 11345799999999999998899999999999999999999999999999999999998887766
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
......++.++++||.+||..||.+||++ .|+++||||.+
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~---~e~l~hp~~~~ 263 (321)
T 1tki_A 224 EEAFKEISIEAMDFVDRLLVKERKSRMTA---SEALQHPWLKQ 263 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCH---HHHHHSHHHHS
T ss_pred hhhhccCCHHHHHHHHHHcCCChhHCcCH---HHHhcChhhcc
Confidence 43333478999999999999999999999 99999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=404.54 Aligned_cols=265 Identities=31% Similarity=0.500 Sum_probs=237.0
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 47899999999999999999999999999999998765432 34457788999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc---EEEeccCCccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~---VKL~DFGLAk~~~~s~~ 519 (810)
|||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-- 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-- 161 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--
Confidence 999999999999988889999999999999999999999999999999999999987665 999999998642211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......++
T Consensus 162 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (284)
T 3kk8_A 162 --------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 227 (284)
T ss_dssp --------------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred --------------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC
Confidence 111345799999999999999999999999999999999999999999999999999988888777
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhh
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~ 647 (810)
......+++++.+||.+||+.||.+||++ .|+++||||.+..+..
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITA---DQALKVPWICNRERVA 272 (284)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCH---HHHTTSHHHHSCCCGG
T ss_pred chhhcccCHHHHHHHHHHcccChhhCCCH---HHHhcCccccCChhHH
Confidence 66555688999999999999999999999 9999999998865543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=422.93 Aligned_cols=252 Identities=20% Similarity=0.210 Sum_probs=193.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc----ee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK----HL 439 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~----~l 439 (810)
.+|.+.+.||+|+||+||+|++ +|+.||||++..... .......|+.++..++|||||++++++.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999987 588999998865432 1122334666677899999999999997654 68
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc--------ccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY--------GIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~--------gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
|||||||+||+|.++|+. ..++++.+..++.|++.||+|||++ +||||||||+||||+.+|++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999986 4699999999999999999999987 9999999999999999999999999999
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc------CCCCCcchhhhHHHHHHHHhCCCCCCC----
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ------GYGKPVDWWSMGVILYEFLVGCVPFFG---- 581 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~------~ys~ksDIWSLGvILyELLtG~~PF~~---- 581 (810)
+....... .........+||+.|||||++.+. .|+.++|||||||+||||++|.+||..
T Consensus 156 ~~~~~~~~-----------~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~ 224 (303)
T 3hmm_A 156 VRHDSATD-----------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp EEEETTTT-----------EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred ccccCCCC-----------ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence 76322111 111122456899999999999764 367899999999999999999776532
Q ss_pred ------C-----CHHHHHHhhccCCCCCCCCCC---CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 582 ------E-----TPEELFAHTVNDDIEWPSEDD---WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 582 ------~-----~~~e~~~~I~~~~~~~p~~~~---~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
. ...++...+.......+.+.. ......+.+|+.+||+.||.+|||+ .|+++
T Consensus 225 ~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~---~ei~~ 290 (303)
T 3hmm_A 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA---LRIKK 290 (303)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCH---HHHHH
T ss_pred cccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCH---HHHHH
Confidence 1 234444445444433221111 1133568899999999999999998 67664
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=408.98 Aligned_cols=261 Identities=25% Similarity=0.432 Sum_probs=216.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|+++.+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 6899999999999999999999999999999998765432 334467889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++|+.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~------ 154 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP------ 154 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC------
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc------
Confidence 99987555555555688999999999999999999999999999999999999999999999999999753211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcC-CCCCcchhhhHHHHHHHHhCCCC-CCCCCHHHHHHhhccCCCC----
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQG-YGKPVDWWSMGVILYEFLVGCVP-FFGETPEELFAHTVNDDIE---- 597 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-ys~ksDIWSLGvILyELLtG~~P-F~~~~~~e~~~~I~~~~~~---- 597 (810)
.......+||+.|+|||++.+.. |+.++|||||||++|||++|..| |.+.+..+.+..+......
T Consensus 155 ---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~ 225 (292)
T 3o0g_A 155 ---------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp ---------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ---------cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 11123457899999999998766 89999999999999999987766 5666666666665431100
Q ss_pred -CCC--------------------CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 598 -WPS--------------------EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 598 -~p~--------------------~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
++. .....++.++++||.+||+.||++||++ +|+++||||+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~e~l~hp~f~~~ 289 (292)
T 3o0g_A 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA---EEALQHPYFSDF 289 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH---HHHHTSGGGTTC
T ss_pred hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH---HHHhcCcccccC
Confidence 000 0001267899999999999999999998 999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=443.60 Aligned_cols=259 Identities=29% Similarity=0.508 Sum_probs=233.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|.+.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 44578999999999999999999999999999999987665443344567889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--- 169 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--- 169 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT---
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc---
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998752211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
......+||+.|+|||++.+..| +.++|||||||++|||++|..||.+.+..+++.++..+.+..|
T Consensus 170 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 236 (476)
T 2y94_A 170 -------------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP 236 (476)
T ss_dssp -------------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC
T ss_pred -------------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence 11235689999999999998876 7899999999999999999999999999999999988776665
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.. +++++++||.+||+.||.+||++ .|+++||||..
T Consensus 237 ~~----~s~~~~~Li~~~L~~dP~~Rpt~---~eil~hp~~~~ 272 (476)
T 2y94_A 237 QY----LNPSVISLLKHMLQVDPMKRATI---KDIREHEWFKQ 272 (476)
T ss_dssp TT----CCHHHHHHHHHHTCSSTTTSCCH---HHHHTCHHHHT
T ss_pred cc----CCHHHHHHHHHHcCCCchhCcCH---HHHHhCHHhhh
Confidence 43 67999999999999999999999 99999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=413.23 Aligned_cols=256 Identities=28% Similarity=0.453 Sum_probs=223.4
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|++..+++.||+|++....... .+.+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 67999999999999999999999999999999987554322 356788999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++||+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------ 169 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------ 169 (297)
T ss_dssp ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST------
T ss_pred ECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc------
Confidence 999999999999874 6999999999999999999999999999999999999999999999999998653211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-CCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI-EWPSED 602 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~-~~p~~~ 602 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.......+..... .+...
T Consensus 170 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 239 (297)
T 3fxz_A 170 ---------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP- 239 (297)
T ss_dssp ---------TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCG-
T ss_pred ---------ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCc-
Confidence 1112356799999999999999999999999999999999999999999888777666654332 22211
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
..++..+++||.+||+.||.+||++ .|+++||||+..
T Consensus 240 -~~~~~~~~~li~~~l~~dp~~Rps~---~ell~h~~~~~~ 276 (297)
T 3fxz_A 240 -EKLSAIFRDFLNRCLEMDVEKRGSA---KELLQHQFLKIA 276 (297)
T ss_dssp -GGSCHHHHHHHHHHSCSSTTTSCCH---HHHTTCGGGGGC
T ss_pred -cccCHHHHHHHHHHccCChhHCcCH---HHHhhChhhccc
Confidence 2367899999999999999999998 999999999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=428.23 Aligned_cols=259 Identities=30% Similarity=0.473 Sum_probs=225.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyLV 442 (810)
++|++++.||+|+||.||+|.++.+|+.||||++.+.... ..+|++++..+ +||||+++++++.+.+.+|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 6799999999999999999999999999999998765432 23577777666 899999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC----CcEEEeccCCcccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL----GHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~----g~VKL~DFGLAk~~~~s~ 518 (810)
|||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+... +.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~- 173 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE- 173 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT-
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC-
Confidence 9999999999999988899999999999999999999999999999999999998543 35999999999753211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCC---CCHHHHHHhhccCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG---ETPEELFAHTVNDD 595 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~---~~~~e~~~~I~~~~ 595 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+ .+..+++..+..+.
T Consensus 174 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 239 (342)
T 2qr7_A 174 --------------NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239 (342)
T ss_dssp --------------TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC
T ss_pred --------------CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC
Confidence 0112356899999999999998999999999999999999999999986 56778888888888
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhh
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLL 649 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~ 649 (810)
+.++......+++++++||.+||..||.+||++ .|+++||||. +|+.+.
T Consensus 240 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~---~~il~hp~~~--~~~~~~ 288 (342)
T 2qr7_A 240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTA---ALVLRHPWIV--HWDQLP 288 (342)
T ss_dssp CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCH---HHHTTSHHHH--TGGGSC
T ss_pred cccCccccccCCHHHHHHHHHHCCCChhHCcCH---HHHhcCCeec--Cccccc
Confidence 777655445588999999999999999999998 9999999994 465543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=414.55 Aligned_cols=264 Identities=27% Similarity=0.442 Sum_probs=215.3
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++++.||+|+||.||+|++. +|+.||+|++..... .....+.+.+|+++++.++||||+++++++.+++.+|+
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 3478999999999999999999986 589999998865432 23344678899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 442 VMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||||++| +|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--- 172 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--- 172 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC---
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC---
Confidence 9999985 77777654 456999999999999999999999999999999999999999999999999999753211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC---
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI--- 596 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~--- 596 (810)
.......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+..+.....
T Consensus 173 ------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 240 (311)
T 3niz_A 173 ------------VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240 (311)
T ss_dssp ------------CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC
T ss_pred ------------cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC
Confidence 011134578999999999987 5689999999999999999999999998777666555543110
Q ss_pred --CCCC----------------CC-----CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 597 --EWPS----------------ED-----DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 597 --~~p~----------------~~-----~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
.++. .. ...+++++++||.+||++||.+||++ .|+++||||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA---RDAMNHPYFKDLDPQ 310 (311)
T ss_dssp TTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCH---HHHHTSGGGTTSCTT
T ss_pred hHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCH---HHHhcCcccccCCcc
Confidence 0000 00 01256789999999999999999998 999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=406.74 Aligned_cols=258 Identities=31% Similarity=0.537 Sum_probs=230.7
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 35578999999999999999999999999999999987765444444567889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+||||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--- 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc---
Confidence 99999999999999988889999999999999999999999999999999999999999999999999988542111
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
.....+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......+|.
T Consensus 163 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (279)
T 3fdn_A 163 --------------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 228 (279)
T ss_dssp -------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT
T ss_pred --------------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC
Confidence 113457999999999999999999999999999999999999999999999998888887776665
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
. ++.++++||.+||+.||.+||++ .|+++||||.+
T Consensus 229 ~----~~~~~~~li~~~l~~~p~~Rps~---~e~l~h~~~~~ 263 (279)
T 3fdn_A 229 F----VTEGARDLISRLLKHNPSQRPML---REVLEHPWITA 263 (279)
T ss_dssp T----SCHHHHHHHHHHCCSSGGGSCCH---HHHHHCHHHHH
T ss_pred c----CCHHHHHHHHHHhccChhhCCCH---HHHhhCccccC
Confidence 4 67899999999999999999998 99999999965
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=425.63 Aligned_cols=276 Identities=19% Similarity=0.330 Sum_probs=225.0
Q ss_pred CCCCCCcEEEEEeccc--CceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 360 TPNENDFTVIKLISNG--AYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G--~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
.+..++|++++.||+| +||.||+|+++.+|+.||||++...... ....+.+.+|+.+++.++|||||+++++|.+++
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 4556889999999999 9999999999999999999998765433 345677889999999999999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999999765 679999999999999999999999999999999999999999999999999986432
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhh--cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR--QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~ 593 (810)
...... ..........+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+..+..
T Consensus 180 ~~~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 180 SHGQRQ--------RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp ETTEEC--------SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred cccccc--------cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 211100 000111234579999999999988 6799999999999999999999999988776665555443
Q ss_pred CCCCC------------------------------------------CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCCh
Q psy16843 594 DDIEW------------------------------------------PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGP 631 (810)
Q Consensus 594 ~~~~~------------------------------------------p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~ 631 (810)
+.... .......+++++++||.+||+.||.+||++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta--- 328 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA--- 328 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH---
T ss_pred CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH---
Confidence 32210 000112267889999999999999999998
Q ss_pred hHHhcCCCcCCCChhh
Q psy16843 632 HEVKEHPYFSNLDWNS 647 (810)
Q Consensus 632 ~EiL~HPfF~~id~~~ 647 (810)
.|+++||||+++.|..
T Consensus 329 ~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 329 STLLNHSFFKQIKRRA 344 (389)
T ss_dssp HHHTTSGGGGGC---C
T ss_pred HHHhcCHHHHHHhhcc
Confidence 9999999999987643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=416.38 Aligned_cols=270 Identities=30% Similarity=0.465 Sum_probs=237.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH---HHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR---NQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~---~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3579999999999999999999999999999999876543211 1246788999999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC----cEEEeccCCccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG----HIKLTDFGLSKMGL 515 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g----~VKL~DFGLAk~~~ 515 (810)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999999888999999999999999999999999999999999999999888 79999999987532
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 171 ~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 234 (321)
T 2a2a_A 171 DG----------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234 (321)
T ss_dssp TT----------------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred cc----------------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc
Confidence 11 11234579999999999999999999999999999999999999999999999988888776
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRH 651 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~ 651 (810)
..++......++.++++||.+||..||.+||++ .|+++||||.+++|......
T Consensus 235 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~e~l~hp~~~~~~~~~~~~~ 287 (321)
T 2a2a_A 235 YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTI---QEALRHPWITPVDNQQAMVR 287 (321)
T ss_dssp CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCH---HHHHHSTTTSCSSHHHHHHH
T ss_pred cccChhhhcccCHHHHHHHHHHcCCChhhCcCH---HHHhcCccccCCCccccccc
Confidence 665532222367899999999999999999999 99999999999998876544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=417.00 Aligned_cols=262 Identities=26% Similarity=0.457 Sum_probs=219.7
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
+..++|++++.||+|+||.||+|+++.+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 3457999999999999999999999999999999998654332 22356788999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 159 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 159 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC--
Confidence 999999999999999988899999999999999999999999999999999999999999999999999997532111
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHH-HHHHhhccCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPE-ELFAHTVNDDIEW 598 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~-e~~~~I~~~~~~~ 598 (810)
........+||+.|+|||++.+..+ +.++|||||||++|||++|..||.+.... ..+..........
T Consensus 160 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 228 (323)
T 3tki_A 160 -----------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228 (323)
T ss_dssp -----------EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS
T ss_pred -----------cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC
Confidence 1111235689999999999998776 78999999999999999999999876543 2333333332222
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+. ...++.++.+||.+||+.||.+||++ .|+++||||..
T Consensus 229 ~~--~~~~~~~~~~li~~~L~~dP~~R~t~---~eil~h~~~~~ 267 (323)
T 3tki_A 229 NP--WKKIDSAPLALLHKILVENPSARITI---PDIKKDRWYNK 267 (323)
T ss_dssp TT--GGGSCHHHHHHHHHHSCSSTTTSCCH---HHHTTCTTTTC
T ss_pred Cc--cccCCHHHHHHHHHHccCChhhCcCH---HHHhhChhhcc
Confidence 22 12377899999999999999999998 99999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=426.33 Aligned_cols=263 Identities=28% Similarity=0.512 Sum_probs=224.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH--HHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR--NQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~--~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
++|++.+.||+|+||.||+|.++.+|+.||||++.+...... ...+.+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 579999999999999999999999999999999865432211 124678899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc---EEEeccCCcccc
Q psy16843 442 VMEYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMG 514 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~---VKL~DFGLAk~~ 514 (810)
|||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 9999999999888753 235999999999999999999999999999999999999987665 999999999753
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND 594 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~ 594 (810)
... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+. ..+++..+..+
T Consensus 184 ~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~ 247 (351)
T 3c0i_A 184 GES---------------GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKG 247 (351)
T ss_dssp CTT---------------SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHT
T ss_pred cCC---------------CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcC
Confidence 211 11123567999999999999999999999999999999999999999875 45667777776
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 595 ~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
.+.++......++.++++||.+||+.||.+||++ .|+++||||.+.++
T Consensus 248 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~---~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 248 KYKMNPRQWSHISESAKDLVRRMLMLDPAERITV---YEALNHPWLKERDR 295 (351)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH---HHHHTSHHHHTHHH
T ss_pred CCCCCccccccCCHHHHHHHHHHCCCChhHCcCH---HHHhcChhhcCCcc
Confidence 6655432222378999999999999999999998 99999999986543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=409.52 Aligned_cols=259 Identities=36% Similarity=0.609 Sum_probs=219.7
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhh-----------------------HHHHHHHHHHHHHH
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML-----------------------RNQMEQVFAERDIM 418 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~-----------------------~~~~~~i~~E~~iL 418 (810)
..++|++.+.||+|+||.||+|+++.+++.||||++.+..... ....+.+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3478999999999999999999999999999999987654321 12235688999999
Q ss_pred hcCCCCeEEEeeeeccc--cceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceE
Q psy16843 419 SFTDNPFVVTMYCSFET--KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLL 496 (810)
Q Consensus 419 ~~l~HPnIVkl~~~f~~--~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNIL 496 (810)
+.++||||+++++++.+ .+.+|+||||+++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99999999999999986 5689999999999999987654 68999999999999999999999999999999999999
Q ss_pred eccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcC---CCCCcchhhhHHHHHHHH
Q psy16843 497 ITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG---YGKPVDWWSMGVILYEFL 573 (810)
Q Consensus 497 Ld~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~---ys~ksDIWSLGvILyELL 573 (810)
++.+|.+||+|||+++...... ......+||+.|+|||++.+.. ++.++|||||||++|||+
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSD---------------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSS---------------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred ECCCCCEEEecCCCcccccccc---------------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 9999999999999987532110 0113457999999999998765 378899999999999999
Q ss_pred hCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 574 VGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 574 tG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
+|..||.+.........+......++... .+++++++||.+||+.||.+||++ .|+++||||.
T Consensus 235 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~R~s~---~e~l~hp~~~ 297 (298)
T 2zv2_A 235 FGQCPFMDERIMCLHSKIKSQALEFPDQP--DIAEDLKDLITRMLDKNPESRIVV---PEIKLHPWVT 297 (298)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSSS--CCCHHHHHHHHHHTCSCTTTSCCH---HHHTTCHHHH
T ss_pred HCCCCCCCccHHHHHHHHhcccCCCCCcc--ccCHHHHHHHHHHhhcChhhCCCH---HHHhcCcccc
Confidence 99999999998888888877766665432 377999999999999999999998 9999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=425.89 Aligned_cols=261 Identities=28% Similarity=0.420 Sum_probs=230.7
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||+|+||.||+|.++.+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 3689999999999999999999999999999999876532 2335688999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc--CCcEEEeccCCccccccccc
Q psy16843 443 MEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA--LGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~--~g~VKL~DFGLAk~~~~s~~ 519 (810)
|||+.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+++.....
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 204 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC--
Confidence 9999999999999765 47999999999999999999999999999999999999984 478999999999753211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+..+......++
T Consensus 205 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 270 (387)
T 1kob_A 205 --------------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270 (387)
T ss_dssp --------------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred --------------cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 011235799999999999999999999999999999999999999999999999888888776666
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
......+++++++||.+||+.||.+||++ .|+++||||.+..+
T Consensus 271 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~---~ell~hp~~~~~~~ 313 (387)
T 1kob_A 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTV---HDALEHPWLKGDHS 313 (387)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCH---HHHHTSTTTSSCCT
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCH---HHHhhCccccCCcc
Confidence 55444578999999999999999999998 99999999987543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=416.66 Aligned_cols=265 Identities=24% Similarity=0.404 Sum_probs=216.5
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|+++.+++.||||++..... .....+.+.+|+++++.++||||+++++++.+++.+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345789999999999999999999999999999998865532 2333456778999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEec-----cCCcEEEeccCCccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLIT-----ALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd-----~~g~VKL~DFGLAk~~~ 515 (810)
+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+ ..+.+||+|||+++...
T Consensus 110 lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999997 49999999888999999999999999999999999999999999999994 45569999999986421
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND 594 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~ 594 (810)
.. .......+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.+..+.+..+...
T Consensus 189 ~~---------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 253 (329)
T 3gbz_A 189 IP---------------IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253 (329)
T ss_dssp --------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred Cc---------------ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence 11 0111345789999999999875 4899999999999999999999999999888877776542
Q ss_pred CCCCCCCCCC---------------------------cccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 595 DIEWPSEDDW---------------------------PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 595 ~~~~p~~~~~---------------------------~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
... +....+ .+++++++||.+||+.||.+||++ .|+++||||++.+|+
T Consensus 254 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 254 LGL-PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA---KNALEHPYFSHNDFD 328 (329)
T ss_dssp HCC-CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH---HHHHTSGGGSSSCSC
T ss_pred hCC-CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH---HHHhCCcccCCCCCC
Confidence 111 110000 156889999999999999999998 999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=418.60 Aligned_cols=258 Identities=33% Similarity=0.514 Sum_probs=214.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++.+.||+|+||.||+|+++.+++.||||++.+.. ..+.+.+|+++++.++||||+++++++.+.+.+|+|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 367999999999999999999999999999999887542 235677899999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc---CCcEEEeccCCccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA---LGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~---~g~VKL~DFGLAk~~~~s~~ 519 (810)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-- 204 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-- 204 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--
Confidence 999999999999998889999999999999999999999999999999999999975 889999999998752111
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHH-HHHhhccCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE-LFAHTVNDDIEW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e-~~~~I~~~~~~~ 598 (810)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+....+ ++..+......+
T Consensus 205 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~ 270 (349)
T 2w4o_A 205 --------------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF 270 (349)
T ss_dssp ----------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC
T ss_pred --------------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc
Confidence 11134679999999999999999999999999999999999999998765544 667777776665
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
+......++.++++||.+||+.||.+||++ .|+++||||.+..
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTT---FQALQHPWVTGKA 313 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCH---HHHHHSTTTTSTT
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCH---HHHhcCcccCCCc
Confidence 554444578999999999999999999999 9999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=416.75 Aligned_cols=268 Identities=29% Similarity=0.484 Sum_probs=227.2
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh--hHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM--LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~--~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
++|++++.||+|+||.||+|.++.+++.||+|++.+.... .....+.+.+|+++++.++||||+++++++.+.+.+|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5799999999999999999999999999999998765332 23445778999999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhc----------------------------------------CCCCCHHHHHHHHHHHHHHHHHhh
Q psy16843 442 VMEYVEGGDCASLLKN----------------------------------------TGPLPADMARFYFAETVLAVEYLH 481 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~----------------------------------------~g~lse~~~~~i~~QIl~AL~yLH 481 (810)
||||++||+|.+++.. ...+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999852 112467889999999999999999
Q ss_pred hcccccccCCCCceEeccCC--cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh--cCCC
Q psy16843 482 SYGIVHRDLKPDNLLITALG--HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR--QGYG 557 (810)
Q Consensus 482 s~gIIHRDLKPeNILLd~~g--~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--~~ys 557 (810)
++||+||||||+||||+.++ .+||+|||+++....... .........+||+.|+|||++.+ ..|+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN-----------GEYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC-----------C--------CCCGGGCCHHHHTCSSSCCC
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCc-----------cccccccccCCCccccCchhhccCCCCCC
Confidence 99999999999999998777 899999999975321110 11112245679999999999976 6789
Q ss_pred CCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 558 KPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 558 ~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.++|||||||++|||++|..||.+.+..+....+......++......+++++++||.+||+.||.+||++ .|+++|
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~~~l~h 331 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA---MRALQH 331 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH---HHHHHS
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCH---HHHhcC
Confidence 99999999999999999999999999999999988887776655444478999999999999999999998 999999
Q ss_pred CCcCCCCh
Q psy16843 638 PYFSNLDW 645 (810)
Q Consensus 638 PfF~~id~ 645 (810)
|||+++.|
T Consensus 332 p~~~~~~~ 339 (345)
T 3hko_A 332 PWISQFSD 339 (345)
T ss_dssp HHHHTTSS
T ss_pred hhhccChH
Confidence 99988654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=402.73 Aligned_cols=258 Identities=31% Similarity=0.551 Sum_probs=231.7
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+++++.++||||+++++++.+.+.+|
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 44578999999999999999999999999999999987654433333467889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~---- 166 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS---- 166 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS----
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc----
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999854211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
......+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......+|.
T Consensus 167 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T 2vgo_A 167 -------------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP 233 (284)
T ss_dssp -------------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT
T ss_pred -------------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC
Confidence 1123457999999999999999999999999999999999999999999998888888887776664
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
. ++.++++||.+||..||.+||++ .|+++||||..
T Consensus 234 ~----~~~~~~~li~~~l~~~p~~Rps~---~~ll~h~~~~~ 268 (284)
T 2vgo_A 234 F----LSDGSKDLISKLLRYHPPQRLPL---KGVMEHPWVKA 268 (284)
T ss_dssp T----SCHHHHHHHHHHSCSSGGGSCCH---HHHHTCHHHHH
T ss_pred c----CCHHHHHHHHHHhhcCHhhCCCH---HHHhhCHHHHh
Confidence 3 67899999999999999999998 99999999964
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=432.88 Aligned_cols=284 Identities=24% Similarity=0.345 Sum_probs=207.0
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecc-----ccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE-----TKK 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~-----~~~ 437 (810)
.++|++++.||+|+||.||+|+++.+++.||||++.+.. ......+.+.+|+++|+.++|||||++++++. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 478999999999999999999999999999999986543 23445678899999999999999999999984 346
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.+|+||||+ +|+|.+++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 799999998 5799999998889999999999999999999999999999999999999999999999999999864321
Q ss_pred ccccchh------------hhhhcccccccCCcccCCCCcCChhHHh-hcCCCCCcchhhhHHHHHHHHh----------
Q psy16843 518 LATNLYE------------CYVERDAKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLV---------- 574 (810)
Q Consensus 518 ~~~~~~~------------~~~~~~~~~~~~~~~~GTp~YmAPEvl~-~~~ys~ksDIWSLGvILyELLt---------- 574 (810)
....... .+.............+||++|+|||++. +..|+.++||||||||||||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 1100000 0000000001224568999999999875 5679999999999999999998
Q ss_pred -CCCCCCCCCH--------------------HHHHHhhcc---CC-----------------CCCCCC-------CCCcc
Q psy16843 575 -GCVPFFGETP--------------------EELFAHTVN---DD-----------------IEWPSE-------DDWPI 606 (810)
Q Consensus 575 -G~~PF~~~~~--------------------~e~~~~I~~---~~-----------------~~~p~~-------~~~~~ 606 (810)
|.++|.+.+. .+.+..|.. .. ..++.. .....
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 7788876542 111111111 00 000000 01125
Q ss_pred cHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhc
Q psy16843 607 QVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRH 651 (810)
Q Consensus 607 S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~ 651 (810)
++++++||.+||++||.+|||+ +|+|+||||.+++|......
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~---~e~L~Hp~f~~~~~~~~e~~ 411 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITI---NECLAHPFFKEVRIAEVETN 411 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCH---HHHHHSGGGTTTCCGGGCCC
T ss_pred CHHHHHHHHHHhccCccccCCH---HHHhcCHhhhhcCCCccCCC
Confidence 7899999999999999999998 99999999999999876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=403.92 Aligned_cols=259 Identities=27% Similarity=0.443 Sum_probs=213.5
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|++ .+|+.||+|++...... ....+.+.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 67899999998654322 222356778999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||+.+ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 153 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP----- 153 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc-----
Confidence 99975 888888753 78999999999999999999999999999999999999999999999999998642110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-----C
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD-----I 596 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~-----~ 596 (810)
.......+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+..+.... .
T Consensus 154 ----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (288)
T 1ob3_A 154 ----------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223 (288)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ----------ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChh
Confidence 0011245789999999999874 58999999999999999999999999988877766654310 0
Q ss_pred CCCC--------------------CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 597 EWPS--------------------EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 597 ~~p~--------------------~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.++. .....+++++++||.+||+.||.+||++ .|+++||||++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~e~l~hp~f~~~ 287 (288)
T 1ob3_A 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA---KQALEHAYFKEN 287 (288)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH---HHHHTSGGGGC-
T ss_pred hchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH---HHHhcCcchhhc
Confidence 0000 0001267899999999999999999998 999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=425.43 Aligned_cols=274 Identities=28% Similarity=0.456 Sum_probs=211.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccc--eee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKK--HLC 440 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~--~ly 440 (810)
++|++++.||+|+||.||+|.++.+|+.||||++.+.. ......+.+.+|+.+++.+. ||||+++++++...+ .+|
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 68999999999999999999999999999999986542 23445577889999999997 999999999997544 799
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+|||||+ |+|..++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+........
T Consensus 88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 9999997 589998876 58999999999999999999999999999999999999999999999999999753221100
Q ss_pred c-chhhhh-----hcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy16843 521 N-LYECYV-----ERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593 (810)
Q Consensus 521 ~-~~~~~~-----~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~ 593 (810)
. ...... ............+||++|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 0 000000 00001112245689999999999987 6799999999999999999999999999998888777753
Q ss_pred CCCCCCCCC--------------------------------------------CCcccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 594 DDIEWPSED--------------------------------------------DWPIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 594 ~~~~~p~~~--------------------------------------------~~~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
. +..|... ....++++++||.+||+.||.+|||+
T Consensus 246 ~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~- 323 (388)
T 3oz6_A 246 V-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA- 323 (388)
T ss_dssp H-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH-
T ss_pred h-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH-
Confidence 1 1111100 01257899999999999999999998
Q ss_pred ChhHHhcCCCcCCCC
Q psy16843 630 GPHEVKEHPYFSNLD 644 (810)
Q Consensus 630 ~~~EiL~HPfF~~id 644 (810)
.|+++||||..+.
T Consensus 324 --~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 324 --NDALKHPFVSIFH 336 (388)
T ss_dssp --HHHTTSTTTTTTC
T ss_pred --HHHhCCHHHHHhc
Confidence 9999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=440.60 Aligned_cols=262 Identities=29% Similarity=0.467 Sum_probs=234.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+++.++|||||++++++.+.+.+|+||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67999999999999999999999999999999987665443444577889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe---ccCCcEEEeccCCcccccccccc
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI---TALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL---d~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-- 183 (484)
T 3nyv_A 106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-- 183 (484)
T ss_dssp CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC--
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc--
Confidence 999999999999988999999999999999999999999999999999999999 467899999999986532110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+..+.+.++.
T Consensus 184 --------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 248 (484)
T 3nyv_A 184 --------------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL 248 (484)
T ss_dssp --------------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred --------------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 1124579999999999976 6999999999999999999999999999999999999988877765
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
+....+++++++||.+||++||.+||++ .|+++||||....+
T Consensus 249 ~~~~~~s~~~~~li~~~L~~dp~~R~s~---~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 249 PQWKKVSESAKDLIRKMLTYVPSMRISA---RDALDHEWIQTYTK 290 (484)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSGGGSCCH---HHHHTSHHHHHHTC
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCH---HHHhhChhhccccc
Confidence 5445588999999999999999999999 99999999986544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=402.52 Aligned_cols=267 Identities=27% Similarity=0.436 Sum_probs=219.5
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 689999999999999999999999999999998866543 2334567889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS----- 156 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-----
Confidence 999999999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC--------
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND-------- 594 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~-------- 594 (810)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 157 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
T 4agu_A 157 ----------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226 (311)
T ss_dssp -------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ----------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccc
Confidence 01134579999999999987 67899999999999999999999999998877666554321
Q ss_pred -----------CCCCCCCCC--------CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhh
Q psy16843 595 -----------DIEWPSEDD--------WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLL 649 (810)
Q Consensus 595 -----------~~~~p~~~~--------~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~ 649 (810)
....+.... ..++.++.+||.+||+.||.+||++ .|+++||||+++.+....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~hp~f~~~~~~~~~ 297 (311)
T 4agu_A 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC---EQLLHHPYFENIREIEDL 297 (311)
T ss_dssp HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCH---HHHHTSGGGTTCC-----
T ss_pred ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCH---HHHhcChHHHhccCHHHH
Confidence 111111110 1367889999999999999999998 999999999998765433
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=418.95 Aligned_cols=257 Identities=33% Similarity=0.535 Sum_probs=214.6
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|+++.+++.||||++.+..... +.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 34578999999999999999999999999999999987654322 45778999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc--EEEeccCCcccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH--IKLTDFGLSKMGLMSL 518 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~--VKL~DFGLAk~~~~s~ 518 (810)
+||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||+++.....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999999999988889999999999999999999999999999999999999988765 999999998642111
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCC-cchhhhHHHHHHHHhCCCCCCCCCH----HHHHHhhcc
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKP-VDWWSMGVILYEFLVGCVPFFGETP----EELFAHTVN 593 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~k-sDIWSLGvILyELLtG~~PF~~~~~----~e~~~~I~~ 593 (810)
......+||+.|+|||++.+..|..+ +|||||||++|+|++|..||.+... ...+..+..
T Consensus 172 ---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 236 (361)
T 3uc3_A 172 ---------------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS 236 (361)
T ss_dssp ------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT
T ss_pred ---------------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc
Confidence 11134579999999999998888655 8999999999999999999987543 456666666
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 594 ~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
....+|... .+++++++||.+||++||.+||++ .|+++||||..
T Consensus 237 ~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rps~---~ell~hp~f~~ 280 (361)
T 3uc3_A 237 VKYSIPDDI--RISPECCHLISRIFVADPATRISI---PEIKTHSWFLK 280 (361)
T ss_dssp TCCCCCTTS--CCCHHHHHHHHHHSCSCTTTSCCH---HHHHTSHHHHT
T ss_pred CCCCCCCcC--CCCHHHHHHHHHHccCChhHCcCH---HHHHhCcchhc
Confidence 666665432 378999999999999999999998 99999999954
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=400.41 Aligned_cols=269 Identities=28% Similarity=0.443 Sum_probs=232.8
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeecc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNS------LMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFE 434 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~------~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~ 434 (810)
..++|++.+.||+|+||.||+|.++.+|+.||||++.... .......+.+.+|+++++.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999999999999999986543 112233467889999999995 999999999999
Q ss_pred ccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccc
Q psy16843 435 TKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514 (810)
Q Consensus 435 ~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~ 514 (810)
+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999998652
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHh------hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHH
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL------RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELF 588 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~------~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~ 588 (810)
... ......+||+.|+|||++. ...++.++||||||+++|+|++|..||.+.+..+..
T Consensus 175 ~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 238 (298)
T 1phk_A 175 DPG----------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238 (298)
T ss_dssp CTT----------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCC----------------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH
Confidence 211 0113457999999999996 346899999999999999999999999999999888
Q ss_pred HhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhh
Q psy16843 589 AHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLL 649 (810)
Q Consensus 589 ~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~ 649 (810)
..+......++......++.++.+||.+||+.||.+||++ .|+++||||.+..|+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 239 RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA---EEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH---HHHTTSGGGCTTC-----
T ss_pred HHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCH---HHHHhChHhhhccchhhc
Confidence 8888877776655444578899999999999999999998 999999999998877653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=412.63 Aligned_cols=264 Identities=27% Similarity=0.440 Sum_probs=206.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||+|+||.||+|.++.+|+.||+|++..... ....+.+.+|+++++.++||||+++++++.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 3689999999999999999999999999999999875432 12235677899999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcC------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 443 MEYVEGGDCASLLKNT------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
|||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99998 5899888643 3599999999999999999999999999999999999999999999999999875321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
. .......+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.+..+.+..+....
T Consensus 161 ~---------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 225 (317)
T 2pmi_A 161 P---------------VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225 (317)
T ss_dssp C---------------CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred C---------------cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 1 0112345799999999999874 68999999999999999999999999998887777664310
Q ss_pred CC-----C-------------C------------CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 596 IE-----W-------------P------------SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 596 ~~-----~-------------p------------~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
.. + + ......++.++++||.+||+.||.+||++ .|+++||||.+..|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~---~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA---KQALHHPWFAEYYH 302 (317)
T ss_dssp CSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH---HHHTTSGGGGGGCC
T ss_pred CCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH---HHHhCChhhhcccc
Confidence 00 0 0 00011367899999999999999999998 99999999988765
Q ss_pred hh
Q psy16843 646 NS 647 (810)
Q Consensus 646 ~~ 647 (810)
..
T Consensus 303 ~~ 304 (317)
T 2pmi_A 303 HA 304 (317)
T ss_dssp --
T ss_pred hh
Confidence 53
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=409.38 Aligned_cols=267 Identities=27% Similarity=0.467 Sum_probs=231.2
Q ss_pred CCcEEE-EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeee
Q psy16843 364 NDFTVI-KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 364 ~dy~il-k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyL 441 (810)
+.|.+. +.||+|+||.||+|+++.+++.||+|++.+..... .....+.+|+.++..+ .||||+++++++.+.+.+|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 468887 89999999999999999999999999987654322 2345678899999888 56999999999999999999
Q ss_pred eeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc---CCcEEEeccCCcccccc
Q psy16843 442 VMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA---LGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~---~g~VKL~DFGLAk~~~~ 516 (810)
||||+.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++. +|.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999999643 67999999999999999999999999999999999999998 78999999999975321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
. ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+..+.....
T Consensus 187 ~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 250 (327)
T 3lm5_A 187 A----------------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV 250 (327)
T ss_dssp -----------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred c----------------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc
Confidence 1 011345799999999999999999999999999999999999999999999998888887776
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhh
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLR 650 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~ 650 (810)
.++......++.++++||.+||+.||.+||++ +|+++||||++++|+.+..
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~~ll~h~~~~~~~~~~~~~ 301 (327)
T 3lm5_A 251 DYSEETFSSVSQLATDFIQSLLVKNPEKRPTA---EICLSHSWLQQWDFENLFH 301 (327)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCH---HHHTTCGGGCCCCTTCC--
T ss_pred ccCchhhcccCHHHHHHHHHHcCCChhhCcCH---HHHhCCHhhcccccccccC
Confidence 66665555688999999999999999999998 9999999999999986643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=399.73 Aligned_cols=259 Identities=34% Similarity=0.564 Sum_probs=202.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999999999999999998765443333456788999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--- 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC---
Confidence 9999999999999865 679999999999999999999999999999999999999999999999999987532110
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
......+||+.|+|||++.+..++.++||||||+++|||++|..||......+.+..+....+..|..
T Consensus 167 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (278)
T 3cok_A 167 ------------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSF 234 (278)
T ss_dssp -------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTT
T ss_pred ------------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccc
Confidence 01124579999999999999999999999999999999999999999877766666666655555433
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
++.++.+||.+||+.||.+||++ .|+++||||.+.
T Consensus 235 ----~~~~~~~li~~~l~~dp~~Rps~---~~~l~h~~~~~~ 269 (278)
T 3cok_A 235 ----LSIEAKDLIHQLLRRNPADRLSL---SSVLDHPFMSRN 269 (278)
T ss_dssp ----SCHHHHHHHHHHSCSSGGGSCCH---HHHTTSTTTC--
T ss_pred ----cCHHHHHHHHHHcccCHhhCCCH---HHHhcCccccCC
Confidence 67899999999999999999998 999999999763
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=432.59 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=211.9
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc------
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK------ 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~------ 436 (810)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+.+.+|+.+|+.++|||||+++++|...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 368999999999999999999999999999999987653 2344567888999999999999999999998654
Q ss_pred ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
..+||||||++++ |...+.. .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+....
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 4679999999765 6666643 499999999999999999999999999999999999999999999999999975321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
. ......+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+.+.+|+....
T Consensus 217 ~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg 280 (464)
T 3ttj_A 217 S----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280 (464)
T ss_dssp C----------------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred C----------------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 1 112356899999999999999999999999999999999999999999988877777654210
Q ss_pred C-------------------CCCCCCC-------------------cccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCC
Q psy16843 597 E-------------------WPSEDDW-------------------PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHP 638 (810)
Q Consensus 597 ~-------------------~p~~~~~-------------------~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HP 638 (810)
. .+..... ..++++++||.+||++||.+||++ +|+++||
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta---~e~L~Hp 357 (464)
T 3ttj_A 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV---DDALQHP 357 (464)
T ss_dssp SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH---HHHHTST
T ss_pred CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH---HHHhcCh
Confidence 0 0000000 015679999999999999999998 9999999
Q ss_pred CcCC
Q psy16843 639 YFSN 642 (810)
Q Consensus 639 fF~~ 642 (810)
||..
T Consensus 358 ~~~~ 361 (464)
T 3ttj_A 358 YINV 361 (464)
T ss_dssp TTGG
T ss_pred hhhh
Confidence 9985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=408.36 Aligned_cols=272 Identities=29% Similarity=0.437 Sum_probs=218.3
Q ss_pred CCCcEEE-EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhc-CCCCeEEEeeeeccccceee
Q psy16843 363 ENDFTVI-KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF-TDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 363 ~~dy~il-k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~-l~HPnIVkl~~~f~~~~~ly 440 (810)
.+.|++. +.||+|+||.||+|+++.+++.||||++.+... ...+.+.+|++++.. .+||||+++++++.+++.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4679995 789999999999999999999999999876532 223567889999988 57999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc---EEEeccCCccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMS 517 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~---VKL~DFGLAk~~~~s 517 (810)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999988889999999999999999999999999999999999999998776 999999998753211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhh-----cCCCCCcchhhhHHHHHHHHhCCCCCCCCC---------
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-----QGYGKPVDWWSMGVILYEFLVGCVPFFGET--------- 583 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----~~ys~ksDIWSLGvILyELLtG~~PF~~~~--------- 583 (810)
.... ..........+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+..
T Consensus 168 ~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 168 GDCS--------PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp ----------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred Cccc--------cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 1000 000111234579999999999986 568999999999999999999999998764
Q ss_pred ------HHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhh
Q psy16843 584 ------PEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSL 648 (810)
Q Consensus 584 ------~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l 648 (810)
...++..+....+.++......++.++++||.+||+.||.+||++ .|+++||||.+..+...
T Consensus 240 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~---~e~l~hp~~~~~~~~~~ 307 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA---AQVLQHPWVQGCAPENT 307 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH---HHHHHSTTCC-------
T ss_pred ccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCH---HHHhcChhhcCCCCccc
Confidence 245666777776666543222367899999999999999999998 99999999998766543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=399.18 Aligned_cols=256 Identities=31% Similarity=0.509 Sum_probs=228.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++.+.||+|+||.||+|.++.++..||+|++.+.... ..+.+.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 5799999999999999999999999999999998765432 2467888999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe---ccCCcEEEeccCCcccccccccc
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI---TALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL---d~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~--- 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--- 162 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT---
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc---
Confidence 999999999999888889999999999999999999999999999999999999 77899999999998652211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
......+||+.|+|||++.+. ++.++||||||+++|||++|..||.+.+..+....+......++.
T Consensus 163 -------------~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (277)
T 3f3z_A 163 -------------KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE 228 (277)
T ss_dssp -------------SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred -------------cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 112345799999999998765 999999999999999999999999999999999998888777665
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.....+++++.+||.+||+.||.+||++ .|+++||||.+
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~---~~~l~h~~~~~ 267 (277)
T 3f3z_A 229 KDWLNVSPQAESLIRRLLTKSPKQRITS---LQALEHEWFEK 267 (277)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCH---HHHTTSHHHHH
T ss_pred hhhhcCCHHHHHHHHHHccCChhhCcCH---HHHhcCHHHhc
Confidence 4333467999999999999999999998 99999999965
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=414.79 Aligned_cols=256 Identities=30% Similarity=0.488 Sum_probs=204.0
Q ss_pred CCcEEE---EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeecccccee
Q psy16843 364 NDFTVI---KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKKHL 439 (810)
Q Consensus 364 ~dy~il---k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~~l 439 (810)
++|++. +.||+|+||.||+|.++.+++.||||++.+.. ...+.+|+.+++.+. ||||+++++++.++..+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 346664 78999999999999999999999999986542 245668999999997 99999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC---cEEEeccCCcccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLM 516 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g---~VKL~DFGLAk~~~~ 516 (810)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999999999999989999999999999999999999999999999999999998766 899999999975221
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC-------HHHHHH
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET-------PEELFA 589 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~-------~~e~~~ 589 (810)
. .......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+ ..+++.
T Consensus 162 ~---------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 226 (325)
T 3kn6_A 162 D---------------NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 226 (325)
T ss_dssp -------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH
T ss_pred C---------------CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH
Confidence 1 111235679999999999999999999999999999999999999998643 357778
Q ss_pred hhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 590 ~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.+..+.+.++......+++++++||.+||+.||.+||++ .|+++||||.+.
T Consensus 227 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~---~ell~h~w~~~~ 277 (325)
T 3kn6_A 227 KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKM---SGLRYNEWLQDG 277 (325)
T ss_dssp HHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCT---TTSTTCGGGCTT
T ss_pred HHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCH---HHHhcChhhccC
Confidence 888777766544333478999999999999999999999 899999999763
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=398.78 Aligned_cols=260 Identities=29% Similarity=0.467 Sum_probs=233.6
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|.+.+.||+|+||.||+|.++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34789999999999999999999999999999999877655555666788899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 168 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---- 168 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST----
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC----
Confidence 9999999999999988889999999999999999999999999999999999999999999999999998753211
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
.......+||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+.+..+......+|..
T Consensus 169 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T 2rku_A 169 -----------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 237 (294)
T ss_dssp -----------TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTT
T ss_pred -----------ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccc
Confidence 011234579999999999999999999999999999999999999999999888888888777666543
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
++.++.+||.+||+.||.+||++ .|+++||||.+.
T Consensus 238 ----~~~~~~~li~~~l~~~p~~Rps~---~~ll~~~~~~~~ 272 (294)
T 2rku_A 238 ----INPVAASLIQKMLQTDPTARPTI---NELLNDEFFTSG 272 (294)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCG---GGGGGSHHHHTS
T ss_pred ----cCHHHHHHHHHHcccChhhCcCH---HHHhhChheecC
Confidence 67899999999999999999999 999999999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=410.61 Aligned_cols=265 Identities=25% Similarity=0.385 Sum_probs=223.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce----
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH---- 438 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~---- 438 (810)
.++|++++.||+|+||.||+|+++.+++.||||++...........+.+.+|+++++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4789999999999999999999999999999999977655555666788999999999999999999999876653
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 49999999999999999988899999999999999999999999999999999999999999999999999987532211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
. ........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....+.......
T Consensus 171 ~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 171 N------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238 (311)
T ss_dssp -----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred c------------ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC
Confidence 0 0111234679999999999999999999999999999999999999999999888877777655443
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+......++.++.+||.+||+.||.+||++ .+++.|+|++.
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~---~~~l~~~l~~~ 279 (311)
T 3ork_A 239 PSARHEGLSADLDAVVLKALAKNPENRYQT---AAEMRADLVRV 279 (311)
T ss_dssp HHHHSTTCCHHHHHHHHHHTCSSGGGSCSS---HHHHHHHHHHH
T ss_pred cccccCCCCHHHHHHHHHHHhcCHhhChhh---HHHHHHHHHHH
Confidence 322222367899999999999999999999 89999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=407.85 Aligned_cols=260 Identities=29% Similarity=0.467 Sum_probs=234.0
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|.+.+.||+|+||.||+++++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34689999999999999999999999999999999887655555666788999999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---- 194 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---- 194 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST----
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC----
Confidence 9999999999999988889999999999999999999999999999999999999999999999999998753211
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+....+.+..+......++..
T Consensus 195 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 263 (335)
T 2owb_A 195 -----------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 263 (335)
T ss_dssp -----------TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTT
T ss_pred -----------cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCcc
Confidence 011234679999999999999999999999999999999999999999999888888888777666643
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
++.++.+||.+||+.||.+||++ .|+++||||...
T Consensus 264 ----~~~~~~~li~~~l~~dp~~Rps~---~ell~~~~~~~~ 298 (335)
T 2owb_A 264 ----INPVAASLIQKMLQTDPTARPTI---NELLNDEFFTSG 298 (335)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCG---GGGGGSHHHHTS
T ss_pred ----CCHHHHHHHHHHccCChhHCcCH---HHHhcCccccCC
Confidence 67899999999999999999999 999999999763
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=402.73 Aligned_cols=261 Identities=28% Similarity=0.451 Sum_probs=211.4
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhh--HHHHHHHHHHHHHHhcC---CCCeEEEeeeeccccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML--RNQMEQVFAERDIMSFT---DNPFVVTMYCSFETKK 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~--~~~~~~i~~E~~iL~~l---~HPnIVkl~~~f~~~~ 437 (810)
.++|++++.||+|+||.||+|+++.+++.||||++....... ......+.+|+.+++.+ +||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 478999999999999999999999999999999986533211 01112344566666555 5999999999987654
Q ss_pred -----eeeeeeeeccCcchhhhhhcCCC--CCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCC
Q psy16843 438 -----HLCLVMEYVEGGDCASLLKNTGP--LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGL 510 (810)
Q Consensus 438 -----~lyLVmEy~~GGsL~~lL~~~g~--lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGL 510 (810)
.+|+||||+. |+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 6899999997 599999986644 99999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~ 590 (810)
++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..
T Consensus 167 a~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 230 (308)
T 3g33_A 167 ARIYSYQ----------------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 230 (308)
T ss_dssp TTTSTTC----------------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH
T ss_pred ccccCCC----------------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 8752111 112346799999999999999999999999999999999999999999998888777
Q ss_pred hccCCC-----CCCCCC------------------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 591 TVNDDI-----EWPSED------------------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 591 I~~~~~-----~~p~~~------------------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
+..... .|+... ...+++++.+||.+||++||.+||++ .|+++||||...
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~e~l~h~~~~~~ 303 (308)
T 3g33_A 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA---FRALQHSYLHKD 303 (308)
T ss_dssp HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH---HHHHTSTTC---
T ss_pred HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH---HHHhcCccccCC
Confidence 754211 111100 01267889999999999999999999 999999999763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=424.78 Aligned_cols=254 Identities=31% Similarity=0.512 Sum_probs=212.2
Q ss_pred CCCCcEEE-EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHH-hcCCCCeEEEeeeeccc----
Q psy16843 362 NENDFTVI-KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVTMYCSFET---- 435 (810)
Q Consensus 362 ~~~dy~il-k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL-~~l~HPnIVkl~~~f~~---- 435 (810)
..++|.+. +.||+|+||+||+|.++.+|+.||||++... ..+.+|+.++ +..+||||++++++|..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 34678887 7899999999999999999999999988643 2345677776 55699999999998875
Q ss_pred cceeeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc---CCcEEEeccCC
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA---LGHIKLTDFGL 510 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~---~g~VKL~DFGL 510 (810)
...+|||||||.||+|.+++...+ .+++..++.|+.||+.||+|||++||+||||||+||||+. ++.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 678999999999999999998654 5999999999999999999999999999999999999998 78999999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH----H
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE----E 586 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~----e 586 (810)
++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.... .
T Consensus 211 a~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 274 (400)
T 1nxk_A 211 AKETTSH----------------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 274 (400)
T ss_dssp CEECC---------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS
T ss_pred ccccCCC----------------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH
Confidence 9752211 1123568999999999999999999999999999999999999999876542 2
Q ss_pred HHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 587 LFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 587 ~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+...+..+.+.++......++.++++||.+||+.||.+||++ .|+++||||.+
T Consensus 275 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~---~eil~hp~~~~ 327 (400)
T 1nxk_A 275 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI---TEFMNHPWIMQ 327 (400)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCH---HHHHHSHHHHT
T ss_pred HHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCH---HHHhcCccccC
Confidence 455666677776665545588999999999999999999998 99999999965
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=435.35 Aligned_cols=260 Identities=27% Similarity=0.480 Sum_probs=229.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|+++.+++.||||++.+.... ......+.+|+++|+.++|||||++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 6799999999999999999999999999999998764322 223467889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEec---cCCcEEEeccCCcccccccccc
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLIT---ALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd---~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
|||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--- 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--- 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC---
Confidence 9999999999998888999999999999999999999999999999999999995 4567999999998752211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+..+.+.++.
T Consensus 178 -------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (486)
T 3mwu_A 178 -------------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243 (486)
T ss_dssp -----------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS
T ss_pred -------------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 01134579999999999876 5999999999999999999999999999999999999988877665
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
+....+++++++||.+||+.||.+||++ .|+++||||....
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~---~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITA---TQCLEHPWIQKYS 284 (486)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSTTTSCCH---HHHHHCHHHHHTC
T ss_pred cccCCCCHHHHHHHHHHcCCChhhCcCH---HHHhcCHhhccCc
Confidence 5545688999999999999999999998 9999999998653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=420.45 Aligned_cols=264 Identities=30% Similarity=0.478 Sum_probs=225.4
Q ss_pred CcEE--EEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 365 DFTV--IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 365 dy~i--lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.|.+ .+.||+|+||.||+|.++.+|+.||+|++..... ...+.+.+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3444 6789999999999999999999999999876543 3346788999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe--ccCCcEEEeccCCccccccccc
Q psy16843 443 MEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI--TALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL--d~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-- 242 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-- 242 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--
Confidence 9999999999988654 479999999999999999999999999999999999999 56789999999999753211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......++
T Consensus 243 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 308 (373)
T 2x4f_A 243 --------------EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308 (373)
T ss_dssp --------------CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC
T ss_pred --------------cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Confidence 011345799999999999999999999999999999999999999999999999999888776665
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhh
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLR 650 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~ 650 (810)
......+++++++||.+||+.||.+||++ .|+++||||.+..|...+.
T Consensus 309 ~~~~~~~~~~~~~li~~~L~~dp~~Rps~---~e~l~hp~~~~~~~~~~~~ 356 (373)
T 2x4f_A 309 DEEFQDISEEAKEFISKLLIKEKSWRISA---SEALKHPWLSDHKLHSRLS 356 (373)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCH---HHHHHSHHHHCHHHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHcCCChhhCCCH---HHHhcCcCcCCCchhhhhh
Confidence 44334478999999999999999999998 9999999999887665443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=410.51 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=215.3
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-----CCeEEEeeeecccc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-----NPFVVTMYCSFETK 436 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-----HPnIVkl~~~f~~~ 436 (810)
..++|++++.||+|+||.||+|++..+++.||||++.... ...+....|+.+++.+. |||||++++++...
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 3478999999999999999999999999999999886432 23355677899998886 99999999999999
Q ss_pred ceeeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc---------------
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA--------------- 499 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~--------------- 499 (810)
+.+|+||||+ |++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence 9999999999 999999997654 5999999999999999999999999999999999999975
Q ss_pred ----------CCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHH
Q psy16843 500 ----------LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVIL 569 (810)
Q Consensus 500 ----------~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvIL 569 (810)
++.+||+|||+++.... .....+||+.|+|||++.+..|+.++|||||||++
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSD------------------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTS------------------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccccCCCCEEEEeccCceecCC------------------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 78999999999864211 11356799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHhhccCCCCCC--------------------------CCCCC----------------ccc
Q psy16843 570 YEFLVGCVPFFGETPEELFAHTVNDDIEWP--------------------------SEDDW----------------PIQ 607 (810)
Q Consensus 570 yELLtG~~PF~~~~~~e~~~~I~~~~~~~p--------------------------~~~~~----------------~~S 607 (810)
|||++|..||.+.+..+.+..+......+| ..... ..+
T Consensus 250 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (360)
T 3llt_A 250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329 (360)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred HHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence 999999999999888777666544222211 11000 012
Q ss_pred HHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 608 VEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 608 ~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
+++.+||.+||+.||.+||++ .|+++||||+
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta---~elL~hp~f~ 360 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSP---AELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCH---HHHTTSGGGC
T ss_pred HHHHHHHHHHhcCChhhCCCH---HHHhcCcccC
Confidence 668899999999999999999 9999999995
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=431.11 Aligned_cols=260 Identities=33% Similarity=0.518 Sum_probs=226.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|+++.++..||+|++.+..... .....+.+|+.+++.++|||||+++++|.+...+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999999999999999987654322 22467889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC---CcEEEeccCCcccccccccc
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL---GHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~---g~VKL~DFGLAk~~~~s~~~ 520 (810)
|||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+++.....
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~--- 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--- 192 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT---
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC---
Confidence 999999999999888899999999999999999999999999999999999999764 45999999998753211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..+++..+..+.+.++.
T Consensus 193 -------------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (494)
T 3lij_A 193 -------------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS 258 (494)
T ss_dssp -------------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS
T ss_pred -------------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 1123467999999999986 56999999999999999999999999999999999999988887776
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
.....+++++++||.+||+.||.+||++ .|+++||||....
T Consensus 259 ~~~~~~s~~~~~li~~~L~~dp~~R~s~---~e~l~hp~~~~~~ 299 (494)
T 3lij_A 259 PEWKNVSEGAKDLIKQMLQFDSQRRISA---QQALEHPWIKEMC 299 (494)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSTTTSCCH---HHHHTCHHHHHHH
T ss_pred hhcccCCHHHHHHHHHHCCCChhhCccH---HHHhcCcccccCc
Confidence 5545588999999999999999999998 9999999997643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=414.13 Aligned_cols=260 Identities=26% Similarity=0.396 Sum_probs=214.7
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc-----
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK----- 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~----- 437 (810)
.++|++++.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+++|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 368999999999999999999999999999999886543 23445577889999999999999999999997763
Q ss_pred -eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 -HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 -~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
.+|+||||+ |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 569999999 8899999987 6799999999999999999999999999999999999999999999999999975211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
.....+||++|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|....
T Consensus 181 ------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 242 (367)
T 1cm8_A 181 ------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 242 (367)
T ss_dssp ------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred ------------------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 1134579999999999988 689999999999999999999999999998877776665311
Q ss_pred CCC-----------------------CCC----CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 596 IEW-----------------------PSE----DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 596 ~~~-----------------------p~~----~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
... +.. .....++++++||.+||+.||.+||++ .|+++||||.++.+.
T Consensus 243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~---~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA---GEALAHPYFESLHDT 317 (367)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH---HHHHHSGGGTTTC--
T ss_pred CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCH---HHHhcChHHHhhcCC
Confidence 100 000 011257899999999999999999998 999999999987554
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=402.62 Aligned_cols=256 Identities=35% Similarity=0.559 Sum_probs=227.4
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|.+.+.||+|+||.||+|+++.+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 579999999999999999999999999999999876432 22356788999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe---ccCCcEEEeccCCcccccccccc
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI---TALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL---d~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--- 162 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--- 162 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---
Confidence 999999999999888899999999999999999999999999999999999999 77899999999998642110
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+..+.+.++.
T Consensus 163 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 228 (304)
T 2jam_A 163 --------------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES 228 (304)
T ss_dssp --------------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT
T ss_pred --------------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 112346999999999999999999999999999999999999999999999998888887776665
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.....++.++.+||.+||..||.+||++ .|+++||||.+
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~---~~~l~h~~~~~ 267 (304)
T 2jam_A 229 PFWDDISESAKDFICHLLEKDPNERYTC---EKALSHPWIDG 267 (304)
T ss_dssp TTTTTSCHHHHHHHHHHHCSSTTTSCCH---HHHHTSHHHHS
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCH---HHHhcCccccC
Confidence 5444578999999999999999999999 99999999976
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=433.35 Aligned_cols=261 Identities=29% Similarity=0.474 Sum_probs=227.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH----------HHHHHHHHHHHHHhcCCCCeEEEeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR----------NQMEQVFAERDIMSFTDNPFVVTMYCS 432 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~----------~~~~~i~~E~~iL~~l~HPnIVkl~~~ 432 (810)
.++|++++.||+|+||.||+|+++.+++.||+|++.+...... ...+.+.+|+.+|+.++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4689999999999999999999999999999999876543211 234678899999999999999999999
Q ss_pred ccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC---cEEEeccC
Q psy16843 433 FETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKLTDFG 509 (810)
Q Consensus 433 f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g---~VKL~DFG 509 (810)
+.+...+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 999999999999999999999998888999999999999999999999999999999999999999876 69999999
Q ss_pred CcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16843 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589 (810)
Q Consensus 510 LAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~ 589 (810)
+++..... ......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..+++.
T Consensus 195 ~a~~~~~~----------------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 257 (504)
T 3q5i_A 195 LSSFFSKD----------------YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK 257 (504)
T ss_dssp TCEECCTT----------------SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCEEcCCC----------------CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99753211 1123567999999999987 469999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 590 ~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.+..+.+.++......+++++++||.+||++||.+||++ .|+++||||...
T Consensus 258 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~---~e~l~h~~~~~~ 308 (504)
T 3q5i_A 258 KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA---EEALNSRWIKKY 308 (504)
T ss_dssp HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH---HHHHTSHHHHHT
T ss_pred HHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCH---HHHhcCHhhhhc
Confidence 999888766543333478999999999999999999999 999999999754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=421.30 Aligned_cols=284 Identities=25% Similarity=0.390 Sum_probs=216.6
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc-----
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK----- 436 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~----- 436 (810)
..++|++++.||+|+||.||+|+++.+++.||||++.+.. ......+.+.+|+++|+.++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 4578999999999999999999999999999999986542 3344557889999999999999999999999776
Q ss_pred ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 57999999996 59999999888999999999999999999999999999999999999999999999999999986432
Q ss_pred cccccchhhhhhc-------ccccccCCcccCCCCcCChhHHh-hcCCCCCcchhhhHHHHHHHHh-----------CCC
Q psy16843 517 SLATNLYECYVER-------DAKQFSDKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLV-----------GCV 577 (810)
Q Consensus 517 s~~~~~~~~~~~~-------~~~~~~~~~~~GTp~YmAPEvl~-~~~ys~ksDIWSLGvILyELLt-----------G~~ 577 (810)
............. ..........+||++|+|||++. +..|+.++|||||||++|||++ |.+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2111000000000 00001124678999999999975 5679999999999999999998 445
Q ss_pred CCCCCCH-----------------HHHHHhhcc------------------------CCCCCCCC---CCCcccHHHHHH
Q psy16843 578 PFFGETP-----------------EELFAHTVN------------------------DDIEWPSE---DDWPIQVEAKSI 613 (810)
Q Consensus 578 PF~~~~~-----------------~e~~~~I~~------------------------~~~~~p~~---~~~~~S~el~dL 613 (810)
+|.+.+. .+.+..|.. .....+.. ....+++++++|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 5544331 111111111 00000000 001267999999
Q ss_pred HHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhh
Q psy16843 614 ITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLR 650 (810)
Q Consensus 614 I~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~ 650 (810)
|.+||+.||.+||++ +|+++||||.+++|.....
T Consensus 342 l~~mL~~dP~~R~ta---~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 342 LESMLKFNPNKRITI---DQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp HHHHSCSSTTTSCCH---HHHHTCGGGTTTCCTTTC-
T ss_pred HHHHhcCCcccCCCH---HHHhcChhhhhccCcccCc
Confidence 999999999999998 9999999999999886653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=399.55 Aligned_cols=264 Identities=30% Similarity=0.488 Sum_probs=228.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH---HHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR---NQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~---~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
++|++++.||+|+||.||+|+++.+++.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 569999999999999999999999999999999876543211 12467889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC----cEEEeccCCcccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG----HIKLTDFGLSKMGLM 516 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g----~VKL~DFGLAk~~~~ 516 (810)
+||||++|++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888899999999999999999999999999999999999999877 899999999865321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+.....
T Consensus 165 ~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 228 (283)
T 3bhy_A 165 G----------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY 228 (283)
T ss_dssp -----------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC
T ss_pred C----------------CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc
Confidence 1 011245699999999999999999999999999999999999999999999888888877665
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
.++......++.++.+||.+||..||.+||++ .|+++||||+.+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 229 DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTI---AQSLEHSWIKAIRRR 275 (283)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCH---HHHHHCHHHHHHHHC
T ss_pred CCcchhcccCCHHHHHHHHHHccCCHhHCcCH---HHHHhCHHHHHHHHH
Confidence 55432222367899999999999999999998 999999999876543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=411.55 Aligned_cols=274 Identities=25% Similarity=0.384 Sum_probs=216.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc-----
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK----- 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~----- 437 (810)
.++|++++.||+|+||.||+|.++.+++.||||++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3689999999999999999999999999999999876432 2345567889999999999999999999987665
Q ss_pred -eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 -HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 -~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
.+|+||||+.| +|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 78999999975 7888876 4599999999999999999999999999999999999999999999999999875221
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
. ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+..+.....
T Consensus 180 ~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 243 (371)
T 2xrw_A 180 S----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243 (371)
T ss_dssp --------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CC
T ss_pred c----------------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 1 111345799999999999999999999999999999999999999999988887777664311
Q ss_pred CC-------------------CCCCC-------------------CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCC
Q psy16843 597 EW-------------------PSEDD-------------------WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHP 638 (810)
Q Consensus 597 ~~-------------------p~~~~-------------------~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HP 638 (810)
.. +.... ...+.++++||.+||+.||.+||++ .|+++||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~---~e~l~hp 320 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV---DEALQHP 320 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH---HHHHHSH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH---HHHhCCc
Confidence 10 00000 0025689999999999999999998 9999999
Q ss_pred CcCCCChhhhhhccCCcccCC
Q psy16843 639 YFSNLDWNSLLRHKAEFIPQL 659 (810)
Q Consensus 639 fF~~id~~~l~~~~~~f~P~~ 659 (810)
||............++..|..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~ 341 (371)
T 2xrw_A 321 YINVWYDPSEAEAPPPKIPDK 341 (371)
T ss_dssp HHHTTCCHHHHTCCCCCCCTT
T ss_pred chhhhcCccccCCCCCCCCCh
Confidence 998644333333334454443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=393.86 Aligned_cols=259 Identities=30% Similarity=0.502 Sum_probs=222.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++.+.||+|+||.||+|.++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 34578999999999999999999999999999999987654333344567889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--- 164 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--- 164 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC---
Confidence 99999999999999988888999999999999999999999999999999999999999999999999998653211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+....+.+..+......+|
T Consensus 165 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (276)
T 2h6d_A 165 -------------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP 231 (276)
T ss_dssp -------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred -------------cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc
Confidence 01124568999999999998776 6899999999999999999999999998888888877766555
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.. ++.++.+||.+||+.||.+||++ .|+++||||.+
T Consensus 232 ~~----~~~~l~~li~~~l~~~p~~Rps~---~~~l~h~~~~~ 267 (276)
T 2h6d_A 232 EY----LNRSVATLLMHMLQVDPLKRATI---KDIREHEWFKQ 267 (276)
T ss_dssp TT----SCHHHHHHHHHHTCSSGGGSCCH---HHHHHSHHHHT
T ss_pred hh----cCHHHHHHHHHHccCChhhCCCH---HHHHhChhhcc
Confidence 43 67899999999999999999999 99999999965
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=400.83 Aligned_cols=257 Identities=27% Similarity=0.469 Sum_probs=223.4
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
.|+..+.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 48888999999999999999999999999999865432 223567889999999999999999999999999999999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
|++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~------- 194 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD------- 194 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-------
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC-------
Confidence 9999999999875 57999999999999999999999999999999999999999999999999998653211
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDW 604 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~ 604 (810)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....+......... ...
T Consensus 195 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~ 265 (321)
T 2c30_A 195 --------VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK-NSH 265 (321)
T ss_dssp --------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCT-TGG
T ss_pred --------ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcC-ccc
Confidence 01123567999999999999999999999999999999999999999999988887777654432111 122
Q ss_pred cccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 605 PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 605 ~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
.+++++++||.+||+.||.+||++ .|+++||||....
T Consensus 266 ~~~~~l~~li~~~l~~dp~~Rps~---~ell~hp~~~~~~ 302 (321)
T 2c30_A 266 KVSPVLRDFLERMLVRDPQERATA---QELLDHPFLLQTG 302 (321)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCH---HHHHTSGGGGGCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCH---HHHhcChhhccCC
Confidence 367899999999999999999998 9999999997654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=395.14 Aligned_cols=256 Identities=29% Similarity=0.513 Sum_probs=219.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|.+.+.||+|+||.||+|+++.+++.||+|++.+.... ...+.+.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 6799999999999999999999999999999998765432 23467889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe---ccCCcEEEeccCCcccccc
Q psy16843 444 EYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI---TALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 444 Ey~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL---d~~g~VKL~DFGLAk~~~~ 516 (810)
||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 99999999998853 3689999999999999999999999999999999999999 4567899999999864221
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
. ......+||+.|+|||++. ..++.++|||||||++|||++|..||.+.+..+....+.....
T Consensus 180 ~----------------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 242 (285)
T 3is5_A 180 D----------------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242 (285)
T ss_dssp -----------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred c----------------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc
Confidence 1 1113457999999999985 5689999999999999999999999999998888877766555
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.++.. ..++++++.+||.+||+.||.+||++ .|+++||||++
T Consensus 243 ~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~---~e~l~hp~f~~ 284 (285)
T 3is5_A 243 NYAVE-CRPLTPQAVDLLKQMLTKDPERRPSA---AQVLHHEWFKQ 284 (285)
T ss_dssp CCCC---CCCCHHHHHHHHHHTCSCTTTSCCH---HHHHTSGGGGC
T ss_pred ccccc-cCcCCHHHHHHHHHHccCChhhCcCH---HHHhcCHHhhc
Confidence 44332 22367999999999999999999999 99999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=411.80 Aligned_cols=259 Identities=29% Similarity=0.496 Sum_probs=226.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccch-----hhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccc
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL-----MLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKK 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~-----~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~ 437 (810)
++|++.+.||+|+||.||+|+++.+|+.||||++..... ......+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 569999999999999999999999999999998865431 1223345678999999998 8999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++......
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999988788999999999999999999999999999999999999999999999999998653211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhc------CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ------GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~------~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I 591 (810)
......+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.+....+..+
T Consensus 254 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 254 ----------------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp ----------------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ----------------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 112346799999999999743 5899999999999999999999999999988888888
Q ss_pred ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 592 ~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
..+.+.++.......+.++.+||.+||+.||.+||++ .|+++||||+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~---~ell~hp~f~ 364 (365)
T 2y7j_A 318 MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTA---EQALQHPFFE 364 (365)
T ss_dssp HHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCH---HHHHHSGGGC
T ss_pred HhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCH---HHHhcCcccC
Confidence 8777665543223467889999999999999999998 9999999996
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=425.52 Aligned_cols=267 Identities=30% Similarity=0.543 Sum_probs=216.0
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhh-----HHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML-----RNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~-----~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
.++|.+.+.||+|+||.||+|.++.+++.||||++.+..... ......+.+|+.+|+.++|||||++++++..+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 368999999999999999999999999999999987654321 12223578899999999999999999998654
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC---cEEEeccCCcccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKLTDFGLSKMG 514 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g---~VKL~DFGLAk~~ 514 (810)
.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5899999999999999999889999999999999999999999999999999999999997654 5999999999753
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhh---cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH-HHHHh
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR---QGYGKPVDWWSMGVILYEFLVGCVPFFGETPE-ELFAH 590 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~---~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~-e~~~~ 590 (810)
... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.... .+...
T Consensus 293 ~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~ 356 (419)
T 3i6u_A 293 GET----------------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 356 (419)
T ss_dssp C---------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH
T ss_pred CCC----------------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH
Confidence 211 11235689999999999864 57889999999999999999999999865432 34444
Q ss_pred hccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhh
Q psy16843 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLL 649 (810)
Q Consensus 591 I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~ 649 (810)
+......++......+++++.+||.+||+.||.+||++ .|+++||||.+.+|....
T Consensus 357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~---~e~l~hp~~~~~~~~~~~ 412 (419)
T 3i6u_A 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT---EEALRHPWLQDEDMKRKF 412 (419)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH---HHHHHSGGGCCHHHHHHH
T ss_pred HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCH---HHHhCCcccCChhHHHHH
Confidence 55555544332222367899999999999999999999 999999999988776543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=407.22 Aligned_cols=261 Identities=26% Similarity=0.447 Sum_probs=212.4
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|+++.+++.||+|++..... ......+.+|+++++.++||||+++++++.+++.+|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 689999999999999999999999999999998865432 111123457999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~----- 153 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP----- 153 (324)
T ss_dssp ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-----
Confidence 9997 5888888754 46999999999999999999999999999999999999999999999999998642211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-----
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI----- 596 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~----- 596 (810)
.......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+..+.....
T Consensus 154 ----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (324)
T 3mtl_A 154 ----------TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE 223 (324)
T ss_dssp -------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ----------ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChH
Confidence 011134578999999999987 5789999999999999999999999999998887776654211
Q ss_pred CCCC--------------CC-------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 597 EWPS--------------ED-------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 597 ~~p~--------------~~-------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
.++. .. ...+++++++||.+||+.||.+||++ .|+++||||.++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA---EDAMKHPFFLSLGE 290 (324)
T ss_dssp TSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCH---HHHTTSGGGGGGCS
T ss_pred hchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCH---HHHhcChhhhhccc
Confidence 1110 00 01257889999999999999999998 99999999987643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=409.72 Aligned_cols=263 Identities=28% Similarity=0.447 Sum_probs=223.0
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|+++.+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 44578999999999999999999999999999999887653 2344577889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY-GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
+||||++||+|.+++...+.+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++......
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999999999999999888999999999999999999999996 9999999999999999999999999998642110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhh--------
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT-------- 591 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I-------- 591 (810)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....+
T Consensus 186 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (360)
T 3eqc_A 186 ---------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250 (360)
T ss_dssp ---------------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------
T ss_pred ---------------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccC
Confidence 113457999999999999999999999999999999999999999887765543222
Q ss_pred ----------------------------------ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 592 ----------------------------------VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 592 ----------------------------------~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
..... +......++.++++||.+||+.||.+||++ .|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~h 325 (360)
T 3eqc_A 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADL---KQLMVH 325 (360)
T ss_dssp -----------------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCH---HHHHTS
T ss_pred CCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCH---HHHhhC
Confidence 11111 111112267899999999999999999999 999999
Q ss_pred CCcCCCChhh
Q psy16843 638 PYFSNLDWNS 647 (810)
Q Consensus 638 PfF~~id~~~ 647 (810)
|||.+.+|+.
T Consensus 326 p~~~~~~~~~ 335 (360)
T 3eqc_A 326 AFIKRSDAEE 335 (360)
T ss_dssp HHHHHHHHSC
T ss_pred hHhhcchHhh
Confidence 9998765543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=407.41 Aligned_cols=268 Identities=25% Similarity=0.347 Sum_probs=218.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc-------
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET------- 435 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~------- 435 (810)
.++|++++.||+|+||.||+|+++.+|+.||||++...... ......+.+|+++++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 36899999999999999999999999999999988654332 2223467789999999999999999999876
Q ss_pred -cceeeeeeeeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 436 -KKHLCLVMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 436 -~~~lyLVmEy~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
.+.+|+||||++| +|.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 4578999999976 6666655 446899999999999999999999999999999999999999999999999999975
Q ss_pred ccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy16843 514 GLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592 (810)
Q Consensus 514 ~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~ 592 (810)
...... .........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..+.
T Consensus 174 ~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 174 FSLAKN-----------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp CCCCSS-----------SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccc-----------ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 321110 01112235679999999999987 458999999999999999999999999998888777765
Q ss_pred cCCCCCCCCCCCc----------------------------ccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 593 NDDIEWPSEDDWP----------------------------IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 593 ~~~~~~p~~~~~~----------------------------~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
.....++...... .++++++||.+||+.||.+||++ .|+++||||.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS---DDALNHDFFWSDP 319 (351)
T ss_dssp HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH---HHHHTSGGGGSSS
T ss_pred HHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH---HHHhCCCCcCCCC
Confidence 4222222111100 15779999999999999999999 9999999997754
Q ss_pred hh
Q psy16843 645 WN 646 (810)
Q Consensus 645 ~~ 646 (810)
+.
T Consensus 320 ~~ 321 (351)
T 3mi9_A 320 MP 321 (351)
T ss_dssp CC
T ss_pred Cc
Confidence 43
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=396.22 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=219.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 47899999999999999999999999999999998766555566678899999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET----- 164 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc-----
Confidence 999999999999998889999999999999999999999999999999999999999999999999998753211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC-CC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP-SE 601 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p-~~ 601 (810)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+...+......... ..
T Consensus 165 ---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T 4eqm_A 165 ---------SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTD 235 (294)
T ss_dssp -------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHH
T ss_pred ---------cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchh
Confidence 11112346799999999999999999999999999999999999999999988777666665443221 11
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCC
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPf 639 (810)
....+++.+.++|.+||.+||.+||+. .+.+.+.|
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~---~~~l~~~l 270 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKT---IQEMKDDL 270 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSS---HHHHHHHH
T ss_pred cccCCCHHHHHHHHHHhcCCHhHcccc---HHHHHHHH
Confidence 112367899999999999999999976 45555444
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=404.49 Aligned_cols=267 Identities=24% Similarity=0.366 Sum_probs=208.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc------
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK------ 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~------ 437 (810)
++|++++.||+|+||.||+|+++.+|+.||||++..... ....+.+.+|+++|+.++|||||+++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST--TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 579999999999999999999999999999999875442 234567899999999999999999999875432
Q ss_pred ---------------------------------------------------eeeeeeeeccCcchhhhhhcCCC---CCH
Q psy16843 438 ---------------------------------------------------HLCLVMEYVEGGDCASLLKNTGP---LPA 463 (810)
Q Consensus 438 ---------------------------------------------------~lyLVmEy~~GGsL~~lL~~~g~---lse 463 (810)
.+|+|||||+||+|.+++...+. .++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999999999999987654 455
Q ss_pred HHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCC
Q psy16843 464 DMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543 (810)
Q Consensus 464 ~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp 543 (810)
..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++........... .............+||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~---~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV---LTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-----------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc---cccccccccccccCCCc
Confidence 678999999999999999999999999999999999999999999999764322111000 00000011224567999
Q ss_pred CcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCC
Q psy16843 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPR 623 (810)
Q Consensus 544 ~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~ 623 (810)
.|+|||++.+..|+.++|||||||++|||++|..|+.. .......+..... +.. ....++++.+||.+||+.||.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~--~~~-~~~~~~~~~~li~~~l~~~p~ 315 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKF--PLL-FTQKYPQEHMMVQDMLSPSPT 315 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCC--CHH-HHHHCHHHHHHHHHHHCSSGG
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCC--Ccc-cccCChhHHHHHHHHccCCCC
Confidence 99999999999999999999999999999998777532 2223333333221 211 112567889999999999999
Q ss_pred CCCCCCChhHHhcCCCcCCC
Q psy16843 624 DRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 624 ~Rpta~~~~EiL~HPfF~~i 643 (810)
+||++ .|+++||||+++
T Consensus 316 ~Rps~---~~~l~~~~f~~~ 332 (332)
T 3qd2_B 316 ERPEA---TDIIENAIFENL 332 (332)
T ss_dssp GSCCH---HHHHHSTTCCCC
T ss_pred cCCCH---HHHhhchhhhcC
Confidence 99998 999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=388.37 Aligned_cols=260 Identities=25% Similarity=0.454 Sum_probs=220.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|.++.+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 5799999999999999999999999999999988654332 33467889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~----- 159 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN----- 159 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT-----
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc-----
Confidence 999999999999988889999999999999999999999999999999999999999999999999986532110
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHH-HHHHhhccCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPE-ELFAHTVNDDIEWPSE 601 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~-e~~~~I~~~~~~~p~~ 601 (810)
........+||+.|+|||++.+..+ +.++||||||+++|||++|..||.+.... ..+..+.......+.
T Consensus 160 --------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 230 (276)
T 2yex_A 160 --------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP- 230 (276)
T ss_dssp --------EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTT-
T ss_pred --------chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCc-
Confidence 0111235679999999999988775 78999999999999999999999876543 233333333222221
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
...++.++++||.+||+.||.+||++ .|+++||||.+.
T Consensus 231 -~~~~~~~~~~li~~~l~~~p~~Rps~---~~il~~~~~~~~ 268 (276)
T 2yex_A 231 -WKKIDSAPLALLHKILVENPSARITI---PDIKKDRWYNKP 268 (276)
T ss_dssp -GGGSCHHHHHHHHHHSCSSTTTSCCH---HHHTTCTTTTCC
T ss_pred -hhhcCHHHHHHHHHHCCCCchhCCCH---HHHhcCccccCh
Confidence 12367899999999999999999998 999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=410.58 Aligned_cols=258 Identities=29% Similarity=0.461 Sum_probs=218.6
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH-----HHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR-----NQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~-----~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
++|++++.||+|+||.||+|+++.+++.||||++.+...... ...+.+.+|+.+++.++||||++++++|.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 579999999999999999999999999999999876543211 123456779999999999999999999999999
Q ss_pred eeeeeeeccCc-chhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGG-DCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GG-sL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
+|+||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 99999999776 99999998889999999999999999999999999999999999999999999999999998753211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
......+||+.|+|||++.+..+ +.++|||||||++|||++|..||.+.. .......
T Consensus 184 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~ 241 (335)
T 3dls_A 184 ----------------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAI 241 (335)
T ss_dssp ----------------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCC
T ss_pred ----------------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhcc
Confidence 11234679999999999998887 889999999999999999999997632 2222222
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC------CChhhhhh
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN------LDWNSLLR 650 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~------id~~~l~~ 650 (810)
..|. .+++++.+||.+||+.||.+||++ .|+++||||.+ .+|+.+.+
T Consensus 242 ~~~~----~~~~~l~~li~~~L~~dP~~Rps~---~ell~hp~~~~~~~~~~~~~~~~~~ 294 (335)
T 3dls_A 242 HPPY----LVSKELMSLVSGLLQPVPERRTTL---EKLVTDPWVTQPVNLADYTWEEVFR 294 (335)
T ss_dssp CCSS----CCCHHHHHHHHHHTCSSGGGSCCH---HHHHHCTTTTCCCCGGGCCHHHHC-
T ss_pred CCCc----ccCHHHHHHHHHHccCChhhCcCH---HHHhcCccccCCccccccCHHHHhh
Confidence 2222 267999999999999999999998 99999999965 44555544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=405.31 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=222.5
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+.|++++.||+|+||.||+|++..+|+.||||++...........+.+.+|+++++.++||||+++++++.+++.+|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999987665444555678899999999999999999999999999999999
Q ss_pred eeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||+. |+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 9997 57777774 457899999999999999999999999999999999999999999999999999864211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHh---hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVIL---RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~---~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
....+||+.|+|||++. +..|+.++|||||||++|||++|..||.+.+..+.+..+........
T Consensus 207 -------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 273 (348)
T 1u5q_A 207 -------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 273 (348)
T ss_dssp -------------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred -------------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Confidence 13457999999999996 46789999999999999999999999999888877777766543322
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.. ...++++++||.+||+.||.+||++ .|+++||||...
T Consensus 274 ~~--~~~~~~l~~li~~~l~~dP~~Rps~---~~ll~h~~~~~~ 312 (348)
T 1u5q_A 274 QS--GHWSEYFRNFVDSCLQKIPQDRPTS---EVLLKHRFVLRE 312 (348)
T ss_dssp CC--TTSCHHHHHHHHHHTCSSGGGSCCH---HHHTTCHHHHSC
T ss_pred CC--CCCCHHHHHHHHHHcccChhhCcCH---HHHhhChhhhcc
Confidence 22 2367899999999999999999998 999999999654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=404.06 Aligned_cols=269 Identities=23% Similarity=0.367 Sum_probs=224.2
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 34789999999999999999999999999999998866543 23344667899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 177 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP---- 177 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC----
Confidence 9999999999999888888999999999999999999999999999999999999999999999999998642211
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC------
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND------ 594 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~------ 594 (810)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 178 -----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (331)
T 4aaa_A 178 -----------GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP 246 (331)
T ss_dssp -----------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred -----------ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence 0111345799999999999876 7899999999999999999999999998877766655421
Q ss_pred -------------CCCCCCCC--------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhh
Q psy16843 595 -------------DIEWPSED--------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLL 649 (810)
Q Consensus 595 -------------~~~~p~~~--------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~ 649 (810)
...++... ...+++++.+||.+||+.||.+||++ .|+++||||+..+|....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~---~ell~hp~f~~~~~~~~~ 319 (331)
T 4aaa_A 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC---AELLHHDFFQMDGFAERF 319 (331)
T ss_dssp HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCG---GGGGGSHHHHGGGHHHHH
T ss_pred hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCH---HHHhcCchhccCChhhhh
Confidence 11111110 01257899999999999999999999 899999999887665544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=394.08 Aligned_cols=277 Identities=27% Similarity=0.460 Sum_probs=200.4
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
.....++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 44566899999999999999999999999999999998765432 2334678899999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCC
Q psy16843 439 LCLVMEYVEGGDCASLLKN--------TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGL 510 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~--------~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGL 510 (810)
+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999863 46799999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~ 589 (810)
+......... .........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+........
T Consensus 168 ~~~~~~~~~~----------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 237 (303)
T 2vwi_A 168 SAFLATGGDI----------TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM 237 (303)
T ss_dssp HHHCC-------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH
T ss_pred hheeccCCCc----------cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH
Confidence 8653211000 00111234579999999999986 678999999999999999999999999877766555
Q ss_pred hhccCCCCC-CC-----CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhh
Q psy16843 590 HTVNDDIEW-PS-----EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLR 650 (810)
Q Consensus 590 ~I~~~~~~~-p~-----~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~ 650 (810)
......... .. .....++.++.+||.+||+.||.+||++ .|+++||||.+..+..+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~~ll~h~~~~~~~~~~~~q 301 (303)
T 2vwi_A 238 LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA---AELLRHKFFQKAKNKEFLQ 301 (303)
T ss_dssp HHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCH---HHHHTSTTC----------
T ss_pred HHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCH---HHHhhChhhhcCCCCcccc
Confidence 444432211 10 1112367899999999999999999998 9999999999887766554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=387.52 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=216.2
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc----cc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET----KK 437 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~----~~ 437 (810)
....|.+.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 345689999999999999999999999999999988765433 3456788899999999999999999998765 46
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCCCceEec-cCCcEEEeccCCcccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG--IVHRDLKPDNLLIT-ALGHIKLTDFGLSKMG 514 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~g--IIHRDLKPeNILLd-~~g~VKL~DFGLAk~~ 514 (810)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 79999999999999999998889999999999999999999999999 99999999999998 7899999999998642
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH-HHHHHhhcc
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFAHTVN 593 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~-~e~~~~I~~ 593 (810)
... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+... ...+..+..
T Consensus 183 ~~~-----------------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (290)
T 1t4h_A 183 RAS-----------------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp CTT-----------------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred ccc-----------------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc
Confidence 111 112457999999999886 4599999999999999999999999988544 444444444
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 594 ~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.... .......++++.+||.+||+.||.+||++ .|+++||||++
T Consensus 245 ~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~ell~h~~f~~ 288 (290)
T 1t4h_A 245 GVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSI---KDLLNHAFFQE 288 (290)
T ss_dssp TCCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCH---HHHHTSGGGC-
T ss_pred cCCc--cccCCCCCHHHHHHHHHHccCChhhCCCH---HHHhhCccccc
Confidence 3221 11112256889999999999999999998 99999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=403.40 Aligned_cols=265 Identities=27% Similarity=0.407 Sum_probs=214.9
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhh--HHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML--RNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~--~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
.++|++++.||+|+||.||+|+++.+|+.||||++....... ....+.+.+|+++++.++||||+++++++.+.+.+|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 478999999999999999999999999999999886543221 111246778999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
+||||+++ +|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-- 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-- 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC--
Confidence 99999986 788887654 57999999999999999999999999999999999999999999999999998753211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC--
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI-- 596 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~-- 596 (810)
.......+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+..+.....
T Consensus 166 -------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 166 -------------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232 (346)
T ss_dssp -------------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred -------------cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 1112345799999999999764 589999999999999999999999999998888777664211
Q ss_pred ---CCCCCC-------------------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 597 ---EWPSED-------------------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 597 ---~~p~~~-------------------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
.|+... ...++.++++||.+||+.||.+||++ .|+++||||.+..+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA---TQALKMKYFSNRPGP 301 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH---HHHHTSGGGTSSSCC
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH---HHHhcChhhhcCCCC
Confidence 111100 01256889999999999999999999 999999999876543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=401.51 Aligned_cols=263 Identities=31% Similarity=0.549 Sum_probs=214.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh-----hHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM-----LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~-----~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
++|++.+.||+|+||.||+|+++.+++.||||++.+.... .......+.+|+++++.++||||+++++++..++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999999999999999998764321 1122345788999999999999999999987665
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc---EEEeccCCccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGL 515 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~---VKL~DFGLAk~~~ 515 (810)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 8999999999999999998889999999999999999999999999999999999999987665 9999999987532
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHh---hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH-HHHHhh
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL---RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE-ELFAHT 591 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~---~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~-e~~~~I 591 (810)
... .....+||+.|+|||++. ...|+.++|||||||++|+|++|..||.+.... .+...+
T Consensus 169 ~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 232 (322)
T 2ycf_A 169 ETS----------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 232 (322)
T ss_dssp CCH----------------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH
T ss_pred ccc----------------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH
Confidence 110 012356999999999985 457899999999999999999999999765432 333444
Q ss_pred ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 592 ~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
..+...+.......++.++.+||.+||..||.+||++ .|+++||||.+.+|.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~---~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT---EEALRHPWLQDEDMK 284 (322)
T ss_dssp HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH---HHHHTSGGGCCHHHH
T ss_pred HhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCH---HHHhhCcCcCCHHHH
Confidence 4444433222112367899999999999999999999 999999999886654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=391.39 Aligned_cols=266 Identities=28% Similarity=0.471 Sum_probs=222.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||+|+||.||+|+++.+++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+.+|+|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4689999999999999999999999999999998865432 2346788899999999999999999999999999999
Q ss_pred eeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 170 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT---- 170 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH----
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc----
Confidence 999999999998865 567999999999999999999999999999999999999999999999999987531110
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHh-----hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-----~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 171 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (302)
T 2j7t_A 171 -----------LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP 239 (302)
T ss_dssp -----------HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred -----------ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC
Confidence 00113457999999999995 56789999999999999999999999999988887777665543
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhh
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLR 650 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~ 650 (810)
... .....++.++.+||.+||..||.+||++ .|+++||||.++.|...++
T Consensus 240 ~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~h~~~~~~~~~~~~~ 289 (302)
T 2j7t_A 240 PTL-LTPSKWSVEFRDFLKIALDKNPETRPSA---AQLLEHPFVSSITSNKALR 289 (302)
T ss_dssp CCC-SSGGGSCHHHHHHHHHHSCSCTTTSCCH---HHHTTSTTTTTCCCCHHHH
T ss_pred ccc-CCccccCHHHHHHHHHHcccChhhCCCH---HHHhcChHHhhhccchhHH
Confidence 211 1112367899999999999999999998 9999999999988765443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=407.25 Aligned_cols=255 Identities=29% Similarity=0.494 Sum_probs=210.4
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecc-------
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE------- 434 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~------- 434 (810)
..++|++++.||+|+||.||+|+++.+|+.||||++...... ..+|+++|+.++|||||+++++|.
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 347899999999999999999999999999999988655322 236999999999999999999983
Q ss_pred -------------------------------ccceeeeeeeeccCcchhhhh----hcCCCCCHHHHHHHHHHHHHHHHH
Q psy16843 435 -------------------------------TKKHLCLVMEYVEGGDCASLL----KNTGPLPADMARFYFAETVLAVEY 479 (810)
Q Consensus 435 -------------------------------~~~~lyLVmEy~~GGsL~~lL----~~~g~lse~~~~~i~~QIl~AL~y 479 (810)
...++|+||||++| +|.+.+ ...+.+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 33458999999985 666555 456789999999999999999999
Q ss_pred hhhcccccccCCCCceEec-cCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCC
Q psy16843 480 LHSYGIVHRDLKPDNLLIT-ALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYG 557 (810)
Q Consensus 480 LHs~gIIHRDLKPeNILLd-~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys 557 (810)
||++||+||||||+|||++ .++.+||+|||+++..... ......+||+.|+|||++.+. .|+
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~t~~y~aPE~~~~~~~~~ 220 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS----------------EPSVAYICSRFYRAPELMLGATEYT 220 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT----------------SCCCCCCCCSSCCCHHHHTTCSSCC
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC----------------CCCcCcccCCCccCHHHhcCCCCCC
Confidence 9999999999999999998 5899999999999753211 112345789999999999875 489
Q ss_pred CCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC-----------------CCCCCCCC--------CCcccHHHHH
Q psy16843 558 KPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND-----------------DIEWPSED--------DWPIQVEAKS 612 (810)
Q Consensus 558 ~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~-----------------~~~~p~~~--------~~~~S~el~d 612 (810)
.++|||||||++|||++|.+||.+.+..+.+..++.. ...+|... ....++++++
T Consensus 221 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (383)
T 3eb0_A 221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300 (383)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence 9999999999999999999999999888877776531 11111110 1126788999
Q ss_pred HHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 613 IITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 613 LI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
||.+||+.||.+||++ .|+++||||+++
T Consensus 301 li~~~L~~dP~~R~t~---~e~l~hp~f~~~ 328 (383)
T 3eb0_A 301 LLEQILRYEPDLRINP---YEAMAHPFFDHL 328 (383)
T ss_dssp HHHHHCCSSGGGSCCH---HHHHTSGGGHHH
T ss_pred HHHHHccCChhhCCCH---HHHhcCHHHHHH
Confidence 9999999999999998 999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=402.26 Aligned_cols=266 Identities=25% Similarity=0.471 Sum_probs=230.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHH--------------HHHHHHHHHHHHhcCCCCeEEE
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRN--------------QMEQVFAERDIMSFTDNPFVVT 428 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~--------------~~~~i~~E~~iL~~l~HPnIVk 428 (810)
.++|++++.||+|+||.||+|++ +|+.||||++......... ..+.+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 47899999999999999999998 8999999998754332111 1267889999999999999999
Q ss_pred eeeeccccceeeeeeeeccCcchhhh------hhc--CCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEecc
Q psy16843 429 MYCSFETKKHLCLVMEYVEGGDCASL------LKN--TGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITA 499 (810)
Q Consensus 429 l~~~f~~~~~lyLVmEy~~GGsL~~l------L~~--~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~ 499 (810)
+++++.+.+.+|+||||++||+|.++ +.. .+.+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999999 765 5789999999999999999999999 99999999999999999
Q ss_pred CCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCC-CcchhhhHHHHHHHHhCCC
Q psy16843 500 LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGK-PVDWWSMGVILYEFLVGCV 577 (810)
Q Consensus 500 ~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~-ksDIWSLGvILyELLtG~~ 577 (810)
++.+||+|||++...... ......||+.|+|||++.+. .|+. ++|||||||++|||++|..
T Consensus 188 ~~~~kl~dfg~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 250 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK-----------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250 (348)
T ss_dssp TSCEEECCCTTCEECBTT-----------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred CCcEEEeccccccccccc-----------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 999999999998753211 11345799999999999887 6666 9999999999999999999
Q ss_pred CCCCCCH-HHHHHhhccCCCCCCCCCC---------------CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 578 PFFGETP-EELFAHTVNDDIEWPSEDD---------------WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 578 PF~~~~~-~e~~~~I~~~~~~~p~~~~---------------~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
||.+.+. .+....+......+|.... ..++.++.+||.+||+.||.+||++ .|+++||||.
T Consensus 251 pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~---~e~l~hp~f~ 327 (348)
T 2pml_X 251 PFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS---EDALKHEWLA 327 (348)
T ss_dssp SSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCH---HHHHTSGGGT
T ss_pred CCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCH---HHHhcCcccc
Confidence 9998777 7888888877766663210 2367899999999999999999998 9999999999
Q ss_pred CCChhhhhh
Q psy16843 642 NLDWNSLLR 650 (810)
Q Consensus 642 ~id~~~l~~ 650 (810)
+.+|..+..
T Consensus 328 ~~~~~~~~~ 336 (348)
T 2pml_X 328 DTNIEDLRE 336 (348)
T ss_dssp TCCHHHHHH
T ss_pred CCCHHHHHH
Confidence 999987754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=399.62 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=211.4
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC--CeEEEeeeecccccee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN--PFVVTMYCSFETKKHL 439 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H--PnIVkl~~~f~~~~~l 439 (810)
..++|++++.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.+|+.++| |||+++++++.+++.+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 4567999999999999999999885 588999999876543 23455778899999999987 9999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||| +.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+ +|.+||+|||+++.....
T Consensus 85 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~-- 160 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD-- 160 (343)
T ss_dssp EEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc--
Confidence 99999 56889999999989999999999999999999999999999999999999997 689999999999753211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhh-----------cCCCCCcchhhhHHHHHHHHhCCCCCCCCCH-HHH
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-----------QGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EEL 587 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----------~~ys~ksDIWSLGvILyELLtG~~PF~~~~~-~e~ 587 (810)
.........+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+... ...
T Consensus 161 -----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 229 (343)
T 3dbq_A 161 -----------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229 (343)
T ss_dssp --------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred -----------cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH
Confidence 11111235679999999999976 6789999999999999999999999987533 344
Q ss_pred HHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 588 ~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+..+........... ..+.++.+||.+||+.||.+||++ .|+++||||..
T Consensus 230 ~~~~~~~~~~~~~~~--~~~~~l~~li~~~L~~dp~~Rpt~---~e~l~hp~~~~ 279 (343)
T 3dbq_A 230 LHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRISI---PELLAHPYVQI 279 (343)
T ss_dssp HHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCCH---HHHHTSHHHHS
T ss_pred HHHHhcCCcccCCcc--cCCHHHHHHHHHHcCCChhHCCCH---HHHHhCccccc
Confidence 444444333222111 256789999999999999999998 99999999964
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=413.39 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=211.3
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc------
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET------ 435 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~------ 435 (810)
...+|++++.||+|+||.||+|+++.+|+.||||++.+... ...+|+++|+.++|||||+++++|..
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34579999999999999999999999999999999865432 22369999999999999999988843
Q ss_pred cceeeeeeeeccCcchhhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC-CcEEEeccCC
Q psy16843 436 KKHLCLVMEYVEGGDCASLLK----NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL-GHIKLTDFGL 510 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~----~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~-g~VKL~DFGL 510 (810)
..++++||||+++ +|..++. ..+.+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 3357899999986 5555543 45789999999999999999999999999999999999999965 5789999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~ 589 (810)
++..... ......+||+.|+|||++.+. .|+.++|||||||+||||++|++||.+.+..+.+.
T Consensus 204 a~~~~~~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~ 267 (420)
T 1j1b_A 204 AKQLVRG----------------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267 (420)
T ss_dssp CEECCTT----------------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred hhhcccC----------------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9753211 112346799999999999875 79999999999999999999999999988877666
Q ss_pred hhccC-----------------CCCCCCCC--------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 590 HTVND-----------------DIEWPSED--------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 590 ~I~~~-----------------~~~~p~~~--------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
+++.. .+.+|... ...+++++++||.+||++||.+||++ .|+++||||.++.
T Consensus 268 ~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~---~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP---LEACAHSFFDELR 344 (420)
T ss_dssp HHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH---HHHHTSGGGGGGG
T ss_pred HHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH---HHHhCCHhhcccc
Confidence 65531 12222211 11257899999999999999999999 9999999998765
Q ss_pred hh
Q psy16843 645 WN 646 (810)
Q Consensus 645 ~~ 646 (810)
+.
T Consensus 345 ~~ 346 (420)
T 1j1b_A 345 DP 346 (420)
T ss_dssp CT
T ss_pred cc
Confidence 43
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=397.45 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=204.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||+||+|+++.+|+.||||++...........+.+..+..+.+..+||||+++++++.+++.+|+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999876544333333333433444445559999999999999999999999
Q ss_pred eeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||+ +|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~----- 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA----- 210 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-----
Confidence 999 6688888764 457999999999999999999999999999999999999999999999999998653211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~ 602 (810)
......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.... ..+..... +...
T Consensus 211 -----------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~--~~~~ 273 (311)
T 3p1a_A 211 -----------GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYL--PPEF 273 (311)
T ss_dssp ---------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCC--CHHH
T ss_pred -----------CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCC--Cccc
Confidence 11234569999999999876 7999999999999999999997777654332 23332221 1111
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
...+++++.+||.+||+.||.+||++ .|+++||||++
T Consensus 274 ~~~~~~~l~~li~~~L~~dP~~Rpt~---~ell~hp~~~~ 310 (311)
T 3p1a_A 274 TAGLSSELRSVLVMMLEPDPKLRATA---EALLALPVLRQ 310 (311)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCH---HHHHTSGGGSC
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCH---HHHHhCccccC
Confidence 11267899999999999999999999 99999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=394.97 Aligned_cols=257 Identities=26% Similarity=0.446 Sum_probs=211.4
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccc--cce
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFET--KKH 438 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~--~~~ 438 (810)
..++|++++.||+|+||.||+|+++.+++.||||++.... .+.+.+|+.+++.+. ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3478999999999999999999999999999999886432 256788999999997 9999999999987 668
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC-cEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG-HIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g-~VKL~DFGLAk~~~~s 517 (810)
.++||||+.+++|.+++.. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 108 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999999999999864 89999999999999999999999999999999999999777 8999999999753211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCC-CHHHHHHhhc---
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGE-TPEELFAHTV--- 592 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~-~~~e~~~~I~--- 592 (810)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||... ...+.+..+.
T Consensus 185 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~ 248 (330)
T 3nsz_A 185 ----------------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248 (330)
T ss_dssp ----------------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred ----------------CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhc
Confidence 11234579999999999987 67899999999999999999999999543 3322222211
Q ss_pred ----------cCCCCC--------------------CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 593 ----------NDDIEW--------------------PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 593 ----------~~~~~~--------------------p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
...... .......+++++++||.+||+.||.+||++ .|+++||||.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta---~e~l~hp~f~~ 325 (330)
T 3nsz_A 249 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA---REAMEHPYFYT 325 (330)
T ss_dssp CHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCH---HHHHTSGGGTT
T ss_pred CCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCH---HHHhcCccHhh
Confidence 111111 011111267899999999999999999998 99999999999
Q ss_pred CChh
Q psy16843 643 LDWN 646 (810)
Q Consensus 643 id~~ 646 (810)
+.|+
T Consensus 326 ~~~~ 329 (330)
T 3nsz_A 326 VVKD 329 (330)
T ss_dssp CC--
T ss_pred hccC
Confidence 8765
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=418.74 Aligned_cols=250 Identities=14% Similarity=0.148 Sum_probs=204.9
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHH---HHHhcCCCCeEEEee-------ee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAER---DIMSFTDNPFVVTMY-------CS 432 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~---~iL~~l~HPnIVkl~-------~~ 432 (810)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+ ++|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999999999999999999765444445667888999 455666899999998 44
Q ss_pred ccccc-----------------eeeeeeeeccCcchhhhhhcCCCCCH-------HHHHHHHHHHHHHHHHhhhcccccc
Q psy16843 433 FETKK-----------------HLCLVMEYVEGGDCASLLKNTGPLPA-------DMARFYFAETVLAVEYLHSYGIVHR 488 (810)
Q Consensus 433 f~~~~-----------------~lyLVmEy~~GGsL~~lL~~~g~lse-------~~~~~i~~QIl~AL~yLHs~gIIHR 488 (810)
+.+.+ ..||||||+ +|+|.+++...+.+++ ..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 44442 389999999 6899999987666666 7788899999999999999999999
Q ss_pred cCCCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-----------CCC
Q psy16843 489 DLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-----------GYG 557 (810)
Q Consensus 489 DLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-----------~ys 557 (810)
||||+||||+.+|.+||+|||+++.... .....+| +.|+|||++.+. .|+
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~ 291 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA------------------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMT 291 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC------------------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC------------------cccCCCC-cCccChhhhcccccccccccccccCC
Confidence 9999999999999999999999874211 1134578 999999999988 899
Q ss_pred CCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 558 KPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 558 ~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.++|||||||+||||++|..||.+.+..+....+.... ..+++++.+||.+||+.||.+||++ .|+++|
T Consensus 292 ~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~L~~dp~~Rpt~---~e~l~h 360 (377)
T 3byv_A 292 FSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC--------KNIPQPVRALLEGFLRYPKEDRLLP---LQAMET 360 (377)
T ss_dssp HHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSSC--------CCCCHHHHHHHHHHTCSSGGGCCCH---HHHHTS
T ss_pred hhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhhc--------cCCCHHHHHHHHHHcCCCchhCCCH---HHHhhC
Confidence 99999999999999999999998876655444443321 1267899999999999999999998 999999
Q ss_pred CCcCCC
Q psy16843 638 PYFSNL 643 (810)
Q Consensus 638 PfF~~i 643 (810)
|||.++
T Consensus 361 p~f~~~ 366 (377)
T 3byv_A 361 PEYEQL 366 (377)
T ss_dssp HHHHHH
T ss_pred hHHHHH
Confidence 999764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=408.15 Aligned_cols=259 Identities=25% Similarity=0.388 Sum_probs=203.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc------c
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK------K 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~------~ 437 (810)
++|++++.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+++|+.++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 68999999999999999999999999999999886542 2234557788999999999999999999998654 5
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.+|+||||+ |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~- 184 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD- 184 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence 689999999 7899999876 6799999999999999999999999999999999999999999999999999875211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+.....
T Consensus 185 -----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 185 -----------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp -----------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred -----------------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 0134579999999999987 6789999999999999999999999999988777666543100
Q ss_pred -----------------------CCCCCC----CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 597 -----------------------EWPSED----DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 597 -----------------------~~p~~~----~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
..+... ....++++++||.+||+.||.+||++ .|+++||||......
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~---~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA---AQALAHAYFAQYHDP 321 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCH---HHHHTSGGGTTTCCG
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCH---HHHhcChhhhhccCC
Confidence 001000 01256889999999999999999999 999999999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=411.40 Aligned_cols=259 Identities=29% Similarity=0.483 Sum_probs=211.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc------c
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET------K 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~------~ 436 (810)
..+|++++.||+|+||.||+|+++.+++ ||+|++...... ..+|+++|+.++||||++++++|.. .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 3579999999999999999999987766 899988654322 2359999999999999999999844 3
Q ss_pred ceeeeeeeeccCcchhhhh---hcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEec-cCCcEEEeccCCcc
Q psy16843 437 KHLCLVMEYVEGGDCASLL---KNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLIT-ALGHIKLTDFGLSK 512 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL---~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd-~~g~VKL~DFGLAk 512 (810)
..+|+||||++++.+..+. ...+.+++..++.|+.||+.||+|||++||+||||||+||||+ .+|.+||+|||+|+
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 3589999999876444333 2457899999999999999999999999999999999999999 79999999999997
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I 591 (810)
..... ......+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+..+
T Consensus 191 ~~~~~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i 254 (394)
T 4e7w_A 191 ILIAG----------------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI 254 (394)
T ss_dssp ECCTT----------------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccCC----------------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 53211 112345789999999999875 5899999999999999999999999999887777666
Q ss_pred ccC-----------------CCCCCCCC--------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 592 VND-----------------DIEWPSED--------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 592 ~~~-----------------~~~~p~~~--------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
... ...++... ...+++++++||.+||++||.+||++ .|+++||||+++.|.
T Consensus 255 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 255 IKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA---IEALCHPFFDELRTG 331 (394)
T ss_dssp HHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH---HHHHTSGGGSTTTSS
T ss_pred HHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH---HHHhcChhhhhhccc
Confidence 531 01111110 11267899999999999999999998 999999999998775
Q ss_pred hh
Q psy16843 647 SL 648 (810)
Q Consensus 647 ~l 648 (810)
..
T Consensus 332 ~~ 333 (394)
T 4e7w_A 332 EA 333 (394)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=384.36 Aligned_cols=250 Identities=16% Similarity=0.249 Sum_probs=208.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyLV 442 (810)
++|++++.||+|+||.||+|.++.+++.||+|++....... .....+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 57999999999999999999999999999999987653332 3346677888888888 999999999999999999999
Q ss_pred eeeccCcchhhhhhcC----CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC-----------------
Q psy16843 443 MEYVEGGDCASLLKNT----GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG----------------- 501 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~----g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g----------------- 501 (810)
|||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999754 6799999999999999999999999999999999999998544
Q ss_pred --cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCC
Q psy16843 502 --HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVP 578 (810)
Q Consensus 502 --~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~P 578 (810)
.+||+|||++..... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+|
T Consensus 170 ~~~~kl~Dfg~~~~~~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~ 230 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISS-------------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230 (289)
T ss_dssp CCCEEECCCTTCEETTC-------------------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred ceEEEEcccccccccCC-------------------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 799999999865211 1234599999999999876 567899999999999999999888
Q ss_pred CCCCCHHHHHHhhccCCC-CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 579 FFGETPEELFAHTVNDDI-EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 579 F~~~~~~e~~~~I~~~~~-~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
+...... ..+..... .++. .+++++.+||.+||..||.+||++ .|+++||||.+.
T Consensus 231 ~~~~~~~---~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~---~~ll~h~~~~~~ 286 (289)
T 1x8b_A 231 PRNGDQW---HEIRQGRLPRIPQ----VLSQEFTELLKVMIHPDPERRPSA---MALVKHSVLLSA 286 (289)
T ss_dssp CSSSHHH---HHHHTTCCCCCSS----CCCHHHHHHHHHHTCSSGGGSCCH---HHHHTCTTC---
T ss_pred CcchhHH---HHHHcCCCCCCCc----ccCHHHHHHHHHHhCCCcccCCCH---HHHhhChHhhhh
Confidence 7655432 33333332 2222 367999999999999999999999 999999999763
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=391.35 Aligned_cols=262 Identities=27% Similarity=0.481 Sum_probs=227.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|+++.+++.||+|++.+.... ....+.+.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 5799999999999999999999999999999998764432 223467889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC---cEEEeccCCcccccccccc
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g---~VKL~DFGLAk~~~~s~~~ 520 (810)
||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~--- 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--- 177 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC---
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC---
Confidence 9999999999998778899999999999999999999999999999999999997644 6999999998642211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
.......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+....+..+...++.
T Consensus 178 -------------~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (287)
T 2wei_A 178 -------------TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243 (287)
T ss_dssp -------------SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred -------------CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 011234689999999998764 899999999999999999999999999999888888877765554
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
.....++.++.+||.+||..||.+||++ .|+++||||.+..|+
T Consensus 244 ~~~~~~~~~~~~li~~~l~~dp~~Rps~---~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITA---TQCLEHPWIQKYSSE 286 (287)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSGGGSCCH---HHHHHSHHHHHHCCC
T ss_pred hhhhhcCHHHHHHHHHHcccChhhCcCH---HHHhcCHHHhccccC
Confidence 3333478999999999999999999998 999999999876543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=390.33 Aligned_cols=262 Identities=28% Similarity=0.447 Sum_probs=221.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhh-HHHHHHHHHHHHHHhcCCCCeEEEeeeec--ccccee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML-RNQMEQVFAERDIMSFTDNPFVVTMYCSF--ETKKHL 439 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~-~~~~~~i~~E~~iL~~l~HPnIVkl~~~f--~~~~~l 439 (810)
.++|++.+.||+|+||.||+|.++.+++.||+|++.+..... ....+.+.+|+++++.++||||+++++++ .+...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999999999999999987654321 23456788999999999999999999998 556689
Q ss_pred eeeeeeccCcchhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKN--TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~--~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
|+||||+.+| |.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999887 6666654 457999999999999999999999999999999999999999999999999998753211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCC--CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY--GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y--s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
. .........||+.|+|||++.+... +.++|||||||++|||++|..||.+.+..+.+..+....
T Consensus 163 ~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~ 229 (305)
T 2wtk_C 163 A-------------ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS 229 (305)
T ss_dssp C-------------SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC
T ss_pred c-------------cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC
Confidence 0 0111134569999999999987543 789999999999999999999999999999888888877
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
..++.. +++++.+||.+||..||.+||++ .|+++||||.....
T Consensus 230 ~~~~~~----~~~~l~~li~~~l~~dp~~Rps~---~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 230 YAIPGD----CGPPLSDLLKGMLEYEPAKRFSI---RQIRQHSWFRKKHP 272 (305)
T ss_dssp CCCCSS----SCHHHHHHHHHHTCSSTTTSCCH---HHHHHSHHHHSCCC
T ss_pred CCCCCc----cCHHHHHHHHHHccCChhhCCCH---HHHhcCcccccCCC
Confidence 666543 67899999999999999999998 99999999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=407.40 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=214.4
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC--CCeEEEeeeeccccceee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD--NPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~--HPnIVkl~~~f~~~~~ly 440 (810)
..+|++++.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+|+.+. |||||++++++..++.+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3569999999999999999999875 89999999876543 2345578899999999996 599999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
|||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.....
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~--- 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD--- 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC---
Confidence 9999 56889999999888999999999999999999999999999999999999996 589999999999753211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhh-----------cCCCCCcchhhhHHHHHHHHhCCCCCCCCC-HHHHH
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-----------QGYGKPVDWWSMGVILYEFLVGCVPFFGET-PEELF 588 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----------~~ys~ksDIWSLGvILyELLtG~~PF~~~~-~~e~~ 588 (810)
.........+||+.|+|||++.+ ..|+.++|||||||+||||++|..||.+.. ....+
T Consensus 208 ----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 277 (390)
T 2zmd_A 208 ----------TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 277 (390)
T ss_dssp ----------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH
T ss_pred ----------CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH
Confidence 01111235689999999999975 368999999999999999999999998754 34555
Q ss_pred HhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 589 AHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 589 ~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
..++.....++.... .+.++++||.+||+.||.+||++ .|+++||||..
T Consensus 278 ~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps~---~ell~hp~~~~ 326 (390)
T 2zmd_A 278 HAIIDPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISI---PELLAHPYVQI 326 (390)
T ss_dssp HHHHCTTSCCCCCCC--SCHHHHHHHHHHTCSSTTTSCCH---HHHHTSHHHHS
T ss_pred HHHhCccccCCCCcc--chHHHHHHHHHHcccChhhCCCH---HHHhhCcCccc
Confidence 666654443322221 46889999999999999999998 99999999965
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=388.14 Aligned_cols=264 Identities=30% Similarity=0.485 Sum_probs=221.3
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++++.||+|+||.||+|.++.+|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3478999999999999999999999999999999887543 23567889999999999999999999999999999
Q ss_pred eeeeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 442 VMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 442 VmEy~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||||++||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--- 178 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT---
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh---
Confidence 999999999999997 4578999999999999999999999999999999999999999999999999998653211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-CCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI-EWP 599 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~-~~p 599 (810)
........||+.|+|||++.+..|+.++||||||+++|+|++|..||.+.........+..... .+.
T Consensus 179 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (314)
T 3com_A 179 ------------MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFR 246 (314)
T ss_dssp ------------BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred ------------ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccC
Confidence 0112345799999999999999999999999999999999999999998887766655544322 111
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhh
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLR 650 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~ 650 (810)
. ...++.++.+||.+||..||.+||++ .|+++||||.+..+....+
T Consensus 247 ~--~~~~~~~l~~li~~~l~~dp~~Rpt~---~~ll~~~~~~~~~~~~~~~ 292 (314)
T 3com_A 247 K--PELWSDNFTDFVKQCLVKSPEQRATA---TQLLQHPFVRSAKGVSILR 292 (314)
T ss_dssp S--GGGSCHHHHHHHHHHTCSCTTTSCCH---HHHTTSHHHHTCCCGGGGH
T ss_pred C--cccCCHHHHHHHHHHccCChhhCcCH---HHHHhCHHHhcCCcchHHH
Confidence 1 12257899999999999999999998 9999999999887665544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=384.97 Aligned_cols=258 Identities=29% Similarity=0.459 Sum_probs=203.8
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+..+..+++.++||||+++++++.+++.+|
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 455789999999999999999999999999999998865432 2233344555666688999999999999999999999
Q ss_pred eeeeeccCcchhhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 441 LVMEYVEGGDCASLLK----NTGPLPADMARFYFAETVLAVEYLHSY-GIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~----~~g~lse~~~~~i~~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
+||||++| +|.+++. ..+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999975 7776664 457899999999999999999999998 99999999999999999999999999986532
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHH----hhcCCCCCcchhhhHHHHHHHHhCCCCCCC-CCHHHHHHh
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI----LRQGYGKPVDWWSMGVILYEFLVGCVPFFG-ETPEELFAH 590 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl----~~~~ys~ksDIWSLGvILyELLtG~~PF~~-~~~~e~~~~ 590 (810)
.. ......+||+.|+|||++ .+..++.++|||||||++|||++|..||.+ ......+..
T Consensus 162 ~~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 225 (290)
T 3fme_A 162 DD----------------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ 225 (290)
T ss_dssp ------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH
T ss_pred cc----------------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH
Confidence 11 111234699999999997 456789999999999999999999999986 344444444
Q ss_pred hccCCC-CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 591 TVNDDI-EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 591 I~~~~~-~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+..... ..+. ..+++++.+||.+||+.||.+||++ .|+++||||..
T Consensus 226 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~---~e~l~hp~f~~ 272 (290)
T 3fme_A 226 VVEEPSPQLPA---DKFSAEFVDFTSQCLKKNSKERPTY---PELMQHPFFTL 272 (290)
T ss_dssp HHHSCCCCCCT---TTSCHHHHHHHHHHTCSSGGGSCCH---HHHTTSHHHHH
T ss_pred HhccCCCCccc---ccCCHHHHHHHHHHhhcChhhCcCH---HHHHhCccccc
Confidence 444332 2222 2367899999999999999999998 99999999964
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=393.09 Aligned_cols=273 Identities=27% Similarity=0.396 Sum_probs=218.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc-----c
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK-----K 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~-----~ 437 (810)
.++|++.+.||+|+||.||+|.++.+|+.||||++.... .......+.+|+++++.++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 478999999999999999999999999999999886432 233456778999999999999999999887654 6
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 8999999997 589998876 57999999999999999999999999999999999999999999999999999764322
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccC--
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVND-- 594 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~-- 594 (810)
..... ............+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+...
T Consensus 166 ~~~~~-----~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 166 AADNS-----EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp -------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccc-----CccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 11100 00000111234679999999999875 67899999999999999999999999998876655544321
Q ss_pred CC----------------------CCCCCC----CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhh
Q psy16843 595 DI----------------------EWPSED----DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647 (810)
Q Consensus 595 ~~----------------------~~p~~~----~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~ 647 (810)
.. ..+... ...+++++++||.+||+.||.+||++ .|+++||||....+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA---KEALEHPYLQTYHDPN 316 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH---HHHHTSGGGTTTCCTT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH---HHHhcCccccccCCcc
Confidence 00 000000 01367899999999999999999998 9999999999877654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=410.27 Aligned_cols=259 Identities=20% Similarity=0.239 Sum_probs=197.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHH---HHhcCCCCeEEEeeeecc------
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERD---IMSFTDNPFVVTMYCSFE------ 434 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~---iL~~l~HPnIVkl~~~f~------ 434 (810)
.+|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+. +|+. +||||++++..+.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45999999999999999999999999999999998876555566677888854 4555 7999888664432
Q ss_pred -cc-----------------ceeeeeeeeccCcchhhhhhcCC-CCCHHHH------HHHHHHHHHHHHHhhhccccccc
Q psy16843 435 -TK-----------------KHLCLVMEYVEGGDCASLLKNTG-PLPADMA------RFYFAETVLAVEYLHSYGIVHRD 489 (810)
Q Consensus 435 -~~-----------------~~lyLVmEy~~GGsL~~lL~~~g-~lse~~~------~~i~~QIl~AL~yLHs~gIIHRD 489 (810)
.. ..+||||||++ |+|.+++...+ .+.+... ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 11 45899999998 89999998643 4444444 56669999999999999999999
Q ss_pred CCCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh--cCCCCCcchhhhHH
Q psy16843 490 LKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR--QGYGKPVDWWSMGV 567 (810)
Q Consensus 490 LKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--~~ys~ksDIWSLGv 567 (810)
|||+||||+.+|.+||+|||+|+..... .....||+.|+|||++.+ ..|+.++|||||||
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~ 281 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR------------------GPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE------------------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC------------------ccCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence 9999999999999999999998752110 013457799999999987 78999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHH--HHh---h--ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 568 ILYEFLVGCVPFFGETPEEL--FAH---T--VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 568 ILyELLtG~~PF~~~~~~e~--~~~---I--~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
+||||++|..||.+...... +.. . ....+.++. ...+++++.+||.+||+.||++||++ .|+++||||
T Consensus 282 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~---~e~l~hp~f 356 (371)
T 3q60_A 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS--CTPLPDFVKTLIGRFLNFDRRRRLLP---LEAMETPEF 356 (371)
T ss_dssp HHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTT--SSCCCHHHHHHHHHHTCSSTTTCCCH---HHHTTSHHH
T ss_pred HHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhh--ccCCCHHHHHHHHHHcCCChhhCCCH---HHHhcCHHH
Confidence 99999999999987743211 111 0 111222222 12478999999999999999999999 999999999
Q ss_pred CCCChhh
Q psy16843 641 SNLDWNS 647 (810)
Q Consensus 641 ~~id~~~ 647 (810)
.++.|..
T Consensus 357 ~~~~~~~ 363 (371)
T 3q60_A 357 LQLQNEI 363 (371)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9887753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=389.15 Aligned_cols=262 Identities=27% Similarity=0.407 Sum_probs=217.7
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccc-----
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFET----- 435 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~----- 435 (810)
..++|++++.||+|+||.||+|++..+|+.||||++..... ..+.+.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 45789999999999999999999999999999998865432 225677899999888 89999999999876
Q ss_pred -cceeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 436 -KKHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 436 -~~~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
.+.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 46899999999999999999754 579999999999999999999999999999999999999999999999999986
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHh-----hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHH
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL 587 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-----~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~ 587 (810)
..... .......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+......
T Consensus 178 ~~~~~---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 242 (326)
T 2x7f_A 178 QLDRT---------------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242 (326)
T ss_dssp ----------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ecCcC---------------ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH
Confidence 52211 00113457999999999997 56789999999999999999999999999888777
Q ss_pred HHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhh
Q psy16843 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647 (810)
Q Consensus 588 ~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~ 647 (810)
...+........ ....++.++.+||.+||..||.+||++ .|+++||||.+..+..
T Consensus 243 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~hp~~~~~~~~~ 297 (326)
T 2x7f_A 243 LFLIPRNPAPRL--KSKKWSKKFQSFIESCLVKNHSQRPAT---EQLMKHPFIRDQPNER 297 (326)
T ss_dssp HHHHHHSCCCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCH---HHHHTSHHHHCCTTHH
T ss_pred HHHhhcCccccC--CccccCHHHHHHHHHHhccChhhCCCH---HHHhhChHHhhCcccc
Confidence 766655443222 122367899999999999999999998 9999999999876554
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=400.12 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=217.3
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc-----c
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK-----K 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~-----~ 437 (810)
.++|++++.||+|+||.||+|++..+++.||||++.... .....+.+.+|+++++.++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 368999999999999999999999999999999986533 234456788999999999999999999998654 4
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.+|+||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 7899999997 589998876 57999999999999999999999999999999999999999999999999999753221
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.. ........+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+..+.....
T Consensus 182 ~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 249 (364)
T 3qyz_A 182 HD------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249 (364)
T ss_dssp GC------------BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred CC------------ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence 10 01112346899999999998754 589999999999999999999999999887766666542100
Q ss_pred --------------------CCCCCC-------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 597 --------------------EWPSED-------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 597 --------------------~~p~~~-------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
..+... ...+++++.+||.+||+.||.+||++ .|+++||||.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~e~l~hp~~~~~ 320 (364)
T 3qyz_A 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV---EQALAHPYLEQY 320 (364)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH---HHHHTSGGGTTT
T ss_pred CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH---HHHhcCcchhhc
Confidence 001000 01257899999999999999999998 999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=409.43 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=212.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC------CCCeEEEeeeecccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT------DNPFVVTMYCSFETK 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l------~HPnIVkl~~~f~~~ 436 (810)
..+|++++.||+|+||.||+|.+..+++.||||++.... ...+.+..|+.+++.+ +|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 467999999999999999999999999999999886543 2234566677777665 678999999999999
Q ss_pred ceeeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc--EEEeccCCcc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH--IKLTDFGLSK 512 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~--VKL~DFGLAk 512 (810)
+.+|+||||+. |+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||+++
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999996 68999887553 5999999999999999999999999999999999999999987 9999999986
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~ 592 (810)
.... .....+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+..+.+..+.
T Consensus 251 ~~~~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~ 312 (429)
T 3kvw_A 251 YEHQ------------------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312 (429)
T ss_dssp ETTC------------------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ecCC------------------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4211 1234679999999999999999999999999999999999999999998877766654
Q ss_pred cCCC--------------------CCC-----------------------------CCCC------CcccHHHHHHHHhh
Q psy16843 593 NDDI--------------------EWP-----------------------------SEDD------WPIQVEAKSIITDL 617 (810)
Q Consensus 593 ~~~~--------------------~~p-----------------------------~~~~------~~~S~el~dLI~kl 617 (810)
...- .+| .... ...++++++||.+|
T Consensus 313 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~ 392 (429)
T 3kvw_A 313 ELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQC 392 (429)
T ss_dssp HHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHH
T ss_pred HHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHH
Confidence 3100 000 0000 01267899999999
Q ss_pred hcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 618 LQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 618 L~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
|+.||.+|||+ .|+++||||+..
T Consensus 393 L~~dP~~Rpta---~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 393 LEWDPAVRMTP---GQALRHPWLRRR 415 (429)
T ss_dssp TCSSTTTSCCH---HHHHTSTTTC--
T ss_pred CCCChhhCCCH---HHHhCChhhccC
Confidence 99999999999 999999999763
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=398.96 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=217.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee----
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL---- 439 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l---- 439 (810)
++|.+.+.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 68999999999999999999999999999999887543 2334557788999999999999999999999887755
Q ss_pred --eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 440 --CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 440 --yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
|+||||+. |+|.+++.. .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~- 196 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 196 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence 99999997 588888753 499999999999999999999999999999999999999999999999999864211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 197 -----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 197 -----------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp --------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred -----------------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 1134578999999999987 6889999999999999999999999999988777766643110
Q ss_pred -----------------------CCCCCC----CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhh
Q psy16843 597 -----------------------EWPSED----DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647 (810)
Q Consensus 597 -----------------------~~p~~~----~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~ 647 (810)
..+... ...+++++++||.+||+.||.+||++ .|+++||||+.+....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA---AQALTHPFFEPFRDPE 334 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCH---HHHHTSGGGTTTCCGG
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCH---HHHhcCcccccCCCcc
Confidence 000000 01257899999999999999999998 9999999999876543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=382.66 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=221.0
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeec--cccceee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSF--ETKKHLC 440 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f--~~~~~ly 440 (810)
.++|++++.||+|+||.||+|+++.+++.||+|++...... ....+.+.+|+.+++.++||||+++++++ .....+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 46899999999999999999999999999999998765432 34457789999999999999999999987 4467899
Q ss_pred eeeeeccCcchhhhhhcC----CCCCHHHHHHHHHHHHHHHHHhhhcc-----cccccCCCCceEeccCCcEEEeccCCc
Q psy16843 441 LVMEYVEGGDCASLLKNT----GPLPADMARFYFAETVLAVEYLHSYG-----IVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~----g~lse~~~~~i~~QIl~AL~yLHs~g-----IIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
+||||++||+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999643 35999999999999999999999999 999999999999999999999999998
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I 591 (810)
+....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..++...+
T Consensus 164 ~~~~~~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i 228 (279)
T 2w5a_A 164 RILNHDTS---------------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228 (279)
T ss_dssp HHC---CH---------------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred eeeccccc---------------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH
Confidence 65321100 012346899999999999999999999999999999999999999999988888887
Q ss_pred ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 592 ~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
..+...... ..++.++.+||.+||+.||.+||++ .|+++|+|+.+
T Consensus 229 ~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~---~~ll~~~~~~~ 273 (279)
T 2w5a_A 229 REGKFRRIP---YRYSDELNEIITRMLNLKDYHRPSV---EEILENPLILE 273 (279)
T ss_dssp HHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCH---HHHHTSTTCCG
T ss_pred hhcccccCC---cccCHHHHHHHHHHcCCCcccCCCH---HHHHhChhhhh
Confidence 776543211 1367899999999999999999998 99999999865
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=388.69 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=212.7
Q ss_pred CCCcEEEEEecccCceEEEEEEE-cCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCC------eEEEeeeeccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRH-KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP------FVVTMYCSFET 435 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~-k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HP------nIVkl~~~f~~ 435 (810)
.++|++++.||+|+||.||+|.+ +.+++.||+|++.... ...+.+.+|+++++.++|+ +|+++++++.+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 46899999999999999999998 5688999999886532 3346677888888887665 59999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc--------------
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA-------------- 499 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~-------------- 499 (810)
.+.+|+||||+ +++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999999 889999998665 6899999999999999999999999999999999999987
Q ss_pred -----CCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh
Q psy16843 500 -----LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV 574 (810)
Q Consensus 500 -----~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt 574 (810)
++.+||+|||+++.... .....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE------------------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS------------------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred cccccCCCceEeeCcccccCcc------------------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence 66899999999864211 1134579999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHhhccCCCC---------------------CCCC-------------------CCCcccHHHHHHH
Q psy16843 575 GCVPFFGETPEELFAHTVNDDIE---------------------WPSE-------------------DDWPIQVEAKSII 614 (810)
Q Consensus 575 G~~PF~~~~~~e~~~~I~~~~~~---------------------~p~~-------------------~~~~~S~el~dLI 614 (810)
|..||.+.+..+....+...... |... .....++++.+||
T Consensus 230 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 309 (339)
T 1z57_A 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309 (339)
T ss_dssp SSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHH
Confidence 99999988877655544321111 1100 0112357789999
Q ss_pred HhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 615 TDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 615 ~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.+||+.||.+||++ .|+++||||+.+
T Consensus 310 ~~~L~~dP~~Rpt~---~ell~hp~f~~~ 335 (339)
T 1z57_A 310 QKMLEYDPAKRITL---REALKHPFFDLL 335 (339)
T ss_dssp HHHTCSSTTTSCCH---HHHTTSGGGGGG
T ss_pred HHHhCcCcccccCH---HHHhcCHHHHHH
Confidence 99999999999998 999999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=389.33 Aligned_cols=265 Identities=27% Similarity=0.428 Sum_probs=213.3
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecc--------
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE-------- 434 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~-------- 434 (810)
.++|++++.||+|+||.||+|.++.+++.||+|++.... ....+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 478999999999999999999999999999999886543 345577889999999999999999998873
Q ss_pred ------ccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEec-cCCcEEEec
Q psy16843 435 ------TKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLIT-ALGHIKLTD 507 (810)
Q Consensus 435 ------~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd-~~g~VKL~D 507 (810)
+...+|+||||++ |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4468999999997 599999875 6799999999999999999999999999999999999997 567999999
Q ss_pred cCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHH
Q psy16843 508 FGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE 586 (810)
Q Consensus 508 FGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e 586 (810)
||+++....... .........||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+
T Consensus 165 fg~~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 232 (320)
T 2i6l_A 165 FGLARIMDPHYS------------HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232 (320)
T ss_dssp CTTCBCC--------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CccccccCCCcc------------cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 999975321100 0111234568999999999876 678999999999999999999999999998877
Q ss_pred HHHhhccCCCCC----------------------CCC----CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 587 LFAHTVNDDIEW----------------------PSE----DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 587 ~~~~I~~~~~~~----------------------p~~----~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.+..+....... +.. ....++.++++||.+||+.||.+||++ .|+++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~hp~~ 309 (320)
T 2i6l_A 233 QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA---EEALSHPYM 309 (320)
T ss_dssp HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCH---HHHHTSHHH
T ss_pred HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCH---HHHhCCccc
Confidence 776665432110 000 001267899999999999999999998 999999999
Q ss_pred CCCChhh
Q psy16843 641 SNLDWNS 647 (810)
Q Consensus 641 ~~id~~~ 647 (810)
...+|..
T Consensus 310 ~~~~~p~ 316 (320)
T 2i6l_A 310 SIYSFPM 316 (320)
T ss_dssp HTTCC--
T ss_pred ccccCcc
Confidence 9887764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=381.79 Aligned_cols=276 Identities=26% Similarity=0.439 Sum_probs=217.2
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc--------
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET-------- 435 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~-------- 435 (810)
++|++++.||+|+||.||+|+++.+++.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 5799999999999999999999999999999988653 2345678899999999999999999988744
Q ss_pred -----cceeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccC
Q psy16843 436 -----KKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFG 509 (810)
Q Consensus 436 -----~~~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFG 509 (810)
...+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 56899999999999999999854 468899999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCC-CCHHHH
Q psy16843 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFG-ETPEEL 587 (810)
Q Consensus 510 LAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~-~~~~e~ 587 (810)
++............... ............+||+.|+|||++.+. .++.++|||||||++|||++ ||.. .+..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQ-NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCSCTTC--------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred chhhcccccchhccccc-cccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 98753321100000000 000001112356799999999999875 68999999999999999998 5543 344556
Q ss_pred HHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhh
Q psy16843 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLR 650 (810)
Q Consensus 588 ~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~ 650 (810)
...+......+|.......+..+++||.+||+.||.+||++ .|+++||||....++...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~~ll~h~~~~~~~~~~~~~ 297 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA---RTLLNSGWLPVKHQDEVIK 297 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCH---HHHHHSSCSCCCCHHHHHH
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCH---HHHhCCCCcCCCChHHHHH
Confidence 66666666666655444567889999999999999999999 9999999999887776554
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=388.37 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=210.3
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++.+.||+|+||.||+|++ +|+.||+|++..... .....+.+.+|+++++.++||||+++++++.+.+.+|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 4557899999999999999999977 578899998876543 2345577889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCC---CCHHHHHHHHHHHHHHHHHhhhcc--cccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGP---LPADMARFYFAETVLAVEYLHSYG--IVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~---lse~~~~~i~~QIl~AL~yLHs~g--IIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
+||||++||+|.+++...+. +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999999987654 999999999999999999999999 9999999999999999999999999986421
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....
T Consensus 191 ~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~ 255 (309)
T 3p86_A 191 ST---------------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC 255 (309)
T ss_dssp --------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC
T ss_pred cc---------------ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence 11 111235679999999999999999999999999999999999999999999888877765433
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
....... .+++++.+||.+||+.||.+||++ .|+++
T Consensus 256 ~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~---~~ll~ 291 (309)
T 3p86_A 256 KRLEIPR--NLNPQVAAIIEGCWTNEPWKRPSF---ATIMD 291 (309)
T ss_dssp CCCCCCT--TSCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CCCCCCc--cCCHHHHHHHHHHccCChhhCcCH---HHHHH
Confidence 2222221 267999999999999999999998 67664
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=391.68 Aligned_cols=261 Identities=25% Similarity=0.411 Sum_probs=214.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCC-cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCe------EEEeeeeccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETR-QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF------VVTMYCSFET 435 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg-~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPn------IVkl~~~f~~ 435 (810)
.++|++++.||+|+||.||+|.++.++ +.||+|++.... ...+.+..|+.+++.+.|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 478999999999999999999998777 689999886532 23456778888888887655 9999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe----------------
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI---------------- 497 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL---------------- 497 (810)
.+.+|+||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999999 55666666544 479999999999999999999999999999999999999
Q ss_pred ---ccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh
Q psy16843 498 ---TALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV 574 (810)
Q Consensus 498 ---d~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt 574 (810)
+.++.+||+|||+++.... .....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE------------------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS------------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccCCCcEEEeecCccccccc------------------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 5678999999999864211 1134579999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHhhccCCCCCCC----------------------------------------CCCCcccHHHHHHH
Q psy16843 575 GCVPFFGETPEELFAHTVNDDIEWPS----------------------------------------EDDWPIQVEAKSII 614 (810)
Q Consensus 575 G~~PF~~~~~~e~~~~I~~~~~~~p~----------------------------------------~~~~~~S~el~dLI 614 (810)
|..||.+.+..+.+..+.......|. ......+.++.+||
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 314 (355)
T 2eu9_A 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 314 (355)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence 99999988876655443321111110 00111346889999
Q ss_pred HhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhh
Q psy16843 615 TDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLL 649 (810)
Q Consensus 615 ~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~ 649 (810)
.+||+.||.+||++ .|+++||||.+++|+...
T Consensus 315 ~~~L~~dP~~Rpt~---~e~l~hp~f~~~~~~~~~ 346 (355)
T 2eu9_A 315 RRMLEFDPAQRITL---AEALLHPFFAGLTPEERS 346 (355)
T ss_dssp HHHTCSSTTTSCCH---HHHTTSGGGGGCCHHHHC
T ss_pred HHHhcCChhhCcCH---HHHhcChhhcCCChhhcc
Confidence 99999999999999 999999999999887553
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=390.93 Aligned_cols=272 Identities=19% Similarity=0.294 Sum_probs=202.6
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCc---EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQ---RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~---~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
...++|++.+.||+|+||.||+|+++.++. .||||++...... ....+.+.+|+++++.++||||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 445789999999999999999999887765 8999988654322 344578899999999999999999999998776
Q ss_pred ee------eeeeeeccCcchhhhhhcCC------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEE
Q psy16843 438 HL------CLVMEYVEGGDCASLLKNTG------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 505 (810)
Q Consensus 438 ~l------yLVmEy~~GGsL~~lL~~~g------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL 505 (810)
.. |+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 55 99999999999999986432 6999999999999999999999999999999999999999999999
Q ss_pred eccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCH
Q psy16843 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETP 584 (810)
Q Consensus 506 ~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~ 584 (810)
+|||+++....... ........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+.
T Consensus 179 ~Dfg~a~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 245 (323)
T 3qup_A 179 ADFGLSRKIYSGDY-------------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245 (323)
T ss_dssp CCCCC------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred eecccccccccccc-------------ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh
Confidence 99999975322110 011123457889999999999999999999999999999999 9999999988
Q ss_pred HHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC----ChhHHhcCCCcCCCChhhhh
Q psy16843 585 EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG----GPHEVKEHPYFSNLDWNSLL 649 (810)
Q Consensus 585 ~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~----~~~EiL~HPfF~~id~~~l~ 649 (810)
.+....+......... ..++.++.+||.+||+.||.+||++. .+++++.|||+....++.+.
T Consensus 246 ~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~ 311 (323)
T 3qup_A 246 AEIYNYLIGGNRLKQP---PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY 311 (323)
T ss_dssp GGHHHHHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------
T ss_pred HHHHHHHhcCCCCCCC---CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence 8888877765432211 13678999999999999999999952 24889999999876655443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=399.57 Aligned_cols=254 Identities=22% Similarity=0.395 Sum_probs=205.3
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC--------CCeEEEeeeecc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD--------NPFVVTMYCSFE 434 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~--------HPnIVkl~~~f~ 434 (810)
.++|++++.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.+. |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 478999999999999999999999999999999986542 33466788999998875 788999999987
Q ss_pred ----ccceeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCCCceEeccCC------
Q psy16843 435 ----TKKHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSY-GIVHRDLKPDNLLITALG------ 501 (810)
Q Consensus 435 ----~~~~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~g------ 501 (810)
+...+|+||||+ +|+|.+++... +.+++..++.++.||+.||.|||++ ||+||||||+||||+.+|
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 667899999999 55555555433 5799999999999999999999998 999999999999999776
Q ss_pred -------------------------------------------cEEEeccCCcccccccccccchhhhhhcccccccCCc
Q psy16843 502 -------------------------------------------HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ 538 (810)
Q Consensus 502 -------------------------------------------~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~ 538 (810)
.+||+|||+++.... ....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~------------------~~~~ 252 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK------------------HFTE 252 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB------------------CSCS
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc------------------cCcc
Confidence 799999999875211 1134
Q ss_pred ccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC------HHHHHHhhcc--CCC--------------
Q psy16843 539 VYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET------PEELFAHTVN--DDI-------------- 596 (810)
Q Consensus 539 ~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~------~~e~~~~I~~--~~~-------------- 596 (810)
.+||+.|+|||++.+..|+.++|||||||+||||++|..||.+.+ ....+..+.. +..
T Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 332 (397)
T 1wak_A 253 DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332 (397)
T ss_dssp CCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGT
T ss_pred CCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccc
Confidence 579999999999999999999999999999999999999997654 2222222211 000
Q ss_pred --------CCCC--------------CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 597 --------EWPS--------------EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 597 --------~~p~--------------~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.+.. ......+.++++||.+||+.||.+||++ .|+++||||++
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~e~l~hp~~~~ 397 (397)
T 1wak_A 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA---AECLRHPWLNS 397 (397)
T ss_dssp BCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCH---HHHHTSGGGGC
T ss_pred cCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCH---HHHhhCccccC
Confidence 0000 0011245678999999999999999999 99999999964
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=384.48 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=223.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+.|++++.||+|+||.||+|.++.+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 5799999999999999999999999999999998765432 33567889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~------ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT------ 172 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT------
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc------
Confidence 99999999999975 67999999999999999999999999999999999999999999999999998653211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
.......+||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+....... ..
T Consensus 173 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 240 (303)
T 3a7i_A 173 ---------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT---LE 240 (303)
T ss_dssp ---------BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---CC
T ss_pred ---------ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---Cc
Confidence 111235679999999999999999999999999999999999999999988887777666543321 11
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
..++.++.+||.+||..||.+||++ .|+++||||..
T Consensus 241 ~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~~~~~~~ 276 (303)
T 3a7i_A 241 GNYSKPLKEFVEACLNKEPSFRPTA---KELLKHKFILR 276 (303)
T ss_dssp SSCCHHHHHHHHHHCCSSGGGSCCH---HHHTTCHHHHH
T ss_pred cccCHHHHHHHHHHcCCChhhCcCH---HHHhhChhhhc
Confidence 2367899999999999999999998 99999999954
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=396.03 Aligned_cols=260 Identities=28% Similarity=0.405 Sum_probs=201.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc-----
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK----- 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~----- 437 (810)
.++|++.+.||+|+||.||+|+++.+|+.||||++....... .....|++.+..++||||++++++|...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 368999999999999999999999999999999886643322 34456777888899999999999986533
Q ss_pred --eeeeeeeeccCcchh---hhhhcCCCCCHHHHHHHHHHHHHHHHHhh--hcccccccCCCCceEecc-CCcEEEeccC
Q psy16843 438 --HLCLVMEYVEGGDCA---SLLKNTGPLPADMARFYFAETVLAVEYLH--SYGIVHRDLKPDNLLITA-LGHIKLTDFG 509 (810)
Q Consensus 438 --~lyLVmEy~~GGsL~---~lL~~~g~lse~~~~~i~~QIl~AL~yLH--s~gIIHRDLKPeNILLd~-~g~VKL~DFG 509 (810)
.+|+||||++|+.+. .++.....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 389999999875332 33346678999999999999999999999 999999999999999997 8999999999
Q ss_pred CcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcC-CCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHH
Q psy16843 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG-YGKPVDWWSMGVILYEFLVGCVPFFGETPEELF 588 (810)
Q Consensus 510 LAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~ 588 (810)
+++..... ......+||+.|+|||++.+.. |+.++|||||||++|||++|..||.+.+..+.+
T Consensus 178 ~a~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 241 (360)
T 3e3p_A 178 SAKKLSPS----------------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL 241 (360)
T ss_dssp TCBCCCTT----------------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CceecCCC----------------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH
Confidence 99753211 1123457899999999997654 899999999999999999999999999888777
Q ss_pred HhhccCCCC-----------------CC-----------CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 589 AHTVNDDIE-----------------WP-----------SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 589 ~~I~~~~~~-----------------~p-----------~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..+...... +. .......++++++||.+||+.||.+||++ .|+++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~e~l~hp~f 318 (360)
T 3e3p_A 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP---YEALCHPYF 318 (360)
T ss_dssp HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH---HHHTTSGGG
T ss_pred HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH---HHHhcCccc
Confidence 766531100 00 00011146789999999999999999998 999999999
Q ss_pred CCCCh
Q psy16843 641 SNLDW 645 (810)
Q Consensus 641 ~~id~ 645 (810)
.++.+
T Consensus 319 ~~~~~ 323 (360)
T 3e3p_A 319 DELHD 323 (360)
T ss_dssp GGGGC
T ss_pred cccCC
Confidence 88644
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=389.00 Aligned_cols=257 Identities=24% Similarity=0.393 Sum_probs=215.5
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce-----
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH----- 438 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~----- 438 (810)
++|.+.+.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 68999999999999999999999999999999886543 233455778899999999999999999999987654
Q ss_pred -eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 439 -LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 -lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
+|+||||+. |+|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~- 178 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 178 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC-
Confidence 499999997 588888854 599999999999999999999999999999999999999999999999999864211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC-
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD- 595 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~- 595 (810)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+....
T Consensus 179 -----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 241 (353)
T 3coi_A 179 -----------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241 (353)
T ss_dssp ----------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC
T ss_pred -----------------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 0124578999999999987 678999999999999999999999999988776666554310
Q ss_pred ---------------------------CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 596 ---------------------------IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 596 ---------------------------~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
..+.. ....+++++++||.+||+.||.+||++ .|+++||||..+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~---~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTA---AQALTHPFFEPFRDP 315 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCH---HHHHTSGGGTTTCCG
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCH---HHHhcCcchhhccCc
Confidence 00110 112367899999999999999999999 999999999876544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=390.00 Aligned_cols=257 Identities=24% Similarity=0.411 Sum_probs=211.4
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc--ee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK--HL 439 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~--~l 439 (810)
..++|++.+.||+|+||.||+|+++.+++.||||++...... ...+.+.+|+++++.++||||+++++++.... .+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 346899999999999999999999999999999998754432 22456778999999999999999999987655 88
Q ss_pred eeeeeeccCcchhhhhhcCC---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe----ccCCcEEEeccCCcc
Q psy16843 440 CLVMEYVEGGDCASLLKNTG---PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI----TALGHIKLTDFGLSK 512 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g---~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL----d~~g~VKL~DFGLAk 512 (810)
|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999999997543 39999999999999999999999999999999999999 778889999999997
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHh--------hcCCCCCcchhhhHHHHHHHHhCCCCCCCC--
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL--------RQGYGKPVDWWSMGVILYEFLVGCVPFFGE-- 582 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~--------~~~ys~ksDIWSLGvILyELLtG~~PF~~~-- 582 (810)
..... ......+||+.|+|||++. +..|+.++|||||||++|||++|..||...
T Consensus 165 ~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 228 (319)
T 4euu_A 165 ELEDD----------------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (319)
T ss_dssp ECCTT----------------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred ecCCC----------------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 53211 1113457999999999997 467899999999999999999999999643
Q ss_pred --CHHHHHHhhccCCC-------------------CCCC--CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCC
Q psy16843 583 --TPEELFAHTVNDDI-------------------EWPS--EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639 (810)
Q Consensus 583 --~~~e~~~~I~~~~~-------------------~~p~--~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPf 639 (810)
...+.+..+..+.. .++. .....++..+.+||.+||+.||++||++ .|+++||=
T Consensus 229 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~---~ell~h~~ 305 (319)
T 4euu_A 229 PRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF---DQFFAETS 305 (319)
T ss_dssp GGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH---HHHHHHHH
T ss_pred cchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH---HHhhhccH
Confidence 23445555544322 1111 1112256689999999999999999999 99999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=391.09 Aligned_cols=256 Identities=19% Similarity=0.273 Sum_probs=209.7
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcE----EEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQR----FAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~----vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
....++|++++.||+|+||.||+|+++.+++. ||+|.+..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 34568999999999999999999999988876 56665533221 122245677999999999999999999986
Q ss_pred cceeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccc
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~ 514 (810)
++.+|+||||+.||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 46799999999999999999764 68999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhcc
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVN 593 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~ 593 (810)
.... .........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+....++...+..
T Consensus 166 ~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 232 (325)
T 3kex_A 166 PPDD-------------KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232 (325)
T ss_dssp CCCT-------------TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT
T ss_pred Cccc-------------ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence 2211 1112234568899999999999999999999999999999999 9999999887777777665
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 594 ~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
........ ..+.++.+||.+||..||.+||++ .|+++|
T Consensus 233 ~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~---~el~~~ 270 (325)
T 3kex_A 233 GERLAQPQ---ICTIDVYMVMVKCWMIDENIRPTF---KELANE 270 (325)
T ss_dssp TCBCCCCT---TBCTTTTHHHHHHTCSCTTTSCCH---HHHHHH
T ss_pred CCCCCCCC---cCcHHHHHHHHHHcCCChhhCcCH---HHHHHH
Confidence 43322211 266889999999999999999998 677665
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=398.31 Aligned_cols=255 Identities=20% Similarity=0.311 Sum_probs=215.5
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEc-------CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHK-------ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCS 432 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k-------~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~ 432 (810)
...++|++.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.+|+.+ +||||++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 34578999999999999999999975 345679999886543 244567889999999999 89999999999
Q ss_pred ccccceeeeeeeeccCcchhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceE
Q psy16843 433 FETKKHLCLVMEYVEGGDCASLLKNTG----------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLL 496 (810)
Q Consensus 433 f~~~~~lyLVmEy~~GGsL~~lL~~~g----------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNIL 496 (810)
+.+.+.+|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 999999999999999999999997643 4889999999999999999999999999999999999
Q ss_pred eccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-C
Q psy16843 497 ITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-G 575 (810)
Q Consensus 497 Ld~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G 575 (810)
|+.+|.+||+|||+++...... .........||+.|+|||++.+..|+.++|||||||++|||++ |
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~-------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g 302 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNID-------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 302 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCC-------------TTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ECCCCCEEEccccCCcccCccc-------------ceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 9999999999999997532110 0011233467899999999999999999999999999999999 9
Q ss_pred CCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 576 CVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 576 ~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..||.+....+++..+..+... +.. ..++.++.+||.+||+.||.+||++ .|+++
T Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~l~~li~~~l~~dP~~Rpt~---~ell~ 357 (370)
T 2psq_A 303 GSPYPGIPVEELFKLLKEGHRM-DKP--ANCTNELYMMMRDCWHAVPSQRPTF---KQLVE 357 (370)
T ss_dssp CCSSTTCCGGGHHHHHHTTCCC-CCC--TTSCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCCCC-CCC--CCCCHHHHHHHHHHcCCChhhCcCH---HHHHH
Confidence 9999998888877776654321 111 2367899999999999999999998 77765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=401.89 Aligned_cols=261 Identities=21% Similarity=0.308 Sum_probs=219.8
Q ss_pred CCCCCcEEEEEecccCceEEEEEE-----EcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVR-----HKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~-----~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
...++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+++.++|||||++++++.+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 445789999999999999999999 44577899999886432 23344578889999999999999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC---cEEE
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNT-------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKL 505 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~-------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g---~VKL 505 (810)
....|+||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.+| .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999999753 3599999999999999999999999999999999999999665 4999
Q ss_pred eccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCH
Q psy16843 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETP 584 (810)
Q Consensus 506 ~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~ 584 (810)
+|||+++..... .........+||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+.
T Consensus 226 ~DFG~a~~~~~~-------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~ 292 (367)
T 3l9p_A 226 GDFGMARDIYRA-------------GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292 (367)
T ss_dssp CCCHHHHHHHHH-------------SSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred CCCccccccccc-------------cccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999998742211 11112234578999999999999999999999999999999998 9999999999
Q ss_pred HHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 585 EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 585 ~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.+++..+..+....+.. .++.++.+||.+||+.||.+||++ .|+++|.++-.
T Consensus 293 ~~~~~~i~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~---~eil~~l~~~~ 344 (367)
T 3l9p_A 293 QEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPEDRPNF---AIILERIEYCT 344 (367)
T ss_dssp HHHHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCH---HHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCc---cCCHHHHHHHHHHcCCCHhHCcCH---HHHHHHHHHHh
Confidence 99888887765332221 267899999999999999999998 89999877643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=385.24 Aligned_cols=263 Identities=28% Similarity=0.474 Sum_probs=215.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEc-CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC---CCCeEEEeeeecc----
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHK-ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT---DNPFVVTMYCSFE---- 434 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k-~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l---~HPnIVkl~~~f~---- 434 (810)
.++|++++.||+|+||.||+|++. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 368999999999999999999995 678999999886543221 1112344566666555 8999999999987
Q ss_pred -ccceeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 435 -TKKHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 435 -~~~~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
....+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 6678999999997 5999999764 35999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I 591 (810)
+..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+
T Consensus 168 ~~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 231 (326)
T 1blx_A 168 RIYSFQ----------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231 (326)
T ss_dssp CCCCGG----------------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccccCC----------------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 753211 0113457999999999999999999999999999999999999999999888777766
Q ss_pred ccCC-----CCCCC------------------CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 592 VNDD-----IEWPS------------------EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 592 ~~~~-----~~~p~------------------~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
.... ..|+. .....++.++++||.+||..||.+||++ .|+++||||.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA---YSALSHPYFQDLERC 306 (326)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH---HHHHTSGGGTTCCCC
T ss_pred HHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH---HHHhcCccccccchh
Confidence 5310 01110 0012367889999999999999999998 999999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=395.54 Aligned_cols=258 Identities=22% Similarity=0.356 Sum_probs=212.3
Q ss_pred CCCCCCcEEEEEecccCceEEEEEE-----EcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeec
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVR-----HKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSF 433 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~-----~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f 433 (810)
....++|++.+.||+|+||.||+|+ +..+++.||||++..... ....+.+.+|++++..+ +|||||++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 3455789999999999999999999 455678999999865432 33456789999999999 889999999998
Q ss_pred cccc-eeeeeeeeccCcchhhhhhcCCC----------------------------------------------------
Q psy16843 434 ETKK-HLCLVMEYVEGGDCASLLKNTGP---------------------------------------------------- 460 (810)
Q Consensus 434 ~~~~-~lyLVmEy~~GGsL~~lL~~~g~---------------------------------------------------- 460 (810)
.+.+ .+|+||||+.||+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8755 59999999999999999976432
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhh
Q psy16843 461 --------------LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECY 526 (810)
Q Consensus 461 --------------lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~ 526 (810)
+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~--------- 246 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD--------- 246 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC---------
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc---------
Confidence 899999999999999999999999999999999999999999999999999753211
Q ss_pred hhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCc
Q psy16843 527 VERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWP 605 (810)
Q Consensus 527 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~ 605 (810)
..........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+....+.+...+......+... .
T Consensus 247 ----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~ 320 (359)
T 3vhe_A 247 ----PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--Y 320 (359)
T ss_dssp ----TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT--T
T ss_pred ----ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCC--C
Confidence 11112234578999999999999999999999999999999998 9999988765444444443332222222 2
Q ss_pred ccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 606 IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 606 ~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
+++++.+||.+||+.||.+||++ .|+++|
T Consensus 321 ~~~~l~~li~~~l~~dP~~Rps~---~ell~~ 349 (359)
T 3vhe_A 321 TTPEMYQTMLDCWHGEPSQRPTF---SELVEH 349 (359)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCH---HHHHHH
Confidence 67899999999999999999998 788765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=375.03 Aligned_cols=253 Identities=22% Similarity=0.371 Sum_probs=217.3
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
....++|++++.||+|+||.||+|++. +++.||+|++....... +.+.+|+++++.++||||+++++++.+.+.+
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 345578999999999999999999987 46779999987654322 5678899999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999999999965 4579999999999999999999999999999999999999999999999999987532211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+......
T Consensus 161 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~ 226 (269)
T 4hcu_A 161 --------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 226 (269)
T ss_dssp --------------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred --------------cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC
Confidence 111233457889999999999999999999999999999999 99999999999888887765332
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
... ...++++.+||.+||+.||.+||++ .|+++|
T Consensus 227 ~~~---~~~~~~~~~li~~~l~~~p~~Rps~---~~ll~~ 260 (269)
T 4hcu_A 227 YKP---RLASTHVYQIMNHCWRERPEDRPAF---SRLLRQ 260 (269)
T ss_dssp CCC---TTSCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCC---CcCCHHHHHHHHHHccCCcccCcCH---HHHHHH
Confidence 222 1267899999999999999999998 777765
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=387.79 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=216.7
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCc---EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQ---RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~---~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
.....++|++.+.||+|+||.||+|+++.+++ .||||++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34556789999999999999999999986655 59999886543 23445678899999999999999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccc
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~ 514 (810)
.+.+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999654 68999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhcc
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVN 593 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~ 593 (810)
..... .........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+....++...+..
T Consensus 202 ~~~~~------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 269 (325)
T 3kul_A 202 EDDPD------------AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269 (325)
T ss_dssp C----------------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred ccCcc------------ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 22110 1111223457889999999999999999999999999999998 9999999999888888776
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 594 ~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
... .+.. ..++.++.+||.+||..||.+||++ .|+++
T Consensus 270 ~~~-~~~~--~~~~~~l~~li~~~l~~dp~~Rps~---~eil~ 306 (325)
T 3kul_A 270 GYR-LPAP--MGCPHALHQLMLDCWHKDRAQRPRF---SQIVS 306 (325)
T ss_dssp TCC-CCCC--TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CCC-CCCC--CCcCHHHHHHHHHHccCChhhCcCH---HHHHH
Confidence 532 2222 2367899999999999999999998 66654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=397.79 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=211.0
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CC-----eEEEeeeecccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NP-----FVVTMYCSFETK 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HP-----nIVkl~~~f~~~ 436 (810)
.++|++.+.||+|+||.||+|+++.+++.||||++.... .....+..|+.+++.++ |+ +|+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 478999999999999999999999999999999886542 23456667888877764 44 599999999999
Q ss_pred ceeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhh--hcccccccCCCCceEec--cCCcEEEeccCC
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLH--SYGIVHRDLKPDNLLIT--ALGHIKLTDFGL 510 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLH--s~gIIHRDLKPeNILLd--~~g~VKL~DFGL 510 (810)
+.+|+||||+. |+|.+++... +.+++..++.++.||+.||.||| +.||+||||||+||||+ .++.+||+|||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 99999999996 5999999765 46999999999999999999999 57999999999999995 478899999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~ 590 (810)
++.... .....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..
T Consensus 208 a~~~~~------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 269 (382)
T 2vx3_A 208 SCQLGQ------------------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 269 (382)
T ss_dssp CEETTC------------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ceeccc------------------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 975211 11346799999999999999999999999999999999999999999988887776
Q ss_pred hccCCCCCC------------------C-----------------CCCC-------------------------cccHHH
Q psy16843 591 TVNDDIEWP------------------S-----------------EDDW-------------------------PIQVEA 610 (810)
Q Consensus 591 I~~~~~~~p------------------~-----------------~~~~-------------------------~~S~el 610 (810)
+.......+ . .... ..++++
T Consensus 270 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (382)
T 2vx3_A 270 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKF 349 (382)
T ss_dssp HHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHH
T ss_pred HHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHH
Confidence 654211000 0 0000 011478
Q ss_pred HHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 611 KSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 611 ~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
++||.+||+.||.+|||+ .|+|+||||.+..+
T Consensus 350 ~dli~~mL~~dP~~Rpta---~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 350 KDLILRMLDYDPKTRIQP---YYALQHSFFKKTAD 381 (382)
T ss_dssp HHHHHHHTCSCTTTSCCH---HHHTTSGGGCC---
T ss_pred HHHHHHhcCCChhhCCCH---HHHhcCcccccCCC
Confidence 999999999999999999 99999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=389.20 Aligned_cols=260 Identities=25% Similarity=0.423 Sum_probs=208.4
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccch--------hhHHHHHHHHHHHHHHhcCCCCeEEEeeeec-
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL--------MLRNQMEQVFAERDIMSFTDNPFVVTMYCSF- 433 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~--------~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f- 433 (810)
.++|++++.||+|+||.||+|.+.. |+.||||++..... ......+.+.+|+++++.++||||+++++++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4789999999999999999999865 89999998865322 1233447789999999999999999999998
Q ss_pred ----cccceeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEecc
Q psy16843 434 ----ETKKHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDF 508 (810)
Q Consensus 434 ----~~~~~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DF 508 (810)
.....+|+||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 34457999999997 577777754 457999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHH
Q psy16843 509 GLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL 587 (810)
Q Consensus 509 GLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~ 587 (810)
|+++..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 179 g~~~~~~~~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 179 NLAREDTAD----------------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp TC-------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred Ccccccccc----------------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 998642111 11134579999999999987 6789999999999999999999999999888777
Q ss_pred HHhhccCCC------------------------CCCCCC----CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCC
Q psy16843 588 FAHTVNDDI------------------------EWPSED----DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639 (810)
Q Consensus 588 ~~~I~~~~~------------------------~~p~~~----~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPf 639 (810)
+..+..... ..+... ....++++.+||.+||+.||.+||++ .|+++|||
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~hp~ 319 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST---EQALRHPY 319 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH---HHHHTSGG
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH---HHHHcCch
Confidence 666643100 011000 01246789999999999999999998 99999999
Q ss_pred cCCC
Q psy16843 640 FSNL 643 (810)
Q Consensus 640 F~~i 643 (810)
|+++
T Consensus 320 f~~~ 323 (362)
T 3pg1_A 320 FESL 323 (362)
T ss_dssp GTTT
T ss_pred hhhc
Confidence 9886
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=385.92 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=217.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
...++|++++.||+|+||.||+|+++ .+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 34578999999999999999999997 3558999998865432 3445678999999999999999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcC------------------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCC
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNT------------------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLK 491 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~------------------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLK 491 (810)
.+.+|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 99999999999999999999763 579999999999999999999999999999999
Q ss_pred CCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHH
Q psy16843 492 PDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE 571 (810)
Q Consensus 492 PeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyE 571 (810)
|+|||++.++.+||+|||+++...... .........||+.|+|||++.+..|+.++|||||||++||
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 268 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSAD-------------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGG-------------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cceEEECCCCeEEEeecCCCcccccCc-------------cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHH
Confidence 999999999999999999986532110 0111234568999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 572 FLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 572 LLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
|++ |..||.+.+..++...+..+...... ..++.++.+||.+||+.||.+||++ .|+++
T Consensus 269 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~---~~~~~ 328 (343)
T 1luf_A 269 IFSYGLQPYYGMAHEEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSF---CSIHR 328 (343)
T ss_dssp HHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred HHhcCCCcCCCCChHHHHHHHhCCCcCCCC---CCCCHHHHHHHHHHcccCcccCCCH---HHHHH
Confidence 998 99999999999888888776543221 1367899999999999999999998 66664
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=402.66 Aligned_cols=261 Identities=25% Similarity=0.459 Sum_probs=195.0
Q ss_pred CCcEE-EEEecccCceEEEEEEEc--CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeec--cccce
Q psy16843 364 NDFTV-IKLISNGAYGSVYLVRHK--ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSF--ETKKH 438 (810)
Q Consensus 364 ~dy~i-lk~LG~G~FG~Vyla~~k--~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f--~~~~~ 438 (810)
+.|++ .++||+|+||.||+|+++ .+++.||||++...... ..+.+|+.+|+.++|||||+++++| .....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 34666 457999999999999977 46889999988654322 3567899999999999999999999 55779
Q ss_pred eeeeeeeccCcchhhhhhc---------CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe----ccCCcEEE
Q psy16843 439 LCLVMEYVEGGDCASLLKN---------TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI----TALGHIKL 505 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~---------~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL----d~~g~VKL 505 (810)
+|+||||+.| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||
T Consensus 95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999999964 78777752 1259999999999999999999999999999999999999 67789999
Q ss_pred eccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCH
Q psy16843 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETP 584 (810)
Q Consensus 506 ~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~ 584 (810)
+|||+|+....... ........+||+.|+|||++.+. .|+.++|||||||+||||++|.+||.+...
T Consensus 174 ~Dfg~a~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 174 ADMGFARLFNSPLK------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CCTTCCC----------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EECCCceecCCCCc------------ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 99999975321100 00112356899999999999885 589999999999999999999999987654
Q ss_pred H---------HHHHhhccCCCCCCCCCCC-----------------------------------cccHHHHHHHHhhhcC
Q psy16843 585 E---------ELFAHTVNDDIEWPSEDDW-----------------------------------PIQVEAKSIITDLLQQ 620 (810)
Q Consensus 585 ~---------e~~~~I~~~~~~~p~~~~~-----------------------------------~~S~el~dLI~klL~~ 620 (810)
. +.+..+... +..|....| ..++++.+||.+||+.
T Consensus 242 ~~~~~~~~~~~~l~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~ 320 (405)
T 3rgf_A 242 DIKTSNPYHHDQLDRIFNV-MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM 320 (405)
T ss_dssp -----CCCCHHHHHHHHHH-HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCS
T ss_pred cccccccchHHHHHHHHHh-hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccC
Confidence 2 333333321 111111111 1267899999999999
Q ss_pred CCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 621 NPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 621 dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
||.+|||+ .|+|+||||.+..|.
T Consensus 321 dP~~R~ta---~e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 321 DPIKRITS---EQAMQDPYFLEDPLP 343 (405)
T ss_dssp SGGGSCCH---HHHHTSGGGTSSSCC
T ss_pred CcccCCCH---HHHhcChhhccCCCC
Confidence 99999999 999999999876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=381.84 Aligned_cols=257 Identities=21% Similarity=0.335 Sum_probs=217.3
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecc
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE 434 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~ 434 (810)
....++|.+.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+++++.++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 344578999999999999999999984 456889999886543 2445578899999999999999999999999
Q ss_pred ccceeeeeeeeccCcchhhhhhcCCC------------------------CCHHHHHHHHHHHHHHHHHhhhcccccccC
Q psy16843 435 TKKHLCLVMEYVEGGDCASLLKNTGP------------------------LPADMARFYFAETVLAVEYLHSYGIVHRDL 490 (810)
Q Consensus 435 ~~~~lyLVmEy~~GGsL~~lL~~~g~------------------------lse~~~~~i~~QIl~AL~yLHs~gIIHRDL 490 (810)
+.+.+|+||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 99999999999999999999976543 899999999999999999999999999999
Q ss_pred CCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHH
Q psy16843 491 KPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILY 570 (810)
Q Consensus 491 KPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILy 570 (810)
||+|||++.++.+||+|||+++...... .........||+.|+|||++.+..|+.++|||||||++|
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 243 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEED-------------SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLW 243 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTS-------------CEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred chheEEEcCCCCEEEccccccccccccc-------------cceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHH
Confidence 9999999999999999999987532110 111123446789999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 571 EFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 571 ELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
||++ |..||.+....++...+....... .. ..+++++.+||.+||+.||.+||++ .|++++
T Consensus 244 el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~li~~~l~~dp~~Rps~---~~l~~~ 305 (314)
T 2ivs_A 244 EIVTLGGNPYPGIPPERLFNLLKTGHRME-RP--DNCSEEMYRLMLQCWKQEPDKRPVF---ADISKD 305 (314)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTTCCCC-CC--TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHhhcCCcCC-CC--ccCCHHHHHHHHHHccCChhhCcCH---HHHHHH
Confidence 9999 999999988887777666543221 11 2367999999999999999999998 777754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=375.08 Aligned_cols=254 Identities=21% Similarity=0.318 Sum_probs=215.4
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
+....++|++++.||+|+||.||++.++ ++..||+|++...... .+.+.+|+++++.++||||+++++++.+.+.
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 3455689999999999999999999886 5678999998765432 2567889999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999999999999976 567999999999999999999999999999999999999999999999999998753211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
. ........||+.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+.....
T Consensus 174 ~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (283)
T 3gen_A 174 E--------------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 239 (283)
T ss_dssp H--------------HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred c--------------cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC
Confidence 0 011123457889999999999999999999999999999998 9999999998888888776543
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
..... ..++++.+||.+||+.||.+||++ .|+++|
T Consensus 240 ~~~~~---~~~~~l~~li~~~l~~~p~~Rps~---~~ll~~ 274 (283)
T 3gen_A 240 LYRPH---LASEKVYTIMYSCWHEKADERPTF---KILLSN 274 (283)
T ss_dssp CCCCT---TCCHHHHHHHHHTTCSSGGGSCCH---HHHHHH
T ss_pred CCCCC---cCCHHHHHHHHHHccCChhHCcCH---HHHHHH
Confidence 33222 257899999999999999999998 788765
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=393.50 Aligned_cols=255 Identities=30% Similarity=0.500 Sum_probs=186.7
Q ss_pred CCCCCcEEEE-EecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc----
Q psy16843 361 PNENDFTVIK-LISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET---- 435 (810)
Q Consensus 361 ~~~~dy~ilk-~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~---- 435 (810)
...++|.+++ .||+|+||.||+|+++.+|+.||||++..... ........++.++||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 3457899966 59999999999999999999999998865421 11222334567899999999999876
Q ss_pred cceeeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC---CcEEEeccCC
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL---GHIKLTDFGL 510 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~---g~VKL~DFGL 510 (810)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 557999999999999999998654 69999999999999999999999999999999999999864 4599999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHH---
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL--- 587 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~--- 587 (810)
++..... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+......
T Consensus 178 ~~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 240 (336)
T 3fhr_A 178 AKETTQN-----------------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG 240 (336)
T ss_dssp CEEC---------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceecccc-----------------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh
Confidence 8642211 11345789999999999888899999999999999999999999987665443
Q ss_pred -HHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 588 -FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 588 -~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
...+......++......++.++++||.+||+.||.+||++ .|+++||||.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~hp~~~~ 293 (336)
T 3fhr_A 241 MKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI---TQFMNHPWINQ 293 (336)
T ss_dssp ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH---HHHHHSHHHHT
T ss_pred HHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCH---HHHhcCccccc
Confidence 33333444445544444578999999999999999999998 99999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=383.42 Aligned_cols=266 Identities=20% Similarity=0.268 Sum_probs=223.3
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecc
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE 434 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~ 434 (810)
....++|++.+.||+|+||.||+|.++ .+++.||+|++..... ......+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 345578999999999999999999887 4578899998865432 234467889999999999999999999999
Q ss_pred ccceeeeeeeeccCcchhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEE
Q psy16843 435 TKKHLCLVMEYVEGGDCASLLKNT----------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIK 504 (810)
Q Consensus 435 ~~~~lyLVmEy~~GGsL~~lL~~~----------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VK 504 (810)
+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 999999999999999999999642 4579999999999999999999999999999999999999999999
Q ss_pred EeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCC
Q psy16843 505 LTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGET 583 (810)
Q Consensus 505 L~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~ 583 (810)
|+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus 179 l~Dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 179 IGDFGMTRDIYETDY-------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp ECCTTCCCGGGGGGC-------------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred ECcCccccccccccc-------------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 999999875321110 011123467999999999999999999999999999999999 899999999
Q ss_pred HHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC------CCcCCCChh
Q psy16843 584 PEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH------PYFSNLDWN 646 (810)
Q Consensus 584 ~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H------PfF~~id~~ 646 (810)
..+....+......... ..++.++.+||.+||..||.+||++ .|+++| ++|++++|.
T Consensus 246 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~---~e~l~~L~~~~~~~~~~~~~~ 308 (322)
T 1p4o_A 246 NEQVLRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSF---LEIISSIKEEMEPGFREVSFY 308 (322)
T ss_dssp HHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHHHHGGGSCTTHHHHCST
T ss_pred HHHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCcCH---HHHHHHHHHhhccCCcccccc
Confidence 98888887765543221 2367899999999999999999998 777765 666555544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=372.24 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=216.3
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|.++ ++..||+|++...... .+.+.+|+++++.++||||+++++++.+.+.+|
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 34578999999999999999999876 5677999988765432 255788999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 158 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ- 158 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh-
Confidence 9999999999999997654 59999999999999999999999999999999999999999999999999987532211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
........||+.|+|||++.+..++.++||||||+++|||++ |..||.+....+....+.......
T Consensus 159 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 225 (268)
T 3sxs_A 159 -------------YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY 225 (268)
T ss_dssp -------------EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred -------------hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC
Confidence 111123457888999999999999999999999999999998 999999999888888777655433
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
... ..++++.+||.+||+.||.+||++ .|+++|
T Consensus 226 ~~~---~~~~~l~~li~~~l~~~p~~Rps~---~~ll~~ 258 (268)
T 3sxs_A 226 RPH---LASDTIYQIMYSCWHELPEKRPTF---QQLLSS 258 (268)
T ss_dssp CCT---TSCHHHHHHHHHTTCSSGGGSCCH---HHHHHH
T ss_pred CCC---cChHHHHHHHHHHcCCChhhCcCH---HHHHHH
Confidence 322 267899999999999999999998 777765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=387.39 Aligned_cols=253 Identities=21% Similarity=0.249 Sum_probs=208.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyL 441 (810)
.++|++.+.||+|+||.||+|+++.+|+.||||++...... +.+..|+++++.+ +||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 47899999999999999999999999999999988654321 3577899999999 99999999999999999999
Q ss_pred eeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc-----EEEeccCCccccc
Q psy16843 442 VMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH-----IKLTDFGLSKMGL 515 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~-----VKL~DFGLAk~~~ 515 (810)
||||+ ||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||||+.++. +||+|||+++...
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999 9999999986 468999999999999999999999999999999999999999887 9999999997532
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCC---CCHHHHHHhhc
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG---ETPEELFAHTV 592 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~---~~~~e~~~~I~ 592 (810)
...... ..........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+ ....+.+..+.
T Consensus 162 ~~~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 233 (330)
T 2izr_A 162 DPETKK--------HIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233 (330)
T ss_dssp CTTTCC--------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred cCCCCc--------cccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence 211100 0001112467899999999999999999999999999999999999999987 44455566655
Q ss_pred cCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 593 ~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
......+........+++.+||.+||..||.+||++.
T Consensus 234 ~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~ 270 (330)
T 2izr_A 234 DTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYD 270 (330)
T ss_dssp HHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred hhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHH
Confidence 4433332211011123899999999999999999983
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=369.65 Aligned_cols=251 Identities=26% Similarity=0.433 Sum_probs=206.0
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhh-HHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLML-RNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~-~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
..++|++.+.||+|+||.||+|.+. ++.||+|++....... ....+.+.+|+++++.++||||+++++++.+++.+|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 4578999999999999999999974 7899999886543222 233467889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCCCceEecc--------CCcEEEeccC
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG---IVHRDLKPDNLLITA--------LGHIKLTDFG 509 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~g---IIHRDLKPeNILLd~--------~g~VKL~DFG 509 (810)
+||||++||+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999999999864 58999999999999999999999999 999999999999986 7789999999
Q ss_pred CcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16843 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589 (810)
Q Consensus 510 LAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~ 589 (810)
+++..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+......
T Consensus 162 ~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 224 (271)
T 3dtc_A 162 LAREWHRT-----------------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224 (271)
T ss_dssp C------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH
T ss_pred cccccccc-----------------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 98642111 1123469999999999999999999999999999999999999999998888877
Q ss_pred hhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 590 ~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.+.......+... .+++++.+||.+||+.||.+||++ .|+++|
T Consensus 225 ~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~---~e~l~~ 267 (271)
T 3dtc_A 225 GVAMNKLALPIPS--TCPEPFAKLMEDCWNPDPHSRPSF---TNILDQ 267 (271)
T ss_dssp HHHTSCCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred hhhcCCCCCCCCc--ccCHHHHHHHHHHhcCCcccCcCH---HHHHHH
Confidence 7776655444332 367899999999999999999998 777754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=388.31 Aligned_cols=256 Identities=23% Similarity=0.409 Sum_probs=205.9
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-----------CCeEEEee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-----------NPFVVTMY 430 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-----------HPnIVkl~ 430 (810)
..++|++++.||+|+||.||+|+++.+++.||||++.... ...+.+.+|+++++.+. ||||++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 4578999999999999999999999999999999987543 23356778888888776 89999999
Q ss_pred eeccccc----eeeeeeeeccCcchhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCCCceEecc----
Q psy16843 431 CSFETKK----HLCLVMEYVEGGDCASLLKN--TGPLPADMARFYFAETVLAVEYLHSY-GIVHRDLKPDNLLITA---- 499 (810)
Q Consensus 431 ~~f~~~~----~lyLVmEy~~GGsL~~lL~~--~g~lse~~~~~i~~QIl~AL~yLHs~-gIIHRDLKPeNILLd~---- 499 (810)
+++...+ .+++||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++ ||+||||||+||||+.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9998654 899999999 8999999975 35699999999999999999999998 9999999999999954
Q ss_pred --CCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCC
Q psy16843 500 --LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCV 577 (810)
Q Consensus 500 --~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~ 577 (810)
.+.+||+|||+++.... .....+||+.|+|||++.+..|+.++|||||||++|||++|..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 233 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233 (373)
T ss_dssp TTEEEEEECCCTTCEETTB------------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCcceEEEcccccccccCC------------------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 44899999999865211 1124579999999999999999999999999999999999999
Q ss_pred CCCCCC------HHHHHHhhccCCCCCCC--------------------------------------CCCCcccHHHHHH
Q psy16843 578 PFFGET------PEELFAHTVNDDIEWPS--------------------------------------EDDWPIQVEAKSI 613 (810)
Q Consensus 578 PF~~~~------~~e~~~~I~~~~~~~p~--------------------------------------~~~~~~S~el~dL 613 (810)
||.+.+ ..+.+..+....-.+|. ......+.++.+|
T Consensus 234 pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 313 (373)
T 1q8y_A 234 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313 (373)
T ss_dssp CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHH
Confidence 998654 22222222210000000 0011256789999
Q ss_pred HHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 614 ITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 614 I~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
|.+||+.||.+||++ .|+++||||.+.
T Consensus 314 i~~~L~~dP~~Rpt~---~ell~hp~f~~~ 340 (373)
T 1q8y_A 314 LSPMLQLDPRKRADA---GGLVNHPWLKDT 340 (373)
T ss_dssp HGGGGCSSTTTCBCH---HHHHTCGGGTTC
T ss_pred HHHHhccCccccCCH---HHHhhChhhhcc
Confidence 999999999999999 999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=386.14 Aligned_cols=258 Identities=20% Similarity=0.289 Sum_probs=213.9
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeec
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSF 433 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f 433 (810)
....++|++.+.||+|+||.||+|.+. .++..||+|++..... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345578999999999999999999973 4567899998865432 23446788999999999 999999999999
Q ss_pred cccceeeeeeeeccCcchhhhhhcCC-----------------------CCCHHHHHHHHHHHHHHHHHhhhcccccccC
Q psy16843 434 ETKKHLCLVMEYVEGGDCASLLKNTG-----------------------PLPADMARFYFAETVLAVEYLHSYGIVHRDL 490 (810)
Q Consensus 434 ~~~~~lyLVmEy~~GGsL~~lL~~~g-----------------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDL 490 (810)
...+.+|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 99999999999999999999997643 3799999999999999999999999999999
Q ss_pred CCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHH
Q psy16843 491 KPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILY 570 (810)
Q Consensus 491 KPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILy 570 (810)
||+||||+.++.+||+|||++....... .........||+.|+|||++.+..|+.++|||||||++|
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~-------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 265 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDS-------------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCT-------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCc-------------cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHH
Confidence 9999999999999999999987532110 111123456899999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 571 EFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 571 ELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
||++ |..||.+......+..++......+... ..++++.+||.+||..||.+||++ .|+++|
T Consensus 266 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~---~~l~~~ 328 (344)
T 1rjb_A 266 EIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF--YATEEIYIIMQSCWAFDSRKRPSF---PNLTSF 328 (344)
T ss_dssp HHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred HHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCC--CCCHHHHHHHHHHcCCCchhCcCH---HHHHHH
Confidence 9998 9999998776655555555544433322 367999999999999999999998 777765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=376.70 Aligned_cols=247 Identities=20% Similarity=0.284 Sum_probs=207.5
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCC-------cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeec
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETR-------QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSF 433 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg-------~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f 433 (810)
...++|++.+.||+|+||.||+|+++.++ ..||+|++.+.. ....+.+.+|+.+++.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 44578999999999999999999998877 479999886543 23346788999999999999999999999
Q ss_pred cccceeeeeeeeccCcchhhhhhcCCC-CCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc--------EE
Q psy16843 434 ETKKHLCLVMEYVEGGDCASLLKNTGP-LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH--------IK 504 (810)
Q Consensus 434 ~~~~~lyLVmEy~~GGsL~~lL~~~g~-lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~--------VK 504 (810)
.+++..|+||||+.||+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 999999999999999999999999999999999999998887 99
Q ss_pred EeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhC-CCCCCCC
Q psy16843 505 LTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVG-CVPFFGE 582 (810)
Q Consensus 505 L~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG-~~PF~~~ 582 (810)
|+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++| .+||...
T Consensus 162 l~Dfg~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~ 222 (289)
T 4fvq_A 162 LSDPGISITVLP-------------------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222 (289)
T ss_dssp ECCCCSCTTTSC-------------------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred eccCcccccccC-------------------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc
Confidence 999999864211 123458999999999987 7789999999999999999995 5555555
Q ss_pred CHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 583 TPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 583 ~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
...... .+......++.. .+.++.+||.+||+.||.+||++ .|+++|
T Consensus 223 ~~~~~~-~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~---~~ll~~ 269 (289)
T 4fvq_A 223 DSQRKL-QFYEDRHQLPAP----KAAELANLINNCMDYEPDHRPSF---RAIIRD 269 (289)
T ss_dssp CHHHHH-HHHHTTCCCCCC----SSCTTHHHHHHHSCSSGGGSCCH---HHHHHH
T ss_pred chHHHH-HHhhccCCCCCC----CCHHHHHHHHHHcCCChhHCcCH---HHHHHH
Confidence 554443 333334444432 46789999999999999999998 777764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=378.93 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=205.7
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++.+.||+|+||.||+|+++.+++.||+|++...........+.+.+|+.+++.++||||+++++++..++.+|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 35789999999999999999999999999999999876654445556788999999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---- 187 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE---- 187 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc----
Confidence 9999999999999998889999999999999999999999999999999999999999999999999998653211
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
........+||+.|+|||++.+..++.++||||||+++|||++|..||.+.+...+...+. .....+..
T Consensus 188 ----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~ 256 (309)
T 2h34_A 188 ----------KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-QAIPRPST 256 (309)
T ss_dssp -------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-SCCCCGGG
T ss_pred ----------ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-cCCCCccc
Confidence 0011134579999999999999999999999999999999999999999877665444433 33222222
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCC-CC
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRL-GT 628 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rp-ta 628 (810)
....++.++.+||.+||..||.+|| ++
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~ 284 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTC 284 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSH
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhH
Confidence 2233778999999999999999999 55
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=364.06 Aligned_cols=249 Identities=13% Similarity=0.206 Sum_probs=213.4
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc--c
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK--K 437 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~--~ 437 (810)
....++|++.+.||+|+||.||+|+++ ++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+. +
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 345578999999999999999999985 788999988765332 34456789999999999999999999999887 7
Q ss_pred eeeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYG--IVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~g--IIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
.+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++| |+||||||+|||++.+|.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 8999999999999999998765 5999999999999999999999999 99999999999999999999999998643
Q ss_pred ccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCC---CcchhhhHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy16843 514 GLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGK---PVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590 (810)
Q Consensus 514 ~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~---ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~ 590 (810)
. .....+||+.|+|||++.+..++. ++|||||||++|||++|..||.+.+..+....
T Consensus 163 ~--------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 222 (271)
T 3kmu_A 163 F--------------------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK 222 (271)
T ss_dssp T--------------------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH
T ss_pred e--------------------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH
Confidence 1 112456899999999999766544 79999999999999999999999998888777
Q ss_pred hccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 591 I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
+.......+... .+++++.+||.+||+.||.+||++ .|+++
T Consensus 223 ~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~---~~il~ 263 (271)
T 3kmu_A 223 VALEGLRPTIPP--GISPHVSKLMKICMNEDPAKRPKF---DMIVP 263 (271)
T ss_dssp HHHSCCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred HHhcCCCCCCCC--CCCHHHHHHHHHHcCCChhhCcCH---HHHHH
Confidence 776554433222 367999999999999999999998 66664
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=386.29 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=204.9
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEE----EEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRF----AMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~v----AIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
...++|++++.||+|+||.||+|++..+++.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 45578999999999999999999998888765 556553322 123346788999999999999999999999875
Q ss_pred ceeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
. .++||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 4 7899999999999999976 4679999999999999999999999999999999999999999999999999987532
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccC
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVND 594 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~ 594 (810)
.. ..........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+....++...+...
T Consensus 169 ~~-------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 235 (327)
T 3poz_A 169 AE-------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235 (327)
T ss_dssp TT-------------CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred CC-------------cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC
Confidence 11 11111233457889999999999999999999999999999999 99999998877776665544
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 595 ~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.. .+... ..+.++.+||.+||+.||.+||++ .|+++|
T Consensus 236 ~~-~~~~~--~~~~~~~~li~~~l~~~p~~Rps~---~ell~~ 272 (327)
T 3poz_A 236 ER-LPQPP--ICTIDVYMIMVKCWMIDADSRPKF---RELIIE 272 (327)
T ss_dssp CC-CCCCT--TBCHHHHHHHHHHTCSCGGGSCCH---HHHHHH
T ss_pred CC-CCCCc--cCCHHHHHHHHHHcCCChhhCCCH---HHHHHH
Confidence 32 22221 267899999999999999999998 777765
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=387.32 Aligned_cols=258 Identities=26% Similarity=0.442 Sum_probs=217.1
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH---HHHHHHHHHHHHHhcCC--CCeEEEeeeecc
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR---NQMEQVFAERDIMSFTD--NPFVVTMYCSFE 434 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~---~~~~~i~~E~~iL~~l~--HPnIVkl~~~f~ 434 (810)
....++|++.+.||+|+||.||+|+++.+++.||||++........ ...+.+..|+.+++.+. ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3456789999999999999999999999999999999876543211 11234567889998886 599999999999
Q ss_pred ccceeeeeeeeccC-cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEec-cCCcEEEeccCCcc
Q psy16843 435 TKKHLCLVMEYVEG-GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLIT-ALGHIKLTDFGLSK 512 (810)
Q Consensus 435 ~~~~lyLVmEy~~G-GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd-~~g~VKL~DFGLAk 512 (810)
+.+.+++||||+.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999999986 89999999888999999999999999999999999999999999999999 68999999999987
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I 591 (810)
..... ......||+.|+|||++.+..+ +.++|||||||++|||++|..||.+.. .+
T Consensus 199 ~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~ 255 (320)
T 3a99_A 199 LLKDT-----------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EI 255 (320)
T ss_dssp ECCSS-----------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH
T ss_pred ccccc-----------------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hh
Confidence 53211 1134569999999999988776 788999999999999999999997542 22
Q ss_pred ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhh
Q psy16843 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNS 647 (810)
Q Consensus 592 ~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~ 647 (810)
......++. .+++++.+||.+||+.||.+||++ .|+++||||.++.+..
T Consensus 256 ~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~---~~ll~hp~~~~~~~~~ 304 (320)
T 3a99_A 256 IRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTF---EEIQNHPWMQDVLLPQ 304 (320)
T ss_dssp HHCCCCCSS----CCCHHHHHHHHHHTCSSGGGSCCH---HHHHTSGGGSSCCCHH
T ss_pred hcccccccc----cCCHHHHHHHHHHccCChhhCcCH---HHHhcCHhhcCccCcc
Confidence 233333332 267999999999999999999998 9999999999876543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=377.62 Aligned_cols=257 Identities=20% Similarity=0.308 Sum_probs=215.0
Q ss_pred CCCCCcEEEEEecccCceEEEEEEE-----cCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRH-----KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFE 434 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~-----k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~ 434 (810)
...++|++.+.||+|+||.||+|.+ ..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 4457899999999999999999985 45678999998875432 23457788999999999 9999999999999
Q ss_pred ccceeeeeeeeccCcchhhhhhcCC------------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceE
Q psy16843 435 TKKHLCLVMEYVEGGDCASLLKNTG------------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLL 496 (810)
Q Consensus 435 ~~~~lyLVmEy~~GGsL~~lL~~~g------------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNIL 496 (810)
+.+.+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 9999999999999999999997643 4899999999999999999999999999999999999
Q ss_pred eccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-C
Q psy16843 497 ITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-G 575 (810)
Q Consensus 497 Ld~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G 575 (810)
++.++.+||+|||+++..... ..........||+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~-------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 244 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKND-------------SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSC-------------TTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred EcCCCCEEEcccccccccccc-------------ccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 999999999999998753211 01111234568899999999999999999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 576 CVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 576 ~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
..||.+.........+.......+... .++.++.+||.+||..||.+||++ .|++++
T Consensus 245 ~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~---~ell~~ 301 (313)
T 1t46_A 245 SSPYPGMPVDSKFYKMIKEGFRMLSPE--HAPAEMYDIMKTCWDADPLKRPTF---KQIVQL 301 (313)
T ss_dssp CCSSTTCCSSHHHHHHHHHTCCCCCCT--TSCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCCCCcccchhHHHHHhccCCCCCCcc--cCCHHHHHHHHHHcCCCchhCcCH---HHHHHH
Confidence 999988766555555544433333222 367899999999999999999998 777653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=393.75 Aligned_cols=257 Identities=21% Similarity=0.330 Sum_probs=216.6
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
+....++|++.+.||+|+||.||+|+++.+++.||||++.... .....+.+.+|+++|+.++|||||++++++.+++.
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 3455679999999999999999999999999999999876542 23344678899999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
+|+||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999999999764 46999999999999999999999999999999999999999999999999998752211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
. .........+++.|+|||++.+..|+.++|||||||++|||++ |..||.+.+..+....+..+.
T Consensus 267 ~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~- 332 (377)
T 3cbl_A 267 V-------------YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG- 332 (377)
T ss_dssp E-------------EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-
T ss_pred c-------------eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 0 0001122346788999999999999999999999999999998 999999998888777665543
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..+.+. ..++++.+||.+||+.||.+||++ .++++
T Consensus 333 ~~~~~~--~~~~~l~~li~~cl~~dP~~Rps~---~~i~~ 367 (377)
T 3cbl_A 333 RLPCPE--LCPDAVFRLMEQCWAYEPGQRPSF---STIYQ 367 (377)
T ss_dssp CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CCCCCC--CCCHHHHHHHHHHcCCCchhCcCH---HHHHH
Confidence 222222 267899999999999999999998 66653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=388.08 Aligned_cols=258 Identities=21% Similarity=0.307 Sum_probs=218.8
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCC-------CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEee
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKET-------RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMY 430 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~t-------g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~ 430 (810)
+....++|++.+.||+|+||.||+|++..+ +..||+|++.... .....+.+.+|+++++.+ +|||||+++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 345568999999999999999999997643 3579999886553 234557788999999999 999999999
Q ss_pred eeccccceeeeeeeeccCcchhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCc
Q psy16843 431 CSFETKKHLCLVMEYVEGGDCASLLKNTG----------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDN 494 (810)
Q Consensus 431 ~~f~~~~~lyLVmEy~~GGsL~~lL~~~g----------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeN 494 (810)
+++.+++.+|+||||+.||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999997643 59999999999999999999999999999999999
Q ss_pred eEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh
Q psy16843 495 LLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV 574 (810)
Q Consensus 495 ILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt 574 (810)
|||+.++.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~-------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 288 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHID-------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCC-------------TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred EEEcCCCcEEEcccCccccccccc-------------ccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHh
Confidence 999999999999999997532110 0011233467899999999999999999999999999999999
Q ss_pred -CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 575 -GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 575 -G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
|..||.+.+..++...+......... ..+++++.+||.+||+.||.+||++ .|++++
T Consensus 289 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~---~ell~~ 346 (382)
T 3tt0_A 289 LGGSPYPGVPVEELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTF---KQLVED 346 (382)
T ss_dssp TSCCSSTTCCHHHHHHHHHTTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCH---HHHHHH
Confidence 99999999988888877665332211 2367999999999999999999998 787764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=373.82 Aligned_cols=262 Identities=21% Similarity=0.359 Sum_probs=208.8
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++.+.||+|+||.||+|.++.+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++.+|+
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 3478999999999999999999999999999999885532 3455778899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 442 VMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999999986 568999999999999999999999999999999999999999999999999999764322111
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHH-----HHhhccCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEEL-----FAHTVNDD 595 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~-----~~~I~~~~ 595 (810)
....... ...........+||+.|+|||++.+..|+.++|||||||++|||++|..||........ .......
T Consensus 165 ~~~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 242 (310)
T 3s95_A 165 PEGLRSL-KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR- 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred ccccccc-cccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence 0000000 00011112356899999999999999999999999999999999999999875422110 0000100
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..+. .+++++.+||.+||+.||.+||++ .|+++
T Consensus 243 -~~~~----~~~~~l~~li~~~l~~dP~~Rps~---~~l~~ 275 (310)
T 3s95_A 243 -YCPP----NCPPSFFPITVRCCDLDPEKRPSF---VKLEH 275 (310)
T ss_dssp -TCCT----TCCTTHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred -cCCC----CCCHHHHHHHHHHccCChhhCcCH---HHHHH
Confidence 1111 256789999999999999999998 67765
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=372.45 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=209.2
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|.....||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 445556689999999999999999999999998876532 33467889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC---CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc-CCcEEEeccCCccccccccc
Q psy16843 444 EYVEGGDCASLLKNT---GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA-LGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~---g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~g~VKL~DFGLAk~~~~s~~ 519 (810)
||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-- 176 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-- 176 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--
Confidence 999999999999754 25678999999999999999999999999999999999998 899999999998753211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcC--CCCCcchhhhHHHHHHHHhCCCCCCCCCHH-HHHHhh--ccC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG--YGKPVDWWSMGVILYEFLVGCVPFFGETPE-ELFAHT--VND 594 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~--ys~ksDIWSLGvILyELLtG~~PF~~~~~~-e~~~~I--~~~ 594 (810)
........||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.... ...... ...
T Consensus 177 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (295)
T 2clq_A 177 -------------NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV 243 (295)
T ss_dssp -----------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC
T ss_pred -------------CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc
Confidence 00113457999999999998754 899999999999999999999999764332 222221 112
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 595 ~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
...++. .++.++.+||.+||+.||.+||++ .|+++||||...
T Consensus 244 ~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~---~~ll~~~~~~~~ 285 (295)
T 2clq_A 244 HPEIPE----SMSAEAKAFILKCFEPDPDKRACA---NDLLVDEFLKVS 285 (295)
T ss_dssp CCCCCT----TSCHHHHHHHHHTTCSSTTTSCCH---HHHHTSGGGCC-
T ss_pred cccccc----cCCHHHHHHHHHHccCChhhCCCH---HHHhcChhhhhc
Confidence 222222 367999999999999999999998 999999999764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=383.88 Aligned_cols=264 Identities=27% Similarity=0.434 Sum_probs=195.9
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHH-HHhcCCCCeEEEeeeeccccc
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERD-IMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~-iL~~l~HPnIVkl~~~f~~~~ 437 (810)
+....++|++++.||+|+||.||+|.++.+|+.||||++..... ......+..|.. +++.++||||+++++++.+.+
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 34566899999999999999999999999999999999876532 223344455555 778899999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 438 HLCLVMEYVEGGDCASLLKN-----TGPLPADMARFYFAETVLAVEYLHSY-GIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~-----~g~lse~~~~~i~~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
.+|+||||+.| +|.+++.. .+.+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999999975 77777652 57899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHH----hhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH-HH
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI----LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP-EE 586 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl----~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~-~e 586 (810)
+..... .......||+.|+|||++ .+..|+.++|||||||++|||++|..||.+... .+
T Consensus 174 ~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (327)
T 3aln_A 174 GQLVDS----------------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237 (327)
T ss_dssp CC----------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----
T ss_pred eecccc----------------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH
Confidence 753211 011234699999999999 466789999999999999999999999987543 23
Q ss_pred HHHhhccCC-CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCC
Q psy16843 587 LFAHTVNDD-IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLD 644 (810)
Q Consensus 587 ~~~~I~~~~-~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id 644 (810)
.+..+..+. ..++......+++++.+||.+||..||.+||++ .|+++||||...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~ell~hp~~~~~~ 293 (327)
T 3aln_A 238 QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY---KELLKHPFILMYE 293 (327)
T ss_dssp --CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCH---HHHTTSHHHHHHH
T ss_pred HHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCH---HHHHhChHHHHhH
Confidence 333333322 222322223477899999999999999999998 9999999997644
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=364.63 Aligned_cols=252 Identities=22% Similarity=0.371 Sum_probs=216.2
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+++++.++||||+++++++.+.+.+|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 44578999999999999999999987 5778999998765432 256788999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 158 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 158 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence 999999999999999764 579999999999999999999999999999999999999999999999999987532110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
........||+.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+..+....
T Consensus 159 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~ 225 (267)
T 3t9t_A 159 -------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY 225 (267)
T ss_dssp -------------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred -------------ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC
Confidence 011123457889999999999999999999999999999999 999999999888888877653322
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.. ...+.++.+||.+||+.||.+||++ .|++++
T Consensus 226 ~~---~~~~~~l~~li~~~l~~~p~~Rps~---~~ll~~ 258 (267)
T 3t9t_A 226 KP---RLASTHVYQIMNHCWRERPEDRPAF---SRLLRQ 258 (267)
T ss_dssp CC---TTSCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CC---ccCcHHHHHHHHHHccCChhhCcCH---HHHHHH
Confidence 21 1267899999999999999999998 777653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=371.26 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=203.8
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKET---RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~t---g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
...++|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++. ++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 4457899999999999999999998754 4579999875532 2344567889999999999999999999985 46
Q ss_pred eeeeeeeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
.+|+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 7899999999999999998654 799999999999999999999999999999999999999999999999999875321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
.. ........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+....+....+....
T Consensus 169 ~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~ 234 (281)
T 1mp8_A 169 ST--------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 234 (281)
T ss_dssp ------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred cc--------------ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC
Confidence 10 111123457889999999999999999999999999999996 999999988888777776643
Q ss_pred C-CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 I-EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~-~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
. ..+. .+++++.+||.+||..||.+||++ .|+++
T Consensus 235 ~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~---~~l~~ 269 (281)
T 1mp8_A 235 RLPMPP----NCPPTLYSLMTKCWAYDPSRRPRF---TELKA 269 (281)
T ss_dssp CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CCCCCC----CCCHHHHHHHHHHccCChhhCcCH---HHHHH
Confidence 2 2222 367999999999999999999998 67665
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=371.77 Aligned_cols=253 Identities=19% Similarity=0.221 Sum_probs=207.3
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~ly 440 (810)
..++|++.+.||+|+||.||+|++..+++.||||++..... .+.+.+|+.+++.+ +|+||+++++++.+....|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 34789999999999999999999999999999998865432 13467789999888 8999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc-----EEEeccCCcccc
Q psy16843 441 LVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH-----IKLTDFGLSKMG 514 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~-----VKL~DFGLAk~~ 514 (810)
+||||+ |++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|. +||+|||+++..
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999999 999999998654 6999999999999999999999999999999999999988776 999999999753
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC---CHHHHHHhh
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE---TPEELFAHT 591 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~---~~~e~~~~I 591 (810)
....... ..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+. ...+.+..+
T Consensus 162 ~~~~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 162 RDPVTKQ--------HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp BCTTTCC--------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ccccccc--------cccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 3211100 00011234567999999999999999999999999999999999999999874 445555554
Q ss_pred ccCCCCCCCC-CCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 592 VNDDIEWPSE-DDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 592 ~~~~~~~p~~-~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
.......+.. ....+++++.+||.+||+.||.+||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~ 271 (298)
T 1csn_A 234 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDY 271 (298)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred HhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCH
Confidence 4332221110 011267899999999999999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=378.29 Aligned_cols=252 Identities=27% Similarity=0.480 Sum_probs=205.5
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH---HHHHHHHHHHHHHhcC----CCCeEEEeeeecc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR---NQMEQVFAERDIMSFT----DNPFVVTMYCSFE 434 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~---~~~~~i~~E~~iL~~l----~HPnIVkl~~~f~ 434 (810)
..++|++.+.||+|+||.||+|+++.+++.||||++........ .....+..|+.++..+ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 45789999999999999999999999999999999866543221 1223455688888887 8999999999999
Q ss_pred ccceeeeeeee-ccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEec-cCCcEEEeccCCcc
Q psy16843 435 TKKHLCLVMEY-VEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLIT-ALGHIKLTDFGLSK 512 (810)
Q Consensus 435 ~~~~lyLVmEy-~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd-~~g~VKL~DFGLAk 512 (810)
+.+..++|||| +.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .+|.+||+|||++.
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~ 188 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA 188 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence 99999999999 78999999999888899999999999999999999999999999999999999 78999999999987
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I 591 (810)
..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.. .+
T Consensus 189 ~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~ 245 (312)
T 2iwi_A 189 LLHDE-----------------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EI 245 (312)
T ss_dssp ECCSS-----------------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH
T ss_pred hcccC-----------------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HH
Confidence 53211 1134569999999999988776 458999999999999999999997542 22
Q ss_pred ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 592 ~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
......++.. ++.++++||.+||+.||.+||++ .|+++||||...
T Consensus 246 ~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~---~e~l~~~~~~~~ 290 (312)
T 2iwi_A 246 LEAELHFPAH----VSPDCCALIRRCLAPKPSSRPSL---EEILLDPWMQTP 290 (312)
T ss_dssp HHTCCCCCTT----SCHHHHHHHHHHTCSSTTTSCCH---HHHHHSTTTCC-
T ss_pred hhhccCCccc----CCHHHHHHHHHHccCChhhCcCH---HHHhcChhhcCc
Confidence 3333444432 67899999999999999999998 999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=374.98 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=210.4
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC--CCeEEEeeeecccccee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD--NPFVVTMYCSFETKKHL 439 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~--HPnIVkl~~~f~~~~~l 439 (810)
..++|++++.||+|+||.||+|.+. +++.||+|++...... ....+.+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3467999999999999999999986 4889999998764432 345577889999999997 59999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. |.+||+|||+++......
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~- 180 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT- 180 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcc-
Confidence 99999 568899999998889999999999999999999999999999999999999964 999999999987532110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhh-----------cCCCCCcchhhhHHHHHHHHhCCCCCCCCC-HHHH
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-----------QGYGKPVDWWSMGVILYEFLVGCVPFFGET-PEEL 587 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----------~~ys~ksDIWSLGvILyELLtG~~PF~~~~-~~e~ 587 (810)
........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.. ....
T Consensus 181 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (313)
T 3cek_A 181 ------------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248 (313)
T ss_dssp ---------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred ------------ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence 1111234579999999999976 468899999999999999999999998753 3344
Q ss_pred HHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 588 ~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+..+........... ..+.++.+||.+||..||.+||++ .|+++||||..
T Consensus 249 ~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~---~ell~h~~~~~ 298 (313)
T 3cek_A 249 LHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRISI---PELLAHPYVQI 298 (313)
T ss_dssp HHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCCH---HHHHTSHHHHC
T ss_pred HHHHHhcccccCCcc--cchHHHHHHHHHHccCCcccCcCH---HHHhcCccccC
Confidence 444444333222211 246889999999999999999998 99999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=373.23 Aligned_cols=260 Identities=25% Similarity=0.452 Sum_probs=201.3
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||.||+|+++.+|+.||||++...... ....+.+..+..+++.++||||+++++++.+.+.+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 3457899999999999999999999999999999998765432 223344555666788899999999999999999999
Q ss_pred eeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 441 LVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSY-GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+||||+ ++.+..++.. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD- 178 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-
Confidence 999999 5566655543 57899999999999999999999995 9999999999999999999999999998642211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHh-----hcCCCCCcchhhhHHHHHHHHhCCCCCCC-CCHHHHHHhhc
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFG-ETPEELFAHTV 592 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-----~~~ys~ksDIWSLGvILyELLtG~~PF~~-~~~~e~~~~I~ 592 (810)
.......||+.|+|||++. +..|+.++|||||||++|||++|..||.+ ....+.+..+.
T Consensus 179 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 243 (318)
T 2dyl_A 179 ---------------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL 243 (318)
T ss_dssp -----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred ---------------ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh
Confidence 0112456999999999994 56789999999999999999999999987 45556666666
Q ss_pred cCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 593 ~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
........ ....++.++.+||.+||..||.+||++ .|+++||||.+
T Consensus 244 ~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~h~~~~~ 289 (318)
T 2dyl_A 244 QEEPPLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKY---NKLLEHSFIKR 289 (318)
T ss_dssp HSCCCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCH---HHHTTSHHHHH
T ss_pred ccCCCCCC-ccCCCCHHHHHHHHHHccCChhHCcCH---HHHhhCHHHHh
Confidence 54432211 112367999999999999999999998 99999999975
|
| >1v9v_A KIAA0561 protein; helix bundle, MAST205, microtubule-associated serine/threonine protein kinase, structural genomics; NMR {Homo sapiens} SCOP: a.29.10.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=322.20 Aligned_cols=108 Identities=47% Similarity=0.693 Sum_probs=105.8
Q ss_pred hhhchhHHHHHHHHHHHHHhhcCccccCCcCCcCCCcchhhhhhHHHHHHHHHHHHhhccccceehHHHHHHHHHHHHHH
Q psy16843 169 KERFPKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSKEKLISSRYFYEMSEKLERLL 248 (810)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~ 248 (810)
+|||||||+||||||++||+++++ ++++|+|||+++|+||||||+|||||+||++++||++|||||+||||+|+
T Consensus 4 ~erFPKAtaQMEErL~~~i~~~~~------~~~~~laDgvl~FiHHQiiElARDCL~KSr~~LITsrYF~El~E~LEkLl 77 (114)
T 1v9v_A 4 GSSGPKATAQMEGRLQEFLTAYAP------GARLALADGVLGFIHHQIVELARDCLAKSGENLVTSRYFLEMQEKLERLL 77 (114)
T ss_dssp SCSCCCTTHHHHHHHHHHHHHSCB------TTTBCCSCHHHHHHHHHHHHHHHHHHHHHHHTCCCHHHHHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHHHHHhcCc------cccccchHHHHHHHHHHHHHHHHHHHHHHHccchHHHHHHHHHHHHHHHH
Confidence 799999999999999999999999 89999999999999999999999999999999999999999999999999
Q ss_pred HHHhhhhh-HHHhHHHHHhhheeeeeeCCCceeec
Q psy16843 249 TETKEKSL-EAATVLTFTLKKLLLIISRPARLLEC 282 (810)
Q Consensus 249 ~~~~~~~~-~~~~~~~~~~~~~~~ii~rp~k~l~~ 282 (810)
+|+++||. ++++++.++|||++|||+||||+|+.
T Consensus 78 ~ea~erSes~~~~~v~~lvkKlLiIIsRPARLLE~ 112 (114)
T 1v9v_A 78 QDAHERSDSEEVSFIVQLVRKLLIIISRPARSGPS 112 (114)
T ss_dssp HHHHHTSCHHHHHHHHHHHHHHHHHHSSCCCCSSC
T ss_pred HHHhhcCchhhhHHHHHHHHHHHHhccChHhhccc
Confidence 99999999 59999999999999999999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=369.43 Aligned_cols=253 Identities=21% Similarity=0.339 Sum_probs=216.6
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
....++|++.+.||+|+||.||+|.++.+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+++.+
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 3456789999999999999999999999999999998865432 346788999999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
|+||||+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999999999763 45999999999999999999999999999999999999999999999999998753211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
. ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.....
T Consensus 165 ~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~ 230 (288)
T 3kfa_A 165 T--------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 230 (288)
T ss_dssp S--------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred c--------------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC
Confidence 1 011123457889999999999999999999999999999999 9999999887777666655422
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.+.. ..+++++.+||.+||..||.+||++ .|+++
T Consensus 231 -~~~~--~~~~~~l~~li~~~l~~dp~~Rps~---~~~~~ 264 (288)
T 3kfa_A 231 -MERP--EGCPEKVYELMRACWQWNPSDRPSF---AEIHQ 264 (288)
T ss_dssp -CCCC--TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred -CCCC--CCCCHHHHHHHHHHhCCChhhCcCH---HHHHH
Confidence 2211 2367899999999999999999998 66654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=378.01 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=215.1
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCc-----EEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeec
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQ-----RFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSF 433 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~-----~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f 433 (810)
....++|++.+.||+|+||.||+|.+..+++ .||+|.+..... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3456899999999999999999999987664 799998865432 33456788999999999 899999999999
Q ss_pred cccceeeeeeeeccCcchhhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc
Q psy16843 434 ETKKHLCLVMEYVEGGDCASLLKN--------------TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA 499 (810)
Q Consensus 434 ~~~~~lyLVmEy~~GGsL~~lL~~--------------~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~ 499 (810)
.+.+.+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 999999999999999999999864 346899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCC
Q psy16843 500 LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVP 578 (810)
Q Consensus 500 ~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~P 578 (810)
++.+||+|||+++..... ..........||+.|+|||++.+..|+.++|||||||++|||++ |..|
T Consensus 200 ~~~~kl~Dfg~~~~~~~~-------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 266 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMND-------------SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266 (333)
T ss_dssp GGEEEBCCCGGGCCGGGC-------------TTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCeEEECccccccccccc-------------cceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCC
Confidence 999999999998753211 11111234567899999999999999999999999999999998 9999
Q ss_pred CCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 579 FFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 579 F~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
|.+......+..+.......+... ..+.++.+||.+||+.||.+||++ .|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~---~~l~~ 319 (333)
T 2i1m_A 267 YPGILVNSKFYKLVKDGYQMAQPA--FAPKNIYSIMQACWALEPTHRPTF---QQICS 319 (333)
T ss_dssp STTCCSSHHHHHHHHHTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CcccchhHHHHHHHhcCCCCCCCC--CCCHHHHHHHHHHhccChhhCcCH---HHHHH
Confidence 988766555555555444333222 257899999999999999999998 77765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=369.20 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=206.7
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHH----HHHHHHHHHHhcCCCCeEEEeeeecccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQM----EQVFAERDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~----~~i~~E~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
...++|++.+.||+|+||.||+|++..+++.||+|++........... +.+.+|+++++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 455889999999999999999999999999999998865443322221 6788999999999999999999999876
Q ss_pred ceeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCCCceEeccCCc-----EEEecc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYG--IVHRDLKPDNLLITALGH-----IKLTDF 508 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~g--IIHRDLKPeNILLd~~g~-----VKL~DF 508 (810)
. ++||||++||+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 7999999999998888644 57999999999999999999999999 999999999999998876 999999
Q ss_pred CCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHh--hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHH
Q psy16843 509 GLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL--RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE 586 (810)
Q Consensus 509 GLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~--~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e 586 (810)
|+++.... .....+||+.|+|||++. ...|+.++|||||||++|||++|..||.+.....
T Consensus 174 g~~~~~~~------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 235 (287)
T 4f0f_A 174 GLSQQSVH------------------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235 (287)
T ss_dssp TTCBCCSS------------------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred Cccccccc------------------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence 99864211 112457999999999994 4567899999999999999999999998754333
Q ss_pred --HHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 587 --LFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 587 --~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
....+.......... ..+++++.+||.+||+.||.+||++ .|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~ 282 (287)
T 4f0f_A 236 IKFINMIREEGLRPTIP--EDCPPRLRNVIELCWSGDPKKRPHF---SYIVK 282 (287)
T ss_dssp HHHHHHHHHSCCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred HHHHHHHhccCCCCCCC--cccCHHHHHHHHHHhcCChhhCcCH---HHHHH
Confidence 244444333322222 2367899999999999999999998 66664
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=377.11 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=213.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEE--EEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRF--AMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKK 437 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~v--AIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~ 437 (810)
...++|++.+.||+|+||.||+|+++.++..+ |+|.+.... .....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 34578999999999999999999999998865 889876432 233446788999999999 9999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTG----------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG 501 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g----------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g 501 (810)
.+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997654 799999999999999999999999999999999999999999
Q ss_pred cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCC
Q psy16843 502 HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFF 580 (810)
Q Consensus 502 ~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~ 580 (810)
.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 180 ~~kL~Dfg~~~~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY----------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp CEEECCTTCEESSCEE----------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred eEEEcccCcCcccccc----------------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence 9999999998632110 11123457899999999999999999999999999999998 999999
Q ss_pred CCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 581 GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 581 ~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
+.+..++...+..+.. .+.. ..+++++.+||.+||..||.+||++ .|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~-~~~~--~~~~~~l~~li~~~l~~dp~~Rps~---~ell~~ 294 (327)
T 1fvr_A 244 GMTCAELYEKLPQGYR-LEKP--LNCDDEVYDLMRQCWREKPYERPSF---AQILVS 294 (327)
T ss_dssp TCCHHHHHHHGGGTCC-CCCC--TTBCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCcHHHHHHHhhcCCC-CCCC--CCCCHHHHHHHHHHccCChhhCcCH---HHHHHH
Confidence 9999888887766532 1111 2377999999999999999999998 788764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=375.83 Aligned_cols=257 Identities=22% Similarity=0.339 Sum_probs=210.7
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFE 434 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~ 434 (810)
...++|++.+.||+|+||.||+|++. .+++.||+|++..... ....+.+.+|+.++..+ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 34578999999999999999999853 5678999998876432 33446788999999999 7899999999987
Q ss_pred ccc-eeeeeeeeccCcchhhhhhcCCC----------------CCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe
Q psy16843 435 TKK-HLCLVMEYVEGGDCASLLKNTGP----------------LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI 497 (810)
Q Consensus 435 ~~~-~lyLVmEy~~GGsL~~lL~~~g~----------------lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL 497 (810)
..+ .+|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 654 59999999999999999986543 8999999999999999999999999999999999999
Q ss_pred ccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CC
Q psy16843 498 TALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GC 576 (810)
Q Consensus 498 d~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~ 576 (810)
+.+|.+||+|||+++..... ..........||+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~-------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKD-------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTC-------------TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCCEEECCCccccccccC-------------ccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 99999999999998753211 01111234568999999999999999999999999999999998 99
Q ss_pred CCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 577 VPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 577 ~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.||.+....+.+...+......+.. ...++++.+||.+||..||.+||++ .|+++|
T Consensus 249 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~---~ell~~ 304 (316)
T 2xir_A 249 SPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTF---SELVEH 304 (316)
T ss_dssp CSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCCcccchhHHHHHHhccCccCCCC--CCCCHHHHHHHHHHcCCChhhCcCH---HHHHHH
Confidence 9998876444333333322222211 1267899999999999999999998 788875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=371.07 Aligned_cols=255 Identities=22% Similarity=0.307 Sum_probs=204.0
Q ss_pred CCCCCcEEEEEecccCceEEEEEE----EcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVR----HKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~----~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
...++|++++.||+|+||.||+|+ +..+++.||||++.... ....+.+.+|+++++.++||||+++++++...
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345789999999999999999998 56689999999886543 34456788999999999999999999988554
Q ss_pred --ceeeeeeeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 437 --KHLCLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 437 --~~lyLVmEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
..+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 46999999999999999997654 599999999999999999999999999999999999999999999999999975
Q ss_pred ccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH--------
Q psy16843 514 GLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE-------- 585 (810)
Q Consensus 514 ~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~-------- 585 (810)
...... .........||+.|+|||++.+..|+.++|||||||++|||++|..||......
T Consensus 164 ~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 231 (295)
T 3ugc_A 164 LPQDKE------------FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231 (295)
T ss_dssp ------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTT
T ss_pred ccCCcc------------eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCc
Confidence 322110 001112345788899999999999999999999999999999999998653221
Q ss_pred --------HHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 586 --------ELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 586 --------e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.....+.. ....+... .+++++.+||.+||+.||.+||++ .|+++
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~---~el~~ 284 (295)
T 3ugc_A 232 KQGQMIVFHLIELLKN-NGRLPRPD--GCPDEIYMIMTECWNNNVNQRPSF---RDLAL 284 (295)
T ss_dssp CCTHHHHHHHHHHHHT-TCCCCCCT--TCCHHHHHHHHHHSCSSGGGSCCH---HHHHH
T ss_pred cccchhHHHHHHHHhc-cCcCCCCc--CcCHHHHHHHHHHcCCChhhCCCH---HHHHH
Confidence 12222222 22222222 367899999999999999999998 66654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=378.36 Aligned_cols=260 Identities=21% Similarity=0.305 Sum_probs=214.8
Q ss_pred CCCCCcEEEEEecccCceEEEEEE-----EcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVR-----HKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~-----~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
...++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 455789999999999999999999 55678899999886432 23345678899999999999999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC---cEEE
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNT-------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---HIKL 505 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~-------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g---~VKL 505 (810)
...+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999999765 3489999999999999999999999999999999999999544 6999
Q ss_pred eccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCH
Q psy16843 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETP 584 (810)
Q Consensus 506 ~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~ 584 (810)
+|||++...... ..........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+...
T Consensus 185 ~Dfg~~~~~~~~-------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 185 GDFGMARDIYRA-------------SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp CCCHHHHHHHC-------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred Cccccccccccc-------------cccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 999998642211 01111234568999999999999999999999999999999998 9999999988
Q ss_pred HHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 585 EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 585 ~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
.+....+.......+. ..++.++.+||.+||+.||.+||++ .|+++|.|+-
T Consensus 252 ~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~~l~~~ 302 (327)
T 2yfx_A 252 QEVLEFVTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNF---AIILERIEYC 302 (327)
T ss_dssp HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHhcCChhhCcCH---HHHHHHHHHH
Confidence 8888777765432222 1367899999999999999999998 8999998763
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=376.51 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=215.7
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEc-------CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeee
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHK-------ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYC 431 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k-------~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~ 431 (810)
....++|++.+.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+++++.+ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 445589999999999999999999986 457789999886543 234557788999999999 9999999999
Q ss_pred eccccceeeeeeeeccCcchhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCce
Q psy16843 432 SFETKKHLCLVMEYVEGGDCASLLKNTG----------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNL 495 (810)
Q Consensus 432 ~f~~~~~lyLVmEy~~GGsL~~lL~~~g----------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNI 495 (810)
++.+.+.+|+||||+.||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999997653 389999999999999999999999999999999999
Q ss_pred EeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-
Q psy16843 496 LITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV- 574 (810)
Q Consensus 496 LLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt- 574 (810)
|++.+|.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 255 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNID-------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTS-------------SEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred EEcCCCCEEEccccccccccccc-------------cccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhC
Confidence 99999999999999987532110 0011223457899999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 575 GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 575 G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
|..||.+....++...+........ . ..++.++.+||.+||..||.+||++ .|++++
T Consensus 256 g~~p~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~l~~li~~~l~~dp~~Rps~---~ell~~ 312 (334)
T 2pvf_A 256 GGSPYPGIPVEELFKLLKEGHRMDK-P--ANCTNELYMMMRDCWHAVPSQRPTF---KQLVED 312 (334)
T ss_dssp SCCSSTTCCHHHHHHHHHHTCCCCC-C--TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCCCcCcCCHHHHHHHHhcCCCCCC-C--ccCCHHHHHHHHHHccCChhhCcCH---HHHHHH
Confidence 9999999998888777765532211 1 2367899999999999999999998 777753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=372.01 Aligned_cols=255 Identities=28% Similarity=0.452 Sum_probs=205.1
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 34689999999999999999999999999999999876544445566788899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 442 VMEYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999999863 467999999999999999999999999999999999999999999999999998642211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC--CHHHHHHhhccCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE--TPEELFAHTVNDD 595 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~--~~~e~~~~I~~~~ 595 (810)
........||+.|+|||++.+..++.++||||||+++|+|++|..||.+. ........+....
T Consensus 190 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 254 (310)
T 2wqm_A 190 ---------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 254 (310)
T ss_dssp ------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC
T ss_pred ---------------CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc
Confidence 01112456999999999999999999999999999999999999999764 3344555554443
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.. ......++.++.+||.+||..||.+||++ .++++
T Consensus 255 ~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~il~ 290 (310)
T 2wqm_A 255 YP--PLPSDHYSEELRQLVNMCINPDPEKRPDV---TYVYD 290 (310)
T ss_dssp SC--CCCTTTSCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CC--CCcccccCHHHHHHHHHHcCCChhhCCCH---HHHHH
Confidence 32 21122367899999999999999999998 67765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=387.14 Aligned_cols=258 Identities=21% Similarity=0.342 Sum_probs=206.5
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHK---ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET 435 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k---~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~ 435 (810)
.....++|++.+.||+|+||.||+|+++ .++..||||++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 3445578999999999999999999987 467789999886542 23445778999999999999999999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccc
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~ 514 (810)
.+.+|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999999998654 7999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhcc
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVN 593 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~ 593 (810)
..... .........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+..++...+..
T Consensus 198 ~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~ 265 (373)
T 2qol_A 198 EDDPE------------AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265 (373)
T ss_dssp ----------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT
T ss_pred ccCCc------------cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 21110 0011122346789999999999999999999999999999997 9999999998888777665
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 594 ~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
+. ..+... ..+.++.+||.+||+.||.+||++ .|+++
T Consensus 266 ~~-~~~~~~--~~~~~l~~li~~cl~~dp~~RPs~---~~i~~ 302 (373)
T 2qol_A 266 GY-RLPPPM--DCPAALYQLMLDCWQKDRNNRPKF---EQIVS 302 (373)
T ss_dssp TE-ECCCCT--TCBHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CC-CCCCCc--cccHHHHHHHHHHhCcChhhCcCH---HHHHH
Confidence 42 222222 367899999999999999999998 66654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=378.73 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=206.3
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEE----EEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRF----AMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~v----AIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
...++|++++.||+|+||.||+|++..+++.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 45689999999999999999999999888766 445443222 122346788999999999999999999999876
Q ss_pred ceeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
. .++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 4 8899999999999999975 4679999999999999999999999999999999999999999999999999997532
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccC
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVND 594 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~ 594 (810)
... .........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+....++...+...
T Consensus 169 ~~~-------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 235 (327)
T 3lzb_A 169 AEE-------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235 (327)
T ss_dssp ------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred Ccc-------------ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 111 1111223457889999999999999999999999999999999 99999998887777666554
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 595 ~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.. .+.. ...+.++.+||.+||..||.+||++ .|+++
T Consensus 236 ~~-~~~~--~~~~~~l~~li~~~l~~dp~~Rps~---~ell~ 271 (327)
T 3lzb_A 236 ER-LPQP--PICTIDVYMIMRKCWMIDADSRPKF---RELII 271 (327)
T ss_dssp CC-CCCC--TTBCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CC-CCCC--ccCCHHHHHHHHHHcCCChhHCcCH---HHHHH
Confidence 32 2222 2267899999999999999999998 77775
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=376.79 Aligned_cols=253 Identities=20% Similarity=0.221 Sum_probs=201.3
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc---
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK--- 437 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~--- 437 (810)
...++|++++.||+|+||.||+|++. ++.||||++.... ........|+.+++.++|||||++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 34578999999999999999999875 7899999886543 22344556899999999999999999998744
Q ss_pred -eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc----------ccccccCCCCceEeccCCcEEEe
Q psy16843 438 -HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY----------GIVHRDLKPDNLLITALGHIKLT 506 (810)
Q Consensus 438 -~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~----------gIIHRDLKPeNILLd~~g~VKL~ 506 (810)
.+|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 47999999999999999976 4699999999999999999999999 99999999999999999999999
Q ss_pred ccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-----cCCCCCcchhhhHHHHHHHHhCCCCCCC
Q psy16843 507 DFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-----QGYGKPVDWWSMGVILYEFLVGCVPFFG 581 (810)
Q Consensus 507 DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----~~ys~ksDIWSLGvILyELLtG~~PF~~ 581 (810)
|||+++...... ........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+
T Consensus 174 DFg~a~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 174 DFGLALKFEAGK-------------SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp CCTTCEEECTTS-------------CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred cCCccccccccc-------------CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 999997532111 1111234679999999999987 3567789999999999999999999975
Q ss_pred C----------------CHHHHHHhhccCCCCCCCCCC---CcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 582 E----------------TPEELFAHTVNDDIEWPSEDD---WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 582 ~----------------~~~e~~~~I~~~~~~~p~~~~---~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
. ...++...+............ ...+.++.+||.+||+.||.+||++ .|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~---~ell~ 311 (322)
T 3soc_A 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA---GCVGE 311 (322)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH---HHHHH
Confidence 4 223333333333222111111 1134569999999999999999998 66654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=372.93 Aligned_cols=260 Identities=20% Similarity=0.297 Sum_probs=212.2
Q ss_pred cCCCCCCCcEEEEEecccCceEEEEEEEcCCC----cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeec
Q psy16843 358 SKTPNENDFTVIKLISNGAYGSVYLVRHKETR----QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSF 433 (810)
Q Consensus 358 ~~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg----~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f 433 (810)
......++|.+.+.||+|+||.||+|.++.++ ..||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34556689999999999999999999987653 359999886543 233446788999999999999999999999
Q ss_pred cccceeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 434 ETKKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 434 ~~~~~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
.+.+.+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999999999754 679999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHT 591 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I 591 (810)
....... .........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+
T Consensus 196 ~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 263 (333)
T 1mqb_A 196 VLEDDPE------------ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263 (333)
T ss_dssp ---------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred hhccccc------------cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 5322110 0111123356889999999999999999999999999999998 99999999888888777
Q ss_pred ccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 592 ~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
..+. ..+.. ..++.++.+||.+||+.||.+||++ .|++++
T Consensus 264 ~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~---~~l~~~ 303 (333)
T 1mqb_A 264 NDGF-RLPTP--MDCPSAIYQLMMQCWQQERARRPKF---ADIVSI 303 (333)
T ss_dssp HTTC-CCCCC--TTCBHHHHHHHHHHTCSSTTTSCCH---HHHHHH
T ss_pred HCCC-cCCCc--ccCCHHHHHHHHHHcCCChhhCcCH---HHHHHH
Confidence 6542 22222 2367899999999999999999998 666653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=390.92 Aligned_cols=251 Identities=20% Similarity=0.341 Sum_probs=212.9
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
+....++|++.+.||+|+||.||+|.++. +..||||++..... ..+.+.+|+.+|+.++|||||++++++. .+.
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 34556789999999999999999999864 67899999876432 2467889999999999999999999986 567
Q ss_pred eeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+|+||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999999999999754 3789999999999999999999999999999999999999999999999999975321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
.. ........+|+.|+|||++....|+.++|||||||+||||++ |..||.+.+..++...+..+
T Consensus 337 ~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~- 401 (454)
T 1qcf_A 337 NE--------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG- 401 (454)
T ss_dssp HH--------------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-
T ss_pred Cc--------------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 10 001123457889999999999999999999999999999999 99999999998888877654
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
...+.+. .+++++.+||.+||..||.+||++ .+++
T Consensus 402 ~~~~~~~--~~~~~l~~li~~cl~~dp~~RPt~---~~i~ 436 (454)
T 1qcf_A 402 YRMPRPE--NCPEELYNIMMRCWKNRPEERPTF---EYIQ 436 (454)
T ss_dssp CCCCCCT--TSCHHHHHHHHHHTCSSGGGSCCH---HHHH
T ss_pred CCCCCCC--CCCHHHHHHHHHHccCChhHCcCH---HHHH
Confidence 2333322 367899999999999999999998 5554
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=376.61 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=208.2
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++.+.||+|+||.||+|+++ +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 4578999999999999999999965 688999998765432 345678899999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCC----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTG----PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g----~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999997543 5999999999999999999999999999999999999999999999999998752211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHH-------Hh
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELF-------AH 590 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~-------~~ 590 (810)
. .........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+..+.+.. ..
T Consensus 193 ~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 259 (321)
T 2qkw_B 193 D-------------QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259 (321)
T ss_dssp S-------------CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred c-------------ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence 0 111123456999999999999999999999999999999999999999765432211 11
Q ss_pred hccCCC------CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 591 TVNDDI------EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 591 I~~~~~------~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.....+ ..........+.++.+||.+||+.||++||++ .|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~ell~~ 309 (321)
T 2qkw_B 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM---GDVLWK 309 (321)
T ss_dssp HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCH---HHHHHH
Confidence 111111 11111122356789999999999999999998 788765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=366.07 Aligned_cols=254 Identities=23% Similarity=0.297 Sum_probs=210.9
Q ss_pred CCCCcEEEE-EecccCceEEEEEEE--cCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 362 NENDFTVIK-LISNGAYGSVYLVRH--KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 362 ~~~dy~ilk-~LG~G~FG~Vyla~~--k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
..++|.+.+ .||+|+||.||+|.+ +.+++.||+|++..... .....+.+.+|+++++.++||||+++++++ ..+.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 346899998 999999999999954 56678999998865432 233457788999999999999999999999 5667
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 89999999999999999988889999999999999999999999999999999999999999999999999987532211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC-
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI- 596 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~- 596 (810)
. .........||+.|+|||++.+..++.++||||||+++|||++ |..||.+.+..++...+.....
T Consensus 172 ~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 239 (291)
T 1xbb_A 172 N------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 239 (291)
T ss_dssp S------------EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred C------------cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 0 0001123357889999999999999999999999999999999 9999999998888777766432
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..+. .++.++.+||.+||+.||.+||++ .|+++
T Consensus 240 ~~~~----~~~~~l~~li~~~l~~dp~~Rps~---~~l~~ 272 (291)
T 1xbb_A 240 GCPA----GCPREMYDLMNLCWTYDVENRPGF---AAVEL 272 (291)
T ss_dssp CCCT----TCCHHHHHHHHHHTCSSTTTSCCH---HHHHH
T ss_pred CCCC----CCCHHHHHHHHHHcCCChhhCcCH---HHHHH
Confidence 2222 367899999999999999999998 55553
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=368.14 Aligned_cols=258 Identities=20% Similarity=0.328 Sum_probs=207.9
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcC-CCc--EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKE-TRQ--RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~-tg~--~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
...++|++++.||+|+||.||+|++.. +++ .||+|++...........+.+.+|+++++.++||||+++++++.++.
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 345789999999999999999998754 333 68999887654434455678899999999999999999999998765
Q ss_pred eeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
.++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 89999999999999999754 6799999999999999999999999999999999999999999999999999875322
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
... .........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+....
T Consensus 174 ~~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 241 (291)
T 1u46_A 174 NDD------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241 (291)
T ss_dssp -CC------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred ccc------------chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence 111 0111234468889999999999999999999999999999999 999999999999888887765
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..++... .++.++.+||.+||..||.+||++ .++++
T Consensus 242 ~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~---~~l~~ 277 (291)
T 1u46_A 242 ERLPRPE--DCPQDIYNVMVQCWAHKPEDRPTF---VALRD 277 (291)
T ss_dssp CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CCCCCCc--CcCHHHHHHHHHHccCCcccCcCH---HHHHH
Confidence 5554433 367999999999999999999998 77775
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=363.18 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=213.3
Q ss_pred CCCCcEEEE-EecccCceEEEEEEEc--CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 362 NENDFTVIK-LISNGAYGSVYLVRHK--ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 362 ~~~dy~ilk-~LG~G~FG~Vyla~~k--~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
..++|.++. .||+|+||.||+|.++ .++..||+|++.... .....+.+.+|+++++.++||||+++++++ ..+.
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 346788887 9999999999999864 467889999887643 234567789999999999999999999999 4567
Q ss_pred eeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999999999643 57999999999999999999999999999999999999999999999999998753211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.. .........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+.....
T Consensus 164 ~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~ 231 (287)
T 1u59_A 164 DS------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 231 (287)
T ss_dssp SC------------EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC
T ss_pred cc------------eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc
Confidence 00 0111233457899999999999999999999999999999998 9999999888888777766542
Q ss_pred -CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 597 -EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 597 -~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.++. .+++++.+||.+||..||.+||++ .|+++|
T Consensus 232 ~~~~~----~~~~~l~~li~~~l~~~p~~Rps~---~~l~~~ 266 (287)
T 1u59_A 232 MECPP----ECPPELYALMSDCWIYKWEDRPDF---LTVEQR 266 (287)
T ss_dssp CCCCT----TCCHHHHHHHHHTTCSSGGGSCCH---HHHHHH
T ss_pred CCCCC----CcCHHHHHHHHHHcCCChhhCcCH---HHHHHH
Confidence 2222 367999999999999999999998 788776
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=396.66 Aligned_cols=254 Identities=21% Similarity=0.347 Sum_probs=216.4
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
+....++|++.+.||+|+||.||+|.++.++..||||++..... ..+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 34455789999999999999999999999999999998875432 23678899999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+||||||+.||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999999753 4699999999999999999999999999999999999999999999999999975321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
. .........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+.+..++...+...
T Consensus 371 ~--------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~- 435 (495)
T 1opk_A 371 D--------------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD- 435 (495)
T ss_dssp C--------------CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-
T ss_pred C--------------ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 1 0011123457889999999999999999999999999999998 99999998887777666543
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
...+... .+++++.+||.+||+.||.+||++ .++++
T Consensus 436 ~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~---~el~~ 471 (495)
T 1opk_A 436 YRMERPE--GCPEKVYELMRACWQWNPSDRPSF---AEIHQ 471 (495)
T ss_dssp CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CCCCCCC--CCCHHHHHHHHHHcCcChhHCcCH---HHHHH
Confidence 2222222 367899999999999999999998 56553
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=368.51 Aligned_cols=257 Identities=20% Similarity=0.289 Sum_probs=205.8
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcC---CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKE---TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~---tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
...++|.+.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 345789999999999999999998875 456899998865432 2344577889999999999999999999987655
Q ss_pred -----eeeeeeeeccCcchhhhhh------cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEe
Q psy16843 438 -----HLCLVMEYVEGGDCASLLK------NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLT 506 (810)
Q Consensus 438 -----~lyLVmEy~~GGsL~~lL~------~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~ 506 (810)
..|+||||+++|+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence 4599999999999999983 34579999999999999999999999999999999999999999999999
Q ss_pred ccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHH
Q psy16843 507 DFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPE 585 (810)
Q Consensus 507 DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~ 585 (810)
|||+++...... .........|++.|+|||++.+..|+.++|||||||++|||++ |..||.+....
T Consensus 190 Dfg~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 190 DFGLSKKIYSGD-------------YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256 (313)
T ss_dssp SCSCC-----------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ecCcceeccccc-------------ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 999987532110 0011223457889999999999999999999999999999999 99999998888
Q ss_pred HHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 586 ELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 586 e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
+....+......... ..+++++.+||.+||..||.+||++ .++++|
T Consensus 257 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~---~~l~~~ 302 (313)
T 3brb_A 257 EMYDYLLHGHRLKQP---EDCLDELYEIMYSCWRTDPLDRPTF---SVLRLQ 302 (313)
T ss_dssp GHHHHHHTTCCCCCB---TTCCHHHHHHHHHTTCSSGGGSCCH---HHHHHH
T ss_pred HHHHHHHcCCCCCCC---ccccHHHHHHHHHHcCCChhhCcCH---HHHHHH
Confidence 877777665322111 2367899999999999999999998 777653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=359.94 Aligned_cols=251 Identities=20% Similarity=0.322 Sum_probs=211.1
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
....++|++++.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+++++.++||||+++++++.. +.+
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence 345578999999999999999999976 5678999988654322 3567889999999999999999999874 568
Q ss_pred eeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999999999997543 7999999999999999999999999999999999999999999999999998753211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
. ........||+.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+.....
T Consensus 163 ~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 228 (279)
T 1qpc_A 163 E--------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228 (279)
T ss_dssp C--------------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred c--------------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC
Confidence 0 011123457889999999999999999999999999999999 9999999988888877765432
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
. ... ..++.++.+||.+||..||.+||++ .++++
T Consensus 229 ~-~~~--~~~~~~l~~li~~~l~~~p~~Rps~---~~l~~ 262 (279)
T 1qpc_A 229 M-VRP--DNCPEELYQLMRLCWKERPEDRPTF---DYLRS 262 (279)
T ss_dssp C-CCC--TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred C-CCc--ccccHHHHHHHHHHhccChhhCCCH---HHHHH
Confidence 2 111 2367899999999999999999998 55553
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=363.53 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=198.4
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
.....++|++.+.||+|+||.||+|++.. .||+|++..... .....+.+.+|+++++.++||||++++++. ....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 34566899999999999999999998643 599998865432 345567889999999999999999999965 5567
Q ss_pred eeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
+++||||+.|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 8999999999999999964 467999999999999999999999999999999999999999999999999998642211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHh---hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhc-c
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL---RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV-N 593 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~---~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~-~ 593 (810)
. .........||+.|+|||++. +..|+.++|||||||++|||++|..||.+....+....+. .
T Consensus 174 ~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 240 (289)
T 3og7_A 174 S-------------GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240 (289)
T ss_dssp -----------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH
T ss_pred c-------------ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc
Confidence 0 011123457999999999997 5678899999999999999999999998865544444433 3
Q ss_pred CCCCCC-CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 594 DDIEWP-SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 594 ~~~~~p-~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.....+ ......+++++.+||.+||+.||.+||++ .|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~---~ell~ 281 (289)
T 3og7_A 241 GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSF---PRILA 281 (289)
T ss_dssp TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred cccCcchhhccccCCHHHHHHHHHHccCChhhCCCH---HHHHH
Confidence 332221 11112367899999999999999999998 66664
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=385.24 Aligned_cols=254 Identities=25% Similarity=0.425 Sum_probs=207.7
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc--ee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK--HL 439 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~--~l 439 (810)
..++|++.+.||+|+||.||+|+++.+|+.||||++...... ...+.+.+|+++++.++||||+++++++...+ .+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 346899999999999999999999999999999998754432 23456778999999999999999999987655 78
Q ss_pred eeeeeeccCcchhhhhhcCC---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe----ccCCcEEEeccCCcc
Q psy16843 440 CLVMEYVEGGDCASLLKNTG---PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI----TALGHIKLTDFGLSK 512 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g---~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL----d~~g~VKL~DFGLAk 512 (810)
|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999999997543 39999999999999999999999999999999999999 778889999999997
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh--------cCCCCCcchhhhHHHHHHHHhCCCCCCC---
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR--------QGYGKPVDWWSMGVILYEFLVGCVPFFG--- 581 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--------~~ys~ksDIWSLGvILyELLtG~~PF~~--- 581 (810)
..... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+
T Consensus 165 ~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~ 228 (396)
T 4eut_A 165 ELEDD----------------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (396)
T ss_dssp ECCCG----------------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred EccCC----------------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence 53211 01134579999999999976 5678999999999999999999999964
Q ss_pred -CCHHHHHHhhccCCCC-------------------CCC--CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 582 -ETPEELFAHTVNDDIE-------------------WPS--EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 582 -~~~~e~~~~I~~~~~~-------------------~p~--~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
....+.+.++..+... ++. .....++..+.+||.+||+.||++||++ .|+++
T Consensus 229 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~---~e~l~ 302 (396)
T 4eut_A 229 PRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF---DQFFA 302 (396)
T ss_dssp TTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH---HHHHH
T ss_pred ccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccH---HHHHH
Confidence 2334555555543321 111 1112255678999999999999999998 67654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=362.56 Aligned_cols=256 Identities=19% Similarity=0.240 Sum_probs=208.4
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCC---cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeee-ccccc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETR---QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCS-FETKK 437 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg---~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~-f~~~~ 437 (810)
...+|++.+.||+|+||.||+|.+..++ ..+|+|.+.... .....+.+.+|+.+++.++||||++++++ +..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 3457999999999999999999976443 458999876533 23455778899999999999999999998 45667
Q ss_pred eeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
..|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 89999999999999999975 45699999999999999999999999999999999999999999999999999975322
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
.... .........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 181 ~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 3f66_A 181 KEYY-----------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 249 (298)
T ss_dssp GGGC-----------BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC
T ss_pred cchh-----------ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC
Confidence 1110 1111234568899999999999999999999999999999999 778888877777766666654
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
...... .++.++.+||.+||..||.+||++ .|+++
T Consensus 250 ~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~---~ell~ 284 (298)
T 3f66_A 250 RLLQPE---YCPDPLYEVMLKCWHPKAEMRPSF---SELVS 284 (298)
T ss_dssp CCCCCT---TCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CCCCCc---cCCHHHHHHHHHHcCCChhhCcCH---HHHHH
Confidence 433222 267899999999999999999998 66664
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=381.94 Aligned_cols=255 Identities=15% Similarity=0.158 Sum_probs=199.1
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeeccchhhHHHH--------HHHHHHHHHHhcCCCCeEEE
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKET-----RQRFAMKKIIKNSLMLRNQM--------EQVFAERDIMSFTDNPFVVT 428 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~t-----g~~vAIK~I~k~~~~~~~~~--------~~i~~E~~iL~~l~HPnIVk 428 (810)
..++|++++.||+|+||.||+|.++.+ ++.||||++........... .....|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 446899999999999999999999765 58899998876542221111 12445666788899999999
Q ss_pred eeeecccc----ceeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEec--cCC
Q psy16843 429 MYCSFETK----KHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLIT--ALG 501 (810)
Q Consensus 429 l~~~f~~~----~~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd--~~g 501 (810)
+++++... ..+||||||+ ||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||||+ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998765 5689999999 99999999865 6899999999999999999999999999999999999999 889
Q ss_pred cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCC
Q psy16843 502 HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG 581 (810)
Q Consensus 502 ~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~ 581 (810)
.+||+|||+++......... ..........+||+.|+|||++.+..|+.++|||||||+||||++|..||.+
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHK--------AYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp CEEECCCTTCEESSGGGCCC--------CSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred eEEEEECCcceecccCCccc--------ccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999999997643221110 0011122456799999999999999999999999999999999999999986
Q ss_pred CCHHHHHHhhcc----CCC------CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 582 ETPEELFAHTVN----DDI------EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 582 ~~~~e~~~~I~~----~~~------~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
......+..... ..+ .++. ...+.++.+||..||..||.+||++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~ 317 (364)
T 3op5_A 264 NLKDPKYVRDSKIRYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLY 317 (364)
T ss_dssp GTTCHHHHHHHHHHHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred cccCHHHHHHHHHHhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCH
Confidence 432222111111 000 0111 1256899999999999999999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=373.21 Aligned_cols=264 Identities=24% Similarity=0.350 Sum_probs=210.1
Q ss_pred CCCCCCcEEEEEecccCceEEEEEE----EcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecc-
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVR----HKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE- 434 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~----~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~- 434 (810)
....++|++++.||+|+||.||+|+ +..+++.||+|++.... ....+.+.+|+++++.++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 3455789999999999999999999 46788999999887653 334467889999999999999999999875
Q ss_pred -ccceeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 435 -TKKHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 435 -~~~~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
+...+|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 55679999999999999999976 4579999999999999999999999999999999999999999999999999997
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH-------
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE------- 585 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~------- 585 (810)
....... .........||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 176 ~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~ 243 (327)
T 3lxl_A 176 LLPLDKD------------YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC 243 (327)
T ss_dssp ECCTTCS------------EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-
T ss_pred ecccCCc------------cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc
Confidence 5321110 111223456899999999999999999999999999999999999999654332
Q ss_pred --------HHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 586 --------ELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 586 --------e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
.+...+ ......+.. ..+++++.+||.+||+.||.+||++..+.+.|+..|..
T Consensus 244 ~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 244 ERDVPALSRLLELL-EEGQRLPAP--PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp ---CCHHHHHHHHH-HTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred ccccccHHHHHHHh-hcccCCCCC--CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 122222 222222222 23679999999999999999999993333334444443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=365.52 Aligned_cols=255 Identities=22% Similarity=0.295 Sum_probs=204.0
Q ss_pred CCCcEEEEEecccCceEEEEEE----EcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc--
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVR----HKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK-- 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~----~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~-- 436 (810)
...|++++.||+|+||.||+|+ +..+++.||+|++..... ....+.+.+|+++++.++||||+++++++.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3569999999999999999999 467899999998865432 23346788999999999999999999999876
Q ss_pred ceeeeeeeeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
..+|+||||++||+|.+++. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 67899999999999999994 45679999999999999999999999999999999999999999999999999997532
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC-------------
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE------------- 582 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~------------- 582 (810)
.... .........||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 178 ~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (302)
T 4e5w_A 178 TDKE------------YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245 (302)
T ss_dssp TTCC------------EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG
T ss_pred CCCc------------ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc
Confidence 2110 011123456899999999999999999999999999999999999876322
Q ss_pred -CHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 583 -TPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 583 -~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
................+... .+++++.+||.+||+.||.+||++ .|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~---~~ll~ 295 (302)
T 4e5w_A 246 QMTVTRLVNTLKEGKRLPCPP--NCPDEVYQLMRKCWEFQPSNRTSF---QNLIE 295 (302)
T ss_dssp GGHHHHHHHHHHTTCCCCCCT--TCCHHHHHHHHHTTCSSGGGSCCH---HHHHH
T ss_pred ccCHHHHHHHHhccCCCCCCC--CCCHHHHHHHHHHcCCCCCCCCCH---HHHHH
Confidence 22222222222222222222 367999999999999999999998 66653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=362.90 Aligned_cols=243 Identities=28% Similarity=0.469 Sum_probs=206.6
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc--------
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET-------- 435 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~-------- 435 (810)
++|++++.||+|+||.||+|+++.+++.||+|++.... +.+.+|+++++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 57999999999999999999999999999999887543 245679999999999999999998854
Q ss_pred --------cceeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEE
Q psy16843 436 --------KKHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKL 505 (810)
Q Consensus 436 --------~~~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL 505 (810)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 45689999999999999999643 67999999999999999999999999999999999999999999999
Q ss_pred eccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH
Q psy16843 506 TDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE 585 (810)
Q Consensus 506 ~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~ 585 (810)
+|||++...... .......||+.|+|||++.+..++.++||||||+++|||++|..||... .
T Consensus 164 ~Dfg~~~~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~ 225 (284)
T 2a19_B 164 GDFGLVTSLKND----------------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--S 225 (284)
T ss_dssp CCCTTCEESSCC----------------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--H
T ss_pred Ccchhheecccc----------------ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--H
Confidence 999998653211 0113456999999999999999999999999999999999999988532 2
Q ss_pred HHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 586 ELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 586 e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.....+....+ +. .++.++++||.+||..||.+||++ .|+++|.|.
T Consensus 226 ~~~~~~~~~~~--~~----~~~~~~~~li~~~l~~dp~~Rps~---~e~l~~l~~ 271 (284)
T 2a19_B 226 KFFTDLRDGII--SD----IFDKKEKTLLQKLLSKKPEDRPNT---SEILRTLTV 271 (284)
T ss_dssp HHHHHHHTTCC--CT----TSCHHHHHHHHHHTCSSGGGSCCH---HHHHHHHHH
T ss_pred HHHHHhhcccc--cc----cCCHHHHHHHHHHccCChhhCcCH---HHHHHHHHH
Confidence 33333333322 21 267899999999999999999998 899998775
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=361.63 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=210.0
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKET---RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~t---g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
....++|++.+.||+|+||.||+|.+... +..||+|.+.+... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC--HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC--chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 34557899999999999999999987643 44699998876532 33457788999999999999999999998754
Q ss_pred ceeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
..|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 578999999999999999754 569999999999999999999999999999999999999999999999999987532
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccC
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVND 594 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~ 594 (810)
.. .........||+.|+|||++.+..++.++|||||||++|||++ |..||......+....+...
T Consensus 165 ~~--------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~ 230 (281)
T 3cc6_A 165 DE--------------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230 (281)
T ss_dssp ----------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT
T ss_pred cc--------------cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC
Confidence 11 0111123457889999999999999999999999999999998 99999887777666665554
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 595 ~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
... +.. ..+++++.+||.+||..||.+||++ .|++++
T Consensus 231 ~~~-~~~--~~~~~~l~~li~~~l~~~p~~Rps~---~ell~~ 267 (281)
T 3cc6_A 231 DRL-PKP--DLCPPVLYTLMTRCWDYDPSDRPRF---TELVCS 267 (281)
T ss_dssp CCC-CCC--TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCC-CCC--CCCCHHHHHHHHHHccCCchhCcCH---HHHHHH
Confidence 321 211 1267899999999999999999998 777754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=362.36 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=196.3
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhc--CCCCeEEEeeeeccc----
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF--TDNPFVVTMYCSFET---- 435 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~--l~HPnIVkl~~~f~~---- 435 (810)
..++|++++.||+|+||.||+|++ +++.||||++.... ......|.+++.. ++||||+++++++.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 347899999999999999999987 68899999886542 2344556666655 899999999988543
Q ss_pred cceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhh--------hcccccccCCCCceEeccCCcEEEec
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLH--------SYGIVHRDLKPDNLLITALGHIKLTD 507 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLH--------s~gIIHRDLKPeNILLd~~g~VKL~D 507 (810)
...+|+||||+++|+|.++++. +.+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 4679999999999999999965 57999999999999999999999 99999999999999999999999999
Q ss_pred cCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc------CCCCCcchhhhHHHHHHHHhC------
Q psy16843 508 FGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ------GYGKPVDWWSMGVILYEFLVG------ 575 (810)
Q Consensus 508 FGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~------~ys~ksDIWSLGvILyELLtG------ 575 (810)
||+++........ ........+||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 157 fg~a~~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 157 LGLAVMHSQSTNQ-----------LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp CTTCEEEETTTTE-----------EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred CCCeeeccccccc-----------ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 9999753221110 11112345799999999999876 455799999999999999999
Q ss_pred ----CCCCCCCC----HHHHHHhhccCCCCCCCCC----CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 576 ----CVPFFGET----PEELFAHTVNDDIEWPSED----DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 576 ----~~PF~~~~----~~e~~~~I~~~~~~~p~~~----~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..||.+.. ...............+... ....+.++.+||.+||+.||.+||++ .|+++
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~---~~i~~ 295 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA---LRIKK 295 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCH---HHHHH
T ss_pred cccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCH---HHHHH
Confidence 89996532 2222333222211111111 11255789999999999999999998 66664
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=359.55 Aligned_cols=253 Identities=20% Similarity=0.254 Sum_probs=208.4
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCc---EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee-e
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQ---RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL-C 440 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~---~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l-y 440 (810)
.|.+.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57788999999999999999876554 79999886533 234567888999999999999999999999876655 9
Q ss_pred eeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
+||||+.+|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999986 46799999999999999999999999999999999999999999999999999975321110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEW 598 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~ 598 (810)
..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+..... .
T Consensus 180 -----------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~ 247 (298)
T 3pls_A 180 -----------YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-L 247 (298)
T ss_dssp -----------GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC-C
T ss_pred -----------cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC-C
Confidence 01112234568999999999999999999999999999999999 5666666776666666555432 2
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
+.. ..+++++.+||.+||+.||.+||++ .++++
T Consensus 248 ~~~--~~~~~~l~~li~~~l~~~p~~Rps~---~~ll~ 280 (298)
T 3pls_A 248 PQP--EYCPDSLYQVMQQCWEADPAVRPTF---RVLVG 280 (298)
T ss_dssp CCC--TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CCC--ccchHHHHHHHHHHccCChhhCcCH---HHHHH
Confidence 222 2267899999999999999999998 66664
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=362.66 Aligned_cols=257 Identities=19% Similarity=0.258 Sum_probs=199.7
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeee-ccccceeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCS-FETKKHLCL 441 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~-f~~~~~lyL 441 (810)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+..|+.+++.++|++++..+.. +...+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 36899999999999999999999999999999986554322 346779999999988776665554 466778999
Q ss_pred eeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe---ccCCcEEEeccCCccccccc
Q psy16843 442 VMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI---TALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL---d~~g~VKL~DFGLAk~~~~s 517 (810)
||||+ +|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 9999999974 4679999999999999999999999999999999999999 78899999999999753321
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH---HHHHHhhccC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP---EELFAHTVND 594 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~---~e~~~~I~~~ 594 (810)
.... ...........||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+...
T Consensus 162 ~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 162 RTHQ--------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TTCC--------BCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred ccCc--------cCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 1100 0001122456899999999999999999999999999999999999999986432 2233333332
Q ss_pred CCCCCCC-CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 595 DIEWPSE-DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 595 ~~~~p~~-~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
....+.. ....+++++.+||.+||+.||.+||++ .++++
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~---~~l~~ 273 (296)
T 4hgt_A 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY---SYLRQ 273 (296)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCH---HHHHH
T ss_pred cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCH---HHHHH
Confidence 2222210 001256899999999999999999998 45443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=389.34 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=208.8
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc-
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK- 437 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~- 437 (810)
+....++|++++.||+|+||.||+|.++ |+.||||++.... ..+.+.+|+.+|+.++|||||++++++...+
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 3456688999999999999999999875 6799999886543 2356889999999999999999999976554
Q ss_pred eeeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
.+|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 7999999999999999998654 37999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccC
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVND 594 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~ 594 (810)
. ......+++.|+|||++.+..|+.++|||||||+||||++ |..||.+.+..++...+..+
T Consensus 341 ~------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~ 402 (450)
T 1k9a_A 341 S------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402 (450)
T ss_dssp ------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT
T ss_pred c------------------cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 1 0112357899999999999999999999999999999998 99999988877777776654
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 595 ~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
. ..+.+. .+++++.+||.+||..||.+||++ .+++
T Consensus 403 ~-~~~~p~--~~~~~l~~li~~cl~~dp~~Rpt~---~~l~ 437 (450)
T 1k9a_A 403 Y-KMDAPD--GCPPAVYDVMKNCWHLDAATRPTF---LQLR 437 (450)
T ss_dssp C-CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHH
T ss_pred C-CCCCCC--cCCHHHHHHHHHHcCCChhHCcCH---HHHH
Confidence 2 222222 367999999999999999999998 5554
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=374.31 Aligned_cols=263 Identities=19% Similarity=0.189 Sum_probs=200.8
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcC---CCcEEEEEEeeccchhhHHH--------HHHHHHHHHHHhcCCCCeEEEee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKE---TRQRFAMKKIIKNSLMLRNQ--------MEQVFAERDIMSFTDNPFVVTMY 430 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~---tg~~vAIK~I~k~~~~~~~~--------~~~i~~E~~iL~~l~HPnIVkl~ 430 (810)
..++|++.+.||+|+||.||+|.++. ++..+|+|++.......... ...+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 44789999999999999999999987 78899999887653221111 12356788899999999999999
Q ss_pred eeccc----cceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC--cEE
Q psy16843 431 CSFET----KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG--HIK 504 (810)
Q Consensus 431 ~~f~~----~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g--~VK 504 (810)
+++.+ ...+|+||||+ |++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99887 78999999999 999999998878999999999999999999999999999999999999999887 999
Q ss_pred EeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCC--C
Q psy16843 505 LTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG--E 582 (810)
Q Consensus 505 L~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~--~ 582 (810)
|+|||+++......... ..........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+ .
T Consensus 194 L~Dfg~a~~~~~~~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHK--------QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp ECCCTTCEESSGGGCCC--------CCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred EEeCCCceecccccccc--------cchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 99999997643211100 0011112356799999999999999999999999999999999999999965 2
Q ss_pred CHHHHHHhhccCCCCCCCC-----CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 583 TPEELFAHTVNDDIEWPSE-----DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 583 ~~~e~~~~I~~~~~~~p~~-----~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
+..............++.. ....++.++.+||.+||..||.+||++ .++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~l~~ 321 (345)
T 2v62_A 266 DPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNY---QALKK 321 (345)
T ss_dssp CHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCH---HHHHH
T ss_pred ccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCH---HHHHH
Confidence 3332222111111111110 001267899999999999999999999 55543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=362.98 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=201.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeee-ccccceeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCS-FETKKHLCL 441 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~-f~~~~~lyL 441 (810)
.++|++.+.||+|+||.||+|+++.+|+.||||++...... +.+.+|+.+++.+.|++++..+.. +...+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 37899999999999999999999999999999988654322 357789999999998876555544 466778899
Q ss_pred eeeeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe---ccCCcEEEeccCCccccccc
Q psy16843 442 VMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI---TALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 442 VmEy~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL---d~~g~VKL~DFGLAk~~~~s 517 (810)
||||+ +++|.+++. ..+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 999999997 44679999999999999999999999999999999999999 47899999999999753321
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC---HHHHHHhhccC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET---PEELFAHTVND 594 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~---~~e~~~~I~~~ 594 (810)
.... ..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+.+..+...
T Consensus 162 ~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 3uzp_A 162 RTHQ--------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TTCC--------BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cccc--------ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence 1100 000112245679999999999999999999999999999999999999998642 22333343333
Q ss_pred CCCCCCC-CCCcccHHHHHHHHhhhcCCCCCCCCCC
Q psy16843 595 DIEWPSE-DDWPIQVEAKSIITDLLQQNPRDRLGTG 629 (810)
Q Consensus 595 ~~~~p~~-~~~~~S~el~dLI~klL~~dP~~Rpta~ 629 (810)
....+.. ....+++++.+||.+||+.||.+||++.
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 269 (296)
T 3uzp_A 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS 269 (296)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHH
T ss_pred ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHH
Confidence 2222210 0012568999999999999999999983
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=377.29 Aligned_cols=241 Identities=17% Similarity=0.228 Sum_probs=195.1
Q ss_pred CCCCCcEEEEEecccCceEEEEE-----EEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC---CCeEEEeeee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLV-----RHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD---NPFVVTMYCS 432 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla-----~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~---HPnIVkl~~~ 432 (810)
...++|.+.+.||+|+||.||+| .+..+++.||||++..... ..+..|++++..+. |+||+.++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP------WEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH------HHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh------hHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 44578999999999999999999 4677899999998865432 34556677766665 9999999999
Q ss_pred ccccceeeeeeeeccCcchhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc--------
Q psy16843 433 FETKKHLCLVMEYVEGGDCASLLK-----NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA-------- 499 (810)
Q Consensus 433 f~~~~~lyLVmEy~~GGsL~~lL~-----~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~-------- 499 (810)
+...+..|+|||||+||+|.+++. ..+.+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 999999999999999999999997 3567999999999999999999999999999999999999998
Q ss_pred ---CCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCC
Q psy16843 500 ---LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC 576 (810)
Q Consensus 500 ---~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~ 576 (810)
++.+||+|||+|+...... ........+||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 282 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFP-------------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSC-------------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred ccccCCEEEeeCchhhhhhccC-------------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 8999999999996422110 111124567999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 577 VPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 577 ~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
.||........ .... .+.. .+.++...+++.+||+.+|.+|+..
T Consensus 283 ~pf~~~~~~~~---~~~~--~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~ 326 (365)
T 3e7e_A 283 YMKVKNEGGEC---KPEG--LFRR---LPHLDMWNEFFHVMLNIPDCHHLPS 326 (365)
T ss_dssp CCCEEEETTEE---EECS--CCTT---CSSHHHHHHHHHHHHCCCCTTCCCC
T ss_pred CccccCCCCce---eech--hccc---cCcHHHHHHHHHHHcCCCCCCcchH
Confidence 99965432110 0111 1111 1246789999999999999999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=387.05 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=196.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~lyLV 442 (810)
+.|.+.+.||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+|..+ +|||||++++++.+++.+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 45677899999999999875 45679999999886542 24567899999865 899999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCC-------CHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC-------------Cc
Q psy16843 443 MEYVEGGDCASLLKNTGPL-------PADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL-------------GH 502 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~l-------se~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~-------------g~ 502 (810)
||||. |+|.+++...+.. .+..+..++.||+.||+|||++||+||||||+||||+.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 6999999865433 334567899999999999999999999999999999754 48
Q ss_pred EEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-------cCCCCCcchhhhHHHHHHHHh-
Q psy16843 503 IKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-------QGYGKPVDWWSMGVILYEFLV- 574 (810)
Q Consensus 503 VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-------~~ys~ksDIWSLGvILyELLt- 574 (810)
+||+|||+++........ ........+||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 167 ~kL~DFG~a~~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~ 235 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSS-----------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235 (434)
T ss_dssp EEECCCTTCEECCC-------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEEcccccceecCCCCcc-----------ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhC
Confidence 999999999753221100 0001234579999999999976 678999999999999999999
Q ss_pred CCCCCCCCCHHHHHHhhccCCCCCCCC---CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 575 GCVPFFGETPEELFAHTVNDDIEWPSE---DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 575 G~~PF~~~~~~e~~~~I~~~~~~~p~~---~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
|..||.+....+ ..+......++.. ....+++++++||.+||+.||.+||++ .|+++||||.+.
T Consensus 236 g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~---~eil~hp~f~~~ 302 (434)
T 2rio_A 236 GKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA---MKVLRHPLFWPK 302 (434)
T ss_dssp SCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCH---HHHHTSGGGSCH
T ss_pred CCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCH---HHHHhCCccCCc
Confidence 999997765443 2333333333222 122356889999999999999999998 999999999753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=360.05 Aligned_cols=246 Identities=22% Similarity=0.353 Sum_probs=202.9
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc-cce
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET-KKH 438 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~-~~~ 438 (810)
....++|++++.||+|+||.||+|.++ |+.||+|++.... ..+.+.+|+++++.++||||+++++++.+ .+.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 455689999999999999999999874 7899999886543 34678899999999999999999998654 458
Q ss_pred eeeeeeeccCcchhhhhhcCCC--CCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGP--LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~--lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+|+||||++||+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999999999976543 89999999999999999999999999999999999999999999999999864211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
. .....|++.|+|||++.+..++.++||||||+++|||++ |..||.+....+....+....
T Consensus 170 ~------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~ 231 (278)
T 1byg_A 170 T------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 231 (278)
T ss_dssp ------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC
T ss_pred c------------------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC
Confidence 0 123357899999999999999999999999999999998 999999888877777766542
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
. .+.. ..+++++.+||.+||..||.+||++ .|+++
T Consensus 232 ~-~~~~--~~~~~~l~~li~~~l~~~p~~Rps~---~~l~~ 266 (278)
T 1byg_A 232 K-MDAP--DGCPPAVYEVMKNCWHLDAAMRPSF---LQLRE 266 (278)
T ss_dssp C-CCCC--TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred C-CCCc--ccCCHHHHHHHHHHhcCChhhCCCH---HHHHH
Confidence 2 1111 2367899999999999999999998 56553
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=370.97 Aligned_cols=262 Identities=19% Similarity=0.304 Sum_probs=205.5
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecc----cc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE----TK 436 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~----~~ 436 (810)
...++|++++.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+++++.++||||+++++++. ..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 34578999999999999999999999999999999886543 344567889999999999999999999986 45
Q ss_pred ceeeeeeeeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
..+|+||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 589999999999999999875 5679999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcC---CCCCcchhhhHHHHHHHHhCCCCCCCCCH--HHH
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG---YGKPVDWWSMGVILYEFLVGCVPFFGETP--EEL 587 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~---ys~ksDIWSLGvILyELLtG~~PF~~~~~--~e~ 587 (810)
............. .........||+.|+|||++.+.. ++.++|||||||++|||++|..||..... ...
T Consensus 183 ~~~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 256 (317)
T 2buj_A 183 QACIHVEGSRQAL------TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256 (317)
T ss_dssp ESCEEEESHHHHH------HHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred hcccccccccccc------cccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence 5322111100000 000012346899999999997654 79999999999999999999999953111 011
Q ss_pred HHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 588 ~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
... ......++.. ..++.++.+||.+||+.||.+||++ .|+++|
T Consensus 257 ~~~-~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~~ 300 (317)
T 2buj_A 257 ALA-VQNQLSIPQS--PRHSSALWQLLNSMMTVDPHQRPHI---PLLLSQ 300 (317)
T ss_dssp HHH-HHCC--CCCC--TTSCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred hHH-hhccCCCCcc--ccCCHHHHHHHHHHhhcChhhCCCH---HHHHHH
Confidence 111 2223333332 2367899999999999999999998 788765
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=391.23 Aligned_cols=261 Identities=22% Similarity=0.347 Sum_probs=203.4
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~ly 440 (810)
...+|.+.+.||+|+||.|+. ....+|+.||||++..... ..+.+|+++|+.+ +|||||++++++.+...+|
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 335799999999999999764 4456789999999865432 2245689999988 8999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc---C--CcEEEeccCCcccc
Q psy16843 441 LVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA---L--GHIKLTDFGLSKMG 514 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~---~--g~VKL~DFGLAk~~ 514 (810)
||||||. |+|.+++.... .+.+..+..++.||+.||.|||++||+||||||+||||+. + ..+||+|||+|+..
T Consensus 95 lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp EEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred EEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 9999996 59999987553 5677788899999999999999999999999999999953 2 35889999999753
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHh---hcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVIL---RQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAH 590 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~---~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~ 590 (810)
..... ........+||+.|+|||++. ...++.++|||||||++|||++ |..||...........
T Consensus 174 ~~~~~------------~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~ 241 (432)
T 3p23_A 174 AVGRH------------SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241 (432)
T ss_dssp ------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH
T ss_pred cCCCc------------ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH
Confidence 22110 001123467999999999998 4567889999999999999999 9999977665554433
Q ss_pred hccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 591 I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
+.......... ....+..+++||.+||+.||.+||++ .|+++||||.+++|.
T Consensus 242 ~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~---~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 242 LGACSLDCLHP-EKHEDVIARELIEKMIAMDPQKRPSA---KHVLKHPFFWSLEKQ 293 (432)
T ss_dssp TTCCCCTTSCT-TCHHHHHHHHHHHHHSCSSGGGSCCH---HHHHTSTTTCCHHHH
T ss_pred hccCCccccCc-cccccHHHHHHHHHHHhCCHhhCCCH---HHHHhCccccChHHH
Confidence 33222222111 12356778999999999999999998 999999999988773
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=386.12 Aligned_cols=252 Identities=20% Similarity=0.309 Sum_probs=209.2
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
+....++|++.+.||+|+||.||+|.++. +..||||++...... .+.+.+|+++|+.++||||+++++++.+ +.
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 34556789999999999999999999875 467999988754422 3568899999999999999999999876 67
Q ss_pred eeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+|+||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 99999999999999999743 5699999999999999999999999999999999999999999999999999975321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
.. ........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+....++...+..+.
T Consensus 333 ~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~ 398 (452)
T 1fmk_A 333 NE--------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 398 (452)
T ss_dssp ------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred Cc--------------eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 10 001123457889999999999999999999999999999999 999999999988888776542
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..+.+. .+++++.+||.+||+.||.+||++ .++++
T Consensus 399 -~~~~~~--~~~~~l~~li~~cl~~dP~~Rpt~---~~l~~ 433 (452)
T 1fmk_A 399 -RMPCPP--ECPESLHDLMCQCWRKEPEERPTF---EYLQA 433 (452)
T ss_dssp -CCCCCT--TSCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred -CCCCCC--CCCHHHHHHHHHHccCChhhCcCH---HHHHH
Confidence 222222 367899999999999999999998 56654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=365.54 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=187.8
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeec-------
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSF------- 433 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f------- 433 (810)
...+|++.+.||+|+||.||+|+++.+++.||||++.... ....+.+.+|+.++..+. ||||+++++++
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3468999999999999999999999999999999886543 234467888999999995 99999999988
Q ss_pred -cccceeeeeeeeccCcchhhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCCCceEeccCCcEEEec
Q psy16843 434 -ETKKHLCLVMEYVEGGDCASLLKN---TGPLPADMARFYFAETVLAVEYLHSYG--IVHRDLKPDNLLITALGHIKLTD 507 (810)
Q Consensus 434 -~~~~~lyLVmEy~~GGsL~~lL~~---~g~lse~~~~~i~~QIl~AL~yLHs~g--IIHRDLKPeNILLd~~g~VKL~D 507 (810)
.....+|+||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence 45567999999996 688888754 567999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHH---hhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCH
Q psy16843 508 FGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI---LRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584 (810)
Q Consensus 508 FGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl---~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~ 584 (810)
||+++........... .............+||+.|+|||++ .+..++.++|||||||++|||++|..||.+...
T Consensus 182 fg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 182 FGSATTISHYPDYSWS---AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp CTTCBCCSSCC----------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred CccceeccccCccccc---ccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999763321110000 0000000112245799999999999 566789999999999999999999999987655
Q ss_pred HHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 585 EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 585 ~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
..... .....+... ..+..+.+||.+||+.||.+||++ .|+++|
T Consensus 259 ~~~~~----~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~---~e~l~~ 302 (337)
T 3ll6_A 259 LRIVN----GKYSIPPHD--TQYTVFHSLIRAMLQVNPEERLSI---AEVVHQ 302 (337)
T ss_dssp -----------CCCCTTC--CSSGGGHHHHHHHSCSSGGGSCCH---HHHHHH
T ss_pred HHhhc----CcccCCccc--ccchHHHHHHHHHccCChhhCcCH---HHHHHH
Confidence 44333 233333222 256789999999999999999998 888876
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=363.80 Aligned_cols=233 Identities=30% Similarity=0.531 Sum_probs=190.9
Q ss_pred CCCCcEEE-EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHH-hcCCCCeEEEeeeeccc----
Q psy16843 362 NENDFTVI-KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM-SFTDNPFVVTMYCSFET---- 435 (810)
Q Consensus 362 ~~~dy~il-k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL-~~l~HPnIVkl~~~f~~---- 435 (810)
..++|.++ +.||+|+||.||+|.++.+++.||+|++... ....+|+.++ +.++||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 34779888 7899999999999999999999999988643 2455677777 67799999999999876
Q ss_pred cceeeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc---CCcEEEeccCC
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA---LGHIKLTDFGL 510 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~---~g~VKL~DFGL 510 (810)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 778999999999999999998654 6999999999999999999999999999999999999998 78899999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~ 590 (810)
+.... +..|+.++|||||||++|||++|..||.+.........
T Consensus 167 a~~~~-------------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 209 (299)
T 3m2w_A 167 AKETT-------------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 209 (299)
T ss_dssp CEECT-------------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC
T ss_pred ccccc-------------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH
Confidence 85310 13467889999999999999999999987765544322
Q ss_pred hcc----CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 591 TVN----DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 591 I~~----~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+.. ....++......+++++++||.+||+.||.+||++ .|+++||||.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~---~e~l~hp~~~~ 262 (299)
T 3m2w_A 210 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI---TEFMNHPWIMQ 262 (299)
T ss_dssp SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH---HHHHTSHHHHT
T ss_pred HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCH---HHHhcChhhcc
Confidence 222 22222211112367899999999999999999998 99999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=359.81 Aligned_cols=242 Identities=27% Similarity=0.425 Sum_probs=196.4
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++.+.||+|+||.||+|++. ++.||+|++... ...+.+.+|+++++.++||||+++++++.+ ..|+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence 4468999999999999999999874 688999988543 234678899999999999999999999874 4899
Q ss_pred eeeeccCcchhhhhhcCC---CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCCCceEeccCCc-EEEeccCCcccc
Q psy16843 442 VMEYVEGGDCASLLKNTG---PLPADMARFYFAETVLAVEYLHS---YGIVHRDLKPDNLLITALGH-IKLTDFGLSKMG 514 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g---~lse~~~~~i~~QIl~AL~yLHs---~gIIHRDLKPeNILLd~~g~-VKL~DFGLAk~~ 514 (810)
||||++||+|.+++...+ .+++..+..++.||+.||+|||+ +||+||||||+|||++.+|. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999999999999998655 47899999999999999999999 89999999999999998886 799999998642
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC--HHHHHHhhc
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET--PEELFAHTV 592 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~--~~e~~~~I~ 592 (810)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||.... .......+.
T Consensus 157 ~~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 218 (307)
T 2eva_A 157 QTH------------------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH 218 (307)
T ss_dssp --------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH
T ss_pred ccc------------------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh
Confidence 110 123469999999999999999999999999999999999999997543 333333333
Q ss_pred cCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 593 ~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..... +. ...++.++.+||.+||+.||.+||++ .|+++
T Consensus 219 ~~~~~-~~--~~~~~~~l~~li~~~l~~dp~~Rps~---~ell~ 256 (307)
T 2eva_A 219 NGTRP-PL--IKNLPKPIESLMTRCWSKDPSQRPSM---EEIVK 256 (307)
T ss_dssp TTCCC-CC--BTTCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred cCCCC-Cc--ccccCHHHHHHHHHHhcCChhhCcCH---HHHHH
Confidence 32211 11 12367899999999999999999998 67665
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=368.16 Aligned_cols=259 Identities=21% Similarity=0.250 Sum_probs=204.8
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++.+.||+|+||.||+|+++ +|+.||||++...... .....+.+|+++++.++||||+++++++.+.+..|
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 34578999999999999999999854 6889999988654322 11235788999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCC----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 441 LVMEYVEGGDCASLLKNTG----PLPADMARFYFAETVLAVEYLHSY---GIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g----~lse~~~~~i~~QIl~AL~yLHs~---gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
+||||+.||+|.+++.... .+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 9999999999999997543 499999999999999999999999 999999999999999999999999999975
Q ss_pred ccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC--------CHH
Q psy16843 514 GLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE--------TPE 585 (810)
Q Consensus 514 ~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~--------~~~ 585 (810)
.... ........+||+.|+|||++.+..++.++|||||||++|||++|..||... ...
T Consensus 184 ~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 249 (326)
T 3uim_A 184 MDYK--------------DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249 (326)
T ss_dssp CCSS--------------SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred cCcc--------------cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence 3211 011123456999999999999999999999999999999999999999521 111
Q ss_pred HHHHhhccCC-C------CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCC
Q psy16843 586 ELFAHTVNDD-I------EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639 (810)
Q Consensus 586 e~~~~I~~~~-~------~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPf 639 (810)
+......... . ..........+.++.+||.+||+.||.+||++ .|+++|-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~---~ell~~L~ 307 (326)
T 3uim_A 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM---SEVVRMLE 307 (326)
T ss_dssp HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCH---HHHHHHHH
T ss_pred HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCH---HHHHHHhc
Confidence 1111111110 0 01111112245789999999999999999999 78887643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=391.30 Aligned_cols=252 Identities=20% Similarity=0.309 Sum_probs=212.8
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
+....++|++.+.||+|+||.||+|.++. +..||||++...... .+.+.+|+++|+.++|||||++++++.+ +.
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 34556789999999999999999999875 467999988764422 2568899999999999999999999876 67
Q ss_pred eeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+||||||+.+|+|.++|... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999999999999743 5699999999999999999999999999999999999999999999999999975321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
.. ........|++.|+|||++.+..|+.++|||||||+||||++ |..||.+....+++..+..+.
T Consensus 416 ~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~ 481 (535)
T 2h8h_A 416 NE--------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 481 (535)
T ss_dssp HH--------------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred Cc--------------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 10 001123457889999999999999999999999999999999 999999999888888776542
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..+... .++.++.+||.+||..||++||++ .+|++
T Consensus 482 -~~~~~~--~~~~~l~~li~~cl~~dP~~RPt~---~~l~~ 516 (535)
T 2h8h_A 482 -RMPCPP--ECPESLHDLMCQCWRKEPEERPTF---EYLQA 516 (535)
T ss_dssp -CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred -CCCCCC--CCCHHHHHHHHHHcCCChhHCcCH---HHHHH
Confidence 222222 367899999999999999999998 56554
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=375.82 Aligned_cols=256 Identities=18% Similarity=0.221 Sum_probs=201.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCC---cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeec-cccce
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETR---QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSF-ETKKH 438 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg---~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f-~~~~~ 438 (810)
...|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+.+++.++||||+++++++ ..++.
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 346899999999999999999986543 468999876432 234557889999999999999999999985 45668
Q ss_pred eeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 89999999999999999765 46899999999999999999999999999999999999999999999999999753211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
... .........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+....+..+..
T Consensus 246 ~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~ 314 (373)
T 3c1x_A 246 EFD-----------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 314 (373)
T ss_dssp -----------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC
T ss_pred ccc-----------cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC
Confidence 100 0011123467899999999999999999999999999999999 7889988776666666665443
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
.... ..++.++.+||.+||..||.+||++ .|++++
T Consensus 315 ~~~p---~~~~~~l~~li~~cl~~dp~~RPs~---~ell~~ 349 (373)
T 3c1x_A 315 LLQP---EYCPDPLYEVMLKCWHPKAEMRPSF---SELVSR 349 (373)
T ss_dssp CCCC---TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCCC---CCCCHHHHHHHHHHcCCChhhCcCH---HHHHHH
Confidence 2221 1267899999999999999999998 677653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=359.38 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=195.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhc--CCCCeEEEeeeecccc----c
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF--TDNPFVVTMYCSFETK----K 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~--l~HPnIVkl~~~f~~~----~ 437 (810)
++|++++.||+|+||.||+|+++ ++.||||++..... .....|.+++.. ++||||+++++++... .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 68999999999999999999875 88999998864421 233445555544 5999999999998776 7
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc--------ccccccCCCCceEeccCCcEEEeccC
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY--------GIVHRDLKPDNLLITALGHIKLTDFG 509 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~--------gIIHRDLKPeNILLd~~g~VKL~DFG 509 (810)
.+|+||||++||+|.++++. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 89999999999999999976 4799999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCC------cchhhhHHHHHHHHhC--------
Q psy16843 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKP------VDWWSMGVILYEFLVG-------- 575 (810)
Q Consensus 510 LAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~k------sDIWSLGvILyELLtG-------- 575 (810)
+++....... .........+||+.|+|||++.+..++.. +|||||||++|||++|
T Consensus 188 ~a~~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 188 LAVKFISDTN-----------EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TCEECC--------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred Cceeeccccc-----------cccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 9965322111 01112235679999999999998877665 9999999999999999
Q ss_pred --CCCCCCC-----CHHHHHHhhccCCCCCCCCC---CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 576 --CVPFFGE-----TPEELFAHTVNDDIEWPSED---DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 576 --~~PF~~~-----~~~e~~~~I~~~~~~~p~~~---~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
..||... ........+........... ...++.++.+||.+||+.||.+||++ .|+++|
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~ell~~ 325 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA---LRVKKT 325 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH---HHHHHH
T ss_pred cccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH---HHHHHH
Confidence 7777543 22233332322222211111 01256779999999999999999998 777764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=372.15 Aligned_cols=255 Identities=16% Similarity=0.199 Sum_probs=201.3
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCC--------CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEE-----
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKET--------RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVT----- 428 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~t--------g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVk----- 428 (810)
..++|++.+.||+|+||.||+|+++.+ ++.||+|++.+. +.+.+|+++++.++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhh
Confidence 347899999999999999999999874 889999988654 35678999999999999988
Q ss_pred ----------eeeeccc-cceeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCce
Q psy16843 429 ----------MYCSFET-KKHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNL 495 (810)
Q Consensus 429 ----------l~~~f~~-~~~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNI 495 (810)
+++++.. +..+|+||||+ ||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 4455544 67899999999 99999999876 7899999999999999999999999999999999999
Q ss_pred EeccCC--cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHH
Q psy16843 496 LITALG--HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL 573 (810)
Q Consensus 496 LLd~~g--~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELL 573 (810)
|++.++ .+||+|||+++.......... .........+||+.|+|||++.+..|+.++|||||||+||||+
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVA--------YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCC--------CCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred EEcCCCCceEEEecCcceeeccCCCcccc--------ccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 999988 999999999975432211100 0011123457999999999999999999999999999999999
Q ss_pred hCCCCCCCCC--HHHHHHhhc---cCCCCCCCC--CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 574 VGCVPFFGET--PEELFAHTV---NDDIEWPSE--DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 574 tG~~PF~~~~--~~e~~~~I~---~~~~~~p~~--~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
+|..||.+.. ...+..... .....++.. ....++.++.+||.+||..||.+||++ .++++
T Consensus 263 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~l~~ 329 (352)
T 2jii_A 263 YGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPY---AMLRN 329 (352)
T ss_dssp HSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCH---HHHHH
T ss_pred hCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCH---HHHHH
Confidence 9999998753 333332221 222211111 111257899999999999999999998 56553
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=364.01 Aligned_cols=257 Identities=21% Similarity=0.314 Sum_probs=191.1
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHH--HHHHHHhcCCCCeEEEeeee-----
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVF--AERDIMSFTDNPFVVTMYCS----- 432 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~--~E~~iL~~l~HPnIVkl~~~----- 432 (810)
....++|++++.||+|+||.||+|++ +++.||||++..... ..+. .|+..+..++||||+++++.
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 34568999999999999999999976 689999998865432 2233 34444556899999999873
Q ss_pred ccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc---------ccccccCCCCceEeccCCcE
Q psy16843 433 FETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY---------GIVHRDLKPDNLLITALGHI 503 (810)
Q Consensus 433 f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~---------gIIHRDLKPeNILLd~~g~V 503 (810)
+.....+|+||||++||+|.+++... .+++..+..++.||+.||.|||++ ||+||||||+||||+.+|.+
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 34455789999999999999999764 458999999999999999999999 99999999999999999999
Q ss_pred EEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-------cCCCCCcchhhhHHHHHHHHhCC
Q psy16843 504 KLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-------QGYGKPVDWWSMGVILYEFLVGC 576 (810)
Q Consensus 504 KL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-------~~ys~ksDIWSLGvILyELLtG~ 576 (810)
||+|||+++......... ...........+||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 160 kL~DFG~a~~~~~~~~~~-------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVR-------PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp EECCCTTCEECSSSSCC----------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EEeeccceeecccccccC-------ccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 999999997533211100 0001112235679999999999987 46678999999999999999997
Q ss_pred CCCCCCC------------------HHHHHHhhccC--CCCCCCC--CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHH
Q psy16843 577 VPFFGET------------------PEELFAHTVND--DIEWPSE--DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEV 634 (810)
Q Consensus 577 ~PF~~~~------------------~~e~~~~I~~~--~~~~p~~--~~~~~S~el~dLI~klL~~dP~~Rpta~~~~Ei 634 (810)
.||.... ..+....+... ...+|.. .....++++.+||.+||+.||++||++ .|+
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~---~e~ 309 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA---QXA 309 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCH---HHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcch---HHH
Confidence 7764321 11111111111 1122211 111255689999999999999999998 666
Q ss_pred h
Q psy16843 635 K 635 (810)
Q Consensus 635 L 635 (810)
+
T Consensus 310 l 310 (336)
T 3g2f_A 310 E 310 (336)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=395.48 Aligned_cols=259 Identities=23% Similarity=0.316 Sum_probs=209.9
Q ss_pred CCCCcEEEE-EecccCceEEEEEEEcC--CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 362 NENDFTVIK-LISNGAYGSVYLVRHKE--TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 362 ~~~dy~ilk-~LG~G~FG~Vyla~~k~--tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
..+++.+.+ .||+|+||.||+|.++. ++..||||++..... ....+.+.+|+++|+.++|||||++++++.+ +.
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 345677766 89999999999998763 556799998865432 2345778899999999999999999999976 56
Q ss_pred eeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
+|+|||||.||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999999999754 56999999999999999999999999999999999999999999999999999753211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.. .........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+.+..++...+..+..
T Consensus 490 ~~------------~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~ 557 (613)
T 2ozo_A 490 DS------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 557 (613)
T ss_dssp ------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC
T ss_pred Cc------------eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence 10 0001122346789999999999999999999999999999998 9999999998888888776542
Q ss_pred -CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCC
Q psy16843 597 -EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639 (810)
Q Consensus 597 -~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPf 639 (810)
..|. .+++++.+||.+||..||.+||++..+.+.|++.|
T Consensus 558 ~~~p~----~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 558 MECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp CCCCT----TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCC----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2222 26799999999999999999999944444444433
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=395.27 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=206.1
Q ss_pred cEE-EEEecccCceEEEEEEE--cCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 366 FTV-IKLISNGAYGSVYLVRH--KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 366 y~i-lk~LG~G~FG~Vyla~~--k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
+.+ .+.||+|+||.||+|.+ +.+++.||||++..... .....+.+.+|+++|+.++|||||++++++.. +.+|+|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 444 35899999999999965 45678999998865432 23345778999999999999999999999965 468999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||||.||+|.+++...+.+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.......
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~--- 524 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--- 524 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc---
Confidence 99999999999999888999999999999999999999999999999999999999999999999999975322110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCC-CCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIE-WPS 600 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~-~p~ 600 (810)
.........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+.+..++...+..+... .|.
T Consensus 525 ---------~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~ 595 (635)
T 4fl3_A 525 ---------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 595 (635)
T ss_dssp -------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ---------ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 0011123457889999999999999999999999999999998 99999999999888887765422 222
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
.++.++.+||.+||..||++||++ .+++
T Consensus 596 ----~~~~~l~~li~~cl~~dP~~RPs~---~~l~ 623 (635)
T 4fl3_A 596 ----GCPREMYDLMNLCWTYDVENRPGF---AAVE 623 (635)
T ss_dssp ----TCCHHHHHHHHHHTCSSTTTSCCH---HHHH
T ss_pred ----CCCHHHHHHHHHHcCCCHhHCcCH---HHHH
Confidence 267999999999999999999998 5554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=379.64 Aligned_cols=248 Identities=15% Similarity=0.202 Sum_probs=192.5
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh-----hHHHHHHHHHHHHHHhcCC--------------
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM-----LRNQMEQVFAERDIMSFTD-------------- 422 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~-----~~~~~~~i~~E~~iL~~l~-------------- 422 (810)
..++|++++.||+|+||.||+|++ +|+.||||++.+.... .....+.+.+|+.+|+.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 346899999999999999999988 6899999999765321 1223356778888887775
Q ss_pred ------------CCeEEEeeeeccc-------------cceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHH
Q psy16843 423 ------------NPFVVTMYCSFET-------------KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAV 477 (810)
Q Consensus 423 ------------HPnIVkl~~~f~~-------------~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL 477 (810)
||||++++++|.+ .+.+|||||||++|++.+.+.+ +.+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 5555555555554 7899999999999987777754 6799999999999999999
Q ss_pred HHhh-hcccccccCCCCceEeccCC--------------------cEEEeccCCcccccccccccchhhhhhcccccccC
Q psy16843 478 EYLH-SYGIVHRDLKPDNLLITALG--------------------HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536 (810)
Q Consensus 478 ~yLH-s~gIIHRDLKPeNILLd~~g--------------------~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~ 536 (810)
+||| ++||+||||||+||||+.+| .+||+|||+|+... .
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~--------------------~ 234 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER--------------------D 234 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE--------------------T
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC--------------------C
Confidence 9999 99999999999999999987 99999999997521 1
Q ss_pred CcccCCCCcCChhHHhhcCCCCCcchhhhHHH-HHHHHhCCCCCCCCCH-HHHHHhhccC---CCCCCCCCCCcccHHHH
Q psy16843 537 KQVYGTPEYIAPEVILRQGYGKPVDWWSMGVI-LYEFLVGCVPFFGETP-EELFAHTVND---DIEWPSEDDWPIQVEAK 611 (810)
Q Consensus 537 ~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvI-LyELLtG~~PF~~~~~-~e~~~~I~~~---~~~~p~~~~~~~S~el~ 611 (810)
...+||+.|||||++.+.. +.++||||||++ .++++.|..||.+... ......+... ....+......++++++
T Consensus 235 ~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 235 GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHH
T ss_pred CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHH
Confidence 2457999999999998776 899999998777 7788899999954321 1122222211 11111111113678999
Q ss_pred HHHHhhhcCCCCCCCCCCChhHHh-cCCCcC
Q psy16843 612 SIITDLLQQNPRDRLGTGGPHEVK-EHPYFS 641 (810)
Q Consensus 612 dLI~klL~~dP~~Rpta~~~~EiL-~HPfF~ 641 (810)
+||.+||++| ++ .|++ +||||+
T Consensus 314 dli~~~L~~d-----sa---~e~l~~Hp~f~ 336 (336)
T 2vuw_A 314 EFHRTMLNFS-----SA---TDLLCQHSLFK 336 (336)
T ss_dssp HHHHHGGGSS-----SH---HHHHHHCGGGC
T ss_pred HHHHHHhccC-----CH---HHHHhcCCCcC
Confidence 9999999987 55 9999 999995
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=361.74 Aligned_cols=252 Identities=21% Similarity=0.243 Sum_probs=202.4
Q ss_pred CcEEEEEecccCceEEEEEEE----cCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc--cce
Q psy16843 365 DFTVIKLISNGAYGSVYLVRH----KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET--KKH 438 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~----k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~--~~~ 438 (810)
.|++++.||+|+||.||++.. ..+++.||||++.... .....+.+.+|+++++.++||||+++++++.+ ...
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 349999999999999988764 3578999999987653 23445778899999999999999999999987 468
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 99999999999999999874 59999999999999999999999999999999999999999999999999997532211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHH------------
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE------------ 586 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e------------ 586 (810)
. .........||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 189 ~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 3lxp_A 189 E------------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256 (318)
T ss_dssp S------------EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH
T ss_pred c------------ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh
Confidence 0 0011234568999999999999999999999999999999999999997543211
Q ss_pred --HHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 587 --LFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 587 --~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.....+......+.. ..++.++.+||.+||+.||.+||++ .|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~---~ell~ 303 (318)
T 3lxp_A 257 VLRLTELLERGERLPRP--DKCPAEVYHLMKNCWETEASFRPTF---ENLIP 303 (318)
T ss_dssp HHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred HHHHHHHHhcccCCCCC--ccccHHHHHHHHHHcCCCcccCcCH---HHHHH
Confidence 111222222222222 2367899999999999999999998 66663
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=383.21 Aligned_cols=276 Identities=21% Similarity=0.260 Sum_probs=217.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC-CeEEEeeeeccccceeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN-PFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H-PnIVkl~~~f~~~~~lyL 441 (810)
.++|++++.||+|+||.||+|++..+++.||||++...... ..+..|+++++.+.| ++|..+..++...+..||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 37899999999999999999999999999999987654322 346789999999987 556666666777889999
Q ss_pred eeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe---ccCCcEEEeccCCccccccc
Q psy16843 442 VMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI---TALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL---d~~g~VKL~DFGLAk~~~~s 517 (810)
||||+ |++|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.....
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999 9999999974 5689999999999999999999999999999999999999 58899999999999764322
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC---HHHHHHhhccC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET---PEELFAHTVND 594 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~---~~e~~~~I~~~ 594 (810)
.... ..........+||+.|+|||++.+..|+.++|||||||+||||++|..||.+.. ..+.+..+...
T Consensus 160 ~~~~--------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (483)
T 3sv0_A 160 STHQ--------HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (483)
T ss_dssp TTCC--------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred cccc--------ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence 1100 000112246789999999999999999999999999999999999999998743 34444444433
Q ss_pred CCCCCCC-CCCcccHHHHHHHHhhhcCCCCCCCCCCChhH-------HhcCCCcCCCChhhhhhcc
Q psy16843 595 DIEWPSE-DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHE-------VKEHPYFSNLDWNSLLRHK 652 (810)
Q Consensus 595 ~~~~p~~-~~~~~S~el~dLI~klL~~dP~~Rpta~~~~E-------iL~HPfF~~id~~~l~~~~ 652 (810)
....... ....++.++.+||.+||..||.+||++..+.+ ...|+|+..+||+.+....
T Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~ 297 (483)
T 3sv0_A 232 KVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQ 297 (483)
T ss_dssp HHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC--
T ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhcccc
Confidence 2211100 00125689999999999999999999843222 2457999999999876543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=358.31 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=200.4
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccch-hhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL-MLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~-~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
|...+.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44568899999999999986 578999998865432 223345678899999999999999999999999999999999
Q ss_pred eccCcchhhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 445 YVEGGDCASLLKN---TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 445 y~~GGsL~~lL~~---~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~---- 186 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF---- 186 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC----
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc----
Confidence 9999999999863 356999999999999999999999999999999999999999999999999998753211
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHH----HHHhhccCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE----LFAHTVNDDIE 597 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e----~~~~I~~~~~~ 597 (810)
.........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+ +...+......
T Consensus 187 ---------~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 256 (307)
T 2nru_A 187 ---------AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT 256 (307)
T ss_dssp ---------SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC
T ss_pred ---------cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh
Confidence 01111234579999999999876 48999999999999999999999998654322 11111111100
Q ss_pred -------CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 598 -------WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 598 -------~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.........+..+.+||.+||..||.+||++ .++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~---~~l~~ 299 (307)
T 2nru_A 257 IEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI---KKVQQ 299 (307)
T ss_dssp HHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCH---HHHHH
T ss_pred hhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCH---HHHHH
Confidence 0011112355789999999999999999998 67664
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=361.22 Aligned_cols=258 Identities=22% Similarity=0.264 Sum_probs=208.6
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
.....++|++.+.||+|+||.||+|.++. .+|+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 44566899999999999999999998864 4999988654321 1223456779999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
+|+||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ +|.+||+|||+++.....
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 999999999999999998754 799999999999999999999999999999999999998 689999999998653211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhh---------cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHH
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR---------QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELF 588 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~---------~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~ 588 (810)
.. ...........||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+....+..
T Consensus 183 ~~----------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 252 (319)
T 2y4i_B 183 QA----------GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252 (319)
T ss_dssp ---------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred cc----------cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 00 001111234569999999999975 35789999999999999999999999999988888
Q ss_pred HhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 589 AHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 589 ~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..+......... ...++.++.+||.+||..||.+||++ .++++
T Consensus 253 ~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~---~~l~~ 295 (319)
T 2y4i_B 253 WQMGTGMKPNLS--QIGMGKEISDILLFCWAFEQEERPTF---TKLMD 295 (319)
T ss_dssp HHHHTTCCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCH---HHHHH
T ss_pred HHhccCCCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCH---HHHHH
Confidence 777665433222 22367899999999999999999998 66664
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.04 Aligned_cols=251 Identities=21% Similarity=0.278 Sum_probs=201.6
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhc--CCCCeEEEeeeeccccc----
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF--TDNPFVVTMYCSFETKK---- 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~--l~HPnIVkl~~~f~~~~---- 437 (810)
++|++.+.||+|+||.||+|++ +|+.||||++.... ...+..|.+++.. ++||||+++++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 5799999999999999999987 58999999886432 2456678888876 79999999999998776
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhh--------hcccccccCCCCceEeccCCcEEEeccC
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLH--------SYGIVHRDLKPDNLLITALGHIKLTDFG 509 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLH--------s~gIIHRDLKPeNILLd~~g~VKL~DFG 509 (810)
.+|+||||+++|+|.+++.+ ..+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 89999999999999999976 47999999999999999999999 8999999999999999999999999999
Q ss_pred CcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcC------CCCCcchhhhHHHHHHHHhC--------
Q psy16843 510 LSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG------YGKPVDWWSMGVILYEFLVG-------- 575 (810)
Q Consensus 510 LAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~------ys~ksDIWSLGvILyELLtG-------- 575 (810)
++......... ........+||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 193 ~~~~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 193 LAVRHDSATDT-----------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TCEEEETTTTE-----------EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred Cceeccccccc-----------cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 99753221100 011224557999999999998752 34689999999999999999
Q ss_pred --CCCCCCC-----CHHHHHHhhccCCCCCCCCC---CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 576 --CVPFFGE-----TPEELFAHTVNDDIEWPSED---DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 576 --~~PF~~~-----~~~e~~~~I~~~~~~~p~~~---~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
..||.+. ....+...+........... ....+..+.+||.+||+.||.+||++ .|+++|
T Consensus 262 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~---~~i~~~ 330 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA---LRIKKT 330 (342)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH---HHHHHH
T ss_pred ccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCH---HHHHHH
Confidence 7899764 33445555444333222111 11244679999999999999999998 777764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.81 Aligned_cols=256 Identities=21% Similarity=0.283 Sum_probs=204.8
Q ss_pred CCCCCcEEEEEecccCceEEEEEEE----cCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRH----KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~----k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
...++|++++.||+|+||.||+|+. ..+++.||+|++.... ....+.+.+|+++++.++||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 3457899999999999999999984 5689999999986543 33456788999999999999999999988665
Q ss_pred c--eeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 437 K--HLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 437 ~--~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
+ .+++||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 4 789999999999999999865 5699999999999999999999999999999999999999999999999999975
Q ss_pred ccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHH--------
Q psy16843 514 GLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE-------- 585 (810)
Q Consensus 514 ~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~-------- 585 (810)
...... .........|++.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 195 ~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~ 262 (326)
T 2w1i_A 195 LPQDKE------------YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262 (326)
T ss_dssp CCSSCS------------EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTT
T ss_pred cccccc------------ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccc
Confidence 322110 001112345788899999999999999999999999999999999998643111
Q ss_pred ----H---HHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 586 ----E---LFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 586 ----e---~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
. .+...+......+.. ..++.++.+||.+||..||.+||++ .|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~---~el~~ 315 (326)
T 2w1i_A 263 KQGQMIVFHLIELLKNNGRLPRP--DGCPDEIYMIMTECWNNNVNQRPSF---RDLAL 315 (326)
T ss_dssp CCTHHHHHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHSCSSGGGSCCH---HHHHH
T ss_pred cchhhhHHHHHHHhhcCCCCCCC--CcccHHHHHHHHHHcCCChhhCcCH---HHHHH
Confidence 0 111112222222222 2367899999999999999999998 66653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=378.84 Aligned_cols=249 Identities=15% Similarity=0.144 Sum_probs=196.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC-Ce---------------EE
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN-PF---------------VV 427 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H-Pn---------------IV 427 (810)
..|.+.+.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.+.| .+ ++
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 468899999999999999999999999999998874443333445778899999999987 21 11
Q ss_pred Ee------eeeccc-----cceeeeeeeeccCcchhhhhh------c-CCCCCHHHHHHHHHHHHHHHHHhhhccccccc
Q psy16843 428 TM------YCSFET-----KKHLCLVMEYVEGGDCASLLK------N-TGPLPADMARFYFAETVLAVEYLHSYGIVHRD 489 (810)
Q Consensus 428 kl------~~~f~~-----~~~lyLVmEy~~GGsL~~lL~------~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRD 489 (810)
.+ +.++.. ...++++|+++ +++|.++++ . .+.+++..+..++.||+.||+|||++||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 11 111121 12467777766 689999884 1 34578889999999999999999999999999
Q ss_pred CCCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHH----------hhcCCCCC
Q psy16843 490 LKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVI----------LRQGYGKP 559 (810)
Q Consensus 490 LKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl----------~~~~ys~k 559 (810)
|||+||||+.+|.+||+|||+++..... ....+| +.|+|||++ .+..|+.+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~------------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 297 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS------------------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFA 297 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE------------------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc------------------cccCCC-CceeCchhhhccccccccccCcCCCch
Confidence 9999999999999999999998752111 235578 999999999 44558889
Q ss_pred cchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCC
Q psy16843 560 VDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639 (810)
Q Consensus 560 sDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPf 639 (810)
+|||||||++|||++|+.||.+.+..+....+..... .+++++++||.+||+.||.+||++ .|+++|||
T Consensus 298 ~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~--------~~~~~~~~li~~~l~~dP~~Rpt~---~~~l~~~~ 366 (413)
T 3dzo_A 298 FDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCK--------NIPQPVRALLEGFLRYPKEDRLLP---LQAMETPE 366 (413)
T ss_dssp HHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSSCC--------CCCHHHHHHHHHHTCSSGGGSCCH---HHHTTSHH
T ss_pred hhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhhcc--------cCCHHHHHHHHHHccCChhhCcCH---HHHHhCHH
Confidence 9999999999999999999998776555544443221 256899999999999999999998 99999999
Q ss_pred cCCC
Q psy16843 640 FSNL 643 (810)
Q Consensus 640 F~~i 643 (810)
|+.+
T Consensus 367 ~~~~ 370 (413)
T 3dzo_A 367 YEQL 370 (413)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=397.75 Aligned_cols=266 Identities=24% Similarity=0.362 Sum_probs=212.5
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc------c
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET------K 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~------~ 436 (810)
.++|++.+.||+|+||.||+|.++.+|+.||||++.... .....+.+.+|+++++.++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 478999999999999999999999999999999876542 23445778899999999999999999998766 6
Q ss_pred ceeeeeeeeccCcchhhhhhcCC---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCc---EEEeccCC
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTG---PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGH---IKLTDFGL 510 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g---~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~---VKL~DFGL 510 (810)
+..|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 78899999999999999997644 6999999999999999999999999999999999999997765 99999999
Q ss_pred cccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHH-
Q psy16843 511 SKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA- 589 (810)
Q Consensus 511 Ak~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~- 589 (810)
+...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+......+.
T Consensus 171 a~~~~~~----------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~ 234 (676)
T 3qa8_A 171 AKELDQG----------------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG 234 (676)
T ss_dssp CCBTTSC----------------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST
T ss_pred ccccccc----------------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhh
Confidence 8753211 11234679999999999999999999999999999999999999997653322111
Q ss_pred -------------hhccCCCCC------CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhh
Q psy16843 590 -------------HTVNDDIEW------PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLR 650 (810)
Q Consensus 590 -------------~I~~~~~~~------p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~ 650 (810)
....+.+.+ +......+++++.+||.+||..||.+||++ .|+++||||.. +..++.
T Consensus 235 ~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa---~elL~hp~F~~--l~~iL~ 309 (676)
T 3qa8_A 235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD---PQNPNVGCFQA--LDSILS 309 (676)
T ss_dssp TCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CC---TTCCCCTTHHH--HHHHHC
T ss_pred hhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCH---HHHhcCHHHHH--HHHHHh
Confidence 111122222 111222367889999999999999999999 89999999987 444444
Q ss_pred c
Q psy16843 651 H 651 (810)
Q Consensus 651 ~ 651 (810)
.
T Consensus 310 ~ 310 (676)
T 3qa8_A 310 L 310 (676)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=386.99 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=210.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKET---RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~t---g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
...++|++.+.||+|+||.||+|.++.+ +..||+|++.... .....+.+.+|+.+|+.++||||+++++++. ++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 3457899999999999999999998654 4579999875432 2344567889999999999999999999985 46
Q ss_pred eeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 789999999999999999855 4799999999999999999999999999999999999999999999999999975321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
.. ........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+....+....+..+.
T Consensus 544 ~~--------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~ 609 (656)
T 2j0j_A 544 ST--------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 609 (656)
T ss_dssp ------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC
T ss_pred Cc--------------ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Confidence 10 111123457889999999999999999999999999999997 999999999988888877654
Q ss_pred C-CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 I-EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~-~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
. ..+. .+++++.+||.+||..||.+||++ .|+++
T Consensus 610 ~~~~~~----~~~~~l~~li~~~l~~dP~~RPs~---~el~~ 644 (656)
T 2j0j_A 610 RLPMPP----NCPPTLYSLMTKCWAYDPSRRPRF---TELKA 644 (656)
T ss_dssp CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CCCCCc----cccHHHHHHHHHHcCCChhHCcCH---HHHHH
Confidence 2 2222 367899999999999999999998 66664
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=348.56 Aligned_cols=226 Identities=13% Similarity=0.136 Sum_probs=188.3
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||+|+||.||+|++..+++.||||++...........+.+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 37899999999999999999999999999999998776554455667889999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||++|++|.++++. + .....+..++.||+.||+|||++||+||||||+||||+.+|.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred EEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 999999999999965 3 4566788899999999999999999999999999999999999998555
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHH---hhccCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA---HTVNDDIEWP 599 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~---~I~~~~~~~p 599 (810)
|++ +++.++|||||||++|||++|+.||.+.+..+.+. ++.......+
T Consensus 175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T 3uqc_A 175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP 225 (286)
T ss_dssp ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCH
T ss_pred ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCCh
Confidence 233 37889999999999999999999998876543221 1112222111
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
......+++++.+||.+||++||.+| ++ .|+++
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~---~el~~ 258 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SA---STLLN 258 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CH---HHHHH
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CH---HHHHH
Confidence 11112367899999999999999999 87 66664
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=381.35 Aligned_cols=241 Identities=24% Similarity=0.364 Sum_probs=198.9
Q ss_pred CCCcEEEEEecccCceEEEEEEEcC-CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce---
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKE-TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH--- 438 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~-tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~--- 438 (810)
.++|++++.||+|+||.||+|.++. +|+.||||++..... ....+.+.+|+++++.++|||||++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD--AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC--HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 4789999999999999999999986 789999998765432 3344678899999999999999999999987665
Q ss_pred --eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 439 --LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 439 --lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+||||||++|++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+||||+. +.+||+|||+++....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~-~~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS-SCEEECCCTTCEETTC
T ss_pred ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC-CcEEEEecccchhccc
Confidence 7999999999999998765 7999999999999999999999999999999999999998 4999999999875211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~ 596 (810)
....+||+.|+|||++.+. ++.++|||||||+||+|++|.+||.+.... .+
T Consensus 234 -------------------~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~ 284 (681)
T 2pzi_A 234 -------------------FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GL 284 (681)
T ss_dssp -------------------CSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SC
T ss_pred -------------------CCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc---------cc
Confidence 1345799999999999765 589999999999999999999998753211 11
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
. ........++.+.+||.+||++||.+||+. .+.+.|+|+.
T Consensus 285 ~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~---~~~l~~~l~~ 325 (681)
T 2pzi_A 285 P-EDDPVLKTYDSYGRLLRRAIDPDPRQRFTT---AEEMSAQLTG 325 (681)
T ss_dssp C-TTCHHHHHCHHHHHHHHHHTCSSGGGSCSS---HHHHHHHHHH
T ss_pred c-ccccccccCHHHHHHHhhhccCChhhCCCH---HHHHHHHHHH
Confidence 0 000111245789999999999999999998 7888888874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-33 Score=327.51 Aligned_cols=233 Identities=12% Similarity=0.062 Sum_probs=160.4
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeeccch-------hhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccceee
Q psy16843 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL-------MLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~-------~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~~ly 440 (810)
...++.|++|.+..++....|+.||+|++.+... ......+++.+|+++|+++ .|+||+++++++++++.+|
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 3457789999999989888999999999876421 1233446799999999999 7999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
|||||++||+|.++|...+++++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--- 392 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--- 392 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC---
Confidence 999999999999999998999875 47899999999999999999999999999999999999999999753211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
.....+.+||+.|||||++.+. +..++|+||+|+++|+|.+|..+|. ..+... +.
T Consensus 393 ------------~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~~----~~ 447 (569)
T 4azs_A 393 ------------CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQE----PV 447 (569)
T ss_dssp -------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHHH--------HHHHTS----CG
T ss_pred ------------CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchhH--------HHhhcC----CC
Confidence 1112457899999999999764 6778999999999999877655431 111111 11
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
....+.+++..++..+|..|+.. .....|+|.
T Consensus 448 -----~~~~~~~l~~~l~~~~~~~~~~~---~~~~~~~~~ 479 (569)
T 4azs_A 448 -----ERWNFVLLLALFEKKAKLPSAEQ---QRGATEQWI 479 (569)
T ss_dssp -----GGCSHHHHHHHHHTGGGSCCGGG---SSCCHHHHH
T ss_pred -----CCCcHHHHHHHHhCCCCCCCCCh---hhhccchhH
Confidence 11234667777788888888765 344444443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.8e-28 Score=279.21 Aligned_cols=194 Identities=17% Similarity=0.198 Sum_probs=147.2
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh-----hHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 367 TVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM-----LRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 367 ~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~-----~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
...+.||+|+||.||+| ...++.+|+|++...... .....+++.+|+++|+.++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44678999999999999 445788999987543322 22234568999999999999999955555556677899
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||++||+|.+++.. +..++.||+.||+|||++||+||||||+|||++. .+||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999986 6689999999999999999999999999999998 99999999998643211100
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhh--cCCCCCcchhhhHHHHHHHHhCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILR--QGYGKPVDWWSMGVILYEFLVGCVPFF 580 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--~~ys~ksDIWSLGvILyELLtG~~PF~ 580 (810)
. . .......++||+.|||||++.+ ..|+..+|+|+.++-..+.+.++.+|.
T Consensus 487 ~-~-------~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 V-D-------LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp H-H-------HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred c-c-------hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 0 0 0001235789999999999987 778889999999998888887777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=237.36 Aligned_cols=161 Identities=17% Similarity=0.122 Sum_probs=129.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH---------------HHHHHHHHHHHHHhcCCCCeEEE
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR---------------NQMEQVFAERDIMSFTDNPFVVT 428 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~---------------~~~~~i~~E~~iL~~l~HPnIVk 428 (810)
..|.+.+.||+|+||.||+|.+ .+|+.||||++........ .....+.+|+.+|+.++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4577889999999999999999 8899999998864322111 23467889999999998 4 56
Q ss_pred eeeeccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEecc
Q psy16843 429 MYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDF 508 (810)
Q Consensus 429 l~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DF 508 (810)
+++++. .+..|+||||++||+|.+ +.. .....++.||+.||.|||++||+||||||+|||++ +|.+||+||
T Consensus 166 v~~~~~-~~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 166 VPKVYA-WEGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp SCCEEE-EETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred cCeEEe-ccceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 666553 366799999999999998 422 34567999999999999999999999999999999 999999999
Q ss_pred CCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh----------cCCCCCcchhhh
Q psy16843 509 GLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR----------QGYGKPVDWWSM 565 (810)
Q Consensus 509 GLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~----------~~ys~ksDIWSL 565 (810)
|+|+ ++..|+|||++.+ ..|+..+|+|.+
T Consensus 237 G~a~----------------------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 237 PQSV----------------------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp TTCE----------------------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred CCCe----------------------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 9985 3556899999864 457777787753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.3e-20 Score=195.96 Aligned_cols=140 Identities=18% Similarity=0.134 Sum_probs=108.2
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcE--EEEEEeeccchhh---------------------HHHHHHHHHHHHHHhcC
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQR--FAMKKIIKNSLML---------------------RNQMEQVFAERDIMSFT 421 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~--vAIK~I~k~~~~~---------------------~~~~~~i~~E~~iL~~l 421 (810)
-|++.+.||+|+||.||+|.+..+|+. ||||++....... ......+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999999788999 9999865432110 11123578899999988
Q ss_pred CCCeE--EEeeeeccccceeeeeeeeccC-c----chhhhhhcCCCCCHHHHHHHHHHHHHHHHHhh-hcccccccCCCC
Q psy16843 422 DNPFV--VTMYCSFETKKHLCLVMEYVEG-G----DCASLLKNTGPLPADMARFYFAETVLAVEYLH-SYGIVHRDLKPD 493 (810)
Q Consensus 422 ~HPnI--Vkl~~~f~~~~~lyLVmEy~~G-G----sL~~lL~~~g~lse~~~~~i~~QIl~AL~yLH-s~gIIHRDLKPe 493 (810)
.|++| ..+++. +..||||||+.+ | .|.+++.. .++..+..++.||+.||.||| +.||+||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 77653 223322 467899999942 4 55554432 346678899999999999999 999999999999
Q ss_pred ceEeccCCcEEEeccCCccc
Q psy16843 494 NLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 494 NILLd~~g~VKL~DFGLAk~ 513 (810)
|||++. .++|+|||+|..
T Consensus 201 NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SEEESS--SEEECCCTTCEE
T ss_pred HEEEcC--cEEEEECccccc
Confidence 999998 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-17 Score=185.90 Aligned_cols=139 Identities=14% Similarity=0.101 Sum_probs=98.5
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh---------------hHHH--H--HHHHHHHHHHhcCCCCe
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM---------------LRNQ--M--EQVFAERDIMSFTDNPF 425 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~---------------~~~~--~--~~i~~E~~iL~~l~HPn 425 (810)
-|++.+.||.|+||.||+|.+. +|+.||||++...... .... . -....|...|..+.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3999999999999999999875 6899999986432110 0000 0 01234555555553333
Q ss_pred EEEeeeeccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC----
Q psy16843 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG---- 501 (810)
Q Consensus 426 IVkl~~~f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g---- 501 (810)
+.- ...+. ....+|||||++|+.|..+.. ...+..++.||+.||.|||+.|||||||||.||||+.+|
T Consensus 175 v~v-p~p~~-~~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 175 FPV-PEPIA-QSRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CSC-CCEEE-EETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCC-Ceeee-ccCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 211 11111 123479999999999876543 234567889999999999999999999999999999877
Q ss_pred ------cEEEeccCCcc
Q psy16843 502 ------HIKLTDFGLSK 512 (810)
Q Consensus 502 ------~VKL~DFGLAk 512 (810)
.+.|+||+-+-
T Consensus 247 ~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMV 263 (397)
T ss_dssp TTSEEEEEEECCCTTCE
T ss_pred ccccccceEEEEeCCcc
Confidence 38999999764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.3e-11 Score=128.18 Aligned_cols=140 Identities=16% Similarity=0.132 Sum_probs=110.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccceeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~~lyLV 442 (810)
..|++...+|.|+++.||++.. .++.+++|........ ....+.+|..+++.+. +..+.++++++.+.+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 4699999999999999999974 3678999987542111 1134777888888774 56677888888888899999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh----------------------------------------
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS---------------------------------------- 482 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs---------------------------------------- 482 (810)
|||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999887632 223345788899999999998
Q ss_pred -------------------cccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 483 -------------------YGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 483 -------------------~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 5589999999999998765667999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=4.6e-11 Score=122.45 Aligned_cols=135 Identities=13% Similarity=0.120 Sum_probs=97.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCe--EEEeeeeccccceeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF--VVTMYCSFETKKHLCL 441 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPn--IVkl~~~f~~~~~lyL 441 (810)
.+|.+....+.|..+.||++.. .+|..|++|...... ...+..|..+++.+.+.+ +.+++++...++..|+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 4566655445666799999964 457789999765431 134567888887775433 5567888777778999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcc-------------------------------------
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG------------------------------------- 484 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~g------------------------------------- 484 (810)
||||++|.+|. ... .. ...++.+++.+|..||+..
T Consensus 93 v~e~i~G~~l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEECCSSEETT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEecCCcccC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99999999884 211 11 2356677777888888643
Q ss_pred ---------------------cccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 485 ---------------------IVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 485 ---------------------IIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998766677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=3.5e-10 Score=123.25 Aligned_cols=142 Identities=20% Similarity=0.267 Sum_probs=105.7
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEee--ccchhhHHHHHHHHHHHHHHhcCCC--CeEEEeeeecccc---cee
Q psy16843 367 TVIKLISNGAYGSVYLVRHKETRQRFAMKKII--KNSLMLRNQMEQVFAERDIMSFTDN--PFVVTMYCSFETK---KHL 439 (810)
Q Consensus 367 ~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~--k~~~~~~~~~~~i~~E~~iL~~l~H--PnIVkl~~~f~~~---~~l 439 (810)
..++.|+.|.++.||++... +..+++|+.. .... ......+.+|..+++.+.. ..+.+++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 34778999999999998764 4678888654 2211 1123467789999888863 4567777777665 458
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-------------------------------------
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS------------------------------------- 482 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs------------------------------------- 482 (810)
|+||||++|..+.+... ..+++.....++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99999999988854222 347788888999999999999997
Q ss_pred ---------------------cccccccCCCCceEeccCCc--EEEeccCCcccc
Q psy16843 483 ---------------------YGIVHRDLKPDNLLITALGH--IKLTDFGLSKMG 514 (810)
Q Consensus 483 ---------------------~gIIHRDLKPeNILLd~~g~--VKL~DFGLAk~~ 514 (810)
.+++|+|+++.|||++.++. +.|+||+.+..+
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 46899999999999998753 699999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.99 E-value=5.2e-10 Score=119.22 Aligned_cols=195 Identities=17% Similarity=0.214 Sum_probs=119.0
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCe--EEEeeeeccccc---eeeeee
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPF--VVTMYCSFETKK---HLCLVM 443 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPn--IVkl~~~f~~~~---~lyLVm 443 (810)
+.++.|....||++. ..+++|+-... .....+..|..+|+.+ .+.. +.+++....... ..|+||
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 458999999999873 45888965322 2345678899998776 3322 333444433333 458999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-----------------------------------------
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS----------------------------------------- 482 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs----------------------------------------- 482 (810)
++++|..|..... ..++.++...++.|++..|..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999998875433 246777777888888888888885
Q ss_pred -----------------cccccccCCCCceEecc--CCcEEEeccCCcccccccccc-cchhhhhhcccccccCCcccCC
Q psy16843 483 -----------------YGIVHRDLKPDNLLITA--LGHIKLTDFGLSKMGLMSLAT-NLYECYVERDAKQFSDKQVYGT 542 (810)
Q Consensus 483 -----------------~gIIHRDLKPeNILLd~--~g~VKL~DFGLAk~~~~s~~~-~~~~~~~~~~~~~~~~~~~~GT 542 (810)
..++|+|++|.|||++. .+.+.|+||+.+..+.....- ...... ....... ...+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~-~~~~l~~ 251 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEF-VSKILNH 251 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHH-HHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHH-HHHHHHH
Confidence 13799999999999998 456899999998653211000 000000 0000000 0000000
Q ss_pred CCcCC-hhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCC
Q psy16843 543 PEYIA-PEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF 580 (810)
Q Consensus 543 p~YmA-PEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~ 580 (810)
.++.. |+..... ..-.+.|++|.++|.+.+|..+|.
T Consensus 252 Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence 01122 3332221 122589999999999999988764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=2.5e-06 Score=91.21 Aligned_cols=134 Identities=14% Similarity=0.142 Sum_probs=89.7
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCC---eEEEeeeec-cccceeeeeee
Q psy16843 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP---FVVTMYCSF-ETKKHLCLVME 444 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HP---nIVkl~~~f-~~~~~lyLVmE 444 (810)
++.++.|....||++ |..+++|+-.. ......+..|..+|+.+.+. .+.+.+.+. ...+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 556789999999988 46688896422 12346788899999888652 233444444 24456789999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh------------------------------------------
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS------------------------------------------ 482 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs------------------------------------------ 482 (810)
|++|..|....- ..++......++.++...|..||+
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988865321 123444444444444444444442
Q ss_pred ------------------cccccccCCCCceEecc---CCc-EEEeccCCcccc
Q psy16843 483 ------------------YGIVHRDLKPDNLLITA---LGH-IKLTDFGLSKMG 514 (810)
Q Consensus 483 ------------------~gIIHRDLKPeNILLd~---~g~-VKL~DFGLAk~~ 514 (810)
..++|+|++|.|||++. ++. +.|+||+.+..+
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 24699999999999997 455 489999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=4.6e-06 Score=86.40 Aligned_cols=132 Identities=18% Similarity=0.177 Sum_probs=91.3
Q ss_pred ecccCce-EEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC-CeEEEeeeeccccceeeeeeeeccCc
Q psy16843 372 ISNGAYG-SVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN-PFVVTMYCSFETKKHLCLVMEYVEGG 449 (810)
Q Consensus 372 LG~G~FG-~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H-PnIVkl~~~f~~~~~lyLVmEy~~GG 449 (810)
+..|..| .||+......+..+++|.-... ....+..|..+|+.+.. --+.+++.++.+.+..|+|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 4445554 7999888777888999965322 23456778888876642 22556677777888899999999998
Q ss_pred chhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc----------------------------------------------
Q psy16843 450 DCASLLKNTGPLPADMARFYFAETVLAVEYLHSY---------------------------------------------- 483 (810)
Q Consensus 450 sL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~---------------------------------------------- 483 (810)
++.+..... ......+..++...|.-||..
T Consensus 106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 877654321 122233444555555555531
Q ss_pred ------------ccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 484 ------------GIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 484 ------------gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 278999999999999877778999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=2.8e-06 Score=93.67 Aligned_cols=80 Identities=15% Similarity=0.215 Sum_probs=48.1
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeeccch-hhH---HHHHHHHHHHHHHhcCCC--C-eEEEeeeeccccceee
Q psy16843 368 VIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL-MLR---NQMEQVFAERDIMSFTDN--P-FVVTMYCSFETKKHLC 440 (810)
Q Consensus 368 ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~-~~~---~~~~~i~~E~~iL~~l~H--P-nIVkl~~~f~~~~~ly 440 (810)
.++.||.|.++.||++....+++.|++|....... ... ....++..|.++++.+.. | .+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 36789999999999997766678899997543211 000 112345668888776532 3 33344443 334568
Q ss_pred eeeeeccCc
Q psy16843 441 LVMEYVEGG 449 (810)
Q Consensus 441 LVmEy~~GG 449 (810)
+||||++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.91 E-value=5.3e-05 Score=80.56 Aligned_cols=31 Identities=19% Similarity=0.269 Sum_probs=28.1
Q ss_pred cccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 483 ~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
.+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=3.9e-05 Score=82.97 Aligned_cols=87 Identities=14% Similarity=0.098 Sum_probs=52.4
Q ss_pred EEEEEe-cccCceEEEEEEEc--C----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC---CeEEEeeeecccc
Q psy16843 367 TVIKLI-SNGAYGSVYLVRHK--E----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN---PFVVTMYCSFETK 436 (810)
Q Consensus 367 ~ilk~L-G~G~FG~Vyla~~k--~----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H---PnIVkl~~~f~~~ 436 (810)
..++.| +.|..+.+|++... . ++..+++|.-.............+..|..+|+.+.. -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 446778 88999999988754 1 156788886543220000001234567777665532 2355566655544
Q ss_pred ---ceeeeeeeeccCcchhh
Q psy16843 437 ---KHLCLVMEYVEGGDCAS 453 (810)
Q Consensus 437 ---~~lyLVmEy~~GGsL~~ 453 (810)
+..|+||||++|..+.+
T Consensus 103 ~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTTSSCEEEEECCCCBCCCB
T ss_pred CccCCceEEEEecCCCChhh
Confidence 35689999999977653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0002 Score=79.69 Aligned_cols=33 Identities=21% Similarity=0.382 Sum_probs=29.1
Q ss_pred hhcccccccCCCCceEeccCCcEEEeccCCcccc
Q psy16843 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514 (810)
Q Consensus 481 Hs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~ 514 (810)
+...++|+|++|.|||++.++ ++|+||+.+..+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 456899999999999999877 999999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0009 Score=72.17 Aligned_cols=76 Identities=16% Similarity=0.158 Sum_probs=56.7
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC---CCeEEEeeeeccccceeeeeee
Q psy16843 368 VIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD---NPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 368 ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~---HPnIVkl~~~f~~~~~lyLVmE 444 (810)
-++.|+.|....+|++.. ++..|++|.-... ....+..|...|+.+. ...+.+++.+....+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 467789999999999874 4678899965432 1345677888777663 3567777777777788999999
Q ss_pred eccCcch
Q psy16843 445 YVEGGDC 451 (810)
Q Consensus 445 y~~GGsL 451 (810)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9999764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00068 Score=71.91 Aligned_cols=141 Identities=17% Similarity=0.143 Sum_probs=77.0
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCe--EEEeeeec------cccc
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF--VVTMYCSF------ETKK 437 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPn--IVkl~~~f------~~~~ 437 (810)
..-++.|+.|....||++... +| .+++|...... ..+.+..|..++..+.... +.+++... ...+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 345677888999999998754 23 68899765421 1123445666665542211 22233211 1235
Q ss_pred eeeeeeeeccCcchhh-----------h---hhc-CCCC--------CHHHHHH---------------HHHHHHHHHHH
Q psy16843 438 HLCLVMEYVEGGDCAS-----------L---LKN-TGPL--------PADMARF---------------YFAETVLAVEY 479 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~-----------l---L~~-~g~l--------se~~~~~---------------i~~QIl~AL~y 479 (810)
..++||+|++|..+.. . ++. ...+ ....... +...+...+++
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 6789999999865421 0 111 0011 1000000 00113344555
Q ss_pred hh-------hcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 480 LH-------SYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 480 LH-------s~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
++ ..+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 54 24799999999999999876668999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00051 Score=72.66 Aligned_cols=29 Identities=24% Similarity=0.276 Sum_probs=25.3
Q ss_pred ccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 484 gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
.++|+|+.+.||| ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5667899999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0034 Score=66.69 Aligned_cols=136 Identities=15% Similarity=0.119 Sum_probs=75.1
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCC--eEEEeeee-----ccccceeeee
Q psy16843 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP--FVVTMYCS-----FETKKHLCLV 442 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HP--nIVkl~~~-----f~~~~~lyLV 442 (810)
..|+ |....||++... +|+.+++|....... . ...+..|..++..+... .+.+++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4466 888899987543 466799997653211 1 13445566666655321 13334332 1123456889
Q ss_pred eeeccCcchhh-----------h---hh----cC-----CCCCHHHH----------------------HHHHHHHHHHH
Q psy16843 443 MEYVEGGDCAS-----------L---LK----NT-----GPLPADMA----------------------RFYFAETVLAV 477 (810)
Q Consensus 443 mEy~~GGsL~~-----------l---L~----~~-----g~lse~~~----------------------~~i~~QIl~AL 477 (810)
|+|++|..+.. . ++ .. ..++.... ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 99998865421 0 11 00 01111100 01111222222
Q ss_pred HHh----hhcccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 478 EYL----HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 478 ~yL----Hs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
+-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 221 235689999999999999 4 899999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0086 Score=62.70 Aligned_cols=80 Identities=14% Similarity=0.061 Sum_probs=51.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC---CeEEEeeeeccccceee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN---PFVVTMYCSFETKKHLC 440 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H---PnIVkl~~~f~~~~~ly 440 (810)
....-+..+|.|..+.||++... +|+.|.+|+-....... ...+..|...|+.+.. -.+.++++. +.-+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec----cCce
Confidence 34667889999999999999864 67889999654322111 1245668887776632 123334443 2347
Q ss_pred eeeeeccCcch
Q psy16843 441 LVMEYVEGGDC 451 (810)
Q Consensus 441 LVmEy~~GGsL 451 (810)
+||||+.++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0018 Score=69.19 Aligned_cols=33 Identities=33% Similarity=0.521 Sum_probs=28.4
Q ss_pred hcccccccCCCCceEeccC----CcEEEeccCCcccc
Q psy16843 482 SYGIVHRDLKPDNLLITAL----GHIKLTDFGLSKMG 514 (810)
Q Consensus 482 s~gIIHRDLKPeNILLd~~----g~VKL~DFGLAk~~ 514 (810)
...++|||+.+.|||++.+ +.+.|+||+.+..+
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3579999999999999874 78999999998653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0038 Score=70.05 Aligned_cols=75 Identities=17% Similarity=0.260 Sum_probs=47.6
Q ss_pred EEEEecccCceEEEEEEEcC-------CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCC-eEEEeeeecccccee
Q psy16843 368 VIKLISNGAYGSVYLVRHKE-------TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP-FVVTMYCSFETKKHL 439 (810)
Q Consensus 368 ilk~LG~G~FG~Vyla~~k~-------tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HP-nIVkl~~~f~~~~~l 439 (810)
-++.|+.|....||++.... +++.|++|+...... ...+..|..+++.+... ...++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 46778889899999998653 257899997633111 12334677777665322 22455665543
Q ss_pred eeeeeeccCcch
Q psy16843 440 CLVMEYVEGGDC 451 (810)
Q Consensus 440 yLVmEy~~GGsL 451 (810)
.+||||++|..|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 289999987554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0032 Score=69.69 Aligned_cols=136 Identities=13% Similarity=0.183 Sum_probs=79.0
Q ss_pred EEecccCceEEEEEEEcC-------CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccceeee
Q psy16843 370 KLISNGAYGSVYLVRHKE-------TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~-------tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~~lyL 441 (810)
+.|..|-...+|++.... +++.|++|+--.. . .....+.+|..+++.+. +....++++.+.+. +
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPEG----R 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----c
Confidence 456667778888887642 3578888864221 1 11234457888876653 22234556666542 8
Q ss_pred eeeeccCcchhhh--------------h---hcC----C-CC--CHHHHHHHHHHHHH-------------------HHH
Q psy16843 442 VMEYVEGGDCASL--------------L---KNT----G-PL--PADMARFYFAETVL-------------------AVE 478 (810)
Q Consensus 442 VmEy~~GGsL~~l--------------L---~~~----g-~l--se~~~~~i~~QIl~-------------------AL~ 478 (810)
||||++|..|..- | +.. + .. -..++..|..++-. .++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998665311 1 111 1 11 13455666554422 223
Q ss_pred Hhh--------hcccccccCCCCceEeccC----CcEEEeccCCccc
Q psy16843 479 YLH--------SYGIVHRDLKPDNLLITAL----GHIKLTDFGLSKM 513 (810)
Q Consensus 479 yLH--------s~gIIHRDLKPeNILLd~~----g~VKL~DFGLAk~ 513 (810)
.|. ...++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 1368999999999999876 7899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0033 Score=68.33 Aligned_cols=30 Identities=30% Similarity=0.472 Sum_probs=25.2
Q ss_pred cccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 483 ~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
..++|+|+++.|||++.++ +.|+||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 3689999999999998654 89999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0034 Score=64.41 Aligned_cols=121 Identities=14% Similarity=0.156 Sum_probs=79.3
Q ss_pred cchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHh-hhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhh
Q psy16843 449 GDCASLLK-NTGPLPADMARFYFAETVLAVEYL-HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECY 526 (810)
Q Consensus 449 GsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yL-Hs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~ 526 (810)
-+|.++|+ ..++++|+++|.++.|.+.+|.-+ +...-..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 37888887 457999999999999999998776 211212333457899999999998764 2221
Q ss_pred hhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCc
Q psy16843 527 VERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWP 605 (810)
Q Consensus 527 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~ 605 (810)
.....+.|||... ...+.+.=|||||+++|.-+- |-++ .....
T Consensus 98 -------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e----------------------~eE~e 141 (229)
T 2yle_A 98 -------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE----------------------NEERE 141 (229)
T ss_dssp ----------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT----------------------TEEEC
T ss_pred -------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc----------------------ccchh
Confidence 0122355777652 344567789999999999874 4222 22223
Q ss_pred ccHHHHHHHHhhhcC
Q psy16843 606 IQVEAKSIITDLLQQ 620 (810)
Q Consensus 606 ~S~el~dLI~klL~~ 620 (810)
+|+++..||..|..-
T Consensus 142 LS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 142 LSPPLEQLIDHMANT 156 (229)
T ss_dssp CCHHHHHHHHHHTTC
T ss_pred hCHHHHHHHHHHHhc
Confidence 789999999999865
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.17 E-value=0.017 Score=65.41 Aligned_cols=76 Identities=13% Similarity=0.222 Sum_probs=46.9
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeE-EEeeeeccccceeeeeeeec
Q psy16843 368 VIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFV-VTMYCSFETKKHLCLVMEYV 446 (810)
Q Consensus 368 ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnI-Vkl~~~f~~~~~lyLVmEy~ 446 (810)
-++.|+.|-...+|++.....+..|++|+........ + ....|..++..+...++ .++++.+.. .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---I-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---S-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---c-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEee
Confidence 4677888999999999876545788899653321100 0 11357777777654333 456666642 2599999
Q ss_pred cCcch
Q psy16843 447 EGGDC 451 (810)
Q Consensus 447 ~GGsL 451 (810)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 98655
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.00 E-value=0.04 Score=59.43 Aligned_cols=31 Identities=23% Similarity=0.438 Sum_probs=27.9
Q ss_pred cccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 483 ~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888999999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.64 E-value=0.056 Score=60.61 Aligned_cols=29 Identities=31% Similarity=0.582 Sum_probs=26.1
Q ss_pred ccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 484 gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
.++|+|+.+.||| +.++.+.|+||..|..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 5899999999999 7788999999999864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.79 E-value=0.11 Score=57.50 Aligned_cols=30 Identities=27% Similarity=0.429 Sum_probs=25.5
Q ss_pred ccccccCCCCceEe------ccCCcEEEeccCCccc
Q psy16843 484 GIVHRDLKPDNLLI------TALGHIKLTDFGLSKM 513 (810)
Q Consensus 484 gIIHRDLKPeNILL------d~~g~VKL~DFGLAk~ 513 (810)
.++|+|+.+.|||+ +.++.++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 3457799999999865
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 810 | ||||
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-85 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-81 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-81 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-78 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-78 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-78 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-76 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-73 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-73 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-72 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-72 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-71 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-71 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-71 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-70 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-68 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-68 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-67 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-66 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-66 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-65 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-65 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-62 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-60 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-58 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-57 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-55 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-54 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-54 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-52 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-52 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-51 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-51 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-51 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-50 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-50 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-45 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-45 | |
| d1v9va1 | 101 | a.29.10.1 (A:8-108) Microtubule-associated serine/ | 2e-44 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-39 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-35 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-18 |
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 271 bits (695), Expect = 3e-85
Identities = 116/335 (34%), Positives = 182/335 (54%), Gaps = 24/335 (7%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-D 422
DF + K++ G++G V+L K+T Q FA+K + K+ +++ + +E E+ ++S +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+PF+ M+C+F+TK++L VMEY+ GGD +++ A FY AE +L +++LHS
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
GIV+RDLK DN+L+ GHIK+ DFG+ K ++ A C GT
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC---------------GT 166
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602
P+YIAPE++L Q Y VDWWS GV+LYE L+G PF G+ EELF D+ +P
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW- 225
Query: 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAE--FIPQLD 660
++ EAK ++ L + P RLG G ++++HP F ++W L R + + F P++
Sbjct: 226 ---LEKEAKDLLVKLFVREPEKRLGVRG--DIRQHPLFREINWEELERKEIDPPFRPKVK 280
Query: 661 DEEDTSYFDSRMERYNHDIGEDTDETEDSFSLGTF 695
D S FD + +S F
Sbjct: 281 SPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMF 315
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (667), Expect = 1e-81
Identities = 87/296 (29%), Positives = 152/296 (51%), Gaps = 20/296 (6%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
DF K++ G++ +V L R T + +A+K + K ++ N++ V ERD+MS D+P
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG 484
F V +Y +F+ + L + Y + G+ ++ G RFY AE V A+EYLH G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 485 IVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPE 544
I+HRDLKP+N+L+ HI++TDFG +K+ + ++KQ GT +
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANSFVGTAQ 175
Query: 545 YIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDW 604
Y++PE++ + K D W++G I+Y+ + G PF +F + + ++P +
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--- 232
Query: 605 PIQVEAKSIITDLLQQNPRDRLG---TGGPHEVKEHPYFSNLDWNSLLRHKAEFIP 657
+A+ ++ LL + RLG G +K HP+F ++ W +L + +
Sbjct: 233 -FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (668), Expect = 4e-81
Identities = 125/342 (36%), Positives = 185/342 (54%), Gaps = 25/342 (7%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
NDF +KL+ G +G V LVR K T + +AMK + K ++ ++++ E ++ T +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
PF+ + +F+T LC VMEY GG+ L + ARFY AE V A+EYLHS
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
+V+RD+K +NL++ GHIK+TDFGL K G+ AT C GTP
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---------------GTP 169
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
EY+APEV+ YG+ VDWW +GV++YE + G +PF+ + E LF + ++I +P
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT-- 227
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTGGP--HEVKEHPYFSNLDWNSLLRHKAE--FIPQL 659
+ EAKS++ LL+++P+ RLG G EV EH +F +++W +++ K F PQ+
Sbjct: 228 --LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 285
Query: 660 DDEEDTSYFDSRMERYNHDIGEDTDETEDSFSLGTFSSCTHQ 701
E DT YFD E I + DS L Q
Sbjct: 286 TSEVDTRYFDD--EFTAQSITITPPDRYDSLGLLELDQREEQ 325
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (644), Expect = 1e-78
Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 24/278 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
DF + + + G +G+VYL R K+++ A+K + K L Q+ E +I S +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
P ++ +Y F + L++EY G L+ Y E A+ Y HS
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
++HRD+KP+NLL+ + G +K+ DFG S S + GT
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----------------RRTTLCGTL 168
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
+Y+ PE+I + + + VD WS+GV+ YEFLVG PF T +E + + +P
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-- 226
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641
+ A+ +I+ LL+ NP R EV EHP+ +
Sbjct: 227 --VTEGARDLISRLLKHNPSQRP---MLREVLEHPWIT 259
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 254 bits (649), Expect = 1e-78
Identities = 107/333 (32%), Positives = 179/333 (53%), Gaps = 27/333 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
DF +++ + G++G V+L+R + + +AMK + K ++ Q+E ER ++S +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
PF++ M+ +F+ + + ++M+Y+EGG+ SLL+ + P +A+FY AE LA+EYLHS
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
I++RDLKP+N+L+ GHIK+TDFG +K T + GTP
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT------------------LCGTP 165
Query: 544 EYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603
+YIAPEV+ + Y K +DWWS G+++YE L G PF+ + + +N ++ +P
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF-- 223
Query: 604 WPIQVEAKSIITDLLQQNPRDRLGTGGP--HEVKEHPYFSNLDWNSLLRHKAE--FIPQL 659
+ K +++ L+ ++ RLG +VK HP+F + W LL E + P +
Sbjct: 224 --FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPI 281
Query: 660 -DDEEDTSYFDSRMERYNHDIGEDTDETEDSFS 691
+ DTS FD E + + D D F
Sbjct: 282 QQGQGDTSQFDKYPEEDINYGVQGEDPYADLFR 314
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 255 bits (652), Expect = 2e-78
Identities = 94/316 (29%), Positives = 147/316 (46%), Gaps = 26/316 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-- 421
NDF+V ++I G +G VY R +T + +AMK + K + ++ ER ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 422 -DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYL 480
D PF+V M +F T L +++ + GGD L G RFY AE +L +E++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
H+ +V+RDLKP N+L+ GH++++D GL+ D +
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLA-----------------CDFSKKKPHASV 166
Query: 541 GTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599
GT Y+APEV+ + Y DW+S+G +L++ L G PF ++
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226
Query: 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHKAE--F 655
D E +S++ LLQ++ RLG G EVKE P+F +LDW + K
Sbjct: 227 ELPDS-FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 285
Query: 656 IPQLDDEEDTSYFDSR 671
IP + FD
Sbjct: 286 IPPRGEVNAADAFDIG 301
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 248 bits (635), Expect = 3e-76
Identities = 116/338 (34%), Positives = 180/338 (53%), Gaps = 26/338 (7%)
Query: 337 SLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKK 396
S+ + ++ D + T + F IK + G++G V LV+HKE+ +AMK
Sbjct: 14 SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 397 IIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK 456
+ K ++ Q+E E+ I+ + PF+V + SF+ +L +VMEYV GG+ S L+
Sbjct: 74 LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 457 NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516
G ARFY A+ VL EYLHS +++RDLKP+NLLI G+I++TDFG +K
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC 576
T + GTPE +APE+IL +GY K VDWW++GV++YE G
Sbjct: 194 RTWT------------------LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 577 VPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGP--HEV 634
PFF + P +++ V+ + +PS + K ++ +LLQ + R G +++
Sbjct: 236 PPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291
Query: 635 KEHPYFSNLDWNSLLRHKAE--FIPQLDDEEDTSYFDS 670
K H +F+ DW ++ + K E FIP+ DTS FD
Sbjct: 292 KNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 1e-73
Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 32/302 (10%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
E+ + +I + +GA+G VY ++KET A K I S ++E E DI++ D
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCD 67
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEYLH 481
+P +V + +F + +L +++E+ GG +++ + PL + +T+ A+ YLH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
I+HRDLK N+L T G IKL DFG+S ++ G
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---------------DSFIG 172
Query: 542 TPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596
TP ++APEV++ + Y D WS+G+ L E P P + +
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP 232
Query: 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFI 656
++ K + L++N R ++ +HP+ + D N +R E I
Sbjct: 233 PTLAQPSR-WSSNFKDFLKKCLEKNVDARW---TTSQLLQHPFVTV-DSNKPIR---ELI 284
Query: 657 PQ 658
+
Sbjct: 285 AE 286
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 5e-73
Identities = 67/282 (23%), Positives = 131/282 (46%), Gaps = 20/282 (7%)
Query: 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF 420
P D+ +++ + GAYG V L ++ T + A+K + + + E + E I
Sbjct: 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKM 59
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYL 480
++ VV Y L +EY GG+ ++ +P A+ +F + + V YL
Sbjct: 60 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
H GI HRD+KP+NLL+ ++K++DFGL+ + + ++ ++
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATV-------------FRYNNRERLLNKMC 166
Query: 541 GTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599
GT Y+APE++ R+ + +PVD WS G++L L G +P+ + + +
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 226
Query: 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641
+ I +++ +L +NP R+ ++K+ +++
Sbjct: 227 NPWK-KIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 3e-72
Identities = 75/326 (23%), Positives = 122/326 (37%), Gaps = 63/326 (19%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
++DF I + G G V+ V HK + A K I + Q+ E ++
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHEC 61
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLH 481
++P++V Y +F + + + ME+++GG +LK G +P + + + YL
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 482 S-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
+ I+HRD+KP N+L+ + G IKL DFG+S + S+A
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-----------------SFV 164
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELF----AHTVNDDI 596
GT Y++PE + Y D WSMG+ L E VG P +EL D
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 597 EWPSEDDWPIQV------------------------------------EAKSIITDLLQQ 620
E P P + E + + L +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 621 NPRDRLGTGGPHEVKEHPYFSNLDWN 646
NP +R ++ H + D
Sbjct: 285 NPAERA---DLKQLMVHAFIKRSDAE 307
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 237 bits (606), Expect = 6e-72
Identities = 76/313 (24%), Positives = 128/313 (40%), Gaps = 25/313 (7%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ + + + + GA+G V+ V + T FA K ++ + E V E MS +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRH 82
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEYLHS 482
P +V ++ +FE + ++ E++ GG+ + + D A Y + + ++H
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 483 YGIVHRDLKPDNLLITAL--GHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
VH DLKP+N++ T +KL DFGL+ + S K
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL----------------DPKQSVKVTT 186
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600
GT E+ APEV + G D WS+GV+ Y L G PF GE +E + + D
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 246
Query: 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLD 660
I + K I LL +P R+ H+ EHP+ + +
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 303
Query: 661 DEEDTSYFDSRME 673
+ + +D+ E
Sbjct: 304 RDSIKTKYDAWPE 316
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 235 bits (600), Expect = 1e-71
Identities = 89/310 (28%), Positives = 140/310 (45%), Gaps = 25/310 (8%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
+ + ++ GA+ V L K T++ A+K I K +L + + E ++
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIK 65
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+P +V + +E+ HL L+M+ V GG+ + G A + + AV+YLH
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 125
Query: 483 YGIVHRDLKPDNLLITAL---GHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
GIVHRDLKP+NLL +L I ++DFGLSKM +
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS----------------TA 169
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599
GTP Y+APEV+ ++ Y K VD WS+GVI Y L G PF+ E +LF + + E+
Sbjct: 170 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD 229
Query: 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQL 659
S I AK I L++++P R + +HP+ + H+ Q+
Sbjct: 230 SPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAGDTALDKNIHQ-SVSEQI 285
Query: 660 DDEEDTSYFD 669
S +
Sbjct: 286 KKNFAKSKWK 295
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 234 bits (598), Expect = 3e-71
Identities = 68/316 (21%), Positives = 119/316 (37%), Gaps = 27/316 (8%)
Query: 352 SKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQV 411
+ F K E F+ ++ I +G++G+VY R + A+KK+ + + + +
Sbjct: 3 DVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 62
Query: 412 FAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFA 471
E + +P + + + LVMEY G L + PL
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 122
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531
+ + YLHS+ ++HRD+K N+L++ G +KL DFG + +
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------------------ 164
Query: 532 KQFSDKQVYGTPEYIAPEVILRQG---YGKPVDWWSMGVILYEFLVGCVPFFGETPEELF 588
GTP ++APEVIL Y VD WS+G+ E P F
Sbjct: 165 -MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 589 AHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSL 648
H ++ W ++ + LQ+ P+DR + +H + ++
Sbjct: 224 YHIAQNESPALQSGHWS--EYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLRERPPTV 278
Query: 649 LRHKAEFIPQLDDEED 664
+ + E D
Sbjct: 279 IMDLIQRTKDAVRELD 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 234 bits (599), Expect = 6e-71
Identities = 80/342 (23%), Positives = 144/342 (42%), Gaps = 25/342 (7%)
Query: 336 ISLTDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMK 395
I+ D E Y + + + + + +++ + +GA+G V+ K T + F K
Sbjct: 1 INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60
Query: 396 KIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL 455
I + V E IM+ +P ++ ++ +FE K + L++E++ GG+ +
Sbjct: 61 FINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI 117
Query: 456 -KNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA--LGHIKLTDFGLSK 512
+ Y + ++++H + IVH D+KP+N++ +K+ DFGL+
Sbjct: 118 AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177
Query: 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEF 572
+ D T E+ APE++ R+ G D W++GV+ Y
Sbjct: 178 -------------KLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 221
Query: 573 LVGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPH 632
L G PF GE E + D E+ + + EAK I +LLQ+ PR RL H
Sbjct: 222 LSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVH 278
Query: 633 EVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMER 674
+ EHP+ N R + ++ + Y D +
Sbjct: 279 DALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQ 320
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 231 bits (589), Expect = 1e-70
Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSL------MLRNQMEQVFAERDIM 418
++ +++ G V HK T + +A+K I ++ E E DI+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 419 S-FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAV 477
+ +P ++ + ++ET LV + ++ G+ L L R + +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537
LH IVHRDLKP+N+L+ +IKLTDFG S + +
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC----------------QLDPGEKLR 167
Query: 538 QVYGTPEYIAPEVIL------RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591
+V GTP Y+APE+I GYGK VD WS GVI+Y L G PF+ +
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227
Query: 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
++ + ++ S + K +++ L P+ R E HP+F
Sbjct: 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHPFF 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 4e-68
Identities = 74/286 (25%), Positives = 118/286 (41%), Gaps = 33/286 (11%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
D+ V+ I G+YG +R K + K++ S M + + + +E +++ +P
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELKHP 63
Query: 425 FVVTMYCSF--ETKKHLCLVMEYVEGGDCASLL----KNTGPLPADMARFYFAETVLAVE 478
+V Y T L +VMEY EGGD AS++ K L + + LA++
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 479 YLHSYG-----IVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
H ++HRDLKP N+ + ++KL DFGL+++ +
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---------------NHDT 168
Query: 534 FSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593
K GTP Y++PE + R Y + D WS+G +LYE PF + +EL
Sbjct: 169 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639
E IIT +L R E+ E+P
Sbjct: 229 GKFRRIPYRYSD---ELNEIITRMLNLKDYHRP---SVEEILENPL 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 7e-68
Identities = 68/278 (24%), Positives = 124/278 (44%), Gaps = 30/278 (10%)
Query: 370 KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTM 429
I G++ +VY ET A ++ ++ + +++ ++ E +++ +P +V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 430 YCSFET----KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG- 484
Y S+E+ KK + LV E + G + LK + + R + + + +++LH+
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 133
Query: 485 -IVHRDLKPDNLLITA-LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGT 542
I+HRDLK DN+ IT G +K+ D GL+ + S A V GT
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-----------------AVIGT 176
Query: 543 PEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602
PE++APE+ + Y + VD ++ G+ + E P+ V ++ S D
Sbjct: 177 PEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235
Query: 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
I E K II ++QN +R ++ H +F
Sbjct: 236 KVAIP-EVKEIIEGCIRQNKDERYSI---KDLLNHAFF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 5e-67
Identities = 84/311 (27%), Positives = 137/311 (44%), Gaps = 27/311 (8%)
Query: 357 FSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQ---MEQVFA 413
F + ++ + + + +G + V R K T ++A K I K + E +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 414 ERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAET 473
E I+ +P V+T++ +E K + L++E V GG+ L L + A + +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITALG----HIKLTDFGLSKMGLMSLATNLYECYVER 529
+ V YLHS I H DLKP+N+++ IK+ DFGL+
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--------- 173
Query: 530 DAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFA 589
K ++GTPE++APE++ + G D WS+GVI Y L G PF G+T +E A
Sbjct: 174 -------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226
Query: 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLL 649
+ + E+ E AK I LL ++P+ R+ + +HP+ D L
Sbjct: 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKDTQQAL 283
Query: 650 RHKAEFIPQLD 660
A PQ +
Sbjct: 284 S-SAWSHPQFE 293
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 3e-66
Identities = 101/312 (32%), Positives = 167/312 (53%), Gaps = 25/312 (8%)
Query: 364 NDFTVIKLISNGAYGSVYLVRH---KETRQRFAMKKIIKNSLMLRNQM-EQVFAERDIMS 419
+F ++K++ GAYG V+LVR +T + +AMK + K +++ + + E ER ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 420 -FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVE 478
+PF+VT++ +F+T+ L L+++Y+ GG+ + L + Y E VLA+E
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ 538
+LH GI++RD+K +N+L+ + GH+ LTDFGLSK + Y+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF------------- 190
Query: 539 VYGTPEYIAPEVIL--RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI 596
GT EY+AP+++ G+ K VDWWS+GV++YE L G PF + + A +
Sbjct: 191 -CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249
Query: 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGP--HEVKEHPYFSNLDWNSLLRHKAE 654
+ + AK +I LL ++P+ RLG G E+KEH +F ++W+ L K
Sbjct: 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 309
Query: 655 --FIPQLDDEED 664
F P + DE D
Sbjct: 310 APFKPVIRDELD 321
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 3e-66
Identities = 75/304 (24%), Positives = 125/304 (41%), Gaps = 29/304 (9%)
Query: 339 TDTSIESNSDSYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKII 398
+D I S S D P + +T + I GA G+VY T Q A++++
Sbjct: 1 SDEEILEKLRSIVSVGD-----PKKK-YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN 54
Query: 399 KNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT 458
+ + E + E +M NP +V S+ L +VMEY+ GG ++
Sbjct: 55 LQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE- 110
Query: 459 GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518
+ E + A+E+LHS ++HRD+K DN+L+ G +KLTDFG
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------ 164
Query: 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP 578
+ +Q + GTP ++APEV+ R+ YG VD WS+G++ E + G P
Sbjct: 165 ---------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
Query: 579 FFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHP 638
+ E P + + + + + L + R E+ +H
Sbjct: 216 YLNENPLRALYLIATNGTPELQNPEK-LSAIFRDFLNRCLDMDVEKRG---SAKELLQHQ 271
Query: 639 YFSN 642
+
Sbjct: 272 FLKI 275
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 217 bits (554), Expect = 2e-65
Identities = 66/275 (24%), Positives = 123/275 (44%), Gaps = 18/275 (6%)
Query: 360 TPNE--NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDI 417
TP+ + + + +++ G V+L R + A+K + + + + E
Sbjct: 1 TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 418 MSFTDNPFVVTMYCSFETKKH----LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAET 473
+ ++P +V +Y + E + +VMEYV+G ++ GP+ A A+
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 120
Query: 474 VLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
A+ + H GI+HRD+KP N++I+A +K+ DFG+++ +
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR------------AIADSGNSV 168
Query: 534 FSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593
V GT +Y++PE D +S+G +LYE L G PF G++P + V
Sbjct: 169 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228
Query: 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGT 628
+D PS + + +++ L +NP +R T
Sbjct: 229 EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 3e-65
Identities = 59/279 (21%), Positives = 117/279 (41%), Gaps = 26/279 (9%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
+ + + + G +G V+ +++ + K + V E I++ +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHR 61
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSY 483
++ ++ SFE+ + L ++ E++ G D + + L Y + A+++LHS+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 484 GIVHRDLKPDNLLITAL--GHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
I H D++P+N++ IK+ +FG ++ L +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL----------------FT 165
Query: 542 TPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601
PEY APEV D WS+G ++Y L G PF ET +++ + +N + + E
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE 225
Query: 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
I +EA + LL + + R+ E +HP+
Sbjct: 226 AFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWL 261
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 5e-62
Identities = 56/270 (20%), Positives = 110/270 (40%), Gaps = 24/270 (8%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
+ TV + I +G++G+VY + A+K ++ + Q++ E ++ T
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVK-MLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYL 480
+ ++ + T L +V ++ EG L +T ++YL
Sbjct: 62 RHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
H+ I+HRDLK +N+ + +K+ DFGL+ + R + +Q+
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV-------------KSRWSGSHQFEQLS 167
Query: 541 GTPEYIAPEVILRQG---YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597
G+ ++APEVI Q Y D ++ G++LYE + G +P+ + V
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 227
Query: 598 WPSEDDWPIQV--EAKSIITDLLQQNPRDR 625
P K ++ + L++ +R
Sbjct: 228 SPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-60
Identities = 86/342 (25%), Positives = 145/342 (42%), Gaps = 50/342 (14%)
Query: 356 KFSKTPNENDFTVI-KLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAE 414
+ K +D+ V +++ G G V + +K T+++FA+K + R E
Sbjct: 3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------E 54
Query: 415 RDIMS-FTDNPFVVTMYCSFET----KKHLCLVMEYVEGGDCASLLKNTG--PLPADMAR 467
++ + P +V + +E +K L +VME ++GG+ S +++ G A
Sbjct: 55 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 114
Query: 468 FYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL---GHIKLTDFGLSKMGLMSLATNLYE 524
A++YLHS I HRD+KP+NLL T+ +KLTDFG +K
Sbjct: 115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE----------- 163
Query: 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETP 584
S TP Y+APEV+ + Y K D WS+GVI+Y L G PF+
Sbjct: 164 -----TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218
Query: 585 ----EELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640
+ E+P+ + + E K +I +LL+ P R+ E HP+
Sbjct: 219 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWI 275
Query: 641 SN--------LDWNSLLRHKAEFIPQLDDEEDTSYFDSRMER 674
L + +L+ E + +E ++ R++
Sbjct: 276 MQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDY 317
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-58
Identities = 69/291 (23%), Positives = 122/291 (41%), Gaps = 38/291 (13%)
Query: 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQME---QVFAERDI 417
P E+ + V L+ +G +GSVY A+K + K+ + ++ +V E +
Sbjct: 1 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 418 MSFTDN--PFVVTMYCSFETKKHLCLVMEYVEGG-DCASLLKNTGPLPADMARFYFAETV 474
+ + V+ + FE L++E E D + G L ++AR +F + +
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 475 LAVEYLHSYGIVHRDLKPDNLLITA-LGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQ 533
AV + H+ G++HRD+K +N+LI G +KL DFG + K
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----------------LKD 163
Query: 534 FSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592
GT Y PE I Y G+ WS+G++LY+ + G +PF + +
Sbjct: 164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II 217
Query: 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643
+ + + E + +I L P DR E++ HP+ ++
Sbjct: 218 RGQVFFRQR----VSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDV 261
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 5e-57
Identities = 81/317 (25%), Positives = 129/317 (40%), Gaps = 53/317 (16%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM--- 418
+ + + I GAYG V+ R + RF K ++ E ++
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 419 SFTDNPFVVTMYCSFETKK-----HLCLVMEYVEGGDCASLLKNTGP-LPADMARFYFAE 472
++P VV ++ + L LV E+V+ L K P +P + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 473 TVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAK 532
+ +++LHS+ +VHRDLKP N+L+T+ G IKL DFGL+++ +
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI----------------YSF 168
Query: 533 QFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592
Q + V T Y APEV+L+ Y PVD WS+G I E F G + + +
Sbjct: 169 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228
Query: 593 NDDIEWPSEDDWPIQV------------------------EAKSIITDLLQQNPRDRLGT 628
+ I P E+DWP V K ++ L NP R+
Sbjct: 229 D-VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-- 285
Query: 629 GGPHEVKEHPYFSNLDW 645
+ HPYF +L+
Sbjct: 286 -SAYSALSHPYFQDLER 301
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-56
Identities = 73/304 (24%), Positives = 122/304 (40%), Gaps = 47/304 (15%)
Query: 368 VIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQM--EQVFAERDIMSFTDNPF 425
+ + G + +VY R K T Q A+KKI E ++ +P
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 426 VVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGI 485
++ + +F K ++ LV +++E + N+ L + Y T+ +EYLH + I
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 486 VHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEY 545
+HRDLKP+NLL+ G +KL DFGL+K ++ T Y
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV---------------VTRWY 166
Query: 546 IAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDW 604
APE++ + YG VD W++G IL E L+ G++ + + + + P+E+ W
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR-IFETLGTPTEEQW 225
Query: 605 P-------------------------IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639
P + +I L NP R+ + + Y
Sbjct: 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI---TATQALKMKY 282
Query: 640 FSNL 643
FSN
Sbjct: 283 FSNR 286
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-56
Identities = 55/269 (20%), Positives = 98/269 (36%), Gaps = 20/269 (7%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQR---FAMKKIIKNSLMLRNQMEQVFAERDIM 418
E D +++ + +G++G V + A+K + + L M+ E + M
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 419 SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAV 477
D+ ++ +Y T + +V E G L K+ G Y + +
Sbjct: 66 HSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537
YL S +HRDL NLL+ +K+ DFGL + + D +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR------------ALPQNDDHYVMQE 172
Query: 538 QVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596
+ APE + + + D W GV L+E G P+ G ++ +
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232
Query: 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
P +D P + +++ P DR
Sbjct: 233 RLPRPEDCPQ--DIYNVMVQCWAHKPEDR 259
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 8e-56
Identities = 63/326 (19%), Positives = 122/326 (37%), Gaps = 20/326 (6%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIK--NSLMLRNQMEQVFAERDIMS 419
E +F IK++ +GA+G+VY ++ + IK +++ E +M+
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 420 FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEY 479
DNP V + T + G + ++ + + + + + Y
Sbjct: 67 SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
L +VHRDL N+L+ H+K+TDFGL+K+ + + K++ +
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-------------LGAEEKEYHAEGG 173
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599
+++A E IL + Y D WS GV ++E + + P + + P
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 233
Query: 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQL 659
I + I+ + R E+ D L + + L
Sbjct: 234 QPPICTI--DVYMIMVKCWMIDADSRPKF---RELIIEFSKMARDPQRYLVIQGDERMHL 288
Query: 660 DDEEDTSYFDSRMERYNHDIGEDTDE 685
D++++ + M+ + D D DE
Sbjct: 289 PSPTDSNFYRALMDEEDMDDVVDADE 314
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 8e-56
Identities = 62/279 (22%), Positives = 109/279 (39%), Gaps = 20/279 (7%)
Query: 370 KLISNGAYGSVYLVRH--KETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVV 427
K + +G +G+V + K+ + A+K I+KN +++ AE ++M DNP++V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVK-ILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 428 TMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVH 487
M E + LVME E G L+ + + + ++YL VH
Sbjct: 72 RMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 488 RDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIA 547
RDL N+L+ + K++DFGLSK + + ++ A
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSK------------ALRADENYYKAQTHGKWPVKWYA 178
Query: 548 PEVILRQGYGKPVDWWSMGVILYEFL-VGCVPFFGETPEELFAHTVNDDIEWPSEDDWPI 606
PE I + D WS GV+++E G P+ G E+ A + P
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCPAGCP- 236
Query: 607 QVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645
E ++ + +R G + Y+ ++
Sbjct: 237 -REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-55
Identities = 55/267 (20%), Positives = 102/267 (38%), Gaps = 30/267 (11%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
N + +++ I G +G V L ++ + A+K I ++ + AE +M+
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDA-----TAQAFLAEASVMTQL 57
Query: 422 DNPFVVTMY-CSFETKKHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVE 478
+ +V + E K L +V EY+ G L++ G L D + + A+E
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ 538
YL VHRDL N+L++ K++DFGL+K +
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------------------SSTQDT 159
Query: 539 VYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEW 598
++ APE + + + D WS G++L+E + P + V +
Sbjct: 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 219
Query: 599 PSEDDWPIQVEAKSIITDLLQQNPRDR 625
+ D P ++ + + R
Sbjct: 220 DAPDGCP--PAVYEVMKNCWHLDAAMR 244
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-54
Identities = 66/316 (20%), Positives = 113/316 (35%), Gaps = 52/316 (16%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ + + I G +G V+ RH++T Q+ A+KK++ + E I+ +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKH 68
Query: 424 PFVVTMYCSFET--------KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL 475
VV + T K + LV ++ E L + +
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 476 AVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFS 535
+ Y+H I+HRD+K N+LIT G +KL DFGL++ ++ +
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT--------- 179
Query: 536 DKQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN- 593
T Y PE++L + YG P+D W G I+ E G T + A
Sbjct: 180 --NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 594 ----DDIEWPSEDDWPIQV-----------------------EAKSIITDLLQQNPRDRL 626
WP+ D++ + A +I LL +P R+
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 627 GTGGPHEVKEHPYFSN 642
+ H +F +
Sbjct: 298 ---DSDDALNHDFFWS 310
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (478), Expect = 1e-54
Identities = 59/274 (21%), Positives = 104/274 (37%), Gaps = 16/274 (5%)
Query: 355 DKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKI-IKNSLMLRNQMEQVFA 413
+F+K + + + ++I G +G V K +R I S Q +
Sbjct: 17 REFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLS 76
Query: 414 ERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASL-LKNTGPLPADMARFYFAE 472
E IM D+P V+ + + ++ E++E G S +N G
Sbjct: 77 EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136
Query: 473 TVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAK 532
++YL VHRDL N+L+ + K++DFGLS+ D
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD----------TSDPT 186
Query: 533 QFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL-VGCVPFFGETPEELFAHT 591
S + APE I + + D WS G++++E + G P++ T +++
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA- 245
Query: 592 VNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
+ D P D P ++ D Q++ R
Sbjct: 246 IEQDYRLPPPMDCPS--ALHQLMLDCWQKDRNHR 277
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 3e-54
Identities = 53/300 (17%), Positives = 102/300 (34%), Gaps = 28/300 (9%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS-FTD 422
N + + + I +G++G +YL + A+K + + Q+ E I
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQG 61
Query: 423 NPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS 482
+ T+ + +VME + + + + +EY+HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 483 YGIVHRDLKPDNLLITALGH---IKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
+HRD+KPDN L+ + + DFGL+K + + +K +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK--------YRDARTHQHIPYRENKNL 173
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPF---FGETPEELFAHTVNDDI 596
GT Y + L + D S+G +L F +G +P+ T + + +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233
Query: 597 EWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN-------LDWNSL 648
P E E + + D+ ++ + + DWN L
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 293
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 8e-54
Identities = 51/292 (17%), Positives = 103/292 (35%), Gaps = 43/292 (14%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR---NQMEQVFAERDIM 418
+ K++ +GA+G V + ++ L + ++ E + +E +M
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 419 S-FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKN-------------------- 457
+ + +V + + + L+ EY GD + L++
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 458 ---TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514
L + + + +E+L VHRDL N+L+T +K+ DFGL++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD- 213
Query: 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL- 573
+ D+ +++APE + Y D WS G++L+E
Sbjct: 214 ------------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261
Query: 574 VGCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
+G P+ G + F + + + E I+ + R R
Sbjct: 262 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATE--EIYIIMQSCWAFDSRKR 311
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-53
Identities = 72/306 (23%), Positives = 126/306 (41%), Gaps = 46/306 (15%)
Query: 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNP 424
+F ++ I G YG VY R+K T + A+K I+ E ++ ++P
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALK-KIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSY 483
+V + T+ L LV E++ + + +P + + Y + + + + HS+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
++HRDLKP NLLI G IKL DFGL++ + + T +E T
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---------------VTL 166
Query: 544 EYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN-----DDIE 597
Y APE++L Y VD WS+G I E + F G++ + D++
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226
Query: 598 WPSEDDWP--------------------IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637
WP P + + +S+++ +L +P R+ H
Sbjct: 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI---SAKAALAH 283
Query: 638 PYFSNL 643
P+F ++
Sbjct: 284 PFFQDV 289
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 1e-52
Identities = 62/285 (21%), Positives = 113/285 (39%), Gaps = 23/285 (8%)
Query: 362 NENDFTVIKL-ISNGAYGSVYLVRHKETRQR--FAMKKIIKNSLMLRNQMEQVFAERDIM 418
++ + + + G +GSV ++ +++ A+K + + + + E++ E IM
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIM 63
Query: 419 SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAV 477
DNP++V + + + L LVME GG L +P + + +
Sbjct: 64 HQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537
+YL VHRDL N+L+ + K++DFGLSK D+ +
Sbjct: 123 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK------------ALGADDSYYTARS 170
Query: 538 QVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL-VGCVPFFGETPEELFAHTVNDDI 596
++ APE I + + D WS GV ++E L G P+ E+ A +
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGK 229
Query: 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641
+ P E ++++D DR + Y+S
Sbjct: 230 RMECPPECPP--ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 182 bits (463), Expect = 1e-52
Identities = 70/304 (23%), Positives = 120/304 (39%), Gaps = 48/304 (15%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ ++ I G YG VY ++ + FA+KKI + E I+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
+V +Y TKK L LV E+++ L G L + A+ + + + + Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
++HRDLKP NLLI G +K+ DFGL++ + + +E T
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV---------------TL 164
Query: 544 EYIAPEVILRQG-YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602
Y AP+V++ Y +D WS+G I E + G F G + + + P+
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI-LGTPNSK 223
Query: 603 DWP--------------------------IQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636
+WP + +++ +L+ +P R+ + E
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---TAKQALE 280
Query: 637 HPYF 640
H YF
Sbjct: 281 HAYF 284
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-52
Identities = 72/336 (21%), Positives = 124/336 (36%), Gaps = 60/336 (17%)
Query: 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF 420
P E +T K+I NG++G VY + ++ + A+KK++++ E IM
Sbjct: 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRK 69
Query: 421 TDNPFVVTMYCSFET------KKHLCLVMEYVEGGDCASLL---KNTGPLPADMARFYFA 471
D+ +V + F + + +L LV++YV + LP + Y
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 472 ETVLAVEYLHSYGIVHRDLKPDNLLITALG-HIKLTDFGLSKMGLMSLATNLYECYVERD 530
+ ++ Y+HS+GI HRD+KP NLL+ +KL DFG +K +
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---------------QLV 174
Query: 531 AKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590
+ + + + Y +D WS G +L E L+G F G++ +
Sbjct: 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 591 TVN-------------------------DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
+ W EA ++ + LL+ P R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 626 LGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDD 661
L P E H +F L ++ P L +
Sbjct: 295 L---TPLEACAHSFFDELRDPNVKLPNGRDTPALFN 327
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-52
Identities = 53/266 (19%), Positives = 104/266 (39%), Gaps = 24/266 (9%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
+ D T +K + G +G V + + + A+K I + S+ ++ E +M
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL 56
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYL 480
+ +V +Y ++ + ++ EY+ G + L+ + A+EYL
Sbjct: 57 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
S +HRDL N L+ G +K++DFGLS+ D + S
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV--------------LDDEYTSSVGSK 162
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL-VGCVPFFGETPEELFAHTVNDDIEWP 599
+ PEV++ + D W+ GV+++E +G +P+ T E H + +
Sbjct: 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLY 221
Query: 600 SEDDWPIQVEAKSIITDLLQQNPRDR 625
+ +I+ + +R
Sbjct: 222 RPHLASE--KVYTIMYSCWHEKADER 245
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 3e-52
Identities = 62/292 (21%), Positives = 108/292 (36%), Gaps = 48/292 (16%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIM 418
N+ ++ I GA+G V+ R E A+K + + + + E +M
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 70
Query: 419 SFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG------------------- 459
+ DNP +V + K +CL+ EY+ GD L++
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 460 -----PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514
PL + + YL VHRDL N L+ +K+ DFGLS+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN- 189
Query: 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV 574
+ +D ++ PE I Y D W+ GV+L+E
Sbjct: 190 ------------IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 575 GCV-PFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
+ P++G EE+ + + +I ++ P+ E +++ + P DR
Sbjct: 238 YGLQPYYGMAHEEVIYYVRDGNIL-ACPENCPL--ELYNLMRLCWSKLPADR 286
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (459), Expect = 4e-52
Identities = 52/266 (19%), Positives = 100/266 (37%), Gaps = 22/266 (8%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
D T+ + G YG VY K+ A+K + ++++ ++E+ E +M
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI 70
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL--KNTGPLPADMARFYFAETVLAVEY 479
+P +V + + ++ E++ G+ L N + A + + + A+EY
Sbjct: 71 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
L +HRDL N L+ +K+ DFGLS++ +
Sbjct: 131 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTAHAGA 176
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599
++ APE + + D W+ GV+L+E + + + D
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 600 SEDDWPIQVEAKSIITDLLQQNPRDR 625
+ P + ++ Q NP DR
Sbjct: 237 RPEGCPE--KVYELMRACWQWNPSDR 260
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 6e-52
Identities = 48/266 (18%), Positives = 103/266 (38%), Gaps = 24/266 (9%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
+++ + G +G V++ + + A+K + + S+ + AE ++M
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 65
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEY 479
+ +V +Y T++ + ++ EY+E G LK L + A+ + +
Sbjct: 66 QHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
+ +HRDL+ N+L++ K+ DFGL+++ D + + +
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLI--------------EDNEYTAREGA 170
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599
++ APE I + D WS G++L E + + +
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230
Query: 600 SEDDWPIQVEAKSIITDLLQQNPRDR 625
D+ P E ++ ++ P DR
Sbjct: 231 RPDNCP--EELYQLMRLCWKERPEDR 254
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-51
Identities = 50/287 (17%), Positives = 99/287 (34%), Gaps = 29/287 (10%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
+ + G +G V++ T R A+K + ++ E E +M
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKL 69
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPA--DMARFYFAETVLAVEY 479
+ +V +Y +++ + +V EY+ G LK A+ + Y
Sbjct: 70 RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
+ VHRDL+ N+L+ K+ DFGL+++ D + + +
Sbjct: 129 VERMNYVHRDLRAANILVGENLVCKVADFGLARLI--------------EDNEYTARQGA 174
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599
++ APE L + D WS G++L E + V P
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 234
Query: 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE--HPYFSNLD 644
+ P ++ ++ P +R ++ YF++ +
Sbjct: 235 CPPECP--ESLHDLMCQCWRKEPEERP---TFEYLQAFLEDYFTSTE 276
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-51
Identities = 72/332 (21%), Positives = 127/332 (38%), Gaps = 53/332 (15%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF 425
+T + I GAYG V + R A+KKI + ++ E I+ +
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHEN 67
Query: 426 VVTMYCSFETK----KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLH 481
++ + ++ ++ G D LLK L D ++ + + ++Y+H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIH 126
Query: 482 SYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYG 541
S ++HRDLKP NLL+ +K+ DFGL+++ +
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARV------------ADPDHDHTGFLTEYVA 174
Query: 542 TPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600
T Y APE++L GY K +D WS+G IL E L F G+ + H + + PS
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG-ILGSPS 233
Query: 601 EDDWPIQV----------------------------EAKSIITDLLQQNPRDRLGTGGPH 632
++D + +A ++ +L NP R+
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI---EVE 290
Query: 633 EVKEHPYFSNL-DWNSLLRHKAEFIPQLDDEE 663
+ HPY D + +A F ++ ++
Sbjct: 291 QALAHPYLEQYYDPSDEPIAEAPFKFDMELDD 322
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 179 bits (454), Expect = 3e-51
Identities = 50/300 (16%), Positives = 95/300 (31%), Gaps = 30/300 (10%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN-P 424
+ V + I G++G ++ + Q+ A+K + R+ Q+ E
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 425 FVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG 484
+ +Y + H LV++ + L + + V+ +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 485 IVHRDLKPDNLLITAL-----GHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
+V+RD+KPDN LI I + DFG+ K + ++ K +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF--------YRDPVTKQHIPYREKKNL 173
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPE---ELFAHTVNDDI 596
GT Y++ L + + D ++G + FL G +P+ G + +
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233
Query: 597 EWPSEDDWP-IQVEAKSIITDLLQQNPRDRLGTGGPHEV-------KEHPYFSNLDWNSL 648
P + E + + N DWN L
Sbjct: 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 6e-51
Identities = 66/307 (21%), Positives = 119/307 (38%), Gaps = 46/307 (14%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ ++ I G YG+V+ +++ET + A+K ++ E ++ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK-RVRLDDDDEGVPSSALREICLLKELKH 60
Query: 424 PFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSY 483
+V ++ + K L LV E+ + G L ++ + + + + + + HS
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 484 GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTP 543
++HRDLKP NLLI G +KL +FGL++ + Y V T
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLAR--AFGIPVRCYSAEVV-------------TL 165
Query: 544 EYIAPEVILRQG-YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602
Y P+V+ Y +D WS G I E P F + + + P+E+
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225
Query: 603 DWP--------------------------IQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636
WP + + ++ +LL+ NP R+ E +
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI---SAEEALQ 282
Query: 637 HPYFSNL 643
HPYFS+
Sbjct: 283 HPYFSDF 289
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-50
Identities = 54/265 (20%), Positives = 101/265 (38%), Gaps = 22/265 (8%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT 421
+ ++ T ++ I +G +G V+L + + A+K I + ++ E E ++M
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL 57
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVL-AVEYL 480
+P +V +Y + +CLV E++E G + L+ L A V + YL
Sbjct: 58 SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
++HRDL N L+ IK++DFG+++ L T+
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK-------------- 163
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600
++ +PEV Y D WS GV+++E + ++
Sbjct: 164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223
Query: 601 EDDWPIQVEAKSIITDLLQQNPRDR 625
I+ ++ P DR
Sbjct: 224 PRLAS--THVYQIMNHCWKERPEDR 246
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-50
Identities = 72/337 (21%), Positives = 126/337 (37%), Gaps = 58/337 (17%)
Query: 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD 422
+ ++ + +GAYG+V T + A+K + ++ + E ++
Sbjct: 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-KLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 423 NPFVVTMYCSFETKK------HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLA 476
+ V+ + F + LVM ++ G D L+K+ L D +F + +
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKG 133
Query: 477 VEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSD 536
+ Y+H+ GI+HRDLKP NL + +K+ DFGL++ + +
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV-------------- 179
Query: 537 KQVYGTPEYIAPEVIL-RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595
T Y APEVIL Y + VD WS+G I+ E + G F G + +
Sbjct: 180 ----VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 596 IEWPSEDDWPIQV---------------------------EAKSIITDLLQQNPRDRLGT 628
P+E +Q A +++ +L + R+
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV-- 293
Query: 629 GGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDT 665
E HPYF +L ++ DD + T
Sbjct: 294 -TAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRT 329
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 177 bits (450), Expect = 3e-50
Identities = 64/337 (18%), Positives = 122/337 (36%), Gaps = 67/337 (19%)
Query: 349 SYCSKKDKFSKTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQM 408
Y + + N++D+ +++ + G Y V+ + ++ +K + +
Sbjct: 20 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKK 73
Query: 409 EQVFAERDIMS-FTDNPFVVTMYCSFE--TKKHLCLVMEYVEGGDCASLLKNTGPLPADM 465
+++ E I+ P ++T+ + + LV E+V D L + L
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYD 130
Query: 466 ARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG-HIKLTDFGLSKMGLMSLATNLYE 524
RFY E + A++Y HS GI+HRD+KP N++I ++L D+GL++
Sbjct: 131 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---------- 180
Query: 525 CYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGET 583
+ + PE+++ Q Y +D WS+G +L + PFF
Sbjct: 181 ------HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234
Query: 584 PEELFAHTVNDDIEWPSEDDWP----------------------------------IQVE 609
+ + D+ + E
Sbjct: 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 294
Query: 610 AKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646
A + LL+ + + RL E EHPYF + +
Sbjct: 295 ALDFLDKLLRYDHQSRL---TAREAMEHPYFYTVVKD 328
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 4e-49
Identities = 53/282 (18%), Positives = 99/282 (35%), Gaps = 37/282 (13%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS-F 420
+ ND +I G +G V R K+ R ++ E +++
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKN----------------TGPLPAD 464
+P ++ + + E + +L L +EY G+ L+ L +
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 465 MARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524
+ A+ ++YL +HRDL N+L+ K+ DFGLS+ + +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT--- 184
Query: 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGET 583
++A E + Y D WS GV+L+E + G P+ G T
Sbjct: 185 -------------MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231
Query: 584 PEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
EL+ + + E ++ ++ P +R
Sbjct: 232 CAELYEK-LPQGYRLEKPLNCDD--EVYDLMRQCWREKPYER 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-48
Identities = 58/267 (21%), Positives = 101/267 (37%), Gaps = 21/267 (7%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVF-AERDIMSF 420
+ + I G +G V+ + I + + + F E M
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 421 TDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL-KNTGPLPADMARFYFAETVLAVEY 479
D+P +V + T+ + ++ME G+ S L L Y + A+ Y
Sbjct: 65 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 480 LHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQV 539
L S VHRD+ N+L+++ +KL DFGLS+ D+ + +
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--------------MEDSTYYKASKG 169
Query: 540 YGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEW 598
+++APE I + + D W GV ++E L+ G PF G ++ N +
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL- 228
Query: 599 PSEDDWPIQVEAKSIITDLLQQNPRDR 625
P + P S++T +P R
Sbjct: 229 PMPPNCP--PTLYSLMTKCWAYDPSRR 253
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 6e-48
Identities = 53/265 (20%), Positives = 94/265 (35%), Gaps = 17/265 (6%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIK--NSLMLRNQMEQVFAERDIMSFT 421
+ T K+I G +G VY K + + + IK + Q E IM
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 422 DNPFVVTMYCSFETKKHLCLVMEYVEGGDCASL-LKNTGPLPADMARFYFAETVLAVEYL 480
+ ++ + K + ++ EY+E G + G ++YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 481 HSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVY 540
+ VHRDL N+L+ + K++DFGLS+ + ++
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR------------VLEDDPEATYTTSGGK 174
Query: 541 GTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600
+ APE I + + D WS G++++E + + E +ND P+
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 234
Query: 601 EDDWPIQVEAKSIITDLLQQNPRDR 625
D P ++ QQ R
Sbjct: 235 PMDCP--SAIYQLMMQCWQQERARR 257
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-47
Identities = 52/289 (17%), Positives = 101/289 (34%), Gaps = 42/289 (14%)
Query: 362 NENDFTVIKLISNGAYGSVYLVR-----HKETRQRFAMKKIIKNSLMLRNQMEQVFAERD 416
N + K + GA+G V + A+K + ++ + + E + +E
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELK 78
Query: 417 IMS-FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG---------------- 459
++S ++ +V + + ++ EY GD + L+
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 460 --PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517
L + + + + +L S +HRDL N+L+T K+ DFGL++
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD---- 194
Query: 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCV 577
++ D+ +++APE I Y D WS G+ L+E
Sbjct: 195 ---------IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 578 PFF-GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
+ G + F + + S + P E I+ +P R
Sbjct: 246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAP--AEMYDIMKTCWDADPLKR 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-46
Identities = 55/289 (19%), Positives = 104/289 (35%), Gaps = 43/289 (14%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQ-------RFAMKKIIKNSLMLRNQMEQVFAE 414
+ + K + GA+G V L + + A+K + + + + +E
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISE 68
Query: 415 RDIMS-FTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGP------------- 460
++M + ++ + + L +++EY G+ L+ P
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 461 ---LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517
L + + +EYL S +HRDL N+L+T +K+ DFGL++
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD---- 184
Query: 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL-VGC 576
+ +++APE + + Y D WS GV+L+E +G
Sbjct: 185 ---------IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
Query: 577 VPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
P+ G EELF + + + E ++ D P R
Sbjct: 236 SPYPGVPVEELFKL-LKEGHRMDKPSNCT--NELYMMMRDCWHAVPSQR 281
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 54/298 (18%), Positives = 106/298 (35%), Gaps = 40/298 (13%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMK----KIIKNSLMLRNQMEQVFAERDI 417
+ + K + GA+G V + + K++K + + +
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 418 MSFTDNPFVVT-MYCSFETKKHLCLVMEYVEGGDCASLLKNTG----------------P 460
+ + VV + + L +++E+ + G+ ++ L++
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 461 LPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520
L + Y + +E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR-------- 182
Query: 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCV-PF 579
+ +D +++APE I + Y D WS GV+L+E P+
Sbjct: 183 -----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237
Query: 580 FGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637
G +E F + + + D E + D P R E+ EH
Sbjct: 238 PGVKIDEEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRP---TFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-45
Identities = 53/280 (18%), Positives = 102/280 (36%), Gaps = 34/280 (12%)
Query: 362 NENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERD 416
T+ + + G++G VY K E R A+K + + + M + + E
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEAS 75
Query: 417 IMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTG----------PLPADMA 466
+M + VV + + ++ME + GD S L++ P
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 467 RFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECY 526
E + YL++ VHRDL N ++ +K+ DFG+++
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD------------- 182
Query: 527 VERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGC-VPFFGETPE 585
+ + +++PE + + D WS GV+L+E P+ G + E
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242
Query: 586 ELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDR 625
++ + + D+ P ++ Q NP+ R
Sbjct: 243 QVLRFVMEGGLL-DKPDNCP--DMLFELMRMCWQYNPKMR 279
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-45
Identities = 70/351 (19%), Positives = 122/351 (34%), Gaps = 69/351 (19%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ + + +GAYGSV +T R A+K + ++ + E ++ +
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK-KLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 424 PFVVTMYCSFETKKHLC-----LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVE 478
V+ + F + L ++ ++ G D +++K L D +F + + ++
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLK 135
Query: 479 YLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQ 538
Y+HS I+HRDLKP NL + +K+ DFGL++
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH------------------TDDEMTG 177
Query: 539 VYGTPEYIAPEVILRQG-YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597
T Y APE++L Y + VD WS+G I+ E L G F G + +
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 598 WPSEDDWPIQV---------------------------EAKSIITDLLQQNPRDRLGTGG 630
+E I A ++ +L + R+
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI---T 294
Query: 631 PHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTSYFDSRMERYNHDIGE 681
+ H YF+ DDE +D E + I E
Sbjct: 295 AAQALAHAYFAQY-------------HDPDDEPVADPYDQSFESRDLLIDE 332
|
| >d1v9va1 a.29.10.1 (A:8-108) Microtubule-associated serine/threonine-protein kinase 3, MAST3 (KIAA0561) {Human (Homo sapiens) [TaxId: 9606]} Length = 101 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Bromodomain-like superfamily: MAST3 pre-PK domain-like family: MAST3 pre-PK domain-like domain: Microtubule-associated serine/threonine-protein kinase 3, MAST3 (KIAA0561) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (387), Expect = 2e-44
Identities = 51/107 (47%), Positives = 67/107 (62%), Gaps = 7/107 (6%)
Query: 173 PKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSKEKLI 232
PKA QME RL F+ + A ++ F+HHQI+E+ARDCL KS E L+
Sbjct: 1 PKATAQMEGRLQEFLTAYAP------GARLALADGVLGFIHHQIVELARDCLAKSGENLV 54
Query: 233 SSRYFYEMSEKLERLLTETKEKS-LEAATVLTFTLKKLLLIISRPAR 278
+SRYF EM EKLERLL + E+S E + + ++KLL+IISRPAR
Sbjct: 55 TSRYFLEMQEKLERLLQDAHERSDSEEVSFIVQLVRKLLIIISRPAR 101
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 7e-44
Identities = 71/348 (20%), Positives = 132/348 (37%), Gaps = 69/348 (19%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ +K I +GA G V + A+KK+ + ++ + E +M ++
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 424 PFVVTMYCSFETKK------HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAV 477
++++ F +K + LVME ++ C + + + + + +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGI 132
Query: 478 EYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDK 537
++LHS GI+HRDLKP N+++ + +K+ DFGL++ S Y
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-------------- 178
Query: 538 QVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597
T Y APEVIL GY + VD WS+G I+ E + + F G + + +
Sbjct: 179 --VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
Query: 598 WPSEDDWPIQV--------------------------------------EAKSIITDLLQ 619
E +Q +A+ +++ +L
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 620 QNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIP--QLDDEEDT 665
+P R+ + +HPY + + + I QLD+ E T
Sbjct: 297 IDPAKRI---SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHT 341
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-42
Identities = 48/261 (18%), Positives = 98/261 (37%), Gaps = 20/261 (7%)
Query: 370 KLISNGAYGSVYLVRHKETRQR---FAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFV 426
++I G +G VY + + A+K + N + ++ Q E IM +P V
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 427 VTMY-CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFA-ETVLAVEYLHSYG 484
+++ ++ +V+ Y++ GD + ++N P F + +++L S
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 485 IVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPE 544
VHRDL N ++ +K+ DFGL++ + Y + + +
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLAR-----------DMYDKEFDSVHNKTGAKLPVK 199
Query: 545 YIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDDW 604
++A E + Q + D WS GV+L+E + P + + + +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 259
Query: 605 PIQVEAKSIITDLLQQNPRDR 625
P ++ R
Sbjct: 260 P--DPLYEVMLKCWHPKAEMR 278
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 54/299 (18%), Positives = 89/299 (29%), Gaps = 54/299 (18%)
Query: 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN 423
+ + I G +G V+ + + A+K + AE +
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRH 56
Query: 424 PFVVTMYCSFE----TKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEY 479
++ + T L LV +Y E G L + + T + +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAH 115
Query: 480 LHSY--------GIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDA 531
LH I HRDLK N+L+ G + D GL+ D
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR-----------HDSATDT 164
Query: 532 KQFSDKQVYGTPEYIAPEVILRQ------GYGKPVDWWSMGVILYEFLVGCVPF------ 579
+ GT Y+APEV+ K D ++MG++ +E C
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
Query: 580 --------FGETPEELFAHTVNDDIEWPSEDDWPIQVEA----KSIITDLLQQNPRDRL 626
+ E V + P+ + EA I+ + N RL
Sbjct: 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (338), Expect = 6e-35
Identities = 55/363 (15%), Positives = 117/363 (32%), Gaps = 77/363 (21%)
Query: 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQV---------FAERD 416
+ +++ + G + +V+L + AMK + + + +++ ++
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 417 IMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLL---KNTGPLPADMARFYFAET 473
++ + + + + + +VM + G+ L +P + +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 474 VLAVEYLH-SYGIVHRDLKPDNLLITALGHI-KLTDFGLSKMGLMSLATNLYECYVERDA 531
+L ++Y+H GI+H D+KP+N+L+ + L ++ +G Y
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----- 189
Query: 532 KQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPF------------ 579
T EY +PEV+L +G D WS +++E + G F
Sbjct: 190 --------IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 580 ---------FGETPEELFAHTVNDDIEWPSEDDWP-----------------------IQ 607
GE P L + + S
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 608 VEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHKAEFIPQLDDEEDTS- 666
E ++ +LQ +PR R + HP+ D + + D
Sbjct: 302 KEISDFLSPMLQLDPRKRA---DAGGLVNHPWLK--DTLGMEEIRVPDRELYGSGSDIPG 356
Query: 667 YFD 669
+F+
Sbjct: 357 WFE 359
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.5 bits (203), Expect = 1e-18
Identities = 32/219 (14%), Positives = 66/219 (30%), Gaps = 46/219 (21%)
Query: 368 VIKLISNGAYGSVYLVRHKETRQRFAMKKI------IKNSLMLRNQMEQVFAER------ 415
+ KL+ G +V+ ++ + +K K R+ + F+
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 416 ---DIMSFTDNPFVVTMYCSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAE 472
+ V +Y ++ME ++ + + +
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELY-------RVRVENPDEVLDM 111
Query: 473 TVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAK 532
+ V + GIVH DL N+L++ G I + DF S + + + +ERD +
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS----VEVGEEGWREILERDVR 166
Query: 533 QFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYE 571
+ Y D S + +
Sbjct: 167 NIIT--------------YFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 810 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1v9va1 | 101 | Microtubule-associated serine/threonine-protein ki | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.19 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.78 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.69 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.38 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.31 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.32 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-63 Score=539.65 Aligned_cols=294 Identities=40% Similarity=0.774 Sum_probs=268.2
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
+..++|++++.||+|+||+||+|+++.+|+.||||++.+.........+++.+|+.+|+.++|||||+++++|++++.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 34578999999999999999999999999999999998876655556788899999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
+|||||+||+|.+++.+.+.+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--- 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--- 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT---
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC---
Confidence 99999999999999999899999999999999999999999999999999999999999999999999999753211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
.......+||+.|||||++.+.+|+.++|||||||++|||++|++||.+.+..+++..+....+.+|.
T Consensus 159 ------------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~ 226 (337)
T d1o6la_ 159 ------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 226 (337)
T ss_dssp ------------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred ------------CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc
Confidence 11224678999999999999999999999999999999999999999999999999999999988876
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHh
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRME 673 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~ 673 (810)
. +|+++++||.+||++||.+|++.. +++|+++||||.+++|+.+..++ +|+.|.+..+.+..+|++.+.
T Consensus 227 ~----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~~~~f~~~~~ 299 (337)
T d1o6la_ 227 T----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFT 299 (337)
T ss_dssp T----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHH
T ss_pred c----CCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhhhhhcCchhh
Confidence 4 789999999999999999999753 46999999999999999997764 689999998999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-62 Score=521.20 Aligned_cols=277 Identities=31% Similarity=0.612 Sum_probs=247.3
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 68999999999999999999999999999999998766555555678999999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
|||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~------ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------ 161 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC------
Confidence 99999999999998899999999999999999999999999999999999999999999999999999753211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSEDD 603 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~~ 603 (810)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+..+++.+|....+.+|..
T Consensus 162 -------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~-- 232 (288)
T d1uu3a_ 162 -------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK-- 232 (288)
T ss_dssp ---------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTT--
T ss_pred -------CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCcc--
Confidence 11112245689999999999999999999999999999999999999999999999999999988887754
Q ss_pred CcccHHHHHHHHhhhcCCCCCCCCCCC---hhHHhcCCCcCCCChhhhhhccCCccc
Q psy16843 604 WPIQVEAKSIITDLLQQNPRDRLGTGG---PHEVKEHPYFSNLDWNSLLRHKAEFIP 657 (810)
Q Consensus 604 ~~~S~el~dLI~klL~~dP~~Rpta~~---~~EiL~HPfF~~id~~~l~~~~~~f~P 657 (810)
+++++++||.+||++||.+|||+.. ..++++||||++++|+.+.++.+|-+|
T Consensus 233 --~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 233 --FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp --CCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred --CCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 7899999999999999999999832 234799999999999999988777554
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-60 Score=517.03 Aligned_cols=286 Identities=36% Similarity=0.753 Sum_probs=250.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 36899999999999999999999999999999999876555555667899999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||||.||+|..++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~------ 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------ 156 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS------
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999975321
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~ 602 (810)
...+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++.++......+|..
T Consensus 157 ------------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~- 223 (316)
T d1fota_ 157 ------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF- 223 (316)
T ss_dssp ------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTT-
T ss_pred ------------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCC-
Confidence 1235789999999999999999999999999999999999999999999999999999988877654
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCC-CccCcccch
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDD-EEDTSYFDS 670 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~-~~d~~~fd~ 670 (810)
+++++++||.+||++||.+|++.. .++|+++||||++++|+.+..+. +|+.|.... ..|.++||.
T Consensus 224 ---~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~~d~~~f~~ 293 (316)
T d1fota_ 224 ---FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK 293 (316)
T ss_dssp ---SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC------------
T ss_pred ---CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCCCcchhhhcCC
Confidence 779999999999999999998431 34999999999999999987654 578877543 456777764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-60 Score=522.65 Aligned_cols=287 Identities=39% Similarity=0.753 Sum_probs=259.8
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeee
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyL 441 (810)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+.++|||||+++++|.+...+|+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 35789999999999999999999999999999999987655555556788999999999999999999999999999999
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~----- 193 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----- 193 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-----
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-----
Confidence 999999999999999888999999999999999999999999999999999999999999999999999975311
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
...+.+||+.|||||++.+.+|+.++|||||||+||||++|++||.+.+..+++.+|....+.+|..
T Consensus 194 -------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 260 (350)
T d1rdqe_ 194 -------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260 (350)
T ss_dssp -------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred -------------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCcc
Confidence 1235689999999999999999999999999999999999999999999999999999988777653
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCC--CChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccch
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGT--GGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDS 670 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta--~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~ 670 (810)
+++++.+||++||++||.+|+.. ..++|+++||||++++|..+.++. +||+|.+.++.|.++|++
T Consensus 261 ----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s~~~~ 329 (350)
T d1rdqe_ 261 ----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329 (350)
T ss_dssp ----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCC
T ss_pred ----CCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchhhhcCC
Confidence 78999999999999999999621 123999999999999999997764 689999988888888864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-61 Score=518.09 Aligned_cols=289 Identities=38% Similarity=0.763 Sum_probs=242.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHh-cCCCCeEEEeeeeccccceeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS-FTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~-~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+..|..++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999999999999999998765544455566777777764 78999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||||+||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~----- 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----- 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-----
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc-----
Confidence 999999999999998899999999999999999999999999999999999999999999999999999753211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~ 602 (810)
.......+||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+.+..+++.++..+.+.+|..
T Consensus 157 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~- 225 (320)
T d1xjda_ 157 ----------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW- 225 (320)
T ss_dssp ----------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-
T ss_pred ----------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc-
Confidence 112245689999999999999999999999999999999999999999999999999999888877753
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccchHHh
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFDSRME 673 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd~~~~ 673 (810)
+|+++++||.+||++||.+||++. .|+++||||++++|+.+.... +|+.|.+.++.|.++||..+.
T Consensus 226 ---~s~~~~dli~~~L~~dP~~R~s~~--~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~ 293 (320)
T d1xjda_ 226 ---LEKEAKDLLVKLFVREPEKRLGVR--GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFL 293 (320)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSBTTB--SCGGGSGGGTTCCHHHHHTTCSCC--------------------
T ss_pred ---CCHHHHHHHHHhcccCCCCCcCHH--HHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhhcChHhh
Confidence 789999999999999999999982 379999999999999987654 678999888888888886553
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-59 Score=495.49 Aligned_cols=256 Identities=32% Similarity=0.547 Sum_probs=235.3
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+++|+.++|||||++++++.+++.+|||
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999876555445567788999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~----- 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----- 159 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-----
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-----
Confidence 999999999999998889999999999999999999999999999999999999999999999999999752211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSED 602 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~~ 602 (810)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++.++....+.+|..
T Consensus 160 ------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~- 226 (263)
T d2j4za1 160 ------------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF- 226 (263)
T ss_dssp ------------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTT-
T ss_pred ------------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCcc-
Confidence 1234679999999999999999999999999999999999999999999999999999888877754
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+++++++||.+||++||.+|||+ +|+++||||..
T Consensus 227 ---~s~~~~~li~~~L~~dp~~R~t~---~eil~hp~~~~ 260 (263)
T d2j4za1 227 ---VTEGARDLISRLLKHNPSQRPML---REVLEHPWITA 260 (263)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCH---HHHHTCHHHHH
T ss_pred ---CCHHHHHHHHHHccCCHhHCcCH---HHHHcCcCcCC
Confidence 78999999999999999999998 99999999953
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.1e-58 Score=505.22 Aligned_cols=287 Identities=33% Similarity=0.588 Sum_probs=237.4
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHH---HHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQV---FAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i---~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+ ..|+.+++.++|||||+++++|.+++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 45789999999999999999999999999999999976554333222333 345777888899999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 9999999999999999998899999999999999999999999999999999999999999999999999999753211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCH---HHHHHhhccC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETP---EELFAHTVND 594 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~---~e~~~~I~~~ 594 (810)
.....+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.+. .++...+...
T Consensus 161 ----------------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~ 224 (364)
T d1omwa3 161 ----------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224 (364)
T ss_dssp ----------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC
T ss_pred ----------------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 1235689999999999974 6799999999999999999999999987543 3444555555
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCccCcccc
Q psy16843 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEEDTSYFD 669 (810)
Q Consensus 595 ~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d~~~fd 669 (810)
.+.+|. .+|+++++||.+||++||.+||+.. .++|+++||||++++|..+..++ +|++|........++||
T Consensus 225 ~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~~~~~~~~~d 299 (364)
T d1omwa3 225 AVELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 299 (364)
T ss_dssp CCCCCS----SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC---------
T ss_pred CCCCCC----CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCCCCCcCCccc
Confidence 555443 3789999999999999999999962 36999999999999999987654 67888766655555554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-58 Score=490.23 Aligned_cols=262 Identities=26% Similarity=0.451 Sum_probs=221.0
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
|..++|++++.||+|+||+||+|+++.+|+.||||++.+.... ...+.+.+|+++|+.++|||||++++++.+++.+|
T Consensus 2 Pf~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 3467899999999999999999999999999999998765432 23456889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
||||||+||+|.++|.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+......
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-- 157 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 157 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC--
Confidence 999999999999999988899999999999999999999999999999999999999999999999999997532211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHH-HHHhhccCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEE-LFAHTVNDDIEW 598 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e-~~~~I~~~~~~~ 598 (810)
........+||+.|||||++.+..| +.++|||||||+||||++|++||.+..... .+..+.......
T Consensus 158 -----------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~ 226 (271)
T d1nvra_ 158 -----------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 226 (271)
T ss_dssp -----------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS
T ss_pred -----------ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Confidence 1112345789999999999998876 688999999999999999999998765433 333333332222
Q ss_pred CCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 599 PSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 599 p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+. ...+++++++||.+||++||++||++ +|+++||||+.
T Consensus 227 ~~--~~~~s~~~~~li~~~L~~dP~~R~t~---~eil~hpwf~~ 265 (271)
T d1nvra_ 227 NP--WKKIDSAPLALLHKILVENPSARITI---PDIKKDRWYNK 265 (271)
T ss_dssp TT--GGGSCHHHHHHHHHHSCSSTTTSCCH---HHHTTCTTTTC
T ss_pred Cc--cccCCHHHHHHHHHHcCCChhHCcCH---HHHhcCHhhCc
Confidence 21 22478999999999999999999998 99999999964
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-58 Score=488.80 Aligned_cols=270 Identities=30% Similarity=0.478 Sum_probs=234.0
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH---HHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR---NQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~---~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+++|+.++|||||+++++|.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3579999999999999999999999999999999976543321 2346788999999999999999999999999999
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC----cEEEeccCCccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG----HIKLTDFGLSKMGL 515 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g----~VKL~DFGLAk~~~ 515 (810)
|||||||+||+|.++|.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+...
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999999888999999999999999999999999999999999999999877 59999999997532
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
.. ....+.+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+..+++..+....
T Consensus 169 ~~----------------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 232 (293)
T d1jksa_ 169 FG----------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232 (293)
T ss_dssp TS----------------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred CC----------------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence 11 11235679999999999999999999999999999999999999999999999999999887
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChhhhhhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWNSLLRH 651 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~~l~~~ 651 (810)
..++......+|+++++||++||++||.+||++ +|+++||||++.+|...+..
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~---~eil~hp~~~~~~~~~~l~~ 285 (293)
T d1jksa_ 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI---QDSLQHPWIKPKDTQQALSS 285 (293)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCH---HHHHHSTTTCC---------
T ss_pred CCCCchhcCCCCHHHHHHHHHHccCChhHCcCH---HHHhcCcccCCCChhHhhcc
Confidence 776644333478999999999999999999998 99999999999999877654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-57 Score=491.10 Aligned_cols=258 Identities=33% Similarity=0.529 Sum_probs=219.4
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+.|++++.||+|+||+||+|+++.+|+.||||++.+..... ..+.+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999997765432 2356788999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEec---cCCcEEEeccCCcccccccccc
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLIT---ALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd---~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
|||+||+|.++|.+.+.+++..++.|+.||+.||+|||++||+||||||+|||+. .+|.+||+|||+|+.....
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~--- 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--- 163 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC---
Confidence 9999999999999889999999999999999999999999999999999999995 4789999999999752211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
....+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..++...+......++.
T Consensus 164 -------------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 230 (307)
T d1a06a_ 164 -------------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 230 (307)
T ss_dssp ----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT
T ss_pred -------------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC
Confidence 1123568999999999999999999999999999999999999999999999999999998887776
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.....+|+++++||.+||++||.+|||+ .|+++||||.+
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~---~eil~hp~~~~ 269 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTC---EQALQHPWIAG 269 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCH---HHHHHSTTTTS
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCH---HHHhcCHhhCC
Confidence 6555688999999999999999999998 99999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=493.08 Aligned_cols=262 Identities=28% Similarity=0.447 Sum_probs=221.4
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
...++|++++.||+|+||+||+|+++.+|+.||+|++.+... ....+++.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 345789999999999999999999999999999999876532 233467889999999999999999999999999999
Q ss_pred eeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 441 LVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
||||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+.....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999999999988899999999999999999999997 59999999999999999999999999999752110
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHh---------
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH--------- 590 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~--------- 590 (810)
...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....
T Consensus 159 ---------------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 223 (322)
T d1s9ja_ 159 ---------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223 (322)
T ss_dssp ---------------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------
T ss_pred ---------------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCc
Confidence 12356899999999999999999999999999999999999999987654322111
Q ss_pred ---------------------------------hccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 591 ---------------------------------TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 591 ---------------------------------I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
+.... .+.......|.+++|||.+||++||.+|||+ +|+|+|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta---~e~L~H 298 (322)
T d1s9ja_ 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADL---KQLMVH 298 (322)
T ss_dssp ----------------------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCH---HHHHTS
T ss_pred ccCCcccccccccccccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCH---HHHhhC
Confidence 11110 0111112267899999999999999999999 999999
Q ss_pred CCcCCCChh
Q psy16843 638 PYFSNLDWN 646 (810)
Q Consensus 638 PfF~~id~~ 646 (810)
|||+..+|+
T Consensus 299 pf~~~~~~~ 307 (322)
T d1s9ja_ 299 AFIKRSDAE 307 (322)
T ss_dssp HHHHHHHHS
T ss_pred HhhCcCCcc
Confidence 999876554
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.5e-57 Score=493.51 Aligned_cols=262 Identities=28% Similarity=0.429 Sum_probs=235.0
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... ...+.+.+|+++|+.++|||||+++++|.+++.+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3689999999999999999999999999999999876543 3346788999999999999999999999999999999
Q ss_pred eeeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc--CCcEEEeccCCccccccccc
Q psy16843 443 MEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA--LGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 443 mEy~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~--~g~VKL~DFGLAk~~~~s~~ 519 (810)
||||+||+|.++|. ..+.+++..++.|+.||+.||+|||++|||||||||+||||+. +|.+||+|||+|+.....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 99999999999985 4568999999999999999999999999999999999999964 688999999999753211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++..|......++
T Consensus 180 --------------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 245 (350)
T d1koaa2 180 --------------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 245 (350)
T ss_dssp --------------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC
T ss_pred --------------cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 112356899999999999999999999999999999999999999999999999999998887776
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
......+|+++++||.+||++||.+|||+ .|+|+||||.+.+|.
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~---~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTI---HQALEHPWLTPGNAP 289 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCH---HHHHHSTTTSCTTCC
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCH---HHHhcCcccCCCCCC
Confidence 65445588999999999999999999998 999999999987654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-57 Score=482.02 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=225.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 5799999999999999999999999999999998765432 2356889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
|||+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~------ 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------ 169 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST------
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc------
Confidence 99999999998876 57999999999999999999999999999999999999999999999999999753211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-CCCCCC
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI-EWPSED 602 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~-~~p~~~ 602 (810)
.......+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..+..... .++.
T Consensus 170 ---------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 238 (293)
T d1yhwa1 170 ---------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-- 238 (293)
T ss_dssp ---------TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSS--
T ss_pred ---------cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC--
Confidence 1122456899999999999999999999999999999999999999999998887777765432 2222
Q ss_pred CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 603 DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 603 ~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
...+++++++||.+||++||.+||++ .|+|+||||+.
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~---~eil~Hp~~~~ 275 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSA---KELLQHQFLKI 275 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCH---HHHTTCGGGGG
T ss_pred cccCCHHHHHHHHHHccCChhHCcCH---HHHhcCHhhCC
Confidence 12378999999999999999999998 99999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=474.57 Aligned_cols=255 Identities=28% Similarity=0.461 Sum_probs=216.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc--cceeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET--KKHLCL 441 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~--~~~lyL 441 (810)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+++|+.++|||||++++++.+ .+.+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 6899999999999999999999999999999998776543 4456778999999999999999999998854 567999
Q ss_pred eeeeccCcchhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcc-----cccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 442 VMEYVEGGDCASLLKN----TGPLPADMARFYFAETVLAVEYLHSYG-----IVHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~----~g~lse~~~~~i~~QIl~AL~yLHs~g-----IIHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
|||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999853 468999999999999999999999976 9999999999999999999999999997
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~ 592 (810)
..... .......+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++.++.
T Consensus 163 ~~~~~---------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~ 227 (269)
T d2java1 163 ILNHD---------------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 227 (269)
T ss_dssp HC--------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ecccC---------------CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 53211 111245689999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 593 NDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 593 ~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
.+.+.... ..+|+++++||.+||+.||.+||++ .|+++|||+
T Consensus 228 ~~~~~~~~---~~~s~~l~~li~~~L~~dp~~Rps~---~ell~hp~i 269 (269)
T d2java1 228 EGKFRRIP---YRYSDELNEIITRMLNLKDYHRPSV---EEILENPLI 269 (269)
T ss_dssp HTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCH---HHHHTSTTC
T ss_pred cCCCCCCC---cccCHHHHHHHHHHcCCChhHCcCH---HHHHhCCcC
Confidence 77654222 2378999999999999999999998 999999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-56 Score=482.05 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=229.5
Q ss_pred CcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 365 DFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 365 dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
.|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+.++|||||+++++|.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999999987766666667889999999999999999999999999999999999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
||.||+|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~--------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA--------- 166 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS---------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC---------
Confidence 99999998888888899999999999999999999999999999999999999999999999999997521
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhh---cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCCC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILR---QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPSE 601 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~---~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~~ 601 (810)
.....+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+.++.......+..
T Consensus 167 ----------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 236 (309)
T d1u5ra_ 167 ----------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS 236 (309)
T ss_dssp ----------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred ----------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence 1135679999999999975 458999999999999999999999999999988888888765543332
Q ss_pred CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 602 DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 602 ~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
..+|+++++||.+||++||.+|||+ .|+++||||..
T Consensus 237 --~~~s~~~~~li~~~L~~dP~~Rpt~---~ell~Hp~~~~ 272 (309)
T d1u5ra_ 237 --GHWSEYFRNFVDSCLQKIPQDRPTS---EVLLKHRFVLR 272 (309)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCH---HHHTTCHHHHS
T ss_pred --CCCCHHHHHHHHHHCcCChhHCcCH---HHHHhCHHhcC
Confidence 2378999999999999999999998 99999999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4e-56 Score=488.12 Aligned_cols=257 Identities=28% Similarity=0.438 Sum_probs=232.4
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||.||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 679999999999999999999999999999999876543 23356788999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEec--cCCcEEEeccCCcccccccccc
Q psy16843 444 EYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLIT--ALGHIKLTDFGLSKMGLMSLAT 520 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd--~~g~VKL~DFGLAk~~~~s~~~ 520 (810)
|||+||+|.+++... .++++..++.|+.||+.||+|||++|||||||||+||||+ .+|.+||+|||+|+.....
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--- 182 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--- 182 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC---
Confidence 999999999887654 4799999999999999999999999999999999999998 5789999999999753211
Q ss_pred cchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 521 NLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
......+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+++..+....+.++.
T Consensus 183 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 249 (352)
T d1koba_ 183 -------------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE 249 (352)
T ss_dssp -------------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred -------------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 1123467999999999999999999999999999999999999999999999999999998888776
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.....+++++++||.+||++||.+||++ .|+|+||||++
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~---~eil~Hp~~~~ 288 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTV---HDALEHPWLKG 288 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCH---HHHHTSTTTSS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCH---HHHhcCHhhCC
Confidence 6555689999999999999999999998 99999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=477.69 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=225.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
+.|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 569999999999999999999999999999999876532 33467889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
|||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+......
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---- 164 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 164 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence 99999999999764 5679999999999999999999999999999999999999999999999999997532110
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHh-----hcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVIL-----RQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~-----~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
....+.+||+.|||||++. +..|+.++|||||||+||||++|++||.+.+..+++.++......
T Consensus 165 -----------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~ 233 (288)
T d2jfla1 165 -----------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP 233 (288)
T ss_dssp -----------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC
T ss_pred -----------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 0113568999999999995 456899999999999999999999999999999888888876543
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
.... ...+++++++||.+||++||.+|||+ .|+++||||..
T Consensus 234 ~~~~-~~~~s~~~~~li~~~L~~dp~~R~t~---~ell~hp~~~~ 274 (288)
T d2jfla1 234 TLAQ-PSRWSSNFKDFLKKCLEKNVDARWTT---SQLLQHPFVTV 274 (288)
T ss_dssp CCSS-GGGSCHHHHHHHHHHSCSSTTTSCCH---HHHTTSGGGCC
T ss_pred CCCc-cccCCHHHHHHHHHHccCChhHCcCH---HHHhcCcccCC
Confidence 2211 12478999999999999999999998 99999999974
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.8e-55 Score=467.44 Aligned_cols=260 Identities=29% Similarity=0.464 Sum_probs=233.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh------hHHHHHHHHHHHHHHhcCC-CCeEEEeeeecccc
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM------LRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETK 436 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~------~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~ 436 (810)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... .....+.+.+|+.+|+.++ |||||+++++|.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 7899999999999999999999999999999998765432 1233456889999999997 99999999999999
Q ss_pred ceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+.+|||||||+||+|.++|+..+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence 99999999999999999999889999999999999999999999999999999999999999999999999999975321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhh------cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR------QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAH 590 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~------~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~ 590 (810)
. ......+||+.|+|||++.+ ..|+.++||||+||+||||++|+.||.+.+..+.+..
T Consensus 163 ~----------------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~ 226 (277)
T d1phka_ 163 G----------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 226 (277)
T ss_dssp T----------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred C----------------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH
Confidence 1 11235679999999999974 3478899999999999999999999999999999999
Q ss_pred hccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 591 TVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 591 I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+..+...++......+|+++++||.+||++||.+||++ +|+++||||+.
T Consensus 227 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~---~eil~h~~~~~ 275 (277)
T d1phka_ 227 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA---EEALAHPFFQQ 275 (277)
T ss_dssp HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH---HHHTTSGGGCT
T ss_pred HHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCH---HHHHcCHHHHH
Confidence 99988877766655689999999999999999999998 99999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=464.67 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=215.7
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc----cceeee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET----KKHLCL 441 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~----~~~lyL 441 (810)
|++.++||+|+||+||+|+++.+++.||+|++...... ....+.+.+|+++|+.++|||||+++++|.+ +..+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 47788999999999999999999999999998765433 3455778999999999999999999999864 457899
Q ss_pred eeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCCCceEec-cCCcEEEeccCCcccccccc
Q psy16843 442 VMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYG--IVHRDLKPDNLLIT-ALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~g--IIHRDLKPeNILLd-~~g~VKL~DFGLAk~~~~s~ 518 (810)
|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+||||+ .+|.+||+|||+|+....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-- 167 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 167 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--
Confidence 9999999999999998889999999999999999999999998 99999999999996 479999999999974211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCC-HHHHHHhhccCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGET-PEELFAHTVNDDIE 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~-~~e~~~~I~~~~~~ 597 (810)
....+.+||+.|||||++.+ +|+.++|||||||++|||++|+.||.+.. ..+++..+..+...
T Consensus 168 ---------------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~ 231 (270)
T d1t4ha_ 168 ---------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 231 (270)
T ss_dssp ---------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred ---------------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC
Confidence 11235689999999999865 69999999999999999999999998754 45555666554321
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcC
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFS 641 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~ 641 (810)
.......++++++||.+||++||++||++ +|+++||||+
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~dp~~R~s~---~ell~Hp~fk 270 (270)
T d1t4ha_ 232 --ASFDKVAIPEVKEIIEGCIRQNKDERYSI---KDLLNHAFFQ 270 (270)
T ss_dssp --GGGGGCCCHHHHHHHHHHSCSSGGGSCCH---HHHHTSGGGC
T ss_pred --cccCccCCHHHHHHHHHHccCCHhHCcCH---HHHhCCcccC
Confidence 11122367899999999999999999998 9999999995
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=476.17 Aligned_cols=257 Identities=23% Similarity=0.419 Sum_probs=230.3
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ....+.+|+++|+.++|||||+++++|++++.+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3789999999999999999999999999999999876542 224578899999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccC--CcEEEeccCCccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTG-PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITAL--GHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g-~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~--g~VKL~DFGLAk~~~~s~~ 519 (810)
||||+||+|.++|...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 99999999999998665 79999999999999999999999999999999999999864 48999999998753211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+++.+|....+.++
T Consensus 158 --------------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~ 223 (321)
T d1tkia_ 158 --------------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223 (321)
T ss_dssp --------------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC
T ss_pred --------------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 112346799999999999999999999999999999999999999999999999999999888776
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
......+|+++++||.+||++||.+||++ +|+++||||..
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~---~eil~hp~~~~ 263 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTA---SEALQHPWLKQ 263 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCH---HHHHHSHHHHS
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCH---HHHhcCHhhcc
Confidence 54433478999999999999999999998 99999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=461.73 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=216.5
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhH--HHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeee
Q psy16843 367 TVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLR--NQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVME 444 (810)
Q Consensus 367 ~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~--~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmE 444 (810)
+.++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+++|+.++|||||+++++|.+++.+|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 357899999999999999999999999999866543221 123568899999999999999999999999999999999
Q ss_pred eccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchh
Q psy16843 445 YVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYE 524 (810)
Q Consensus 445 y~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~ 524 (810)
|+.|+++..++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~------- 153 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------- 153 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-------
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC-------
Confidence 9999999888888889999999999999999999999999999999999999999999999999999752211
Q ss_pred hhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-----CC
Q psy16843 525 CYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI-----EW 598 (810)
Q Consensus 525 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~-----~~ 598 (810)
.......+||+.|||||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+.+|..... .+
T Consensus 154 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~ 225 (299)
T d1ua2a_ 154 --------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 225 (299)
T ss_dssp --------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred --------cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 1122456899999999999754 689999999999999999999999999999888877654210 00
Q ss_pred CCC------------C-------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 599 PSE------------D-------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 599 p~~------------~-------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
+.. . ...+++++++||.+||++||++|||+ +|+|+||||++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa---~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA---TQALKMKYFSNR 286 (299)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH---HHHHTSGGGTSS
T ss_pred cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCH---HHHhCCHhhCCC
Confidence 000 0 01257899999999999999999998 999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=467.67 Aligned_cols=286 Identities=35% Similarity=0.676 Sum_probs=238.7
Q ss_pred CCCCCcEEEEEecccCceEEEEEEE---cCCCcEEEEEEeeccchh-hHHHHHHHHHHHHHHhcCCC-CeEEEeeeeccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRH---KETRQRFAMKKIIKNSLM-LRNQMEQVFAERDIMSFTDN-PFVVTMYCSFET 435 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~---k~tg~~vAIK~I~k~~~~-~~~~~~~i~~E~~iL~~l~H-PnIVkl~~~f~~ 435 (810)
...++|++++.||+|+||+||+|++ +.+|+.||||++.+.... .....+.+.+|+++|+.++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 3558899999999999999999997 447899999998664322 12233567889999999977 899999999999
Q ss_pred cceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 436 KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 436 ~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
...+|+||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+...
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999997532
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc--CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHH----H
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ--GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELF----A 589 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~--~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~----~ 589 (810)
.... ....+..||+.|+|||.+.+. .|+.++|||||||+||||++|..||.+.+..+.. .
T Consensus 181 ~~~~--------------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~ 246 (322)
T d1vzoa_ 181 ADET--------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 246 (322)
T ss_dssp GGGG--------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred cccc--------------ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2111 112356799999999999865 4688999999999999999999999876544333 3
Q ss_pred hhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCC--ChhHHhcCCCcCCCChhhhhhcc--CCcccCCCCCcc
Q psy16843 590 HTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTG--GPHEVKEHPYFSNLDWNSLLRHK--AEFIPQLDDEED 664 (810)
Q Consensus 590 ~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~--~~~EiL~HPfF~~id~~~l~~~~--~~f~P~~~~~~d 664 (810)
........+|. .+++++++||.+||++||.+||++. .++|+++||||++++|..+..+. +|++|.+.++.|
T Consensus 247 ~~~~~~~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~~~~ 321 (322)
T d1vzoa_ 247 RILKSEPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321 (322)
T ss_dssp HHHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CC
T ss_pred hcccCCCCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCCCCC
Confidence 33334444443 3789999999999999999999864 46999999999999999998765 689998887765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=469.12 Aligned_cols=253 Identities=31% Similarity=0.503 Sum_probs=214.8
Q ss_pred CCCcEEEE-EecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHh-cCCCCeEEEeeeeccc----c
Q psy16843 363 ENDFTVIK-LISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMS-FTDNPFVVTMYCSFET----K 436 (810)
Q Consensus 363 ~~dy~ilk-~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~-~l~HPnIVkl~~~f~~----~ 436 (810)
.++|+++. .||+|+||+||+|+++.+|+.||||++.+. ..+.+|+.++. ..+|||||+++++|++ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 47899985 599999999999999999999999998653 34567888864 5689999999999875 5
Q ss_pred ceeeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc---CCcEEEeccCCc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA---LGHIKLTDFGLS 511 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~---~g~VKL~DFGLA 511 (810)
..+|||||||+||+|.++|.+. ..+++.+++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 6899999999999999999865 36999999999999999999999999999999999999986 567999999999
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHH----H
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEE----L 587 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e----~ 587 (810)
+..... ......+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+ +
T Consensus 162 ~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~ 225 (335)
T d2ozaa1 162 KETTSH----------------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 225 (335)
T ss_dssp EECCCC----------------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------
T ss_pred eeccCC----------------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH
Confidence 753211 11245689999999999999999999999999999999999999998766433 3
Q ss_pred HHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 588 FAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 588 ~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
...+....+.+|......+|+++++||.+||++||.+||++ .|+++||||.+
T Consensus 226 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~---~eil~hp~~~~ 277 (335)
T d2ozaa1 226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI---TEFMNHPWIMQ 277 (335)
T ss_dssp --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCH---HHHHHSHHHHT
T ss_pred HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCH---HHHHcCHHhhC
Confidence 44555566666655444578999999999999999999998 99999999954
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=452.58 Aligned_cols=261 Identities=27% Similarity=0.451 Sum_probs=216.5
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+++|+.++|||||+++++|.+++.+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 689999999999999999999999999999999865432 2233467889999999999999999999999999999999
Q ss_pred eeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccc
Q psy16843 444 EYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNL 522 (810)
Q Consensus 444 Ey~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~ 522 (810)
||+.|+.+..+.. ..+.+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~----- 155 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP----- 155 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-----
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC-----
Confidence 9997765544433 3467999999999999999999999999999999999999999999999999998752211
Q ss_pred hhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC----
Q psy16843 523 YECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE---- 597 (810)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~---- 597 (810)
.......+||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..+.+.++......
T Consensus 156 ----------~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 225 (298)
T d1gz8a_ 156 ----------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225 (298)
T ss_dssp ----------SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ----------cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence 112234579999999999988765 89999999999999999999999999888877766431110
Q ss_pred -C-------------CCCC-------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 598 -W-------------PSED-------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 598 -~-------------p~~~-------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
+ +... ...+++++++||.+||++||.+|||+ +|+++||||+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~---~ell~H~ff~~~ 289 (298)
T d1gz8a_ 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA---KAALAHPFFQDV 289 (298)
T ss_dssp TSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH---HHHHTSGGGTTC
T ss_pred hccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH---HHHhCCHhhccC
Confidence 0 0000 01367889999999999999999998 999999999876
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-54 Score=452.46 Aligned_cols=254 Identities=26% Similarity=0.443 Sum_probs=217.1
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHH---HHHHHHHHHHHHhcCC--CCeEEEeeeecccc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRN---QMEQVFAERDIMSFTD--NPFVVTMYCSFETK 436 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~---~~~~i~~E~~iL~~l~--HPnIVkl~~~f~~~ 436 (810)
..++|++.+.||+|+||+||+|+++.+|+.||||++.+....... ...++.+|+.+|+.++ |||||+++++|.++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 357899999999999999999999999999999998765432111 1233567999999886 89999999999999
Q ss_pred ceeeeeeeeccC-cchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc-CCcEEEeccCCcccc
Q psy16843 437 KHLCLVMEYVEG-GDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA-LGHIKLTDFGLSKMG 514 (810)
Q Consensus 437 ~~lyLVmEy~~G-GsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~g~VKL~DFGLAk~~ 514 (810)
+.+|+||||+.+ +++.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999976 688899988889999999999999999999999999999999999999985 479999999999752
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCC-CCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGY-GKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-s~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~ 593 (810)
... ...+.+||+.|||||++.+..| +.++|||||||++|||++|+.||.+.+ .+..
T Consensus 162 ~~~-----------------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~ 218 (273)
T d1xwsa_ 162 KDT-----------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR 218 (273)
T ss_dssp CSS-----------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH
T ss_pred ccc-----------------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh
Confidence 111 1235689999999999998776 678999999999999999999997642 3445
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 594 DDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 594 ~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
..+.++.. +|+++++||.+||++||.+|||+ +|+++||||+++..
T Consensus 219 ~~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~---~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 219 GQVFFRQR----VSSECQHLIRWCLALRPSDRPTF---EEIQNHPWMQDVLL 263 (273)
T ss_dssp CCCCCSSC----CCHHHHHHHHHHTCSSGGGSCCH---HHHHTSGGGSSCCC
T ss_pred cccCCCCC----CCHHHHHHHHHHccCCHhHCcCH---HHHhcCHhhCCCCC
Confidence 55555543 78999999999999999999998 99999999988643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.2e-53 Score=449.19 Aligned_cols=262 Identities=25% Similarity=0.390 Sum_probs=221.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc----ee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK----HL 439 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~----~l 439 (810)
++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+++|+.++|||||++++++.+.+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 67999999999999999999999999999999998766555566678999999999999999999999987654 48
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
|||||||+||+|.+++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||+++.......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 99999999999999999889999999999999999999999999999999999999999999999999999865322111
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIEWP 599 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~~p 599 (810)
........+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++.+++......+
T Consensus 167 ------------~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 167 ------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234 (277)
T ss_dssp ------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG
T ss_pred ------------cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC
Confidence 11123467899999999999999999999999999999999999999999999999988888776665
Q ss_pred CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 600 SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 600 ~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
......+|+++++||.+||++||.+||+. .+.+.|+|.
T Consensus 235 ~~~~~~~s~~l~~li~~~L~~dp~~R~~s---a~~l~~~l~ 272 (277)
T d1o6ya_ 235 SARHEGLSADLDAVVLKALAKNPENRYQT---AAEMRADLV 272 (277)
T ss_dssp GGTSSSCCHHHHHHHHHHTCSSGGGSCSS---HHHHHHHHH
T ss_pred chhccCCCHHHHHHHHHHccCCHhHCHhH---HHHHHHHHH
Confidence 55455688999999999999999999965 344445443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-53 Score=448.83 Aligned_cols=263 Identities=28% Similarity=0.460 Sum_probs=214.9
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCC-CcEEEEEEeeccchhhHHHHHHHHHHHHHHhc---CCCCeEEEeeeecc----
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKET-RQRFAMKKIIKNSLMLRNQMEQVFAERDIMSF---TDNPFVVTMYCSFE---- 434 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~t-g~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~---l~HPnIVkl~~~f~---- 434 (810)
.++|++++.||+|+||+||+|+++.+ ++.||||++....... .....+.+|+.+|+. .+|||||+++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 36899999999999999999999765 6679999986643321 112234566666655 48999999999885
Q ss_pred -ccceeeeeeeeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcc
Q psy16843 435 -TKKHLCLVMEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSK 512 (810)
Q Consensus 435 -~~~~lyLVmEy~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk 512 (810)
....+|++|||+.||.+..... ....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3468999999999988765544 44679999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV 592 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~ 592 (810)
..... ......+||+.|||||++.+.+|+.++|||||||++|||++|++||.+.+..+.+.++.
T Consensus 165 ~~~~~----------------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 228 (305)
T d1blxa_ 165 IYSFQ----------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228 (305)
T ss_dssp CCCGG----------------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred hhccc----------------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 53211 11245689999999999999999999999999999999999999999999988887765
Q ss_pred cCC-----CCCCC------------------CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 593 NDD-----IEWPS------------------EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 593 ~~~-----~~~p~------------------~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
... ..++. .....+++++++||.+||++||.+|||+ .|+|+||||+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa---~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA---YSALSHPYFQDLER 301 (305)
T ss_dssp HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH---HHHHTSGGGTTCCC
T ss_pred HhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH---HHHhcChhhcCchh
Confidence 310 00100 0112367899999999999999999998 99999999998864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.1e-52 Score=440.67 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=218.0
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||+||+|+++ +|+.||||++...... ....+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 68999999999999999999986 7899999998665432 333467889999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||+.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|......
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~------ 153 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP------ 153 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC------
Confidence 99999988888888899999999999999999999999999999999999999999999999999998652211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC-----
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE----- 597 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~----- 597 (810)
.......+|++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+.++......
T Consensus 154 ---------~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 154 ---------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224 (286)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ---------ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhh
Confidence 1112345799999999999875 5699999999999999999999999999888877765431100
Q ss_pred C-------------C-------CCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 598 W-------------P-------SEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 598 ~-------------p-------~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+ . ......++++++|||++||++||++||++ .|+++||||++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~---~ell~Hp~f~~ 286 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA---KQALEHAYFKE 286 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH---HHHHTSGGGGC
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH---HHHhcCcccCc
Confidence 0 0 00012267899999999999999999998 99999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=449.72 Aligned_cols=258 Identities=20% Similarity=0.294 Sum_probs=216.1
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCc-----EEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeec
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQ-----RFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSF 433 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~-----~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f 433 (810)
+...++|++.+.||+|+||+||+|+++.+++ .||+|.+..... ......+.+|+.+|..+ +|||||++++++
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 3455789999999999999999999876554 689998765432 23346788899999887 899999999999
Q ss_pred cccceeeeeeeeccCcchhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccC
Q psy16843 434 ETKKHLCLVMEYVEGGDCASLLKNT-----------------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDL 490 (810)
Q Consensus 434 ~~~~~lyLVmEy~~GGsL~~lL~~~-----------------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDL 490 (810)
.+.+.+|||||||+||+|.++|+.. +.+++..++.|+.||+.||+|||++|||||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 9999999999999999999999754 24899999999999999999999999999999
Q ss_pred CCCceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHH
Q psy16843 491 KPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILY 570 (810)
Q Consensus 491 KPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILy 570 (810)
||+|||++.+|++||+|||+|+...... ......+.+||+.|||||++.+..|+.++|||||||+||
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~-------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~ 257 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDS-------------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 257 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCT-------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred chhccccccCCeEEEeeccccccccCCC-------------ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHH
Confidence 9999999999999999999997532211 111123567899999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 571 EFLV-GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 571 ELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
||++ |.+||.+.+..+.+.+++.....++.+. .+++++++||.+||+.||++|||+ +||++|
T Consensus 258 emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~--~~~~~l~~li~~cl~~dP~~RPt~---~ei~~~ 320 (325)
T d1rjba_ 258 EIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF--YATEEIYIIMQSCWAFDSRKRPSF---PNLTSF 320 (325)
T ss_dssp HHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCC--cCCHHHHHHHHHHcCCChhHCcCH---HHHHHH
Confidence 9997 9999998877777777776665544433 367999999999999999999998 788765
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-52 Score=441.71 Aligned_cols=254 Identities=20% Similarity=0.328 Sum_probs=214.2
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
++...++|++.+.||+|+||+||+|+++.+|+.||||++.+... ..+++.+|+++|+.++|||||+++++|.+++.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 34556789999999999999999999999999999998876543 23568899999999999999999999999999
Q ss_pred eeeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999999653 5799999999999999999999999999999999999999999999999999975322
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCC-CCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVP-FFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~P-F~~~~~~e~~~~I~~~~ 595 (810)
.. ........||+.|||||++.+..|+.++|||||||++|||++|..| |.+.+..+++..+..+
T Consensus 168 ~~--------------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~- 232 (287)
T d1opja_ 168 DT--------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD- 232 (287)
T ss_dssp SS--------------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-
T ss_pred CC--------------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-
Confidence 11 1111234689999999999999999999999999999999996555 5566666665554443
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
...+.+. .+++++++||.+||+.||++||++ .|+++
T Consensus 233 ~~~~~~~--~~~~~l~~li~~cl~~dP~~Rps~---~ei~~ 268 (287)
T d1opja_ 233 YRMERPE--GCPEKVYELMRACWQWNPSDRPSF---AEIHQ 268 (287)
T ss_dssp CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CCCCCCc--cchHHHHHHHHHHcCCCHhHCcCH---HHHHH
Confidence 3333222 377999999999999999999998 77754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=445.36 Aligned_cols=260 Identities=26% Similarity=0.398 Sum_probs=212.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc-----
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK----- 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~----- 437 (810)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 368999999999999999999999999999999987643 33455678899999999999999999999997655
Q ss_pred -eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 -HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 -~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
.+|+||||| |++|..+++. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 6677777654 6899999999999999999999999999999999999999999999999999975211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
.....+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+....
T Consensus 174 ------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~ 235 (346)
T d1cm8a_ 174 ------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235 (346)
T ss_dssp ------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred ------------------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhcc
Confidence 12346799999999999875 56999999999999999999999999988776655543311
Q ss_pred CC-----------------------CCC----CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCCChh
Q psy16843 596 IE-----------------------WPS----EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNLDWN 646 (810)
Q Consensus 596 ~~-----------------------~p~----~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~id~~ 646 (810)
.. ... .....++++++|||.+||+.||.+|||+ .|+|+||||+++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta---~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA---GEALAHPYFESLHDT 310 (346)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH---HHHHHSGGGTTTC--
T ss_pred CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH---HHHhcChhhCcCCCc
Confidence 10 000 0112367899999999999999999998 999999999987643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=439.82 Aligned_cols=265 Identities=24% Similarity=0.338 Sum_probs=217.0
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc-------
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET------- 435 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~------- 435 (810)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+++|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 37899999999999999999999999999999988665332 2344667899999999999999999998755
Q ss_pred -cceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccc
Q psy16843 436 -KKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMG 514 (810)
Q Consensus 436 -~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~ 514 (810)
++.+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++..
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 4568999999999888877777789999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy16843 515 LMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVN 593 (810)
Q Consensus 515 ~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~ 593 (810)
..... .......+.+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+....+..
T Consensus 168 ~~~~~-----------~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 168 SLAKN-----------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp CC----------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccc-----------cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 22111 111123456899999999999875 689999999999999999999999999988887766654
Q ss_pred CCCCCCCCCCC----------------------------cccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 594 DDIEWPSEDDW----------------------------PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 594 ~~~~~p~~~~~----------------------------~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
....++..... ..+++++|||.+||+.||++|||+ +|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa---~elL~Hpff~~ 310 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS---DDALNHDFFWS 310 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH---HHHHHSGGGSS
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH---HHHHcChhhcc
Confidence 22111111000 136788999999999999999999 99999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-51 Score=437.84 Aligned_cols=259 Identities=20% Similarity=0.298 Sum_probs=207.3
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCc---EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQ---RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK 436 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~---~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~ 436 (810)
....++|++.+.||+|+||+||+|+++.+++ .||||.+..... ....+.+.+|+++|+.++|||||++++++.++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 3445789999999999999999999987765 588887755432 34456789999999999999999999999999
Q ss_pred ceeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccc
Q psy16843 437 KHLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGL 515 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~ 515 (810)
+.+|+|||||+||+|.+++.. .+.+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+...
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999999999998876 4579999999999999999999999999999999999999999999999999997633
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccC
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVND 594 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~ 594 (810)
...... .........||+.|||||++.+..|+.++|||||||+||||++ |.+||.+.+..+++..+..+
T Consensus 180 ~~~~~~----------~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~ 249 (299)
T d1jpaa_ 180 DDTSDP----------TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD 249 (299)
T ss_dssp --------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred CCCCcc----------eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 221110 0111123468999999999999999999999999999999998 89999999999988887765
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 595 DIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 595 ~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
.. .+.+. .++.++.+||.+||+.||.+||++ .|+++
T Consensus 250 ~~-~~~~~--~~~~~l~~li~~cl~~~P~~RPs~---~ei~~ 285 (299)
T d1jpaa_ 250 YR-LPPPM--DCPSALHQLMLDCWQKDRNHRPKF---GQIVN 285 (299)
T ss_dssp CC-CCCCT--TCCHHHHHHHHHHTCSSTTTSCCH---HHHHH
T ss_pred CC-CCCCc--cchHHHHHHHHHHcCCCHhHCcCH---HHHHH
Confidence 32 22222 367999999999999999999998 66654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=436.91 Aligned_cols=255 Identities=23% Similarity=0.303 Sum_probs=211.8
Q ss_pred EEecccCceEEEEEEEcC--CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeeeeecc
Q psy16843 370 KLISNGAYGSVYLVRHKE--TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVMEYVE 447 (810)
Q Consensus 370 k~LG~G~FG~Vyla~~k~--tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVmEy~~ 447 (810)
++||+|+||+||+|.++. +++.||||++..... .....+.+.+|+++|+.++|||||++++++.++ .+|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 579999999999998754 457899998865433 234457789999999999999999999999654 5789999999
Q ss_pred CcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccchhhhh
Q psy16843 448 GGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLYECYV 527 (810)
Q Consensus 448 GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~ 527 (810)
||+|.+++.+.+.+++..+..|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~-------- 162 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-------- 162 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS--------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc--------
Confidence 999999999989999999999999999999999999999999999999999999999999999975322111
Q ss_pred hcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC-CCCCCCCCCc
Q psy16843 528 ERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD-IEWPSEDDWP 605 (810)
Q Consensus 528 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~-~~~p~~~~~~ 605 (810)
.........||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..++...+..+. +..|. .
T Consensus 163 ----~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~----~ 234 (277)
T d1xbba_ 163 ----YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA----G 234 (277)
T ss_dssp ----EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT----T
T ss_pred ----ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCc----c
Confidence 1111234579999999999999999999999999999999997 999999999998888877653 22332 3
Q ss_pred ccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCC
Q psy16843 606 IQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSN 642 (810)
Q Consensus 606 ~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~ 642 (810)
+++++++||.+||+.||.+||++..+.+.|+|+|++-
T Consensus 235 ~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 6799999999999999999999954445577877643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=437.24 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=208.4
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
+...++|++.+.||+|+||+||+|+++ ..||||++...... ....+.+.+|+.+|+.++|||||++++++. ++.+
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~ 78 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL 78 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence 345578999999999999999999754 35999988654332 345678899999999999999999999865 4578
Q ss_pred eeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
|||||||+||+|.++|.. .+.+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999999999999964 4679999999999999999999999999999999999999999999999999997532111
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhc---CCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ---GYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~---~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~ 595 (810)
......+.+||+.|||||++.+. .|+.++|||||||+||||++|+.||.+.+....+..++...
T Consensus 159 -------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 225 (276)
T d1uwha_ 159 -------------GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 225 (276)
T ss_dssp --------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT
T ss_pred -------------CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC
Confidence 11122456899999999999753 58999999999999999999999999877665555544433
Q ss_pred CCCCC--CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 596 IEWPS--EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 596 ~~~p~--~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
...|. .....+++++++||.+||..||.+||++ .|+++|
T Consensus 226 ~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~---~~il~~ 266 (276)
T d1uwha_ 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLF---PQILAS 266 (276)
T ss_dssp SCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCCCcchhccccchHHHHHHHHHHcCCCHhHCcCH---HHHHHH
Confidence 33221 1122367899999999999999999998 788765
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=428.50 Aligned_cols=250 Identities=22% Similarity=0.382 Sum_probs=207.4
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|++++.||+|+||.||+|+++ +++.||||++.+.... .+.+.+|+++++.++|||||++++++.+++.+|+|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 468999999999999999999986 4678999998765432 25688999999999999999999999999999999
Q ss_pred eeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~---- 154 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD---- 154 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC----
Confidence 9999999999998654 57899999999999999999999999999999999999999999999999999753211
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
.........||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..+++..+..+.....+
T Consensus 155 ----------~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p 224 (263)
T d1sm2a_ 155 ----------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 224 (263)
T ss_dssp --------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC
T ss_pred ----------CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 1111234579999999999999999999999999999999998 68888888888888887765332221
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
...++++.+||.+||+.||++||++ .|+++|
T Consensus 225 ---~~~~~~l~~li~~cl~~~p~~Rps~---~~il~~ 255 (263)
T d1sm2a_ 225 ---RLASTHVYQIMNHCWKERPEDRPAF---SRLLRQ 255 (263)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred ---cccCHHHHHHHHHHccCCHhHCcCH---HHHHHH
Confidence 1267899999999999999999998 888875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=436.40 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=219.0
Q ss_pred CCCcEEEEE-ecccCceEEEEEEEcC--CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 363 ENDFTVIKL-ISNGAYGSVYLVRHKE--TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 363 ~~dy~ilk~-LG~G~FG~Vyla~~k~--tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
.++|.+.+. ||+|+||.||+|.++. ++..||||++.+.. .....+.+.+|+++|+.++|||||++++++.+ +.+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 367888885 9999999999998764 44579999986543 23456788999999999999999999999875 468
Q ss_pred eeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
|||||||+||+|.+++.. .+.+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+......
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999999998764 4689999999999999999999999999999999999999999999999999997632211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC-
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI- 596 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~- 596 (810)
.........+||+.|||||++.+..|+.++|||||||++|||++ |..||.+.+..+++..+..+..
T Consensus 164 ------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~ 231 (285)
T d1u59a_ 164 ------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231 (285)
T ss_dssp ------------CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC
T ss_pred ------------cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 11112235579999999999999999999999999999999998 9999999988888888876543
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..|. .+++++.+||.+||+.||++||++..+.+.|+|+|+
T Consensus 232 ~~p~----~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 232 ECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2332 377999999999999999999999666666888876
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=445.57 Aligned_cols=255 Identities=29% Similarity=0.454 Sum_probs=211.1
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecc------cc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE------TK 436 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~------~~ 436 (810)
.-+|..+++||+|+||+||+|+++.+|+.||||++.+.... ..+|+++|+.++|||||+++++|. +.
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 34799999999999999999999999999999998765422 236999999999999999999884 33
Q ss_pred ceeeeeeeeccCcchhhhh---hcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC-cEEEeccCCcc
Q psy16843 437 KHLCLVMEYVEGGDCASLL---KNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG-HIKLTDFGLSK 512 (810)
Q Consensus 437 ~~lyLVmEy~~GGsL~~lL---~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g-~VKL~DFGLAk 512 (810)
.++|||||||++|.+..+. .....+++..++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||+++
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 4689999999877544433 4566899999999999999999999999999999999999999876 89999999987
Q ss_pred cccccccccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy16843 513 MGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHT 591 (810)
Q Consensus 513 ~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I 591 (810)
..... ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+
T Consensus 172 ~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i 235 (350)
T d1q5ka_ 172 QLVRG----------------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235 (350)
T ss_dssp ECCTT----------------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred hccCC----------------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHH
Confidence 53211 11235689999999999886 46899999999999999999999999998888777666
Q ss_pred ccC-----------------CCCCCCC--------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 592 VND-----------------DIEWPSE--------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 592 ~~~-----------------~~~~p~~--------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
... ...++.. .....++++++||.+||++||.+|||+ .|+|+||||+++
T Consensus 236 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta---~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP---LEACAHSFFDEL 309 (350)
T ss_dssp HHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCH---HHHHTSGGGGGG
T ss_pred HHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCH---HHHhcCHhhccc
Confidence 421 1111111 112367899999999999999999998 999999999765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.7e-51 Score=438.60 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=210.6
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccc--ccee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFET--KKHL 439 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~--~~~l 439 (810)
.++|+++++||+|+||+||+|+++.+|+.||||++.+.. .+++.+|+++|+.+. ||||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 468999999999999999999999999999999986543 256788999999985 9999999999874 4579
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC-cEEEeccCCcccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG-HIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g-~VKL~DFGLAk~~~~s~ 518 (810)
|+|||||.+|+|..+. +.+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+.....
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 9999999999998765 4699999999999999999999999999999999999999755 6999999999753211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhc-CCCCCcchhhhHHHHHHHHhCCCCCCCCCH-HHHHHhhcc---
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQ-GYGKPVDWWSMGVILYEFLVGCVPFFGETP-EELFAHTVN--- 593 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~ys~ksDIWSLGvILyELLtG~~PF~~~~~-~e~~~~I~~--- 593 (810)
......+||+.|+|||++.+. .|+.++|||||||++|||++|..||..... .+....+..
T Consensus 184 ---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g 248 (328)
T d3bqca1 184 ---------------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248 (328)
T ss_dssp ---------------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred ---------------CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHC
Confidence 112456799999999999875 579999999999999999999999976543 222221110
Q ss_pred ----------CCC--------------------CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 594 ----------DDI--------------------EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 594 ----------~~~--------------------~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
... ..+......++++++|||++||++||.+|||+ +|+|+||||+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta---~e~L~Hp~F~~v 325 (328)
T d3bqca1 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA---REAMEHPYFYTV 325 (328)
T ss_dssp HHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCH---HHHHTSGGGTTS
T ss_pred CchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCH---HHHhcCcccCCC
Confidence 000 01111112367899999999999999999999 999999999999
Q ss_pred Chh
Q psy16843 644 DWN 646 (810)
Q Consensus 644 d~~ 646 (810)
.|+
T Consensus 326 ~~~ 328 (328)
T d3bqca1 326 VKD 328 (328)
T ss_dssp CCC
T ss_pred CCC
Confidence 885
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=430.65 Aligned_cols=256 Identities=20% Similarity=0.344 Sum_probs=215.1
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccccee
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHL 439 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~l 439 (810)
+...++|++++.||+|+||.||+|+++ +++.||||++...... .+.+.+|+++|+.++|||||++++++.+ +.+
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~ 82 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence 344578999999999999999999986 5678999998764432 2568899999999999999999998754 568
Q ss_pred eeeeeeccCcchhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNT--GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~--g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 9999999999999987543 36999999999999999999999999999999999999999999999999999753221
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.........||+.|||||++.+..|+.++|||||||+||||++ |.+||...+..+++..+..+..
T Consensus 163 --------------~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~ 228 (272)
T d1qpca_ 163 --------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228 (272)
T ss_dssp --------------CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred --------------ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC
Confidence 1112234579999999999999999999999999999999999 5667777888888887766432
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc--CCCcC
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE--HPYFS 641 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~--HPfF~ 641 (810)
. +.+. .+++++.+||.+||+.||++||++ .|+++ |+||.
T Consensus 229 ~-~~p~--~~~~~l~~li~~cl~~~P~~Rpt~---~ei~~~L~~~ft 269 (272)
T d1qpca_ 229 M-VRPD--NCPEELYQLMRLCWKERPEDRPTF---DYLRSVLEDFFT 269 (272)
T ss_dssp C-CCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHHHHHHHHH
T ss_pred C-CCcc--cChHHHHHHHHHHcCCCHhHCcCH---HHHHHHhhhhhh
Confidence 2 2222 377899999999999999999998 78877 67764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=426.36 Aligned_cols=261 Identities=23% Similarity=0.389 Sum_probs=221.1
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLVM 443 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLVm 443 (810)
++|++++.||+|+||+||+|+++.+|+.||||++..... .....+++.+|+.+|+.++|||||+++++|.+...+++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 689999999999999999999999999999999876543 3455678899999999999999999999999999999999
Q ss_pred eeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccccccch
Q psy16843 444 EYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATNLY 523 (810)
Q Consensus 444 Ey~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~~~ 523 (810)
||+.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+||||+.++.+||+|||.|+......
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~----- 155 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----- 155 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-----
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-----
Confidence 999999999999998999999999999999999999999999999999999999999999999999997532211
Q ss_pred hhhhhcccccccCCcccCCCCcCChhHHhhcC-CCCCcchhhhHHHHHHHHhCCCCC-CCCCHHHHHHhhccCCCC----
Q psy16843 524 ECYVERDAKQFSDKQVYGTPEYIAPEVILRQG-YGKPVDWWSMGVILYEFLVGCVPF-FGETPEELFAHTVNDDIE---- 597 (810)
Q Consensus 524 ~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-ys~ksDIWSLGvILyELLtG~~PF-~~~~~~e~~~~I~~~~~~---- 597 (810)
.......+++.|+|||++.+.. ++.++|||||||++|||++|..|| .+.+..+.+.++......
T Consensus 156 ----------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (292)
T d1unla_ 156 ----------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp ----------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ----------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChh
Confidence 1123346789999999998765 599999999999999999999885 455666655554321100
Q ss_pred ---------------------CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 598 ---------------------WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 598 ---------------------~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
........+++++++||.+||++||.+|||+ +|+|+||||+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa---~e~L~Hp~f~~~ 289 (292)
T d1unla_ 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA---EEALQHPYFSDF 289 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH---HHHTTSGGGSSC
T ss_pred hhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCH---HHHhcChhhcCC
Confidence 0000111267889999999999999999998 999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=423.41 Aligned_cols=250 Identities=21% Similarity=0.322 Sum_probs=218.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceeeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~lyLV 442 (810)
.++|+++++||+|+||+||+|+++ +++.||||++.+..... +.+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 478999999999999999999985 67889999988755432 5688999999999999999999999999999999
Q ss_pred eeeccCcchhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLK-NTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~-~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
|||+++|+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~---- 153 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---- 153 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS----
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC----
Confidence 99999999999875 4467999999999999999999999999999999999999999999999999999753211
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~~p~ 600 (810)
........+||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+.+..++..++..+.. .+.
T Consensus 154 ----------~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~-~~~ 222 (258)
T d1k2pa_ 154 ----------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-LYR 222 (258)
T ss_dssp ----------SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-CCC
T ss_pred ----------CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC-CCC
Confidence 1111234579999999999999999999999999999999998 8999999999999888877543 222
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
+. ..++++++||.+||+.||++||++ +|+++|
T Consensus 223 p~--~~~~~l~~li~~cl~~dP~~RPt~---~eil~~ 254 (258)
T d1k2pa_ 223 PH--LASEKVYTIMYSCWHEKADERPTF---KILLSN 254 (258)
T ss_dssp CT--TCCHHHHHHHHHTTCSSGGGSCCH---HHHHHH
T ss_pred cc--cccHHHHHHHHHHccCCHhHCcCH---HHHHHH
Confidence 22 367899999999999999999998 898876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=435.84 Aligned_cols=263 Identities=24% Similarity=0.404 Sum_probs=209.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc------cc
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET------KK 437 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~------~~ 437 (810)
++|+++++||+|+||+||+|+++.+|+.||||++.+... .....+++.+|+.+|+.++|||||+++++|.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 579999999999999999999999999999999876543 34555778999999999999999999999853 46
Q ss_pred eeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
.+|+|||||.|+.+. .+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHH-hhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 899999999776554 443 46999999999999999999999999999999999999999999999999998752211
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC-
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI- 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~- 596 (810)
......+||+.|+|||++.+..|+.++||||+||++|||++|++||.+.+......+++....
T Consensus 173 ----------------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~ 236 (355)
T d2b1pa1 173 ----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_dssp ------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred ----------------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence 122455799999999999999999999999999999999999999999887776665542110
Q ss_pred ---------------------CCCCC----------------CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCC
Q psy16843 597 ---------------------EWPSE----------------DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPY 639 (810)
Q Consensus 597 ---------------------~~p~~----------------~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPf 639 (810)
..... .....++++++||++||..||++|||+ +|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta---~elL~Hpw 313 (355)
T d2b1pa1 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV---DDALQHPY 313 (355)
T ss_dssp CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH---HHHHTSTT
T ss_pred CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH---HHHhcCcc
Confidence 00000 000146789999999999999999999 99999999
Q ss_pred cCCCChhhhh
Q psy16843 640 FSNLDWNSLL 649 (810)
Q Consensus 640 F~~id~~~l~ 649 (810)
|+..-+..-.
T Consensus 314 ~~~~~~~~~~ 323 (355)
T d2b1pa1 314 INVWYDPAEV 323 (355)
T ss_dssp TGGGCCHHHH
T ss_pred cCCCCCcccc
Confidence 9875443333
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-50 Score=434.64 Aligned_cols=262 Identities=26% Similarity=0.395 Sum_probs=211.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc----ee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK----HL 439 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~----~l 439 (810)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+++|+++|+.++|||||++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 56999999999999999999999999999999987543 2445578899999999999999999999986643 23
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~ 519 (810)
+++|+|+.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.......
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 444556779999999976 4799999999999999999999999999999999999999999999999999976332211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhh-cCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCC--
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILR-QGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDI-- 596 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~-- 596 (810)
........+||+.|+|||++.. ..|+.++||||+||++|||++|..||.+.+..+....+.....
T Consensus 165 ------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 165 ------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp ------------BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred ------------cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence 1112245689999999999855 5679999999999999999999999998887665555432100
Q ss_pred ------------------CCCCCC-------CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 597 ------------------EWPSED-------DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 597 ------------------~~p~~~-------~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
..+... ...+++++++||.+||++||.+||++ .|+|+||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta---~e~L~hpf~~~~ 301 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV---EQALAHPYLEQY 301 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH---HHHHTSGGGTTT
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH---HHHhcCHhhccC
Confidence 011100 11257889999999999999999998 999999999754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=435.55 Aligned_cols=257 Identities=24% Similarity=0.348 Sum_probs=214.2
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecccc-----ce
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETK-----KH 438 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~-----~~ 438 (810)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+++.+|+++|+.++|||||+++++|... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 679999999999999999999999999999999876543 334456788999999999999999999998643 34
Q ss_pred eeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
.++||+|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 5667788889999999965 5799999999999999999999999999999999999999999999999999864211
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcC-CCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhccCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG-YGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
...+.+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+......
T Consensus 174 ----------------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 174 ----------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237 (348)
T ss_dssp ----------------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred ----------------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 123567999999999988765 589999999999999999999999999888777766543221
Q ss_pred CC-----------------------CCC----CCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCcCCC
Q psy16843 598 WP-----------------------SED----DWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYFSNL 643 (810)
Q Consensus 598 ~p-----------------------~~~----~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF~~i 643 (810)
.+ ... ...++++++|||.+||+.||.+|||+ .|+|+||||.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta---~elL~Hp~f~~~ 307 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA---AQALAHAYFAQY 307 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCH---HHHHTSGGGTTT
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCH---HHHhcCHhhCCC
Confidence 11 000 01267899999999999999999998 999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=431.49 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=207.5
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCCc----EEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETRQ----RFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg~----~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
..++|++++.||+|+||+||+|+++.+|+ +||+|++.... .....+.+.+|+++|+.++|||||++++++.++
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 44789999999999999999999998876 47777665432 223456789999999999999999999999865
Q ss_pred eeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
..++||||+.+|+|.+++.. ...+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 57788899999999988765 46899999999999999999999999999999999999999999999999999975322
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
.. .........||+.|||||++.+..|+.++|||||||+||||++ |.+||.+.+..++...+..+.
T Consensus 164 ~~-------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~ 230 (317)
T d1xkka_ 164 EE-------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 230 (317)
T ss_dssp TC-------------C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC
T ss_pred cc-------------ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 11 1111234568999999999999999999999999999999998 899999988888777766543
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
. .+.+. .+++++.+||.+||+.||.+||++ .|++.|
T Consensus 231 ~-~~~p~--~~~~~~~~li~~cl~~dP~~RPs~---~eil~~ 266 (317)
T d1xkka_ 231 R-LPQPP--ICTIDVYMIMVKCWMIDADSRPKF---RELIIE 266 (317)
T ss_dssp C-CCCCT--TBCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred C-CCCCc--ccCHHHHHHHHHhCCCChhhCcCH---HHHHHH
Confidence 2 22222 277999999999999999999998 899887
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=417.14 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=206.5
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCCC----cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKETR----QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~tg----~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
..+.|++.+.||+|+||.||+|.++.++ ..||||++..... ......+.+|+++|+.++|||||++++++.+.+
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 3467999999999999999999988665 4699998865432 334467889999999999999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
.+++|||||.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999999988654 6799999999999999999999999999999999999999999999999999976322
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
... .........||+.|||||++.+..|+.++|||||||+||||++ |.+||.+.+..+++..+..+.
T Consensus 163 ~~~------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~ 230 (283)
T d1mqba_ 163 DPE------------ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF 230 (283)
T ss_dssp -----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred CCc------------cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC
Confidence 111 1112234568999999999999999999999999999999998 556666677777777665543
Q ss_pred CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 ~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..+.+. .++.++++||.+||+.||++||++ .||++
T Consensus 231 -~~~~~~--~~~~~l~~li~~cl~~~p~~RPt~---~eil~ 265 (283)
T d1mqba_ 231 -RLPTPM--DCPSAIYQLMMQCWQQERARRPKF---ADIVS 265 (283)
T ss_dssp -CCCCCT--TCBHHHHHHHHHHTCSSTTTSCCH---HHHHH
T ss_pred -CCCCch--hhHHHHHHHHHHHCcCCHhHCcCH---HHHHH
Confidence 333322 267899999999999999999998 67764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=417.66 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=206.5
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCC---cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETR---QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg---~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
+..++|++.+.||+|+||.||+|++..++ ..||||.+.... .....+.+.+|+++|+.++|||||++++++. ++
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 34478999999999999999999987553 468888775432 2344567899999999999999999999996 46
Q ss_pred eeeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 438 HLCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
.+|+||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 79999999999999998754 46799999999999999999999999999999999999999999999999999975321
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
. ........+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+++.++..+.
T Consensus 161 ~--------------~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~ 226 (273)
T d1mp8a_ 161 S--------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 226 (273)
T ss_dssp ------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred C--------------cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 1 1111234568999999999999999999999999999999997 999999999999988887764
Q ss_pred C-CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 596 I-EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 596 ~-~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
. ..|. .+++++.+||.+||+.||.+||++ .||++|
T Consensus 227 ~~~~~~----~~~~~~~~li~~cl~~dp~~Rps~---~ei~~~ 262 (273)
T d1mp8a_ 227 RLPMPP----NCPPTLYSLMTKCWAYDPSRRPRF---TELKAQ 262 (273)
T ss_dssp CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCCCCC----CCCHHHHHHHHHHcCCCHhHCcCH---HHHHHH
Confidence 3 2222 378999999999999999999998 888765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=423.34 Aligned_cols=257 Identities=22% Similarity=0.333 Sum_probs=200.8
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeecc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKE-----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFE 434 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~-----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~ 434 (810)
...++|++++.||+|+||.||+|+++. +++.||||++..... ....+.+..|..++..+ +|+|||.+++++.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 344789999999999999999999865 346899998865432 23345667777777655 7899999998875
Q ss_pred c-cceeeeeeeeccCcchhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEe
Q psy16843 435 T-KKHLCLVMEYVEGGDCASLLKNT----------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLI 497 (810)
Q Consensus 435 ~-~~~lyLVmEy~~GGsL~~lL~~~----------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILL 497 (810)
. +..+|+|||||+||+|.++|... ..+++..+..|+.||+.||+|||++|||||||||+||||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 5 45799999999999999999643 348999999999999999999999999999999999999
Q ss_pred ccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhC-C
Q psy16843 498 TALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVG-C 576 (810)
Q Consensus 498 d~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG-~ 576 (810)
+.+|++||+|||+|+..... .........+||+.|||||++.+..|+.++|||||||++|||++| .
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~-------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~ 234 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKD-------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234 (299)
T ss_dssp CGGGCEEECC------CCSC-------------TTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCcEEEccCcchhhcccc-------------ccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCC
Confidence 99999999999999753211 111123456899999999999999999999999999999999986 6
Q ss_pred CCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 577 VPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 577 ~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
+||.+....+.+..++.....++.+. .+++++++||.+||+.||++||++ .|+++|
T Consensus 235 ~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rpt~---~eil~~ 290 (299)
T d1ywna1 235 SPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDCWHGEPSQRPTF---SELVEH 290 (299)
T ss_dssp CSSTTCCCSHHHHHHHHHTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHHcCCChhHCcCH---HHHHHH
Confidence 78887765555555544433333222 267999999999999999999998 888876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=420.14 Aligned_cols=256 Identities=20% Similarity=0.325 Sum_probs=207.9
Q ss_pred CCCCcEEEEEecccCceEEEEEEEcCC-C--cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccce
Q psy16843 362 NENDFTVIKLISNGAYGSVYLVRHKET-R--QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKH 438 (810)
Q Consensus 362 ~~~dy~ilk~LG~G~FG~Vyla~~k~t-g--~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ 438 (810)
..++|++++.||+|+||.||+|+++.. + ..||||++.+.........+.+.+|+.+|+.++|||||++++++.+ ..
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 447899999999999999999987543 3 3689998877655555666789999999999999999999999976 47
Q ss_pred eeeeeeeccCcchhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKN-TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMS 517 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~-~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s 517 (810)
+++|||||++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 8999999999999987754 467999999999999999999999999999999999999999999999999999863222
Q ss_pred ccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCC
Q psy16843 518 LATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDI 596 (810)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~ 596 (810)
.. ........+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..++..++.....
T Consensus 165 ~~------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~ 232 (273)
T d1u46a_ 165 DD------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232 (273)
T ss_dssp CC------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred CC------------cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC
Confidence 11 1112234568899999999999999999999999999999998 8999999999999999988776
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 597 EWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 597 ~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
.++... .+++++++||.+||..||++||++ .||+
T Consensus 233 ~~~~~~--~~~~~l~~li~~cl~~dp~~RPt~---~ei~ 266 (273)
T d1u46a_ 233 RLPRPE--DCPQDIYNVMVQCWAHKPEDRPTF---VALR 266 (273)
T ss_dssp CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHH
T ss_pred CCCCcc--cccHHHHHHHHHHcCCChhHCcCH---HHHH
Confidence 655443 367999999999999999999998 5654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=418.90 Aligned_cols=257 Identities=21% Similarity=0.321 Sum_probs=212.0
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccceee
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~~ly 440 (810)
+..++|++.+.||+|+||+||+|+++.+ +.||||++...... .+.+.+|+.+|+.++|||||++++++.+ +.+|
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 3457899999999999999999998765 56999998655432 2568899999999999999999999865 5689
Q ss_pred eeeeeccCcchhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccccc
Q psy16843 441 LVMEYVEGGDCASLLKN--TGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSL 518 (810)
Q Consensus 441 LVmEy~~GGsL~~lL~~--~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~ 518 (810)
+|||||++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+....+.
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999999999988853 3579999999999999999999999999999999999999999999999999997532111
Q ss_pred cccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCCCC
Q psy16843 519 ATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDDIE 597 (810)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~~~ 597 (810)
.......+||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+....+++..+..+..
T Consensus 168 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~- 232 (285)
T d1fmka3 168 --------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR- 232 (285)
T ss_dssp ----------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-
T ss_pred --------------ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-
Confidence 111234579999999999999999999999999999999999 5666777888888887776432
Q ss_pred CCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc--CCCcCCC
Q psy16843 598 WPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE--HPYFSNL 643 (810)
Q Consensus 598 ~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~--HPfF~~i 643 (810)
.+.. ..+++++++||.+||+.||++||++ ++|++ |+||...
T Consensus 233 ~~~~--~~~~~~l~~li~~cl~~dP~~Rps~---~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 233 MPCP--PECPESLHDLMCQCWRKEPEERPTF---EYLQAFLEDYFTST 275 (285)
T ss_dssp CCCC--TTSCHHHHHHHHHHTCSSGGGSCCH---HHHHHHHHTTTSCS
T ss_pred CCCC--cccCHHHHHHHHHHcccCHhHCcCH---HHHHHHHhhhhcCC
Confidence 2222 2377999999999999999999998 88877 7888653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-48 Score=417.40 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=214.7
Q ss_pred CCCcEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKE-----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK 437 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~-----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~ 437 (810)
.++|++++.||+|+||+||+|+++. +++.||||++.+... ....+++.+|+++|+.++||||+++++++.+.+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 4689999999999999999999863 567899998865432 344577899999999999999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcCC------------------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCC
Q psy16843 438 HLCLVMEYVEGGDCASLLKNTG------------------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPD 493 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~g------------------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPe 493 (810)
.+++||||+++|+|.++|.... .+++..+..|+.||+.||+|||++|||||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999996432 3889999999999999999999999999999999
Q ss_pred ceEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHH
Q psy16843 494 NLLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFL 573 (810)
Q Consensus 494 NILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELL 573 (810)
||||+.++++||+|||+|+..... .......+.+||+.|+|||++.+..|+.++|||||||+||||+
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~-------------~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell 236 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSA-------------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGG-------------GCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred ceEECCCCcEEEccchhheeccCC-------------ccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHH
Confidence 999999999999999999742211 1111224567999999999999999999999999999999999
Q ss_pred hC-CCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHh
Q psy16843 574 VG-CVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVK 635 (810)
Q Consensus 574 tG-~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL 635 (810)
+| .+||.+.+..++...+..+.... .+ ..+++++.+||.+||+.||.+||++ .||+
T Consensus 237 ~~~~~p~~~~~~~e~~~~v~~~~~~~-~p--~~~~~~~~~li~~cl~~~P~~RPt~---~ev~ 293 (301)
T d1lufa_ 237 SYGLQPYYGMAHEEVIYYVRDGNILA-CP--ENCPLELYNLMRLCWSKLPADRPSF---CSIH 293 (301)
T ss_dssp TTTCCTTTTSCHHHHHHHHHTTCCCC-CC--TTCCHHHHHHHHHHTCSSGGGSCCH---HHHH
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCCCC-CC--ccchHHHHHHHHHHcCCChhHCcCH---HHHH
Confidence 98 57899999999999888766421 11 2367899999999999999999998 6664
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=419.61 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=212.9
Q ss_pred CCCCCcEEEEEecccCceEEEEEEEcCCCcE--EEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeeeccccc
Q psy16843 361 PNENDFTVIKLISNGAYGSVYLVRHKETRQR--FAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCSFETKK 437 (810)
Q Consensus 361 ~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~--vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~f~~~~ 437 (810)
+..++|++.+.||+|+||.||+|+++.+|.. ||||.+.... .....+.+.+|+++|..+ +|||||++++++.+++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 3457999999999999999999999998875 5666654332 233456789999999998 7999999999999999
Q ss_pred eeeeeeeeccCcchhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCC
Q psy16843 438 HLCLVMEYVEGGDCASLLKNT----------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALG 501 (810)
Q Consensus 438 ~lyLVmEy~~GGsL~~lL~~~----------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g 501 (810)
.+|+||||++||+|.++|++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999643 5799999999999999999999999999999999999999999
Q ss_pred cEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhC-CCCCC
Q psy16843 502 HIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVG-CVPFF 580 (810)
Q Consensus 502 ~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG-~~PF~ 580 (810)
.+||+|||+|+..... ......+||+.|+|||.+.+..|+.++|||||||++|||++| .+||.
T Consensus 165 ~~kl~DfG~a~~~~~~----------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY----------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp CEEECCTTCEESSCEE----------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ceEEcccccccccccc----------------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 9999999999753211 111345699999999999999999999999999999999995 56899
Q ss_pred CCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 581 GETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 581 ~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
+.+..+++..+..+.. .+.+ ..+++++++||.+||+.||++||++ .|+++|
T Consensus 229 ~~~~~~~~~~i~~~~~-~~~~--~~~~~~~~~li~~cl~~dP~~RPs~---~eil~~ 279 (309)
T d1fvra_ 229 GMTCAELYEKLPQGYR-LEKP--LNCDDEVYDLMRQCWREKPYERPSF---AQILVS 279 (309)
T ss_dssp TCCHHHHHHHGGGTCC-CCCC--TTBCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred CCCHHHHHHHHHhcCC-CCCC--ccCCHHHHHHHHHHcCCChhHCcCH---HHHHHH
Confidence 9999999888876532 2211 2378999999999999999999998 899876
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=409.74 Aligned_cols=245 Identities=22% Similarity=0.378 Sum_probs=205.5
Q ss_pred CCCCCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeecc-ccce
Q psy16843 360 TPNENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFE-TKKH 438 (810)
Q Consensus 360 ~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~-~~~~ 438 (810)
....++|++++.||+|+||.||+|+++ |+.||||++.+.. ..+.+.+|+++++.++|||||++++++. +.+.
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 75 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence 455678999999999999999999984 6789999986543 2367889999999999999999999875 4567
Q ss_pred eeeeeeeccCcchhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCcccccc
Q psy16843 439 LCLVMEYVEGGDCASLLKNTG--PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLM 516 (810)
Q Consensus 439 lyLVmEy~~GGsL~~lL~~~g--~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~ 516 (810)
+|+||||+++|+|.++|.+.+ .+++..+..++.||+.||.|||+++|+||||||+|||++.+|++||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999999997543 599999999999999999999999999999999999999999999999999875211
Q ss_pred cccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh-CCCCCCCCCHHHHHHhhccCC
Q psy16843 517 SLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV-GCVPFFGETPEELFAHTVNDD 595 (810)
Q Consensus 517 s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt-G~~PF~~~~~~e~~~~I~~~~ 595 (810)
......||+.|+|||++.+..|+.++|||||||++|||++ |++||.+.+..+++..+.++.
T Consensus 156 ------------------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~ 217 (262)
T d1byga_ 156 ------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 217 (262)
T ss_dssp ------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC
T ss_pred ------------------CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 1123468999999999999999999999999999999998 899999998888888887643
Q ss_pred -CCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 596 -IEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 596 -~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
..+|. ..++++++||.+||..||.+||++ .|+++
T Consensus 218 ~~~~~~----~~~~~~~~li~~cl~~dP~~Rps~---~~l~~ 252 (262)
T d1byga_ 218 KMDAPD----GCPPAVYEVMKNCWHLDAAMRPSF---LQLRE 252 (262)
T ss_dssp CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CCCCCc----cCCHHHHHHHHHHcccCHhHCcCH---HHHHH
Confidence 22332 367999999999999999999998 67665
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=412.80 Aligned_cols=257 Identities=21% Similarity=0.326 Sum_probs=211.7
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcCCC-------cEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEee
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKETR-------QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMY 430 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~tg-------~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~ 430 (810)
+....++|++++.||+|+||.||+|++..++ ..||||++.+... ......+.+|..++..+ +|||||+++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 3455589999999999999999999987654 4799998866543 33456778888888777 899999999
Q ss_pred eeccccceeeeeeeeccCcchhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCc
Q psy16843 431 CSFETKKHLCLVMEYVEGGDCASLLKNT----------------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDN 494 (810)
Q Consensus 431 ~~f~~~~~lyLVmEy~~GGsL~~lL~~~----------------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeN 494 (810)
++|.+++.+|+|||||.+|+|.++|... ..+++..+..++.||+.||+|||++|||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 9999999999999999999999999644 358999999999999999999999999999999999
Q ss_pred eEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh
Q psy16843 495 LLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV 574 (810)
Q Consensus 495 ILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt 574 (810)
||++.+|.+||+|||+++..... .........+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~-------------~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~ 232 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHI-------------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGC-------------CTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eeecCCCCeEeccchhhcccccc-------------ccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhcc
Confidence 99999999999999999753221 11112345679999999999999999999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 575 -GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 575 -G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
|.+||.+.+..+++..+..+. ..+.+ ..+++++++||.+||++||.+||++ .|+++
T Consensus 233 ~g~~p~~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~dP~~Rps~---~eil~ 289 (299)
T d1fgka_ 233 LGGSPYPGVPVEELFKLLKEGH-RMDKP--SNCTNELYMMMRDCWHAVPSQRPTF---KQLVE 289 (299)
T ss_dssp TSCCSSTTCCHHHHHHHHHTTC-CCCCC--SSCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccchHHHHHHHHHHccCCHhHCcCH---HHHHH
Confidence 799999999988887776643 22222 2377999999999999999999998 77764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=413.33 Aligned_cols=257 Identities=19% Similarity=0.240 Sum_probs=218.7
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeec
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHKE-----TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSF 433 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k~-----tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f 433 (810)
++...++|++.+.||+|+||.||+|.++. +++.||||++.+... ......+.+|+++++.++|||||++++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC--hHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 34556899999999999999999999863 357899998875432 34456789999999999999999999999
Q ss_pred cccceeeeeeeeccCcchhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcE
Q psy16843 434 ETKKHLCLVMEYVEGGDCASLLKNT----------GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHI 503 (810)
Q Consensus 434 ~~~~~lyLVmEy~~GGsL~~lL~~~----------g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~V 503 (810)
..++.+++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||||+.++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 9999999999999999999988532 347889999999999999999999999999999999999999999
Q ss_pred EEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhC-CCCCCCC
Q psy16843 504 KLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVG-CVPFFGE 582 (810)
Q Consensus 504 KL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG-~~PF~~~ 582 (810)
||+|||+|+...... ........+||+.|+|||.+.+..|+.++|||||||+||||++| .+||.+.
T Consensus 173 Kl~DFGla~~~~~~~-------------~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETD-------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp EECCTTCCCGGGGGG-------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred EEeecccceeccCCc-------------ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 999999997532211 11122345799999999999999999999999999999999997 6899999
Q ss_pred CHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 583 TPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 583 ~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
+..+++..+..+.... .+ ..+++++.+||.+||+.||.+||++ .|+++
T Consensus 240 ~~~~~~~~i~~~~~~~-~p--~~~~~~l~~li~~cl~~~P~~RPs~---~~il~ 287 (308)
T d1p4oa_ 240 SNEQVLRFVMEGGLLD-KP--DNCPDMLFELMRMCWQYNPKMRPSF---LEIIS 287 (308)
T ss_dssp CHHHHHHHHHTTCCCC-CC--TTCCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CHHHHHHHHHhCCCCC-Cc--ccchHHHHHHHHHHcCCChhHCcCH---HHHHH
Confidence 9999999888755322 11 1267899999999999999999998 77776
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=412.44 Aligned_cols=258 Identities=20% Similarity=0.302 Sum_probs=217.2
Q ss_pred CCCCCCCcEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcC-CCCeEEEeeee
Q psy16843 359 KTPNENDFTVIKLISNGAYGSVYLVRHK-----ETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFT-DNPFVVTMYCS 432 (810)
Q Consensus 359 ~~~~~~dy~ilk~LG~G~FG~Vyla~~k-----~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l-~HPnIVkl~~~ 432 (810)
+....++|++.+.||+|+||.||+|+++ .+++.||||++.+... ......+.+|+.+++.+ +|||||+++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3345589999999999999999999874 4567899999876543 33456788999999988 79999999999
Q ss_pred ccccceeeeeeeeccCcchhhhhhcCC------------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCc
Q psy16843 433 FETKKHLCLVMEYVEGGDCASLLKNTG------------------PLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDN 494 (810)
Q Consensus 433 f~~~~~lyLVmEy~~GGsL~~lL~~~g------------------~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeN 494 (810)
+.+.+.+|||||||+||+|.++|.... .+++..+..|+.||+.||+|||++|||||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 999999999999999999999986533 58999999999999999999999999999999999
Q ss_pred eEeccCCcEEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHh
Q psy16843 495 LLITALGHIKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLV 574 (810)
Q Consensus 495 ILLd~~g~VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLt 574 (810)
||++.++.+||+|||+++..... .........+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~-------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt 242 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKND-------------SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSC-------------TTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccccccCcccccccchheeccCC-------------CcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHh
Confidence 99999999999999999753211 11122345689999999999999999999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHhhccCCCCCCCCCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 575 -GCVPFFGETPEELFAHTVNDDIEWPSEDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 575 -G~~PF~~~~~~e~~~~I~~~~~~~p~~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
|.+||.+.+..+.+.+++......+.+. ..++++.+||.+||+.||.+||++ .||++
T Consensus 243 ~g~p~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~l~~Li~~cl~~dP~~RPs~---~~il~ 300 (311)
T d1t46a_ 243 LGSSPYPGMPVDSKFYKMIKEGFRMLSPE--HAPAEMYDIMKTCWDADPLKRPTF---KQIVQ 300 (311)
T ss_dssp TTCCSSTTCCSSHHHHHHHHHTCCCCCCT--TSCHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCCCCCcc--cccHHHHHHHHHHcCCChhHCcCH---HHHHH
Confidence 7777877777666666666555443332 267999999999999999999998 67664
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-47 Score=406.19 Aligned_cols=264 Identities=19% Similarity=0.209 Sum_probs=203.2
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCe-EEEeeeeccccceeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF-VVTMYCSFETKKHLCLV 442 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPn-IVkl~~~f~~~~~lyLV 442 (810)
++|++++.||+|+||.||+|+++.+|+.||||++...... +.+..|+++++.++|++ |+.+++++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 5799999999999999999999999999999987764322 34678999999998766 55556667788899999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc---CCcEEEeccCCccccccccc
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA---LGHIKLTDFGLSKMGLMSLA 519 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~---~g~VKL~DFGLAk~~~~s~~ 519 (810)
|||+.++.+..+....+.+++..+..++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.......
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999955444444455678999999999999999999999999999999999999864 45799999999986432211
Q ss_pred ccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCCCHHHHHHhhc---cCCC
Q psy16843 520 TNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGETPEELFAHTV---NDDI 596 (810)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~~~~e~~~~I~---~~~~ 596 (810)
.. ..........+||+.|||||++.+..|+.++|||||||++|||++|..||.+.........+. ....
T Consensus 162 ~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 162 HQ--------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp CC--------BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred cc--------ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 10 011122356789999999999999999999999999999999999999998765544332221 1111
Q ss_pred CCCCC-CCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcCCCc
Q psy16843 597 EWPSE-DDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEHPYF 640 (810)
Q Consensus 597 ~~p~~-~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~HPfF 640 (810)
..+.. ....+++++.+||.+||+.||.+||++..+.++|+|+|.
T Consensus 234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 11110 011267899999999999999999998666677888765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=393.94 Aligned_cols=252 Identities=17% Similarity=0.219 Sum_probs=202.1
Q ss_pred EEEEEecccCceEEEEEEEcCCC---cEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccc-cceeeee
Q psy16843 367 TVIKLISNGAYGSVYLVRHKETR---QRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFET-KKHLCLV 442 (810)
Q Consensus 367 ~ilk~LG~G~FG~Vyla~~k~tg---~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~-~~~lyLV 442 (810)
.+.++||+|+||+||+|++..++ ..||||++.+.. .....+.+.+|+++|+.++|||||++++++.. ++.+++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34678999999999999987643 368999886532 34556789999999999999999999998764 5689999
Q ss_pred eeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCCccccccccccc
Q psy16843 443 MEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGLSKMGLMSLATN 521 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~~~~s~~~~ 521 (810)
||||++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~-- 185 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF-- 185 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC--
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc--
Confidence 9999999999998754 4678888999999999999999999999999999999999999999999999976332111
Q ss_pred chhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCC-CCHHHHHHhhccCCCCCCC
Q psy16843 522 LYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFG-ETPEELFAHTVNDDIEWPS 600 (810)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~-~~~~e~~~~I~~~~~~~p~ 600 (810)
..........||+.|+|||++....|+.++||||||++||||++|..||.. .+..++...+..+... +.
T Consensus 186 ---------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~-~~ 255 (311)
T d1r0pa_ 186 ---------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-LQ 255 (311)
T ss_dssp ---------CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC-CC
T ss_pred ---------ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CC
Confidence 111122345799999999999999999999999999999999996666654 4455555665554322 22
Q ss_pred CCCCcccHHHHHHHHhhhcCCCCCCCCCCChhHHhcC
Q psy16843 601 EDDWPIQVEAKSIITDLLQQNPRDRLGTGGPHEVKEH 637 (810)
Q Consensus 601 ~~~~~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~H 637 (810)
+. .+++++.+||.+||+.||++||++ .|+++|
T Consensus 256 p~--~~~~~l~~li~~cl~~dP~~RPs~---~ei~~~ 287 (311)
T d1r0pa_ 256 PE--YCPDPLYEVMLKCWHPKAEMRPSF---SELVSR 287 (311)
T ss_dssp CT--TCCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred cc--cCcHHHHHHHHHHcCCCHhHCcCH---HHHHHH
Confidence 22 267899999999999999999998 888876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-45 Score=390.75 Aligned_cols=252 Identities=19% Similarity=0.221 Sum_probs=203.2
Q ss_pred CCCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC-CeEEEeeeeccccceeee
Q psy16843 363 ENDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN-PFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 363 ~~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H-PnIVkl~~~f~~~~~lyL 441 (810)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+|+++++.+.| +||+.+++++.++...|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 36899999999999999999999999999999987654321 345678888888866 899999999999999999
Q ss_pred eeeeccCcchhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEecc-----CCcEEEeccCCccccc
Q psy16843 442 VMEYVEGGDCASLLKNT-GPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITA-----LGHIKLTDFGLSKMGL 515 (810)
Q Consensus 442 VmEy~~GGsL~~lL~~~-g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~-----~g~VKL~DFGLAk~~~ 515 (810)
||||+ ||+|.+++... +.+++..+..++.|++.||+|||++|||||||||+||||+. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 78999988754 47999999999999999999999999999999999999974 5789999999998643
Q ss_pred ccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCCCC---CHHHHHHhhc
Q psy16843 516 MSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFFGE---TPEELFAHTV 592 (810)
Q Consensus 516 ~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~~~---~~~e~~~~I~ 592 (810)
...... ..........+||+.|||||++.+..|+.++|||||||++|||++|..||.+. +..+.+.++.
T Consensus 158 ~~~~~~--------~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 158 DPVTKQ--------HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp CTTTCC--------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred cCcccc--------ceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence 221110 01112234678999999999999999999999999999999999999999764 3334444443
Q ss_pred cCCCCCCC-CCCCcccHHHHHHHHhhhcCCCCCCCCC
Q psy16843 593 NDDIEWPS-EDDWPIQVEAKSIITDLLQQNPRDRLGT 628 (810)
Q Consensus 593 ~~~~~~p~-~~~~~~S~el~dLI~klL~~dP~~Rpta 628 (810)
......+. .....+++++.+|+..|+..+|++||++
T Consensus 230 ~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y 266 (293)
T d1csna_ 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDY 266 (293)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred hccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCH
Confidence 32211110 0011256899999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=386.98 Aligned_cols=252 Identities=20% Similarity=0.231 Sum_probs=192.7
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCeEEEeeeeccccc----ee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPFVVTMYCSFETKK----HL 439 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPnIVkl~~~f~~~~----~l 439 (810)
.+|.+.+.||+|+||.||+|++ +|+.||||++..... .......|+..+..++|||||++++++.+++ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4689999999999999999986 588999998864421 1122234555567789999999999987654 68
Q ss_pred eeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh--------cccccccCCCCceEeccCCcEEEeccCCc
Q psy16843 440 CLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS--------YGIVHRDLKPDNLLITALGHIKLTDFGLS 511 (810)
Q Consensus 440 yLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs--------~gIIHRDLKPeNILLd~~g~VKL~DFGLA 511 (810)
|+|||||++|+|.++|++. .+++.....++.|++.||.|||+ +|||||||||+||||+.+|.+||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999999874 69999999999999999999996 59999999999999999999999999999
Q ss_pred ccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcC------CCCCcchhhhHHHHHHHHhCCCCCCCC---
Q psy16843 512 KMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQG------YGKPVDWWSMGVILYEFLVGCVPFFGE--- 582 (810)
Q Consensus 512 k~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~------ys~ksDIWSLGvILyELLtG~~PF~~~--- 582 (810)
+....... .........+||+.|||||++.+.. |+.++|||||||+||||++|.+||...
T Consensus 156 ~~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~ 224 (303)
T d1vjya_ 156 VRHDSATD-----------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp EEEETTTT-----------EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred ccccCCCc-----------ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccc
Confidence 86432111 1112234568999999999997643 577899999999999999998877321
Q ss_pred ------------CHHHHHHhhccCCCCCCCCCCC---cccHHHHHHHHhhhcCCCCCCCCCCChhHHhc
Q psy16843 583 ------------TPEELFAHTVNDDIEWPSEDDW---PIQVEAKSIITDLLQQNPRDRLGTGGPHEVKE 636 (810)
Q Consensus 583 ------------~~~e~~~~I~~~~~~~p~~~~~---~~S~el~dLI~klL~~dP~~Rpta~~~~EiL~ 636 (810)
........+.......+....+ ....++.+|+.+||+.||.+||++ .|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~---~ei~~ 290 (303)
T d1vjya_ 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA---LRIKK 290 (303)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCH---HHHHH
T ss_pred ccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCH---HHHHH
Confidence 2233333333333321111111 123458999999999999999998 77765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.2e-44 Score=387.47 Aligned_cols=257 Identities=21% Similarity=0.361 Sum_probs=196.8
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-----------CCeEEEeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-----------NPFVVTMYCS 432 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-----------HPnIVkl~~~ 432 (810)
++|+++++||+|+||+||+|+++.+|+.||||++.+... ..+.+.+|+++++.++ |+|||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 569999999999999999999999999999999876542 2345667888877664 5789999988
Q ss_pred cccc--ceeeeeeeeccCcchhhhh---hcCCCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCCCceEeccCCc----
Q psy16843 433 FETK--KHLCLVMEYVEGGDCASLL---KNTGPLPADMARFYFAETVLAVEYLHS-YGIVHRDLKPDNLLITALGH---- 502 (810)
Q Consensus 433 f~~~--~~lyLVmEy~~GGsL~~lL---~~~g~lse~~~~~i~~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~g~---- 502 (810)
+... ...+++|+++.++...... .....+++..++.++.||+.||.|||+ .||+||||||+||||+.+|.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 7654 4667777776555433322 344689999999999999999999998 89999999999999987664
Q ss_pred --EEEeccCCcccccccccccchhhhhhcccccccCCcccCCCCcCChhHHhhcCCCCCcchhhhHHHHHHHHhCCCCCC
Q psy16843 503 --IKLTDFGLSKMGLMSLATNLYECYVERDAKQFSDKQVYGTPEYIAPEVILRQGYGKPVDWWSMGVILYEFLVGCVPFF 580 (810)
Q Consensus 503 --VKL~DFGLAk~~~~s~~~~~~~~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~ys~ksDIWSLGvILyELLtG~~PF~ 580 (810)
+||+|||.|.... ......+||+.|+|||++.+..|+.++||||+||++++|++|+.||.
T Consensus 169 ~~~kl~dfg~s~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD------------------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp EEEEECCCTTCEETT------------------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred ceeeEeecccccccc------------------cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence 9999999986421 11235679999999999999999999999999999999999999997
Q ss_pred CCCHH------HHHHhhcc--CC----------------------CCCCC--------------CCCCcccHHHHHHHHh
Q psy16843 581 GETPE------ELFAHTVN--DD----------------------IEWPS--------------EDDWPIQVEAKSIITD 616 (810)
Q Consensus 581 ~~~~~------e~~~~I~~--~~----------------------~~~p~--------------~~~~~~S~el~dLI~k 616 (810)
+.... +.+..+.. +. ..... ......+++++|||.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 310 (362)
T d1q8ya_ 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310 (362)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence 54321 11111100 00 00000 0011256789999999
Q ss_pred hhcCCCCCCCCCCChhHHhcCCCcCCCCh
Q psy16843 617 LLQQNPRDRLGTGGPHEVKEHPYFSNLDW 645 (810)
Q Consensus 617 lL~~dP~~Rpta~~~~EiL~HPfF~~id~ 645 (810)
||.+||.+|||+ +|+|+||||++..+
T Consensus 311 mL~~dP~~Rpta---~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 311 MLQLDPRKRADA---GGLVNHPWLKDTLG 336 (362)
T ss_dssp GGCSSTTTCBCH---HHHHTCGGGTTCTT
T ss_pred HCCCChhHCcCH---HHHhcCcccCCCCC
Confidence 999999999999 99999999997643
|
| >d1v9va1 a.29.10.1 (A:8-108) Microtubule-associated serine/threonine-protein kinase 3, MAST3 (KIAA0561) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Bromodomain-like superfamily: MAST3 pre-PK domain-like family: MAST3 pre-PK domain-like domain: Microtubule-associated serine/threonine-protein kinase 3, MAST3 (KIAA0561) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-40 Score=285.00 Aligned_cols=100 Identities=51% Similarity=0.792 Sum_probs=98.2
Q ss_pred hhHHHHHHHHHHHHHhhcCccccCCcCCcCCCcchhhhhhHHHHHHHHHHHHhhccccceehHHHHHHHHHHHHHHHHHh
Q psy16843 173 PKAIQQMETRLSNFINENSSLATNNLETASPDAAPIIRFVHHQILEIARDCLFKSKEKLISSRYFYEMSEKLERLLTETK 252 (810)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 252 (810)
||||+||||||.+||++|++ +++.+++||+++|+||||||+|||||+||++++||++|||||+||||+|++|++
T Consensus 1 PKAt~QMEerL~~fi~~~~~------~~~~~~aDgvl~FvhHQiiElARDCL~KS~e~lITs~YF~Else~LekLl~ea~ 74 (101)
T d1v9va1 1 PKATAQMEGRLQEFLTAYAP------GARLALADGVLGFIHHQIVELARDCLAKSGENLVTSRYFLEMQEKLERLLQDAH 74 (101)
T ss_dssp CCTTHHHHHHHHHHHHHSCB------TTTBCCSCHHHHHHHHHHHHHHHHHHHHHHHTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CchHHHHHHHHHHHHHHcCC------ccccchhHHHHHHHHHHHHHHHHHHHHhhhhcChhHHHHHHHHHHHHHHHHHHH
Confidence 89999999999999999999 999999999999999999999999999999999999999999999999999999
Q ss_pred hhhh-HHHhHHHHHhhheeeeeeCCCc
Q psy16843 253 EKSL-EAATVLTFTLKKLLLIISRPAR 278 (810)
Q Consensus 253 ~~~~-~~~~~~~~~~~~~~~ii~rp~k 278 (810)
+||. +++.++..+||||+|||+||||
T Consensus 75 erSe~~~~~~i~~lvkkLL~IIsRPAR 101 (101)
T d1v9va1 75 ERSDSEEVSFIVQLVRKLLIIISRPAR 101 (101)
T ss_dssp HTSCHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred hccCHHHHHHHHHHHHHHHhhcccCCC
Confidence 9995 6999999999999999999997
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2e-24 Score=214.31 Aligned_cols=135 Identities=17% Similarity=0.115 Sum_probs=107.2
Q ss_pred cEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchh---------------hHHHHHHHHHHHHHHhcCCCCeEEEee
Q psy16843 366 FTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM---------------LRNQMEQVFAERDIMSFTDNPFVVTMY 430 (810)
Q Consensus 366 y~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~---------------~~~~~~~i~~E~~iL~~l~HPnIVkl~ 430 (810)
+.+.+.||+|+||.||+|++. +|+.||||++...... ..........|..++..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568899999999999999885 6889999976421110 011123455688899999999998887
Q ss_pred eeccccceeeeeeeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcccccccCCCCceEeccCCcEEEeccCC
Q psy16843 431 CSFETKKHLCLVMEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHSYGIVHRDLKPDNLLITALGHIKLTDFGL 510 (810)
Q Consensus 431 ~~f~~~~~lyLVmEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs~gIIHRDLKPeNILLd~~g~VKL~DFGL 510 (810)
++.. .++||||++++.+.. +++..+..++.||+.||.|||++||+||||||+|||++.+ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 6532 379999998876543 4566778899999999999999999999999999999864 589999999
Q ss_pred ccc
Q psy16843 511 SKM 513 (810)
Q Consensus 511 Ak~ 513 (810)
|..
T Consensus 149 a~~ 151 (191)
T d1zara2 149 SVE 151 (191)
T ss_dssp CEE
T ss_pred ccc
Confidence 865
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.19 E-value=3.8e-06 Score=84.12 Aligned_cols=140 Identities=16% Similarity=0.137 Sum_probs=88.9
Q ss_pred CCcEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccceeeee
Q psy16843 364 NDFTVIKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKKHLCLV 442 (810)
Q Consensus 364 ~dy~ilk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~~lyLV 442 (810)
+.|+..+..+.|+.+.||++. .+++.+++|......... ...+.+|..++..+. +--+.+++++..+++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 467777766656667999875 356678888765433211 234556777766553 32245566667777889999
Q ss_pred eeeccCcchhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh----------------------------------------
Q psy16843 443 MEYVEGGDCASLLKNTGPLPADMARFYFAETVLAVEYLHS---------------------------------------- 482 (810)
Q Consensus 443 mEy~~GGsL~~lL~~~g~lse~~~~~i~~QIl~AL~yLHs---------------------------------------- 482 (810)
|++++|..+....... .....++.++...|..||+
T Consensus 89 ~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9999998875543211 1111222333333333331
Q ss_pred -------------------cccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 483 -------------------YGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 483 -------------------~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1378999999999999866677999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.78 E-value=1.7e-05 Score=85.37 Aligned_cols=80 Identities=14% Similarity=0.184 Sum_probs=46.9
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeeccchh----hHHHHHHHHHHHHHHhcCC---CCeEEEeeeeccccceeee
Q psy16843 369 IKLISNGAYGSVYLVRHKETRQRFAMKKIIKNSLM----LRNQMEQVFAERDIMSFTD---NPFVVTMYCSFETKKHLCL 441 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~tg~~vAIK~I~k~~~~----~~~~~~~i~~E~~iL~~l~---HPnIVkl~~~f~~~~~lyL 441 (810)
.+.||.|....||++....+++.|++|.-...... ......+...|.+.|+.+. ...+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56799999999999988777888999854321100 0011234455776665442 2345555544 3445678
Q ss_pred eeeeccCcc
Q psy16843 442 VMEYVEGGD 450 (810)
Q Consensus 442 VmEy~~GGs 450 (810)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.69 E-value=4.8e-05 Score=75.37 Aligned_cols=136 Identities=15% Similarity=0.120 Sum_probs=78.0
Q ss_pred EecccC-ceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCC--CeEEEeeeeccccceeeeeeeecc
Q psy16843 371 LISNGA-YGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDN--PFVVTMYCSFETKKHLCLVMEYVE 447 (810)
Q Consensus 371 ~LG~G~-FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~H--PnIVkl~~~f~~~~~lyLVmEy~~ 447 (810)
.+..|. -+.||++... ++..+++|.-..... ..+..|...++.+.. -.+.+++.+..+++..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 344454 3688988753 466688886543321 234556666655432 225566677777788999999999
Q ss_pred Ccchhhhh--------------hc-------CCCCCHHHHHHHH--H--------------------HHHHHHHHhhh--
Q psy16843 448 GGDCASLL--------------KN-------TGPLPADMARFYF--A--------------------ETVLAVEYLHS-- 482 (810)
Q Consensus 448 GGsL~~lL--------------~~-------~g~lse~~~~~i~--~--------------------QIl~AL~yLHs-- 482 (810)
|.++.... .+ ...+.......+. . .....+..+..
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 87764321 00 0000000000000 0 01111222221
Q ss_pred -----cccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 483 -----YGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 483 -----~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2389999999999999876678999998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.38 E-value=0.0052 Score=65.12 Aligned_cols=75 Identities=17% Similarity=0.287 Sum_probs=47.9
Q ss_pred EEEecccCceEEEEEEEcC-------CCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCC-CCeEEEeeeeccccceee
Q psy16843 369 IKLISNGAYGSVYLVRHKE-------TRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTD-NPFVVTMYCSFETKKHLC 440 (810)
Q Consensus 369 lk~LG~G~FG~Vyla~~k~-------tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~-HPnIVkl~~~f~~~~~ly 440 (810)
++.|+.|---.+|++.... .++.|.+++.-.... . ....+|..+++.+. +....++++++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~----~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----E-SHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----H-HHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch----h-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4678888889999998754 345677776542211 1 22346777777653 3333466777653 6
Q ss_pred eeeeeccCcchh
Q psy16843 441 LVMEYVEGGDCA 452 (810)
Q Consensus 441 LVmEy~~GGsL~ 452 (810)
+||||++|..|.
T Consensus 118 ~I~efi~g~~l~ 129 (395)
T d1nw1a_ 118 RLEEYIPSRPLS 129 (395)
T ss_dssp EEECCCCEEECC
T ss_pred eEEEEeccccCC
Confidence 899999886543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.31 E-value=0.0048 Score=63.72 Aligned_cols=70 Identities=20% Similarity=0.209 Sum_probs=40.4
Q ss_pred ceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHHHHHHHhcCCCCe--EEEee-----eeccccceeeeeeeeccCc
Q psy16843 377 YGSVYLVRHKETRQRFAMKKIIKNSLMLRNQMEQVFAERDIMSFTDNPF--VVTMY-----CSFETKKHLCLVMEYVEGG 449 (810)
Q Consensus 377 FG~Vyla~~k~tg~~vAIK~I~k~~~~~~~~~~~i~~E~~iL~~l~HPn--IVkl~-----~~f~~~~~lyLVmEy~~GG 449 (810)
--.||++.. .+|..|++|+..... . ..+++..|...|..|.... ++... ..+...+..+.|++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~-~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER-W---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT-S---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC-C---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 468999976 467889999754321 1 1245666777766553211 11111 1223345778899999875
Q ss_pred ch
Q psy16843 450 DC 451 (810)
Q Consensus 450 sL 451 (810)
.+
T Consensus 110 ~~ 111 (325)
T d1zyla1 110 QF 111 (325)
T ss_dssp EC
T ss_pred CC
Confidence 43
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.32 E-value=0.065 Score=54.02 Aligned_cols=31 Identities=29% Similarity=0.359 Sum_probs=27.7
Q ss_pred cccccccCCCCceEeccCCcEEEeccCCccc
Q psy16843 483 YGIVHRDLKPDNLLITALGHIKLTDFGLSKM 513 (810)
Q Consensus 483 ~gIIHRDLKPeNILLd~~g~VKL~DFGLAk~ 513 (810)
.|+||+|+.++||+++.++..-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 5899999999999999887778999998753
|